Column1; baid;acvalue;aid;sid;cid;geneid;pmid;aidtype;aidmdate;hasdrc;rnai;activity;protacxn;acname;acqualifier;aidsrcname;aidname;cmpdname;targetname;targeturl;ecs;repacxn;taxid;cellids;targettaxid;anatomyid;anatomy;Smiles
0;59130236;;1793;56405461;25067404;10280;;Other;20090528;0;0;Unspecified;;;;Vanderbilt High Throughput Screening Facility;Identification of Novel Modulators of Cl- dependent Transport Process via HTS: Antagonist Ancillary Profile;N-methyl-N-(4-methyl-2-thiazolyl)-2-[(6-phenyl-3-pyridazinyl)thio]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CC1=CSC(=N1)N(C)C(=O)CSC2=NN=C(C=C2)C3=CC=CC=C3
1;59130432;;1793;56405461;25067404;10280;;Other;20090528;0;0;Unspecified;NP_005857;;;Vanderbilt High Throughput Screening Facility;Identification of Novel Modulators of Cl- dependent Transport Process via HTS: Antagonist Ancillary Profile;N-methyl-N-(4-methyl-2-thiazolyl)-2-[(6-phenyl-3-pyridazinyl)thio]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CSC(=N1)N(C)C(=O)CSC2=NN=C(C=C2)C3=CC=CC=C3
2;60313692;;1788;56353039;25010775;10280;;Other;20090911;0;0;Inactive;NP_005857;;;Vanderbilt High Throughput Screening Facility;Discovery of novel allosteric modulators of the M1 muscarinic receptor: Agonist Ancillary Activity;VU 0357017 Hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC(=O)N1CCC(CC1)NCCNC(=O)C2=CC=CC=C2C.Cl
3;65810128;;1921;85163689;1541501;10280;;Other;20091010;0;0;Unspecified;NP_005857;;;Vanderbilt High Throughput Screening Facility;Discovery of a Highly Selective in vitro and in vivo M4 Positive Allosteric Modulator: Ancillary Activity;3-amino-N-(1,3-benzodioxol-5-ylmethyl)-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=NC2=C1C(=C(S2)C(=O)NCC3=CC4=C(C=C3)OCO4)N)C
4;65810287;;1921;85163688;864492;10280;;Other;20091010;0;0;Unspecified;NP_005857;;;Vanderbilt High Throughput Screening Facility;Discovery of a Highly Selective in vitro and in vivo M4 Positive Allosteric Modulator: Ancillary Activity;3-amino-N-[(4-methoxyphenyl)methyl]-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=NC2=C1C(=C(S2)C(=O)NCC3=CC=C(C=C3)OC)N)C
5;65947977;;1924;84975340;44123657;10280;;Other;20100223;0;0;Active;NP_005857;;;Vanderbilt High Throughput Screening Facility;High throughput discovery of novel modulators of ROMK K+ channel activity: Ancillary Activity;2,2'-(Oxydimethanediyl)Bis(5-Nitro-1H-Benzimidazole);SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC2=C(C=C1[N+](=O)[O-])NC(=N2)COCC3=NC4=C(N3)C=C(C=C4)[N+](=O)[O-]
6;65948056;;1924;84975340;44123657;10280;;Other;20100223;0;0;Active;;;;Vanderbilt High Throughput Screening Facility;High throughput discovery of novel modulators of ROMK K+ channel activity: Ancillary Activity;2,2'-(Oxydimethanediyl)Bis(5-Nitro-1H-Benzimidazole);SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1=CC2=C(C=C1[N+](=O)[O-])NC(=N2)COCC3=NC4=C(N3)C=C(C=C4)[N+](=O)[O-]
7;99810460;;204002;103309325;14632723;10280;25364350;Literature-derived;20181012;0;0;Unspecified;Q99720;;;ChEMBL;In vitro inhibition for opioid binding site in guinea pig brain membrane using [3H]DADLE as radioligand;N-Methyl-N-[(1R,2R)-2alpha-(1-pyrrolidinyl)cyclohexan-1beta-yl]-2-isothiocyanatobenzeneacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN([C@@H]1CCCC[C@H]1N2CCCC2)C(=O)CC3=CC=CC=C3N=C=S
8;99810461;;204002;103309323;3082908;10280;25364350;Literature-derived;20181012;0;0;Unspecified;Q99720;;;ChEMBL;In vitro inhibition for opioid binding site in guinea pig brain membrane using [3H]DADLE as radioligand;2-Isothiocyanato-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)benzeneacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN([C@H]1CCCC[C@@H]1N2CCCC2)C(=O)CC3=CC=CC=C3N=C=S
9;99812192;;203856;103309325;14632723;10280;25364350;Literature-derived;20181012;0;0;Unspecified;Q99720;;;ChEMBL;Percent inhibition of binding of selective kappa agonist to that of control in guinea pig brain membrane using [3H]DADLE as radioligand;N-Methyl-N-[(1R,2R)-2alpha-(1-pyrrolidinyl)cyclohexan-1beta-yl]-2-isothiocyanatobenzeneacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN([C@@H]1CCCC[C@H]1N2CCCC2)C(=O)CC3=CC=CC=C3N=C=S
10;99812193;;203856;103309323;3082908;10280;25364350;Literature-derived;20181012;0;0;Unspecified;Q99720;;;ChEMBL;Percent inhibition of binding of selective kappa agonist to that of control in guinea pig brain membrane using [3H]DADLE as radioligand;2-Isothiocyanato-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)benzeneacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN([C@H]1CCCC[C@@H]1N2CCCC2)C(=O)CC3=CC=CC=C3N=C=S
11;99906551;;204594;103186197;7333;10280;80219130;Literature-derived;20181014;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity against sigma receptor was expressed as Bmax;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
12;99950568;;204622;103225534;9864749;10280;91718750;Literature-derived;20181015;0;0;Unspecified;Q99720;;;ChEMBL;50% inhibitory dose against sigma receptor;4-[1-((E)-3-Iodo-allyl)-piperidin-4-ylmethoxy]-benzonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1COC2=CC=C(C=C2)C#N)C/C=C/I
13;99981691;;204282;103341233;10668661;10280;99867030;Literature-derived;20181016;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma opioid receptor type 1 of pig brain membranes at 10e-7 M;2-[3-[4-(3-Chlorophenyl)-2-methyl-3-oxopiperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C(=O)N(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
14;99981692;;204282;103341267;10807497;10280;99867030;Literature-derived;20181016;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma opioid receptor type 1 of pig brain membranes at 10e-7 M;2-[3-[2-(3-Chloroanilino)ethylamino]propyl]-1,2,4-triazolo[4,3-a]pyridine-3(2H)-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC2=NN(C(=O)N2C=C1)CCCNCCNC3=CC(=CC=C3)Cl
15;99981693;;204282;103341602;10524995;10280;99867030;Literature-derived;20181016;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma opioid receptor type 1 of pig brain membranes at 10e-7 M;2-{3-[4-(3-Chloro-phenyl)-2-ethyl-piperazin-1-yl]-propyl}-2H-[1,2,4]triazolo[4,3-a]pyridin-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
16;99981694;;204282;103341187;10786357;10280;99867030;Literature-derived;20181016;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma opioid receptor type 1 of pig brain membranes at 10e-7 M;2-[3-[4-(3-Chlorophenyl)-3-methylpiperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CN(CCN1C2=CC(=CC=C2)Cl)CCCN3C(=O)N4C=CC=CC4=N3
17;99981695;;204282;103341687;9908172;10280;99867030;Literature-derived;20181016;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma opioid receptor type 1 of pig brain membranes at 10e-7 M;2-{3-[4-(3-Chloro-phenyl)-piperazin-1-yl]-butyl}-2H-[1,2,4]triazolo[4,3-a]pyridin-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(CCN1C(=O)N2C=CC=CC2=N1)N3CCN(CC3)C4=CC(=CC=C4)Cl
18;99981696;;204282;103341239;10760958;10280;99867030;Literature-derived;20181016;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma opioid receptor type 1 of pig brain membranes at 10e-7 M;2-[3-[2-(3-Chloro-N-methylanilino)ethylamino]propyl]-1,2,4-triazolo[4,3-a]pyridine-3(2H)-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCNCCCN1C(=O)N2C=CC=CC2=N1)C3=CC(=CC=C3)Cl
19;99981697;;204282;103341097;10667838;10280;99867030;Literature-derived;20181016;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma opioid receptor type 1 of pig brain membranes at 10e-7 M;2-[2-[4-(3-Chlorophenyl)piperazinomethyl]propyl]-1,2,4-triazolo[4,3-a]pyridine-3(2H)-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(CN1CCN(CC1)C2=CC(=CC=C2)Cl)CN3C(=O)N4C=CC=CC4=N3
20;99981698;;204282;103188158;5533;10280;99867030;Literature-derived;20181016;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma opioid receptor type 1 of pig brain membranes at 10e-7 M;Trazodone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
21;99981699;;204282;103341293;10525813;10280;99867030;Literature-derived;20181016;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma opioid receptor type 1 of pig brain membranes at 10e-7 M;2-[3-[4-(3-Chlorophenyl)-2,2,5-trimethylpiperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CN(C(CN1C2=CC(=CC=C2)Cl)(C)C)CCCN3C(=O)N4C=CC=CC4=N3
22;99981700;;204282;103341234;10667836;10280;99867030;Literature-derived;20181016;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma opioid receptor type 1 of pig brain membranes at 10e-7 M;2-[3-[4-(3-Chlorophenyl)-3-oxopiperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(C(=O)CN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
23;99981701;;204282;103341264;10713512;10280;99867030;Literature-derived;20181016;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma opioid receptor type 1 of pig brain membranes at 10e-7 M;2-[3-[Methyl[2-(3-chloroanilino)ethyl]amino]propyl]-1,2,4-triazolo[4,3-a]pyridine-3(2H)-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCN1C(=O)N2C=CC=CC2=N1)CCNC3=CC(=CC=C3)Cl
24;99981702;;204282;103341256;10787137;10280;99867030;Literature-derived;20181016;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma opioid receptor type 1 of pig brain membranes at 10e-7 M;2-[2-[4-(3-Chlorophenyl)-3-methylpiperazinomethyl]propyl]-1,2,4-triazolo[4,3-a]pyridine-3(2H)-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CN(CCN1C2=CC(=CC=C2)Cl)CC(C)CN3C(=O)N4C=CC=CC4=N3
25;99981703;;204282;103341686;10643843;10280;99867030;Literature-derived;20181016;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma opioid receptor type 1 of pig brain membranes at 10e-7 M;2-{3-[4-(3-Chloro-phenyl)-2-methyl-piperazin-1-yl]-propyl}-2H-[1,2,4]triazolo[4,3-a]pyridin-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
26;99985564;;204943;103278782;10684194;10280;108823620;Literature-derived;20181016;0;0;Inconclusive;Q99720;;;ChEMBL;"Sigma-1 binding assay was performed using [3H](+)-pentazocine to label sigma-1 binding sites, in guinea pig cerebral cortex; Not tested";n-(4-Chlorophenyl)-n'-(3-pyrrolidin-1-yl-propyl)-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CCN(C1)CCCN=C(N)NC2=CC=C(C=C2)Cl
27;100002418;;229211;103389930;44364124;10280;111706390;Literature-derived;20181017;0;0;Unspecified;Q99720;;;ChEMBL;Tested for effective dose of L-745870 required to displace the compound from sigma recognition site after oral administration;13-Methyl-10-prop-2-enyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CCN(C1CC3=C2C=C(C=C3)O)CC=C
28;100005038;;204137;103252465;12259685;10280;120363760;Literature-derived;20181017;0;0;Unspecified;Q99720;;;ChEMBL;Maximum binding capacity ([3H]DTG) to Sigma opioid receptor type 1 of guinea pig brain membranes at 200 nM concentration of the compound;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
29;100005103;;204007;103186197;7333;10280;120363760;Literature-derived;20181017;0;0;Unspecified;Q99720;;;ChEMBL;Maximum binding capacity of [3H]DTG to Sigma opioid receptor at a concentration of 5 uM BNIT;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
30;100005279;;204135;103252465;12259685;10280;120363760;Literature-derived;20181017;0;0;Unspecified;Q99720;;;ChEMBL;Effect of BNIT ( 0.1 uM) on binding of [3H](+)-pentazocine to Sigma opioid receptor type 1 sites in Guinea Pig Brain Membranes;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
31;100005280;;204136;103252465;12259685;10280;120363760;Literature-derived;20181017;0;0;Unspecified;Q99720;;;ChEMBL;Effect of BNIT ( 1 uM) on binding of [3H](+)-pentazocine to Sigma opioid receptor type 1 sites in Guinea Pig Brain Membranes;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
32;100005572;;204006;103186197;7333;10280;120363760;Literature-derived;20181017;0;0;Unspecified;Q99720;;;ChEMBL;Maximum binding capacity of [3H]DTG to Sigma opioid receptor at a concentration of 1 uM BNIT;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
33;100013267;;204009;103203227;10414953;10280;119062790;Literature-derived;20181017;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]DPDPE from human Sigma opioid receptor at 0.1 uM;2-(4-hydroxyphenyl)ethyl (6S,9aS)-4,7-dioxo-6,8-bis(2-phenylethyl)-3,6,9,9a-tetrahydro-2H-pyrazino[1,2-a]pyrimidine-1-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN([C@H]2CN(C(=O)[C@@H](N2C1=O)CCC3=CC=CC=C3)CCC4=CC=CC=C4)C(=O)OCCC5=CC=C(C=C5)O
34;100014259;;204008;103202696;10029244;10280;119062790;Literature-derived;20181017;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]DPDPE from human Sigma opioid receptor at 0.1 uM;2-(4-hydroxyphenyl)ethyl (6S,9aS)-4,7-dioxo-8-pentyl-6-(2-phenylethyl)-3,6,9,9a-tetrahydro-2H-pyrazino[1,2-a]pyrimidine-1-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCCN1C[C@@H]2N(CCC(=O)N2[C@H](C1=O)CCC3=CC=CC=C3)C(=O)OCCC4=CC=C(C=C4)O
35;100100811;;204288;103178578;9863340;10280;119345760;Literature-derived;20200630;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity ratio between Sigma opioid receptor type 1 and Sigma opioid receptor type 2;3-Methyl-6-[2-(4-phenyl-piperidin-1-yl)-ethyl]-3H-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C=C(C=C2)CCN3CCC(CC3)C4=CC=CC=C4)SC1=O
36;100100960;;204289;103178796;22413499;10280;119345760;Literature-derived;20200630;0;0;Unspecified;Q99720;;;ChEMBL;In vitro binding affinity ratio between sigma-1 receptor and sigma 2 receptor;6-[4-(4-Benzyl-piperazin-1-yl)-butyl]-3-methyl-3H-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C=C(C=C2)CCCCN3CCN(CC3)CC4=CC=CC=C4)SC1=O
37;100101738;;204288;103178531;10027435;10280;119345760;Literature-derived;20200630;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity ratio between Sigma opioid receptor type 1 and Sigma opioid receptor type 2;6-{4-[4-(3,4-Dichloro-benzyl)-piperazin-1-yl]-butyl}-3-methyl-3H-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C=C(C=C2)CCCCN3CCN(CC3)CC4=CC(=C(C=C4)Cl)Cl)SC1=O
38;100105030;;229817;103252210;10458892;10280;146843270;Literature-derived;20200630;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki of sigma-1 receptor versus Ki of sigma-2 receptor;5-bromo-N-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-2,3-dimethoxybenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC(=CC(=C1OC)C(=O)NCCCCN2CCC3=CC(=C(C=C3C2)OC)OC)Br
39;100105031;;229817;103252283;11165837;10280;146843270;Literature-derived;20200630;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki of sigma-1 receptor versus Ki of sigma-2 receptor;N-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-2-methoxy-5-methylbenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=C(C=C1)OC)C(=O)NCCCCN2CCC3=CC(=C(C=C3C2)OC)OC
40;100105032;;229817;103252319;25184808;10280;146843270;Literature-derived;20200630;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki of sigma-1 receptor versus Ki of sigma-2 receptor;5-Bromo-N-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-2-methoxy-benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=C(C=C1)Br)C(=O)NCCN2CCC3=CC(=C(C=C3C2)OC)OC
41;100105033;;229817;103252288;11315257;10280;146843270;Literature-derived;20200630;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki of sigma-1 receptor versus Ki of sigma-2 receptor;5-Bromo-N-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-2-methoxy-benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=C(C=C1)Br)C(=O)NCCN2CCC3=CC=CC=C3C2
42;100105034;;229817;103252318;11338096;10280;146843270;Literature-derived;20200630;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki of sigma-1 receptor versus Ki of sigma-2 receptor;N-[2-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-2-methoxy-5-methyl-benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=C(C=C1)OC)C(=O)NCCN2CCC3=CC(=C(C=C3C2)OC)OC
43;100107573;;204769;103267892;44310857;10280;150810120;Literature-derived;20200630;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity for sigma 2 compared to sigma 1 receptor;(5,5-Diphenyl-pentyl)-phenethyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)CCNCCCCC(C2=CC=CC=C2)C3=CC=CC=C3
44;100107713;;234548;103196273;4910;10280;150810120;Literature-derived;20200630;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity for sigma 2 compared to sigma 1 receptor;Proadifen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)OCCN(CC)CC
45;100107714;;234548;103267552;12730763;10280;150810120;Literature-derived;20200630;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity for sigma 2 compared to sigma 1 receptor;1-Methyl-4-(4-phenyl-butyl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)CCCCC2=CC=CC=C2
46;100107715;;234548;103267197;12730765;10280;150810120;Literature-derived;20200630;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity for sigma 2 compared to sigma 1 receptor;1-Methyl-4-(4-phenyl-but-3-enyl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)CC/C=C/C2=CC=CC=C2
47;100107716;;234548;103268074;12730766;10280;150810120;Literature-derived;20200630;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity for sigma 2 compared to sigma 1 receptor;1-Methyl-4-((Z)-4-phenyl-but-3-enyl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)CC/C=C\C2=CC=CC=C2
48;100107717;;234548;103267380;44310585;10280;150810120;Literature-derived;20200630;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity for sigma 2 compared to sigma 1 receptor;1-(5,5-Diphenyl-pent-4-enyl)-4-methyl-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)CCCC=C(C2=CC=CC=C2)C3=CC=CC=C3
49;100107718;;234548;103267898;44310861;10280;150810120;Literature-derived;20200630;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity for sigma 2 compared to sigma 1 receptor;(5,5-Diphenyl-pent-4-enyl)-methyl-phenethyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCC=C(C1=CC=CC=C1)C2=CC=CC=C2)CCC3=CC=CC=C3
50;100107719;;234548;103267923;44310878;10280;150810120;Literature-derived;20200630;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity for sigma 2 compared to sigma 1 receptor;(5,5-Diphenyl-pent-4-enyl)-phenethyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)CCNCCCC=C(C2=CC=CC=C2)C3=CC=CC=C3
51;100107720;;234548;103267550;10358719;10280;150810120;Literature-derived;20200630;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity for sigma 2 compared to sigma 1 receptor;1-(5,5-Diphenyl-pentyl)-4-methyl-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)CCCCC(C2=CC=CC=C2)C3=CC=CC=C3
52;100107721;;234548;103267551;44310683;10280;150810120;Literature-derived;20200630;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity for sigma 2 compared to sigma 1 receptor;1-(4,4-Diphenyl-butyl)-4-methyl-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)CCCC(C2=CC=CC=C2)C3=CC=CC=C3
53;100107722;;234548;103268073;44310961;10280;150810120;Literature-derived;20200630;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity for sigma 2 compared to sigma 1 receptor;1-(4,4-Diphenyl-but-3-enyl)-4-methyl-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)CCC=C(C2=CC=CC=C2)C3=CC=CC=C3
54;100107723;;234548;103267893;44310858;10280;150810120;Literature-derived;20200630;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity for sigma 2 compared to sigma 1 receptor;(5,5-Diphenyl-pentyl)-methyl-phenethyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCCC(C1=CC=CC=C1)C2=CC=CC=C2)CCC3=CC=CC=C3
55;100107724;;234548;103267515;44310664;10280;150810120;Literature-derived;20200630;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity for sigma 2 compared to sigma 1 receptor;4-Methyl-1-(3-thioxanthen-9-ylidenepropyl)piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=CC=CC=C42
56;100107725;;234548;103267924;44310879;10280;150810120;Literature-derived;20200630;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity for sigma 2 compared to sigma 1 receptor;(5,5-Diphenyl-pentyl)-diethyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CC)CCCCC(C1=CC=CC=C1)C2=CC=CC=C2
57;100107726;;234548;103267319;4598397;10280;150810120;Literature-derived;20200630;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity for sigma 2 compared to sigma 1 receptor;5-Diethylamino-1,1-diphenyl-pentan-1-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CC)CCCCC(C1=CC=CC=C1)(C2=CC=CC=C2)O
58;100136569;;232211;103273808;44313623;10280;;Literature-derived;20200702;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma-1 and sigma 2 receptor binding;(S)-3-Cyclohexylmethyl-1,8,8-trimethyl-3-aza-bicyclo[3.2.1]octane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@]12CCC(C1(C)C)CN(C2)CC3CCCCC3
59;100136570;;232211;103273809;22875688;10280;;Literature-derived;20200702;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma-1 and sigma 2 receptor binding;(R)-3-Cyclohexylmethyl-1,8,8-trimethyl-3-aza-bicyclo[3.2.1]octane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@]12CCC(C1(C)C)CN(C2)CC3CCCCC3
60;100136571;;232211;103274107;22875693;10280;;Literature-derived;20200702;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma-1 and sigma 2 receptor binding;(S)-3-(3-Cyclohexyl-propyl)-1,8,8-trimethyl-3-aza-bicyclo[3.2.1]octane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@]12CCC(C1(C)C)CN(C2)CCCC3CCCCC3
61;100136572;;232211;103167216;3559;10280;;Literature-derived;20200702;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma-1 and sigma 2 receptor binding;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
62;100136573;;232211;103273810;10264753;10280;;Literature-derived;20200702;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma-1 and sigma 2 receptor binding;(S)-3-(2-Cyclohexyl-ethyl)-1,8,8-trimethyl-3-aza-bicyclo[3.2.1]octane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@]12CCC(C1(C)C)CN(C2)CCC3CCCCC3
63;100136574;;232211;103274046;44313729;10280;;Literature-derived;20200702;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma-1 and sigma 2 receptor binding;(S)-3-(2-Cyclopentyl-ethyl)-1,8,8-trimethyl-3-aza-bicyclo[3.2.1]octane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@]12CCC(C1(C)C)CN(C2)CCC3CCCC3
64;100136575;;232211;103274164;44313811;10280;;Literature-derived;20200702;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma-1 and sigma 2 receptor binding;(S)-3-(2-Cyclooctyl-ethyl)-1,8,8-trimethyl-3-aza-bicyclo[3.2.1]octane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@]12CCC(C1(C)C)CN(C2)CCC3CCCCCCC3
65;100136576;;232211;103274166;44313813;10280;;Literature-derived;20200702;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma-1 and sigma 2 receptor binding;(S)-3-(2-Cycloheptyl-ethyl)-1,8,8-trimethyl-3-aza-bicyclo[3.2.1]octane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@]12CCC(C1(C)C)CN(C2)CCC3CCCCCC3
66;100136577;;232211;103315468;44330983;10280;;Literature-derived;20200702;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma-1 and sigma 2 receptor binding;(1S,9S,13S)-10-allyl-1,13-dimethyl-10-azatricyclo[7.3.1.0~2,7~]trideca-2,4,6-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2CC=C)C)C=C(C=C3)O
67;100136578;;232211;103273263;9861694;10280;;Literature-derived;20200702;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma-1 and sigma 2 receptor binding;(S)-3-(2-Adamantan-2-yl-ethyl)-1,8,8-trimethyl-3-aza-bicyclo[3.2.1]octane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@]12CCC(C1(C)C)CN(C2)CCC3C4CC5CC(C4)CC3C5
68;100136579;;232211;103274106;44313766;10280;;Literature-derived;20200702;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma-1 and sigma 2 receptor binding;(S)-3-Cyclohexyl-1,8,8-trimethyl-3-aza-bicyclo[3.2.1]octane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@]12CCC(C1(C)C)CN(C2)C3CCCCC3
69;100136580;;232211;103186197;7333;10280;;Literature-derived;20200702;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma-1 and sigma 2 receptor binding;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
70;100136581;;232211;103274191;22875695;10280;;Literature-derived;20200702;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma-1 and sigma 2 receptor binding;(S)-3-(4-Cyclohexyl-butyl)-1,8,8-trimethyl-3-aza-bicyclo[3.2.1]octane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@]12CCC(C1(C)C)CN(C2)CCCCC3CCCCC3
71;100136582;;232211;103274192;10106826;10280;;Literature-derived;20200702;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma-1 and sigma 2 receptor binding;(R)-3-(2-Cyclohexyl-ethyl)-1,8,8-trimethyl-3-aza-bicyclo[3.2.1]octane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@]12CCC(C1(C)C)CN(C2)CCC3CCCCC3
72;100141899;;232239;103186198;126388;10280;106362330;Literature-derived;20200702;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity and expressed as ratio of sigma 2/sigma 1;N-(2-(3,4-Dichlorophenyl)ethyl)-N-methyl-2-(1-pyrrolidinyl)ethylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=C(C=C1)Cl)Cl)CCN2CCCC2
73;100141900;;232239;103236454;5236783;10280;106362330;Literature-derived;20200702;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity and expressed as ratio of sigma 2/sigma 1;Benzeneacetic acid, 3,4-dichloro-, 2-(1-pyrrolidinyl)ethyl ester;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(C1)CCOC(=O)CC2=CC(=C(C=C2)Cl)Cl
74;100141901;;232239;103252465;12259685;10280;106362330;Literature-derived;20200702;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity and expressed as ratio of sigma 2/sigma 1;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
75;100144394;;242958;103442113;11237443;10280;156340210;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki against Sigma receptor type 1 and 2 ;1-Benzyl-4-(2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2COC3=CC=CC=C3O2)CC4=CC=CC=C4
76;100144395;;242958;103442049;10758083;10280;156340210;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki against Sigma receptor type 1 and 2 ;1-Benzyl-4-(1,2,3,4-tetrahydro-naphthalen-2-ylmethyl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2=CC=CC=C2CC1CN3CCN(CC3)CC4=CC=CC=C4
77;100144396;;242958;103442085;11773145;10280;156340210;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki against Sigma receptor type 1 and 2 ;3-(4-Benzyl-piperidin-1-ylmethyl)-chroman-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3COC4=CC=CC=C4C3=O
78;100144397;;242958;103442135;10449555;10280;156340210;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki against Sigma receptor type 1 and 2 ;2-[(4-Benzylpiperazino)methyl]chromone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2=CC=CC=C2)CC3=CC(=O)C4=CC=CC=C4O3
79;100144398;;242958;103442133;11405584;10280;156340210;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki against Sigma receptor type 1 and 2 ;4-Benzyl-1-(1,2,3,4-tetrahydro-naphthalen-2-ylmethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2=CC=CC=C2CC1CN3CCC(CC3)CC4=CC=CC=C4
80;100144399;;242958;103442130;11451971;10280;156340210;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki against Sigma receptor type 1 and 2 ;4-Benzyl-1-(6-methoxy-1,2,3,4-tetrahydro-naphthalen-2-ylmethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(CC(CC2)CN3CCC(CC3)CC4=CC=CC=C4)C=C1
81;100144400;;242958;103442161;11168272;10280;156340210;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki against Sigma receptor type 1 and 2 ;3-(4-Benzyl-piperazin-1-ylmethyl)-chroman-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2COC3=CC=CC=C3C2=O)CC4=CC=CC=C4
82;100144401;;242958;103183665;11722772;10280;156340210;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki against Sigma receptor type 1 and 2 ;1-(4-Phenylbutyl)-4-benzylpiperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CCCCC3=CC=CC=C3
83;100144402;;242958;103442109;11234470;10280;156340210;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki against Sigma receptor type 1 and 2 ;6-(4-Benzyl-piperidin-1-ylmethyl)-6,7,8,9-tetrahydro-benzocyclohepten-5-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC(C(=O)C2=CC=CC=C2C1)CN3CCC(CC3)CC4=CC=CC=C4
84;100144403;;242958;103442159;11349674;10280;156340210;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki against Sigma receptor type 1 and 2 ;4-Benzyl-1-(7-methoxy-1,2,3,4-tetrahydro-naphthalen-2-ylmethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(CCC(C2)CN3CCC(CC3)CC4=CC=CC=C4)C=C1
85;100144404;;242958;103441938;11234042;10280;156340210;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki against Sigma receptor type 1 and 2 ;2-(4-Benzyl-piperidin-1-ylmethyl)-3,4-dihydro-2H-naphthalen-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2=CC=CC=C2C(=O)C1CN3CCC(CC3)CC4=CC=CC=C4
86;100144405;;242958;103442059;11338418;10280;156340210;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki against Sigma receptor type 1 and 2 ;1-Benzyl-4-chroman-3-ylmethyl-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2CC3=CC=CC=C3OC2)CC4=CC=CC=C4
87;100144406;;242958;103442132;11336800;10280;156340210;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki against Sigma receptor type 1 and 2 ;4-Benzyl-1-indan-2-ylmethyl-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3CC4=CC=CC=C4C3
88;100144407;;242958;103442043;11152527;10280;156340210;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki against Sigma receptor type 1 and 2 ;4-Benzyl-1-chroman-3-ylmethyl-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3CC4=CC=CC=C4OC3
89;100144408;;242958;103442090;10758200;10280;156340210;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki against Sigma receptor type 1 and 2 ;1-Benzyl-4-chroman-2-ylmethyl-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2=CC=CC=C2OC1CN3CCN(CC3)CC4=CC=CC=C4
90;100144409;;242958;103441929;10616657;10280;156340210;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki against Sigma receptor type 1 and 2 ;2-[(4-Benzylpiperidino)methyl]chromone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3=CC(=O)C4=CC=CC=C4O3
91;100144410;;242958;103442048;11406043;10280;156340210;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki against Sigma receptor type 1 and 2 ;3-(4-Benzyl-piperidin-1-ylmethyl)-3,4-dihydro-2H-naphthalen-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3CC4=CC=CC=C4C(=O)C3
92;100144411;;242958;103442126;11220953;10280;156340210;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki against Sigma receptor type 1 and 2 ;4-Benzyl-1-chroman-2-ylmethyl-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2=CC=CC=C2OC1CN3CCC(CC3)CC4=CC=CC=C4
93;100144412;;242958;103442151;11245709;10280;156340210;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki against Sigma receptor type 1 and 2 ;2-(4-Benzyl-piperidin-1-ylmethyl)-chroman-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3CC(=O)C4=CC=CC=C4O3
94;100145633;;242958;103442160;11326158;10280;156340210;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki against Sigma receptor type 1 and 2 ;4-Benzyl-1-(6,7,8,9-tetrahydro-5H-benzocyclohepten-6-ylmethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC(CC2=CC=CC=C2C1)CN3CCC(CC3)CC4=CC=CC=C4
95;100145634;;242958;103441939;785789;10280;156340210;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki against Sigma receptor type 1 and 2 ;3-(4-Benzyl-piperazin-1-ylmethyl)-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2=CC=CC=C2)CC3=COC4=CC=CC=C4C3=O
96;100145635;;242958;103442086;2838196;10280;156340210;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki against Sigma receptor type 1 and 2 ;3-(4-Benzyl-piperidin-1-ylmethyl)-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3=COC4=CC=CC=C4C3=O
97;100145636;;242958;103442089;11407131;10280;156340210;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki against Sigma receptor type 1 and 2 ;3-(4-Benzyl-piperazin-1-ylmethyl)-3,4-dihydro-2H-naphthalen-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2CC3=CC=CC=C3C(=O)C2)CC4=CC=CC=C4
98;100145637;;242958;103442123;11372576;10280;156340210;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki against Sigma receptor type 1 and 2 ;4-Benzyl-1-(5-methoxy-1,2,3,4-tetrahydro-naphthalen-2-ylmethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCC(C2)CN3CCC(CC3)CC4=CC=CC=C4
99;100145638;;242958;103442127;11189143;10280;156340210;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki against Sigma receptor type 1 and 2 ;4-Benzyl-1-(2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3COC4=CC=CC=C4O3
100;100145639;;242958;103442134;11154079;10280;156340210;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki against Sigma receptor type 1 and 2 ;2-(4-Benzyl-piperazin-1-ylmethyl)-chroman-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2CC(=O)C3=CC=CC=C3O2)CC4=CC=CC=C4
101;100145640;;242958;103442152;11407133;10280;156340210;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki against Sigma receptor type 1 and 2 ;2-(4-Benzyl-piperazin-1-ylmethyl)-3,4-dihydro-2H-naphthalen-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2=CC=CC=C2C(=O)C1CN3CCN(CC3)CC4=CC=CC=C4
102;100145641;;242958;103442166;11440556;10280;156340210;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki against Sigma receptor type 1 and 2 ;4-Benzyl-1-(8-methoxy-1,2,3,4-tetrahydro-naphthalen-2-ylmethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CC(CC2)CN3CCC(CC3)CC4=CC=CC=C4
103;100159390;;234273;103278159;2817997;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-(1-benzylpiperidin-4-yl)-2-phenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC=CC=C3
104;100159391;;234273;103375736;9840310;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-[1-(3-Fluoro-benzyl)-piperidin-4-yl]-2-phenyl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC(=CC=C3)F
105;100159392;;234273;103375761;10981062;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-(1-Benzo[1,3]dioxol-5-ylmethyl-piperidin-4-yl)-2-phenyl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC4=C(C=C3)OCO4
106;100159393;;234273;103376377;11016707;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-[1-(3-Iodobenzyl)-4-piperidinyl]-3-bromophenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)Br)CC3=CC(=CC=C3)I
107;100159394;;234273;103376009;10862129;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-(1-Benzyl-piperidin-4-yl)-2-(6-methoxy-3-oxo-indan-1-yl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(C=C1)C(=O)CC2CC(=O)NC3CCN(CC3)CC4=CC=CC=C4
108;100159395;;234273;103376027;9889113;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-[1-(4-Iodo-benzyl)-piperidin-4-yl]-2-phenyl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC=C(C=C3)I
109;100159396;;234273;103376497;9883820;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-[1-(2-Fluoro-benzyl)-piperidin-4-yl]-2-phenyl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC=CC=C3F
110;100159397;;234273;103278445;119265;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;Reduced haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(C3=CC=C(C=C3)F)O
111;100159398;;234273;103375759;10969339;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-(1-Phenethyl-piperidin-4-yl)-2-phenyl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CCC3=CC=CC=C3
112;100159399;;234273;103376054;9906138;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-[1-(4-Fluorobenzyl)-4-piperidinyl]-3-fluorophenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)F)CC3=CC=C(C=C3)F
113;100159400;;234273;103376452;10870255;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-(1-Benzyl-piperidin-4-yl)-2-(1H-imidazol-4-yl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CN=CN2)CC3=CC=CC=C3
114;100159401;;234273;103376010;11111624;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-(1-Benzyl-piperidin-4-yl)-2-(5-methoxy-1H-indol-3-yl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(C=C1)NC=C2CC(=O)NC3CCN(CC3)CC4=CC=CC=C4
115;100159402;;234273;103375248;10902954;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-(1-Benzyl-piperidin-4-yl)-2-pyridin-4-yl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=NC=C2)CC3=CC=CC=C3
116;100159434;;234273;103375646;2712605;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-(1-benzylpiperidin-4-yl)-2-(thiophen-2-yl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CS2)CC3=CC=CC=C3
117;100159435;;234273;103376433;11102433;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-[1-(3-Iodobenzyl)-4-piperidinyl]-3-fluorophenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)F)CC3=CC(=CC=C3)I
118;100159436;;234273;103376448;10925078;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-(1-Benzyl-piperidin-4-yl)-2-thiophen-3-yl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CSC=C2)CC3=CC=CC=C3
119;100159437;;234273;103376467;10970390;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-(1-Benzyl-piperidin-4-yl)-2-naphthalen-1-yl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC3=CC=CC=C32)CC4=CC=CC=C4
120;100159438;;234273;103375836;9887523;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-[1-(4-Fluorobenzyl)-4-piperidinyl]-3-bromophenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)Br)CC3=CC=C(C=C3)F
121;100159439;;234273;103375952;44358368;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-(1-benzylpiperidin-4-yl)-2-(7-hydroxy-2-oxo-4a,8a-dihydrochromen-4-yl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC(=O)OC3C2C=CC(=C3)O)CC4=CC=CC=C4
122;100159440;;234273;103375993;10948807;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;2-Phenyl-N-[1-(3-trifluoromethyl-benzyl)-piperidin-4-yl]-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC(=CC=C3)C(F)(F)F
123;100159441;;234273;103375249;3562491;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;1-(1-Benzylpiperidin-4-yl)-3-naphthalen-1-ylurea;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)NC2=CC=CC3=CC=CC=C32)CC4=CC=CC=C4
124;100159442;;234273;103375837;9804703;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-[1-(4-Iodobenzyl)-4-piperidinyl]-3-chlorophenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)Cl)CC3=CC=C(C=C3)I
125;100159443;;234273;103376026;11760579;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;2-Phenyl-N-[1-(2-trifluoromethyl-benzyl)-piperidin-4-yl]-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC=CC=C3C(F)(F)F
126;100159444;;234273;103376055;11733099;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-[1-(3-Iodobenzyl)-4-piperidinyl]-2-fluorophenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC=C2F)CC3=CC(=CC=C3)I
127;100159445;;234273;103375771;11012319;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-(1-Benzyl-piperidin-4-yl)-2-pyridin-3-yl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CN=CC=C2)CC3=CC=CC=C3
128;100159446;;234273;103375819;9841846;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-[1-(4-Fluorobenzyl)-4-piperidinyl]-3-chlorophenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)Cl)CC3=CC=C(C=C3)F
129;100159447;;234273;103375679;9889112;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-[1-(3-Iodo-benzyl)-piperidin-4-yl]-2-phenyl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC(=CC=C3)I
130;100159448;;234273;103375680;9797419;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-[1-(4-Fluoro-benzyl)-piperidin-4-yl]-2-phenyl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC=C(C=C3)F
131;100159449;;234273;103376031;10895188;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;5-Bromo-N-(1-benzyl-4-piperidinyl)-1H-indole-3-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CNC3=C2C=C(C=C3)Br)CC4=CC=CC=C4
132;100159450;;234273;103376033;11035595;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-[1-(4-Nitro-benzyl)-piperidin-4-yl]-2-phenyl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC=C(C=C3)[N+](=O)[O-]
133;100159451;;234273;103376064;10950137;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-[1-(2-Iodo-benzyl)-piperidin-4-yl]-2-phenyl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC=CC=C3I
134;100159452;;234273;103376317;11143323;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-[1-(3,4-Dichloro-benzyl)-piperidin-4-yl]-2-phenyl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC(=C(C=C3)Cl)Cl
135;100159453;;234273;103376482;10946809;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-(1-Benzyl-piperidin-4-yl)-2-pyridin-2-yl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC=N2)CC3=CC=CC=C3
136;100159454;;234273;103375667;9868470;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-[1-(4-Iodobenzyl)-4-piperidinyl]-2-fluorophenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC=C2F)CC3=CC=C(C=C3)I
137;100159455;;234273;103375760;11783308;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-(1-Naphthalen-2-ylmethyl-piperidin-4-yl)-2-phenyl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC4=CC=CC=C4C=C3
138;100159795;;234273;103375951;11142430;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-(1-Benzyl-piperidin-4-yl)-2-(pyrimidin-2-ylsulfanyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CSC2=NC=CC=N2)CC3=CC=CC=C3
139;100159796;;234273;103376032;10991643;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-(1-benzylpiperidin-4-yl)-2-(1H-indol-3-yl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4
140;100159797;;234273;103376466;9802946;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-(1-Benzyl-4-piperidinyl)-4-iodophenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=C(C=C2)I)CC3=CC=CC=C3
141;100159798;;234273;103376003;10926436;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-(1-benzylpiperidin-4-yl)-2-(naphthalen-2-yl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC3=CC=CC=C3C=C2)CC4=CC=CC=C4
142;100159799;;234273;103167216;3559;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
143;100159800;;234273;103376056;9906139;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-[1-(4-Fluorobenzyl)-4-piperidinyl]-2-fluorophenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC=C2F)CC3=CC=C(C=C3)F
144;100159801;;234273;103376352;9936242;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-[1-(4-Iodobenzyl)-4-piperidinyl]-3-bromophenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)Br)CC3=CC=C(C=C3)I
145;100159802;;234273;103375762;9819510;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-[1-(3,4-Difluoro-benzyl)-piperidin-4-yl]-2-phenyl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC(=C(C=C3)F)F
146;100159803;;234273;103375796;11016132;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-[1-(3-Iodobenzyl)-4-piperidinyl]-3-chlorophenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)Cl)CC3=CC(=CC=C3)I
147;100159804;;234273;103375963;10883323;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;2-Phenyl-N-[1-(4-trifluoromethyl-benzyl)-piperidin-4-yl]-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC=C(C=C3)C(F)(F)F
148;100159805;;234273;103376431;9803895;10280;117281860;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity is determined by the ratio of Ki for rat sigma 2 receptor to that of guinea pig sigma-1 receptor;N-[1-(4-Iodobenzyl)-4-piperidinyl]-3-fluorophenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)F)CC3=CC=C(C=C3)I
149;100162185;;204138;103186197;7333;10280;120363760;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Maximum binding capacity against Sigma opioid receptor type 1 at 0.1 uM BNIT;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
150;100163386;;204293;103186197;7333;10280;120363760;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Maximum binding capacity against Sigma opioid receptor type 2 at 0.1 uM BNIT;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
151;100164447;;204292;103167216;3559;10280;117841480;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio Sigma opioid receptor type 1 to Sigma opioid receptor type 2;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
152;100164585;;233687;103377937;10357986;10280;117841480;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio (Sigma1/Sigma2);1'-Benzyl-3-methoxyspiro[isobenzofuran-1(3H),4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1C2=CC=CC=C2C3(O1)CCN(CC3)CC4=CC=CC=C4
153;100164586;;233687;103378371;11034660;10280;117841480;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio (Sigma1/Sigma2);1'-Phenethyl-3,4-dihydrospiro[1H-2-benzopyran-1,4'-piperidine]-3-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3CC(O2)O)CCC4=CC=CC=C4
154;100164587;;233687;103377942;11784333;10280;117841480;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio (Sigma1/Sigma2);1''-benzyl-3-benzyloxyspiro[3,4-dihydro-1H-isochromene-1,4''-(hexahydropyridine)];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3CC(O2)OCC4=CC=CC=C4)CC5=CC=CC=C5
155;100164588;;233687;103378365;11822555;10280;117841480;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio (Sigma1/Sigma2);1'-Benzylspiro[isobenzofuran-1(3H),4'-piperidine]-3-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3C(O2)O)CC4=CC=CC=C4
156;100164589;;233687;103378841;10086666;10280;117841480;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio (Sigma1/Sigma2);1'-Benzyl-3,4-dihydrospiro[1H-2-benzopyran-1,4'-piperidine]-3-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3CC(O2)O)CC4=CC=CC=C4
157;100164590;;233687;103248082;108046;10280;117841480;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio (Sigma1/Sigma2);alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC(C2=CC=C(C=C2)F)O)C3=NC=C(C=N3)F
158;100164591;;233687;103378319;10266413;10280;117841480;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio (Sigma1/Sigma2);1'-Benzylspiro[isochroman-1,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COC2(CCN(CC2)CC3=CC=CC=C3)C4=CC=CC=C41
159;100164592;;233687;103186197;7333;10280;117841480;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio (Sigma1/Sigma2);1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
160;100164593;;233687;103377948;11782688;10280;117841480;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio (Sigma1/Sigma2);1'-Benzyl-3-ethoxy-3,4-dihydrospiro[1H-2-benzopyran-1,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC1CC2=CC=CC=C2C3(O1)CCN(CC3)CC4=CC=CC=C4
161;100164594;;233687;103377508;10980649;10280;117841480;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio (Sigma1/Sigma2);1'-Phenethyl-3-methoxy-3,4-dihydrospiro[1H-2-benzopyran-1,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1CC2=CC=CC=C2C3(O1)CCN(CC3)CCC4=CC=CC=C4
162;100164595;;233687;103378083;10871797;10280;117841480;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio (Sigma1/Sigma2);1'-Cinnamyl-3-methoxy-3,4-dihydrospiro[1H-2-benzopyran-1,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1CC2=CC=CC=C2C3(O1)CCN(CC3)C/C=C/C4=CC=CC=C4
163;100164596;;233687;103378107;11810652;10280;117841480;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio (Sigma1/Sigma2);1'-(4-Phenylbutyl)-3-methoxy-3,4-dihydrospiro[1H-2-benzopyran-1,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1CC2=CC=CC=C2C3(O1)CCN(CC3)CCCCC4=CC=CC=C4
164;100164597;;233687;103378334;10266406;10280;117841480;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio (Sigma1/Sigma2);1'-Benzyl-3H-spiro[isobenzofuran-1,4'-piperidin]-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3C(=O)O2)CC4=CC=CC=C4
165;100164598;;233687;103378084;10915140;10280;117841480;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio (Sigma1/Sigma2);1'-(3-Phenylpropyl)-3-methoxy-3,4-dihydrospiro[1H-2-benzopyran-1,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1CC2=CC=CC=C2C3(O1)CCN(CC3)CCCC4=CC=CC=C4
166;100164599;;233687;103377949;11013161;10280;117841480;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio (Sigma1/Sigma2);1''-(3-phenylpropyl)spiro[3,4-dihydro-1H-isochromene-1,4''-(hexahydropyridine)]-3-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3CC(O2)O)CCCC4=CC=CC=C4
167;100164600;;233687;103378197;11748820;10280;117841480;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio (Sigma1/Sigma2);1''-Benzylspiro[isochroman-1,4''-piperidin]-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3CC(=O)O2)CC4=CC=CC=C4
168;100164601;;233687;103378222;11143217;10280;117841480;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio (Sigma1/Sigma2);1'-Benzylspiro[1H-2-benzopyran-1,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3C=CO2)CC4=CC=CC=C4
169;100164602;;233687;103377542;10019102;10280;117841480;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio (Sigma1/Sigma2);1'-Benzyl-3-methoxyspiro[isochroman-1,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1CC2=CC=CC=C2C3(O1)CCN(CC3)CC4=CC=CC=C4
170;100168547;;232236;103671540;45260615;10280;127477840;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative affinity for sigma-2 over sigma-1 receptors;"1-[(3S)-3-(4-chlorophenoxy)butyl]-4-methylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)CC[C@H](C)OC2=CC=C(C=C2)Cl.Cl
171;100168901;;232236;103671505;45260581;10280;127477840;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative affinity for sigma-2 over sigma-1 receptors;"1-[(2R)-4-(4-chlorophenoxy)butan-2-yl]-4-methylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)[C@H](C)CCOC2=CC=C(C=C2)Cl.Cl
172;100168902;;232236;103671548;45260623;10280;127477840;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative affinity for sigma-2 over sigma-1 receptors;"1-[2-(4-Chlorophenoxy)ethyl]-4-methylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)CCOC2=CC=C(C=C2)Cl.Cl
173;100168903;;232236;103671563;45260632;10280;127477840;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative affinity for sigma-2 over sigma-1 receptors;"1-[(2S)-4-(4-chlorophenoxy)butan-2-yl]-4-methylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)[C@@H](C)CCOC2=CC=C(C=C2)Cl.Cl
174;100168904;;232236;103671530;45260606;10280;127477840;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative affinity for sigma-2 over sigma-1 receptors;"1-[(2R)-3-(4-chlorophenoxy)-2-methylpropyl]-4-methylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)C[C@@H](C)COC2=CC=C(C=C2)Cl.Cl
175;100168905;;232236;103677475;45264579;10280;127477840;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative affinity for sigma-2 over sigma-1 receptors;"1-[3-(4-Chlorophenoxy)propyl]-4-methylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)CCCOC2=CC=C(C=C2)Cl.Cl
176;100168906;;232236;103671533;45260608;10280;127477840;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative affinity for sigma-2 over sigma-1 receptors;"1-[(3R)-3-(4-chlorophenoxy)butyl]-4-methylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)CC[C@@H](C)OC2=CC=C(C=C2)Cl.Cl
177;100168907;;232236;103671515;45260591;10280;127477840;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative affinity for sigma-2 over sigma-1 receptors;"1-[(2R)-2-(4-chlorophenoxy)propyl]-4-methylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)C[C@@H](C)OC2=CC=C(C=C2)Cl.Cl
178;100168908;;232236;103671566;10335163;10280;127477840;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative affinity for sigma-2 over sigma-1 receptors;"1-[(2S)-1-(4-chlorophenoxy)propan-2-yl]-4-methylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)[C@@H](C)COC2=CC=C(C=C2)Cl.Cl
179;100168909;;232236;103671525;45260601;10280;127477840;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative affinity for sigma-2 over sigma-1 receptors;"1-[(2R)-1-(4-chlorophenoxy)propan-2-yl]-4-methylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)[C@H](C)COC2=CC=C(C=C2)Cl.Cl
180;100168910;;232236;103671503;45260579;10280;127477840;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative affinity for sigma-2 over sigma-1 receptors;"1-[(2S)-2-(4-chlorophenoxy)propyl]-4-methylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)C[C@H](C)OC2=CC=C(C=C2)Cl.Cl
181;100168911;;232236;103677380;45264514;10280;127477840;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative affinity for sigma-2 over sigma-1 receptors;"1-[(2S)-3-(4-chlorophenoxy)-2-methylpropyl]-4-methylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)C[C@H](C)COC2=CC=C(C=C2)Cl.Cl
182;100176436;;231644;103237360;10474335;10280;150841290;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity ratio of sigma 1 receptor to that of sigma 2 receptor;1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCCC2CCCN3CCN(CC3)C4CCCCC4
183;100176437;;231644;103275038;11462448;10280;150841290;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity ratio of sigma 1 receptor to that of sigma 2 receptor;5-[3-(4-Cyclohexyl-piperazin-1-yl)-propyl]-5,6,7,8-tetrahydro-naphthalen-1-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)N2CCN(CC2)CCCC3CCCC4=C3C=CC=C4O
184;100176438;;231644;103274518;44314013;10280;150841290;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity ratio of sigma 1 receptor to that of sigma 2 receptor;1-Cyclohexyl-4-[3-(7-methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-propyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(CCCC2CCCN3CCN(CC3)C4CCCCC4)C=C1
185;100177550;;231644;103275170;9513;10280;150841290;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity ratio of sigma 1 receptor to that of sigma 2 receptor;1-Phenethylpiperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCC2=CC=CC=C2
186;100177551;;231644;103275198;11405872;10280;150841290;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity ratio of sigma 1 receptor to that of sigma 2 receptor;1-Cyclohexyl-4-(5-naphthalen-1-yl-pentyl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)N2CCN(CC2)CCCCCC3=CC=CC4=CC=CC=C43
187;100177552;;231644;103274327;11739209;10280;150841290;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity ratio of sigma 1 receptor to that of sigma 2 receptor;1-Cyclohexyl-4-(3-naphthalen-1-yl-propyl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)N2CCN(CC2)CCCC3=CC=CC4=CC=CC=C43
188;100177553;;231644;103274578;11152920;10280;150841290;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity ratio of sigma 1 receptor to that of sigma 2 receptor;1-Cyclohexyl-4-[3-((R)-5-methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-propyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCC[C@@H]2CCCN3CCN(CC3)C4CCCCC4
189;100177554;;231644;103275072;11292472;10280;150841290;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity ratio of sigma 1 receptor to that of sigma 2 receptor;1-Cyclohexyl-4-[5-(5-methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-pentyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCCC2CCCCCN3CCN(CC3)C4CCCCC4
190;100177605;;231645;103274576;11268724;10280;150841290;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity ratio of sigma 2 receptor to that of sigma 1 receptor;1-Cyclohexyl-4-[3-(6-methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-propyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(C=C1)C(CCC2)CCCN3CCN(CC3)C4CCCCC4
191;100177606;;231645;103275199;11416825;10280;150841290;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity ratio of sigma 2 receptor to that of sigma 1 receptor;1-Cyclohexyl-4-(4-naphthalen-1-yl-butyl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)N2CCN(CC2)CCCCC3=CC=CC4=CC=CC=C43
192;100177607;;231645;103274291;11381875;10280;150841290;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity ratio of sigma 2 receptor to that of sigma 1 receptor;1-Cyclohexyl-4-(5-methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCCC2N3CCN(CC3)C4CCCCC4
193;100177608;;231645;103275040;11281378;10280;150841290;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity ratio of sigma 2 receptor to that of sigma 1 receptor;1-Cyclohexyl-4-[6-(5-methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-hexyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCCC2CCCCCCN3CCN(CC3)C4CCCCC4
194;100177609;;231645;103275215;11428574;10280;150841290;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity ratio of sigma 2 receptor to that of sigma 1 receptor;1-Cyclohexyl-4-(3-(5-methoxynaphthalen-1-yl)propyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C(C=CC=C21)CCCN3CCN(CC3)C4CCCCC4
195;100177610;;231645;103275254;11233111;10280;150841290;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity ratio of sigma 2 receptor to that of sigma 1 receptor;1-Cyclohexyl-4-[3-(1,2,3,4-tetrahydro-naphthalen-1-yl)-propyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)N2CCN(CC2)CCCC3CCCC4=CC=CC=C34
196;100177611;;231645;103275074;11303155;10280;150841290;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity ratio of sigma 2 receptor to that of sigma 1 receptor;1-Cyclohexyl-4-[5-(1,2,3,4-tetrahydro-naphthalen-1-yl)-pentyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)N2CCN(CC2)CCCCCC3CCCC4=CC=CC=C34
197;100177612;;231645;103274328;11451147;10280;150841290;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity ratio of sigma 2 receptor to that of sigma 1 receptor;5-[3-(4-Cyclohexyl-piperazin-1-yl)-propyl]-5,6,7,8-tetrahydro-naphthalen-2-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)N2CCN(CC2)CCCC3CCCC4=C3C=CC(=C4)O
198;100177613;;231645;103274644;11439301;10280;150841290;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity ratio of sigma 2 receptor to that of sigma 1 receptor;1-Cyclohexyl-4-(5-methoxy-1,2,3,4-tetrahydro-naphthalen-1-ylmethyl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCCC2CN3CCN(CC3)C4CCCCC4
199;100177614;;231645;103274477;11302686;10280;150841290;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity ratio of sigma 2 receptor to that of sigma 1 receptor;1-Cyclohexyl-4-[4-(1,2,3,4-tetrahydro-naphthalen-1-yl)-butyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)N2CCN(CC2)CCCCC3CCCC4=CC=CC=C34
200;100177615;;231645;103274544;11428679;10280;150841290;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity ratio of sigma 2 receptor to that of sigma 1 receptor;1-Cyclohexyl-4-[3-((S)-5-methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-propyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCC[C@H]2CCCN3CCN(CC3)C4CCCCC4
201;100177616;;231645;103274476;11199981;10280;150841290;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity ratio of sigma 2 receptor to that of sigma 1 receptor;1-Cyclohexyl-4-(4-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)butyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCCC2CCCCN3CCN(CC3)C4CCCCC4
202;100177617;;231645;103274608;11405620;10280;150841290;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity ratio of sigma 2 receptor to that of sigma 1 receptor;1-Cyclohexyl-4-[2-(5-methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-ethyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCCC2CCN3CCN(CC3)C4CCCCC4
203;100184927;;231161;103384535;558800;10280;84969360;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of the sigma-2 receptor versus sigma-1 receptor;3-Azapentane, N-methyl-5-[4-chlorophenyl]-1-[pyrrolidin-1-yl]-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC=C(C=C1)Cl)CCN2CCCC2
204;100184928;;231161;103401204;10316321;10280;84969360;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of the sigma-2 receptor versus sigma-1 receptor;N-(2-(4-Iodophenyl)ethyl)-N-methyl-2-(1-pyrrolidinyl)ethylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC=C(C=C1)I)CCN2CCCC2
205;100184929;;231161;103401221;10021279;10280;84969360;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of the sigma-2 receptor versus sigma-1 receptor;N-Methyl-N-[2-(1-pyrrolidinyl)ethyl]-3-iodophenethylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=CC=C1)I)CCN2CCCC2
206;100184930;;231161;103401223;10470687;10280;84969360;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of the sigma-2 receptor versus sigma-1 receptor;[2-(3-Bromo-phenyl)-ethyl]-methyl-(2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=CC=C1)Br)CCN2CCCC2
207;100184931;;231161;103401228;10066063;10280;84969360;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of the sigma-2 receptor versus sigma-1 receptor;N-Methyl-N-[2-(1-pyrrolidinyl)ethyl]-2-iodobenzylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCN1CCCC1)CC2=CC=CC=C2I
208;100184932;;231161;103401222;10450158;10280;84969360;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of the sigma-2 receptor versus sigma-1 receptor;(3-Iodo-benzyl)-methyl-(2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCN1CCCC1)CC2=CC(=CC=C2)I
209;100184933;;231161;103167216;3559;10280;84969360;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of the sigma-2 receptor versus sigma-1 receptor;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
210;100184934;;231161;103401056;10470688;10280;84969360;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of the sigma-2 receptor versus sigma-1 receptor;[2-(4-Bromo-phenyl)-ethyl]-methyl-(2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC=C(C=C1)Br)CCN2CCCC2
211;100184935;;231161;160677132;41011;10280;84969360;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of the sigma-2 receptor versus sigma-1 receptor;Guanidine, N,N'-bis(4-methylphenyl)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=C(C=C1)NC(=NC2=CC=C(C=C2)C)N
212;100184936;;231161;103401055;10085970;10280;84969360;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of the sigma-2 receptor versus sigma-1 receptor;N-Methyl-N-[2-(1-pyrrolidinyl)ethyl]-3-bromobenzylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCN1CCCC1)CC2=CC(=CC=C2)Br
213;100184937;;231161;103401032;10354750;10280;84969360;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of the sigma-2 receptor versus sigma-1 receptor;[2-(4-Fluoro-phenyl)-ethyl]-methyl-(2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC=C(C=C1)F)CCN2CCCC2
214;100184938;;231161;103401054;10422239;10280;84969360;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of the sigma-2 receptor versus sigma-1 receptor;[2-(3-Fluoro-phenyl)-ethyl]-methyl-(2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=CC=C1)F)CCN2CCCC2
215;100184939;;231161;103383718;15113306;10280;84969360;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of the sigma-2 receptor versus sigma-1 receptor;2-(3-Chlorophenyl)-N-methyl-N-[2-(pyrrolidin-1-yl)ethyl]ethan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=CC=C1)Cl)CCN2CCCC2
216;100184940;;231161;103400994;11725031;10280;84969360;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of the sigma-2 receptor versus sigma-1 receptor;N-Methyl-N-[2-(1-pyrrolidinyl)ethyl]-4-iodobenzylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCN1CCCC1)CC2=CC=C(C=C2)I
217;100184941;;231161;103252465;12259685;10280;84969360;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of the sigma-2 receptor versus sigma-1 receptor;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
218;100184942;;231161;103186198;126388;10280;84969360;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of the sigma-2 receptor versus sigma-1 receptor;N-(2-(3,4-Dichlorophenyl)ethyl)-N-methyl-2-(1-pyrrolidinyl)ethylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=C(C=C1)Cl)Cl)CCN2CCCC2
219;100188973;;203851;103329969;10254219;10280;82952200;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative binding to sigma-2 and sigma-1 type receptors, ratio of Ki;Tetrahydro-1-[2-[methyl[2-[methyl[2-[methyl[2-[methyl[2-(3,4-dichlorophenyl)ethyl]amino]ethyl]amino]ethyl]amino]ethyl]amino]ethyl]-1H-pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=C(C=C1)Cl)Cl)CCN(C)CCN(C)CCN(C)CCN2CCCC2
220;100188974;;203851;103330546;10001888;10280;82952200;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative binding to sigma-2 and sigma-1 type receptors, ratio of Ki;Tetrahydro-1-[2-[methyl[2-[methyl[2-[methyl[2-(3,4-dichlorophenyl)ethyl]amino]ethyl]amino]ethyl]amino]ethyl]-1H-pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=C(C=C1)Cl)Cl)CCN(C)CCN(C)CCN2CCCC2
221;100188975;;203851;103330609;10001045;10280;82952200;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative binding to sigma-2 and sigma-1 type receptors, ratio of Ki;Tetrahydro-1-[4-[methyl[3-[methyl[2-(3,4-dichlorophenyl)ethyl]amino]propyl]amino]butyl]-1H-pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCCN1CCCC1)CCCN(C)CCC2=CC(=C(C=C2)Cl)Cl
222;100188976;;203851;103330115;398580;10280;82952200;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative binding to sigma-2 and sigma-1 type receptors, ratio of Ki;Tetrahydro-1-[4-[methyl[4-[methyl[2-(3,4-dichlorophenyl)ethyl]amino]butyl]amino]butyl]-1H-pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCCN1CCCC1)CCCCN(C)CCC2=CC(=C(C=C2)Cl)Cl
223;100189882;;230304;103339981;12371110;10280;79325690;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of potencies of (+) and (-) enantiomers against sigma receptors in guinea pig;(6S)-6alpha,11alpha-Dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1C2CC3=C([C@]1(CCN2)C)C=C(C=C3)O
224;100189883;;230304;103339885;44342598;10280;79325690;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of potencies of (+) and (-) enantiomers against sigma receptors in guinea pig;(1S,13R)-1,13-dimethyl-10-octyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCCCCCN1CC[C@]2([C@H](C1CC3=C2C=C(C=C3)O)C)C
225;100190110;;203851;103672721;45261469;10280;82952200;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative binding to sigma-2 and sigma-1 type receptors, ratio of Ki;"1-[2-(3,4-Dichlorophenyl)ethyl]pyrrolidine;hydrobromide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(C1)CCC2=CC(=C(C=C2)Cl)Cl.Br
226;100190111;;203851;103167216;3559;10280;82952200;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative binding to sigma-2 and sigma-1 type receptors, ratio of Ki;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
227;100190112;;203851;103330080;10087999;10280;82952200;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative binding to sigma-2 and sigma-1 type receptors, ratio of Ki;N-[2-(3,4-Dichlorophenyl)ethyl]-N'-[2-[(tetrahydro-1H-pyrrol)-1-yl]ethyl]ethylenediamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(C1)CCNCCNCCC2=CC(=C(C=C2)Cl)Cl
228;100190113;;203851;103330116;398578;10280;82952200;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative binding to sigma-2 and sigma-1 type receptors, ratio of Ki;Tetrahydro-1-[2-[methyl[2-[methyl(3,4-dichlorobenzyl)amino]ethyl]amino]ethyl]-1H-pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCN1CCCC1)CCN(C)CC2=CC(=C(C=C2)Cl)Cl
229;100190114;;203851;103330179;398582;10280;82952200;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative binding to sigma-2 and sigma-1 type receptors, ratio of Ki;Tetrahydro-1-[3-[methyl[3-[methyl[2-(3,4-dichlorophenyl)ethyl]amino]propyl]amino]propyl]-1H-pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCN1CCCC1)CCCN(C)CCC2=CC(=C(C=C2)Cl)Cl
230;100190115;;203851;103331185;11725919;10280;82952200;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative binding to sigma-2 and sigma-1 type receptors, ratio of Ki;Tetrahydro-1-[3-[methyl[2-[methyl(3,4-dichlorobenzyl)amino]ethyl]amino]propyl]-1H-pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCN1CCCC1)CCN(C)CC2=CC(=C(C=C2)Cl)Cl
231;100190116;;203851;103186197;7333;10280;82952200;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative binding to sigma-2 and sigma-1 type receptors, ratio of Ki;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
232;100190117;;203851;103329968;398588;10280;82952200;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative binding to sigma-2 and sigma-1 type receptors, ratio of Ki;Tetrahydro-1-[2-[methyl[3-[methyl(3,4-dichlorobenzyl)amino]propyl]amino]ethyl]-1H-pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCN(C)CC1=CC(=C(C=C1)Cl)Cl)CCN2CCCC2
233;100190118;;203851;103330154;9973880;10280;82952200;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative binding to sigma-2 and sigma-1 type receptors, ratio of Ki;Tetrahydro-1-[2-[(2-aminoethyl)[2-(3,4-dichlorophenyl)ethyl]amino]ethyl]-1H-pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(C1)CCN(CCC2=CC(=C(C=C2)Cl)Cl)CCN
234;100190119;;203851;103252465;12259685;10280;82952200;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative binding to sigma-2 and sigma-1 type receptors, ratio of Ki;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
235;100190120;;203851;103330150;10107472;10280;82952200;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative binding to sigma-2 and sigma-1 type receptors, ratio of Ki;N-[2-(3,4-Dichlorophenyl)ethyl]-N'-(2-aminoethyl)ethylenediamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC(=C(C=C1CCNCCNCCN)Cl)Cl
236;100190121;;203851;103186198;126388;10280;82952200;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative binding to sigma-2 and sigma-1 type receptors, ratio of Ki;N-(2-(3,4-Dichlorophenyl)ethyl)-N-methyl-2-(1-pyrrolidinyl)ethylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=C(C=C1)Cl)Cl)CCN2CCCC2
237;100190122;;203851;103330067;398586;10280;82952200;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative binding to sigma-2 and sigma-1 type receptors, ratio of Ki;Tetrahydro-1-[2-[methyl[2-[methyl[2-(3,4-dichlorophenyl)ethyl]amino]ethyl]amino]ethyl]-1H-pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=C(C=C1)Cl)Cl)CCN(C)CCN2CCCC2
238;100190123;;203851;103330151;15113301;10280;82952200;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Relative binding to sigma-2 and sigma-1 type receptors, ratio of Ki;2-(3,4-Dichlorophenyl)-N-(2-aminoethyl)ethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC(=C(C=C1CCNCCN)Cl)Cl
239;100190341;;230304;103340516;44342911;10280;79325690;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of potencies of (+) and (-) enantiomers against sigma receptors in guinea pig;(1S,13R)-1,13-dimethyl-10-propyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CC[C@]2([C@H](C1CC3=C2C=C(C=C3)O)C)C
240;100190342;;230304;103340515;44342910;10280;79325690;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of potencies of (+) and (-) enantiomers against sigma receptors in guinea pig;(6S)-3-Methyl-6alpha,11alpha-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1C2CC3=C([C@]1(CCN2C)C)C=C(C=C3)O
241;100190343;;230304;103340549;44342925;10280;79325690;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of potencies of (+) and (-) enantiomers against sigma receptors in guinea pig;(1S,13R)-10-hexyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCCCN1CC[C@]2([C@H](C1CC3=C2C=C(C=C3)O)C)C
242;100190344;;230304;103339996;44342661;10280;79325690;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of potencies of (+) and (-) enantiomers against sigma receptors in guinea pig;(1S,13R)-10-heptyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCCCCN1CC[C@]2([C@H](C1CC3=C2C=C(C=C3)O)C)C
243;100190345;;230304;103340146;44342747;10280;79325690;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of potencies of (+) and (-) enantiomers against sigma receptors in guinea pig;(1S,13R)-10-decyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCCCCCCCN1CC[C@]2([C@H](C1CC3=C2C=C(C=C3)O)C)C
244;100190346;;230304;103340563;44342934;10280;79325690;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of potencies of (+) and (-) enantiomers against sigma receptors in guinea pig;(1S,13R)-10-ethyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC[C@]2([C@H](C1CC3=C2C=C(C=C3)O)C)C
245;100190347;;230304;103340562;44342933;10280;79325690;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of potencies of (+) and (-) enantiomers against sigma receptors in guinea pig;(1S,13R)-10-butyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCN1CC[C@]2([C@H](C1CC3=C2C=C(C=C3)O)C)C
246;100190348;;230304;103339884;44342597;10280;79325690;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of potencies of (+) and (-) enantiomers against sigma receptors in guinea pig;(1S,13R)-1,13-dimethyl-10-nonyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCCCCCCN1CC[C@]2([C@H](C1CC3=C2C=C(C=C3)O)C)C
247;100190349;;230304;103340518;44342912;10280;79325690;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of potencies of (+) and (-) enantiomers against sigma receptors in guinea pig;(1S,13R)-1,13-dimethyl-10-pentyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCCN1CC[C@]2([C@H](C1CC3=C2C=C(C=C3)O)C)C
248;100190696;;230301;103340185;12371111;10280;79325690;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of potencies of (+) and (-) enantiomers against PCP receptor and sigma receptor;(1R,13S)-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1C2CC3=C([C@@]1(CCN2)C)C=C(C=C3)O
249;100194480;;204768;103318463;15767684;10280;76368600;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of binding affinities at Sigma receptor type 2 and type 1;10-Benzyl-4-iodo-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)I
250;100194481;;204768;103318534;15767678;10280;76368600;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of binding affinities at Sigma receptor type 2 and type 1;10-Benzyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)N
251;100194482;;204768;103173563;1235;10280;76368600;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of binding affinities at Sigma receptor type 2 and type 1;2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-3-allyl-6,11-dimethyl-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=C(C1(CCN2CC=C)C)C=C(C=C3)O
252;100194483;;204768;103318136;15767679;10280;76368600;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of binding affinities at Sigma receptor type 2 and type 1;10-benzyl-N,N,1,13-tetramethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)N(C)C
253;100194484;;204768;103317804;15767674;10280;76368600;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of binding affinities at Sigma receptor type 2 and type 1;Deoxypentazocin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=CC=CC=C3C1(CCN2CC=C(C)C)C
254;100194485;;204768;103318178;90748;10280;76368600;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of binding affinities at Sigma receptor type 2 and type 1;3-Benzyl-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)O
255;100194486;;204768;103318178;90748;10280;76368600;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of binding affinities at Sigma receptor type 2 and type 1;3-Benzyl-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)O
256;100194487;;204768;103317801;15767676;10280;76368600;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of binding affinities at Sigma receptor type 2 and type 1;10-Benzyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=CC=CC=C3C1(CCN2CC4=CC=CC=C4)C
257;100194488;;204768;103317801;15767676;10280;76368600;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of binding affinities at Sigma receptor type 2 and type 1;10-Benzyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=CC=CC=C3C1(CCN2CC4=CC=CC=C4)C
258;100194489;;204768;103318462;15767677;10280;76368600;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of binding affinities at Sigma receptor type 2 and type 1;N-(10-benzyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-yl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)NC(=O)C
259;100194490;;204768;103252465;12259685;10280;76368600;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of binding affinities at Sigma receptor type 2 and type 1;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
260;100194491;;204768;103318128;15767681;10280;76368600;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of binding affinities at Sigma receptor type 2 and type 1;10-Benzyl-4-fluoro-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)F
261;100194492;;204768;103318128;15767681;10280;76368600;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of binding affinities at Sigma receptor type 2 and type 1;10-Benzyl-4-fluoro-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)F
262;100194493;;204768;163336456;9669;10280;76368600;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of binding affinities at Sigma receptor type 2 and type 1;Fortral;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@H]2CC3=C([C@@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
263;100194494;;204768;103318422;15767685;10280;76368600;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of binding affinities at Sigma receptor type 2 and type 1;4-Fluoro-1,13-dimethyl-10-(3-methylbutyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=C(C1(CCN2CCC(C)C)C)C=C(C=C3)F
264;100194495;;204768;103318523;15767682;10280;76368600;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of binding affinities at Sigma receptor type 2 and type 1;10-Benzyl-4-chloro-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)Cl
265;100194496;;204768;103318523;15767682;10280;76368600;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of binding affinities at Sigma receptor type 2 and type 1;10-Benzyl-4-chloro-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)Cl
266;100194497;;204768;103318497;15767680;10280;76368600;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of binding affinities at Sigma receptor type 2 and type 1;N-(10-benzyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-yl)methanesulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)NS(=O)(=O)C
267;100194498;;204768;103318418;44332487;10280;76368600;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of binding affinities at Sigma receptor type 2 and type 1;10-Benzyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),5-dien-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)CC(=O)C=C3
268;100194499;;204768;103318423;10085466;10280;76368600;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of binding affinities at Sigma receptor type 2 and type 1;4-Fluoro-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)F
269;100194500;;204768;103318423;10085466;10280;76368600;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of binding affinities at Sigma receptor type 2 and type 1;4-Fluoro-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)F
270;100194501;;204768;103318492;15767683;10280;76368600;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of binding affinities at Sigma receptor type 2 and type 1;10-Benzyl-4-bromo-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)Br
271;100201384;;229802;103345256;10564493;10280;87844550;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Relative affinity for sigma-1 compared to sigma-2 type receptors;Methyl-[2-(3-nitro-phenyl)-ethyl]-(2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=CC=C1)[N+](=O)[O-])CCN2CCCC2
272;100201385;;229802;103345303;10637326;10280;87844550;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Relative affinity for sigma-1 compared to sigma-2 type receptors;N-Methyl-2-(2-nitro-phenyl)-N-(2-pyrrolidin-1-yl-ethyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCN1CCCC1)C(=O)CC2=CC=CC=C2[N+](=O)[O-]
273;100201386;;229802;103345300;10564492;10280;87844550;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Relative affinity for sigma-1 compared to sigma-2 type receptors;Methyl-[2-(2-nitro-phenyl)-ethyl]-(2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC=CC=C1[N+](=O)[O-])CCN2CCCC2
274;100201387;;229802;103345897;10851124;10280;87844550;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Relative affinity for sigma-1 compared to sigma-2 type receptors;N-Methyl-2-(3-nitro-phenyl)-N-(2-pyrrolidin-1-yl-ethyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCN1CCCC1)C(=O)CC2=CC(=CC=C2)[N+](=O)[O-]
275;100201388;;229802;103346132;401810;10280;87844550;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Relative affinity for sigma-1 compared to sigma-2 type receptors;4-{2-[Methyl-(2-pyrrolidin-1-yl-ethyl)-amino]-ethyl}-phenylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC=C(C=C1)N)CCN2CCCC2
276;100201389;;229802;103345301;10587586;10280;87844550;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Relative affinity for sigma-1 compared to sigma-2 type receptors;[2-(4-Methoxy-phenyl)-ethyl]-methyl-(2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC=C(C=C1)OC)CCN2CCCC2
277;100201390;;229802;103345960;10635235;10280;87844550;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Relative affinity for sigma-1 compared to sigma-2 type receptors;[2-(2-Methoxy-phenyl)-ethyl]-methyl-(2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC=CC=C1OC)CCN2CCCC2
278;100201391;;229802;103346094;401808;10280;87844550;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Relative affinity for sigma-1 compared to sigma-2 type receptors;2-(3-Methoxy-phenyl)-N-methyl-N-(2-pyrrolidin-1-yl-ethyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCN1CCCC1)C(=O)CC2=CC(=CC=C2)OC
279;100201392;;229802;103345222;401812;10280;87844550;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Relative affinity for sigma-1 compared to sigma-2 type receptors;2-{2-[Methyl-(2-pyrrolidin-1-yl-ethyl)-amino]-ethyl}-phenylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC=CC=C1N)CCN2CCCC2
280;100201393;;229802;103345255;10356159;10280;87844550;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Relative affinity for sigma-1 compared to sigma-2 type receptors;Methyl-[2-(4-nitro-phenyl)-ethyl]-(2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC=C(C=C1)[N+](=O)[O-])CCN2CCCC2
281;100201394;;229802;103345961;401804;10280;87844550;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Relative affinity for sigma-1 compared to sigma-2 type receptors;2-(4-Methoxy-phenyl)-N-methyl-N-(2-pyrrolidin-1-yl-ethyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCN1CCCC1)C(=O)CC2=CC=C(C=C2)OC
282;100201395;;229802;103345923;10849098;10280;87844550;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Relative affinity for sigma-1 compared to sigma-2 type receptors;[2-(3-Methoxy-phenyl)-ethyl]-methyl-(2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=CC=C1)OC)CCN2CCCC2
283;100201396;;229802;103345898;398839;10280;87844550;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Relative affinity for sigma-1 compared to sigma-2 type receptors;N-Methyl-2-(4-nitro-phenyl)-N-(2-pyrrolidin-1-yl-ethyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCN1CCCC1)C(=O)CC2=CC=C(C=C2)[N+](=O)[O-]
284;100201397;;229802;103346133;401816;10280;87844550;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Relative affinity for sigma-1 compared to sigma-2 type receptors;3-{2-[Methyl-(2-pyrrolidin-1-yl-ethyl)-amino]-ethyl}-phenylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=CC=C1)N)CCN2CCCC2
285;100201398;;229802;103346095;401806;10280;87844550;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Relative affinity for sigma-1 compared to sigma-2 type receptors;2-(2-Methoxy-phenyl)-N-methyl-N-(2-pyrrolidin-1-yl-ethyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCN1CCCC1)C(=O)CC2=CC=CC=C2OC
286;100206953;;204800;103225352;10805917;10280;91718750;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ki ratio measured as Ki of sigma-2 receptor to that of sigma-1 receptor;4-[1-(4-Fluoro-benzyl)-piperidin-4-ylmethoxy]-benzonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1COC2=CC=C(C=C2)C#N)CC3=CC=C(C=C3)F
287;100207058;;204797;103225534;9864749;10280;91718750;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ki ratio measured as Ki of sigma-2 receptor to that of sigma-1 receptor;4-[1-((E)-3-Iodo-allyl)-piperidin-4-ylmethoxy]-benzonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1COC2=CC=C(C=C2)C#N)C/C=C/I
288;100209044;;204935;103225499;10831286;10280;91718750;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ki ratio measured as Ki of sigma-2 receptor to that of sigma-1 receptor.;1-(4-Fluoro-benzyl)-4-(4-nitro-phenoxymethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1COC2=CC=C(C=C2)[N+](=O)[O-])CC3=CC=C(C=C3)F
289;100213010;;203837;103252465;12259685;10280;95728800;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity for sigma 2 receptor and sigma 1 receptor from guinea pig brain was evaluated;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
290;100213011;;203837;103167216;3559;10280;95728800;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity for sigma 2 receptor and sigma 1 receptor from guinea pig brain was evaluated;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
291;100213012;;203837;103216164;10380647;10280;95728800;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity for sigma 2 receptor and sigma 1 receptor from guinea pig brain was evaluated;Spipethiane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCN(CC2)CC3=CC=CC=C3)SC4=CC=CC=C41
292;100213013;;203837;103216163;10521200;10280;95728800;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity for sigma 2 receptor and sigma 1 receptor from guinea pig brain was evaluated;1'-Benzyl-3,4-dihydrospiro[2H-1-benzothiopyran-2,4'-piperidine]1,1-dioxide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCN(CC2)CC3=CC=CC=C3)S(=O)(=O)C4=CC=CC=C41
293;100213014;;203837;103217409;9839491;10280;95728800;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity for sigma 2 receptor and sigma 1 receptor from guinea pig brain was evaluated;1'-Benzylspiro[tetralin-2,4'-piperidine]-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCN(CC2)CC3=CC=CC=C3)C(=O)C4=CC=CC=C41
294;100213015;;203837;103217373;10661409;10280;95728800;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity for sigma 2 receptor and sigma 1 receptor from guinea pig brain was evaluated;1''-Benzylspiro[chroman-2,4''-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCN(CC2)CC3=CC=CC=C3)OC4=CC=CC=C41
295;100213016;;203837;103216162;10782325;10280;95728800;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity for sigma 2 receptor and sigma 1 receptor from guinea pig brain was evaluated;1'-Benzyl-3,4-dihydrospiro[2H-1-benzothiopyran-2,4'-piperidine]1-oxide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCN(CC2)CC3=CC=CC=C3)S(=O)C4=CC=CC=C41
296;100213784;;203850;103278346;2225138;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-benzylpiperidin-4-yl)-2-(2-nitrophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC=C2[N+](=O)[O-])CC3=CC=CC=C3
297;100213785;;203850;103277872;10499273;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzylpiperidine-4-yl)-2-(2,5-dimethoxyphenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC(=C(C=C1)OC)CC(=O)NC2CCN(CC2)CC3=CC=CC=C3
298;100213786;;203850;103277887;1245023;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-benzylpiperidin-4-yl)-2-(4-chlorophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=C(C=C2)Cl)CC3=CC=CC=C3
299;100213787;;203850;103278189;10712370;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzylpiperidine-4-yl)-2-(3-chlorophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)Cl)CC3=CC=CC=C3
300;100213788;;203850;103278473;9927364;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-benzylpiperidin-4-yl)-2-(2-fluorophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC=C2F)CC3=CC=CC=C3
301;100213789;;203850;103277881;11792375;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzylpiperidine-4-yl)-2-(4-nitrophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=C(C=C2)[N+](=O)[O-])CC3=CC=CC=C3
302;100213790;;203850;103278732;11793400;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzylpiperidine-4-yl)-2-(3,5-dimethoxyphenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC(=CC(=C1)CC(=O)NC2CCN(CC2)CC3=CC=CC=C3)OC
303;100213791;;203850;103278068;10665131;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzylpiperidine-4-yl)-2-(3,4-difluorophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC(=C(C=C2)F)F)CC3=CC=CC=C3
304;100213792;;203850;103278159;2817997;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-benzylpiperidin-4-yl)-2-phenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC=CC=C3
305;100213793;;203850;103278468;10023073;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzyl-piperidin-4-yl)-2-(3-bromo-phenyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)Br)CC3=CC=CC=C3
306;100213794;;203850;103278850;10571211;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;2-(1-Benzyl-piperidin-4-ylamino)-1-(2,3-dimethoxy-phenyl)-ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC(=C1OC)C(CNC2CCN(CC2)CC3=CC=CC=C3)O
307;100213795;;203850;103278173;10712473;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzylpiperidine-4-yl)-2-(2,5-difluorophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=C(C=CC(=C2)F)F)CC3=CC=CC=C3
308;100213796;;203850;103278306;11792374;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzylpiperidine-4-yl)-2-(3-nitrophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)[N+](=O)[O-])CC3=CC=CC=C3
309;100213797;;203850;103278723;6465840;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;1-(1-Benzylpiperidin-4-yl)-3-(2,4-dimethoxyphenyl)urea;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC(=C(C=C1)NC(=O)NC2CCN(CC2)CC3=CC=CC=C3)OC
310;100213798;;203850;103278635;10739649;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzylpiperidine-4-yl)-2-(3,4,5-trimethoxyphenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC(=CC(=C1OC)OC)CC(=O)NC2CCN(CC2)CC3=CC=CC=C3
311;100213799;;203850;103278290;10829840;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzylpiperidine-4-yl)-2-(3-hydroxyphenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)O)CC3=CC=CC=C3
312;100213800;;203850;103277886;10834075;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzylpiperidin-4-yl)-2-(2-bromophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC=C2Br)CC3=CC=CC=C3
313;100213801;;203850;103278821;10594382;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;1-(1-Benzylpiperidine-4-yl)-3-[4-(methylthio)phenyl]urea;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CSC1=CC=C(C=C1)NC(=O)NC2CCN(CC2)CC3=CC=CC=C3
314;100213802;;203850;103278716;10616993;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzylpiperidine-4-yl)-2-(3-methoxyphenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC(=C1)CC(=O)NC2CCN(CC2)CC3=CC=CC=C3
315;100213803;;203850;103278747;10735925;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzyl-piperidin-4-yl)-2-(3,4-dihydroxy-phenyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC(=C(C=C2)O)O)CC3=CC=CC=C3
316;100213804;;203850;103277874;3296345;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzyl-4-piperidinyl)-2-(4-methoxyphenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)CC(=O)NC2CCN(CC2)CC3=CC=CC=C3
317;100213805;;203850;103277885;9208936;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-benzylpiperidin-4-yl)-2-(4-bromophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=C(C=C2)Br)CC3=CC=CC=C3
318;100213806;;203850;103278560;10805927;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzyl-piperidin-4-yl)-2-(4-hydroxy-phenyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=C(C=C2)O)CC3=CC=CC=C3
319;100213807;;203850;103278409;10763386;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzylpiperidine-4-yl)-2-(2,4-dinitrophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-])CC3=CC=CC=C3
320;100213808;;203850;103278445;119265;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;Reduced haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(C3=CC=C(C=C3)F)O
321;100213809;;203850;103278820;10829775;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;2-(4-Amino-phenyl)-N-(1-benzyl-piperidin-4-yl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=C(C=C2)N)CC3=CC=CC=C3
322;100213810;;203850;103277857;4827344;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzyl-4-piperidinyl)-2-(2,4-dichlorophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=C(C=C(C=C2)Cl)Cl)CC3=CC=CC=C3
323;100213811;;203850;103278066;10617417;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzyl-piperidin-4-yl)-2-(3,5-difluoro-phenyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC(=CC(=C2)F)F)CC3=CC=CC=C3
324;100213812;;203850;103167216;3559;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
325;100213813;;203850;103277871;10666733;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzylpiperidine-4-yl)-2-(3,4-dimethoxyphenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=C(C=C1)CC(=O)NC2CCN(CC2)CC3=CC=CC=C3)OC
326;100213814;;203850;103278105;11791714;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzylpiperidine-4-yl)-2-(2,6-difluorophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=C(C=CC=C2F)F)CC3=CC=CC=C3
327;100213815;;203850;103278541;10762065;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzylpiperidine-4-yl)-2-[4-(trifluoromethyl)phenyl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=C(C=C2)C(F)(F)F)CC3=CC=CC=C3
328;100213816;;203850;103277898;10736122;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-benzylpiperidin-4-yl)-2-(2-chlorophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC=C2Cl)CC3=CC=CC=C3
329;100213817;;203850;103278291;10711119;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzylpiperidine-4-yl)-2-(2-hydroxyphenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC=C2O)CC3=CC=CC=C3
330;100213818;;203850;103278634;10689336;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;2-Benzo[1,3]dioxol-5-yl-N-(1-benzyl-piperidin-4-yl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC3=C(C=C2)OCO3)CC4=CC=CC=C4
331;100213819;;203850;103278838;10592242;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzyl-4-piperidinyl)-2-(4-fluorophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=C(C=C2)F)CC3=CC=CC=C3
332;100213820;;203850;103278011;10665130;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzylpiperidine-4-yl)-2-(2,4-difluorophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=C(C=C(C=C2)F)F)CC3=CC=CC=C3
333;100213821;;203850;103278065;11793930;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzyl-piperidin-4-yl)-2-(2-trifluoromethyl-phenyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC=C2C(F)(F)F)CC3=CC=CC=C3
334;100213822;;203850;103278426;10762119;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzylpiperidine-4-yl)-2-(3,4-dichlorophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC(=C(C=C2)Cl)Cl)CC3=CC=CC=C3
335;100213823;;203850;103278467;10738339;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-benzylpiperidin-4-yl)-2-(2,6-dichlorophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=C(C=CC=C2Cl)Cl)CC3=CC=CC=C3
336;100213824;;203850;103278744;2729533;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-benzylpiperidin-4-yl)-2-(2-methoxyphenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1CC(=O)NC2CCN(CC2)CC3=CC=CC=C3
337;100213825;;203850;103278869;10616126;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzylpiperidine-4-yl)-2-(3-fluorophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)F)CC3=CC=CC=C3
338;100213826;;203850;103278559;10642179;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzyl-piperidin-4-yl)-2-(3-chloro-4-hydroxy-phenyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC(=C(C=C2)O)Cl)CC3=CC=CC=C3
339;100213827;;203850;103278677;11793931;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-benzylpiperidin-4-yl)-2-[3-(trifluoromethyl)phenyl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)C(F)(F)F)CC3=CC=CC=C3
340;100213828;;203850;103278823;10689502;10280;96323690;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity ratio for sigma 2 receptor site in rat liver membranes and sigma 1 receptor site in quinea pig brain membranes;N-(1-Benzylpiperidine-4-yl)-2-[4-(methylthio)phenyl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CSC1=CC=C(C=C1)CC(=O)NC2CCN(CC2)CC3=CC=CC=C3
341;100216424;;203693;103389233;10644162;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;1-[4-(3-Phenylpropyl)piperazine-1-yl]-2-(3,4-dichlorophenyl)ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)C(=O)CC3=CC(=C(C=C3)Cl)Cl
342;100216632;;203693;103389303;10546938;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;1-[4-(3-Phenylpropyl)piperazine-1-yl]-2-(3-nitrophenyl)ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)C(=O)CC3=CC(=CC=C3)[N+](=O)[O-]
343;100216633;;203693;103389969;10571528;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;[3-[4-(3-Phenylpropyl)piperazine-1-yl]-3-oxopropyl]carbamic acid tert-butyl ester;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC(=O)NCCC(=O)N1CCN(CC1)CCCC2=CC=CC=C2
344;100216634;;203693;103389275;401820;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;1-[4-(3-Phenylpropyl)piperazine-1-yl]-2-(3-methoxyphenyl)ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC(=C1)CC(=O)N2CCN(CC2)CCCC3=CC=CC=C3
345;100216635;;203693;103389793;401860;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;1-(3-Phenylpropyl)-4-(2-methoxyphenethyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1CCN2CCN(CC2)CCCC3=CC=CC=C3
346;100216636;;203693;103389274;10522997;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;1-[4-(3-Phenylpropyl)piperazine-1-yl]-2-(2-nitrophenyl)ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)C(=O)CC3=CC=CC=C3[N+](=O)[O-]
347;100216637;;203693;103389849;401827;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;1-(3-Phenylpropyl)-4-(3,4-dichlorophenethyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)CCC3=CC(=C(C=C3)Cl)Cl
348;100216638;;203693;103389472;401843;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;3-Amino-1-[4-(3-phenyl-propyl)-piperazin-1-yl]-propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)C(=O)CCN
349;100216639;;203693;103389444;401854;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;2-[2-[4-(3-Phenylpropyl)piperazine-1-yl]ethyl]benzenamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)CCC3=CC=CC=C3N
350;100216640;;203693;103390160;401822;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;1-[4-(3-Phenylpropyl)piperazine-1-yl]-2-(4-methoxyphenyl)ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)CC(=O)N2CCN(CC2)CCCC3=CC=CC=C3
351;100216641;;203693;103389254;9864023;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;1-[4-(3-Phenylpropyl)piperazine-1-yl]-2-(4-nitrophenyl)ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)C(=O)CC3=CC=C(C=C3)[N+](=O)[O-]
352;100216642;;203693;103389504;401844;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;2-Amino-1-[4-(3-phenyl-propyl)-piperazin-1-yl]-ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)C(=O)CN
353;100216643;;203693;103389824;401829;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;1-(3-Phenylpropyl)-4-(4-methoxyphenethyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)CCN2CCN(CC2)CCCC3=CC=CC=C3
354;100216644;;203693;103389852;10660038;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;4-[4-(3-Phenyl-propyl)-piperazin-1-yl]-butylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCCN)CCCC2=CC=CC=C2
355;100216645;;203693;103389470;401846;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;2-[4-(3-Phenylpropyl)piperazine-1-yl]ethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)CCN
356;100216646;;203693;103389887;10473287;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;1-(3-Phenylpropyl)-4-(2-nitrophenethyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)CCC3=CC=CC=C3[N+](=O)[O-]
357;100216647;;203693;103389850;401862;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;1-(3-Phenylpropyl)-4-(3-methoxyphenethyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC(=C1)CCN2CCN(CC2)CCCC3=CC=CC=C3
358;100216648;;203693;103390030;44364145;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;1-[4-(4-Methoxyphenethyl)piperazine-1-yl]-2-(4-methoxyphenyl)ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)CCN2CCN(CC2)C(=O)CC3=CC=C(C=C3)OC
359;100216649;;203693;103389979;10570139;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;1,4-Bis-[2-(3-methoxy-phenyl)-ethyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC(=C1)CCN2CCN(CC2)CCC3=CC(=CC=C3)OC
360;100216650;;203693;103389392;10641797;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;1-(3-Phenylpropyl)-4-(4-nitrophenethyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)CCC3=CC=C(C=C3)[N+](=O)[O-]
361;100216651;;203693;103389978;401826;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;1,4-Bis-[2-(4-methoxy-phenyl)-ethyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)CCN2CCN(CC2)CCC3=CC=C(C=C3)OC
362;100216652;;203693;103390029;10618129;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;1,4-Bis-[2-(2-methoxy-phenyl)-ethyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1CCN2CCN(CC2)CCC3=CC=CC=C3OC
363;100216653;;203693;103389853;10539358;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;3-[4-(3-Phenyl-propyl)-piperazin-1-yl]-propylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)CCCN
364;100216654;;203693;103389886;10338172;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;1-(3-Phenylpropyl)-4-(3-nitrophenethyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)CCC3=CC(=CC=C3)[N+](=O)[O-]
365;100216655;;203693;103389255;401818;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;1-[4-(3-Phenylpropyl)piperazine-1-yl]-2-(2-methoxyphenyl)ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1CC(=O)N2CCN(CC2)CCCC3=CC=CC=C3
366;100216656;;203693;103389414;401850;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;4-[2-[4-(3-Phenylpropyl)piperazine-1-yl]ethyl]benzenamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)CCC3=CC=C(C=C3)N
367;100216657;;203693;103390159;44364189;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;1-[4-(2-Methoxyphenethyl)piperazine-1-yl]-2-(2-methoxyphenyl)ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1CCN2CCN(CC2)C(=O)CC3=CC=CC=C3OC
368;100216869;;203693;103389997;10691769;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;[4-[4-(3-Phenylpropyl)piperazine-1-yl]-4-oxobutyl]carbamic acid tert-butyl ester;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC(=O)NCCCC(=O)N1CCN(CC1)CCCC2=CC=CC=C2
369;100216870;;203693;103389471;10779812;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;1-[4-(3-Phenylpropyl)piperazine-1-yl]-4-amino-1-butanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)C(=O)CCCN
370;100216871;;203693;103389416;401856;10280;98366120;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki value of sigma-1 receptor site to that of sigma-2 receptor site;3-[2-[4-(3-Phenylpropyl)piperazine-1-yl]ethyl]benzenamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)CCC3=CC(=CC=C3)N
371;100218962;;234394;103177652;10017936;10280;95442130;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio between the Ki(nM)values of sigma-2 and sigma-1;3-(2-Piperidinoethyl)-6-propylbenzothiazol-2(3H)-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCC1=CC2=C(C=C1)N(C(=O)S2)CCN3CCCCC3
372;100218963;;234394;103177773;10828366;10280;95442130;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio between the Ki(nM)values of sigma-2 and sigma-1;6-Propionyl-3-(2-pyrrolidin-1-yl-ethyl)-3H-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)C1=CC2=C(C=C1)N(C(=O)S2)CCN3CCCC3
373;100218964;;234394;103177730;10733148;10280;95442130;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio between the Ki(nM)values of sigma-2 and sigma-1;3-(2-Piperidin-1-yl-ethyl)-6-propionyl-3H-benzooxazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)C1=CC2=C(C=C1)N(C(=O)O2)CCN3CCCCC3
374;100218965;;234394;103177691;473073;10280;95442130;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio between the Ki(nM)values of sigma-2 and sigma-1;3-(2-Piperidin-1-yl-ethyl)-6-propionyl-3H-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)C1=CC2=C(C=C1)N(C(=O)S2)CCN3CCCCC3
375;100218966;;234394;103177817;10662728;10280;95442130;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio between the Ki(nM)values of sigma-2 and sigma-1;3-[2-(Dimethylamino)ethyl]-6-benzoylbenzoxazol-2(3H)-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCN1C2=C(C=C(C=C2)C(=O)C3=CC=CC=C3)OC1=O
376;100218967;;234394;103177933;473059;10280;95442130;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio between the Ki(nM)values of sigma-2 and sigma-1;6-Benzyl-3-(2-morpholinoethyl)-1,3-benzoxazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCN1CCN2C3=C(C=C(C=C3)CC4=CC=CC=C4)OC2=O
377;100218968;;234394;103177905;10614630;10280;95442130;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio between the Ki(nM)values of sigma-2 and sigma-1;3-(2-Dimethylamino-ethyl)-6-pentanoyl-3H-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCC(=O)C1=CC2=C(C=C1)N(C(=O)S2)CCN(C)C
378;100218969;;234482;103177932;11792320;10280;95442130;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio between the Ki(nM)values of sigma-2 and sigma-1;6-Benzoyl-3-(2-pyrrolidin-1-yl-ethyl)-3H-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(C1)CCN2C3=C(C=C(C=C3)C(=O)C4=CC=CC=C4)SC2=O
379;100219148;;203838;103177882;10635279;10280;95442130;Literature-derived;20200704;0;0;Unspecified;Q99720;;;ChEMBL;Ratio between the Ki(nM)values of sigma-2 and sigma-1;3,6-Dipropanoylbenzothiazol-2(3H)-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)C1=CC2=C(C=C1)N(C(=O)S2)C(=O)CC
380;100230221;;204156;103678333;9823428;10280;105084440;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement; Not tested.";"1-[4-methoxy-3-(2-phenylethoxy)phenyl]-5-methyl-N-propylhexan-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCNC(CCC(C)C)CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2.Cl
381;100230245;;204156;103678333;9823428;10280;105084440;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement; Not tested.";"1-[4-methoxy-3-(2-phenylethoxy)phenyl]-5-methyl-N-propylhexan-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCNC(CCC(C)C)CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2.Cl
382;100230246;;204296;103669493;18986843;10280;105084440;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"In vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine; Not tested.";"2-[4-Methoxy-3-(2-phenylethoxy)phenyl]ethanamine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C=C1)CCN)OCCC2=CC=CC=C2.Cl
383;100230247;;204296;103669496;18986852;10280;105084440;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"In vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine; Not tested.";N-n-propyl-2-[4-methoxy-3-(2-phenylethoxy)phenyl]ethylamine hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCNCCC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2.Cl
384;100230248;;204296;103673257;45261873;10280;105084440;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"In vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine; Not tested.";"1-[4-methoxy-3-(2-phenylethoxy)phenyl]-N,N-dipropylheptan-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N(CCC)CCC.Cl
385;100230249;;204296;103361798;10503221;10280;105084440;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"In vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine; Not tested.";[1-(4-Methoxy-3-phenethyloxy-benzyl)-heptyl]-dipropyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N(CCC)CCC
386;100230250;;204296;103678287;45265169;10280;105084440;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"In vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine; Not tested.";"1-[4-Methoxy-3-(2-phenylethoxy)phenyl]butan-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N.Cl
387;100230251;;204296;103361823;10642861;10280;105084440;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"In vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine; Not tested.";1-(4-Methoxy-3-phenethyloxy-benzyl)-octylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N
388;100230252;;204296;103361930;10618199;10280;105084440;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"In vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine; Not tested.";1-(4-Methoxy-3-phenethyloxy-benzyl)-heptylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N
389;100230253;;204296;103673246;45261862;10280;105084440;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"In vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine; Not tested.";"1-[4-methoxy-3-(2-phenylethoxy)phenyl]-N-propylpropan-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCNC(C)CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2.Cl
390;100230254;;204296;103361381;10666808;10280;105084440;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"In vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine; Not tested.";[2-(4-Methoxy-3-phenethyloxy-phenyl)-1-methyl-ethyl]-dipropyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCN(CCC)C(C)CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2
391;100230255;;204296;103361484;10764130;10280;105084440;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"In vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine; Not tested.";[1-(4-Methoxy-3-phenethyloxy-benzyl)-pentyl]-dipropyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N(CCC)CCC
392;100230256;;204296;103678353;45265213;10280;105084440;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"In vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine; Not tested.";"1-[4-Methoxy-3-(2-phenylethoxy)phenyl]propan-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N.Cl
393;100230257;;204296;103361354;10811587;10280;105084440;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"In vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine; Not tested.";[1-(4-Methoxy-3-phenethyloxy-benzyl)-octyl]-propyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)NCCC
394;100230258;;204296;103361672;44351760;10280;105084440;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"In vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine; Not tested.";"(E)-but-2-enedioic acid;4-[[4-methoxy-3-(2-phenylethoxy)phenyl]methyl]heptan-4-amine";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCC(CCC)(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N.C(=C/C(=O)O)\C(=O)O
395;100230259;;204296;103172152;18986896;10280;105084440;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"In vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine; Not tested.";"1-[2-[4-Methoxy-3-(2-phenylethoxy)phenyl]ethyl]pyrrolidine;oxalic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C=C1)CCN2CCCC2)OCCC3=CC=CC=C3.C(=O)(C(=O)O)O
396;100230260;;204296;103361793;10599798;10280;105084440;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"In vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine; Not tested.";[1-(4-Methoxy-3-phenethyloxy-benzyl)-octyl]-dipropyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N(CCC)CCC
397;100230261;;204296;103673331;45261928;10280;105084440;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"In vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine; Not tested.";"1-[4-Methoxy-3-(2-phenylethoxy)phenyl]pentan-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N.Cl
398;100230262;;204296;103673293;45261904;10280;105084440;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"In vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine; Not tested.";"1-[4-Methoxy-3-(2-phenylethoxy)phenyl]heptan-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N.Cl
399;100230471;;204162;103311010;10717135;10280;104250950;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"Binding affinity against Sigma opioid receptor type 1 in guinea pig brain membranes using [3H](+)-pentazocine as radioligand; Not tested";trans-trans-1-(4-Fluorobenzyl)-6-(4-phenylpiperidin-1-yl)-decahydroquinolin-7-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C[C@@H]2C[C@H]([C@@H](C[C@H]2N(C1)CC3=CC=C(C=C3)F)O)N4CCC(CC4)C5=CC=CC=C5
400;100230472;;204162;103311011;10744775;10280;104250950;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"Binding affinity against Sigma opioid receptor type 1 in guinea pig brain membranes using [3H](+)-pentazocine as radioligand; Not tested";trans-trans-1-(3-Iodobenzyl)-6-(4-phenylpiperidin-1-yl)-decahydroquinolin-7-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C[C@@H]2C[C@H]([C@@H](C[C@H]2N(C1)CC3=CC(=CC=C3)I)O)N4CCC(CC4)C5=CC=CC=C5
401;100230473;;204162;103310962;10768549;10280;104250950;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"Binding affinity against Sigma opioid receptor type 1 in guinea pig brain membranes using [3H](+)-pentazocine as radioligand; Not tested";trans-trans-1-(3-Iodobenzyl)-7-(4-phenylpiperidin-1-yl)-decahydroquinolin-6-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C[C@@H]2C[C@H]([C@@H](C[C@H]2N(C1)CC3=CC(=CC=C3)I)N4CCC(CC4)C5=CC=CC=C5)O
402;100230474;;204162;103310962;10768549;10280;104250950;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"Binding affinity against Sigma opioid receptor type 1 in guinea pig brain membranes using [3H](+)-pentazocine as radioligand; Not tested";trans-trans-1-(3-Iodobenzyl)-7-(4-phenylpiperidin-1-yl)-decahydroquinolin-6-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C[C@@H]2C[C@H]([C@@H](C[C@H]2N(C1)CC3=CC(=CC=C3)I)N4CCC(CC4)C5=CC=CC=C5)O
403;100230475;;204162;103311096;9859994;10280;104250950;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"Binding affinity against Sigma opioid receptor type 1 in guinea pig brain membranes using [3H](+)-pentazocine as radioligand; Not tested";Trozamicol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CNC[C@H]([C@@H]1O)N2CCC(CC2)C3=CC=CC=C3
404;100230511;;204296;103361384;10646068;10280;105084440;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"In vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine; Not tested.";[1-(4-Methoxy-3-phenethyloxy-benzyl)-nonyl]-propyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCCCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)NCCC
405;100230512;;204296;103679645;45266087;10280;105084440;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"In vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine; Not tested.";"1-[4-Methoxy-3-(2-phenylethoxy)phenyl]-5-methylhexan-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC(C)CCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N.Cl
406;100230513;;204296;103361789;11794387;10280;105084440;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"In vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine; Not tested.";1-(4-Methoxy-3-phenethyloxy-benzyl)-nonylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCCCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N
407;100230514;;204296;103361400;10616210;10280;105084440;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"In vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine; Not tested.";1-(4-Methoxy-3-phenethyloxy-benzyl)-pentylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N
408;100230515;;204296;103361767;10504449;10280;105084440;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"In vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine; Not tested.";[1-(4-Methoxy-3-phenethyloxy-benzyl)-nonyl]-dipropyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCCCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N(CCC)CCC
409;100235741;;204760;163312619;10086238;10280;78372400;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"In vitro binding affinity towards Sigma receptor type 1 was determined by measuring its ability to displace [3H](+)-pentazocine from guinea pig brain membrane; Not assayed";3-(5-fluoropentylsulfanyl)-4-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)-1,2,5-thiadiazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC=C(C1)C2=NSN=C2SCCCCCF
410;100235742;;204760;103421045;44378914;10280;78372400;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"In vitro binding affinity towards Sigma receptor type 1 was determined by measuring its ability to displace [3H](+)-pentazocine from guinea pig brain membrane; Not assayed";1-Methyl-4-(4-pentylsulfanyl-[1,2,5]thiadiazol-3-yl)-1,2,3,6-tetrahydro-pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCCSC1=NSN=C1C2=CCN(CC2)C
411;100236213;;204449;103165167;2756;10280;85688040;Literature-derived;20220318;0;0;Inactive;Q99720;;;ChEMBL;"Inhibitory activity against sigma receptor isolated from guinea pig brain cortex membrane using [3H]DTG as radioligand; Inactive";Cimetidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(N=CN1)CSCCNC(=NC)NC#N
412;100236214;;204449;194154859;11968014;10280;85688040;Literature-derived;20220318;0;0;Inactive;Q99720;;;ChEMBL;"Inhibitory activity against sigma receptor isolated from guinea pig brain cortex membrane using [3H]DTG as radioligand; Inactive";[(1R,2S,4S,5S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1[C@@H]2CC(C[C@H]1[C@H]3[C@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4
413;100236551;;229199;103384791;10693949;10280;89413830;Literature-derived;20220318;0;0;Unspecified;Q99720;;;ChEMBL;"Compound was tested for binding affinity against sigma receptor using radioligand ([3H](+)-pentazocine) binding assay;n/d= not done";N-(2-benzhydryloxyethyl)-2,2-dimethyl-N'-(3-phenylpropyl)propane-1,3-diamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CNCCCC1=CC=CC=C1)CNCCOC(C2=CC=CC=C2)C3=CC=CC=C3
414;100236552;;229199;103384282;10757515;10280;89413830;Literature-derived;20220318;0;0;Unspecified;Q99720;;;ChEMBL;"Compound was tested for binding affinity against sigma receptor using radioligand ([3H](+)-pentazocine) binding assay;n/d= not done";N*1*-(2-Benzhydryloxy-ethyl)-2,2-dimethyl-propane-1,3-diamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CN)CNCCOC(C1=CC=CC=C1)C2=CC=CC=C2
415;100237174;;229198;103383894;621280;10280;89413830;Literature-derived;20220318;0;0;Unspecified;Q99720;;;ChEMBL;"Compound was tested for binding affinity against sigma receptor using radioligand ([3H](+)-pentazocine) binding assay; n/d= not done";1,4-Diazacycloheptane, 1-[2-(diphenylmethoxy)ethyl]-4-[3-phenpropyl]-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1(CN(CCN(C1)CCOC(C2=CC=CC=C2)C3=CC=CC=C3)CCCC4=CC=CC=C4)C
416;100243600;;203858;103735218;46878003;10280;21725380;Literature-derived;20220318;0;0;Inactive;Q99720;;;ChEMBL;"Compound was evaluated by measuring the affinity of compound to Sigma opioid receptor labelled with [3H](+)-3-PPP; no inhibition";3-Chloro-N-methyl-N-[(1R)-2beta-(1-pyrrolidinyl)cyclohexan-1beta-yl]benzeneacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)CC3=CC(=CC=C3)Cl
417;100244584;;203983;103241016;14895997;10280;16481400;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"In vitro affinity to bind competitively with sigma opioid receptor in the homogenized guinea pig whole brain using [3H]DTG as radioligand; ND- Not determined";1-(1-Adamantyl)-3-(4-hydroxyphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C2CC3CC1CC(C2)(C3)N=C(N)NC4=CC=C(C=C4)O
418;100244585;;203983;103241057;15065455;10280;16481400;Literature-derived;20220318;0;0;Inconclusive;Q99720;;;ChEMBL;"In vitro affinity to bind competitively with sigma opioid receptor in the homogenized guinea pig whole brain using [3H]DTG as radioligand; ND- Not determined";1-(1-Adamantyl)-3-(4-hydroxy-2-methylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=C(C=CC(=C1)O)NC(=NC23CC4CC(C2)CC(C4)C3)N
419;100297836;;239347;103215995;1549008;10280;160332550;Confirmatory;20220830;0;0;Inconclusive;Q99720;Ki;;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;Terbinafine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)C#C/C=C/CN(C)CC1=CC=CC2=CC=CC=C21
420;100319792;;204154;103678347;19606389;10280;105084440;Confirmatory;20220830;0;0;Inconclusive;Q99720;IC50;;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;"1-[4-methoxy-3-(2-phenylethoxy)phenyl]-N-propylhexan-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)NCCC.Cl
421;100497235;;203984;103196448;10001519;10280;76997100;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;1-[4-[4-(2-Methoxyphenyl)piperazino]butyl]-5-methoxy-1,2,3,4-tetrahydronaphthalene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1N2CCN(CC2)CCCCC3CCCC4=C3C=CC=C4OC
422;100497236;;203984;103432696;11742092;10280;76997100;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;1-[4-[4-(2-Methoxyphenyl)piperazino]butyl]-5-methoxy-3,4-dihydronaphthalene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1N2CCN(CC2)CCCCC3=CCCC4=C3C=CC=C4OC
423;100497245;;203984;103431821;10408398;10280;76997100;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;1-[[2-[4-(2-Methoxyphenyl)piperazino]ethyl]amino]-7-methoxy-1,2,3,4-tetrahydronaphthalene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(CCCC2NCCN3CCN(CC3)C4=CC=CC=C4OC)C=C1
424;100497246;;203984;103434411;10067369;10280;76997100;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;1-[3-[4-(2-Methoxyphenyl)piperazino]propyl]-1,2,3,4-tetrahydronaphthalene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1N2CCN(CC2)CCCC3CCCC4=CC=CC=C34
425;100497247;;203984;103434579;10025711;10280;76997100;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;1-[3-(7-Methoxy-3,4-dihydro-naphthalen-1-yl)-propyl]-4-(3-trifluoromethyl-phenyl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(CCC=C2CCCN3CCN(CC3)C4=CC=CC(=C4)C(F)(F)F)C=C1
426;100497248;;203984;103436551;10406491;10280;76997100;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;1-[3-(4-Phenylpiperazino)propyl]-7-methoxy-1,2,3,4-tetrahydronaphthalene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(CCCC2CCCN3CCN(CC3)C4=CC=CC=C4)C=C1
427;100497404;;203984;103436152;10409457;10280;76997100;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;1-[[2-[4-(2-Methoxyphenyl)piperazino]ethyl]thio]-5-methoxy-1,2,3,4-tetrahydronaphthalene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1N2CCN(CC2)CCSC3CCCC4=C3C=CC=C4OC
428;100497408;;203984;103434449;10025712;10280;76997100;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;1-[3-(5-Methoxy-3,4-dihydro-naphthalen-1-yl)-propyl]-4-(3-trifluoromethyl-phenyl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCC=C2CCCN3CCN(CC3)C4=CC=CC(=C4)C(F)(F)F
429;100497409;;203984;103434718;10388096;10280;76997100;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;1-[3-[4-[3-(Trifluoromethyl)phenyl]piperazino]propyl]-5-methoxy-1,2,3,4-tetrahydronaphthalene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCCC2CCCN3CCN(CC3)C4=CC=CC(=C4)C(F)(F)F
430;100745594;;204454;103247676;15729913;10280;;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;;ChEMBL;In vitro binding affinity towards sigma receptor by the displacement of [3H]PPP from guinea pig brain;1-Cyclohexyl-1-(4-fluorophenyl)-4-(4-(5-fluoro-2-pyrimidinyl)-1-piperazinyl)-1-butanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)C(CCCN2CCN(CC2)C3=NC=C(C=N3)F)(C4=CC=C(C=C4)F)O
431;100745605;;204454;103247766;15729908;10280;;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;;ChEMBL;In vitro binding affinity towards sigma receptor by the displacement of [3H]PPP from guinea pig brain;2-[4-(4-Cyclohexyl-butyl)-piperazin-1-yl]-5-fluoro-pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)CCCCN2CCN(CC2)C3=NC=C(C=N3)F
432;100800763;;229170;103378082;11064325;10280;117841480;Literature-derived;20230314;0;0;Unspecified;Q99720;;;ChEMBL;"Selectivity ratio (Sigma1/Sigma2); ND is Not Data";3-Methoxy-3,4-dihydrospiro[1H-2-benzopyran-1,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1CC2=CC=CC=C2C3(O1)CCNCC3
433;100800764;;229170;103378195;11758674;10280;117841480;Literature-derived;20230314;0;0;Unspecified;Q99720;;;ChEMBL;"Selectivity ratio (Sigma1/Sigma2); ND is Not Data";1'-Phenyl-3-methoxy-3,4-dihydrospiro[1H-2-benzopyran-1,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1CC2=CC=CC=C2C3(O1)CCN(CC3)C4=CC=CC=C4
434;100801812;;229170;103378194;14976641;10280;117841480;Literature-derived;20230314;0;0;Unspecified;Q99720;;;ChEMBL;"Selectivity ratio (Sigma1/Sigma2); ND is Not Data";3-Methoxy-1'-methylspiro[isochroman-1,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1)C3=CC=CC=C3CC(O2)OC
435;100901195;;243571;103451967;10434776;10280;153802020;Literature-derived;20181018;0;0;Unspecified;Q99720;;;ChEMBL;Inhibitory activity against Opioid receptor sigma 1 at 10 uM;N-(2-Diethylamino-ethyl)-2-methoxy-4-[3-(4-trifluoromethoxy-phenyl)-ureido]-benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CC)CCNC(=O)C1=C(C=C(C=C1)NC(=O)NC2=CC=C(C=C2)OC(F)(F)F)OC
436;100928530;;256527;103468464;44403182;10280;161400110;Literature-derived;20181018;0;0;Inconclusive;Q99720;;;ChEMBL;Ratio of inhibitory concentration against rat opioid receptor sigma 2 and guinea pig opioid receptor sigma 1;(8aS)-2-(2-piperidin-1-ylethyl)-6,7,8,8a-tetrahydro-5H-imidazo[1,5-a]pyridine-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C(=O)[C@@H]3CCCCN3C2=O
437;100928531;;256527;103468578;44403249;10280;161400110;Literature-derived;20181018;0;0;Inconclusive;Q99720;;;ChEMBL;Ratio of inhibitory concentration against rat opioid receptor sigma 2 and guinea pig opioid receptor sigma 1;(10aS)-10,10a-Dihydro-7-hydroxy-2-[2-(1-piperidinyl)ethyl]imidazo[1,5-b]isoquinoline-1,3(2H,5H)-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C(=O)[C@@H]3CC4=C(CN3C2=O)C=C(C=C4)O
438;100940016;;258873;103476625;135453290;10280;163928160;Literature-derived;20181020;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of non selective binding to sigma receptor at 1 nM;1-((S)-2-aminopropyl)-1H-indazol-6-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](CN1C2=C(C=CC(=C2)O)C=N1)N
439;100940017;;258875;103476625;135453290;10280;163928160;Literature-derived;20181020;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of non selective binding to sigma receptor at 10 uM;1-((S)-2-aminopropyl)-1H-indazol-6-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](CN1C2=C(C=CC(=C2)O)C=N1)N
440;100940589;;258874;103476625;135453290;10280;163928160;Literature-derived;20181020;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of non selective binding to sigma receptor at 100 nM;1-((S)-2-aminopropyl)-1H-indazol-6-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](CN1C2=C(C=CC(=C2)O)C=N1)N
441;100964362;;265275;103570372;9851104;10280;167226310;Confirmatory;20181020;0;0;Inconclusive;Q99720;Ki;;ChEMBL;Binding affinity to sigma receptor by radioligand binding assay;cyclo(Arg-Gly-Asp-D-Phe-Val);SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C(=O)N1)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N
442;100969153;;267388;103493230;9930121;10280;168218010;Literature-derived;20181020;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma receptor at 1 uM;N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN2CCC1[C@H](C2)NC(=O)C3=NC=C4C(=C3)C=CO4
443;100981097;;271831;103501213;11647012;10280;171544910;Literature-derived;20181020;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma receptor at 10 uM;2-[4-bromo-2-(1-phenylpyrazole-4-carbonyl)phenoxy]acetic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)N2C=C(C=N2)C(=O)C3=C(C=CC(=C3)Br)OCC(=O)O
444;100985469;;273936;103501289;11539096;10280;172344050;Literature-derived;20181021;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma receptor at 10uM;7-Fluorochromone-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)C2=CC(=O)C3=C(O2)C=C(C=C3)F)CC4=CC5=C(C=C4)OCO5
445;100985470;;273936;103502580;11583193;10280;172344050;Literature-derived;20181021;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma receptor at 10uM;7-fluoro-4-oxo-N-(1-((2-oxo-2H-chromen-7-yl)methyl)piperidin-4-yl)-4H-chromene-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)C2=CC(=O)C3=C(O2)C=C(C=C3)F)CC4=CC5=C(C=C4)C=CC(=O)O5
446;101076495;;303171;103540481;10150497;10280;179489780;Literature-derived;20181022;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of radio ligand from Sigma 1 receptor at 100 nM;2-(1-((6-Chloroimidazo(2,1-b)(1,3)thiazol-5-yl)sulfonyl)-1H-indol-3-yl)ethylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C2C(=C1)C(=CN2S(=O)(=O)C3=C(N=C4N3C=CS4)Cl)CCN
447;101093436;;309245;103552313;10142792;10280;177204920;Literature-derived;20181022;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma 1 receptor at 10 uM;(S)-N-(2-(3-(2,4-dimethylbenzylamino)-1-(tert-butylamino)-1-oxopropan-2-ylamino)-2-oxoethyl)-2-amino-5-(trifluoromethyl)benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=C(C=C1)CNC[C@@H](C(=O)NC(C)(C)C)NC(=O)CNC(=O)C2=C(C=CC(=C2)C(F)(F)F)N)C
448;101248292;;390199;103646952;25093235;10280;188341070;Literature-derived;20181026;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of human sigma 1-type opioid receptor at 3 uM;N-(2-(2-(dimethylamino)ethoxy)-4-(1H-pyrazol-4-yl)phenyl)-2,3-dihydrobenzo[b][1,4]dioxine-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCOC1=C(C=CC(=C1)C2=CNN=C2)NC(=O)C3COC4=CC=CC=C4O3
449;101328274;;256534;103468525;44403211;10280;161400090;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity index against opioid receptor sigma 1 versus cytotoxicity to that of inhibitory concentration;(10aS)-2-[3-[benzyl(methyl)amino]propyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCN1C(=O)[C@@H]2CC3=CC=CC=C3CN2C1=O)CC4=CC=CC=C4
450;101328275;;256534;103468512;44403205;10280;161400090;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity index against opioid receptor sigma 1 versus cytotoxicity to that of inhibitory concentration;(10aS)-2-[2-[methyl(3-phenylpropyl)amino]ethyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCC1=CC=CC=C1)CCN2C(=O)[C@@H]3CC4=CC=CC=C4CN3C2=O
451;101328276;;256534;103468532;44403216;10280;161400090;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity index against opioid receptor sigma 1 versus cytotoxicity to that of inhibitory concentration;(10aS)-2-[4-[methyl(2-phenylethyl)amino]butyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCCN1C(=O)[C@@H]2CC3=CC=CC=C3CN2C1=O)CCC4=CC=CC=C4
452;101328277;;256534;103468539;44403221;10280;161400090;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity index against opioid receptor sigma 1 versus cytotoxicity to that of inhibitory concentration;(10aS)-2-[5-[benzyl(methyl)amino]pentyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCCCN1C(=O)[C@@H]2CC3=CC=CC=C3CN2C1=O)CC4=CC=CC=C4
453;101328278;;256534;103468503;44403202;10280;161400090;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity index against opioid receptor sigma 1 versus cytotoxicity to that of inhibitory concentration;(10aS)-2-[2-[benzyl(methyl)amino]ethyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCN1C(=O)[C@@H]2CC3=CC=CC=C3CN2C1=O)CC4=CC=CC=C4
454;101328279;;256534;103468502;44403201;10280;161400090;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Selectivity index against opioid receptor sigma 1 versus cytotoxicity to that of inhibitory concentration;(10aS)-2-[3-(4-phenylbutylamino)propyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@H]2C(=O)N(C(=O)N2CC3=CC=CC=C31)CCCNCCCCC4=CC=CC=C4
455;101328765;;255170;103167216;3559;10280;161400110;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of inhibitory concentration against rat opioid receptor sigma 2 and guinea pig opioid sigma 1;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
456;101328766;;255170;103468465;44403183;10280;161400110;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of inhibitory concentration against rat opioid receptor sigma 2 and guinea pig opioid sigma 1;(10aR)-2-(2-piperidin-1-ylethyl)-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C(=O)[C@H]3CC4=CC=CC=C4CN3C2=O
457;101328767;;255170;103468463;44403181;10280;161400110;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of inhibitory concentration against rat opioid receptor sigma 2 and guinea pig opioid sigma 1;(3aS)-2-(3-piperidin-1-ylpropyl)-3a,4-dihydroimidazo[1,5-a]indole-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCCN2C(=O)[C@@H]3CC4=CC=CC=C4N3C2=O
458;101328768;;255170;103468470;44403185;10280;161400110;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of inhibitory concentration against rat opioid receptor sigma 2 and guinea pig opioid sigma 1;(10aS)-2-(3-piperidin-1-ylpropyl)-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCCN2C(=O)[C@@H]3CC4=CC=CC=C4CN3C2=O
459;101328769;;255170;103468568;11558686;10280;161400110;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of inhibitory concentration against rat opioid receptor sigma 2 and guinea pig opioid sigma 1;(10aS)-2-(2-piperidin-1-ylethyl)-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C(=O)[C@@H]3CC4=CC=CC=C4CN3C2=O
460;101328770;;255170;103468575;44403246;10280;161400110;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of inhibitory concentration against rat opioid receptor sigma 2 and guinea pig opioid sigma 1;(S)-2-(2-Piperidin-1-yl-ethyl)-1,5,10,10a-tetrahydro-2H-imidazo[1,5-b]isoquinolin-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C[C@@H]3CC4=CC=CC=C4CN3C2=O
461;101328771;;255170;103468576;44403247;10280;161400110;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of inhibitory concentration against rat opioid receptor sigma 2 and guinea pig opioid sigma 1;(S)-2-(2-Piperidin-1-yl-ethyl)-1,2,3,5,10,10a-hexahydro-imidazo[1,5-b]isoquinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C[C@@H]3CC4=CC=CC=C4CN3C2
462;101328772;;255170;103468569;44403241;10280;161400110;Literature-derived;20200703;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of inhibitory concentration against rat opioid receptor sigma 2 and guinea pig opioid sigma 1;(10aS)-2-(2-piperidin-1-ylethyl)-3-sulfanylidene-10,10a-dihydro-5H-imidazo[1,5-b]isoquinolin-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C(=O)[C@@H]3CC4=CC=CC=C4CN3C2=S
463;101886019;;265284;103570372;9851104;10280;167226310;Confirmatory;20220830;0;0;Inconclusive;Q99720;Ki;;ChEMBL;Binding affinity to guinea pig sigma receptor by radioligand binding assay;cyclo(Arg-Gly-Asp-D-Phe-Val);SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C(=O)N1)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N
464;155663082;;468959;103743025;44471685;10280;197672060;Literature-derived;20180912;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]Pentazocine from sigma1 opioid receptor at 10 uM by scintillation counting;4-cyano-1-(2-(125I)iodanylphenyl)-5-(4-methoxyphenyl)-N-piperidin-1-ylpyrazole-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)C2=C(C(=NN2C3=CC=CC=C3[125I])C(=O)NN4CCCCC4)C#N
465;155678655;;465531;103738515;16005087;10280;201385150;Literature-derived;20180912;0;0;Inactive;Q99720;;;ChEMBL;Inhibition of sigma 1 receptor at 10 nM;Fluorfenidine F-18;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C1=CC(=CC=C1)SC)C(=NC2=C(C=CC(=C2)SCC[18F])Cl)N
466;155678701;;465523;103738515;16005087;10280;201385150;Literature-derived;20180912;0;0;Active;Q99720;;;ChEMBL;Inhibition of sigma 1 receptor at 1 uM;Fluorfenidine F-18;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C1=CC(=CC=C1)SC)C(=NC2=C(C=CC(=C2)SCC[18F])Cl)N
467;155694815;;476924;103749646;45113656;10280;199395130;Literature-derived;20180913;0;0;Active;Q99720;;;ChEMBL;Binding affinity to sigma 1 receptor at 10 uM by radioligand displacement assay;"8-(benzenesulfonyl)-2,5-dimethyl-3,4-dihydro-1H-pyrido[4,3-b]indole;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2=C(C1)C3=C(N2C)C=CC(=C3)S(=O)(=O)C4=CC=CC=C4.Cl
468;155694817;;477723;103750113;45113653;10280;199395130;Literature-derived;20180913;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity to sigma 1 receptor at 1 uM by radioligand displacement assay;"N-(3-fluorophenyl)-2-methyl-1,3,4,5-tetrahydropyrido[4,3-b]indole-8-sulfonamide;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2=C(C1)C3=C(N2)C=CC(=C3)S(=O)(=O)NC4=CC(=CC=C4)F.Cl
469;155698398;;480585;103753582;46888467;10280;204271840;Literature-derived;20180913;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma 1 receptor at 1 uM;1-(2,3-Dichlorophenyl)-2,2,2-trifluoro-1-(1-(4-fluorophenyl)-1H-indazol-5-YL)ethanol (enantiomeric mix);SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC(=C(C(=C1)Cl)Cl)C(C2=CC3=C(C=C2)N(N=C3)C4=CC=C(C=C4)F)(C(F)(F)F)O
470;155698399;;480585;103753583;46888468;10280;204271840;Literature-derived;20180913;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma 1 receptor at 1 uM;1-(2-chloropyridin-4-yl)-2,2,2-trifluoro-1-(1-(4-fluorophenyl)-1H-indazol-5-yl)ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC(=CC=C1N2C3=C(C=C(C=C3)C(C4=CC(=NC=C4)Cl)(C(F)(F)F)O)C=N2)F
471;155698400;;480585;103753530;46888441;10280;204271840;Literature-derived;20180913;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma 1 receptor at 1 uM;1-(3-Chloro-4-fluorophenyl)-2,2,2-trifluoro-1-(1-(4-fluorophenyl)-1H-indazol-5-YL)ethanol (enantiomeric mix);SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC(=CC=C1N2C3=C(C=C(C=C3)C(C4=CC(=C(C=C4)F)Cl)(C(F)(F)F)O)C=N2)F
472;155698401;;480585;103753636;46888443;10280;204271840;Literature-derived;20180913;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma 1 receptor at 1 uM;2-chloro-4-(2,2,2-trifluoro-1-(1-(4-fluorophenyl)-1H-indazol-5-yl)-1-hydroxyethyl)benzonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC(=CC=C1N2C3=C(C=C(C=C3)C(C4=CC(=C(C=C4)F)C#N)(C(F)(F)F)O)C=N2)F
473;155698402;;480585;103753637;46888487;10280;204271840;Literature-derived;20180913;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma 1 receptor at 1 uM;2,2,2-trifluoro-1-(4-fluoro-3-methylphenyl)-1-(1-(4-fluorophenyl)-1H-indazol-5-yl)ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC(=C1)C(C2=CC3=C(C=C2)N(N=C3)C4=CC=C(C=C4)F)(C(F)(F)F)O)F
474;172440159;;493017;103857068;15061888;10280;16481390;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;(1-Methyl-2-naphthalen-1-yl-ethyl)-(3-phenyl-propyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CC(CC1=CC=CC2=CC=CC=C21)NCCCC3=CC=CC=C3
475;172472404;;493017;103903978;11796233;10280;;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;1-[2-[3-Methoxy-2-(2-phenylethoxy)phenyl]ethyl]-4-pyridin-2-ylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;COC1=CC=CC(=C1OCCC2=CC=CC=C2)CCN3CCN(CC3)C4=CC=CC=N4
476;172472405;;493017;103903993;49830200;10280;13229870;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;(1R)-10-but-2-enyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CC=CCN1CC[C@@]2(C(C1CC3=C2C=C(C=C3)O)C)C
477;172472406;;493017;103903996;14982981;10280;13158690;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;6-[6-(4-Oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)hexyloxy]-2-phenyl-4H-1-benzopyran-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CCCCCCOC4=CC5=C(C=C4)OC(=CC5=O)C6=CC=CC=C6
478;172573678;;493017;103857081;14831244;10280;18482950;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;1-phenyl-N-(3-phenylprop-2-ynyl)propan-2-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CC(CC1=CC=CC=C1)NCC#CC2=CC=CC=C2
479;172607762;;493017;103903998;66749;10280;79028690;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;3-(Diethylamino)propiophenone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CCN(CC)CCC(=O)C1=CC=CC=C1
480;172607763;;493017;103904007;14982974;10280;13158690;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;6-[6-[4-(2-Pyrimidinyl)-1-piperazinyl]hexyloxy]-2-phenyl-4H-1-benzopyran-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CN(CCN1CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4)C5=NC=CC=N5
481;172607764;;493017;103904023;15751758;10280;13179220;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;1,2,3,4,5,6-Hexahydro-9-methoxy-3-methylbenz[f]isoquinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CN1CCC2=C(C1)CCC3=C2C=C(C=C3)OC
482;172775340;;493017;103903985;11794387;10280;;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;1-(4-Methoxy-3-phenethyloxy-benzyl)-nonylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CCCCCCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N
483;172775341;;493017;103903987;49830198;10280;13229870;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;(6R)-3-Allyl-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CC1C2CC3=C([C@@]1(CCN2CC=C)C)C=C(C=C3)O
484;172775342;;493017;103904003;44285482;10280;79325400;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;5-(3-Hydroxy-phenyl)-2-methyl-2-aza-bicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CN1CCC2(CC1CC(=O)C2)C3=CC(=CC=C3)O
485;172809291;;493017;103904020;15149413;10280;84263630;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;5-Fluoro-15-[(2-iodophenyl)methyl]-9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3(8),4,6-tetraene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CC2C3=C(CC1N2CC4=CC=CC=C4I)NC5=C3C=C(C=C5)F
486;172809292;;493017;103904021;49830208;10280;79325400;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;(5R)-8-[(3,4-dichlorophenyl)methylidene]-5-(3-hydroxyphenyl)-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CN1CC[C@]2(CC1C(=CC3=CC(=C(C=C3)Cl)Cl)C(=O)C2)C4=CC(=CC=C4)O
487;172809320;;493017;103903992;10645430;10280;106499730;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;1-[3-[4-(3-Chlorophenyl)piperazin-1-yl]propyl]-7-methoxy-3,4-dihydroquinolin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;COC1=CC2=C(CCC(=O)N2CCCN3CCN(CC3)C4=CC(=CC=C4)Cl)C=C1
488;172809321;;493017;103904026;15149426;10280;84263630;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;5,6,7,8,9,10-Hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CC2C3=C(CC1N2)NC4=CC=CC=C43
489;172975832;;493017;103904008;103544;10280;18482950;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;N-Propylamphetamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CCCNC(C)CC1=CC=CC=C1
490;172975833;;493017;103904015;10692612;10280;106499730;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;3-[4-[3-(5-Methoxy-2-oxo-3,4-dihydroquinolin-1-yl)propyl]piperazin-1-yl]benzonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;COC1=CC=CC2=C1CCC(=O)N2CCCN3CCN(CC3)C4=CC=CC(=C4)C#N
491;173070109;;493017;103857047;15175722;10280;13194930;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;1-[2-[N-Methyl-N-[2-(4,5-dichloro-2-iodophenyl)ethyl]amino]ethyl]pyrrolidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CN(CCC1=CC(=C(C=C1I)Cl)Cl)CCN2CCCC2
492;173070110;;493017;103857088;6430604;10280;18482950;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;alpha-methyl-N-(1-phenylethyl)-benzenethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CC(CC1=CC=CC=C1)NC(C)C2=CC=CC=C2
493;173070437;;493017;103857050;49823891;10280;13101140;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-1-pyrrolidin-1-ylpropan-2-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CC(CN1CCCC1)N(C)CCC2=CC(=C(C=C2)Cl)Cl
494;173070438;;493017;103857065;15061899;10280;16481390;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;N-[1-Methyl-2-(3,4-dichlorophenyl)ethyl]-3-phenylpropan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CC(CC1=CC(=C(C=C1)Cl)Cl)NCCCC2=CC=CC=C2
495;173070439;;493017;103857066;10090127;10280;79059260;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;6-Methoxy-2-[1-phenethyl-4-piperidinyl]-3,4-dihydronaphthalen-1(2H)-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;COC1=CC2=C(C=C1)C(=O)C(CC2)C3CCN(CC3)CCC4=CC=CC=C4
496;173070440;;493017;103857067;49823892;10280;13229870;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;(1S)-10-but-2-enyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CC=CCN1CC[C@]2(C(C1CC3=C2C=C(C=C3)O)C)C
497;173070441;;493017;103857082;49823893;10280;13158690;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;6-[6-(4-Hydroxypiperidin-1-yl)hex-4-enoxy]-3-methyl-2-phenylchromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CC1=C(OC2=C(C1=O)C=C(C=C2)OCCCC=CCN3CCC(CC3)O)C4=CC=CC=C4
498;173070442;;493017;103857083;15149381;10280;84263630;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;9-Methyl-15-(4-phenylbutyl)-9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3,5,7-tetraene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CN1C2=C(C3CCC(C2)N3CCCCC4=CC=CC=C4)C5=CC=CC=C51
499;173070443;;493017;103857084;15723888;10280;16627250;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;1-Benzoyl-4-(4-phenylbutyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CN(CCN1CCCCC2=CC=CC=C2)C(=O)C3=CC=CC=C3
500;173070662;;493017;103857046;18930452;10280;16560440;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;N-[2-(3,4-dichlorophenyl)ethyl]-2-pyrrolidin-1-ylcyclohexan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CCC(C(C1)NCCC2=CC(=C(C=C2)Cl)Cl)N3CCCC3
501;173070663;;493017;103857064;15163155;10280;13179230;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;1'-(pyridin-2-ylmethyl)spiro[2,3-dihydro-1H-naphthalene-4,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CC2=CC=CC=C2C3(C1)CCN(CC3)CC4=CC=CC=N4
502;173070664;;493017;103857089;15113301;10280;13101140;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;2-(3,4-Dichlorophenyl)-N-(2-aminoethyl)ethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1=CC(=C(C=C1CCNCCN)Cl)Cl
503;173070785;;493017;103857048;4687238;10280;13179230;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;1'-(Phenylmethyl)spiro[1,2-dihydroindene-3,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CC2(CCN(CC2)CC3=CC=CC=C3)C4=CC=CC=C41
504;173070786;;493017;103857049;3035672;10280;16627250;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;4-Phenyl-1-(4-phenylbutyl)piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CN(CCC1C2=CC=CC=C2)CCCCC3=CC=CC=C3
505;173070787;;493017;103857051;15113306;10280;13101140;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;2-(3-Chlorophenyl)-N-methyl-N-[2-(pyrrolidin-1-yl)ethyl]ethan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CN(CCC1=CC(=CC=C1)Cl)CCN2CCCC2
506;173070814;;493017;103857085;10526856;10280;;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;5-Chloro-2-(phenethyloxy)-1-[3-[4-phenylpiperazino]propyl]benzene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CN(CCN1CCCC2=C(C=CC(=C2)Cl)OCCC3=CC=CC=C3)C4=CC=CC=C4
507;173070921;;493017;103857086;10766202;10280;106499730;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;1-{3-[4-(3-Bromo-phenyl)-piperazin-1-yl]-propyl}-5-methoxy-1H-quinolin-2-one (HCl);SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;COC1=CC=CC2=C1C=CC(=O)N2CCCN3CCN(CC3)C4=CC(=CC=C4)Br
508;173071024;;493017;103857053;188914;10280;13101140;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;N-(2-(3,4-Dichlorophenyl)ethyl)-N-methyl-2-(dimethylamino)ethylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CN(C)CCN(C)CCC1=CC(=C(C=C1)Cl)Cl
509;173071025;;493017;103857069;4992580;10280;16627250;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;1-(3-Chlorophenyl)-4-(3-phenylpropyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)C3=CC(=CC=C3)Cl
510;173071151;;493017;103857063;743379;10280;16627250;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;1-Phenyl-4-(3-phenylpropyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)C3=CC=CC=C3
511;173071152;;493017;103857070;15061906;10280;16481390;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;1,2,3,4-Tetrahydro-N-(3-phenylpropyl)naphthalen-2-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CC2=CC=CC=C2CC1NCCCC3=CC=CC=C3
512;173071153;;493017;103857077;44364442;10280;13229870;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;(1S)-1,13-dimethyl-10-prop-2-enyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CC1C2CC3=C([C@]1(CCN2CC=C)C)C=C(C=C3)O
513;173071272;;493017;103857055;10402464;10280;14477350;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;6,7-Dichloro-2-[2-(pyrrolidin-1-yl)ethyl]-1,2,3,4-tetrahydroisoquinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CCN(C1)CCN2CCC3=CC(=C(C=C3C2)Cl)Cl
514;173071273;;493017;103857080;44314137;10280;83608750;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;[2-(3,4-Dichloro-phenyl)-ethyl]-methyl-(1-piperidin-1-yl-cyclohexylmethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CN(CCC1=CC(=C(C=C1)Cl)Cl)CC2(CCCCC2)N3CCCCC3
515;173071274;;493017;103857094;49823894;10280;84263630;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;15-But-1-enyl-9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3,5,7-tetraene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CCC=CN1C2CCC1C3=C(C2)NC4=CC=CC=C43
516;173071361;;493017;103857073;10734857;10280;;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;1-[2-[3-Methoxy-2-(2-phenylethoxy)phenyl]ethyl]pyrrolidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;COC1=CC=CC(=C1OCCC2=CC=CC=C2)CCN3CCCC3
517;173071362;;493017;103857076;14983053;10280;13158690;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;2-Cyclobutyl-6-(6-piperidin-1-yl-hexyloxy)-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CCN(CC1)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4CCC4
518;173071363;;493017;103857093;10787910;10280;106499730;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;1-[3-[4-(3-Chlorophenyl)piperazin-1-yl]propyl]-6-methoxy-3,4-dihydroquinolin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;COC1=CC2=C(C=C1)N(C(=O)CC2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl
519;173071655;;493017;103857056;44314603;10280;83608750;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;1,4-Bis(3,4-dichlorophenethyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CN(CCN1CCC2=CC(=C(C=C2)Cl)Cl)CCC3=CC(=C(C=C3)Cl)Cl
520;173071656;;493017;103857090;10593974;10280;;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;"1-(4-Methoxy-3-phenethyloxy-benzyl)-butylamine; hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N
521;173071738;;493017;103904005;15149408;10280;84263630;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;11-(3,3-Diphenylpropyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CC2C3=C(CC1N2CCC(C4=CC=CC=C4)C5=CC=CC=C5)NC6=CC=CC=C63
522;173071739;;493017;103904022;49830209;10280;13229870;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;(1S)-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CC1C2CC3=C([C@]1(CCN2)C)C=C(C=C3)O
523;173071759;;493017;103857057;10021099;10280;79059260;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;1'-Phenethyl-6,8-difluoro-3,4-dihydrospiro[naphthalene-2(1H),4'-piperidin]-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CC2(CCN(CC2)CCC3=CC=CC=C3)C(=O)C4=C1C=C(C=C4F)F
524;173071760;;493017;103857058;547467;10280;14477350;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;3,4-Dichlorophenylethanamine, N-[1-methylazacyclohex-3-yl]-N-methyl-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CN1CCCC(C1)N(C)CCC2=CC(=C(C=C2)Cl)Cl
525;173071761;;493017;103857059;15723894;10280;16627250;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;4-Phenyl-1-(3-phenylpropyl)piperidin-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CN(CCC1(C2=CC=CC=C2)O)CCCC3=CC=CC=C3
526;173071937;;493017;103904016;5072;10280;106499730;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;9-[3-(3,5-Dimethyl-1-piperazinyl)propyl]carbazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CC1CN(CC(N1)C)CCCN2C3=CC=CC=C3C4=CC=CC=C42
527;173071940;;493017;103857062;14831231;10280;18482950;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;N-methyl-1-phenyl-N-(2-phenylethyl)propan-2-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CC(CC1=CC=CC=C1)N(C)CCC2=CC=CC=C2
528;173071941;;493017;103857071;5025;10280;18482950;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;alpha-Methyl-N-(3-phenylpropyl)phenethylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CC(CC1=CC=CC=C1)NCCCC2=CC=CC=C2
529;173071942;;493017;103857078;131253;10280;16560440;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;2-Azabutane, N-[[2-pyrrolidin-1-yl]cyclohexyl]-4-[3,4-dichlorophenyl]-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CN(CCC1=CC(=C(C=C1)Cl)Cl)C2CCCCC2N3CCCC3
530;173071943;;493017;103857087;15149394;10280;84263630;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;11-(2-Phenylethyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CC2C3=C(CC1N2CCC4=CC=CC=C4)NC5=CC=CC=C53
531;173072175;;493017;103903990;10263215;10280;79059260;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;1'-Methyl-3,4-dihydrospiro[naphthalene-2(1H),4'-piperidin]-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CN1CCC2(CCC3=CC=CC=C3C2=O)CC1
532;173072176;;493017;103903999;44351070;10280;79028690;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;3-Dipropylamino-1-phenyl-propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CCCN(CCC)CCC(=O)C1=CC=CC=C1
533;173072177;;493017;103904006;15149384;10280;84263630;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;N-[2-(9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3,5,7-tetraen-15-yl)ethyl]-2-(3,4-dichlorophenyl)-N-methylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CN(CCN1C2CCC1C3=C(C2)NC4=CC=CC=C43)C(=O)CC5=CC(=C(C=C5)Cl)Cl
534;173072178;;493017;103904017;356862;10280;84263630;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;11-Methyl-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohepta[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CN1C2CCC1C3=C(C2)NC4=CC=CC=C43
535;173072367;;493017;103857045;126388;10280;13101140;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;N-(2-(3,4-Dichlorophenyl)ethyl)-N-methyl-2-(1-pyrrolidinyl)ethylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CN(CCC1=CC(=C(C=C1)Cl)Cl)CCN2CCCC2
536;173072368;;493017;103857052;15163141;10280;13179230;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;1'-Butyl-3,4-dihydrospiro[naphthalene-1(2H),4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CCCCN1CCC2(CCCC3=CC=CC=C32)CC1
537;173072369;;493017;103857054;9841596;10280;;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;N-(4-methoxy-3-phenethoxyphenethyl)-N-propylpropan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CCCN(CCC)CCC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2
538;173072370;;493017;103857061;9998085;10280;79059260;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;6-Fluoro-2-[1-phenethyl-4-piperidinyl]-3,4-dihydronaphthalen-1(2H)-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CC2=C(C=CC(=C2)F)C(=O)C1C3CCN(CC3)CCC4=CC=CC=C4
539;173072371;;493017;103857072;15646135;10280;84263630;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;11-(4-Phenylbutyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CC2C3=C(CC1N2CCCCC4=CC=CC=C4)NC5=CC=CC=C53
540;173072372;;493017;103857079;11791902;10280;85688040;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;1-Benzyl-4-[3-(3,4-dihydro-naphthalen-1-yl)-propyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CC2=CC=CC=C2C(=C1)CCCN3CCN(CC3)CC4=CC=CC=C4
541;173072510;;493017;103904010;13078350;10280;84263630;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;5-Phenyl-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CC2C3=C(CC1N2)N(C4=CC=CC=C43)C5=CC=CC=C5
542;173072511;;493017;103904011;69873;10280;16627250;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;4-Phenylpiperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CNCCC1C2=CC=CC=C2
543;173072512;;493017;103904027;15601069;10280;79325400;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;5-(3-Methoxyphenyl)-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CN1CCC2(CC1CC(=O)C2)C3=CC(=CC=C3)OC
544;173072513;;493017;103904030;15149415;10280;84263630;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;2-[2-(9,15-Diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3,5,7-tetraen-15-yl)ethyl]isoindole-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CC2C3=C(CC1N2CCN4C(=O)C5=CC=CC=C5C4=O)NC6=CC=CC=C63
545;173072570;;493017;103903991;15149391;10280;84263630;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;11-Propyl-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CCCN1C2CCC1C3=C(C2)NC4=CC=CC=C43
546;173072571;;493017;103904032;49830210;10280;13229870;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;(1R)-10-but-2-ynyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CC#CCN1CC[C@@]2(C(C1CC3=C2C=C(C=C3)O)C)C
547;173072666;;493017;103903979;10712276;10280;;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;4-[2-[4-Methoxy-3-(2-phenylethoxy)phenyl]ethyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;COC1=C(C=C(C=C1)CCN2CCOCC2)OCCC3=CC=CC=C3
548;173072667;;493017;103903980;10717092;10280;;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;1-[2-[5-Chloro-2-(2-phenylethoxy)phenyl]ethyl]-4-pyridin-2-ylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CN(CCN1CCC2=C(C=CC(=C2)Cl)OCCC3=CC=CC=C3)C4=CC=CC=N4
549;173072668;;493017;103903995;49830201;10280;13179220;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;9-methoxy-3-methyl-2,4,4a,5,6,10b-hexahydro-1H-benzo[f]isoquinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CN1CCC2C(C1)CCC3=C2C=C(C=C3)OC
550;173072669;;493017;103904012;62751;10280;14696970;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;Tenocyclidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CCC(CC1)(C2=CC=CS2)N3CCCCC3
551;173072670;;493017;103904028;269722;10280;16627250;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;1-(4-Methoxyphenyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;COC1=CC=C(C=C1)N2CCNCC2
552;173072699;;493017;103903982;10695744;10280;;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;4-[3-(Phenethyloxy)-4-methoxybenzyl]heptane-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CCCC(CCC)(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N
553;173072700;;493017;103904014;49830206;10280;13229870;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;(1S)-1,10,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CC1C2CC3=C([C@]1(CCN2C)C)C=C(C=C3)O
554;173072701;;493017;103904025;49830205;10280;13229870;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;(1R)-10-but-3-en-2-yl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CC1C2CC3=C([C@@]1(CCN2C(C)C=C)C)C=C(C=C3)O
555;173072723;;493017;103857060;401834;10280;83608750;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;(6,7-Dichloro-1,2,3,4-tetrahydro-naphthalen-2-yl)-(2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CCN(C1)CCNC2CCC3=CC(=C(C=C3C2)Cl)Cl
556;173072810;;493017;103903981;10616816;10280;;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;"1-(4-Methoxy-3-phenethyloxy-benzyl)-propylamine; hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N
557;173072811;;493017;103904001;49830203;10280;106499730;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;1-[3-[4-(4-Fluorophenyl)piperazin-1-yl]propyl]-7-hydroxy-3,4-dihydroquinolin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CC(=O)N(C2=C1C=CC(=C2)O)CCCN3CCN(CC3)C4=CC=C(C=C4)F
558;173072812;;493017;103904024;15149390;10280;84263630;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;11-Ethyl-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CCN1C2CCC1C3=C(C2)NC4=CC=CC=C43
559;173072813;;493017;103904031;75994;10280;16627250;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;1-Benzylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CN(CCN1)CC2=CC=CC=C2
560;173072847;;493017;103903986;10574272;10280;;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;2-[4-[2-[5-Chloro-2-(2-phenylethoxy)phenyl]ethyl]piperazin-1-yl]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CN(CCN1CCC2=C(C=CC(=C2)Cl)OCCC3=CC=CC=C3)C4=NC=CC=N4
561;173072848;;493017;103904004;15646123;10280;84263630;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;2-Fluoro-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CC2C3=C(CC1N2)NC4=C3C=C(C=C4)F
562;173072849;;493017;103904018;49830207;10280;13229870;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;(1R)-10-(cyclopropylmethyl)-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CC1C2CC3=C([C@@]1(CCN2CC4CC4)C)C=C(C=C3)O
563;173072856;;493017;103857074;10788071;10280;;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;1-[2-[4-Methoxy-3-(2-phenylethoxy)phenyl]ethyl]-4-phenylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;COC1=C(C=C(C=C1)CCN2CCN(CC2)C3=CC=CC=C3)OCCC4=CC=CC=C4
564;173072857;;493017;103857075;15646141;10280;84263630;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;2-Fluoro-11-(4-phenylbutyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CC2C3=C(CC1N2CCCCC4=CC=CC=C4)NC5=C3C=C(C=C5)F
565;173072858;;493017;103857091;18959716;10280;13158690;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;6-[4-(4-Hydroxy-piperidin-1-yl)-butoxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CN(CCC1O)CCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
566;173072859;;493017;103857092;9892540;10280;106499730;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;1-(3-(4-(3-Chlorophenyl)-1-piperazinyl)propyl)-5-methoxy-3,4-dihydro-2-quinolinone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;COC1=CC=CC2=C1CCC(=O)N2CCCN3CCN(CC3)C4=CC(=CC=C4)Cl
567;173072913;;493017;103903994;97478;10280;16627250;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;1-(4-Chlorophenyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CN(CCN1)C2=CC=C(C=C2)Cl
568;173072914;;493017;103904029;1355;10280;16627250;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;1-(3-Chlorophenyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CN(CCN1)C2=CC(=CC=C2)Cl
569;173072929;;493017;103903984;10683536;10280;;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;3-(Phenethyloxy)-4-methoxyphenethylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;COC1=C(C=C(C=C1)CCN)OCCC2=CC=CC=C2
570;173072930;;493017;103903989;49830199;10280;106499730;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;6-Phenylmethoxy-1-[3-(4-phenylpiperazin-1-yl)propyl]-3,4-dihydroquinolin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CC(=O)N(C2=C1C=C(C=C2)OCC3=CC=CC=C3)CCCN4CCN(CC4)C5=CC=CC=C5
571;173072931;;493017;103904000;49830202;10280;79325400;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;(5R)-8-benzylidene-5-(3-hydroxyphenyl)-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CN1CC[C@]2(CC1C(=CC3=CC=CC=C3)C(=O)C2)C4=CC(=CC=C4)O
572;173072932;;493017;103904009;49830205;10280;13229870;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;(1R)-10-but-3-en-2-yl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CC1C2CC3=C([C@@]1(CCN2C(C)C=C)C)C=C(C=C3)O
573;173073036;;493017;103903997;10620662;10280;106499730;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;1-{3-[4-(3-Amino-phenyl)-piperazin-1-yl]-propyl}-5-methoxy-3,4-dihydro-1H-quinolin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;COC1=CC=CC2=C1CCC(=O)N2CCCN3CCN(CC3)C4=CC=CC(=C4)N
574;173073037;;493017;103904013;14982984;10280;13158690;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;6-(6-Amino-hexyloxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=CC(=C3)OCCCCCCN
575;173073125;;493017;103903988;44300895;10280;13229870;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;(1R)-1,10,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CC1C2CC3=C([C@@]1(CCN2C)C)C=C(C=C3)O
576;173073126;;493017;103904002;49830204;10280;13229870;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;(1S)-10-but-3-en-2-yl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CC1C2CC3=C([C@]1(CCN2C(C)C=C)C)C=C(C=C3)O
577;173073127;;493017;103904019;1342;10280;16627250;Literature-derived;20110107;0;0;Unspecified;;;;Abbott Labs;Wombat Data for BeliefDocking;1-Naphthylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;C1CN(CCN1)C2=CC=CC3=CC=CC=C32
578;173073134;;493017;103903983;10496036;10280;;Literature-derived;20110107;0;0;Active;;;;Abbott Labs;Wombat Data for BeliefDocking;"2-(4-Methoxy-3-phenethyloxy-phenyl)-1-methyl-ethylamine; hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;;9606;;;;;CC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N
579;178260461;;502431;104244813;46933845;10280;206928330;Literature-derived;20180914;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]Pentazocine from human sigma 1 receptor at 10 uM;N-cyclohexyl-8-fluoro-3,3a,4,9b-tetrahydrothiochromeno[4,3-c][1,2]oxazole-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)NC(=O)N2C3C(CO2)CSC4=C3C=C(C=C4)F
580;198304106;;538900;123099027;49832807;10280;209657390;Literature-derived;20180915;0;0;Inactive;Q99720;;;ChEMBL;Displacement of [3H]Haloperidol from Sigma1 receptor at 1 to 3 uM;(+/-)-3-(4-Phenylbutyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-1,7-diol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CC(C2=C1C=C(C=C2)O)O)CCCCC3=CC=CC=C3
581;198317440;;527771;123097761;49788941;10280;208737190;Literature-derived;20200626;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in MCF7 cells at 1 uM after 180 mins by scintillation counting;N-[2-[4-(3-cyanopyridin-2-yl)piperazin-1-yl]ethyl]-4-fluorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;C1CN(CCN1CCNC(=O)C2=CC=C(C=C2)F)C3=C(C=CC=N3)C#N
582;198317441;;527771;103401607;44369020;10280;208737190;Literature-derived;20200626;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in MCF7 cells at 1 uM after 180 mins by scintillation counting;N-{2-[4-(5-Chloro-pyridin-2-yl)-piperazin-1-yl]-ethyl}-3-methoxy-benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;COC1=CC=CC(=C1)C(=O)NCCN2CCN(CC2)C3=NC=C(C=C3)Cl
583;198317442;;527771;123097917;49788868;10280;208737190;Literature-derived;20200626;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in MCF7 cells at 1 uM after 180 mins by scintillation counting;N-[2-[4-(4-cyanophenyl)piperazin-1-yl]ethyl]-3-methoxybenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;COC1=CC=CC(=C1)C(=O)NCCN2CCN(CC2)C3=CC=C(C=C3)C#N
584;198317443;;527771;103401587;11131951;10280;208737190;Literature-derived;20200626;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in MCF7 cells at 1 uM after 180 mins by scintillation counting;3-Methoxy-N-[2-(4-p-tolyl-piperazin-1-yl)-ethyl]-benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;CC1=CC=C(C=C1)N2CCN(CC2)CCNC(=O)C3=CC(=CC=C3)OC
585;198317444;;527771;123090929;49788939;10280;208737190;Literature-derived;20200626;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in MCF7 cells at 1 uM after 180 mins by scintillation counting;N-(2-(4-(benzo[d]isoxazol-3-yl)piperazin-1-yl)ethyl)-4-fluorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;C1CN(CCN1CCNC(=O)C2=CC=C(C=C2)F)C3=NOC4=CC=CC=C43
586;198317445;;527771;123088776;42266988;10280;208737190;Literature-derived;20200626;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in MCF7 cells at 1 uM after 180 mins by scintillation counting;N-(2-(4-(4-chlorophenyl)piperazin-1-yl)ethyl)-4-fluorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;C1CN(CCN1CCNC(=O)C2=CC=C(C=C2)F)C3=CC=C(C=C3)Cl
587;198317446;;527771;123088699;49788869;10280;208737190;Literature-derived;20200626;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in MCF7 cells at 1 uM after 180 mins by scintillation counting;N-[2-[4-(3-cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-methoxybenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;COC1=CC=CC(=C1)C(=O)NCCN2CCN(CC2)C3=C(C=CC=N3)C#N
588;198317447;;527771;123086222;49788940;10280;208737190;Literature-derived;20200626;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in MCF7 cells at 1 uM after 180 mins by scintillation counting;N-[2-[4-(4-cyanophenyl)piperazin-1-yl]ethyl]-4-fluorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;C1CN(CCN1CCNC(=O)C2=CC=C(C=C2)F)C3=CC=C(C=C3)C#N
589;198317448;;527771;123095498;49788942;10280;208737190;Literature-derived;20200626;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in MCF7 cells at 1 uM after 180 mins by scintillation counting;N-[2-[4-(5-chloropyridin-2-yl)piperazin-1-yl]ethyl]-4-fluorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;C1CN(CCN1CCNC(=O)C2=CC=C(C=C2)F)C3=NC=C(C=C3)Cl
590;198317449;;527771;123100279;49788867;10280;208737190;Literature-derived;20200626;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in MCF7 cells at 1 uM after 180 mins by scintillation counting;N-(2-(4-(benzo[d]isoxazol-3-yl)piperazin-1-yl)ethyl)-3-methoxybenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;COC1=CC=CC(=C1)C(=O)NCCN2CCN(CC2)C3=NOC4=CC=CC=C43
591;198317450;;527771;103305504;3626837;10280;208737190;Literature-derived;20200626;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in MCF7 cells at 1 uM after 180 mins by scintillation counting;N-(2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl)-3-methoxybenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;COC1=CC=CC(=C1)C(=O)NCCN2CCN(CC2)C3=CC=C(C=C3)Cl
592;198317451;;527771;123084056;49788870;10280;208737190;Literature-derived;20200626;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in MCF7 cells at 1 uM after 180 mins by scintillation counting;N-[2-[4-(4-Methylphenyl)piperazin-1-yl]ethyl]-4-fluorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;CC1=CC=C(C=C1)N2CCN(CC2)CCNC(=O)C3=CC=C(C=C3)F
593;224451397;;593769;131284740;52951482;10280;214284060;Literature-derived;20180918;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity to sigma 1 receptor at 10 uM by radioligand binding assay;1-(2-Bromophenyl)-N-(1-cyanocyclohexyl)-5-(4-methoxyphenyl)-4-methyl-1H-pyrazole-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(N(N=C1C(=O)NC2(CCCCC2)C#N)C3=CC=CC=C3Br)C4=CC=C(C=C4)OC
594;224451398;;593769;131274674;52951481;10280;214284060;Literature-derived;20180918;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity to sigma 1 receptor at 10 uM by radioligand binding assay;1-(2-Bromophenyl)-N-(4-cyanotetrahydro-2H-pyran-4-yl)-5-(4-methoxyphenyl)-4-methyl-1H-pyrazole-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(N(N=C1C(=O)NC2(CCOCC2)C#N)C3=CC=CC=C3Br)C4=CC=C(C=C4)OC
595;224457946;;597319;103202618;5684;10280;215209400;Literature-derived;20180918;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma 1 receptor at 10 uM;Cyclohexanecarboxamide, n-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-n-2-pyridinyl-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1N2CCN(CC2)CCN(C3=CC=CC=N3)C(=O)C4CCCCC4
596;224457947;;597319;131279908;53248365;10280;215209400;Literature-derived;20180918;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma 1 receptor at 10 uM;N-[2-[4-(2-hydroxyphenyl)piperazin-1-yl]ethyl]-4-iodo-N-pyridin-2-ylcubane-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCN(C2=CC=CC=N2)C(=O)C34C5C6C3C7C4C5C67I)C8=CC=CC=C8O
597;224457948;;597319;131281899;53248361;10280;215209400;Literature-derived;20180918;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma 1 receptor at 10 uM;4-iodo-N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-pyridin-2-ylcubane-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1N2CCN(CC2)CCN(C3=CC=CC=N3)C(=O)C45C6C7C4C8C5C6C78I
598;224475840;;590246;124975282;44516817;10280;213334080;Literature-derived;20200629;0;0;Inactive;Q99720;;;ChEMBL;Binding affinity to sigma 1 receptor at 10 uM by radioligand binding assay;N,5,7-trimethyl-3-(phenylsulfonyl)pyrazolo[1,5-a]pyrimidin-2-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=NC2=C(C(=NN12)NC)S(=O)(=O)C3=CC=CC=C3)C
599;237754380;;621387;134461578;51346964;10280;218730510;Literature-derived;20180919;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity to human sigma 1 receptor at 10 uM by radioligand binding assay;S2JB42Bbp5;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N[C@H]1CC[C@H](C1)C(=O)N(C)C2=CC=C(C=C2)C3=NC4=CC=CC=C4O3
600;237803277;;622119;134450722;56595309;10280;219056690;Literature-derived;20200629;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity to sigma1 receptor at 10 uM by radioligand displacement assay;"3-[5-[5-[[(2S)-azetidin-2-yl]methoxy]pyridin-3-yl]-1,2-oxazol-3-yl]propan-1-ol;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN[C@@H]1COC2=CN=CC(=C2)C3=CC(=NO3)CCCO.Cl
601;254375730;;635314;103167216;3559;10280;220557140;Literature-derived;20200626;0;0;Active;Q99720;;;ChEMBL;Displacement of [125I]IAF from sigma 1 receptor in human RT4 cells at 10 uM after 30 mins preincubation by photoaffinity labeling experiment;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;36.0;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
602;254375731;;635314;136931087;57395787;10280;220557140;Literature-derived;20200626;0;0;Inactive;Q99720;;;ChEMBL;Displacement of [125I]IAF from sigma 1 receptor in human RT4 cells at 10 uM after 30 mins preincubation by photoaffinity labeling experiment;2,3-dimethoxy-N-[4-(7-nitro-3,4-dihydro-1H-isoquinolin-2-yl)butyl]benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;36.0;;;;COC1=CC=CC(=C1OC)C(=O)NCCCCN2CCC3=C(C2)C=C(C=C3)[N+](=O)[O-]
603;254375732;;635314;136944217;22132529;10280;220557140;Literature-derived;20200626;0;0;Active;Q99720;;;ChEMBL;Displacement of [125I]IAF from sigma 1 receptor in human RT4 cells at 10 uM after 30 mins preincubation by photoaffinity labeling experiment;7-Nitro-2-(4-phthalimidobutyl)-1,2,3,4-tetrahydroisoquinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;36.0;;;;C1CN(CC2=C1C=CC(=C2)[N+](=O)[O-])CCCCN3C(=O)C4=CC=CC=C4C3=O
604;254742255;;647273;136925004;49857811;10280;222971110;Literature-derived;20180921;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of human sigma 1 receptor at 10 uM;1-[4-[3-[(2R)-2-methylpyrrolidin-1-yl]propoxy]phenyl]-2-morpholin-4-ylethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CCCN1CCCOC2=CC=C(C=C2)C(=O)CN3CCOCC3
605;255009819;;625223;103164490;448537;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Diethylstilbestrol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC/C(=C(/CC)\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)O
606;255009820;;625223;103164490;448537;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Diethylstilbestrol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC/C(=C(/CC)\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)O
607;255009821;;625223;103557046;4485;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nifedipine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
608;255009822;;625223;103557046;4485;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nifedipine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
609;255010205;;625223;103188188;3308;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Etodolac;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O
610;255010206;;625223;160703999;14982;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Glycyrrhizin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O[C@@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)O)O)O)O)C)(C)C(=O)O
611;255010207;;625223;160703999;14982;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Glycyrrhizin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O[C@@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)O)O)O)O)C)(C)C(=O)O
612;255010208;;625223;103215824;2478;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Busulfan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CS(=O)(=O)OCCCCOS(=O)(=O)C
613;255010209;;625223;103215824;2478;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Busulfan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CS(=O)(=O)OCCCCOS(=O)(=O)C
614;255010210;;625223;103206701;2406;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Bithionol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=C(C=C(C(=C1SC2=C(C(=CC(=C2)Cl)Cl)O)O)Cl)Cl
615;255010211;;625223;103206701;2406;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Bithionol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=C(C=C(C(=C1SC2=C(C(=CC(=C2)Cl)Cl)O)O)Cl)Cl
616;255010212;;625223;103189005;4913;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Procainamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CC)CCNC(=O)C1=CC=C(C=C1)N
617;255010213;;625223;103189005;4913;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Procainamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CC)CCNC(=O)C1=CC=C(C=C1)N
618;255010214;;625223;136941379;1379258;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(4-Benzylpiperidin-1-yl)(2-methylphenyl)methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC=CC=C1C(=O)N2CCC(CC2)CC3=CC=CC=C3
619;255010215;;625223;136941379;1379258;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(4-Benzylpiperidin-1-yl)(2-methylphenyl)methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC=CC=C1C(=O)N2CCC(CC2)CC3=CC=CC=C3
620;255010216;;625223;103179008;4748;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Perphenazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
621;255010217;;625223;103179008;4748;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Perphenazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
622;255010218;;625223;103169867;3676;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lidocaine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
623;255010219;;625223;103169867;3676;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lidocaine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
624;255010220;;625223;103216314;3229;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Enoxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O
625;255010221;;625223;103216314;3229;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Enoxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O
626;255010222;;625223;103172948;679;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dimethyl Sulfoxide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CS(=O)C
627;255010223;;625223;103172948;679;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dimethyl Sulfoxide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CS(=O)C
628;255010224;;625223;103533730;135401907;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Allopurinol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=NNC2=C1C(=O)NC=N2
629;255010225;;625223;103533730;135401907;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Allopurinol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=NNC2=C1C(=O)NC=N2
630;255010226;;625223;103168962;135398738;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dacarbazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)/N=N/C1=C(NC=N1)C(=O)N
631;255010227;;625223;103168962;135398738;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dacarbazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)/N=N/C1=C(NC=N1)C(=O)N
632;255010631;;625223;103173870;2708;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Chlorambucil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl
633;255010632;;625223;103173870;2708;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Chlorambucil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl
634;255010633;;625223;103543150;3333;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Felodipine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
635;255010634;;625223;103543150;3333;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Felodipine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
636;255010635;;625223;103572434;7057919;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Diethylhexylphthalate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCC[C@@H](CC)COC(=O)C1=CC=CC=C1C(=O)OC[C@@H](CC)CCCC
637;255010636;;625223;103572434;7057919;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Diethylhexylphthalate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCC[C@@H](CC)COC(=O)C1=CC=CC=C1C(=O)OC[C@@H](CC)CCCC
638;255010637;;625223;103556970;441207;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Digitoxin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5CC[C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)C)C)C)O)O
639;255010638;;625223;103556970;441207;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Digitoxin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5CC[C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)C)C)C)O)O
640;255010639;;625223;103293043;3478;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Glipizide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
641;255010640;;625223;103293043;3478;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Glipizide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
642;255010641;;625223;103682056;27447;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cephalexin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)SC1)C(=O)O
643;255010642;;625223;103682056;27447;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cephalexin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)SC1)C(=O)O
644;255010643;;625223;103206766;5311309;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nateglinide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)C1CCC(CC1)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)O
645;255010644;;625223;103206766;5311309;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nateglinide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)C1CCC(CC1)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)O
646;255010645;;625223;103199382;3878;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lamotrigine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
647;255010646;;625223;103199382;3878;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lamotrigine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
648;255010647;;625223;103177124;6167;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Colchicine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC
649;255010650;;625223;103567590;17134;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulfadoxine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N
650;255010651;;625223;103567590;17134;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulfadoxine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N
651;255010652;;625223;104234271;448042;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Y-27632 dihydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H](C1CCC(CC1)C(=O)NC2=CC=NC=C2)N
652;255010653;;625223;104234271;448042;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Y-27632 dihydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H](C1CCC(CC1)C(=O)NC2=CC=NC=C2)N
653;255010654;;625223;103189409;3415;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Foscarnet;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(=O)(O)P(=O)(O)O
654;255010655;;625223;103195217;135398745;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Olanzapine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C
655;255010990;;625223;103195217;135398745;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Olanzapine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C
656;255010993;;625223;103252336;26757;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Selegiline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H](CC1=CC=CC=C1)N(C)CC#C
657;255010994;;625223;103252336;26757;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Selegiline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H](CC1=CC=CC=C1)N(C)CC#C
658;255010995;;625223;103202464;9904;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nandrolone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@H]34
659;255010996;;625223;103202464;9904;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nandrolone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@H]34
660;255010997;;625223;103234668;5311304;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nalbuphine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC(C1)CN2CC[C@]34[C@@H]5[C@H](CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O)O
661;255010998;;625223;103234668;5311304;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nalbuphine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC(C1)CN2CC[C@]34[C@@H]5[C@H](CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O)O
662;255010999;;625223;103189011;1978;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Acebutolol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C
663;255011000;;625223;103189011;1978;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Acebutolol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C
664;255011001;;625223;103567215;5280793;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ergocalciferol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C
665;255011002;;625223;103567215;5280793;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ergocalciferol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C
666;255011003;;625223;103370406;5029;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Rabeprazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC
667;255011004;;625223;103370406;5029;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Rabeprazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC
668;255011009;;625223;103176475;3365;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fluconazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O
669;255011010;;625223;103176475;3365;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fluconazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O
670;255011011;;625223;103303791;71771;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Aceclofenac;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C(=C1)CC(=O)OCC(=O)O)NC2=C(C=CC=C2Cl)Cl
671;255011012;;625223;103303791;71771;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Aceclofenac;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C(=C1)CC(=O)OCC(=O)O)NC2=C(C=CC=C2Cl)Cl
672;255011013;;625223;103408740;28864;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lisuride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CC)C(=O)N[C@@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C
673;255011014;;625223;103408740;28864;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lisuride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CC)C(=O)N[C@@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C
674;255011398;;625223;103183978;28693;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Metergoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C[C@@H](C[C@H]2[C@H]1CC3=CN(C4=CC=CC2=C34)C)CNC(=O)OCC5=CC=CC=C5
675;255011399;;625223;103183978;28693;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Metergoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C[C@@H](C[C@H]2[C@H]1CC3=CN(C4=CC=CC2=C34)C)CNC(=O)OCC5=CC=CC=C5
676;255011400;;625223;103178942;2796;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Clofibrate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl
677;255011401;;625223;103178942;2796;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Clofibrate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl
678;255011402;;625223;104234183;656665;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tropisetron;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C3=CNC4=CC=CC=C43
679;255011403;;625223;104234183;656665;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tropisetron;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C3=CNC4=CC=CC=C43
680;255011404;;625223;136939962;36119;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sisomicin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@]1(CO[C@@H]([C@@H]([C@H]1NC)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H](CC=C(O3)CN)N)N)N)O
681;255011405;;625223;136939962;36119;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sisomicin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@]1(CO[C@@H]([C@@H]([C@H]1NC)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H](CC=C(O3)CN)N)N)N)O
682;255011406;;625223;103558443;3749;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Irbesartan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
683;255011407;;625223;103558443;3749;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Irbesartan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
684;255011408;;625223;103245064;3446;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Gabapentin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCC(CC1)(CC(=O)O)CN
685;255011409;;625223;103245064;3446;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Gabapentin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCC(CC1)(CC(=O)O)CN
686;255011410;;625223;123094738;159055;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Camphor (synthetic);SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@]12CC[C@@H](C1(C)C)CC2=O
687;255011411;;625223;123094738;159055;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Camphor (synthetic);SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@]12CC[C@@H](C1(C)C)CC2=O
688;255011412;;625223;103179088;6604200;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nitrofurantoin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1C(=O)NC(=O)N1/N=C/C2=CC=C(O2)[N+](=O)[O-]
689;255011413;;625223;103179088;6604200;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nitrofurantoin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1C(=O)NC(=O)N1/N=C/C2=CC=C(O2)[N+](=O)[O-]
690;255011414;;625223;103188188;3308;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Etodolac;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O
691;255011415;;625223;103411217;4915;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Procarbazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)NC(=O)C1=CC=C(C=C1)CNNC
692;255011416;;625223;103411217;4915;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Procarbazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)NC(=O)C1=CC=C(C=C1)CNNC
693;255011417;;625223;103184643;4912;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Probucol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C
694;255011418;;625223;103184643;4912;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Probucol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C
695;255011419;;625223;103235071;3059;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Diflunisal;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O
696;255011420;;625223;103235071;3059;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Diflunisal;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O
697;255011421;;625223;103696081;84029;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Clarithromycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
698;255011422;;625223;103282650;1645;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);3-Aminobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC(=C1)N)C(=O)N
699;255011801;;625223;103282650;1645;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);3-Aminobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC(=C1)N)C(=O)N
700;255011802;;625223;312365533;13690207;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);H-D-Phe-Cys(1)-Phe-D-Trp-Lys-Thr-Cys(1)-D-aThr-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@@H](CO)[C@@H](C)O)O
701;255011803;;625223;312365533;13690207;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);H-D-Phe-Cys(1)-Phe-D-Trp-Lys-Thr-Cys(1)-D-aThr-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@@H](CO)[C@@H](C)O)O
702;255011804;;625223;103234908;4911;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Probenecid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
703;255011805;;625223;103234908;4911;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Probenecid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
704;255011808;;625223;442046374;156009462;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);"3-[[2-[2-[2-[[(2S,3R)-2-[[(2S,3S,4R)-4-[[(2S,3R)-2-[[6-amino-2-[(1S)-3-amino-1-[[(2S)-2,3-diamino-3-oxopropyl]amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[(2R,3S,4S,5S,6S)-3-[(2R,3S,4S,5R,6R)-4-carbamoyloxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-2-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]ethyl]-1,3-thiazol-4-yl]-1,3-thiazole-4-carbonyl]amino]propyl-dimethylsulfanium;bromide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H]([C@H](C2=CN=CN2)O[C@H]3[C@H]([C@H]([C@@H]([C@@H](O3)CO)O)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O.[Br-]
705;255011809;;625223;442046374;156009462;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);"3-[[2-[2-[2-[[(2S,3R)-2-[[(2S,3S,4R)-4-[[(2S,3R)-2-[[6-amino-2-[(1S)-3-amino-1-[[(2S)-2,3-diamino-3-oxopropyl]amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[(2R,3S,4S,5S,6S)-3-[(2R,3S,4S,5R,6R)-4-carbamoyloxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-2-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]ethyl]-1,3-thiazol-4-yl]-1,3-thiazole-4-carbonyl]amino]propyl-dimethylsulfanium;bromide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H]([C@H](C2=CN=CN2)O[C@H]3[C@H]([C@H]([C@@H]([C@@H](O3)CO)O)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O.[Br-]
706;255011812;;625223;103166463;896;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Melatonin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC
707;255011813;;625223;103166463;896;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Melatonin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC
708;255011816;;625223;103512892;169371;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Aminopterin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=NC(=N3)N)N
709;255011817;;625223;103512892;169371;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Aminopterin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=NC(=N3)N)N
710;255011818;;625223;104247004;444913;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);alpha-CYCLODEXTRIN;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C([C@@H]1[C@@H]2[C@@H]([C@H]([C@H](O1)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)O)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6O)O)O[C@@H]7[C@H](O[C@H](O2)[C@@H]([C@H]7O)O)CO)CO)CO)CO)CO)O)O)O
711;255011819;;625223;104247004;444913;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);alpha-CYCLODEXTRIN;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C([C@@H]1[C@@H]2[C@@H]([C@H]([C@H](O1)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)O)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6O)O)O[C@@H]7[C@H](O[C@H](O2)[C@@H]([C@H]7O)O)CO)CO)CO)CO)CO)O)O)O
712;255011820;;625223;103245564;2391;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Bisacodyl;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)OC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC(=O)C)C3=CC=CC=N3
713;255011821;;625223;103245564;2391;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Bisacodyl;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)OC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC(=O)C)C3=CC=CC=N3
714;255011822;;625223;103696081;84029;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Clarithromycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
715;255011823;;625223;103179013;1548887;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulindac;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC\1=C(C2=C(/C1=C\C3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
716;255011824;;625223;103179013;1548887;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulindac;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC\1=C(C2=C(/C1=C\C3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
717;255012208;;625223;103168755;12124;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Metacetamol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)NC1=CC(=CC=C1)O
718;255012209;;625223;103168755;12124;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Metacetamol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)NC1=CC(=CC=C1)O
719;255012210;;625223;103589983;54766;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Bambuterol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)NCC(C1=CC(=CC(=C1)OC(=O)N(C)C)OC(=O)N(C)C)O
720;255012211;;625223;103589983;54766;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Bambuterol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)NCC(C1=CC(=CC(=C1)OC(=O)N(C)C)OC(=O)N(C)C)O
721;255012212;;625223;104247295;47866;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cyromazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC1NC2=NC(=NC(=N2)N)N
722;255012213;;625223;104247295;47866;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cyromazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC1NC2=NC(=NC(=N2)N)N
723;255012214;;625223;103494075;14957;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Antimycin A;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCCC[C@@H]1[C@H]([C@@H](OC(=O)[C@H]([C@H](OC1=O)C)NC(=O)C2=C(C(=CC=C2)NC=O)O)C)OC(=O)CC(C)C
724;255012215;;625223;103494075;14957;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Antimycin A;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCCC[C@@H]1[C@H]([C@@H](OC(=O)[C@H]([C@H](OC1=O)C)NC(=O)C2=C(C(=CC=C2)NC=O)O)C)OC(=O)CC(C)C
725;255012216;;625223;103382993;9880;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cyproterone acetate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)[C@@H]5C[C@@H]5[C@]34C)Cl)C)OC(=O)C
726;255012217;;625223;103382993;9880;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cyproterone acetate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)[C@@H]5C[C@@H]5[C@]34C)Cl)C)OC(=O)C
727;255012218;;625223;103284327;1923;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Oxyquinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC2=C(C(=C1)O)N=CC=C2
728;255012219;;625223;103284327;1923;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Oxyquinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC2=C(C(=C1)O)N=CC=C2
729;255012220;;625223;103178971;1983;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Acetaminophen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)NC1=CC=C(C=C1)O
730;255012221;;625223;103178971;1983;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Acetaminophen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)NC1=CC=C(C=C1)O
731;255012222;;625223;103207410;445858;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ferulic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C(C=CC(=C1)/C=C/C(=O)O)O
732;255012223;;625223;103207410;445858;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ferulic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C(C=CC(=C1)/C=C/C(=O)O)O
733;255012224;;625223;103770606;13765;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ethylestrenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CCCC[C@H]34)C)O
734;255012225;;625223;103770606;13765;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ethylestrenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CCCC[C@H]34)C)O
735;255012226;;625223;103770541;10909430;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Bacitracin A;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@H]([C@@H](C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4
736;255012227;;625223;103770541;10909430;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Bacitracin A;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@H](C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@H]([C@@H](C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4
737;255012228;;625223;103166129;3278;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ethacrynic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC(=C)C(=O)C1=C(C(=C(C=C1)OCC(=O)O)Cl)Cl
738;255012229;;625223;103166129;3278;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ethacrynic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC(=C)C(=O)C1=C(C(=C(C=C1)OCC(=O)O)Cl)Cl
739;255012230;;625223;103226170;6212;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Chloroform;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(Cl)(Cl)Cl
740;255012231;;625223;103226170;6212;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Chloroform;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(Cl)(Cl)Cl
741;255012595;;625223;103524732;5144;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Safrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C=CCC1=CC2=C(C=C1)OCO2
742;255012596;;625223;103524732;5144;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Safrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C=CCC1=CC2=C(C=C1)OCO2
743;255012597;;625223;123084917;119020;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Arcaine sulfate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(CCN=C(N)N)CN=C(N)N.OS(=O)(=O)O
744;255012598;;625223;123084917;119020;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Arcaine sulfate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(CCN=C(N)N)CN=C(N)N.OS(=O)(=O)O
745;255012599;;625223;103332887;10917;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Levocarnitine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[N+](C)(C)C[C@@H](CC(=O)[O-])O
746;255012600;;625223;103332887;10917;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Levocarnitine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[N+](C)(C)C[C@@H](CC(=O)[O-])O
747;255012601;;625223;103548420;135398744;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sildenafil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
748;255012602;;625223;103548420;135398744;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sildenafil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
749;255012605;;625223;103529091;135398739;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Didanosine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2N=CNC3=O
750;255012606;;625223;103529091;135398739;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Didanosine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2N=CNC3=O
751;255012607;;625223;103755607;460129;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Azaserine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C([C@@H](C(=O)O)N)OC(=O)C=[N+]=[N-]
752;255012608;;625223;103755607;460129;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Azaserine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C([C@@H](C(=O)O)N)OC(=O)C=[N+]=[N-]
753;255012611;;625223;103179212;2337;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Benzocaine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)C1=CC=C(C=C1)N
754;255012612;;625223;103507191;8478;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Benzethonium Chloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)CC(C)(C)C1=CC=C(C=C1)OCCOCC[N+](C)(C)CC2=CC=CC=C2.[Cl-]
755;255012613;;625223;103507191;8478;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Benzethonium Chloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)CC(C)(C)C1=CC=C(C=C1)OCCOCC[N+](C)(C)CC2=CC=CC=C2.[Cl-]
756;255012616;;625223;160703994;54677971;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tenoxicam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C(=C(C2=C(S1(=O)=O)C=CS2)O)C(=O)NC3=CC=CC=N3
757;255012617;;625223;160703994;54677971;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tenoxicam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C(=C(C2=C(S1(=O)=O)C=CS2)O)C(=O)NC3=CC=CC=N3
758;255012618;;625223;103224166;4909;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Primidone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC1(C(=O)NCNC1=O)C2=CC=CC=C2
759;255012619;;625223;103224166;4909;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Primidone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC1(C(=O)NCNC1=O)C2=CC=CC=C2
760;255012962;;625223;103175312;12560;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Erythromycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O
761;255012963;;625223;103175312;12560;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Erythromycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O
762;255012964;;625223;103168783;4122;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nocodazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CS3
763;255012965;;625223;103168783;4122;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nocodazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CS3
764;255012966;;625223;124966204;107782;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Betamethasone phosphate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COP(=O)(O)O)O)C)O)F)C
765;255012967;;625223;124966204;107782;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Betamethasone phosphate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COP(=O)(O)O)O)C)O)F)C
766;255012968;;625223;103511767;439501;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ouabain;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2C[C@H]([C@@]3([C@@H]4[C@@H](CC[C@@]3(C2)O)[C@]5(CC[C@@H]([C@]5(C[C@H]4O)C)C6=CC(=O)OC6)O)CO)O)O)O)O
767;255012969;;625223;103511767;439501;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ouabain;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2C[C@H]([C@@]3([C@@H]4[C@@H](CC[C@@]3(C2)O)[C@]5(CC[C@@H]([C@]5(C[C@H]4O)C)C6=CC(=O)OC6)O)CO)O)O)O)O
768;255012970;;625223;103268014;6047;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Levodopa;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O
769;255012971;;625223;103268014;6047;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Levodopa;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O
770;255012972;;625223;103291064;5879;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Androsterone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C)O
771;255012973;;625223;103291064;5879;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Androsterone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C)O
772;255012974;;625223;123100235;3085092;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Salinomycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@H]([C@H]1CC[C@@H]([C@@H](O1)[C@@H](C)[C@@H]([C@H](C)C(=O)[C@H](CC)[C@@H]2[C@H](C[C@H]([C@]3(O2)C=C[C@H]([C@@]4(O3)CC[C@@](O4)(C)[C@H]5CC[C@@]([C@@H](O5)C)(CC)O)O)C)C)O)C)C(=O)O
773;255012975;;625223;123100235;3085092;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Salinomycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@H]([C@H]1CC[C@@H]([C@@H](O1)[C@@H](C)[C@@H]([C@H](C)C(=O)[C@H](CC)[C@@H]2[C@H](C[C@H]([C@]3(O2)C=C[C@H]([C@@]4(O3)CC[C@@](O4)(C)[C@H]5CC[C@@]([C@@H](O5)C)(CC)O)O)C)C)O)C)C(=O)O
774;255012976;;625223;103588722;657237;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fludarabine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N
775;255012977;;625223;103588722;657237;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fludarabine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N
776;255012978;;625223;103513368;3902;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Letrozole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
777;255012979;;625223;103513368;3902;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Letrozole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
778;255012980;;625223;103165765;135398737;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Clozapine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCN(CC1)C2=NC3=C(C=CC(=C3)Cl)NC4=CC=CC=C42
779;255012981;;625223;103165765;135398737;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Clozapine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCN(CC1)C2=NC3=C(C=CC(=C3)Cl)NC4=CC=CC=C42
780;255012982;;625223;103558581;657298;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Propylthiouracil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCC1=CC(=O)NC(=S)N1
781;255012983;;625223;103558581;657298;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Propylthiouracil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCC1=CC(=O)NC(=S)N1
782;255012984;;625223;103175725;3827;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ketotifen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
783;255012985;;625223;103175725;3827;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ketotifen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
784;255013346;;625223;104234169;126941;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Methotrexate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O
785;255013347;;625223;104234169;126941;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Methotrexate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O
786;255013348;;625223;103167313;4735;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pentamidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N
787;255013349;;625223;103167313;4735;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pentamidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N
788;255013350;;625223;103165982;5344;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulfisoxazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N
789;255013351;;625223;103165982;5344;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulfisoxazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N
790;255013352;;625223;103200429;222757;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Estradiol Benzoate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)OC(=O)C5=CC=CC=C5
791;255013353;;625223;103200429;222757;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Estradiol Benzoate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)OC(=O)C5=CC=CC=C5
792;255013354;;625223;103232332;2783;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Clenbuterol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O
793;255013355;;625223;136944590;6101868;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Strontium Chloride Hexahydrate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;O.O.O.O.O.O.[Cl-].[Cl-].[Sr+2]
794;255013356;;625223;136944590;6101868;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Strontium Chloride Hexahydrate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;O.O.O.O.O.O.[Cl-].[Cl-].[Sr+2]
795;255013359;;625223;103329683;4133;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Methyl Salicylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC(=O)C1=CC=CC=C1O
796;255013360;;625223;103329683;4133;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Methyl Salicylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC(=O)C1=CC=CC=C1O
797;255013361;;625223;103355081;1720;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);4-Amino-1,8-naphthalimide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC2=C(C=CC3=C2C(=C1)C(=O)NC3=O)N
798;255013362;;625223;103355081;1720;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);4-Amino-1,8-naphthalimide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC2=C(C=CC3=C2C(=C1)C(=O)NC3=O)N
799;255013363;;625223;103179212;2337;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Benzocaine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)C1=CC=C(C=C1)N
800;255013364;;625223;124966244;50942;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Doxofylline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC3OCCO3
801;255013365;;625223;124966244;50942;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Doxofylline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC3OCCO3
802;255013366;;625223;103323115;5281787;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Caffeic acid phenethyl ester;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)CCOC(=O)/C=C/C2=CC(=C(C=C2)O)O
803;255013367;;625223;103323115;5281787;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Caffeic acid phenethyl ester;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)CCOC(=O)/C=C/C2=CC(=C(C=C2)O)O
804;255013368;;625223;103245600;1549120;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Epalrestat;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C/C(=C\C1=CC=CC=C1)/C=C\2/C(=O)N(C(=S)S2)CC(=O)O
805;255013369;;625223;103245600;1549120;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Epalrestat;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C/C(=C\C1=CC=CC=C1)/C=C\2/C(=O)N(C(=S)S2)CC(=O)O
806;255013726;;625223;103590644;656516;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amygdalin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)[C@H](C#N)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)O
807;255013727;;625223;103590644;656516;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amygdalin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)[C@H](C#N)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)O
808;255013730;;625223;103165562;3440;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Furosemide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
809;255013731;;625223;103165562;3440;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Furosemide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
810;255013732;;625223;103224659;442292;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Picrotoxinin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=C)[C@@H]1[C@@H]2[C@@H]3[C@@]4([C@]([C@H]1C(=O)O2)(C[C@@H]5[C@]4(O5)C(=O)O3)O)C
811;255013733;;625223;103224659;442292;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Picrotoxinin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=C)[C@@H]1[C@@H]2[C@@H]3[C@@]4([C@]([C@H]1C(=O)O2)(C[C@@H]5[C@]4(O5)C(=O)O3)O)C
812;255013734;;625223;242566490;5353627;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)N1C2=CC=CC=C2C(=C1/C=C/C(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
813;255013735;;625223;242566490;5353627;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)N1C2=CC=CC=C2C(=C1/C=C/C(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F
814;255013736;;625223;124974125;2447;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Bromisoval;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)C(C(=O)NC(=O)N)Br
815;255013737;;625223;124974125;2447;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Bromisoval;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)C(C(=O)NC(=O)N)Br
816;255013738;;625223;103253261;4488;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Niflumic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC(=C1)NC2=C(C=CC=N2)C(=O)O)C(F)(F)F
817;255013739;;625223;103253261;4488;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Niflumic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC(=C1)NC2=C(C=CC=N2)C(=O)O)C(F)(F)F
818;255013740;;625223;103179077;4914;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Procaine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CC)CCOC(=O)C1=CC=C(C=C1)N
819;255013741;;625223;103179077;4914;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Procaine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CC)CCOC(=O)C1=CC=C(C=C1)N
820;255013742;;625223;103193099;3291;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ethosuximide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC1(CC(=O)NC1=O)C
821;255013743;;625223;103193099;3291;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ethosuximide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC1(CC(=O)NC1=O)C
822;255013744;;625223;103232332;2783;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Clenbuterol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O
823;255013745;;625223;103406603;71335;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Danofloxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C[C@@H]2C[C@H]1CN2C3=C(C=C4C(=C3)N(C=C(C4=O)C(=O)O)C5CC5)F
824;255013746;;625223;103406603;71335;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Danofloxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C[C@@H]2C[C@H]1CN2C3=C(C=C4C(=C3)N(C=C(C4=O)C(=O)O)C5CC5)F
825;255013747;;625223;103504490;135398740;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ganciclovir;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=NC2=C(N1COC(CO)CO)N=C(NC2=O)N
826;255013748;;625223;103504490;135398740;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ganciclovir;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=NC2=C(N1COC(CO)CO)N=C(NC2=O)N
827;255013749;;625223;103179607;5362440;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Indinavir;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@H](C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@@H](CC4=CC=CC=C34)O)O)CC5=CN=CC=C5
828;255013750;;625223;103179607;5362440;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Indinavir;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@H](C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@@H](CC4=CC=CC=C34)O)O)CC5=CN=CC=C5
829;255014091;;625223;103378026;5362119;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lisinopril;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1C[C@H](N(C1)C(=O)[C@H](CCCCN)N[C@@H](CCC2=CC=CC=C2)C(=O)O)C(=O)O
830;255014092;;625223;103378026;5362119;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lisinopril;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1C[C@H](N(C1)C(=O)[C@H](CCCCN)N[C@@H](CCC2=CC=CC=C2)C(=O)O)C(=O)O
831;255014093;;625223;123100913;4284720;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);1-[5-(thiophen-2-ylmethoxy)-1H-indol-3-yl]propan-2-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(CC1=CNC2=C1C=C(C=C2)OCC3=CC=CS3)N
832;255014096;;625223;123100913;4284720;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);1-[5-(thiophen-2-ylmethoxy)-1H-indol-3-yl]propan-2-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(CC1=CNC2=C1C=C(C=C2)OCC3=CC=CS3)N
833;255014097;;625223;103210632;4201;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Minoxidil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
834;255014098;;625223;103210632;4201;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Minoxidil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
835;255014101;;625223;160671847;9433;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Aminophylline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N
836;255014102;;625223;160671847;9433;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Aminophylline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N
837;255014103;;625223;103168313;5426;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Thalidomide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
838;255014104;;625223;103168313;5426;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Thalidomide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
839;255014105;;625223;124974065;36314;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Paclitaxel;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
840;255014106;;625223;124974065;36314;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Paclitaxel;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
841;255014107;;625223;103175236;447043;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Azithromycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
842;255014108;;625223;103175236;447043;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Azithromycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
843;255014111;;625223;103172304;1935;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tacrine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCC2=NC3=CC=CC=C3C(=C2C1)N
844;255014112;;625223;103172304;1935;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tacrine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCC2=NC3=CC=CC=C3C(=C2C1)N
845;255014113;;625223;103770607;9270;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ethynodiol diacetate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)O[C@H]1CC[C@@H]2[C@H]3CC[C@]4([C@H]([C@@H]3CCC2=C1)CC[C@]4(C#C)OC(=O)C)C
846;255014114;;625223;103770607;9270;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ethynodiol diacetate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)O[C@H]1CC[C@@H]2[C@H]3CC[C@]4([C@H]([C@@H]3CCC2=C1)CC[C@]4(C#C)OC(=O)C)C
847;255014115;;625223;103336971;9819053;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);2-(4-Fluorophenyl)-4-methoxy-3-(pyridin-4-YL)-1H-pyrrolo[2,3-B]pyridin-6-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=CC(=NC2=C1C(=C(N2)C3=CC=C(C=C3)F)C4=CC=NC=C4)N
848;255014460;;625223;103336971;9819053;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);2-(4-Fluorophenyl)-4-methoxy-3-(pyridin-4-YL)-1H-pyrrolo[2,3-B]pyridin-6-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=CC(=NC2=C1C(=C(N2)C3=CC=C(C=C3)F)C4=CC=NC=C4)N
849;255014461;;625223;103179819;5546;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Triamterene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N
850;255014462;;625223;103179819;5546;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Triamterene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N
851;255014463;;625223;136920460;7000;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);O-Anisidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=CC=CC=C1N
852;255014464;;625223;136920460;7000;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);O-Anisidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=CC=CC=C1N
853;255014465;;625223;103231282;4170;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Metolazone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
854;255014466;;625223;103231282;4170;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Metolazone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
855;255014467;;625223;103188732;4740;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pentoxifylline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
856;255014468;;625223;103188732;4740;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pentoxifylline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
857;255014469;;625223;103228758;3305;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Etidronic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(O)(P(=O)(O)O)P(=O)(O)O
858;255014470;;625223;103228758;3305;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Etidronic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(O)(P(=O)(O)O)P(=O)(O)O
859;255014471;;625223;103240839;5245;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Risedronic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
860;255014472;;625223;103240839;5245;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Risedronic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
861;255014473;;625223;103462008;275196;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Noscapine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCC2=CC3=C(C(=C2[C@@H]1[C@@H]4C5=C(C(=C(C=C5)OC)OC)C(=O)O4)OC)OCO3
862;255014474;;625223;103462008;275196;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Noscapine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCC2=CC3=C(C(=C2[C@@H]1[C@@H]4C5=C(C(=C(C=C5)OC)OC)C(=O)O4)OC)OCO3
863;255014477;;625223;103173154;42574;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Closantel;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC(=C(C=C1NC(=O)C2=C(C(=CC(=C2)I)I)O)Cl)C(C#N)C3=CC=C(C=C3)Cl
864;255014478;;625223;103173154;42574;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Closantel;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC(=C(C=C1NC(=O)C2=C(C(=CC(=C2)I)I)O)Cl)C(C#N)C3=CC=C(C=C3)Cl
865;255014479;;625223;136926996;657272;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Choline Alfoscerate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[N+](C)(C)CCOP(=O)([O-])OC[C@@H](CO)O
866;255014480;;625223;136926996;657272;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Choline Alfoscerate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[N+](C)(C)CCOP(=O)([O-])OC[C@@H](CO)O
867;255014481;;625223;103654274;9917490;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pharmakon1600-01500602;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCC2=CC(=C3C=C2[C@@H]1CC4=CC=C(C=C4)OC5=C6[C@@H](CC7=CC(=C(C=C7)O)O3)[N+](CCC6=CC(=C5O)OC)(C)C)OC.[Cl-]
868;255014482;;625223;103654274;9917490;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pharmakon1600-01500602;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCC2=CC(=C3C=C2[C@@H]1CC4=CC=C(C=C4)OC5=C6[C@@H](CC7=CC(=C(C=C7)O)O3)[N+](CCC6=CC(=C5O)OC)(C)C)OC.[Cl-]
869;255014483;;625223;494430630;24832676;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Aconitin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN1C[C@@]2([C@@H](C[C@@H]([C@@]34[C@@H]2[C@H]([C@@H]([C@H]31)[C@@]5([C@@H]6[C@H]4C[C@@]([C@@H]6OC(=O)C7=CC=CC=C7)([C@H]([C@@H]5O)OC)O)OC(=O)C)OC)OC)O)COC
870;255014484;;625223;494430630;24832676;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Aconitin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN1C[C@@]2([C@@H](C[C@@H]([C@@]34[C@@H]2[C@H]([C@@H]([C@H]31)[C@@]5([C@@H]6[C@H]4C[C@@]([C@@H]6OC(=O)C7=CC=CC=C7)([C@H]([C@@H]5O)OC)O)OC(=O)C)OC)OC)O)COC
871;255014869;;625223;103533189;44431027;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);gamma-Cyclodextrine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C([C@@H]1[C@@H]2[C@@H]([C@H]([C@H](O1)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](OC([C@@H]([C@H]5O)O)OC6[C@H](OC([C@@H]([C@H]6O)O)C7[C@H](OC([C@@H]([C@H]7O)O)O[C@@H]8[C@H](O[C@@H]([C@@H]([C@H]8O)O)O[C@@H]9[C@H](O[C@H](O2)[C@@H]([C@H]9O)O)CO)CO)CO)CO)CO)CO)CO)O)O)O
872;255014870;;625223;103533189;44431027;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);gamma-Cyclodextrine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C([C@@H]1[C@@H]2[C@@H]([C@H]([C@H](O1)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](OC([C@@H]([C@H]5O)O)OC6[C@H](OC([C@@H]([C@H]6O)O)C7[C@H](OC([C@@H]([C@H]7O)O)O[C@@H]8[C@H](O[C@@H]([C@@H]([C@H]8O)O)O[C@@H]9[C@H](O[C@H](O2)[C@@H]([C@H]9O)O)CO)CO)CO)CO)CO)CO)CO)O)O)O
873;255014871;;625223;103288166;5560;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Trichlormethiazide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl
874;255014872;;625223;103288166;5560;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Trichlormethiazide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl
875;255014875;;625223;103168084;10607;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Podofilox;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=CC(=CC(=C1OC)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](C4=CC5=C(C=C24)OCO5)O
876;255014876;;625223;103168084;10607;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Podofilox;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=CC(=CC(=C1OC)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](C4=CC5=C(C=C24)OCO5)O
877;255014877;;625223;103418150;3747;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ipriflavone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=CC=C3
878;255014878;;625223;103418150;3747;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ipriflavone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=CC=C3
879;255014879;;625223;104234145;2520;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Verapamil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC
880;255014880;;625223;104234145;2520;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Verapamil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC
881;255014881;;625223;103226073;6574;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);1,1,2-Trichloroethane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(C(Cl)Cl)Cl
882;255014882;;625223;103226073;6574;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);1,1,2-Trichloroethane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(C(Cl)Cl)Cl
883;255014883;;625223;103195019;60825;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lamivudine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1[C@H](O[C@H](S1)CO)N2C=CC(=NC2=O)N
884;255014884;;625223;103195019;60825;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lamivudine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1[C@H](O[C@H](S1)CO)N2C=CC(=NC2=O)N
885;255014885;;625223;103554720;60823;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Atorvastatin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4
886;255014886;;625223;103554720;60823;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Atorvastatin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4
887;255014887;;625223;103209992;452261;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Genaconazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]([C@](CN1C=NC=N1)(C2=C(C=C(C=C2)F)F)O)S(=O)(=O)C
888;255014888;;625223;103209992;452261;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Genaconazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]([C@](CN1C=NC=N1)(C2=C(C=C(C=C2)F)F)O)S(=O)(=O)C
889;255014889;;625223;103406649;3406;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fomepizole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CNN=C1
890;255014890;;625223;103406649;3406;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fomepizole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CNN=C1
891;255014891;;625223;164144498;71277;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Erythromycin propionate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)OC(=O)CC)(C)O)C)C)O)(C)O
892;255015200;;625223;164144498;71277;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Erythromycin propionate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)OC(=O)CC)(C)O)C)C)O)(C)O
893;255015201;;625223;103770731;38101;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lodosyn;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)NN.O
894;255015202;;625223;103770731;38101;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lodosyn;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)NN.O
895;255015203;;625223;242084574;19649;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Streptomycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O
896;255015204;;625223;242084574;19649;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Streptomycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O
897;255015205;;625223;103483583;5870;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Estrone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)O
898;255015206;;625223;103483583;5870;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Estrone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)O
899;255015207;;625223;103183095;5087;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCOC1=C(C=CC(=C1)CC2CNC(=O)N2)OC
900;255015208;;625223;103183095;5087;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCOC1=C(C=CC(=C1)CC2CNC(=O)N2)OC
901;255015211;;625223;194134381;25249;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Stanozolol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(CC5=C(C4)NN=C5)C
902;255015212;;625223;194134381;25249;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Stanozolol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(CC5=C(C4)NN=C5)C
903;255015213;;625223;103234890;5360696;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dextromethorphan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC
904;255015214;;625223;103234890;5360696;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dextromethorphan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC
905;255015215;;625223;103223867;460612;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Melphalan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl
906;255015216;;625223;103223867;460612;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Melphalan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl
907;255015217;;625223;103459707;39912;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dexibuprofen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H](C1=CC=C(C=C1)CC(C)C)C(=O)O
908;255015218;;625223;103459707;39912;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dexibuprofen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H](C1=CC=C(C=C1)CC(C)C)C(=O)O
909;255015219;;625223;103188146;441130;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Meropenem;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)N(C)C)C(=O)O)[C@@H](C)O
910;255015220;;625223;103188146;441130;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Meropenem;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)N(C)C)C(=O)O)[C@@H](C)O
911;255015221;;625223;103221477;2435;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Brimonidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br
912;255015222;;625223;103221477;2435;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Brimonidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br
913;255015618;;625223;103245381;14385;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);3,3',4',5-Tetrachlorosalicylanilide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C=C1NC(=O)C2=C(C(=CC(=C2)Cl)Cl)O)Cl)Cl
914;255015619;;625223;103245381;14385;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);3,3',4',5-Tetrachlorosalicylanilide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C=C1NC(=O)C2=C(C(=CC(=C2)Cl)Cl)O)Cl)Cl
915;255015620;;625223;103597669;34001;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cetraxate hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC(CCC1CN)C(=O)OC2=CC=C(C=C2)CCC(=O)O.Cl
916;255015621;;625223;103597669;34001;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cetraxate hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC(CCC1CN)C(=O)OC2=CC=C(C=C2)CCC(=O)O.Cl
917;255015622;;625223;103174429;1221;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);alpha-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(=O)NO1)CC(C(=O)O)N
918;255015623;;625223;103174429;1221;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);alpha-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(=O)NO1)CC(C(=O)O)N
919;255015626;;625223;103168363;3826;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ketorolac;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O
920;255015627;;625223;103168363;3826;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ketorolac;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O
921;255015628;;625223;103168790;3488;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Glyburide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
922;255015629;;625223;103168790;3488;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Glyburide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
923;255015630;;625223;103173774;3950;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lomustine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCC(CC1)NC(=O)N(CCCl)N=O
924;255015631;;625223;103173774;3950;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lomustine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCC(CC1)NC(=O)N(CCCl)N=O
925;255015632;;625223;103709193;5403;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Terbutaline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O
926;255015633;;625223;103709193;5403;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Terbutaline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O
927;255015634;;625223;103167682;4463;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nevirapine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
928;255015635;;625223;103167682;4463;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nevirapine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
929;255015636;;625223;103546496;3961;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Losartan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
930;255015637;;625223;103546496;3961;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Losartan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
931;255015638;;625223;103577988;5353432;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(E)-3-(4-tert-butylphenylsulfonyl)acrylonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)/C=C/C#N
932;255015639;;625223;103577988;5353432;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(E)-3-(4-tert-butylphenylsulfonyl)acrylonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)/C=C/C#N
933;255015640;;625223;103487489;3475;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Gliclazide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2
934;255015641;;625223;103487489;3475;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Gliclazide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2
935;255015642;;625223;124971543;36324;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amitraz;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC(=C(C=C1)N=CN(C)C=NC2=C(C=C(C=C2)C)C)C
936;255015999;;625223;124971543;36324;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amitraz;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC(=C(C=C1)N=CN(C)C=NC2=C(C=C(C=C2)C)C)C
937;255016000;;625223;103210760;6253;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cytarabine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O
938;255016001;;625223;103210760;6253;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cytarabine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O
939;255016004;;625223;123094714;2140;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Diatrizoic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I
940;255016005;;625223;123094714;2140;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Diatrizoic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I
941;255016006;;625223;103169484;2145;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Aminoglutethimide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N
942;255016007;;625223;103169484;2145;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Aminoglutethimide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N
943;255016008;;625223;104234246;2162;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amlodipine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN
944;255016009;;625223;104234246;2162;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amlodipine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN
945;255016010;;625223;103165769;5327;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulfamethazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)C
946;255016011;;625223;103165769;5327;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulfamethazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)C
947;255016012;;625223;103469378;7638;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Monobenzone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)COC2=CC=C(C=C2)O
948;255016013;;625223;103469378;7638;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Monobenzone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)COC2=CC=C(C=C2)O
949;255016014;;625223;103261079;6215;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fluocinolone Acetonide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)C[C@@H](C5=CC(=O)C=C[C@@]53C)F)F)O
950;255016015;;625223;103261079;6215;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fluocinolone Acetonide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)C[C@@H](C5=CC(=O)C=C[C@@]53C)F)F)O
951;255016016;;625223;103267492;2972;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Deferiprone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(=O)C=CN1C)O
952;255016017;;625223;103267492;2972;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Deferiprone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(=O)C=CN1C)O
953;255016018;;625223;103357947;4906;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Prilocaine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCNC(C)C(=O)NC1=CC=CC=C1C
954;255016019;;625223;103357947;4906;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Prilocaine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCNC(C)C(=O)NC1=CC=CC=C1C
955;255016020;;625223;103198694;11790;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);alpha-Naphthoflavone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C4=CC=CC=C4C=C3
956;255016021;;625223;103198694;11790;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);alpha-Naphthoflavone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C4=CC=CC=C4C=C3
957;255016022;;625223;103307981;2170;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amoxapine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
958;255016023;;625223;103307981;2170;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amoxapine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
959;255016379;;625223;163312392;174174;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Atropine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
960;255016380;;625223;163312392;174174;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Atropine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
961;255016381;;625223;136921836;7043232;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(2S)-2-amino-3-(benzylcarbamothioylsulfanyl)propanoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)CNC(=S)SC[C@H](C(=O)O)N
962;255016382;;625223;136921836;7043232;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(2S)-2-amino-3-(benzylcarbamothioylsulfanyl)propanoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)CNC(=S)SC[C@H](C(=O)O)N
963;255016383;;625223;103165722;4763;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Phenobarbital;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
964;255016384;;625223;103165722;4763;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Phenobarbital;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
965;255016385;;625223;103477782;30323;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Daunorubicin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O
966;255016386;;625223;103477782;30323;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Daunorubicin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O
967;255016387;;625223;103173872;2913;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cyproheptadine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1
968;255016388;;625223;103173872;2913;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cyproheptadine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1
969;255016389;;625223;103194771;4760;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Phenindione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)C2C(=O)C3=CC=CC=C3C2=O
970;255016390;;625223;103194771;4760;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Phenindione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)C2C(=O)C3=CC=CC=C3C2=O
971;255016391;;625223;103176321;5746;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mitomycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N
972;255016392;;625223;103176321;5746;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mitomycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N
973;255016393;;625223;103306510;4922;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Proglumide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)C1=CC=CC=C1
974;255016394;;625223;103306510;4922;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Proglumide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)C1=CC=CC=C1
975;255016395;;625223;103239041;637511;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cinnamaldehyde;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)/C=C/C=O
976;255016396;;625223;103239041;637511;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cinnamaldehyde;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)/C=C/C=O
977;255016397;;625223;103193982;637566;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Geraniol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=CCC/C(=C/CO)/C)C
978;255016398;;625223;103193982;637566;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Geraniol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=CCC/C(=C/CO)/C)C
979;255016399;;625223;103689672;2763;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ciprofibrate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CC2(Cl)Cl
980;255016400;;625223;103689672;2763;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ciprofibrate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CC2(Cl)Cl
981;255016401;;625223;103458965;4236;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Modafinil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
982;255016402;;625223;103458965;4236;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Modafinil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
983;255016403;;625223;103292787;34312;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Oxcarbazepine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
984;255016757;;625223;103292787;34312;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Oxcarbazepine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
985;255016758;;625223;194134279;3793;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sporanox;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl
986;255016759;;625223;194134279;3793;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sporanox;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl
987;255016760;;625223;103199552;5070;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Riluzole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N
988;255016761;;625223;103199552;5070;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Riluzole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N
989;255016762;;625223;103166621;4595;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ondansetron;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
990;255016763;;625223;103166621;4595;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ondansetron;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
991;255016764;;625223;103183748;5090;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Rofecoxib;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
992;255016765;;625223;103183748;5090;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Rofecoxib;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
993;255016766;;625223;123097009;5742673;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cefotaxime;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OC)/C3=CSC(=N3)N)SC1)C(=O)O
994;255016767;;625223;123097009;5742673;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cefotaxime;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OC)/C3=CSC(=N3)N)SC1)C(=O)O
995;255016768;;625223;103165869;2164;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amobarbital;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC1(C(=O)NC(=O)NC1=O)CCC(C)C
996;255016769;;625223;103165869;2164;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amobarbital;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC1(C(=O)NC(=O)NC1=O)CCC(C)C
997;255016770;;625223;160698611;5472495;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulindac sulfone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC\1=C(C2=C(/C1=C\C3=CC=C(C=C3)S(=O)(=O)C)C=CC(=C2)F)CC(=O)O
998;255016771;;625223;160698611;5472495;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulindac sulfone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC\1=C(C2=C(/C1=C\C3=CC=C(C=C3)S(=O)(=O)C)C=CC(=C2)F)CC(=O)O
999;255016772;;625223;103178022;60021;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Temafloxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1CN(CCN1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=C(C=C(C=C4)F)F)F
1000;255016773;;625223;103178022;60021;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Temafloxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1CN(CCN1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=C(C=C(C=C4)F)F)F
1001;255016774;;625223;103770976;6172;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Gallamine Triethiodide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[N+](CC)(CC)CCOC1=C(C(=CC=C1)OCC[N+](CC)(CC)CC)OCC[N+](CC)(CC)CC.[I-].[I-].[I-]
1002;255016775;;625223;103770976;6172;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Gallamine Triethiodide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[N+](CC)(CC)CCOC1=C(C(=CC=C1)OCC[N+](CC)(CC)CC)OCC[N+](CC)(CC)CC.[I-].[I-].[I-]
1003;255016776;;625223;103338617;6230;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Norethindrone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34
1004;255016777;;625223;103338617;6230;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Norethindrone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34
1005;255016778;;625223;103188801;14868;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tribromsalan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1NC(=O)C2=C(C(=CC(=C2)Br)Br)O)Br
1006;255016779;;625223;103188801;14868;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tribromsalan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1NC(=O)C2=C(C(=CC(=C2)Br)Br)O)Br
1007;255017104;;625223;103266319;3957;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Loratadine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1
1008;255017105;;625223;103266319;3957;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Loratadine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1
1009;255017106;;625223;103164270;3373;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Flumazenil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C
1010;255017107;;625223;103164270;3373;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Flumazenil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C
1011;255017108;;625223;103311080;3496;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Glyphosate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(C(=O)O)NCP(=O)(O)O
1012;255017109;;625223;103311080;3496;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Glyphosate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(C(=O)O)NCP(=O)(O)O
1013;255017110;;625223;103189265;3100;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Diphenhydramine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
1014;255017111;;625223;103189265;3100;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Diphenhydramine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
1015;255017112;;625223;103173303;4908;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Primaquine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2
1016;255017113;;625223;103173303;4908;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Primaquine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2
1017;255017114;;625223;103288149;5897;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);2-Acetylaminofluorene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)NC1=CC2=C(C=C1)C3=CC=CC=C3C2
1018;255017115;;625223;124971557;2893;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cyclandelate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1CC(CC(C1)(C)C)OC(=O)C(C2=CC=CC=C2)O
1019;255017116;;625223;124971557;2893;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cyclandelate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1CC(CC(C1)(C)C)OC(=O)C(C2=CC=CC=C2)O
1020;255017117;;625223;103588113;522325;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dipyrone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)[O-].[Na+]
1021;255017118;;625223;103588113;522325;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dipyrone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)[O-].[Na+]
1022;255017119;;625223;103589702;7516;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Phenylhydrazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)NN
1023;255017120;;625223;103589702;7516;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Phenylhydrazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)NN
1024;255017121;;625223;104234163;43672;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Piperacillin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O
1025;255017122;;625223;104234163;43672;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Piperacillin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O
1026;255017123;;625223;124968171;186907;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Aflatoxin B1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4[C@@H]5C=CO[C@@H]5OC4=C1
1027;255017124;;625223;124968171;186907;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Aflatoxin B1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4[C@@H]5C=CO[C@@H]5OC4=C1
1028;255017125;;625223;103274172;4855;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Piromidic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN1C=C(C(=O)C2=CN=C(N=C21)N3CCCC3)C(=O)O
1029;255017126;;625223;103274172;4855;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Piromidic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN1C=C(C(=O)C2=CN=C(N=C21)N3CCCC3)C(=O)O
1030;255017127;;625223;103508277;5852;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Penicillamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)([C@H](C(=O)O)N)S
1031;255017128;;625223;103508277;5852;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Penicillamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)([C@H](C(=O)O)N)S
1032;255017407;;625223;103201243;72172;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ubenimex;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)C[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](CC1=CC=CC=C1)N)O
1033;255017408;;625223;103201243;72172;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ubenimex;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)C[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](CC1=CC=CC=C1)N)O
1034;255017409;;625223;160693426;969491;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dieldrin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1[C@@H]2[C@H]3[C@@H]([C@H]1[C@H]4[C@@H]2O4)[C@]5(C(=C([C@@]3(C5(Cl)Cl)Cl)Cl)Cl)Cl
1035;255017410;;625223;160693426;969491;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dieldrin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1[C@@H]2[C@H]3[C@@H]([C@H]1[C@H]4[C@@H]2O4)[C@]5(C(=C([C@@]3(C5(Cl)Cl)Cl)Cl)Cl)Cl
1036;255017411;;625223;103523408;26879;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Levamisole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CSC2=N[C@H](CN21)C3=CC=CC=C3
1037;255017412;;625223;103523408;26879;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Levamisole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CSC2=N[C@H](CN21)C3=CC=CC=C3
1038;255017413;;625223;103558584;5284613;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Proscillaridin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2CC[C@@]3([C@H]4CC[C@@]5([C@H](CC[C@@]5([C@@H]4CCC3=C2)O)C6=COC(=O)C=C6)C)C)O)O)O
1039;255017414;;625223;103558584;5284613;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Proscillaridin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@H]2CC[C@@]3([C@H]4CC[C@@]5([C@H](CC[C@@]5([C@@H]4CCC3=C2)O)C6=COC(=O)C=C6)C)C)O)O)O
1040;255017415;;625223;103225961;14052;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ethambutol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@@H](CO)NCCN[C@@H](CC)CO
1041;255017416;;625223;103225961;14052;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ethambutol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@@H](CO)NCCN[C@@H](CC)CO
1042;255017417;;625223;103188975;35370;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Zidovudine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-]
1043;255017418;;625223;103188975;35370;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Zidovudine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-]
1044;255017419;;625223;103367920;39941;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Benoxaprofen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C1=CC2=C(C=C1)OC(=N2)C3=CC=C(C=C3)Cl)C(=O)O
1045;255017420;;625223;103367920;39941;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Benoxaprofen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C1=CC2=C(C=C1)OC(=N2)C3=CC=C(C=C3)Cl)C(=O)O
1046;255017421;;625223;103618143;4728;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);5-Hydroxy-4-methoxy-5-(1-methylethenyl)-2-furanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=C)C1(C(=CC(=O)O1)OC)O
1047;255017422;;625223;103618143;4728;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);5-Hydroxy-4-methoxy-5-(1-methylethenyl)-2-furanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=C)C1(C(=CC(=O)O1)OC)O
1048;255017423;;625223;160677133;5978;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Vincristine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
1049;255017424;;625223;160677133;5978;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Vincristine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
1050;255017425;;625223;103203986;2336;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Benzo[a]pyrene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C4C(=CC=C5)C=C3
1051;255017426;;625223;103203986;2336;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Benzo[a]pyrene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C2C3=C4C(=CC2=C1)C=CC5=C4C(=CC=C5)C=C3
1052;255017427;;625223;123094713;446598;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Clindamycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)Cl
1053;255017428;;625223;123094713;446598;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Clindamycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)Cl
1054;255017429;;625223;103174500;3672;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ibuprofen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
1055;255017430;;625223;103174500;3672;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ibuprofen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
1056;255017431;;625223;103456563;1981;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Acemetacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)OCC(=O)O
1057;255017777;;625223;103456563;1981;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Acemetacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)OCC(=O)O
1058;255017778;;625223;103168744;5253;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sotalol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O
1059;255017779;;625223;103168744;5253;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sotalol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O
1060;255017780;;625223;103706605;14049689;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Trappsol Cyclo;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(COC[C@@H]1[C@@H]2[C@@H]([C@H]([C@H](O1)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)O)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6O)O)O[C@@H]7[C@H](O[C@@H]([C@@H]([C@H]7O)O)O[C@@H]8[C@H](O[C@H](O2)[C@@H]([C@H]8O)O)COCC(C)O)COCC(C)O)COCC(C)O)COCC(C)O)COCC(C)O)COCC(C)O)O)O)O
1061;255017781;;625223;103706605;14049689;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Trappsol Cyclo;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(COC[C@@H]1[C@@H]2[C@@H]([C@H]([C@H](O1)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)O)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6O)O)O[C@@H]7[C@H](O[C@@H]([C@@H]([C@H]7O)O)O[C@@H]8[C@H](O[C@H](O2)[C@@H]([C@H]8O)O)COCC(C)O)COCC(C)O)COCC(C)O)COCC(C)O)COCC(C)O)COCC(C)O)O)O)O
1062;255017782;;625223;103504725;135398513;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Acyclovir;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=NC2=C(N1COCCO)N=C(NC2=O)N
1063;255017783;;625223;103504725;135398513;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Acyclovir;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=NC2=C(N1COCCO)N=C(NC2=O)N
1064;255017784;;625223;103178852;441140;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Griseofulvin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1CC(=O)C=C([C@]12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC
1065;255017785;;625223;103178852;441140;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Griseofulvin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1CC(=O)C=C([C@]12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC
1066;255017786;;625223;103458646;65359;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Oxiglutatione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(CC(=O)N[C@@H](CSSC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)C(=O)NCC(=O)O)[C@@H](C(=O)O)N
1067;255017787;;625223;103458646;65359;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Oxiglutatione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(CC(=O)N[C@@H](CSSC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)C(=O)NCC(=O)O)[C@@H](C(=O)O)N
1068;255017788;;625223;103507642;3385;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fluorouracil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=C(C(=O)NC(=O)N1)F
1069;255017789;;625223;103507642;3385;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fluorouracil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=C(C(=O)NC(=O)N1)F
1070;255017790;;625223;103178857;3394;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Flurbiprofen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O
1071;255017791;;625223;103178857;3394;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Flurbiprofen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O
1072;255017792;;625223;103196311;5147;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Salicylamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C(=C1)C(=O)N)O
1073;255017793;;625223;103196311;5147;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Salicylamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C(=C1)C(=O)N)O
1074;255017794;;625223;103167089;38853;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Methyldopa;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)N
1075;255017795;;625223;103167089;38853;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Methyldopa;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)N
1076;255017796;;625223;103370789;5479;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tinidazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C
1077;255017797;;625223;103370789;5479;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tinidazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C
1078;255017798;;625223;103770616;9812710;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ivomec;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C.C[C@H]1CC[C@]2(C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)O[C@@H]1C(C)C
1079;255017799;;625223;103770616;9812710;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ivomec;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C.C[C@H]1CC[C@]2(C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)O[C@@H]1C(C)C
1080;255017800;;625223;123099348;10635;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Androstanolone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CCC(=O)C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4O)C
1081;255017801;;625223;123099348;10635;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Androstanolone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CCC(=O)C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4O)C
1082;255018193;;625223;103195621;6279;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Medroxyprogesterone acetate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C
1083;255018194;;625223;103195621;6279;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Medroxyprogesterone acetate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C
1084;255018195;;625223;103759736;32798;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Clobetasol Propionate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)C(=O)CCl
1085;255018196;;625223;103759736;32798;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Clobetasol Propionate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)C(=O)CCl
1086;255018197;;625223;103291866;4156;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Methyl methanesulfonate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COS(=O)(=O)C
1087;255018198;;625223;103291866;4156;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Methyl methanesulfonate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COS(=O)(=O)C
1088;255018201;;625223;160698676;134551;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);alpha-Ergocryptine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=CNC7=CC=CC(=C67)C5=C4)C)O
1089;255018202;;625223;160698676;134551;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);alpha-Ergocryptine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=CNC7=CC=CC(=C67)C5=C4)C)O
1090;255018203;;625223;103178995;2519;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Caffeine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C=NC2=C1C(=O)N(C(=O)N2C)C
1091;255018204;;625223;103178995;2519;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Caffeine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C=NC2=C1C(=O)N(C(=O)N2C)C
1092;255018207;;625223;103164254;3702;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Indapamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
1093;255018208;;625223;103164254;3702;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Indapamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
1094;255018209;;625223;103189409;3415;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Foscarnet;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(=O)(O)P(=O)(O)O
1095;255018210;;625223;123084851;9794806;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(inverted exclamation markA)-Huperzine A;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C/C=C/1\[C@@H]2CC3=C([C@@]1(CC(=C2)C)N)C=CC(=O)N3
1096;255018211;;625223;123084851;9794806;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(inverted exclamation markA)-Huperzine A;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C/C=C/1\[C@@H]2CC3=C([C@@]1(CC(=C2)C)N)C=CC(=O)N3
1097;255018212;;625223;103168230;3767;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Isoniazid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CN=CC=C1C(=O)NN
1098;255018213;;625223;103168230;3767;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Isoniazid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CN=CC=C1C(=O)NN
1099;255018214;;625223;103555920;9444;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Azacitidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=NC(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N
1100;255018215;;625223;103555920;9444;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Azacitidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=NC(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N
1101;255018216;;625223;103189246;2803;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Clonidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl
1102;255018217;;625223;103189246;2803;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Clonidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl
1103;255018601;;625223;136944588;443495;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sodium arsenite;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;[O-][As]=O.[Na+]
1104;255018602;;625223;136944588;443495;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sodium arsenite;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;[O-][As]=O.[Na+]
1105;255018603;;625223;174510203;9838675;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Astemisinin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1CC[C@H]2[C@H](C(=O)O[C@H]3[C@@]24[C@H]1CC[C@@](O3)(OO4)C)C
1106;255018604;;625223;174510203;9838675;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Astemisinin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1CC[C@H]2[C@H](C(=O)O[C@H]3[C@@]24[C@H]1CC[C@@](O3)(OO4)C)C
1107;255018605;;625223;103174523;4496;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nimetazepam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C(=O)CN=C(C2=C1C=CC(=C2)[N+](=O)[O-])C3=CC=CC=C3
1108;255018606;;625223;103174523;4496;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nimetazepam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C(=O)CN=C(C2=C1C=CC(=C2)[N+](=O)[O-])C3=CC=CC=C3
1109;255018607;;625223;104252420;27200;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Thiamphenicol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CS(=O)(=O)C1=CC=C(C=C1)[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O
1110;255018608;;625223;104252420;27200;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Thiamphenicol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CS(=O)(=O)C1=CC=C(C=C1)[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O
1111;255018609;;625223;103543151;3476;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Glimepiride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C
1112;255018610;;625223;103543151;3476;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Glimepiride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C
1113;255018613;;625223;103164548;5284616;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sirolimus;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC
1114;255018614;;625223;103164548;5284616;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sirolimus;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC
1115;255018615;;625223;103771134;6291;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mestranol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)OC
1116;255018616;;625223;103771134;6291;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mestranol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)OC
1117;255018617;;625223;131283791;5360515;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Naltrexone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O
1118;255018618;;625223;131283791;5360515;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Naltrexone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O
1119;255018619;;625223;103166445;3463;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Gemfibrozil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
1120;255018620;;625223;103166445;3463;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Gemfibrozil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
1121;255018621;;625223;103228261;14969;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Vancomycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
1122;255018622;;625223;103228261;14969;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Vancomycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
1123;255018623;;625223;103163765;4893;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Prazosin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC
1124;255018624;;625223;103163765;4893;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Prazosin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC
1125;255018625;;625223;103178831;3948;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lomefloxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN1C=C(C(=O)C2=CC(=C(C(=C21)F)N3CCNC(C3)C)F)C(=O)O
1126;255018969;;625223;103178831;3948;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lomefloxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN1C=C(C(=O)C2=CC(=C(C(=C21)F)N3CCNC(C3)C)F)C(=O)O
1127;255018972;;625223;104246526;78386;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);4-(2-Thienyl)butyric acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CSC(=C1)CCCC(=O)O
1128;255018973;;625223;104246526;78386;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);4-(2-Thienyl)butyric acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CSC(=C1)CCCC(=O)O
1129;255018974;;625223;103190907;2797;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Clofibric acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C(=O)O)OC1=CC=C(C=C1)Cl
1130;255018975;;625223;103190907;2797;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Clofibric acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C(=O)O)OC1=CC=C(C=C1)Cl
1131;255018976;;625223;103211583;3397;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Flutamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F
1132;255018977;;625223;103211583;3397;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Flutamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F
1133;255018978;;625223;160693281;6419941;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Homatropine hydrobromide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C(C3=CC=CC=C3)O.Br
1134;255018979;;625223;160693281;6419941;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Homatropine hydrobromide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C(C3=CC=CC=C3)O.Br
1135;255018980;;625223;103172254;5983;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Physostigmine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@]12CCN([C@@H]1N(C3=C2C=C(C=C3)OC(=O)NC)C)C
1136;255018981;;625223;103172254;5983;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Physostigmine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@]12CCN([C@@H]1N(C3=C2C=C(C=C3)OC(=O)NC)C)C
1137;255018982;;625223;131279814;4411;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Solgol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)NCC(COC1=CC=CC2=C1CC(C(C2)O)O)O
1138;255018983;;625223;131279814;4411;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Solgol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)NCC(COC1=CC=CC2=C1CC(C(C2)O)O)O
1139;255018984;;625223;103348651;6197;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cycloheximide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1C[C@@H](C(=O)[C@@H](C1)[C@@H](CC2CC(=O)NC(=O)C2)O)C
1140;255018985;;625223;103348651;6197;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cycloheximide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1C[C@@H](C(=O)[C@@H](C1)[C@@H](CC2CC(=O)NC(=O)C2)O)C
1141;255018986;;625223;103288373;2732;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Chlorthalidone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O
1142;255018987;;625223;103288373;2732;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Chlorthalidone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O
1143;255018988;;625223;103513016;2333;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Benzbromarone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)Br)O)Br
1144;255018989;;625223;103513016;2333;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Benzbromarone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)Br)O)Br
1145;255018990;;625223;103770568;5281034;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Oxymetholone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(C/C(=C/O)/C(=O)C4)C
1146;255018991;;625223;103770568;5281034;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Oxymetholone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(C/C(=C/O)/C(=O)C4)C
1147;255018992;;625223;103401015;44112;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Bopindolol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)(C)C)OC(=O)C3=CC=CC=C3
1148;255018993;;625223;103401015;44112;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Bopindolol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC2=C(N1)C=CC=C2OCC(CNC(C)(C)C)OC(=O)C3=CC=CC=C3
1149;255019334;;625223;374263482;11643449;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Desacetylvinblastine amide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)N)O)O)CC)OC)C(=O)OC)O
1150;255019335;;625223;374263482;11643449;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Desacetylvinblastine amide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)N)O)O)CC)OC)C(=O)OC)O
1151;255019338;;625223;103558466;1349907;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Methimazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C=CNC1=S
1152;255019339;;625223;103558466;1349907;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Methimazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C=CNC1=S
1153;255019340;;625223;103177124;6167;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Colchicine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC
1154;255019341;;625223;103163873;3357;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fleroxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCN(CC1)C2=C(C=C3C(=C2F)N(C=C(C3=O)C(=O)O)CCF)F
1155;255019342;;625223;103163873;3357;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fleroxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCN(CC1)C2=C(C=C3C(=C2F)N(C=C(C3=O)C(=O)O)CCF)F
1156;255019343;;625223;103179087;3825;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ketoprofen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
1157;255019344;;625223;103179087;3825;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ketoprofen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
1158;255019345;;625223;103173431;4037;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Meclofenamic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(=C(C=C1)Cl)NC2=CC=CC=C2C(=O)O)Cl
1159;255019346;;625223;103173431;4037;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Meclofenamic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(=C(C=C1)Cl)NC2=CC=CC=C2C(=O)O)Cl
1160;255019347;;625223;103207442;5281040;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Montelukast;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O
1161;255019348;;625223;103207442;5281040;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Montelukast;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O
1162;255019349;;625223;103242469;4495;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nimesulide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2
1163;255019350;;625223;103242469;4495;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nimesulide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2
1164;255019351;;625223;123096749;11080;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);1-Naphthyl isothiocyanate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C2C(=C1)C=CC=C2N=C=S
1165;255019352;;625223;123096749;11080;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);1-Naphthyl isothiocyanate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C2C(=C1)C=CC=C2N=C=S
1166;255019353;;625223;103168637;6228;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);N,N-Dimethylformamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)C=O
1167;255019354;;625223;103168637;6228;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);N,N-Dimethylformamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)C=O
1168;255019355;;625223;103170037;5284596;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Naloxone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O
1169;255019356;;625223;103170037;5284596;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Naloxone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O
1170;255019357;;625223;103282209;564;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Aminocaproic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(CCC(=O)O)CCN
1171;255019358;;625223;103282209;564;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Aminocaproic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(CCC(=O)O)CCN
1172;255019723;;625223;103288149;5897;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);2-Acetylaminofluorene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)NC1=CC2=C(C=C1)C3=CC=CC=C3C2
1173;255019724;;625223;104234273;38945;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tocainide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(=CC=C1)C)NC(=O)C(C)N
1174;255019725;;625223;104234273;38945;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tocainide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(=CC=C1)C)NC(=O)C(C)N
1175;255019726;;625223;103176241;2812;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Clotrimazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4
1176;255019727;;625223;103176241;2812;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Clotrimazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4
1177;255019728;;625223;103579573;457193;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dactinomycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1[C@@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N(CC(=O)N([C@H](C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)N[C@H]6[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@H](NC6=O)C(C)C)C)C)C(C)C)C)N)C
1178;255019729;;625223;103579573;457193;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dactinomycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1[C@@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N(CC(=O)N([C@H](C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)N[C@H]6[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@H](NC6=O)C(C)C)C)C)C(C)C)C)N)C
1179;255019730;;625223;103512866;54675776;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tetracycline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O
1180;255019731;;625223;103512866;54675776;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tetracycline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O
1181;255019732;;625223;104234255;439530;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Puromycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)C1=NC=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)NC(=O)[C@H](CC4=CC=C(C=C4)OC)N)O
1182;255019733;;625223;104234255;439530;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Puromycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)C1=NC=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)NC(=O)[C@H](CC4=CC=C(C=C4)OC)N)O
1183;255019734;;625223;103164726;41867;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Epirubicin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O
1184;255019735;;625223;103203421;3518;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Guanethidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCCN(CCC1)CCN=C(N)N
1185;255019736;;625223;103203421;3518;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Guanethidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCCN(CCC1)CCN=C(N)N
1186;255019737;;625223;136928378;667750;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(4-Benzylpiperidin-1-yl)(2-methoxyphenyl)methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=CC=CC=C1C(=O)N2CCC(CC2)CC3=CC=CC=C3
1187;255019738;;625223;136928378;667750;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(4-Benzylpiperidin-1-yl)(2-methoxyphenyl)methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=CC=CC=C1C(=O)N2CCC(CC2)CC3=CC=CC=C3
1188;255019739;;625223;103558703;5719;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Zaleplon;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
1189;255019740;;625223;103558703;5719;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Zaleplon;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
1190;255019741;;625223;103244854;392622;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ritonavir;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O
1191;255019742;;625223;103244854;392622;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ritonavir;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O
1192;255019743;;625223;103181781;5405;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Terfenadine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O
1193;255019744;;625223;103504084;3019;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Diazoxide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl
1194;255019745;;625223;103504084;3019;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Diazoxide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl
1195;255019746;;625223;103175300;47811;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pergolide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCN1C[C@@H](C[C@H]2[C@H]1CC3=CNC4=CC=CC2=C34)CSC
1196;255019747;;625223;103175300;47811;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pergolide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCN1C[C@@H](C[C@H]2[C@H]1CC3=CNC4=CC=CC2=C34)CSC
1197;255020069;;625223;103304486;5323714;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Furoxone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1COC(=O)N1/N=C/C2=CC=C(O2)[N+](=O)[O-]
1198;255020070;;625223;103304486;5323714;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Furoxone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1COC(=O)N1/N=C/C2=CC=C(O2)[N+](=O)[O-]
1199;255020071;;625223;103226142;5943;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Carbon Tetrachloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(Cl)(Cl)(Cl)Cl
1200;255020072;;625223;103226142;5943;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Carbon Tetrachloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(Cl)(Cl)(Cl)Cl
1201;255020073;;625223;123096753;68869;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Flunoxaprofen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H](C1=CC2=C(C=C1)OC(=N2)C3=CC=C(C=C3)F)C(=O)O
1202;255020074;;625223;123096753;68869;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Flunoxaprofen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H](C1=CC2=C(C=C1)OC(=N2)C3=CC=C(C=C3)F)C(=O)O
1203;255020075;;625223;103272743;667550;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dexketoprofen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H](C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
1204;255020076;;625223;103272743;667550;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dexketoprofen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H](C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
1205;255020077;;625223;103541455;446156;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cerivastatin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)C1=C(C(=C(C(=N1)C(C)C)COC)C2=CC=C(C=C2)F)/C=C/[C@H](C[C@H](CC(=O)O)O)O
1206;255020078;;625223;103541455;446156;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cerivastatin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)C1=C(C(=C(C(=N1)C(C)C)COC)C2=CC=C(C=C2)F)/C=C/[C@H](C[C@H](CC(=O)O)O)O
1207;255020079;;625223;103631353;71815;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Secnidazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=NC=C(N1CC(C)O)[N+](=O)[O-]
1208;255020080;;625223;103631353;71815;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Secnidazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=NC=C(N1CC(C)O)[N+](=O)[O-]
1209;255020081;;625223;103169156;3883;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lansoprazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
1210;255020082;;625223;103169156;3883;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lansoprazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
1211;255020083;;625223;103168388;24360;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Camptothecin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O
1212;255020084;;625223;103637704;108068;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);CID 108068;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CCC[C@@]2([C@@H](O2)[C@@H]3[C@@H](CC1)C(=C)C(=O)O3)C
1213;255020085;;625223;103637704;108068;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);CID 108068;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CCC[C@@]2([C@@H](O2)[C@@H]3[C@@H](CC1)C(=C)C(=O)O3)C
1214;255020086;;625223;103503926;667490;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mercaptopurine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=NC2=C(N1)C(=S)N=CN2
1215;255020087;;625223;103503926;667490;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mercaptopurine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=NC2=C(N1)C(=S)N=CN2
1216;255020088;;625223;103544522;2082;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Albendazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC
1217;255020089;;625223;103544522;2082;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Albendazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC
1218;255020090;;625223;123092331;9321;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Hydrazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;NN
1219;255020091;;625223;123092331;9321;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Hydrazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;NN
1220;255020465;;625223;103168388;24360;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Camptothecin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O
1221;255020466;;625223;103545435;440473;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mimosine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CN(C=C(C1=O)O)C[C@@H](C(=O)O)N
1222;255020467;;625223;103545435;440473;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mimosine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CN(C=C(C1=O)O)C[C@@H](C(=O)O)N
1223;255020468;;625223;103165609;5340;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulfathiazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1N)S(=O)(=O)NC2=NC=CS2
1224;255020469;;625223;103165609;5340;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulfathiazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1N)S(=O)(=O)NC2=NC=CS2
1225;255020470;;625223;103466522;6032;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Kanamycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N
1226;255020471;;625223;103466522;6032;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Kanamycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N
1227;255020472;;625223;103292415;9681;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Methysergide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C
1228;255020473;;625223;103292415;9681;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Methysergide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C
1229;255020474;;625223;103182298;5775;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Phentolamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O
1230;255020475;;625223;103182298;5775;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Phentolamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O
1231;255020476;;625223;103602152;54680783;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Citrinin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1[C@H](OC=C2C1=C(C(=C(C2=O)C(=O)O)O)C)C
1232;255020477;;625223;103602152;54680783;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Citrinin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1[C@H](OC=C2C1=C(C(=C(C2=O)C(=O)O)O)C)C
1233;255020478;;625223;103210093;2753;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cilostamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C1CCCCC1)C(=O)CCCOC2=CC3=C(C=C2)NC(=O)C=C3
1234;255020479;;625223;103210093;2753;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cilostamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C1CCCCC1)C(=O)CCCOC2=CC3=C(C=C2)NC(=O)C=C3
1235;255020480;;625223;103176346;702;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCO
1236;255020481;;625223;103176346;702;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCO
1237;255020482;;625223;123097006;8378;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Framycetin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N
1238;255020483;;625223;123097006;8378;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Framycetin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N
1239;255020484;;625223;103204298;750;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Glycine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(C(=O)O)N
1240;255020485;;625223;103204298;750;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Glycine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(C(=O)O)N
1241;255020486;;625223;103170619;60700;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Topotecan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O
1242;255020487;;625223;103170619;60700;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Topotecan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O
1243;255020488;;625223;124963825;3510;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Granisetronum;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
1244;255020489;;625223;124963825;3510;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Granisetronum;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
1245;255020803;;625223;103556931;222786;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cortisone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2C(=O)C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C
1246;255020804;;625223;103556931;222786;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cortisone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2C(=O)C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C
1247;255020805;;625223;103567639;135398748;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Penciclovir;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=NC2=C(N1CCC(CO)CO)N=C(NC2=O)N
1248;255020806;;625223;103567639;135398748;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Penciclovir;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=NC2=C(N1CCC(CO)CO)N=C(NC2=O)N
1249;255020807;;625223;103288110;5510;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tolnaftate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2
1250;255020808;;625223;103288110;5510;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tolnaftate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2
1251;255020809;;625223;103233471;60750;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Gemcitabine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F
1252;255020810;;625223;103233471;60750;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Gemcitabine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F
1253;255020811;;625223;103532317;54678486;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Warfarin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O
1254;255020812;;625223;103532317;54678486;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Warfarin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O
1255;255020813;;625223;103221520;5694;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pirinixic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(=CC=C1)NC2=CC(=NC(=N2)SCC(=O)O)Cl)C
1256;255020814;;625223;103221520;5694;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pirinixic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(=CC=C1)NC2=CC(=NC(=N2)SCC(=O)O)Cl)C
1257;255020815;;625223;124958489;104903;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tirilazad;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4(C3=CC[C@@]2([C@H]1C(=O)CN5CCN(CC5)C6=NC(=NC(=C6)N7CCCC7)N8CCCC8)C)C
1258;255020816;;625223;124958489;104903;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tirilazad;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4(C3=CC[C@@]2([C@H]1C(=O)CN5CCN(CC5)C6=NC(=NC(=C6)N7CCCC7)N8CCCC8)C)C
1259;255020817;;625223;103254526;11057;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Gentian Violet;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C.[Cl-]
1260;255020818;;625223;103254526;11057;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Gentian Violet;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C.[Cl-]
1261;255020819;;625223;103181002;2662;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Celecoxib;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
1262;255020820;;625223;103181002;2662;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Celecoxib;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
1263;255020821;;625223;103339774;5362129;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ramipril;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)O
1264;255020822;;625223;103339774;5362129;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ramipril;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)O
1265;255020823;;625223;103165167;2756;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cimetidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(N=CN1)CSCCNC(=NC)NC#N
1266;255020824;;625223;103165167;2756;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cimetidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(N=CN1)CSCCNC(=NC)NC#N
1267;255020825;;625223;103240093;5790;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Floxuridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)F)CO)O
1268;255020826;;625223;103240093;5790;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Floxuridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)F)CO)O
1269;255020827;;625223;136928379;196129;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cygro;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1C[C@H]([C@@](O[C@@H]1[C@H]2C[C@@H]([C@@H](O2)[C@@]3(CC[C@@H](O3)[C@@]4(CC[C@@]5(O4)C[C@@H]([C@H]([C@H](O5)[C@@H](C)[C@H]6[C@@H]([C@H]([C@@H]([C@](O6)(CC(=O)O)O)C)OC)OC)C)O)C)C)O[C@@H]7C[C@@H]([C@H]([C@@H](O7)C)OC)OC)(C)O)C
1270;255021227;;625223;136928379;196129;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cygro;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1C[C@H]([C@@](O[C@@H]1[C@H]2C[C@@H]([C@@H](O2)[C@@]3(CC[C@@H](O3)[C@@]4(CC[C@@]5(O4)C[C@@H]([C@H]([C@H](O5)[C@@H](C)[C@H]6[C@@H]([C@H]([C@@H]([C@](O6)(CC(=O)O)O)C)OC)OC)C)O)C)C)O[C@@H]7C[C@@H]([C@H]([C@@H](O7)C)OC)OC)(C)O)C
1271;255021228;;625223;136926966;135398735;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Rifampin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1/C=C/C=C(\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C=N/N5CCN(CC5)C)/C
1272;255021229;;625223;136926966;135398735;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Rifampin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1/C=C/C=C(\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C=N/N5CCN(CC5)C)/C
1273;255021230;;625223;103188954;5656;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Venlafaxine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
1274;255021231;;625223;103188954;5656;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Venlafaxine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
1275;255021232;;625223;103167833;4212;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mitoxantrone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO
1276;255021233;;625223;103167833;4212;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mitoxantrone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO
1277;255021234;;625223;103259583;445154;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Resveratrol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1/C=C/C2=CC(=CC(=C2)O)O)O
1278;255021235;;625223;103259583;445154;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Resveratrol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1/C=C/C2=CC(=CC(=C2)O)O)O
1279;255021238;;625223;103498411;5210;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sibutramine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
1280;255021239;;625223;103170197;31101;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Bromocriptine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O
1281;255021240;;625223;103170197;31101;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Bromocriptine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O
1282;255021241;;625223;103273527;5509;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tolmetin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC=C(C=C1)C(=O)C2=CC=C(N2C)CC(=O)O
1283;255021242;;625223;103273527;5509;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tolmetin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC=C(C=C1)C(=O)C2=CC=C(N2C)CC(=O)O
1284;255021243;;625223;103219083;5342;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulfinpyrazone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4
1285;255021244;;625223;103219083;5342;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulfinpyrazone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4
1286;255021245;;625223;103164353;3016;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Diazepam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3
1287;255021246;;625223;103164353;3016;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Diazepam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3
1288;255021247;;625223;103177883;3121;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Valproic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCC(CCC)C(=O)O
1289;255021248;;625223;103177883;3121;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Valproic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCC(CCC)C(=O)O
1290;255021249;;625223;103204244;5770;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Reserpine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([C@H]3C[C@@H]2[C@@H]1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC
1291;255021250;;625223;103204244;5770;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Reserpine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([C@H]3C[C@@H]2[C@@H]1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC
1292;255021251;;625223;103188912;5865;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Prednisone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C
1293;255021595;;625223;103188912;5865;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Prednisone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C
1294;255021596;;625223;103544139;667749;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(4-Benzylpiperidin-1-yl)(2-fluorophenyl)methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCC1CC2=CC=CC=C2)C(=O)C3=CC=CC=C3F
1295;255021597;;625223;103544139;667749;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(4-Benzylpiperidin-1-yl)(2-fluorophenyl)methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCC1CC2=CC=CC=C2)C(=O)C3=CC=CC=C3F
1296;255021598;;625223;103226686;446541;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mycophenolic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\C)/CCC(=O)O)O
1297;255021599;;625223;103226686;446541;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mycophenolic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\C)/CCC(=O)O)O
1298;255021600;;625223;103189031;5755;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Prednisolone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O
1299;255021601;;625223;103189031;5755;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Prednisolone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O
1300;255021602;;625223;103557025;757;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Glycolic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(C(=O)O)O
1301;255021603;;625223;103557025;757;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Glycolic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(C(=O)O)O
1302;255021604;;625223;103215362;5503;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tolazamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CCCCCC2
1303;255021605;;625223;103215362;5503;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tolazamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CCCCCC2
1304;255021606;;625223;124958057;73453;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ergocornine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=CNC7=CC=CC(=C67)C5=C4)C)O
1305;255021607;;625223;124958057;73453;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ergocornine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=CNC7=CC=CC(=C67)C5=C4)C)O
1306;255021608;;625223;103173757;5198;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Semustine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1CCC(CC1)NC(=O)N(CCCl)N=O
1307;255021609;;625223;103173757;5198;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Semustine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1CCC(CC1)NC(=O)N(CCCl)N=O
1308;255021610;;625223;103557069;6436;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Triamcinolone Acetonide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)CCC5=CC(=O)C=C[C@@]53C)F)O
1309;255021611;;625223;103557069;6436;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Triamcinolone Acetonide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)CCC5=CC(=O)C=C[C@@]53C)F)O
1310;255021612;;625223;103540543;5585;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Trioxsalen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC(=O)OC2=C1C=C3C=C(OC3=C2C)C
1311;255021613;;625223;103540543;5585;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Trioxsalen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC(=O)OC2=C1C=C3C=C(OC3=C2C)C
1312;255021614;;625223;103220490;5362124;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Benazepril;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O
1313;255021615;;625223;103220490;5362124;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Benazepril;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O
1314;255021616;;625223;103498411;5210;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sibutramine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
1315;255021617;;625223;136921833;667590;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(4-Benzylpiperidin-1-yl)(2-chlorophenyl)methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCC1CC2=CC=CC=C2)C(=O)C3=CC=CC=C3Cl
1316;255021618;;625223;136921833;667590;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(4-Benzylpiperidin-1-yl)(2-chlorophenyl)methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCC1CC2=CC=CC=C2)C(=O)C3=CC=CC=C3Cl
1317;255021619;;625223;103164821;5339;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulfasalazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O
1318;255022012;;625223;103164821;5339;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulfasalazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O
1319;255022013;;625223;103181781;5405;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Terfenadine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O
1320;255022014;;625223;103611913;8447;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);2,2'-Dithiobisbenzothiazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C2C(=C1)N=C(S2)SSC3=NC4=CC=CC=C4S3
1321;255022015;;625223;103611913;8447;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);2,2'-Dithiobisbenzothiazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C2C(=C1)N=C(S2)SSC3=NC4=CC=CC=C4S3
1322;255022016;;625223;103164726;41867;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Epirubicin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O
1323;255022017;;625223;103195118;2083;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Albuterol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O
1324;255022018;;625223;103195118;2083;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Albuterol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O
1325;255022019;;625223;103190535;5816;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Epinephrine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CNC[C@@H](C1=CC(=C(C=C1)O)O)O
1326;255022020;;625223;103190535;5816;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Epinephrine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CNC[C@@H](C1=CC(=C(C=C1)O)O)O
1327;255022021;;625223;103602769;20279;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cladribine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=C(N=C32)Cl)N)CO)O
1328;255022022;;625223;103602769;20279;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cladribine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=C(N=C32)Cl)N)CO)O
1329;255022023;;625223;103304594;32176;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);6-Methoxy-2-naphthylacetic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=CC2=C(C=C1)C=C(C=C2)CC(=O)O
1330;255022024;;625223;103304594;32176;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);6-Methoxy-2-naphthylacetic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=CC2=C(C=C1)C=C(C=C2)CC(=O)O
1331;255022025;;625223;103770583;9878;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fluorometholone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@]2([C@@]4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O
1332;255022026;;625223;103770583;9878;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fluorometholone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@]2([C@@]4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O
1333;255022027;;625223;103558530;54675779;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Oxytetracycline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@]1([C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O
1334;255022028;;625223;103558530;54675779;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Oxytetracycline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@]1([C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O
1335;255022029;;625223;124971685;71851;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Myrtecaine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CC)CCOCCC1=CCC2CC1C2(C)C
1336;255022030;;625223;124971685;71851;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Myrtecaine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CC)CCOCCC1=CCC2CC1C2(C)C
1337;255022031;;625223;103380806;5319;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulfabenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)C(=O)NS(=O)(=O)C2=CC=C(C=C2)N
1338;255022032;;625223;103380806;5319;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulfabenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)C(=O)NS(=O)(=O)C2=CC=C(C=C2)N
1339;255022033;;625223;103165964;2802;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Clonazepam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl
1340;255022034;;625223;103165964;2802;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Clonazepam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl
1341;255022035;;625223;103301334;3675;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Phenelzine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)CCNN
1342;255022036;;625223;103301334;3675;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Phenelzine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)CCNN
1343;255022378;;625223;103371832;5318;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulconazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1CSC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl
1344;255022379;;625223;103371832;5318;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulconazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1CSC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl
1345;255022380;;625223;103177857;8969;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Yohimbine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC(=O)[C@H]1[C@H](CC[C@@H]2[C@@H]1C[C@H]3C4=C(CCN3C2)C5=CC=CC=C5N4)O
1346;255022381;;625223;103177857;8969;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Yohimbine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC(=O)[C@H]1[C@H](CC[C@@H]2[C@@H]1C[C@H]3C4=C(CCN3C2)C5=CC=CC=C5N4)O
1347;255022382;;625223;103163913;176155;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CS(=O)C1=CC=C(C=C1)C2=NC(=C(N2)C3=CC=NC=C3)C4=CC=C(C=C4)F
1348;255022383;;625223;103163913;176155;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CS(=O)C1=CC=C(C=C1)C2=NC(=C(N2)C3=CC=NC=C3)C4=CC=C(C=C4)F
1349;255022384;;625223;103684622;10531;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dihydroergotamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C
1350;255022385;;625223;103684622;10531;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dihydroergotamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C
1351;255022386;;625223;103193092;5576;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Trimethadione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1(C(=O)N(C(=O)O1)C)C
1352;255022387;;625223;103193092;5576;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Trimethadione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1(C(=O)N(C(=O)O1)C)C
1353;255022388;;625223;123094719;54585;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Balsalazide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1C(=O)NCCC(=O)O)N=NC2=CC(=C(C=C2)O)C(=O)O
1354;255022389;;625223;123094719;54585;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Balsalazide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1C(=O)NCCC(=O)O)N=NC2=CC(=C(C=C2)O)C(=O)O
1355;255022390;;625223;103174787;54676228;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Piroxicam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3
1356;255022391;;625223;103174787;54676228;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Piroxicam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3
1357;255022392;;625223;136925133;17683252;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(4-Benzylpiperidin-1-yl)-[2-(trifluoromethyl)phenyl]methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCC1CC2=CC=CC=C2)C(=O)C3=CC=CC=C3C(F)(F)F
1358;255022393;;625223;136925133;17683252;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(4-Benzylpiperidin-1-yl)-[2-(trifluoromethyl)phenyl]methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCC1CC2=CC=CC=C2)C(=O)C3=CC=CC=C3C(F)(F)F
1359;255022394;;625223;103515892;441071;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Strychnine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN2CC3=CCO[C@H]4CC(=O)N5[C@H]6[C@H]4[C@H]3C[C@H]2[C@@]61C7=CC=CC=C75
1360;255022395;;625223;103515892;441071;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Strychnine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN2CC3=CCO[C@H]4CC(=O)N5[C@H]6[C@H]4[C@H]3C[C@H]2[C@@]61C7=CC=CC=C75
1361;255022396;;625223;103217150;19099;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);10,11-Dihydrocarbamazepine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC2=CC=CC=C2N(C3=CC=CC=C31)C(=O)N
1362;255022397;;625223;103217150;19099;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);10,11-Dihydrocarbamazepine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC2=CC=CC=C2N(C3=CC=CC=C31)C(=O)N
1363;255022398;;625223;103484622;221493;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cholic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C
1364;255022399;;625223;103484622;221493;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cholic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C
1365;255022400;;625223;103377543;5624;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);2-((4-(2,6-Di(pyrrolidin-1-yl)pyrimidin-4-yl)piperazin-1-yl)methyl)-2,5,7,8-tetramethylchroman-6-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C2=C(CCC(O2)(C)CN3CCN(CC3)C4=NC(=NC(=C4)N5CCCC5)N6CCCC6)C(=C1O)C)C
1366;255022401;;625223;103687860;75792;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(+)-Thalidomide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC(=O)NC(=O)[C@@H]1N2C(=O)C3=CC=CC=C3C2=O
1367;255022402;;625223;103687860;75792;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(+)-Thalidomide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC(=O)NC(=O)[C@@H]1N2C(=O)C3=CC=CC=C3C2=O
1368;255023585;;625223;103770587;5593;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tropicamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2
1369;255023586;;625223;103770587;5593;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tropicamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2
1370;255023589;;625223;242084623;11286230;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nystatin A1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1/C=C/C=C/CC/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H]([C@@H](CC[C@H](C[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O
1371;255023590;;625223;242084623;11286230;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nystatin A1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1/C=C/C=C/CC/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H]([C@@H](CC[C@H](C[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O
1372;255023591;;625223;103165933;2712;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Chlordiazepoxide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O
1373;255023592;;625223;103165933;2712;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Chlordiazepoxide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O
1374;255023593;;625223;103188847;9782;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Betamethasone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C
1375;255023594;;625223;103188847;9782;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Betamethasone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C
1376;255023595;;625223;103183576;5717;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Zafirlukast;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
1377;255023596;;625223;103183576;5717;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Zafirlukast;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
1378;255023597;;625223;312468102;148123;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Docetaxel trihydrate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O.O.O.O
1379;255023598;;625223;312468102;148123;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Docetaxel trihydrate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O.O.O.O
1380;255023599;;625223;103245522;5291;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Imatinib;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
1381;255023600;;625223;103245522;5291;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Imatinib;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
1382;255023601;;625223;103770995;15209;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Flurandrenolide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CCC(=O)C=C1[C@H](C[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3C[C@@H]5[C@]4(OC(O5)(C)C)C(=O)CO)C)O)F
1383;255023602;;625223;103770995;15209;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Flurandrenolide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CCC(=O)C=C1[C@H](C[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3C[C@@H]5[C@]4(OC(O5)(C)C)C(=O)CO)C)O)F
1384;255023603;;625223;103469393;10631;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Medroxyprogesterone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)O)C)[C@@]4(C1=CC(=O)CC4)C
1385;255023604;;625223;103469393;10631;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Medroxyprogesterone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)O)C)[C@@]4(C1=CC(=O)CC4)C
1386;255023605;;625223;136930151;5597;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Troxipide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=CC(=CC(=C1OC)OC)C(=O)NC2CCCNC2
1387;255023606;;625223;136930151;5597;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Troxipide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=CC(=CC(=C1OC)OC)C(=O)NC2CCCNC2
1388;255023607;;625223;103164301;5591;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Troglitazone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C2=C(CCC(O2)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C(=C1O)C)C
1389;255023608;;625223;103164301;5591;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Troglitazone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C2=C(CCC(O2)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C(=C1O)C)C
1390;255023609;;625223;103770993;225609;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fludrocortisone Acetate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)CC[C@@]43C)F)O)C)O
1391;255023950;;625223;103770993;225609;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fludrocortisone Acetate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)CC[C@@]43C)F)O)C)O
1392;255023953;;625223;103165643;5325;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulfamerazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N
1393;255023954;;625223;103165643;5325;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulfamerazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N
1394;255023955;;625223;242501998;644020;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sparteine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCN2C[C@@H]3C[C@H]([C@H]2C1)CN4[C@H]3CCCC4
1395;255023956;;625223;242501998;644020;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sparteine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCN2C[C@@H]3C[C@H]([C@H]2C1)CN4[C@H]3CCCC4
1396;255023957;;625223;103601826;174;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ethylene Glycol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(CO)O
1397;255023958;;625223;103601826;174;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ethylene Glycol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(CO)O
1398;255023959;;625223;103516887;3000540;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lincomycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@@H](C)O
1399;255023960;;625223;103516887;3000540;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lincomycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@@H](C)O
1400;255023961;;625223;103188337;5430;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Thiabendazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3
1401;255023962;;625223;103188337;5430;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Thiabendazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3
1402;255023963;;625223;103189263;5757;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Estradiol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)O
1403;255023964;;625223;103189263;5757;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Estradiol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)O
1404;255023965;;625223;104234176;36462;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Etoposide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
1405;255023966;;625223;104234176;36462;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Etoposide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
1406;255023967;;625223;103189275;9651;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Galantamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CC[C@@]23C=C[C@@H](C[C@@H]2OC4=C(C=CC(=C34)C1)OC)O
1407;255023968;;625223;103189275;9651;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Galantamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CC[C@@]23C=C[C@@H](C[C@@H]2OC4=C(C=CC(=C34)C1)OC)O
1408;255023969;;625223;103231964;3324;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Famciclovir;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C
1409;255023970;;625223;103231964;3324;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Famciclovir;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C
1410;255023971;;625223;103556997;9642;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fluocinonide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@@H]([C@]4([C@H]3C[C@@H](C5=CC(=O)C=C[C@@]54C)F)F)O)C)OC(O2)(C)C
1411;255023972;;625223;103556997;9642;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fluocinonide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@@H]([C@]4([C@H]3C[C@@H](C5=CC(=O)C=C[C@@]54C)F)F)O)C)OC(O2)(C)C
1412;255023973;;625223;103637443;4211;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mitotane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl
1413;255023974;;625223;103637443;4211;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mitotane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl
1414;255024389;;625223;103377543;5624;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);2-((4-(2,6-Di(pyrrolidin-1-yl)pyrimidin-4-yl)piperazin-1-yl)methyl)-2,5,7,8-tetramethylchroman-6-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C2=C(CCC(O2)(C)CN3CCN(CC3)C4=NC(=NC(=C4)N5CCCC5)N6CCCC6)C(=C1O)C)C
1415;255024390;;625223;103250329;3899;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Leflunomide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F
1416;255024391;;625223;103250329;3899;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Leflunomide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F
1417;255024392;;625223;103277459;2052;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tyrphostin A23;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C=C1C=C(C#N)C#N)O)O
1418;255024393;;625223;103277459;2052;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tyrphostin A23;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C=C1C=C(C#N)C#N)O)O
1419;255024394;;625223;103164735;1986;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Acetazolamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)NC1=NN=C(S1)S(=O)(=O)N
1420;255024395;;625223;103164735;1986;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Acetazolamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)NC1=NN=C(S1)S(=O)(=O)N
1421;255024396;;625223;103398356;1752;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);4-Nonylphenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCCCCCCC1=CC=C(C=C1)O
1422;255024397;;625223;103398356;1752;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);4-Nonylphenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCCCCCCC1=CC=C(C=C1)O
1423;255024398;;625223;103287107;5467;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tiapride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CC)CCNC(=O)C1=C(C=CC(=C1)S(=O)(=O)C)OC
1424;255024399;;625223;103287107;5467;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tiapride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CC)CCNC(=O)C1=C(C=CC(=C1)S(=O)(=O)C)OC
1425;255024400;;625223;103303946;3748;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Iproniazid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)NNC(=O)C1=CC=NC=C1
1426;255024401;;625223;103303946;3748;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Iproniazid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)NNC(=O)C1=CC=NC=C1
1427;255024402;;625223;103588726;5641;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Urethane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)N
1428;255024403;;625223;103588726;5641;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Urethane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)N
1429;255024404;;625223;494429426;3000261;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ajmalan-17,21-diol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@H]1[C@@H]2C[C@H]3[C@H]4[C@@]5(C[C@@H]([C@@H]2[C@H]5O)N3[C@@H]1O)C6=CC=CC=C6N4C
1430;255024405;;625223;494429426;3000261;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ajmalan-17,21-diol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@H]1[C@@H]2C[C@H]3[C@H]4[C@@]5(C[C@@H]([C@@H]2[C@H]5O)N3[C@@H]1O)C6=CC=CC=C6N4C
1431;255024406;;625223;103250362;5323;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulfadimethoxine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=NC(=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N)OC
1432;255024407;;625223;103250362;5323;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulfadimethoxine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=NC(=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N)OC
1433;255024408;;625223;104234199;54687;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pravastatin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O
1434;255024409;;625223;104234199;54687;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pravastatin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O
1435;255024410;;625223;103469357;5756;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Estriol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H]([C@@H]2O)O)CCC4=C3C=CC(=C4)O
1436;255024411;;625223;103469357;5756;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Estriol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H]([C@@H]2O)O)CCC4=C3C=CC(=C4)O
1437;255024412;;625223;103255183;4891;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Praziquantel;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2
1438;255024413;;625223;103255183;4891;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Praziquantel;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2
1439;255024858;;625223;103257884;22475;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Succinylcholine Chloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-]
1440;255024859;;625223;103257884;22475;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Succinylcholine Chloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-]
1441;255024860;;625223;103504457;4497;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nimodipine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC
1442;255024861;;625223;103504457;4497;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nimodipine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC
1443;255024862;;625223;103174312;51081;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pefloxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O
1444;255024863;;625223;103174312;51081;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pefloxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O
1445;255024864;;625223;103240106;4753;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Phenacemide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)CC(=O)NC(=O)N
1446;255024865;;625223;103240106;4753;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Phenacemide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)CC(=O)NC(=O)N
1447;255024866;;625223;103191605;6251;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mannitol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C([C@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O)O
1448;255024867;;625223;103191605;6251;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mannitol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C([C@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O)O
1449;255024868;;625223;174489643;54675777;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Chlortetracycline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C(C=CC(=C41)Cl)O)O)O)O)C(=O)N)N(C)C)O
1450;255024869;;625223;174489643;54675777;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Chlortetracycline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C(C=CC(=C41)Cl)O)O)O)O)C(=O)N)N(C)C)O
1451;255024870;;625223;103165713;444795;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tretinoin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C
1452;255024871;;625223;103165713;444795;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tretinoin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C
1453;255024872;;625223;103179006;4754;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Phenacetin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC1=CC=C(C=C1)NC(=O)C
1454;255024873;;625223;103179006;4754;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Phenacetin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC1=CC=C(C=C1)NC(=O)C
1455;255024874;;625223;164141688;2733335;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);1-methyl-1-nitroso-3-[(3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C(=O)N[C@@H]1[C@H]([C@@H]([C@H](OC1O)CO)O)O)N=O
1456;255024875;;625223;164141688;2733335;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);1-methyl-1-nitroso-3-[(3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C(=O)N[C@@H]1[C@H]([C@@H]([C@H](OC1O)CO)O)O)N=O
1457;255024876;;625223;136928510;2810;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Clorprenaline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)NCC(C1=CC=CC=C1Cl)O
1458;255024877;;625223;136928510;2810;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Clorprenaline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)NCC(C1=CC=CC=C1Cl)O
1459;255024878;;625223;194161898;76322320;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);"N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxybutan-2-yl]amino]-1-oxobutan-2-yl]-6-methylheptanamide;N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxybutan-2-yl]amino]-1-oxobutan-2-yl]-6-methyloctanamide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CCN)CC(C)C)CC(C)C)CCN)CCN)[C@@H](C)O)[C@@H](C)O.C[C@H]([C@H]1C(=O)NCC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCN)CCN)CC(C)C)CC(C)C)CCN)NC(=O)[C@H](CCN)NC[C@@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)CCCCC(C)C)O
1460;255024879;;625223;194161898;76322320;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);"N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxybutan-2-yl]amino]-1-oxobutan-2-yl]-6-methylheptanamide;N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxybutan-2-yl]amino]-1-oxobutan-2-yl]-6-methyloctanamide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CCN)CC(C)C)CC(C)C)CCN)CCN)[C@@H](C)O)[C@@H](C)O.C[C@H]([C@H]1C(=O)NCC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCN)CCN)CC(C)C)CC(C)C)CCN)NC(=O)[C@H](CCN)NC[C@@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)CCCCC(C)C)O
1461;255024880;;625223;242430918;5282435;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Irsogladine maleate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C=C1Cl)C2=NC(=NC(=N2)N)N)Cl.C(=C\C(=O)O)\C(=O)O
1462;255024881;;625223;242430918;5282435;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Irsogladine maleate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C=C1Cl)C2=NC(=NC(=N2)N)N)Cl.C(=C\C(=O)O)\C(=O)O
1463;255024882;;625223;103183701;5352624;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulindac sulfide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC\1=C(C2=C(/C1=C\C3=CC=C(C=C3)SC)C=CC(=C2)F)CC(=O)O
1464;255025310;;625223;103183701;5352624;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulindac sulfide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC\1=C(C2=C(/C1=C\C3=CC=C(C=C3)SC)C=CC(=C2)F)CC(=O)O
1465;255025311;;625223;103291875;6238;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Hydroxyprogesterone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O
1466;255025312;;625223;103291875;6238;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Hydroxyprogesterone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O
1467;255025313;;625223;103532383;54676038;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dicumarol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C2C(=C1)C(=C(C(=O)O2)CC3=C(C4=CC=CC=C4OC3=O)O)O
1468;255025314;;625223;103532383;54676038;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dicumarol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C2C(=C1)C(=C(C(=O)O2)CC3=C(C4=CC=CC=C4OC3=O)O)O
1469;255025315;;625223;103440109;135398742;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Valacyclovir;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)[C@@H](C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N
1470;255025316;;625223;103440109;135398742;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Valacyclovir;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)[C@@H](C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N
1471;255025317;;625223;103191369;3033;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Diclofenac;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl
1472;255025318;;625223;103191369;3033;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Diclofenac;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl
1473;255025321;;625223;104234146;62959;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Trovafloxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F
1474;255025322;;625223;104234146;62959;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Trovafloxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F
1475;255025323;;625223;103164917;5566;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Trifluoperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F
1476;255025324;;625223;103164917;5566;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Trifluoperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F
1477;255025325;;625223;103556242;3686;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Idebenone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCCO
1478;255025326;;625223;103556242;3686;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Idebenone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCCO
1479;255025327;;625223;103228757;2088;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Alendronic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN
1480;255025328;;625223;103228757;2088;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Alendronic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN
1481;255025329;;625223;103306382;2099;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Alosetron;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C
1482;255025330;;625223;103306382;2099;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Alosetron;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C
1483;255025331;;625223;103189214;6741;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Methylprednisolone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
1484;255025332;;625223;103189214;6741;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Methylprednisolone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
1485;255025333;;625223;103221475;3314;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Eugenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C(C=CC(=C1)CC=C)O
1486;255025334;;625223;103221475;3314;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Eugenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C(C=CC(=C1)CC=C)O
1487;255025659;;625223;103279849;5280795;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cholecalciferol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C
1488;255025660;;625223;103279849;5280795;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cholecalciferol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C
1489;255025661;;625223;103524891;5281078;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mycophenolate Mofetil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)O
1490;255025662;;625223;103524891;5281078;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mycophenolate Mofetil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)O
1491;255025663;;625223;103178134;71188;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Enrofloxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN1CCN(CC1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4CC4)F
1492;255025664;;625223;103178134;71188;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Enrofloxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN1CCN(CC1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4CC4)F
1493;255025669;;625223;103340603;688095;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(S)-(-)-pindolol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)NC[C@@H](COC1=CC=CC2=C1C=CN2)O
1494;255025670;;625223;103340603;688095;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(S)-(-)-pindolol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)NC[C@@H](COC1=CC=CC2=C1C=CN2)O
1495;255025671;;625223;103262836;18283;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Stavudine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CN(C(=O)NC1=O)[C@H]2C=C[C@H](O2)CO
1496;255025672;;625223;103262836;18283;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Stavudine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CN(C(=O)NC1=O)[C@H]2C=C[C@H](O2)CO
1497;255025673;;625223;103164806;5702063;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Guanabenz;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C(=C1)Cl)/C=N/N=C(N)N)Cl
1498;255025674;;625223;103164806;5702063;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Guanabenz;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C(=C1)Cl)/C=N/N=C(N)N)Cl
1499;255025675;;625223;103189345;4011;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Maprotiline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24
1500;255025676;;625223;103189345;4011;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Maprotiline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24
1501;255025677;;625223;103305836;3168;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Droperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F
1502;255025678;;625223;103305836;3168;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Droperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F
1503;255025679;;625223;103164873;2249;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Atenolol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
1504;255025680;;625223;103164873;2249;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Atenolol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
1505;255025681;;625223;103503975;3151;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Domperidone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O
1506;255025682;;625223;103503975;3151;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Domperidone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O
1507;255025683;;625223;103172458;53232;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lovastatin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C
1508;255026024;;625223;103172458;53232;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lovastatin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C
1509;255026025;;625223;103163782;89594;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nicotine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCC[C@H]1C2=CN=CC=C2
1510;255026026;;625223;103163782;89594;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nicotine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCC[C@H]1C2=CN=CC=C2
1511;255026027;;625223;103770692;688020;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);2-Butenamide, N-ethyl-N-(2-methylphenyl)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(C1=CC=CC=C1C)C(=O)/C=C/C
1512;255026028;;625223;103770692;688020;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);2-Butenamide, N-ethyl-N-(2-methylphenyl)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(C1=CC=CC=C1C)C(=O)/C=C/C
1513;255026033;;625223;103399575;3561;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Haloprogin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=C(C(=CC(=C1Cl)Cl)Cl)OCC#CI
1514;255026034;;625223;103399575;3561;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Haloprogin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=C(C(=CC(=C1Cl)Cl)Cl)OCC#CI
1515;255026035;;625223;103164874;2244;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Aspirin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)OC1=CC=CC=C1C(=O)O
1516;255026036;;625223;103164874;2244;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Aspirin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)OC1=CC=CC=C1C(=O)O
1517;255026037;;625223;103716863;5311067;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Desoximetasone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@H]1C(=O)CO)C)O)F)C
1518;255026038;;625223;103716863;5311067;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Desoximetasone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@H]1C(=O)CO)C)O)F)C
1519;255026039;;625223;103771007;49800046;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);"[(1S,2R,4S,5S)-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate;bromide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[N+]1([C@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4)C.[Br-]
1520;255026040;;625223;103171247;3598;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Hexachlorophene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl
1521;255026041;;625223;103171247;3598;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Hexachlorophene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl
1522;255026042;;625223;103568173;2265;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Azathioprine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
1523;255026043;;625223;103568173;2265;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Azathioprine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
1524;255026044;;625223;103183749;4810;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Moxonidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC
1525;255026045;;625223;103183749;4810;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Moxonidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC
1526;255026046;;625223;103165163;5904;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Penicillin G;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C
1527;255026047;;625223;103165163;5904;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Penicillin G;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C
1528;255026048;;625223;103194429;3157;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Doxazosin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
1529;255026437;;625223;103194429;3157;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Doxazosin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
1530;255026438;;625223;131279812;688272;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Levosulpiride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN1CCC[C@H]1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC
1531;255026439;;625223;131279812;688272;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Levosulpiride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN1CCC[C@H]1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC
1532;255026440;;625223;103455384;5281004;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Budesonide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C
1533;255026441;;625223;103455384;5281004;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Budesonide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C
1534;255026442;;625223;103589714;5311217;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lacidipine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2/C=C/C(=O)OC(C)(C)C)C(=O)OCC)C)C
1535;255026443;;625223;103589714;5311217;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lacidipine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2/C=C/C(=O)OC(C)(C)C)C(=O)OCC)C)C
1536;255026446;;625223;103171902;5280965;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amphotericin B;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O
1537;255026447;;625223;103171902;5280965;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amphotericin B;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O
1538;255026448;;625223;103321248;18343;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Doxifluridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=C(C(=O)NC2=O)F)O)O
1539;255026449;;625223;103321248;18343;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Doxifluridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=C(C(=O)NC2=O)F)O)O
1540;255026450;;625223;103200972;135399235;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Zaprinast;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCOC1=CC=CC=C1C2=NC3=NNN=C3C(=O)N2
1541;255026451;;625223;103200972;135399235;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Zaprinast;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCOC1=CC=CC=C1C2=NC3=NNN=C3C(=O)N2
1542;255026452;;625223;136933682;2264;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Azasetron;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C(=O)COC2=C(C=C(C=C21)Cl)C(=O)NC3CN4CCC3CC4
1543;255026453;;625223;136933682;2264;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Azasetron;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C(=O)COC2=C(C=C(C=C21)Cl)C(=O)NC3CN4CCC3CC4
1544;255026454;;625223;103266539;3191;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ebastine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CCC(CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4
1545;255026455;;625223;103266539;3191;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ebastine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CCC(CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4
1546;255026456;;625223;103191130;4030;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mebendazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3
1547;255026457;;625223;103191130;4030;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mebendazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3
1548;255026458;;625223;103288539;7577;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);4,4'-Methylenedianiline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1CC2=CC=C(C=C2)N)N
1549;255026459;;625223;103288539;7577;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);4,4'-Methylenedianiline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1CC2=CC=C(C=C2)N)N
1550;255026460;;625223;103241784;64715;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mevastatin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@H](C)C(=O)O[C@H]1CCC=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O
1551;255026461;;625223;103241784;64715;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mevastatin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@H](C)C(=O)O[C@H]1CCC=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O
1552;255026792;;625223;103212991;2196;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Aniracetam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=CC=C(C=C1)C(=O)N2CCCC2=O
1553;255026793;;625223;103212991;2196;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Aniracetam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=CC=C(C=C1)C(=O)N2CCCC2=O
1554;255026794;;625223;103179319;5388962;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Enalapril;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O
1555;255026795;;625223;103179319;5388962;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Enalapril;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O
1556;255026796;;625223;103770379;64737;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Bupivacaine hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl
1557;255026797;;625223;103770379;64737;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Bupivacaine hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl
1558;255026798;;625223;103771007;49800046;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);"[(1S,2R,4S,5S)-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate;bromide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[N+]1([C@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4)C.[Br-]
1559;255026799;;625223;103174569;4506;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nitrazepam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3
1560;255026800;;625223;103174569;4506;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nitrazepam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3
1561;255026801;;625223;103478231;2187;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Anastrozole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N
1562;255026802;;625223;103478231;2187;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Anastrozole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N
1563;255026803;;625223;103680984;4499;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nisoldipine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
1564;255026804;;625223;103680984;4499;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nisoldipine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
1565;255026805;;625223;103707721;3156;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Doxapram;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4
1566;255026806;;625223;103707721;3156;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Doxapram;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4
1567;255026807;;625223;103707694;3182;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dyphylline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(CO)O
1568;255026808;;625223;103707694;3182;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dyphylline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(CO)O
1569;255026811;;625223;103166132;5280961;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Genistein;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=O)O)O)O
1570;255026812;;625223;103166132;5280961;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Genistein;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=O)O)O)O
1571;255026813;;625223;103618328;44575838;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);"dipotassium;[(2R,3R,4R,5R,6R)-2-[[(1R,4R,5R,7R,9R,13R,15R)-5-carboxy-15-hydroxy-9-methyl-14-methylidene-7-tetracyclo[11.2.1.01,10.04,9]hexadecanyl]oxy]-6-(hydroxymethyl)-3-(3-methylbutanoyloxy)-5-sulfonatooxyoxan-4-yl] sulfate";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)CC(=O)O[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O[C@@H]2C[C@H]([C@H]3CC[C@@]45C[C@@H](CCC4[C@@]3(C2)C)C(=C)[C@H]5O)C(=O)O)CO)OS(=O)(=O)[O-])OS(=O)(=O)[O-].[K+].[K+]
1572;255026814;;625223;103618328;44575838;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);"dipotassium;[(2R,3R,4R,5R,6R)-2-[[(1R,4R,5R,7R,9R,13R,15R)-5-carboxy-15-hydroxy-9-methyl-14-methylidene-7-tetracyclo[11.2.1.01,10.04,9]hexadecanyl]oxy]-6-(hydroxymethyl)-3-(3-methylbutanoyloxy)-5-sulfonatooxyoxan-4-yl] sulfate";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)CC(=O)O[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O[C@@H]2C[C@H]([C@H]3CC[C@@]45C[C@@H](CCC4[C@@]3(C2)C)C(=C)[C@H]5O)C(=O)O)CO)OS(=O)(=O)[O-])OS(=O)(=O)[O-].[K+].[K+]
1573;255026815;;625223;103589735;4507;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nitrendipine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C
1574;255026816;;625223;103164546;1775;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Phenytoin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3
1575;255027163;;625223;103164546;1775;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Phenytoin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3
1576;255027164;;625223;134453344;68911;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Artemether;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC)C
1577;255027165;;625223;134453344;68911;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Artemether;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC)C
1578;255027166;;625223;160671902;2176;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ampiroxicam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)OC(C)OC1=C(N(S(=O)(=O)C2=CC=CC=C21)C)C(=O)NC3=CC=CC=N3
1579;255027167;;625223;160671902;2176;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ampiroxicam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)OC(C)OC1=C(N(S(=O)(=O)C2=CC=CC=C21)C)C(=O)NC3=CC=CC=N3
1580;255027168;;625223;103213021;4843;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Piracetam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC(=O)N(C1)CC(=O)N
1581;255027169;;625223;103213021;4843;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Piracetam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC(=O)N(C1)CC(=O)N
1582;255027170;;625223;103482708;92142;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(-)-Thalidomide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC(=O)NC(=O)[C@H]1N2C(=O)C3=CC=CC=C3C2=O
1583;255027171;;625223;103482708;92142;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(-)-Thalidomide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC(=O)NC(=O)[C@H]1N2C(=O)C3=CC=CC=C3C2=O
1584;255027172;;625223;103194851;2197;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Anisindione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=CC=C(C=C1)C2C(=O)C3=CC=CC=C3C2=O
1585;255027173;;625223;103194851;2197;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Anisindione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=CC=C(C=C1)C2C(=O)C3=CC=CC=C3C2=O
1586;255027174;;625223;103385271;253602;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Anisomycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)O[C@@H]1[C@H](CN[C@@H]1CC2=CC=C(C=C2)OC)O
1587;255027175;;625223;103385271;253602;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Anisomycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)O[C@@H]1[C@H](CN[C@@H]1CC2=CC=C(C=C2)OC)O
1588;255027176;;625223;103219212;4021;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Edaravone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=NN(C(=O)C1)C2=CC=CC=C2
1589;255027177;;625223;103219212;4021;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Edaravone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=NN(C(=O)C1)C2=CC=CC=C2
1590;255027178;;625223;103171590;4828;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pindolol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
1591;255027179;;625223;103171590;4828;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pindolol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
1592;255027180;;625223;103181943;4829;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pioglitazone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
1593;255027181;;625223;103181943;4829;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pioglitazone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
1594;255027182;;625223;103520217;2153;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Theophylline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C2=C(C(=O)N(C1=O)C)NC=N2
1595;255027183;;625223;103520217;2153;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Theophylline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C2=C(C(=O)N(C1=O)C)NC=N2
1596;255027184;;625223;242586088;4513;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nizatidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
1597;255027185;;625223;242586088;4513;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nizatidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
1598;255027186;;625223;103590286;54892;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Quinapril;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)O
1599;255027187;;625223;103590286;54892;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Quinapril;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)O
1600;255027557;;625223;103293005;3728;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Iodoquinol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC2=C(C(=C(C=C2I)I)O)N=C1
1601;255027558;;625223;103293005;3728;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Iodoquinol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC2=C(C(=C(C=C2I)I)O)N=C1
1602;255027559;;625223;103204055;15625;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);2,3,7,8-Tetrachlorodibenzo-P-dioxin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=C2C(=CC(=C1Cl)Cl)OC3=CC(=C(C=C3O2)Cl)Cl
1603;255027560;;625223;103204055;15625;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);2,3,7,8-Tetrachlorodibenzo-P-dioxin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=C2C(=CC(=C1Cl)Cl)OC3=CC(=C(C=C3O2)Cl)Cl
1604;255027561;;625223;103163840;3715;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Indomethacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
1605;255027562;;625223;103163840;3715;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Indomethacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
1606;255027563;;625223;103250959;3117;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Disulfiram;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CC)C(=S)SSC(=S)N(CC)CC
1607;255027564;;625223;103250959;3117;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Disulfiram;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CC)C(=S)SSC(=S)N(CC)CC
1608;255027565;;625223;103770612;39764;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Vecuronium Bromide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1N4CCCCC4)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-]
1609;255027566;;625223;103770612;39764;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Vecuronium Bromide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1N4CCCCC4)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-]
1610;255027567;;625223;103176152;77918;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);1-Benzylimidazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)CN2C=CN=C2
1611;255027568;;625223;103176152;77918;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);1-Benzylimidazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)CN2C=CN=C2
1612;255027569;;625223;103227365;1853;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);6(5H)-Phenanthridinone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C2C(=C1)C3=CC=CC=C3NC2=O
1613;255027570;;625223;103227365;1853;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);6(5H)-Phenanthridinone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C2C(=C1)C3=CC=CC=C3NC2=O
1614;255027571;;625223;103183767;4680;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Papaverine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC
1615;255027572;;625223;103183767;4680;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Papaverine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC
1616;255027574;;625223;103230651;5284373;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);cyclosporin A;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C
1617;255027575;;625223;103230651;5284373;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);cyclosporin A;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C
1618;255027578;;625223;103164678;4114;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Methoxsalen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2
1619;255027579;;625223;103164678;4114;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Methoxsalen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2
1620;255027580;;625223;124963552;3033538;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dapiprazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC=CC=C1N2CCN(CC2)CCC3=NN=C4N3CCCC4
1621;255027581;;625223;124963552;3033538;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dapiprazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC=CC=C1N2CCN(CC2)CCC3=NN=C4N3CCCC4
1622;255027916;;625223;103557047;4679;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pantoprazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
1623;255027917;;625223;103557047;4679;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pantoprazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
1624;255027918;;625223;103589812;16574;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Azaribine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C(=O)NC(=O)C=N2)OC(=O)C)OC(=O)C
1625;255027919;;625223;103589812;16574;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Azaribine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C(=O)NC(=O)C=N2)OC(=O)C)OC(=O)C
1626;255027920;;625223;103165830;5193;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Secobarbital;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCC(C)C1(C(=O)NC(=O)NC1=O)CC=C
1627;255027921;;625223;103165830;5193;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Secobarbital;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCC(C)C1(C(=O)NC(=O)NC1=O)CC=C
1628;255027924;;625223;103589735;4507;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nitrendipine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C
1629;255027925;;625223;103242914;3108;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dipyridamole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
1630;255027926;;625223;103242914;3108;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dipyridamole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
1631;255027931;;625223;104242266;6918276;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);CID 6918276;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@H](C)[C@@H](CO[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCS(=O)(=O)C)C(=O)OC(C)C)NC[C@H](CS)N
1632;255027932;;625223;104242266;6918276;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);CID 6918276;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@H](C)[C@@H](CO[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCS(=O)(=O)C)C(=O)OC(C)C)NC[C@H](CS)N
1633;255027933;;625223;103556420;5901;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);6-Azauridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=NN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O
1634;255027934;;625223;103556420;5901;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);6-Azauridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=NN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O
1635;255027935;;625223;103207636;5905;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Idoxuridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)I)CO)O
1636;255027936;;625223;103207636;5905;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Idoxuridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)I)CO)O
1637;255027940;;625223;103223807;60464;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sparfloxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1CN(C[C@@H](N1)C)C2=C(C(=C3C(=C2F)N(C=C(C3=O)C(=O)O)C4CC4)N)F
1638;255028292;;625223;103223807;60464;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sparfloxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1CN(C[C@@H](N1)C)C2=C(C(=C3C(=C2F)N(C=C(C3=O)C(=O)O)C4CC4)N)F
1639;255028293;;625223;103164922;5355;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulpiride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC
1640;255028294;;625223;103164922;5355;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulpiride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC
1641;255028295;;625223;103333818;9324;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Chlormadinone acetate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)CC[C@]34C)Cl)C)OC(=O)C
1642;255028296;;625223;103333818;9324;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Chlormadinone acetate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)CC[C@]34C)Cl)C)OC(=O)C
1643;255028299;;625223;103178054;5517;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tosufloxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CC1N)C2=C(C=C3C(=O)C(=CN(C3=N2)C4=C(C=C(C=C4)F)F)C(=O)O)F
1644;255028300;;625223;103178054;5517;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tosufloxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CC1N)C2=C(C=C3C(=O)C(=CN(C3=N2)C4=C(C=C(C=C4)F)F)C(=O)O)F
1645;255028301;;625223;104234228;6013;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Testosterone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C
1646;255028302;;625223;104234228;6013;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Testosterone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C
1647;255028303;;625223;160693300;4678;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Panthenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(CO)C(C(=O)NCCCO)O
1648;255028304;;625223;160693300;4678;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Panthenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(CO)C(C(=O)NCCCO)O
1649;255028305;;625223;103770374;6503;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tromethamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(C(CO)(CO)N)O
1650;255028306;;625223;103770374;6503;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tromethamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(C(CO)(CO)N)O
1651;255028309;;625223;103176185;6421;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Trichloroacetic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(=O)(C(Cl)(Cl)Cl)O
1652;255028310;;625223;103176185;6421;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Trichloroacetic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(=O)(C(Cl)(Cl)Cl)O
1653;255028311;;625223;123097261;31703;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Doxorubicin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O
1654;255028312;;625223;123097261;31703;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Doxorubicin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O
1655;255028313;;625223;103724173;60606;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Clopidogrel;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
1656;255028314;;625223;103724173;60606;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Clopidogrel;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
1657;255028315;;625223;103225393;119607;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Valdecoxib;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
1658;255028316;;625223;103225393;119607;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Valdecoxib;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
1659;255028625;;625223;103216614;7108;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Phenothiazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C2C(=C1)NC3=CC=CC=C3S2
1660;255028626;;625223;103216614;7108;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Phenothiazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C2C(=C1)NC3=CC=CC=C3S2
1661;255028627;;625223;103174641;4943;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Propofol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)C1=C(C(=CC=C1)C(C)C)O
1662;255028628;;625223;103174641;4943;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Propofol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)C1=C(C(=CC=C1)C(C)C)O
1663;255028629;;625223;103203075;1030;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Propylene Glycol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(CO)O
1664;255028630;;625223;103203075;1030;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Propylene Glycol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(CO)O
1665;255028631;;625223;103407502;6366;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Vinylidene chloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C=C(Cl)Cl
1666;255028632;;625223;103407502;6366;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Vinylidene chloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C=C(Cl)Cl
1667;255028633;;625223;494428864;3033924;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, hemihydrate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O.C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O.O
1668;255028634;;625223;494428864;3033924;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, hemihydrate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O.C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O.O
1669;255028635;;625223;103176635;5282379;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Isotretinoin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\C(=O)O)/C)/C
1670;255028636;;625223;103176635;5282379;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Isotretinoin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\C(=O)O)/C)/C
1671;255028637;;625223;103275455;1057;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pyrogallol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C(=C1)O)O)O
1672;255028638;;625223;103275455;1057;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pyrogallol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C(=C1)O)O)O
1673;255028639;;625223;103172204;60490;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Zileuton;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O
1674;255028640;;625223;103172204;60490;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Zileuton;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O
1675;255028643;;625223;103189187;6726;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cyclizine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3
1676;255028644;;625223;103189187;6726;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cyclizine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3
1677;255028645;;625223;103176204;996;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Phenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)O
1678;255028646;;625223;103176204;996;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Phenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)O
1679;255028647;;625223;103164872;39186;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Diltiazem;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)O[C@@H]1[C@@H](SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC
1680;255028648;;625223;103164872;39186;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Diltiazem;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)O[C@@H]1[C@@H](SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC
1681;255028649;;625223;103646320;9570327;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Salfuride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=C(OC(=C1)[N+](=O)[O-])/C=N/NC(=O)C2=C(C(=CC(=C2)[N+](=O)[O-])[N+](=O)[O-])O
1682;255028988;;625223;103646320;9570327;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Salfuride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=C(OC(=C1)[N+](=O)[O-])/C=N/NC(=O)C2=C(C(=CC(=C2)[N+](=O)[O-])[N+](=O)[O-])O
1683;255028989;;625223;123083206;5523;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ultram;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
1684;255028990;;625223;123083206;5523;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ultram;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O
1685;255028991;;625223;103770542;612;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lactic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C(=O)O)O
1686;255028992;;625223;103770542;612;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lactic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C(=O)O)O
1687;255028993;;625223;103171825;3637;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Hydralazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C2C(=C1)C=NN=C2NN
1688;255028994;;625223;103171825;3637;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Hydralazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C2C(=C1)C=NN=C2NN
1689;255028995;;625223;103331451;41781;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Torsemide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
1690;255028996;;625223;103331451;41781;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Torsemide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
1691;255028997;;625223;103401161;5161;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Salsalate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C(=C1)C(=O)OC2=CC=CC=C2C(=O)O)O
1692;255028998;;625223;103401161;5161;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Salsalate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C(=C1)C(=O)OC2=CC=CC=C2C(=O)O)O
1693;255029003;;625223;103163813;4583;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ofloxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
1694;255029004;;625223;103163813;4583;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ofloxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
1695;255029005;;625223;103543149;28417;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Danazol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC5=C(C[C@]34C)C=NO5
1696;255029006;;625223;103543149;28417;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Danazol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC5=C(C[C@]34C)C=NO5
1697;255029007;;625223;136920451;5541;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Triacetin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)OCC(COC(=O)C)OC(=O)C
1698;255029008;;625223;136920451;5541;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Triacetin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)OCC(COC(=O)C)OC(=O)C
1699;255029009;;625223;103770639;5284447;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Natamycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@@H]3[C@H](O3)/C=C/C(=O)O1)O)O)O)C(=O)O)O[C@H]4[C@H]([C@H]([C@@H]([C@H](O4)C)O)N)O
1700;255029010;;625223;103770639;5284447;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Natamycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@@H]3[C@H](O3)/C=C/C(=O)O1)O)O)O)C(=O)O)O[C@H]4[C@H]([C@H]([C@@H]([C@H](O4)C)O)N)O
1701;255029011;;625223;103770528;71414;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Diflorasone Diacetate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COC(=O)C)OC(=O)C)C)O)F)C)F
1702;255029012;;625223;103770528;71414;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Diflorasone Diacetate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COC(=O)C)OC(=O)C)C)O)F)C)F
1703;255029368;;625223;103165561;3639;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Hydrochlorothiazide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl
1704;255029369;;625223;103165561;3639;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Hydrochlorothiazide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl
1705;255029370;;625223;103248360;1548943;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Capsaicin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC
1706;255029371;;625223;103248360;1548943;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Capsaicin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC
1707;255029372;;625223;174494812;73348316;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(1S,2R,19R,22R,34S,37R,40R,52S)-2,64-bis[[(2R,3S,4R,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]-22-amino-5,15-dichloro-26,31,44,49-tetrahydroxy-21,35,38,54,56,59-hexaoxo-47-[(2R,3S,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-7,13,28-trioxa-20,36,39,53,55,58-hexazaundecacyclo[38.14.2.23,6.214,17.219,34.18,12.123,27.129,33.141,45.010,37.046,51]hexahexaconta-3,5,8,10,12(64),14,16,23(61),24,26,29(60),30,32,41(57),42,44,46(51),47,49,62,65-henicosaene-52-carboxylic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)N[C@H]1[C@H]([C@@H]([C@@H](O[C@H]1O[C@H]2[C@H]3C(=O)N[C@@H](C4=C(C(=CC(=C4)O)O[C@@H]5[C@H]([C@@H]([C@@H]([C@H](O5)CO)O)O)O)C6=C(C=CC(=C6)[C@H](C(=O)N3)NC(=O)[C@H]7C8=CC(=C(C(=C8)OC9=C(C=C2C=C9)Cl)O[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)CO)O)O)NC(=O)C)OC1=C(C=C(C[C@@H]2C(=O)N[C@@H](C3=CC(=CC(=C3)OC3=C(C=CC(=C3)[C@H](C(=O)N2)N)O)O)C(=O)N7)C=C1)Cl)O)C(=O)O)CO)O)O
1708;255029373;;625223;174494812;73348316;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(1S,2R,19R,22R,34S,37R,40R,52S)-2,64-bis[[(2R,3S,4R,5S,6S)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]-22-amino-5,15-dichloro-26,31,44,49-tetrahydroxy-21,35,38,54,56,59-hexaoxo-47-[(2R,3S,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-7,13,28-trioxa-20,36,39,53,55,58-hexazaundecacyclo[38.14.2.23,6.214,17.219,34.18,12.123,27.129,33.141,45.010,37.046,51]hexahexaconta-3,5,8,10,12(64),14,16,23(61),24,26,29(60),30,32,41(57),42,44,46(51),47,49,62,65-henicosaene-52-carboxylic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)N[C@H]1[C@H]([C@@H]([C@@H](O[C@H]1O[C@H]2[C@H]3C(=O)N[C@@H](C4=C(C(=CC(=C4)O)O[C@@H]5[C@H]([C@@H]([C@@H]([C@H](O5)CO)O)O)O)C6=C(C=CC(=C6)[C@H](C(=O)N3)NC(=O)[C@H]7C8=CC(=C(C(=C8)OC9=C(C=C2C=C9)Cl)O[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)CO)O)O)NC(=O)C)OC1=C(C=C(C[C@@H]2C(=O)N[C@@H](C3=CC(=CC(=C3)OC3=C(C=CC(=C3)[C@H](C(=O)N2)N)O)O)C(=O)N7)C=C1)Cl)O)C(=O)O)CO)O)O
1709;255029374;;625223;103220466;5742832;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Aztreonam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1[C@@H](C(=O)N1S(=O)(=O)O)NC(=O)/C(=N\OC(C)(C)C(=O)O)/C2=CSC(=N2)N
1710;255029375;;625223;103220466;5742832;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Aztreonam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1[C@@H](C(=O)N1S(=O)(=O)O)NC(=O)/C(=N\OC(C)(C)C(=O)O)/C2=CSC(=N2)N
1711;255029376;;625223;194179209;5284517;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Astromicin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]([C@@H]1CC[C@H]([C@H](O1)O[C@@H]2[C@H]([C@@H]([C@@H]([C@H]([C@H]2O)N(C)C(=O)CN)OC)O)N)N)N
1712;255029377;;625223;194179209;5284517;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Astromicin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]([C@@H]1CC[C@H]([C@H](O1)O[C@@H]2[C@H]([C@@H]([C@@H]([C@H]([C@H]2O)N(C)C(=O)CN)OC)O)N)N)N
1713;255029378;;625223;103163858;130313;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulbactam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)C
1714;255029379;;625223;103163858;130313;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulbactam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)C
1715;255029380;;625223;103165644;5215;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulfadiazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
1716;255029381;;625223;103165644;5215;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulfadiazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
1717;255029382;;625223;103164549;445643;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tacrolimus;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC
1718;255029383;;625223;103164549;445643;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tacrolimus;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC
1719;255029384;;625223;103771100;4107;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Methocarbamol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=CC=CC=C1OCC(COC(=O)N)O
1720;255029385;;625223;103771100;4107;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Methocarbamol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=CC=CC=C1OCC(COC(=O)N)O
1721;255029386;;625223;103246205;16231;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amiloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
1722;255029387;;625223;103246205;16231;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amiloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
1723;255029388;;625223;103469610;6010;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Methyltestosterone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C)O)C
1724;255029389;;625223;103469610;6010;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Methyltestosterone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C)O)C
1725;255029390;;625223;103570000;5920;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Liothyronine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O
1726;255029391;;625223;103570000;5920;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Liothyronine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O
1727;255029392;;625223;194183610;444294;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(-)-Camphor;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H](C1(C)C)CC2=O
1728;255029795;;625223;194183610;444294;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(-)-Camphor;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H](C1(C)C)CC2=O
1729;255029796;;625223;103618726;2758;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Eucalyptol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1(C2CCC(O1)(CC2)C)C
1730;255029797;;625223;103618726;2758;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Eucalyptol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1(C2CCC(O1)(CC2)C)C
1731;255029798;;625223;103545170;5284557;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ethisterone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C#C)O)C
1732;255029799;;625223;103545170;5284557;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ethisterone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C#C)O)C
1733;255029800;;625223;103224449;3519;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Guanfacine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl
1734;255029801;;625223;103224449;3519;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Guanfacine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl
1735;255029802;;625223;103185469;1046;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pyrazinamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CN=C(C=N1)C(=O)N
1736;255029803;;625223;103185469;1046;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pyrazinamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CN=C(C=N1)C(=O)N
1737;255029804;;625223;103469360;15730;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);4-Octylphenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCCCCCC1=CC=C(C=C1)O
1738;255029805;;625223;103469360;15730;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);4-Octylphenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCCCCCC1=CC=C(C=C1)O
1739;255029806;;625223;103256288;3516;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Guaifenesin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=CC=CC=C1OCC(CO)O
1740;255029807;;625223;103256288;3516;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Guaifenesin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=CC=CC=C1OCC(CO)O
1741;255029808;;625223;103482102;21109;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Trimetazidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C(C(=C(C=C1)CN2CCNCC2)OC)OC
1742;255029809;;625223;103482102;21109;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Trimetazidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C(C(=C(C=C1)CN2CCNCC2)OC)OC
1743;255029810;;625223;103616777;1549041;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);cis-Isoeugenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C/C=C\C1=CC(=C(C=C1)O)OC
1744;255029811;;625223;103616777;1549041;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);cis-Isoeugenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C/C=C\C1=CC(=C(C=C1)O)OC
1745;255029812;;625223;103771129;5832;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Norethindrone Acetate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)O[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C)C#C
1746;255029813;;625223;103771129;5832;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Norethindrone Acetate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)O[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C)C#C
1747;255029814;;625223;103419062;5921;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);N-Nitrosodiethylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CC)N=O
1748;255029815;;625223;103419062;5921;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);N-Nitrosodiethylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CC)N=O
1749;255029816;;625223;103469419;5833;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Spironolactone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C
1750;255029817;;625223;103469419;5833;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Spironolactone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C
1751;255029818;;625223;103558436;82153;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Flunisolide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)C[C@@H](C5=CC(=O)C=C[C@]35C)F)O
1752;255029819;;625223;103558436;82153;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Flunisolide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)C[C@@H](C5=CC(=O)C=C[C@]35C)F)O
1753;255030216;;625223;103532939;7858;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Allyl alcohol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C=CCO
1754;255030217;;625223;103532939;7858;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Allyl alcohol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C=CCO
1755;255030218;;625223;103165086;2750;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ciglitazone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1(CCCCC1)COC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
1756;255030219;;625223;103165086;2750;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ciglitazone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1(CCCCC1)COC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
1757;255030220;;625223;103164520;5831;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Carbachol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[N+](C)(C)CCOC(=O)N.[Cl-]
1758;255030221;;625223;103164520;5831;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Carbachol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[N+](C)(C)CCOC(=O)N.[Cl-]
1759;255030222;;625223;160671983;60712;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tenidap;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CSC(=C1)C(=O)C2=C(N(C3=C2C=C(C=C3)Cl)C(=O)N)O
1760;255030223;;625223;160671983;60712;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tenidap;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CSC(=C1)C(=O)C2=C(N(C3=C2C=C(C=C3)Cl)C(=O)N)O
1761;255030224;;625223;103188807;5358;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sumatriptan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
1762;255030225;;625223;103188807;5358;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sumatriptan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
1763;255030226;;625223;103168044;3657;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Hydroxyurea;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(=O)(N)NO
1764;255030227;;625223;103168044;3657;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Hydroxyurea;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(=O)(N)NO
1765;255030228;;625223;103182595;54677470;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Meloxicam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O
1766;255030229;;625223;103182595;54677470;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Meloxicam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O
1767;255030230;;625223;103422115;3039;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dichlorvos;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COP(=O)(OC)OC=C(Cl)Cl
1768;255030231;;625223;103422115;3039;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dichlorvos;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COP(=O)(OC)OC=C(Cl)Cl
1769;255030234;;625223;103293849;60726;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Bromfenac;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C(=C1)C(=O)C2=CC=C(C=C2)Br)N)CC(=O)O
1770;255030235;;625223;103293849;60726;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Bromfenac;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C(=C1)C(=O)C2=CC=C(C=C2)Br)N)CC(=O)O
1771;255030236;;625223;103566848;3652;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Hydroxychloroquine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
1772;255030237;;625223;103566848;3652;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Hydroxychloroquine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
1773;255030238;;625223;103227652;5944;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cantharidin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@]12[C@H]3CC[C@@H]([C@@]1(C(=O)OC2=O)C)O3
1774;255030239;;625223;103227652;5944;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cantharidin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@]12[C@H]3CC[C@@H]([C@@]1(C(=O)OC2=O)C)O3
1775;255030240;;625223;123092444;92253;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Levobupivacaine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCN1CCCC[C@H]1C(=O)NC2=C(C=CC=C2C)C
1776;255030593;;625223;123092444;92253;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Levobupivacaine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCN1CCCC[C@H]1C(=O)NC2=C(C=CC=C2C)C
1777;255030594;;625223;103649168;31072;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Carbimazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)N1C=CN(C1=S)C
1778;255030595;;625223;103649168;31072;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Carbimazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC(=O)N1C=CN(C1=S)C
1779;255030596;;625223;103231281;5526;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tranexamic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC(CCC1CN)C(=O)O
1780;255030597;;625223;103231281;5526;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tranexamic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC(CCC1CN)C(=O)O
1781;255030598;;625223;103770662;3007855;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Zincchloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;[Cl-].[Cl-].[Zn+2]
1782;255030599;;625223;103770662;3007855;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Zincchloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;[Cl-].[Cl-].[Zn+2]
1783;255030602;;625223;103210094;2754;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cilostazol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4
1784;255030603;;625223;103210094;2754;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cilostazol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4
1785;255030604;;625223;103292372;54454;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Simvastatin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C
1786;255030605;;625223;103292372;54454;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Simvastatin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C
1787;255030606;;625223;103401163;3342;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fenoprofen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)O
1788;255030607;;625223;103401163;3342;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fenoprofen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)O
1789;255030614;;625223;103532096;3366;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Flucytosine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=NC(=O)NC(=C1F)N
1790;255030615;;625223;103532096;3366;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Flucytosine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=NC(=O)NC(=C1F)N
1791;255030876;;625223;103164944;338;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Salicylic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C(=C1)C(=O)O)O
1792;255030877;;625223;103164944;338;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Salicylic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C(=C1)C(=O)O)O
1793;255030882;;625223;103198693;2361;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);beta-Naphthoflavone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=CC4=CC=CC=C43
1794;255030883;;625223;103198693;2361;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);beta-Naphthoflavone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=CC4=CC=CC=C43
1795;255030886;;625223;104247713;71651;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Betamipron;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)C(=O)NCCC(=O)O
1796;255030887;;625223;104247713;71651;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Betamipron;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)C(=O)NCCC(=O)O
1797;255030888;;625223;103165858;237;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Quinacrine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CC)CCCC(C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC
1798;255030889;;625223;103165858;237;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Quinacrine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CC)CCCC(C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC
1799;255030890;;625223;136935047;168088;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pipethanate ethylbromide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[N+]1(CCCCC1)CCOC(=O)C(C2=CC=CC=C2)(C3=CC=CC=C3)O.[Br-]
1800;255030891;;625223;136935047;168088;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pipethanate ethylbromide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[N+]1(CCCCC1)CCOC(=O)C(C2=CC=CC=C2)(C3=CC=CC=C3)O.[Br-]
1801;255030894;;625223;103345443;8816;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cetylpyridinium bromide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1.[Br-]
1802;255030895;;625223;103345443;8816;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cetylpyridinium bromide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1.[Br-]
1803;255030896;;625223;103308477;6623;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Bisphenol A;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O
1804;255030897;;625223;103308477;6623;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Bisphenol A;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O
1805;255030898;;625223;103305076;3332;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Felbinac;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)C2=CC=C(C=C2)CC(=O)O
1806;255031336;;625223;103305076;3332;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Felbinac;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)C2=CC=C(C=C2)CC(=O)O
1807;255031337;;625223;103164420;4171;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Metoprolol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
1808;255031338;;625223;103164420;4171;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Metoprolol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
1809;255031339;;625223;103164854;323;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Coumarin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C2C(=C1)C=CC(=O)O2
1810;255031340;;625223;103164854;323;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Coumarin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C2C(=C1)C=CC(=O)O2
1811;255031341;;625223;104234256;441306;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Netilmicin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN[C@@H]1C[C@@H]([C@H]([C@@H]([C@H]1O[C@@H]2[C@@H]([C@H]([C@@](CO2)(C)O)NC)O)O)O[C@@H]3[C@@H](CC=C(O3)CN)N)N
1812;255031342;;625223;104234256;441306;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Netilmicin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN[C@@H]1C[C@@H]([C@H]([C@@H]([C@H]1O[C@@H]2[C@@H]([C@H]([C@@](CO2)(C)O)NC)O)O)O[C@@H]3[C@@H](CC=C(O3)CN)N)N
1813;255031343;;625223;103330746;5282230;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tranilast;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C(C=C(C=C1)/C=C/C(=O)NC2=CC=CC=C2C(=O)O)OC
1814;255031344;;625223;103330746;5282230;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tranilast;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C(C=C(C=C1)/C=C/C(=O)NC2=CC=CC=C2C(=O)O)OC
1815;255031349;;625223;103510607;54671203;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Doxycycline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1[C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O
1816;255031350;;625223;103510607;54671203;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Doxycycline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1[C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O
1817;255031353;;625223;160687250;68595;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Maduramicin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1C[C@H]([C@@](O[C@@H]1[C@H]2C[C@@H]([C@@H](O2)[C@@]3(CC[C@@H](O3)[C@@]4(CC[C@@]5(O4)C[C@@H]([C@H]([C@H](O5)[C@@H](C)[C@H]6[C@@H]([C@H]([C@@H]([C@](O6)(CC(=O)O)O)C)OC)OC)C)O)C)C)O[C@@H]7C[C@@H]([C@H]([C@@H](O7)C)OC)OC)(C)O)C.N
1818;255031354;;625223;160687250;68595;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Maduramicin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1C[C@H]([C@@](O[C@@H]1[C@H]2C[C@@H]([C@@H](O2)[C@@]3(CC[C@@H](O3)[C@@]4(CC[C@@]5(O4)C[C@@H]([C@H]([C@H](O5)[C@@H](C)[C@H]6[C@@H]([C@H]([C@@H]([C@](O6)(CC(=O)O)O)C)OC)OC)C)O)C)C)O[C@@H]7C[C@@H]([C@H]([C@@H](O7)C)OC)OC)(C)O)C.N
1819;255031355;;625223;103171578;33624;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Timolol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O
1820;255031356;;625223;103171578;33624;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Timolol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O
1821;255031357;;625223;103185057;5401;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Terazosin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
1822;255031358;;625223;103210646;156391;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Naproxen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O
1823;255031359;;625223;103210646;156391;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Naproxen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O
1824;255031360;;625223;103196138;289;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Catechol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C(=C1)O)O
1825;255031720;;625223;103196138;289;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Catechol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C(=C1)O)O
1826;255031721;;625223;103200240;135445761;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pralidoxime Chloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[N+]1=CC=CC=C1/C=N/O.[Cl-]
1827;255031722;;625223;103200240;135445761;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pralidoxime Chloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[N+]1=CC=CC=C1/C=N/O.[Cl-]
1828;255031723;;625223;103216085;2723949;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Thioacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=S)N
1829;255031724;;625223;103216085;2723949;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Thioacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=S)N
1830;255031725;;625223;103234269;6098;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cloxacillin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O
1831;255031726;;625223;103555996;3354;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Flavoxate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4
1832;255031727;;625223;103555996;3354;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Flavoxate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4
1833;255031728;;625223;103185057;5401;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Terazosin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
1834;255031729;;625223;103177753;2554;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Carbamazepine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N
1835;255031730;;625223;103177753;2554;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Carbamazepine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N
1836;255031731;;625223;136931594;19592;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nafenopin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CCCC3=CC=CC=C23
1837;255031732;;625223;136931594;19592;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nafenopin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CCCC3=CC=CC=C23
1838;255031735;;625223;103590513;2577;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Carmofur;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCCCNC(=O)N1C=C(C(=O)NC1=O)F
1839;255031736;;625223;103590513;2577;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Carmofur;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCCCNC(=O)N1C=C(C(=O)NC1=O)F
1840;255031737;;625223;103234269;6098;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cloxacillin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O
1841;255031738;;625223;104234242;444041;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Betadex;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C([C@@H]1[C@@H]2[C@@H]([C@H]([C@H](O1)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)O)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6O)O)O[C@@H]7[C@H](O[C@@H]([C@@H]([C@H]7O)O)O[C@@H]8[C@H](O[C@H](O2)[C@@H]([C@H]8O)O)CO)CO)CO)CO)CO)CO)O)O)O
1842;255031739;;625223;104234242;444041;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Betadex;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C([C@@H]1[C@@H]2[C@@H]([C@H]([C@H](O1)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)O)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6O)O)O[C@@H]7[C@H](O[C@@H]([C@@H]([C@H]7O)O)O[C@@H]8[C@H](O[C@H](O2)[C@@H]([C@H]8O)O)CO)CO)CO)CO)CO)CO)O)O)O
1843;255031744;;625223;174525699;9898639;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Gentamicinsulfate salt;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC([C@@H]1CC[C@H]([C@H](O1)O[C@@H]2[C@H](C[C@H]([C@@H]([C@H]2O)O[C@@H]3[C@@H]([C@H]([C@@](CO3)(C)O)NC)O)N)N)N)N.CC([C@@H]1CC[C@H]([C@H](O1)O[C@@H]2[C@H](C[C@H]([C@@H]([C@H]2O)O[C@@H]3[C@@H]([C@H]([C@@](CO3)(C)O)NC)O)N)N)N)NC.C[C@@]1(CO[C@@H]([C@@H]([C@H]1NC)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H](CC[C@H](O3)CN)N)N)N)O
1844;255032125;;625223;174525699;9898639;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Gentamicinsulfate salt;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC([C@@H]1CC[C@H]([C@H](O1)O[C@@H]2[C@H](C[C@H]([C@@H]([C@H]2O)O[C@@H]3[C@@H]([C@H]([C@@](CO3)(C)O)NC)O)N)N)N)N.CC([C@@H]1CC[C@H]([C@H](O1)O[C@@H]2[C@H](C[C@H]([C@@H]([C@H]2O)O[C@@H]3[C@@H]([C@H]([C@@](CO3)(C)O)NC)O)N)N)N)NC.C[C@@]1(CO[C@@H]([C@@H]([C@H]1NC)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H](CC[C@H](O3)CN)N)N)N)O
1845;255032130;;625223;103234592;444;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Bupropion;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C
1846;255032131;;625223;103234592;444;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Bupropion;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C
1847;255032134;;625223;136939978;9128;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Benzo[e]pyrene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C2C(=C1)C3=CC=CC4=C3C5=C(C=CC=C25)C=C4
1848;255032135;;625223;136939978;9128;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Benzo[e]pyrene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C2C(=C1)C3=CC=CC4=C3C5=C(C=CC=C25)C=C4
1849;255032136;;625223;103186411;5386;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tegafur;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC(OC1)N2C=C(C(=O)NC2=O)F
1850;255032143;;625223;103189534;4173;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Metronidazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=NC=C(N1CCO)[N+](=O)[O-]
1851;255032144;;625223;103189534;4173;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Metronidazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=NC=C(N1CCO)[N+](=O)[O-]
1852;255032145;;625223;103179145;938;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nicotinic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CN=C1)C(=O)O
1853;255032146;;625223;103179145;938;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nicotinic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CN=C1)C(=O)O
1854;255032147;;625223;103169165;60838;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Irinotecan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7
1855;255032148;;625223;103169165;60838;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Irinotecan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7
1856;255032149;;625223;103222497;40854;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Oxfendazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC(=O)NC1=NC2=C(N1)C=C(C=C2)S(=O)C3=CC=CC=C3
1857;255032512;;625223;103222497;40854;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Oxfendazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC(=O)NC1=NC2=C(N1)C=C(C=C2)S(=O)C3=CC=CC=C3
1858;255032513;;625223;103600468;16129778;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Gallotannin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=C(C=C(C(=C1O)O)O)C(=O)OC2=CC(=CC(=C2O)O)C(=O)OC[C@@H]3[C@H]([C@@H]([C@H]([C@@H](O3)OC(=O)C4=CC(=C(C(=C4)OC(=O)C5=CC(=C(C(=C5)O)O)O)O)O)OC(=O)C6=CC(=C(C(=C6)OC(=O)C7=CC(=C(C(=C7)O)O)O)O)O)OC(=O)C8=CC(=C(C(=C8)OC(=O)C9=CC(=C(C(=C9)O)O)O)O)O)OC(=O)C1=CC(=C(C(=C1)OC(=O)C1=CC(=C(C(=C1)O)O)O)O)O
1859;255032514;;625223;103600468;16129778;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Gallotannin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=C(C=C(C(=C1O)O)O)C(=O)OC2=CC(=CC(=C2O)O)C(=O)OC[C@@H]3[C@H]([C@@H]([C@H]([C@@H](O3)OC(=O)C4=CC(=C(C(=C4)OC(=O)C5=CC(=C(C(=C5)O)O)O)O)O)OC(=O)C6=CC(=C(C(=C6)OC(=O)C7=CC(=C(C(=C7)O)O)O)O)O)OC(=O)C8=CC(=C(C(=C8)OC(=O)C9=CC(=C(C(=C9)O)O)O)O)O)OC(=O)C1=CC(=C(C(=C1)OC(=O)C1=CC(=C(C(=C1)O)O)O)O)O
1860;255032515;;625223;103296891;33613;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amoxicillin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)O)C
1861;255032516;;625223;103296891;33613;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amoxicillin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)O)C
1862;255032517;;625223;160671910;5282181;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Alfacalcidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C
1863;255032518;;625223;160671910;5282181;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Alfacalcidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C
1864;255032521;;625223;103229487;13342;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Vinblastine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
1865;255032522;;625223;103229487;13342;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Vinblastine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
1866;255032525;;625223;103318474;1367;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);1-Aminobenzotriazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C2C(=C1)N=NN2N
1867;255032526;;625223;103318474;1367;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);1-Aminobenzotriazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C2C(=C1)N=NN2N
1868;255032527;;625223;103642911;135403648;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Leucovorin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O
1869;255032528;;625223;103642911;135403648;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Leucovorin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O
1870;255032529;;625223;103186411;5386;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tegafur;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC(OC1)N2C=C(C(=O)NC2=O)F
1871;255032530;;625223;104240364;6915744;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Rulide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OCOCCOC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O
1872;255032531;;625223;104240364;6915744;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Rulide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OCOCCOC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O
1873;255032534;;625223;123087792;42008;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cefmetazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)CSCC#N)OC)SC2)C(=O)O
1874;255032535;;625223;123087792;42008;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cefmetazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)CSCC#N)OC)SC2)C(=O)O
1875;255032536;;625223;103556901;2723;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Chloroxylenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC(=CC(=C1Cl)C)O
1876;255032886;;625223;103556901;2723;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Chloroxylenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC(=CC(=C1Cl)C)O
1877;255032887;;625223;103176121;243;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Benzoic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)C(=O)O
1878;255032888;;625223;103176121;243;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Benzoic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)C(=O)O
1879;255032889;;625223;123089405;444034;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dihydroergocristine mesylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C.CS(=O)(=O)O
1880;255032890;;625223;103179427;3958;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lorazepam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl
1881;255032891;;625223;103179427;3958;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lorazepam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl
1882;255032892;;625223;104234229;5743;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dexamethasone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C
1883;255032893;;625223;104234229;5743;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dexamethasone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C
1884;255032894;;625223;103519121;4197;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Milrinone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2
1885;255032895;;625223;103519121;4197;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Milrinone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2
1886;255032898;;625223;103388855;5353853;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Oxiconazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C=C1Cl)Cl)CO/N=C(\CN2C=CN=C2)/C3=C(C=C(C=C3)Cl)Cl
1887;255032899;;625223;103388855;5353853;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Oxiconazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C=C1Cl)Cl)CO/N=C(\CN2C=CN=C2)/C3=C(C=C(C=C3)Cl)Cl
1888;255032900;;625223;103175225;4781;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Phenylbutazone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3
1889;255032901;;625223;103175225;4781;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Phenylbutazone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3
1890;255032902;;625223;103243148;4174;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Metyrapone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C1=CN=CC=C1)C(=O)C2=CN=CC=C2
1891;255032903;;625223;103243148;4174;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Metyrapone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C1=CN=CC=C1)C(=O)C2=CN=CC=C2
1892;255032904;;625223;103447888;6249;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ampicillin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)C
1893;255032905;;625223;103447888;6249;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ampicillin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)C
1894;255032906;;625223;103535182;135415564;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Rifabutin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1/C=C/C=C(\C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C5=NC6(CCN(CC6)CC(C)C)N=C25)O)/C
1895;255032907;;625223;103535182;135415564;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Rifabutin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1/C=C/C=C(\C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C5=NC6(CCN(CC6)CC(C)C)N=C25)O)/C
1896;255032908;;625223;103179606;441243;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Saquinavir;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@H]([C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
1897;255032909;;625223;103179760;65016;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amprenavir;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N
1898;255032910;;625223;103179760;65016;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amprenavir;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N
1899;255033276;;625223;160671354;5282322;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Leucomycin A1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC(C)C)(C)O)N(C)C)O)CC=O)C)O
1900;255033277;;625223;160671354;5282322;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Leucomycin A1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC(C)C)(C)O)N(C)C)O)CC=O)C)O
1901;255033278;;625223;103197669;2723601;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Thioguanine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=NC2=C(N1)C(=S)N=C(N2)N
1902;255033279;;625223;103197669;2723601;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Thioguanine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=NC2=C(N1)C(=S)N=C(N2)N
1903;255033280;;625223;136923740;5104;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Roxarsone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C=C1[As](=O)(O)O)[N+](=O)[O-])O
1904;255033281;;625223;136923740;5104;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Roxarsone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C=C1[As](=O)(O)O)[N+](=O)[O-])O
1905;255033282;;625223;104251392;716312;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);4-Fluoro-L-phenylalanine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1C[C@@H](C(=O)O)N)F
1906;255033283;;625223;104251392;716312;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);4-Fluoro-L-phenylalanine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1C[C@@H](C(=O)O)N)F
1907;255033284;;625223;103508547;4091;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Metformin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)C(=N)N=C(N)N
1908;255033285;;625223;103508547;4091;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Metformin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)C(=N)N=C(N)N
1909;255033286;;625223;103343350;4723;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pemoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)C2C(=O)N=C(O2)N
1910;255033287;;625223;103343350;4723;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pemoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)C2C(=O)N=C(O2)N
1911;255033288;;625223;103189004;5959;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Chloramphenicol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]
1912;255033289;;625223;103189004;5959;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Chloramphenicol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1[C@H]([C@@H](CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]
1913;255033291;;625223;123085230;4098;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Methapyrilene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)CCN(CC1=CC=CS1)C2=CC=CC=N2
1914;255033292;;625223;123085230;4098;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Methapyrilene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)CCN(CC1=CC=CS1)C2=CC=CC=N2
1915;255033293;;625223;103165247;5379;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Gatifloxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
1916;255033294;;625223;103165247;5379;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Gatifloxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F
1917;255033295;;625223;103218566;1674;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);3-Methylcholanthrene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C2CCC3=C2C(=CC4=C3C=CC5=CC=CC=C54)C=C1
1918;255033296;;625223;103218566;1674;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);3-Methylcholanthrene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C2CCC3=C2C(=CC4=C3C=CC5=CC=CC=C54)C=C1
1919;255033297;;625223;103179606;441243;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Saquinavir;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@H]([C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
1920;255033298;;625223;103326781;936;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Niacinamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CN=C1)C(=O)N
1921;255033299;;625223;103326781;936;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Niacinamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CN=C1)C(=O)N
1922;255033300;;625223;103269962;55652;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Spiradoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN([C@H]1CC[C@@]2(CCCO2)C[C@@H]1N3CCCC3)C(=O)CC4=CC(=C(C=C4)Cl)Cl
1923;255033653;;625223;103269962;55652;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Spiradoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN([C@H]1CC[C@@]2(CCCO2)C[C@@H]1N3CCCC3)C(=O)CC4=CC(=C(C=C4)Cl)Cl
1924;255033654;;625223;103194022;2284;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Baclofen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1C(CC(=O)O)CN)Cl
1925;255033655;;625223;103194022;2284;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Baclofen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1C(CC(=O)O)CN)Cl
1926;255033656;;625223;103341726;124087;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Desloratadine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
1927;255033657;;625223;103341726;124087;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Desloratadine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
1928;255033658;;625223;103707689;2724385;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Digoxin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
1929;255033659;;625223;103707689;2724385;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Digoxin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
1930;255033660;;625223;103267861;2141;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amifostine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(CN)CNCCSP(=O)(O)O
1931;255033661;;625223;103267861;2141;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amifostine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(CN)CNCCSP(=O)(O)O
1932;255033662;;625223;103199488;3821;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ketamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CNC1(CCCCC1=O)C2=CC=CC=C2Cl
1933;255033663;;625223;103199488;3821;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ketamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CNC1(CCCCC1=O)C2=CC=CC=C2Cl
1934;255033664;;625223;103179099;7961;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Bromobenzene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)Br
1935;255033665;;625223;103179099;7961;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Bromobenzene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)Br
1936;255033666;;625223;123085521;8226;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Methylergonovine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C
1937;255033667;;625223;123085521;8226;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Methylergonovine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C
1938;255033668;;625223;103169414;2995;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Desipramine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31
1939;255033669;;625223;103169414;2995;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Desipramine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31
1940;255033670;;625223;123083185;77999;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Rosiglitazone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
1941;255033671;;625223;123083185;77999;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Rosiglitazone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
1942;255033672;;625223;103170845;4168;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Metoclopramide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
1943;255033673;;625223;103170845;4168;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Metoclopramide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
1944;255033674;;625223;103585278;444254;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Precose;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O[C@@H]3[C@H](O[C@H]([C@@H]([C@H]3O)O)O)CO)CO)O)O)N[C@H]4C=C([C@H]([C@@H]([C@H]4O)O)O)CO
1945;255033675;;625223;103585278;444254;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Precose;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O[C@@H]3[C@H](O[C@H]([C@@H]([C@H]3O)O)O)CO)CO)O)O)N[C@H]4C=C([C@H]([C@@H]([C@H]4O)O)O)CO
1946;255033676;;625223;136923751;35802;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Flubendazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=C(C=C3)F
1947;255033677;;625223;136923751;35802;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Flubendazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=C(C=C3)F
1948;255034011;;625223;103567551;6479523;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Azlocillin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)NC(=O)N4CCNC4=O)C(=O)O)C
1949;255034012;;625223;103567551;6479523;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Azlocillin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)NC(=O)N4CCNC4=O)C(=O)O)C
1950;255034015;;625223;103250293;5071;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Rimantadine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C12CC3CC(C1)CC(C3)C2)N
1951;255034016;;625223;103250293;5071;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Rimantadine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C12CC3CC(C1)CC(C3)C2)N
1952;255034017;;625223;103165766;4543;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nortriptyline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
1953;255034018;;625223;103165766;4543;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nortriptyline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
1954;255034019;;625223;103311042;42890;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Idarubicin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O
1955;255034020;;625223;103311042;42890;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Idarubicin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O
1956;255034023;;625223;103217374;56208;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sarafloxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCN1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=CC=C(C=C4)F)F
1957;255034026;;625223;163315720;3823;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);1-[4-[4-[[2-(2,4-Dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl
1958;255034027;;625223;163315720;3823;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);1-[4-[4-[[2-(2,4-Dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl
1959;255034028;;625223;103274495;3690;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ifosfamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(P(=O)(OC1)NCCCl)CCCl
1960;255034029;;625223;103274495;3690;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ifosfamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(P(=O)(OC1)NCCCl)CCCl
1961;255034032;;625223;103258899;56069;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(R)-Bicalutamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@](CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
1962;255034033;;625223;103258899;56069;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(R)-Bicalutamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@](CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
1963;255034034;;625223;103619997;37542;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ribavirin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=NC(=NN1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N
1964;255034386;;625223;103619997;37542;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ribavirin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=NC(=NN1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N
1965;255034387;;625223;103202919;4636;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Oxymetazoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C
1966;255034388;;625223;103202919;4636;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Oxymetazoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C
1967;255034389;;625223;103166276;38409;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tienilic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CSC(=C1)C(=O)C2=C(C(=C(C=C2)OCC(=O)O)Cl)Cl
1968;255034390;;625223;103166276;38409;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tienilic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CSC(=C1)C(=O)C2=C(C(=C(C=C2)OCC(=O)O)Cl)Cl
1969;255034391;;625223;103192563;5991;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ethinyl Estradiol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)O
1970;255034392;;625223;103192563;5991;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ethinyl Estradiol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)O
1971;255034393;;625223;123087788;2882;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cromolyn;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC2=C(C(=C1)OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)O)O)C(=O)C=C(O2)C(=O)O
1972;255034394;;625223;123087788;2882;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cromolyn;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC2=C(C(=C1)OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)O)O)C(=O)C=C(O2)C(=O)O
1973;255034395;;625223;103292864;4235;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Moclobemide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl
1974;255034396;;625223;103292864;4235;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Moclobemide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl
1975;255034399;;625223;103166767;14985;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Alpha-Tocopherol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C
1976;255034400;;625223;103166767;14985;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Alpha-Tocopherol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C
1977;255034403;;625223;103170825;5073;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Risperidone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
1978;255034404;;625223;103170825;5073;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Risperidone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
1979;255034405;;625223;103630533;15938;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Paraquat dichloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[N+]1=CC=C(C=C1)C2=CC=[N+](C=C2)C.[Cl-].[Cl-]
1980;255034406;;625223;103630533;15938;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Paraquat dichloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[N+]1=CC=C(C=C1)C2=CC=[N+](C=C2)C.[Cl-].[Cl-]
1981;255034407;;625223;103557049;4594;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Omeprazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC
1982;255034408;;625223;103557049;4594;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Omeprazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC
1983;255034409;;625223;103217374;56208;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sarafloxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCN1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=CC=C(C=C4)F)F
1984;255034410;;625223;103216609;39042;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Bezafibrate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl
1985;255034736;;625223;103216609;39042;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Bezafibrate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl
1986;255034737;;625223;103770828;443943;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Halcinonide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3C[C@@H]5[C@]4(OC(O5)(C)C)C(=O)CCl)C)O)F
1987;255034738;;625223;103770828;443943;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Halcinonide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3C[C@@H]5[C@]4(OC(O5)(C)C)C(=O)CCl)C)O)F
1988;255034741;;625223;103179577;72474;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Grepafloxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1CN(CCN1)C2=C(C(=C3C(=C2)N(C=C(C3=O)C(=O)O)C4CC4)C)F
1989;255034742;;625223;103179577;72474;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Grepafloxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1CN(CCN1)C2=C(C(=C3C(=C2)N(C=C(C3=O)C(=O)O)C4CC4)C)F
1990;255034743;;625223;103194727;57363;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Finasteride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C
1991;255034744;;625223;103194727;57363;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Finasteride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C
1992;255034749;;625223;103340993;4649;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);4-Aminosalicylic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C=C1N)O)C(=O)O
1993;255034750;;625223;103340993;4649;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);4-Aminosalicylic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C=C1N)O)C(=O)O
1994;255034753;;625223;103437141;3383;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);2-(6-Hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C(=C1)C2=C3C=CC(=O)C=C3OC4=C2C=CC(=C4)O)C(=O)O
1995;255034754;;625223;103437141;3383;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);2-(6-Hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C(=C1)C2=C3C=CC(=O)C=C3OC4=C2C=CC(=C4)O)C(=O)O
1996;255034755;;625223;103387432;311;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Citric Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(C(=O)O)C(CC(=O)O)(C(=O)O)O
1997;255034756;;625223;103387432;311;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Citric Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(C(=O)O)C(CC(=O)O)(C(=O)O)O
1998;255034757;;625223;103703382;36294;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tobramycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N
1999;255034758;;625223;103703382;36294;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tobramycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N
2000;255034759;;625223;103359097;2482;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Butyl 4-aminobenzoate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCOC(=O)C1=CC=C(C=C1)N
2001;255034760;;625223;103359097;2482;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Butyl 4-aminobenzoate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCOC(=O)C1=CC=C(C=C1)N
2002;255035113;;625223;103236900;8246;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Neostigmine bromide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C.[Br-]
2003;255035114;;625223;103236900;8246;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Neostigmine bromide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C.[Br-]
2004;255035115;;625223;103493432;2749;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ciclopirox;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC(=O)N(C(=C1)C2CCCCC2)O
2005;255035116;;625223;103493432;2749;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ciclopirox;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC(=O)N(C(=C1)C2CCCCC2)O
2006;255035117;;625223;103271913;2541;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Candesartan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O
2007;255035118;;625223;103271913;2541;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Candesartan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O
2008;255035119;;625223;103164769;5333;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulfanilamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1N)S(=O)(=O)N
2009;255035120;;625223;103164769;5333;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulfanilamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1N)S(=O)(=O)N
2010;255035121;;625223;103173718;2578;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Carmustine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(CCl)NC(=O)N(CCCl)N=O
2011;255035122;;625223;103173718;2578;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Carmustine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(CCl)NC(=O)N(CCCl)N=O
2012;255035123;;625223;136923736;6319;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);N,N'-Diphenyl-p-phenylenediamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)NC2=CC=C(C=C2)NC3=CC=CC=C3
2013;255035124;;625223;136923736;6319;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);N,N'-Diphenyl-p-phenylenediamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)NC2=CC=C(C=C2)NC3=CC=CC=C3
2014;255035125;;625223;103339676;15541;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Spectinomycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1CC(=O)[C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)NC)O)NC)O)O
2015;255035126;;625223;103339676;15541;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Spectinomycin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1CC(=O)[C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)NC)O)NC)O)O
2016;255035127;;625223;103173925;3698;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amrinone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CN=CC=C1C2=CNC(=O)C(=C2)N
2017;255035128;;625223;103173925;3698;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amrinone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CN=CC=C1C2=CNC(=O)C(=C2)N
2018;255035129;;625223;103239458;25444;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(2S,3R,4S,5S,6R)-2-[(2S,3R,4S,5S,6R)-2-[(2S,3R,4S,6R)-2-[(2R,3R,4R,5R,6R)-6-[(1R,2S,3S,4R,5'R,6R,7S,8R,9S,12S,13S,15R,16R,18S)-3,15-dihydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)[C@H]([C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@@H]6[C@@]5(C[C@H]([C@@H](C6)O[C@H]7[C@@H]([C@H]([C@H]([C@H](O7)CO)O[C@H]8[C@@H]([C@H](C([C@H](O8)CO)O)O[C@H]9[C@@H]([C@H]([C@@H](CO9)O)O)O)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O)O)O)C)C)O)C)OC1
2019;255035130;;625223;103239458;25444;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(2S,3R,4S,5S,6R)-2-[(2S,3R,4S,5S,6R)-2-[(2S,3R,4S,6R)-2-[(2R,3R,4R,5R,6R)-6-[(1R,2S,3S,4R,5'R,6R,7S,8R,9S,12S,13S,15R,16R,18S)-3,15-dihydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)[C@H]([C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@@H]6[C@@]5(C[C@H]([C@@H](C6)O[C@H]7[C@@H]([C@H]([C@H]([C@H](O7)CO)O[C@H]8[C@@H]([C@H](C([C@H](O8)CO)O)O[C@H]9[C@@H]([C@H]([C@@H](CO9)O)O)O)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O)O)O)C)C)O)C)OC1
2020;255035131;;625223;103346479;443884;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ergometrine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C
2021;255035132;;625223;103346479;443884;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ergometrine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C
2022;255035133;;625223;103227310;276389;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Harringtonine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(CC[C@@](CC(=O)OC)(C(=O)O[C@H]1[C@H]2C3=CC4=C(C=C3CCN5[C@@]2(CCC5)C=C1OC)OCO4)O)O
2023;255035134;;625223;103227310;276389;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Harringtonine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(CC[C@@](CC(=O)OC)(C(=O)O[C@H]1[C@H]2C3=CC4=C(C=C3CCN5[C@@]2(CCC5)C=C1OC)OCO4)O)O
2024;255035135;;625223;103292815;60846;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Valsartan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O
2025;255035136;;625223;103292815;60846;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Valsartan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O
2026;255035137;;625223;103211461;3334;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fenbendazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC(=O)NC1=NC2=C(N1)C=C(C=C2)SC3=CC=CC=C3
2027;255035466;;625223;103211461;3334;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fenbendazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC(=O)NC1=NC2=C(N1)C=C(C=C2)SC3=CC=CC=C3
2028;255035467;;625223;103163870;123630;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tazobactam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@]1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3
2029;255035468;;625223;103163870;123630;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tazobactam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@]1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3
2030;255035469;;625223;104234147;3779;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Isoproterenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)NCC(C1=CC(=C(C=C1)O)O)O
2031;255035470;;625223;103188539;2206;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Antipyrine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC(=O)N(N1C)C2=CC=CC=C2
2032;255035471;;625223;103188539;2206;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Antipyrine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC(=O)N(N1C)C2=CC=CC=C2
2033;255035472;;625223;103520216;31307;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Triamcinolone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O
2034;255035473;;625223;103520216;31307;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Triamcinolone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O
2035;255035474;;625223;103191448;4044;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mefenamic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C
2036;255035475;;625223;103191448;4044;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mefenamic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C
2037;255035476;;625223;103184855;3965;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Loxoprofen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C1=CC=C(C=C1)CC2CCCC2=O)C(=O)O
2038;255035477;;625223;103184855;3965;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Loxoprofen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C1=CC=C(C=C1)CC2CCCC2=O)C(=O)O
2039;255035478;;625223;104234238;5754;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Hydrocortisone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O
2040;255035479;;625223;104234238;5754;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Hydrocortisone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O
2041;255035480;;625223;103235689;5702160;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Famotidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=C(N=C(S1)N=C(N)N)CSCC/C(=N/S(=O)(=O)N)/N
2042;255035481;;625223;103235689;5702160;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Famotidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=C(N=C(S1)N=C(N)N)CSCC/C(=N/S(=O)(=O)N)/N
2043;255035482;;625223;104234226;37768;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amikacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N
2044;255035483;;625223;104234226;37768;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amikacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N
2045;255035484;;625223;103771122;11683;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Megestrol Acetate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C
2046;255035485;;625223;103771122;11683;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Megestrol Acetate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)OC(=O)C)C)[C@@]4(C1=CC(=O)CC4)C
2047;255035486;;625223;103329864;7456;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Methylparaben;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC(=O)C1=CC=C(C=C1)O
2048;255035487;;625223;103329864;7456;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Methylparaben;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC(=O)C1=CC=C(C=C1)O
2049;255035488;;625223;103372397;6112;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lipoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CSS[C@@H]1CCCCC(=O)O
2050;255035489;;625223;103372397;6112;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Lipoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CSS[C@@H]1CCCCC(=O)O
2051;255035490;;625223;103581295;44093;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Captopril;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O
2052;255035847;;625223;103581295;44093;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Captopril;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O
2053;255035848;;625223;103194399;6209;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Choline Chloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[N+](C)(C)CCO.[Cl-]
2054;255035849;;625223;103194399;6209;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Choline Chloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[N+](C)(C)CCO.[Cl-]
2055;255035850;;625223;103459872;114864;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(R)-(-)-Ibuprofen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H](C1=CC=C(C=C1)CC(C)C)C(=O)O
2056;255035851;;625223;103459872;114864;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(R)-(-)-Ibuprofen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H](C1=CC=C(C=C1)CC(C)C)C(=O)O
2057;255035852;;625223;104234148;8223;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ergotamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@H]5CN([C@@H]6CC7=CNC8=CC=CC(=C78)C6=C5)C
2058;255035853;;625223;104234148;8223;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ergotamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@H]5CN([C@@H]6CC7=CNC8=CC=CC(=C78)C6=C5)C
2059;255035854;;625223;103292984;4614;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Oxaprozin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
2060;255035855;;625223;103292984;4614;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Oxaprozin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
2061;255035856;;625223;103238871;3348;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fexofenadine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O
2062;255035857;;625223;103238871;3348;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fexofenadine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O
2063;255035858;;625223;103235190;4601;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Orphenadrine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
2064;255035859;;625223;103235190;4601;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Orphenadrine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
2065;255035860;;625223;103178542;4178;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mexiletine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(=CC=C1)C)OCC(C)N
2066;255035861;;625223;103178542;4178;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mexiletine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(=CC=C1)C)OCC(C)N
2067;255035862;;625223;103196411;244;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Benzyl Alcohol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)CO
2068;255035863;;625223;103196411;244;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Benzyl Alcohol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)CO
2069;255035864;;625223;103171565;2727;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Chlorpropamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl
2070;255035865;;625223;103171565;2727;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Chlorpropamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl
2071;255035866;;625223;104234147;3779;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Isoproterenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)NCC(C1=CC(=C(C=C1)O)O)O
2072;255035867;;625223;103579966;54670067;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ascorbic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C([C@@H]([C@@H]1C(=C(C(=O)O1)O)O)O)O
2073;255035868;;625223;103579966;54670067;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ascorbic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C([C@@H]([C@@H]1C(=C(C(=O)O1)O)O)O)O
2074;255035869;;625223;103234593;10219;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Emetine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@H]1CN2CCC3=CC(=C(C=C3[C@@H]2C[C@@H]1C[C@@H]4C5=CC(=C(C=C5CCN4)OC)OC)OC)OC
2075;255035870;;625223;103234593;10219;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Emetine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@H]1CN2CCC3=CC(=C(C=C3[C@@H]2C[C@@H]1C[C@@H]4C5=CC(=C(C=C5CCN4)OC)OC)OC)OC
2076;255035871;;625223;103171472;2907;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cyclophosphamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CNP(=O)(OC1)N(CCCl)CCCl
2077;255036178;;625223;103171472;2907;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cyclophosphamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CNP(=O)(OC1)N(CCCl)CCCl
2078;255036181;;625223;103252877;23662354;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mesna;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(CS(=O)(=O)[O-])S.[Na+]
2079;255036182;;625223;103252877;23662354;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mesna;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C(CS(=O)(=O)[O-])S.[Na+]
2080;255036183;;625223;103189939;3339;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fenofibrate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
2081;255036184;;625223;103189939;3339;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fenofibrate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
2082;255036185;;625223;160698338;16051930;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);CID 16051930;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@]12CC[C@H]3[C@H]([C@@H]1CCC2(C#C)O)CCC4=CC(=O)CC[C@H]34
2083;255036186;;625223;160698338;16051930;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);CID 16051930;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@]12CC[C@H]3[C@H]([C@@H]1CCC2(C#C)O)CCC4=CC(=O)CC[C@H]34
2084;255036187;;625223;163312394;5311497;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Vinorelbine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC1=C[C@H]2C[C@@](C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
2085;255036188;;625223;163312394;5311497;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Vinorelbine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC1=C[C@H]2C[C@@](C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
2086;255036191;;625223;103396795;57469;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Imiquimod;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N
2087;255036192;;625223;103396795;57469;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Imiquimod;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N
2088;255036193;;625223;103166269;6758;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Rotenone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=C)[C@H]1CC2=C(O1)C=CC3=C2O[C@@H]4COC5=CC(=C(C=C5[C@@H]4C3=O)OC)OC
2089;255036194;;625223;103353725;5328;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulfamethizole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)N
2090;255036195;;625223;103353725;5328;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulfamethizole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)N
2091;255036198;;625223;103598676;451415;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Aclarubicin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@]1(C[C@@H](C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O[C@H]7CCC(=O)[C@@H](O7)C)O)N(C)C)O
2092;255036199;;625223;103598676;451415;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Aclarubicin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@]1(C[C@@H](C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C3=O)C(=CC=C4)O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O[C@H]7CCC(=O)[C@@H](O7)C)O)N(C)C)O
2093;255036200;;625223;103164209;4184;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mianserin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42
2094;255036201;;625223;103164209;4184;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mianserin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42
2095;255036202;;625223;103203672;59768;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Esmolol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O
2096;255036561;;625223;103203672;59768;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Esmolol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O
2097;255036564;;625223;103165751;5329;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulfamethoxazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N
2098;255036565;;625223;103165751;5329;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulfamethoxazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N
2099;255036566;;625223;134437966;5039;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ranitidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
2100;255036567;;625223;134437966;5039;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ranitidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
2101;255036568;;625223;103306370;5335;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulfaphenazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)N2C(=CC=N2)NS(=O)(=O)C3=CC=C(C=C3)N
2102;255036569;;625223;103306370;5335;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sulfaphenazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)N2C(=CC=N2)NS(=O)(=O)C3=CC=C(C=C3)N
2103;255036570;;625223;103621816;5745;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cortisone Acetate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O
2104;255036571;;625223;103621816;5745;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cortisone Acetate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O
2105;255036572;;625223;123089405;444034;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dihydroergocristine mesylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C.CS(=O)(=O)O
2106;255036575;;625223;103189284;2118;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Alprazolam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4
2107;255036576;;625223;103189284;2118;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Alprazolam;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4
2108;255036577;;625223;103391063;6518171;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(S)-2-(2-benzoylphenylamino)-3-(4-(2-(methyl(pyridin-2-yl)amino)ethoxy)phenyl)propanoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCOC1=CC=C(C=C1)C[C@@H](C(=O)O)NC2=CC=CC=C2C(=O)C3=CC=CC=C3)C4=CC=CC=N4
2109;255036578;;625223;103391063;6518171;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(S)-2-(2-benzoylphenylamino)-3-(4-(2-(methyl(pyridin-2-yl)amino)ethoxy)phenyl)propanoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCOC1=CC=C(C=C1)C[C@@H](C(=O)O)NC2=CC=CC=C2C(=O)C3=CC=CC=C3)C4=CC=CC=N4
2110;255036579;;625223;242610449;9920327;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Agri-Mek;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@H](C)[C@@H]1[C@H](C=C[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C.C[C@H]1/C=C/C=C/2\CO[C@H]3[C@@]2([C@@H](C=C([C@H]3O)C)C(=O)O[C@H]4C[C@@H](C/C=C(/[C@H]1O[C@H]5C[C@@H]([C@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O)OC)OC)\C)O[C@]7(C4)C=C[C@@H]([C@H](O7)C(C)C)C)O
2111;255036580;;625223;242610449;9920327;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Agri-Mek;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC[C@H](C)[C@@H]1[C@H](C=C[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C.C[C@H]1/C=C/C=C/2\CO[C@H]3[C@@]2([C@@H](C=C([C@H]3O)C)C(=O)O[C@H]4C[C@@H](C/C=C(/[C@H]1O[C@H]5C[C@@H]([C@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O)OC)OC)\C)O[C@]7(C4)C=C[C@@H]([C@H](O7)C(C)C)C)O
2112;255036581;;625223;103292969;4409;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nabumetone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
2113;255036582;;625223;103292969;4409;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nabumetone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
2114;255036583;;625223;103399308;2132;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ambroxol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC(CCC1NCC2=C(C(=CC(=C2)Br)Br)N)O
2115;255036584;;625223;103399308;2132;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ambroxol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC(CCC1NCC2=C(C(=CC(=C2)Br)Br)N)O
2116;255036585;;625223;103589984;20469;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Beclomethasone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)Cl)C
2117;255036918;;625223;103589984;20469;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Beclomethasone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)Cl)C
2118;255036919;;625223;103171942;4189;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Miconazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
2119;255036920;;625223;103171942;4189;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Miconazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
2120;255036921;;625223;104234156;64143;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nelfinavir;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@@H](CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C)O
2121;255036922;;625223;104234156;64143;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Nelfinavir;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@@H](CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C)O
2122;255036923;;625223;103524762;2123;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Altretamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C
2123;255036924;;625223;103524762;2123;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Altretamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C
2124;255036925;;625223;103301299;4062;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mepivacaine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C
2125;255036926;;625223;103301299;4062;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mepivacaine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C
2126;255036927;;625223;103166269;6758;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Rotenone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=C)[C@H]1CC2=C(O1)C=CC3=C2O[C@@H]4COC5=CC(=C(C=C5[C@@H]4C3=O)OC)OC
2127;255036928;;625223;103163904;2764;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ciprofloxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
2128;255036929;;625223;103163904;2764;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ciprofloxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
2129;255036930;;625223;124960987;9576413;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Naloxonazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C=CCN1[C@H]2[C@]3([C@]4(C5=C(C2)C=CC(=C5O[C@H]4/C(=N/N=C\6/[C@@H]7OC8=C(C=CC9=C8[C@]72[C@]([C@@H](C9)N(CC2)CC=C)(CC6)O)O)/CC3)O)CC1)O
2130;255036931;;625223;124960987;9576413;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Naloxonazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C=CCN1[C@H]2[C@]3([C@]4(C5=C(C2)C=CC(=C5O[C@H]4/C(=N/N=C\6/[C@@H]7OC8=C(C=CC9=C8[C@]72[C@]([C@@H](C9)N(CC2)CC=C)(CC6)O)O)/CC3)O)CC1)O
2131;255036932;;625223;103309971;3973;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC=C4
2132;255036933;;625223;103309971;3973;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC=C4
2133;255036934;;625223;103630897;135403821;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Rifapentine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1/C=C/C=C(\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C=N/N5CCN(CC5)C6CCCC6)/C
2134;255036935;;625223;103630897;135403821;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Rifapentine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1/C=C/C=C(\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C=N/N5CCN(CC5)C6CCCC6)/C
2135;255036936;;625223;103457055;2733;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Chlorzoxazone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC2=C(C=C1Cl)NC(=O)O2
2136;255036937;;625223;103457055;2733;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Chlorzoxazone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC2=C(C=C1Cl)NC(=O)O2
2137;255036938;;625223;103189283;2130;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amantadine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1C2CC3CC1CC(C2)(C3)N
2138;255036939;;625223;103189283;2130;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amantadine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1C2CC3CC1CC(C2)(C3)N
2139;255036940;;625223;103163909;4539;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Norfloxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O
2140;255036941;;625223;103163909;4539;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Norfloxacin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O
2141;255036942;;625223;103197484;2585;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Carvedilol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O
2142;255037301;;625223;103197484;2585;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Carvedilol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O
2143;255037302;;625223;160692461;444008;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tibolone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1CC2=C(CCC(=O)C2)[C@@H]3[C@@H]1[C@@H]4CC[C@]([C@]4(CC3)C)(C#C)O
2144;255037303;;625223;160692461;444008;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tibolone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@H]1CC2=C(CCC(=O)C2)[C@@H]3[C@@H]1[C@@H]4CC[C@]([C@]4(CC3)C)(C#C)O
2145;255037304;;625223;103344166;3038525;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Neflamapimod;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C(=C1)Cl)C2=C3C=CC(=NN3C=NC2=O)SC4=C(C=C(C=C4)F)F)Cl
2146;255037305;;625223;103344166;3038525;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Neflamapimod;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=C(C(=C1)Cl)C2=C3C=CC(=NN3C=NC2=O)SC4=C(C=C(C=C4)F)F)Cl
2147;255037306;;625223;103193678;2366;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Betahistine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CNCCC1=CC=CC=N1
2148;255037307;;625223;103193678;2366;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Betahistine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CNCCC1=CC=CC=N1
2149;255037308;;625223;103770845;441350;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Metyrosine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@](CC1=CC=C(C=C1)O)(C(=O)O)N
2150;255037309;;625223;103770845;441350;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Metyrosine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@](CC1=CC=C(C=C1)O)(C(=O)O)N
2151;321454606;;658886;160678244;56951495;10280;221715430;Literature-derived;20200626;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]Pentazocine from sigma1 receptor at 10 uM;3-[(2s)-Azetidin-2-Ylmethoxy]-5-[(1s,2r)-2-(2-Methoxyethyl)cyclopropyl]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COCC[C@H]1C[C@@H]1C2=CC(=CN=C2)OC[C@@H]3CCN3
2152;321454607;;658886;160705128;45254040;10280;221715430;Literature-derived;20200626;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]Pentazocine from sigma1 receptor at 10 uM;2-[(1r,2s)-2-[5-[[(2s)-Azetidin-2-Yl]methoxy]pyridin-3-Yl]cyclopropyl]ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN[C@@H]1COC2=CN=CC(=C2)[C@H]3C[C@@H]3CCO
2153;321454608;;658886;160688954;56951368;10280;221715430;Literature-derived;20200626;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]Pentazocine from sigma1 receptor at 10 uM;2-[(1R,2S)-2-[5-[[(2S)-azetidin-2-yl]methoxy]pyridin-3-yl]cyclopropyl]ethyl N-methylcarbamate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CNC(=O)OCC[C@H]1C[C@@H]1C2=CC(=CN=C2)OC[C@@H]3CCN3
2154;321565532;;671086;103292916;15925918;10280;227390890;Confirmatory;20220830;0;0;Inconclusive;Q99720;Ki;;ChEMBL;Binding affinity to sigma1 receptor;Benzovesamicol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1C2=CC=CC=C2)[C@@H]3CC4=CC=CC=C4C[C@H]3O
2155;325846919;;699089;163313792;23290944;10280;227386280;Literature-derived;20180923;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity to sigma 1 receptor at 10 uM by radioligand binding assay;N-[2-(4-phenylpiperazin-1-yl)ethyl]-N-pyridin-2-ylcyclohexanecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)C(=O)N(CCN2CCN(CC2)C3=CC=CC=C3)C4=CC=CC=N4
2156;325846920;;699089;163324070;71455083;10280;227386280;Literature-derived;20180923;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity to sigma 1 receptor at 10 uM by radioligand binding assay;N-[2-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)ethyl]-N-pyridin-2-ylcyclohexanecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)C(=O)N(CCN2CCC(=CC2)C3=CC=CC=C3)C4=CC=CC=N4
2157;325854939;;706544;163318141;68490431;10280;230434200;Literature-derived;20180923;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of human sigma 1 at 100 uM;4-[2-[4-[[(1-Propan-2-ylindazole-3-carbonyl)amino]methyl]piperidin-1-yl]ethyl]benzoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)N1C2=CC=CC=C2C(=N1)C(=O)NCC3CCN(CC3)CCC4=CC=C(C=C4)C(=O)O
2158;325855068;;706536;163331945;44628198;10280;230434200;Literature-derived;20180923;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of human sigma 1 at 10 uM;4-[2-[4-[(2-Methylpyrrolo[3,4-c]quinolin-4-yl)oxymethyl]piperidin-1-yl]ethyl]benzoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C=C2C3=CC=CC=C3N=C(C2=C1)OCC4CCN(CC4)CCC5=CC=C(C=C5)C(=O)O
2159;325967761;;701154;163334751;44247568;10280;227840080;Literature-derived;20200625;0;0;Unspecified;Q99720;;;ChEMBL;Ratio of Ki for human sigma1 receptor in absence of phenytoin to Ki for human sigma 1 receptor in presence of phenytoin;4-(2-((5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yl)oxy)ethyl)morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)OCCN4CCOCC4
2160;325972273;;705720;163328705;56643509;10280;228538010;Literature-derived;20200625;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity to Sigma1 receptor overexpressed in CHO cells after 120 mins by gamma counting relative to control;Unii-E72kvv51KN;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;197.0;;;;C1CCCN(CC1)CCN2C3=C(C=C(C=C3)CCC[18F])SC2=O
2161;325972448;;705716;164133399;71717297;10280;228538010;Literature-derived;20200625;0;0;Active;Q99720;;;ChEMBL;Binding affinity to Sigma1 receptor overexpressed in CHO cells after 30 to 120 mins by liquid scintillation counting;[3H]pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;197.0;;;;[3H]C1=CC2=C(C(=C1O)[3H])[C@]3(CCN([C@@H](C2)[C@H]3C)CC=C(C)C)C
2162;325972724;;705715;163328705;56643509;10280;228538010;Literature-derived;20200625;0;0;Active;Q99720;;;ChEMBL;Binding affinity to Sigma1 receptor overexpressed in CHO cells after 30 to 120 mins by gamma counting;Unii-E72kvv51KN;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;197.0;;;;C1CCCN(CC1)CCN2C3=C(C=C(C=C3)CCC[18F])SC2=O
2163;333999623;;738300;164147094;71720194;10280;234150620;Literature-derived;20200626;0;0;Inactive;Q99720;;;ChEMBL;Activity at human sigma 1 receptor transfected in human MCF7 cells assessed as Ca2+ mobilization by fluorescence analysis;"(2S,6R)-1-[3-(6-methoxynaphthalen-1-yl)propyl]-2,6-dimethylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;C[C@@H]1CCC[C@@H](N1CCCC2=CC=CC3=C2C=CC(=C3)OC)C.Cl
2164;333999624;;738300;164133122;71717158;10280;234150620;Literature-derived;20200626;0;0;Inactive;Q99720;;;ChEMBL;Activity at human sigma 1 receptor transfected in human MCF7 cells assessed as Ca2+ mobilization by fluorescence analysis;"(2S,6R)-1-[4-(6-methoxynaphthalen-1-yl)butyl]-2,6-dimethylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;C[C@@H]1CCC[C@@H](N1CCCCC2=CC=CC3=C2C=CC(=C3)OC)C.Cl
2165;333999625;;738300;164130275;71583637;10280;234150620;Literature-derived;20200626;0;0;Inactive;Q99720;;;ChEMBL;Activity at human sigma 1 receptor transfected in human MCF7 cells assessed as Ca2+ mobilization by fluorescence analysis;(2S,6R)-1-[4-(6-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)butyl]-2,6-dimethylpiperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;C[C@@H]1CCC[C@@H](N1CCCCC2CCCC3=C2C=CC(=C3)OC)C
2166;333999626;;738300;164133123;71717159;10280;234150620;Literature-derived;20200626;0;0;Inactive;Q99720;;;ChEMBL;Activity at human sigma 1 receptor transfected in human MCF7 cells assessed as Ca2+ mobilization by fluorescence analysis;"(2R,6S)-1-[3-(6-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-2,6-dimethylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;C[C@@H]1CCC[C@@H](N1CCCC2CCCC3=C2C=CC(=C3)OC)C.Cl
2167;333999656;;738041;164147094;71720194;10280;234150620;Literature-derived;20200626;0;0;Inactive;Q99720;;;ChEMBL;Agonist activity at human sigma 1 receptor transfected in human MCF7 cells assessed as increase in bradykinin-triggered Ca2+ response at 1 uM pretreated for 10 mins measured every 5 secs by fluorescence analysis in presence of 1 uM sigma 1 receptor antago;"(2S,6R)-1-[3-(6-methoxynaphthalen-1-yl)propyl]-2,6-dimethylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;C[C@@H]1CCC[C@@H](N1CCCC2=CC=CC3=C2C=CC(=C3)OC)C.Cl
2168;334000565;;738045;164133122;71717158;10280;234150620;Literature-derived;20200626;0;0;Active;Q99720;;;ChEMBL;Agonist activity at human sigma 1 receptor transfected in human MCF7 cells assessed as increase in bradykinin-triggered Ca2+ response at 1 uM pretreated for 10 mins measured every 5 secs by fluorescence analysis;"(2S,6R)-1-[4-(6-methoxynaphthalen-1-yl)butyl]-2,6-dimethylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;C[C@@H]1CCC[C@@H](N1CCCCC2=CC=CC3=C2C=CC(=C3)OC)C.Cl
2169;334000566;;738045;164147094;71720194;10280;234150620;Literature-derived;20200626;0;0;Active;Q99720;;;ChEMBL;Agonist activity at human sigma 1 receptor transfected in human MCF7 cells assessed as increase in bradykinin-triggered Ca2+ response at 1 uM pretreated for 10 mins measured every 5 secs by fluorescence analysis;"(2S,6R)-1-[3-(6-methoxynaphthalen-1-yl)propyl]-2,6-dimethylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;C[C@@H]1CCC[C@@H](N1CCCC2=CC=CC3=C2C=CC(=C3)OC)C.Cl
2170;334000567;;738045;164133123;71717159;10280;234150620;Literature-derived;20200626;0;0;Active;Q99720;;;ChEMBL;Agonist activity at human sigma 1 receptor transfected in human MCF7 cells assessed as increase in bradykinin-triggered Ca2+ response at 1 uM pretreated for 10 mins measured every 5 secs by fluorescence analysis;"(2R,6S)-1-[3-(6-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-2,6-dimethylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;C[C@@H]1CCC[C@@H](N1CCCC2CCCC3=C2C=CC(=C3)OC)C.Cl
2171;334008731;;729609;164138116;71658646;10280;232686940;Literature-derived;20220318;0;0;Inactive;Q99720;;;ChEMBL;Displacement of [3H]pentazocine from sigma1 receptor (unknown origin) at 10 uM;Maristachone A;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=C(C(=C1OC)COC)C(C)O)O
2172;334010759;;738042;164130275;71583637;10280;234150620;Literature-derived;20220318;0;0;Inactive;Q99720;;;ChEMBL;Antagonist activity at human sigma 1 receptor transfected in human MCF7 cells assessed as decrease in bradykinin-triggered Ca2+ response at 1 uM pretreated for 10 mins measured every 5 secs by fluorescence analysis in presence of 1 uM sigma 1 receptor ago;(2S,6R)-1-[4-(6-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)butyl]-2,6-dimethylpiperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;C[C@@H]1CCC[C@@H](N1CCCCC2CCCC3=C2C=CC(=C3)OC)C
2173;334010760;;738044;164130275;71583637;10280;234150620;Literature-derived;20220318;0;0;Active;Q99720;;;ChEMBL;Antagonist activity at human sigma 1 receptor transfected in human MCF7 cells assessed as decrease in bradykinin-triggered Ca2+ response at 1 uM pretreated for 10 mins measured every 5 secs by fluorescence analysis;(2S,6R)-1-[4-(6-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)butyl]-2,6-dimethylpiperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;C[C@@H]1CCC[C@@H](N1CCCCC2CCCC3=C2C=CC(=C3)OC)C
2174;339863662;;752373;174496375;52912210;10280;235824490;Literature-derived;20180927;0;0;Unspecified;Q99720;;;ChEMBL;Modulation of sigma 1 receptor (unknown origin) by radioligand displacement assay relative to control;2-[(2S,3R)-2-methyl-5-oxo-3-phenylpyrrolidin-1-yl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1[C@H](CC(=O)N1CC(=O)N)C2=CC=CC=C2
2175;339863707;;751711;103167216;3559;10280;234030820;Literature-derived;20180927;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]Haloperidol from sigma 1 receptor in human jurkat cells at 10 uM after 4 hrs relative to control;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2176;339863719;;752346;174496375;52912210;10280;235824490;Literature-derived;20180927;0;0;Inactive;Q99720;;;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) at 10 uM by radioligand displacement assay;2-[(2S,3R)-2-methyl-5-oxo-3-phenylpyrrolidin-1-yl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1[C@H](CC(=O)N1CC(=O)N)C2=CC=CC=C2
2177;339863729;;752343;174496375;52912210;10280;235824490;Literature-derived;20180927;0;0;Unspecified;Q99720;;;ChEMBL;Increase in [3H]1,3-di(2-tolyl)guanidine binding to sigma 1 receptor in human Jurkat cells relative to control;2-[(2S,3R)-2-methyl-5-oxo-3-phenylpyrrolidin-1-yl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1[C@H](CC(=O)N1CC(=O)N)C2=CC=CC=C2
2178;339864064;;752664;174484676;46926514;10280;236424790;Literature-derived;20180927;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of human sigma 1 receptor at 10 uM relative to control;5-(benzo[d][1,3]dioxol-5-yl)-N-(3,5-dichlorobenzyl)pyrimidin-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1OC2=C(O1)C=C(C=C2)C3=CN=CN=C3NCC4=CC(=CC(=C4)Cl)Cl
2179;339867850;;754630;174491735;71746034;10280;236273110;Literature-derived;20180927;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma1 receptor (unknown origin) at 5 uM by psychoactive drug screening programme assay;(3-bromophenyl)-[1-[(4-methoxyphenoxy)methyl]-6-phenylmethoxy-3,4-dihydro-1H-isoquinolin-2-yl]methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)OCC2C3=C(CCN2C(=O)C4=CC(=CC=C4)Br)C=C(C=C3)OCC5=CC=CC=C5
2180;339871118;;756293;174512354;71680760;10280;237270460;Literature-derived;20180927;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) at 10 uM by radioligand binding assay;2-Pyridinecarbonitrile, 3-[(3R)-3-methyl-4-(tricyclo[3.3.1.13,7]dec-1-ylcarbonyl)-1-piperazinyl]-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(CCN1C(=O)C23CC4CC(C2)CC(C4)C3)C5=C(N=CC=C5)C#N
2181;339886232;;767423;174508400;72163432;10280;239327920;Literature-derived;20180927;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity to human sigma1 receptor by radioligand binding assay;[(3aR,6aS)-2-pyridin-2-yl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl]-(1-adamantyl)methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@@H]2CN(C[C@@H]2CN1C3=CC=CC=N3)C(=O)C45CC6CC(C4)CC(C6)C5
2182;339909909;;779835;174509591;50990953;10280;240748430;Literature-derived;20180928;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-Haloperidol from sigma1 receptor in human Jurkat cells at 10 uM relative to control;3-Fluoro-N-(4-methyl-2-thiazolyl)-5-(5-pyrimidinyloxy)benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CSC(=N1)NC(=O)C2=CC(=CC(=C2)F)OC3=CN=CN=C3
2183;339910214;;780172;174509730;25265516;10280;240761720;Literature-derived;20180928;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma 1 receptor (unknown origin) at 10 uM;N-[2-methyl-4-[(3S)-3-[(2S)-2-methylpyrrolidin-1-yl]pyrrolidin-1-yl]phenyl]oxane-4-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1CCCN1[C@H]2CCN(C2)C3=CC(=C(C=C3)NC(=O)C4CCOCC4)C
2184;339910672;;780758;174489341;71061756;10280;241000770;Confirmatory;20180928;0;0;Unspecified;Q99720;Inhibition;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) by radioligand binding assay;3-[2-[4-[2-(4-methoxyphenyl)phenyl]piperazin-1-yl]ethoxy]-N-(pyridin-2-ylmethyl)propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)C2=CC=CC=C2N3CCN(CC3)CCOCCC(=O)NCC4=CC=CC=N4
2185;339910674;;780758;174504765;71062123;10280;241000770;Confirmatory;20180928;0;0;Inconclusive;Q99720;Inhibition;;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) by radioligand binding assay;4-[2-(4-Methoxyphenyl) phenyl]-N-(3-pyridinylmethyl)-1-piperazinehexanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)C2=CC=CC=C2N3CCN(CC3)CCCCCC(=O)NCC4=CN=CC=C4
2186;339910675;;780758;174489340;71061887;10280;241000770;Confirmatory;20180928;0;0;Unspecified;Q99720;Inhibition;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) by radioligand binding assay;4-[2-(4-Methoxyphenyl)phenyl]-N-(4-pyridinylmethyl)-1-piperazinehexanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)C2=CC=CC=C2N3CCN(CC3)CCCCCC(=O)NCC4=CC=NC=C4
2187;339910994;;780758;103605292;25107716;10280;241000770;Confirmatory;20180928;0;0;Unspecified;Q99720;Inhibition;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) by radioligand binding assay;N-[(4-cyanophenyl)methyl]-6-[4-(2-phenylphenyl)piperazin-1-yl]hexanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCCCC(=O)NCC2=CC=C(C=C2)C#N)C3=CC=CC=C3C4=CC=CC=C4
2188;339910996;;780758;174489342;71061659;10280;241000770;Confirmatory;20180928;0;0;Unspecified;Q99720;Inhibition;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) by radioligand binding assay;3-[2-[4-[2-(4-methoxyphenyl)phenyl]piperazin-1-yl]ethoxy]-N-(pyridin-3-ylmethyl)propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)C2=CC=CC=C2N3CCN(CC3)CCOCCC(=O)NCC4=CN=CC=C4
2189;339910998;;780758;174504766;71061607;10280;241000770;Confirmatory;20180928;0;0;Unspecified;Q99720;Inhibition;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) by radioligand binding assay;3-[2-[4-[2-(4-methoxyphenyl)phenyl]piperazin-1-yl]ethoxy]-N-(pyridin-4-ylmethyl)propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)C2=CC=CC=C2N3CCN(CC3)CCOCCC(=O)NCC4=CC=NC=C4
2190;339911000;;780758;174499532;71062035;10280;241000770;Confirmatory;20180928;0;0;Inconclusive;Q99720;Inhibition;;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) by radioligand binding assay;4-[2-(4-Methoxyphenyl)phenyl]-N-(2-pyridinylmethyl)-1-piperazinehexanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)C2=CC=CC=C2N3CCN(CC3)CCCCCC(=O)NCC4=CC=CC=N4
2191;339967526;;772286;174498737;53245590;10280;246110850;Literature-derived;20200629;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin) at 10 uM relative to control;2-Cyclopropyl-6,7-dimethoxy-4-(4-(2-methoxyphenyl)piperazin-1-yl)quinazoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1N2CCN(CC2)C3=NC(=NC4=CC(=C(C=C43)OC)OC)C5CC5
2192;339993782;;779384;174525368;72793912;10280;240507900;Literature-derived;20220318;0;0;Inactive;Q99720;;;ChEMBL;Binding affinity to human sigma1 receptor at 10 uM by radioligand binding assay;N-Methyl-N-[p-(trifluoromethyl)phenyl]-5-(3-pyridyl)-2-oxo-2,3-dihydrobenzoxazole-3-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C1=CC=C(C=C1)C(F)(F)F)C(=O)CN2C3=C(C=CC(=C3)C4=CN=CC=C4)OC2=O
2193;340959006;;1054491;194151918;25265089;10280;241395840;Literature-derived;20180928;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma-1 receptor (unknown origin) at 10 uM relative to control;3,5-dimethyl-N-[2-methyl-4-[(3S)-3-[(2S)-2-methylpyrrolidin-1-yl]pyrrolidin-1-yl]phenyl]-1,2-oxazole-4-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1CCCN1[C@H]2CCN(C2)C3=CC(=C(C=C3)NC(=O)C4=C(ON=C4C)C)C
2194;340964431;;1058978;194166328;72736159;10280;242389030;Literature-derived;20180928;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma-1 receptor (unknown origin) at 10 uM relative to control;"[4-[[2-(Trifluoromethoxy)phenyl]methoxy]phenyl]methanamine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C(=C1)COC2=CC=C(C=C2)CN)OC(F)(F)F.Cl
2195;340964432;;1058978;194186818;72736163;10280;242389030;Literature-derived;20180928;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma-1 receptor (unknown origin) at 10 uM relative to control;"[4-[[4-(Trifluoromethoxy)phenyl]methoxy]phenyl]methanamine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC(=CC=C1CN)OCC2=CC=C(C=C2)OC(F)(F)F.Cl
2196;340965349;;1058978;194152382;76317228;10280;242389030;Literature-derived;20180928;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma-1 receptor (unknown origin) at 10 uM relative to control;"[4-[(3-Chlorophenyl)methoxy]phenyl]methanamine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC(=CC(=C1)Cl)COC2=CC=C(C=C2)CN.Cl
2197;340965350;;1058978;194173164;23372523;10280;242389030;Literature-derived;20180928;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma-1 receptor (unknown origin) at 10 uM relative to control;[4-(Benzyloxy)phenyl]methanamine hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)COC2=CC=C(C=C2)CN.Cl
2198;340965351;;1058978;194159323;76320939;10280;242389030;Literature-derived;20180928;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma-1 receptor (unknown origin) at 10 uM relative to control;"[4-[(4-Chlorophenyl)methoxy]phenyl]methanamine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC(=CC=C1CN)OCC2=CC=C(C=C2)Cl.Cl
2199;340965352;;1058978;194159324;47003377;10280;242389030;Literature-derived;20180928;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma-1 receptor (unknown origin) at 10 uM relative to control;{4-[(3-Fluorophenyl)methoxy]phenyl}methanamine hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC(=CC(=C1)F)COC2=CC=C(C=C2)CN.Cl
2200;340965353;;1058978;194173165;75414421;10280;242389030;Literature-derived;20180928;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma-1 receptor (unknown origin) at 10 uM relative to control;{4-[(2-Fluorophenyl)methoxy]phenyl}methanamine hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C(=C1)COC2=CC=C(C=C2)CN)F.Cl
2201;340965354;;1058978;194166329;72736161;10280;242389030;Literature-derived;20180928;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma-1 receptor (unknown origin) at 10 uM relative to control;"[4-[[3-(Trifluoromethoxy)phenyl]methoxy]phenyl]methanamine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC(=CC(=C1)OC(F)(F)F)COC2=CC=C(C=C2)CN.Cl
2202;340965355;;1058978;194152381;76317227;10280;242389030;Literature-derived;20180928;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma-1 receptor (unknown origin) at 10 uM relative to control;"[4-[(4-Fluorophenyl)methoxy]phenyl]methanamine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC(=CC=C1CN)OCC2=CC=C(C=C2)F.Cl
2203;342711625;;1129877;242620293;90670089;10280;246178360;Literature-derived;20200619;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human RPMI8226 cell membranes at 10'-5 to 10'-10 mol/L after 120 mins by scintillation counting analysis relative to control;2-[(2S)-4-methyl-1-(naphthalen-1-ylmethyl)piperazin-2-yl]ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;CN1CCN([C@H](C1)CCO)CC2=CC=CC3=CC=CC=C32
2204;342711626;;1129877;242620283;90670088;10280;246178360;Literature-derived;20200619;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human RPMI8226 cell membranes at 10'-5 to 10'-10 mol/L after 120 mins by scintillation counting analysis relative to control;2-[(2S)-1-benzyl-4-methylpiperazin-2-yl]ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;CN1CCN([C@H](C1)CCO)CC2=CC=CC=C2
2205;342711627;;1129877;242620294;90655535;10280;246178360;Literature-derived;20200619;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human RPMI8226 cell membranes at 10'-5 to 10'-10 mol/L after 120 mins by scintillation counting analysis relative to control;2-[(2S)-4-methyl-1-[(4-phenylphenyl)methyl]piperazin-2-yl]ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;CN1CCN([C@H](C1)CCO)CC2=CC=C(C=C2)C3=CC=CC=C3
2206;342811087;;1129882;242620293;90670089;10280;246178360;Confirmatory;20220830;0;0;Inconclusive;Q99720;Ki;;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human RPMI8226 cell membranes after 120 mins by scintillation counting analysis;2-[(2S)-4-methyl-1-(naphthalen-1-ylmethyl)piperazin-2-yl]ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;CN1CCN([C@H](C1)CCO)CC2=CC=CC3=CC=CC=C32
2207;342811243;;1129882;242620283;90670088;10280;246178360;Confirmatory;20220830;0;0;Inconclusive;Q99720;Ki;;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human RPMI8226 cell membranes after 120 mins by scintillation counting analysis;2-[(2S)-1-benzyl-4-methylpiperazin-2-yl]ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;CN1CCN([C@H](C1)CCO)CC2=CC=CC=C2
2208;345243845;;1160791;312356083;71737672;10280;251479290;Literature-derived;20181005;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of radioligand from human sigma-1 receptor at 10 uM;CID 71737672;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CC1=CC=CC=C1C(F)(F)F)C(=O)C2CCN(CC2)S(=O)(=O)C3=CC4=C(C=C3)NN=C4
2209;345263865;;1178505;312347341;118706800;10280;248560640;Literature-derived;20181005;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of human sigma1 receptor at 3 uM by radioligand binding assay;"(E)-but-2-enedioic acid;ethyl 4-[[1-(dimethylcarbamoyl)spiro[2H-pyrrolo[2,3-b]pyridine-3,4'-piperidine]-1'-yl]methyl]piperidine-1-carboxylate";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC(=O)N1CCC(CC1)CN2CCC3(CC2)CN(C4=C3C=CC=N4)C(=O)N(C)C.C(=C/C(=O)O)\C(=O)O
2210;345286763;;1195912;312384124;118730369;10280;254898820;Literature-derived;20181006;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity to human sigma-1 receptor at 10 uM after 90 mins by radioligand displacement assay relative to control;"3-(3-fluorophenyl)-N-[2-(2-imidazol-1-ylpyrimidin-4-yl)ethyl]propan-1-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC(=CC(=C1)F)CCCNCCC2=NC(=NC=C2)N3C=CN=C3.Cl
2211;345476344;;1195797;312384098;118730351;10280;254228610;Literature-derived;20200625;0;0;Active;Q99720;;;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by PDSP screening;(1s,2r,3s,4r,5s)-4-(2-((5-chlorothiophen-2-yl)ethynyl)-6-(methylamino)-9h-purin-9-yl)-2,3-dihydroxy-N-methylbicyclo[3.1.0]hexane-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CNC1=C2C(=NC(=N1)C#CC3=CC=C(S3)Cl)N(C=N2)[C@@H]4[C@H]5C[C@]5([C@H]([C@H]4O)O)C(=O)NC
2212;345507955;;1164460;312358993;72737723;10280;252216670;Literature-derived;20200625;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) at 10 uM by radioligand binding assay;(2R)-4-[(4-chlorophenyl)methyl]-2-(2-phenylethyl)morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CO[C@@H](CN1CC2=CC=C(C=C2)Cl)CCC3=CC=CC=C3
2213;345509660;;1165374;242589776;71301451;10280;252445720;Literature-derived;20200625;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]haloperidol from human sigma1 receptor at 10 uM;(E)-2-((1,4-dimethylpiperazin-2-ylidene)-amino)-5-nitro-n-phenylbenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(C(=NC2=C(C=C(C=C2)[N+](=O)[O-])C(=O)NC3=CC=CC=C3)C1)C
2214;346949136;;1242882;318385131;122186880;10280;262277720;Literature-derived;20200624;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin) at 10 uM;18,19-Dimethoxy-13-methyl-15-phenyl-5,7-dioxa-13-azapentacyclo[10.7.1.02,10.04,8.016,20]icosa-1(20),2,4(8),9,16,18-hexaene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC(C2=CC(=C(C3=C2C1CC4=CC5=C(C=C43)OCO5)OC)OC)C6=CC=CC=C6
2215;353651661;;1276976;103252465;12259685;10280;267172070;Literature-derived;20200623;0;0;Inactive;Q99720;;;ChEMBL;Displacement of 5-(Dimethylamino)-2-(6-((5-(4-(4-methylpiperidin-1-yl)butyl)-5,6,7,8-tetrahydronaphthalen-2-yl)oxy)hexyl)isoindoline-1,3-dione from sigma receptor in human MCF7 cells at 10 uM after 45 and 75 mins by flow cytometry;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
2216;353651668;;1276977;103252465;12259685;10280;267172070;Literature-derived;20200623;0;0;Inactive;Q99720;;;ChEMBL;Displacement of 5-(Dimethylamino)-2-{6-[(5-(4-(4-methylpiperidin-1-yl)butyl)naphthalen-2-yl)oxy]hexyl}isoindole-1,3-dione from sigma receptor in human MCF7 cells at 10 uM after 45 and 75 mins by flow cytometry;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
2217;353651669;;1276977;174514682;73354071;10280;267172070;Literature-derived;20200623;0;0;Inactive;Q99720;;;ChEMBL;Displacement of 5-(Dimethylamino)-2-{6-[(5-(4-(4-methylpiperidin-1-yl)butyl)naphthalen-2-yl)oxy]hexyl}isoindole-1,3-dione from sigma receptor in human MCF7 cells at 10 uM after 45 and 75 mins by flow cytometry;2-[3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)propyl]-5-methoxy-3,4-dihydroisoquinolin-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;COC1=CC=CC2=C1CCN(C2=O)CCCN3CCC4=CC(=C(C=C4C3)OC)OC
2218;353651824;;1276978;103252465;12259685;10280;267172070;Literature-derived;20200623;0;0;Active;Q99720;;;ChEMBL;Displacement of 5-(Dimethylamino)-2-(6-((5-(4-(4-methylpiperidin-1-yl)butyl)-5,6,7,8-tetrahydronaphthalen-2-yl)oxy)hexyl)isoindoline-1,3-dione from sigma1 receptor (unknown origin) expressed in human MCF7 cells at 10 uM after 45 and 75 mins by flow cytome;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
2219;353651825;;1276978;174514682;73354071;10280;267172070;Literature-derived;20200623;0;0;Active;Q99720;;;ChEMBL;Displacement of 5-(Dimethylamino)-2-(6-((5-(4-(4-methylpiperidin-1-yl)butyl)-5,6,7,8-tetrahydronaphthalen-2-yl)oxy)hexyl)isoindoline-1,3-dione from sigma1 receptor (unknown origin) expressed in human MCF7 cells at 10 uM after 45 and 75 mins by flow cytome;2-[3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)propyl]-5-methoxy-3,4-dihydroisoquinolin-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;COC1=CC=CC2=C1CCN(C2=O)CCCN3CCC4=CC(=C(C=C4C3)OC)OC
2220;353652081;;1276979;103252465;12259685;10280;267172070;Literature-derived;20200623;0;0;Active;Q99720;;;ChEMBL;Displacement of 5-(Dimethylamino)-2-{6-[(5-(4-(4-methylpiperidin-1-yl)butyl)naphthalen-2-yl)oxy]hexyl}isoindole-1,3-dione from sigma1 receptor (unknown origin) expressed in human MCF7 cells at 10 uM after 45 and 75 mins by flow cytometry;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
2221;353652082;;1276979;174514682;73354071;10280;267172070;Literature-derived;20200623;0;0;Active;Q99720;;;ChEMBL;Displacement of 5-(Dimethylamino)-2-{6-[(5-(4-(4-methylpiperidin-1-yl)butyl)naphthalen-2-yl)oxy]hexyl}isoindole-1,3-dione from sigma1 receptor (unknown origin) expressed in human MCF7 cells at 10 uM after 45 and 75 mins by flow cytometry;2-[3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)propyl]-5-methoxy-3,4-dihydroisoquinolin-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;COC1=CC=CC2=C1CCN(C2=O)CCCN3CCC4=CC(=C(C=C4C3)OC)OC
2222;353652614;;1276976;103252465;12259685;10280;267172070;Literature-derived;20200623;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of 5-(Dimethylamino)-2-(6-((5-(4-(4-methylpiperidin-1-yl)butyl)-5,6,7,8-tetrahydronaphthalen-2-yl)oxy)hexyl)isoindoline-1,3-dione from sigma receptor in human MCF7 cells at 10 uM after 45 and 75 mins by flow cytometry;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
2223;353652615;;1276976;174514682;73354071;10280;267172070;Literature-derived;20200623;0;0;Inactive;Q99720;;;ChEMBL;Displacement of 5-(Dimethylamino)-2-(6-((5-(4-(4-methylpiperidin-1-yl)butyl)-5,6,7,8-tetrahydronaphthalen-2-yl)oxy)hexyl)isoindoline-1,3-dione from sigma receptor in human MCF7 cells at 10 uM after 45 and 75 mins by flow cytometry;2-[3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)propyl]-5-methoxy-3,4-dihydroisoquinolin-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;COC1=CC=CC2=C1CCN(C2=O)CCCN3CCC4=CC(=C(C=C4C3)OC)OC
2224;354638025;;1276981;103252465;12259685;10280;267172070;Confirmatory;20220830;0;0;Unspecified;Q99720;Activity;;ChEMBL;Displacement of 5-(Dimethylamino)-2-(6-((5-(4-(4-methylpiperidin-1-yl)butyl)-5,6,7,8-tetrahydronaphthalen-2-yl)oxy)hexyl)isoindoline-1,3-dione from sigma 1 receptor (unknown origin) expressed in MCF7 after 45 mins by flow cytometry in presence of 2-(3-(6,;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
2225;354638057;;1276982;103472688;11652595;10280;267172070;Confirmatory;20220830;0;0;Unspecified;Q99720;Activity;;ChEMBL;Displacement of 5-(Dimethylamino)-2-{6-[(5-(4-(4-methylpiperidin-1-yl)butyl)naphthalen-2-yl)oxy]hexyl}isoindole-1,3-dione from sigma 1 receptor (unknown origin) expressed in MCF7 cells after 75 mins by flow cytometry;1-(4-(6-Methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)butyl)-4-methylpiperidine hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;CC1CCN(CC1)CCCCC2CCCC3=C2C=CC(=C3)OC
2226;354638059;;1276982;103472696;11558654;10280;267172070;Confirmatory;20220830;0;0;Unspecified;Q99720;Activity;;ChEMBL;Displacement of 5-(Dimethylamino)-2-{6-[(5-(4-(4-methylpiperidin-1-yl)butyl)naphthalen-2-yl)oxy]hexyl}isoindole-1,3-dione from sigma 1 receptor (unknown origin) expressed in MCF7 cells after 75 mins by flow cytometry;1-(4-(6-Methoxynaphthalen-1-yl)butyl)-4-methylpiperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;CC1CCN(CC1)CCCCC2=CC=CC3=C2C=CC(=C3)OC
2227;354638180;;1276980;103472696;11558654;10280;267172070;Confirmatory;20220830;0;0;Unspecified;Q99720;Activity;;ChEMBL;Displacement of 5-(Dimethylamino)-2-(6-((5-(4-(4-methylpiperidin-1-yl)butyl)-5,6,7,8-tetrahydronaphthalen-2-yl)oxy)hexyl)isoindoline-1,3-dione from sigma 1 receptor (unknown origin) expressed in MCF7 after 75 mins by flow cytometry;1-(4-(6-Methoxynaphthalen-1-yl)butyl)-4-methylpiperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;CC1CCN(CC1)CCCCC2=CC=CC3=C2C=CC(=C3)OC
2228;354638182;;1276980;103472688;11652595;10280;267172070;Confirmatory;20220830;0;0;Unspecified;Q99720;Activity;;ChEMBL;Displacement of 5-(Dimethylamino)-2-(6-((5-(4-(4-methylpiperidin-1-yl)butyl)-5,6,7,8-tetrahydronaphthalen-2-yl)oxy)hexyl)isoindoline-1,3-dione from sigma 1 receptor (unknown origin) expressed in MCF7 after 75 mins by flow cytometry;1-(4-(6-Methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)butyl)-4-methylpiperidine hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;CC1CCN(CC1)CCCCC2CCCC3=C2C=CC(=C3)OC
2229;354638247;;1276983;103252465;12259685;10280;267172070;Confirmatory;20220830;0;0;Unspecified;Q99720;Activity;;ChEMBL;Displacement of 5-(Dimethylamino)-2-{6-[(5-(4-(4-methylpiperidin-1-yl)butyl)naphthalen-2-yl)oxy]hexyl}isoindole-1,3-dione from sigma 1 receptor (unknown origin) expressed in MCF7 cells after 45 mins by flow cytometry in presence of 2-(3-(6,7-dimethoxy-3,4;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
2230;355532694;;1308620;336902618;127049361;10280;271565650;Literature-derived;20200624;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H](+)-Pentazocine from sigma 1 receptor in human RPMI8226 cell membranes at 1 uM;(1R,4S,7S)-5-benzyl-2-methyl-2,5-diazabicyclo[2.2.2]octan-7-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;CN1C[C@@H]2C[C@@H]([C@H]1CN2CC3=CC=CC=C3)O
2231;355548465;;1318842;374315104;134144946;10280;273669020;Literature-derived;20200624;0;0;Unspecified;Q99720;;;ChEMBL;Antagonist activity at sigma1 receptor in human SH-SY5Y cells assessed as cytotoxic effect by measuring inhibition of cell viability at 50 uM after 48 hrs by MTT assay relative to NE-100;(4R)-3-[4-[(4-chlorophenyl)methyl-methylamino]butyl]-4-phenyl-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;19.0;;;;CN(CCCCN1[C@@H](COC1=O)C2=CC=CC=C2)CC3=CC=C(C=C3)Cl
2232;355548466;;1318842;374313050;134144380;10280;273669020;Literature-derived;20200624;0;0;Unspecified;Q99720;;;ChEMBL;Antagonist activity at sigma1 receptor in human SH-SY5Y cells assessed as cytotoxic effect by measuring inhibition of cell viability at 50 uM after 48 hrs by MTT assay relative to NE-100;4-[4-[Benzyl(methyl)amino]butyl]-1,4-benzothiazin-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;19.0;;;;CN(CCCCN1C(=O)CSC2=CC=CC=C21)CC3=CC=CC=C3
2233;355548467;;1318842;103167216;3559;10280;273669020;Literature-derived;20200624;0;0;Unspecified;Q99720;;;ChEMBL;Antagonist activity at sigma1 receptor in human SH-SY5Y cells assessed as cytotoxic effect by measuring inhibition of cell viability at 50 uM after 48 hrs by MTT assay relative to NE-100;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;19.0;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2234;355548468;;1318842;374334106;134150200;10280;273669020;Literature-derived;20200624;0;0;Unspecified;Q99720;;;ChEMBL;Antagonist activity at sigma1 receptor in human SH-SY5Y cells assessed as cytotoxic effect by measuring inhibition of cell viability at 50 uM after 48 hrs by MTT assay relative to NE-100;3-[4-[(4-Chlorophenyl)methyl-methylamino]butyl]-4-phenyl-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;19.0;;;;CN(CCCCN1C(COC1=O)C2=CC=CC=C2)CC3=CC=C(C=C3)Cl
2235;355548469;;1318842;374326929;134148211;10280;273669020;Literature-derived;20200624;0;0;Unspecified;Q99720;;;ChEMBL;Antagonist activity at sigma1 receptor in human SH-SY5Y cells assessed as cytotoxic effect by measuring inhibition of cell viability at 50 uM after 48 hrs by MTT assay relative to NE-100;(4S)-3-[4-[(4-chlorophenyl)methyl-methylamino]butyl]-4-phenyl-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;19.0;;;;CN(CCCCN1[C@H](COC1=O)C2=CC=CC=C2)CC3=CC=C(C=C3)Cl
2236;355548470;;1318842;103252465;12259685;10280;273669020;Literature-derived;20200624;0;0;Unspecified;Q99720;;;ChEMBL;Antagonist activity at sigma1 receptor in human SH-SY5Y cells assessed as cytotoxic effect by measuring inhibition of cell viability at 50 uM after 48 hrs by MTT assay relative to NE-100;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;19.0;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
2237;355548471;;1318842;103693262;44249191;10280;273669020;Literature-derived;20200624;0;0;Unspecified;Q99720;;;ChEMBL;Antagonist activity at sigma1 receptor in human SH-SY5Y cells assessed as cytotoxic effect by measuring inhibition of cell viability at 50 uM after 48 hrs by MTT assay relative to NE-100;3-[4-(N-Benzyl-N-methylamino)butyl]benzo[d]oxazol-2(3H)-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;19.0;;;;CN(CCCCN1C2=CC=CC=C2OC1=O)CC3=CC=CC=C3
2238;355548472;;1318842;374342672;134152668;10280;273669020;Literature-derived;20200624;0;0;Unspecified;Q99720;;;ChEMBL;Antagonist activity at sigma1 receptor in human SH-SY5Y cells assessed as cytotoxic effect by measuring inhibition of cell viability at 50 uM after 48 hrs by MTT assay relative to NE-100;3-[4-[Benzyl(methyl)amino]butyl]-5-phenyl-1,3,4-oxadiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;19.0;;;;CN(CCCCN1C(=O)OC(=N1)C2=CC=CC=C2)CC3=CC=CC=C3
2239;355548473;;1318842;103688007;44248805;10280;273669020;Literature-derived;20200624;0;0;Unspecified;Q99720;;;ChEMBL;Antagonist activity at sigma1 receptor in human SH-SY5Y cells assessed as cytotoxic effect by measuring inhibition of cell viability at 50 uM after 48 hrs by MTT assay relative to NE-100;3-[4-[N-(4-Chlorobenzyl)-N-methylamino]butyl]benzo[d]oxazol-2(3H)-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;19.0;;;;CN(CCCCN1C2=CC=CC=C2OC1=O)CC3=CC=C(C=C3)Cl
2240;355637711;;1308619;336904918;127050996;10280;271565650;Confirmatory;20220830;0;0;Inconclusive;Q99720;Ki;;ChEMBL;Displacement of [3H](+)-Pentazocine from sigma 1 receptor in human RPMI8226 cell membranes;(1R,4S,7R)-5-benzyl-2-methyl-2,5-diazabicyclo[2.2.2]octan-7-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;CN1C[C@@H]2C[C@H]([C@H]1CN2CC3=CC=CC=C3)O
2241;363006049;;1367899;404685485;118560618;10280;291167860;Literature-derived;20200618;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of human sigma 1 receptor at 10 uM by radioligand binding assay relative to control;N-(1-((5-Cyanopyridin-2-yl)methyl)-1H-pyrazol-3-yl)-2-(4-(1-(trifluoromethyl)cyclopropyl)phenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC1(C2=CC=C(C=C2)CC(=O)NC3=NN(C=C3)CC4=NC=C(C=C4)C#N)C(F)(F)F
2242;363107637;;1403091;404696002;145979347;10280;292872490;Literature-derived;20200619;0;0;Inactive;Q99720;;;ChEMBL;Binding affinity to sigma1 receptor in human MCF7 cells at 1 nM 10 uM using fluorescent sigma1FC incubated for 75 mins by flow cytometry;3-[(Z)-1,2-dihydroindol-3-ylideneamino]-1,1-dimethylthiourea;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)C(=S)N/N=C/1\CNC2=CC=CC=C12
2243;363107638;;1403091;404715413;145992209;10280;292872490;Literature-derived;20200619;0;0;Inactive;Q99720;;;ChEMBL;Binding affinity to sigma1 receptor in human MCF7 cells at 1 nM 10 uM using fluorescent sigma1FC incubated for 75 mins by flow cytometry;3-[(Z)-[1-[4-(4-cyclohexylpiperazin-1-yl)butyl]-2H-indol-3-ylidene]amino]-1,1-dimethylthiourea;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)C(=S)N/N=C/1\CN(C2=CC=CC=C12)CCCCN3CCN(CC3)C4CCCCC4
2244;363107639;;1403091;404706747;145986644;10280;292872490;Literature-derived;20200619;0;0;Inactive;Q99720;;;ChEMBL;Binding affinity to sigma1 receptor in human MCF7 cells at 1 nM 10 uM using fluorescent sigma1FC incubated for 75 mins by flow cytometry;3-[(Z)-[1-[4-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)butyl]-2H-indol-3-ylidene]amino]-1,1-dimethylthiourea;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)C(=S)N/N=C/1\CN(C2=CC=CC=C12)CCCCN3CCC4=CC(=C(C=C4C3)OC)OC
2245;363134496;;1417076;404710804;124088406;10280;301446970;Literature-derived;20200619;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-Pentazocine from human sigma1 receptor expressed in HEKT cells at 10 uM after 90 mins by microbeta scintillation counting method;4-[4-(Hydroxymethyl)cycloheptyl]phenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC(CCC(C1)C2=CC=C(C=C2)O)CO
2246;363245045;;1458451;381881807;86294073;10280;287533130;Literature-derived;20200621;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H](+)pentazocine from human sigma1-receptor at 10 uM after 120 mins by scintillation counting;Zuranolone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@]1(CC[C@H]2[C@@H](C1)CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4C(=O)CN5C=C(C=N5)C#N)C)O
2247;363324990;;1492989;404662724;131954513;10280;290570600;Literature-derived;20200623;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H] haloperidol from sigma1 receptor in human Jurkat cells at 10 uM after 4 hrs by scintillation counting method relative to control;3-(2,3-Difluoro-4-methoxyphenyl)-2,5-dimethyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NC2=C(C(=NN2C(=C1)C(F)(F)F)C)C3=C(C(=C(C=C3)OC)F)F
2248;363347978;;1502429;404651665;145949267;10280;289479380;Literature-derived;20200623;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of human sigma 1 receptor at 10 uM relative to control;1-(4-fluorophenyl)-4-[(2S)-2-phenoxypropoxy]pyridin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](COC1=CC(=O)N(C=C1)C2=CC=C(C=C2)F)OC3=CC=CC=C3
2249;363424602;;1370351;374349964;121269371;10280;292759350;Literature-derived;20220318;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H] haloperidol from sigma1 receptor in human Jurkat cells at 10 uM after 4 hrs by scintillation counting method;(E)-6-[2-[[[4-(furan-2-yl)phenyl]carbonyl-methyl-amino]methyl]phenoxy]-4-methyl-hex-4-enoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C/C(=C\COC1=CC=CC=C1CN(C)C(=O)C2=CC=C(C=C2)C3=CC=CO3)/CCC(=O)O
2250;363436037;;1412630;404712919;145990586;10280;301089290;Literature-derived;20220318;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) assessed as inhibition of radioligand binding by radioligand competition binding assay;(6aR,7R)-1,2-dimethoxy-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinolin-7-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C2=C3[C@H]([C@@H](C4=CC=CC=C42)O)NCCC3=C1)OC
2251;364897400;;1512500;440132439;153287537;10280;316202300;Literature-derived;20210302;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells at 10 uM after 90 mins by microbeta scintillation counting method relative to control;1-[(3aS,9bS)-3a-methyl-5-phenyl-1,2,4,9b-tetrahydropyrrolo[2,3-c]quinolin-3-yl]ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)N1CC[C@@H]2[C@]1(CN(C3=CC=CC=C23)C4=CC=CC=C4)C
2252;364897401;;1512500;440146114;153287550;10280;316202300;Literature-derived;20210302;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells at 10 uM after 90 mins by microbeta scintillation counting method relative to control;1-[(3aS,9bS)-7-hydroxy-3a-methyl-1,2,4,9b-tetrahydrochromeno[3,4-b]pyrrol-3-yl]ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)N1CC[C@@H]2[C@]1(COC3=C2C=CC(=C3)O)C
2253;364897402;;1512500;440117345;153287551;10280;316202300;Literature-derived;20210302;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells at 10 uM after 90 mins by microbeta scintillation counting method relative to control;1-[(3aS,9bS)-3a-methyl-6-phenyl-1,2,4,9b-tetrahydrochromeno[3,4-b]pyrrol-3-yl]ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)N1CC[C@@H]2[C@]1(COC3=C(C=CC=C23)C4=CC=CC=C4)C
2254;364897403;;1512500;440171121;147636204;10280;316202300;Literature-derived;20210302;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells at 10 uM after 90 mins by microbeta scintillation counting method relative to control;(3aS,9bS)-3a-methyl-2,3,4,9b-tetrahydro-1H-chromeno[3,4-b]pyrrol-7-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@]12COC3=C([C@@H]1CCN2)C=CC(=C3)O
2255;364897404;;1512500;440215686;147652368;10280;316202300;Literature-derived;20210302;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells at 10 uM after 90 mins by microbeta scintillation counting method relative to control;(3S,4S)-3-amino-4-ethyl-3-methyl-2,4-dihydrochromen-7-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC[C@H]1C2=C(C=C(C=C2)O)OC[C@@]1(C)N
2256;364906760;;1514809;440112865;86302836;10280;304638020;Literature-derived;20210302;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]DTG from human sigma receptor at 10 uM after 120 mins by scintillation counting method relative to control;2-(2-fluorophenyl)-N-hydroxy-2-[4-(2-methylpyrimidin-5-yl)phenyl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NC=C(C=N1)C2=CC=C(C=C2)C(C3=CC=CC=C3F)C(=O)NO
2257;364906762;;1514809;440130958;81689842;10280;304638020;Literature-derived;20210302;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]DTG from human sigma receptor at 10 uM after 120 mins by scintillation counting method relative to control;2-(2-fluorophenyl)-N-hydroxy-2-[4-[5-(trifluoromethyl)pyrimidin-2-yl]phenyl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C(=C1)C(C2=CC=C(C=C2)C3=NC=C(C=N3)C(F)(F)F)C(=O)NO)F
2258;365377934;;1558962;103189261;5284603;10280;317436420;Literature-derived;20210302;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes at 10 uM incubated for 120 mins by liquid scintillation counting method relative to control;Oxycodone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O
2259;365378154;;1558964;440189012;118567678;10280;317436420;Literature-derived;20210302;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes at 1 uM incubated for 120 mins by liquid scintillation counting method relative to control;2-[3-Oxo-4-phenyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-2-yl]acetic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CN(CCC12CN(C(=O)C(O2)CC(=O)O)C3=CC=CC=C3)CCC4=CC=CC=C4
2260;365381784;;1560968;440157246;118107483;10280;320838580;Literature-derived;20210302;0;0;Inactive;Q99720;;;ChEMBL;Activity at human sigma 1 receptor up to 10 uM;Remibrutinib;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=C(C=C1NC(=O)C2=C(C=C(C=C2)C3CC3)F)F)C4=C(C(=NC=N4)N)OCCN(C)C(=O)C=C
2261;365493361;;1607499;103245538;119570;10280;323426850;Literature-derived;20210302;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-pentazocine from sigma1 receptor (unknown origin) at 10 uM after 90 mins by microbeta scintillation counting method relative to control;Pramipexole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN[C@H]1CCC2=C(C1)SC(=N2)N
2262;365493362;;1607499;440152736;27842480;10280;323426850;Literature-derived;20210302;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-pentazocine from sigma1 receptor (unknown origin) at 10 uM after 90 mins by microbeta scintillation counting method relative to control;1H-indol-2-yl-[4-[2-(4-methoxyphenoxy)ethyl]piperazin-1-yl]methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)OCCN2CCN(CC2)C(=O)C3=CC4=CC=CC=C4N3
2263;365493363;;1607499;163332281;53475319;10280;323426850;Literature-derived;20210302;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-pentazocine from sigma1 receptor (unknown origin) at 10 uM after 90 mins by microbeta scintillation counting method relative to control;N-((1R,3R)-3-(2-(((S)-2-amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)(propyl)amino)ethyl)-3-hydroxycyclobutyl)-2-naphthamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN(CCC1(CC(C1)NC(=O)C2=CC3=CC=CC=C3C=C2)O)[C@H]4CCC5=C(C4)SC(=N5)N
2264;365520146;;1621544;164140745;46735335;10280;;Other;20210302;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of human sigma1 receptor at 10 uM relative to control;2-Hydroxy-6-(2-naphthalen-2-yl-ethyl)-benzoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C2C=C(C=CC2=C1)CCC3=C(C(=CC=C3)O)C(=O)O
2265;366234448;;1519581;194137287;6817;10280;317066390;Literature-derived;20220318;0;0;Inactive;Q99720;;;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells incubated for 90 mins by microbeta scintillation counting method;Pyocyanine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=CC=CC=C2N=C3C1=CC=CC3=O
2266;366316130;;1532592;440179890;155549709;10280;304474340;Confirmatory;20220830;0;0;Inconclusive;Q99720;Ki;;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human Jurkat cell membranes after 2 hrs by liquid scintillation counting method;3-(1-benzylpiperidin-4-yl)-1-(7-chloro-4-methoxy-2-trimethylsilyl-1H-indol-5-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C2C=C(NC2=C(C=C1C(=O)CCC3CCN(CC3)CC4=CC=CC=C4)Cl)[Si](C)(C)C
2267;366316131;;1532592;440167296;155544687;10280;304474340;Confirmatory;20220830;0;0;Inconclusive;Q99720;Ki;;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human Jurkat cell membranes after 2 hrs by liquid scintillation counting method;3-(1-butylpiperidin-4-yl)-1-(1H-indol-5-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCN1CCC(CC1)CCC(=O)C2=CC3=C(C=C2)NC=C3
2268;366316132;;1532592;103172342;3152;10280;304474340;Confirmatory;20220830;0;0;Inconclusive;Q99720;Ki;;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human Jurkat cell membranes after 2 hrs by liquid scintillation counting method;Donepezil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC
2269;366316134;;1532592;440200749;155557995;10280;304474340;Confirmatory;20220830;0;0;Inconclusive;Q99720;Ki;;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human Jurkat cell membranes after 2 hrs by liquid scintillation counting method;1-(7-Chloro-4-methoxy-1-methylindol-5-yl)-3-[1-(cyclohexylmethyl)piperidin-4-yl]propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C=CC2=C(C(=CC(=C21)Cl)C(=O)CCC3CCN(CC3)CC4CCCCC4)OC
2270;366316135;;1532592;440205319;155559813;10280;304474340;Confirmatory;20220830;0;0;Inconclusive;Q99720;Ki;;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human Jurkat cell membranes after 2 hrs by liquid scintillation counting method;3-[1-(cyclopentylmethyl)piperidin-4-yl]-1-(1H-indol-5-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCC(C1)CN2CCC(CC2)CCC(=O)C3=CC4=C(C=C3)NC=C4
2271;366316137;;1532592;440218916;155565221;10280;304474340;Confirmatory;20220830;0;0;Inconclusive;Q99720;Ki;;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human Jurkat cell membranes after 2 hrs by liquid scintillation counting method;1-(1-Benzylindol-5-yl)-3-[1-(cyclohexylmethyl)piperidin-4-yl]propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCC(CC1)CN2CCC(CC2)CCC(=O)C3=CC4=C(C=C3)N(C=C4)CC5=CC=CC=C5
2272;366316138;;1532592;103286284;183782;10280;304474340;Confirmatory;20220830;0;0;Inconclusive;Q99720;Ki;;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human Jurkat cell membranes after 2 hrs by liquid scintillation counting method;1-(4-Amino-5-chloro-2-methoxyphenyl)-3-(1-butyl-4-piperidinyl)-1-propanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCN1CCC(CC1)CCC(=O)C2=CC(=C(C=C2OC)N)Cl
2273;366316139;;1532592;440129884;155523661;10280;304474340;Confirmatory;20220830;0;0;Inconclusive;Q99720;Ki;;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human Jurkat cell membranes after 2 hrs by liquid scintillation counting method;3-[1-(cyclohexylmethyl)piperidin-4-yl]-1-(4-methoxy-1H-indol-5-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C(C=CC2=C1C=CN2)C(=O)CCC3CCN(CC3)CC4CCCCC4
2274;366316140;;1532592;440183613;155551190;10280;304474340;Confirmatory;20220830;0;0;Inconclusive;Q99720;Ki;;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human Jurkat cell membranes after 2 hrs by liquid scintillation counting method;1-(1-Benzyl-7-chloro-4-methoxyindol-5-yl)-3-[1-(cyclohexylmethyl)piperidin-4-yl]propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C2C=CN(C2=C(C=C1C(=O)CCC3CCN(CC3)CC4CCCCC4)Cl)CC5=CC=CC=C5
2275;366316142;;1532592;440220401;155565787;10280;304474340;Confirmatory;20220830;0;0;Inconclusive;Q99720;Ki;;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human Jurkat cell membranes after 2 hrs by liquid scintillation counting method;"1-[1-(benzenesulfonyl)-7-chloro-4-methoxyindol-5-yl]-3-[1-(cyclohexylmethyl)piperidin-4-yl]propan-1-one;(E)-but-2-enedioic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C2C=CN(C2=C(C=C1C(=O)CCC3CCN(CC3)CC4CCCCC4)Cl)S(=O)(=O)C5=CC=CC=C5.C(=C/C(=O)O)\C(=O)O
2276;371787126;;1673122;461557059;134263768;10280;311137060;Literature-derived;20220318;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor in human T lymphocyte Jurkat cell membrane assessed as residual binding level for radioligand at 10 uM incubated for 120 mins by liquid scintillation counting method relative to control;CID 134263768;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;CC1=C2C(=C(SC2=NN=C1OC)C(=O)NC3CN(C3)C4=NC=C(C=N4)C(F)(F)F)N
2277;371795933;;1676717;461531283;162654767;10280;329441460;Literature-derived;20220318;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma 1 receptor at 10 uM incubated for 120 mins by scintillation counting analysis relative to control;4-[4-(2-Fluorophenyl)piperazin-1-yl]-8-methoxyquinoline-3-carbonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C(C(=CN=C21)C#N)N3CCN(CC3)C4=CC=CC=C4F
2278;371795934;;1676717;461539738;162660757;10280;329441460;Literature-derived;20220318;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma 1 receptor at 10 uM incubated for 120 mins by scintillation counting analysis relative to control;6-Fluoro-4-[4-(2-fluorophenyl)piperazin-1-yl]-8-(trideuteriomethoxy)quinoline-3-carbonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;[2H]C([2H])([2H])OC1=CC(=CC2=C(C(=CN=C12)C#N)N3CCN(CC3)C4=CC=CC=C4F)F
2279;371809939;;1681767;103189261;5284603;10280;330649470;Literature-derived;20220318;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes at 10 uM incubated for 120 mins by liquid scintillation counting method;Oxycodone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O
2280;371811349;;1682276;103707730;854019;10280;331200800;Literature-derived;20220318;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma 1 receptor (unknown origin) at 10 uM relative to control;Cotinine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1[C@@H](CCC1=O)C2=CN=CC=C2
2281;371841015;;1692641;103460177;644019;10280;328045020;Literature-derived;20220318;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma 1 receptor (unknown origin) at 10 uM relative to control;Cannabidiol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCCC1=CC(=C(C(=C1)O)[C@@H]2C=C(CC[C@H]2C(=C)C)C)O
2282;371845713;;1694608;461560844;162675553;10280;337380650;Literature-derived;20220318;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma1 receptor at 10 uM incubated for 120 mins by radiometric scintillation counting analysis;N-((R)-1-((S)-2-Methylpyrrolidin-1-yl)propan-2-yl)-4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1CCCN1C[C@@H](C)NC(=O)C2=CC=C(C=C2)C3=NOC(=N3)C(F)(F)F
2283;371953481;;1701213;461517944;121418768;10280;332377850;Literature-derived;20220318;0;0;Unspecified;Q99720;;;ChEMBL;Antagonist activity at human sigma1 receptor expressed in HEK293 cell membranes assessed as ratio of Ki without phenytoin/Ki with phenytoin by [3H]-(+)-pentazocine displacement assay;EST64454 (hydrochloride);SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)N1CCN(CC1)CCOCC2=NN(C=C2)C3=CC(=C(C=C3)F)F.Cl
2284;371959289;;1703697;461556274;72550767;10280;326981100;Literature-derived;20220318;0;0;Inactive;Q99720;;;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) 10 umol/L by radioligand binding assay;(1S,2S,3S,5R,6S)-2-amino-3-fluoro-6-[(1S)-1-[(1R,2S,5R)-5-methyl-2-propan-2-ylcyclohexyl]oxycarbonyloxyethoxy]carbonylbicyclo[3.1.0]hexane-2-carboxylic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CC[C@H]([C@@H](C1)OC(=O)O[C@@H](C)OC(=O)[C@H]2[C@H]3[C@@H]2[C@@]([C@H](C3)F)(C(=O)O)N)C(C)C
2285;371959290;;1703697;103348150;9815616;10280;326981100;Literature-derived;20220318;0;0;Inactive;Q99720;;;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) 10 umol/L by radioligand binding assay;(1s,2s,3s,5r,6s)-2-Amino-3-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@H]2[C@@H]([C@H]2[C@@]([C@H]1F)(C(=O)O)N)C(=O)O
2286;372015072;;1725045;461547259;162665987;10280;330621630;Literature-derived;20220318;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma1 receptor (unknown origin) relative to control;[3-(3,4-Dichlorophenyl)imidazo[4,5-b]pyridin-2-yl]-(3,3-difluoroazetidin-1-yl)methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C(CN1C(=O)C2=NC3=C(N2C4=CC(=C(C=C4)Cl)Cl)N=CC=C3)(F)F
2287;372074950;;1744235;461557885;154929649;10280;333727820;Literature-derived;20220318;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane at 100 nM incubated for 2 hr by liquid scintillation counting method relative to control;5-[3-Chloro-4-(3,4-dichlorophenyl)phenyl]-1-methyl-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;CN1C(=NC(=N1)CN2CCCC2)C3=CC(=C(C=C3)C4=CC(=C(C=C4)Cl)Cl)Cl
2288;372074951;;1744235;461542100;154929697;10280;333727820;Literature-derived;20220318;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane at 100 nM incubated for 2 hr by liquid scintillation counting method relative to control;1-Methyl-5-(4-methylphenyl)-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;CC1=CC=C(C=C1)C2=NC(=NN2C)CN3CCCC3
2289;372074952;;1744235;461553907;154929738;10280;333727820;Literature-derived;20220318;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane at 100 nM incubated for 2 hr by liquid scintillation counting method relative to control;1-Methyl-5-(3-phenylphenyl)-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;CN1C(=NC(=N1)CN2CCCC2)C3=CC=CC(=C3)C4=CC=CC=C4
2290;372074953;;1744235;461548331;154929623;10280;333727820;Literature-derived;20220318;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane at 100 nM incubated for 2 hr by liquid scintillation counting method relative to control;1-Methyl-5-(4-phenoxyphenyl)-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;CN1C(=NC(=N1)CN2CCCC2)C3=CC=C(C=C3)OC4=CC=CC=C4
2291;372074954;;1744235;461514518;152658541;10280;333727820;Literature-derived;20220318;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane at 100 nM incubated for 2 hr by liquid scintillation counting method relative to control;5-(4-Cyclopropylphenyl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;CN1C(=NC(=N1)CN2CCCC2)C3=CC=C(C=C3)C4CC4
2292;372074955;;1744235;461546621;153610500;10280;333727820;Literature-derived;20220318;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane at 100 nM incubated for 2 hr by liquid scintillation counting method relative to control;5-(2,3-dihydro-1H-inden-5-yl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;CN1C(=NC(=N1)CN2CCCC2)C3=CC4=C(CCC4)C=C3
2293;372074956;;1744235;461543410;162663264;10280;333727820;Literature-derived;20220318;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane at 100 nM incubated for 2 hr by liquid scintillation counting method relative to control;5-(4-Chlorophenyl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;CN1C(=NC(=N1)CN2CCCC2)C3=CC=C(C=C3)Cl
2294;372074957;;1744235;461552545;154929834;10280;333727820;Literature-derived;20220318;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane at 100 nM incubated for 2 hr by liquid scintillation counting method relative to control;1-Methyl-5-(3-phenoxyphenyl)-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;CN1C(=NC(=N1)CN2CCCC2)C3=CC(=CC=C3)OC4=CC=CC=C4
2295;372074958;;1744235;461543540;162663358;10280;333727820;Literature-derived;20220318;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane at 100 nM incubated for 2 hr by liquid scintillation counting method relative to control;5-(3,4-Dimethylphenyl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;CC1=C(C=C(C=C1)C2=NC(=NN2C)CN3CCCC3)C
2296;373797218;;1751702;404719049;86705695;10280;342695760;Literature-derived;20220830;0;0;Inactive;Q99720;;;ChEMBL;Inhibition of sigma 1 receptor (unknown origin) at 0.1 to 1 uM;Pemigatinib;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C2=C3C=C(NC3=NC=C2CN(C1=O)C4=C(C(=CC(=C4F)OC)OC)F)CN5CCOCC5
2297;373867272;;1764012;469803762;164612645;10280;340488820;Literature-derived;20220830;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-Pentazocine from sigma-1 receptor (unknown origin) at 10 uM relative to control;"N,N-diethylethanamine;[[(2R,3S,4R,5R)-3,4-dihydroxy-5-[2-oxo-4-[[4-(pentafluoro-lambda6-sulfanyl)phenyl]methoxyamino]pyrimidin-1-yl]oxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CC)CC.CCN(CC)CC.C1=CC(=CC=C1CONC2=NC(=O)N(C=C2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(CP(=O)(O)O)O)O)O)S(F)(F)(F)(F)F
2298;373882469;;1766519;469798418;147197909;10280;347958700;Literature-derived;20220830;0;0;Active;Q99720;;;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);6-bromo-3-ethyl-2-[(1R)-1-[(3R)-3-methylpiperazin-1-yl]butyl]quinazolin-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC[C@H](C1=NC2=C(C=C(C=C2)Br)C(=O)N1CC)N3CCN[C@@H](C3)C
2299;373882470;;1766519;469817690;147197912;10280;347958700;Literature-derived;20220830;0;0;Active;Q99720;;;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);6-bromo-3-ethyl-2-[(1R)-1-[(3S)-3-methylpiperazin-1-yl]butyl]quinazolin-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC[C@H](C1=NC2=C(C=C(C=C2)Br)C(=O)N1CC)N3CCN[C@H](C3)C
2300;373886119;;1767478;469821321;146296943;10280;341118280;Literature-derived;20220830;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity to human recombinant sigma-1 receptor assessed as displacement of radioligand at 10 uM by displacement binding assay;N-(1-methylindol-5-yl)-2-[4-[(4-methylphenyl)methyl]piperazin-1-yl]-2-oxoacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=C(C=C1)CN2CCN(CC2)C(=O)C(=O)NC3=CC4=C(C=C3)N(C=C4)C
2301;373949236;;1779770;469801699;164606754;10280;344139640;Literature-derived;20220830;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of human sigma1 receptor at 10 uM relative to control;(3aS,6aR)-2-(oxan-4-ylmethyl)-N-[6-(2,3,5-trifluorophenyl)pyridazin-3-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-5-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCC1CN2C[C@H]3CC(C[C@H]3C2)NC4=NN=C(C=C4)C5=C(C(=CC(=C5)F)F)F
2302;373985073;;1788234;318456509;42641861;10280;;Other;20220830;0;0;Inactive;Q99720;;;ChEMBL;sigma CEREP ligand profiling;(1e,3e)-1-(4-Fluorophenyl)-2-methylpent-1-en-3-one oxime;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC/C(=N\O)/C(=C/C1=CC=C(C=C1)F)/C
2303;373985116;;1788385;103333158;9915028;10280;;Other;20220830;0;0;Inactive;Q99720;;;ChEMBL;sigma-Receptor (non-selective) CEREP ligand profiling;A-216546 free base;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCN(CCCC)C(=O)CN1C[C@@H]([C@H]([C@@H]1CC(C)(C)CCC)C(=O)O)C2=CC3=C(C(=C2)OC)OCO3
2304;373985319;;1788309;440224957;6451154;10280;;Other;20220830;0;0;Inactive;Q99720;;;ChEMBL;Sigma (non selective) Ligand binding assay;4-[(2S)-2-(4-cyanophenyl)-2-hydroxy-2-(3-methylimidazol-4-yl)ethoxy]-3-[4-(trifluoromethoxy)phenyl]benzonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C=NC=C1[C@](COC2=C(C=C(C=C2)C#N)C3=CC=C(C=C3)OC(F)(F)F)(C4=CC=C(C=C4)C#N)O
2305;373985321;;1788309;440224957;6451154;10280;;Other;20220830;0;0;Unspecified;Q99720;;;ChEMBL;Sigma (non selective) Ligand binding assay;4-[(2S)-2-(4-cyanophenyl)-2-hydroxy-2-(3-methylimidazol-4-yl)ethoxy]-3-[4-(trifluoromethoxy)phenyl]benzonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C=NC=C1[C@](COC2=C(C=C(C=C2)C#N)C3=CC=C(C=C3)OC(F)(F)F)(C4=CC=C(C=C4)C#N)O
2306;373985541;;1788455;404696611;118958122;10280;;Other;20220830;0;0;Inactive;Q99720;;;ChEMBL;sigma  (non-selective) (h) CEREP ligand profiling;N-(4-Fluorobenzyl)-2-((R)-5-(3-methylureido)-2',4'-dioxo-2,3-dihydrospiro[indene-1,5'-oxazolidin]-3'-yl)-N-((S)-1,1,1-trifluoropropan-2-yl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](C(F)(F)F)N(CC1=CC=C(C=C1)F)C(=O)CN2C(=O)[C@]3(CCC4=C3C=CC(=C4)NC(=O)NC)OC2=O
2307;373985826;;1788659;440177378;137332060;10280;;Other;20220830;0;0;Inactive;Q99720;;;ChEMBL;sigma  (non-selective) (h) CEREP ligand profiling;N-[(4-fluorophenyl)methyl]-2-[(3R)-5-(methylcarbamoylamino)-2',4'-dioxospiro[1,2-dihydroindene-3,5'-1,3-oxazolidine]-3'-yl]-N-[(2S)-1,1,1-trifluoropropan-2-yl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](C(F)(F)F)N(CC1=CC=C(C=C1)F)C(=O)CN2C(=O)[C@]3(CCC4=C3C=C(C=C4)NC(=O)NC)OC2=O
2308;373986060;;1788829;103349868;5310991;10280;;Other;20220830;0;0;Unspecified;Q99720;;;ChEMBL;sigma (non-selective) (h) Eurofins-Cerep binding assay;3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-((2,6-diethylphenyl)amino)-2-oxoethyl)-2-(4-propoxyphenyl)-, (2R,3R,4S)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCOC1=CC=C(C=C1)[C@H]2[C@@H]([C@H](CN2CC(=O)NC3=C(C=CC=C3CC)CC)C4=CC5=C(C=C4)OCO5)C(=O)O
2309;373986061;;1788829;440174202;101933292;10280;;Other;20220830;0;0;Unspecified;Q99720;;;ChEMBL;sigma (non-selective) (h) Eurofins-Cerep binding assay;(2S,3S,4R)-4-(1,3-benzodioxol-5-yl)-1-[2-(2,6-diethylanilino)-2-oxoethyl]-2-(4-propoxyphenyl)pyrrolidine-3-carboxylic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCOC1=CC=C(C=C1)[C@@H]2[C@H]([C@@H](CN2CC(=O)NC3=C(C=CC=C3CC)CC)C4=CC5=C(C=C4)OCO5)C(=O)O
2310;373986366;;1788911;381872584;121301295;10280;;Other;20220830;0;0;Unspecified;Q99720;;;ChEMBL;sigma (non-selective) (h) Eurofins-Cerep binding assay;CFTR corrector 4;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(C=C1)[C@@H](C[C@@H](O2)C3=CC(=C(C=C3)OC)OC)NC(=O)C4(CC4)C5=CC6=C(C=C5)OC(O6)(F)F
2311;373986367;;1788911;381840647;121301422;10280;;Other;20220830;0;0;Unspecified;Q99720;;;ChEMBL;sigma (non-selective) (h) Eurofins-Cerep binding assay;CFTR corrector 8;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(C=C1)[C@H](C[C@H](O2)C3=CC(=C(C=C3)OC)OC)NC(=O)C4(CC4)C5=CC6=C(C=C5)OC(O6)(F)F
2312;373987351;;1790085;312390293;66764813;10280;;Other;20220830;0;0;Inactive;Q99720;;;ChEMBL;SIGMA1/HU Eurofins-Panlabs selectivity data (BI);2-[4-[3-[(1R)-1-[4-(2-aminopyrimidin-5-yl)phenyl]-1-cyclopropylethyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@](C1CC1)(C2=CC=C(C=C2)C3=CN=C(N=C3)N)C4=NOC(=N4)C5=CN(N=C5)CC(=O)N(C)C
2313;373987474;;1790011;312390293;66764813;10280;;Other;20220830;0;0;Inactive;Q99720;;;ChEMBL;SIGMA/NS Cerep selectivity data (BI);2-[4-[3-[(1R)-1-[4-(2-aminopyrimidin-5-yl)phenyl]-1-cyclopropylethyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@](C1CC1)(C2=CC=C(C=C2)C3=CN=C(N=C3)N)C4=NOC(=N4)C5=CN(N=C5)CC(=O)N(C)C
2314;373987858;;1790519;440132255;52916803;10280;;Other;20220830;0;0;Inactive;Q99720;;;ChEMBL;SIGMA1/HU Eurofins-Panlabs selectivity data (BI);CCR1 antagonist 8;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CS(=O)(=O)C1=NC=CC(=C1)C2(CC2)NC(=O)C3=CN=CC4=C3C=NN4C5=CC=C(C=C5)F
2315;373987993;;1790628;134461578;51346964;10280;;Other;20220830;0;0;Inactive;Q99720;;;ChEMBL;SIGMA1/HU Eurofins-Panlabs selectivity data (BI);S2JB42Bbp5;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N[C@H]1CC[C@H](C1)C(=O)N(C)C2=CC=C(C=C2)C3=NC4=CC=CC=C4O3
2316;373988013;;1790448;312372725;44543970;10280;;Other;20220830;0;0;Inactive;Q99720;;;ChEMBL;SIGMA/NS/GP Eurofins-Panlabs selectivity data (BI);Unii-KQ33evh4KU;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCS(=O)(=O)C1=NC=C2C(=C1)C=C(N2)C[C@](CC(C)(C)C3=C(C=C(C=C3)F)C(=O)N)(C(F)(F)F)O
2317;373988237;;1790591;163338225;51031001;10280;;Other;20220830;0;0;Inactive;Q99720;;;ChEMBL;SIGMA1/HU Eurofins-Panlabs selectivity data (BI);4-(1-Acetylpiperidin-4-yl)-N-carbamimidoyl-3-(trifluoromethyl)benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)N1CCC(CC1)C2=C(C=C(C=C2)C(=O)N=C(N)N)C(F)(F)F
2318;373988321;;1790745;440170924;58431184;10280;;Other;20220830;0;0;Inactive;Q99720;;;ChEMBL;SIGMA/NS/GP Eurofins-Panlabs selectivity data (BI);(5R)-5-[(4-cyanophenyl)methyl]-7-(3,5-dichloro-4-fluorophenyl)-5-methyl-6-oxo-N-[(2S)-1-oxo-1-[(1-pyridin-2-ylcyclopropyl)amino]propan-2-yl]imidazo[1,2-a]imidazole-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](C(=O)NC1(CC1)C2=CC=CC=N2)NC(=O)C3=CN=C4N3[C@](C(=O)N4C5=CC(=C(C(=C5)Cl)F)Cl)(C)CC6=CC=C(C=C6)C#N
2319;373989607;;1791444;242645573;25114442;10280;;Other;20220830;0;0;Inactive;Q99720;;;ChEMBL;sigma (non-selective) CEREP ligand profiling;PF-04418948;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(C=C1)C=C(C=C2)OCC3(CN(C3)C(=O)C4=CC=C(C=C4)F)C(=O)O
2320;373990320;;1792119;312361547;46836243;10280;;Other;20220830;0;0;Unspecified;Q99720;;;ChEMBL;sigma (non-selective) (h) Eurofins-Cerep binding assay;CID 46836243;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CC2=C1C=CC=C2C(=O)NC3=NC4=CC=CC=C4S3)C5=NC(=C(S5)CCOC6=CC=C(C=C6)N7C8=NC=NC=C8C=N7)C(=O)O
2321;373990321;;1792119;312361687;59447577;10280;;Other;20220830;0;0;Unspecified;Q99720;;;ChEMBL;sigma (non-selective) (h) Eurofins-Cerep binding assay;2-[8-(1,3-Benzothiazol-2-Ylcarbamoyl)-3,4-Dihydroisoquinolin-2(1h)-Yl]-5-(3-{4-[3-(Dimethylamino)prop-1-Yn-1-Yl]-2-Fluorophenoxy}propyl)-1,3-Thiazole-4-Carboxylic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CC#CC1=CC(=C(C=C1)OCCCC2=C(N=C(S2)N3CCC4=C(C3)C(=CC=C4)C(=O)NC5=NC6=CC=CC=C6S5)C(=O)O)F
2322;373990393;;1792038;440193399;155555047;10280;;Other;20220830;0;0;Unspecified;Q99720;;;ChEMBL;sigma (non-selective) (h) Eurofins-Cerep binding assay;4-[4-[[2-(4-Chlorophenyl)-4-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]-N-[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCC1CNC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=C(C=C(C=C3)N4CCN(CC4)CC5=C(C=C(C=C5)C(F)(F)F)C6=CC=C(C=C6)Cl)OC7=CN=C8C(=C7)C=CN8)[N+](=O)[O-]
2323;373990394;;1792038;404679711;49846946;10280;;Other;20220830;0;0;Unspecified;Q99720;;;ChEMBL;sigma (non-selective) (h) Eurofins-Cerep binding assay;Bcl2-IN-1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCC(CC6)OC)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C
2324;374042712;;1794511;442046238;154701640;10280;;Other;20220830;0;0;Inactive;Q99720;;;ChEMBL;Sigma 1 Eurofins-Panlabs radioligand binding assay;[(3S,5S)-3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-5-[4-(trifluoromethoxy)phenyl]piperidin-1-yl]-(1,1-dioxo-1,4-thiazinan-4-yl)methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC1C2=NOC(=N2)[C@H]3C[C@H](CN(C3)C(=O)N4CCS(=O)(=O)CC4)C5=CC=C(C=C5)OC(F)(F)F
2325;374042713;;1794511;440230063;24959105;10280;;Other;20220830;0;0;Inactive;Q99720;;;ChEMBL;Sigma 1 Eurofins-Panlabs radioligand binding assay;2,6-Dimethyl-4-(3-methyl-1H-indazol-5-yl)-1,4-dihydropyridine-3,5-dicarbonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C2C=C(C=CC2=NN1)C3C(=C(NC(=C3C#N)C)C)C#N
2326;374042714;;1794511;440162092;124125214;10280;;Other;20220830;0;0;Inactive;Q99720;;;ChEMBL;Sigma 1 Eurofins-Panlabs radioligand binding assay;N-[4-(3-chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)CC(=O)NC2=CC(=C(C=C2)OC3=CC(=CC=C3)Cl)S(=O)(=O)N
2327;374042715;;1794511;440217121;118425786;10280;;Other;20220830;0;0;Inactive;Q99720;;;ChEMBL;Sigma 1 Eurofins-Panlabs radioligand binding assay;(1S,2S,5R)-2-[4-[2-(oxan-4-yl)ethoxy]benzoyl]-5-[(4-oxo-1,2,3-benzotriazin-3-yl)methyl]cyclopentane-1-carboxylic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C[C@@H]([C@H]([C@@H]1CN2C(=O)C3=CC=CC=C3N=N2)C(=O)O)C(=O)C4=CC=C(C=C4)OCCC5CCOCC5
2328;374042716;;1794511;440175888;85469632;10280;;Other;20220830;0;0;Inactive;Q99720;;;ChEMBL;Sigma 1 Eurofins-Panlabs radioligand binding assay;Unii-66vrx9TN9T;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC1[C@H]2C3(CCS(=O)(=O)CC3)C4=C(N2S(=O)(=O)C5=CC=C(C=C5)F)C=CC(=C4)C(=O)NCC6=C(C=C(C=N6)C(F)(F)F)Cl
2329;374043700;;1794709;381855577;135308996;10280;;Other;20220830;0;0;Inactive;Q99720;;;ChEMBL;Sigma 1 Eurofins-Panlabs radioligand binding assay;(3S)-3-(2-benzyl-7-oxo-4,5-dihydropyrazolo[3,4-c]pyridin-6-yl)-5-methyl-2,3-dihydro-1,5-benzoxazepin-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=CC=CC=C2OC[C@@H](C1=O)N3CCC4=CN(N=C4C3=O)CC5=CC=CC=C5
2330;374043701;;1794709;440164301;135309104;10280;;Other;20220830;0;0;Inactive;Q99720;;;ChEMBL;Sigma 1 Eurofins-Panlabs radioligand binding assay;(3S)-3-(2-benzyl-3-bromo-7-oxo-4,5-dihydropyrazolo[3,4-c]pyridin-6-yl)-5-methyl-2,3-dihydro-1,5-benzoxazepin-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=CC=CC=C2OC[C@@H](C1=O)N3CCC4=C(N(N=C4C3=O)CC5=CC=CC=C5)Br
2331;374043702;;1794709;381887463;135308922;10280;;Other;20220830;0;0;Inactive;Q99720;;;ChEMBL;Sigma 1 Eurofins-Panlabs radioligand binding assay;(3S)-3-[2-[(1,1-dioxothian-4-yl)methyl]-7-oxo-4,5-dihydropyrazolo[3,4-c]pyridin-6-yl]-5-methyl-2,3-dihydro-1,5-benzoxazepin-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=CC=CC=C2OC[C@@H](C1=O)N3CCC4=CN(N=C4C3=O)CC5CCS(=O)(=O)CC5
2332;380499474;;1834682;475980076;71738995;10280;;Other;20230314;0;0;Inactive;Q99720;;;ChEMBL;SIGMA1/HU Eurofins SafetyScreen44 (BI);2-((S)-6-((R)-7-Fluoro-4-(4-(3-hydroxy-3-methylbutoxy)-2,6-dimethylphenyl)-2,3-dihydro-1H-inden-1-yloxy)-2,3-dihydrobenzofuran-3-yl)acetic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=CC(=C1C2=C3CC[C@H](C3=C(C=C2)F)OC4=CC5=C(C=C4)[C@@H](CO5)CC(=O)O)C)OCCC(C)(C)O
2333;380512496;;1846433;482057955;168276975;10280;338263220;Literature-derived;20230629;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes at 1 uM measured after 120 mins by liquid scintillation counting analysis relative to control;(2R,6R)-10-(5-fluoropyridin-2-yl)-4-(oxan-4-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCC1N2C[C@@H]3[C@@H](C2)OCC4=C(N=NN34)C5=NC=C(C=C5)F
2334;380512497;;1846433;482072612;168287632;10280;338263220;Literature-derived;20230629;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes at 1 uM measured after 120 mins by liquid scintillation counting analysis relative to control;(2R,6R)-10-(2-fluorophenyl)-4-[(1-methylimidazol-2-yl)methyl]-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C=CN=C1CN2C[C@@H]3[C@@H](C2)OCC4=C(N=NN34)C5=CC=CC=C5F
2335;380512615;;1846432;482079438;168292590;10280;338263220;Literature-derived;20230629;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes at 10 uM measured after 120 mins by liquid scintillation counting analysis relative to control;(2R,6R)-4-[(4-fluorophenyl)methyl]-10-pyrimidin-2-yl-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CC=C(C=C3)F)OCC4=C(N=NN24)C5=NC=CC=N5
2336;380581319;;1861723;123099351;3036289;10280;357249250;Confirmatory;20230629;0;0;Unspecified;Q99720;Ki;;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay;trans-3,4-Dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzeneacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@H]1N2CCCC2)C(=O)CC3=CC(=C(C=C3)Cl)Cl
2337;380581321;;1861723;103186197;7333;10280;357249250;Confirmatory;20230629;0;0;Unspecified;Q99720;Ki;;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
2338;380581327;;1861723;103217856;5462471;10280;357249250;Confirmatory;20230629;0;0;Unspecified;Q99720;Ki;;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay;Damgo;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](C(=O)NCC(=O)N(C)[C@@H](CC1=CC=CC=C1)C(=O)NCCO)NC(=O)[C@H](CC2=CC=C(C=C2)O)N
2339;380581329;;1861723;103697951;5497186;10280;357249250;Confirmatory;20230629;0;0;Unspecified;Q99720;Ki;;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay;Naltrindole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC1CN2CC[C@]34[C@@H]5C6=C(C[C@]3([C@H]2CC7=C4C(=C(C=C7)O)O5)O)C8=CC=CC=C8N6
2340;380581513;;1861763;440110049;155510683;10280;357532630;Literature-derived;20230629;0;0;Active;Q99720;;;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor at 3 uM measured after 120 mins by scintillation counting analysis;1-Benzyl-4-(4-benzyl-1H-1,2,3-triazol-1-yl)piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1N2C=C(N=N2)CC3=CC=CC=C3)CC4=CC=CC=C4
2341;380644763;;1877641;482074287;168288869;10280;348962130;Literature-derived;20230629;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma 1 receptor (unknown origin) at 50 uM by radioligand receptor binding assay relative to control;Propyl 2-[3-ethoxy-4-[2-oxo-2-(4-phenylpiperazin-1-yl)ethoxy]phenyl]acetate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCOC(=O)CC1=CC(=C(C=C1)OCC(=O)N2CCN(CC2)C3=CC=CC=C3)OCC
2342;380656832;;1880166;482081205;168293874;10280;354503690;Literature-derived;20230629;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma 1 receptor (unknown origin);2-(6-fluoro-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)-5-methoxyphenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC(=C(C=C1)C2C3=C(CCN2)C4=C(N3)C=CC(=C4)F)O
2343;380774497;;1907590;482076392;168290376;10280;353974000;Literature-derived;20230629;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of human Sigma 1 receptor at 10 uM relative to control;1-[(3-Chlorophenyl)methyl]-4-(4,4-difluoropiperidin-1-yl)pyrrolo[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(F)F)C2=NC3=CC=CC=C3C4=C2C=CN4CC5=CC(=CC=C5)Cl
2344;380785392;;1910977;482085820;164886639;10280;355941500;Literature-derived;20230629;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of sigma1 receptor (unknown origin) at 10 uM relative to control;N-[4-[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]phenyl]-1-(furan-2-ylmethyl)-5-oxopyrrolidine-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C(CN(C1=O)CC2=CC=CO2)C(=O)NC3=CC=C(C=C3)C4=NC(=NO4)C5=CC=C(C=C5)Cl
2345;380789936;;1912419;440200558;50985821;10280;356966460;Literature-derived;20230629;0;0;Unspecified;Q99720;;;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) at 10000 nM by radioligand displacement assay relative to control;Metarrestin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC(CCC1N2C=NC3=C(C2=N)C(=C(N3CC4=CC=CC=C4)C5=CC=CC=C5)C6=CC=CC=C6)O
2346;407918347;;1925768;494419988;169444309;10280;345698030;Literature-derived;20240503;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of Sigma1 receptor (unknown origin) at 10 uM;[1-(4-Fluorophenyl)indol-5-yl]-[3-(4-pyrimidin-2-ylpiperazin-1-yl)azetidin-1-yl]methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1C2CN(C2)C(=O)C3=CC4=C(C=C3)N(C=C4)C5=CC=C(C=C5)F)C6=NC=CC=N6
2347;407958213;;1936969;494411942;171352798;10280;365282300;Literature-derived;20240503;0;0;Unspecified;Q99720;;;ChEMBL;Inhibition of human sigma-1 receptor at 10 uM relative to control;4-[(4aS)-10-fluoro-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-3-yl]-6-fluoro-8-methoxycinnoline-3-carbonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC(=CC2=C1N=NC(=C2N3CCN4[C@@H](C3)COC5=C4C(=CC=C5)F)C#N)F
2348;407996747;;1946586;482076510;168290461;10280;362831800;Literature-derived;20240503;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane assessed as inhibition constant relative to control;2-[[(3S)-3-[(6-methylpyridin-2-yl)methoxy]piperidin-1-yl]methyl]imidazo[1,2-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NC(=CC=C1)CO[C@H]2CCCN(C2)CC3=CN4C=CC=CC4=N3
2349;407996748;;1946586;482087155;168297304;10280;362831800;Literature-derived;20240503;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane assessed as inhibition constant relative to control;3-[[(3S)-3-[(6-methylpyridin-2-yl)methoxy]piperidin-1-yl]methyl]imidazo[1,5-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NC(=CC=C1)CO[C@H]2CCCN(C2)CC3=NC=C4N3C=CC=C4
2350;407996749;;1946586;494397611;171344175;10280;362831800;Literature-derived;20240503;0;0;Unspecified;Q99720;;;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane assessed as inhibition constant relative to control;(2S)-4-(imidazo[1,2-a]pyridin-2-ylmethyl)-2-[(4-methyl-1,3-thiazol-2-yl)oxymethyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CSC(=N1)OC[C@@H]2CN(CCO2)CC3=CN4C=CC=CC4=N3
2351;408049075;;1959999;103218326;10336644;10280;299084420;Literature-derived;20240503;0;0;Unspecified;Q99720;;;ChEMBL;Agonist activity at sigma1 receptor (unknown origin);(1R,9S,13S)-1,13-dimethyl-10-(2-piperidin-1-ylethyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2CCN4CCCCC4)C)C=C(C=C3)O
2352;408049859;;1959999;103218288;10404406;10280;299084420;Literature-derived;20240503;0;0;Unspecified;Q99720;;;ChEMBL;Agonist activity at sigma1 receptor (unknown origin);(1R,9S,13S)-1,13-dimethyl-10-(2-morpholin-4-ylethyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2CCN4CCOCC4)C)C=C(C=C3)O
2353;409046718;;1794447;163327014;45279963;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Skepinone-L;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2=C(C=CC(=C2)NC3=C(C=C(C=C3)F)F)C(=O)C4=C1C=CC(=C4)OC[C@@H](CO)O
2354;409046719;;1794447;163339280;49821991;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;[2-(6-chloropyridin-3-yl)-4-(2-methoxyethoxy)-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-6-yl]-imidazo[1,5-a]pyridin-1-ylmethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COCCOC1=NC(=NC2=C1CN(CC2)C(=O)C3=C4C=CC=CN4C=N3)C5=CN=C(C=C5)Cl
2355;409046720;;1794447;381887626;137662140;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;5-[4-Methyl-2-[[3-(trifluoromethyl)phenyl]methyl]-1,3-thiazol-5-yl]pyridine-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(SC(=N1)CC2=CC(=CC=C2)C(F)(F)F)C3=CN=C(C=C3)C(=O)N
2356;409046721;;1794447;404679711;49846946;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Bcl2-IN-1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCC(CC6)OC)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C
2357;409047160;;1794447;440159327;11996298;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;N-methyl-N-[2-[[[2-[(2-oxo-1,3-dihydroindol-5-yl)amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]methyl]pyrimidin-4-yl]methanesulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C1=NC(=NC=C1)CNC2=NC(=NC=C2C(F)(F)F)NC3=CC4=C(C=C3)NC(=O)C4)S(=O)(=O)C
2358;409047161;;1794447;440198624;155557179;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;ERKi-NC;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](C1=CC=CC=N1)NC(=O)NC2=NC(=C3C=NNC3=C2)CO
2359;409047162;;1794447;440226684;155568238;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;N-[[4-[[(2S)-4-cyclohexyl-1-[(1-methylsulfonylpiperidin-3-yl)amino]-1-oxobutan-2-yl]carbamoyl]phenyl]methyl]imidazo[1,2-a]pyridine-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CS(=O)(=O)N1CCCC(C1)NC(=O)[C@H](CCC2CCCCC2)NC(=O)C3=CC=C(C=C3)CNC(=O)C4=CN=C5N4C=CC=C5
2360;409047163;;1794447;442061337;146681130;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(3~{R},4~{R})-~{N}-cyclohexyl-4-[[5-(furan-2-yl)-3-methyl-2-oxidanylidene-1~{H}-1,7-naphthyridin-8-yl]amino]-1-methyl-piperidine-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC2=C(C(=NC=C2C3=CC=CO3)N[C@@H]4CCN(C[C@H]4C(=O)NC5CCCCC5)C)NC1=O
2361;409047164;;1794447;461523307;44548528;10280;;Confirmatory;20240503;0;0;Active;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;4-(4-methylpiperazin-1-yl)-N-(2-phenylethyl)pyrimidin-2-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)C2=NC(=NC=C2)NCCC3=CC=CC=C3
2362;409047169;;1794447;475988474;166630510;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;3-[3,5-Difluoro-4-[[3-[5-methoxy-4-(2-methoxyanilino)pyrimidin-2-yl]indazol-1-yl]methyl]phenoxy]propan-1-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1NC2=NC(=NC=C2OC)C3=NN(C4=CC=CC=C43)CC5=C(C=C(C=C5F)OCCCO)F
2363;409047170;;1794447;194175385;25117126;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Defactinib;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CNC(=O)C1=CC=C(C=C1)NC2=NC=C(C(=N2)NCC3=NC=CN=C3N(C)S(=O)(=O)C)C(F)(F)F
2364;409047171;;1794447;381840647;121301422;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;CFTR corrector 8;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(C=C1)[C@H](C[C@H](O2)C3=CC(=C(C=C3)OC)OC)NC(=O)C4(CC4)C5=CC6=C(C=C5)OC(O6)(F)F
2365;409047174;;1794447;404661187;131953432;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;[3,5-bis(trifluoromethyl)phenyl]methyl (1~{S},5~{R})-6-[(1~{H}-benzotriazol-5-ylcarbonylamino)methyl]-3-azabicyclo[3.1.0]hexane-3-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@@H]2[C@@H](C2CNC(=O)C3=CC4=NNN=C4C=C3)CN1C(=O)OCC5=CC(=CC(=C5)C(F)(F)F)C(F)(F)F
2366;409047177;;1794447;440157481;155540682;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;N-[4-(3-chlorophenoxy)-3-sulfamoylphenyl]-1-(2-chlorophenyl)cyclopropane-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC1(C2=CC=CC=C2Cl)C(=O)NC3=CC(=C(C=C3)OC4=CC(=CC=C4)Cl)S(=O)(=O)N
2367;409047178;;1794447;440165585;10278851;10280;;Confirmatory;20240503;0;0;Active;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;4-[(2R)-2-(4-cyanophenyl)-2-hydroxy-2-(3-methylimidazol-4-yl)ethoxy]-3-[4-(trifluoromethoxy)phenyl]benzonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C=NC=C1[C@@](COC2=C(C=C(C=C2)C#N)C3=CC=C(C=C3)OC(F)(F)F)(C4=CC=C(C=C4)C#N)O
2368;409047181;;1794447;440199577;155557564;10280;;Confirmatory;20240503;0;0;Active;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Gsi-NC;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC(=O)N1CCCC1CNC2CCC(CC2)(C3=C(C=CC(=C3)F)F)S(=O)(=O)C4=CC=C(C=C4)Cl
2369;409047184;;1794447;440202169;56849304;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;2-[4-[3-[1-[4-(2-aminopyrimidin-5-yl)phenyl]cyclopropyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)C(=O)CN1C=C(C=N1)C2=NC(=NO2)C3(CC3)C4=CC=C(C=C4)C5=CN=C(N=C5)N
2370;409047185;;1794447;461563593;151094027;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;5-[2-[2-[[4-(Dimethylamino)quinolin-8-yl]sulfonylamino]phenyl]ethynyl]-4-methoxypyridine-2-carboxylic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)C1=C2C=CC=C(C2=NC=C1)S(=O)(=O)NC3=CC=CC=C3C#CC4=CN=C(C=C4OC)C(=O)O
2371;409047186;;1794447;134451810;42611190;10280;;Confirmatory;20240503;0;0;Active;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;4-((Piperindin-4-yl)-phenyl)-(7-(4-(trifluoromethyl)-phenyl)-2-naphthoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CNCCC1C2=CC=C(C=C2)C3=C4C=CC(=CC4=CC(=C3)C(=O)O)C5=CC=C(C=C5)C(F)(F)F
2372;409047496;;1794447;242510763;11524200;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;6-Chloro-N4-[3,5-difluoro-4-[(3-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy]phenyl]-2,4-pyrimidinediamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CNC2=NC=CC(=C12)OC3=C(C=C(C=C3F)NC4=CC(=NC(=N4)N)Cl)F
2373;409047499;;1794447;381863071;131801156;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;BCL6-IN-8c;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCC1OC2=C(C=C(C(=C2)NC3=CC4=C(C=C3)NC(=O)CC4)Cl)[N+](=O)[O-]
2374;409047500;;1794447;440164595;155543618;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(4R)-2-(4-chlorophenyl)-6-methyl-4-(3-methyl-2H-indazol-5-yl)-1,4-dihydropyridine-3,5-dicarbonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C2C=C(C=CC2=NN1)[C@@H]3C(=C(NC(=C3C#N)C4=CC=C(C=C4)Cl)C)C#N
2375;409047501;;1794447;440207296;155560620;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Nvs-malt1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](C1=C(C=NC2=CC(=NN21)Cl)NC3=CC=C(C=C3)[C@@H](C(F)(F)F)N(C)C(=O)C4CCS(=O)(=O)CC4)OC
2376;409047502;;1794447;461563589;162677478;10280;;Confirmatory;20240503;0;0;Active;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;1-[4-[(S)-[4-chloro-2-methoxy-3-[(4-pyrazol-1-ylphenyl)methyl]quinolin-6-yl]-hydroxy-phenylmethyl]piperidin-1-yl]ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)N1CCC(CC1)[C@](C2=CC=CC=C2)(C3=CC4=C(C=C3)N=C(C(=C4Cl)CC5=CC=C(C=C5)N6C=CC=N6)OC)O
2377;409047505;;1794447;103478702;11386747;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;CB1 inverse agonist 1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)C1=C(C2=CC(=C(N=C2N(C1=O)C)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl)NC(=O)C
2378;409047508;;1794447;381855577;135308996;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(3S)-3-(2-benzyl-7-oxo-4,5-dihydropyrazolo[3,4-c]pyridin-6-yl)-5-methyl-2,3-dihydro-1,5-benzoxazepin-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=CC=CC=C2OC[C@@H](C1=O)N3CCC4=CN(N=C4C3=O)CC5=CC=CC=C5
2379;409047509;;1794447;440131106;133080719;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;2-Fluoro-N'-(3-fluoro-5-(pyridin-2-yl)benzoyl)benzenesulfonohydrazide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C(=C1)F)S(=O)(=O)NNC(=O)C2=CC(=CC(=C2)C3=CC=CC=N3)F
2380;409047510;;1794447;440162092;124125214;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;N-[4-(3-chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)CC(=O)NC2=CC(=C(C=C2)OC3=CC(=CC=C3)Cl)S(=O)(=O)N
2381;409047511;;1794447;440177709;155548816;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;2-[1-(3a,7a-dihydro-1H-imidazo[4,5-b]pyridin-2-ylmethyl)piperidin-4-yl]-4-(1-benzofuran-2-yl)-1,3-thiazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1C2=NC(=CS2)C3=CC4=CC=CC=C4O3)CC5=NC6C(N5)C=CC=N6
2382;409047514;;1794447;440196822;59842446;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;3-[(4-Bromophenoxy)methyl]-1-(4-fluorobenzoyl)azetidine-3-carboxylic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C(CN1C(=O)C2=CC=C(C=C2)F)(COC3=CC=C(C=C3)Br)C(=O)O
2383;409047515;;1794447;318390136;23728722;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;5-[(6r)-5-Ethanoyl-4-Methyl-2-Oxidanylidene-3-[3-(Trifluoromethyl)phenyl]-1,6-Dihydropyrimidin-6-Yl]pyridine-2-Carbonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C([C@H](NC(=O)N1C2=CC=CC(=C2)C(F)(F)F)C3=CN=C(C=C3)C#N)C(=O)C
2384;409047516;;1794447;381857418;137645416;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;N-ethyl-1-methyl-4-[(3S)-3-methylmorpholin-4-yl]pyrrolo[2,3-b]pyridine-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCNC(=O)C1=CC2=C(C=CN=C2N1C)N3CCOC[C@@H]3C
2385;409047517;;1794447;381857418;137645416;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;N-ethyl-1-methyl-4-[(3S)-3-methylmorpholin-4-yl]pyrrolo[2,3-b]pyridine-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCNC(=O)C1=CC2=C(C=CN=C2N1C)N3CCOC[C@@H]3C
2386;409047518;;1794447;381857418;137645416;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;N-ethyl-1-methyl-4-[(3S)-3-methylmorpholin-4-yl]pyrrolo[2,3-b]pyridine-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCNC(=O)C1=CC2=C(C=CN=C2N1C)N3CCOC[C@@H]3C
2387;409047519;;1794447;440112062;139030333;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;5-amino-N-[[4-(3-cyclohexylpropylcarbamoyl)phenyl]methyl]-1-phenylpyrazole-4-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)CCCNC(=O)C2=CC=C(C=C2)CNC(=O)C3=C(N(N=C3)C4=CC=CC=C4)N
2388;409047520;;1794447;440122181;131750228;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Moz-IN-2;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)S(=O)(=O)NNC(=O)C2=C(C=CC(=C2)C3=CN=NC=C3)F
2389;409047521;;1794447;440154412;155539293;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(1R,2R)-2-(4-fluoroanilino)-1-(trifluoromethyl)cyclohexan-1-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC[C@@]([C@@H](C1)NC2=CC=C(C=C2)F)(C(F)(F)F)O
2390;409047522;;1794447;440156611;155540255;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(1S,4R,7Z,14S,18R)-14-(cyclopentyloxycarbonylamino)-2,15-dioxo-18-pyridin-4-yloxy-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxylic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC/C=C\C2C[C@]2(NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](CC1)NC(=O)OC4CCCC4)OC5=CC=NC=C5)C(=O)O
2391;409047523;;1794447;440160912;95882507;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(R)-ZINC-3573;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)[C@@H]1CCN(C1)C2=CC(=NC3=CC=NN32)C4=CC=CC=C4
2392;409047524;;1794447;440175888;85469632;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Unii-66vrx9TN9T;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC1[C@H]2C3(CCS(=O)(=O)CC3)C4=C(N2S(=O)(=O)C5=CC=C(C=C5)F)C=CC(=C4)C(=O)NCC6=C(C=C(C=N6)C(F)(F)F)Cl
2393;409047525;;1794447;440179305;137479135;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;1-[4-[[2-[[6-[5-chloro-6-(dimethylamino)pyrimidin-4-yl]-1H-benzimidazol-2-yl]amino]pyridin-4-yl]methyl]piperazin-1-yl]-3,3,3-trifluoropropan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)C1=NC=NC(=C1Cl)C2=CC3=C(C=C2)N=C(N3)NC4=NC=CC(=C4)CN5CCN(CC5)C(=O)CC(F)(F)F
2394;409047908;;1794447;440204884;145925651;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;2-[1-[2-(5-Chloro-2-fluorophenyl)-5-methylpyridin-4-yl]-2-oxoimidazo[4,5-c]pyridin-3-yl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CN=C(C=C1N2C3=C(C=NC=C3)N(C2=O)CC(=O)N)C4=C(C=CC(=C4)Cl)F
2395;409047911;;1794447;440208510;155561056;10280;;Confirmatory;20240503;0;0;Active;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Pptn-NC;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=C(C2=C1C=C(C=C2)C3=CC=C(C=C3)C(F)(F)F)C4=CC=C(C=C4)C5CCNCC5)C(=O)O
2396;409047914;;1794447;440217259;11364870;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;N-(3-Acetyl-6-(4-chlorophenyl)-7-(2,4-dichlorophenyl)-1-methyl-2-oxo-1,2-dihydro-1,8-naphthyridin-4-yl)methanesulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)C1=C(C2=CC(=C(N=C2N(C1=O)C)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl)NS(=O)(=O)C
2397;409047915;;1794447;442046237;156009445;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(1,1-dioxo-1,3-thiazolidin-3-yl)-[(3S,5S)-3-(3-methyl-1,2,4-oxadiazol-5-yl)-5-[4-(trifluoromethyl)phenyl]piperidin-1-yl]methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NOC(=N1)[C@H]2C[C@H](CN(C2)C(=O)N3CCS(=O)(=O)C3)C4=CC=C(C=C4)C(F)(F)F
2398;409047916;;1794447;461563591;162677479;10280;;Confirmatory;20240503;0;0;Active;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;1-(4-((3-((2,6-Dimethyl-pyridin-4-yl)-methyl)-piperidin-1-yl)-methyl)-thiazol-2-ylamino)-ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=CC(=N1)C)C[C@H]2CCCN(C2)CC3=CSC(=N3)NC(=O)C
2399;409047919;;1794447;312361687;59447577;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;2-[8-(1,3-Benzothiazol-2-Ylcarbamoyl)-3,4-Dihydroisoquinolin-2(1h)-Yl]-5-(3-{4-[3-(Dimethylamino)prop-1-Yn-1-Yl]-2-Fluorophenoxy}propyl)-1,3-Thiazole-4-Carboxylic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CC#CC1=CC(=C(C=C1)OCCCC2=C(N=C(S2)N3CCC4=C(C3)C(=CC=C4)C(=O)NC5=NC6=CC=CC=C6S5)C(=O)O)F
2400;409047922;;1794447;318459881;87522699;10280;;Confirmatory;20240503;0;0;Active;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(NE)-N-[(E)-1-(4-fluoro-3-methylphenyl)-2-methylpent-1-en-3-ylidene]hydroxylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC/C(=N\O)/C(=C/C1=CC(=C(C=C1)F)C)/C
2401;409047925;;1794447;404696611;118958122;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;N-(4-Fluorobenzyl)-2-((R)-5-(3-methylureido)-2',4'-dioxo-2,3-dihydrospiro[indene-1,5'-oxazolidin]-3'-yl)-N-((S)-1,1,1-trifluoropropan-2-yl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](C(F)(F)F)N(CC1=CC=C(C=C1)F)C(=O)CN2C(=O)[C@]3(CCC4=C3C=CC(=C4)NC(=O)NC)OC2=O
2402;409047926;;1794447;440132040;154701643;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;[2-Amino-4-(trifluoromethoxy)phenyl]-[4-[2-methyl-7-(4-methylpiperazin-1-yl)pyrido[3,2-d]pyrimidin-4-yl]piperidin-1-yl]methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NC2=C(C(=N1)C3CCN(CC3)C(=O)C4=C(C=C(C=C4)OC(F)(F)F)N)N=CC(=C2)N5CCN(CC5)C
2403;409047929;;1794447;440151760;129284334;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;N-{2-[(2R)-2-fluoro-3-hydroxy-3-methylbutyl]-6-(morpholin-4-yl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl}pyrazolo[1,5-a]pyrimidine-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)([C@@H](CN1CC2=CC(=C(C=C2C1=O)N3CCOCC3)NC(=O)C4=C5N=CC=CN5N=C4)F)O
2404;409047930;;1794447;163338225;51031001;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;4-(1-Acetylpiperidin-4-yl)-N-carbamimidoyl-3-(trifluoromethyl)benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)N1CCC(CC1)C2=C(C=C(C=C2)C(=O)N=C(N)N)C(F)(F)F
2405;409047931;;1794447;318386330;59472574;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;gamma-Secretase modulator 2;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CN(C=N1)C2=C(C=C(C=C2)C3=CN(N=N3)C4CCC5=C(C=CC=C5F)N(C4=O)CC(F)(F)F)OC
2406;409047932;;1794447;381861468;56649300;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Ftbmt;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC(=C1)N2C(=NC(=N2)CC3=CC(=CC(=C3)F)C(F)(F)F)C)C(=O)N
2407;409047933;;1794447;440156172;9837640;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;2-(pyridin-2-yl)-4H-benzo[e][1,3]thiazin-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C2C(=C1)C(=O)N=C(S2)C3=CC=CC=N3
2408;409047934;;1794447;440179852;155549686;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(1R,2R,5S)-2-[4-[2-(oxan-4-yl)ethoxy]benzoyl]-5-[(4-oxo-1,2,3-benzotriazin-3-yl)methyl]cyclopentane-1-carboxylic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C[C@H]([C@@H]([C@H]1CN2C(=O)C3=CC=CC=C3N=N2)C(=O)O)C(=O)C4=CC=C(C=C4)OCCC5CCOCC5
2409;409047935;;1794447;440180856;155550101;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;1-(4-fluorophenyl)-N-[(1S)-3-(methanesulfonamido)-1-(2-methylsulfonylpyridin-4-yl)propyl]pyrazolo[3,4-c]pyridine-4-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CS(=O)(=O)C1=NC=CC(=C1)[C@H](CCNS(=O)(=O)C)NC(=O)C2=CN=CC3=C2C=NN3C4=CC=C(C=C4)F
2410;409047936;;1794447;440217121;118425786;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(1S,2S,5R)-2-[4-[2-(oxan-4-yl)ethoxy]benzoyl]-5-[(4-oxo-1,2,3-benzotriazin-3-yl)methyl]cyclopentane-1-carboxylic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C[C@@H]([C@H]([C@@H]1CN2C(=O)C3=CC=CC=C3N=N2)C(=O)O)C(=O)C4=CC=C(C=C4)OCCC5CCOCC5
2411;409047937;;1794447;442046236;156009444;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;N-[5-(3,5-dicyano-2,6-dimethyl-1,4-dihydropyridin-4-yl)-1-methylindazol-3-yl]-2-methylbenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1C(=O)NC2=NN(C3=C2C=C(C=C3)C4C(=C(NC(=C4C#N)C)C)C#N)C
2412;409048254;;1794447;461540474;162640825;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;O-GlcNAcase-IN-1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)C2=NC(=NC=C2)NCC3=CN(C=N3)C
2413;409048255;;1794447;461563590;150189198;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Mct4-IN-1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC1=C2C=CC=NC2=C(C=C1)S(=O)(=O)NC3=C(C=C(C=C3)Cl)C#CC4=CN=C(C=C4OC)C(=O)O
2414;409048256;;1794447;475992981;166632756;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;7-(4-acetamidophenyl)-N-(3-imidazol-1-ylpropyl)-5-phenylpyrazolo[1,5-a]pyrimidine-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)NC1=CC=C(C=C1)C2=CC(=NC3=CC(=NN23)C(=O)NCCCN4C=CN=C4)C5=CC=CC=C5
2415;409048257;;1794447;312390293;66764813;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;2-[4-[3-[(1R)-1-[4-(2-aminopyrimidin-5-yl)phenyl]-1-cyclopropylethyl]-1,2,4-oxadiazol-5-yl]pyrazol-1-yl]-N,N-dimethylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@](C1CC1)(C2=CC=C(C=C2)C3=CN=C(N=C3)N)C4=NOC(=N4)C5=CN(N=C5)CC(=O)N(C)C
2416;409048258;;1794447;318398468;46853762;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(R)-3-[2,4-dioxo-1-(1,4,6-trimethyl-1H-indol-3-ylmethyl)-1,4-dihydro-2H-pyrido[3,2-d]pyrimidin-3-yl]-pentanoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC[C@H](CC(=O)O)N1C(=O)C2=C(C=CC=N2)N(C1=O)CC3=CN(C4=CC(=CC(=C43)C)C)C
2417;409048259;;1794447;336898977;44470113;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;ADRA1D receptor antagonist 1 (free base);SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](C1=CC=CC(=C1)C#N)N2C=C(C=C(C2=N)C(=O)N)Cl
2418;409048260;;1794447;442046238;154701640;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;[(3S,5S)-3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-5-[4-(trifluoromethoxy)phenyl]piperidin-1-yl]-(1,1-dioxo-1,4-thiazinan-4-yl)methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC1C2=NOC(=N2)[C@H]3C[C@H](CN(C3)C(=O)N4CCS(=O)(=O)CC4)C5=CC=C(C=C5)OC(F)(F)F
2419;409048261;;1794447;442052558;126648559;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;1-Benzyl-N5-cyclopropyl-N3-methyl-2-oxo-1,2-dihydropyridine-3,5-dicarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CNC(=O)C1=CC(=CN(C1=O)CC2=CC=CC=C2)C(=O)NC3CC3
2420;409048262;;1794447;442064588;156022246;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(3S,4S)-N-cyclohexyl-4-[[5-(furan-2-yl)-3-methyl-2-oxo-1H-1,7-naphthyridin-8-yl]amino]-1-methylpiperidine-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC2=C(C(=NC=C2C3=CC=CO3)N[C@H]4CCN(C[C@@H]4C(=O)NC5CCCCC5)C)NC1=O
2421;409048263;;1794447;124963756;24771824;10280;;Confirmatory;20240503;0;0;Active;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;N-pyridazin-3-yl-4-[[3-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methylidene]piperidine-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1=CC2=CC(=CC=C2)OC3=NC=C(C=C3)C(F)(F)F)C(=O)NC4=NN=CC=C4
2422;409048266;;1794447;194172536;11622248;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(2S)-2-[[(2R)-2-[[(2R)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-pyridin-4-ylpropanoyl]amino]-N-[(2S)-1-[[(2S)-1-[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-5-[(N'-methylcarbamimidoyl)amino]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]hydrazinyl]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]butanediamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)C[C@@H](C(=O)N[C@@H](CCCNC(=NC)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)NC(=O)NNC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)NC(=O)[C@@H](CC3=CC=NC=C3)NC(=O)[C@@H](CC4=CC=C(C=C4)O)N
2423;409048267;;1794447;312359683;11525848;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;4-(((2-((3-Methoxybenzyl)carbamoyl)-4-oxo-1,4-dihydrothieno[2,3-d]pyrimidin-5-yl)methoxy)methyl)benzoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC(=C1)CNC(=O)C2=NC3=C(C(=CS3)COCC4=CC=C(C=C4)C(=O)O)C(=O)N2
2424;409048268;;1794447;381842065;137635074;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;3-Chloro-4-((2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)amino)benzonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC(=C(C=C1C#N)Cl)NC2=CC3=C(C=C2)NC(=O)N3
2425;409048269;;1794447;440162068;138973681;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;BAY 293 Negative Control;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NC2=CC(=C(C=C2C(=N1)N[C@@H](C)C3=CC(=CS3)C4=CC=CC=C4CNC)OC)OC
2426;409048270;;1794447;440188647;57861719;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;3-fluoro-4-phenyl-N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridin-2-yl]benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)C2=C(C=C(C=C2)C(=O)NC3=NC=C(C=C3)N4C(=CC(=N4)C5=CN=CC=C5)C(F)(F)F)F
2427;409048271;;1794447;440228548;155568985;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(5R)-N-[4-(4-fluorophenoxy)phenyl]-5-(4-fluorophenyl)-7,8-dihydro-5H-1,6-naphthyridine-6-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN([C@@H](C2=C1N=CC=C2)C3=CC=C(C=C3)F)C(=O)NC4=CC=C(C=C4)OC5=CC=C(C=C5)F
2428;409048274;;1794447;440230063;24959105;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;2,6-Dimethyl-4-(3-methyl-1H-indazol-5-yl)-1,4-dihydropyridine-3,5-dicarbonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C2C=C(C=CC2=NN1)C3C(=C(NC(=C3C#N)C)C)C#N
2429;409048275;;1794447;461563586;135135317;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;N-[5-[[(3R)-3-[(2,6-dimethylpyridin-4-yl)methyl]piperidin-1-yl]methyl]-1,3-thiazol-2-yl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=CC(=N1)C)C[C@H]2CCCN(C2)CC3=CN=C(S3)NC(=O)C
2430;409048276;;1794447;103333158;9915028;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;A-216546 free base;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCN(CCCC)C(=O)CN1C[C@@H]([C@H]([C@@H]1CC(C)(C)CCC)C(=O)O)C2=CC3=C(C(=C2)OC)OCO3
2431;409048277;;1794447;163314754;51352628;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Imidazo(1,2-b)pyridazine, 3-(6-(2-methoxyethyl)-3-pyridinyl)-2-methyl-8-(4-morpholinyl)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(N2C(=N1)C(=CC=N2)N3CCOCC3)C4=CN=C(C=C4)CCOC
2432;409048278;;1794447;318456509;42641861;10280;;Confirmatory;20240503;0;0;Active;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;1-Penten-3-one, 1-(4-fluorophenyl)-2-methyl-, oxime, (1E,3E)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC/C(=N\O)/C(=C/C1=CC=C(C=C1)F)/C
2433;409048281;;1794447;374280463;71623052;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;[3-Cyano-5-[[[2,4-dimethyl-5-[6-(3-pyridinyl)-1H-imidazo[1,2-b]pyrazol-1-yl]phenyl]amino]carbonyl]phenyl]pentafluorosulfur;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=C(C=C1NC(=O)C2=CC(=CC(=C2)C#N)S(F)(F)(F)(F)F)N3C=CN4C3=CC(=N4)C5=CN=CC=C5)C
2434;409048282;;1794447;381873421;129012086;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;CID 129012086;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCNC(=O)C1=CC2=C(C=CN=C2N1)N3CCOC[C@@H]3C
2435;409048283;;1794447;440170924;58431184;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(5R)-5-[(4-cyanophenyl)methyl]-7-(3,5-dichloro-4-fluorophenyl)-5-methyl-6-oxo-N-[(2S)-1-oxo-1-[(1-pyridin-2-ylcyclopropyl)amino]propan-2-yl]imidazo[1,2-a]imidazole-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](C(=O)NC1(CC1)C2=CC=CC=N2)NC(=O)C3=CN=C4N3[C@](C(=O)N4C5=CC(=C(C(=C5)Cl)F)Cl)(C)CC6=CC=C(C=C6)C#N
2436;409048593;;1794447;440171401;155546287;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;N-[[4-(3-cyclohexylpropylcarbamoyl)phenyl]methyl]-1-phenyl-5-(trifluoromethyl)pyrazole-4-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)CCCNC(=O)C2=CC=C(C=C2)CNC(=O)C3=C(N(N=C3)C4=CC=CC=C4)C(F)(F)F
2437;409048594;;1794447;440178405;145925680;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;ERK-IN-2 (free base);SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](C1=CC=CC=C1)NC(=O)NC2=NC(=C3C=NNC3=C2)CO
2438;409048595;;1794447;440178544;56707820;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Ogerin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)CNC2=NC(=NC(=N2)N)C3=CC=CC=C3CO
2439;409048596;;1794447;440191048;146673143;10280;;Confirmatory;20240503;0;0;Active;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Clk-IN-T3N;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)C1=CC(=CC(=C1)C2=CN3C=C(N=C3C=C2)NC(=O)C4=CC=C(C=C4)C(C)(C)C(=O)N5CCN(CC5)C)C(C)(C)C
2440;409048599;;1794447;461525873;70817911;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;2-(4-(1-Aminocyclobutyl)phenyl)-3-phenylimidazo[1,2-b]pyridazine-6-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC(C1)(C2=CC=C(C=C2)C3=C(N4C(=N3)C=CC(=N4)C(=O)N)C5=CC=CC=C5)N
2441;409048600;;1794447;461563600;162677485;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(3R)-N-[5-(2-azidoacetyl)-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl]-1-cyanopyrrolidine-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(C[C@@H]1C(=O)NC2=NC3=C(S2)CN(CC3)C(=O)CN=[N+]=[N-])C#N
2442;409048601;;1794447;475979315;166625943;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(3S)-3-[2-[[5-chloro-3-(difluoromethyl)pyrazol-1-yl]methyl]-7-methyl-4-oxopyrazolo[1,5-a]pyrazin-5-yl]butanenitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CN(C(=O)C2=CC(=NN12)CN3C(=CC(=N3)C(F)F)Cl)[C@@H](C)CC#N
2443;409048602;;1794447;475988416;162760083;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;2-(5-fluoropyridin-2-yl)-3-(1H-pyrazolo[3,4-b]pyridin-4-yl)-6,6-bis(trideuteriomethyl)-4,7-dihydropyrazolo[5,1-c][1,4]oxazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;[2H]C([2H])([2H])C1(CN2C(=C(C(=N2)C3=NC=C(C=C3)F)C4=C5C=NNC5=NC=C4)CO1)C([2H])([2H])[2H]
2444;409048603;;1794447;103745040;11577204;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;N-[4-(4-chlorophenyl)sulfonyl-4-(2,5-difluorophenyl)cyclohexyl]-1,1,1-trifluoromethanesulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC(CCC1NS(=O)(=O)C(F)(F)F)(C2=C(C=CC(=C2)F)F)S(=O)(=O)C3=CC=C(C=C3)Cl
2445;409048604;;1794447;163325400;71455782;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Msd-M1pam-NC;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(C1)C(=O)C2=CC(=C3C=CC=CN3C2=O)CN4CCC(CC4)(C#N)C5=CC=CC=N5
2446;409048605;;1794447;318376732;118430456;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Dhodh-IN-1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C(=NN1C2=C(C=C(C=N2)C3CC3)F)OC(C)C)OC4=C(C=CC=C4F)F
2447;409048606;;1794447;318444609;53251189;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Syk-IN-3;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NC(=NC=C1)NC2=CC(=CC(=C2)C3=CN=C(S3)[C@]4(CC[C@@H](C(C4)(C)C)C(=O)O)O)C
2448;409048607;;1794447;336898978;127046693;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;5-chloro-1-[(1S)-1-(3-cyanophenyl)ethyl]-2-iminopyridine-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](C1=CC=CC(=C1)C#N)N2C=C(C=C(C2=N)C(=O)N)Cl
2449;409048608;;1794447;440131550;91885570;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Mgat2-IN-1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C(=CC(=N1)C(F)(F)F)C2=CN=C(N=C2)N3CCC4=C3C(=CC(=C4)S(=O)(=O)NC5=C(C=C(C=C5F)Cl)F)N6CCCC6=O
2450;409048609;;1794447;440153796;91827581;10280;;Confirmatory;20240503;0;0;Active;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(2R,3S,4R)-1-[2-(dibutylamino)-2-oxoethyl]-2-(2,2-dimethylpentyl)-4-(7-methoxy-1,3-benzodioxol-5-yl)pyrrolidine-3-carboxylic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCN(CCCC)C(=O)CN1C[C@H]([C@@H]([C@H]1CC(C)(C)CCC)C(=O)O)C2=CC3=C(C(=C2)OC)OCO3
2451;409048612;;1794447;440164983;23652660;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;3-Amino-4-(1,1-difluoropropyl)-6-(4-methylsulfonylpiperidin-1-yl)thieno[2,3-b]pyridine-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(C1=CC(=NC2=C1C(=C(S2)C(=O)N)N)N3CCC(CC3)S(=O)(=O)C)(F)F
2452;409048613;;1794447;440175420;95882508;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(S)-ZINC-3573;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)[C@H]1CCN(C1)C2=CC(=NC3=CC=NN32)C4=CC=CC=C4
2453;409048614;;1794447;440186718;155552436;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;2-[3-[2-(5-Chloro-2-fluorophenyl)-5-methylpyridin-4-yl]-2-oxobenzimidazol-1-yl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CN=C(C=C1N2C3=CC=CC=C3N(C2=O)CC(=O)N)C4=C(C=CC(=C4)Cl)F
2454;409048615;;1794447;440186768;155552454;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;6-chloro-4-N-[4-(3-chloro-1-methylpyrrolo[2,3-b]pyridin-4-yl)oxy-3,5-difluorophenyl]pyrimidine-2,4-diamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C=C(C2=C(C=CN=C21)OC3=C(C=C(C=C3F)NC4=CC(=NC(=N4)N)Cl)F)Cl
2455;409048616;;1794447;440201576;155558331;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;MLi-2-NC;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(C[C@@H](O1)C)C2=NC=NC(=C2)C3=NN(C4=C3C=C(C=C4)OC5(CC5)C)C
2456;409048618;;1794447;103349868;5310991;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-((2,6-diethylphenyl)amino)-2-oxoethyl)-2-(4-propoxyphenyl)-, (2R,3R,4S)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCOC1=CC=C(C=C1)[C@H]2[C@@H]([C@H](CN2CC(=O)NC3=C(C=CC=C3CC)CC)C4=CC5=C(C=C4)OCO5)C(=O)O
2457;409048619;;1794447;134461578;51346964;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;S2JB42Bbp5;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N[C@H]1CC[C@H](C1)C(=O)N(C)C2=CC=C(C=C2)C3=NC4=CC=CC=C4O3
2458;409048620;;1794447;160701240;11203294;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;CID 11203294;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=CC(=C1C2=CC=CC(=C2)COC3=CC(=C(C=C3)CCC(=O)O)F)C)OC4CCS(=O)(=O)CC4
2459;409048621;;1794447;318374355;122179556;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;MSD-CYP11B2-Negative-control;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC1N2C3=C(C=C(C=C3)C(F)(F)F)N=C2C4=CN=CC=C4
2460;409048622;;1794447;318377030;118430525;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Ipp/cnrs-A019;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C(=NN1C2=NC=C(C=C2)C3CC3)OC(C)C)OC4=CC=C(C=C4)F
2461;409048976;;1794447;336900042;89794927;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(R)-1-(4-Methyl-5-(6-(trifluoromethyl)-1H-indazol-4-yl)pyrimidin-2-yl)pyrrolidin-3-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NC(=NC=C1C2=C3C=NNC3=CC(=C2)C(F)(F)F)N4CC[C@H](C4)O
2462;409048977;;1794447;440195453;155555842;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;3-(4-Chloro-3-(o-tolyloxy)naphthalen-1-yl)-6-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1OC2=C(C3=CC=CC=C3C(=C2)N4C(=O)C=C(NC4=O)C(F)(F)F)Cl
2463;409048978;;1794447;440225117;59126962;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(1S,4R,7Z,14S,18R)-14-(cyclopentyloxycarbonylamino)-18-[7-methoxy-8-methyl-2-[2-(2-methylpropanoylamino)-1,3-thiazol-4-yl]quinolin-4-yl]oxy-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxylic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC2=C1N=C(C=C2O[C@@H]3C[C@H]4C(=O)N[C@@]5(CC5/C=C\CCCCC[C@@H](C(=O)N4C3)NC(=O)OC6CCCC6)C(=O)O)C7=CSC(=N7)NC(=O)C(C)C)OC
2464;409048979;;1794447;461563595;162677480;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(2S)-2-[[3-cyano-2-[4-(2-fluoro-3-methylphenyl)phenyl]-1,7-naphthyridin-4-yl]amino]butanoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC[C@@H](C(=O)O)NC1=C(C(=NC2=C1C=CN=C2)C3=CC=C(C=C3)C4=CC=CC(=C4F)C)C#N
2465;409048980;;1794447;494422364;168310320;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;N-[(2S)-3-methoxy-1-[[4-[3-(1-methylpyrazol-3-yl)phenyl]-1,3-thiazol-2-yl]amino]-1-oxopropan-2-yl]-1-methylsulfonylpyrrole-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C=CC(=N1)C2=CC(=CC=C2)C3=CSC(=N3)NC(=O)[C@H](COC)NC(=O)C4=CN(C=C4)S(=O)(=O)C
2466;409048981;;1794447;440161803;68944900;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;5-[(4S)-5-Acetyl-1,2,3,4-tetrahydro-6-methyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-4-pyrimidinyl]-2-pyridinecarbonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C([C@@H](NC(=O)N1C2=CC=CC(=C2)C(F)(F)F)C3=CN=C(C=C3)C#N)C(=O)C
2467;409048982;;1794447;442051800;138618774;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(2R,3R)-2-(fluoromethyl)-7-N-methyl-5-N-[(1S,5R)-3-oxabicyclo[3.1.0]hexan-6-yl]-3-phenyl-2,3-dihydro-1-benzofuran-5,7-dicarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CNC(=O)C1=CC(=CC2=C1O[C@H]([C@@H]2C3=CC=CC=C3)CF)C(=O)NC4[C@H]5[C@@H]4COC5
2468;409048983;;1794447;475992648;162760334;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;2-(5-Fluoropyridin-2-yl)-6,6-dimethyl-3-(2-methylpyrazolo[3,4-b]pyridin-4-yl)-4,7-dihydropyrazolo[5,1-c][1,4]oxazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1(CN2C(=C(C(=N2)C3=NC=C(C=C3)F)C4=CC=NC5=NN(C=C45)C)CO1)C
2469;409048984;;1794447;103683319;45268455;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Pyrido(1,2-a)indole-10-acetic acid, 7-(((4-fluorophenyl)sulfonyl)methylamino)-6,7,8,9-tetrahydro-, (7R)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCC2=C(C3=CC=CC=C3N2C1)CC(=O)O)S(=O)(=O)C4=CC=C(C=C4)F
2470;409048985;;1794447;134457814;56678756;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(1S,3R)-N-[4-(1,3-benzoxazol-2-yl)phenyl]-N-methyl-3-(propanoylamino)cyclopentane-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N[C@@H]1CC[C@@H](C1)C(=O)N(C)C2=CC=C(C=C2)C3=NC4=CC=CC=C4O3
2471;409048986;;1794447;318393143;86277887;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;SAFit2;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=C(C=C1)CC[C@H](C2=CC(=CC=C2)OCCN3CCOCC3)OC(=O)[C@@H]4CCCCN4C(=O)[C@@H](C5CCCCC5)C6=CC(=C(C(=C6)OC)OC)OC)OC
2472;409048987;;1794447;381872584;121301295;10280;;Confirmatory;20240503;0;0;Active;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;CFTR corrector 4;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(C=C1)[C@@H](C[C@@H](O2)C3=CC(=C(C=C3)OC)OC)NC(=O)C4(CC4)C5=CC6=C(C=C5)OC(O6)(F)F
2473;409048990;;1794447;440124631;118191391;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;N4-[1-[(4-cyanophenyl)methyl]-5-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]-7-fluoro-2,4-Quinolinedicarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C(=NN1CC2=CC=C(C=C2)C#N)C(F)(F)F)NC(=O)C3=CC(=NC4=C3C=CC(=C4)F)C(=O)N
2474;409048991;;1794447;440171575;132585205;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Clk-IN-T3;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C1=CC=C(C=C1)C(=O)NC2=CN3C=C(C=CC3=N2)C4=CC=NC=C4)C(=O)N5CCN(CC5)C
2475;409048992;;1794447;440190963;155554081;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(5R)-5-[(4-cyanophenyl)methyl]-N-[1-(3-cyclobutyl-1,2,4-oxadiazol-5-yl)cyclopropyl]-7-(3,5-dichlorophenyl)-5-methyl-6-oxoimidazo[1,2-a]imidazole-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@]1(C(=O)N(C2=NC=C(N21)C(=O)NC3(CC3)C4=NC(=NO4)C5CCC5)C6=CC(=CC(=C6)Cl)Cl)CC7=CC=C(C=C7)C#N
2476;409048993;;1794447;440202897;155558842;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;2-Pyridin-2-yl-2,3-dihydro-1,3-benzothiazin-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C2C(=C1)C(=O)NC(S2)C3=CC=CC=N3
2477;409048994;;1794447;461563592;155884467;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(2~{R})-2-[[3-cyano-2-[4-(2-fluoranyl-3-methyl-phenyl)phenyl]-1,7-naphthyridin-4-yl]amino]butanoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC[C@H](C(=O)O)NC1=C(C(=NC2=C1C=CN=C2)C3=CC=C(C=C3)C4=CC=CC(=C4F)C)C#N
2478;409048995;;1794447;494417403;171355807;10280;;Confirmatory;20240503;0;0;Active;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;1-(1-cyanocyclopropyl)-N-[(2S)-1-[[4-[3-(1-methylpyrazol-3-yl)phenyl]-1,3-thiazol-2-yl]amino]-1-oxopropan-2-yl]imidazole-4-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](C(=O)NC1=NC(=CS1)C2=CC=CC(=C2)C3=NN(C=C3)C)NC(=O)C4=CN(C=N4)C5(CC5)C#N
2479;409048998;;1794447;381885815;78319901;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;MLi-2-Bio-X;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(C[C@@H](O1)C)C2=NC=NC(=C2)C3=NNC4=C3C=C(C=C4)OC5(CC5)C
2480;409048999;;1794447;440134679;139600336;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;CID 139600336;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN([C@H](C2=C1N=CC=C2)C3=CC=C(C=C3)F)C(=O)NC4=CN=C(N=C4)OC5=CC=C(C=C5)F
2481;409049002;;1794447;440180707;155550034;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;4-(1-acetylpiperidin-4-yl)-N-(4,5-dihydro-1H-imidazol-2-yl)-3-(trifluoromethyl)benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)N1CCC(CC1)C2=C(C=C(C=C2)C(=O)NC3=NCCN3)C(F)(F)F
2482;409049003;;1794447;440205039;118877194;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;CID 118877194;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC1[C@@H]2C3(CCS(=O)(=O)CC3)C4=C(N2S(=O)(=O)C5=CC=C(C=C5)F)C=CC(=C4)C(=O)NCC6=C(C=C(C=N6)C(F)(F)F)Cl
2483;409049004;;1794447;442055944;156016206;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(4R)-5-[(6-bromo-3-methyl-2-piperazin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCNCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl
2484;409049005;;1794447;442057934;146368333;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;CID 146368333;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl
2485;409049344;;1794447;461558359;122668091;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Borussertib;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C=CC(=O)NC1=CC2=C(C=C1)NC(=O)N2C3CCN(CC3)CC4=CC=C(C=C4)C5=C(C=C6C(=N5)C=CNC6=O)C7=CC=CC=C7
2486;409049345;;1794447;124976534;53326879;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;CRTH2-negative-control;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCC2=C(C3=C(N2C1)C=CC(=C3)S(=O)(=O)C)CC(=O)O)S(=O)(=O)C4=CC=C(C=C4)F
2487;409049346;;1794447;134447941;25229646;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;1-((4-cyano-4-(pyridin-2-yl)piperidin-1-yl)methyl)-4-oxo-4H-quinolizine-3-carboxylic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C#N)C2=CC=CC=N2)CC3=C4C=CC=CN4C(=O)C(=C3)C(=O)O
2488;409049347;;1794447;318372032;60195662;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(R)-3-((N-(1-(4-fluorophenyl)ethyl)quinoline-3-carboxamido)methyl)benzoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](C1=CC=C(C=C1)F)N(CC2=CC(=CC=C2)C(=O)O)C(=O)C3=CC4=CC=CC=C4N=C3
2489;409049348;;1794447;440120698;134128280;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(2-Amino-4-(trifluoromethoxy)phenyl)(4-(7-(4-methylpiperazin-1-yl)pyrido[3,2-d]pyrimidin-4-yl)piperidin-1-yl)methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)C2=CC3=C(C(=NC=N3)C4CCN(CC4)C(=O)C5=C(C=C(C=C5)OC(F)(F)F)N)N=C2
2490;409049351;;1794447;440170404;155545891;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;MRL-SYKi-NC;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=C(C=C1)C2=CN=C(S2)[C@]3(CC[C@@H](C(C3)(C)C)C(=O)O)O)NC4=CC=CC(=N4)C(F)(F)F
2491;409049352;;1794447;440174729;137322663;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(R)-6,7-Dimethoxy-2-methyl-N-(1-(4-(2-((methylamino)methyl)phenyl)thiophen-2-yl)ethyl)quinazolin-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NC2=CC(=C(C=C2C(=N1)N[C@H](C)C3=CC(=CS3)C4=CC=CC=C4CNC)OC)OC
2492;409049353;;1794447;440189837;155553652;10280;;Confirmatory;20240503;0;0;Active;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;2-[1-(3a,7a-dihydro-1H-imidazo[4,5-b]pyridin-2-ylmethyl)piperidin-4-yl]-4-(1-methylbenzimidazol-2-yl)-1,3-thiazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=CC=CC=C2N=C1C3=CSC(=N3)C4CCN(CC4)CC5=NC6C(N5)C=CC=N6
2493;409049356;;1794447;440192898;155554839;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(2-methylpyrimidin-4-yl)methyl (1R,5S)-6-[(2H-benzotriazole-5-carbonylamino)methyl]-3-azabicyclo[3.1.0]hexane-3-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NC=CC(=N1)COC(=O)N2C[C@@H]3[C@H](C2)C3CNC(=O)C4=CC5=NNN=C5C=C4
2494;409049357;;1794447;440197846;155556859;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(1R,2R)-2-(4-fluoro-3-methoxyanilino)-1-(trifluoromethyl)cyclohexan-1-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=CC(=C1)N[C@@H]2CCCC[C@@]2(C(F)(F)F)O)F
2495;409049358;;1794447;440218803;134817183;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;N-[5-(3,5-dicyano-1,2,6-trimethyl-4H-pyridin-4-yl)-6-fluoro-7-methyl-1H-indazol-3-yl]-2-ethylbenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC1=CC=CC=C1C(=O)NC2=NNC3=C(C(=C(C=C32)C4C(=C(N(C(=C4C#N)C)C)C)C#N)F)C
2496;409049359;;1794447;440224265;155567293;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(2S)-2-[[(2R)-2-[[(2R)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-N-[(2S)-1-[[(2S)-1-[2-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-5-[(N'-methylcarbamimidoyl)amino]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]hydrazinyl]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]butanediamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)C[C@@H](C(=O)N[C@@H](CCCNC(=NC)N)C(=O)NCC(=O)N)NC(=O)NNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)NC(=O)[C@@H](CC2=CN=CC=C2)NC(=O)[C@@H](CC3=CC=C(C=C3)O)N
2497;409049362;;1794447;475994610;166633549;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;[(1R)-3-(3,4-dimethoxyphenyl)-1-[3-(2-morpholin-4-ylethoxy)phenyl]propyl] (2R)-1-[(2R)-2-cyclohexyl-2-(3,4,5-trimethoxyphenyl)acetyl]piperidine-2-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=C(C=C1)CC[C@H](C2=CC(=CC=C2)OCCN3CCOCC3)OC(=O)[C@H]4CCCCN4C(=O)[C@H](C5CCCCC5)C6=CC(=C(C(=C6)OC)OC)OC)OC
2498;409049363;;1794447;475995198;118958833;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;1891087-61-8;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CN=C(N=C1NC2=C(C=NC=C2)OC)C3=NN(C4=CC=CC=C43)CC5=C(C=C(C=C5F)OCCO)F
2499;409049364;;1794447;312372725;44543970;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Unii-KQ33evh4KU;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCS(=O)(=O)C1=NC=C2C(=C1)C=C(N2)C[C@](CC(C)(C)C3=C(C=C(C=C3)F)C(=O)N)(C(F)(F)F)O
2500;409049365;;1794447;440172743;155546818;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Gsm-NC;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NN(C=C1)C2=C(C=C(C=C2)C3=CN(N=N3)C4CCC5=CC=CC=C5N(C4=O)CC(F)(F)F)OC
2501;409049366;;1794447;440193399;155555047;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;4-[4-[[2-(4-Chlorophenyl)-4-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]-N-[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCC1CNC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=C(C=C(C=C3)N4CCN(CC4)CC5=C(C=C(C=C5)C(F)(F)F)C6=CC=C(C=C6)Cl)OC7=CN=C8C(=C7)C=CN8)[N+](=O)[O-]
2502;409049367;;1794447;440194870;124203924;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;4-N-[1-[(4-tert-butylphenyl)methyl]-5-methyl-3-(trifluoromethyl)pyrazol-4-yl]-7-fluoroquinoline-2,4-dicarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C(=NN1CC2=CC=C(C=C2)C(C)(C)C)C(F)(F)F)NC(=O)C3=CC(=NC4=C3C=CC(=C4)F)C(=O)N
2503;409049368;;1794447;475982193;166627367;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;4-[[3-[4-(1,1-Dioxothian-4-yl)oxy-2,6-dimethylphenyl]phenyl]methoxy]-2-fluorobenzoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=CC(=C1C2=CC=CC(=C2)COC3=CC(=C(C=C3)C(=O)O)F)C)OC4CCS(=O)(=O)CC4
2504;409049369;;1794447;136929043;45376872;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;4-[[[5-(2-ethoxycarbonyl-1H-indol-5-yl)-1-methylpyrazole-3-carbonyl]amino]methyl]benzoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC(=O)C1=CC2=C(N1)C=CC(=C2)C3=CC(=NN3C)C(=O)NCC4=CC=C(C=C4)C(=O)O
2505;409049370;;1794447;440121033;135386938;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;5-[[2-[(3~{S},5~{R})-4,4-bis(fluoranyl)-3,5-dimethyl-piperidin-1-yl]-5-chloranyl-pyrimidin-4-yl]amino]-1-methyl-3-(3-methyl-3-oxidanyl-butyl)benzimidazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(C[C@@H](C1(F)F)C)C2=NC=C(C(=N2)NC3=CC4=C(C=C3)N(C(=O)N4CCC(C)(C)O)C)Cl
2506;409049371;;1794447;440164301;135309104;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(3S)-3-(2-benzyl-3-bromo-7-oxo-4,5-dihydropyrazolo[3,4-c]pyridin-6-yl)-5-methyl-2,3-dihydro-1,5-benzoxazepin-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=CC=CC=C2OC[C@@H](C1=O)N3CCC4=C(N(N=C4C3=O)CC5=CC=CC=C5)Br
2507;409049372;;1794447;440222829;68287831;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;2-chloro-5-[[[(1R)-1-(4-fluorophenyl)ethyl]-(quinoline-3-carbonyl)amino]methyl]benzoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](C1=CC=C(C=C1)F)N(CC2=CC(=C(C=C2)Cl)C(=O)O)C(=O)C3=CC4=CC=CC=C4N=C3
2508;409049373;;1794447;461542924;162662928;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;N-pyridazin-3-yl-3-[(E)-3-[6-[5-(trifluoromethyl)pyridin-2-yl]oxypyrazin-2-yl]prop-2-enyl]azetidine-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C(CN1C(=O)NC2=NN=CC=C2)C/C=C/C3=CN=CC(=N3)OC4=NC=C(C=C4)C(F)(F)F
2509;409049713;;1794447;242645573;25114442;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;PF-04418948;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(C=C1)C=C(C=C2)OCC3(CN(C3)C(=O)C4=CC=C(C=C4)F)C(=O)O
2510;409049714;;1794447;318374372;56645363;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Cyp11B2-IN-1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C1=CN=CC(=C1)C2=NC3=C(N2C4CC4)C=C(C=C3)F)O
2511;409049715;;1794447;440135457;39791182;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(3-(4-Amino-6-(benzylamino)-1,3,5-triazin-2-yl)phenyl)methanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)CNC2=NC(=NC(=N2)N)C3=CC=CC(=C3)CO
2512;409049716;;1794447;440170635;58026161;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;2-[(4S)-4-[(5-ethylsulfonyl-1H-pyrrolo[2,3-c]pyridin-2-yl)methyl]-5,5,5-trifluoro-4-hydroxy-2-methylpentan-2-yl]-5-fluorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCS(=O)(=O)C1=NC=C2C(=C1)C=C(N2)C[C@@](CC(C)(C)C3=C(C=C(C=C3)F)C(=O)N)(C(F)(F)F)O
2513;409049717;;1794447;440175882;145925685;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(R)-1-(4-(1-(2-((6-(6-(Dimethylamino)pyrimidin-4-yl)-1H-benzo[d]imidazol-2-yl)amino)pyridin-4-yl)ethyl)piperazin-1-yl)-3,3,3-trifluoropropan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](C1=CC(=NC=C1)NC2=NC3=C(N2)C=C(C=C3)C4=CC(=NC=N4)N(C)C)N5CCN(CC5)C(=O)CC(F)(F)F
2514;409049718;;1794447;440210612;155561913;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Nvs-malt1-C;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](C1=C(C=NC2=CC(=NN21)Cl)NC3=CC=C(C=C3)[C@H](C(F)(F)F)N(C)C(=O)C4CCS(=O)(=O)CC4)OC
2515;409049721;;1794447;442051944;146018691;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;4-[2-(methoxymethyl)-1-[(1~{R})-1-phenylethyl]-8-[[(3~{S})-pyrrolidin-3-yl]methoxy]imidazo[4,5-c]quinolin-7-yl]-3,5-dimethyl-1,2-oxazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C(=NO1)C)C2=C(C=C3C(=C2)N=CC4=C3N(C(=N4)COC)[C@H](C)C5=CC=CC=C5)OC[C@H]6CCNC6
2516;409049724;;1794447;461563597;162677482;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(3S)-N-[5-(2-azidoacetyl)-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl]-1-cyanopyrrolidine-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(C[C@H]1C(=O)NC2=NC3=C(S2)CN(CC3)C(=O)CN=[N+]=[N-])C#N
2517;409049725;;1794447;475994378;3113005;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;N-[3-(1H-imidazol-1-yl)propyl]-5,7-diphenylpyrazolo[1,5-a]pyrimidine-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)C2=CC(=NC3=CC(=NN23)C(=O)NCCCN4C=CN=C4)C5=CC=CC=C5
2518;409049726;;1794447;312441821;72901200;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;6-Methyl-2-{[(3-phenoxypropyl)amino]methyl}quinolin-4-OL;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC2=C(C=C1)NC(=CC2=O)CNCCCOC3=CC=CC=C3
2519;409049727;;1794447;440132255;52916803;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;CCR1 antagonist 8;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CS(=O)(=O)C1=NC=CC(=C1)C2(CC2)NC(=O)C3=CN=CC4=C3C=NN4C5=CC=C(C=C5)F
2520;409049728;;1794447;440157493;57861407;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;1-(2-ethoxyethyl)-6-oxo-N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridin-2-yl]pyridine-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOCCN1C=C(C=CC1=O)C(=O)NC2=NC=C(C=C2)N3C(=CC(=N3)C4=CN=CC=C4)C(F)(F)F
2521;409049731;;1794447;440177378;137332060;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;N-[(4-fluorophenyl)methyl]-2-[(3R)-5-(methylcarbamoylamino)-2',4'-dioxospiro[1,2-dihydroindene-3,5'-1,3-oxazolidine]-3'-yl]-N-[(2S)-1,1,1-trifluoropropan-2-yl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](C(F)(F)F)N(CC1=CC=C(C=C1)F)C(=O)CN2C(=O)[C@]3(CCC4=C3C=C(C=C4)NC(=O)NC)OC2=O
2522;409049732;;1794447;469851451;164631600;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;4-[3-(4-Phenylpiperidin-1-yl)imidazo[1,2-a]pyrazin-8-yl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1C2=CC=CC=C2)C3=CN=C4N3C=CN=C4N5CCOCC5
2523;409049733;;1794447;475996307;165413047;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(3R)-3-[2-[[5-chloro-3-(difluoromethyl)pyrazol-1-yl]methyl]-7-methyl-4-oxopyrazolo[1,5-a]pyrazin-5-yl]butanenitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CN(C(=O)C2=CC(=NN12)CN3C(=CC(=N3)C(F)F)Cl)[C@H](C)CC#N
2524;409049735;;1794447;440223918;140309892;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;1-(5-aminopyrimidin-2-yl)-N-(4-chloro-2,6-difluorophenyl)-7-(2-oxopyrrolidin-1-yl)-2,3-dihydroindole-5-sulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC(=O)N(C1)C2=CC(=CC3=C2N(CC3)C4=NC=C(C=N4)N)S(=O)(=O)NC5=C(C=C(C=C5F)Cl)F
2525;409049736;;1794447;442048931;156011311;10280;;Confirmatory;20240503;0;0;Active;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;[9-(4-chloro-3-ethoxyphenyl)-3-oxa-7,9-diazabicyclo[3.3.1]nonan-7-yl]-[(2R,4S)-1-(4-chlorophenyl)-4-hydroxypyrrolidin-2-yl]methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC1=C(C=CC(=C1)N2C3CN(CC2COC3)C(=O)[C@H]4C[C@@H](CN4C5=CC=C(C=C5)Cl)O)Cl
2526;409049739;;1794447;442049681;132004022;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(2~{S},3~{S})-2-(fluoranylmethyl)-~{N}7-methyl-~{N}5-[(1~{R},5~{S})-3-oxabicyclo[3.1.0]hexan-6-yl]-3-phenyl-2,3-dihydro-1-benzofuran-5,7-dicarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CNC(=O)C1=CC(=CC2=C1O[C@@H]([C@H]2C3=CC=CC=C3)CF)C(=O)NC4[C@H]5[C@@H]4COC5
2527;409049740;;1794447;461563584;162677475;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;3-amino-N,N-dimethyl-6-(4-methylsulfonylpiperidin-1-yl)-4-(trifluoromethyl)thieno[2,3-b]pyridine-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)C(=O)C1=C(C2=C(S1)N=C(C=C2C(F)(F)F)N3CCC(CC3)S(=O)(=O)C)N
2528;409049741;;1794447;136938862;56850410;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;4-[[[5-(1H-indol-5-yl)-1-methylpyrazole-3-carbonyl]amino]methyl]benzoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C(=CC(=N1)C(=O)NCC2=CC=C(C=C2)C(=O)O)C3=CC4=C(C=C3)NC=C4
2529;409049742;;1794447;312359684;59652086;10280;;Confirmatory;20240503;0;0;Active;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;5-[[benzyl(methyl)amino]methyl]-N-[(3-methoxyphenyl)methyl]-4-oxo-3H-thieno[2,3-d]pyrimidine-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CC1=CC=CC=C1)CC2=CSC3=C2C(=O)NC(=N3)C(=O)NCC4=CC(=CC=C4)OC
2530;409050114;;1794447;440159052;155541355;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Thpp-1-NC;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CC(=O)N1CCC2=C(C1)C(=NC(=N2)C3=CC=C(C=C3)Br)N(C)CC4=CC=CC=C4
2531;409050115;;1794447;440165545;155544007;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;N-[3-methyl-5-(6-pyridin-3-ylimidazo[1,2-b]pyrazol-1-yl)phenyl]-3-(pentafluoro-lambda6-sulfanyl)benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=CC(=C1)N2C=CN3C2=CC(=N3)C4=CN=CC=C4)NC(=O)C5=CC(=CC=C5)S(F)(F)(F)(F)F
2532;409050116;;1794447;440224957;6451154;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;4-[(2S)-2-(4-cyanophenyl)-2-hydroxy-2-(3-methylimidazol-4-yl)ethoxy]-3-[4-(trifluoromethoxy)phenyl]benzonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C=NC=C1[C@](COC2=C(C=C(C=C2)C#N)C3=CC=C(C=C3)OC(F)(F)F)(C4=CC=C(C=C4)C#N)O
2533;409050117;;1794447;442049255;146018690;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;iBET-BD2;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](C1=CC=CC=C1)OC2=C(C(=CC(=C2)C(=O)NC3CCC(CC3)O)F)NC(=O)C
2534;409050118;;1794447;442063095;156021282;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Inhibition;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;[(2R,4S)-1-(4-chlorophenyl)-4-hydroxypyrrolidin-2-yl]-[9-[(4-chlorophenyl)methyl]-3-oxa-7,9-diazabicyclo[3.3.1]nonan-7-yl]methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@@H](CN([C@H]1C(=O)N2CC3COCC(C2)N3CC4=CC=C(C=C4)Cl)C5=CC=C(C=C5)Cl)O
2535;409050121;;1794447;461563585;162677476;10280;;Confirmatory;20240503;0;0;Inactive;Q99720;Inhibition;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;2-phenyl-N-[5-[(1R,4R)-5-pyridazin-3-yl-2,5-diazabicyclo[2.2.1]heptan-2-yl]-1,3,4-thiadiazol-2-yl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@@H]2CN([C@H]1CN2C3=NN=C(S3)NC(=O)CC4=CC=CC=C4)C5=NN=CC=C5
2536;410126311;;1962574;494423007;171358032;10280;;Other;20240503;0;0;Unspecified;Q99720;;;ChEMBL;Sigma1 Eurofins Panlabs panel;(8S)-4-(6-azaspiro[2.5]octan-6-yl)-2-oxo-8-propyl-5,6,7,8-tetrahydro-1H-1,6-naphthyridine-3-carbonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC[C@H]1CNCC2=C1NC(=O)C(=C2N3CCC4(CC4)CC3)C#N
2537;407906196;2.5e-06;1922160;163339105;58511957;10280;362020630;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);2(3H)-Benzothiazolone, 6-(3-fluoropropyl)-3-(2-(hexahydro-1H-azepin-1-yl)ethyl)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCCN(CC1)CCN2C3=C(C=C(C=C3)CCCF)SC2=O
2538;100297863;1e-05;239347;103458196;93365;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;Fenpropimorph;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(C[C@@H](O1)C)CC(C)CC2=CC=C(C=C2)C(C)(C)C
2539;408003844;3e-05;1948305;336888945;127039559;10280;369199560;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) assessed as inhibition constant;5-(Dimethylamino)-2-[6-[5-[4-(4-methylpiperidin-1-yl)butyl]naphthalen-2-yl]oxyhexyl]isoindole-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)CCCCC2=CC=CC3=C2C=CC(=C3)OCCCCCCN4C(=O)C5=C(C4=O)C=C(C=C5)N(C)C
2540;100435163;3.6e-05;203682;103274477;11302686;10280;150841290;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity at opioid sigma-1 receptor in guinea pig brain membranes by (+)-[3H]pentazocine displacement.;1-Cyclohexyl-4-[4-(1,2,3,4-tetrahydro-naphthalen-1-yl)-butyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)N2CCN(CC2)CCCCC3CCCC4=CC=CC=C34
2541;100298504;4e-05;239347;103458393;185834;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;Morpholine, 2,6-dimethyl-4-tridecyl-, cis-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCCCCCCCCCCN1C[C@H](O[C@H](C1)C)C
2542;100464388;5e-05;204467;103677078;190867;10280;80279780;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Shows potent sigma ligands for [3H](=)-PENT-labeled sigma site in guinea pig;2-(4-Phenylpiperidinyl)ethyl 1-(4-nitrophenyl)cyclopentanecarboxylate hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)(C2=CC=C(C=C2)[N+](=O)[O-])C(=O)OCCN3CCC(CC3)C4=CC=CC=C4.Cl
2543;100464775;5e-05;203701;103677078;190867;10280;80279780;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity at sigma-1 site by inhibition of [3H](+)-pentazocine (PENT) binding in guinea pig brain;2-(4-Phenylpiperidinyl)ethyl 1-(4-nitrophenyl)cyclopentanecarboxylate hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)(C2=CC=C(C=C2)[N+](=O)[O-])C(=O)OCCN3CCC(CC3)C4=CC=CC=C4.Cl
2544;106041566;5.248e-05;444005;103707604;45487212;10280;200672710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from sigma1 receptor in human Jurkat cell membrane;2-(1-Benzylpiperidin-4-yl)thiochroman-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCC1C2CC(=O)C3=CC=CC=C3S2)CC4=CC=CC=C4
2545;106041567;5.754e-05;444005;103707589;45487204;10280;200672710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from sigma1 receptor in human Jurkat cell membrane;1-benzyl-4-(3,4-dihydro-2H-thiochromen-2-yl)piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC2=CC=CC=C2SC1C3CCN(CC3)CC4=CC=CC=C4
2546;106041252;6.607e-05;444005;103707603;23465639;10280;200672710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from sigma1 receptor in human Jurkat cell membrane;2-(1-Benzylpiperidin-4-yl)-2,3-dihydrochromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCC1C2CC(=O)C3=CC=CC=C3O2)CC4=CC=CC=C4
2547;100722953;7e-05;204635;103267978;9992101;10280;150810120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma receptor type 1,using [3H](+)-pentazocine as radioligand;4-Methyl-1-(5-phenylpentyl)piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)CCCCCC2=CC=CC=C2
2548;163949961;8e-05;486624;103458196;93365;10280;204937180;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of (+)-[3H]pentazocine from sigma 1 receptor expressed in Saccharomyces cerevisiae WA0;Fenpropimorph;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(C[C@@H](O1)C)CC(C)CC2=CC=C(C=C2)C(C)(C)C
2549;407907023;8e-05;1922166;381854209;9817231;10280;362020630;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to human sigma 1 receptor;3-(4-methylphenyl)-5-(1-propyl-3,6-dihydro-2H-pyridin-5-yl)-1,2-oxazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCC=C(C1)C2=CC(=NO2)C3=CC=C(C=C3)C
2550;106041565;8.913e-05;444005;103707536;45487184;10280;200672710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from sigma1 receptor in human Jurkat cell membrane;1'-benzylspiro[4H-3,1-benzoxathiine-2,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCC12OCC3=CC=CC=C3S2)CC4=CC=CC=C4
2551;100722949;9e-05;204635;103267550;10358719;10280;150810120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma receptor type 1,using [3H](+)-pentazocine as radioligand;1-(5,5-Diphenyl-pentyl)-4-methyl-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)CCCCC(C2=CC=CC=C2)C3=CC=CC=C3
2552;106041559;9.772e-05;444005;103707575;45487199;10280;200672710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from sigma1 receptor in human Jurkat cell membrane;1'-benzylspiro[4H-1,3-benzodioxine-2,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCC12OCC3=CC=CC=C3O2)CC4=CC=CC=C4
2553;106041564;0.0001096;444005;103707616;45487215;10280;200672710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from sigma1 receptor in human Jurkat cell membrane;2-[1-(2-Phenylethyl)piperidin-4-yl]-2,3-dihydrochromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCC1C2CC(=O)C3=CC=CC=C3O2)CCC4=CC=CC=C4
2554;100722943;0.00013;204635;103267380;44310585;10280;150810120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma receptor type 1,using [3H](+)-pentazocine as radioligand;1-(5,5-Diphenyl-pent-4-enyl)-4-methyl-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)CCCC=C(C2=CC=CC=C2)C3=CC=CC=C3
2555;100546288;0.00014;203689;103283944;10835977;10280;96511500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma-1 receptor in guinea pig brain membranes;N-(2-Azepan-1-yl-ethyl)-4-iodo-N-methyl-benzenesulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCN1CCCCCC1)S(=O)(=O)C2=CC=C(C=C2)I
2556;100478315;0.00017;203696;103185474;18703016;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;Phenethyl-(5-phenyl-pentyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)CCCCCNCCC2=CC=CC=C2
2557;100626486;0.00017;229194;103383719;5026275;10280;13101140;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+) -3PPP from sigma receptor in guinea pig brain membranes;(2-Azepan-1-yl-ethyl)-[2-(3,4-dichloro-phenyl)-ethyl]-methyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=C(C=C1)Cl)Cl)CCN2CCCCCC2
2558;100722939;0.00017;204635;103185474;18703016;10280;150810120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma receptor type 1,using [3H](+)-pentazocine as radioligand;Phenethyl-(5-phenyl-pentyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)CCCCCNCCC2=CC=CC=C2
2559;100546520;0.00018;203689;103284578;10595615;10280;96511500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma-1 receptor in guinea pig brain membranes;N-(2-Azepan-1-yl-ethyl)-4-bromo-N-methyl-benzenesulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCN1CCCCCC1)S(=O)(=O)C2=CC=C(C=C2)Br
2560;100478312;0.00019;203696;103185508;18790196;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;Benzyl-methyl-(5-phenyl-pentyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCCCC1=CC=CC=C1)CC2=CC=CC=C2
2561;100297859;0.0002;239347;103167216;3559;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2562;100298502;0.0002;239347;103458117;9417;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;Opipramol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCN2C3=CC=CC=C3C=CC4=CC=CC=C42)CCO
2563;100451368;0.0002;204435;103672017;45260913;10280;81026510;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using the novel [3H]-(+/-)-4 as radioligand;"(2R,4S)-N,N,2-trimethyl-4-phenyl-3,4-dihydro-1H-naphthalen-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C[C@]1(C[C@H](C2=CC=CC=C2C1)C3=CC=CC=C3)N(C)C.Cl
2564;106041561;0.0002089;444005;103707584;2427316;10280;200672710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from sigma1 receptor in human Jurkat cell membrane;1'-Benzylspiro[chroman-2,4'-piperidin]-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCC12CC(=O)C3=CC=CC=C3O2)CC4=CC=CC=C4
2565;363850271;0.00021;1449796;103167216;3559;10280;283855030;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 in human MDA-MB-468 cell membranes;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2566;100435170;0.00022;203682;103275199;11416825;10280;150841290;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity at opioid sigma-1 receptor in guinea pig brain membranes by (+)-[3H]pentazocine displacement.;1-Cyclohexyl-4-(4-naphthalen-1-yl-butyl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)N2CCN(CC2)CCCCC3=CC=CC4=CC=CC=C43
2567;100478429;0.00025;203696;103185462;9925741;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;Methyl-phenethyl-(5-phenyl-pentyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCCCC1=CC=CC=C1)CCC2=CC=CC=C2
2568;100722947;0.00025;204635;103185462;9925741;10280;150810120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma receptor type 1,using [3H](+)-pentazocine as radioligand;Methyl-phenethyl-(5-phenyl-pentyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCCCC1=CC=CC=C1)CCC2=CC=CC=C2
2569;100627934;0.0002512;204453;103671434;45260529;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"(4aR,10bR)-3-cyclohexyl-2,4,4a,5,6,10b-hexahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CCC(CC1)N2CC[C@@H]3[C@H](C2)CCC4=CC=CC=C34.Cl
2570;100478464;0.00026;203696;103186269;18790234;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;(5-Cyclohexyl-pentyl)-dimethyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCCCCC1CCCCC1
2571;100626494;0.00026;229194;103383721;9883360;10280;13101140;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+) -3PPP from sigma receptor in guinea pig brain membranes;[2-(3,4-Dichloro-phenyl)-ethyl]-methyl-(2-piperidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=C(C=C1)Cl)Cl)CCN2CCCCC2
2572;100464304;0.00027;203701;103671274;45260426;10280;80279780;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity at sigma-1 site by inhibition of [3H](+)-pentazocine (PENT) binding in guinea pig brain;"3-(4-Phenylpiperidin-1-yl)propyl 1-(4-nitrophenyl)cyclopentane-1-carboxylate;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)(C2=CC=C(C=C2)[N+](=O)[O-])C(=O)OCCCN3CCC(CC3)C4=CC=CC=C4.Cl
2573;321525566;0.00027;658997;160705096;70696149;10280;225129080;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H](+)pentazocine from sigma-1 receptor expressed in human Jurkat cell membranes after 2 hrs by liquid scintillation spectroscopy;1-[4-[1-Adamantyl(phenyl)methyl]phenyl]-4-cyclohexylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCC(CC1)N2CCN(CC2)C3=CC=C(C=C3)C(C4=CC=CC=C4)C56CC7CC(C5)CC(C7)C6
2574;100478473;0.00028;203696;103185461;18790194;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;(5-Phenyl-pentyl)-(3-phenyl-propyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)CCCCCNCCCC2=CC=CC=C2
2575;100471783;0.0002884;203852;103321238;15657202;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;"cis-3-Chloro-6-dimethylamino-8-phenyl-5,6,7,8-tetrahydro-naphthalen-2-ol; hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)C1CC(C2=CC(=C(C=C2C1)Cl)O)C3=CC=CC=C3
2576;100451376;0.00029;204435;103672153;45261009;10280;81026510;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using the novel [3H]-(+/-)-4 as radioligand;"(6R,8S)-3-chloro-6-(dimethylamino)-8-phenyl-5,6,7,8-tetrahydronaphthalen-2-ol;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CN(C)[C@@H]1C[C@H](C2=CC(=C(C=C2C1)Cl)O)C3=CC=CC=C3.Cl
2577;100478469;0.00029;203696;103186088;18790258;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;Methyl-(5-phenyl-pentyl)-propyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN(C)CCCCCC1=CC=CC=C1
2578;100630341;0.00029;229195;103340139;44342741;10280;13194930;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain, using [3H](+)-3-PPP as radioligand.;(1R,13S)-1,13-dimethyl-10-pentyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCCN1CC[C@@]2([C@@H](C1CC3=C2C=C(C=C3)O)C)C
2579;100292949;0.0003;239105;103442089;11407131;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;3-(4-Benzyl-piperazin-1-ylmethyl)-3,4-dihydro-2H-naphthalen-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2CC3=CC=CC=C3C(=O)C2)CC4=CC=CC=C4
2580;100292955;0.0003;239105;103442059;11338418;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;1-Benzyl-4-chroman-3-ylmethyl-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2CC3=CC=CC=C3OC2)CC4=CC=CC=C4
2581;100292963;0.0003;239105;103442090;10758200;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;1-Benzyl-4-chroman-2-ylmethyl-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2=CC=CC=C2OC1CN3CCN(CC3)CC4=CC=CC=C4
2582;100435176;0.00031;203682;103274644;11439301;10280;150841290;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity at opioid sigma-1 receptor in guinea pig brain membranes by (+)-[3H]pentazocine displacement.;1-Cyclohexyl-4-(5-methoxy-1,2,3,4-tetrahydro-naphthalen-1-ylmethyl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC=CC2=C1CCCC2CN3CCN(CC3)C4CCCCC4
2583;100630338;0.00031;229195;103268004;587944;10280;13194930;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain, using [3H](+)-3-PPP as radioligand.;1-[2-(3,4-Dichlorophenyl)ethyl]-4-propylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCN(CC1)CCC2=CC(=C(C=C2)Cl)Cl
2584;100478743;0.00032;203696;103185509;18790272;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;Benzyl-(5-phenyl-pentyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)CCCCCNCC2=CC=CC=C2
2585;100558843;0.00032;203684;103389997;10691769;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;[4-[4-(3-Phenylpropyl)piperazine-1-yl]-4-oxobutyl]carbamic acid tert-butyl ester;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC(=O)NCCCC(=O)N1CCN(CC1)CCCC2=CC=CC=C2
2586;100628014;0.0003236;204453;103677058;45264284;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"(4aR,10bR)-3-(2-phenylethyl)-2,4,4a,5,6,10b-hexahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC2=CC=CC=C2[C@H]3[C@@H]1CN(CC3)CCC4=CC=CC=C4.Cl
2587;100458859;0.00033;229213;103167216;3559;10280;79028700;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Tested for [3H](+)-pentazocine binding to sigma-1 receptor in guinea pig brain membrane;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2588;100399845;0.00034;204632;103671566;10335163;10280;127477840;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma receptor type 1 in guinea pig brain membrane without cerebellum;"1-[(2S)-1-(4-chlorophenoxy)propan-2-yl]-4-methylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1CCN(CC1)[C@@H](C)COC2=CC=C(C=C2)Cl.Cl
2589;100481034;0.00034;204460;103186198;126388;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against [3H]-3-PPP labelled sigma sites;N-(2-(3,4-Dichlorophenyl)ethyl)-N-methyl-2-(1-pyrrolidinyl)ethylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=C(C=C1)Cl)Cl)CCN2CCCC2
2590;100626484;0.00034;229194;103186198;126388;10280;13101140;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+) -3PPP from sigma receptor in guinea pig brain membranes;N-(2-(3,4-Dichlorophenyl)ethyl)-N-methyl-2-(1-pyrrolidinyl)ethylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=C(C=C1)Cl)Cl)CCN2CCCC2
2591;100630345;0.00034;229195;103186198;126388;10280;13194930;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain, using [3H](+)-3-PPP as radioligand.;N-(2-(3,4-Dichlorophenyl)ethyl)-N-methyl-2-(1-pyrrolidinyl)ethylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=C(C=C1)Cl)Cl)CCN2CCCC2
2592;100435169;0.00036;203682;103274576;11268724;10280;150841290;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity at opioid sigma-1 receptor in guinea pig brain membranes by (+)-[3H]pentazocine displacement.;1-Cyclohexyl-4-[3-(6-methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-propyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC2=C(C=C1)C(CCC2)CCCN3CCN(CC3)C4CCCCC4
2593;100478472;0.00038;203696;103185460;18790190;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;Methyl-(5-phenyl-pentyl)-(3-phenyl-propyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCCCC1=CC=CC=C1)CCCC2=CC=CC=C2
2594;100626492;0.00038;229194;103383750;15113313;10280;13101140;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+) -3PPP from sigma receptor in guinea pig brain membranes;N-(3,4-Dichlorobenzyl)-N-methyl-2-(1-pyrrolidinyl)ethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCN1CCCC1)CC2=CC(=C(C=C2)Cl)Cl
2595;407906174;0.00038;1922168;103237360;10474335;10280;362020630;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [H3]DTG from sigma 1 receptor (unknown origin) by competition binding assay;1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCCC2CCCN3CCN(CC3)C4CCCCC4
2596;408003842;0.00038;1948305;103237360;10474335;10280;369199560;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) assessed as inhibition constant;1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCCC2CCCN3CCN(CC3)C4CCCCC4
2597;100627870;0.00039;229196;103268577;594236;10280;13194930;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain, using [3H](+)-pentazocine as radioligand.;1-[2-(3,4-Dichlorophenyl)ethyl]-4-(3-fluoropropyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCF)CCC2=CC(=C(C=C2)Cl)Cl
2598;100702228;0.00039;204766;103417069;763622;10280;126395730;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards Sigma-1 receptor;1-Benzyl-4-(3-methoxybenzyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC(=C1)CN2CCN(CC2)CC3=CC=CC=C3
2599;372384974;0.00039;1736834;103182112;3345;10280;320874650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma 1 receptor (unknown origin);Fentanyl;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
2600;100292832;0.0004;239105;103442152;11407133;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;2-(4-Benzyl-piperazin-1-ylmethyl)-3,4-dihydro-2H-naphthalen-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2=CC=CC=C2C(=O)C1CN3CCN(CC3)CC4=CC=CC=C4
2601;100435060;0.0004;203682;103274291;11381875;10280;150841290;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity at opioid sigma-1 receptor in guinea pig brain membranes by (+)-[3H]pentazocine displacement.;1-Cyclohexyl-4-(5-methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC=CC2=C1CCCC2N3CCN(CC3)C4CCCCC4
2602;106041558;0.0004365;444005;103707523;45487178;10280;200672710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from sigma1 receptor in human Jurkat cell membrane;1'-benzylspiro[2,4-dihydro-1H-naphthalene-3,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC2(CCN(CC2)CC3=CC=CC=C3)CC4=CC=CC=C41
2603;100768700;0.00044;204149;103167216;3559;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma opioid receptor type 1;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2604;100741917;0.00045;203989;103308172;44327700;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor in guinea pig brain preparation was estimated using [3H]3-PPP as radioligand;4-{4-[4-(4-Methoxy-phenyl)-3,6-dihydro-2H-pyridin-1-yl]-butyl}-pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC=C(C=C1)C2=CCN(CC2)CCCCC3=CC=NC=C3
2605;100546522;0.00046;203689;103283881;10023529;10280;96511500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma-1 receptor in guinea pig brain membranes;4-Iodo-N-(2-piperidin-1-yl-ethyl)-benzenesulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCN(CC1)CCNS(=O)(=O)C2=CC=C(C=C2)I
2606;100702229;0.00046;204766;103417538;765219;10280;126395730;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards Sigma-1 receptor;1-(3-Chlorobenzyl)-4-benzylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2=CC=CC=C2)CC3=CC(=CC=C3)Cl
2607;100702226;0.00047;204766;103417508;762919;10280;126395730;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards Sigma-1 receptor;1-Benzyl-4-(4-methoxybenzyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)CN2CCN(CC2)CC3=CC=CC=C3
2608;103125587;0.00047;418680;103417508;762919;10280;192431730;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor;1-Benzyl-4-(4-methoxybenzyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)CN2CCN(CC2)CC3=CC=CC=C3
2609;100478309;0.00048;203696;103185535;44273063;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;(4-Phenyl-butyl)-(5-phenyl-pentyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)CCCCCNCCCCC2=CC=CC=C2
2610;100478457;0.00048;203696;103186297;10331473;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;Piperidine, 1-(5-phenylpentyl)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCCCCC2=CC=CC=C2
2611;100722936;0.00048;204635;103267893;44310858;10280;150810120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma receptor type 1,using [3H](+)-pentazocine as radioligand;(5,5-Diphenyl-pentyl)-methyl-phenethyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCCC(C1=CC=CC=C1)C2=CC=CC=C2)CCC3=CC=CC=C3
2612;100292610;0.00049;239200;103183665;11722772;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;1-(4-Phenylbutyl)-4-benzylpiperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CCCCC3=CC=CC=C3
2613;100615439;0.00049;204447;103321245;9905985;10280;16560440;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]-(+)-3-PPP binding to sigma of guinea pig brain;[2-(3,4-Dichloro-phenyl)-ethyl]-(2-pyrrolidin-1-yl-cyclohexyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC[C@@H]([C@@H](C1)NCCC2=CC(=C(C=C2)Cl)Cl)N3CCCC3
2614;100297862;0.0005;239347;103181613;9799239;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;5,8a-Dimethyl-2-(1,5,9-trimethyl-decyl)-decahydro-isoquinolin-6-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1[C@@H]2CCN(C[C@]2(CC[C@@H]1O)C)C(C)CCCC(C)CCCC(C)C
2615;100298517;0.0005;239347;103458147;44398036;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;(2-{4-[(2-Chloro-benzylamino)-methyl]-cyclohexyl}-ethyl)-(2-chloro-phenyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC(CCC1CCNC2=CC=CC=C2Cl)CNCC3=CC=CC=C3Cl
2616;100456211;0.0005;229183;103360154;3083457;10280;79028690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor in bovine cerebellum using 2.0 nM [3H]haloperidol in the presence of 25 nM unlabeled spiperone;N-Phprop-clphetp;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CN(CC=C1C2=CC=C(C=C2)Cl)CCC(=O)C3=CC=CC=C3
2617;100464783;0.0005;203701;103677050;45264279;10280;80279780;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity at sigma-1 site by inhibition of [3H](+)-pentazocine (PENT) binding in guinea pig brain;"3-(4-Phenylpiperidin-1-yl)propyl 1-phenylcyclopentane-1-carboxylate;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)(C2=CC=CC=C2)C(=O)OCCCN3CCC(CC3)C4=CC=CC=C4.Cl
2618;100478455;0.0005;203696;103186067;10265752;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;((S)-1-Methyl-2-phenyl-ethyl)-(5-phenyl-pentyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](CC1=CC=CC=C1)NCCCCCC2=CC=CC=C2
2619;100513228;0.0005;229200;103383706;10782120;10280;89413830;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor using radioligand ([3H](+)-pentazocine) binding assay;1,4-Bis(3-phenylpropyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)CCCC3=CC=CC=C3
2620;100543130;0.0005;203698;103216164;10380647;10280;95728800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was tested for its binding affinity towards sigma 1 receptor using [3H](+)-pentazocine from guinea pig brain;Spipethiane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCN(CC2)CC3=CC=CC=C3)SC4=CC=CC=C41
2621;367478258;0.0005;1655949;442059881;156019016;10280;324354210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human Sigma 1 receptor by radioligand displacement assay;"4-Benzyl-1-(1,3-dithiolan-4-ylmethyl)piperidine;oxalic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3CSCS3.C(=O)(C(=O)O)O
2622;100451367;0.00051;204435;103672017;45260913;10280;81026510;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using the novel [3H]-(+/-)-4 as radioligand;"(2R,4S)-N,N,2-trimethyl-4-phenyl-3,4-dihydro-1H-naphthalen-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C[C@]1(C[C@H](C2=CC=CC=C2C1)C3=CC=CC=C3)N(C)C.Cl
2623;100464780;0.00051;203701;103671356;45260485;10280;80279780;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity at sigma-1 site by inhibition of [3H](+)-pentazocine (PENT) binding in guinea pig brain;"4-(4-Phenylpiperidin-1-yl)butyl 1-phenylcyclopentane-1-carboxylate;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)(C2=CC=CC=C2)C(=O)OCCCCN3CCC(CC3)C4=CC=CC=C4.Cl
2624;100626489;0.00051;229194;103384340;9796923;10280;13101140;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+) -3PPP from sigma receptor in guinea pig brain membranes;1-Pyrrolidineethanamine, N-(2-(3,4-dichlorophenyl)ethyl)-N-ethyl-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CCC1=CC(=C(C=C1)Cl)Cl)CCN2CCCC2
2625;100627874;0.00052;229196;103268651;604376;10280;13194930;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain, using [3H](+)-pentazocine as radioligand.;1-[2-(3,4-Dichlorophenyl)ethyl]-4-(5-fluoropentyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCCCF)CCC2=CC(=C(C=C2)Cl)Cl
2626;100473788;0.0005248;203852;103321169;132954;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;N,N-dimethyl-4-phenyl-1,2,3,4-tetrahydronaphthalen-2-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)C1CC(C2=CC=CC=C2C1)C3=CC=CC=C3
2627;100630340;0.00054;229195;103267909;15175722;10280;13194930;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain, using [3H](+)-3-PPP as radioligand.;1-[2-[N-Methyl-N-[2-(4,5-dichloro-2-iodophenyl)ethyl]amino]ethyl]pyrrolidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=C(C=C1I)Cl)Cl)CCN2CCCC2
2628;100449433;0.00055;204443;103274444;44313950;10280;83608750;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine at sigma receptor in guinea pig brain membrane was determined;1-(3,4-Dichlorophenethyl)-4-butylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCN1CCN(CC1)CCC2=CC(=C(C=C2)Cl)Cl
2629;388740021;0.00057;1797293;386051265;118282824;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 20;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC(=C(C=C3C2)OC)OC
2630;388878824;0.00057;1797475;386051265;118282824;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 20;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC(=C(C=C3C2)OC)OC
2631;389383288;0.00057;1804286;386051265;118282824;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 20;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC(=C(C=C3C2)OC)OC
2632;100702230;0.00058;204766;103417547;764022;10280;126395730;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards Sigma-1 receptor;1-Benzyl-4-(3,4-dichlorobenzyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2=CC=CC=C2)CC3=CC(=C(C=C3)Cl)Cl
2633;106041560;0.0005888;444005;103216164;10380647;10280;200672710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from sigma1 receptor in human Jurkat cell membrane;Spipethiane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC2(CCN(CC2)CC3=CC=CC=C3)SC4=CC=CC=C41
2634;100746111;0.00059;204147;103265811;44309721;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma opioid receptor type 1 in guinea pig brain homogenate with 0.5 nM [3H](+)-PENT;5,5-Diphenyl-3-[6-(4-phenyl-piperidin-1-yl)-hexyl]-imidazolidine-2,4-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1C2=CC=CC=C2)CCCCCCN3C(=O)C(NC3=O)(C4=CC=CC=C4)C5=CC=CC=C5
2635;254408911;0.00059;630467;124958368;50994498;10280;219625780;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor by radioligand displacement assay;1'-Benzyl-3-(2-fluoroethyl)-3h-spiro[isobenzofurane-1,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3C(O2)CCF)CC4=CC=CC=C4
2636;100298515;0.0006;239347;103253334;15163141;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;1'-Butyl-3,4-dihydrospiro[naphthalene-1(2H),4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCN1CCC2(CCCC3=CC=CC=C32)CC1
2637;100464763;0.0006;203702;103167216;3559;10280;80279780;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;The compound was evaluated for affinity at sigma-1 site by inhibition of [3H](+)-pentazocine (PENT) binding in guinea pig brain.;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2638;100565309;0.0006;203703;103177652;10017936;10280;95442130;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;The compound was tested for the affinity on sigma 1 receptor using [3H]- pentazocine as radioligand;3-(2-Piperidinoethyl)-6-propylbenzothiazol-2(3H)-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCC1=CC2=C(C=C1)N(C(=O)S2)CCN3CCCCC3
2639;100746121;0.0006;204147;103167216;3559;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma opioid receptor type 1 in guinea pig brain homogenate with 0.5 nM [3H](+)-PENT;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2640;345593883;0.0006;1197502;312385708;118731572;10280;256029320;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor in human Jurkat cells after 120 mins by liquid scintillation counting analysis;3-[3-[Benzyl(methyl)amino]propyl]-6-bromo-1,3-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1C2=C(C=C(C=C2)Br)SC1=O)CC3=CC=CC=C3
2641;367478261;0.0006;1655949;442061455;156020131;10280;324354210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human Sigma 1 receptor by radioligand displacement assay;"4-Benzyl-1-[(2,2-dimethyl-1,3-dioxolan-4-yl)methyl]piperidine;oxalic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1(OCC(O1)CN2CCC(CC2)CC3=CC=CC=C3)C.C(=O)(C(=O)O)O
2642;367478795;0.0006;1655949;442046446;156009509;10280;324354210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human Sigma 1 receptor by radioligand displacement assay;"1-Benzyl-4-[(2,2-dimethyl-1,3-dithiolan-4-yl)methyl]piperazine;oxalic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1(SCC(S1)CN2CCN(CC2)CC3=CC=CC=C3)C.C(=O)(C(=O)O)O.C(=O)(C(=O)O)O
2643;100435174;0.00061;203682;103275254;11233111;10280;150841290;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity at opioid sigma-1 receptor in guinea pig brain membranes by (+)-[3H]pentazocine displacement.;1-Cyclohexyl-4-[3-(1,2,3,4-tetrahydro-naphthalen-1-yl)-propyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)N2CCN(CC2)CCCC3CCCC4=CC=CC=C34
2644;100464778;0.00061;203701;103671277;45260428;10280;80279780;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity at sigma-1 site by inhibition of [3H](+)-pentazocine (PENT) binding in guinea pig brain;"5-(4-Phenylpiperidin-1-yl)pentyl 1-phenylcyclopentane-1-carboxylate;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)(C2=CC=CC=C2)C(=O)OCCCCCN3CCC(CC3)C4=CC=CC=C4.Cl
2645;106041563;0.0006166;444005;103217373;10661409;10280;200672710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from sigma1 receptor in human Jurkat cell membrane;1''-Benzylspiro[chroman-2,4''-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CC2(CCN(CC2)CC3=CC=CC=C3)OC4=CC=CC=C41
2646;100543131;0.00062;203698;103217373;10661409;10280;95728800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was tested for its binding affinity towards sigma 1 receptor using [3H](+)-pentazocine from guinea pig brain;1''-Benzylspiro[chroman-2,4''-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCN(CC2)CC3=CC=CC=C3)OC4=CC=CC=C41
2647;100627296;0.00062;229194;103384129;15113312;10280;13101140;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+) -3PPP from sigma receptor in guinea pig brain membranes;2-(3,4-Dichlorophenyl)-N-[(S)-1-methyl-2-(1-pyrrolidinyl)ethyl]-N-methylethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](CN1CCCC1)N(C)CCC2=CC(=C(C=C2)Cl)Cl
2648;100546526;0.00063;203689;103284043;10522573;10280;96511500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma-1 receptor in guinea pig brain membranes;N-(2-Azepan-1-yl-ethyl)-4-bromo-benzenesulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCCN(CC1)CCNS(=O)(=O)C2=CC=C(C=C2)Br
2649;100464771;0.00065;203701;103676292;45263816;10280;80279780;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity at sigma-1 site by inhibition of [3H](+)-pentazocine (PENT) binding in guinea pig brain;"3-(4-Phenylpiperidin-1-yl)propyl 1-(4-methoxyphenyl)cyclopentane-1-carboxylate;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)C2(CCCC2)C(=O)OCCCN3CCC(CC3)C4=CC=CC=C4.Cl
2650;100722945;0.00066;204635;103267892;44310857;10280;150810120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma receptor type 1,using [3H](+)-pentazocine as radioligand;(5,5-Diphenyl-pentyl)-phenethyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)CCNCCCCC(C2=CC=CC=C2)C3=CC=CC=C3
2651;100322589;0.00067;204151;103383077;44328085;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 1 using [3H](+)-pentazocine in guinea pig brain membranes;(9S,13S)-10-benzyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1[C@@H]2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)O
2652;100485146;0.00067;204636;103318178;90748;10280;76368600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured on Sigma receptor type 1 from guinea pig brain membranes using [3H]pentazocine as radioligand.;3-Benzyl-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)O
2653;100487780;0.00067;204638;103318178;90748;10280;76368610;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was measured on Sigma receptor type 1 using [3H]- pentazocine as radioligand;3-Benzyl-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)O
2654;100496817;0.00067;204761;103383077;44328085;10280;78533490;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity at Sigma receptor type 1, displacement of [3H](+)-pentazocine from guinea pig brain membranes;(9S,13S)-10-benzyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)O
2655;100523892;0.00067;204793;103225534;9864749;10280;91718750;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Receptor binding affinity against Sigma-1 receptor from guinea pig membranes;4-[1-((E)-3-Iodo-allyl)-piperidin-4-ylmethoxy]-benzonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1COC2=CC=C(C=C2)C#N)C/C=C/I
2656;334073806;0.00067;737384;164132836;5461916;10280;235662450;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to human brain sigma1 receptor;4-[[1-[(E)-3-(123I)iodanylprop-2-enyl]piperidin-4-yl]methoxy]benzonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1COC2=CC=C(C=C2)C#N)C/C=C/[123I]
2657;100386145;0.00069;204153;103378319;10266413;10280;117841480;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma opioid receptor type 1 affinity in guinea pig brain by employing [3H](+)-pentazocine as radioligand.;1'-Benzylspiro[isochroman-1,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COC2(CCN(CC2)CC3=CC=CC=C3)C4=CC=CC=C41
2658;100435175;0.00069;203682;103274328;11451147;10280;150841290;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity at opioid sigma-1 receptor in guinea pig brain membranes by (+)-[3H]pentazocine displacement.;5-[3-(4-Cyclohexyl-piperazin-1-yl)-propyl]-5,6,7,8-tetrahydro-naphthalen-2-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)N2CCN(CC2)CCCC3CCCC4=C3C=CC(=C4)O
2659;100354358;0.0007;204790;103238223;10645614;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-[(3R)-1-Cyclopentyl-3-pyrrolidinyl]-1-methoxy-4-bromo-2-naphthalenecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)N[C@@H]3CCN(C3)C4CCCC4
2660;100436302;0.0007;204148;103437159;44386517;10280;72415060;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to Sigma opioid receptor type 1 in guinea pig brain homogenate with 0.5 nM of [3H](+)-PENT as radioligand;5,5-Diphenyl-3-[5-(4-phenylpiperidin-1-yl)pentyl]imidazolidine-2,4-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1C2=CC=CC=C2)CCCCCN3C(=O)C(NC3=O)(C4=CC=CC=C4)C5=CC=CC=C5
2661;100549946;0.0007;203691;103186198;126388;10280;96511500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition Constant for 4-[125I]-IPBS binding to sigma 1 receptor in guinea pig brain membranes;N-(2-(3,4-Dichlorophenyl)ethyl)-N-methyl-2-(1-pyrrolidinyl)ethylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCC1=CC(=C(C=C1)Cl)Cl)CCN2CCCC2
2662;407996331;0.0007;1946583;482072744;168287735;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;5-[[4-[(4-chloro-3-fluorophenyl)methoxy]piperidin-1-yl]methyl]-1H-indazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=C(C=C2)Cl)F)CC3=CC4=C(C=C3)NN=C4
2663;100471782;0.0007079;203852;103321238;15657202;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;"cis-3-Chloro-6-dimethylamino-8-phenyl-5,6,7,8-tetrahydro-naphthalen-2-ol; hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)C1CC(C2=CC(=C(C=C2C1)Cl)O)C3=CC=CC=C3
2664;407996248;0.0007079;1946583;482070803;168286314;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;5-[[4-[[3-(trifluoromethyl)phenyl]methoxy]piperidin-1-yl]methyl]-1H-indazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=CC=C2)C(F)(F)F)CC3=CC4=C(C=C3)NN=C4
2665;100559081;0.00072;203684;103389886;10338172;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;1-(3-Phenylpropyl)-4-(3-nitrophenethyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)CCC3=CC(=CC=C3)[N+](=O)[O-]
2666;100627647;0.0007244;204452;131284018;54585888;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;1'-Benzyl-2,3-dihydrospiro[indene-1,4'-piperidine] hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC2(CCN(CC2)CC3=CC=CC=C3)C4=CC=CC=C41.Cl
2667;100627301;0.00073;229194;103383625;15113308;10280;13101140;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+) -3PPP from sigma receptor in guinea pig brain membranes;2-(3,4-Dichlorophenyl)-N-(2-diethylaminoethyl)-N-methylethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CC)CCN(C)CCC1=CC(=C(C=C1)Cl)Cl
2668;100478419;0.00076;203696;103186298;18703006;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;1-(5-Phenylpentyl)pyrrolidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(C1)CCCCCC2=CC=CC=C2
2669;100292959;0.0008;239105;103442049;10758083;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;1-Benzyl-4-(1,2,3,4-tetrahydro-naphthalen-2-ylmethyl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2=CC=CC=C2CC1CN3CCN(CC3)CC4=CC=CC=C4
2670;100617496;0.0008;204001;103336908;3035672;10280;16627250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;The compound was tested for its binding affinity towards Sigma opioid receptor in guinea pig brain membranes;4-Phenyl-1-(4-phenylbutyl)piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1C2=CC=CC=C2)CCCCC3=CC=CC=C3
2671;100722940;0.0008;204635;103267515;44310664;10280;150810120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma receptor type 1,using [3H](+)-pentazocine as radioligand;4-Methyl-1-(3-thioxanthen-9-ylidenepropyl)piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)CCC=C2C3=CC=CC=C3SC4=CC=CC=C42
2672;100478427;0.00081;203696;103186270;18790208;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;Benzyl-(5-cyclohexyl-pentyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)CCCCCNCC2=CC=CC=C2
2673;100297844;0.00083;239347;103177556;5567;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;Trifluperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC(=CC=C2)C(F)(F)F)O)CCCC(=O)C3=CC=C(C=C3)F
2674;100627305;0.00083;229194;103383626;9883362;10280;13101140;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+) -3PPP from sigma receptor in guinea pig brain membranes;[2-(3,4-Dichloro-phenyl)-ethyl]-methyl-(1-methyl-2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CN1CCCC1)N(C)CCC2=CC(=C(C=C2)Cl)Cl
2675;100626485;0.00084;229194;103383718;15113306;10280;13101140;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+) -3PPP from sigma receptor in guinea pig brain membranes;2-(3-Chlorophenyl)-N-methyl-N-[2-(pyrrolidin-1-yl)ethyl]ethan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=CC=C1)Cl)CCN2CCCC2
2676;100399843;0.00086;204632;103260245;5370189;10280;127477840;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma receptor type 1 in guinea pig brain membrane without cerebellum;1,3-Pentadiene, 1-(3,4-methylenedioxybenzyl)-5-(piperidine-1-yl)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCN(CC1)C/C=C/C=C/C2=CC3=C(C=C2)OCO3
2677;100399846;0.00086;204632;103671548;45260623;10280;127477840;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma receptor type 1 in guinea pig brain membrane without cerebellum;"1-[2-(4-Chlorophenoxy)ethyl]-4-methylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1CCN(CC1)CCOC2=CC=C(C=C2)Cl.Cl
2678;100630337;0.00086;229195;103268651;604376;10280;13194930;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain, using [3H](+)-3-PPP as radioligand.;1-[2-(3,4-Dichlorophenyl)ethyl]-4-(5-fluoropentyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCCCF)CCC2=CC(=C(C=C2)Cl)Cl
2679;100546184;0.00087;203685;103278468;10023073;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-Benzyl-piperidin-4-yl)-2-(3-bromo-phenyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)Br)CC3=CC=CC=C3
2680;100464784;0.00088;203701;103677314;45264470;10280;80279780;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity at sigma-1 site by inhibition of [3H](+)-pentazocine (PENT) binding in guinea pig brain;"3-(4-Phenylpiperidin-1-yl)propyl 1-(4-iodophenyl)cyclopentane-1-carboxylate;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)(C2=CC=C(C=C2)I)C(=O)OCCCN3CCC(CC3)C4=CC=CC=C4.Cl
2681;100722944;0.00089;204635;103267898;44310861;10280;150810120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma receptor type 1,using [3H](+)-pentazocine as radioligand;(5,5-Diphenyl-pent-4-enyl)-methyl-phenethyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCC=C(C1=CC=CC=C1)C2=CC=CC=C2)CCC3=CC=CC=C3
2682;100478428;0.0009;203696;103185289;44272942;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;N-[(R)-alpha-Methylphenethyl]-5-phenyl-1-pentanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CC1=CC=CC=C1)NCCCCCC2=CC=CC=C2
2683;100617499;0.0009;204450;103336983;126229;10280;16627250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;The compound was tested for its binding affinity towards sigma receptor in guinea pig brain membranes;4-Phenyl-1-(5-phenylpentyl)piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1C2=CC=CC=C2)CCCCCC3=CC=CC=C3
2684;101830502;0.0009;255057;103468569;44403241;10280;161400110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory concentration against opioid receptor sigma 1 of guinea pig cerebral cortex using [3H](+)-pentazocine upon incubation for 150 minutes at 22 degree C;(10aS)-2-(2-piperidin-1-ylethyl)-3-sulfanylidene-10,10a-dihydro-5H-imidazo[1,5-b]isoquinolin-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CCN(CC1)CCN2C(=O)[C@@H]3CC4=CC=CC=C4CN3C2=S
2685;345594073;0.0009;1197502;312385704;118731568;10280;256029320;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor in human Jurkat cells after 120 mins by liquid scintillation counting analysis;3-[3-[Benzyl(methyl)amino]propyl]-6-bromo-1,3-benzoxazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1C2=C(C=C(C=C2)Br)OC1=O)CC3=CC=CC=C3
2686;341083369;0.00091;1054575;194144919;76313525;10280;241409500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);6-Benzyl-8-[(4-methoxyphenyl)methyl]-6,8-diazabicyclo[3.2.2]nonane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)CN2CC3CCCC2CN3CC4=CC=CC=C4
2687;100323568;0.00096;204151;103382687;10333740;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 1 using [3H](+)-pentazocine in guinea pig brain membranes;(1R,9R,13R)-10-benzyl-13-methyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1[C@H]2CCN([C@@H]1CC3=CC=CC=C23)CC4=CC=CC=C4
2688;100496810;0.00097;204761;103401096;11723852;10280;78533490;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity at Sigma receptor type 1, displacement of [3H](+)-pentazocine from guinea pig brain membranes;(1S,9S,13S)-10-[(4-fluorophenyl)methyl]-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC4=CC=C(C=C4)F)C)C=C(C=C3)O
2689;100449437;0.00098;204443;103274924;9926814;10280;83608750;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine at sigma receptor in guinea pig brain membrane was determined;2-[2-(3,4-Dichloro-phenyl)-ethyl]-octahydro-pyrido[1,2-a]pyrazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCN2CCN(CC2C1)CCC3=CC(=C(C=C3)Cl)Cl
2690;100297838;0.001;239347;103458141;9841596;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;N-(4-methoxy-3-phenethoxyphenethyl)-N-propylpropan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN(CCC)CCC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2
2691;100297849;0.001;239347;103188875;2157;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;Amiodarone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I
2692;100297852;0.001;239347;103458139;9954083;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;3beta-(2-(Diethylamino)ethoxy)androst-5-en-17-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CC)CCO[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CCC4=O)C)C
2693;100297856;0.001;239347;103458373;65638;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;Ronipamil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCCCCCCCCCC(CCCN(C)CCC1=CC=CC=C1)(C#N)C2=CC=CC=C2
2694;100298509;0.001;239347;103458318;44398114;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;(+)-Emopamil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)[C@@](CCCN(C)CCC1=CC=CC=C1)(C#N)C2=CC=CC=C2
2695;100456552;0.001;229185;103336908;3035672;10280;79028690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor in bovine cerebellum using 2.0 nM [3H]haloperidol in the presence of 25 nM unlabeled spiperone;4-Phenyl-1-(4-phenylbutyl)piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CN(CCC1C2=CC=CC=C2)CCCCC3=CC=CC=C3
2696;100471773;0.001;203852;103186824;3455;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;Vanoxerine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)CCOC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F
2697;100471778;0.001;203852;103167043;3822;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;Ketanserin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1C(=O)C2=CC=C(C=C2)F)CCN3C(=O)C4=CC=CC=C4NC3=O
2698;100475268;0.001;204462;103673100;45261757;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;"1'-Benzylspiro[3,4-dihydronaphthalene-2,4'-piperidine]-1-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2(CCN(CC2)CC3=CC=CC=C3)C(=O)C4=CC=CC=C41.Cl
2699;100737358;0.001;203993;103228639;44292354;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor from guinea pig brain using the radioligand [3H]SKF-10047;(5S)-5-[[4-(1,3-benzodioxol-5-yl)-4-hydroxypiperidin-1-yl]methyl]-3-[4-(trifluoromethoxy)phenyl]-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC3=C(C=C2)OCO3)O)C[C@H]4CN(C(=O)O4)C5=CC=C(C=C5)OC(F)(F)F
2700;100741877;0.001;203992;103671661;45260691;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"8-(Cyclohexylmethyl)-3-phenyl-1-oxa-8-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)CN2CCC3(CC2)C(=O)C(=CO3)C4=CC=CC=C4.Cl
2701;100742328;0.001;204129;103671688;45260702;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"3-(2-Fluorophenyl)-9-(2-phenylethyl)-1-oxa-9-azaspiro[5.5]undec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12CC(=O)C(=CO2)C3=CC=CC=C3F)CCC4=CC=CC=C4.Cl
2702;100742359;0.001;203992;103671595;45260656;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"8-Benzyl-2-phenyl-1-oxa-8-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC12C(=O)C=C(O2)C3=CC=CC=C3)CC4=CC=CC=C4.Cl
2703;100742362;0.001;203992;103671575;45260642;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"2-Phenyl-8-(2-phenylethyl)-1-oxa-8-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC12C(=O)C=C(O2)C3=CC=CC=C3)CCC4=CC=CC=C4.Cl
2704;100745597;0.001;204454;103247702;15729921;10280;;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;In vitro binding affinity towards sigma receptor by the displacement of [3H]PPP from guinea pig brain;4-Fluoro-N-{1-(4-fluoro-naphthalen-1-yl)-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butyl}-benzenesulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC(C2=CC=C(C3=CC=CC=C32)F)NS(=O)(=O)C4=CC=C(C=C4)F)C5=NC=C(C=N5)F
2705;100746458;0.001;204018;103277526;44315510;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor using [3H](+)-SKF-10047 as radioligand;1-Cyclopropylmethyl-4-[2-(3-phenyl-prop-2-ynyloxy)-ethyl]-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC1CN2CCC(CC2)CCOCC#CC3=CC=CC=C3
2706;100464786;0.00102;203701;103671305;45260454;10280;80279780;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity at sigma-1 site by inhibition of [3H](+)-pentazocine (PENT) binding in guinea pig brain;"2-(4-Phenylpiperidin-1-yl)ethyl 1-(4-methoxyphenyl)cyclopentane-1-carboxylate;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)C2(CCCC2)C(=O)OCCN3CCC(CC3)C4=CC=CC=C4.Cl
2707;100742178;0.00104;203989;103308173;44327701;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor in guinea pig brain preparation was estimated using [3H]3-PPP as radioligand;4-{4-[4-(4-Chloro-phenyl)-3,6-dihydro-2H-pyridin-1-yl]-butyl}-pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CC=C1C2=CC=C(C=C2)Cl)CCCCC3=CC=NC=C3
2708;100627347;0.001047;204452;103253333;15163140;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;1'-(3-Methyl-2-butenyl)-3,4-dihydrospiro[naphthalene-1(2H),4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CC(=CCN1CCC2(CCCC3=CC=CC=C32)CC1)C
2709;100768699;0.00108;204149;103273809;22875688;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma opioid receptor type 1;(R)-3-Cyclohexylmethyl-1,8,8-trimethyl-3-aza-bicyclo[3.2.1]octane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@]12CCC(C1(C)C)CN(C2)CC3CCCCC3
2710;100399127;0.00109;204632;103677380;45264514;10280;127477840;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma receptor type 1 in guinea pig brain membrane without cerebellum;"1-[(2S)-3-(4-chlorophenoxy)-2-methylpropyl]-4-methylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1CCN(CC1)C[C@H](C)COC2=CC=C(C=C2)Cl.Cl
2711;100354294;0.0011;204790;103237992;10789481;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;4-Bromo-1-methoxy-naphthalene-2-carboxylic acid (1-cyclohexyl-piperidin-4-yl)-amide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)NC3CCN(CC3)C4CCCCC4
2712;100354364;0.0011;204790;103238014;10599997;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-(1-Cycloheptyl-4-piperidinyl)-1-methoxy-4-bromo-2-naphthalenecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)NC3CCN(CC3)C4CCCCCC4
2713;100617497;0.0011;204001;103336907;44341349;10280;16627250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;The compound was tested for its binding affinity towards Sigma opioid receptor in guinea pig brain membranes;4-Phenyl-1-(3-phenylpropyl)piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1C2=CC=CC=C2)CCCC3=CC=CC=C3
2714;100722950;0.0011;204635;103267551;44310683;10280;150810120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma receptor type 1,using [3H](+)-pentazocine as radioligand;1-(4,4-Diphenyl-butyl)-4-methyl-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)CCCC(C2=CC=CC=C2)C3=CC=CC=C3
2715;354664022;0.0011;1288457;103167216;3559;10280;270328900;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma1 receptor by PDSP assay;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2716;363958036;0.0011;1500193;404667049;118607364;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-3,4-dichlorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC(=C(C=C1)Cl)Cl)CC2=CC=CC=C2
2717;366437015;0.0011;1594271;312373013;101910737;10280;309043830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;Sigma-1 receptor antagonist 1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=C(C(=NC(=N1)C2=CC=C(C=C2)Cl)OCCCN3CCCCC3)Cl
2718;402102522;0.0011;1796671;384224365;118607364;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-3,4-dichlorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC(=C(C=C1)Cl)Cl)CC2=CC=CC=C2
2719;407906156;0.0011;1922166;103458141;9841596;10280;362020630;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to human sigma 1 receptor;N-(4-methoxy-3-phenethoxyphenethyl)-N-propylpropan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN(CCC)CCC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2
2720;100626488;0.00111;229194;103384863;9882367;10280;13101140;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+) -3PPP from sigma receptor in guinea pig brain membranes;[2-(3,4-Dichloro-phenyl)-ethyl]-(2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(C1)CCNCCC2=CC(=C(C=C2)Cl)Cl
2721;100386147;0.00114;204153;103377937;10357986;10280;117841480;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma opioid receptor type 1 affinity in guinea pig brain by employing [3H](+)-pentazocine as radioligand.;1'-Benzyl-3-methoxyspiro[isobenzofuran-1(3H),4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1C2=CC=CC=C2C3(O1)CCN(CC3)CC4=CC=CC=C4
2722;100387735;0.00114;204145;103377937;10357986;10280;123830180;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine from Sigma opioid receptor type 1 of guinea pig brain;1'-Benzyl-3-methoxyspiro[isobenzofuran-1(3H),4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1C2=CC=CC=C2C3(O1)CCN(CC3)CC4=CC=CC=C4
2723;100367071;0.00115;226337;103375819;9841846;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-[1-(4-Fluorobenzyl)-4-piperidinyl]-3-chlorophenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)Cl)CC3=CC=C(C=C3)F
2724;100627652;0.001175;204452;131271988;54580004;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-(3-Methylbut-2-enyl)spiro[1,2-dihydroindene-3,4'-piperidine];hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CC(=CCN1CCC2(CCC3=CC=CC=C32)CC1)C.Cl
2725;100627938;0.001175;204453;103671474;45260556;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"(4aR,10bR)-3-(3-methylbut-2-enyl)-2,4,4a,5,6,10b-hexahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CC(=CCN1CC[C@@H]2[C@H](C1)CCC3=CC=CC=C23)C.Cl
2726;100399131;0.00118;204632;103671525;45260601;10280;127477840;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma receptor type 1 in guinea pig brain membrane without cerebellum;"1-[(2R)-1-(4-chlorophenoxy)propan-2-yl]-4-methylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1CCN(CC1)[C@H](C)COC2=CC=C(C=C2)Cl.Cl
2727;100627871;0.00119;229196;103268578;15175719;10280;13194930;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain, using [3H](+)-pentazocine as radioligand.;1-[2-(3,4-Dichlorophenyl)ethyl]-4-(3-iodopropyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCI)CCC2=CC(=C(C=C2)Cl)Cl
2728;100292831;0.0012;239105;103442134;11154079;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;2-(4-Benzyl-piperazin-1-ylmethyl)-chroman-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2CC(=O)C3=CC=CC=C3O2)CC4=CC=CC=C4
2729;100354289;0.0012;204790;103238222;10741325;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-[(3R)-1-Cyclohexyl-3-pyrrolidinyl]-1-methoxy-4-bromo-2-naphthalenecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)N[C@@H]3CCN(C3)C4CCCCC4
2730;100354366;0.0012;204790;103237903;10582642;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;4-Bromo-1-methoxy-naphthalene-2-carboxylic acid (1-cyclopentyl-piperidin-4-yl)-amide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)NC3CCN(CC3)C4CCCC4
2731;100449431;0.0012;204443;103268004;587944;10280;83608750;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine at sigma receptor in guinea pig brain membrane was determined;1-[2-(3,4-Dichlorophenyl)ethyl]-4-propylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCN1CCN(CC1)CCC2=CC(=C(C=C2)Cl)Cl
2732;100523893;0.0012;204793;103225499;10831286;10280;91718750;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Receptor binding affinity against Sigma-1 receptor from guinea pig membranes;1-(4-Fluoro-benzyl)-4-(4-nitro-phenoxymethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1COC2=CC=C(C=C2)[N+](=O)[O-])CC3=CC=C(C=C3)F
2733;100559073;0.0012;203684;103389887;10473287;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;1-(3-Phenylpropyl)-4-(2-nitrophenethyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)CCC3=CC=CC=C3[N+](=O)[O-]
2734;100768697;0.0012;204149;103274191;22875695;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma opioid receptor type 1;(S)-3-(4-Cyclohexyl-butyl)-1,8,8-trimethyl-3-aza-bicyclo[3.2.1]octane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@]12CCC(C1(C)C)CN(C2)CCCCC3CCCCC3
2735;341107079;0.0012;1063782;103167216;3559;10280;243651590;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor (unknown origin);Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2736;345594063;0.0012;1197502;312385703;118731567;10280;256029320;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor in human Jurkat cells after 120 mins by liquid scintillation counting analysis;3-[3-[Benzyl(methyl)amino]propyl]-5-bromo-1,3-benzoxazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1C2=C(C=CC(=C2)Br)OC1=O)CC3=CC=CC=C3
2737;363958037;0.0012;1500193;404651932;118607283;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N-(2-(benzyl(methyl)amino)ethyl)-4-cyanobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCNC(=O)C1=CC=C(C=C1)C#N)CC2=CC=CC=C2
2738;402102360;0.0012;1796671;384224374;118607283;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-(2-(benzyl(methyl)amino)ethyl)-4-cyanobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCNC(=O)C1=CC=C(C=C1)C#N)CC2=CC=CC=C2
2739;407996247;0.0012;1946583;482070803;168286314;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;5-[[4-[[3-(trifluoromethyl)phenyl]methoxy]piperidin-1-yl]methyl]-1H-indazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=CC=C2)C(F)(F)F)CC3=CC4=C(C=C3)NN=C4
2740;100627350;0.001202;204452;131273951;54581003;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-butylspiro[2,3-dihydro-1H-naphthalene-4,4'-piperidine];hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCCN1CCC2(CCCC3=CC=CC=C32)CC1.Cl
2741;407996265;0.001202;1946583;482085506;168296363;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;5-[[4-[(3,4-Difluorophenyl)methoxy]piperidin-1-yl]methyl]-1-methylindazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C=C(C=C2)CN3CCC(CC3)OCC4=CC(=C(C=C4)F)F)C=N1
2742;100367067;0.00121;226337;103375836;9887523;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-[1-(4-Fluorobenzyl)-4-piperidinyl]-3-bromophenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)Br)CC3=CC=C(C=C3)F
2743;100464773;0.00121;203701;103677121;45264328;10280;80279780;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity at sigma-1 site by inhibition of [3H](+)-pentazocine (PENT) binding in guinea pig brain;"6-(4-Phenylpiperidin-1-yl)hexyl 1-phenylcyclopentane-1-carboxylate;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)(C2=CC=CC=C2)C(=O)OCCCCCCN3CCC(CC3)C4=CC=CC=C4.Cl
2744;100627702;0.00123;229196;103267909;15175722;10280;13194930;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain, using [3H](+)-pentazocine as radioligand.;1-[2-[N-Methyl-N-[2-(4,5-dichloro-2-iodophenyl)ethyl]amino]ethyl]pyrrolidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=C(C=C1I)Cl)Cl)CCN2CCCC2
2745;100615557;0.00124;203999;103321551;44334211;10280;16560440;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was tested for the inhibitory activity against Sigma opioid receptor by using [3H](+)-3-PPP as radioligand in guinea pig brain;(3,4-Dichloro-benzyl)-methyl-(2-pyrrolidin-1-yl-cyclohexyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CC1=CC(=C(C=C1)Cl)Cl)[C@H]2CCCC[C@H]2N3CCCC3
2746;100626493;0.00126;229194;103383624;188914;10280;13101140;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+) -3PPP from sigma receptor in guinea pig brain membranes;N-(2-(3,4-Dichlorophenyl)ethyl)-N-methyl-2-(dimethylamino)ethylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCN(C)CCC1=CC(=C(C=C1)Cl)Cl
2747;100386141;0.00129;204153;103377542;10019102;10280;117841480;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma opioid receptor type 1 affinity in guinea pig brain by employing [3H](+)-pentazocine as radioligand.;1'-Benzyl-3-methoxyspiro[isochroman-1,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1CC2=CC=CC=C2C3(O1)CCN(CC3)CC4=CC=CC=C4
2748;100387734;0.00129;204145;103377542;10019102;10280;123830180;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine from Sigma opioid receptor type 1 of guinea pig brain;1'-Benzyl-3-methoxyspiro[isochroman-1,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1CC2=CC=CC=C2C3(O1)CCN(CC3)CC4=CC=CC=C4
2749;100298505;0.0013;239347;103458479;9951886;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;Benzothiazol-2-yl-methyl-[1-(4-phenoxy-butyl)-pyrrolidin-3-yl]-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C1CCN(C1)CCCCOC2=CC=CC=C2)C3=NC4=CC=CC=C4S3
2750;100319797;0.0013;204154;103626805;9952420;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;N,N-Dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCN(CCC)CCC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2.Cl
2751;100449440;0.0013;204443;103274403;401839;10280;83608750;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine at sigma receptor in guinea pig brain membrane was determined;(6,7-Dichloro-1,2,3,4-tetrahydro-naphthalen-2-yl)-methyl-(2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCN1CCCC1)C2CCC3=CC(=C(C=C3C2)Cl)Cl
2752;100464781;0.0013;203701;103671267;45260423;10280;80279780;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity at sigma-1 site by inhibition of [3H](+)-pentazocine (PENT) binding in guinea pig brain;"2-(4-Phenylpiperidin-1-yl)ethyl 1-(4-cyanophenyl)cyclopentane-1-carboxylate;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)(C2=CC=C(C=C2)C#N)C(=O)OCCN3CCC(CC3)C4=CC=CC=C4.Cl
2753;100478425;0.0013;203696;103186031;10107042;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;Methyl-((R)-1-methyl-2-phenyl-ethyl)-(3-phenyl-propyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CC1=CC=CC=C1)N(C)CCCC2=CC=CC=C2
2754;100558840;0.0013;203684;103389824;401829;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;1-(3-Phenylpropyl)-4-(4-methoxyphenethyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)CCN2CCN(CC2)CCCC3=CC=CC=C3
2755;100605299;0.0013;203995;103321333;3036027;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity of compound to Sigma opioid receptor labelled with [3H](+)-3-PPP;[2-(3,4-Dichloro-phenyl)-ethyl]-methyl-(2-pyrrolidin-1-yl-cyclohexyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=C(C=C1)Cl)Cl)[C@H]2CCCC[C@H]2N3CCCC3
2756;100615704;0.0013;204447;103321333;3036027;10280;16560440;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]-(+)-3-PPP binding to sigma of guinea pig brain;[2-(3,4-Dichloro-phenyl)-ethyl]-methyl-(2-pyrrolidin-1-yl-cyclohexyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=C(C=C1)Cl)Cl)[C@H]2CCCC[C@H]2N3CCCC3
2757;100722954;0.0013;204635;103267923;44310878;10280;150810120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma receptor type 1,using [3H](+)-pentazocine as radioligand;(5,5-Diphenyl-pent-4-enyl)-phenethyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)CCNCCCC=C(C2=CC=CC=C2)C3=CC=CC=C3
2758;112788083;0.0013;204633;103328401;5478726;10280;74907270;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to inhibit [3H](+)-pentazocine binding to guinea pig brain Sigma receptor type 1;(8E)-8-benzylidene-5-(3-hydroxyphenyl)-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1/C(=C\C3=CC=CC=C3)/C(=O)C2)C4=CC(=CC=C4)O
2759;342804594;0.0013;1127667;103251266;10365874;10280;237346340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 opioid receptor (unknown origin);1-(Methylsulfonyl)-3-[4-[spiro[piperidine-4,1'(3'H)-isobenzofuran]-1-yl]butyl]-1H-indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CS(=O)(=O)N1C=C(C2=CC=CC=C21)CCCCN3CCC4(CC3)C5=CC=CC=C5CO4
2760;402102371;0.0013;1796671;384224364;41306378;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-2,4-dichlorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=C(C=C(C=C1)Cl)Cl)CC2=CC=CC=C2
2761;407996251;0.0013;1946583;482077112;168290895;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;5-[[4-[(4-Chloro-3-fluorophenyl)methoxy]piperidin-1-yl]methyl]-1-methylindazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C=C(C=C2)CN3CCC(CC3)OCC4=CC(=C(C=C4)Cl)F)C=N1
2762;100546287;0.00132;203689;103283891;10501583;10280;96511500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma-1 receptor in guinea pig brain membranes;N-(2-Azepan-1-yl-ethyl)-4-iodo-benzenesulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCCN(CC1)CCNS(=O)(=O)C2=CC=C(C=C2)I
2763;100630343;0.00132;229195;103268578;15175719;10280;13194930;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain, using [3H](+)-3-PPP as radioligand.;1-[2-(3,4-Dichlorophenyl)ethyl]-4-(3-iodopropyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCI)CCC2=CC(=C(C=C2)Cl)Cl
2764;100768698;0.00133;204149;103273808;44313623;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma opioid receptor type 1;(S)-3-Cyclohexylmethyl-1,8,8-trimethyl-3-aza-bicyclo[3.2.1]octane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@]12CCC(C1(C)C)CN(C2)CC3CCCCC3
2765;100438235;0.00134;204445;103373802;10402464;10280;14477350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor using [3H](+)-pentazocine in guinea pig brain homogenates;6,7-Dichloro-2-[2-(pyrrolidin-1-yl)ethyl]-1,2,3,4-tetrahydroisoquinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCN(C1)CCN2CCC3=CC(=C(C=C3C2)Cl)Cl
2766;100464779;0.00134;203701;103671308;45260457;10280;80279780;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity at sigma-1 site by inhibition of [3H](+)-pentazocine (PENT) binding in guinea pig brain;"2-(4-Phenylpiperidin-1-yl)ethyl 1-(4-chlorophenyl)cyclopentane-1-carboxylate;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)(C2=CC=C(C=C2)Cl)C(=O)OCCN3CCC(CC3)C4=CC=CC=C4.Cl
2767;100627641;0.001349;204452;131277594;54582815;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-(Cyclohexylmethyl)spiro[1,2-dihydroindene-3,4'-piperidine];hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CCC(CC1)CN2CCC3(CCC4=CC=CC=C43)CC2.Cl
2768;100627299;0.00135;229194;103384368;15113304;10280;13101140;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+) -3PPP from sigma receptor in guinea pig brain membranes;2-(3,4-Dichlorophenyl)-N-[2-(1-pyrrolidinyl)ethyl]-N-propylethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN(CCC1=CC(=C(C=C1)Cl)Cl)CCN2CCCC2
2769;100768696;0.00135;204149;103274192;10106826;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma opioid receptor type 1;(R)-3-(2-Cyclohexyl-ethyl)-1,8,8-trimethyl-3-aza-bicyclo[3.2.1]octane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@]12CCC(C1(C)C)CN(C2)CCC3CCCCC3
2770;100626491;0.00139;229194;103384338;9797436;10280;13101140;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+) -3PPP from sigma receptor in guinea pig brain membranes;Allyl-[2-(3,4-dichloro-phenyl)-ethyl]-(2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C=CCN(CCC1=CC(=C(C=C1)Cl)Cl)CCN2CCCC2
2771;100292616;0.0014;239200;103442152;11407133;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;2-(4-Benzyl-piperazin-1-ylmethyl)-3,4-dihydro-2H-naphthalen-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2=CC=CC=C2C(=O)C1CN3CCN(CC3)CC4=CC=CC=C4
2772;100292836;0.0014;239105;103442151;11245709;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;2-(4-Benzyl-piperidin-1-ylmethyl)-chroman-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3CC(=O)C4=CC=CC=C4O3
2773;100292838;0.0014;239105;103183665;11722772;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;1-(4-Phenylbutyl)-4-benzylpiperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CCCCC3=CC=CC=C3
2774;100292951;0.0014;239105;103442048;11406043;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;3-(4-Benzyl-piperidin-1-ylmethyl)-3,4-dihydro-2H-naphthalen-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3CC4=CC=CC=C4C(=O)C3
2775;100292956;0.0014;239105;103442132;11336800;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;4-Benzyl-1-indan-2-ylmethyl-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3CC4=CC=CC=C4C3
2776;100399125;0.0014;204632;103671533;45260608;10280;127477840;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma receptor type 1 in guinea pig brain membrane without cerebellum;"1-[(3R)-3-(4-chlorophenoxy)butyl]-4-methylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1CCN(CC1)CC[C@@H](C)OC2=CC=C(C=C2)Cl.Cl
2777;100449429;0.0014;204443;103275019;15428989;10280;83608750;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine at sigma receptor in guinea pig brain membrane was determined;(8aR)-2-[2-(3,4-Dichlorophenyl)ethyl]octahydropyrrolo[1,2-a]pyrazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C[C@@H]2CN(CCN2C1)CCC3=CC(=C(C=C3)Cl)Cl
2778;100451369;0.0014;204435;103672152;45261008;10280;81026510;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using the novel [3H]-(+/-)-4 as radioligand;"3-Chloro-6-(dimethylamino)-8-phenyl-5,6,7,8-tetrahydronaphthalen-2-ol;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CN(C)C1CC(C2=CC(=C(C=C2C1)Cl)O)C3=CC=CC=C3.Cl
2779;100543129;0.0014;203698;103217409;9839491;10280;95728800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was tested for its binding affinity towards sigma 1 receptor using [3H](+)-pentazocine from guinea pig brain;1'-Benzylspiro[tetralin-2,4'-piperidine]-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCN(CC2)CC3=CC=CC=C3)C(=O)C4=CC=CC=C41
2780;100546617;0.0014;203685;103278189;10712370;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-Benzylpiperidine-4-yl)-2-(3-chlorophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)Cl)CC3=CC=CC=C3
2781;100558838;0.0014;203684;103389850;401862;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;1-(3-Phenylpropyl)-4-(3-methoxyphenethyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC(=C1)CCN2CCN(CC2)CCCC3=CC=CC=C3
2782;100702222;0.0014;204766;103417549;764613;10280;126395730;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards Sigma-1 receptor;1-Benzyl-4-(4-chlorobenzyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2=CC=CC=C2)CC3=CC=C(C=C3)Cl
2783;100722941;0.0014;204635;103267924;44310879;10280;150810120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma receptor type 1,using [3H](+)-pentazocine as radioligand;(5,5-Diphenyl-pentyl)-diethyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CC)CCCCC(C1=CC=CC=C1)C2=CC=CC=C2
2784;321582718;0.0014;677526;103389850;401862;10280;228502100;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma1 receptor;1-(3-Phenylpropyl)-4-(3-methoxyphenethyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC(=C1)CCN2CCN(CC2)CCCC3=CC=CC=C3
2785;363958378;0.0014;1500193;404662101;110445832;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-4-trifluoromethylbenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)C(F)(F)F)CC2=CC=CC=C2
2786;380581532;0.0014;1861768;440110049;155510683;10280;357532630;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor measured after 120 mins by scintillation counting analysis;1-Benzyl-4-(4-benzyl-1H-1,2,3-triazol-1-yl)piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1N2C=C(N=N2)CC3=CC=CC=C3)CC4=CC=CC=C4
2787;388740093;0.0014;1797293;386051125;118282972;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 10;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC4=C(C=C3C2)OCO4
2788;388878697;0.0014;1797475;386051125;118282972;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 10;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC4=C(C=C3C2)OCO4
2789;389383283;0.0014;1804286;386051125;118282972;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 10;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC4=C(C=C3C2)OCO4
2790;402102470;0.0014;1796671;384224351;110445832;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-4-trifluoromethylbenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)C(F)(F)F)CC2=CC=CC=C2
2791;100627645;0.001413;204452;131285665;54586712;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-[(4-methylphenyl)methyl]spiro[2,3-dihydro-1H-naphthalene-4,4'-piperidine];hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CC1=CC=C(C=C1)CN2CCC3(CCCC4=CC=CC=C43)CC2.Cl
2792;100628052;0.001413;204453;103677348;45264494;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"5-Cyclohexyl-5-azatricyclo[9.4.0.02,7]pentadeca-1(15),11,13-triene;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CCC(CC1)N2CCC3C(C2)CCCC4=CC=CC=C34.Cl
2793;100464776;0.00144;203701;103677253;45264427;10280;80279780;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity at sigma-1 site by inhibition of [3H](+)-pentazocine (PENT) binding in guinea pig brain;"2-(4-Phenylpiperidin-1-yl)ethyl 1-(4-iodophenyl)cyclopentane-1-carboxylate;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)(C2=CC=C(C=C2)I)C(=O)OCCN3CCC(CC3)C4=CC=CC=C4.Cl
2794;100435177;0.00145;203682;103275074;11303155;10280;150841290;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity at opioid sigma-1 receptor in guinea pig brain membranes by (+)-[3H]pentazocine displacement.;1-Cyclohexyl-4-[5-(1,2,3,4-tetrahydro-naphthalen-1-yl)-pentyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)N2CCN(CC2)CCCCCC3CCCC4=CC=CC=C34
2795;100496815;0.00145;204761;103401567;10314247;10280;78533490;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity at Sigma receptor type 1, displacement of [3H](+)-pentazocine from guinea pig brain membranes;(1S,9S,13S)-10-[(2-fluorophenyl)methyl]-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC4=CC=CC=C4F)C)C=C(C=C3)O
2796;100549947;0.00146;203691;103284445;3869448;10280;96511500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition Constant for 4-[125I]-IPBS binding to sigma 1 receptor in guinea pig brain membranes;4-iodo-N-[2-(1-pyrrolidinyl)ethyl]benzenesulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCN(C1)CCNS(=O)(=O)C2=CC=C(C=C2)I
2797;100627297;0.00146;229194;103384128;15113311;10280;13101140;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+) -3PPP from sigma receptor in guinea pig brain membranes;N*1*-[2-(3,4-Dichloro-phenyl)-ethyl]-N*1*,N*2*,N*2*-trimethyl-propane-1,2-diamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(CN(C)CCC1=CC(=C(C=C1)Cl)Cl)N(C)C
2798;100485162;0.00147;204636;103318534;15767678;10280;76368600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured on Sigma receptor type 1 from guinea pig brain membranes using [3H]pentazocine as radioligand.;10-Benzyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)N
2799;100627303;0.00147;229194;103384535;558800;10280;13101140;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+) -3PPP from sigma receptor in guinea pig brain membranes;3-Azapentane, N-methyl-5-[4-chlorophenyl]-1-[pyrrolidin-1-yl]-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC=C(C=C1)Cl)CCN2CCCC2
2800;100295623;0.00148;239200;103442059;11338418;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;1-Benzyl-4-chroman-3-ylmethyl-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2CC3=CC=CC=C3OC2)CC4=CC=CC=C4
2801;100438232;0.00148;204445;103373803;9883361;10280;14477350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor using [3H](+)-pentazocine in guinea pig brain homogenates;Methyl[(1-ethylpyrrolidin-2-yl)methyl](3,4-dichlorophenethyl)amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCN1CCCC1CN(C)CCC2=CC(=C(C=C2)Cl)Cl
2802;100485157;0.00148;204636;103318423;10085466;10280;76368600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured on Sigma receptor type 1 from guinea pig brain membranes using [3H]pentazocine as radioligand.;4-Fluoro-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)F
2803;100468431;0.00149;203697;103330116;398578;10280;82952200;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma 1 receptor was determined in guinea pig brain membrane using [3H](+)-pentazocine as radioligand;Tetrahydro-1-[2-[methyl[2-[methyl(3,4-dichlorobenzyl)amino]ethyl]amino]ethyl]-1H-pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCN1CCCC1)CCN(C)CC2=CC(=C(C=C2)Cl)Cl
2804;100292842;0.0015;239105;103442133;11405584;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;4-Benzyl-1-(1,2,3,4-tetrahydro-naphthalen-2-ylmethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2=CC=CC=C2CC1CN3CCC(CC3)CC4=CC=CC=C4
2805;100319803;0.0015;204154;103673261;45261876;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;"1-[4-methoxy-3-(2-phenylethoxy)phenyl]-N-propylheptan-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)NCCC.Cl
2806;100354811;0.0015;204791;103167216;3559;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2807;100478462;0.0015;203696;103184733;18790283;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;Phenethyl-(7-phenyl-heptyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)CCCCCCCNCCC2=CC=CC=C2
2808;100561759;0.0015;204461;103167216;3559;10280;98761100;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured at the sigma receptor by the inhibition of [3H]-3-PPP binding to guinea pig cerebellum using unlabeled 3-PPP for nonspecific binding.;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2809;363860756;0.0015;1467149;381862167;137648624;10280;284950850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of (+)-[3H]-pentazocine from recombinant human sigma 1 receptor expressed in baculovirus infected Sf9 insect cell membranes after 90 mins by scintillation counting method;1-[3-(4-Tert-butylphenyl)propyl]piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)C1=CC=C(C=C1)CCCN2CCCCC2
2810;380581529;0.0015;1861768;440167759;155544861;10280;357532630;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor measured after 120 mins by scintillation counting analysis;1-Benzyl-4-[4-[(4-bromophenyl)methyl]triazol-1-yl]piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1N2C=C(N=N2)CC3=CC=C(C=C3)Br)CC4=CC=CC=C4
2811;100464782;0.00151;203701;103671414;45260516;10280;80279780;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity at sigma-1 site by inhibition of [3H](+)-pentazocine (PENT) binding in guinea pig brain;"3-(4-Phenylpiperidin-1-yl)propyl 1-(4-chlorophenyl)cyclopentane-1-carboxylate;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)(C2=CC=C(C=C2)Cl)C(=O)OCCCN3CCC(CC3)C4=CC=CC=C4.Cl
2812;100627640;0.001514;204452;131273633;19018943;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-Hexylspiro[1,2-dihydroindene-3,4'-piperidine];hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCCCCN1CCC2(CCC3=CC=CC=C32)CC1.Cl
2813;100435173;0.00152;203682;103275072;11292472;10280;150841290;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity at opioid sigma-1 receptor in guinea pig brain membranes by (+)-[3H]pentazocine displacement.;1-Cyclohexyl-4-[5-(5-methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-pentyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC=CC2=C1CCCC2CCCCCN3CCN(CC3)C4CCCCC4
2814;100496812;0.00153;204761;103401127;10065362;10280;78533490;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity at Sigma receptor type 1, displacement of [3H](+)-pentazocine from guinea pig brain membranes;4-[[(1S,9S,13S)-4-hydroxy-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methyl]benzonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC4=CC=C(C=C4)C#N)C)C=C(C=C3)O
2815;100387745;0.00154;204145;103388699;10064484;10280;123830180;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine from Sigma opioid receptor type 1 of guinea pig brain;1'-Benzylspiro[3,4-dihydroisochromene-1,4'-piperidine]-3-carbonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3CC(O2)C#N)CC4=CC=CC=C4
2816;100435057;0.00154;203682;103274476;11199981;10280;150841290;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity at opioid sigma-1 receptor in guinea pig brain membranes by (+)-[3H]pentazocine displacement.;1-Cyclohexyl-4-(4-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)butyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC=CC2=C1CCCC2CCCCN3CCN(CC3)C4CCCCC4
2817;100546289;0.00154;203689;103284446;10497826;10280;96511500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma-1 receptor in guinea pig brain membranes;4-Bromo-N-(2-piperidin-1-yl-ethyl)-benzenesulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCN(CC1)CCNS(=O)(=O)C2=CC=C(C=C2)Br
2818;100435058;0.00157;203682;103274608;11405620;10280;150841290;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity at opioid sigma-1 receptor in guinea pig brain membranes by (+)-[3H]pentazocine displacement.;1-Cyclohexyl-4-[2-(5-methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-ethyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC=CC2=C1CCCC2CCN3CCN(CC3)C4CCCCC4
2819;100435179;0.00157;203682;103275215;11428574;10280;150841290;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity at opioid sigma-1 receptor in guinea pig brain membranes by (+)-[3H]pentazocine displacement.;1-Cyclohexyl-4-(3-(5-methoxynaphthalen-1-yl)propyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC=CC2=C(C=CC=C21)CCCN3CCN(CC3)C4CCCCC4
2820;100485159;0.00157;204636;103317804;15767674;10280;76368600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured on Sigma receptor type 1 from guinea pig brain membranes using [3H]pentazocine as radioligand.;Deoxypentazocin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1C2CC3=CC=CC=C3C1(CCN2CC=C(C)C)C
2821;100295621;0.00159;239200;103442089;11407131;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;3-(4-Benzyl-piperazin-1-ylmethyl)-3,4-dihydro-2H-naphthalen-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2CC3=CC=CC=C3C(=O)C2)CC4=CC=CC=C4
2822;100449426;0.0016;204443;103274769;44314136;10280;83608750;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine at sigma receptor in guinea pig brain membrane was determined;1-[2-(3,4-Dichlorophenyl)ethyl]-4-ethylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCN1CCN(CC1)CCC2=CC(=C(C=C2)Cl)Cl
2823;100543220;0.0016;203699;103167216;3559;10280;95728830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to sigma-1 sites in guinea pig brain membranes;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2824;355638085;0.0016;1308619;336904917;127050995;10280;271565650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-Pentazocine from sigma 1 receptor in human RPMI8226 cell membranes;(1S,4R,7S)-5-benzyl-2-(cyclohexylmethyl)-2,5-diazabicyclo[2.2.2]octan-7-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;C1CCC(CC1)CN2C[C@H]3C[C@@H]([C@@H]2CN3CC4=CC=CC=C4)O
2825;363896558;0.0016;1456743;103390257;9884781;10280;284899500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma1 receptor (unknown origin);CID 9884781;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2CC3=CC=CC=C3C2)C4=CC5=C(C=C4)OCCO5
2826;363958028;0.0016;1500193;404656733;110440208;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-4-tertbutylbenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)C1=CC=C(C=C1)C(=O)NCCCN(C)CC2=CC=CC=C2
2827;366316133;0.0016;1532592;103167216;3559;10280;304474340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human Jurkat cell membranes after 2 hrs by liquid scintillation counting method;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2828;389712924;0.0016;1919146;476002756;166637132;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assay from US Patent US11535596: 'Analogs of dextromethorphan with balanced receptor activities';17-(3-Methoxypropyl)-4-(2,2,2-trifluoroethoxy)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COCCCN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OCC(F)(F)F
2829;402102373;0.0016;1796671;384224350;110440208;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-4-tertbutylbenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)C1=CC=C(C=C1)C(=O)NCCCN(C)CC2=CC=CC=C2
2830;112788429;0.00162;204633;103385250;44362252;10280;74907270;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to inhibit [3H](+)-pentazocine binding to guinea pig brain Sigma receptor type 1;(8E)-5-(3-hydroxyphenyl)-8-[(3-iodophenyl)methylidene]-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1/C(=C\C3=CC(=CC=C3)I)/C(=O)C2)C4=CC(=CC=C4)O
2831;100463906;0.00164;203695;103230801;381254;10280;80219130;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain using [3H](+)-pentazocine as radioligand.;N-(1-Benzyl-4-piperidinyl)-2-iodobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)C2=CC=CC=C2I)CC3=CC=CC=C3
2832;100627656;0.00166;204452;131283677;54585732;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-[(4-methoxyphenyl)methyl]spiro[2,3-dihydro-1H-naphthalene-4,4'-piperidine];hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;COC1=CC=C(C=C1)CN2CCC3(CCCC4=CC=CC=C43)CC2.Cl
2833;341107078;0.00166;1063782;103167216;3559;10280;243651590;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor (unknown origin);Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2834;100768706;0.00167;204149;103274046;44313729;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma opioid receptor type 1;(S)-3-(2-Cyclopentyl-ethyl)-1,8,8-trimethyl-3-aza-bicyclo[3.2.1]octane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@]12CCC(C1(C)C)CN(C2)CCC3CCCC3
2835;100295631;0.0017;239200;103442049;10758083;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;1-Benzyl-4-(1,2,3,4-tetrahydro-naphthalen-2-ylmethyl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2=CC=CC=C2CC1CN3CCN(CC3)CC4=CC=CC=C4
2836;100297853;0.0017;239347;174499861;44303090;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;(7S,8R)-7,8-Dimethyl-6-(3-methyl-but-2-enylamino)-8-propyl-5,6,7,8-tetrahydro-naphthalen-2-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1C2CC3=C([C@@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
2837;100354296;0.0017;204790;103238490;10741970;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-[(3R)-1-Cycloheptyl-3-pyrrolidinyl]-1-methoxy-4-bromo-2-naphthalenecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)N[C@@H]3CCN(C3)C4CCCCCC4
2838;100399129;0.0017;204632;103671530;45260606;10280;127477840;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma receptor type 1 in guinea pig brain membrane without cerebellum;"1-[(2R)-3-(4-chlorophenoxy)-2-methylpropyl]-4-methylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1CCN(CC1)C[C@@H](C)COC2=CC=C(C=C2)Cl.Cl
2839;100449381;0.0017;204443;103274742;44314123;10280;83608750;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine at sigma receptor in guinea pig brain membrane was determined;1-(3,4-Dichlorophenethyl)-4-pentylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCCN1CCN(CC1)CCC2=CC(=C(C=C2)Cl)Cl
2840;100449443;0.0017;204443;103275643;44314603;10280;83608750;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine at sigma receptor in guinea pig brain membrane was determined;1,4-Bis(3,4-dichlorophenethyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCC2=CC(=C(C=C2)Cl)Cl)CCC3=CC(=C(C=C3)Cl)Cl
2841;100463905;0.0017;203695;103230778;132995;10280;80219130;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain using [3H](+)-pentazocine as radioligand.;N-(1-benzylpiperidin-4-yl)-4-iodobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)C2=CC=C(C=C2)I)CC3=CC=CC=C3
2842;100478909;0.0017;203700;103252465;12259685;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Tested for binding affinity against sigma 1 receptor;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
2843;363958026;0.0017;1500193;404671993;118607455;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N-[4-(benzylmethylamino)butyl]-4-chlorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCCNC(=O)C1=CC=C(C=C1)Cl)CC2=CC=CC=C2
2844;367478797;0.0017;1655949;442052548;156013934;10280;324354210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human Sigma 1 receptor by radioligand displacement assay;"4-Benzyl-1-(1,4-dithiaspiro[4.6]undecan-3-ylmethyl)piperidine;oxalic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCCC2(CC1)SCC(S2)CN3CCC(CC3)CC4=CC=CC=C4.C(=O)(C(=O)O)O
2845;389483957;0.0017;1805386;160849726;132075278;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';4-(2-benzyl-3,4-dihydro-1H-isoquinolin-6-yl)morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CC2=C1C=C(C=C2)N3CCOCC3)CC4=CC=CC=C4
2846;402102365;0.0017;1796671;384224357;118607455;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[4-(benzylmethylamino)butyl]-4-chlorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCCNC(=O)C1=CC=C(C=C1)Cl)CC2=CC=CC=C2
2847;407907025;0.0017;1922166;103230778;132995;10280;362020630;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to human sigma 1 receptor;N-(1-benzylpiperidin-4-yl)-4-iodobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)C2=CC=C(C=C2)I)CC3=CC=CC=C3
2848;407996253;0.0017;1946583;482055741;168275381;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;1-Methyl-5-[[4-[[3-(trifluoromethyl)phenyl]methoxy]piperidin-1-yl]methyl]indazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C=C(C=C2)CN3CCC(CC3)OCC4=CC(=CC=C4)C(F)(F)F)C=N1
2849;255025320;0.001704;625223;136925223;3236;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Eperisone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC1=CC=C(C=C1)C(=O)C(C)CN2CCCCC2
2850;112788423;0.00171;204633;103386382;44362800;10280;74907270;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to inhibit [3H](+)-pentazocine binding to guinea pig brain Sigma receptor type 1;(8E)-5-(3-hydroxyphenyl)-8-[(4-iodophenyl)methylidene]-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1/C(=C\C3=CC=C(C=C3)I)/C(=O)C2)C4=CC(=CC=C4)O
2851;100487681;0.00172;204638;103318471;44332508;10280;76368610;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was measured on Sigma receptor type 1 using [3H]- pentazocine as radioligand;10-Benzyl-3-chloro-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C(=C(C=C3)O)Cl
2852;100473789;0.001738;203852;103321169;132954;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;N,N-dimethyl-4-phenyl-1,2,3,4-tetrahydronaphthalen-2-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)C1CC(C2=CC=CC=C2C1)C3=CC=CC=C3
2853;100628004;0.001738;204453;103671332;45260471;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"(4aR,10bR)-3-but-3-enyl-2,4,4a,5,6,10b-hexahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C=CCCN1CC[C@@H]2[C@H](C1)CCC3=CC=CC=C23.Cl
2854;407996254;0.001738;1946583;482055741;168275381;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;1-Methyl-5-[[4-[[3-(trifluoromethyl)phenyl]methoxy]piperidin-1-yl]methyl]indazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C=C(C=C2)CN3CCC(CC3)OCC4=CC(=CC=C4)C(F)(F)F)C=N1
2855;100438237;0.00175;204445;103374109;9973696;10280;14477350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor using [3H](+)-pentazocine in guinea pig brain homogenates;(-)-1-[2-(3,4-Dichloro-phenyl)-ethyl]-2-pyrrolidin-1-ylmethyl-pyrrolidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCN(C1)C[C@@H]2CCCN2CCC3=CC(=C(C=C3)Cl)Cl
2856;100485970;0.00175;204636;103318136;15767679;10280;76368600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured on Sigma receptor type 1 from guinea pig brain membranes using [3H]pentazocine as radioligand.;10-benzyl-N,N,1,13-tetramethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)N(C)C
2857;100487781;0.00175;204638;103318488;44332515;10280;76368610;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was measured on Sigma receptor type 1 using [3H]- pentazocine as radioligand;10-Benzyl-3-bromo-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C(=C(C=C3)O)Br
2858;100741918;0.00175;203989;103308220;44327733;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor in guinea pig brain preparation was estimated using [3H]3-PPP as radioligand;4-{4-[4-(4-Fluoro-phenyl)-3,6-dihydro-2H-pyridin-1-yl]-butyl}-pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CC=C1C2=CC=C(C=C2)F)CCCCC3=CC=NC=C3
2859;100626487;0.00176;229194;103384127;15113293;10280;13101140;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+) -3PPP from sigma receptor in guinea pig brain membranes;2-(3,4-Dichlorophenyl)-N-[3-(1-pyrrolidinyl)propyl]-N-methylethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCN1CCCC1)CCC2=CC(=C(C=C2)Cl)Cl
2860;100367032;0.00178;226337;103376352;9936242;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-[1-(4-Iodobenzyl)-4-piperidinyl]-3-bromophenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)Br)CC3=CC=C(C=C3)I
2861;100399842;0.00178;204632;103677475;45264579;10280;127477840;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma receptor type 1 in guinea pig brain membrane without cerebellum;"1-[3-(4-Chlorophenoxy)propyl]-4-methylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1CCN(CC1)CCCOC2=CC=C(C=C2)Cl.Cl
2862;100319813;0.0018;204154;103678333;9823428;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;"1-[4-methoxy-3-(2-phenylethoxy)phenyl]-5-methyl-N-propylhexan-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCNC(CCC(C)C)CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2.Cl
2863;100322108;0.0018;204152;103167216;3559;10280;106027030;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]- pentazocine binding against alpha-1 from guinea pig brain;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2864;100458854;0.0018;229213;103359652;24867245;10280;79028700;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Tested for [3H](+)-pentazocine binding to sigma-1 receptor in guinea pig brain membrane;Dihydrohaloperidol, (R)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCC[C@H](C3=CC=C(C=C3)F)O
2865;100534035;0.0018;204794;103359534;10807863;10280;93971710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was done in guinea pig membranes by labeling the binding site with [3H](+)-pentazocine;1-(4-Fluorophenyl)-4-[spiro[indan-1,4'-piperidin]-1'-yl]-1-butanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCN(CC2)CCCC(=O)C3=CC=C(C=C3)F)C4=CC=CC=C41
2866;407996163;0.0018;1946583;482079938;168292951;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;5-[[4-[(3,4-difluorophenyl)methoxy]piperidin-1-yl]methyl]-1H-indazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=C(C=C2)F)F)CC3=CC4=C(C=C3)NN=C4
2867;407996264;0.0018;1946583;482085506;168296363;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;5-[[4-[(3,4-Difluorophenyl)methoxy]piperidin-1-yl]methyl]-1-methylindazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C=C(C=C2)CN3CCC(CC3)OCC4=CC(=C(C=C4)F)F)C=N1
2868;100399132;0.00181;204632;103671515;45260591;10280;127477840;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma receptor type 1 in guinea pig brain membrane without cerebellum;"1-[(2R)-2-(4-chlorophenoxy)propyl]-4-methylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1CCN(CC1)C[C@@H](C)OC2=CC=C(C=C2)Cl.Cl
2869;100627936;0.00182;204453;103671341;45260477;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"(4aR,10bR)-3-benzyl-2,4,4a,5,6,10b-hexahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC2=CC=CC=C2[C@H]3[C@@H]1CN(CC3)CC4=CC=CC=C4.Cl
2870;407996252;0.00182;1946583;482077112;168290895;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;5-[[4-[(4-Chloro-3-fluorophenyl)methoxy]piperidin-1-yl]methyl]-1-methylindazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C=C(C=C2)CN3CCC(CC3)OCC4=CC(=C(C=C4)Cl)F)C=N1
2871;407996332;0.00182;1946583;482072744;168287735;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;5-[[4-[(4-chloro-3-fluorophenyl)methoxy]piperidin-1-yl]methyl]-1H-indazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=C(C=C2)Cl)F)CC3=CC4=C(C=C3)NN=C4
2872;100399128;0.00183;204632;103671540;45260615;10280;127477840;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma receptor type 1 in guinea pig brain membrane without cerebellum;"1-[(3S)-3-(4-chlorophenoxy)butyl]-4-methylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1CCN(CC1)CC[C@H](C)OC2=CC=C(C=C2)Cl.Cl
2873;100627937;0.001862;204453;103671425;45260524;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"2-Butyl-1,3,4,9-tetrahydroindeno[2,1-c]pyridine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCCN1CCC2=C(C1)CC3=CC=CC=C23.Cl
2874;100385641;0.00187;204153;103378222;11143217;10280;117841480;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma opioid receptor type 1 affinity in guinea pig brain by employing [3H](+)-pentazocine as radioligand.;1'-Benzylspiro[1H-2-benzopyran-1,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3C=CO2)CC4=CC=CC=C4
2875;100356310;0.0019;204790;103237733;10582670;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-[1-(9-bicyclo[3.3.1]nonanyl)piperidin-4-yl]-4-bromo-1-methoxynaphthalene-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)NC3CCN(CC3)C4C5CCCC4CCC5
2876;100470630;0.0019;204469;103340108;44342724;10280;79325690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition against sigma receptor using displacement of 3 nM [3H]pentazocine in homogenate of guinea pig brain cerebellum;(1S,13S)-10-heptyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCCCCCN1CC[C@]2([C@@H](C1CC3=C2C=C(C=C3)O)C)C
2877;100475174;0.0019;204462;103673033;45261707;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;"1'-[(4-Nitrophenyl)methyl]spiro[3,4-dihydronaphthalene-2,4'-piperidine]-1-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2(CCN(CC2)CC3=CC=C(C=C3)[N+](=O)[O-])C(=O)C4=CC=CC=C41.Cl
2878;100722951;0.0019;204635;103268073;44310961;10280;150810120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma receptor type 1,using [3H](+)-pentazocine as radioligand;1-(4,4-Diphenyl-but-3-enyl)-4-methyl-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)CCC=C(C2=CC=CC=C2)C3=CC=CC=C3
2879;326060878;0.0019;711577;103167216;3559;10280;214138080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma 1 receptor;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2880;363958022;0.0019;1500193;404688747;31588412;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-3-dimethylaminobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)C1=CC=CC(=C1)C(=O)NCCCN(C)CC2=CC=CC=C2
2881;402102404;0.0019;1796671;384224370;31588412;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-3-dimethylaminobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)C1=CC=CC(=C1)C(=O)NCCCN(C)CC2=CC=CC=C2
2882;112788091;0.00191;204633;103385149;10713756;10280;74907270;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to inhibit [3H](+)-pentazocine binding to guinea pig brain Sigma receptor type 1;(8E)-5-(3-hydroxyphenyl)-8-[(4-methoxyphenyl)methylidene]-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1/C(=C\C3=CC=C(C=C3)OC)/C(=O)C2)C4=CC(=CC=C4)O
2883;100627931;0.001995;204453;103677403;45264531;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"(4aR,10bR)-3-[(4-methoxyphenyl)methyl]-2,4,4a,5,6,10b-hexahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;COC1=CC=C(C=C1)CN2CC[C@@H]3[C@H](C2)CCC4=CC=CC=C34.Cl
2884;363701196;0.001995;1409616;103237360;10474335;10280;323538590;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocin from the Sigma1 receptor;1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCCC2CCCN3CCN(CC3)C4CCCCC4
2885;363701199;0.001995;1409616;381854209;9817231;10280;323538590;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocin from the Sigma1 receptor;3-(4-methylphenyl)-5-(1-propyl-3,6-dihydro-2H-pyridin-5-yl)-1,2-oxazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCC=C(C1)C2=CC(=NO2)C3=CC=C(C=C3)C
2886;100297861;0.002;239347;103340357;11198145;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;4-[2-(4-Benzyl-piperidin-1-yl)-1-hydroxy-propyl]-phenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]([C@H](C1=CC=C(C=C1)O)O)N2CCC(CC2)CC3=CC=CC=C3
2887;100459319;0.002;229212;103400994;11725031;10280;84969360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was evaluated against sigma-1 binding site in guinea pig, using [3H]- -(+)- Pentazocine;N-Methyl-N-[2-(1-pyrrolidinyl)ethyl]-4-iodobenzylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCN1CCCC1)CC2=CC=C(C=C2)I
2888;100475168;0.002;204462;103673091;45261752;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;"1'-(Cyclohexylmethyl)spiro[3,4-dihydronaphthalene-2,4'-piperidine]-1-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)CN2CCC3(CCC4=CC=CC=C4C3=O)CC2.Cl
2889;100476452;0.002;204462;103351728;44347784;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;"(E)-but-2-enedioic acid;6,8-difluoro-1'-(2-phenylethyl)spiro[3,4-dihydronaphthalene-2,4'-piperidine]-1-one";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2(CCN(CC2)CCC3=CC=CC=C3)C(=O)C4=C1C=C(C=C4F)F.C(=C/C(=O)O)\C(=O)O
2890;100559075;0.002;203684;103389416;401856;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;3-[2-[4-(3-Phenylpropyl)piperazine-1-yl]ethyl]benzenamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)CCC3=CC(=CC=C3)N
2891;100604690;0.002;203857;164127609;131253;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;2-Azabutane, N-[[2-pyrrolidin-1-yl]cyclohexyl]-4-[3,4-dichlorophenyl]-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=C(C=C1)Cl)Cl)C2CCCCC2N3CCCC3
2892;100615706;0.002;204447;164127609;131253;10280;16560440;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]-(+)-3-PPP binding to sigma of guinea pig brain;2-Azabutane, N-[[2-pyrrolidin-1-yl]cyclohexyl]-4-[3,4-dichlorophenyl]-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=C(C=C1)Cl)Cl)C2CCCCC2N3CCCC3
2893;100680629;0.002;204130;103178531;10027435;10280;119345760;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity for Sigma opioid receptor by displacement of [3H]DTG;6-{4-[4-(3,4-Dichloro-benzyl)-piperazin-1-yl]-butyl}-3-methyl-3H-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C=C(C=C2)CCCCN3CCN(CC3)CC4=CC(=C(C=C4)Cl)Cl)SC1=O
2894;100680630;0.002;204130;103178578;9863340;10280;119345760;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity for Sigma opioid receptor by displacement of [3H]DTG;3-Methyl-6-[2-(4-phenyl-piperidin-1-yl)-ethyl]-3H-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C=C(C=C2)CCN3CCC(CC3)C4=CC=CC=C4)SC1=O
2895;100680635;0.002;204130;103178796;22413499;10280;119345760;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity for Sigma opioid receptor by displacement of [3H]DTG;6-[4-(4-Benzyl-piperazin-1-yl)-butyl]-3-methyl-3H-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C=C(C=C2)CCCCN3CCN(CC3)CC4=CC=CC=C4)SC1=O
2896;100702224;0.002;204766;103186198;126388;10280;126395730;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards Sigma-1 receptor;N-(2-(3,4-Dichlorophenyl)ethyl)-N-methyl-2-(1-pyrrolidinyl)ethylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=C(C=C1)Cl)Cl)CCN2CCCC2
2897;100736354;0.002;203993;103228640;15034738;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor from guinea pig brain using the radioligand [3H]SKF-10047;(5S)-5-[[4-(1,3-benzodioxol-5-yl)-4-hydroxypiperidin-1-yl]methyl]-3-[4-(cyclopropylmethoxy)phenyl]-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC1COC2=CC=C(C=C2)N3C[C@@H](OC3=O)CN4CCC(CC4)(C5=CC6=C(C=C5)OCO6)O
2898;100741875;0.002;203992;103671597;45260657;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"8-(Cyclohexylmethyl)-3-(4-fluorophenyl)-1-oxa-8-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)CN2CCC3(CC2)C(=O)C(=CO3)C4=CC=C(C=C4)F.Cl
2899;100745600;0.002;204454;103247694;15729925;10280;;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;In vitro binding affinity towards sigma receptor by the displacement of [3H]PPP from guinea pig brain;N-{1-Cyclohexyl-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butyl}-4-fluoro-benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)C(CCCN2CCN(CC2)C3=NC=C(C=N3)F)NC(=O)C4=CC=C(C=C4)F
2900;100746447;0.002;204018;103277708;44315581;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor using [3H](+)-SKF-10047 as radioligand;4-{2-[3-(4-Fluoro-phenyl)-prop-2-ynyloxy]-ethyl}-1-phenethyl-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CCOCC#CC2=CC=C(C=C2)F)CCC3=CC=CC=C3
2901;345680795;0.002;1174258;312374342;118724298;10280;254622400;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor in human Jurkat cell membranes incubated for 2 hrs by liquid scintillation counting;N-benzyl-3-(3,4-dihydro-1H-[1]benzofuro[3,2-c]pyridin-2-yl)-N-methylpropan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1CCC2=C(C1)C3=CC=CC=C3O2)CC4=CC=CC=C4
2902;366366656;0.002;1558961;103167216;3559;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2903;367478256;0.002;1655949;442061282;156020008;10280;324354210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human Sigma 1 receptor by radioligand displacement assay;"4-Benzyl-1-[(2,2-dimethyl-1,3-dithiolan-4-yl)methyl]piperidine;oxalic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1(SCC(S1)CN2CCC(CC2)CC3=CC=CC=C3)C.C(=O)(C(=O)O)O
2904;372306727;0.002;1701184;461554310;54673619;10280;332377850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;4-[2-[[1-(3,4-Dichlorophenyl)pyrazol-3-yl]methoxy]ethyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCN1CCOCC2=NN(C=C2)C3=CC(=C(C=C3)Cl)Cl
2905;372306737;0.002;1701184;461535594;54589397;10280;332377850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;1-[2-[[1-(3,4-Dichlorophenyl)-5-methylpyrazol-3-yl]methoxy]ethyl]piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)COCCN3CCCCC3
2906;372306821;0.002;1701184;103167216;3559;10280;332377850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2907;380581530;0.002;1861768;440189121;155553381;10280;357532630;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor measured after 120 mins by scintillation counting analysis;4-[4-[(4-Bromophenyl)methyl]triazol-1-yl]-1-[(4-fluorophenyl)methyl]piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1N2C=C(N=N2)CC3=CC=C(C=C3)Br)CC4=CC=C(C=C4)F
2908;407906504;0.002;1922168;461554908;6913112;10280;362020630;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [H3]DTG from sigma 1 receptor (unknown origin) by competition binding assay;SR-31747 free base;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(C/C=C\C1=CC(=C(C=C1)C2CCCCC2)Cl)C3CCCCC3
2909;100627345;0.002042;204452;131273634;54580841;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-Butylspiro[1,2-dihydroindene-3,4'-piperidine];hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCCN1CCC2(CCC3=CC=CC=C32)CC1.Cl
2910;100627923;0.002042;204453;103671321;45260467;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"(4aR,10bR)-3-butyl-7,9-dimethyl-2,4,4a,5,6,10b-hexahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCCN1CC[C@@H]2[C@H](C1)CCC3=C(C=C(C=C23)C)C.Cl
2911;255013358;0.002055;625223;103318016;3042;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dicyclomine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
2912;100385646;0.00207;204153;103378084;10915140;10280;117841480;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma opioid receptor type 1 affinity in guinea pig brain by employing [3H](+)-pentazocine as radioligand.;1'-(3-Phenylpropyl)-3-methoxy-3,4-dihydrospiro[1H-2-benzopyran-1,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1CC2=CC=CC=C2C3(O1)CCN(CC3)CCCC4=CC=CC=C4
2913;100496822;0.00208;204761;103401366;10448771;10280;78533490;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity at Sigma receptor type 1, displacement of [3H](+)-pentazocine from guinea pig brain membranes;(1S,9S,13S)-1,13-dimethyl-10-[(4-methylphenyl)methyl]-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC4=CC=C(C=C4)C)C)C=C(C=C3)O
2914;100627304;0.00209;229194;103384552;15113307;10280;13101140;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+) -3PPP from sigma receptor in guinea pig brain membranes;N-[2-(2-Naphthalenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC2=CC=CC=C2C=C1)CCN3CCCC3
2915;100319798;0.0021;204154;103361875;9999184;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;[1-[3-(Phenethyloxy)-4-methoxybenzyl]pentyl]propylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)NCCC
2916;100438231;0.0021;204445;103186198;126388;10280;14477350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor using [3H](+)-pentazocine in guinea pig brain homogenates;N-(2-(3,4-Dichlorophenyl)ethyl)-N-methyl-2-(1-pyrrolidinyl)ethylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCC1=CC(=C(C=C1)Cl)Cl)CCN2CCCC2
2917;100449436;0.0021;204443;103186198;126388;10280;83608750;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine at sigma receptor in guinea pig brain membrane was determined;N-(2-(3,4-Dichlorophenyl)ethyl)-N-methyl-2-(1-pyrrolidinyl)ethylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCC1=CC(=C(C=C1)Cl)Cl)CCN2CCCC2
2918;100459318;0.0021;229212;103186198;126388;10280;84969360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was evaluated against sigma-1 binding site in guinea pig, using [3H]- -(+)- Pentazocine;N-(2-(3,4-Dichlorophenyl)ethyl)-N-methyl-2-(1-pyrrolidinyl)ethylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=C(C=C1)Cl)Cl)CCN2CCCC2
2919;100464762;0.0021;203702;103252465;12259685;10280;80279780;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;The compound was evaluated for affinity at sigma-1 site by inhibition of [3H](+)-pentazocine (PENT) binding in guinea pig brain.;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
2920;100468422;0.0021;203697;103186198;126388;10280;82952200;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma 1 receptor was determined in guinea pig brain membrane using [3H](+)-pentazocine as radioligand;N-(2-(3,4-Dichlorophenyl)ethyl)-N-methyl-2-(1-pyrrolidinyl)ethylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCC1=CC(=C(C=C1)Cl)Cl)CCN2CCCC2
2921;100746114;0.0021;204147;103252465;12259685;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma opioid receptor type 1 in guinea pig brain homogenate with 0.5 nM [3H](+)-PENT;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
2922;101829947;0.0021;255065;103167216;3559;10280;161400090;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory activity against opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 degree C ;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2923;101829966;0.0021;255065;103468526;44403212;10280;161400090;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory activity against opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 degree C ;(10aS)-2-[3-[methyl(2-phenylethyl)amino]propyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;CN(CCCN1C(=O)[C@@H]2CC3=CC=CC=C3CN2C1=O)CCC4=CC=CC=C4
2924;101830001;0.0021;255057;103167216;3559;10280;161400110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory concentration against opioid receptor sigma 1 of guinea pig cerebral cortex using [3H](+)-pentazocine upon incubation for 150 minutes at 22 degree C;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2925;321573029;0.0021;675973;160674986;25167087;10280;225154050;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to human sigma 1-type opioid receptor;1'-Benzylspiro[6,7-dihydrothieno[3,2-c]pyran-4,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COC2(CCN(CC2)CC3=CC=CC=C3)C4=C1SC=C4
2926;326035166;0.0021;701162;103167216;3559;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2927;326059153;0.0021;712773;163339156;16664364;10280;236413110;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor;(1S,2R)-2-[Methyl(1-adamantyl)aminomethyl]-1-phenylcyclopropanecarboxylic acid methyl ester;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C[C@@H]1C[C@]1(C2=CC=CC=C2)C(=O)OC)C34CC5CC(C3)CC(C5)C4
2928;334064874;0.0021;735278;103167216;3559;10280;235606500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2929;363958044;0.0021;1500193;404658374;9049339;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-4-bromobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)Br)CC2=CC=CC=C2
2930;367478260;0.0021;1655949;442050493;156012478;10280;324354210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human Sigma 1 receptor by radioligand displacement assay;"1-Benzyl-4-(1,3-dithiolan-4-ylmethyl)piperazine;oxalic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2CSCS2)CC3=CC=CC=C3.C(=O)(C(=O)O)O.C(=O)(C(=O)O)O
2931;388740383;0.0021;1797293;386051279;118282879;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 35;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC=C(C=C1)F)N2CC3=C(C2)C=C(C=C3)F
2932;388879192;0.0021;1797475;386051279;118282879;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 35;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC=C(C=C1)F)N2CC3=C(C2)C=C(C=C3)F
2933;389383657;0.0021;1804286;386051279;118282879;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 35;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC=C(C=C1)F)N2CC3=C(C2)C=C(C=C3)F
2934;402102481;0.0021;1796671;384224362;9049339;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-4-bromobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)Br)CC2=CC=CC=C2
2935;100742179;0.00213;203989;103307811;15166845;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor in guinea pig brain preparation was estimated using [3H]3-PPP as radioligand;4-[4-(4-Thiophen-2-yl-3,6-dihydro-2H-pyridin-1-yl)-butyl]-pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CC=C1C2=CC=CS2)CCCCC3=CC=NC=C3
2936;100628002;0.002138;204453;103671486;45260562;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"5-Butyl-5-azatricyclo[9.4.0.02,7]pentadeca-1(15),11,13-triene;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCCN1CCC2C(C1)CCCC3=CC=CC=C23.Cl
2937;100387474;0.00216;204145;103389481;11109952;10280;123830180;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine from Sigma opioid receptor type 1 of guinea pig brain;2-(1'-benzylspiro[1H-2-benzofuran-3,4'-piperidine]-1-yl)acetonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3C(O2)CC#N)CC4=CC=CC=C4
2938;100435162;0.00216;203682;103274327;11739209;10280;150841290;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity at opioid sigma-1 receptor in guinea pig brain membranes by (+)-[3H]pentazocine displacement.;1-Cyclohexyl-4-(3-naphthalen-1-yl-propyl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)N2CCN(CC2)CCCC3=CC=CC4=CC=CC=C43
2939;100385640;0.00217;204153;103378841;10086666;10280;117841480;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma opioid receptor type 1 affinity in guinea pig brain by employing [3H](+)-pentazocine as radioligand.;1'-Benzyl-3,4-dihydrospiro[1H-2-benzopyran-1,4'-piperidine]-3-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3CC(O2)O)CC4=CC=CC=C4
2940;100387743;0.00217;204145;103378841;10086666;10280;123830180;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine from Sigma opioid receptor type 1 of guinea pig brain;1'-Benzyl-3,4-dihydrospiro[1H-2-benzopyran-1,4'-piperidine]-3-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3CC(O2)O)CC4=CC=CC=C4
2941;100768701;0.00217;204149;103273810;10264753;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma opioid receptor type 1;(S)-3-(2-Cyclohexyl-ethyl)-1,8,8-trimethyl-3-aza-bicyclo[3.2.1]octane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@]12CCC(C1(C)C)CN(C2)CCC3CCCCC3
2942;100387470;0.00218;204145;103389482;11109490;10280;123830180;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine from Sigma opioid receptor type 1 of guinea pig brain;1'-Benzyl-3H-spiro[isobenzofuran-1,4'-piperidine]-3-carbonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3C(O2)C#N)CC4=CC=CC=C4
2943;100627927;0.002188;204453;103671410;45260513;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"(4aR,10bR)-3-(2-adamantyl)-2,4,4a,5,6,10b-hexahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC2=CC=CC=C2[C@H]3[C@@H]1CN(CC3)C4C5CC6CC(C5)CC4C6.Cl
2944;100496816;0.00219;204761;103401097;10383371;10280;78533490;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity at Sigma receptor type 1, displacement of [3H](+)-pentazocine from guinea pig brain membranes;(1S,9S,13S)-1,13-dimethyl-10-[(4-nitrophenyl)methyl]-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC4=CC=C(C=C4)[N+](=O)[O-])C)C=C(C=C3)O
2945;100292957;0.0022;239105;103167216;3559;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2946;100386140;0.0022;204153;103167216;3559;10280;117841480;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma opioid receptor type 1 affinity in guinea pig brain by employing [3H](+)-pentazocine as radioligand.;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2947;100387475;0.0022;204145;103167216;3559;10280;123830180;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine from Sigma opioid receptor type 1 of guinea pig brain;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2948;100458855;0.0022;229213;103359654;16048564;10280;79028700;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Tested for [3H](+)-pentazocine binding to sigma-1 receptor in guinea pig brain membrane;Dihydrohaloperidol, (S)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCC[C@@H](C3=CC=C(C=C3)F)O
2949;100459320;0.0022;229212;103383718;15113306;10280;84969360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was evaluated against sigma-1 binding site in guinea pig, using [3H]- -(+)- Pentazocine;2-(3-Chlorophenyl)-N-methyl-N-[2-(pyrrolidin-1-yl)ethyl]ethan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=CC=C1)Cl)CCN2CCCC2
2950;100559064;0.0022;203684;103389849;401827;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;1-(3-Phenylpropyl)-4-(3,4-dichlorophenethyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)CCC3=CC(=C(C=C3)Cl)Cl
2951;100796024;0.0022;203683;103186198;126388;10280;106362330;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was tested for its binding affinity against sigma 1 opioid receptor using 3[H](+)-pentazocine as radioligand;N-(2-(3,4-Dichlorophenyl)ethyl)-N-methyl-2-(1-pyrrolidinyl)ethylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=C(C=C1)Cl)Cl)CCN2CCCC2
2952;345594071;0.0022;1197502;312385711;118731575;10280;256029320;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor in human Jurkat cells after 120 mins by liquid scintillation counting analysis;4-[3-[Benzyl(methyl)amino]propyl]-6-bromo-1,4-benzothiazin-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1C(=O)CSC2=C1C=C(C=C2)Br)CC3=CC=CC=C3
2953;355638089;0.0022;1308619;336905238;127051216;10280;271565650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-Pentazocine from sigma 1 receptor in human RPMI8226 cell membranes;(1R,2R,5S)-6-benzyl-8-(cyclohexylmethyl)-6,8-diazabicyclo[3.2.2]nonan-2-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;C1CCC(CC1)CN2C[C@@H]3CC[C@H]([C@H]2CN3CC4=CC=CC=C4)O
2954;372400420;0.0022;1744234;461556559;162672543;10280;333727820;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane incubated for 2 hr by liquid scintillation counting method;5-(4-Tert-butylphenyl)-1-propan-2-yl-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;CC(C)N1C(=NC(=N1)CN2CCCC2)C3=CC=C(C=C3)C(C)(C)C
2955;407907515;0.0022;1922374;103272556;126402;10280;364903250;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to SIGMAR1 (unknown origin);2-(4-Morpholino)ethyl-1-phenylcyclohexane-1-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)(C2=CC=CC=C2)C(=O)OCCN3CCOCC3
2956;100399130;0.00221;204632;103671505;45260581;10280;127477840;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma receptor type 1 in guinea pig brain membrane without cerebellum;"1-[(2R)-4-(4-chlorophenoxy)butan-2-yl]-4-methylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1CCN(CC1)[C@H](C)CCOC2=CC=C(C=C2)Cl.Cl
2957;100471774;0.002239;203852;131279811;5281881;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;Flupentixol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC/C=C\2/C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO
2958;100473771;0.002239;203852;103321632;15657218;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;"trans-Diethyl-(4-phenyl-1,2,3,4-tetrahydro-naphthalen-2-yl)-amine; hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CC)C1CC(C2=CC=CC=C2C1)C3=CC=CC=C3
2959;407996160;0.002239;1946583;482072652;168287664;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[[4-[(4-Chloro-3-fluorophenyl)methoxy]piperidin-1-yl]methyl]imidazo[1,2-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=C(C=C2)Cl)F)CC3=CN4C=CC=CC4=N3
2960;100367087;0.00225;226337;103376431;9803895;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-[1-(4-Iodobenzyl)-4-piperidinyl]-3-fluorophenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)F)CC3=CC=C(C=C3)I
2961;100627644;0.002291;204452;131287756;54587753;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-(cyclohexylmethyl)spiro[2,3-dihydro-1H-naphthalene-4,4'-piperidine];hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CCC(CC1)CN2CCC3(CCCC4=CC=CC=C43)CC2.Cl
2962;100627929;0.002291;204453;103671471;45260553;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"(4aR,10bR)-3-(1-adamantyl)-2,4,4a,5,6,10b-hexahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC2=CC=CC=C2[C@H]3[C@@H]1CN(CC3)C45CC6CC(C4)CC(C6)C5.Cl
2963;100438229;0.0023;204445;103373806;547467;10280;14477350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor using [3H](+)-pentazocine in guinea pig brain homogenates;3,4-Dichlorophenylethanamine, N-[1-methylazacyclohex-3-yl]-N-methyl-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN1CCCC(C1)N(C)CCC2=CC(=C(C=C2)Cl)Cl
2964;100470635;0.0023;204469;103340141;44342743;10280;79325690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition against sigma receptor using displacement of 3 nM [3H]pentazocine in homogenate of guinea pig brain cerebellum;(1R,13S)-10-hexyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCCCCN1CC[C@@]2([C@@H](C1CC3=C2C=C(C=C3)O)C)C
2965;100478420;0.0023;203696;103185526;18790248;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;Benzyl-(7-phenyl-heptyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)CCCCCCCNCC2=CC=CC=C2
2966;363860757;0.0023;1467149;381848102;137639103;10280;284950850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of (+)-[3H]-pentazocine from recombinant human sigma 1 receptor expressed in baculovirus infected Sf9 insect cell membranes after 90 mins by scintillation counting method;(2R,6R)-4-[3-(4-tert-butylphenyl)propyl]-2,6-dimethylmorpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(C[C@H](O1)C)CCCC2=CC=C(C=C2)C(C)(C)C
2967;372400433;0.0023;1744234;103167216;3559;10280;333727820;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane incubated for 2 hr by liquid scintillation counting method;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2968;407996159;0.0023;1946583;482072652;168287664;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[[4-[(4-Chloro-3-fluorophenyl)methoxy]piperidin-1-yl]methyl]imidazo[1,2-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=C(C=C2)Cl)F)CC3=CN4C=CC=CC4=N3
2969;100367029;0.00231;226337;103375796;11016132;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-[1-(3-Iodobenzyl)-4-piperidinyl]-3-chlorophenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)Cl)CC3=CC(=CC=C3)I
2970;407996256;0.002344;1946583;482056009;163322330;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;D4R antagonist-1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC(=C1)CO[C@H]2CCCN(C2)CC3=CC(=C(C=C3)OC)F)F
2971;100496811;0.00237;204761;103401155;10405079;10280;78533490;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity at Sigma receptor type 1, displacement of [3H](+)-pentazocine from guinea pig brain membranes;(1S,9S,13S)-10-[(4-chlorophenyl)methyl]-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC4=CC=C(C=C4)Cl)C)C=C(C=C3)O
2972;100435178;0.0024;203682;103275198;11405872;10280;150841290;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity at opioid sigma-1 receptor in guinea pig brain membranes by (+)-[3H]pentazocine displacement.;1-Cyclohexyl-4-(5-naphthalen-1-yl-pentyl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)N2CCN(CC2)CCCCCC3=CC=CC4=CC=CC=C43
2973;100458981;0.0024;229212;103384535;558800;10280;84969360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was evaluated against sigma-1 binding site in guinea pig, using [3H]- -(+)- Pentazocine;3-Azapentane, N-methyl-5-[4-chlorophenyl]-1-[pyrrolidin-1-yl]-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC=C(C=C1)Cl)CCN2CCCC2
2974;100475260;0.0024;204462;103251882;125328;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;1'-benzyl-3,4-dihydro-2H-spiro[naphthalene-1,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2=CC=CC=C2C3(C1)CCN(CC3)CC4=CC=CC=C4
2975;100615701;0.0024;204447;103321343;5471948;10280;16560440;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]-(+)-3-PPP binding to sigma of guinea pig brain;K7C7Xkk3P3;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC[C@H]([C@H](C1)NCCC2=CC(=C(C=C2)Cl)Cl)N3CCCC3
2976;101831628;0.0024;255051;103468559;44403234;10280;161400090;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory activity against Opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 C ;(10aS)-2-(1-benzylpiperidin-4-yl)-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CN(CCC1N2C(=O)[C@@H]3CC4=CC=CC=C4CN3C2=O)CC5=CC=CC=C5
2977;355638087;0.0024;1308619;336904915;127050993;10280;271565650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-Pentazocine from sigma 1 receptor in human RPMI8226 cell membranes;(1alpha,4alpha,7R)-2-(Cyclohexylmethyl)-5-benzyl-2,5-diazabicyclo[2.2.2]octane-7-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;C1CCC(CC1)CN2C[C@@H]3C[C@H]([C@H]2CN3CC4=CC=CC=C4)O
2978;407996255;0.0024;1946583;482056009;163322330;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;D4R antagonist-1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC(=C1)CO[C@H]2CCCN(C2)CC3=CC(=C(C=C3)OC)F)F
2979;100435164;0.00245;203682;103274544;11428679;10280;150841290;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity at opioid sigma-1 receptor in guinea pig brain membranes by (+)-[3H]pentazocine displacement.;1-Cyclohexyl-4-[3-((S)-5-methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-propyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC=CC2=C1CCC[C@H]2CCCN3CCN(CC3)C4CCCCC4
2980;100546605;0.00245;203685;103278869;10616126;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-Benzylpiperidine-4-yl)-2-(3-fluorophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)F)CC3=CC=CC=C3
2981;100628005;0.002455;204453;103671382;45260498;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"(4aR,10bR)-3-(cyclopropylmethyl)-2,4,4a,5,6,10b-hexahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC2=CC=CC=C2[C@H]3[C@@H]1CN(CC3)CC4CC4.Cl
2982;366435743;0.002455;1593893;103167216;3559;10280;309877800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK293T cell membranes;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2983;366435744;0.00246;1593893;103167216;3559;10280;309877800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK293T cell membranes;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2984;100487779;0.00249;204638;103318665;44332579;10280;76368610;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was measured on Sigma receptor type 1 using [3H]- pentazocine as radioligand;3-Bromo-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C(=C(C=C3)O)Br
2985;100292834;0.0025;239105;103442043;11152527;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;4-Benzyl-1-chroman-3-ylmethyl-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3CC4=CC=CC=C4OC3
2986;100298513;0.0025;239347;103458416;5417;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;DL-Tetrahydropalmatine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C2=C(CC3C4=CC(=C(C=C4CCN3C2)OC)OC)C=C1)OC
2987;100354360;0.0025;204790;103237641;11796923;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-[[(2S)-1-Cyclopentyl-2-pyrrolidinyl]methyl]-1-methoxy-4-bromo-2-naphthalenecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)NC[C@@H]3CCCN3C4CCCC4
2988;100458982;0.0025;229212;103401204;10316321;10280;84969360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was evaluated against sigma-1 binding site in guinea pig, using [3H]- -(+)- Pentazocine;N-(2-(4-Iodophenyl)ethyl)-N-methyl-2-(1-pyrrolidinyl)ethylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC=C(C=C1)I)CCN2CCCC2
2989;100459321;0.0025;229212;103401221;10021279;10280;84969360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was evaluated against sigma-1 binding site in guinea pig, using [3H]- -(+)- Pentazocine;N-Methyl-N-[2-(1-pyrrolidinyl)ethyl]-3-iodophenethylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=CC=C1)I)CCN2CCCC2
2990;100746558;0.0025;204019;103336519;44341163;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-SKF-10047 binding to sigma receptor;"1-benzyl-N-(3-phenylprop-2-ynyl)piperidin-4-amine;(E)-but-2-enedioic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NCC#CC2=CC=CC=C2)CC3=CC=CC=C3.C(=C/C(=O)O)\C(=O)O
2991;345681153;0.0025;1174258;312374350;118724306;10280;254622400;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor in human Jurkat cell membranes incubated for 2 hrs by liquid scintillation counting;3-(3,4-dihydro-1H-[1]benzofuro[3,2-c]pyridin-2-yl)-N-methyl-N-(2-phenylethyl)propan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1CCC2=C(C1)C3=CC=CC=C3O2)CCC4=CC=CC=C4
2992;380581324;0.0025;1861723;103167216;3559;10280;357249250;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2993;407907022;0.0025;1922166;103167216;3559;10280;362020630;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to human sigma 1 receptor;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2994;100399848;0.00251;204632;103671570;45260638;10280;127477840;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma receptor type 1 in guinea pig brain membrane without cerebellum;"2-Pyrrolidin-1-ylethyl 2-(3,4-dichlorophenyl)acetate;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCN(C1)CCOC(=O)CC2=CC(=C(C=C2)Cl)Cl.Cl
2995;100295626;0.00252;239200;103442133;11405584;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;4-Benzyl-1-(1,2,3,4-tetrahydro-naphthalen-2-ylmethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2=CC=CC=C2CC1CN3CCC(CC3)CC4=CC=CC=C4
2996;100367084;0.00253;226337;103167216;3559;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2997;100547847;0.00253;203686;103167216;3559;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound tested for binding affinity towards sigma 1 receptor in quinea pig brain membranes using [3H](+)-pentazocine as the radioligand.;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
2998;100768703;0.00253;204149;103274107;22875693;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma opioid receptor type 1;(S)-3-(3-Cyclohexyl-propyl)-1,8,8-trimethyl-3-aza-bicyclo[3.2.1]octane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@]12CCC(C1(C)C)CN(C2)CCCC3CCCCC3
2999;100628012;0.00257;204453;103671499;45260576;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"(4aR,10bR)-3-propyl-2,4,4a,5,6,10b-hexahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCN1CC[C@@H]2[C@H](C1)CCC3=CC=CC=C23.Cl
3000;100478313;0.0026;203696;103185511;10708590;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;Phenethyl-(4-phenyl-butyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)CCCCNCCC2=CC=CC=C2
3001;100559066;0.0026;203684;103389392;10641797;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;1-(3-Phenylpropyl)-4-(4-nitrophenethyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)CCC3=CC=C(C=C3)[N+](=O)[O-]
3002;100559072;0.0026;203684;103389470;401846;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;2-[4-(3-Phenylpropyl)piperazine-1-yl]ethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)CCN
3003;100617254;0.0026;204444;103288929;15723883;10280;16627250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membranes using [3H]DTG as radioligand;1-Phenyl-4-(4-phenylbutyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCCCC2=CC=CC=C2)C3=CC=CC=C3
3004;100619165;0.0026;203990;136927022;14831240;10280;18482950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma opioid receptor in guinea pig cerebral homogenate using [3H]DTG as radioligand;N-Methyl-N-[(S)-1-methyl-2-phenylethyl]-5-phenylpentan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](CC1=CC=CC=C1)N(C)CCCCCC2=CC=CC=C2
3005;100746559;0.0026;204019;103335864;44340880;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-SKF-10047 binding to sigma receptor;"1-benzyl-N-methyl-N-[(E)-3-phenylprop-2-enyl]piperidin-4-amine;(E)-but-2-enedioic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C/C=C/C1=CC=CC=C1)C2CCN(CC2)CC3=CC=CC=C3.C(=C/C(=O)O)\C(=O)O
3006;363860759;0.0026;1467149;381854313;137643283;10280;284950850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of (+)-[3H]-pentazocine from recombinant human sigma 1 receptor expressed in baculovirus infected Sf9 insect cell membranes after 90 mins by scintillation counting method;4-[3-(4-Tert-butylphenyl)propyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)C1=CC=C(C=C1)CCCN2CCOCC2
3007;100487678;0.00262;204638;103318180;44332382;10280;76368610;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was measured on Sigma receptor type 1 using [3H]- pentazocine as radioligand;3-Chloro-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C(=C(C=C3)O)Cl
3008;100292962;0.00266;239105;103442135;10449555;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;2-[(4-Benzylpiperazino)methyl]chromone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2=CC=CC=C2)CC3=CC(=O)C4=CC=CC=C4O3
3009;100438227;0.00267;204445;103374108;573546;10280;14477350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor using [3H](+)-pentazocine in guinea pig brain homogenates;Azacycloheptane, 1-[2-[3,4-dichlorophenyl]ethyl]-3-[1-pyrrolidinyl]-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCN(CC(C1)N2CCCC2)CCC3=CC(=C(C=C3)Cl)Cl
3010;100399847;0.00269;204632;103671563;45260632;10280;127477840;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma receptor type 1 in guinea pig brain membrane without cerebellum;"1-[(2S)-4-(4-chlorophenoxy)butan-2-yl]-4-methylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1CCN(CC1)[C@@H](C)CCOC2=CC=C(C=C2)Cl.Cl
3011;100399844;0.0027;204632;103252465;12259685;10280;127477840;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma receptor type 1 in guinea pig brain membrane without cerebellum;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
3012;100478460;0.0027;203696;103186015;10017418;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;(1-Benzyl-butyl)-(4-phenyl-butyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCC(CC1=CC=CC=C1)NCCCCC2=CC=CC=C2
3013;363850274;0.0027;1449796;103241078;131698;10280;283855030;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 in human MDA-MB-468 cell membranes;1-(4-Iodophenyl)-3-(1-adamantyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C2CC3CC1CC(C2)(C3)N=C(N)NC4=CC=C(C=C4)I
3014;100742177;0.00272;203989;103308193;15166841;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor in guinea pig brain preparation was estimated using [3H]3-PPP as radioligand;4-[4-(3,6-dihydro-4-phenyl-1(2H)-pyridinyl)butyl]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CC=C1C2=CC=CC=C2)CCCCC3=CC=NC=C3
3015;334073849;0.00275;737383;164132834;71717119;10280;235662450;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin);1'-(4-Iodobenzyl)spiro[isobenzofuran-1(3H),4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3CO2)CC4=CC=C(C=C4)I
3016;100627648;0.002754;204452;131279690;54583825;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-(2-Phenylethyl)spiro[1,2-dihydroindene-3,4'-piperidine];hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC2(CCN(CC2)CCC3=CC=CC=C3)C4=CC=CC=C41.Cl
3017;100464787;0.00278;203701;103671403;45260510;10280;80279780;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity at sigma-1 site by inhibition of [3H](+)-pentazocine (PENT) binding in guinea pig brain;"2-(4-Phenylpiperazin-1-yl)ethyl 1-(4-nitrophenyl)cyclopentane-1-carboxylate;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)(C2=CC=C(C=C2)[N+](=O)[O-])C(=O)OCCN3CCN(CC3)C4=CC=CC=C4.Cl
3018;100468790;0.0028;204469;103340145;44342746;10280;79325690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition against sigma receptor using displacement of 3 nM [3H]pentazocine in homogenate of guinea pig brain cerebellum;(1S,13S)-1,13-dimethyl-10-octyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCCCCCCN1CC[C@]2([C@@H](C1CC3=C2C=C(C=C3)O)C)C
3019;100617257;0.0028;204444;103337543;15723887;10280;16627250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membranes using [3H]DTG as radioligand;1-(2-Naphthalenyl)-4-(3-phenylpropyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCCC2=CC=CC=C2)C3=CC4=CC=CC=C4C=C3
3020;100622191;0.0028;203982;103241078;131698;10280;16481400;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H]DTG from sigma opioid receptor of homogenized guinea pig whole brain;1-(4-Iodophenyl)-3-(1-adamantyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C2CC3CC1CC(C2)(C3)N=C(N)NC4=CC=C(C=C4)I
3021;355637710;0.0028;1308619;336904916;127050994;10280;271565650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-Pentazocine from sigma 1 receptor in human RPMI8226 cell membranes;(1S,4R,7R)-5-benzyl-2-(cyclohexylmethyl)-2,5-diazabicyclo[2.2.2]octan-7-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;C1CCC(CC1)CN2C[C@H]3C[C@H]([C@@H]2CN3CC4=CC=CC=C4)O
3022;363970593;0.00283;1506085;136928086;53378764;10280;299690300;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of (+)-[3H]pentazocine from human sigma1 receptor expressed in HEK293 cell membranes after 60 mins by liquid scintillation counting method;N-[[5-[3-(1-benzylpiperidin-4-yl)propoxy]-1-methylindol-2-yl]methyl]-N-methylprop-2-yn-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C=C(C=C2)OCCCC3CCN(CC3)CC4=CC=CC=C4)C=C1CN(C)CC#C
3023;100768705;0.00287;204149;103274166;44313813;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma opioid receptor type 1;(S)-3-(2-Cycloheptyl-ethyl)-1,8,8-trimethyl-3-aza-bicyclo[3.2.1]octane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@]12CCC(C1(C)C)CN(C2)CCC3CCCCCC3
3024;100768707;0.00287;204149;103274164;44313811;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma opioid receptor type 1;(S)-3-(2-Cyclooctyl-ethyl)-1,8,8-trimethyl-3-aza-bicyclo[3.2.1]octane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@]12CCC(C1(C)C)CN(C2)CCC3CCCCCCC3
3025;100627654;0.002884;204452;131285664;54586711;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-hexylspiro[2,3-dihydro-1H-naphthalene-4,4'-piperidine];hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCCCCN1CCC2(CCCC3=CC=CC=C32)CC1.Cl
3026;366431535;0.002884;1592018;136931562;57345618;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;1-(4-Chlorophenyl)-4-[3-(4-fluorophenoxy)propyl]-1,4-diazepane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=CC=C(C=C2)Cl)CCCOC3=CC=C(C=C3)F
3027;100496809;0.00289;204761;103401553;10042708;10280;78533490;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity at Sigma receptor type 1, displacement of [3H](+)-pentazocine from guinea pig brain membranes;(1S,9S,13S)-10-[(4-methoxyphenyl)methyl]-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC4=CC=C(C=C4)OC)C)C=C(C=C3)O
3028;100546175;0.00289;203685;103277886;10834075;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-Benzylpiperidin-4-yl)-2-(2-bromophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CC=C2Br)CC3=CC=CC=C3
3029;100459316;0.0029;229212;103401056;10470688;10280;84969360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was evaluated against sigma-1 binding site in guinea pig, using [3H]- -(+)- Pentazocine;[2-(4-Bromo-phenyl)-ethyl]-methyl-(2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC=C(C=C1)Br)CCN2CCCC2
3030;100617250;0.0029;204444;103337585;3299322;10280;16627250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membranes using [3H]DTG as radioligand;1-(4-Chlorophenyl)-4-(3-phenylpropyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCCC2=CC=CC=C2)C3=CC=C(C=C3)Cl
3031;101829963;0.0029;255065;103468520;11697109;10280;161400090;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory activity against opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 degree C ;(10aS)-2-[2-[methyl(5-phenylpentyl)amino]ethyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;CN(CCCCCC1=CC=CC=C1)CCN2C(=O)[C@@H]3CC4=CC=CC=C4CN3C2=O
3032;321525569;0.0029;658997;160683578;25006786;10280;225129080;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H](+)pentazocine from sigma-1 receptor expressed in human Jurkat cell membranes after 2 hrs by liquid scintillation spectroscopy;1-[4-[1-Adamantyl(phenyl)methyl]phenyl]-4-ethylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN1CCN(CC1)C2=CC=C(C=C2)C(C3=CC=CC=C3)C45CC6CC(C4)CC(C6)C5
3033;326067557;0.0029;718362;163332448;71459491;10280;230949920;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma 1 receptor in human Jurkat cell membrane;1-[2-[4-[1-Adamantyl(phenyl)methyl]phenyl]ethyl]-4-methylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCN(CC1)CCC2=CC=C(C=C2)C(C3=CC=CC=C3)C45CC6CC(C4)CC(C6)C5
3034;342827625;0.0029;1122321;242615239;25059251;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin);1-Phenyl-4-[2-(4-phenylpiperazino)ethyl]-1,4,6,7-tetrahydropyrano[4,3-c]pyrazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COC(C2=C1N(N=C2)C3=CC=CC=C3)CCN4CCN(CC4)C5=CC=CC=C5
3035;363958021;0.0029;1500193;404665537;41307231;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-4-bromo-2-fluorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=C(C=C(C=C1)Br)F)CC2=CC=CC=C2
3036;363958025;0.0029;1500193;404655149;29048070;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N'-benzyl-N-[(4-chlorophenyl)methyl]-N'-methylpropane-1,3-diamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNCC1=CC=C(C=C1)Cl)CC2=CC=CC=C2
3037;366431534;0.0029;1592018;136931562;57345618;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;1-(4-Chlorophenyl)-4-[3-(4-fluorophenoxy)propyl]-1,4-diazepane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=CC=C(C=C2)Cl)CCCOC3=CC=C(C=C3)F
3038;402102363;0.0029;1796671;384224367;41307231;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-4-bromo-2-fluorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=C(C=C(C=C1)Br)F)CC2=CC=CC=C2
3039;100297851;0.003;239347;103458451;5474589;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;[2-(4-{(E)-2-[4-(2-Diethylamino-ethoxy)-phenyl]-1-ethyl-but-1-enyl}-phenoxy)-ethyl]-diethyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC/C(=C(/CC)\C1=CC=C(C=C1)OCCN(CC)CC)/C2=CC=C(C=C2)OCCN(CC)CC
3040;100298507;0.003;239347;103458497;6439331;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;[(E)-3-(3-Chloro-4-cyclohexyl-phenyl)-allyl]-cyclohexyl-ethyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(C/C=C/C1=CC(=C(C=C1)C2CCCCC2)Cl)C3CCCCC3
3041;100475272;0.003;204462;103673081;45261745;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;"1'-[(4-Methoxyphenyl)methyl]spiro[3,4-dihydronaphthalene-2,4'-piperidine]-1-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC=C(C=C1)CN2CCC3(CCC4=CC=CC=C4C3=O)CC2.Cl
3042;100617495;0.003;204001;103337130;15723894;10280;16627250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;The compound was tested for its binding affinity towards Sigma opioid receptor in guinea pig brain membranes;4-Phenyl-1-(3-phenylpropyl)piperidin-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1(C2=CC=CC=C2)O)CCCC3=CC=CC=C3
3043;100680636;0.003;204130;103178720;15288693;10280;119345760;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity for Sigma opioid receptor by displacement of [3H]DTG;6-[2-(4-Benzyl-piperazin-1-yl)-ethyl]-3-methyl-3H-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C=C(C=C2)CCN3CCN(CC3)CC4=CC=CC=C4)SC1=O
3044;100680637;0.003;204130;103178877;10339767;10280;119345760;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity for Sigma opioid receptor by displacement of [3H]DTG;3-Methyl-6-[4-(4-phenyl-piperidin-1-yl)-butyl]-3H-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C=C(C=C2)CCCCN3CCC(CC3)C4=CC=CC=C4)SC1=O
3045;100737360;0.003;203993;103227875;15034734;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor from guinea pig brain using the radioligand [3H]SKF-10047;(5S)-5-[[4-(1,3-benzodioxol-5-yl)-4-hydroxypiperidin-1-yl]methyl]-3-(4-chlorophenyl)-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC3=C(C=C2)OCO3)O)C[C@H]4CN(C(=O)O4)C5=CC=C(C=C5)Cl
3046;100742363;0.003;203992;103671592;45260653;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"8-[(4-Fluorophenyl)methyl]-3-phenyl-1-oxa-8-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC12C(=O)C(=CO2)C3=CC=CC=C3)CC4=CC=C(C=C4)F.Cl
3047;100746101;0.003;204298;103265811;44309721;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma opioid receptor type 2 in guinea pig brain homogenate with 4 nM [3H]-(+)-DTG;5,5-Diphenyl-3-[6-(4-phenyl-piperidin-1-yl)-hexyl]-imidazolidine-2,4-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1C2=CC=CC=C2)CCCCCCN3C(=O)C(NC3=O)(C4=CC=CC=C4)C5=CC=CC=C5
3048;100768694;0.003;204149;103274106;44313766;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma opioid receptor type 1;(S)-3-Cyclohexyl-1,8,8-trimethyl-3-aza-bicyclo[3.2.1]octane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@]12CCC(C1(C)C)CN(C2)C3CCCCC3
3049;363851586;0.003;1449797;381862025;15340879;10280;283855030;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [125I]-IPAG from sigma1 in human MDA-MB-468 cell membranes;1,2-Bis(4-iodophenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC(=CC=C1NC(=NC2=CC=C(C=C2)I)N)I
3050;366366987;0.003;1558961;440145795;118567547;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;4-(5-Fluoropyridin-3-yl)-2-methyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=CC(=CN=C4)F
3051;372306730;0.003;1701184;461536399;54673483;10280;332377850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;(2S,6R)-4-[2-[[1-(3,4-dichlorophenyl)-5-methylpyrazol-3-yl]methoxy]ethyl]-2,6-dimethylmorpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(C[C@@H](O1)C)CCOCC2=NN(C(=C2)C)C3=CC(=C(C=C3)Cl)Cl
3052;380512726;0.003;1846430;482066921;24862176;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-4-benzyl-10-(3-fluorophenyl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CC=CC=C3)OCC4=C(N=NN24)C5=CC(=CC=C5)F
3053;100292609;0.00302;239200;103442090;10758200;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;1-Benzyl-4-chroman-2-ylmethyl-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2=CC=CC=C2OC1CN3CCN(CC3)CC4=CC=CC=C4
3054;100464002;0.00302;203694;103230821;381255;10280;80219130;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain using [3H](+)-pentazocine as radioligand;N-(1-Benzyl-4-piperidinyl)-3-iodobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)C2=CC(=CC=C2)I)CC3=CC=CC=C3
3055;100435172;0.00305;203682;103252465;12259685;10280;150841290;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity at opioid sigma-1 receptor in guinea pig brain membranes by (+)-[3H]pentazocine displacement.;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
3056;100435171;0.00307;203682;103275040;11281378;10280;150841290;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity at opioid sigma-1 receptor in guinea pig brain membranes by (+)-[3H]pentazocine displacement.;1-Cyclohexyl-4-[6-(5-methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-hexyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC=CC2=C1CCCC2CCCCCCN3CCN(CC3)C4CCCCC4
3057;100742175;0.00307;203989;103308174;44327702;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor in guinea pig brain preparation was estimated using [3H]3-PPP as radioligand;4-[4-(4-Naphthalen-2-yl-3,6-dihydro-2H-pyridin-1-yl)-butyl]-pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CC=C1C2=CC3=CC=CC=C3C=C2)CCCCC4=CC=NC=C4
3058;100546610;0.00308;203685;103277898;10736122;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-benzylpiperidin-4-yl)-2-(2-chlorophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CC=C2Cl)CC3=CC=CC=C3
3059;100627925;0.00309;204453;160692198;70691300;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"(4aR,10bS)-3-butyl-2,4,4a,5,6,10b-hexahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCCN1CC[C@H]2[C@H](C1)CCC3=CC=CC=C23.Cl
3060;407996428;0.00309;1946583;482060851;168279082;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;6-[[4-[[3-(trifluoromethyl)phenyl]methoxy]piperidin-1-yl]methyl]-1H-benzimidazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=CC=C2)C(F)(F)F)CC3=CC4=C(C=C3)N=CN4
3061;100322593;0.0031;204151;103252465;12259685;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 1 using [3H](+)-pentazocine in guinea pig brain membranes;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
3062;100438233;0.0031;204445;103252465;12259685;10280;14477350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor using [3H](+)-pentazocine in guinea pig brain homogenates;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
3063;100449438;0.0031;204443;103252465;12259685;10280;83608750;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine at sigma receptor in guinea pig brain membrane was determined;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
3064;100458980;0.0031;229212;160677132;41011;10280;84969360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was evaluated against sigma-1 binding site in guinea pig, using [3H]- -(+)- Pentazocine;Guanidine, N,N'-bis(4-methylphenyl)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=C(C=C1)NC(=NC2=CC=C(C=C2)C)N
3065;100459325;0.0031;229212;103252465;12259685;10280;84969360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was evaluated against sigma-1 binding site in guinea pig, using [3H]- -(+)- Pentazocine;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
3066;100468427;0.0031;203697;103252465;12259685;10280;82952200;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma 1 receptor was determined in guinea pig brain membrane using [3H](+)-pentazocine as radioligand;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
3067;100484997;0.0031;204637;103252465;12259685;10280;76368610;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was measured on Sigma receptor type 1 using [3H]- pentazocine as radioligand;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
3068;100485161;0.0031;204636;103252465;12259685;10280;76368600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured on Sigma receptor type 1 from guinea pig brain membranes using [3H]pentazocine as radioligand.;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
3069;100549945;0.0031;203688;103252465;12259685;10280;96511500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was evaluated for its in vitro competition binding studies using sigma-ligand (0.05-10000 nM) - [3H](+)-pentazocine (sigma1 receptor) in guinea pig brain membranes;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
3070;100615705;0.0031;204447;103321344;15701663;10280;16560440;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]-(+)-3-PPP binding to sigma of guinea pig brain;[1S,2R,(+)]-N-[2-(3,4-Dichlorophenyl)ethyl]-N-ethyl-2-(1-pyrrolidinyl)cyclohexanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CCC1=CC(=C(C=C1)Cl)Cl)[C@H]2CCCC[C@H]2N3CCCC3
3071;100796635;0.0031;203683;103252465;12259685;10280;106362330;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was tested for its binding affinity against sigma 1 opioid receptor using 3[H](+)-pentazocine as radioligand;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
3072;112788097;0.0031;204633;103386352;10809006;10280;74907270;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to inhibit [3H](+)-pentazocine binding to guinea pig brain Sigma receptor type 1;(8E)-8-[(3-chlorophenyl)methylidene]-5-(3-hydroxyphenyl)-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1/C(=C\C3=CC(=CC=C3)Cl)/C(=O)C2)C4=CC(=CC=C4)O
3073;326059155;0.0031;712773;103252465;12259685;10280;236413110;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
3074;345594057;0.0031;1197502;312385707;118731571;10280;256029320;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor in human Jurkat cells after 120 mins by liquid scintillation counting analysis;3-[3-[Benzyl(methyl)amino]propyl]-5-bromo-1,3-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1C2=C(C=CC(=C2)Br)SC1=O)CC3=CC=CC=C3
3075;366437011;0.0031;1594271;103252465;12259685;10280;309043830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
3076;407907021;0.0031;1922166;494397724;171344250;10280;362020630;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to human sigma 1 receptor;(1R,9S,13S)-1,13-dimethyl-10-(2-methylprop-1-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2C=C(C)C)C)C=C(C=C3)O
3077;407996464;0.0031;1946583;482065857;168282745;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;6-[[4-[(4-chloro-3-fluorophenyl)methoxy]piperidin-1-yl]methyl]-1H-benzimidazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=C(C=C2)Cl)F)CC3=CC4=C(C=C3)N=CN4
3078;100496819;0.00311;204761;103401594;10023021;10280;78533490;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity at Sigma receptor type 1, displacement of [3H](+)-pentazocine from guinea pig brain membranes;(1S,9S,13S)-10-[(4-bromophenyl)methyl]-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC4=CC=C(C=C4)Br)C)C=C(C=C3)O
3079;100546524;0.00311;203689;103283942;10718443;10280;96511500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma-1 receptor in guinea pig brain membranes;N-(2-Azepan-1-yl-ethyl)-3-iodo-4-methoxy-N-methyl-benzenesulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCN1CCCCCC1)S(=O)(=O)C2=CC(=C(C=C2)OC)I
3080;100367085;0.00315;226337;103376056;9906139;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-[1-(4-Fluorobenzyl)-4-piperidinyl]-2-fluorophenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CC=C2F)CC3=CC=C(C=C3)F
3081;100627354;0.003162;204452;131285666;54586713;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-(Oxolan-2-ylmethyl)spiro[1,2-dihydroindene-3,4'-piperidine];hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC(OC1)CN2CCC3(CCC4=CC=CC=C43)CC2.Cl
3082;342817232;0.003162;1118248;103576610;9907323;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human recombinant sigma-1 receptor expressed in CHO cells after 180 mins by beta counting analysis;Cutamesine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;197.0;;;;COC1=C(C=C(C=C1)CCN2CCN(CC2)CCCC3=CC=CC=C3)OC
3083;100546182;0.00317;203685;103278068;10665131;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-Benzylpiperidine-4-yl)-2-(3,4-difluorophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC(=C(C=C2)F)F)CC3=CC=CC=C3
3084;100354373;0.0032;204790;103238403;10622914;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-[(3S)-1-Benzyl-3-pyrrolidinyl]-1-methoxy-4-bromo-2-naphthalenecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)N[C@H]3CCN(C3)CC4=CC=CC=C4
3085;100543134;0.0032;203698;103167216;3559;10280;95728800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was tested for its binding affinity towards sigma 1 receptor using [3H](+)-pentazocine from guinea pig brain;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3086;100622185;0.0032;203982;103241017;15065454;10280;16481400;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H]DTG from sigma opioid receptor of homogenized guinea pig whole brain;1-(1-Adamantyl)-3-(4-fluoro-2-methylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=C(C=CC(=C1)F)NC(=NC23CC4CC(C2)CC(C4)C3)N
3087;101829941;0.0032;255065;103468519;11610835;10280;161400090;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory activity against opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 degree C ;(10aS)-2-[2-[methyl(4-phenylbutyl)amino]ethyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;CN(CCCCC1=CC=CC=C1)CCN2C(=O)[C@@H]3CC4=CC=CC=C4CN3C2=O
3088;112788427;0.0032;204633;103328102;6273133;10280;74907270;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to inhibit [3H](+)-pentazocine binding to guinea pig brain Sigma receptor type 1;(8E)-8-[(3,4-dichlorophenyl)methylidene]-5-(3-hydroxyphenyl)-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1/C(=C\C3=CC(=C(C=C3)Cl)Cl)/C(=O)C2)C4=CC(=CC=C4)O
3089;321525568;0.0032;658997;160694397;25005670;10280;225129080;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H](+)pentazocine from sigma-1 receptor expressed in human Jurkat cell membranes after 2 hrs by liquid scintillation spectroscopy;1-[4-[1-Adamantyl(phenyl)methyl]phenyl]-4-methylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCN(CC1)C2=CC=C(C=C2)C(C3=CC=CC=C3)C45CC6CC(C4)CC(C6)C5
3090;355638084;0.0032;1308619;336906138;127051889;10280;271565650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-Pentazocine from sigma 1 receptor in human RPMI8226 cell membranes;(1alpha,4alpha,7S)-2-(Cyclohexylmethyl)-5-benzyl-2,5-diazabicyclo[2.2.2]octane-7-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;C1CCC(CC1)CN2C[C@@H]3C[C@@H]([C@H]2CN3CC4=CC=CC=C4)O
3091;363958380;0.0032;1500193;404654122;41306362;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-4-chlorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)Cl)CC2=CC=CC=C2
3092;402102367;0.0032;1796671;384224356;41306362;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';Benzamide derivative 11;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)Cl)CC2=CC=CC=C2
3093;100367034;0.00321;226337;103375837;9804703;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-[1-(4-Iodobenzyl)-4-piperidinyl]-3-chlorophenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)Cl)CC3=CC=C(C=C3)I
3094;366316136;0.0033;1532592;440223651;9924349;10280;304474340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human Jurkat cell membranes after 2 hrs by liquid scintillation counting method;3-(1-benzylpiperidin-4-yl)-1-(1H-indol-5-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCC1CCC(=O)C2=CC3=C(C=C2)NC=C3)CC4=CC=CC=C4
3095;380581528;0.0033;1861768;440119880;155517242;10280;357532630;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor measured after 120 mins by scintillation counting analysis;4-[[4-[4-[(4-Bromophenyl)methyl]triazol-1-yl]piperidin-1-yl]methyl]aniline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1N2C=C(N=N2)CC3=CC=C(C=C3)Br)CC4=CC=C(C=C4)N
3096;100322587;0.00336;204151;103382686;44361281;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 1 using [3H](+)-pentazocine in guinea pig brain membranes;(1R,9R,13R)-10-benzyl-13-ethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC[C@@H]1[C@H]2CCN([C@@H]1CC3=CC=CC=C23)CC4=CC=CC=C4
3097;100292618;0.00338;239200;103442085;11773145;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;3-(4-Benzyl-piperidin-1-ylmethyl)-chroman-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3COC4=CC=CC=C4C3=O
3098;100295625;0.00338;239200;103441938;11234042;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;2-(4-Benzyl-piperidin-1-ylmethyl)-3,4-dihydro-2H-naphthalen-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2=CC=CC=C2C(=O)C1CN3CCC(CC3)CC4=CC=CC=C4
3099;100478456;0.0034;203696;103186165;15061887;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;N-[1-Methyl-2-(4-ethoxyphenyl)ethyl]-3-phenylpropan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC1=CC=C(C=C1)CC(C)NCCCC2=CC=CC=C2
3100;326060879;0.0034;711577;163318559;10200496;10280;214138080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma 1 receptor;4-[4-(4-Chlorophenyl)-4-hydroxy-1,4-azasilinan-1-yl]-1-(4-fluorophenyl)butan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C[Si](CCN1CCCC(=O)C2=CC=C(C=C2)F)(C3=CC=C(C=C3)Cl)O
3101;100546613;0.00343;203685;103278838;10592242;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-Benzyl-4-piperidinyl)-2-(4-fluorophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=C(C=C2)F)CC3=CC=CC=C3
3102;100627355;0.003467;204452;131287757;54587754;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-[(4-Methoxyphenyl)methyl]spiro[1,2-dihydroindene-3,4'-piperidine];hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;COC1=CC=C(C=C1)CN2CCC3(CCC4=CC=CC=C43)CC2.Cl
3103;100628006;0.003467;204453;103671418;45260519;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"(4aR,10bR)-3-[2-(4-nitrophenyl)ethyl]-2,4,4a,5,6,10b-hexahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC2=CC=CC=C2[C@H]3[C@@H]1CN(CC3)CCC4=CC=C(C=C4)[N+](=O)[O-].Cl
3104;407996508;0.003467;1946583;482055377;168275089;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[[4-[[3-(Trifluoromethyl)phenyl]methoxy]piperidin-1-yl]methyl]imidazo[1,2-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=CC=C2)C(F)(F)F)CC3=CN4C=CC=CC4=N3
3105;100451374;0.00347;204435;103672099;45260969;10280;81026510;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using the novel [3H]-(+/-)-4 as radioligand;"N,N-dimethyl-4-phenyl-1,2,3,4-tetrahydronaphthalen-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CN(C)C1CC(C2=CC=CC=C2C1)C3=CC=CC=C3.Cl
3106;100367031;0.00349;226337;103376377;11016707;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-[1-(3-Iodobenzyl)-4-piperidinyl]-3-bromophenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)Br)CC3=CC(=CC=C3)I
3107;100615558;0.0035;203999;103321909;15701662;10280;16560440;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was tested for the inhibitory activity against Sigma opioid receptor by using [3H](+)-3-PPP as radioligand in guinea pig brain;[2-(3,4-Dichloro-phenyl)-ethyl]-ethyl-(2-pyrrolidin-1-yl-cyclohexyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CCC1=CC(=C(C=C1)Cl)Cl)[C@@H]2CCCC[C@@H]2N3CCCC3
3108;407996476;0.0035;1946583;482055377;168275089;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[[4-[[3-(Trifluoromethyl)phenyl]methoxy]piperidin-1-yl]methyl]imidazo[1,2-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=CC=C2)C(F)(F)F)CC3=CN4C=CC=CC4=N3
3109;372355919;0.00353;1726849;103167216;3559;10280;342231650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]pentazocine from human sigma 1 receptor expressed in HEK293 cell membrane incubated for 2 hrs by liquid scintillation counting method;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3110;407996250;0.003548;1946583;494395548;171342825;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[[1-[(3,4-Difluorophenyl)methyl]-1,7-diazaspiro[4.4]nonan-7-yl]methyl]imidazo[1,2-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCN(C2)CC3=CN4C=CC=CC4=N3)N(C1)CC5=CC(=C(C=C5)F)F
3111;100438234;0.00356;204445;103373783;573661;10280;14477350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor using [3H](+)-pentazocine in guinea pig brain homogenates;Azacyclohexane, 1-[2-[3,4-dichlorophenyl]ethyl]-3-[1-pyrrolidyl]-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCN(C1)C2CCCN(C2)CCC3=CC(=C(C=C3)Cl)Cl
3112;100546618;0.00356;203685;103278473;9927364;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-benzylpiperidin-4-yl)-2-(2-fluorophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CC=C2F)CC3=CC=CC=C3
3113;100386146;0.00358;204153;103252465;12259685;10280;117841480;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma opioid receptor type 1 affinity in guinea pig brain by employing [3H](+)-pentazocine as radioligand.;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
3114;100356312;0.0036;204790;103237599;10835756;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-[(3S)-1-Cyclopentyl-3-pyrrolidinyl]-1-methoxy-4-bromo-2-naphthalenecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)N[C@H]3CCN(C3)C4CCCC4
3115;100459324;0.0036;229212;103401222;10450158;10280;84969360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was evaluated against sigma-1 binding site in guinea pig, using [3H]- -(+)- Pentazocine;(3-Iodo-benzyl)-methyl-(2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCN1CCCC1)CC2=CC(=CC=C2)I
3116;326059154;0.0036;712773;103278473;9927364;10280;236413110;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor;N-(1-benzylpiperidin-4-yl)-2-(2-fluorophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)CC2=CC=CC=C2F)CC3=CC=CC=C3
3117;363958043;0.0036;1500193;404658224;118607309;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N-(2-(benzyl(methyl)amino)ethyl)-4-nitrobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCNC(=O)C1=CC=C(C=C1)[N+](=O)[O-])CC2=CC=CC=C2
3118;363958382;0.0036;1500193;404689082;60346448;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N-[2-[benzyl(methyl)amino]ethyl]-4-chlorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCNC(=O)C1=CC=C(C=C1)Cl)CC2=CC=CC=C2
3119;366431679;0.0036;1592018;136921693;57345619;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;1-(4-Chlorophenyl)-4-[4-(4-fluorophenyl)butyl]-1,4-diazepane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=CC=C(C=C2)Cl)CCCCC3=CC=C(C=C3)F
3120;402102359;0.0036;1796671;384224375;118607309;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-(2-(benzyl(methyl)amino)ethyl)-4-nitrobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCNC(=O)C1=CC=C(C=C1)[N+](=O)[O-])CC2=CC=CC=C2
3121;402102370;0.0036;1796671;384224355;138375187;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(2-(N-methylbenzyl)amino)ethyl]-4-chlorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CNC1=CC=CC=C1CNCCCNC(=O)C2=CC=C(C=C2)Cl
3122;407996249;0.0036;1946583;494395548;171342825;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[[1-[(3,4-Difluorophenyl)methyl]-1,7-diazaspiro[4.4]nonan-7-yl]methyl]imidazo[1,2-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCN(C2)CC3=CN4C=CC=CC4=N3)N(C1)CC5=CC(=C(C=C5)F)F
3123;366431680;0.003631;1592018;136921693;57345619;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;1-(4-Chlorophenyl)-4-[4-(4-fluorophenyl)butyl]-1,4-diazepane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=CC=C(C=C2)Cl)CCCCC3=CC=C(C=C3)F
3124;100438241;0.00369;204445;103373782;566741;10280;14477350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor using [3H](+)-pentazocine in guinea pig brain homogenates;2-Azabutane, 1-[1-methylazacyclohex-2-yl]-2-methyl-4-[3,4-dichlorophenyl]-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN1CCCCC1CN(C)CCC2=CC(=C(C=C2)Cl)Cl
3125;100438239;0.0037;204445;103167216;3559;10280;14477350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor using [3H](+)-pentazocine in guinea pig brain homogenates;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3126;100449382;0.0037;204443;103167216;3559;10280;83608750;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine at sigma receptor in guinea pig brain membrane was determined;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3127;100459314;0.0037;229212;103167216;3559;10280;84969360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was evaluated against sigma-1 binding site in guinea pig, using [3H]- -(+)- Pentazocine;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3128;100467670;0.0037;203697;103167216;3559;10280;82952200;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma 1 receptor was determined in guinea pig brain membrane using [3H](+)-pentazocine as radioligand;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3129;100548898;0.0037;203688;103167216;3559;10280;96511500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was evaluated for its in vitro competition binding studies using sigma-ligand (0.05-10000 nM) - [3H](+)-pentazocine (sigma1 receptor) in guinea pig brain membranes;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3130;363958023;0.0037;1500193;404652243;52750322;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-4-propylbenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCC1=CC=C(C=C1)C(=O)NCCCN(C)CC2=CC=CC=C2
3131;388740407;0.0037;1797293;386051276;118282976;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 31;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C=C(C=C3)F
3132;388879203;0.0037;1797475;386051276;118282976;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 31;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C=C(C=C3)F
3133;389383744;0.0037;1804286;386051276;118282976;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 31;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C=C(C=C3)F
3134;402102362;0.0037;1796671;384224348;52750322;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-4-propylbenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCC1=CC=C(C=C1)C(=O)NCCCN(C)CC2=CC=CC=C2
3135;100461277;0.00377;204456;103252465;12259685;10280;80980660;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma receptor of guinea pig brain homogenates;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
3136;372356133;0.00377;1726849;103576610;9907323;10280;342231650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]pentazocine from human sigma 1 receptor expressed in HEK293 cell membrane incubated for 2 hrs by liquid scintillation counting method;Cutamesine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=C(C=C1)CCN2CCN(CC2)CCCC3=CC=CC=C3)OC
3137;100292843;0.0038;239105;103441939;785789;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;3-(4-Benzyl-piperazin-1-ylmethyl)-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2=CC=CC=C2)CC3=COC4=CC=CC=C4C3=O
3138;100470631;0.0038;204469;103340139;44342741;10280;79325690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition against sigma receptor using displacement of 3 nM [3H]pentazocine in homogenate of guinea pig brain cerebellum;(1R,13S)-1,13-dimethyl-10-pentyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCCCN1CC[C@@]2([C@@H](C1CC3=C2C=C(C=C3)O)C)C
3139;380773265;0.0038;1907474;482085106;168296125;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;Benzyl 2-[3-(4-propylpiperazin-1-yl)phenyl]piperidine-1-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCN(CC1)C2=CC=CC(=C2)C3CCCCN3C(=O)OCC4=CC=CC=C4
3140;100627649;0.003802;204452;123084566;11957591;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;L-687,384 hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC2=CC=CC=C2C3(C1)CCN(CC3)CC4=CC=CC=C4.Cl
3141;380773037;0.003802;1907474;482085106;168296125;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;Benzyl 2-[3-(4-propylpiperazin-1-yl)phenyl]piperidine-1-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCN(CC1)C2=CC=CC(=C2)C3CCCCN3C(=O)OCC4=CC=CC=C4
3142;100485973;0.00381;204636;103318128;15767681;10280;76368600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured on Sigma receptor type 1 from guinea pig brain membranes using [3H]pentazocine as radioligand.;10-Benzyl-4-fluoro-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)F
3143;100546185;0.00387;203685;103278011;10665130;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-Benzylpiperidine-4-yl)-2-(2,4-difluorophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=C(C=C(C=C2)F)F)CC3=CC=CC=C3
3144;100367082;0.0039;226337;103278159;2817997;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-(1-benzylpiperidin-4-yl)-2-phenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC=CC=C3
3145;100449380;0.0039;204443;103274991;401834;10280;83608750;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine at sigma receptor in guinea pig brain membrane was determined;(6,7-Dichloro-1,2,3,4-tetrahydro-naphthalen-2-yl)-(2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCN(C1)CCNC2CCC3=CC(=C(C=C3C2)Cl)Cl
3146;100546183;0.0039;203685;103278159;2817997;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-benzylpiperidin-4-yl)-2-phenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC=CC=C3
3147;100558842;0.0039;203684;103389793;401860;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;1-(3-Phenylpropyl)-4-(2-methoxyphenethyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1CCN2CCN(CC2)CCCC3=CC=CC=C3
3148;100615902;0.0039;229210;124960908;3689;10280;16811060;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Compound was tested for the binding affinity against sigma receptor by using [3H]-+3PPP as radioligand;Ifenprodil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C(C1=CC=C(C=C1)O)O)N2CCC(CC2)CC3=CC=CC=C3
3149;100622096;0.0039;203998;103186016;5221975;10280;16481390;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]DTG binding to Sigma opioid receptor;[1-Methyl-2-(3-trifluoromethyl-phenyl)-ethyl]-(3-phenyl-propyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(CC1=CC(=CC=C1)C(F)(F)F)NCCCC2=CC=CC=C2
3150;101829944;0.0039;255065;103468525;44403211;10280;161400090;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory activity against opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 degree C ;(10aS)-2-[3-[benzyl(methyl)amino]propyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;CN(CCCN1C(=O)[C@@H]2CC3=CC=CC=C3CN2C1=O)CC4=CC=CC=C4
3151;363958041;0.0039;1500193;404656716;41306385;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-3-bromobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC(=CC=C1)Br)CC2=CC=CC=C2
3152;402102468;0.0039;1796671;384224361;41306385;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-3-bromobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC(=CC=C1)Br)CC2=CC=CC=C2
3153;407997181;0.0039;1946585;482065857;168282745;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor in human Jurkat cells;6-[[4-[(4-chloro-3-fluorophenyl)methoxy]piperidin-1-yl]methyl]-1H-benzimidazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=C(C=C2)Cl)F)CC3=CC4=C(C=C3)N=CN4
3154;100546620;0.00392;203685;103278677;11793931;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-benzylpiperidin-4-yl)-2-[3-(trifluoromethyl)phenyl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)C(F)(F)F)CC3=CC=CC=C3
3155;100367040;0.00393;226337;103375646;2712605;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-(1-benzylpiperidin-4-yl)-2-(thiophen-2-yl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CS2)CC3=CC=CC=C3
3156;100464777;0.00395;203701;103671401;45260509;10280;80279780;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity at sigma-1 site by inhibition of [3H](+)-pentazocine (PENT) binding in guinea pig brain;"2-(4-Phenylpiperidin-1-yl)ethyl 1-phenylcyclopentane-1-carboxylate;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)(C2=CC=CC=C2)C(=O)OCCN3CCC(CC3)C4=CC=CC=C4.Cl
3157;100367030;0.00397;226337;103375761;10981062;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-(1-Benzo[1,3]dioxol-5-ylmethyl-piperidin-4-yl)-2-phenyl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC4=C(C=C3)OCO4
3158;100546842;0.00397;203685;103277885;9208936;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-benzylpiperidin-4-yl)-2-(4-bromophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=C(C=C2)Br)CC3=CC=CC=C3
3159;100628010;0.003981;204453;103671415;45260517;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"5-Butyl-5-azatricyclo[9.4.0.02,7]pentadeca-1(15),2(7),11,13-tetraene;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCCN1CCC2=C(C1)CCCC3=CC=CC=C32.Cl
3160;100298503;0.004;239347;103458344;72027;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;Levemopamil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)[C@](CCCN(C)CCC1=CC=CC=C1)(C#N)C2=CC=CC=C2
3161;100356313;0.004;204790;103237674;10525997;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-[[(2S)-1-Cyclobutyl-2-pyrrolidinyl]methyl]-1-methoxy-4-bromo-2-naphthalenecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)NC[C@@H]3CCCN3C4CCC4
3162;100440594;0.004;229192;103167216;3559;10280;14696970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of specific binding of [3H]NANM of sigma binding site in Guinea pig brain membranes;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3163;100456210;0.004;229183;103360153;3083456;10280;79028690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor in bovine cerebellum using 2.0 nM [3H]haloperidol in the presence of 25 nM unlabeled spiperone;N-Phprop-fphetp;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CN(CC=C1C2=CC=C(C=C2)F)CCC(=O)C3=CC=CC=C3
3164;100475170;0.004;204462;103673053;45261723;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;"1'-[(4-Fluorophenyl)methyl]spiro[3,4-dihydronaphthalene-2,4'-piperidine]-1-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2(CCN(CC2)CC3=CC=C(C=C3)F)C(=O)C4=CC=CC=C41.Cl
3165;100475259;0.004;204462;103673129;45261780;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;"2-(1-benzylpiperidin-4-yl)-3,4-dihydro-2H-naphthalen-1-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2=CC=CC=C2C(=O)C1C3CCN(CC3)CC4=CC=CC=C4.Cl
3166;100475264;0.004;204462;103351707;9998085;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;6-Fluoro-2-[1-phenethyl-4-piperidinyl]-3,4-dihydronaphthalen-1(2H)-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2=C(C=CC(=C2)F)C(=O)C1C3CCN(CC3)CCC4=CC=CC=C4
3167;100614620;0.004;203986;103282212;14771699;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N-Bicyclo[2.2.1]hept-2-yl-N''-(2-iodo-phenyl)-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2CC1CC2N=C(N)NC3=CC=CC=C3I
3168;100617255;0.004;204444;103336892;15723897;10280;16627250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membranes using [3H]DTG as radioligand;1-Phenyl-4-[3-(2-naphthalenyl)propyl]piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCCC2=CC3=CC=CC=C3C=C2)C4=CC=CC=C4
3169;100741864;0.004;203992;103671650;45260687;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"8-Benzyl-3-phenyl-1-oxa-8-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC12C(=O)C(=CO2)C3=CC=CC=C3)CC4=CC=CC=C4.Cl
3170;100741873;0.004;203992;103671586;45260649;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"3-(4-Fluorophenyl)-8-[(4-fluorophenyl)methyl]-1-oxa-8-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC12C(=O)C(=CO2)C3=CC=C(C=C3)F)CC4=CC=C(C=C4)F.Cl
3171;100741874;0.004;203992;103671588;45260651;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"8-Benzyl-3-(4-fluorophenyl)-1-oxa-8-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC12C(=O)C(=CO2)C3=CC=C(C=C3)F)CC4=CC=CC=C4.Cl
3172;100742322;0.004;204129;103671617;45260670;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"8-Benzyl-3-(4-fluorophenyl)-1-oxa-8-azaspiro[4.5]decan-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C(=O)C(CO2)C3=CC=C(C=C3)F)CC4=CC=CC=C4.Cl
3173;100742324;0.004;204129;103677446;45264558;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"3-(4-Fluorophenyl)-9-(2-phenylethyl)-1-oxa-9-azaspiro[5.5]undecan-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12CC(=O)C(CO2)C3=CC=C(C=C3)F)CCC4=CC=CC=C4.Cl
3174;100742340;0.004;204020;103671740;45260726;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor using [3H]-(+)-SKF- 10,047;"9-Benzyl-3-phenyl-1-oxa-9-azaspiro[5.5]undec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12CC(=O)C(=CO2)C3=CC=CC=C3)CC4=CC=CC=C4.Cl
3175;100742368;0.004;203992;103671617;45260670;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"8-Benzyl-3-(4-fluorophenyl)-1-oxa-8-azaspiro[4.5]decan-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC12C(=O)C(CO2)C3=CC=C(C=C3)F)CC4=CC=CC=C4.Cl
3176;100746226;0.004;204018;103278206;44315794;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor using [3H](+)-SKF-10047 as radioligand;1-Benzyl-4-(3-phenyl-prop-2-ynyloxymethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1COCC#CC2=CC=CC=C2)CC3=CC=CC=C3
3177;100746460;0.004;204018;103277643;44315552;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor using [3H](+)-SKF-10047 as radioligand;1-Phenethyl-4-(3-phenyl-prop-2-ynyloxy)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC#CC2=CC=CC=C2)CCC3=CC=CC=C3
3178;100746549;0.004;204019;103335945;44340918;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-SKF-10047 binding to sigma receptor;"N-(1-benzylpiperidin-4-yl)-N-methyl-3-phenylprop-2-ynamide;(E)-but-2-enedioic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C1CCN(CC1)CC2=CC=CC=C2)C(=O)C#CC3=CC=CC=C3.C(=C/C(=O)O)\C(=O)O
3179;363666387;0.004;1415965;404714757;11531451;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);4,5,6,7-tetrahydro-4-(2-(morpholin-4-yl)ethyl)-1-phenyl-1H-indazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC(C2=C(C1)N(N=C2)C3=CC=CC=C3)CCN4CCOCC4
3180;255025319;0.004055;625223;136925223;3236;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Eperisone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC1=CC=C(C=C1)C(=O)C(C)CN2CCCCC2
3181;100558839;0.0041;203684;103389504;401844;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;2-Amino-1-[4-(3-phenyl-propyl)-piperazin-1-yl]-ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)C(=O)CN
3182;100558845;0.0041;203684;103389414;401850;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;4-[2-[4-(3-Phenylpropyl)piperazine-1-yl]ethyl]benzenamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)CCC3=CC=C(C=C3)N
3183;100617628;0.0041;204451;103336982;18790204;10280;16627250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;The compound was tested for its binding affinity towards sigma receptor in guinea pig brain membranes.;4-(4-Chlorophenyl)-1,2,5,6-tetrahydro-1-(4-phenylbutyl)pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CC=C1C2=CC=C(C=C2)Cl)CCCCC3=CC=CC=C3
3184;366437018;0.0041;1594271;163318446;71452172;10280;309043830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;5-(phenoxymethyl)-3-[[(2S)-pyrrolidin-2-yl]methoxy]-1,2-oxazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1C[C@H](NC1)COC2=NOC(=C2)COC3=CC=CC=C3
3185;388740028;0.0041;1797293;386051280;118282888;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 36;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC=C(C=C1)F)N2CC3=CC4=C(C=C3C2)OCO4
3186;388878699;0.0041;1797475;386051280;118282888;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 36;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC=C(C=C1)F)N2CC3=CC4=C(C=C3C2)OCO4
3187;389383281;0.0041;1804286;386051280;118282888;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 36;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC=C(C=C1)F)N2CC3=CC4=C(C=C3C2)OCO4
3188;389483899;0.0041;1805386;160849705;132060720;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';2-Benzyl-5-(3-methoxyphenyl)-1,3-dihydroisoindole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC(=C1)C2=CC3=C(CN(C3)CC4=CC=CC=C4)C=C2
3189;100367036;0.0042;226337;103375667;9868470;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-[1-(4-Iodobenzyl)-4-piperidinyl]-2-fluorophenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CC=C2F)CC3=CC=C(C=C3)I
3190;100500350;0.0042;204448;103167216;3559;10280;85688040;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory activity against sigma receptor isolated from guinea pig brain cortex membrane using [3H]DTG as radioligand;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3191;101829959;0.0042;255065;103468531;44403215;10280;161400090;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory activity against opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 degree C ;(10aS)-2-[4-[benzyl(methyl)amino]butyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;CN(CCCCN1C(=O)[C@@H]2CC3=CC=CC=C3CN2C1=O)CC4=CC=CC=C4
3192;367478794;0.0042;1655949;442056085;156016311;10280;324354210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human Sigma 1 receptor by radioligand displacement assay;"4-Benzyl-1-(1,4-dithiaspiro[4.4]nonan-3-ylmethyl)piperidine;oxalic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC2(C1)SCC(S2)CN3CCC(CC3)CC4=CC=CC=C4.C(=O)(C(=O)O)O
3193;100546177;0.00421;203685;103278173;10712473;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-Benzylpiperidine-4-yl)-2-(2,5-difluorophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=C(C=CC(=C2)F)F)CC3=CC=CC=C3
3194;100630344;0.00422;229195;103268005;558843;10280;13194930;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain, using [3H](+)-3-PPP as radioligand.;beta-(3,4-Dichlorophenyl)ethylamine, N-(3-fluoropropyl)-N-[2-(1-pyrrolidinyl)ethyl]-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(C1)CCN(CCCF)CCC2=CC(=C(C=C2)Cl)Cl
3195;100630342;0.00424;229195;103268577;594236;10280;13194930;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain, using [3H](+)-3-PPP as radioligand.;1-[2-(3,4-Dichlorophenyl)ethyl]-4-(3-fluoropropyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCF)CCC2=CC(=C(C=C2)Cl)Cl
3196;100546284;0.00425;203689;103284445;3869448;10280;96511500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma-1 receptor in guinea pig brain membranes;4-iodo-N-[2-(1-pyrrolidinyl)ethyl]benzenesulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCN(C1)CCNS(=O)(=O)C2=CC=C(C=C2)I
3197;100627924;0.004266;204453;103677365;45264506;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"(4aR,10bR)-3-(3-phenylpropyl)-2,4,4a,5,6,10b-hexahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC2=CC=CC=C2[C@H]3[C@@H]1CN(CC3)CCCC4=CC=CC=C4.Cl
3198;407996261;0.004266;1946583;482083031;168294958;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(3S)-1-[(3-fluoro-4-methoxyphenyl)methyl]-3-[(3-fluorophenyl)methoxy]piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=C(C=C1)CN2CCC[C@@H](C2)OCC3=CC(=CC=C3)F)F
3199;100367041;0.00429;226337;103376433;11102433;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-[1-(3-Iodobenzyl)-4-piperidinyl]-3-fluorophenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)F)CC3=CC(=CC=C3)I
3200;100459322;0.0043;229212;103401223;10470687;10280;84969360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was evaluated against sigma-1 binding site in guinea pig, using [3H]- -(+)- Pentazocine;[2-(3-Bromo-phenyl)-ethyl]-methyl-(2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=CC=C1)Br)CCN2CCCC2
3201;100507190;0.0043;204150;103345255;10356159;10280;87844550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from Sigma opioid receptor type 1 in guinea pig brain membrane;Methyl-[2-(4-nitro-phenyl)-ethyl]-(2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCC1=CC=C(C=C1)[N+](=O)[O-])CCN2CCCC2
3202;100768695;0.0043;204149;103273263;9861694;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma opioid receptor type 1;(S)-3-(2-Adamantan-2-yl-ethyl)-1,8,8-trimethyl-3-aza-bicyclo[3.2.1]octane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@]12CCC(C1(C)C)CN(C2)CCC3C4CC5CC(C4)CC3C5
3203;254407582;0.0043;630410;103225438;128032;10280;219625780;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor;1-(3-Fluoropropyl)-4-(4-cyanophenoxymethyl)piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1COC2=CC=C(C=C2)C#N)CCCF
3204;334073832;0.0043;737384;164135664;6918656;10280;235662450;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to human brain sigma1 receptor;4-((1-(3-(Fluoro-18F)propyl)-4-piperidinyl)methoxy)benzonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1COC2=CC=C(C=C2)C#N)CCC[18F]
3205;345681160;0.0043;1174258;312374340;118724296;10280;254622400;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor in human Jurkat cell membranes incubated for 2 hrs by liquid scintillation counting;N-benzyl-N-methyl-3-(1-phenyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl)propan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1CCC2=C(C1C3=CC=CC=C3)NC4=CC=CC=C24)CC5=CC=CC=C5
3206;363958038;0.0043;1500193;404652702;27148262;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-4-nitrobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)[N+](=O)[O-])CC2=CC=CC=C2
3207;363958039;0.0043;1500193;404661725;118607351;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N-[3-(N-methyl-2-phenylethylamino)propyl]-4-chlorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)Cl)CCC2=CC=CC=C2
3208;402102397;0.0043;1796671;384224358;118607351;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(N-methyl-2-phenylethylamino)propyl]-4-chlorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)Cl)CCC2=CC=CC=C2
3209;402102408;0.0043;1796671;384224372;27148262;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-4-nitrobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)[N+](=O)[O-])CC2=CC=CC=C2
3210;407996463;0.0043;1946583;482083031;168294958;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(3S)-1-[(3-fluoro-4-methoxyphenyl)methyl]-3-[(3-fluorophenyl)methoxy]piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=C(C=C1)CN2CCC[C@@H](C2)OCC3=CC(=CC=C3)F)F
3211;100438230;0.00434;204445;103374118;10064992;10280;14477350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor using [3H](+)-pentazocine in guinea pig brain homogenates;(+)-1-[2-(3,4-Dichloro-phenyl)-ethyl]-2-pyrrolidin-1-ylmethyl-pyrrolidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCN(C1)C[C@H]2CCCN2CCC3=CC(=C(C=C3)Cl)Cl
3212;100468910;0.0044;204625;103252465;12259685;10280;79325690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor was determined;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
3213;100475171;0.0044;204462;103673088;3083480;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;3,4-Dhspp;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2(CCN(CC2)CCC3=CC=CC=C3)C(C4=CC=CC=C41)O.Cl
3214;334073833;0.0044;737384;164136166;9820591;10280;235662450;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to human brain sigma1 receptor;Cutamesine C-11;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=CC(=C1)CCN2CCN(CC2)CCCC3=CC=CC=C3)O[11CH3]
3215;100471771;0.004467;203852;103367393;42601651;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;N-methyl-4-phenyl-N-propyl-1,2,3,4-tetrahydronaphthalen-2-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN(C)C1CC(C2=CC=CC=C2C1)C3=CC=CC=C3
3216;100473790;0.004467;203852;103321169;132954;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;N,N-dimethyl-4-phenyl-1,2,3,4-tetrahydronaphthalen-2-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)C1CC(C2=CC=CC=C2C1)C3=CC=CC=C3
3217;380773042;0.004467;1907474;482074600;168289094;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;1-[3-[1-(3,5-Dichlorophenyl)sulfonylpiperidin-2-yl]phenyl]-4-propylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCN(CC1)C2=CC=CC(=C2)C3CCCCN3S(=O)(=O)C4=CC(=CC(=C4)Cl)Cl
3218;100451648;0.00449;204435;103672130;45260990;10280;81026510;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using the novel [3H]-(+/-)-4 as radioligand;"N,N-diethyl-4-phenyl-1,2,3,4-tetrahydronaphthalen-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCN(CC)C1CC(C2=CC=CC=C2C1)C3=CC=CC=C3.Cl
3219;100319815;0.0045;204154;103362048;10713214;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;[1-(4-Methoxy-3-phenethyloxy-benzyl)-butyl]-propyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)NCCC
3220;100436448;0.0045;204299;103437159;44386517;10280;72415060;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to Sigma opioid receptor type 2 in guinea pig brain homogenate with 4 nM of [3H](+)-DTG as radioligand;5,5-Diphenyl-3-[5-(4-phenylpiperidin-1-yl)pentyl]imidazolidine-2,4-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1C2=CC=CC=C2)CCCCCN3C(=O)C(NC3=O)(C4=CC=CC=C4)C5=CC=CC=C5
3221;100535938;0.0045;204457;103673575;45262109;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(2-Chloro-3,5-diethylphenyl)-1-(3-ethylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)NC(=NC2=CC(=CC(=C2Cl)CC)CC)N.Cl
3222;101830215;0.0045;255065;103468503;44403202;10280;161400090;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory activity against opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 degree C ;(10aS)-2-[2-[benzyl(methyl)amino]ethyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;CN(CCN1C(=O)[C@@H]2CC3=CC=CC=C3CN2C1=O)CC4=CC=CC=C4
3223;321573030;0.0045;675973;160701913;25167085;10280;225154050;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to human sigma 1-type opioid receptor;1'-Benzylspiro[6,7-dihydrothieno[3,2-c]pyran-4,4'-piperidine]-6-carbonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=C(CC(O2)C#N)SC=C3)CC4=CC=CC=C4
3224;345594061;0.0045;1197502;103468525;44403211;10280;256029320;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor in human Jurkat cells after 120 mins by liquid scintillation counting analysis;(10aS)-2-[3-[benzyl(methyl)amino]propyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1C(=O)[C@@H]2CC3=CC=CC=C3CN2C1=O)CC4=CC=CC=C4
3225;345680794;0.0045;1174258;103468525;44403211;10280;254622400;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor in human Jurkat cell membranes incubated for 2 hrs by liquid scintillation counting;(10aS)-2-[3-[benzyl(methyl)amino]propyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1C(=O)[C@@H]2CC3=CC=CC=C3CN2C1=O)CC4=CC=CC=C4
3226;380773272;0.0045;1907474;482074600;168289094;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;1-[3-[1-(3,5-Dichlorophenyl)sulfonylpiperidin-2-yl]phenyl]-4-propylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCN(CC1)C2=CC=CC(=C2)C3CCCCN3S(=O)(=O)C4=CC(=CC(=C4)Cl)Cl
3227;100546178;0.00456;203685;103278306;11792374;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-Benzylpiperidine-4-yl)-2-(3-nitrophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)[N+](=O)[O-])CC3=CC=CC=C3
3228;100628007;0.004571;204453;103671450;45260542;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"(4aR,10bR)-3-prop-2-enyl-2,4,4a,5,6,10b-hexahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C=CCN1CC[C@@H]2[C@H](C1)CCC3=CC=CC=C23.Cl
3229;100464200;0.0046;204596;103167216;3559;10280;80219130;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor of MCF cells;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3230;407906193;0.0046;1922160;103576610;9907323;10280;362020630;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);Cutamesine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=C(C=C1)CCN2CCN(CC2)CCCC3=CC=CC=C3)OC
3231;100295629;0.00463;239200;103442048;11406043;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;3-(4-Benzyl-piperidin-1-ylmethyl)-3,4-dihydro-2H-naphthalen-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3CC4=CC=CC=C4C(=O)C3
3232;100367043;0.00464;226337;103376467;10970390;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-(1-Benzyl-piperidin-4-yl)-2-naphthalen-1-yl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CC3=CC=CC=C32)CC4=CC=CC=C4
3233;100627932;0.004677;204453;103671331;45260470;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"(4aR,10bR)-3-[(4-chlorophenyl)methyl]-2,4,4a,5,6,10b-hexahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC2=CC=CC=C2[C@H]3[C@@H]1CN(CC3)CC4=CC=C(C=C4)Cl.Cl
3234;100485151;0.00468;204636;103318422;15767685;10280;76368600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured on Sigma receptor type 1 from guinea pig brain membranes using [3H]pentazocine as radioligand.;4-Fluoro-1,13-dimethyl-10-(3-methylbutyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1C2CC3=C(C1(CCN2CCC(C)C)C)C=C(C=C3)F
3235;345594062;0.0047;1197502;312385709;118731573;10280;256029320;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor in human Jurkat cells after 120 mins by liquid scintillation counting analysis;3-[3-[Benzyl(methyl)amino]propyl]-5-chloro-1,3-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1C2=C(C=CC(=C2)Cl)SC1=O)CC3=CC=CC=C3
3236;380581320;0.0047;1861723;103178693;441278;10280;357249250;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay;Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1[C@H]2CC3=C([C@@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
3237;100292615;0.00475;239200;103442134;11154079;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;2-(4-Benzyl-piperazin-1-ylmethyl)-chroman-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2CC(=O)C3=CC=CC=C3O2)CC4=CC=CC=C4
3238;100627646;0.004786;204452;131279688;19018944;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-Butylspiro[6,7,8,9-tetrahydrobenzo[7]annulene-5,4'-piperidine];hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCCN1CCC2(CCCCC3=CC=CC=C32)CC1.Cl
3239;380773268;0.004786;1907474;482065550;168282509;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;(E)-3-phenyl-1-[2-[3-(4-propylpiperazin-1-yl)phenyl]piperidin-1-yl]prop-2-en-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCN(CC1)C2=CC=CC(=C2)C3CCCCN3C(=O)/C=C/C4=CC=CC=C4
3240;100295632;0.0048;239200;103442126;11220953;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;4-Benzyl-1-chroman-2-ylmethyl-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2=CC=CC=C2OC1CN3CCC(CC3)CC4=CC=CC=C4
3241;100354362;0.0048;204790;103238484;9889709;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-[(3S)-1-Cycloheptyl-3-pyrrolidinyl]-1-methoxy-4-bromo-2-naphthalenecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)N[C@H]3CCN(C3)C4CCCCCC4
3242;100558836;0.0048;203684;103389444;401854;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;2-[2-[4-(3-Phenylpropyl)piperazine-1-yl]ethyl]benzenamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)CCC3=CC=CC=C3N
3243;100619858;0.0048;203991;103186083;10467461;10280;18482950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma opioid receptor was determined in guinea pig cerebral homogenate using [3H]haloperidol as radioligand;Methyl-((S)-1-methyl-2-phenyl-ethyl)-phenethyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](CC1=CC=CC=C1)N(C)CCC2=CC=CC=C2
3244;372400423;0.0048;1744234;461563521;162677436;10280;333727820;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane incubated for 2 hr by liquid scintillation counting method;5-(4-Tert-butylphenyl)-1-ethyl-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;CCN1C(=NC(=N1)CN2CCCC2)C3=CC=C(C=C3)C(C)(C)C
3245;380773269;0.0048;1907474;482065550;168282509;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;(E)-3-phenyl-1-[2-[3-(4-propylpiperazin-1-yl)phenyl]piperidin-1-yl]prop-2-en-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCN(CC1)C2=CC=CC(=C2)C3CCCCN3C(=O)/C=C/C4=CC=CC=C4
3246;100796023;0.00489;203683;103236454;5236783;10280;106362330;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was tested for its binding affinity against sigma 1 opioid receptor using 3[H](+)-pentazocine as radioligand;Benzeneacetic acid, 3,4-dichloro-, 2-(1-pyrrolidinyl)ethyl ester;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(C1)CCOC(=O)CC2=CC(=C(C=C2)Cl)Cl
3247;255013357;0.00489;625223;103318016;3042;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dicyclomine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
3248;366435746;0.0049;1593893;440197399;155556668;10280;309877800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK293T cell membranes;5-Chloro-2-[2-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]ethyl]inden-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=CC=C(C=C2)Cl)CCC3=CC4=C(C3=O)C=CC(=C4)Cl
3249;388740372;0.0049;1797293;386051269;118282826;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 24;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=CC4=C(C=C3C2)OCO4
3250;388879043;0.0049;1797475;386051269;118282826;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 24;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=CC4=C(C=C3C2)OCO4
3251;389383652;0.0049;1804286;386051269;118282826;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 24;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=CC4=C(C=C3C2)OCO4
3252;389483960;0.0049;1805386;160849673;132060812;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';2-benzyl-6-(3-methoxyphenyl)-3,4-dihydro-1H-isoquinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC(=C1)C2=CC3=C(CN(CC3)CC4=CC=CC=C4)C=C2
3253;100546521;0.00497;203689;103283880;10833752;10280;96511500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma-1 receptor in guinea pig brain membranes;N-(2-Diethylamino-ethyl)-4-iodo-benzenesulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCN(CC)CCNS(=O)(=O)C1=CC=C(C=C1)I
3254;100297858;0.005;239347;103458474;44398162;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;(4aS,10bS)-4-Benzyl-9-methoxy-1,2,3,4,4a,5,6,10b-octahydro-benzo[f]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(CC[C@H]3[C@H]2CCCN3CC4=CC=CC=C4)C=C1
3255;100298501;0.005;239347;103418036;1548955;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;Clomifene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CC)CCOC1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\Cl)/C3=CC=CC=C3
3256;100439806;0.005;229190;103167216;3559;10280;14696970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of specific binding of [3H]DTG to sigma binding site in Guinea pig brain membranes;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3257;100475175;0.005;204462;103673108;45261764;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;"5-fluoro-2-[1-(2-phenylethyl)piperidin-4-yl]-3,4-dihydro-2H-naphthalen-1-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2=C(C=CC=C2F)C(=O)C1C3CCN(CC3)CCC4=CC=CC=C4.Cl
3258;100613255;0.005;204440;103282212;14771699;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]-DTG in guinea pig brain membrane homogenates;N-Bicyclo[2.2.1]hept-2-yl-N''-(2-iodo-phenyl)-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2CC1CC2N=C(N)NC3=CC=CC=C3I
3259;100617147;0.005;203985;103677556;14771665;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N-(Adamantan-1-yl)-N'-(2-iodophenyl)guanidine HCl;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C2CC3CC1CC(C2)(C3)N=C(N)NC4=CC=CC=C4I.Cl
3260;100622092;0.005;203998;103167216;3559;10280;16481390;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]DTG binding to Sigma opioid receptor;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3261;100622188;0.005;203982;103167216;3559;10280;16481400;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H]DTG from sigma opioid receptor of homogenized guinea pig whole brain;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3262;100680628;0.005;204130;103178673;17867054;10280;119345760;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity for Sigma opioid receptor by displacement of [3H]DTG;6-{2-[4-(3,4-Dichloro-benzyl)-piperazin-1-yl]-ethyl}-3-methyl-3H-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C=C(C=C2)CCN3CCN(CC3)CC4=CC(=C(C=C4)Cl)Cl)SC1=O
3263;100680632;0.005;204130;103178876;10361564;10280;119345760;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity for Sigma opioid receptor by displacement of [3H]DTG;6-[2-(4-Benzyl-piperidin-1-yl)-ethyl]-3-methyl-3H-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C=C(C=C2)CCN3CCC(CC3)CC4=CC=CC=C4)SC1=O
3264;100680634;0.005;204130;103178712;21474204;10280;119345760;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity for Sigma opioid receptor by displacement of [3H]DTG;6-[4-(4-Benzyl-piperidin-1-yl)-butyl]-3-methyl-3H-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C=C(C=C2)CCCCN3CCC(CC3)CC4=CC=CC=C4)SC1=O
3265;100737369;0.005;203993;103228265;15034731;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor from guinea pig brain using the radioligand [3H]SKF-10047;(5S)-5-[[4-(1,3-benzodioxol-5-yl)-4-hydroxypiperidin-1-yl]methyl]-3-phenyl-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC3=C(C=C2)OCO3)O)C[C@H]4CN(C(=O)O4)C5=CC=CC=C5
3266;100742327;0.005;204129;103677444;45264556;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"3-Phenyl-9-(2-phenylethyl)-1-oxa-9-azaspiro[5.5]undec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12CC(=O)C(=CO2)C3=CC=CC=C3)CCC4=CC=CC=C4.Cl
3267;100746227;0.005;204018;103277592;19022852;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor using [3H](+)-SKF-10047 as radioligand;1-Phenethyl-4-((E)-3-phenyl-allyloxymethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1COC/C=C/C2=CC=CC=C2)CCC3=CC=CC=C3
3268;100746452;0.005;204018;103277593;44315535;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor using [3H](+)-SKF-10047 as radioligand;1-Cyclopropylmethyl-4-((E)-3-phenyl-allyloxymethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC1CN2CCC(CC2)COC/C=C/C3=CC=CC=C3
3269;100746556;0.005;204019;103336579;44341180;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-SKF-10047 binding to sigma receptor;"(E)-N-(1-benzylpiperidin-4-yl)-N-methyl-3-phenylprop-2-enamide;(E)-but-2-enedioic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C1CCN(CC1)CC2=CC=CC=C2)C(=O)/C=C/C3=CC=CC=C3.C(=C/C(=O)O)\C(=O)O
3270;100746720;0.005;204019;103335912;44340899;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-SKF-10047 binding to sigma receptor;"1-benzyl-N-methyl-N-(3-phenylprop-2-ynyl)piperidin-4-amine;(E)-but-2-enedioic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CC#CC1=CC=CC=C1)C2CCN(CC2)CC3=CC=CC=C3.C(=C/C(=O)O)\C(=O)O
3271;101829954;0.005;255065;103468539;44403221;10280;161400090;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory activity against opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 degree C ;(10aS)-2-[5-[benzyl(methyl)amino]pentyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;CN(CCCCCN1C(=O)[C@@H]2CC3=CC=CC=C3CN2C1=O)CC4=CC=CC=C4
3272;345602965;0.005;1200082;312389805;76073628;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-(3,4-dichlorophenyl)-N-(2-piperidin-1-ylethyl)triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)CCNC2=CN(N=N2)C3=CC(=C(C=C3)Cl)Cl
3273;372306546;0.005;1701184;461537752;58514002;10280;332377850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;4-[3-[1-(3,4-Dichlorophenyl)-5-methylpyrazol-3-yl]propyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)CCCN3CCOCC3
3274;100333027;0.005012;204944;103277921;10589924;10280;108823620;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was performed using [3H](+)-pentazocine to label sigma-1 binding sites, in guinea pig cerebral cortex;2-(Cyclohexylmethyl)-1-(5-pyrrolidin-1-ylpentyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CCC(CC1)CN=C(N)NCCCCCN2CCCC2
3275;100627356;0.005012;204452;131273632;54580840;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-(2-phenylethyl)spiro[2,3-dihydro-1H-naphthalene-4,4'-piperidine];hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC2=CC=CC=C2C3(C1)CCN(CC3)CCC4=CC=CC=C4.Cl
3276;366435745;0.005012;1593893;440197399;155556668;10280;309877800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK293T cell membranes;5-Chloro-2-[2-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]ethyl]inden-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=CC=C(C=C2)Cl)CCC3=CC4=C(C3=O)C=CC(=C4)Cl
3277;100627875;0.00507;229196;103268005;558843;10280;13194930;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain, using [3H](+)-pentazocine as radioligand.;beta-(3,4-Dichlorophenyl)ethylamine, N-(3-fluoropropyl)-N-[2-(1-pyrrolidinyl)ethyl]-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(C1)CCN(CCCF)CCC2=CC(=C(C=C2)Cl)Cl
3278;366316129;0.0051;1532592;440120528;155517675;10280;304474340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human Jurkat cell membranes after 2 hrs by liquid scintillation counting method;1-(7-chloro-1H-indol-5-yl)-3-[1-(cyclohexylmethyl)piperidin-4-yl]propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCC(CC1)CN2CCC(CC2)CCC(=O)C3=CC(=C4C(=C3)C=CN4)Cl
3279;366316141;0.0051;1532592;440176774;134828071;10280;304474340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human Jurkat cell membranes after 2 hrs by liquid scintillation counting method;1-(7-chloranyl-4-methoxy-1~{H}-indol-5-yl)-3-[1-(cyclohexylmethyl)piperidin-4-yl]propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C2C=CNC2=C(C=C1C(=O)CCC3CCN(CC3)CC4CCCCC4)Cl
3280;366435750;0.0051;1593893;440182348;155550691;10280;309877800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK293T cell membranes;(NE)-N-[4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butylidene]hydroxylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=CC=C(C=C2)Cl)CCC/C(=N\O)/C3=CC=C(C=C3)F
3281;366435749;0.005129;1593893;440182348;155550691;10280;309877800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK293T cell membranes;(NE)-N-[4-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butylidene]hydroxylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=CC=C(C=C2)Cl)CCC/C(=N\O)/C3=CC=C(C=C3)F
3282;407996518;0.005129;1946583;482083049;168294968;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[[4-[(3,4-Difluorophenyl)methoxy]piperidin-1-yl]methyl]imidazo[1,2-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=C(C=C2)F)F)CC3=CN4C=CC=CC4=N3
3283;100614630;0.0052;203986;103671903;14771710;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;"2-(2-Adamantyl)-1-(2-iodophenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C2CC3CC1CC(C2)C3N=C(N)NC4=CC=CC=C4I.Cl
3284;326035165;0.0052;701162;163320936;11522946;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-(3,4-Dichlorophenyl)-5-methyl-3-(2-pyrrolidin-1-ylethoxy)pyrazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)OCCN3CCCC3
3285;326067556;0.0052;718362;163328886;71457595;10280;230949920;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma 1 receptor in human Jurkat cell membrane;1-[[4-[1-Adamantyl(phenyl)methyl]phenyl]methyl]-4-methylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCN(CC1)CC2=CC=C(C=C2)C(C3=CC=CC=C3)C45CC6CC(C4)CC(C6)C5
3286;407996423;0.0052;1946583;494402162;171347009;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(3S)-3-[(3-fluoro-4-methoxyphenyl)methoxy]-1-[(4-methylphenyl)methyl]piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=C(C=C1)CN2CCC[C@@H](C2)OCC3=CC(=C(C=C3)OC)F
3287;407996517;0.0052;1946583;482083049;168294968;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[[4-[(3,4-Difluorophenyl)methoxy]piperidin-1-yl]methyl]imidazo[1,2-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=C(C=C2)F)F)CC3=CN4C=CC=CC4=N3
3288;100546187;0.00522;203685;103278426;10762119;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-Benzylpiperidine-4-yl)-2-(3,4-dichlorophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC(=C(C=C2)Cl)Cl)CC3=CC=CC=C3
3289;407996424;0.005248;1946583;494402162;171347009;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(3S)-3-[(3-fluoro-4-methoxyphenyl)methoxy]-1-[(4-methylphenyl)methyl]piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=C(C=C1)CN2CCC[C@@H](C2)OCC3=CC(=C(C=C3)OC)F
3290;100500104;0.0053;204466;103237360;10474335;10280;85688040;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]DTG binding to sigma receptor from guinea pig brain cortex membrane;1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCCC2CCCN3CCN(CC3)C4CCCCC4
3291;100559076;0.0053;203684;103389979;10570139;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;1,4-Bis-[2-(3-methoxy-phenyl)-ethyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC(=C1)CCN2CCN(CC2)CCC3=CC(=CC=C3)OC
3292;100702223;0.0053;204766;103417509;764825;10280;126395730;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards Sigma-1 receptor;1-Benzyl-4-(2-chlorobenzyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2=CC=CC=C2)CC3=CC=CC=C3Cl
3293;345594066;0.0053;1197502;312385702;118731566;10280;256029320;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor in human Jurkat cells after 120 mins by liquid scintillation counting analysis;(10aS)-2-[3-(1,3-dihydroisoindol-2-yl)propyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1[C@H]2C(=O)N(C(=O)N2CC3=CC=CC=C31)CCCN4CC5=CC=CC=C5C4
3294;345681152;0.0053;1174258;312374338;118724294;10280;254622400;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor in human Jurkat cell membranes incubated for 2 hrs by liquid scintillation counting;2-[3-(1,3-dihydroisoindol-2-yl)propyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1C2C(=O)N(C(=O)N2CC3=CC=CC=C31)CCCN4CC5=CC=CC=C5C4
3295;389536475;0.00534;1805702;459092168;122576855;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';(1R,8R)-9-(1,3-benzodioxol-5-ylmethyl)-5-(3-methylphenyl)-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=CC=C1)C2=CC3=C(C=C2)[C@@H]4CCN([C@@H]3C4)CC5=CC6=C(C=C5)OCO6
3296;100292620;0.00535;239200;103442135;10449555;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;2-[(4-Benzylpiperazino)methyl]chromone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2=CC=CC=C2)CC3=CC(=O)C4=CC=CC=C4O3
3297;380773266;0.00537;1907474;482074897;168289302;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;(3,5-Dichlorophenyl)methyl 2-[3-(4-propylpiperazin-1-yl)phenyl]piperidine-1-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCN(CC1)C2=CC=CC(=C2)C3CCCCN3C(=O)OCC4=CC(=CC(=C4)Cl)Cl
3298;407996524;0.00537;1946583;494418671;171356469;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;7-[(6-chloro-1H-indol-2-yl)methyl]-1-[(3,4-difluorophenyl)methyl]-1,7-diazaspiro[4.4]nonane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCN(C2)CC3=CC4=C(N3)C=C(C=C4)Cl)N(C1)CC5=CC(=C(C=C5)F)F
3299;408003841;0.00537;1948305;494398235;171344553;10280;369199560;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) assessed as inhibition constant;2-[[5-[3-(4-Cyclohexylpiperazin-1-yl)propyl]-5,6,7,8-tetrahydronaphthalen-1-yl]oxy]-5-(dimethylamino)isoindole-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)C1=CC2=C(C=C1)C(=O)N(C2=O)OC3=CC=CC4=C3CCCC4CCCN5CCN(CC5)C6CCCCC6
3300;100435166;0.0054;203682;103275038;11462448;10280;150841290;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity at opioid sigma-1 receptor in guinea pig brain membranes by (+)-[3H]pentazocine displacement.;5-[3-(4-Cyclohexyl-piperazin-1-yl)-propyl]-5,6,7,8-tetrahydro-naphthalen-1-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)N2CCN(CC2)CCCC3CCCC4=C3C=CC=C4O
3301;100449444;0.0054;204443;103274746;9796317;10280;83608750;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine at sigma receptor in guinea pig brain membrane was determined;2-[2-(3,4-Dichloro-phenyl)-ethyl]-octahydro-pyrrolo[1,2-a]pyrazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C[C@H]2CN(CCN2C1)CCC3=CC(=C(C=C3)Cl)Cl
3302;100459315;0.0054;229212;103401054;10422239;10280;84969360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was evaluated against sigma-1 binding site in guinea pig, using [3H]- -(+)- Pentazocine;[2-(3-Fluoro-phenyl)-ethyl]-methyl-(2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=CC=C1)F)CCN2CCCC2
3303;100617220;0.0054;204444;103337424;15723885;10280;16627250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membranes using [3H]DTG as radioligand;1-(3-Trifluoromethylphenyl)-4-(4-phenylbutyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCCCC2=CC=CC=C2)C3=CC=CC(=C3)C(F)(F)F
3304;363860758;0.0054;1467149;381882836;137658890;10280;284950850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of (+)-[3H]-pentazocine from recombinant human sigma 1 receptor expressed in baculovirus infected Sf9 insect cell membranes after 90 mins by scintillation counting method;1-[3-(4-Tert-butylphenyl)propyl]-4-methylpiperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)CCCC2=CC=C(C=C2)C(C)(C)C
3305;367478255;0.0054;1655949;442054092;156014992;10280;324354210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human Sigma 1 receptor by radioligand displacement assay;"1-Benzyl-4-[(2,2-dimethyl-1,3-dioxolan-4-yl)methyl]piperazine;oxalic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1(OCC(O1)CN2CCN(CC2)CC3=CC=CC=C3)C.C(=O)(C(=O)O)O.C(=O)(C(=O)O)O
3306;380773267;0.0054;1907474;482074897;168289302;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;(3,5-Dichlorophenyl)methyl 2-[3-(4-propylpiperazin-1-yl)phenyl]piperidine-1-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCN(CC1)C2=CC=CC(=C2)C3CCCCN3C(=O)OCC4=CC(=CC(=C4)Cl)Cl
3307;100473782;0.005495;203852;103321742;42601814;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;N,N,4-trimethyl-4-phenyl-2,3-dihydro-1H-naphthalen-2-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1(CC(CC2=CC=CC=C21)N(C)C)C3=CC=CC=C3
3308;100627346;0.005495;204452;131275606;54581855;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-benzyl-7-methylspiro[2,3-dihydro-1H-naphthalene-4,4'-piperidine];hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CC1=CC2=C(C=C1)C3(CCC2)CCN(CC3)CC4=CC=CC=C4.Cl
3309;100627353;0.005495;204452;131285632;54586690;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-(oxolan-2-ylmethyl)spiro[2,3-dihydro-1H-naphthalene-4,4'-piperidine];hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC(OC1)CN2CCC3(CCCC4=CC=CC=C43)CC2.Cl
3310;407996512;0.005495;1946583;482063618;168281091;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(3S)-1-[(3-fluoro-4-methoxyphenyl)methyl]-3-[(4-methylphenyl)methoxy]piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=C(C=C1)CO[C@H]2CCCN(C2)CC3=CC(=C(C=C3)OC)F
3311;326034768;0.0055;701162;163314039;11508643;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-[2-[1-(3,4-Dichlorophenyl)-5-methylpyrazol-3-yl]oxyethyl]piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)OCCN3CCCCC3
3312;407996511;0.0055;1946583;482063618;168281091;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(3S)-1-[(3-fluoro-4-methoxyphenyl)methyl]-3-[(4-methylphenyl)methoxy]piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=C(C=C1)CO[C@H]2CCCN(C2)CC3=CC(=C(C=C3)OC)F
3313;407996523;0.0055;1946583;494418671;171356469;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;7-[(6-chloro-1H-indol-2-yl)methyl]-1-[(3,4-difluorophenyl)methyl]-1,7-diazaspiro[4.4]nonane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCN(C2)CC3=CC4=C(N3)C=C(C=C4)Cl)N(C1)CC5=CC(=C(C=C5)F)F
3314;100367079;0.00551;226337;103376054;9906138;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-[1-(4-Fluorobenzyl)-4-piperidinyl]-3-fluorophenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)F)CC3=CC=C(C=C3)F
3315;100435165;0.00554;203682;103274578;11152920;10280;150841290;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity at opioid sigma-1 receptor in guinea pig brain membranes by (+)-[3H]pentazocine displacement.;1-Cyclohexyl-4-[3-((R)-5-methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-propyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC=CC2=C1CCC[C@@H]2CCCN3CCN(CC3)C4CCCCC4
3316;255030601;0.005587;625223;103737203;5511;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tolperisone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC=C(C=C1)C(=O)C(C)CN2CCCCC2
3317;100354810;0.0056;204791;103237990;10789834;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand;N-(1-Benzyl-4-piperidinyl)-1-methoxy-4-bromo-2-naphthalenecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)NC3CCN(CC3)CC4=CC=CC=C4
3318;100544895;0.0056;203699;103217894;10784078;10280;95728830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to sigma-1 sites in guinea pig brain membranes;(1R,9S,13S)-1,13-dimethyl-10-[2-(N-methylanilino)ethyl]-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2CCN(C)C4=CC=CC=C4)C)C=C(C=C3)O
3319;100497241;0.00564;203984;103167216;3559;10280;76997100;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3320;100387736;0.00566;204145;103389452;11120436;10280;123830180;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine from Sigma opioid receptor type 1 of guinea pig brain;1''-Benzylspiro[1,3-dihydroisobenzofuran-1,4''-(hexahydropyridine)]-3-ylmethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3C(O2)CO)CC4=CC=CC=C4
3321;255025668;0.005665;625223;103167216;3559;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3322;100485150;0.00568;204636;103318462;15767677;10280;76368600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured on Sigma receptor type 1 from guinea pig brain membranes using [3H]pentazocine as radioligand.;N-(10-benzyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-yl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)NC(=O)C
3323;100319793;0.0057;204154;103361346;10691389;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;[1-(4-Methoxy-3-phenethyloxy-benzyl)-propyl]-dipropyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCN(CCC)C(CC)CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2
3324;100478463;0.0057;203696;103184932;44272754;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;((R)-1-Methyl-2-phenyl-ethyl)-(3-naphthalen-2-yl-propyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CC1=CC=CC=C1)NCCCC2=CC3=CC=CC=C3C=C2
3325;100535944;0.0057;204457;103673567;45262103;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(2-Bromo-3,5-diethylphenyl)-1-(3-ethylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)NC(=NC2=CC(=CC(=C2Br)CC)CC)N.Cl
3326;345594064;0.0057;1197502;312385717;118731581;10280;256029320;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor in human Jurkat cells after 120 mins by liquid scintillation counting analysis;6-Bromo-3-[3-(1,3-dihydroisoindol-2-yl)propyl]-1,3-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1C2=CC=CC=C2CN1CCCN3C4=C(C=C(C=C4)Br)SC3=O
3327;366315881;0.0057;1532592;440163953;134828069;10280;304474340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human Jurkat cell membranes after 2 hrs by liquid scintillation counting method;1-(7-chloranyl-4-methoxy-1~{H}-indol-5-yl)-3-[1-(phenylmethyl)piperidin-4-yl]propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C2C=CNC2=C(C=C1C(=O)CCC3CCN(CC3)CC4=CC=CC=C4)Cl
3328;388740033;0.0057;1797293;386051270;118282850;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 25;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)C)N2CC3=CC4=C(C=C3C2)OCO4
3329;388878698;0.0057;1797475;386051270;118282850;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 25;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)C)N2CC3=CC4=C(C=C3C2)OCO4
3330;389383284;0.0057;1804286;386051270;118282850;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 25;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)C)N2CC3=CC4=C(C=C3C2)OCO4
3331;100322585;0.00574;204151;103383040;44361388;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 1 using [3H](+)-pentazocine in guinea pig brain membranes;(1S,9S,13S)-10-benzyl-13-methyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@H]1[C@@H]2CCN([C@H]1CC3=CC=CC=C23)CC4=CC=CC=C4
3332;100333035;0.005754;204944;103277916;10757227;10280;108823620;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was performed using [3H](+)-pentazocine to label sigma-1 binding sites, in guinea pig cerebral cortex;2-(Cycloheptylmethyl)-1-(5-pyrrolidin-1-ylpentyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CCCC(CC1)CN=C(N)NCCCCCN2CCCC2
3333;100626490;0.00578;229194;103384132;15113300;10280;13101140;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+) -3PPP from sigma receptor in guinea pig brain membranes;2-(3,4-Dichlorophenyl)-N-(2-methylaminoethyl)-N-methylethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CNCCN(C)CCC1=CC(=C(C=C1)Cl)Cl
3334;100354372;0.0058;204790;103238170;10836428;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-[(3S)-1-Cyclohexyl-3-pyrrolidinyl]-1-methoxy-4-bromo-2-naphthalenecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)N[C@H]3CCN(C3)C4CCCCC4
3335;100478316;0.0058;203696;103185525;44273058;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;(alphaR)-N,alpha-Dimethyl-N-phenethylbenzeneethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CC1=CC=CC=C1)N(C)CCC2=CC=CC=C2
3336;100546836;0.0058;203685;103278105;11791714;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-Benzylpiperidine-4-yl)-2-(2,6-difluorophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=C(C=CC=C2F)F)CC3=CC=CC=C3
3337;112788096;0.0058;204633;103385723;10713754;10280;74907270;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to inhibit [3H](+)-pentazocine binding to guinea pig brain Sigma receptor type 1;(8E)-5-(3-hydroxyphenyl)-8-[(3-methoxyphenyl)methylidene]-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1/C(=C\C3=CC(=CC=C3)OC)/C(=O)C2)C4=CC(=CC=C4)O
3338;363958024;0.0058;1500193;404663989;52149645;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N-[3-[benzyl(methyl)amino]propyl]-4-chlorobenzenesulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNS(=O)(=O)C1=CC=C(C=C1)Cl)CC2=CC=CC=C2
3339;100702227;0.00581;204766;103417106;200601;10280;126395730;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards Sigma-1 receptor;1,4-Dibenzylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2=CC=CC=C2)CC3=CC=CC=C3
3340;321583102;0.00581;677526;103417106;200601;10280;228502100;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma1 receptor;1,4-Dibenzylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2=CC=CC=C2)CC3=CC=CC=C3
3341;100385644;0.00583;204153;103377948;11782688;10280;117841480;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma opioid receptor type 1 affinity in guinea pig brain by employing [3H](+)-pentazocine as radioligand.;1'-Benzyl-3-ethoxy-3,4-dihydrospiro[1H-2-benzopyran-1,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC1CC2=CC=CC=C2C3(O1)CCN(CC3)CC4=CC=CC=C4
3342;100741916;0.00586;203989;103308137;44327682;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor in guinea pig brain preparation was estimated using [3H]3-PPP as radioligand;4-[4-(4-p-Tolyl-3,6-dihydro-2H-pyridin-1-yl)-butyl]-pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=C(C=C1)C2=CCN(CC2)CCCCC3=CC=NC=C3
3343;100627657;0.005888;204452;131273631;54580839;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-[(4-Methylphenyl)methyl]spiro[1,2-dihydroindene-3,4'-piperidine];hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CC1=CC=C(C=C1)CN2CCC3(CCC4=CC=CC=C43)CC2.Cl
3344;100356311;0.0059;204790;103238224;10551026;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-[(3R)-1-Benzyl-3-pyrrolidinyl]-1-methoxy-4-bromo-2-naphthalenecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)N[C@@H]3CCN(C3)CC4=CC=CC=C4
3345;100543216;0.0059;203699;103217947;10664642;10280;95728830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to sigma-1 sites in guinea pig brain membranes;(1R,9S,13S)-10-(2-anilinoethyl)-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2CCNC4=CC=CC=C4)C)C=C(C=C3)O
3346;363970595;0.0059;1506085;103167216;3559;10280;299690300;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of (+)-[3H]pentazocine from human sigma1 receptor expressed in HEK293 cell membranes after 60 mins by liquid scintillation counting method;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3347;389483949;0.0059;1805386;160849764;132060733;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';4-(2-Benzylisoindolin-5-yl)morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCN1C2=CC3=C(CN(C3)CC4=CC=CC=C4)C=C2
3348;100292608;0.00598;239200;103442043;11152527;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;4-Benzyl-1-chroman-3-ylmethyl-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3CC4=CC=CC=C4OC3
3349;100297840;0.006;239347;103458149;13998486;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;N-(2-Benzhydrylsulfanyl-ethyl)-N''-[2-(1H-imidazol-4-yl)-ethyl]-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)C(C2=CC=CC=C2)SCCN=C(N)NCCC3=CN=CN3
3350;100298512;0.006;239347;103166030;202478;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;(R)-preclamol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCC[C@@H](C1)C2=CC(=CC=C2)O
3351;100459317;0.006;229212;103401032;10354750;10280;84969360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was evaluated against sigma-1 binding site in guinea pig, using [3H]- -(+)- Pentazocine;[2-(4-Fluoro-phenyl)-ethyl]-methyl-(2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC=C(C=C1)F)CCN2CCCC2
3352;100470628;0.006;204469;103340236;44342792;10280;79325690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition against sigma receptor using displacement of 3 nM [3H]pentazocine in homogenate of guinea pig brain cerebellum;(1R,13S)-10-butyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCCN1CC[C@@]2([C@@H](C1CC3=C2C=C(C=C3)O)C)C
3353;100605296;0.006;203995;103321526;10369311;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity of compound to Sigma opioid receptor labelled with [3H](+)-3-PPP;3,4-Dichloro-N-methyl-N-[(1R,2S)-2-(1-pyrrolidinyl)cyclohexyl]benzeneethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=C(C=C1)Cl)Cl)[C@@H]2CCCC[C@@H]2N3CCCC3
3354;100614101;0.006;203986;103677556;14771665;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N-(Adamantan-1-yl)-N'-(2-iodophenyl)guanidine HCl;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C2CC3CC1CC(C2)(C3)N=C(N)NC4=CC=CC=C4I.Cl
3355;100614373;0.006;203986;103283104;14771695;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N-Adamantan-2-yl-N''-o-tolyl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC2C3CC4CC(C3)CC2C4)N
3356;100614376;0.006;203986;103282211;14771702;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N-Bicyclo[2.2.1]hept-2-yl-N''-o-tolyl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC2CC3CCC2C3)N
3357;100615702;0.006;204447;103321526;10369311;10280;16560440;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]-(+)-3-PPP binding to sigma of guinea pig brain;3,4-Dichloro-N-methyl-N-[(1R,2S)-2-(1-pyrrolidinyl)cyclohexyl]benzeneethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=C(C=C1)Cl)Cl)[C@@H]2CCCC[C@@H]2N3CCCC3
3358;100622104;0.006;203998;103186018;15061897;10280;16481390;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]DTG binding to Sigma opioid receptor;N-[1-Methyl-2-(3-bromophenyl)ethyl]-3-phenylpropan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(CC1=CC(=CC=C1)Br)NCCCC2=CC=CC=C2
3359;100741863;0.006;203992;103671632;45260678;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"2-(4-Fluorophenyl)-8-(2-phenylethyl)-1-oxa-8-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC12C(=O)C=C(O2)C3=CC=C(C=C3)F)CCC4=CC=CC=C4.Cl
3360;100742325;0.006;204129;103671627;45260676;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"3-(4-Fluorophenyl)-9-(2-phenylethyl)-1-oxa-9-azaspiro[5.5]undec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12CC(=O)C(=CO2)C3=CC=C(C=C3)F)CCC4=CC=CC=C4.Cl
3361;100742383;0.006;203987;103671519;45260595;10280;;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was evaluated for binding affinity against sigma opioid receptor using [3H]DTG radioligand in guinea pig membranes;"N'-(1-adamantyl)-N-(2-methylphenyl)ethanimidamide;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC23CC4CC(C2)CC(C4)C3)C.Cl
3362;100746106;0.006;204298;103167216;3559;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma opioid receptor type 2 in guinea pig brain homogenate with 4 nM [3H]-(+)-DTG;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3363;100746554;0.006;204019;103335942;44340914;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-SKF-10047 binding to sigma receptor;"N-(1-benzylpiperidin-4-yl)-N,3-diphenylprop-2-ynamide;(E)-but-2-enedioic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1N(C2=CC=CC=C2)C(=O)C#CC3=CC=CC=C3)CC4=CC=CC=C4.C(=C/C(=O)O)\C(=O)O
3364;112788095;0.006;204633;103385723;10713754;10280;74907270;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to inhibit [3H](+)-pentazocine binding to guinea pig brain Sigma receptor type 1;(8E)-5-(3-hydroxyphenyl)-8-[(3-methoxyphenyl)methylidene]-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1/C(=C\C3=CC(=CC=C3)OC)/C(=O)C2)C4=CC(=CC=C4)O
3365;355637716;0.006;1308619;336904025;127050366;10280;271565650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-Pentazocine from sigma 1 receptor in human RPMI8226 cell membranes;(1S,4R,7S)-2-(cyclohexylmethyl)-5-(naphthalen-1-ylmethyl)-2,5-diazabicyclo[2.2.2]octan-7-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;C1CCC(CC1)CN2C[C@H]3C[C@@H]([C@@H]2CN3CC4=CC=CC5=CC=CC=C54)O
3366;366366386;0.006;1558961;440183758;102004349;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;2-Methyl-4-phenyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=CC=CC=C4
3367;366366663;0.006;1558961;440155729;118562510;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;2-Ethyl-4-phenyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=CC=CC=C4
3368;372120972;0.006;1681775;440183758;102004349;10280;330649470;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;2-Methyl-4-phenyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=CC=CC=C4
3369;372306738;0.006;1701184;461555583;54673481;10280;332377850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;1-(3,4-Dichlorophenyl)-5-methyl-3-(2-pyrrolidin-1-ylethoxymethyl)pyrazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)COCCN3CCCC3
3370;380512533;0.006;1846430;482064849;42611023;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-4-pentyl-10-phenyl-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCCN1C[C@@H]2[C@@H](C1)OCC3=C(N=NN23)C4=CC=CC=C4
3371;380647302;0.006;1877930;381859220;702501;10280;350161130;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from Sigma 1-receptor (unknown origin);N-(1-benzylpiperidin-4-yl)-4-fluorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)C2=CC=C(C=C2)F)CC3=CC=CC=C3
3372;100543217;0.0061;203699;103252465;12259685;10280;95728830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to sigma-1 sites in guinea pig brain membranes;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
3373;100543693;0.0061;203690;103252465;12259685;10280;95728800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was tested for its binding affinity towards sigma 1 receptor using [3H](+)-pentazocine from guinea pig brain;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
3374;389483952;0.0061;1805386;160849763;132075203;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';4-(2-Benzyl-1,3,4,5-tetrahydro-2-benzazepin-7-yl)morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2=C(CN(C1)CC3=CC=CC=C3)C=CC(=C2)N4CCOCC4
3375;100473783;0.006166;203852;103321743;15657199;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;"cis-7-Dimethylamino-5-phenyl-5,6,7,8-tetrahydro-naphthalene-2,3-diol; hydrobromide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)C1CC(C2=CC(=C(C=C2C1)O)O)C3=CC=CC=C3
3376;100354290;0.0062;204790;103238489;10719189;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-[(3R)-1-(Bicyclo[3.3.1]nonane-9-yl)-3-pyrrolidinyl]-1-methoxy-4-bromo-2-naphthalenecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)N[C@@H]3CCN(C3)C4C5CCCC4CCC5
3377;100356309;0.0062;204790;103238487;12084054;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-[(3R)-1-(2-Adamantyl)-3-pyrrolidinyl]-1-methoxy-4-bromo-2-naphthalenecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)N[C@@H]3CCN(C3)C4C5CC6CC(C5)CC4C6
3378;100622100;0.0062;203998;103240388;15061886;10280;16481390;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]DTG binding to Sigma opioid receptor;N-[1-Methyl-2-(4-propylphenyl)ethyl]-3-phenylpropan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCC1=CC=C(C=C1)CC(C)NCCCC2=CC=CC=C2
3379;100622189;0.0062;203982;103241013;64600;10280;16481400;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H]DTG from sigma opioid receptor of homogenized guinea pig whole brain;N-Adamanty-1-yl-N'-(2-iodophenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C2CC3CC1CC(C2)(C3)N=C(N)NC4=CC=CC=C4I
3380;345680791;0.0062;1174258;312374339;118724295;10280;254622400;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor in human Jurkat cell membranes incubated for 2 hrs by liquid scintillation counting;N-benzyl-N-methyl-3-(1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl)propan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1CCC2=C(C1)NC3=CC=CC=C23)CC4=CC=CC=C4
3381;100367028;0.0063;226337;103375762;9819510;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-[1-(3,4-Difluoro-benzyl)-piperidin-4-yl]-2-phenyl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC(=C(C=C3)F)F
3382;100619163;0.0063;203990;103186067;10265752;10280;18482950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma opioid receptor in guinea pig cerebral homogenate using [3H]DTG as radioligand;((S)-1-Methyl-2-phenyl-ethyl)-(5-phenyl-pentyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](CC1=CC=CC=C1)NCCCCCC2=CC=CC=C2
3383;100622095;0.0063;203998;103185288;15061889;10280;16481390;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]DTG binding to Sigma opioid receptor;(1-Methyl-2-naphthalen-2-yl-ethyl)-(3-phenyl-propyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(CC1=CC2=CC=CC=C2C=C1)NCCCC3=CC=CC=C3
3384;326034773;0.0063;701162;103275267;574780;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-[2-(3,4-Dichlorophenyl)ethyl]-4-methylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CN1CCN(CC1)CCC2=CC(=C(C=C2)Cl)Cl
3385;334065174;0.0063;735278;164129955;71716507;10280;235606500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;4-(3,4-Dichlorophenethyl)Morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1COCCN1CCC2=CC(=C(C=C2)Cl)Cl
3386;354626043;0.0063;1272497;103167216;3559;10280;267502540;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin) by radioligand displacement assay;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3387;100627658;0.00631;204452;131283643;54585707;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-(thiophen-2-ylmethyl)spiro[2,3-dihydro-1H-naphthalene-4,4'-piperidine];hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC2=CC=CC=C2C3(C1)CCN(CC3)CC4=CC=CS4.Cl
3388;100627996;0.00631;204453;103671475;45260557;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"(4aR,10bR)-3-butyl-2,4,4a,5,6,10b-hexahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCCN1CC[C@@H]2[C@H](C1)CCC3=CC=CC=C23.Cl
3389;100507183;0.0064;204150;103345256;10564493;10280;87844550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from Sigma opioid receptor type 1 in guinea pig brain membrane;Methyl-[2-(3-nitro-phenyl)-ethyl]-(2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCC1=CC(=CC=C1)[N+](=O)[O-])CCN2CCCC2
3390;345594058;0.0064;1197502;312385705;118731569;10280;256029320;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor in human Jurkat cells after 120 mins by liquid scintillation counting analysis;3-[3-[Benzyl(methyl)amino]propyl]-5-chloro-1,3-benzoxazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1C2=C(C=CC(=C2)Cl)OC1=O)CC3=CC=CC=C3
3391;355638090;0.0064;1308619;336905220;127051201;10280;271565650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-Pentazocine from sigma 1 receptor in human RPMI8226 cell membranes;(1R,2S,5S)-6-benzyl-8-(cyclohexylmethyl)-6,8-diazabicyclo[3.2.2]nonan-2-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;C1CCC(CC1)CN2C[C@@H]3CC[C@@H]([C@H]2CN3CC4=CC=CC=C4)O
3392;372338884;0.0064;1718132;103167216;3559;10280;331115250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin);Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3393;100333030;0.006457;204944;103278683;10569632;10280;108823620;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was performed using [3H](+)-pentazocine to label sigma-1 binding sites, in guinea pig cerebral cortex;2-(1-Adamantylmethyl)-1-(5-pyrrolidin-1-ylpentyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CCN(C1)CCCCCNC(=NCC23CC4CC(C2)CC(C4)C3)N
3394;407996330;0.006457;1946583;482066608;168283295;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(3S)-3-[(4-fluoro-3-methylphenyl)methoxy]-1-[(4-methylphenyl)methyl]piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=C(C=C1)CN2CCC[C@@H](C2)OCC3=CC(=C(C=C3)F)C
3395;100546616;0.00646;203685;103277887;1245023;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-benzylpiperidin-4-yl)-2-(4-chlorophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=C(C=C2)Cl)CC3=CC=CC=C3
3396;363958034;0.0065;1500193;404657249;145953153;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N-[2-[benzyl(methyl)amino]ethyl]-2,3-dichlorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCNC(=O)C1=C(C(=CC=C1)Cl)Cl)CC2=CC=CC=C2
3397;363958040;0.0065;1500193;404652648;118607439;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;4-[benzyl(methyl)amino]-N-(4-chlorophenyl)butanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCC(=O)NC1=CC=C(C=C1)Cl)CC2=CC=CC=C2
3398;402102361;0.0065;1796671;384224373;118607454;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-(2-(benzyl(methyl)amino)ethyl)-2,4-dichlorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCNC(=O)C1=C(C=C(C=C1)Cl)Cl)CC2=CC=CC=C2
3399;407996329;0.0065;1946583;482066608;168283295;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(3S)-3-[(4-fluoro-3-methylphenyl)methoxy]-1-[(4-methylphenyl)methyl]piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=C(C=C1)CN2CCC[C@@H](C2)OCC3=CC(=C(C=C3)F)C
3400;100366975;0.00659;226337;103375680;9797419;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-[1-(4-Fluoro-benzyl)-piperidin-4-yl]-2-phenyl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC=C(C=C3)F
3401;100619099;0.0066;203990;103186083;10467461;10280;18482950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma opioid receptor in guinea pig cerebral homogenate using [3H]DTG as radioligand;Methyl-((S)-1-methyl-2-phenyl-ethyl)-phenethyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](CC1=CC=CC=C1)N(C)CCC2=CC=CC=C2
3402;100619157;0.0066;203990;103186063;10264983;10280;18482950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma opioid receptor in guinea pig cerebral homogenate using [3H]DTG as radioligand;((S)-1-Methyl-2-phenyl-ethyl)-(4-phenyl-butyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](CC1=CC=CC=C1)NCCCCC2=CC=CC=C2
3403;101830501;0.0066;255057;103468465;44403183;10280;161400110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory concentration against opioid receptor sigma 1 of guinea pig cerebral cortex using [3H](+)-pentazocine upon incubation for 150 minutes at 22 degree C;(10aR)-2-(2-piperidin-1-ylethyl)-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CCN(CC1)CCN2C(=O)[C@H]3CC4=CC=CC=C4CN3C2=O
3404;100628013;0.006607;204453;103671426;45260525;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"(4aR,10bR)-3-(furan-2-ylmethyl)-2,4,4a,5,6,10b-hexahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC2=CC=CC=C2[C@H]3[C@@H]1CN(CC3)CC4=CC=CO4.Cl
3405;100630852;0.006607;204452;131281687;54584774;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-but-3-enylspiro[2,3-dihydro-1H-naphthalene-4,4'-piperidine];hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C=CCCN1CCC2(CCCC3=CC=CC=C32)CC1.Cl
3406;100385647;0.00664;204153;103377508;10980649;10280;117841480;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma opioid receptor type 1 affinity in guinea pig brain by employing [3H](+)-pentazocine as radioligand.;1'-Phenethyl-3-methoxy-3,4-dihydrospiro[1H-2-benzopyran-1,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1CC2=CC=CC=C2C3(O1)CCN(CC3)CCC4=CC=CC=C4
3407;100546523;0.00665;203689;103284454;4033090;10280;96511500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma-1 receptor in guinea pig brain membranes;4-bromo-N-(2-pyrrolidin-1-ylethyl)benzenesulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCN(C1)CCNS(=O)(=O)C2=CC=C(C=C2)Br
3408;100617246;0.0067;204444;103336885;743379;10280;16627250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membranes using [3H]DTG as radioligand;1-Phenyl-4-(3-phenylpropyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCCC2=CC=CC=C2)C3=CC=CC=C3
3409;380773464;0.0067;1907474;482086231;168296763;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;Benzyl 2-[4-(4-propylpiperazin-1-yl)phenyl]piperidine-1-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCN(CC1)C2=CC=C(C=C2)C3CCCCN3C(=O)OCC4=CC=CC=C4
3410;100366974;0.00675;226337;103375679;9889112;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-[1-(3-Iodo-benzyl)-piperidin-4-yl]-2-phenyl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC(=CC=C3)I
3411;100333033;0.006761;204944;103278293;10761980;10280;108823620;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was performed using [3H](+)-pentazocine to label sigma-1 binding sites, in guinea pig cerebral cortex;2-(1-Adamantylmethyl)-1-[5-(azepan-1-yl)pentyl]guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CCCN(CC1)CCCCCNC(=NCC23CC4CC(C2)CC(C4)C3)N
3412;100627348;0.006761;204452;131279687;54583823;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-benzyl-7-chlorospiro[2,3-dihydro-1H-naphthalene-4,4'-piperidine];hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC2=C(C=CC(=C2)Cl)C3(C1)CCN(CC3)CC4=CC=CC=C4.Cl
3413;100627351;0.006761;204452;131283644;54585708;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-[(4-chlorophenyl)methyl]spiro[2,3-dihydro-1H-naphthalene-4,4'-piperidine];hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC2=CC=CC=C2C3(C1)CCN(CC3)CC4=CC=C(C=C4)Cl.Cl
3414;100627642;0.006761;204452;131277595;54582816;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-Benzylspiro[6,7,8,9-tetrahydrobenzo[7]annulene-5,4'-piperidine];hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CCC2(CCN(CC2)CC3=CC=CC=C3)C4=CC=CC=C4C1.Cl
3415;100478461;0.0068;203696;103186132;18790250;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;(5-Cyclohexyl-pentyl)-methyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CNCCCCCC1CCCCC1
3416;100622169;0.0068;204000;103186165;15061887;10280;16481390;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Opioid activity in terms of inhibition of [3H]dihydromorphine binding to opioid receptor mu in rat brain membrane.;N-[1-Methyl-2-(4-ethoxyphenyl)ethyl]-3-phenylpropan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCOC1=CC=C(C=C1)CC(C)NCCCC2=CC=CC=C2
3417;342811250;0.0068;1129882;242620291;90655531;10280;246178360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human RPMI8226 cell membranes after 120 mins by scintillation counting analysis;2-[(2S)-4-(cyclohexylmethyl)-1-(naphthalen-2-ylmethyl)piperazin-2-yl]ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;C1CCC(CC1)CN2CCN([C@H](C2)CCO)CC3=CC4=CC=CC=C4C=C3
3418;100765036;0.0069;204446;103678524;10025402;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membrane was determined by using [3H]DTG as the radioligand;"N-[(3-bromophenyl)methyl]spiro[1,3-dioxolane-2,11'-pentacyclo[5.4.0.02,6.03,10.05,9]undecane]-8'-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1COC2(O1)C3C4CC5C3C(C6C5C4C26)NCC7=CC(=CC=C7)Br.Cl
3419;326035177;0.0069;701162;163331303;11494380;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-(3,4-Dichlorophenyl)-5-methyl-3-(4-pyrrolidin-1-ylbutoxy)pyrazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)OCCCCN3CCCC3
3420;366423707;0.0069;1587567;440190734;155553997;10280;309390140;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from sigma 1 receptor in human RPMI8226 cell membranes incubated for 2 hrs under shaking by scintillation counting analysis;N-(cyclohexylmethyl)-3-methoxy-N-methylspiro[3,4-dihydroisochromene-1,4'-cyclohexane]-1'-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CC1CCCCC1)C2CCC3(CC2)C4=CC=CC=C4CC(O3)OC
3421;380773463;0.006918;1907474;482086231;168296763;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;Benzyl 2-[4-(4-propylpiperazin-1-yl)phenyl]piperidine-1-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCN(CC1)C2=CC=C(C=C2)C3CCCCN3C(=O)OCC4=CC=CC=C4
3422;100456544;0.007;229183;103360124;14970538;10280;79028690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor in bovine cerebellum using 2.0 nM [3H]haloperidol in the presence of 25 nM unlabeled spiperone;1-Phenyl-3-(4-phenyl-piperidin-1-yl)-propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CN(CCC1C2=CC=CC=C2)CCC(=O)C3=CC=CC=C3
3423;100475167;0.007;204462;103351511;10066419;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;6-Methoxy-2-[1-benzyl-4-piperidinyl]-3,4-dihydronaphthalen-1(2H)-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC2=C(C=C1)C(=O)C(CC2)C3CCN(CC3)CC4=CC=CC=C4
3424;100500101;0.007;204466;103237426;10714699;10280;85688040;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]DTG binding to sigma receptor from guinea pig brain cortex membrane;1-Benzyl-4-[3-(5-methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-propyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCCC2CCCN3CCN(CC3)CC4=CC=CC=C4
3425;100622180;0.007;203982;103240994;15065449;10280;16481400;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H]DTG from sigma opioid receptor of homogenized guinea pig whole brain;1-(1-Adamantyl)-3-(3-methoxyphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC=CC(=C1)NC(=NC23CC4CC(C2)CC(C4)C3)N
3426;100622182;0.007;203982;103241033;15065450;10280;16481400;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H]DTG from sigma opioid receptor of homogenized guinea pig whole brain;1-(1-Adamantyl)-3-(2-methyl-4-methoxyphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=C(C=CC(=C1)OC)NC(=NC23CC4CC(C2)CC(C4)C3)N
3427;100737197;0.007;203994;103227942;14368954;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor of guinea pig brain by using [3H]SKF-10047 radioligand;(5S)-5-[(4-hydroxy-4-phenylpiperidin-1-yl)methyl]-3-(4-methoxyphenyl)-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)N2C[C@@H](OC2=O)CN3CCC(CC3)(C4=CC=CC=C4)O
3428;100742343;0.007;204020;103671628;45260677;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor using [3H]-(+)-SKF- 10,047;"9-(2-Phenylethyl)-3-thiophen-2-yl-1-oxa-9-azaspiro[5.5]undec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12CC(=O)C(=CO2)C3=CC=CS3)CCC4=CC=CC=C4.Cl
3429;100746228;0.007;204018;103277642;15229597;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor using [3H](+)-SKF-10047 as radioligand;1-Phenethyl-4-[2-(3-phenyl-prop-2-ynyloxy)-ethyl]-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CCOCC#CC2=CC=CC=C2)CCC3=CC=CC=C3
3430;100746449;0.007;204018;103277465;9905222;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor using [3H](+)-SKF-10047 as radioligand;1-Benzyl-4-((E)-3-phenyl-allyloxymethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1COC/C=C/C2=CC=CC=C2)CC3=CC=CC=C3
3431;100746560;0.007;204019;103335898;44340892;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-SKF-10047 binding to sigma receptor;"1-benzyl-N,N-bis[(E)-3-phenylprop-2-enyl]piperidin-4-amine;(E)-but-2-enedioic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C(CCN(C1)CC2=CC=CC=C2)N(C/C=C/C3=CC=CC=C3)C/C=C/C4=CC=CC=C4.C(=C/C(=O)O)\C(=O)O
3432;340085307;0.007;776370;174488823;11573361;10280;240957440;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin);1-Methyl-4-[2-(4-phenylpiperidin-1-yl)ethyl]-4,5,6,7-tetrahydroindazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C=N1)C(CCC2)CCN3CCC(CC3)C4=CC=CC=C4
3433;363665759;0.007;1415921;404715664;71503148;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;1-(1-(2-(azepan-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-3-propylthiourea;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCNC(=S)NC1=C2C=NN(C2=NC=N1)CCN3CCCCCC3
3434;366437014;0.007;1594271;103167216;3559;10280;309043830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3435;100627930;0.007079;204453;103677076;45264298;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"(4aR,10bR)-3-(thiophen-2-ylmethyl)-2,4,4a,5,6,10b-hexahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC2=CC=CC=C2[C@H]3[C@@H]1CN(CC3)CC4=CC=CS4.Cl
3436;407996176;0.007079;1946583;494423267;171358061;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[(6-chloro-1H-indol-2-yl)methyl]-9-[(3,4-difluorophenyl)methyl]-2,9-diazaspiro[4.5]decane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCN(C2)CC3=CC4=C(N3)C=C(C=C4)Cl)CN(C1)CC5=CC(=C(C=C5)F)F
3437;326035171;0.0071;701162;163324312;11625126;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-{4-[1-(3,4-Dichlorophenyl)-5-methyl-1H-pyrazol-3-yloxy]butyl}piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)OCCCCN3CCCCC3
3438;345594067;0.0071;1197502;103744839;44818602;10280;256029320;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor in human Jurkat cells after 120 mins by liquid scintillation counting analysis;(10aR)-2-[3-[benzyl(methyl)amino]propyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1C(=O)[C@H]2CC3=CC=CC=C3CN2C1=O)CC4=CC=CC=C4
3439;345681159;0.0071;1174258;103744839;44818602;10280;254622400;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor in human Jurkat cell membranes incubated for 2 hrs by liquid scintillation counting;(10aR)-2-[3-[benzyl(methyl)amino]propyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1C(=O)[C@H]2CC3=CC=CC=C3CN2C1=O)CC4=CC=CC=C4
3440;407996175;0.0071;1946583;494423267;171358061;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[(6-chloro-1H-indol-2-yl)methyl]-9-[(3,4-difluorophenyl)methyl]-2,9-diazaspiro[4.5]decane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCN(C2)CC3=CC4=C(N3)C=C(C=C4)Cl)CN(C1)CC5=CC(=C(C=C5)F)F
3441;100387744;0.00716;204145;103388667;11110106;10280;123830180;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine from Sigma opioid receptor type 1 of guinea pig brain;(1'-Benzylspiro[3,4-dihydroisochromene-1,4'-piperidine]-3-yl)methanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3CC(O2)CO)CC4=CC=CC=C4
3442;100485153;0.00716;204636;103318523;15767682;10280;76368600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured on Sigma receptor type 1 from guinea pig brain membranes using [3H]pentazocine as radioligand.;10-Benzyl-4-chloro-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)Cl
3443;100367042;0.0072;226337;103376448;10925078;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-(1-Benzyl-piperidin-4-yl)-2-thiophen-3-yl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CSC=C2)CC3=CC=CC=C3
3444;326034955;0.0072;701162;163331301;24743739;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-[1-[2-[1-(3,4-Dichlorophenyl)pyrazol-3-yl]oxyethyl]piperidin-4-yl]ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC(=O)C1CCN(CC1)CCOC2=NN(C=C2)C3=CC(=C(C=C3)Cl)Cl
3445;341102484;0.0072;1062228;194180342;76331926;10280;239649010;Confirmatory;20220830;0;0;Active;Q99720;Kd;=;ChEMBL;Displacement of [125I]N-IAC44 from sigma 1 receptor (unknown origin);N-[2-(4-azido-3-(125I)iodanylphenyl)ethyl]-3-phenyl-N-propylpropan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN(CCCC1=CC=CC=C1)CCC2=CC(=C(C=C2)N=[N+]=[N-])[125I]
3446;345680796;0.0072;1174258;312374347;118724303;10280;254622400;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor in human Jurkat cell membranes incubated for 2 hrs by liquid scintillation counting;N-methyl-N-(2-phenylethyl)-3-(1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl)propan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1CCC2=C(C1)NC3=CC=CC=C23)CCC4=CC=CC=C4
3447;355637714;0.0072;1308619;336905310;127051268;10280;271565650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-Pentazocine from sigma 1 receptor in human RPMI8226 cell membranes;(1R,4S,7R)-2-(cyclohexylmethyl)-5-(naphthalen-1-ylmethyl)-2,5-diazabicyclo[2.2.2]octan-7-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;C1CCC(CC1)CN2C[C@@H]3C[C@H]([C@H]2CN3CC4=CC=CC5=CC=CC=C54)O
3448;366431547;0.0072;1592018;440190959;155554079;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;1-(5-Chloropyridin-2-yl)-4-[3-(4-fluorophenyl)sulfanylpropyl]-1,4-diazepane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=NC=C(C=C2)Cl)CCCSC3=CC=C(C=C3)F
3449;100366979;0.00724;226337;103376317;11143323;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-[1-(3,4-Dichloro-benzyl)-piperidin-4-yl]-2-phenyl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC(=C(C=C3)Cl)Cl
3450;366431548;0.007244;1592018;440190959;155554079;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;1-(5-Chloropyridin-2-yl)-4-[3-(4-fluorophenyl)sulfanylpropyl]-1,4-diazepane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=NC=C(C=C2)Cl)CCCSC3=CC=C(C=C3)F
3451;100387740;0.00727;204145;103388787;11001837;10280;123830180;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine from Sigma opioid receptor type 1 of guinea pig brain;2-(1'-benzylspiro[1H-2-benzofuran-3,4'-piperidine]-1-yl)ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3C(O2)CCO)CC4=CC=CC=C4
3452;100546188;0.00728;203685;103278467;10738339;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-benzylpiperidin-4-yl)-2-(2,6-dichlorophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=C(C=CC=C2Cl)Cl)CC3=CC=CC=C3
3453;363958029;0.0073;1500193;404664142;118607453;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-4-butylbenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCC1=CC=C(C=C1)C(=O)NCCCN(C)CC2=CC=CC=C2
3454;366423848;0.0073;1587567;440203023;155553997;10280;309390140;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from sigma 1 receptor in human RPMI8226 cell membranes incubated for 2 hrs under shaking by scintillation counting analysis;N-(cyclohexylmethyl)-3-methoxy-N-methylspiro[3,4-dihydroisochromene-1,4'-cyclohexane]-1'-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CC1CCCCC1)C2CCC3(CC2)C4=CC=CC=C4CC(O3)OC
3455;402102399;0.0073;1796671;384224349;118607453;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-4-butylbenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCC1=CC=C(C=C1)C(=O)NCCCN(C)CC2=CC=CC=C2
3456;100546612;0.00732;203685;103278634;10689336;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;2-Benzo[1,3]dioxol-5-yl-N-(1-benzyl-piperidin-4-yl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC3=C(C=C2)OCO3)CC4=CC=CC=C4
3457;100386143;0.00733;204153;103378365;11822555;10280;117841480;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma opioid receptor type 1 affinity in guinea pig brain by employing [3H](+)-pentazocine as radioligand.;1'-Benzylspiro[isobenzofuran-1(3H),4'-piperidine]-3-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3C(O2)O)CC4=CC=CC=C4
3458;100387471;0.00733;204145;103378365;11822555;10280;123830180;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine from Sigma opioid receptor type 1 of guinea pig brain;1'-Benzylspiro[isobenzofuran-1(3H),4'-piperidine]-3-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3C(O2)O)CC4=CC=CC=C4
3459;100478426;0.0074;203696;103186063;10264983;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;((S)-1-Methyl-2-phenyl-ethyl)-(4-phenyl-butyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](CC1=CC=CC=C1)NCCCCC2=CC=CC=C2
3460;100536564;0.0074;204457;103673576;45262110;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(3,5-Diethyl-2-fluorophenyl)-1-(3-ethylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)NC(=NC2=CC(=CC(=C2F)CC)CC)N.Cl
3461;100543225;0.0074;203699;103218327;10852782;10280;95728830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to sigma-1 sites in guinea pig brain membranes;(1R,9S,13S)-1,13-dimethyl-10-(2-pyrrolidin-1-ylethyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2CCN4CCCC4)C)C=C(C=C3)O
3462;100627298;0.0074;229194;103186122;10376919;10280;13101140;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+) -3PPP from sigma receptor in guinea pig brain membranes;Methyl-phenethyl-(2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC=CC=C1)CCN2CCCC2
3463;100617252;0.0075;204444;103336917;2845594;10280;16627250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membranes using [3H]DTG as radioligand;1-Phenethyl-4-[3-(trifluoromethyl)phenyl]piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCC2=CC=CC=C2)C3=CC=CC(=C3)C(F)(F)F
3464;342811244;0.0075;1129882;242620290;90655530;10280;246178360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human RPMI8226 cell membranes after 120 mins by scintillation counting analysis;2-[(2R)-4-(cyclohexylmethyl)-1-(naphthalen-1-ylmethyl)piperazin-2-yl]ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;C1CCC(CC1)CN2CCN([C@@H](C2)CCO)CC3=CC=CC4=CC=CC=C43
3465;372400436;0.0075;1744234;461562359;162676630;10280;333727820;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane incubated for 2 hr by liquid scintillation counting method;5-(4-Tert-butylphenyl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;CC(C)(C)C1=CC=C(C=C1)C2=NC(=NN2C)CN3CCCC3
3466;388740096;0.0075;1797293;386051278;118282831;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 34;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC=C(C=C1)F)N2CC3=CC(=C(C=C3C2)OC)OC
3467;388878694;0.0075;1797475;386051278;118282831;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 34;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC=C(C=C1)F)N2CC3=CC(=C(C=C3C2)OC)OC
3468;389383365;0.0075;1804286;386051278;118282831;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 34;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC=C(C=C1)F)N2CC3=CC(=C(C=C3C2)OC)OC
3469;407906241;0.0075;1922177;494410530;171352041;10280;362020630;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) expressed in human RPMI-8226 cells;2-[(2R)-4-ethyl-1-(naphthalen-1-ylmethyl)piperazin-2-yl]ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CCN([C@@H](C1)CCO)CC2=CC=CC3=CC=CC=C32
3470;100628009;0.007586;204453;103677409;19093638;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;3-Butyl-1,2,3,4,5,6-hexahydro-benz[f]isoquinoline hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCCN1CCC2=C(C1)CCC3=CC=CC=C32.Cl
3471;354638246;0.00759;1276983;103252465;12259685;10280;267172070;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of 5-(Dimethylamino)-2-{6-[(5-(4-(4-methylpiperidin-1-yl)butyl)naphthalen-2-yl)oxy]hexyl}isoindole-1,3-dione from sigma 1 receptor (unknown origin) expressed in MCF7 cells after 45 mins by flow cytometry in presence of 2-(3-(6,7-dimethoxy-3,4;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
3472;100559070;0.0076;203684;103389303;10546938;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;1-[4-(3-Phenylpropyl)piperazine-1-yl]-2-(3-nitrophenyl)ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)C(=O)CC3=CC(=CC=C3)[N+](=O)[O-]
3473;100702225;0.0076;204766;103417548;409922;10280;126395730;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards Sigma-1 receptor;1-Benzyl-4-(2,4-dichlorobenzyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2=CC=CC=C2)CC3=C(C=C(C=C3)Cl)Cl
3474;100546608;0.00763;203685;103278066;10617417;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-Benzyl-piperidin-4-yl)-2-(3,5-difluoro-phenyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC(=CC(=C2)F)F)CC3=CC=CC=C3
3475;100507188;0.0077;204150;103345300;10564492;10280;87844550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from Sigma opioid receptor type 1 in guinea pig brain membrane;Methyl-[2-(2-nitro-phenyl)-ethyl]-(2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCC1=CC=CC=C1[N+](=O)[O-])CCN2CCCC2
3476;100613261;0.0077;204440;103282211;14771702;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]-DTG in guinea pig brain membrane homogenates;N-Bicyclo[2.2.1]hept-2-yl-N''-o-tolyl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC2CC3CCC2C3)N
3477;100333036;0.007762;204944;103278334;10761018;10280;108823620;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was performed using [3H](+)-pentazocine to label sigma-1 binding sites, in guinea pig cerebral cortex;2-(1-Adamantylmethyl)-1-(5-piperidin-1-ylpentyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CCN(CC1)CCCCCNC(=NCC23CC4CC(C2)CC(C4)C3)N
3478;106041562;0.007762;444005;103167216;3559;10280;200672710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from sigma1 receptor in human Jurkat cell membrane;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3479;100438236;0.00778;204445;103321333;3036027;10280;14477350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor using [3H](+)-pentazocine in guinea pig brain homogenates;[2-(3,4-Dichloro-phenyl)-ethyl]-methyl-(2-pyrrolidin-1-yl-cyclohexyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCC1=CC(=C(C=C1)Cl)Cl)[C@H]2CCCC[C@H]2N3CCCC3
3480;112788092;0.0078;204633;103385149;10713756;10280;74907270;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to inhibit [3H](+)-pentazocine binding to guinea pig brain Sigma receptor type 1;(8E)-5-(3-hydroxyphenyl)-8-[(4-methoxyphenyl)methylidene]-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1/C(=C\C3=CC=C(C=C3)OC)/C(=O)C2)C4=CC(=CC=C4)O
3481;388740414;0.0078;1797293;386051284;118282964;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 40;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(C)C)OC(C)C)N2CC3=CC4=C(C=C3C2)OCO4
3482;388879257;0.0078;1797475;386051284;118282964;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 40;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(C)C)OC(C)C)N2CC3=CC4=C(C=C3C2)OCO4
3483;389383745;0.0078;1804286;386051284;118282964;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 40;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(C)C)OC(C)C)N2CC3=CC4=C(C=C3C2)OCO4
3484;389712931;0.0078;1919146;476002745;166637128;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assay from US Patent US11535596: 'Analogs of dextromethorphan with balanced receptor activities';N-[[6-(difluoromethoxy)-2,3,4,10a-tetrahydro-1H-phenanthren-4a-yl]methyl]-N-methylprop-2-en-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CC=C)CC12CCCCC1C=CC3=C2C=C(C=C3)OC(F)F
3485;100295633;0.0079;239200;103442151;11245709;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;2-(4-Benzyl-piperidin-1-ylmethyl)-chroman-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3CC(=O)C4=CC=CC=C4O3
3486;100558847;0.0079;203684;103389274;10522997;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;1-[4-(3-Phenylpropyl)piperazine-1-yl]-2-(2-nitrophenyl)ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)C(=O)CC3=CC=CC=C3[N+](=O)[O-]
3487;100622101;0.0079;203998;103240389;15061905;10280;16481390;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]DTG binding to Sigma opioid receptor;7-(3-Phenylpropylamino)-6,7,8,9-tetrahydro-5H-benzocycloheptene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2=CC=CC=C2CCC1NCCCC3=CC=CC=C3
3488;112788094;0.0079;204633;103385723;10713754;10280;74907270;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to inhibit [3H](+)-pentazocine binding to guinea pig brain Sigma receptor type 1;(8E)-5-(3-hydroxyphenyl)-8-[(3-methoxyphenyl)methylidene]-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1/C(=C\C3=CC(=CC=C3)OC)/C(=O)C2)C4=CC(=CC=C4)O
3489;388740108;0.0079;1797293;386051271;118282827;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 26;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)C)N2CC3=C(C2)C(=CC=C3)F
3490;388878828;0.0079;1797475;386051271;118282827;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 26;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)C)N2CC3=C(C2)C(=CC=C3)F
3491;389383361;0.0079;1804286;386051271;118282827;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 26;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)C)N2CC3=C(C2)C(=CC=C3)F
3492;365267545;0.007943;1512456;440228796;149396365;10280;316202300;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-3a-methyl-7-phenylmethoxy-2,3,4,9b-tetrahydro-1H-chromeno[3,4-b]pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@]12COC3=C([C@@H]1CCN2)C=CC(=C3)OCC4=CC=CC=C4
3493;380773035;0.007943;1907474;482051358;168272172;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;Benzyl 2-[3-(4-cyclopentylpiperazin-1-yl)phenyl]piperidine-1-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)N2CCN(CC2)C3=CC=CC(=C3)C4CCCCN4C(=O)OCC5=CC=CC=C5
3494;100297839;0.008;239347;103249489;1548953;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;Clomiphene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CC)CCOC1=CC=C(C=C1)/C(=C(\C2=CC=CC=C2)/Cl)/C3=CC=CC=C3
3495;100297847;0.008;239347;103458476;6536;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;Triparanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CC)CCOC1=CC=C(C=C1)C(CC2=CC=C(C=C2)Cl)(C3=CC=C(C=C3)C)O
3496;100320724;0.008;204154;103362119;10545203;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;[1-(4-Methoxy-3-phenethyloxy-benzyl)-propyl]-propyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCNC(CC)CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2
3497;100441639;0.008;229186;103167216;3559;10280;14696970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of specific binding of [125I]-PIPAG to sigma binding site in Guinea pig brain membranes;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3498;100456540;0.008;229183;103360143;14970526;10280;79028690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor in bovine cerebellum using 2.0 nM [3H]haloperidol in the presence of 25 nM unlabeled spiperone;1-Phenyl-3-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)-propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CN(CC=C1C2=CC=CC=C2)CCC(=O)C3=CC=CC=C3
3499;100468425;0.008;203697;103329968;398588;10280;82952200;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma 1 receptor was determined in guinea pig brain membrane using [3H](+)-pentazocine as radioligand;Tetrahydro-1-[2-[methyl[3-[methyl(3,4-dichlorobenzyl)amino]propyl]amino]ethyl]-1H-pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCCN(C)CC1=CC(=C(C=C1)Cl)Cl)CCN2CCCC2
3500;100471360;0.008;204459;103282235;10378304;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;Guanidine, N,N'-bis(3-ethylphenyl)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)NC(=NC2=CC=CC(=C2)CC)N
3501;100475275;0.008;204462;103351527;44347697;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;"2-[1-[(4-methylphenyl)methyl]piperidin-4-yl]-3,4-dihydro-2H-naphthalen-1-one;hydrate";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=C(C=C1)CN2CCC(CC2)C3CCC4=CC=CC=C4C3=O.O
3502;100536694;0.008;204457;103673666;45262177;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"1-(3,5-Diethylphenyl)-2-(3-ethylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N=C(N)NC2=CC(=CC(=C2)CC)CC.Cl
3503;100613856;0.008;203986;103283304;14771696;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N-(Adamantan-1-yl)-N'-(2-methylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC23CC4CC(C2)CC(C4)C3)N
3504;100617160;0.008;203985;103283304;14771696;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N-(Adamantan-1-yl)-N'-(2-methylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC23CC4CC(C2)CC(C4)C3)N
3505;100617161;0.008;203985;103671885;14771739;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;Adamantan-1-yl-N'-cyclohexylguanidine HCl;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)N=C(N)NC23CC4CC(C2)CC(C4)C3.Cl
3506;100622179;0.008;203982;103241150;15065451;10280;16481400;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H]DTG from sigma opioid receptor of homogenized guinea pig whole brain;1-(1-Adamantyl)-3-(2-fluorophenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C2CC3CC1CC(C2)(C3)N=C(N)NC4=CC=CC=C4F
3507;100622190;0.008;203982;103241112;15065456;10280;16481400;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H]DTG from sigma opioid receptor of homogenized guinea pig whole brain;1-(1-Adamantyl)-3-(3-iodophenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C2CC3CC1CC(C2)(C3)N=C(N)NC4=CC(=CC=C4)I
3508;100680638;0.008;204130;103178692;17867053;10280;119345760;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity for Sigma opioid receptor by displacement of [3H]DTG;6-{2-[4-(2,4-Dichloro-benzyl)-piperazin-1-yl]-ethyl}-3-methyl-3H-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C=C(C=C2)CCN3CCN(CC3)CC4=C(C=C(C=C4)Cl)Cl)SC1=O
3509;100746451;0.008;204018;103278285;44315815;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor using [3H](+)-SKF-10047 as radioligand;1-Naphthalen-1-ylmethyl-4-((E)-3-phenyl-allyloxymethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1COC/C=C/C2=CC=CC=C2)CC3=CC=CC4=CC=CC=C43
3510;100746459;0.008;204018;103277594;44315536;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor using [3H](+)-SKF-10047 as radioligand;1-((E)-But-2-enyl)-4-((E)-3-phenyl-allyloxymethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C/C=C/CN1CCC(CC1)COC/C=C/C2=CC=CC=C2
3511;100746550;0.008;204019;103335996;44340941;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-SKF-10047 binding to sigma receptor;"N-(1-benzylpiperidin-4-yl)-3-phenylprop-2-ynamide;(E)-but-2-enedioic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)C#CC2=CC=CC=C2)CC3=CC=CC=C3.C(=C/C(=O)O)\C(=O)O
3512;345680787;0.008;1174258;312374355;118724311;10280;254622400;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor in human Jurkat cell membranes incubated for 2 hrs by liquid scintillation counting;2-[3-(1,3-Dihydroisoindol-2-yl)propyl]-1,3,4,9-tetrahydropyrido[3,4-b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CC2=C1C3=CC=CC=C3N2)CCCN4CC5=CC=CC=C5C4
3513;366366196;0.008;1558961;440172505;118562440;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;9-[2-(3-Fluorophenyl)ethyl]-2-methyl-4-phenyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC(=CC=C3)F)C4=CC=CC=C4
3514;366366202;0.008;1558961;440176589;118562384;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;9-[2-(2-Fluorophenyl)ethyl]-2-methyl-4-phenyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3F)C4=CC=CC=C4
3515;366366653;0.008;1558961;440128004;118567608;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;4-(2-Chlorophenyl)-2-methyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=CC=CC=C4Cl
3516;366366661;0.008;1558961;440178209;118567743;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;CID 118567743;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=CC=CC(=N4)C(F)(F)F
3517;372338888;0.008;1718132;461515217;162643475;10280;331115250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin);(1S,6R)-9-methoxy-17-methylidene-14-azatetracyclo[12.4.0.01,6.07,12]octadeca-7(12),8,10-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(CN3CCC(=C)C[C@@]34[C@@H]2CCCC4)C=C1
3518;380264147;0.008;1811100;475985954;126539477;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[1-(4-benzylpiperazin-1-yl)cyclopropyl]methyl]-N-[6-(trifluoromethyl)pyridin-2-yl]propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CC1)N2CCN(CC2)CC3=CC=CC=C3)C4=CC=CC(=N4)C(F)(F)F
3519;380264149;0.008;1811100;475995163;137371461;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-benzyl-N-[[1-(4-benzylpiperazin-1-yl)cyclopropyl]methyl]propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1=CC=CC=C1)CC2(CC2)N3CCN(CC3)CC4=CC=CC=C4
3520;380773036;0.008;1907474;482051358;168272172;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;Benzyl 2-[3-(4-cyclopentylpiperazin-1-yl)phenyl]piperidine-1-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)N2CCN(CC2)C3=CC=CC(=C3)C4CCCCN4C(=O)OCC5=CC=CC=C5
3521;407996333;0.0081;1946583;482047341;168269421;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;6-chloro-2-[[4-[(3,4-difluorophenyl)methoxy]piperidin-1-yl]methyl]-1H-indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=C(C=C2)F)F)CC3=CC4=C(N3)C=C(C=C4)Cl
3522;407996334;0.008128;1946583;482047341;168269421;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;6-chloro-2-[[4-[(3,4-difluorophenyl)methoxy]piperidin-1-yl]methyl]-1H-indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=C(C=C2)F)F)CC3=CC4=C(N3)C=C(C=C4)Cl
3523;100559067;0.0082;203684;103389978;401826;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;1,4-Bis-[2-(4-methoxy-phenyl)-ethyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)CCN2CCN(CC2)CCC3=CC=C(C=C3)OC
3524;326034769;0.0082;701162;163314042;11624298;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;4-[2-[1-(3,4-Dichlorophenyl)pyrazol-3-yl]oxyethyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1COCCN1CCOC2=NN(C=C2)C3=CC(=C(C=C3)Cl)Cl
3525;326035170;0.0082;701162;163324309;11501613;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;4-[1-(3,4-dichlorophenyl)pyrazol-3-yl]oxy-N-(2-methoxyethyl)-N-methylbutan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CN(CCCCOC1=NN(C=C1)C2=CC(=C(C=C2)Cl)Cl)CCOC
3526;100367083;0.00822;226337;103375736;9840310;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-[1-(3-Fluoro-benzyl)-piperidin-4-yl]-2-phenyl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC(=CC=C3)F
3527;354638024;0.00824;1276981;103252465;12259685;10280;267172070;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of 5-(Dimethylamino)-2-(6-((5-(4-(4-methylpiperidin-1-yl)butyl)-5,6,7,8-tetrahydronaphthalen-2-yl)oxy)hexyl)isoindoline-1,3-dione from sigma 1 receptor (unknown origin) expressed in MCF7 after 45 mins by flow cytometry in presence of 2-(3-(6,;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
3528;100614739;0.0083;203986;103282235;10378304;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;Guanidine, N,N'-bis(3-ethylphenyl)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)NC(=NC2=CC=CC(=C2)CC)N
3529;100622170;0.0083;204000;103240492;44298009;10280;16481390;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Opioid activity in terms of inhibition of [3H]dihydromorphine binding to opioid receptor mu in rat brain membrane.;N-[1-Methyl-2-(4-iodophenyl)ethyl]-3-phenylpropan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC(CC1=CC=C(C=C1)I)NCCCC2=CC=CC=C2
3530;407996513;0.0083;1946583;482049009;168270563;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;6-[[4-[(3,4-difluorophenyl)methoxy]piperidin-1-yl]methyl]-1H-benzimidazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=C(C=C2)F)F)CC3=CC4=C(C=C3)N=CN4
3531;407996465;0.008318;1946583;482065857;168282745;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;6-[[4-[(4-chloro-3-fluorophenyl)methoxy]piperidin-1-yl]methyl]-1H-benzimidazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=C(C=C2)Cl)F)CC3=CC4=C(C=C3)N=CN4
3532;100746108;0.0084;204298;103264865;44309298;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma opioid receptor type 2 in guinea pig brain homogenate with 4 nM [3H]-(+)-DTG;5,5-Diphenyl-3-[4-(4-phenyl-piperidin-1-yl)-butyl]-imidazolidine-2,4-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1C2=CC=CC=C2)CCCCN3C(=O)C(NC3=O)(C4=CC=CC=C4)C5=CC=CC=C5
3533;326035172;0.0084;701162;163317464;71451631;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-[2-[1-(3,4-Dichlorophenyl)-5-methylpyrazol-3-yl]oxyethyl]-4-methylpiperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1CCN(CC1)CCOC2=NN(C(=C2)C)C3=CC(=C(C=C3)Cl)Cl
3534;345680784;0.0084;1174258;312374356;118724312;10280;254622400;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor in human Jurkat cell membranes incubated for 2 hrs by liquid scintillation counting;2-[3-(1,3-Dihydroisoindol-2-yl)propyl]-1-phenyl-1,3,4,9-tetrahydropyrido[3,4-b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(C(C2=C1C3=CC=CC=C3N2)C4=CC=CC=C4)CCCN5CC6=CC=CC=C6C5
3535;363860760;0.0084;1467149;381886846;137661600;10280;284950850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of (+)-[3H]-pentazocine from recombinant human sigma 1 receptor expressed in baculovirus infected Sf9 insect cell membranes after 90 mins by scintillation counting method;4-[3-(4-Tert-butylphenyl)propyl]-2,6-dimethylmorpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CN(CC(O1)C)CCCC2=CC=C(C=C2)C(C)(C)C
3536;100513216;0.0085;229197;103384627;10831724;10280;89413830;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor using radioligand ([3H](+)-pentazocine) binding assay;(2S,5R)-2,5-Dimethyl-1,4-bis-(3-phenyl-propyl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN([C@H](CN1CCCC2=CC=CC=C2)C)CCCC3=CC=CC=C3
3537;100513230;0.0085;229200;103383655;44361659;10280;89413830;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor using radioligand ([3H](+)-pentazocine) binding assay;trans-1-(3-Phenylpropyl)-2,5-dimethylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1CN[C@@H](CN1CCCC2=CC=CC=C2)C
3538;100533893;0.0085;204794;103359565;44350886;10280;93971710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was done in guinea pig membranes by labeling the binding site with [3H](+)-pentazocine;(alphaR)-alpha-(4-Bromobenzyl)spiro[indan-1,4'-piperidine]-1'-ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCN(CC2)C[C@@H](CC3=CC=C(C=C3)Br)O)C4=CC=CC=C41
3539;326034770;0.0085;701162;163317466;71451633;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;N-[2-[1-(3,4-dichlorophenyl)-5-methylpyrazol-3-yl]oxyethyl]cyclohexanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)OCCNC3CCCCC3
3540;255030879;0.008575;625223;103197648;3372;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fluphenazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO
3541;100478319;0.0086;203696;103186062;44273356;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;((R)-1-Methyl-2-phenyl-ethyl)-(3-naphthalen-1-yl-propyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CC1=CC=CC=C1)NCCCC2=CC=CC3=CC=CC=C32
3542;100513227;0.0086;229200;103383785;10503374;10280;89413830;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor using radioligand ([3H](+)-pentazocine) binding assay;(2S,5R)-1-(2-Benzhydryloxy-ethyl)-2,5-dimethyl-4-(3-phenyl-propyl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1CN([C@@H](CN1CCOC(C2=CC=CC=C2)C3=CC=CC=C3)C)CCCC4=CC=CC=C4
3543;326035168;0.0086;701162;163317460;71451628;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-[2-[1-(3,4-Dichlorophenyl)pyrazol-3-yl]oxyethyl]-4-methylpiperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1CCN(CC1)CCOC2=NN(C=C2)C3=CC(=C(C=C3)Cl)Cl
3544;100605300;0.00866;203995;103735197;14771452;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity of compound to Sigma opioid receptor labelled with [3H](+)-3-PPP;N-Methyl-N-[(1S)-2alpha-(1-pyrrolidinyl)cyclohexan-1alpha-yl]naphthalene-2-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@H]1CCCC[C@H]1N2CCCC2)C(=O)CC3=CC4=CC=CC=C4C=C3
3545;100546186;0.0087;203685;103278065;11793930;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-Benzyl-piperidin-4-yl)-2-(2-trifluoromethyl-phenyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CC=C2C(F)(F)F)CC3=CC=CC=C3
3546;407996157;0.0087;1946583;482077888;168291477;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(3S)-1-[(3-fluoro-4-methoxyphenyl)methyl]-3-[(2-methylphenyl)methoxy]piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1CO[C@H]2CCCN(C2)CC3=CC(=C(C=C3)OC)F
3547;100627998;0.00871;204453;103671319;45260465;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"(4aR,10bR)-3-[(4-nitrophenyl)methyl]-2,4,4a,5,6,10b-hexahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC2=CC=CC=C2[C@H]3[C@@H]1CN(CC3)CC4=CC=C(C=C4)[N+](=O)[O-].Cl
3548;407996158;0.00871;1946583;482077888;168291477;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(3S)-1-[(3-fluoro-4-methoxyphenyl)methyl]-3-[(2-methylphenyl)methoxy]piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1CO[C@H]2CCCN(C2)CC3=CC(=C(C=C3)OC)F
3549;407996412;0.00871;1946583;482063462;168280974;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(3R)-1-[(3-fluoro-4-methoxyphenyl)methyl]-3-[(4-fluoro-3-methylphenyl)methoxy]piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC(=C1)CO[C@@H]2CCCN(C2)CC3=CC(=C(C=C3)OC)F)F
3550;255014868;0.008714;625223;103170100;2733526;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tamoxifen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3
3551;100478430;0.0088;203696;103186016;5221975;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;[1-Methyl-2-(3-trifluoromethyl-phenyl)-ethyl]-(3-phenyl-propyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(CC1=CC(=CC=C1)C(F)(F)F)NCCCC2=CC=CC=C2
3552;100622099;0.0088;203998;103184731;15061898;10280;16481390;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]DTG binding to Sigma opioid receptor;N-[1-Methyl-2-(4-bromophenyl)ethyl]-3-phenylpropan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(CC1=CC=C(C=C1)Br)NCCCC2=CC=CC=C2
3553;340018569;0.0088;751647;103167216;3559;10280;234030820;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]Haloperidol from sigma 1 receptor in human jurkat cells after 4 hrs;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3554;407996411;0.0088;1946583;482063462;168280974;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(3R)-1-[(3-fluoro-4-methoxyphenyl)methyl]-3-[(4-fluoro-3-methylphenyl)methoxy]piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC(=C1)CO[C@@H]2CCCN(C2)CC3=CC(=C(C=C3)OC)F)F
3555;100451377;0.0089;204435;103677634;45264688;10280;81026510;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using the novel [3H]-(+/-)-4 as radioligand;"N-methyl-4-phenyl-N-prop-2-enyl-1,2,3,4-tetrahydronaphthalen-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CN(CC=C)C1CC(C2=CC=CC=C2C1)C3=CC=CC=C3.Cl
3556;100458983;0.0089;229212;103401055;10085970;10280;84969360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was evaluated against sigma-1 binding site in guinea pig, using [3H]- -(+)- Pentazocine;N-Methyl-N-[2-(1-pyrrolidinyl)ethyl]-3-bromobenzylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCN1CCCC1)CC2=CC(=CC=C2)Br
3557;326034949;0.0089;701162;163314038;71449822;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-[2-[1-(3,4-Dichlorophenyl)pyrazol-3-yl]oxyethyl]azepane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCCN(CC1)CCOC2=NN(C=C2)C3=CC(=C(C=C3)Cl)Cl
3558;100387741;0.00895;204145;103389480;10948128;10280;123830180;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine from Sigma opioid receptor type 1 of guinea pig brain;Ethyl 1''-benzylspiro[1,3-dihydroisobenzofuran-1,4''-(hexahydropyridine)]-3-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC(=O)C1C2=CC=CC=C2C3(O1)CCN(CC3)CC4=CC=CC=C4
3559;100319789;0.009;204154;103361690;10668517;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;[1-(4-Methoxy-3-phenethyloxy-benzyl)-heptyl]-propyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)NCCC
3560;100451650;0.009;204435;160708254;70697540;10280;81026510;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using the novel [3H]-(+/-)-4 as radioligand;"(2S,4R)-N,N,2-trimethyl-4-phenyl-3,4-dihydro-1H-naphthalen-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C[C@@]1(C[C@@H](C2=CC=CC=C2C1)C3=CC=CC=C3)N(C)C.Cl
3561;100475266;0.009;204462;103673138;45261787;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;"6-chloro-2-[1-(2-phenylethyl)piperidin-4-yl]-3,4-dihydro-2H-naphthalen-1-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2=C(C=CC(=C2)Cl)C(=O)C1C3CCN(CC3)CCC4=CC=CC=C4.Cl
3562;100475277;0.009;204462;103351565;10382446;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;6-Fluoro-2-[1-benzyl-4-piperidinyl]-3,4-dihydronaphthalen-1(2H)-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2=C(C=CC(=C2)F)C(=O)C1C3CCN(CC3)CC4=CC=CC=C4
3563;100622186;0.009;203982;103240978;15065453;10280;16481400;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H]DTG from sigma opioid receptor of homogenized guinea pig whole brain;1-(1-Adamantyl)-3-(4-fluorophenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C2CC3CC1CC(C2)(C3)N=C(N)NC4=CC=C(C=C4)F
3564;100680627;0.009;204130;103178797;24835442;10280;119345760;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity for Sigma opioid receptor by displacement of [3H]DTG;6-{4-[4-(2,4-Dichloro-benzyl)-piperazin-1-yl]-butyl}-3-methyl-3H-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C=C(C=C2)CCCCN3CCN(CC3)CC4=C(C=C(C=C4)Cl)Cl)SC1=O
3565;100740709;0.009;203987;103671554;45260627;10280;;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was evaluated for binding affinity against sigma opioid receptor using [3H]DTG radioligand in guinea pig membranes;"N'-cyclohexyl-N-(2-methylphenyl)ethanimidamide;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2CCCCC2)C.Cl
3566;100740711;0.009;203987;103260355;44307427;10280;;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was evaluated for binding affinity against sigma opioid receptor using [3H]DTG radioligand in guinea pig membranes;N-Bicyclo[2.2.1]hept-2-yl-N''-o-tolyl-acetamidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2CC3CCC2C3)C
3567;100742366;0.009;203992;103677392;45264523;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"2-[2-(Diethylamino)ethyl]-2-methyl-4-phenylfuran-3-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCN(CC)CCC1(C(=O)C(=CO1)C2=CC=CC=C2)C.Cl
3568;345602798;0.009;1200082;312389829;76683875;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;N-[2-(azepan-1-yl)ethyl]-1-[(3,4-dichlorophenyl)methyl]triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCCN(CC1)CCNC2=CN(N=N2)CC3=CC(=C(C=C3)Cl)Cl
3569;363665986;0.009;1415921;404717617;71223208;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;N-(1-(2-(azepan-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)pivalamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)C(=O)NC1=C2C=NN(C2=NC=N1)CCN3CCCCCC3
3570;363665992;0.009;1415921;404715638;71223267;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;N-(1-(2-(Azepan-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl) 1-adamantylcarboxamide hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCCN(CC1)CCN2C3=NC=NC(=C3C=N2)NC(=O)C45CC6CC(C4)CC(C6)C5
3571;363666198;0.009;1415921;404697134;71487770;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;1-(1-(2-(azepan-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-3-ethylthiourea;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCNC(=S)NC1=C2C=NN(C2=NC=N1)CCN3CCCCCC3
3572;366366388;0.009;1558961;440114038;118562538;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;12-Phenyl-8-(2-phenylethyl)-4-oxa-8,12-diazadispiro[2.1.55.33]tridecan-13-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CC12C(=O)N(CC3(O2)CCN(CC3)CCC4=CC=CC=C4)C5=CC=CC=C5
3573;366366992;0.009;1558961;440201833;118567742;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;CID 118567742;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=CN=C(C=C4)C(F)(F)F
3574;372306731;0.009;1701184;461559194;54673485;10280;332377850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;4-[4-[1-(3,4-Dichlorophenyl)-5-methylpyrazol-3-yl]butyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)CCCCN3CCOCC3
3575;372306732;0.009;1701184;461515342;54673644;10280;332377850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;1-[4-[3-[[1-(3,4-Dichlorophenyl)-5-methylpyrazol-3-yl]methoxy]propyl]piperazin-1-yl]ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)COCCCN3CCN(CC3)C(=O)C
3576;380512729;0.009;1846430;482069788;24862231;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-4-benzyl-10-(2-fluorophenyl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CC=CC=C3)OCC4=C(N=NN24)C5=CC=CC=C5F
3577;100367073;0.00903;226337;103376027;9889113;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-[1-(4-Iodo-benzyl)-piperidin-4-yl]-2-phenyl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC=C(C=C3)I
3578;100435167;0.00904;203682;103274518;44314013;10280;150841290;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity at opioid sigma-1 receptor in guinea pig brain membranes by (+)-[3H]pentazocine displacement.;1-Cyclohexyl-4-[3-(7-methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-propyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC2=C(CCCC2CCCN3CCN(CC3)C4CCCCC4)C=C1
3579;388740218;0.0091;1797293;386051281;118282962;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 37;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)C)N2CC3=C(C2)C=C(C=C3)F
3580;388878949;0.0091;1797475;386051281;118282962;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 37;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)C)N2CC3=C(C2)C=C(C=C3)F
3581;389383437;0.0091;1804286;386051281;118282962;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 37;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)C)N2CC3=C(C2)C=C(C=C3)F
3582;100449430;0.0092;204443;103275267;574780;10280;83608750;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine at sigma receptor in guinea pig brain membrane was determined;1-[2-(3,4-Dichlorophenyl)ethyl]-4-methylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN1CCN(CC1)CCC2=CC(=C(C=C2)Cl)Cl
3583;380550083;0.0092;1855147;103341547;10499156;10280;359393910;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) assessed as inhibition constant;(2R)-1-(3-Methoxyphenylsulfonyl)-2-[2-(4-methylpiperidino)ethyl]pyrrolidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)CC[C@H]2CCCN2S(=O)(=O)C3=CC=CC(=C3)OC
3584;100478467;0.0093;203696;103185251;15061888;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;(1-Methyl-2-naphthalen-1-yl-ethyl)-(3-phenyl-propyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(CC1=CC=CC2=CC=CC=C21)NCCCC3=CC=CC=C3
3585;100619102;0.0093;203990;103173517;14831233;10280;18482950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma opioid receptor in guinea pig cerebral homogenate using [3H]DTG as radioligand;4-Phenyl-N-(1-phenylpropan-2-yl)butan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(CC1=CC=CC=C1)NCCCCC2=CC=CC=C2
3586;100387746;0.00933;204145;103388702;11046757;10280;123830180;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine from Sigma opioid receptor type 1 of guinea pig brain;Ethyl 1'-benzylspiro[3,4-dihydroisochromene-1,4'-piperidine]-3-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC(=O)C1CC2=CC=CC=C2C3(O1)CCN(CC3)CC4=CC=CC=C4
3587;100292840;0.0094;239105;103442159;11349674;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;4-Benzyl-1-(7-methoxy-1,2,3,4-tetrahydro-naphthalen-2-ylmethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(CCC(C2)CN3CCC(CC3)CC4=CC=CC=C4)C=C1
3588;101829950;0.0094;255065;103468547;44403226;10280;161400090;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory activity against opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 degree C ;(10aS)-2-[6-[benzyl(methyl)amino]hexyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;CN(CCCCCCN1C(=O)[C@@H]2CC3=CC=CC=C3CN2C1=O)CC4=CC=CC=C4
3589;112788081;0.0094;204633;103328401;5478726;10280;74907270;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to inhibit [3H](+)-pentazocine binding to guinea pig brain Sigma receptor type 1;(8E)-8-benzylidene-5-(3-hydroxyphenyl)-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1/C(=C\C3=CC=CC=C3)/C(=O)C2)C4=CC(=CC=C4)O
3590;112851458;0.0094;204465;163336542;10449500;10280;79325400;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma receptor of guinea pig brain;(+)-1R,5R-(E)-8-Benzylidene-5-(3-hydroxyphenyl)-2-methylmorphan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@@]2(C[C@H]1/C(=C\C3=CC=CC=C3)/C(=O)C2)C4=CC(=CC=C4)O
3591;326034775;0.0094;701162;163317463;71451630;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-[2-[1-(3,4-Dichlorophenyl)-5-methylpyrazol-3-yl]oxyethyl]azepane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)OCCN3CCCCCC3
3592;326035324;0.0094;701162;163327761;11682186;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;4-[2-[1-(3,4-Dichlorophenyl)-4,5-dimethylpyrazol-3-yl]oxyethyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=C(N(N=C1OCCN2CCOCC2)C3=CC(=C(C=C3)Cl)Cl)C
3593;100319791;0.0095;204154;103362047;10787011;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;[1-(4-Methoxy-3-phenethyloxy-benzyl)-butyl]-dipropyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N(CCC)CCC
3594;100622167;0.0095;204000;103240506;15061885;10280;16481390;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Opioid activity in terms of inhibition of [3H]dihydromorphine binding to opioid receptor mu in rat brain membrane.;N-[1-Methyl-2-(4-methoxyphenyl)ethyl]-3-phenylpropan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC(CC1=CC=C(C=C1)OC)NCCCC2=CC=CC=C2
3595;326034947;0.0095;701162;163320917;24743572;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-(3,4-dichlorophenyl)-N-(2-piperidin-1-ylethyl)pyrazol-3-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)CCNC2=NN(C=C2)C3=CC(=C(C=C3)Cl)Cl
3596;100333029;0.00955;204944;103278477;10834172;10280;108823620;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was performed using [3H](+)-pentazocine to label sigma-1 binding sites, in guinea pig cerebral cortex;2-(1-Adamantylmethyl)-1-[5-(azocan-1-yl)pentyl]guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CCCN(CCC1)CCCCCNC(=NCC23CC4CC(C2)CC(C4)C3)N
3597;100627653;0.00955;204452;131283642;54585706;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-(furan-2-ylmethyl)spiro[2,3-dihydro-1H-naphthalene-4,4'-piperidine];hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC2=CC=CC=C2C3(C1)CCN(CC3)CC4=CC=CO4.Cl
3598;100478418;0.0096;203696;103185557;22024852;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;Benzyl-(4-phenyl-butyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)CCCCNCC2=CC=CC=C2
3599;100544894;0.0096;203699;103218326;10336644;10280;95728830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to sigma-1 sites in guinea pig brain membranes;(1R,9S,13S)-1,13-dimethyl-10-(2-piperidin-1-ylethyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2CCN4CCCCC4)C)C=C(C=C3)O
3600;101829961;0.0096;255065;103468495;44403198;10280;161400090;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory activity against opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 degree C ;(10aS)-2-[3-(benzylamino)propyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1[C@H]2C(=O)N(C(=O)N2CC3=CC=CC=C31)CCCNCC4=CC=CC=C4
3601;326034761;0.0096;701162;163338185;71462357;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-[3-[1-(3,4-Dichlorophenyl)pyrazol-3-yl]oxypropyl]piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)CCCOC2=NN(C=C2)C3=CC(=C(C=C3)Cl)Cl
3602;100546607;0.00966;203685;103277857;4827344;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-Benzyl-4-piperidinyl)-2-(2,4-dichlorophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=C(C=C(C=C2)Cl)Cl)CC3=CC=CC=C3
3603;100478468;0.0097;203696;103186018;15061897;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;N-[1-Methyl-2-(3-bromophenyl)ethyl]-3-phenylpropan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(CC1=CC(=CC=C1)Br)NCCCC2=CC=CC=C2
3604;100497239;0.0097;203984;103434562;44385319;10280;76997100;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;1-(2-Methoxy-phenyl)-4-[3-(4,5,6,7-tetrahydro-benzo[b]thiophen-7-yl)-propyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1N2CCN(CC2)CCCC3CCCC4=C3SC=C4
3605;100546837;0.00984;203685;103278541;10762065;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-Benzylpiperidine-4-yl)-2-[4-(trifluoromethyl)phenyl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=C(C=C2)C(F)(F)F)CC3=CC=CC=C3
3606;100295622;0.0099;239200;103442123;11372576;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;4-Benzyl-1-(5-methoxy-1,2,3,4-tetrahydro-naphthalen-2-ylmethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCC(C2)CN3CCC(CC3)CC4=CC=CC=C4
3607;101829953;0.0099;255065;103468532;44403216;10280;161400090;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory activity against opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 degree C ;(10aS)-2-[4-[methyl(2-phenylethyl)amino]butyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;CN(CCCCN1C(=O)[C@@H]2CC3=CC=CC=C3CN2C1=O)CCC4=CC=CC=C4
3608;326034616;0.0099;701162;163314020;11594918;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;5-Methyl-1-naphthalen-2-yl-3-(2-pyrrolidin-1-ylethoxy)pyrazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)OCCN4CCCC4
3609;326034619;0.0099;701162;163320937;11602582;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;2-[1-(3,4-dichlorophenyl)-5-methylpyrazol-3-yl]oxy-N,N-diethylethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCN(CC)CCOC1=NN(C(=C1)C)C2=CC(=C(C=C2)Cl)Cl
3610;326035167;0.0099;701162;163317441;11567446;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-[4-[1-(3,4-Dichlorophenyl)-5-methylpyrazol-3-yl]oxybutyl]-4-methylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)OCCCCN3CCN(CC3)C
3611;372400668;0.0099;1744234;461561353;150285231;10280;333727820;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane incubated for 2 hr by liquid scintillation counting method;1-Methyl-3-(pyrrolidin-1-ylmethyl)-5-[4-[1-(trifluoromethyl)cyclopropyl]phenyl]-1,2,4-triazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;CN1C(=NC(=N1)CN2CCCC2)C3=CC=C(C=C3)C4(CC4)C(F)(F)F
3612;100319799;0.01;204154;103673246;45261862;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;"1-[4-methoxy-3-(2-phenylethoxy)phenyl]-N-propylpropan-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCNC(C)CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2.Cl
3613;100455785;0.01;229184;103225404;121968;10280;79028690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor in bovine cerebellum using 2.0 nM [3H]- haloperidol;DUP-734 free base;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC1CN2CCC(CC2)CC(=O)C3=CC=C(C=C3)F
3614;100455786;0.01;229184;103360142;9795762;10280;79028690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor in bovine cerebellum using 2.0 nM [3H]- haloperidol;4-[2-[1-(Cyclopropylmethyl)piperidin-4-yl]acetyl]benzonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC1CN2CCC(CC2)CC(=O)C3=CC=C(C=C3)C#N
3615;100475258;0.01;204462;103673099;121967;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;Ethanone, 2-(1-(cyclopropylmethyl)-4-piperidinyl)-1-(4-fluorophenyl)-, hydrobromide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC1CN2CCC(CC2)CC(=O)C3=CC=C(C=C3)F.Br
3616;100475274;0.01;204462;103678053;45265021;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;"2-[1-(2-phenylethyl)piperidin-4-yl]-3,4-dihydro-2H-naphthalen-1-one;hydrobromide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2=CC=CC=C2C(=O)C1C3CCN(CC3)CCC4=CC=CC=C4.Br
3617;100524440;0.01;204626;103225509;11777930;10280;91718750;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Receptor binding affinity against Sigma receptor;4-(1-Cyclopropylmethyl-piperidin-4-ylmethoxy)-benzonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC1CN2CCC(CC2)COC3=CC=C(C=C3)C#N
3618;100622183;0.01;203982;103241222;14895995;10280;16481400;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H]DTG from sigma opioid receptor of homogenized guinea pig whole brain;1-(1-Adamantyl)-3-(4-methoxyphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC=C(C=C1)NC(=NC23CC4CC(C2)CC(C4)C3)N
3619;100742339;0.01;204020;103677544;45264632;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor using [3H]-(+)-SKF- 10,047;"2-Phenyl-9-(2-phenylethyl)-1-oxa-9-azaspiro[5.5]undec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12CC(=O)C=C(O2)C3=CC=CC=C3)CCC4=CC=CC=C4.Cl
3620;100746115;0.01;204147;103264865;44309298;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma opioid receptor type 1 in guinea pig brain homogenate with 0.5 nM [3H](+)-PENT;5,5-Diphenyl-3-[4-(4-phenyl-piperidin-1-yl)-butyl]-imidazolidine-2,4-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1C2=CC=CC=C2)CCCCN3C(=O)C(NC3=O)(C4=CC=CC=C4)C5=CC=CC=C5
3621;255018971;0.01;625223;103199419;941361;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Flunarizine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F
3622;326034953;0.01;701162;163314019;11537339;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-[2-(5-Methyl-1-naphthalen-2-ylpyrazol-3-yl)oxyethyl]piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)OCCN4CCCCC4
3623;342804581;0.01;1127667;242621881;90654976;10280;237346340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 opioid receptor (unknown origin);1'-[4-[1-(benzenesulfonyl)indol-3-yl]butyl]spiro[1H-2-benzofuran-3,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3CO2)CCCCC4=CN(C5=CC=CC=C54)S(=O)(=O)C6=CC=CC=C6
3624;342817000;0.01;1118248;242613626;90666087;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human recombinant sigma-1 receptor expressed in CHO cells after 180 mins by beta counting analysis;(1S,2S)-N-[2-[4-[(3,4-dichlorophenyl)methyl]piperazin-1-yl]ethyl]-2-phenylcyclopropane-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;197.0;;;;C1CN(CCN1CCNC(=O)[C@H]2C[C@@H]2C3=CC=CC=C3)CC4=CC(=C(C=C4)Cl)Cl
3625;345602793;0.01;1200082;163320917;24743572;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-(3,4-dichlorophenyl)-N-(2-piperidin-1-ylethyl)pyrazol-3-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)CCNC2=NN(C=C2)C3=CC(=C(C=C3)Cl)Cl
3626;345602794;0.01;1200082;312389821;76683781;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-[(3,4-dichlorophenyl)methyl]-N-(2-piperidin-1-ylethyl)triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)CCNC2=CN(N=N2)CC3=CC(=C(C=C3)Cl)Cl
3627;363701194;0.01;1409616;103605085;26987;10280;323538590;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocin from the Sigma1 receptor;Clemastine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@](C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCC[C@H]3CCCN3C
3628;363958016;0.01;1500193;404659742;18118650;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-3-chlorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC(=CC=C1)Cl)CC2=CC=CC=C2
3629;363958376;0.01;1500193;404653612;41306445;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-2,3-dichlorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=C(C(=CC=C1)Cl)Cl)CC2=CC=CC=C2
3630;366366194;0.01;1558961;440111237;118562375;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;4-Phenyl-9-(2-phenylethyl)-2-propan-2-yl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC(C)C1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=CC=CC=C4
3631;372121197;0.01;1681775;461525412;118562403;10280;330649470;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;4-Benzyl-2-methyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)CC4=CC=CC=C4
3632;380263967;0.01;1811100;475980537;126506607;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[2-(4-benzylpiperazin-1-yl)-2-methylpropyl]aniline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CNC1=CC=CC=C1)N2CCN(CC2)CC3=CC=CC=C3
3633;380512530;0.01;1846430;482068812;117651303;10280;338263220;Confirmatory;20230629;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(5aR,8aR)-3-(2-fluorophenyl)-4,5a,6,7,8,8a-hexahydropyrrolo[3,4-b][1,2,3]triazolo[1,5-d][1,4]oxazine dihydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@@H]2[C@@H](CN1)OCC3=C(N=NN23)C4=CC=CC=C4F.Cl.Cl
3634;402102368;0.01;1796671;384224363;41306445;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-2,3-dichlorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=C(C(=CC=C1)Cl)Cl)CC2=CC=CC=C2
3635;402102473;0.01;1796671;384224354;18118650;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-3-chlorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC(=CC=C1)Cl)CC2=CC=CC=C2
3636;100546525;0.0101;203689;103284444;4879851;10280;96511500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma-1 receptor in guinea pig brain membranes;4-Bromo-N-(2-diethylamino-ethyl)-benzenesulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCN(CC)CCNS(=O)(=O)C1=CC=C(C=C1)Br
3637;100367074;0.01016;226337;103376497;9883820;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-[1-(2-Fluoro-benzyl)-piperidin-4-yl]-2-phenyl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC=CC=C3F
3638;100385650;0.0102;204153;103378107;11810652;10280;117841480;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma opioid receptor type 1 affinity in guinea pig brain by employing [3H](+)-pentazocine as radioligand.;1'-(4-Phenylbutyl)-3-methoxy-3,4-dihydrospiro[1H-2-benzopyran-1,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1CC2=CC=CC=C2C3(O1)CCN(CC3)CCCCC4=CC=CC=C4
3639;255014110;0.0102;625223;103376533;4634;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Oxybutynin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
3640;326035175;0.0102;701162;163331284;11531125;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;4-[4-[1-(3,4-Dichlorophenyl)pyrazol-3-yl]oxybutyl]thiomorpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CSCCN1CCCCOC2=NN(C=C2)C3=CC(=C(C=C3)Cl)Cl
3641;388996993;0.0102;1798943;405263571;86275865;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';2-(azepan-1-yl)-1-(3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)ethanone hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCCN(CC1)CC(=O)N2CCN3C(=CC4=CC=CC=C43)C2
3642;100627643;0.01023;204452;131285667;54586714;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-(cyclopropylmethyl)spiro[2,3-dihydro-1H-naphthalene-4,4'-piperidine];hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC2=CC=CC=C2C3(C1)CCN(CC3)CC4CC4.Cl
3643;100535941;0.0103;204457;103673544;45262086;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(3-Bromophenyl)-1-(3-ethylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)NC(=NC2=CC(=CC=C2)Br)N.Cl
3644;100742176;0.0103;203989;103308201;15166844;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor in guinea pig brain preparation was estimated using [3H]3-PPP as radioligand;3-[1-(4-Pyridin-4-yl-butyl)-1,2,3,6-tetrahydro-pyridin-4-yl]-1H-indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CC=C1C2=CNC3=CC=CC=C32)CCCCC4=CC=NC=C4
3645;345594068;0.0103;1197502;312385706;118731570;10280;256029320;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor in human Jurkat cells after 120 mins by liquid scintillation counting analysis;3-[3-[Benzyl(methyl)amino]propyl]-1,3-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1C2=CC=CC=C2SC1=O)CC3=CC=CC=C3
3646;100485968;0.0104;204636;103318497;15767680;10280;76368600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured on Sigma receptor type 1 from guinea pig brain membranes using [3H]pentazocine as radioligand.;N-(10-benzyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-yl)methanesulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)NS(=O)(=O)C
3647;100617494;0.0104;204001;103167216;3559;10280;16627250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;The compound was tested for its binding affinity towards Sigma opioid receptor in guinea pig brain membranes;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3648;100622165;0.0104;204000;103186150;192481;10280;16481390;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Opioid activity in terms of inhibition of [3H]dihydromorphine binding to opioid receptor mu in rat brain membrane.;4-[2-(3-Phenylpropylamino)propyl]phenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC(CC1=CC=C(C=C1)O)NCCCC2=CC=CC=C2
3649;326034774;0.0104;701162;163317461;11501260;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-(3,4-Dichlorophenyl)-5-methyl-3-(3-pyrrolidin-1-ylpropoxy)pyrazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)OCCCN3CCCC3
3650;100471781;0.01047;203852;103290992;15657207;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;3-Chloro-6-methylamino-8-phenyl-5,6,7,8-tetrahydro-naphthalen-2-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CNC1CC(C2=CC(=C(C=C2C1)Cl)O)C3=CC=CC=C3
3651;100546606;0.0105;203685;103278716;10616993;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-Benzylpiperidine-4-yl)-2-(3-methoxyphenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC=CC(=C1)CC(=O)NC2CCN(CC2)CC3=CC=CC=C3
3652;100617224;0.0105;204444;103336837;2845469;10280;16627250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membranes using [3H]DTG as radioligand;1-(3-Chlorophenyl)-4-(2-phenylethyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCC2=CC=CC=C2)C3=CC(=CC=C3)Cl
3653;100627873;0.0105;229196;103340139;44342741;10280;13194930;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain, using [3H](+)-pentazocine as radioligand.;(1R,13S)-1,13-dimethyl-10-pentyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCCN1CC[C@@]2([C@@H](C1CC3=C2C=C(C=C3)O)C)C
3654;101829949;0.0105;255065;103468502;44403201;10280;161400090;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory activity against opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 degree C ;(10aS)-2-[3-(4-phenylbutylamino)propyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1[C@H]2C(=O)N(C(=O)N2CC3=CC=CC=C31)CCCNCCCCC4=CC=CC=C4
3655;342804580;0.0105;1127667;242622245;90654978;10280;237346340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 opioid receptor (unknown origin);(1S,5S,8E)-5-(3-hydroxyphenyl)-8-[(3-hydroxyphenyl)methylidene]-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@@]2(C[C@H]1/C(=C\C3=CC(=CC=C3)O)/C(=O)C2)C4=CC(=CC=C4)O
3656;407906176;0.0105;1922168;103252427;9829526;10280;362020630;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [H3]DTG from sigma 1 receptor (unknown origin) by competition binding assay;Siramesine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3CO2)CCCCC4=CN(C5=CC=CC=C54)C6=CC=C(C=C6)F
3657;408003843;0.0105;1948305;103252427;9829526;10280;369199560;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) assessed as inhibition constant;Siramesine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3CO2)CCCCC4=CN(C5=CC=CC=C54)C6=CC=C(C=C6)F
3658;354638058;0.0106;1276982;103472696;11558654;10280;267172070;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of 5-(Dimethylamino)-2-{6-[(5-(4-(4-methylpiperidin-1-yl)butyl)naphthalen-2-yl)oxy]hexyl}isoindole-1,3-dione from sigma 1 receptor (unknown origin) expressed in MCF7 cells after 75 mins by flow cytometry;1-(4-(6-Methoxynaphthalen-1-yl)butyl)-4-methylpiperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;CC1CCN(CC1)CCCCC2=CC=CC3=C2C=CC(=C3)OC
3659;380773043;0.01072;1907474;482064012;168281403;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;Benzyl 2-[3-(4-cyclopentylpiperazin-1-yl)phenyl]-4-methylpiperazine-1-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(C(C1)C2=CC(=CC=C2)N3CCN(CC3)C4CCCC4)C(=O)OCC5=CC=CC=C5
3660;407996342;0.01072;1946583;494404670;171348511;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[9-[(3,4-difluorophenyl)methyl]-2,9-diazaspiro[4.5]decan-2-yl]-N-(4-fluoro-3-methylphenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC(=C1)NC(=O)CN2CCC3(C2)CCCN(C3)CC4=CC(=C(C=C4)F)F)F
3661;100478318;0.0108;203696;103185860;13011906;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;((S)-1-Methyl-2-phenyl-ethyl)-(3-phenyl-propyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](CC1=CC=CC=C1)NCCCC2=CC=CC=C2
3662;100536687;0.0108;204457;103673558;45262097;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"1-(3-Ethylphenyl)-2-(2-methylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)NC(=NC2=CC=CC=C2C)N.Cl
3663;326035162;0.0108;701162;163338186;11573971;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;4-{2-(1-(3,4-Dichlorophenyl)-5-methyl-1h pyrazol-3-yloxy)ethyl}morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)OCCN3CCOCC3
3664;100367044;0.0109;226337;103376032;10991643;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-(1-benzylpiperidin-4-yl)-2-(1H-indol-3-yl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4
3665;388996813;0.0109;1798943;405263583;86581702;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';3-(azepan-1-yl)-1-(3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCCN(CC1)CCC(=O)N2CCN3C(=CC4=CC=CC=C43)C2
3666;100628008;0.01096;204453;103671424;45260523;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"2-Butyl-1,3,4,4a,9,9a-hexahydroindeno[2,1-c]pyridine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCCN1CCC2C(C1)CC3=CC=CC=C23.Cl
3667;100292612;0.011;239200;103442159;11349674;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;4-Benzyl-1-(7-methoxy-1,2,3,4-tetrahydro-naphthalen-2-ylmethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(CCC(C2)CN3CCC(CC3)CC4=CC=CC=C4)C=C1
3668;100475172;0.011;204462;103351612;44347731;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;"2-Hydroxybutanedioic acid;1'-(naphthalen-2-ylmethyl)spiro[3,4-dihydronaphthalene-2,4'-piperidine]-1-one";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2(CCN(CC2)CC3=CC4=CC=CC=C4C=C3)C(=O)C5=CC=CC=C51.C(C(C(=O)O)O)C(=O)O
3669;100475176;0.011;204462;103673056;45261726;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;"2-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]-3,4-dihydro-2H-naphthalen-1-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2=CC=CC=C2C(=O)C1C3CCN(CC3)CC4=CC=C(C=C4)F.Cl
3670;100605292;0.011;203988;103735224;46878009;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity of compound towards Sigma opioid receptor was determined in presence of [3H](+)-3-PPP radioligand;2-Amino-4,5-dichloro-N-methyl-N-[(1R)-2beta-(1-pyrrolidinyl)cyclohexan-1beta-yl]benzeneacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)CC3=CC(=C(C=C3N)Cl)Cl
3671;100605298;0.011;203995;164136065;14771450;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity of compound to Sigma opioid receptor labelled with [3H](+)-3-PPP;N-methyl-2-naphthalen-2-yl-N-(2-pyrrolidin-1-ylcyclohexyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C1CCCCC1N2CCCC2)C(=O)CC3=CC4=CC=CC=C4C=C3
3672;100617138;0.011;203985;103671880;14771674;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;"1,2-Bis(1-adamantyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C2CC3CC1CC(C2)(C3)NC(=NC45CC6CC(C4)CC(C6)C5)N.Cl
3673;100746109;0.011;204298;103265722;44309667;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma opioid receptor type 2 in guinea pig brain homogenate with 4 nM [3H]-(+)-DTG;5,5-Diphenyl-3-[6-(4-phenyl-piperazin-1-yl)-hexyl]-imidazolidine-2,4-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCCCCCN2C(=O)C(NC2=O)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=CC=C5
3674;341102910;0.011;1062229;194173468;76328247;10280;239649010;Confirmatory;20220830;0;0;Active;Q99720;Kd;=;ChEMBL;Displacement of [125I]N-IACoc from sigma 1 receptor (unknown origin);methyl (1R,2R,3S,5S)-8-[2-(4-azido-3-(125I)iodanylphenyl)ethyl]-3-benzoyloxy-8-azabicyclo[3.2.1]octane-2-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC(=O)[C@@H]1[C@H]2CC[C@H](N2CCC3=CC(=C(C=C3)N=[N+]=[N-])[125I])C[C@@H]1OC(=O)C4=CC=CC=C4
3675;345680785;0.011;1174258;312374352;118724308;10280;254622400;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor in human Jurkat cell membranes incubated for 2 hrs by liquid scintillation counting;N-methyl-3-phenothiazin-10-yl-N-(2-phenylethyl)propan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1C2=CC=CC=C2SC3=CC=CC=C31)CCC4=CC=CC=C4
3676;345681151;0.011;1174258;312374348;118724304;10280;254622400;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor in human Jurkat cell membranes incubated for 2 hrs by liquid scintillation counting;N-methyl-N-(2-phenylethyl)-3-(1-phenyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl)propan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1CCC2=C(C1C3=CC=CC=C3)NC4=CC=CC=C24)CCC5=CC=CC=C5
3677;345681156;0.011;1174258;312374349;118724305;10280;254622400;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor in human Jurkat cell membranes incubated for 2 hrs by liquid scintillation counting;N-methyl-N-(2-phenylethyl)-3-(1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)propan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1CCC2=C(C1)C3=CC=CC=C3N2)CCC4=CC=CC=C4
3678;345681157;0.011;1174258;312374358;118724314;10280;254622400;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor in human Jurkat cell membranes incubated for 2 hrs by liquid scintillation counting;2-[3-(1,3-dihydroisoindol-2-yl)propyl]-3,4-dihydro-1H-[1]benzofuro[3,2-c]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CC2=C1OC3=CC=CC=C23)CCCN4CC5=CC=CC=C5C4
3679;363666192;0.011;1415921;404710901;71223204;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;N-(1-(2-(azepan-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-2,2,3,3-tetramethylcyclopropane-carboxamide citrate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1(C(C1(C)C)C(=O)NC2=C3C=NN(C3=NC=N2)CCN4CCCCCC4)C
3680;366366990;0.011;1558961;440187476;118562567;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;9-[2-(4-Fluorophenyl)ethyl]-2-methyl-4-phenyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=C(C=C3)F)C4=CC=CC=C4
3681;366366993;0.011;1558961;440222216;118567604;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;4-(2-Fluorophenyl)-2-methyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=CC=CC=C4F
3682;380512537;0.011;1846430;482057146;168276410;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-10-(3-fluorophenyl)-4-[(6-methoxypyridin-3-yl)methyl]-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=NC=C(C=C1)CN2C[C@@H]3[C@@H](C2)OCC4=C(N=NN34)C5=CC(=CC=C5)F
3683;380773044;0.011;1907474;482064012;168281403;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;Benzyl 2-[3-(4-cyclopentylpiperazin-1-yl)phenyl]-4-methylpiperazine-1-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(C(C1)C2=CC(=CC=C2)N3CCN(CC3)C4CCCC4)C(=O)OCC5=CC=CC=C5
3684;407996171;0.011;1946583;482059353;168277992;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;5-[[4-[(3,4-Difluorophenyl)methoxy]piperidin-1-yl]methyl]-1-methylbenzimidazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C=NC2=C1C=CC(=C2)CN3CCC(CC3)OCC4=CC(=C(C=C4)F)F
3685;407996341;0.011;1946583;494404670;171348511;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[9-[(3,4-difluorophenyl)methyl]-2,9-diazaspiro[4.5]decan-2-yl]-N-(4-fluoro-3-methylphenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC(=C1)NC(=O)CN2CCC3(C2)CCCN(C3)CC4=CC(=C(C=C4)F)F)F
3686;100403484;0.0111;204630;103295188;44321621;10280;128012230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma receptor type 1 was determined by the displacement of [3H]pentazocine radioligand;{3-[3,5-Dimethyl-4-(3-phenyl-propyl)-piperazin-1-yl]-propyl}-bis-(4-fluoro-phenyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(C[C@H](N1CCCC2=CC=CC=C2)C)CCCN(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F
3687;326034626;0.0111;701162;163314041;11646372;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-[2-[1-(3,4-Dichlorophenyl)-5-methylpyrazol-3-yl]oxyethyl]-4-methylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)OCCN3CCN(CC3)C
3688;389712859;0.0111;1919146;476002745;166637128;10280;;Confirmatory;20231017;0;0;Active;Q99720;IC50;;BindingDB;Receptor Binding Assay from US Patent US11535596: 'Analogs of dextromethorphan with balanced receptor activities';N-[[6-(difluoromethoxy)-2,3,4,10a-tetrahydro-1H-phenanthren-4a-yl]methyl]-N-methylprop-2-en-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CC=C)CC12CCCCC1C=CC3=C2C=C(C=C3)OC(F)F
3689;100615559;0.0112;203999;103321550;6712729;10280;16560440;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was tested for the inhibitory activity against Sigma opioid receptor by using [3H](+)-3-PPP as radioligand in guinea pig brain;2-(3,4-Dichloro-phenyl)-N-(2-pyrrolidin-1-yl-cyclohexyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC[C@@H]([C@@H](C1)NC(=O)CC2=CC(=C(C=C2)Cl)Cl)N3CCCC3
3690;100630853;0.01122;204452;103253288;15163155;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;1'-(pyridin-2-ylmethyl)spiro[2,3-dihydro-1H-naphthalene-4,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC2=CC=CC=C2C3(C1)CCN(CC3)CC4=CC=CC=N4
3691;407996456;0.01122;1946583;482088112;168297847;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;5-[[4-[(4-Chloro-3-fluorophenyl)methoxy]piperidin-1-yl]methyl]-1-methylbenzimidazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C=NC2=C1C=CC(=C2)CN3CCC(CC3)OCC4=CC(=C(C=C4)Cl)F
3692;100478466;0.0113;203696;103184931;408731;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;Phenethyl-(3-phenyl-propyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)CCCNCCC2=CC=CC=C2
3693;100485971;0.0113;204636;103318418;44332487;10280;76368600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured on Sigma receptor type 1 from guinea pig brain membranes using [3H]pentazocine as radioligand.;10-Benzyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),5-dien-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)CC(=O)C=C3
3694;354638181;0.0113;1276980;103472688;11652595;10280;267172070;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of 5-(Dimethylamino)-2-(6-((5-(4-(4-methylpiperidin-1-yl)butyl)-5,6,7,8-tetrahydronaphthalen-2-yl)oxy)hexyl)isoindoline-1,3-dione from sigma 1 receptor (unknown origin) expressed in MCF7 after 75 mins by flow cytometry;1-(4-(6-Methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)butyl)-4-methylpiperidine hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;CC1CCN(CC1)CCCCC2CCCC3=C2C=CC(=C3)OC
3695;100478317;0.0114;203696;103185558;10467460;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;Bis-(3-phenyl-propyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)CCCNCCCC2=CC=CC=C2
3696;407996156;0.01148;1946583;482067608;168284020;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;1-[[4-[(4-Chloro-3-fluorophenyl)methoxy]piperidin-1-yl]methyl]-3-methylimidazo[1,5-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NC(=C2N1C=CC=C2)CN3CCC(CC3)OCC4=CC(=C(C=C4)Cl)F
3697;100292835;0.0116;239105;103442126;11220953;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;4-Benzyl-1-chroman-2-ylmethyl-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2=CC=CC=C2OC1CN3CCC(CC3)CC4=CC=CC=C4
3698;100378107;0.0116;204142;103252465;12259685;10280;120363760;Confirmatory;20220830;0;0;Active;Q99720;Kd;=;ChEMBL;Binding constant (Kd) for [3H]-DTG binding to Sigma opioid receptor type 1 of guinea pig brain membranes at 200 nM concentration of the compound;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
3699;100378187;0.0116;204143;103186197;7333;10280;120363760;Confirmatory;20220830;0;0;Active;Q99720;Kd;=;ChEMBL;Binding constant (Kd) for [3H]DTG binding to Sigma opioid receptor type 1 of guinea pig brain membranes at 5 uM BNIT;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
3700;100322592;0.0117;204151;103382350;44361163;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 1 using [3H](+)-pentazocine in guinea pig brain membranes;N-Benzyl-2-[(1R,2S)-1,2-dihydro-2-isopropylnaphthalene-1-yl]ethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC(C)[C@H]1C=CC2=CC=CC=C2[C@@H]1CCNCC3=CC=CC=C3
3701;100387748;0.0117;204145;103389358;10903339;10280;123830180;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine from Sigma opioid receptor type 1 of guinea pig brain;1'-Benzyl-3-ethylspiro[3,4-dihydroisochromene-1,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC1CC2=CC=CC=C2C3(O1)CCN(CC3)CC4=CC=CC=C4
3702;100478311;0.0117;203696;103186087;12347284;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;N,N-Dimethyl-5-phenylpentan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCCCCC1=CC=CC=C1
3703;100627302;0.0117;229194;103384367;15113305;10280;13101140;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+) -3PPP from sigma receptor in guinea pig brain membranes;2-(3,4-Dichlorophenyl)-N-[2-(1-pyrrolidinyl)ethyl]-N-butylethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCN(CCC1=CC(=C(C=C1)Cl)Cl)CCN2CCCC2
3704;101829946;0.0117;255065;103468540;44403222;10280;161400090;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory activity against opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 degree C ;(10aS)-2-[5-[methyl(2-phenylethyl)amino]pentyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;CN(CCCCCN1C(=O)[C@@H]2CC3=CC=CC=C3CN2C1=O)CCC4=CC=CC=C4
3705;326035328;0.0117;701162;163324290;11632093;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;4-[1-(3,4-dichlorophenyl)-5-methylpyrazol-3-yl]oxy-N,N-diethylbutan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCN(CC)CCCCOC1=NN(C(=C1)C)C2=CC(=C(C=C2)Cl)Cl
3706;100536809;0.0118;204457;103673598;22120071;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(2,5-Dichlorophenyl)-1-(3-ethylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)NC(=NC2=C(C=CC(=C2)Cl)Cl)N.Cl
3707;100559074;0.0118;203684;103390189;44364199;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;1-[4-(3-Methoxyphenethyl)piperazine-1-yl]-2-(3-methoxyphenyl)ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC(=C1)CCN2CCN(CC2)C(=O)CC3=CC(=CC=C3)OC
3708;407906198;0.01182;1922160;494398713;15340337;10280;362020630;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);N-[2-(diethylamino)ethyl]-3-(123I)iodanyl-4-methoxybenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CC)CCNC(=O)C1=CC(=C(C=C1)OC)[123I]
3709;100292952;0.0119;239105;103442130;11451971;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;4-Benzyl-1-(6-methoxy-1,2,3,4-tetrahydro-naphthalen-2-ylmethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(CC(CC2)CN3CCC(CC3)CC4=CC=CC=C4)C=C1
3710;345593886;0.0119;1197502;103167216;3559;10280;256029320;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor in human Jurkat cells after 120 mins by liquid scintillation counting analysis;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3711;345680788;0.0119;1174258;103167216;3559;10280;254622400;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor in human Jurkat cell membranes incubated for 2 hrs by liquid scintillation counting;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3712;100319807;0.012;204154;103361381;10666808;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;[2-(4-Methoxy-3-phenethyloxy-phenyl)-1-methyl-ethyl]-dipropyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCN(CCC)C(C)CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2
3713;100323567;0.012;204151;103382348;10924765;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 1 using [3H](+)-pentazocine in guinea pig brain membranes;N-Benzyl-2-[(1S,2R)-1,2-dihydro-2-isopropylnaphthalene-1-yl]ethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC(C)[C@@H]1C=CC2=CC=CC=C2[C@H]1CCNCC3=CC=CC=C3
3714;100468795;0.012;204469;103340034;44342684;10280;79325690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition against sigma receptor using displacement of 3 nM [3H]pentazocine in homogenate of guinea pig brain cerebellum;(1S,13S)-1,13-dimethyl-10-nonyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCCCCCCCN1CC[C@]2([C@@H](C1CC3=C2C=C(C=C3)O)C)C
3715;100478423;0.012;203696;103184731;15061898;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;N-[1-Methyl-2-(4-bromophenyl)ethyl]-3-phenylpropan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(CC1=CC=C(C=C1)Br)NCCCC2=CC=CC=C2
3716;100604306;0.012;203857;103735224;46878009;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;2-Amino-4,5-dichloro-N-methyl-N-[(1R)-2beta-(1-pyrrolidinyl)cyclohexan-1beta-yl]benzeneacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)CC3=CC(=C(C=C3N)Cl)Cl
3717;100614104;0.012;203986;103282979;14771694;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N''-Cyclohexyl-N-(2-methylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC2CCCCC2)N
3718;100622098;0.012;203998;103240390;15061899;10280;16481390;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]DTG binding to Sigma opioid receptor;N-[1-Methyl-2-(3,4-dichlorophenyl)ethyl]-3-phenylpropan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(CC1=CC(=C(C=C1)Cl)Cl)NCCCC2=CC=CC=C2
3719;100722942;0.012;204635;103267319;4598397;10280;150810120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma receptor type 1,using [3H](+)-pentazocine as radioligand;5-Diethylamino-1,1-diphenyl-pentan-1-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CC)CCCCC(C1=CC=CC=C1)(C2=CC=CC=C2)O
3720;100737359;0.012;203993;103227874;14368960;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor from guinea pig brain using the radioligand [3H]SKF-10047;(5S)-5-[[4-hydroxy-4-(4-methoxyphenyl)piperidin-1-yl]methyl]-3-(4-methoxyphenyl)-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)C2(CCN(CC2)C[C@H]3CN(C(=O)O3)C4=CC=C(C=C4)OC)O
3721;100742360;0.012;203992;103677497;45264594;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"3-Phenyl-8-(2-thiophen-3-ylethyl)-1-oxa-8-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC12C(=O)C(=CO2)C3=CC=CC=C3)CCC4=CSC=C4.Cl
3722;100745739;0.012;204454;103247650;15729900;10280;;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity towards sigma receptor by the displacement of [3H]PPP from guinea pig brain;1-Cyclohexyl-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butan-1-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)C(CCCN2CCN(CC2)C3=NC=C(C=N3)F)O
3723;100746450;0.012;204018;103277706;44315580;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor using [3H](+)-SKF-10047 as radioligand;1-Benzyl-4-[(E)-3-(4-fluoro-phenyl)-allyloxymethyl]-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1COC/C=C/C2=CC=C(C=C2)F)CC3=CC=CC=C3
3724;103125584;0.012;418680;103612577;10087782;10280;192431730;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor;(R)-(1-benzyl-4-(4-methoxybenzyl)piperazin-2-yl)methanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)CN2CCN([C@H](C2)CO)CC3=CC=CC=C3
3725;151267138;0.012;452467;103716562;10040286;10280;199549720;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor;(N-(3'-Fluorophenyl)ethyl-4-azahexacyclo[5.4.1.02,6.03,10.05,9.08,11]dodecan-3-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C2C3C4C1C5C2C6C3C4C5(N6CCC7=CC(=CC=C7)F)O
3726;255028298;0.012;625223;103249489;1548953;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Enclomiphene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CC)CCOC1=CC=C(C=C1)/C(=C(\C2=CC=CC=C2)/Cl)/C3=CC=CC=C3
3727;345602802;0.012;1200082;312389815;76683877;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;N-[2-(azepan-1-yl)ethyl]-1-(3-fluorophenyl)triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCCN(CC1)CCNC2=CN(N=N2)C3=CC(=CC=C3)F
3728;345681158;0.012;1174258;312374360;118724316;10280;254622400;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor in human Jurkat cell membranes incubated for 2 hrs by liquid scintillation counting;10-[3-(1,3-Dihydroisoindol-2-yl)propyl]phenothiazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1C2=CC=CC=C2CN1CCCN3C4=CC=CC=C4SC5=CC=CC=C53
3729;354664027;0.012;1288457;336874677;127031403;10280;270328900;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma1 receptor by PDSP assay;10-(cyclopropylmethoxy)-3,9-dimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-2-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=C2C3CC4=C(CN3CCC2=C1)C(=C(C=C4)OCC5CC5)OC)O
3730;363665993;0.012;1415921;404706763;71225947;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;N-(1-(2-(4-tert-butylpiperidin-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)pivalamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)C1CCN(CC1)CCN2C3=NC=NC(=C3C=N2)NC(=O)C(C)(C)C
3731;372120976;0.012;1681775;461561908;118562325;10280;330649470;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;2-Methyl-4,9-bis(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)CCC4=CC=CC=C4
3732;372306734;0.012;1701184;103252465;12259685;10280;332377850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
3733;380512535;0.012;1846430;482082052;86297371;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2S,6S)-10-(2-chloro-4-fluorophenyl)-4-(oxan-4-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCC1N2C[C@H]3[C@H](C2)OCC4=C(N=NN34)C5=C(C=C(C=C5)F)Cl
3734;380581328;0.012;1861723;482049187;41306319;10280;357249250;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay;N-[3-[benzyl(methyl)amino]propyl]-1-benzofuran-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC2=CC=CC=C2O1)CC3=CC=CC=C3
3735;380581531;0.012;1861768;440111011;155511338;10280;357532630;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor measured after 120 mins by scintillation counting analysis;4-[4-[(4-Bromophenyl)methyl]triazol-1-yl]-1-[(4-nitrophenyl)methyl]piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1N2C=C(N=N2)CC3=CC=C(C=C3)Br)CC4=CC=C(C=C4)[N+](=O)[O-]
3736;407996096;0.012;1946583;482067608;168284020;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;1-[[4-[(4-Chloro-3-fluorophenyl)methoxy]piperidin-1-yl]methyl]-3-methylimidazo[1,5-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NC(=C2N1C=CC=C2)CN3CCC(CC3)OCC4=CC(=C(C=C4)Cl)F
3737;407996169;0.012;1946583;482054930;168274755;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;1-Methyl-5-[[4-[[3-(trifluoromethyl)phenyl]methoxy]piperidin-1-yl]methyl]benzimidazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C=NC2=C1C=CC(=C2)CN3CCC(CC3)OCC4=CC(=CC=C4)C(F)(F)F
3738;407997180;0.012;1946585;482049009;168270563;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor in human Jurkat cells;6-[[4-[(3,4-difluorophenyl)methoxy]piperidin-1-yl]methyl]-1H-benzimidazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=C(C=C2)F)F)CC3=CC4=C(C=C3)N=CN4
3739;354638056;0.0121;1276982;103472688;11652595;10280;267172070;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of 5-(Dimethylamino)-2-{6-[(5-(4-(4-methylpiperidin-1-yl)butyl)naphthalen-2-yl)oxy]hexyl}isoindole-1,3-dione from sigma 1 receptor (unknown origin) expressed in MCF7 cells after 75 mins by flow cytometry;1-(4-(6-Methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)butyl)-4-methylpiperidine hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;CC1CCN(CC1)CCCCC2CCCC3=C2C=CC(=C3)OC
3740;372338885;0.0121;1718132;103178693;441278;10280;331115250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin);Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1[C@H]2CC3=C([C@@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
3741;100295624;0.0122;239200;103442132;11336800;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;4-Benzyl-1-indan-2-ylmethyl-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3CC4=CC=CC=C4C3
3742;100451647;0.0122;204435;103672107;45260974;10280;81026510;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using the novel [3H]-(+/-)-4 as radioligand;"7-(Dimethylamino)-5-phenyl-5,6,7,8-tetrahydronaphthalene-2,3-diol;hydrobromide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CN(C)C1CC(C2=CC(=C(C=C2C1)O)O)C3=CC=CC=C3.Br
3743;326067553;0.0123;718362;163322072;71454076;10280;230949920;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma 1 receptor in human Jurkat cell membrane;1-[3-[4-[1-Adamantyl(phenyl)methyl]phenyl]propyl]piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCN(CC1)CCCC2=CC=C(C=C2)C(C3=CC=CC=C3)C45CC6CC(C4)CC(C6)C5
3744;407996164;0.0123;1946583;482079938;168292951;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;5-[[4-[(3,4-difluorophenyl)methoxy]piperidin-1-yl]methyl]-1H-indazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=C(C=C2)F)F)CC3=CC4=C(C=C3)NN=C4
3745;100385643;0.0124;204153;103377949;11013161;10280;117841480;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma opioid receptor type 1 affinity in guinea pig brain by employing [3H](+)-pentazocine as radioligand.;1''-(3-phenylpropyl)spiro[3,4-dihydro-1H-isochromene-1,4''-(hexahydropyridine)]-3-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3CC(O2)O)CCCC4=CC=CC=C4
3746;321525565;0.0124;658997;160672901;70683538;10280;225129080;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H](+)pentazocine from sigma-1 receptor expressed in human Jurkat cell membranes after 2 hrs by liquid scintillation spectroscopy;1-[4-[1-Adamantyl(phenyl)methyl]phenyl]piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCN1)C2=CC=C(C=C2)C(C3=CC=CC=C3)C45CC6CC(C4)CC(C6)C5
3747;365267548;0.01259;1512456;440226874;153287539;10280;316202300;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-3a-methyl-8-phenyl-2,3,4,9b-tetrahydro-1H-chromeno[3,4-b]pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@]12COC3=C([C@@H]1CCN2)C=C(C=C3)C4=CC=CC=C4
3748;365267550;0.01259;1512456;440171256;148302367;10280;316202300;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3S,4S)-4-ethyl-3-methyl-6-phenyl-2,4-dihydrochromen-3-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC[C@H]1C2=C(C=CC(=C2)C3=CC=CC=C3)OC[C@@]1(C)N
3749;100399126;0.0126;204632;103671503;45260579;10280;127477840;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma receptor type 1 in guinea pig brain membrane without cerebellum;"1-[(2S)-2-(4-chlorophenoxy)propyl]-4-methylpiperidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1CCN(CC1)C[C@H](C)OC2=CC=C(C=C2)Cl.Cl
3750;101829943;0.0126;255065;103468510;44403203;10280;161400090;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory activity against opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 degree C ;(10aS)-2-[2-[methyl(2-phenylethyl)amino]ethyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;CN(CCC1=CC=CC=C1)CCN2C(=O)[C@@H]3CC4=CC=CC=C4CN3C2=O
3751;100354287;0.0127;204790;103237752;10790095;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-[[(2S)-1-Cycloheptyl-2-pyrrolidinyl]methyl]-1-methoxy-4-bromo-2-naphthalenecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)NC[C@@H]3CCCN3C4CCCCCC4
3752;100387749;0.0127;204145;103389512;11013162;10280;123830180;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine from Sigma opioid receptor type 1 of guinea pig brain;2-(1'-Benzylspiro[3,4-dihydroisochromene-1,4'-piperidine]-3-yl)ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3CC(O2)CCO)CC4=CC=CC=C4
3753;100377919;0.0128;204144;103186197;7333;10280;120363760;Confirmatory;20220830;0;0;Active;Q99720;Kd1;=;ChEMBL;Binding affinity against Sigma opioid receptor type 1 at 0.1 uM BNIT;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
3754;100496813;0.01283;204761;103401533;10041770;10280;78533490;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity at Sigma receptor type 1, displacement of [3H](+)-pentazocine from guinea pig brain membranes;(1S,9S,13S)-1,13-dimethyl-10-[(2-methylphenyl)methyl]-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC4=CC=CC=C4C)C)C=C(C=C3)O
3755;100471775;0.01288;203852;103367373;42601650;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;4-phenyl-N,N-dipropyl-1,2,3,4-tetrahydronaphthalen-2-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN(CCC)C1CC(C2=CC=CC=C2C1)C3=CC=CC=C3
3756;100319800;0.013;204154;103361354;10811587;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;[1-(4-Methoxy-3-phenethyloxy-benzyl)-octyl]-propyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)NCCC
3757;100471347;0.013;204459;103282324;9919363;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N,N''-Bis-(2-iodo-phenyl)-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC=C(C(=C1)NC(=NC2=CC=CC=C2I)N)I
3758;100475269;0.013;204462;103351737;44347787;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;1'-Phenethyl-3,4-dihydrospiro[naphthalene-1(2H),4'-piperidin]-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC(=O)C2(CCN(CC2)CCC3=CC=CC=C3)C4=CC=CC=C41
3759;100475271;0.013;204462;103352119;10090127;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;6-Methoxy-2-[1-phenethyl-4-piperidinyl]-3,4-dihydronaphthalen-1(2H)-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC2=C(C=C1)C(=O)C(CC2)C3CCN(CC3)CCC4=CC=CC=C4
3760;100524439;0.013;204626;103225009;10334410;10280;91718750;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Receptor binding affinity against Sigma receptor;4-[(4-Nitrophenoxy)methyl]-1-(cyclopropylmethyl)piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC1CN2CCC(CC2)COC3=CC=C(C=C3)[N+](=O)[O-]
3761;100558837;0.013;203684;103390160;401822;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;1-[4-(3-Phenylpropyl)piperazine-1-yl]-2-(4-methoxyphenyl)ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)CC(=O)N2CCN(CC2)CCCC3=CC=CC=C3
3762;100613857;0.013;203986;103671885;14771739;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;Adamantan-1-yl-N'-cyclohexylguanidine HCl;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)N=C(N)NC23CC4CC(C2)CC(C4)C3.Cl
3763;100622187;0.013;203982;103241111;15065452;10280;16481400;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H]DTG from sigma opioid receptor of homogenized guinea pig whole brain;1-(1-Adamantyl)-3-(3-fluorophenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C2CC3CC1CC(C2)(C3)N=C(N)NC4=CC(=CC=C4)F
3764;100742344;0.013;204020;103671737;45260724;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor using [3H]-(+)-SKF- 10,047;"8-Benzyl-3-phenyl-1-oxa-8-azaspiro[5.5]undec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CC(=O)C(=CO2)C3=CC=CC=C3)CN(C1)CC4=CC=CC=C4.Cl
3765;100746116;0.013;204147;103265722;44309667;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma opioid receptor type 1 in guinea pig brain homogenate with 0.5 nM [3H](+)-PENT;5,5-Diphenyl-3-[6-(4-phenyl-piperazin-1-yl)-hexyl]-imidazolidine-2,4-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCCCCCN2C(=O)C(NC2=O)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=CC=C5
3766;255025667;0.013;625223;103167216;3559;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3767;255030600;0.013;625223;103737203;5511;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tolperisone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=CC=C(C=C1)C(=O)C(C)CN2CCCCC2
3768;341105439;0.013;1063114;103237360;10474335;10280;243317580;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor in human MCF7 cells;1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;COC1=CC=CC2=C1CCCC2CCCN3CCN(CC3)C4CCCCC4
3769;342798100;0.013;1143318;103237360;10474335;10280;248213980;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of (+)-[3H]pentazocine from sigma-1 receptor in human MCF7 cell membranes after 120 mins;1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;COC1=CC=CC2=C1CCCC2CCCN3CCN(CC3)C4CCCCC4
3770;345602803;0.013;1200082;312389831;76684094;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-[(3,4-dichlorophenyl)methyl]-N-[2-(1,4-oxazepan-4-yl)ethyl]triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CN(CCOC1)CCNC2=CN(N=N2)CC3=CC(=C(C=C3)Cl)Cl
3771;354664023;0.013;1288457;336874709;127031424;10280;270328900;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma1 receptor by PDSP assay;10-butoxy-3,9-dimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-2-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCOC1=C(C2=C(CC3C4=CC(=C(C=C4CCN3C2)OC)O)C=C1)OC
3772;355637713;0.013;1308619;336905309;127051267;10280;271565650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-Pentazocine from sigma 1 receptor in human RPMI8226 cell membranes;(1R,4S,7S)-2-(cyclohexylmethyl)-5-(naphthalen-1-ylmethyl)-2,5-diazabicyclo[2.2.2]octan-7-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;C1CCC(CC1)CN2C[C@@H]3C[C@@H]([C@H]2CN3CC4=CC=CC5=CC=CC=C54)O
3773;363666188;0.013;1415921;404711732;71488612;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;1-(1-(2-(azepan-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-3-butylthiourea;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCNC(=S)NC1=C2C=NN(C2=NC=N1)CCN3CCCCCC3
3774;366366198;0.013;1558961;440114780;118567605;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;2-Methyl-9-(2-phenylethyl)-4-pyrazin-2-yl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=NC=CN=C4
3775;366366393;0.013;1558961;440219305;118567606;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;2-Methyl-9-(2-phenylethyl)-4-pyridin-2-yl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=CC=CC=N4
3776;366366397;0.013;1558961;440156523;118562606;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;2,2-Dimethyl-4-phenyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1(C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=CC=CC=C4)C
3777;380263972;0.013;1811100;475994428;126509960;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[1-(4-benzylpiperazin-1-yl)cyclopropyl]methyl]-N-(3-fluorophenyl)propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CC1)N2CCN(CC2)CC3=CC=CC=C3)C4=CC(=CC=C4)F
3778;100403483;0.0131;204630;103295018;11091108;10280;128012230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma receptor type 1 was determined by the displacement of [3H]pentazocine radioligand;[3-(4-Benzyl-piperazin-1-yl)-propyl]-bis-(4-fluoro-phenyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCN(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)CC4=CC=CC=C4
3779;100385648;0.0133;204153;103378083;10871797;10280;117841480;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma opioid receptor type 1 affinity in guinea pig brain by employing [3H](+)-pentazocine as radioligand.;1'-Cinnamyl-3-methoxy-3,4-dihydrospiro[1H-2-benzopyran-1,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1CC2=CC=CC=C2C3(O1)CCN(CC3)C/C=C/C4=CC=CC=C4
3780;100536556;0.0133;204457;103673664;45262175;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(2,3-Dichlorophenyl)-1-(3-ethylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)NC(=NC2=C(C(=CC=C2)Cl)Cl)N.Cl
3781;326034617;0.0133;701162;163317462;71451629;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-[3-[1-(3,4-Dichlorophenyl)-5-methylpyrazol-3-yl]oxypropyl]-4-methylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)OCCCN3CCN(CC3)C
3782;326034624;0.0133;701162;163334767;11552718;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;4-[4-[1-(3,4-Dichlorophenyl)-5-methylpyrazol-3-yl]oxybutyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)OCCCCN3CCOCC3
3783;363849963;0.01336;1449796;381869698;72950535;10280;283855030;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 in human MDA-MB-468 cell membranes;2-[3-(4-Fluorophenoxy)propyl]-1-(4-methoxyphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)NC(=NCCCOC2=CC=C(C=C2)F)N
3784;100543221;0.0134;203699;103218288;10404406;10280;95728830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to sigma-1 sites in guinea pig brain membranes;(1R,9S,13S)-1,13-dimethyl-10-(2-morpholin-4-ylethyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2CCN4CCOCC4)C)C=C(C=C3)O
3785;408003701;0.01359;1948316;494424653;171358892;10280;369199560;Confirmatory;20240503;0;0;Active;Q99720;Kd;=;ChEMBL;Displacement of (+)-pentazocine from sigma 1 receptor in human MCF7 cells assessed as dissociation constant in presence of DTG incubated for 120 mins by saturation binding assay;"6-[(2Z)-3,3-dimethyl-2-[(2E,4E)-5-(1,3,3-trimethylindol-1-ium-2-yl)penta-2,4-dienylidene]indol-1-yl]-N-[6-[3-(4-spiro[1H-2-benzofuran-3,4'-piperidine]-1'-ylbutyl)indol-1-yl]hexyl]hexanamide;iodide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1(C2=CC=CC=C2[N+](=C1/C=C/C=C/C=C\3/C(C4=CC=CC=C4N3CCCCCC(=O)NCCCCCCN5C=C(C6=CC=CC=C65)CCCCN7CCC8(CC7)C9=CC=CC=C9CO8)(C)C)C)C.[I-]
3786;100379671;0.0136;204141;103186197;7333;10280;120363760;Confirmatory;20220830;0;0;Active;Q99720;Kd;=;ChEMBL;Binding constant (Kd) for [3H]DTG binding to Sigma opioid receptor type 1 of guinea pig brain membranes at 1 uM BNIT;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
3787;100435168;0.0136;203682;103237360;10474335;10280;150841290;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity at opioid sigma-1 receptor in guinea pig brain membranes by (+)-[3H]pentazocine displacement.;1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC=CC2=C1CCCC2CCCN3CCN(CC3)C4CCCCC4
3788;100478421;0.0136;203696;103186163;12874567;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;((R)-1-Methyl-2-phenyl-ethyl)-phenethyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CC1=CC=CC=C1)NCCC2=CC=CC=C2
3789;101829952;0.0136;255065;103468512;44403205;10280;161400090;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory activity against opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 degree C ;(10aS)-2-[2-[methyl(3-phenylpropyl)amino]ethyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;CN(CCCC1=CC=CC=C1)CCN2C(=O)[C@@H]3CC4=CC=CC=C4CN3C2=O
3790;363476487;0.0136;1353758;103237360;10474335;10280;294388910;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin);1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCCC2CCCN3CCN(CC3)C4CCCCC4
3791;100468423;0.0138;203697;103330067;398586;10280;82952200;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma 1 receptor was determined in guinea pig brain membrane using [3H](+)-pentazocine as radioligand;Tetrahydro-1-[2-[methyl[2-[methyl[2-(3,4-dichlorophenyl)ethyl]amino]ethyl]amino]ethyl]-1H-pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCC1=CC(=C(C=C1)Cl)Cl)CCN(C)CCN2CCCC2
3792;100614626;0.0138;203986;103282864;13781931;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N,N''-Bis(2-ethylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC=CC=C1NC(=NC2=CC=CC=C2CC)N
3793;407996348;0.0138;1946583;482056687;168276065;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;4-[[(3S)-3-[(4-methylphenyl)methoxy]piperidin-1-yl]methyl]benzonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=C(C=C1)CO[C@H]2CCCN(C2)CC3=CC=C(C=C3)C#N
3794;100367045;0.01382;226337;103376466;9802946;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-(1-Benzyl-4-piperidinyl)-4-iodophenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=C(C=C2)I)CC3=CC=CC=C3
3795;408003724;0.01382;1948317;494413581;171353666;10280;369199560;Confirmatory;20240503;0;0;Active;Q99720;Kd;=;ChEMBL;Displacement of (+)-pentazocine from sigma 1 receptor in human MCF7 cells assessed as dissociation constant in presence of 2-(3-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)propyl)-5-methoxy-3,4-dihydroisoquinolin-1(2H)-one incubated for 120 mins by sat;"6-[(2E)-3,3-dimethyl-2-[(2E,4E)-5-(1,3,3-trimethylindol-1-ium-2-yl)penta-2,4-dienylidene]indol-1-yl]-N-[1-(4-spiro[1H-2-benzofuran-3,4'-piperidine]-1'-ylbutyl)indol-6-yl]hexanamide;iodide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1(C2=CC=CC=C2[N+](=C1/C=C/C=C/C=C/3\C(C4=CC=CC=C4N3CCCCCC(=O)NC5=CC6=C(C=C5)C=CN6CCCCN7CCC8(CC7)C9=CC=CC=C9CO8)(C)C)C)C.[I-]
3796;100471333;0.014;204459;103282864;13781931;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N,N''-Bis(2-ethylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC=CC=C1NC(=NC2=CC=CC=C2CC)N
3797;100558835;0.014;203684;103389254;9864023;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;1-[4-(3-Phenylpropyl)piperazine-1-yl]-2-(4-nitrophenyl)ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)C(=O)CC3=CC=C(C=C3)[N+](=O)[O-]
3798;100614616;0.014;203986;103282324;9919363;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N,N''-Bis-(2-iodo-phenyl)-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC=C(C(=C1)NC(=NC2=CC=CC=C2I)N)I
3799;100721061;0.014;204634;103237081;44296655;10280;150260770;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma receptor type 1;{(4bS,8aR)-4b-[2-(tert-Butoxycarbonylmethyl-methyl-amino)-ethyl]-4b,5,6,7,8,8a-hexahydro-phenanthren-3-yloxy}-acetic acid tert-butyl ester;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC(=O)CN(C)CC[C@@]12CCCC[C@@H]1C=CC3=C2C=C(C=C3)OCC(=O)OC(C)(C)C
3800;100737196;0.014;203994;103227982;15034722;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor of guinea pig brain by using [3H]SKF-10047 radioligand;(5S)-5-[[4-(4-fluorophenyl)-4-hydroxypiperidin-1-yl]methyl]-3-(4-methoxyphenyl)-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)N2C[C@@H](OC2=O)CN3CCC(CC3)(C4=CC=C(C=C4)F)O
3801;255013345;0.014;625223;103605085;26987;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Clemastine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@](C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCC[C@H]3CCCN3C
3802;334065479;0.014;735278;164144049;71655418;10280;235606500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aS,5R,10bS)-5-cyclohexyl-9-(3-methylbutoxy)-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC(C)CCOC1=CC2=C(C=C1)N[C@@H]([C@H]3[C@@H]2OCCC3)C4CCCCC4
3803;366366395;0.014;1558961;440133193;118562522;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;4-(4-Methoxyphenyl)-2-methyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=CC=C(C=C4)OC
3804;366366401;0.014;1558961;440229161;118567534;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;CID 118567534;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=CN=CC(=C4)C(F)(F)F
3805;366366989;0.014;1558961;440143153;118562451;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;(2S)-2-methyl-4-phenyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C[C@H]1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=CC=CC=C4
3806;372306735;0.014;1701184;461555714;54673475;10280;332377850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;4-[2-[[1-(3,4-Dichlorophenyl)-5-methylpyrazol-3-yl]methoxy]ethyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)COCCN3CCOCC3
3807;372400426;0.014;1744234;461561918;162676329;10280;333727820;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane incubated for 2 hr by liquid scintillation counting method;5-(4-Tert-butylphenyl)-1-cyclopropyl-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;CC(C)(C)C1=CC=C(C=C1)C2=NC(=NN2C3CC3)CN4CCCC4
3808;380264144;0.014;1811100;475997919;126539563;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[2-(4-benzylpiperazin-1-yl)-2-methylpropyl]-N-phenylpropanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC(C)(C)N1CCN(CC1)CC2=CC=CC=C2)C3=CC=CC=C3
3809;380512652;0.014;1846430;482059757;44594288;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2S,6S)-4-benzyl-10-(3-fluorophenyl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@H]2[C@H](CN1CC3=CC=CC=C3)OCC4=C(N=NN24)C5=CC(=CC=C5)F
3810;380512734;0.014;1846430;482068443;86295555;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-10-(2-fluorophenyl)-4-(oxan-4-ylmethyl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCC1CN2C[C@@H]3[C@@H](C2)OCC4=C(N=NN34)C5=CC=CC=C5F
3811;388740375;0.014;1797293;386051128;118282969;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';Isoindoline derivative 2;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC(=C(C=C3C2)OC)OC
3812;388879200;0.014;1797475;386051128;118282969;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';Isoindoline derivative 2;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC(=C(C=C3C2)OC)OC
3813;389383757;0.014;1804286;386051128;118282969;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';Isoindoline derivative 2;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC(=C(C=C3C2)OC)OC
3814;407996161;0.014;1946583;482075207;168289523;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;6-chloro-2-[[4-[[3-(trifluoromethyl)phenyl]methoxy]piperidin-1-yl]methyl]-1H-indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=CC=C2)C(F)(F)F)CC3=CC4=C(N3)C=C(C=C4)Cl
3815;407996347;0.014;1946583;482056687;168276065;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;4-[[(3S)-3-[(4-methylphenyl)methoxy]piperidin-1-yl]methyl]benzonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=C(C=C1)CO[C@H]2CCCN(C2)CC3=CC=C(C=C3)C#N
3816;407996521;0.014;1946583;494407734;171350337;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;N-(3-chloro-2-methylphenyl)-2-[1-[(3,4-difluorophenyl)methyl]-1,7-diazaspiro[4.4]nonan-7-yl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC=C1Cl)NC(=O)CN2CCC3(C2)CCCN3CC4=CC(=C(C=C4)F)F
3817;100295635;0.0141;239200;103441939;785789;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;3-(4-Benzyl-piperazin-1-ylmethyl)-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2=CC=CC=C2)CC3=COC4=CC=CC=C4C3=O
3818;100627650;0.01413;204452;131279643;54583793;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-[(4-nitrophenyl)methyl]spiro[2,3-dihydro-1H-naphthalene-4,4'-piperidine];hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC2=CC=CC=C2C3(C1)CCN(CC3)CC4=CC=C(C=C4)[N+](=O)[O-].Cl
3819;407996522;0.01413;1946583;494407734;171350337;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;N-(3-chloro-2-methylphenyl)-2-[1-[(3,4-difluorophenyl)methyl]-1,7-diazaspiro[4.4]nonan-7-yl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC=C1Cl)NC(=O)CN2CCC3(C2)CCCN3CC4=CC(=C(C=C4)F)F
3820;100546838;0.0142;203685;103278409;10763386;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-Benzylpiperidine-4-yl)-2-(2,4-dinitrophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-])CC3=CC=CC=C3
3821;326035163;0.0142;701162;163314016;57705473;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;4-[2-[1-(3,4-Dichlorophenyl)-5-methylpyrazol-3-yl]sulfanylethyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)SCCN3CCOCC3
3822;100367077;0.01434;226337;103278445;119265;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;Reduced haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(C3=CC=C(C=C3)F)O
3823;100546839;0.01434;203685;103278445;119265;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;Reduced haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(C3=CC=C(C=C3)F)O
3824;100536562;0.0144;204457;103673519;45262069;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(2,6-Dichlorophenyl)-1-(3-ethylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)NC(=NC2=C(C=CC=C2Cl)Cl)N.Cl
3825;388996821;0.0144;1798943;405263573;86581556;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';2-(4-benzyl-piperidin-1-yl)-1-(3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)ethanone hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC(=O)N3CCN4C(=CC5=CC=CC=C54)C3
3826;407996162;0.01445;1946583;482075207;168289523;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;6-chloro-2-[[4-[[3-(trifluoromethyl)phenyl]methoxy]piperidin-1-yl]methyl]-1H-indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=CC=C2)C(F)(F)F)CC3=CC4=C(N3)C=C(C=C4)Cl
3827;340019940;0.0146;752341;103172342;3152;10280;235824490;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]DTG from sigma 1 receptor (unknown origin);Donepezil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC
3828;372338117;0.0146;1718166;103172342;3152;10280;331115250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]DTG binding to sigma 1 receptor (unknown origin);Donepezil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC
3829;388996782;0.0146;1798943;405263578;86581697;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';2-(azepan-1-yl)-1-(8-fluoro-3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCCN(CC1)CC(=O)N2CCN3C(=CC4=C3C=CC(=C4)F)C2
3830;100473781;0.01479;203852;103223856;5281878;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;trans-Flupentixol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC/C=C/2\C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO
3831;100322591;0.0148;204151;103382383;44361167;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 1 using [3H](+)-pentazocine in guinea pig brain membranes;N-Benzyl-2-[(1R,2S)-1,2-dihydro-2-ethylnaphthalene-1-yl]ethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC[C@H]1C=CC2=CC=CC=C2[C@@H]1CCNCC3=CC=CC=C3
3832;326034776;0.0148;701162;163331299;11718233;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;(2R,6S)-4-[4-[1-(3,4-dichlorophenyl)pyrazol-3-yl]oxybutyl]-2,6-dimethylmorpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C[C@@H]1CN(C[C@@H](O1)C)CCCCOC2=NN(C=C2)C3=CC(=C(C=C3)Cl)Cl
3833;326034944;0.0148;701162;163317465;71451632;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-[2-[1-(3,4-Dichlorophenyl)-5-methylpyrazol-3-yl]oxyethyl]-4-phenylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)OCCN3CCN(CC3)C4=CC=CC=C4
3834;100297835;0.015;239347;103186197;7333;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
3835;100298514;0.015;239347;103164917;5566;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;Trifluoperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F
3836;100440590;0.015;229192;103186197;7333;10280;14696970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of specific binding of [3H]NANM of sigma binding site in Guinea pig brain membranes;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
3837;100475276;0.015;204462;103673073;45261738;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;"1'-[(4-Tert-butylphenyl)methyl]spiro[3,4-dihydronaphthalene-2,4'-piperidine]-1-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC(C)(C)C1=CC=C(C=C1)CN2CCC3(CCC4=CC=CC=C4C3=O)CC2.Cl
3838;100614096;0.015;203986;103677558;14771712;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;"2-(3,5-Dimethyl-1-adamantyl)-1-(2-methylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC23CC4CC(C2)(CC(C4)(C3)C)C)N.Cl
3839;100617149;0.015;203985;103282979;14771694;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N''-Cyclohexyl-N-(2-methylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC2CCCCC2)N
3840;100736350;0.015;203993;103227944;15034723;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor from guinea pig brain using the radioligand [3H]SKF-10047;(5S)-5-[[4-[4-chloro-3-(trifluoromethyl)phenyl]-4-hydroxypiperidin-1-yl]methyl]-3-(4-methoxyphenyl)-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)N2C[C@@H](OC2=O)CN3CCC(CC3)(C4=CC(=C(C=C4)Cl)C(F)(F)F)O
3841;100737372;0.015;203993;103228641;15034737;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor from guinea pig brain using the radioligand [3H]SKF-10047;(5S)-5-[[4-(1,3-benzodioxol-5-yl)-4-hydroxypiperidin-1-yl]methyl]-3-(4-ethoxyphenyl)-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC1=CC=C(C=C1)N2C[C@@H](OC2=O)CN3CCC(CC3)(C4=CC5=C(C=C4)OCO5)O
3842;100742380;0.015;203987;103677443;45264555;10280;;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was evaluated for binding affinity against sigma opioid receptor using [3H]DTG radioligand in guinea pig membranes;"N,N'-bis(2-methylphenyl)ethanimidamide;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)C.Cl
3843;100746553;0.015;204019;103336155;44341014;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-SKF-10047 binding to sigma receptor;"(E)-N-(1-benzylpiperidin-4-yl)-3-phenylprop-2-enamide;(E)-but-2-enedioic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC(=O)/C=C/C2=CC=CC=C2)CC3=CC=CC=C3.C(=C/C(=O)O)\C(=O)O
3844;334065180;0.015;735278;164135613;71654695;10280;235606500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aS,5R,10bS)-5-(1-benzylpiperidin-4-yl)-9-(3-methylbutoxy)-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC(C)CCOC1=CC2=C(C=C1)N[C@@H]([C@H]3[C@@H]2OCCC3)C4CCN(CC4)CC5=CC=CC=C5
3845;363665764;0.015;1415921;404700588;78043801;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;N-[1-[2-(azepan-1-yl)ethyl]pyrazolo[3,4-d]pyrimidin-4-yl]tricyclo[3.3.1.03,7]nonane-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCCN(CC1)CCN2C3=NC=NC(=C3C=N2)NC(=O)C45CC6CC(C4)CC5C6
3846;366366654;0.015;1558961;440193669;118562556;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;4-(3-Methoxyphenyl)-2-methyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=CC(=CC=C4)OC
3847;366437012;0.015;1594271;103186197;7333;10280;309043830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
3848;366515838;0.015;1626255;103186197;7333;10280;273093760;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
3849;372306736;0.015;1701184;461545649;54673482;10280;332377850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;1-[4-[2-[[1-(3,4-Dichlorophenyl)-5-methylpyrazol-3-yl]methoxy]ethyl]piperazin-1-yl]ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)COCCN3CCN(CC3)C(=O)C
3850;380773462;0.015;1907474;482065364;168282372;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;Benzyl 3-[3-(4-cyclopentylpiperazin-1-yl)phenyl]morpholine-4-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)N2CCN(CC2)C3=CC=CC(=C3)C4COCCN4C(=O)OCC5=CC=CC=C5
3851;389483959;0.015;1805386;444858109;132060814;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A37;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCN(CC1)C2=CC3=C(CCCN(C3)C(=O)OCC4=CC=CC=C4)C=C2
3852;100387739;0.0151;204145;103389453;10893870;10280;123830180;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine from Sigma opioid receptor type 1 of guinea pig brain;ethyl 2-(1'-benzylspiro[1H-2-benzofuran-3,4'-piperidine]-1-yl)acetate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC(=O)CC1C2=CC=CC=C2C3(O1)CCN(CC3)CC4=CC=CC=C4
3853;100708108;0.0151;204146;103252864;11235994;10280;146843270;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma opioid receptor of guiena pig brain membrane;N-[2-(1,2,3,4-Tetrahydroisoquinoline-2-yl)ethyl]-1-methoxy-4-bromonaphthalene-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)NCCN3CCC4=CC=CC=C4C3
3854;100543224;0.0152;203699;103218438;10663237;10280;95728830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to sigma-1 sites in guinea pig brain membranes;(1R,9S,13S)-10-[2-(diethylamino)ethyl]-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCN(CC)CCN1CC[C@@]2([C@@H]([C@@H]1CC3=C2C=C(C=C3)O)C)C
3855;389712930;0.0153;1919146;476002741;163988742;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assay from US Patent US11535596: 'Analogs of dextromethorphan with balanced receptor activities';(1S)-3-bromo-4-(2,2-difluoroethoxy)-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@@]23CCCCC2C1CC4=C3C(=C(C=C4)OCC(F)F)Br
3856;100292954;0.0154;239105;103442113;11237443;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;1-Benzyl-4-(2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2COC3=CC=CC=C3O2)CC4=CC=CC=C4
3857;100367081;0.01541;226337;103376055;11733099;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-[1-(3-Iodobenzyl)-4-piperidinyl]-2-fluorophenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CC=C2F)CC3=CC(=CC=C3)I
3858;100403994;0.0155;204630;103249574;6472;10280;128012230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma receptor type 1 was determined by the displacement of [3H]pentazocine radioligand;Caramiphen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CC)CCOC(=O)C1(CCCC1)C2=CC=CC=C2
3859;354638179;0.0155;1276980;103472696;11558654;10280;267172070;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of 5-(Dimethylamino)-2-(6-((5-(4-(4-methylpiperidin-1-yl)butyl)-5,6,7,8-tetrahydronaphthalen-2-yl)oxy)hexyl)isoindoline-1,3-dione from sigma 1 receptor (unknown origin) expressed in MCF7 after 75 mins by flow cytometry;1-(4-(6-Methoxynaphthalen-1-yl)butyl)-4-methylpiperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;31.0;;;;CC1CCN(CC1)CCCCC2=CC=CC3=C2C=CC(=C3)OC
3860;100507186;0.0157;204150;103345960;10635235;10280;87844550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from Sigma opioid receptor type 1 in guinea pig brain membrane;[2-(2-Methoxy-phenyl)-ethyl]-methyl-(2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCC1=CC=CC=C1OC)CCN2CCCC2
3861;326034958;0.0157;701162;163327783;11652762;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-(3,4-Dichlorophenyl)-3-(2-pyrrolidin-1-ylethoxy)pyrazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(C1)CCOC2=NN(C=C2)C3=CC(=C(C=C3)Cl)Cl
3862;100536372;0.0158;204457;103673439;45262006;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(2-Chloro-3-ethyl-5-methylsulfanylphenyl)-1-(3-ethylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)NC(=NC2=CC(=CC(=C2Cl)CC)SC)N.Cl
3863;342816999;0.01585;1118248;242613625;90666086;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human recombinant sigma-1 receptor expressed in CHO cells after 180 mins by beta counting analysis;(1S,2S)-N-[2-(4-benzylpiperazin-1-yl)ethyl]-2-phenylcyclopropane-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;197.0;;;;C1CN(CCN1CCNC(=O)[C@H]2C[C@@H]2C3=CC=CC=C3)CC4=CC=CC=C4
3864;366437102;0.01585;1594273;440121446;146597626;10280;309043830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;[2-(4-Fluorophenyl)-5-[(4-fluorophenyl)methylamino]-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)C(=O)C2=C3CC(CCC3=NN2C4=CC=C(C=C4)F)NCC5=CC=C(C=C5)F
3865;100387472;0.0159;204145;103388670;10936501;10280;123830180;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine from Sigma opioid receptor type 1 of guinea pig brain;2-(1'-Benzylspiro[3,4-dihydroisochromene-1,4'-piperidine]-3-yl)acetonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3CC(O2)CC#N)CC4=CC=CC=C4
3866;100535942;0.0159;204457;103673553;45262092;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(2-Chlorophenyl)-1-(3-ethylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)NC(=NC2=CC=CC=C2Cl)N.Cl
3867;100292613;0.016;239200;103167216;3559;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3868;100297860;0.016;239347;103251246;10049124;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;1-(4-Fluorophenyl)-3-[4-[4-(4-fluorophenyl)piperidino]butyl]-1H-indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1C2=CC=C(C=C2)F)CCCCC3=CN(C4=CC=CC=C43)C5=CC=C(C=C5)F
3869;100448330;0.016;204471;103215226;14982995;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;7-[7-(4-Hydroxy-piperidin-1-yl)-heptyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCCOC2=CC3=C(C=C2)C(=O)C=C(O3)C4=CC=CC=C4
3870;100448372;0.016;204471;103215079;44285462;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-{6-[2-(2-Hydroxy-ethyl)-piperidin-4-yl]-hexyloxy}-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CNC(CC1CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4)CCO
3871;100614370;0.016;203986;103671994;45260896;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;"1,2-Bis(2-bicyclo[2.2.1]heptanyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2CC1CC2NC(=NC3CC4CCC3C4)N.Cl
3872;100614629;0.016;203986;103671880;14771674;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;"1,2-Bis(1-adamantyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C2CC3CC1CC(C2)(C3)NC(=NC45CC6CC(C4)CC(C6)C5)N.Cl
3873;100614745;0.016;203986;103671956;14771714;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;"2-(3,5-Dimethyl-1-adamantyl)-1-(2-iodophenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC12CC3CC(C1)(CC(C3)(C2)N=C(N)NC4=CC=CC=C4I)C.Cl
3874;100617158;0.016;203985;103282324;9919363;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N,N''-Bis-(2-iodo-phenyl)-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC=C(C(=C1)NC(=NC2=CC=CC=C2I)N)I
3875;100737355;0.016;203993;103228411;15034733;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor from guinea pig brain using the radioligand [3H]SKF-10047;(5S)-5-[[4-(1,3-benzodioxol-5-yl)-4-hydroxypiperidin-1-yl]methyl]-3-(4-fluorophenyl)-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC3=C(C=C2)OCO3)O)C[C@H]4CN(C(=O)O4)C5=CC=C(C=C5)F
3876;100737371;0.016;203993;103228520;15034727;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor from guinea pig brain using the radioligand [3H]SKF-10047;(5S)-5-[[4-(2,2-dimethyl-1,3-benzodioxol-5-yl)-4-hydroxypiperidin-1-yl]methyl]-3-(4-methoxyphenyl)-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1(OC2=C(O1)C=C(C=C2)C3(CCN(CC3)C[C@H]4CN(C(=O)O4)C5=CC=C(C=C5)OC)O)C
3877;100741789;0.016;203992;103671664;45260692;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"3-Phenyl-8-(2-phenylethyl)-1-oxa-8-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC12C(=O)C(=CO2)C3=CC=CC=C3)CCC4=CC=CC=C4.Cl
3878;100741869;0.016;203992;103671625;45260674;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"2-[3-(Diethylamino)propyl]-2-methyl-4-phenylfuran-3-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCN(CC)CCCC1(C(=O)C(=CO1)C2=CC=CC=C2)C.Cl
3879;100742382;0.016;203987;103260294;15379808;10280;;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was evaluated for binding affinity against sigma opioid receptor using [3H]DTG radioligand in guinea pig membranes;N,N'-Bis(1-adamantyl)ethanimidamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=NC12CC3CC(C1)CC(C3)C2)NC45CC6CC(C4)CC(C6)C5
3880;100746557;0.016;204019;103335863;44340879;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-SKF-10047 binding to sigma receptor;"1-benzyl-N-[(E)-3-phenylprop-2-enyl]piperidin-4-amine;(E)-but-2-enedioic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1NC/C=C/C2=CC=CC=C2)CC3=CC=CC=C3.C(=C/C(=O)O)\C(=O)O
3881;101829964;0.016;255065;103468568;11558686;10280;161400090;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory activity against opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 degree C ;(10aS)-2-(2-piperidin-1-ylethyl)-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CCN(CC1)CCN2C(=O)[C@@H]3CC4=CC=CC=C4CN3C2=O
3882;101830499;0.016;255057;103468568;11558686;10280;161400110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory concentration against opioid receptor sigma 1 of guinea pig cerebral cortex using [3H](+)-pentazocine upon incubation for 150 minutes at 22 degree C;(10aS)-2-(2-piperidin-1-ylethyl)-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CCN(CC1)CCN2C(=O)[C@@H]3CC4=CC=CC=C4CN3C2=O
3883;326034625;0.016;701162;163314040;11532920;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;3-{1-[2-(1-(3,4-Dichlorophenyl)-5-methyl-1H-pyrazol-3-yloxy)ethyl]piperidin-4-yl}-3H-imidazo[4,5-b]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)OCCN3CCC(CC3)N4C=NC5=C4N=CC=C5
3884;363665984;0.016;1415921;404717199;71223000;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;N-(1-(2-(azepan-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)cyclopentanecarboxamide maleate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCCN(CC1)CCN2C3=NC=NC(=C3C=N2)NC(=O)C4CCCC4
3885;365267551;0.016;1512456;440171256;148302367;10280;316202300;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3S,4S)-4-ethyl-3-methyl-6-phenyl-2,4-dihydrochromen-3-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC[C@H]1C2=C(C=CC(=C2)C3=CC=CC=C3)OC[C@@]1(C)N
3886;366435754;0.016;1593893;440192889;155554837;10280;309877800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK293T cell membranes;2-[2-[4-(5-Chloropyridin-2-yl)-1,4-diazepan-1-yl]ethyl]-5-fluoro-2,3-dihydroinden-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=NC=C(C=C2)Cl)CCC3CC4=C(C3=O)C=CC(=C4)F
3887;372338116;0.016;1718139;404719272;11338749;10280;331115250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of (+)-pentazocine binding to human sigma 1 receptor expressed in human Jurkat cell membranes;T-817 maleate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C(CN1CCCOCCC2=CC3=C(C=C2)SC=C3)O.C(=C\C(=O)O)\C(=O)O
3888;380512529;0.016;1846430;482058836;168277601;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6S)-4-benzyl-10-(3-fluorophenyl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@@H]2[C@H](CN1CC3=CC=CC=C3)OCC4=C(N=NN24)C5=CC(=CC=C5)F
3889;380512649;0.016;1846430;482058337;74336706;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;4-Benzyl-10-(3-fluorophenyl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C2C(CN1CC3=CC=CC=C3)OCC4=C(N=NN24)C5=CC(=CC=C5)F
3890;380512651;0.016;1846430;482057767;86295561;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2S,6S)-10-(2-fluorophenyl)-4-(oxan-4-ylmethyl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCC1CN2C[C@H]3[C@H](C2)OCC4=C(N=NN34)C5=CC=CC=C5F
3891;380581322;0.016;1861723;482077375;41306366;10280;357249250;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay;N-[3-[benzyl(methyl)amino]propyl]quinoline-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=NC2=CC=CC=C2C=C1)CC3=CC=CC=C3
3892;388740019;0.016;1797293;386051268;118282975;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 23;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC=C(C=C1)F)N2CC3=CC4=C(C=C3C2)OCO4
3893;388878692;0.016;1797475;386051268;118282975;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 23;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC=C(C=C1)F)N2CC3=CC4=C(C=C3C2)OCO4
3894;389383286;0.016;1804286;386051268;118282975;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 23;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC=C(C=C1)F)N2CC3=CC4=C(C=C3C2)OCO4
3895;407906197;0.016;1922160;404650190;9901946;10280;362020630;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);Edonerpic;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C(CN1CCCOCCC2=CC3=C(C=C2)SC=C3)O
3896;407996266;0.016;1946583;494409998;171351690;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[1-[(3,4-difluorophenyl)methyl]-1,7-diazaspiro[4.4]nonan-7-yl]-N-(4-fluoro-3-methylphenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC(=C1)NC(=O)CN2CCC3(C2)CCCN3CC4=CC(=C(C=C4)F)F)F
3897;100438238;0.01605;204445;103374110;10017724;10280;14477350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor using [3H](+)-pentazocine in guinea pig brain homogenates;[(1-Ethylpyrrolidin-2-yl)methyl](3,4-dichlorophenethyl)amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCN1CCCC1CNCCC2=CC(=C(C=C2)Cl)Cl
3898;326035321;0.0161;701162;163334766;71460640;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;4-[3-[1-(3,4-Dichlorophenyl)pyrazol-3-yl]oxypropyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1COCCN1CCCOC2=NN(C=C2)C3=CC(=C(C=C3)Cl)Cl
3899;100292830;0.0162;239105;103442127;11189143;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;4-Benzyl-1-(2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3COC4=CC=CC=C4O3
3900;100627352;0.01622;204452;131283678;54585733;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-(Pyridin-2-ylmethyl)spiro[1,2-dihydroindene-3,4'-piperidine];hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC2(CCN(CC2)CC3=CC=CC=N3)C4=CC=CC=C41.Cl
3901;366435753;0.01622;1593893;440192889;155554837;10280;309877800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK293T cell membranes;2-[2-[4-(5-Chloropyridin-2-yl)-1,4-diazepan-1-yl]ethyl]-5-fluoro-2,3-dihydroinden-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=NC=C(C=C2)Cl)CCC3CC4=C(C3=O)C=CC(=C4)F
3902;380773276;0.01622;1907474;482065364;168282372;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;Benzyl 3-[3-(4-cyclopentylpiperazin-1-yl)phenyl]morpholine-4-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)N2CCN(CC2)C3=CC=CC(=C3)C4COCCN4C(=O)OCC5=CC=CC=C5
3903;407996267;0.01622;1946583;494409998;171351690;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[1-[(3,4-difluorophenyl)methyl]-1,7-diazaspiro[4.4]nonan-7-yl]-N-(4-fluoro-3-methylphenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC(=C1)NC(=O)CN2CCC3(C2)CCCN3CC4=CC(=C(C=C4)F)F)F
3904;100449427;0.0163;204443;103274771;44314138;10280;83608750;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine at sigma receptor in guinea pig brain membrane was determined;[2-(3,4-Dichloro-phenyl)-ethyl]-(1-piperidin-1-yl-cyclohexylmethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)(CNCCC2=CC(=C(C=C2)Cl)Cl)N3CCCCC3
3905;100478417;0.0164;203696;103186083;10467461;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;Methyl-((S)-1-methyl-2-phenyl-ethyl)-phenethyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](CC1=CC=CC=C1)N(C)CCC2=CC=CC=C2
3906;326034948;0.0165;701162;163320935;71453464;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-[3-[1-(3,4-Dichlorophenyl)pyrazol-3-yl]oxypropyl]-4-methylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CN1CCN(CC1)CCCOC2=NN(C=C2)C3=CC(=C(C=C3)Cl)Cl
3907;100496823;0.01653;204761;103401507;10025852;10280;78533490;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity at Sigma receptor type 1, displacement of [3H](+)-pentazocine from guinea pig brain membranes;(1S,9S,13S)-10-[(4-iodophenyl)methyl]-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC4=CC=C(C=C4)I)C)C=C(C=C3)O
3908;100323562;0.0166;204151;103382921;14941803;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 1 using [3H](+)-pentazocine in guinea pig brain membranes;N-Benzyl-2-[(1S,2R)-1,2-dihydro-2-ethylnaphthalene-1-yl]ethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC[C@@H]1C=CC2=CC=CC=C2[C@H]1CCNCC3=CC=CC=C3
3909;100627933;0.0166;204453;103671432;45260527;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"(4aR,10bR)-3-(pyridin-2-ylmethyl)-2,4,4a,5,6,10b-hexahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC2=CC=CC=C2[C@H]3[C@@H]1CN(CC3)CC4=CC=CC=N4.Cl
3910;100628001;0.0166;204453;103677360;45264502;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;3-(2-phenylethyl)-1H,2H,3H,4H,5H,6H-benzo[f]isoquinoline hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC2=CC=CC=C2C3=C1CN(CC3)CCC4=CC=CC=C4.Cl
3911;112788084;0.0166;204633;103385744;10596136;10280;74907270;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to inhibit [3H](+)-pentazocine binding to guinea pig brain Sigma receptor type 1;(8E)-5-(3-hydroxyphenyl)-2-methyl-8-(naphthalen-2-ylmethylidene)-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1/C(=C\C3=CC4=CC=CC=C4C=C3)/C(=O)C2)C5=CC(=CC=C5)O
3912;100354293;0.0167;204790;103237772;10696254;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-[[(2S)-1-(Bicyclo[3.3.1]nonane-9-yl)-2-pyrrolidinyl]methyl]-1-methoxy-4-bromo-2-naphthalenecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)NC[C@@H]3CCCN3C4C5CCCC4CCC5
3913;326035322;0.0167;701162;163317467;11667265;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-[2-[1-(3,4-Dichlorophenyl)pyrazol-3-yl]oxyethyl]piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)CCOC2=NN(C=C2)C3=CC(=C(C=C3)Cl)Cl
3914;100496818;0.01676;204761;103401577;10426298;10280;78533490;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity at Sigma receptor type 1, displacement of [3H](+)-pentazocine from guinea pig brain membranes;(1S,9S,13S)-10-[(4-aminophenyl)methyl]-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC4=CC=C(C=C4)N)C)C=C(C=C3)O
3915;373950060;0.0169;1779772;469801699;164606754;10280;344139640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of human sigma1 receptor by radioligand binding assay;(3aS,6aR)-2-(oxan-4-ylmethyl)-N-[6-(2,3,5-trifluorophenyl)pyridazin-3-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-5-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCC1CN2C[C@H]3CC(C[C@H]3C2)NC4=NN=C(C=C4)C5=C(C(=CC(=C5)F)F)F
3916;100473784;0.01698;203852;103321743;15657199;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;"cis-7-Dimethylamino-5-phenyl-5,6,7,8-tetrahydro-naphthalene-2,3-diol; hydrobromide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)C1CC(C2=CC(=C(C=C2C1)O)O)C3=CC=CC=C3
3917;100439965;0.017;229188;103167216;3559;10280;14696970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of specific binding of [3H]3-PPP to sigma binding site in Guinea pig brain membranes;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
3918;100513231;0.017;229200;103196493;3456;10280;89413830;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor using radioligand ([3H](+)-pentazocine) binding assay;1-[2-(Diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)CCOC(C3=CC=CC=C3)C4=CC=CC=C4
3919;100539433;0.017;204458;103196493;3456;10280;90578570;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Sigma receptor binding was determined by labeling with radioligand [3H](+)-pentazocine on frozen membranes obtained from frozen guinea pig brain;1-[2-(Diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)CCOC(C3=CC=CC=C3)C4=CC=CC=C4
3920;100619856;0.017;203991;103185859;131444;10280;18482950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma opioid receptor was determined in guinea pig cerebral homogenate using [3H]haloperidol as radioligand;((R)-1-Methyl-2-phenyl-ethyl)-(3-phenyl-propyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CC1=CC=CC=C1)NCCCC2=CC=CC=C2
3921;100622184;0.017;203982;103240949;15065448;10280;16481400;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H]DTG from sigma opioid receptor of homogenized guinea pig whole brain;1-(1-Adamantyl)-3-(2-methoxyphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC=CC=C1NC(=NC23CC4CC(C2)CC(C4)C3)N
3922;100722937;0.017;204635;103196273;4910;10280;150810120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma receptor type 1,using [3H](+)-pentazocine as radioligand;Proadifen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)OCCN(CC)CC
3923;100737367;0.017;203993;103228323;15034730;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor from guinea pig brain using the radioligand [3H]SKF-10047;(5S)-5-[[4-(2,3-dihydro-1-benzofuran-5-yl)-4-hydroxypiperidin-1-yl]methyl]-3-(4-methoxyphenyl)-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)N2C[C@@H](OC2=O)CN3CCC(CC3)(C4=CC5=C(C=C4)OCC5)O
3924;100741792;0.017;203992;103677401;45264529;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"8-[4-(4-Fluorophenyl)-4-oxobutyl]-3-phenyl-1-oxa-8-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC12C(=O)C(=CO2)C3=CC=CC=C3)CCCC(=O)C4=CC=C(C=C4)F.Cl
3925;100746113;0.017;204147;103266220;21481466;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma opioid receptor type 1 in guinea pig brain homogenate with 0.5 nM [3H](+)-PENT;5,5-Diphenyl-3-[2-(4-phenyl-piperidin-1-yl)-ethyl]-imidazolidine-2,4-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1C2=CC=CC=C2)CCN3C(=O)C(NC3=O)(C4=CC=CC=C4)C5=CC=CC=C5
3926;237864818;0.017;619421;103252427;9829526;10280;218999310;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor;Siramesine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3CO2)CCCCC4=CN(C5=CC=CC=C54)C6=CC=C(C=C6)F
3927;255036190;0.017;625223;103224720;1547484;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cinnarizine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=CC=C4
3928;326034952;0.017;701162;163334751;44247568;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;4-(2-((5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yl)oxy)ethyl)morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)OCCN4CCOCC4
3929;334065177;0.017;735278;163334751;44247568;10280;235606500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;4-(2-((5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yl)oxy)ethyl)morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)OCCN4CCOCC4
3930;342797729;0.017;1143314;103252427;9829526;10280;248213980;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin);Siramesine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3CO2)CCCCC4=CN(C5=CC=CC=C54)C6=CC=C(C=C6)F
3931;342804585;0.017;1127667;103252427;9829526;10280;237346340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 opioid receptor (unknown origin);Siramesine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3CO2)CCCCC4=CN(C5=CC=CC=C54)C6=CC=C(C=C6)F
3932;345602972;0.017;1200082;163334751;44247568;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;4-(2-((5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yl)oxy)ethyl)morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)OCCN4CCOCC4
3933;363476483;0.017;1353758;103252427;9829526;10280;294388910;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin);Siramesine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3CO2)CCCCC4=CN(C5=CC=CC=C54)C6=CC=C(C=C6)F
3934;363665113;0.017;1415967;163334751;44247568;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(2-((5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yl)oxy)ethyl)morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)OCCN4CCOCC4
3935;363665987;0.017;1415921;163334751;44247568;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;4-(2-((5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yl)oxy)ethyl)morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)OCCN4CCOCC4
3936;366366398;0.017;1558961;163334751;44247568;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;4-(2-((5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yl)oxy)ethyl)morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)OCCN4CCOCC4
3937;366437013;0.017;1594271;163334751;44247568;10280;309043830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(2-((5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yl)oxy)ethyl)morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)OCCN4CCOCC4
3938;366437103;0.017;1594273;440121446;146597626;10280;309043830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;[2-(4-Fluorophenyl)-5-[(4-fluorophenyl)methylamino]-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)C(=O)C2=C3CC(CCC3=NN2C4=CC=C(C=C4)F)NCC5=CC=C(C=C5)F
3939;372121194;0.017;1681775;163334751;44247568;10280;330649470;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;4-(2-((5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yl)oxy)ethyl)morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)OCCN4CCOCC4
3940;372306739;0.017;1701184;163334751;44247568;10280;332377850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;4-(2-((5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yl)oxy)ethyl)morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)OCCN4CCOCC4
3941;372356136;0.017;1726849;163334751;44247568;10280;342231650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]pentazocine from human sigma 1 receptor expressed in HEK293 cell membrane incubated for 2 hrs by liquid scintillation counting method;4-(2-((5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yl)oxy)ethyl)morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)OCCN4CCOCC4
3942;372400773;0.017;1744259;163334751;44247568;10280;333727820;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to human sigma-1 receptor;4-(2-((5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yl)oxy)ethyl)morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)OCCN4CCOCC4
3943;380263966;0.017;1811100;475980044;126509438;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[1-(4-benzylpiperazin-1-yl)cyclopropyl]methyl]-N-(2-fluorophenyl)propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CC1)N2CCN(CC2)CC3=CC=CC=C3)C4=CC=CC=C4F
3944;380263968;0.017;1811100;163334751;44247568;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;4-(2-((5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yl)oxy)ethyl)morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)OCCN4CCOCC4
3945;380512732;0.017;1846430;163334751;44247568;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;4-(2-((5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yl)oxy)ethyl)morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)OCCN4CCOCC4
3946;380600312;0.017;1866071;482066355;168283109;10280;350338840;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Antagonist activity at sigma1 receptor (unknown origin);4-[2-(5-Methyl-1-naphthalen-1-ylpyrazol-3-yl)oxyethyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=NN1C2=CC=CC3=CC=CC=C32)OCCN4CCOCC4
3947;388740025;0.017;1797293;386051085;118282963;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 9;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C(=CC=C3)F
3948;388740026;0.017;1797293;386051308;118282908;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 63;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)(C)C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
3949;388878705;0.017;1797475;386051308;118282908;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 63;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)(C)C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
3950;388878706;0.017;1797475;386051085;118282963;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 9;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C(=CC=C3)F
3951;389383352;0.017;1804286;386051308;118282908;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 63;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)(C)C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
3952;389383432;0.017;1804286;386051085;118282963;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 9;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C(=CC=C3)F
3953;407906155;0.017;1922166;163334751;44247568;10280;362020630;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to human sigma 1 receptor;4-(2-((5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yl)oxy)ethyl)morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)OCCN4CCOCC4
3954;407906192;0.017;1922160;103722307;9795739;10280;362020630;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);Pridopidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCC(CC1)C2=CC(=CC=C2)S(=O)(=O)C
3955;326034762;0.0172;701162;163327782;11494142;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;4-[1-(3,4-dichlorophenyl)pyrazol-3-yl]oxy-N,N-diethylbutan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCN(CC)CCCCOC1=NN(C=C1)C2=CC(=C(C=C2)Cl)Cl
3956;100322588;0.0173;204151;103382359;10802506;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 1 using [3H](+)-pentazocine in guinea pig brain membranes;Benzyl-[2-((1R,2S)-2-methyl-1,2-dihydro-naphthalen-1-yl)-ethyl]-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@H]1C=CC2=CC=CC=C2[C@@H]1CCNCC3=CC=CC=C3
3957;100536812;0.0173;204457;103673665;45262176;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-[2-Chloro-3-ethyl-5-(trifluoromethyl)phenyl]-1-(3-ethylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)NC(=NC2=CC(=CC(=C2Cl)CC)C(F)(F)F)N.Cl
3958;363859520;0.0173;1467149;103458196;93365;10280;284950850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of (+)-[3H]-pentazocine from recombinant human sigma 1 receptor expressed in baculovirus infected Sf9 insect cell membranes after 90 mins by scintillation counting method;Fenpropimorph;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(C[C@@H](O1)C)CC(C)CC2=CC=C(C=C2)C(C)(C)C
3959;389510954;0.0173;1805565;459070364;118250113;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Pharmacological Activity Assay from US Patent US11007200: 'Cycloalkyl-diamines for the treatment of pain';US11007200, Example 2a;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN[C@@]1(CCCC[C@@H]1NCCCN2CCCC2)C3=CC=CC=C3Cl
3960;389686469;0.0173;1806763;459070364;118250113;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Pharmacological Activity from US Patent US11426411: 'Cycloalkyl-diamines for the treatment of inflammation';US11007200, Example 2a;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN[C@@]1(CCCC[C@@H]1NCCCN2CCCC2)C3=CC=CC=C3Cl
3961;100473780;0.01738;203852;103321590;42601815;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;7-dimethylamino-5-phenyl-6,7,8,9-tetrahydro [5H] benzocycloheptene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)C1CCC2=CC=CC=C2C(C1)C3=CC=CC=C3
3962;100534028;0.01749;204794;103358519;44350537;10280;93971710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was done in guinea pig membranes by labeling the binding site with [3H](+)-pentazocine;1-(4-Bromo-phenyl)-2-(3-phenyl-8-aza-bicyclo[3.2.1]oct-8-yl)-ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2CC(CC1N2CC(C3=CC=C(C=C3)Br)O)C4=CC=CC=C4
3963;100622103;0.0176;203998;103185251;15061888;10280;16481390;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]DTG binding to Sigma opioid receptor;(1-Methyl-2-naphthalen-1-yl-ethyl)-(3-phenyl-propyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(CC1=CC=CC2=CC=CC=C21)NCCCC3=CC=CC=C3
3964;326035169;0.0176;701162;163324292;11617627;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;4-[4-[1-(3,4-Dichlorophenyl)pyrazol-3-yl]oxybutyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1COCCN1CCCCOC2=NN(C=C2)C3=CC(=C(C=C3)Cl)Cl
3965;100478424;0.0177;203696;103184732;44272667;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;[(S)-2-(4-Iodo-phenyl)-1-methyl-ethyl]-(3-phenyl-propyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](CC1=CC=C(C=C1)I)NCCCC2=CC=CC=C2
3966;326035164;0.0178;701162;163320918;71453456;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;4-[2-[1-(4-Chlorophenyl)pyrazol-3-yl]oxyethyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1COCCN1CCOC2=NN(C=C2)C3=CC=C(C=C3)Cl
3967;100292953;0.018;239105;103442161;11168272;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;3-(4-Benzyl-piperazin-1-ylmethyl)-chroman-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2COC3=CC=CC=C3C2=O)CC4=CC=CC=C4
3968;100441643;0.018;229186;103186197;7333;10280;14696970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of specific binding of [125I]-PIPAG to sigma binding site in Guinea pig brain membranes;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
3969;100546180;0.018;203685;103277881;11792375;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-Benzylpiperidine-4-yl)-2-(4-nitrophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=C(C=C2)[N+](=O)[O-])CC3=CC=CC=C3
3970;100614375;0.018;203986;103672006;45260905;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;"1-(2-Iodophenyl)-2-(1,7,7-trimethyl-2-bicyclo[2.2.1]heptanyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1(C2CCC1(C(C2)N=C(N)NC3=CC=CC=C3I)C)C.Cl
3971;100708109;0.018;204146;103238193;10599447;10280;146843270;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma opioid receptor of guiena pig brain membrane;N-[[(2R)-1-Cyclohexyl-2-pyrrolidinyl]methyl]-1-methoxy-4-bromo-2-naphthalenecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)NC[C@H]3CCCN3C4CCCCC4
3972;100737357;0.018;203993;103228554;15034725;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor from guinea pig brain using the radioligand [3H]SKF-10047;(5S)-5-[[4-(3,4-dimethoxyphenyl)-4-hydroxypiperidin-1-yl]methyl]-3-(4-methoxyphenyl)-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)N2C[C@@H](OC2=O)CN3CCC(CC3)(C4=CC(=C(C=C4)OC)OC)O
3973;100746455;0.018;204018;103277595;44315537;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor using [3H](+)-SKF-10047 as radioligand;1-[2-(4-Fluoro-phenyl)-ethyl]-4-[2-(3-phenyl-prop-2-ynyloxy)-ethyl]-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CCOCC#CC2=CC=CC=C2)CCC3=CC=C(C=C3)F
3974;100746457;0.018;204018;103278324;44315830;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor using [3H](+)-SKF-10047 as radioligand;4-((E)-3-Phenyl-allyloxymethyl)-1-(3-phenyl-propyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1COC/C=C/C2=CC=CC=C2)CCCC3=CC=CC=C3
3975;345681161;0.018;1174258;312374351;118724307;10280;254622400;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor in human Jurkat cell membranes incubated for 2 hrs by liquid scintillation counting;N-methyl-3-phenoxazin-10-yl-N-(2-phenylethyl)propan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1C2=CC=CC=C2OC3=CC=CC=C31)CCC4=CC=CC=C4
3976;345681162;0.018;1174258;312374341;118724297;10280;254622400;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor in human Jurkat cell membranes incubated for 2 hrs by liquid scintillation counting;N-benzyl-N-methyl-3-(1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)propan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1CCC2=C(C1)C3=CC=CC=C3N2)CC4=CC=CC=C4
3977;363665983;0.018;1415921;404700458;71222985;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;N-(1-(2-(Azepan-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)cyclohexanecarboxamide maleate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCCN(CC1)CCN2C3=NC=NC(=C3C=N2)NC(=O)C4CCCCC4
3978;367490641;0.018;1661755;442063392;156021463;10280;328320230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from recombinant sigma 1 receptor (unknown origin) expressed in baculovirus infected Sf9 cell membranes after 1.5 hrs by scintillation counting analysis;4-[[1-[5-(Trifluoromethyl)pyridin-2-yl]piperidin-4-yl]amino]oxan-3-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;521.0;;;;C1CN(CCC1NC2CCOCC2O)C3=NC=C(C=C3)C(F)(F)F
3979;380773275;0.018;1907474;482086678;168297018;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;Benzyl 2-[3-[4-(3-hydroxypropyl)piperazin-1-yl]phenyl]piperidine-1-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(C(C1)C2=CC(=CC=C2)N3CCN(CC3)CCCO)C(=O)OCC4=CC=CC=C4
3980;388740022;0.018;1797293;386051282;118282836;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 38;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(C)C)OC(C)C)N2CC3=C(C2)C=C(C=C3)F
3981;388878693;0.018;1797475;386051282;118282836;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 38;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(C)C)OC(C)C)N2CC3=C(C2)C=C(C=C3)F
3982;389383287;0.018;1804286;386051282;118282836;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 38;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(C)C)OC(C)C)N2CC3=C(C2)C=C(C=C3)F
3983;407996167;0.018;1946583;494395306;171342680;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(2S)-4-(3H-benzimidazol-5-ylmethyl)-2-[(3,4-difluorophenoxy)methyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CO[C@@H](CN1CC2=CC3=C(C=C2)N=CN3)COC4=CC(=C(C=C4)F)F
3984;100536555;0.0182;204457;103673496;45262050;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(2,5-Dibromo-3-ethylphenyl)-1-(3-ethylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)NC(=NC2=CC(=CC(=C2Br)CC)Br)N.Cl
3985;100627655;0.0182;204452;131275605;54581854;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-prop-2-enylspiro[2,3-dihydro-1H-naphthalene-4,4'-piperidine];hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C=CCN1CCC2(CCCC3=CC=CC=C32)CC1.Cl
3986;380773274;0.0182;1907474;482086678;168297018;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;Benzyl 2-[3-[4-(3-hydroxypropyl)piperazin-1-yl]phenyl]piperidine-1-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(C(C1)C2=CC(=CC=C2)N3CCN(CC3)CCCO)C(=O)OCC4=CC=CC=C4
3987;407996168;0.0182;1946583;494395306;171342680;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(2S)-4-(3H-benzimidazol-5-ylmethyl)-2-[(3,4-difluorophenoxy)methyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CO[C@@H](CN1CC2=CC3=C(C=C2)N=CN3)COC4=CC(=C(C=C4)F)F
3988;407996514;0.0182;1946583;482049009;168270563;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;6-[[4-[(3,4-difluorophenyl)methoxy]piperidin-1-yl]methyl]-1H-benzimidazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=C(C=C2)F)F)CC3=CC4=C(C=C3)N=CN4
3989;100323563;0.0184;204151;103382754;44361297;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 1 using [3H](+)-pentazocine in guinea pig brain membranes;(1S,9S,13S)-10-benzyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1[C@@H]2CC3=CC=CC=C3[C@]1(CCN2CC4=CC=CC=C4)C
3990;100485148;0.0184;204636;103317801;15767676;10280;76368600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured on Sigma receptor type 1 from guinea pig brain membranes using [3H]pentazocine as radioligand.;10-Benzyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1C2CC3=CC=CC=C3C1(CCN2CC4=CC=CC=C4)C
3991;112788087;0.0184;204633;103385146;10546961;10280;74907270;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to inhibit [3H](+)-pentazocine binding to guinea pig brain Sigma receptor type 1;(8E)-8-[(4-chlorophenyl)methylidene]-5-(3-hydroxyphenyl)-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1/C(=C\C3=CC=C(C=C3)Cl)/C(=O)C2)C4=CC(=CC=C4)O
3992;112788093;0.0184;204633;103385149;10713756;10280;74907270;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to inhibit [3H](+)-pentazocine binding to guinea pig brain Sigma receptor type 1;(8E)-5-(3-hydroxyphenyl)-8-[(4-methoxyphenyl)methylidene]-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1/C(=C\C3=CC=C(C=C3)OC)/C(=O)C2)C4=CC(=CC=C4)O
3993;100485158;0.0185;204636;103318492;15767683;10280;76368600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured on Sigma receptor type 1 from guinea pig brain membranes using [3H]pentazocine as radioligand.;10-Benzyl-4-bromo-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)Br
3994;100536813;0.0185;204457;103678110;45265059;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(2-Ethylphenyl)-1-(3-ethylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)NC(=NC2=CC=CC=C2CC)N.Cl
3995;100481150;0.0186;204639;103420799;44378807;10280;78372400;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity towards Sigma receptor type 1 was determined by measuring its ability to displace [3H](+)-pentazocine from guinea pig brain membrane;1-Methyl-4-(4-propylsulfanyl-[1,2,5]thiadiazol-3-yl)-1,2,3,6-tetrahydro-pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCSC1=NSN=C1C2=CCN(CC2)C
3996;407996416;0.01862;1946583;482062057;168279962;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(3S)-1-[(3-fluorophenyl)methyl]-3-[(4-methylphenyl)methoxy]piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=C(C=C1)CO[C@H]2CCCN(C2)CC3=CC(=CC=C3)F
3997;408003700;0.01866;1948316;494413581;171353666;10280;369199560;Confirmatory;20240503;0;0;Active;Q99720;Kd;=;ChEMBL;Displacement of (+)-pentazocine from sigma 1 receptor in human MCF7 cells assessed as dissociation constant in presence of DTG incubated for 120 mins by saturation binding assay;"6-[(2E)-3,3-dimethyl-2-[(2E,4E)-5-(1,3,3-trimethylindol-1-ium-2-yl)penta-2,4-dienylidene]indol-1-yl]-N-[1-(4-spiro[1H-2-benzofuran-3,4'-piperidine]-1'-ylbutyl)indol-6-yl]hexanamide;iodide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1(C2=CC=CC=C2[N+](=C1/C=C/C=C/C=C/3\C(C4=CC=CC=C4N3CCCCCC(=O)NC5=CC6=C(C=C5)C=CN6CCCCN7CCC8(CC7)C9=CC=CC=C9CO8)(C)C)C)C.[I-]
3998;100438228;0.01868;204445;103321526;10369311;10280;14477350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor using [3H](+)-pentazocine in guinea pig brain homogenates;3,4-Dichloro-N-methyl-N-[(1R,2S)-2-(1-pyrrolidinyl)cyclohexyl]benzeneethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCC1=CC(=C(C=C1)Cl)Cl)[C@@H]2CCCC[C@@H]2N3CCCC3
3999;100546611;0.0188;203685;103278291;10711119;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-Benzylpiperidine-4-yl)-2-(2-hydroxyphenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CC=C2O)CC3=CC=CC=C3
4000;326034959;0.0189;701162;163338184;71462356;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;4-[3-[1-(3,4-Dichlorophenyl)-5-methylpyrazol-3-yl]oxypropyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)OCCCN3CCOCC3
4001;100444463;0.019;204470;103215226;14982995;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;7-[7-(4-Hydroxy-piperidin-1-yl)-heptyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCCOC2=CC3=C(C=C2)C(=O)C=C(O3)C4=CC=CC=C4
4002;100475265;0.019;204462;103673069;45261734;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;"2-[1-[[4-(trifluoromethyl)phenyl]methyl]piperidin-4-yl]-3,4-dihydro-2H-naphthalen-1-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2=CC=CC=C2C(=O)C1C3CCN(CC3)CC4=CC=C(C=C4)C(F)(F)F.Cl
4003;100737363;0.019;203993;103228521;3047810;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor from guinea pig brain using the radioligand [3H]SKF-10047;Panamesine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)N2C[C@@H](OC2=O)CN3CCC(CC3)(C4=CC5=C(C=C4)OCO5)O
4004;100737366;0.019;203993;103228173;15034724;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor from guinea pig brain using the radioligand [3H]SKF-10047;(5S)-5-[[4-hydroxy-4-(4-methylphenyl)piperidin-1-yl]methyl]-3-(4-methoxyphenyl)-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=C(C=C1)C2(CCN(CC2)C[C@H]3CN(C(=O)O3)C4=CC=C(C=C4)OC)O
4005;100737368;0.019;203993;103227772;15034744;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor from guinea pig brain using the radioligand [3H]SKF-10047;(5S)-5-[[4-(1,3-benzodioxol-5-yl)piperidin-1-yl]methyl]-3-(4-methoxyphenyl)-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)N2C[C@@H](OC2=O)CN3CCC(CC3)C4=CC5=C(C=C4)OCO5
4006;100746099;0.019;204298;103264863;44309297;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma opioid receptor type 2 in guinea pig brain homogenate with 4 nM [3H]-(+)-DTG;5,5-Diphenyl-3-[5-(4-phenyl-piperazin-1-yl)-pentyl]-imidazolidine-2,4-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCCCCN2C(=O)C(NC2=O)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=CC=C5
4007;100746118;0.019;204147;103264863;44309297;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma opioid receptor type 1 in guinea pig brain homogenate with 0.5 nM [3H](+)-PENT;5,5-Diphenyl-3-[5-(4-phenyl-piperazin-1-yl)-pentyl]-imidazolidine-2,4-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCCCCN2C(=O)C(NC2=O)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=CC=C5
4008;334065474;0.019;735278;164132794;71655413;10280;235606500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aS,5R,10bS)-5-cyclohexyl-9-pentyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCCCCC1=CC2=C(C=C1)N[C@@H]([C@H]3[C@@H]2OCCC3)C4CCCCC4
4009;363958035;0.019;1500193;404662401;145956728;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;4-chloro-N-[3-(1,3-dihydroisoindol-2-yl)propyl]benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C2=CC=CC=C2CN1CCCNC(=O)C3=CC=C(C=C3)Cl
4010;389483962;0.019;1805386;444858077;132060712;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A5;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCN(CC1)C2=CC3=C(CN(C3)C(=O)OCC4=CC=CC=C4)C=C2
4011;402102374;0.019;1796671;384224359;138375188;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(isoindolin-2-yl)methylamino)propyl]-4-chlorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C2=CC=CC=C2CN1CNCCCNC(=O)C3=CC=C(C=C3)Cl
4012;407996415;0.019;1946583;482062057;168279962;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(3S)-1-[(3-fluorophenyl)methyl]-3-[(4-methylphenyl)methoxy]piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=C(C=C1)CO[C@H]2CCCN(C2)CC3=CC(=CC=C3)F
4013;407996472;0.019;1946583;494400348;171345912;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;N-(3-chloro-2-methylphenyl)-2-[9-[(3,4-difluorophenyl)methyl]-2,9-diazaspiro[4.5]decan-2-yl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC=C1Cl)NC(=O)CN2CCC3(C2)CCCN(C3)CC4=CC(=C(C=C4)F)F
4014;407996473;0.01905;1946583;494400348;171345912;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;N-(3-chloro-2-methylphenyl)-2-[9-[(3,4-difluorophenyl)methyl]-2,9-diazaspiro[4.5]decan-2-yl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC=C1Cl)NC(=O)CN2CCC3(C2)CCCN(C3)CC4=CC(=C(C=C4)F)F
4015;100366977;0.01907;226337;103376033;11035595;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-[1-(4-Nitro-benzyl)-piperidin-4-yl]-2-phenyl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC=C(C=C3)[N+](=O)[O-]
4016;100617256;0.0192;204444;103337426;4992580;10280;16627250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membranes using [3H]DTG as radioligand;1-(3-Chlorophenyl)-4-(3-phenylpropyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCCC2=CC=CC=C2)C3=CC(=CC=C3)Cl
4017;408003723;0.01932;1948317;494424653;171358892;10280;369199560;Confirmatory;20240503;0;0;Active;Q99720;Kd;=;ChEMBL;Displacement of (+)-pentazocine from sigma 1 receptor in human MCF7 cells assessed as dissociation constant in presence of 2-(3-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)propyl)-5-methoxy-3,4-dihydroisoquinolin-1(2H)-one incubated for 120 mins by sat;"6-[(2Z)-3,3-dimethyl-2-[(2E,4E)-5-(1,3,3-trimethylindol-1-ium-2-yl)penta-2,4-dienylidene]indol-1-yl]-N-[6-[3-(4-spiro[1H-2-benzofuran-3,4'-piperidine]-1'-ylbutyl)indol-1-yl]hexyl]hexanamide;iodide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1(C2=CC=CC=C2[N+](=C1/C=C/C=C/C=C\3/C(C4=CC=CC=C4N3CCCCCC(=O)NCCCCCCN5C=C(C6=CC=CC=C65)CCCCN7CCC8(CC7)C9=CC=CC=C9CO8)(C)C)C)C.[I-]
4018;100478458;0.0194;203696;103186066;44273357;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;((R)-1-Methyl-2-phenyl-ethyl)-(4-phenyl-butyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CC1=CC=CC=C1)NCCCCC2=CC=CC=C2
4019;100403991;0.0195;204630;103272786;2562;10280;128012230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma receptor type 1 was determined by the displacement of [3H]pentazocine radioligand;Carbetapentane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CC)CCOCCOC(=O)C1(CCCC1)C2=CC=CC=C2
4020;100323565;0.0196;204151;103382756;10850173;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 1 using [3H](+)-pentazocine in guinea pig brain membranes;Benzyl-[2-((1S,2R)-2-methyl-1,2-dihydro-naphthalen-1-yl)-ethyl]-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1C=CC2=CC=CC=C2[C@H]1CCNCC3=CC=CC=C3
4021;100485972;0.0196;204636;103318128;15767681;10280;76368600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured on Sigma receptor type 1 from guinea pig brain membranes using [3H]pentazocine as radioligand.;10-Benzyl-4-fluoro-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)F
4022;100536375;0.0196;204457;103673674;45262183;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-[2-Bromo-3-ethyl-5-(trifluoromethyl)phenyl]-1-(3-ethylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)NC(=NC2=CC(=CC(=C2Br)CC)C(F)(F)F)N.Cl
4023;372356139;0.0196;1726849;461545775;162664969;10280;342231650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]pentazocine from human sigma 1 receptor expressed in HEK293 cell membrane incubated for 2 hrs by liquid scintillation counting method;6-(5-Morpholin-4-ylpentoxy)chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCN1CCCCCOC2=CC3=C(C=C2)OC=CC3=O
4024;407903316;0.0196;1921245;461545775;162664969;10280;354346280;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in human HEK293 cells incubated for 2 hrs by liquid scintillation counting analysis;6-(5-Morpholin-4-ylpentoxy)chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCN1CCCCCOC2=CC3=C(C=C2)OC=CC3=O
4025;100544896;0.0198;203699;103218437;10517496;10280;95728830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to sigma-1 sites in guinea pig brain membranes;(1R,9S,13S)-10-[2-(dimethylamino)ethyl]-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2CCN(C)C)C)C=C(C=C3)O
4026;100536805;0.02;204457;103673518;45262068;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(4-Chlorophenyl)-1-(3-ethylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)NC(=NC2=CC=C(C=C2)Cl)N.Cl
4027;100543128;0.02;203698;103216163;10521200;10280;95728800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was tested for its binding affinity towards sigma 1 receptor using [3H](+)-pentazocine from guinea pig brain;1'-Benzyl-3,4-dihydrospiro[2H-1-benzothiopyran-2,4'-piperidine]1,1-dioxide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCN(CC2)CC3=CC=CC=C3)S(=O)(=O)C4=CC=CC=C41
4028;100617136;0.02;203985;103282696;14771697;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;1-(1-Adamantyl)-3-(2-nitrophenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C2CC3CC1CC(C2)(C3)N=C(N)NC4=CC=CC=C4[N+](=O)[O-]
4029;100622097;0.02;203998;103197421;15061906;10280;16481390;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]DTG binding to Sigma opioid receptor;1,2,3,4-Tetrahydro-N-(3-phenylpropyl)naphthalen-2-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2=CC=CC=C2CC1NCCCC3=CC=CC=C3
4030;100680842;0.02;204287;103178578;9863340;10280;119345760;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity towards Sigma opioid receptor type 1 by using [3H]- (+)-pentazocine as radioligand;3-Methyl-6-[2-(4-phenyl-piperidin-1-yl)-ethyl]-3H-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C=C(C=C2)CCN3CCC(CC3)C4=CC=CC=C4)SC1=O
4031;100722938;0.02;204635;103267552;12730763;10280;150810120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma receptor type 1,using [3H](+)-pentazocine as radioligand;1-Methyl-4-(4-phenyl-butyl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)CCCCC2=CC=CC=C2
4032;101553699;0.02;390823;103604318;16005860;10280;188173680;Confirmatory;20220830;0;0;Active;Q99720;IC50;<;ChEMBL;Inhibition of sigma1 opioid receptor;3,5-Dichloro-N-{[(3S,4R)-1-(3,3-dimethylbutyl)-3-fluoropiperidin-4-yl]methyl}benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)CCN1CC[C@@H]([C@@H](C1)F)CNC(=O)C2=CC(=CC(=C2)Cl)Cl
4033;255030878;0.02;625223;103197648;3372;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fluphenazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO
4034;363958031;0.02;1500193;404652522;51111240;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-4-fluorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)F)CC2=CC=CC=C2
4035;372400422;0.02;1744234;461562037;154929720;10280;333727820;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane incubated for 2 hr by liquid scintillation counting method;5-(4-Cyclohexylphenyl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;CN1C(=NC(=N1)CN2CCCC2)C3=CC=C(C=C3)C4CCCCC4
4036;389712988;0.02;1919146;476002747;166637129;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assay from US Patent US11535596: 'Analogs of dextromethorphan with balanced receptor activities';N-[(6,10a-dimethyl-1,2,3,4-tetrahydrophenanthren-4a-yl)methyl]-2-methoxy-N-methylethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC2=C(C=C1)C=CC3(C2(CCCC3)CN(C)CCOC)C
4037;402102366;0.02;1796671;384224352;51111240;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-4-fluorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)F)CC2=CC=CC=C2
4038;408048982;0.02;1959985;494417519;171355855;10280;299084420;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) assessed as inhibition constant;(1R,9S,13S)-1,13-dimethyl-10-(2-piperidin-1-ylethyl)-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=CC=CC=C3[C@@]1(CCN2CCN4CCCCC4)C
4039;100543223;0.0201;203699;103218467;10807270;10280;95728830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to sigma-1 sites in guinea pig brain membranes;(1R,9S,13S)-10-[2-(azepan-1-yl)ethyl]-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2CCN4CCCCCC4)C)C=C(C=C3)O
4040;100627306;0.02018;229194;103383836;15113309;10280;13101140;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+) -3PPP from sigma receptor in guinea pig brain membranes;2-(3,4-Dichlorophenyl)-N-(2-dimethylaminoethyl)ethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCNCCC1=CC(=C(C=C1)Cl)Cl
4041;100765461;0.02025;204446;103189283;2130;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membrane was determined by using [3H]DTG as the radioligand;Amantadine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C2CC3CC1CC(C2)(C3)N
4042;100496814;0.0205;204761;103401550;10339444;10280;78533490;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity at Sigma receptor type 1, displacement of [3H](+)-pentazocine from guinea pig brain membranes;(1S,9S,13S)-1,13-dimethyl-10-[[4-(trifluoromethyl)phenyl]methyl]-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC4=CC=C(C=C4)C(F)(F)F)C)C=C(C=C3)O
4043;389712932;0.0205;1919146;476002744;166637127;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assay from US Patent US11535596: 'Analogs of dextromethorphan with balanced receptor activities';N-[(6-methoxy-2,3,4,10a-tetrahydro-1H-phenanthren-4a-yl)methyl]-N-methylprop-2-en-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CC=C)CC12CCCCC1C=CC3=C2C=C(C=C3)OC
4044;100535936;0.0206;204457;103678365;45265224;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"1-(3-Ethylphenyl)-2-(2-propan-2-ylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)NC(=NC2=CC=CC=C2C(C)C)N.Cl
4045;100354363;0.0207;204790;103238193;10599447;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-[[(2R)-1-Cyclohexyl-2-pyrrolidinyl]methyl]-1-methoxy-4-bromo-2-naphthalenecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)NC[C@H]3CCCN3C4CCCCC4
4046;366435751;0.02089;1593893;440139564;155529976;10280;309877800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK293T cell membranes;5-Chloro-2-[2-[4-(4-chlorophenyl)piperazin-1-yl]ethyl]-2,3-dihydroinden-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCC2CC3=C(C2=O)C=CC(=C3)Cl)C4=CC=C(C=C4)Cl
4047;100295630;0.021;239200;103186197;7333;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
4048;100458398;0.021;204438;103344468;15149403;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;15-(4-Thiophen-2-ylbutyl)-9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3,5,7-tetraene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCCC4=CC=CS4)NC5=CC=CC=C53
4049;100467869;0.021;204005;103325420;44336365;10280;79325350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vivo binding affinity against sigma Opioid receptor was measured by using labeled ligand [3H]-SKF- 10,047 (1 nM);(4aR,7aS,12bS)-3-Cyclopropylmethyl-2,3,4,4a,5,6,7,7a-octahydro-1H-8-oxa-3-aza-benzo[d]fluoren-9-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C[C@H]2CN(CC[C@]23[C@H](C1)OC4=C3C=CC=C4O)CC5CC5
4050;100534027;0.021;204794;103293450;10334147;10280;93971710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was done in guinea pig membranes by labeling the binding site with [3H](+)-pentazocine;(1R,2R)-2-[Spiro[indan-1,4'-piperidin]-1'-yl]cyclohexanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC[C@H]([C@@H](C1)N2CCC3(CCC4=CC=CC=C43)CC2)O
4051;100613862;0.021;203986;103282278;14771684;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N-(2-Iodo-phenyl)-N''-o-tolyl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1N=C(N)NC2=CC=CC=C2I
4052;100737198;0.021;203994;103228707;14368937;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor of guinea pig brain by using [3H]SKF-10047 radioligand;(5S)-5-[[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]methyl]-3-(4-methoxyphenyl)-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)N2C[C@@H](OC2=O)CN3CCC(CC3)(C4=CC=C(C=C4)Cl)O
4053;255014867;0.021;625223;103170100;2733526;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tamoxifen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3
4054;340018570;0.021;751647;103167216;3559;10280;234030820;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H]Haloperidol from sigma 1 receptor in human jurkat cells after 4 hrs;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
4055;342811251;0.021;1129882;242620287;30675158;10280;246178360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human RPMI8226 cell membranes after 120 mins by scintillation counting analysis;2-[(2S)-1-benzyl-4-(cyclohexylmethyl)piperazin-2-yl]ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;C1CCC(CC1)CN2CCN([C@H](C2)CCO)CC3=CC=CC=C3
4056;363665436;0.021;1415921;404708762;71223459;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;1-(1-(2-(Azepan-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-3-cyclopentylurea hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCCN(CC1)CCN2C3=NC=NC(=C3C=N2)NC(=O)NC4CCCC4
4057;366366658;0.021;1558961;440126848;118562584;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;(2R)-2-methyl-4-phenyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C[C@@H]1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=CC=CC=C4
4058;366435752;0.021;1593893;440139564;155529976;10280;309877800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK293T cell membranes;5-Chloro-2-[2-[4-(4-chlorophenyl)piperazin-1-yl]ethyl]-2,3-dihydroinden-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCC2CC3=C(C2=O)C=CC(=C3)Cl)C4=CC=C(C=C4)Cl
4059;366436222;0.021;1593893;440169996;155545740;10280;309877800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK293T cell membranes;2-[2-[4-(4-Chlorophenyl)-1,4-diazepan-1-yl]ethyl]-2,3-dihydroinden-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=CC=C(C=C2)Cl)CCC3CC4=CC=CC=C4C3=O
4060;372400427;0.021;1744234;461549001;162667190;10280;333727820;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane incubated for 2 hr by liquid scintillation counting method;1-Methyl-5-[3-methyl-4-(trifluoromethyl)phenyl]-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;CC1=C(C=CC(=C1)C2=NC(=NN2C)CN3CCCC3)C(F)(F)F
4061;380263973;0.021;1811100;475977914;126539121;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[4-(4-benzylpiperazin-1-yl)oxan-4-yl]methyl]-N-phenylpropanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CCOCC1)N2CCN(CC2)CC3=CC=CC=C3)C4=CC=CC=C4
4062;380512724;0.021;1846430;482068888;86298403;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-4-[(4-fluorophenyl)methyl]-10-pyridin-2-yl-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CC=C(C=C3)F)OCC4=C(N=NN24)C5=CC=CC=N5
4063;389489780;0.021;1805386;160850029;132075295;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';2-Benzyl-7-(3-methoxyphenyl)-1,3,4,5-tetrahydro-2-benzazepine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC(=C1)C2=CC3=C(CN(CCC3)CC4=CC=CC=C4)C=C2
4064;408048983;0.021;1959985;494423682;171358320;10280;299084420;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) assessed as inhibition constant;N-[2-[(1R,9S,13S)-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-10-yl]ethyl]aniline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=CC=CC=C3[C@@]1(CCN2CCNC4=CC=CC=C4)C
4065;100451375;0.0211;204435;103290992;15657207;10280;81026510;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using the novel [3H]-(+/-)-4 as radioligand;3-Chloro-6-methylamino-8-phenyl-5,6,7,8-tetrahydro-naphthalen-2-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CNC1CC(C2=CC(=C(C=C2C1)Cl)O)C3=CC=CC=C3
4066;100614099;0.0211;203986;103672001;14771743;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;"2-Tert-butyl-1-(2-iodophenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC(C)(C)N=C(N)NC1=CC=CC=C1I.Cl
4067;100385651;0.0213;204153;103378334;10266406;10280;117841480;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma opioid receptor type 1 affinity in guinea pig brain by employing [3H](+)-pentazocine as radioligand.;1'-Benzyl-3H-spiro[isobenzofuran-1,4'-piperidin]-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3C(=O)O2)CC4=CC=CC=C4
4068;100628000;0.02138;204453;103671437;45260531;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"3-propyl-2,4,5,6-tetrahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCN1CCC2=C(C1)CCC3=CC=CC=C32.Cl
4069;100314843;0.0214;204161;103310940;10717134;10280;104250950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma opioid receptor type 1 in guinea pig brain membranes using [3H](+)-pentazocine as radioligand;trans-trans-1-(4-Fluorobenzyl)-7-(4-phenylpiperidin-1-yl)-decahydroquinolin-6-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C[C@@H]2C[C@H]([C@@H](C[C@H]2N(C1)CC3=CC=C(C=C3)F)N4CCC(CC4)C5=CC=CC=C5)O
4070;100379193;0.0214;204294;103186197;7333;10280;120363760;Confirmatory;20220830;0;0;Active;Q99720;Kd2;=;ChEMBL;Binding affinity against Sigma opioid receptor type 2 at 0.1 uM BNIT;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
4071;101829962;0.0215;255065;103468470;44403185;10280;161400090;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory activity against opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 degree C ;(10aS)-2-(3-piperidin-1-ylpropyl)-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CCN(CC1)CCCN2C(=O)[C@@H]3CC4=CC=CC=C4CN3C2=O
4072;101830002;0.0215;255057;103468470;44403185;10280;161400110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory concentration against opioid receptor sigma 1 of guinea pig cerebral cortex using [3H](+)-pentazocine upon incubation for 150 minutes at 22 degree C;(10aS)-2-(3-piperidin-1-ylpropyl)-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CCN(CC1)CCCN2C(=O)[C@@H]3CC4=CC=CC=C4CN3C2=O
4073;321565533;0.0216;671086;103359532;9999116;10280;227390890;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma1 receptor;P-Fluorobenzyltrozamicol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(C[C@H]([C@@H]1O)N2CCC(CC2)C3=CC=CC=C3)CC4=CC=C(C=C4)F
4074;100481149;0.02166;204639;163336690;10061124;10280;78372400;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity towards Sigma receptor type 1 was determined by measuring its ability to displace [3H](+)-pentazocine from guinea pig brain membrane;3-(2-fluoroethylsulfanyl)-4-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)-1,2,5-thiadiazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN1CCC=C(C1)C2=NSN=C2SCCF
4075;100622105;0.0218;203998;103185859;131444;10280;16481390;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]DTG binding to Sigma opioid receptor;((R)-1-Methyl-2-phenyl-ethyl)-(3-phenyl-propyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CC1=CC=CC=C1)NCCCC2=CC=CC=C2
4076;100708106;0.0218;204146;103252288;11315257;10280;146843270;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma opioid receptor of guiena pig brain membrane;5-Bromo-N-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-2-methoxy-benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=C(C=C1)Br)C(=O)NCCN2CCC3=CC=CC=C3C2
4077;389712854;0.0218;1919146;476002741;163988742;10280;;Confirmatory;20231017;0;0;Active;Q99720;IC50;;BindingDB;Receptor Binding Assay from US Patent US11535596: 'Analogs of dextromethorphan with balanced receptor activities';(1S)-3-bromo-4-(2,2-difluoroethoxy)-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@@]23CCCCC2C1CC4=C3C(=C(C=C4)OCC(F)F)Br
4078;366431546;0.02188;1592018;312351717;76518514;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;3-(4-Chlorophenyl)-8-[4-(4-fluorophenyl)butyl]-8-azabicyclo[3.2.1]octan-3-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2CC(CC1N2CCCCC3=CC=C(C=C3)F)(C4=CC=C(C=C4)Cl)O
4079;407996458;0.02188;1946583;494404913;171348668;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;1-methyl-5-[[(3S)-3-[(2-methylphenyl)methoxy]piperidin-1-yl]methyl]indazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1CO[C@H]2CCCN(C2)CC3=CC4=C(C=C3)N(N=C4)C
4080;388996992;0.0219;1798943;405263586;86581847;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';4-(azepan-1-yl)-1-(8-fluoro-3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)butan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCCN(CC1)CCCC(=O)N2CCN3C(=CC4=C3C=CC(=C4)F)C2
4081;100448341;0.022;204471;103214956;14982996;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;7-[8-(4-Hydroxy-piperidin-1-yl)-octyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCCCOC2=CC3=C(C=C2)C(=O)C=C(O3)C4=CC=CC=C4
4082;100614615;0.022;203986;103677601;45264668;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;"1,2-Bis(2-bicyclo[2.2.1]heptanyl)guanidine;hydrobromide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2CC1CC2NC(=NC3CC4CCC3C4)N.Br
4083;100619162;0.022;203990;103185860;13011906;10280;18482950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma opioid receptor in guinea pig cerebral homogenate using [3H]DTG as radioligand;((S)-1-Methyl-2-phenyl-ethyl)-(3-phenyl-propyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](CC1=CC=CC=C1)NCCCC2=CC=CC=C2
4084;100622102;0.022;203998;103185860;13011906;10280;16481390;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]DTG binding to Sigma opioid receptor;((S)-1-Methyl-2-phenyl-ethyl)-(3-phenyl-propyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](CC1=CC=CC=C1)NCCCC2=CC=CC=C2
4085;100746112;0.022;204147;103265782;3043720;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma opioid receptor type 1 in guinea pig brain homogenate with 0.5 nM [3H](+)-PENT;2,4-Imidazolidinedione, 5,5-diphenyl-3-(3-(4-phenyl-1-piperidinyl)propyl)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1C2=CC=CC=C2)CCCN3C(=O)C(NC3=O)(C4=CC=CC=C4)C5=CC=CC=C5
4086;100746456;0.022;204018;103278207;44315795;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor using [3H](+)-SKF-10047 as radioligand;1-Benzyl-4-(3,3-diphenyl-allyloxymethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1COCC=C(C2=CC=CC=C2)C3=CC=CC=C3)CC4=CC=CC=C4
4087;100746551;0.022;204019;103335998;44340944;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-SKF-10047 binding to sigma receptor;"1-benzyl-N-phenyl-N-(3-phenylprop-2-ynyl)piperidin-4-amine;(E)-but-2-enedioic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1N(CC#CC2=CC=CC=C2)C3=CC=CC=C3)CC4=CC=CC=C4.C(=C/C(=O)O)\C(=O)O
4088;363665438;0.022;1415921;404718288;71487772;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;1-(1-(2-(azepan-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-3-cyclopropylthiourea hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCCN(CC1)CCN2C3=NC=NC(=C3C=N2)NC(=S)NC4CC4
4089;366431545;0.022;1592018;312351717;76518514;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;3-(4-Chlorophenyl)-8-[4-(4-fluorophenyl)butyl]-8-azabicyclo[3.2.1]octan-3-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2CC(CC1N2CCCCC3=CC=C(C=C3)F)(C4=CC=C(C=C4)Cl)O
4090;366435758;0.022;1593893;440149685;155536631;10280;309877800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK293T cell membranes;1-[2-(5-fluoro-2,3-dihydro-1H-inden-2-yl)ethyl]-4-pyridin-2-yl-1,4-diazepane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=CC=CC=N2)CCC3CC4=C(C3)C=C(C=C4)F
4091;372306733;0.022;1701184;461517944;121418768;10280;332377850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;EST64454 (hydrochloride);SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)N1CCN(CC1)CCOCC2=NN(C=C2)C3=CC(=C(C=C3)F)F.Cl
4092;372400431;0.022;1744234;461544083;154929836;10280;333727820;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane incubated for 2 hr by liquid scintillation counting method;5-(3,4-Dichlorophenyl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;CN1C(=NC(=N1)CN2CCCC2)C3=CC(=C(C=C3)Cl)Cl
4093;380512641;0.022;1846430;482073283;86295769;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2S,6S)-10-(2-fluorophenyl)-4-(oxan-4-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCC1N2C[C@H]3[C@H](C2)OCC4=C(N=NN34)C5=CC=CC=C5F
4094;380600210;0.022;1866071;482061416;168279516;10280;350338840;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Antagonist activity at sigma1 receptor (unknown origin);1-[4-[2-[1-(3,4-Difluorophenyl)-5-methylpyrazol-3-yl]oxyethyl]piperazin-1-yl]ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=NN1C2=CC(=C(C=C2)F)F)OCCN3CCN(CC3)C(=O)C
4095;388740636;0.022;1797293;386051316;118282903;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 73;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OCCO)OC(F)(F)F)N2CC3=C(C2)C=C(C=C3)F
4096;388879573;0.022;1797475;386051316;118282903;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 73;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OCCO)OC(F)(F)F)N2CC3=C(C2)C=C(C=C3)F
4097;389383889;0.022;1804286;386051316;118282903;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 73;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OCCO)OC(F)(F)F)N2CC3=C(C2)C=C(C=C3)F
4098;389712927;0.022;1919146;476002752;519103;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assay from US Patent US11535596: 'Analogs of dextromethorphan with balanced receptor activities';Morphinan-3-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC23CCNC(C2C1)CC4=C3C=C(C=C4)O
4099;388996781;0.0222;1798943;405263582;86581701;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';1-(8-fluoro-3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)-4-(piperidin-1-yl)butan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCCC(=O)N2CCN3C(=CC4=C3C=CC(=C4)F)C2
4100;366435757;0.02239;1593893;440149685;155536631;10280;309877800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK293T cell membranes;1-[2-(5-fluoro-2,3-dihydro-1H-inden-2-yl)ethyl]-4-pyridin-2-yl-1,4-diazepane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=CC=CC=N2)CCC3CC4=C(C3)C=C(C=C4)F
4101;407996475;0.02239;1946583;494417251;171355750;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(2S)-2-[(3,4-difluorophenoxy)methyl]-4-[(1-methylindazol-5-yl)methyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C=C(C=C2)CN3CCO[C@@H](C3)COC4=CC(=C(C=C4)F)F)C=N1
4102;100367033;0.02266;226337;103375249;3562491;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;1-(1-Benzylpiperidin-4-yl)-3-naphthalen-1-ylurea;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)NC2=CC=CC3=CC=CC=C32)CC4=CC=CC=C4
4103;100464772;0.0228;203701;103677051;45264280;10280;80279780;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity at sigma-1 site by inhibition of [3H](+)-pentazocine (PENT) binding in guinea pig brain;"2-(4-Phenylpiperazin-1-yl)ethyl 1-(4-iodophenyl)cyclopentane-1-carboxylate;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)(C2=CC=C(C=C2)I)C(=O)OCCN3CCN(CC3)C4=CC=CC=C4.Cl
4104;100444350;0.023;204470;103215118;14982968;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-(4-Methyl-piperidin-1-yl)-hexyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
4105;100444476;0.023;204470;103214956;14982996;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;7-[8-(4-Hydroxy-piperidin-1-yl)-octyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCCCOC2=CC3=C(C=C2)C(=O)C=C(O3)C4=CC=CC=C4
4106;100456538;0.023;229183;103360286;14970535;10280;79028690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor in bovine cerebellum using 2.0 nM [3H]haloperidol in the presence of 25 nM unlabeled spiperone;1-(4-Fluoro-phenyl)-3-[4-(4-fluoro-phenyl)-3,6-dihydro-2H-pyridin-1-yl]-propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CN(CC=C1C2=CC=C(C=C2)F)CCC(=O)C3=CC=C(C=C3)F
4107;100617143;0.023;203985;103282278;14771684;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N-(2-Iodo-phenyl)-N''-o-tolyl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1N=C(N)NC2=CC=CC=C2I
4108;100745604;0.023;204454;103247365;15729885;10280;;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity towards sigma receptor by the displacement of [3H]PPP from guinea pig brain;5-Fluoro-2-{4-[4-(4-fluoro-phenyl)-butyl]-piperazin-1-yl}-pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCCC2=CC=C(C=C2)F)C3=NC=C(C=N3)F
4109;255011006;0.023;625223;103198031;4917;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Prochlorperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl
4110;342811249;0.023;1129882;242620288;30853613;10280;246178360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human RPMI8226 cell membranes after 120 mins by scintillation counting analysis;2-[(2R)-1-benzyl-4-(cyclohexylmethyl)piperazin-2-yl]ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;C1CCC(CC1)CN2CCN([C@@H](C2)CCO)CC3=CC=CC=C3
4111;345602975;0.023;1200082;312389830;76683883;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;N-[2-(azepan-1-yl)ethyl]-1-benzyltriazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCCN(CC1)CCNC2=CN(N=N2)CC3=CC=CC=C3
4112;363666194;0.023;1415921;404709216;71223296;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;1-(1-(2-(azepan-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-3-isopropylurea hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)NC(=O)NC1=C2C=NN(C2=NC=N1)CCN3CCCCCC3
4113;363958033;0.023;1500193;404656724;118607347;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-3,5-dichlorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC(=CC(=C1)Cl)Cl)CC2=CC=CC=C2
4114;367490649;0.023;1661755;442057743;4095865;10280;328320230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from recombinant sigma 1 receptor (unknown origin) expressed in baculovirus infected Sf9 cell membranes after 1.5 hrs by scintillation counting analysis;N-(3,5-difluorophenyl)-3-(4-fluorobenzyl)tetrahydropyrimidine-1(2H)-carbothioamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;521.0;;;;C1CN(CN(C1)C(=S)NC2=CC(=CC(=C2)F)F)CC3=CC=C(C=C3)F
4115;380264308;0.023;1811100;475980164;126539533;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[1-(4-benzylpiperazin-1-yl)cyclohexyl]methyl]-N-phenylpropanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CCCCC1)N2CCN(CC2)CC3=CC=CC=C3)C4=CC=CC=C4
4116;388740030;0.023;1797293;386051028;71276947;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 3;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=CC(=C(C=C3C2)Cl)Cl
4117;388878701;0.023;1797475;386051028;71276947;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 3;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=CC(=C(C=C3C2)Cl)Cl
4118;389383279;0.023;1804286;386051028;71276947;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 3;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=CC(=C(C=C3C2)Cl)Cl
4119;389483904;0.023;1805386;444858082;132060745;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example KTL-01-276;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C=CCN1CCN(CC1)C2=CC3=C(CN(C3)S(=O)(=O)C4=CC(=CC(=C4)Cl)Cl)C=C2
4120;402102482;0.023;1796671;384224366;118607347;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';Benzamide derivative 8;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC(=CC(=C1)Cl)Cl)CC2=CC=CC=C2
4121;407996474;0.023;1946583;494417251;171355750;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(2S)-2-[(3,4-difluorophenoxy)methyl]-4-[(1-methylindazol-5-yl)methyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C=C(C=C2)CN3CCO[C@@H](C3)COC4=CC(=C(C=C4)F)F)C=N1
4122;326034772;0.0231;701162;163324287;24744977;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;4-[2-(1-Cyclohexylpyrazol-3-yl)oxyethyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCC(CC1)N2C=CC(=N2)OCCN3CCOCC3
4123;112788082;0.0233;204633;103328401;5478726;10280;74907270;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to inhibit [3H](+)-pentazocine binding to guinea pig brain Sigma receptor type 1;(8E)-8-benzylidene-5-(3-hydroxyphenyl)-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1/C(=C\C3=CC=CC=C3)/C(=O)C2)C4=CC(=CC=C4)O
4124;112851454;0.0233;204465;103328401;5478726;10280;79325400;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma receptor of guinea pig brain;(8E)-8-benzylidene-5-(3-hydroxyphenyl)-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1/C(=C\C3=CC=CC=C3)/C(=O)C2)C4=CC(=CC=C4)O
4125;100354356;0.0234;204790;103237482;12084055;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-[[(2S)-1-(2-Adamantyl)-2-pyrrolidinyl]methyl]-1-methoxy-4-bromo-2-naphthalenecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)NC[C@@H]3CCCN3C4C5CC6CC(C5)CC4C6
4126;366431678;0.02344;1592018;103624002;11653679;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;4-[4-(4-Chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=CC=C(C=C2)Cl)CCCC(=O)C3=CC=C(C=C3)F
4127;100507184;0.0238;204150;103345923;10849098;10280;87844550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from Sigma opioid receptor type 1 in guinea pig brain membrane;[2-(3-Methoxy-phenyl)-ethyl]-methyl-(2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCC1=CC(=CC=C1)OC)CCN2CCCC2
4128;100546619;0.0238;203685;103278559;10642179;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-Benzyl-piperidin-4-yl)-2-(3-chloro-4-hydroxy-phenyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC(=C(C=C2)O)Cl)CC3=CC=CC=C3
4129;101829940;0.0238;255065;103468484;44403192;10280;161400090;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory activity against opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 degree C ;(10aS)-2-[3-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]propyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CN(CCN1CCCN2C(=O)[C@@H]3CC4=CC=CC=C4CN3C2=O)CC5=CC6=C(C=C5)OCO6
4130;100367037;0.02388;226337;103375760;11783308;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-(1-Naphthalen-2-ylmethyl-piperidin-4-yl)-2-phenyl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC4=CC=CC=C4C=C3
4131;100536551;0.0239;204457;103678428;45265271;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-[3-Ethyl-2-fluoro-5-(trifluoromethyl)phenyl]-1-(3-ethylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)NC(=NC2=CC(=CC(=C2F)CC)C(F)(F)F)N.Cl
4132;372356134;0.0239;1726849;461531010;141195395;10280;342231650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]pentazocine from human sigma 1 receptor expressed in HEK293 cell membrane incubated for 2 hrs by liquid scintillation counting method;6-(4-Morpholin-4-ylbutoxy)chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCN1CCCCOC2=CC3=C(C=C2)OC=CC3=O
4133;407906195;0.0239;1922160;103520864;16737780;10280;362020630;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);Benzamide, N-(4-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)butyl)-2-(2-(fluoro-18F)ethoxy)-5-methyl-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=C(C=C1)OCC[18F])C(=O)NCCCCN2CCC3=CC(=C(C=C3C2)OC)OC
4134;100292844;0.024;239105;103441938;11234042;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;2-(4-Benzyl-piperidin-1-ylmethyl)-3,4-dihydro-2H-naphthalen-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2=CC=CC=C2C(=O)C1CN3CCC(CC3)CC4=CC=CC=C4
4135;100292960;0.024;239105;103442085;11773145;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;3-(4-Benzyl-piperidin-1-ylmethyl)-chroman-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3COC4=CC=CC=C4C3=O
4136;100448370;0.024;204471;103215621;14982966;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(6-Azepan-1-yl-hexyloxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCCN(CC1)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
4137;100475270;0.024;204462;103351642;44347742;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;"2-Hydroxybutanedioic acid;1'-[[4-(trifluoromethyl)phenyl]methyl]spiro[3,4-dihydronaphthalene-2,4'-piperidine]-1-one";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2(CCN(CC2)CC3=CC=C(C=C3)C(F)(F)F)C(=O)C4=CC=CC=C41.C(C(C(=O)O)O)C(=O)O
4138;100736353;0.024;203993;103228606;15034735;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor from guinea pig brain using the radioligand [3H]SKF-10047;(5S)-5-[[4-(1,3-benzodioxol-5-yl)-4-hydroxypiperidin-1-yl]methyl]-3-(4-hydroxyphenyl)-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC3=C(C=C2)OCO3)O)C[C@H]4CN(C(=O)O4)C5=CC=C(C=C5)O
4139;100741802;0.024;203992;103671583;45260648;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"3-(4-Fluorophenyl)-8-(2-phenylethyl)-1-oxa-8-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC12C(=O)C(=CO2)C3=CC=C(C=C3)F)CCC4=CC=CC=C4.Cl
4140;326034767;0.024;701162;163338183;11531518;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;N-benzyl-4-[1-(3,4-dichlorophenyl)pyrazol-3-yl]oxy-N-methylbutan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CN(CCCCOC1=NN(C=C1)C2=CC(=C(C=C2)Cl)Cl)CC3=CC=CC=C3
4141;342827624;0.024;1122321;242615238;25060019;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin);N,N-Dimethyl-1-phenyl-1,4,6,7-tetrahydropyrano[4,3-c]pyrazole-4-ethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCC1C2=C(CCO1)N(N=C2)C3=CC=CC=C3
4142;355638083;0.024;1308619;336901331;127048371;10280;271565650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-Pentazocine from sigma 1 receptor in human RPMI8226 cell membranes;(1S,4R,7S)-2-(cyclohexylmethyl)-5-[(4-phenylphenyl)methyl]-2,5-diazabicyclo[2.2.2]octan-7-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;C1CCC(CC1)CN2C[C@H]3C[C@@H]([C@@H]2CN3CC4=CC=C(C=C4)C5=CC=CC=C5)O
4143;363666195;0.024;1415921;404708276;71223439;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;1-(1-(2-(azepan-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-3-propylurea maleate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCNC(=O)NC1=C2C=NN(C2=NC=N1)CCN3CCCCCC3
4144;363958020;0.024;1500193;404665930;41306434;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-4-cyanobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)C#N)CC2=CC=CC=C2
4145;366431677;0.024;1592018;103624002;11653679;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;4-[4-(4-Chlorophenyl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=CC=C(C=C2)Cl)CCCC(=O)C3=CC=C(C=C3)F
4146;372400429;0.024;1744234;163334751;44247568;10280;333727820;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane incubated for 2 hr by liquid scintillation counting method;4-(2-((5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yl)oxy)ethyl)morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)OCCN4CCOCC4
4147;388996790;0.024;1798943;405263580;86581699;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';1-(10-methyl-3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)-2-(piperidin-1-yl)ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C2CN(CCN2C3=CC=CC=C13)C(=O)CN4CCCCC4
4148;402102480;0.024;1796671;384224371;41306434;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-4-cyanobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)C#N)CC2=CC=CC=C2
4149;255014109;0.0242;625223;103376533;4634;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Oxybutynin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
4150;366431691;0.02455;1592018;440214480;155563452;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;4-[4-(5-Chloropyridin-2-yl)piperazin-1-yl]-1-(4-fluorophenyl)butan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC(=O)C2=CC=C(C=C2)F)C3=NC=C(C=C3)Cl
4151;388996994;0.0248;1798943;405263574;86581557;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';2-(azepan-1-yl)-1-(3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C(=O)N1CCN2C(=CC3=CC=CC=C32)C1)N4CCCCCC4
4152;100448364;0.025;204471;103215118;14982968;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-(4-Methyl-piperidin-1-yl)-hexyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CCN(CC1)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
4153;100456543;0.025;229183;103360285;14970536;10280;79028690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor in bovine cerebellum using 2.0 nM [3H]haloperidol in the presence of 25 nM unlabeled spiperone;1-(4-Chloro-phenyl)-3-[4-(4-fluoro-phenyl)-3,6-dihydro-2H-pyridin-1-yl]-propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CN(CC=C1C2=CC=C(C=C2)F)CCC(=O)C3=CC=C(C=C3)Cl
4154;100459025;0.025;204438;103211711;15646135;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;11-(4-Phenylbutyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCCC4=CC=CC=C4)NC5=CC=CC=C53
4155;100534034;0.025;204794;103293421;10069224;10280;93971710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was done in guinea pig membranes by labeling the binding site with [3H](+)-pentazocine;(3R,4R)-1-(4-Fluorobenzyl)-3-[spiro[indan-1,4'-piperidin]-1'-yl]piperidin-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(C[C@H]([C@@H]1O)N2CCC3(CCC4=CC=CC=C43)CC2)CC5=CC=C(C=C5)F
4156;100543132;0.025;203698;103216162;10782325;10280;95728800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was tested for its binding affinity towards sigma 1 receptor using [3H](+)-pentazocine from guinea pig brain;1'-Benzyl-3,4-dihydrospiro[2H-1-benzothiopyran-2,4'-piperidine]1-oxide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCN(CC2)CC3=CC=CC=C3)S(=O)C4=CC=CC=C41
4157;100614106;0.025;203986;103283297;14771705;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N-o-Tolyl-N''-(1,7,7-trimethyl-bicyclo[2.2.1]hept-2-yl)-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC2CC3CCC2(C3(C)C)C)N
4158;100746105;0.025;204298;103265782;3043720;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma opioid receptor type 2 in guinea pig brain homogenate with 4 nM [3H]-(+)-DTG;2,4-Imidazolidinedione, 5,5-diphenyl-3-(3-(4-phenyl-1-piperidinyl)propyl)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1C2=CC=CC=C2)CCCN3C(=O)C(NC3=O)(C4=CC=CC=C4)C5=CC=CC=C5
4159;255016781;0.025;625223;103555936;2442;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Bromhexine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CC1=C(C(=CC(=C1)Br)Br)N)C2CCCCC2
4160;255018970;0.025;625223;103199419;941361;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Flunarizine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F
4161;363665758;0.025;1415921;404705619;71223247;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;N-(1-[2-(Piperidin-1-yl)ethyl]-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-1-adamantylcarboxamide maleate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=NC=NC(=C3C=N2)NC(=O)C45CC6CC(C4)CC(C6)C5
4162;366431690;0.025;1592018;440214480;155563452;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;4-[4-(5-Chloropyridin-2-yl)piperazin-1-yl]-1-(4-fluorophenyl)butan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC(=O)C2=CC=C(C=C2)F)C3=NC=C(C=C3)Cl
4163;380512735;0.025;1846430;482069872;44594147;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2S,6S)-4-benzyl-10-(2-fluorophenyl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@H]2[C@H](CN1CC3=CC=CC=C3)OCC4=C(N=NN24)C5=CC=CC=C5F
4164;388996807;0.025;1798943;405263576;86581560;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';2-(4-benzyl-piperidin-1-yl)-1-(3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C(=O)N1CCN2C(=CC3=CC=CC=C32)C1)N4CCC(CC4)CC5=CC=CC=C5
4165;342816996;0.02512;1118248;242613629;90666090;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human recombinant sigma-1 receptor expressed in CHO cells after 180 mins by beta counting analysis;(1S,2S)-N-[3-[4-[(2-chloro-6-fluorophenyl)methyl]piperazin-1-yl]propyl]-2-phenylcyclopropane-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;197.0;;;;C1CN(CCN1CCCNC(=O)[C@H]2C[C@@H]2C3=CC=CC=C3)CC4=C(C=CC=C4Cl)F
4166;342816998;0.02512;1118248;242613627;90666088;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human recombinant sigma-1 receptor expressed in CHO cells after 180 mins by beta counting analysis;(1S,2S)-N-[2-[4-[(2-chloro-6-fluorophenyl)methyl]piperazin-1-yl]ethyl]-2-phenylcyclopropane-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;197.0;;;;C1CN(CCN1CCNC(=O)[C@H]2C[C@@H]2C3=CC=CC=C3)CC4=C(C=CC=C4Cl)F
4167;100295637;0.0256;239200;103442113;11237443;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;1-Benzyl-4-(2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2COC3=CC=CC=C3O2)CC4=CC=CC=C4
4168;388996816;0.0256;1798943;405263590;86581997;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';2-(4-cyclohexyl-piperazin-1-yl)-1-(8-fluoro-3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C(=O)N1CCN2C(=CC3=C2C=CC(=C3)F)C1)N4CCN(CC4)C5CCCCC5
4169;100478431;0.0257;203696;103186150;192481;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;4-[2-(3-Phenylpropylamino)propyl]phenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(CC1=CC=C(C=C1)O)NCCCC2=CC=CC=C2
4170;366436223;0.0257;1593893;440122206;155518770;10280;309877800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK293T cell membranes;5-Chloro-2-[2-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]ethyl]-2,3-dihydroinden-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=CC=C(C=C2)Cl)CCC3CC4=C(C3=O)C=CC(=C4)Cl
4171;100314841;0.026;204161;103187480;659840;10280;104250950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma opioid receptor type 1 in guinea pig brain membranes using [3H](+)-pentazocine as radioligand;Vesamicol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC[C@H]([C@@H](C1)N2CCC(CC2)C3=CC=CC=C3)O
4172;100448327;0.026;204471;103214872;14983054;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-Cyclopentyl-6-(6-piperidin-1-yl-hexyloxy)-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4CCCC4
4173;100464764;0.026;203702;103249574;6472;10280;80279780;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;The compound was evaluated for affinity at sigma-1 site by inhibition of [3H](+)-pentazocine (PENT) binding in guinea pig brain.;Caramiphen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CC)CCOC(=O)C1(CCCC1)C2=CC=CC=C2
4174;100475262;0.026;204462;103673072;45261737;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;"2-[1-(1-cyclopropylethyl)piperidin-4-yl]-3,4-dihydro-2H-naphthalen-1-one;hydrobromide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC(C1CC1)N2CCC(CC2)C3CCC4=CC=CC=C4C3=O.Br
4175;100475273;0.026;204462;103673093;45261754;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;"2-[1-(cyclopropylmethyl)piperidin-4-yl]-3,4-dihydro-2H-naphthalen-1-one;hydrobromide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC1CN2CCC(CC2)C3CCC4=CC=CC=C4C3=O.Br
4176;100476453;0.026;204462;103351799;10045023;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;2-[1-(4-tert-Butylbenzyl)-4-piperidinyl]-3,4-dihydronaphthalen-1(2H)-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC(C)(C)C1=CC=C(C=C1)CN2CCC(CC2)C3CCC4=CC=CC=C4C3=O
4177;100513218;0.026;229197;103384285;164487;10280;89413830;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor using radioligand ([3H](+)-pentazocine) binding assay;1-(2-(2-(Diphenyl)methoxy)ethyl)-4-(3-phenylpropyl)homopiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)CCOC(C2=CC=CC=C2)C3=CC=CC=C3)CCCC4=CC=CC=C4
4178;100534023;0.026;204794;103187480;659840;10280;93971710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was done in guinea pig membranes by labeling the binding site with [3H](+)-pentazocine;Vesamicol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC[C@H]([C@@H](C1)N2CCC(CC2)C3=CC=CC=C3)O
4179;100558841;0.026;203684;103389275;401820;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;1-[4-(3-Phenylpropyl)piperazine-1-yl]-2-(3-methoxyphenyl)ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC(=C1)CC(=O)N2CCN(CC2)CCCC3=CC=CC=C3
4180;100740710;0.026;203987;103259650;15379806;10280;;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was evaluated for binding affinity against sigma opioid receptor using [3H]DTG radioligand in guinea pig membranes;N,N''-Bis-(4-bromo-2-methyl-phenyl)-acetamidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC(=C1)Br)NC(=NC2=C(C=C(C=C2)Br)C)C
4181;100741867;0.026;203992;103671719;45260717;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"2-(4-Methoxyphenyl)-8-(2-phenylethyl)-1-oxa-8-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC=C(C=C1)C2=CC(=O)C3(O2)CCN(CC3)CCC4=CC=CC=C4.Cl
4182;326034954;0.026;701162;163324313;11518209;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-[4-[1-(3,4-Dichlorophenyl)-5-methylpyrazol-3-yl]oxybutyl]-4-phenylpiperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)OCCCCN3CCC(CC3)C4=CC=CC=C4
4183;366366190;0.026;1558961;440121723;118567654;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;9-Benzyl-4-phenyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CN(CCC12CN(C(=O)CO2)C3=CC=CC=C3)CC4=CC=CC=C4
4184;366436224;0.026;1593893;440122206;155518770;10280;309877800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK293T cell membranes;5-Chloro-2-[2-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]ethyl]-2,3-dihydroinden-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=CC=C(C=C2)Cl)CCC3CC4=C(C3=O)C=CC(=C4)Cl
4185;372400421;0.026;1744234;461560115;162675033;10280;333727820;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane incubated for 2 hr by liquid scintillation counting method;1-Methyl-3-(pyrrolidin-1-ylmethyl)-5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,2,4-triazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;CN1C(=NC(=N1)CN2CCCC2)C3=CC4=C(CCCC4)C=C3
4186;380512643;0.026;1846430;482087135;86297379;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-10-(2,4-difluorophenyl)-4-[2-(oxan-4-yl)ethyl]-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCC1CCN2C[C@@H]3[C@@H](C2)OCC4=C(N=NN34)C5=C(C=C(C=C5)F)F
4187;388996987;0.0262;1798943;405263581;86581700;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';2-(4-benzyl-piperidin-1-yl)-1-(10-methyl-3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C2CN(CCN2C3=CC=CC=C13)C(=O)CN4CCC(CC4)CC5=CC=CC=C5
4188;100485160;0.0264;204636;103317804;15767674;10280;76368600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured on Sigma receptor type 1 from guinea pig brain membranes using [3H]pentazocine as radioligand.;Deoxypentazocin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1C2CC3=CC=CC=C3C1(CCN2CC=C(C)C)C
4189;100451373;0.0265;204435;103677704;45264739;10280;81026510;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using the novel [3H]-(+/-)-4 as radioligand;"4-phenyl-N,N-bis(prop-2-enyl)-1,2,3,4-tetrahydronaphthalen-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C=CCN(CC=C)C1CC(C2=CC=CC=C2C1)C3=CC=CC=C3.Cl
4190;100459323;0.0266;229212;103401228;10066063;10280;84969360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was evaluated against sigma-1 binding site in guinea pig, using [3H]- -(+)- Pentazocine;N-Methyl-N-[2-(1-pyrrolidinyl)ethyl]-2-iodobenzylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCN1CCCC1)CC2=CC=CC=C2I
4191;100323560;0.0267;204151;103382755;10108347;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 1 using [3H](+)-pentazocine in guinea pig brain membranes;(1S,9S,13S)-10-benzyl-13-ethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC[C@H]1[C@@H]2CCN([C@H]1CC3=CC=CC=C23)CC4=CC=CC=C4
4192;100546174;0.0269;203685;103278346;2225138;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-benzylpiperidin-4-yl)-2-(2-nitrophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CC=C2[N+](=O)[O-])CC3=CC=CC=C3
4193;407996172;0.02692;1946583;482059353;168277992;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;5-[[4-[(3,4-Difluorophenyl)methoxy]piperidin-1-yl]methyl]-1-methylbenzimidazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C=NC2=C1C=CC(=C2)CN3CCC(CC3)OCC4=CC(=C(C=C4)F)F
4194;407996340;0.02692;1946583;494401361;171346518;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[1-[(3,4-difluorophenyl)methyl]-1,8-diazaspiro[4.5]decan-8-yl]-N-(4-fluoro-3-methylphenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC(=C1)NC(=O)CN2CCC3(CCCN3CC4=CC(=C(C=C4)F)F)CC2)F
4195;100536386;0.027;204457;103678152;45265082;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(3-Chlorophenyl)-1-(3-ethylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)NC(=NC2=CC(=CC=C2)Cl)N.Cl
4196;100746453;0.027;204018;103277707;10426373;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor using [3H](+)-SKF-10047 as radioligand;1-Benzyl-4-(3-phenylpropoxymethyl)piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1COCCCC2=CC=CC=C2)CC3=CC=CC=C3
4197;342811245;0.027;1129882;242620292;90655532;10280;246178360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human RPMI8226 cell membranes after 120 mins by scintillation counting analysis;2-[(2S)-4-(cyclohexylmethyl)-1-[(6-methoxynaphthalen-2-yl)methyl]piperazin-2-yl]ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;COC1=CC2=C(C=C1)C=C(C=C2)CN3CCN(C[C@@H]3CCO)CC4CCCCC4
4198;355637715;0.027;1308619;336904026;127050367;10280;271565650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-Pentazocine from sigma 1 receptor in human RPMI8226 cell membranes;(1R,4S,7S)-2-(cyclohexylmethyl)-5-[(4-phenylphenyl)methyl]-2,5-diazabicyclo[2.2.2]octan-7-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;C1CCC(CC1)CN2C[C@@H]3C[C@@H]([C@H]2CN3CC4=CC=C(C=C4)C5=CC=CC=C5)O
4199;355638088;0.027;1308619;336901330;127048370;10280;271565650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-Pentazocine from sigma 1 receptor in human RPMI8226 cell membranes;(1S,4R,7R)-2-(cyclohexylmethyl)-5-[(4-phenylphenyl)methyl]-2,5-diazabicyclo[2.2.2]octan-7-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;C1CCC(CC1)CN2C[C@H]3C[C@H]([C@@H]2CN3CC4=CC=C(C=C4)C5=CC=CC=C5)O
4200;380263970;0.027;1811100;475983674;126509963;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[4-[4-(2-propoxyethyl)piperazin-1-yl]oxan-4-yl]methyl]-N-[6-(trifluoromethyl)pyridin-2-yl]propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCOCCN1CCN(CC1)C2(CCOCC2)CN(C3=CC=CC(=N3)C(F)(F)F)C(=O)CC
4201;380512648;0.027;1846430;482058368;67404471;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;4-Benzyl-10-(2-fluorophenyl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C2C(CN1CC3=CC=CC=C3)OCC4=C(N=NN24)C5=CC=CC=C5F
4202;388740381;0.027;1797293;386051314;118282901;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 69;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
4203;388879046;0.027;1797475;386051314;118282901;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 69;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
4204;389383663;0.027;1804286;386051314;118282901;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 69;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
4205;389536405;0.027;1805702;384583194;137660429;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';benzyl (1R,8R)-5-(4-cyclohexylpiperazin-1-yl)-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene-9-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)N2CCN(CC2)C3=CC4=C(C=C3)[C@@H]5CCN([C@@H]4C5)C(=O)OCC6=CC=CC=C6
4206;389536409;0.027;1805702;384583194;137660429;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';benzyl (1R,8R)-5-(4-cyclohexylpiperazin-1-yl)-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene-9-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)N2CCN(CC2)C3=CC4=C(C=C3)[C@@H]5CCN([C@@H]4C5)C(=O)OCC6=CC=CC=C6
4207;407996339;0.027;1946583;494401361;171346518;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[1-[(3,4-difluorophenyl)methyl]-1,8-diazaspiro[4.5]decan-8-yl]-N-(4-fluoro-3-methylphenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC(=C1)NC(=O)CN2CCC3(CCCN3CC4=CC(=C(C=C4)F)F)CC2)F
4208;407996427;0.027;1946583;482060851;168279082;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;6-[[4-[[3-(trifluoromethyl)phenyl]methoxy]piperidin-1-yl]methyl]-1H-benzimidazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=CC=C2)C(F)(F)F)CC3=CC4=C(C=C3)N=CN4
4209;100546844;0.0271;203685;103278823;10689502;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-Benzylpiperidine-4-yl)-2-[4-(methylthio)phenyl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CSC1=CC=C(C=C1)CC(=O)NC2CCN(CC2)CC3=CC=CC=C3
4210;100622171;0.0271;204000;103240496;15061896;10280;16481390;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Opioid activity in terms of inhibition of [3H]dihydromorphine binding to opioid receptor mu in rat brain membrane.;N-[1-Methyl-2-(4-benzyloxyphenyl)ethyl]-3-phenylpropan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC(CC1=CC=C(C=C1)OCC2=CC=CC=C2)NCCCC3=CC=CC=C3
4211;372355908;0.0272;1726849;461530644;162654336;10280;342231650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]pentazocine from human sigma 1 receptor expressed in HEK293 cell membrane incubated for 2 hrs by liquid scintillation counting method;6-[3-(Azepan-1-yl)propoxy]chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCCN(CC1)CCCOC2=CC3=C(C=C2)OC=CC3=O
4212;380546900;0.0272;1854223;461530644;162654336;10280;356359550;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) assessed as inhibition constant;6-[3-(Azepan-1-yl)propoxy]chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCCN(CC1)CCCOC2=CC3=C(C=C2)OC=CC3=O
4213;407902734;0.0272;1921245;461530644;162654336;10280;354346280;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in human HEK293 cells incubated for 2 hrs by liquid scintillation counting analysis;6-[3-(Azepan-1-yl)propoxy]chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCCN(CC1)CCCOC2=CC3=C(C=C2)OC=CC3=O
4214;100496762;0.02722;204761;103401152;10365559;10280;78533490;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity at Sigma receptor type 1, displacement of [3H](+)-pentazocine from guinea pig brain membranes;(1S,9S,13S)-10-[(3-iodophenyl)methyl]-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC4=CC(=CC=C4)I)C)C=C(C=C3)O
4215;342804583;0.0273;1127667;163322742;5468876;10280;237346340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 opioid receptor (unknown origin);(1S,5S,8E)-8-[(3,4-dichlorophenyl)methylidene]-5-(3-hydroxyphenyl)-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@@]2(C[C@H]1/C(=C\C3=CC(=C(C=C3)Cl)Cl)/C(=O)C2)C4=CC(=CC=C4)O
4216;100622093;0.0274;203998;103240535;15061890;10280;16481390;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]DTG binding to Sigma opioid receptor;Indan-2-yl-(3-phenyl-propyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C(CC2=CC=CC=C21)NCCCC3=CC=CC=C3
4217;100768702;0.0274;204149;103186197;7333;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma opioid receptor type 1;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
4218;100438243;0.0277;204445;103186197;7333;10280;14477350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor using [3H](+)-pentazocine in guinea pig brain homogenates;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
4219;100468424;0.0277;203697;103186197;7333;10280;82952200;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma 1 receptor was determined in guinea pig brain membrane using [3H](+)-pentazocine as radioligand;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
4220;100546285;0.0277;203689;103284525;33142;10280;96511500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma-1 receptor in guinea pig brain membranes;1,2-Dibenzylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC=C(C=C1)CNC(=NCC2=CC=CC=C2)N
4221;100354369;0.028;204790;103238451;12084053;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-[(3S)-1-(2-Adamantyl)-3-pyrrolidinyl]-1-methoxy-4-bromo-2-naphthalenecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)N[C@H]3CCN(C3)C4C5CC6CC(C5)CC4C6
4222;100439286;0.028;203854;103359799;6604868;10280;13615780;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory concentration against radioligand [3H]3-PPP binding to haloperidol-sensitive sigma binding site in whole guinea pig brain;(R)-1-(4-Fluoro-phenyl)-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butan-1-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCC[C@H](C2=CC=C(C=C2)F)O)C3=NC=C(C=N3)F
4223;100440712;0.028;229190;103186197;7333;10280;14696970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of specific binding of [3H]DTG to sigma binding site in Guinea pig brain membranes;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
4224;100449442;0.028;204443;103186197;7333;10280;83608750;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine at sigma receptor in guinea pig brain membrane was determined;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
4225;100458514;0.028;204438;103343688;15149404;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;11-[4-(2-Furanyl)butyl]-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCCC4=CC=CO4)NC5=CC=CC=C53
4226;100559069;0.028;203684;103389233;10644162;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;1-[4-(3-Phenylpropyl)piperazine-1-yl]-2-(3,4-dichlorophenyl)ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)C(=O)CC3=CC(=C(C=C3)Cl)Cl
4227;100619104;0.028;203990;103185859;131444;10280;18482950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma opioid receptor in guinea pig cerebral homogenate using [3H]DTG as radioligand;((R)-1-Methyl-2-phenyl-ethyl)-(3-phenyl-propyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CC1=CC=CC=C1)NCCCC2=CC=CC=C2
4228;100622192;0.028;203982;103186197;7333;10280;16481400;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H]DTG from sigma opioid receptor of homogenized guinea pig whole brain;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
4229;100708099;0.028;204146;103252784;44303758;10280;146843270;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma opioid receptor of guiena pig brain membrane;N-[1-(2-adamantyl)pyrrolidin-3-yl]-4-bromo-1-methoxynaphthalene-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)NC3CCN(C3)C4C5CC6CC(C5)CC4C6
4230;100746448;0.028;204018;103277704;44315579;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor using [3H](+)-SKF-10047 as radioligand;1-Benzyl-4-[(E)-3-(4-trifluoromethyl-phenyl)-allyloxymethyl]-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1COC/C=C/C2=CC=C(C=C2)C(F)(F)F)CC3=CC=CC=C3
4231;345680793;0.028;1174258;312374344;118724300;10280;254622400;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor in human Jurkat cell membranes incubated for 2 hrs by liquid scintillation counting;N-benzyl-N-methyl-3-phenothiazin-10-ylpropan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1C2=CC=CC=C2SC3=CC=CC=C31)CC4=CC=CC=C4
4232;366366200;0.028;1558961;440139379;118562359;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;3-[2-(2-Methyl-3-oxo-4-phenyl-1-oxa-4,9-diazaspiro[5.5]undecan-9-yl)ethyl]benzonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC(=CC=C3)C#N)C4=CC=CC=C4
4233;100435377;0.0282;203824;103186197;7333;10280;150841290;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity at opioid sigma-1 receptor in guinea pig brain membranes by (+)-[3H]pentazocine displacement.;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
4234;100292614;0.0284;239200;103442127;11189143;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;4-Benzyl-1-(2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3COC4=CC=CC=C4O3
4235;389712984;0.0284;1919146;476002747;166637129;10280;;Confirmatory;20231017;0;0;Active;Q99720;IC50;;BindingDB;Receptor Binding Assay from US Patent US11535596: 'Analogs of dextromethorphan with balanced receptor activities';N-[(6,10a-dimethyl-1,2,3,4-tetrahydrophenanthren-4a-yl)methyl]-2-methoxy-N-methylethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC2=C(C=C1)C=CC3(C2(CCCC3)CN(C)CCOC)C
4236;100536806;0.0285;204457;103673600;22120065;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;N-(3-ethylphenyl)-N-methyl-N'-(2,5-dichlorophenyl)guanidine hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=C(C=CC(=C2)Cl)Cl)N.Cl
4237;100292837;0.0287;239105;103442160;11326158;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;4-Benzyl-1-(6,7,8,9-tetrahydro-5H-benzocyclohepten-6-ylmethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC(CC2=CC=CC=C2C1)CN3CCC(CC3)CC4=CC=CC=C4
4238;100467667;0.0287;203697;103672721;45261469;10280;82952200;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma 1 receptor was determined in guinea pig brain membrane using [3H](+)-pentazocine as radioligand;"1-[2-(3,4-Dichlorophenyl)ethyl]pyrrolidine;hydrobromide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCN(C1)CCC2=CC(=C(C=C2)Cl)Cl.Br
4239;100622168;0.0288;204000;103186197;7333;10280;16481390;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Opioid activity in terms of inhibition of [3H]dihydromorphine binding to opioid receptor mu in rat brain membrane.;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
4240;388996997;0.0288;1798943;405263585;86581846;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';1-(3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)-4-(piperidin-1-yl)butan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCCC(=O)N2CCN3C(=CC4=CC=CC=C43)C2
4241;407996336;0.02884;1946583;482048861;168270455;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;6-chloro-2-[[4-[(4-chloro-3-fluorophenyl)methoxy]piperidin-1-yl]methyl]-1H-indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=C(C=C2)Cl)F)CC3=CC4=C(N3)C=C(C=C4)Cl
4242;100319808;0.029;204154;103361484;10764130;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;[1-(4-Methoxy-3-phenethyloxy-benzyl)-pentyl]-dipropyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N(CCC)CCC
4243;100444172;0.029;204470;103215508;14983027;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-(2-Chloro-phenyl)-6-[6-(4-hydroxy-piperidin-1-yl)-hexyloxy]-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4Cl
4244;100471366;0.029;204459;103299099;10108342;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N,N''-Di-indan-4-yl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2=C(C1)C(=CC=C2)NC(=NC3=CC=CC4=C3CCC4)N
4245;100500109;0.029;204466;103237331;10619110;10280;85688040;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]DTG binding to sigma receptor from guinea pig brain cortex membrane;1-[3-(7-Methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-propyl]-4-(3,4,5,6-tetrahydro-pyridin-2-yl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(CCCC2CCCN3CCN(CC3)C4=NCCCC4)C=C1
4246;100722946;0.029;204635;103267197;12730765;10280;150810120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma receptor type 1,using [3H](+)-pentazocine as radioligand;1-Methyl-4-(4-phenyl-but-3-enyl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)CC/C=C/C2=CC=CC=C2
4247;100722948;0.029;204635;103268074;12730766;10280;150810120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma receptor type 1,using [3H](+)-pentazocine as radioligand;1-Methyl-4-((Z)-4-phenyl-but-3-enyl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)CC/C=C\C2=CC=CC=C2
4248;255028297;0.029;625223;103249489;1548953;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Enclomiphene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN(CC)CCOC1=CC=C(C=C1)/C(=C(\C2=CC=CC=C2)/Cl)/C3=CC=CC=C3
4249;341105411;0.029;1063115;194166848;73056753;10280;243317580;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human RPMI8226 cells;(2R)-1-(4-Biphenylylmethyl)-4-(cyclohexylmethyl)piperazine-2alpha-ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;C1CCC(CC1)CN2CCN([C@@H](C2)CCO)CC3=CC=C(C=C3)C4=CC=CC=C4
4250;342811088;0.029;1129882;194166848;73056753;10280;246178360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human RPMI8226 cell membranes after 120 mins by scintillation counting analysis;(2R)-1-(4-Biphenylylmethyl)-4-(cyclohexylmethyl)piperazine-2alpha-ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;C1CCC(CC1)CN2CCN([C@@H](C2)CCO)CC3=CC=C(C=C3)C4=CC=CC=C4
4251;342811241;0.029;1129882;242620289;90655529;10280;246178360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human RPMI8226 cell membranes after 120 mins by scintillation counting analysis;2-[(2S)-4-(cyclohexylmethyl)-1-(naphthalen-1-ylmethyl)piperazin-2-yl]ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;C1CCC(CC1)CN2CCN([C@H](C2)CCO)CC3=CC=CC4=CC=CC=C43
4252;363665756;0.029;1415921;404707079;71222835;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;1-(1-(2-(azepan-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-3-butylurea hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCNC(=O)NC1=C2C=NN(C2=NC=N1)CCN3CCCCCC3
4253;372400435;0.029;1744234;461516332;162644273;10280;333727820;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane incubated for 2 hr by liquid scintillation counting method;5-(3-Tert-butylphenyl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;CC(C)(C)C1=CC=CC(=C1)C2=NC(=NN2C)CN3CCCC3
4254;380773271;0.029;1907474;482054008;129056976;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;Benzyl 8-(4-propylpiperazin-1-yl)-1,3,4,5-tetrahydro-2H-1,5-methanobenzo[c]azepine-2-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCN(CC1)C2=CC3=C(C=C2)C4CCN(C3C4)C(=O)OCC5=CC=CC=C5
4255;407906172;0.029;1922168;494418697;154838222;10280;362020630;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [H3]DTG from sigma 1 receptor (unknown origin) by competition binding assay;3-[1-(3-phenylpropyl)-1,2,3,6-tetrahydropyridin-4-yl]-1H-pyrrolo[2,3-b]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CC=C1C2=CNC3=C2C=CC=N3)CCCC4=CC=CC=C4
4256;407906240;0.029;1922177;494423740;171358352;10280;362020630;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) expressed in human RPMI-8226 cells;2-[(2S)-4-ethyl-1-(naphthalen-1-ylmethyl)piperazin-2-yl]ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CCN([C@H](C1)CCO)CC2=CC=CC3=CC=CC=C32
4257;407906364;0.029;1922177;194166848;73056753;10280;362020630;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) expressed in human RPMI-8226 cells;2-[(2R)-4-(cyclohexylmethyl)-1-[(4-phenylphenyl)methyl]piperazin-2-yl]ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)CN2CCN([C@@H](C2)CCO)CC3=CC=C(C=C3)C4=CC=CC=C4
4258;407996335;0.029;1946583;482048861;168270455;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;6-chloro-2-[[4-[(4-chloro-3-fluorophenyl)methoxy]piperidin-1-yl]methyl]-1H-indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=C(C=C2)Cl)F)CC3=CC4=C(N3)C=C(C=C4)Cl
4259;389712858;0.0291;1919146;476002744;166637127;10280;;Confirmatory;20231017;0;0;Active;Q99720;IC50;;BindingDB;Receptor Binding Assay from US Patent US11535596: 'Analogs of dextromethorphan with balanced receptor activities';N-[(6-methoxy-2,3,4,10a-tetrahydro-1H-phenanthren-4a-yl)methyl]-N-methylprop-2-en-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CC=C)CC12CCCCC1C=CC3=C2C=C(C=C3)OC
4260;100385645;0.0293;204153;103378197;11748820;10280;117841480;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma opioid receptor type 1 affinity in guinea pig brain by employing [3H](+)-pentazocine as radioligand.;1''-Benzylspiro[isochroman-1,4''-piperidin]-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3CC(=O)O2)CC4=CC=CC=C4
4261;255030893;0.0293;625223;103213015;68617;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sertraline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
4262;101831627;0.0295;255051;103468549;44403228;10280;161400090;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory activity against Opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 C ;(10aS)-2-[6-[methyl(2-phenylethyl)amino]hexyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;CN(CCCCCCN1C(=O)[C@@H]2CC3=CC=CC=C3CN2C1=O)CCC4=CC=CC=C4
4263;380773270;0.02951;1907474;482054008;129056976;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;Benzyl 8-(4-propylpiperazin-1-yl)-1,3,4,5-tetrahydro-2H-1,5-methanobenzo[c]azepine-2-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCN(CC1)C2=CC3=C(C=C2)C4CCN(C3C4)C(=O)OCC5=CC=CC=C5
4264;100404003;0.0296;204630;103295190;44321623;10280;128012230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma receptor type 1 was determined by the displacement of [3H]pentazocine radioligand;(3-{4-[2-(3,4-Dichloro-phenyl)-ethyl]-3,5-dimethyl-piperazin-1-yl}-propyl)-diphenyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(C[C@H](N1CCC2=CC(=C(C=C2)Cl)Cl)C)CCCN(C3=CC=CC=C3)C4=CC=CC=C4
4265;100543222;0.0296;203699;103217982;10498073;10280;95728830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to sigma-1 sites in guinea pig brain membranes;(1R,9S,13S)-10-[2-(benzylamino)ethyl]-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2CCNCC4=CC=CC=C4)C)C=C(C=C3)O
4266;388996998;0.0296;1798943;405263574;86581557;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';2-(azepan-1-yl)-1-(3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C(=O)N1CCN2C(=CC3=CC=CC=C32)C1)N4CCCCCC4
4267;100468433;0.0299;203697;103331185;11725919;10280;82952200;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma 1 receptor was determined in guinea pig brain membrane using [3H](+)-pentazocine as radioligand;Tetrahydro-1-[3-[methyl[2-[methyl(3,4-dichlorobenzyl)amino]ethyl]amino]propyl]-1H-pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCCN1CCCC1)CCN(C)CC2=CC(=C(C=C2)Cl)Cl
4268;100297845;0.03;239347;103195570;4416;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;Nafoxidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(C=C1)C(=C(CC2)C3=CC=CC=C3)C4=CC=C(C=C4)OCCN5CCCC5
4269;100317428;0.03;204155;103673257;45261873;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]-3-PPP displacement.;"1-[4-methoxy-3-(2-phenylethoxy)phenyl]-N,N-dipropylheptan-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N(CCC)CCC.Cl
4270;100478459;0.03;203696;103185286;44272941;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;Methyl-bis-(3-naphthalen-2-yl-propyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCC1=CC2=CC=CC=C2C=C1)CCCC3=CC4=CC=CC=C4C=C3
4271;100614625;0.03;203986;103282696;14771697;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;1-(1-Adamantyl)-3-(2-nitrophenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C2CC3CC1CC(C2)(C3)N=C(N)NC4=CC=CC=C4[N+](=O)[O-]
4272;100617155;0.03;203985;103282235;10378304;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;Guanidine, N,N'-bis(3-ethylphenyl)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)NC(=NC2=CC=CC(=C2)CC)N
4273;100741790;0.03;203992;103671582;45260647;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"3-(4-Methoxyphenyl)-8-(2-phenylethyl)-1-oxa-8-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC=C(C=C1)C2=COC3(C2=O)CCN(CC3)CCC4=CC=CC=C4.Cl
4274;100742335;0.03;204020;103671679;45260698;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor using [3H]-(+)-SKF- 10,047;"3-(4-Methoxyphenyl)-9-(2-phenylethyl)-1-oxa-9-azaspiro[5.5]undec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)C2=COC3(CCN(CC3)CCC4=CC=CC=C4)CC2=O.Cl
4275;334065471;0.03;735278;164135552;71655748;10280;235606500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aS,5R,10bS)-9-(3-methylbutoxy)-5-(oxan-4-yl)-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC(C)CCOC1=CC2=C(C=C1)N[C@@H]([C@H]3[C@@H]2OCCC3)C4CCOCC4
4276;366431687;0.03;1592018;440216108;155564110;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;4-[4-(5-Chloropyridin-2-yl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=NC=C(C=C2)Cl)CCCC(=O)C3=CC=C(C=C3)F
4277;366437016;0.03;1594271;164135552;71655748;10280;309043830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;(4aS,5R,10bS)-9-(3-methylbutoxy)-5-(oxan-4-yl)-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC(C)CCOC1=CC2=C(C=C1)N[C@@H]([C@H]3[C@@H]2OCCC3)C4CCOCC4
4278;372120975;0.03;1681775;461536823;118561045;10280;330649470;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;2-Methyl-9-(2-phenylethyl)-4-propan-2-yl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C(C)C
4279;380264157;0.03;1811100;475991205;126539376;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[4-(4-benzylpiperazin-1-yl)oxan-4-yl]methyl]-N-[6-(trifluoromethyl)pyridin-2-yl]propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CCOCC1)N2CCN(CC2)CC3=CC=CC=C3)C4=CC=CC(=N4)C(F)(F)F
4280;100536381;0.0301;204457;103673678;45262186;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"1,2-Bis(3-ethylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)NC(=NC2=CC=CC(=C2)CC)N.Cl
4281;100546179;0.0301;203685;103278723;6465840;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;1-(1-Benzylpiperidin-4-yl)-3-(2,4-dimethoxyphenyl)urea;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC(=C(C=C1)NC(=O)NC2CCN(CC2)CC3=CC=CC=C3)OC
4282;100765458;0.0301;204446;103678545;45265350;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membrane was determined by using [3H]DTG as the radioligand;"5-Benzyl-5-azahexacyclo[5.4.1.02,6.03,10.04,8.09,12]dodecan-4-ol;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C2C3C4C1C5C2C6C3C4C5(N6CC7=CC=CC=C7)O.Cl
4283;366431688;0.0302;1592018;440216108;155564110;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;4-[4-(5-Chloropyridin-2-yl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=NC=C(C=C2)Cl)CCCC(=O)C3=CC=C(C=C3)F
4284;100507185;0.0303;204150;103345301;10587586;10280;87844550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from Sigma opioid receptor type 1 in guinea pig brain membrane;[2-(4-Methoxy-phenyl)-ethyl]-methyl-(2-pyrrolidin-1-yl-ethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCC1=CC=C(C=C1)OC)CCN2CCCC2
4285;112788422;0.0303;204633;103386352;10809006;10280;74907270;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to inhibit [3H](+)-pentazocine binding to guinea pig brain Sigma receptor type 1;(8E)-8-[(3-chlorophenyl)methylidene]-5-(3-hydroxyphenyl)-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1/C(=C\C3=CC(=CC=C3)Cl)/C(=O)C2)C4=CC(=CC=C4)O
4286;345593882;0.0303;1197502;312385716;118731580;10280;256029320;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor in human Jurkat cells after 120 mins by liquid scintillation counting analysis;3-[3-(1,3-Dihydroisoindol-2-yl)propyl]-1,3-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1C2=CC=CC=C2CN1CCCN3C4=CC=CC=C4SC3=O
4287;100485156;0.0305;204636;103318423;10085466;10280;76368600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured on Sigma receptor type 1 from guinea pig brain membranes using [3H]pentazocine as radioligand.;4-Fluoro-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)F
4288;100605293;0.0305;203995;103735241;14771482;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity of compound to Sigma opioid receptor labelled with [3H](+)-3-PPP;(1R,2S)-N-[2-(1,3-benzodioxol-5-yl)ethyl]-N-methyl-2-pyrrolidin-1-ylcyclohexan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC2=C(C=C1)OCO2)[C@@H]3CCCC[C@@H]3N4CCCC4
4289;100295627;0.0306;239200;103442130;11451971;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;4-Benzyl-1-(6-methoxy-1,2,3,4-tetrahydro-naphthalen-2-ylmethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(CC(CC2)CN3CCC(CC3)CC4=CC=CC=C4)C=C1
4290;100535939;0.0307;204457;103673501;45262054;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(2-Chloro-3-ethyl-5-methylphenyl)-1-(3-ethylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)NC(=NC2=CC(=CC(=C2Cl)CC)C)N.Cl
4291;100546604;0.0308;203685;103278744;2729533;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-benzylpiperidin-4-yl)-2-(2-methoxyphenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC=CC=C1CC(=O)NC2CCN(CC2)CC3=CC=CC=C3
4292;100533892;0.03089;204794;103359408;44350827;10280;93971710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was done in guinea pig membranes by labeling the binding site with [3H](+)-pentazocine;1-(4-Bromo-phenyl)-3-(3-phenyl-8-aza-bicyclo[3.2.1]oct-8-yl)-propan-2-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2CC(CC1N2CC(CC3=CC=C(C=C3)Br)O)C4=CC=CC=C4
4293;407996170;0.0309;1946583;482054930;168274755;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;1-Methyl-5-[[4-[[3-(trifluoromethyl)phenyl]methoxy]piperidin-1-yl]methyl]benzimidazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C=NC2=C1C=CC(=C2)CN3CCC(CC3)OCC4=CC(=CC=C4)C(F)(F)F
4294;100354368;0.031;204790;103238195;10550623;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-[[(2R)-1-Cyclopentyl-2-pyrrolidinyl]methyl]-1-methoxy-4-bromo-2-naphthalenecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)NC[C@H]3CCCN3C4CCCC4
4295;100471329;0.031;204459;103186197;7333;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
4296;100478433;0.031;203696;103185288;15061889;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;(1-Methyl-2-naphthalen-2-yl-ethyl)-(3-phenyl-propyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(CC1=CC2=CC=CC=C2C=C1)NCCCC3=CC=CC=C3
4297;100619160;0.031;203990;103186164;12874569;10280;18482950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma opioid receptor in guinea pig cerebral homogenate using [3H]DTG as radioligand;((S)-1-Methyl-2-phenyl-ethyl)-phenethyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](CC1=CC=CC=C1)NCCC2=CC=CC=C2
4298;100737361;0.031;203993;103228268;15034729;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor from guinea pig brain using the radioligand [3H]SKF-10047;(5S)-5-[[4-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-hydroxypiperidin-1-yl]methyl]-3-(4-methoxyphenyl)-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)N2C[C@@H](OC2=O)CN3CCC(CC3)(C4=CC5=C(C=C4)OCCO5)O
4299;345602795;0.031;1200082;312389806;76683680;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-(2,4-dichlorophenyl)-N-(2-piperidin-1-ylethyl)triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)CCNC2=CN(N=N2)C3=C(C=C(C=C3)Cl)Cl
4300;345602964;0.031;1200082;312389810;76684296;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-(3,4-difluorophenyl)-N-(2-piperidin-1-ylethyl)triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)CCNC2=CN(N=N2)C3=CC(=C(C=C3)F)F
4301;354626044;0.031;1272497;336866866;127026013;10280;267502540;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin) by radioligand displacement assay;3-Benzyl-1,2,4,5-tetrahydro-3-benzazepin-5-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CC(C2=CC=CC=C21)O)CC3=CC=CC=C3
4302;363665119;0.031;1415967;404716234;74767285;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(1-Methylpyrrol-2-yl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C=CC=C1C2=C3C=NN(C3=NC=N2)CCN4CCCCC4
4303;363665664;0.031;1415967;404709391;74767212;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(2-Chloro-5-methylphenyl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=C(C=C1)Cl)C2=C3C=NN(C3=NC=N2)CCN4CCCCC4
4304;380512730;0.031;1846430;482070072;86297577;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-10-(2,4-dichlorophenyl)-4-(oxan-4-ylmethyl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCC1CN2C[C@@H]3[C@@H](C2)OCC4=C(N=NN34)C5=C(C=C(C=C5)Cl)Cl
4305;388740020;0.031;1797293;386051010;71277004;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C=C(C=C3)Cl
4306;388878691;0.031;1797475;386051010;71277004;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C=C(C=C3)Cl
4307;389383289;0.031;1804286;386051010;71277004;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C=C(C=C3)Cl
4308;407996165;0.031;1946583;482087760;168297637;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;3-[[4-[(4-Chloro-3-fluorophenyl)methoxy]piperidin-1-yl]methyl]imidazo[1,5-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=C(C=C2)Cl)F)CC3=NC=C4N3C=CC=C4
4309;407996455;0.031;1946583;482088112;168297847;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;5-[[4-[(4-Chloro-3-fluorophenyl)methoxy]piperidin-1-yl]methyl]-1-methylbenzimidazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C=NC2=C1C=CC(=C2)CN3CCC(CC3)OCC4=CC(=C(C=C4)Cl)F
4310;100367078;0.03125;226337;103375759;10969339;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-(1-Phenethyl-piperidin-4-yl)-2-phenyl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CCC3=CC=CC=C3
4311;366437247;0.03162;1594273;440132889;155525645;10280;309043830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;[5-[(4-Fluorophenyl)methylamino]-2-phenyl-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)C(=O)C2=C3CC(CCC3=NN2C4=CC=CC=C4)NCC5=CC=C(C=C5)F
4312;100323566;0.0317;204151;103382360;44361164;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 1 using [3H](+)-pentazocine in guinea pig brain membranes;(1R,9R,13R)-10-benzyl-13-propan-2-yl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC(C)[C@@H]1[C@H]2CCN([C@@H]1CC3=CC=CC=C23)CC4=CC=CC=C4
4313;100535940;0.0318;204457;103673517;45262067;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(3,4-Dichlorophenyl)-1-(3-ethylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)NC(=NC2=CC(=C(C=C2)Cl)Cl)N.Cl
4314;112788086;0.0318;204633;103215106;44285482;10280;74907270;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to inhibit [3H](+)-pentazocine binding to guinea pig brain Sigma receptor type 1;5-(3-Hydroxy-phenyl)-2-methyl-2-aza-bicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1CC(=O)C2)C3=CC(=CC=C3)O
4315;100440761;0.032;203855;103359799;6604868;10280;13615780;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory concentration against radioligand [3H]DTG binding to haloperidol-sensitive sigma binding site in whole guinea pig brain;(R)-1-(4-Fluoro-phenyl)-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butan-1-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCC[C@H](C2=CC=C(C=C2)F)O)C3=NC=C(C=N3)F
4316;100444335;0.032;204470;103215528;14983046;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-Cyclohexyl-6-{[6-(piperidin-1-yl)hexyl]oxy}-4H-1-benzopyran-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)C2=CC(=O)C3=C(O2)C=CC(=C3)OCCCCCCN4CCCCC4
4317;100470622;0.032;204469;103339884;44342597;10280;79325690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition against sigma receptor using displacement of 3 nM [3H]pentazocine in homogenate of guinea pig brain cerebellum;(1S,13R)-1,13-dimethyl-10-nonyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCCCCCCCN1CC[C@]2([C@H](C1CC3=C2C=C(C=C3)O)C)C
4318;100614372;0.032;203986;103186197;7333;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
4319;100617153;0.032;203985;103283129;14125583;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N,N''-Bis(4-bromo-2-methylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=C(C=CC(=C1)Br)NC(=NC2=C(C=C(C=C2)Br)C)N
4320;100741876;0.032;203992;103671606;45260662;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"7-Benzyl-3-phenyl-1-oxa-7-azaspiro[4.4]non-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CC12C(=O)C(=CO2)C3=CC=CC=C3)CC4=CC=CC=C4.Cl
4321;100742381;0.032;203987;103186197;7333;10280;;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was evaluated for binding affinity against sigma opioid receptor using [3H]DTG radioligand in guinea pig membranes;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
4322;101829958;0.032;255065;103468483;44403191;10280;161400090;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory activity against opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 degree C ;(10aS)-2-[3-(4-benzylpiperazin-1-yl)propyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CN(CCN1CCCN2C(=O)[C@@H]3CC4=CC=CC=C4CN3C2=O)CC5=CC=CC=C5
4323;112788428;0.032;204633;103328102;6273133;10280;74907270;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to inhibit [3H](+)-pentazocine binding to guinea pig brain Sigma receptor type 1;(8E)-8-[(3,4-dichlorophenyl)methylidene]-5-(3-hydroxyphenyl)-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1/C(=C\C3=CC(=C(C=C3)Cl)Cl)/C(=O)C2)C4=CC(=CC=C4)O
4324;112851452;0.032;204465;163322742;5468876;10280;79325400;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma receptor of guinea pig brain;(1S,5S,8E)-8-[(3,4-dichlorophenyl)methylidene]-5-(3-hydroxyphenyl)-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@@]2(C[C@H]1/C(=C\C3=CC(=C(C=C3)Cl)Cl)/C(=O)C2)C4=CC(=CC=C4)O
4325;366366662;0.032;1558961;440114866;118567313;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;2-(Methoxymethyl)-4-phenyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;COCC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=CC=CC=C4
4326;372400425;0.032;1744234;461515490;162643678;10280;333727820;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane incubated for 2 hr by liquid scintillation counting method;1-Methyl-3-(pyrrolidin-1-ylmethyl)-5-[3-[1-(trifluoromethyl)cyclopropyl]phenyl]-1,2,4-triazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;CN1C(=NC(=N1)CN2CCCC2)C3=CC(=CC=C3)C4(CC4)C(F)(F)F
4327;388740209;0.032;1797293;386051277;118282880;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 33;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC=C(C=C1)F)N2CC3=C(C2)C(=CC=C3)F
4328;388878838;0.032;1797475;386051277;118282880;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 33;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC=C(C=C1)F)N2CC3=C(C2)C(=CC=C3)F
4329;389383442;0.032;1804286;386051277;118282880;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 33;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC=C(C=C1)F)N2CC3=C(C2)C(=CC=C3)F
4330;100546176;0.0321;203685;103278850;10571211;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;2-(1-Benzyl-piperidin-4-ylamino)-1-(2,3-dimethoxy-phenyl)-ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC=CC(=C1OC)C(CNC2CCN(CC2)CC3=CC=CC=C3)O
4331;100403993;0.0325;204630;103295189;44321622;10280;128012230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma receptor type 1 was determined by the displacement of [3H]pentazocine radioligand;(3-{4-[2-(3,4-Dichloro-phenyl)-ethyl]-3,5-dimethyl-piperazin-1-yl}-propyl)-bis-(4-fluoro-phenyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(C[C@H](N1CCC2=CC(=C(C=C2)Cl)Cl)C)CCCN(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F
4332;100458861;0.0325;229213;103359798;44350991;10280;79028700;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Tested for [3H](+)-pentazocine binding to sigma-1 receptor in guinea pig brain membrane;(R)-1-(4-Fluorophenyl)-4-[4-(2-pyridyl)piperazino]butan-1-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCC[C@H](C2=CC=C(C=C2)F)O)C3=CC=CC=N3
4333;100295628;0.0328;239200;103442161;11168272;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;3-(4-Benzyl-piperazin-1-ylmethyl)-chroman-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2COC3=CC=CC=C3C2=O)CC4=CC=CC=C4
4334;100448384;0.033;204471;103215293;14982992;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;7-[4-(4-Hydroxy-piperidin-1-yl)-butoxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCOC2=CC3=C(C=C2)C(=O)C=C(O3)C4=CC=CC=C4
4335;100471324;0.033;204459;103283474;14771672;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;1,3-Bis(4-bromophenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC(=CC=C1NC(=NC2=CC=C(C=C2)Br)N)Br
4336;100497244;0.033;203984;103431814;192639;10280;76997100;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;1-[3-(5-Methoxy-3,4-dihydronaphthalen-1-yl)propyl]-4-(2-methoxyphenyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1N2CCN(CC2)CCCC3=CCCC4=C3C=CC=C4OC
4337;100617154;0.033;203985;103677548;12549981;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N,N'-Dibenzyl-Guanidine Hydrobromide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC=C(C=C1)CNC(=NCC2=CC=CC=C2)N.Br
4338;345602804;0.033;1200082;312389824;76684100;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-[(3,4-difluorophenyl)methyl]-N-(2-piperidin-1-ylethyl)triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)CCNC2=CN(N=N2)CC3=CC(=C(C=C3)F)F
4339;363666190;0.033;1415921;404716369;71223397;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;N-(1-(3-(azepan-1-yl)propyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)pivalamide maleate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)C(=O)NC1=C2C=NN(C2=NC=N1)CCCN3CCCCCC3
4340;388740210;0.033;1797293;386051067;71276953;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 4;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C=C(C=C3)C(F)(F)F
4341;388740214;0.033;1797293;386051306;118282978;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 61;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
4342;388878837;0.033;1797475;386051067;71276953;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 4;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C=C(C=C3)C(F)(F)F
4343;388878945;0.033;1797475;386051306;118282978;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 61;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
4344;389383433;0.033;1804286;386051306;118282978;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 61;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
4345;389383445;0.033;1804286;386051067;71276953;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 4;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C=C(C=C3)C(F)(F)F
4346;326035329;0.0333;701162;163334752;71460636;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;4-[2-(1-Naphthalen-2-ylpyrazol-3-yl)oxyethyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1COCCN1CCOC2=NN(C=C2)C3=CC4=CC=CC=C4C=C3
4347;326034957;0.0338;701162;163324289;71455166;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;(2R,6S)-2,6-dimethyl-4-[2-(5-methyl-1-naphthalen-2-ylpyrazol-3-yl)oxyethyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C[C@@H]1CN(C[C@@H](O1)C)CCOC2=NN(C(=C2)C)C3=CC4=CC=CC=C4C=C3
4348;100319812;0.034;204154;103669496;18986852;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;N-n-propyl-2-[4-methoxy-3-(2-phenylethoxy)phenyl]ethylamine hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCNCCC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2.Cl
4349;100444466;0.034;204470;103214873;14983053;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-Cyclobutyl-6-(6-piperidin-1-yl-hexyloxy)-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4CCC4
4350;100513217;0.034;229197;103384284;10621853;10280;89413830;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor using radioligand ([3H](+)-pentazocine) binding assay;N'-(2-benzhydryloxyethyl)-N,N'-dimethyl-N-(3-phenylpropyl)ethane-1,2-diamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCC1=CC=CC=C1)CCN(C)CCOC(C2=CC=CC=C2)C3=CC=CC=C3
4351;100736356;0.034;203993;103227674;44291865;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor from guinea pig brain using the radioligand [3H]SKF-10047;(5R)-5-[(4-hydroxy-4-phenylpiperidin-1-yl)methyl]-3-(4-methoxyphenyl)-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)N2C[C@H](OC2=O)CN3CCC(CC3)(C4=CC=CC=C4)O
4352;100737200;0.034;203994;103228174;15034721;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor of guinea pig brain by using [3H]SKF-10047 radioligand;(5S)-5-[(4-hydroxy-4-thiophen-3-ylpiperidin-1-yl)methyl]-3-(4-methoxyphenyl)-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)N2C[C@@H](OC2=O)CN3CCC(CC3)(C4=CSC=C4)O
4353;100742321;0.034;204129;103671687;45260701;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"2-[3-(diethylamino)propyl]-2-methyl-5-phenyl-3H-pyran-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CC)CCCC1(CC(=O)C(=CO1)C2=CC=CC=C2)C.Cl
4354;255012986;0.034;625223;103605085;26987;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Clemastine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@@](C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCC[C@H]3CCCN3C
4355;341105412;0.034;1063115;194180558;73056461;10280;243317580;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human RPMI8226 cells;(2S)-1-(4-Biphenylylmethyl)-4-(cyclohexylmethyl)piperazine-2beta-ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;C1CCC(CC1)CN2CCN([C@H](C2)CCO)CC3=CC=C(C=C3)C4=CC=CC=C4
4356;342811255;0.034;1129882;194180558;73056461;10280;246178360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human RPMI8226 cell membranes after 120 mins by scintillation counting analysis;(2S)-1-(4-Biphenylylmethyl)-4-(cyclohexylmethyl)piperazine-2beta-ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;C1CCC(CC1)CN2CCN([C@H](C2)CCO)CC3=CC=C(C=C3)C4=CC=CC=C4
4357;380264299;0.034;1811100;475991314;126509586;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[4-[4-(1-phenylethyl)piperazin-1-yl]oxan-4-yl]methyl]-N-[6-(trifluoromethyl)pyridin-2-yl]propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CCOCC1)N2CCN(CC2)C(C)C3=CC=CC=C3)C4=CC=CC(=N4)C(F)(F)F
4358;407906365;0.034;1922177;194180558;73056461;10280;362020630;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) expressed in human RPMI-8226 cells;2-[(2S)-4-(cyclohexylmethyl)-1-[(4-phenylphenyl)methyl]piperazin-2-yl]ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)CN2CCN([C@H](C2)CCO)CC3=CC=C(C=C3)C4=CC=CC=C4
4359;408048981;0.034;1959985;494415206;171354558;10280;299084420;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) assessed as inhibition constant;(1R,9S,13S)-1,13-dimethyl-10-(2-pyrrolidin-1-ylethyl)-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=CC=CC=C3[C@@]1(CCN2CCN4CCCC4)C
4360;100534032;0.0341;204794;103358908;44350664;10280;93971710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was done in guinea pig membranes by labeling the binding site with [3H](+)-pentazocine;1-(4-Fluorophenyl)-4-(3-phenyl-8-aza-bicyclo[3.2.1]octan-8-yl)butan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2CC(CC1N2CCCC(=O)C3=CC=C(C=C3)F)C4=CC=CC=C4
4361;100451378;0.0343;204435;103672107;45260974;10280;81026510;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using the novel [3H]-(+/-)-4 as radioligand;"7-(Dimethylamino)-5-phenyl-5,6,7,8-tetrahydronaphthalene-2,3-diol;hydrobromide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CN(C)C1CC(C2=CC(=C(C=C2C1)O)O)C3=CC=CC=C3.Br
4362;321583103;0.0344;677526;103237426;10714699;10280;228502100;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma1 receptor;1-Benzyl-4-[3-(5-methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-propyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCCC2CCCN3CCN(CC3)CC4=CC=CC=C4
4363;100377589;0.0345;204140;103252465;12259685;10280;120363760;Confirmatory;20220830;0;0;Active;Q99720;Kd;=;ChEMBL;Binding affinity to Sigma opioid receptor type 1 sites in guinea pig brain membranes at 0.1 uM of BNIT;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
4364;100765457;0.0345;204446;103678694;45265451;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membrane was determined by using [3H]DTG as the radioligand;"N-[(4-iodophenyl)methyl]spiro[1,3-dioxolane-2,11'-pentacyclo[5.4.0.02,6.03,10.05,9]undecane]-8'-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1COC2(O1)C3C4CC5C3C(C6C5C4C26)NCC7=CC=C(C=C7)I.Cl
4365;407996346;0.03467;1946583;482050037;168271259;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;3-Methyl-1-[[4-[[3-(trifluoromethyl)phenyl]methoxy]piperidin-1-yl]methyl]imidazo[1,5-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NC(=C2N1C=CC=C2)CN3CCC(CC3)OCC4=CC(=CC=C4)C(F)(F)F
4366;407996469;0.03467;1946583;482055066;168274850;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[[(3S)-3-[[3-(trifluoromethoxy)phenyl]methoxy]piperidin-1-yl]methyl]imidazo[1,2-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C[C@@H](CN(C1)CC2=CN3C=CC=CC3=N2)OCC4=CC(=CC=C4)OC(F)(F)F
4367;100297843;0.035;239347;103170100;2733526;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;Tamoxifen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3
4368;100444184;0.035;204470;103215621;14982966;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(6-Azepan-1-yl-hexyloxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCCN(CC1)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
4369;100468792;0.035;204469;103339885;44342598;10280;79325690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition against sigma receptor using displacement of 3 nM [3H]pentazocine in homogenate of guinea pig brain cerebellum;(1S,13R)-1,13-dimethyl-10-octyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCCCCCCN1CC[C@]2([C@H](C1CC3=C2C=C(C=C3)O)C)C
4370;100475173;0.035;204462;103351676;10450758;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;1'-Phenethyl-6-chlorospiro[tetralin-2,4'-piperidine]-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2(CCN(CC2)CCC3=CC=CC=C3)C(=O)C4=C1C=C(C=C4)Cl
4371;100741797;0.035;203992;103671615;45260668;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"3-Naphthalen-2-yl-8-(2-phenylethyl)-1-oxa-8-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC12C(=O)C(=CO2)C3=CC4=CC=CC=C4C=C3)CCC5=CC=CC=C5.Cl
4372;345602966;0.035;1200082;312389823;76683976;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-[(3-fluorophenyl)methyl]-N-(2-piperidin-1-ylethyl)triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)CCNC2=CN(N=N2)CC3=CC(=CC=C3)F
4373;363665654;0.035;1415967;404707582;74767207;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(5-Chlorothiophen-2-yl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=NC=NC(=C3C=N2)C4=CC=C(S4)Cl
4374;380264647;0.035;1811100;475987291;126509529;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[4-[4-(2-phenylethyl)piperazin-1-yl]oxan-4-yl]methyl]-N-[6-(trifluoromethyl)pyridin-2-yl]propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CCOCC1)N2CCN(CC2)CCC3=CC=CC=C3)C4=CC=CC(=N4)C(F)(F)F
4375;389483956;0.035;1805386;444858088;132060753;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A16;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)N2CCN(CC2)C3=CC4=C(CCN(C4)C(=O)OCC5=CC=CC=C5)C=C3
4376;407996345;0.035;1946583;482050037;168271259;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;3-Methyl-1-[[4-[[3-(trifluoromethyl)phenyl]methoxy]piperidin-1-yl]methyl]imidazo[1,5-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NC(=C2N1C=CC=C2)CN3CCC(CC3)OCC4=CC(=CC=C4)C(F)(F)F
4377;407996468;0.035;1946583;482055066;168274850;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[[(3S)-3-[[3-(trifluoromethoxy)phenyl]methoxy]piperidin-1-yl]methyl]imidazo[1,2-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C[C@@H](CN(C1)CC2=CN3C=CC=CC3=N2)OCC4=CC(=CC=C4)OC(F)(F)F
4378;100487774;0.0352;204638;103317758;44332157;10280;76368610;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was measured on Sigma receptor type 1 using [3H]- pentazocine as radioligand;5-Iodo-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=CC(=C(C=C3C1(CCN2CC=C(C)C)C)O)I
4379;389511205;0.0354;1805565;459070366;156086530;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Pharmacological Activity Assay from US Patent US11007200: 'Cycloalkyl-diamines for the treatment of pain';US11007200, Example 3a;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN[C@@]1(CCCC[C@@H]1NCCCC2=CC=C(C=C2)F)C3=CC=CC=C3Cl
4380;389686472;0.0354;1806763;459070366;156086530;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Pharmacological Activity from US Patent US11426411: 'Cycloalkyl-diamines for the treatment of inflammation';US11007200, Example 3a;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN[C@@]1(CCCC[C@@H]1NCCCC2=CC=C(C=C2)F)C3=CC=CC=C3Cl
4381;100448324;0.036;204471;103215541;9890959;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;Sigma-LIGAND-1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(OC2=C(C1=O)C=C(C=C2)OCCCCCCN3CCC(CC3)O)C4=CC=CC=C4
4382;100448354;0.036;204471;103214780;44285332;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;5-[7-(4-Hydroxy-piperidin-1-yl)-heptyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCCOC2=CC=CC3=C2C(=O)C=C(O3)C4=CC=CC=C4
4383;100448362;0.036;204471;103214568;14982997;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;8-[6-(4-Hydroxy-piperidin-1-yl)-hexyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCOC2=CC=CC3=C2OC(=CC3=O)C4=CC=CC=C4
4384;100614627;0.036;203986;103283130;14771668;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N,N''-Bis(3-propylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCC1=CC(=CC=C1)NC(=NC2=CC=CC(=C2)CCC)N
4385;326059157;0.036;712773;103214033;5324346;10280;236413110;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor;Fluvoxamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COCCCC/C(=N\OCCN)/C1=CC=C(C=C1)C(F)(F)F
4386;342811246;0.036;1129882;103252465;12259685;10280;246178360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human RPMI8226 cell membranes after 120 mins by scintillation counting analysis;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
4387;345603244;0.036;1200082;312389817;76684092;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-(3-fluorophenyl)-N-[2-(1,4-oxazepan-4-yl)ethyl]triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CN(CCOC1)CCNC2=CN(N=N2)C3=CC(=CC=C3)F
4388;345680792;0.036;1174258;312374354;118724310;10280;254622400;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor in human Jurkat cell membranes incubated for 2 hrs by liquid scintillation counting;1-Phenyl-2-(3-pyrrolidin-1-ylpropyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCN(C1)CCCN2CCC3=C(C2C4=CC=CC=C4)NC5=CC=CC=C35
4389;355638086;0.036;1308619;103252465;12259685;10280;271565650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-Pentazocine from sigma 1 receptor in human RPMI8226 cell membranes;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
4390;366431550;0.036;1592018;136942320;57401819;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;1-(4-Chlorophenyl)-4-[4-(4-fluorophenyl)butyl]piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCCC2=CC=C(C=C2)F)C3=CC=C(C=C3)Cl
4391;380264310;0.036;1811100;475988657;126508904;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[1-(4-benzylpiperazin-1-yl)cyclopropyl]methyl]-N-[3-(trifluoromethyl)pyridin-2-yl]propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CC1)N2CCN(CC2)CC3=CC=CC=C3)C4=C(C=CC=N4)C(F)(F)F
4392;389483951;0.036;1805386;444858091;132060755;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A19;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C=CCN1CCN(CC1)C2=CC3=C(CN(CC3)C(=O)OCC4=CC=CC=C4)C=C2
4393;326067555;0.0361;718362;163325460;71455809;10280;230949920;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma 1 receptor in human Jurkat cell membrane;1-[3-[4-[1-Adamantyl(phenyl)methyl]phenyl]propyl]-4-benzylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCN1CCCC2=CC=C(C=C2)C(C3=CC=CC=C3)C45CC6CC(C4)CC(C6)C5)CC7=CC=CC=C7
4394;100292833;0.0363;239105;103442166;11440556;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;4-Benzyl-1-(8-methoxy-1,2,3,4-tetrahydro-naphthalen-2-ylmethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CC(CC2)CN3CCC(CC3)CC4=CC=CC=C4
4395;100473786;0.03631;203852;103166970;2477;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;Buspirone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4
4396;100292839;0.0364;239105;103442109;11234470;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;6-(4-Benzyl-piperidin-1-ylmethyl)-6,7,8,9-tetrahydro-benzocyclohepten-5-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC(C(=O)C2=CC=CC=C2C1)CN3CCC(CC3)CC4=CC=CC=C4
4397;100320349;0.0365;204310;163336456;9669;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 2 using [3H]- DTG in rat liver membranes;Fortral;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;21070;Liver;C[C@@H]1[C@H]2CC3=C([C@@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
4398;100322590;0.0365;204151;103382349;44327509;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 1 using [3H](+)-pentazocine in guinea pig brain membranes;(9R,13R)-10-benzyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@H]1[C@H]2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)O
4399;100485147;0.0365;204636;103318178;90748;10280;76368600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured on Sigma receptor type 1 from guinea pig brain membranes using [3H]pentazocine as radioligand.;3-Benzyl-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)O
4400;100536814;0.0365;204457;103678309;45265184;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(2,4-Dichlorophenyl)-1-(3-ethylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)NC(=NC2=C(C=C(C=C2)Cl)Cl)N.Cl
4401;326034766;0.0368;701162;163324310;16730082;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-(2-(2-(1-(3,4-dichlorophenyl)-1H-pyrazol-3-yloxy)ethoxy)ethyl)piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)CCOCCOC2=NN(C=C2)C3=CC(=C(C=C3)Cl)Cl
4402;100458525;0.037;204438;103211710;15646139;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;11-[4-(4-Fluorophenyl)butyl]-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCCC4=CC=C(C=C4)F)NC5=CC=CC=C53
4403;100604316;0.037;203857;103735240;14771475;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;N-Methyl-N-[(1S)-2alpha-(1-pyrrolidinyl)cyclohexan-1alpha-yl]2-(2-naphthalenyl)ethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC2=CC=CC=C2C=C1)[C@H]3CCCC[C@H]3N4CCCC4
4404;100614377;0.037;203986;103282329;14771685;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N-(2-Methyl-4-nitro-phenyl)-N''-o-tolyl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC2=C(C=C(C=C2)[N+](=O)[O-])C)N
4405;100614743;0.037;203986;103283129;14125583;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N,N''-Bis(4-bromo-2-methylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=C(C=CC(=C1)Br)NC(=NC2=C(C=C(C=C2)Br)C)N
4406;100721051;0.037;204634;103677306;45264464;10280;150260770;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma receptor type 1;"tert-butyl 2-[2-[(4aS,10aR)-6-methoxy-2,3,4,10a-tetrahydro-1H-phenanthren-4a-yl]ethyl-methylamino]acetate;hydrobromide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC(=O)CN(C)CC[C@@]12CCCC[C@@H]1C=CC3=C2C=C(C=C3)OC.Br
4407;354664017;0.037;1288457;336874671;127031398;10280;270328900;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma1 receptor by PDSP assay;10-hexoxy-3,9-dimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-2-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCCCOC1=C(C2=C(CC3C4=CC(=C(C=C4CCN3C2)OC)O)C=C1)OC
4408;363958045;0.037;1500193;404661697;18118651;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-4-methoxybenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)OC)CC2=CC=CC=C2
4409;372400434;0.037;1744234;461559469;162674577;10280;333727820;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane incubated for 2 hr by liquid scintillation counting method;5-(2-Chloro-1-benzothiophen-6-yl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;CN1C(=NC(=N1)CN2CCCC2)C3=CC4=C(C=C3)C=C(S4)Cl
4410;388740469;0.037;1797293;386051305;118282907;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 60B;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)(C)C)N2CC3=C(C2)C(=CC=C3)F
4411;388879271;0.037;1797475;386051305;118282907;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 60B;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)(C)C)N2CC3=C(C2)C(=CC=C3)F
4412;389383759;0.037;1804286;386051305;118282907;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 60B;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)(C)C)N2CC3=C(C2)C(=CC=C3)F
4413;402102471;0.037;1796671;384224369;18118651;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-4-methoxybenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC=C(C=C1)OC)CC2=CC=CC=C2
4414;407996457;0.037;1946583;494404913;171348668;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;1-methyl-5-[[(3S)-3-[(2-methylphenyl)methoxy]piperidin-1-yl]methyl]indazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1CO[C@H]2CCCN(C2)CC3=CC4=C(C=C3)N(N=C4)C
4415;407996510;0.03715;1946583;482056799;168276142;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(3S)-3-[(3-fluorophenyl)methoxy]-1-[(2-methylphenyl)methyl]piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1CN2CCC[C@@H](C2)OCC3=CC(=CC=C3)F
4416;100680841;0.0372;204287;103178796;22413499;10280;119345760;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity towards Sigma opioid receptor type 1 by using [3H]- (+)-pentazocine as radioligand;6-[4-(4-Benzyl-piperazin-1-yl)-butyl]-3-methyl-3H-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C=C(C=C2)CCCCN3CCN(CC3)CC4=CC=CC=C4)SC1=O
4417;389510950;0.0372;1805565;459070371;118250105;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Pharmacological Activity Assay from US Patent US11007200: 'Cycloalkyl-diamines for the treatment of pain';US11007200, Example 2b;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN[C@]1(CCCC[C@@H]1NCCCN2CCCC2)C3=CC=CC=C3Cl
4418;389686575;0.0372;1806763;473129772;165436724;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Pharmacological Activity from US Patent US11426411: 'Cycloalkyl-diamines for the treatment of inflammation';US11426411, Example 2b;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN[C@]1(CCCCC1NCCCN2CCCC2)C3=CC=CC=C3Cl
4419;100500351;0.0373;204448;103186197;7333;10280;85688040;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory activity against sigma receptor isolated from guinea pig brain cortex membrane using [3H]DTG as radioligand;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
4420;100487777;0.0374;204638;103318200;44332389;10280;76368610;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was measured on Sigma receptor type 1 using [3H]- pentazocine as radioligand;5-Bromo-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=CC(=C(C=C3C1(CCN2CC=C(C)C)C)O)Br
4421;388996996;0.0376;1798943;405263588;86581850;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';2-(4-cyclohexyl-piperazin-1-yl)-1-(3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C(=O)N1CCN2C(=CC3=CC=CC=C32)C1)N4CCN(CC4)C5CCCCC5
4422;100297837;0.038;239347;103170049;5035;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;Raloxifene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O
4423;100444460;0.038;204470;103214872;14983054;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-Cyclopentyl-6-(6-piperidin-1-yl-hexyloxy)-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4CCCC4
4424;100458401;0.038;204438;103211676;15646141;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;2-Fluoro-11-(4-phenylbutyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCCC4=CC=CC=C4)NC5=C3C=C(C=C5)F
4425;100470633;0.038;204469;103340146;44342747;10280;79325690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition against sigma receptor using displacement of 3 nM [3H]pentazocine in homogenate of guinea pig brain cerebellum;(1S,13R)-10-decyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCCCCCCCCN1CC[C@]2([C@H](C1CC3=C2C=C(C=C3)O)C)C
4426;100539429;0.038;204458;103414861;10742465;10280;90578570;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Sigma receptor binding was determined by labeling with radioligand [3H](+)-pentazocine on frozen membranes obtained from frozen guinea pig brain;1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-[3-(2-thienyl)propyl]piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CS2)CCOC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F
4427;100615707;0.038;204447;103321224;15701664;10280;16560440;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]-(+)-3-PPP binding to sigma of guinea pig brain;Cyclopropylmethyl-[2-(3,4-dichloro-phenyl)-ethyl]-(2-pyrrolidin-1-yl-cyclohexyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC[C@H]([C@H](C1)N2CCCC2)N(CCC3=CC(=C(C=C3)Cl)Cl)CC4CC4
4428;100617145;0.038;203985;103186197;7333;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
4429;355638091;0.038;1308619;336905311;127051269;10280;271565650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-Pentazocine from sigma 1 receptor in human RPMI8226 cell membranes;(1S,4R,7R)-2-(cyclohexylmethyl)-5-(naphthalen-1-ylmethyl)-2,5-diazabicyclo[2.2.2]octan-7-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;C1CCC(CC1)CN2C[C@H]3C[C@H]([C@@H]2CN3CC4=CC=CC5=CC=CC=C54)O
4430;363850272;0.038;1449796;381857391;72950698;10280;283855030;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 in human MDA-MB-468 cell membranes;1-(4-Chlorophenyl)-2-[3-(4-fluorophenoxy)propyl]guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC(=CC=C1NC(=NCCCOC2=CC=C(C=C2)F)N)Cl
4431;366366664;0.038;1558961;440164117;118567744;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;4-(2-Methoxyphenyl)-2-methyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=CC=CC=C4OC
4432;380263965;0.038;1811100;475992263;126509156;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[4-[4-(3-methoxypropyl)piperazin-1-yl]oxan-4-yl]methyl]-N-[6-(trifluoromethyl)pyridin-2-yl]propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CCOCC1)N2CCN(CC2)CCCOC)C3=CC=CC(=N3)C(F)(F)F
4433;112788089;0.0381;204633;103385146;10546961;10280;74907270;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to inhibit [3H](+)-pentazocine binding to guinea pig brain Sigma receptor type 1;(8E)-8-[(4-chlorophenyl)methylidene]-5-(3-hydroxyphenyl)-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1/C(=C\C3=CC=C(C=C3)Cl)/C(=O)C2)C4=CC(=CC=C4)O
4434;100463773;0.0382;204595;103186197;7333;10280;80219130;Confirmatory;20220830;0;0;Active;Q99720;Kd;=;ChEMBL;Binding affinity against MCF cells in the membrane preparation using radioligand binding assay.;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
4435;100627872;0.0389;229196;174515595;73354414;10280;13194930;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain, using [3H](+)-pentazocine as radioligand.;(1S,9R,13R)-10-(5-fluoropentyl)-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1[C@H]2CC3=C([C@]1(CCN2CCCCCF)C)C=C(C=C3)O
4436;100478422;0.039;203696;103185859;131444;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;((R)-1-Methyl-2-phenyl-ethyl)-(3-phenyl-propyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CC1=CC=CC=C1)NCCCC2=CC=CC=C2
4437;100535943;0.039;204457;103673560;45262099;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(3,4-Dichlorophenyl)-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=CC(=C(C=C2)Cl)Cl)N.Cl
4438;100617140;0.039;203985;103282329;14771685;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N-(2-Methyl-4-nitro-phenyl)-N''-o-tolyl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC2=C(C=C(C=C2)[N+](=O)[O-])C)N
4439;345602962;0.039;1200082;163327760;24743568;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-(3,4-dichlorophenyl)-N-(2-morpholinoethyl)-1H-pyrazol-3-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1COCCN1CCNC2=NN(C=C2)C3=CC(=C(C=C3)Cl)Cl
4440;363665115;0.039;1415967;404709803;74767286;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(4-Fluoro-2-methoxyphenyl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=CC(=C1)F)C2=C3C=NN(C3=NC=N2)CCN4CCCCC4
4441;366366399;0.039;1558961;440156861;118567747;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;4-(3-Fluoropyridin-2-yl)-2-methyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=C(C=CC=N4)F
4442;366423849;0.039;1587567;131279338;54583594;10280;309390140;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from sigma 1 receptor in human RPMI8226 cell membranes incubated for 2 hrs under shaking by scintillation counting analysis;N-benzyl-3-methoxy-N-methylspiro[3,4-dihydroisochromene-1,4'-cyclohexane]-1'-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CC1=CC=CC=C1)C2CCC3(CC2)C4=CC=CC=C4CC(O3)OC
4443;100536549;0.0393;204457;103673428;22120124;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"1-(2,5-Dichlorophenyl)-3-(3-ethylphenyl)-1,3-dimethylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=N)N(C)C2=C(C=CC(=C2)Cl)Cl.Cl
4444;326035323;0.0394;701162;163327760;24743568;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-(3,4-dichlorophenyl)-N-(2-morpholinoethyl)-1H-pyrazol-3-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1COCCN1CCNC2=NN(C=C2)C3=CC(=C(C=C3)Cl)Cl
4445;388996784;0.0398;1798943;405263572;86581554;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';1-(3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)-2-(piperidin-1-yl)ethanone hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CC(=O)N2CCN3C(=CC4=CC=CC=C43)C2
4446;365267155;0.03981;1512456;440123917;155519891;10280;316202300;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-7,9-dimethoxy-3a-methyl-2,3,4,9b-tetrahydro-1H-chromeno[3,4-b]pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@]12COC3=C([C@@H]1CCN2)C(=CC(=C3)OC)OC
4447;365267161;0.03981;1512456;440110637;153287542;10280;316202300;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-3a-methyl-6-phenyl-2,3,4,9b-tetrahydro-1H-chromeno[3,4-b]pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@]12COC3=C(C=CC=C3[C@@H]1CCN2)C4=CC=CC=C4
4448;366437244;0.03981;1594273;440191481;155554287;10280;309043830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;[5-(Benzylamino)-2-phenyl-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)C(=O)C2=C3CC(CCC3=NN2C4=CC=CC=C4)NCC5=CC=CC=C5
4449;407996414;0.03981;1946583;482055924;168275515;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;1-[[4-[(3,4-Difluorophenyl)methoxy]piperidin-1-yl]methyl]-3-methylimidazo[1,5-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NC(=C2N1C=CC=C2)CN3CCC(CC3)OCC4=CC(=C(C=C4)F)F
4450;100297848;0.04;239347;174484804;73345319;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;(7S,8R)-6-Allylamino-7,8-dimethyl-8-propyl-5,6,7,8-tetrahydro-naphthalen-2-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1C2CC3=C([C@@]1(CCN2CC=C)C)C=C(C=C3)O
4451;100445888;0.04;204470;103215418;14982949;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(2-Dimethylamino-ethoxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCOC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3
4452;100468796;0.04;204469;103340549;44342925;10280;79325690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition against sigma receptor using displacement of 3 nM [3H]pentazocine in homogenate of guinea pig brain cerebellum;(1S,13R)-10-hexyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCCCCN1CC[C@]2([C@H](C1CC3=C2C=C(C=C3)O)C)C
4453;100471343;0.04;204459;103298801;10407855;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N-(1-naphthyl)-N'-(o-iodophenyl)-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC=C2C(=C1)C=CC=C2NC(=NC3=CC=CC=C3I)N
4454;100536380;0.04;204457;103678118;45265062;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(3-Bromophenyl)-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=CC(=CC=C2)Br)N.Cl
4455;255036189;0.04;625223;103224720;1547484;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Cinnarizine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=CC=C4
4456;342811248;0.04;1129882;103167216;3559;10280;246178360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human RPMI8226 cell membranes after 120 mins by scintillation counting analysis;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
4457;355638082;0.04;1308619;103167216;3559;10280;271565650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-Pentazocine from sigma 1 receptor in human RPMI8226 cell membranes;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
4458;363958027;0.04;1500193;404652614;18118654;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-3-methoxybenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC(=CC=C1)OC)CC2=CC=CC=C2
4459;366366391;0.04;1558961;440168323;118562576;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;4-Phenyl-9-(2-phenylethyl)-2-(phenylmethoxymethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CN(CCC12CN(C(=O)C(O2)COCC3=CC=CC=C3)C4=CC=CC=C4)CCC5=CC=CC=C5
4460;366423706;0.04;1587567;131281397;54583594;10280;309390140;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from sigma 1 receptor in human RPMI8226 cell membranes incubated for 2 hrs under shaking by scintillation counting analysis;N-benzyl-3-methoxy-N-methylspiro[3,4-dihydroisochromene-1,4'-cyclohexane]-1'-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CC1=CC=CC=C1)C2CCC3(CC2)C4=CC=CC=C4CC(O3)OC
4461;402102364;0.04;1796671;384224368;18118654;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-3-methoxybenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC(=CC=C1)OC)CC2=CC=CC=C2
4462;407996413;0.04;1946583;482055924;168275515;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;1-[[4-[(3,4-Difluorophenyl)methoxy]piperidin-1-yl]methyl]-3-methylimidazo[1,5-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NC(=C2N1C=CC=C2)CN3CCC(CC3)OCC4=CC(=C(C=C4)F)F
4463;100485152;0.0401;204636;103318523;15767682;10280;76368600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured on Sigma receptor type 1 from guinea pig brain membranes using [3H]pentazocine as radioligand.;10-Benzyl-4-chloro-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)Cl
4464;100536374;0.0402;204457;103673556;45262095;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(2,5-Dibromo-3-ethylphenyl)-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=CC(=CC(=C2Br)CC)Br)N.Cl
4465;100535592;0.0404;204794;103359294;44350786;10280;93971710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was done in guinea pig membranes by labeling the binding site with [3H](+)-pentazocine;1-Phenyl-2-(3-phenyl-8-aza-bicyclo[3.2.1]oct-8-yl)-ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2CC(CC1N2CC(C3=CC=CC=C3)O)C4=CC=CC=C4
4466;389712937;0.0406;1919146;476002751;166637131;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assay from US Patent US11535596: 'Analogs of dextromethorphan with balanced receptor activities';4-(2,2-Difluoroethoxy)-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OCC(F)F
4467;100468430;0.0407;203697;103330154;9973880;10280;82952200;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma 1 receptor was determined in guinea pig brain membrane using [3H](+)-pentazocine as radioligand;Tetrahydro-1-[2-[(2-aminoethyl)[2-(3,4-dichlorophenyl)ethyl]amino]ethyl]-1H-pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCN(C1)CCN(CCC2=CC(=C(C=C2)Cl)Cl)CCN
4468;363534302;0.04074;1380349;404685459;74767047;10280;296208900;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 cell membranes after 120 mins by HTS assay;4-(2-Methylpyrazol-3-yl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C(=CC=N1)C2=C3C=NN(C3=NC=N2)CCN4CCCCC4
4469;407996328;0.04074;1946583;336874879;127031515;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(2S)-4-[(3-fluoro-4-methoxyphenyl)methyl]-2-(phenoxymethyl)morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=C(C=C1)CN2CCO[C@@H](C2)COC3=CC=CC=C3)F
4470;100478908;0.041;203700;103186197;7333;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Tested for binding affinity against sigma 1 receptor;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
4471;100539434;0.041;204458;103414803;10742360;10280;90578570;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Sigma receptor binding was determined by labeling with radioligand [3H](+)-pentazocine on frozen membranes obtained from frozen guinea pig brain;1-{2-[Bis-(4-fluoro-phenyl)-methoxy]-ethyl}-4-((E)-3-thiophen-2-yl-allyl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCOC(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)C/C=C/C4=CC=CS4
4472;100737199;0.041;203994;103228721;15034720;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor of guinea pig brain by using [3H]SKF-10047 radioligand;(5S)-5-[(4-hydroxy-4-thiophen-2-ylpiperidin-1-yl)methyl]-3-(4-methoxyphenyl)-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)N2C[C@@H](OC2=O)CN3CCC(CC3)(C4=CC=CS4)O
4473;255028308;0.041;625223;103188875;2157;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amiodarone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I
4474;342811247;0.041;1129882;242620286;29150590;10280;246178360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human RPMI8226 cell membranes after 120 mins by scintillation counting analysis;2-[(2S)-1-benzyl-4-(2-phenylethyl)piperazin-2-yl]ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;C1CN([C@H](CN1CCC2=CC=CC=C2)CCO)CC3=CC=CC=C3
4475;363665331;0.041;1415967;404685459;74767047;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(2-Methylpyrazol-3-yl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C(=CC=N1)C2=C3C=NN(C3=NC=N2)CCN4CCCCC4
4476;363665768;0.041;1415921;404699206;71223250;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;1-(1-(2-(azepan-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-3-tert-butylurea hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)NC(=O)NC1=C2C=NN(C2=NC=N1)CCN3CCCCCC3
4477;388740104;0.041;1797293;386051084;118282956;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 8;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)F
4478;388878832;0.041;1797475;386051084;118282956;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 8;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)F
4479;389383357;0.041;1804286;386051084;118282956;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 8;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)F
4480;407996327;0.041;1946583;336874879;127031515;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(2S)-4-[(3-fluoro-4-methoxyphenyl)methyl]-2-(phenoxymethyl)morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=C(C=C1)CN2CCO[C@@H](C2)COC3=CC=CC=C3)F
4481;366431538;0.0415;1592018;136932520;3069135;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;Piperazine, 1-(3-(4-fluorophenoxy)propyl)-4-phenyl-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCOC2=CC=C(C=C2)F)C3=CC=CC=C3
4482;100543215;0.0416;203699;103218436;10783531;10280;95728830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to sigma-1 sites in guinea pig brain membranes;(1R,9S,13S)-10-[2-(cyclohexylamino)ethyl]-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2CCNC4CCCCC4)C)C=C(C=C3)O
4483;100546286;0.0418;203689;103283898;10836067;10280;96511500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma-1 receptor in guinea pig brain membranes;3-Iodo-4-methoxy-N-(2-piperidin-1-yl-ethyl)-benzenesulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C=C1)S(=O)(=O)NCCN2CCCCC2)I
4484;100471334;0.042;204459;103283130;14771668;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N,N''-Bis(3-propylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCC1=CC(=CC=C1)NC(=NC2=CC=CC(=C2)CCC)N
4485;100604302;0.042;203857;103735204;46877995;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;N-Methyl-N-[(1R)-2beta-(1-pyrrolidinyl)cyclohexan-1beta-yl]-2,3-dichlorophenoxyacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)COC3=C(C(=CC=C3)Cl)Cl
4486;100612547;0.042;204439;103283175;14771686;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to sigma receptor in guinea pig brain membrane homogenates;N-(2,6-Dimethyl-phenyl)-N''-o-tolyl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=C(C(=CC=C1)C)N=C(N)NC2=CC=CC=C2C
4487;326067558;0.042;718362;163332450;71459493;10280;230949920;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma 1 receptor in human Jurkat cell membrane;1-[3-[4-[1-Adamantyl(phenyl)methyl]phenyl]propyl]piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCN1)CCCC2=CC=C(C=C2)C(C3=CC=CC=C3)C45CC6CC(C4)CC(C6)C5
4488;363958042;0.042;1500193;404651607;40624141;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-2-bromobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC=CC=C1Br)CC2=CC=CC=C2
4489;380263969;0.042;1811100;475996681;126539472;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[1-(4-benzylpiperazin-1-yl)cyclopropyl]methyl]-N-phenylpropanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CC1)N2CCN(CC2)CC3=CC=CC=C3)C4=CC=CC=C4
4490;380264148;0.042;1811100;475987326;126539532;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[3-(4-benzylpiperazin-1-yl)oxetan-3-yl]methyl]-N-phenylpropanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(COC1)N2CCN(CC2)CC3=CC=CC=C3)C4=CC=CC=C4
4491;388740023;0.042;1797293;386051083;118282951;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 7;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=CC(=C(C=C3C2)OC)OC
4492;388740100;0.042;1797293;386051147;118282959;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 18;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC4=CC=CC=C4C=C3C2
4493;388878704;0.042;1797475;386051083;118282951;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 7;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=CC(=C(C=C3C2)OC)OC
4494;388878836;0.042;1797475;386051147;118282959;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 18;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC4=CC=CC=C4C=C3C2
4495;389383282;0.042;1804286;386051083;118282951;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 7;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=CC(=C(C=C3C2)OC)OC
4496;389383353;0.042;1804286;386051147;118282959;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 18;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC4=CC=CC=C4C=C3C2
4497;402102410;0.042;1796671;384224360;40624141;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-2-bromobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC=CC=C1Br)CC2=CC=CC=C2
4498;100543219;0.0422;203699;103217983;10618791;10280;95728830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to sigma-1 sites in guinea pig brain membranes;(1R,9S,13S)-10-[2-(N-ethylanilino)ethyl]-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCN(CCN1CC[C@@]2([C@@H]([C@@H]1CC3=C2C=C(C=C3)O)C)C)C4=CC=CC=C4
4499;100536693;0.0428;204457;103673584;45262117;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"1-(3-Ethylphenyl)-1-methyl-2-phenylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=CC=CC=C2)N.Cl
4500;100439266;0.043;203853;103359799;6604868;10280;13615780;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory concentration against radioligand [3H](+)-NAN binding to haloperidol-sensitive sigma binding site in whole guinea pig brain;(R)-1-(4-Fluoro-phenyl)-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butan-1-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCC[C@H](C2=CC=C(C=C2)F)O)C3=NC=C(C=N3)F
4501;100444471;0.043;204470;103215541;9890959;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;Sigma-LIGAND-1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(OC2=C(C1=O)C=C(C=C2)OCCCCCCN3CCC(CC3)O)C4=CC=CC=C4
4502;100468794;0.043;204469;103340237;44342793;10280;79325690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition against sigma receptor using displacement of 3 nM [3H]pentazocine in homogenate of guinea pig brain cerebellum;(1R,13S)-1,13-dimethyl-10-propyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCN1CC[C@@]2([C@@H](C1CC3=C2C=C(C=C3)O)C)C
4503;100471346;0.043;204459;103282513;10243335;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N,N''-Di-m-tolyl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC(=CC=C1)NC(=NC2=CC=CC(=C2)C)N
4504;100539432;0.043;204458;103186824;3455;10280;90578570;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Sigma receptor binding was determined by labeling with radioligand [3H](+)-pentazocine on frozen membranes obtained from frozen guinea pig brain;Vanoxerine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)CCOC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F
4505;100539436;0.043;204458;103414801;11797295;10280;90578570;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Sigma receptor binding was determined by labeling with radioligand [3H](+)-pentazocine on frozen membranes obtained from frozen guinea pig brain;1-{2-[Bis-(4-fluoro-phenyl)-methoxy]-ethyl}-4-((E)-3-furan-2-yl-allyl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCOC(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)C/C=C/C4=CC=CO4
4506;100746098;0.043;204298;103266220;21481466;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma opioid receptor type 2 in guinea pig brain homogenate with 4 nM [3H]-(+)-DTG;5,5-Diphenyl-3-[2-(4-phenyl-piperidin-1-yl)-ethyl]-imidazolidine-2,4-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1C2=CC=CC=C2)CCN3C(=O)C(NC3=O)(C4=CC=CC=C4)C5=CC=CC=C5
4507;334065475;0.043;735278;164132794;71655413;10280;235606500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aS,5R,10bS)-5-cyclohexyl-9-pentyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCCCCC1=CC2=C(C=C1)N[C@@H]([C@H]3[C@@H]2OCCC3)C4CCCCC4
4508;340019834;0.043;752344;174496375;52912210;10280;235824490;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H]1,3-di(2-tolyl)guanidine from sigma 1 receptor in human Jurkat cells;2-[(2S,3R)-2-methyl-5-oxo-3-phenylpyrrolidin-1-yl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C[C@H]1[C@H](CC(=O)N1CC(=O)N)C2=CC=CC=C2
4509;363665338;0.043;1415967;404706732;74767208;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(4-Chlorophenyl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=NC=NC(=C3C=N2)C4=CC=C(C=C4)Cl
4510;372121201;0.043;1681775;461531854;118561097;10280;330649470;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;4-Ethyl-2-methyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CCC3=CC=CC=C3)OC(C1=O)C
4511;100546615;0.0434;203685;103277872;10499273;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-Benzylpiperidine-4-yl)-2-(2,5-dimethoxyphenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC(=C(C=C1)OC)CC(=O)NC2CCN(CC2)CC3=CC=CC=C3
4512;100536698;0.0435;204457;103673587;45262120;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(3-Chlorophenyl)-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=CC(=CC=C2)Cl)N.Cl
4513;366436225;0.04365;1593893;440212272;155562543;10280;309877800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK293T cell membranes;5-Fluoro-2-[2-(4-pyridin-2-yl-1,4-diazepan-1-yl)ethyl]-2,3-dihydroinden-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=CC=CC=N2)CCC3CC4=C(C3=O)C=CC(=C4)F
4514;407996263;0.04365;1946583;336876198;127032383;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(2S)-4-(1H-indol-5-ylmethyl)-2-(phenoxymethyl)morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CO[C@@H](CN1CC2=CC3=C(C=C2)NC=C3)COC4=CC=CC=C4
4515;100386148;0.0437;204153;103378371;11034660;10280;117841480;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma opioid receptor type 1 affinity in guinea pig brain by employing [3H](+)-pentazocine as radioligand.;1'-Phenethyl-3,4-dihydrospiro[1H-2-benzopyran-1,4'-piperidine]-3-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3CC(O2)O)CCC4=CC=CC=C4
4516;100478432;0.0437;203696;103186164;12874569;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;((S)-1-Methyl-2-phenyl-ethyl)-phenethyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](CC1=CC=CC=C1)NCCC2=CC=CC=C2
4517;100500105;0.0438;204466;103237392;10807028;10280;85688040;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]DTG binding to sigma receptor from guinea pig brain cortex membrane;1-[3-(1,2,3,4-Tetrahydro-naphthalen-1-yl)-propyl]-4-(3,4,5,6-tetrahydro-pyridin-2-yl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN=C(C1)N2CCN(CC2)CCCC3CCCC4=CC=CC=C34
4518;100458529;0.044;204438;103344314;15149414;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;5-Fluoro-15-(3-pyridin-3-ylpropyl)-9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3(8),4,6-tetraene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCC4=CN=CC=C4)NC5=C3C=C(C=C5)F
4519;100617137;0.044;203985;103282864;13781931;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N,N''-Bis(2-ethylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC=CC=C1NC(=NC2=CC=CC=C2CC)N
4520;100742365;0.044;203992;103677389;45264520;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"2-[2-(Diethylamino)ethyl]-2-methyl-5-phenylfuran-3-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCN(CC)CCC1(C(=O)C=C(O1)C2=CC=CC=C2)C.Cl
4521;326034943;0.044;701162;163338187;11704592;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;ethyl 4-{2-[1-(3,4-dichlorophenyl)-5-methyl-1H-pyrazol-3-yloxy]ethyl}piperazine carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCOC(=O)N1CCN(CC1)CCOC2=NN(C(=C2)C)C3=CC(=C(C=C3)Cl)Cl
4522;326034946;0.044;701162;163314017;71449813;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;4-[2-[1-(2,4-Dichlorophenyl)-5-methylpyrazol-3-yl]oxyethyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=C(C=C(C=C2)Cl)Cl)OCCN3CCOCC3
4523;365267156;0.044;1512456;440123917;155519891;10280;316202300;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-7,9-dimethoxy-3a-methyl-2,3,4,9b-tetrahydro-1H-chromeno[3,4-b]pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@]12COC3=C([C@@H]1CCN2)C(=CC(=C3)OC)OC
4524;366436226;0.044;1593893;440212272;155562543;10280;309877800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK293T cell membranes;5-Fluoro-2-[2-(4-pyridin-2-yl-1,4-diazepan-1-yl)ethyl]-2,3-dihydroinden-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=CC=CC=N2)CCC3CC4=C(C3=O)C=CC(=C4)F
4525;388740250;0.044;1797293;386051267;118282970;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 22;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC=C(C=C1)F)N2CC3=C(C2)C=C(C=C3)F
4526;388878959;0.044;1797475;386051267;118282970;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 22;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC=C(C=C1)F)N2CC3=C(C2)C=C(C=C3)F
4527;389383531;0.044;1804286;386051267;118282970;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 22;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC=C(C=C1)F)N2CC3=C(C2)C=C(C=C3)F
4528;389483900;0.044;1805386;160849620;132060746;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';Benzyl 5-(4-cyclopentylpiperazin-1-yl)-1,3-dihydroisoindole-2-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)N2CCN(CC2)C3=CC4=C(CN(C4)C(=O)OCC5=CC=CC=C5)C=C3
4529;407996262;0.044;1946583;336876198;127032383;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(2S)-4-(1H-indol-5-ylmethyl)-2-(phenoxymethyl)morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CO[C@@H](CN1CC2=CC3=C(C=C2)NC=C3)COC4=CC=CC=C4
4530;100741915;0.0445;203989;103307736;15166843;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor in guinea pig brain preparation was estimated using [3H]3-PPP as radioligand;2-[1-(4-pyridin-4-ylbutyl)-3,6-dihydro-2H-pyridin-4-yl]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CC=C1C2=CC=CC=N2)CCCCC3=CC=NC=C3
4531;100448366;0.045;204471;103215261;14982994;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;7-[6-(4-Hydroxy-piperidin-1-yl)-hexyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCOC2=CC3=C(C=C2)C(=O)C=C(O3)C4=CC=CC=C4
4532;100470624;0.045;204469;103340518;44342912;10280;79325690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition against sigma receptor using displacement of 3 nM [3H]pentazocine in homogenate of guinea pig brain cerebellum;(1S,13R)-1,13-dimethyl-10-pentyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCCCN1CC[C@]2([C@H](C1CC3=C2C=C(C=C3)O)C)C
4533;100619100;0.045;203990;136943218;21968329;10280;18482950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma opioid receptor in guinea pig cerebral homogenate using [3H]DTG as radioligand;(2R)-N-(2-phenoxyethyl)-1-phenylpropan-2-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CC1=CC=CC=C1)NCCOC2=CC=CC=C2
4534;100745601;0.045;204454;103247795;15729898;10280;;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;In vitro binding affinity towards sigma receptor by the displacement of [3H]PPP from guinea pig brain;5-Fluoro-2-{4-[3-(4-fluoro-benzenesulfonyl)-propyl]-piperazin-1-yl}-pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCS(=O)(=O)C2=CC=C(C=C2)F)C3=NC=C(C=N3)F
4535;255012604;0.045;625223;103555930;5572;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Trihexyphenidyl;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O
4536;363665766;0.045;1415921;404696372;71225577;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;N-(1-(3-(piperidin-1-yl)propyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)pivalamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)C(=O)NC1=C2C=NN(C2=NC=N1)CCCN3CCCCC3
4537;407996509;0.045;1946583;482056799;168276142;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(3S)-3-[(3-fluorophenyl)methoxy]-1-[(2-methylphenyl)methyl]piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1CN2CCC[C@@H](C2)OCC3=CC(=CC=C3)F
4538;100536692;0.0453;204457;103673559;45262098;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(2-Chloro-3-ethyl-5-methylphenyl)-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=CC(=CC(=C2Cl)CC)C)N.Cl
4539;363850275;0.04532;1449796;381842831;72950697;10280;283855030;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 in human MDA-MB-468 cell membranes;2-[3-(4-Fluorophenoxy)propyl]-1-[4-(trifluoromethyl)phenyl]guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC(=CC=C1C(F)(F)F)NC(=NCCCOC2=CC=C(C=C2)F)N
4540;100536686;0.0457;204457;103678138;45265074;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(4-Chlorophenyl)-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=CC=C(C=C2)Cl)N.Cl
4541;100444459;0.046;204470;103215586;14983042;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-Cyclohexyl-6-[6-(4-hydroxy-piperidin-1-yl)-hexyloxy]-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)C2=CC(=O)C3=C(O2)C=CC(=C3)OCCCCCCN4CCC(CC4)O
4542;100458515;0.046;204438;103343688;15149404;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;11-[4-(2-Furanyl)butyl]-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCCC4=CC=CO4)NC5=CC=CC=C53
4543;100475263;0.046;204462;103673103;45261760;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;"1'-[4-(4-Fluorophenyl)-4-oxobutyl]spiro[3,4-dihydronaphthalene-2,4'-piperidine]-1-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2(CCN(CC2)CCCC(=O)C3=CC=C(C=C3)F)C(=O)C4=CC=CC=C41.Cl
4544;345602800;0.046;1200082;312389812;76683773;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-(3,4-dichlorophenyl)-N-(2-morpholinoethyl)-1H-1,2,3-triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1COCCN1CCNC2=CN(N=N2)C3=CC(=C(C=C3)Cl)Cl
4545;345602976;0.046;1200082;312389832;76684202;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-[(3,4-difluorophenyl)methyl]-N-[2-(4,4-difluoropiperidin-1-yl)ethyl]triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CN(CCC1(F)F)CCNC2=CN(N=N2)CC3=CC(=C(C=C3)F)F
4546;388740379;0.046;1797293;386051272;118282877;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 27;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)F)O
4547;388878702;0.046;1797475;386051272;118282877;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 27;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)F)O
4548;389383653;0.046;1804286;386051272;118282877;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 27;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)F)O
4549;363850273;0.04608;1449796;381884776;72950534;10280;283855030;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 in human MDA-MB-468 cell membranes;2-[3-(4-Fluorophenoxy)propyl]-1-(4-iodophenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC(=CC=C1NC(=NCCCOC2=CC=C(C=C2)F)N)I
4550;100403481;0.0465;204630;103272556;126402;10280;128012230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma receptor type 1 was determined by the displacement of [3H]pentazocine radioligand;2-(4-Morpholino)ethyl-1-phenylcyclohexane-1-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)(C2=CC=CC=C2)C(=O)OCCN3CCOCC3
4551;100500100;0.0465;204466;103237313;15205702;10280;85688040;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]DTG binding to sigma receptor from guinea pig brain cortex membrane;1-[4-(5-Methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-butyl]-4-(3,4,5,6-tetrahydro-pyridin-2-yl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCCC2CCCCN3CCN(CC3)C4=NCCCC4
4552;100496808;0.04698;204761;103401467;10428881;10280;78533490;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity at Sigma receptor type 1, displacement of [3H](+)-pentazocine from guinea pig brain membranes;N-[4-[[(1S,9S,13S)-4-hydroxy-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methyl]phenyl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC4=CC=C(C=C4)NC(=O)C)C)C=C(C=C3)O
4553;100448345;0.047;204471;103215508;14983027;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-(2-Chloro-phenyl)-6-[6-(4-hydroxy-piperidin-1-yl)-hexyloxy]-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4Cl
4554;100565308;0.047;203703;103177691;473073;10280;95442130;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;The compound was tested for the affinity on sigma 1 receptor using [3H]- pentazocine as radioligand;3-(2-Piperidin-1-yl-ethyl)-6-propionyl-3H-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)C1=CC2=C(C=C1)N(C(=O)S2)CCN3CCCCC3
4555;326034620;0.047;701162;163324288;11659822;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;N,N-Diethyl-2-[[5-methyl-1-(2-naphthalenyl)-1H-pyrazol-3-yl]oxy]ethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCN(CC)CCOC1=NN(C(=C1)C)C2=CC3=CC=CC=C3C=C2
4556;342802961;0.047;1127317;103242071;9892540;10280;247356470;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);1-(3-(4-(3-Chlorophenyl)-1-piperazinyl)propyl)-5-methoxy-3,4-dihydro-2-quinolinone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCC(=O)N2CCCN3CCN(CC3)C4=CC(=CC=C4)Cl
4557;363958017;0.047;1500193;404661803;41306333;10280;287562630;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N-[3-(benzylmethylamino)propyl]-2-chlorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC=CC=C1Cl)CC2=CC=CC=C2
4558;380264150;0.047;1811100;475997501;137371209;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[4-(4-benzylpiperazin-1-yl)thian-4-yl]methyl]-N-[6-(trifluoromethyl)pyridin-2-yl]propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CCSCC1)N2CCN(CC2)CC3=CC=CC=C3)C4=CC=CC(=N4)C(F)(F)F
4559;388740217;0.047;1797293;386051274;118282878;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 29;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=CC4=C(C=C3C2)OCO4)O
4560;388878950;0.047;1797475;386051274;118282878;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 29;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=CC4=C(C=C3C2)OCO4)O
4561;389383434;0.047;1804286;386051274;118282878;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 29;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=CC4=C(C=C3C2)OCO4)O
4562;402102409;0.047;1796671;384224353;41306333;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Binding Assay to Sigma Receptors from US Patent US10179761: 'Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases';N-[3-(benzylmethylamino)propyl]-2-chlorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC=CC=C1Cl)CC2=CC=CC=C2
4563;100295634;0.0473;239200;103442160;11326158;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;4-Benzyl-1-(6,7,8,9-tetrahydro-5H-benzocyclohepten-6-ylmethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC(CC2=CC=CC=C2C1)CN3CCC(CC3)CC4=CC=CC=C4
4564;100354292;0.048;204790;103237515;10811875;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-[[(2R)-1-Cyclobutyl-2-pyrrolidinyl]methyl]-1-methoxy-4-bromo-2-naphthalenecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)NC[C@H]3CCCN3C4CCC4
4565;100440053;0.048;229193;103575820;5284595;10280;14696970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of specific binding of [3H]NANM of sigma receptor in Guinea pig brain membranes;Nalorphine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C=CCN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O
4566;100617152;0.048;203985;103282940;407725;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;1,2-Dicyclohexylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)NC(=NC2CCCCC2)N
4567;255034398;0.048;625223;136928380;6761;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pipamazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCC1C(=O)N)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl
4568;363665667;0.048;1415967;404715789;74767287;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(4-Fluoro-2-methylphenyl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC(=C1)F)C2=C3C=NN(C3=NC=N2)CCN4CCCCC4
4569;366366665;0.048;1558961;440175267;118567545;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;CID 118567545;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=C(N=CC=C4)C(F)(F)F
4570;380264146;0.048;1811100;475980222;126539774;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[2-(4-benzylpiperazin-1-yl)-2-methylpropyl]-2-methoxy-N-phenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CN(C1=CC=CC=C1)C(=O)COC)N2CCN(CC2)CC3=CC=CC=C3
4571;389483906;0.048;1805386;160849721;132060795;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';Benzyl 8-[4-(2-methylprop-2-enyl)piperazin-1-yl]-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=C)CN1CCN(CC1)C2=CC3=C(CCCN(C3)C(=O)OCC4=CC=CC=C4)C=C2
4572;326067554;0.0481;718362;163328890;25006418;10280;230949920;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma 1 receptor in human Jurkat cell membrane;1-[3-[4-[1-Adamantyl(phenyl)methyl]phenyl]propyl]-4-methylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCN(CC1)CCCC2=CC=C(C=C2)C(C3=CC=CC=C3)C45CC6CC(C4)CC(C6)C5
4573;100478465;0.0482;203696;103186089;12914591;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;N-(2-phenylethyl)pentan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCCNCCC1=CC=CC=C1
4574;100445887;0.049;204470;103215214;14982982;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-{6-[4-(4-Chloro-phenyl)-3,6-dihydro-2H-pyridin-1-yl]-hexyloxy}-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CC=C1C2=CC=C(C=C2)Cl)CCCCCCOC3=CC4=C(C=C3)OC(=CC4=O)C5=CC=CC=C5
4575;100448351;0.049;204471;103215214;14982982;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-{6-[4-(4-Chloro-phenyl)-3,6-dihydro-2H-pyridin-1-yl]-hexyloxy}-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CC=C1C2=CC=C(C=C2)Cl)CCCCCCOC3=CC4=C(C=C3)OC(=CC4=O)C5=CC=CC=C5
4576;100470632;0.049;204469;103339996;44342661;10280;79325690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition against sigma receptor using displacement of 3 nM [3H]pentazocine in homogenate of guinea pig brain cerebellum;(1S,13R)-10-heptyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCCCCCN1CC[C@]2([C@H](C1CC3=C2C=C(C=C3)O)C)C
4577;100721055;0.049;204634;103671111;45260300;10280;150260770;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma receptor type 1;"N-[2-[(4aS,10aR)-6-methoxy-2,3,4,10a-tetrahydro-1H-phenanthren-4a-yl]ethyl]-N-methylprop-2-en-1-amine;hydrobromide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CC[C@@]12CCCC[C@@H]1C=CC3=C2C=C(C=C3)OC)CC=C.Br
4578;100721998;0.049;204634;103671025;45260245;10280;150260770;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma receptor type 1;"2-[(4aS,10aR)-6-methoxy-2,3,4,10a-tetrahydro-1H-phenanthren-4a-yl]-N-(2-methoxyethyl)-N-methylethanamine;hydrobromide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CC[C@@]12CCCC[C@@H]1C=CC3=C2C=C(C=C3)OC)CCOC.Br
4579;100745598;0.049;204454;103247818;20068647;10280;;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;In vitro binding affinity towards sigma receptor by the displacement of [3H]PPP from guinea pig brain;N-{1-(4-Fluoro-phenyl)-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butyl}-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)NC(CCCN1CCN(CC1)C2=NC=C(C=N2)F)C3=CC=C(C=C3)F
4580;100746103;0.049;204298;103265849;44309737;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma opioid receptor type 2 in guinea pig brain homogenate with 4 nM [3H]-(+)-DTG;5,5-Diphenyl-3-[4-(4-phenyl-piperazin-1-yl)-butyl]-imidazolidine-2,4-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCCCN2C(=O)C(NC2=O)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=CC=C5
4581;345602524;0.049;1200082;312389820;76683678;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-benzyl-N-(2-piperidin-1-ylethyl)triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)CCNC2=CN(N=N2)CC3=CC=CC=C3
4582;372400428;0.049;1744234;461555458;154929675;10280;333727820;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane incubated for 2 hr by liquid scintillation counting method;1-[[5-(4-Tert-butylphenyl)-1-methyl-1,2,4-triazol-3-yl]methyl]-4-(2-phenylethyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;CC(C)(C)C1=CC=C(C=C1)C2=NC(=NN2C)CN3CCN(CC3)CCC4=CC=CC=C4
4583;380512728;0.049;1846430;482069579;168285428;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-4-[(4-fluorophenyl)methyl]-10-(5-fluoropyridin-2-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CC=C(C=C3)F)OCC4=C(N=NN24)C5=NC=C(C=C5)F
4584;389483969;0.049;1805386;160849730;132060758;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';Benzyl 8-(4-cyclopentylpiperazin-1-yl)-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)N2CCN(CC2)C3=CC4=C(CCCN(C4)C(=O)OCC5=CC=CC=C5)C=C3
4585;255034752;0.0493;625223;103712397;657255;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(1S,2R)-2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCCCCCN[C@H](C)[C@H](C1=CC=C(C=C1)SC(C)C)O
4586;388996818;0.0495;1798943;405263603;86582459;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';(R)-1-(3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)-2-methyl-3-(4-methyl-piperazin-1-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CN1CCN(CC1)C)C(=O)N2CCN3C(=CC4=CC=CC=C43)C2
4587;100445889;0.05;204470;103215849;14983039;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-Cyclobutyl-6-[6-(4-hydroxy-piperidin-1-yl)-hexyloxy]-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC(C1)C2=CC(=O)C3=C(O2)C=CC(=C3)OCCCCCCN4CCC(CC4)O
4588;100456551;0.05;229183;103314862;185717;10280;79028690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor in bovine cerebellum using 2.0 nM [3H]haloperidol in the presence of 25 nM unlabeled spiperone;4-(4-Chlorophenyl)-1,2,3,6-tetrahydropyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CNCC=C1C2=CC=C(C=C2)Cl
4589;100551431;0.05;204463;103235608;122065;10280;97034600;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Compound is evaluated for binding affinity towards Sigma receptor using [3H]pentazocine in guinea pig brain;3-[2-[4-(2-Methoxyphenyl)-1-piperazinyl]ethyl]-2,4(1H,3H)-quinazolinedione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)C4=CC=CC=C4NC3=O
4590;372120969;0.05;1681775;461527641;118560993;10280;330649470;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;2,2,4-Trimethyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1(C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C)C
4591;380773041;0.05;1907474;482049024;168270573;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;Benzyl 3-[3-(4-propylpiperazin-2-yl)phenyl]morpholine-4-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCNC(C1)C2=CC(=CC=C2)C3COCCN3C(=O)OCC4=CC=CC=C4
4592;388740473;0.05;1797293;386051315;118283052;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 70;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C)O
4593;388879267;0.05;1797475;386051315;118283052;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 70;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C)O
4594;389383771;0.05;1804286;386051315;118283052;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 70;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C)O
4595;389712987;0.05;1919146;476002753;86231036;10280;;Confirmatory;20231017;0;0;Active;Q99720;IC50;;BindingDB;Receptor Binding Assay from US Patent US11535596: 'Analogs of dextromethorphan with balanced receptor activities';17-Methyl-4-(2,2,2-trifluoroethoxy)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OCC(F)(F)F
4596;365267543;0.05012;1512456;440149911;153287541;10280;316202300;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-3,3a-dimethyl-6-phenyl-1,2,4,9b-tetrahydrochromeno[3,4-b]pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@]12COC3=C(C=CC=C3[C@@H]1CCN2C)C4=CC=CC=C4
4597;365267552;0.05012;1512456;440204965;153287535;10280;316202300;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-3,3a-dimethyl-1,2,4,9b-tetrahydrochromeno[3,4-b]pyrrol-7-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@]12COC3=C([C@@H]1CCN2C)C=CC(=C3)O
4598;380773040;0.05012;1907474;482049024;168270573;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;Benzyl 3-[3-(4-propylpiperazin-2-yl)phenyl]morpholine-4-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCNC(C1)C2=CC(=CC=C2)C3COCCN3C(=O)OCC4=CC=CC=C4
4599;100448319;0.051;204471;103214873;14983053;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-Cyclobutyl-6-(6-piperidin-1-yl-hexyloxy)-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4CCC4
4600;100448340;0.051;204471;103215847;14983040;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-Cyclopentyl-6-[6-(4-hydroxy-piperidin-1-yl)-hexyloxy]-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)C2=CC(=O)C3=C(O2)C=CC(=C3)OCCCCCCN4CCC(CC4)O
4601;100539430;0.051;204458;103200483;5974189;10280;90578570;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Sigma receptor binding was determined by labeling with radioligand [3H](+)-pentazocine on frozen membranes obtained from frozen guinea pig brain;1-(2-(Bis(4-fluorophenyl)methoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCOC(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)C/C=C/C4=CC=CC=C4
4602;100745738;0.051;204454;103247334;15729886;10280;;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity towards sigma receptor by the displacement of [3H]PPP from guinea pig brain;1-[3-(4-Fluorophenylthio)propyl]-4-(5-fluoro-2-pyrimidinyl) piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCSC2=CC=C(C=C2)F)C3=NC=C(C=N3)F
4603;255014476;0.051;625223;103358404;4886;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pramoxine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCOC1=CC=C(C=C1)OCCCN2CCOCC2
4604;363666001;0.051;1415967;404674272;71223252;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;N-(1-(2-(Piperidin-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)pivalamide maleate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)C(=O)NC1=C2C=NN(C2=NC=N1)CCN3CCCCC3
4605;363666193;0.051;1415921;404674272;71223252;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;N-(1-(2-(Piperidin-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)pivalamide maleate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)C(=O)NC1=C2C=NN(C2=NC=N1)CCN3CCCCC3
4606;366315880;0.051;1532592;312389772;86582973;10280;304474340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human Jurkat cell membranes after 2 hrs by liquid scintillation counting method;Donecopride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=CC(=C(C=C1C(=O)CCC2CCN(CC2)CC3CCCCC3)Cl)N
4607;366366666;0.051;1558961;440229198;118567618;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;4-(2-Hydroxyphenyl)-2-methyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=CC=CC=C4O
4608;380264649;0.051;1811100;475998454;137371326;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[4-[4-(2-phenoxyethyl)piperazin-1-yl]oxan-4-yl]methyl]-N-[6-(trifluoromethyl)pyridin-2-yl]propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CCOCC1)N2CCN(CC2)CCOC3=CC=CC=C3)C4=CC=CC(=N4)C(F)(F)F
4609;380512736;0.051;1846430;482075824;86295356;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-10-(2-fluorophenyl)-4-[(6-methoxypyridin-3-yl)methyl]-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=NC=C(C=C1)CN2C[C@@H]3[C@@H](C2)OCC4=C(N=NN34)C5=CC=CC=C5F
4610;389483946;0.051;1805386;160849725;132060776;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';benzyl 7-(4-cyclopentylpiperazin-1-yl)-3,4-dihydro-1H-isoquinoline-2-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)N2CCN(CC2)C3=CC4=C(CCN(C4)C(=O)OCC5=CC=CC=C5)C=C3
4611;363534303;0.05129;1380349;404674272;71223252;10280;296208900;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 cell membranes after 120 mins by HTS assay;N-(1-(2-(Piperidin-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)pivalamide maleate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)C(=O)NC1=C2C=NN(C2=NC=N1)CCN3CCCCC3
4612;112788098;0.0513;204633;103386352;10809006;10280;74907270;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to inhibit [3H](+)-pentazocine binding to guinea pig brain Sigma receptor type 1;(8E)-8-[(3-chlorophenyl)methylidene]-5-(3-hydroxyphenyl)-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1/C(=C\C3=CC(=CC=C3)Cl)/C(=O)C2)C4=CC(=CC=C4)O
4613;366431689;0.0517;1592018;136932521;57396571;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;1-(4-Chlorophenyl)-4-(3-phenoxypropyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCOC2=CC=CC=C2)C3=CC=C(C=C3)Cl
4614;100366976;0.05194;226337;103376031;10895188;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;5-Bromo-N-(1-benzyl-4-piperidinyl)-1H-indole-3-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CNC3=C2C=C(C=C3)Br)CC4=CC=CC=C4
4615;100448361;0.052;204471;103215704;14982969;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-(Benzyl-methyl-amino)-hexyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCCCCOC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3)CC4=CC=CC=C4
4616;100497230;0.052;203984;103436022;9975973;10280;76997100;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;1-[3-(5-Methoxy-3,4-dihydro-naphthalen-1-yl)-propyl]-4-pyridin-2-yl-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCC=C2CCCN3CCN(CC3)C4=CC=CC=N4
4617;100745609;0.052;204454;103247695;15729927;10280;;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity towards sigma receptor by the displacement of [3H]PPP from guinea pig brain;1-Cyclohexyl-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)C(CCCN2CCN(CC2)C3=NC=C(C=N3)F)N
4618;334066176;0.052;735278;164144049;71655418;10280;235606500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aS,5R,10bS)-5-cyclohexyl-9-(3-methylbutoxy)-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC(C)CCOC1=CC2=C(C=C1)N[C@@H]([C@H]3[C@@H]2OCCC3)C4CCCCC4
4619;345603241;0.052;1200082;312389822;76683885;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-[(4-fluorophenyl)methyl]-N-(2-piperidin-1-ylethyl)triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)CCNC2=CN(N=N2)CC3=CC=C(C=C3)F
4620;367478254;0.052;1655949;442058583;156018103;10280;324354210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human Sigma 1 receptor by radioligand displacement assay;"4-benzyl-1-[[(2S,4R)-spiro[1,3-dithiolane-2,4'-2,3-dihydro-1H-naphthalene]-4-yl]methyl]piperidine;oxalic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2=CC=CC=C2[C@@]3(C1)SC[C@H](S3)CN4CCC(CC4)CC5=CC=CC=C5.C(=O)(C(=O)O)O
4621;407996094;0.052;1946583;374281438;134135650;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;3-[[(3R)-4,4-difluoro-3-(2-phenylethyl)piperidin-1-yl]methyl]-6-fluoro-1H-indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(C[C@H](C1(F)F)CCC2=CC=CC=C2)CC3=CNC4=C3C=CC(=C4)F
4622;407996343;0.052;1946583;482046616;168268918;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;6-chloro-2-[[(3S)-3-[(6-methylpyridin-2-yl)methoxy]piperidin-1-yl]methyl]-1H-indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NC(=CC=C1)CO[C@H]2CCCN(C2)CC3=CC4=C(N3)C=C(C=C4)Cl
4623;100497238;0.0522;203984;103432826;10475634;10280;76997100;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;1-[(E)-3-[4-(2-Methoxyphenyl)piperazino]propylidene]-5-methoxy-1,2,3,4-tetrahydronaphthalene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1N2CCN(CC2)CC/C=C/3\CCCC4=C3C=CC=C4OC
4624;100473770;0.05248;203852;123090849;37461;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;Butaclamol free base;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)[C@]1(CCN2C[C@@H]3C4=CC=CC=C4CCC5=C3C(=CC=C5)[C@H]2C1)O
4625;407996095;0.05248;1946583;374281438;134135650;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;3-[[(3R)-4,4-difluoro-3-(2-phenylethyl)piperidin-1-yl]methyl]-6-fluoro-1H-indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(C[C@H](C1(F)F)CCC2=CC=CC=C2)CC3=CNC4=C3C=CC(=C4)F
4626;407996344;0.05248;1946583;482046616;168268918;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;6-chloro-2-[[(3S)-3-[(6-methylpyridin-2-yl)methoxy]piperidin-1-yl]methyl]-1H-indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NC(=CC=C1)CO[C@H]2CCCN(C2)CC3=CC4=C(N3)C=C(C=C4)Cl
4627;100439964;0.053;229188;103186197;7333;10280;14696970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of specific binding of [3H]3-PPP to sigma binding site in Guinea pig brain membranes;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
4628;100444170;0.053;204470;103215655;14982980;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]hexyloxy]-2-phenyl-4H-1-benzopyran-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCCCCOC3=CC4=C(C=C3)OC(=CC4=O)C5=CC=CC=C5
4629;103125585;0.053;418680;103612795;44573260;10280;192431730;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor;6-Benzyl-8-(4-methoxybenzyl)-6,8-diazabicyclo[3.2.2]nonan-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)CN2CC3CCC(=O)C2CN3CC4=CC=CC=C4
4630;354664016;0.053;1288457;336874672;127031399;10280;270328900;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma1 receptor by PDSP assay;10-(3-hydroxypropoxy)-3,9-dimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-2-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=C2C3CC4=C(CN3CCC2=C1)C(=C(C=C4)OCCCO)OC)O
4631;366366197;0.053;1558961;440183742;118562428;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;9-Phenyl-2-(2-phenylethyl)-6-oxa-2,9-diazaspiro[4.5]decan-8-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CN(CC12CN(C(=O)CO2)C3=CC=CC=C3)CCC4=CC=CC=C4
4632;366366201;0.053;1558961;440149851;118562598;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;2-Methyl-4-phenyl-9-(2-pyridin-2-ylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=N3)C4=CC=CC=C4
4633;380264311;0.053;1811100;475994439;126509225;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;CID 126509225;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CCOCC1)N2CCN(CC2)CCOCC(F)(F)F)C3=CC=CC(=N3)C(F)(F)F
4634;407907024;0.0532;1922166;103272556;126402;10280;362020630;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to human sigma 1 receptor;2-(4-Morpholino)ethyl-1-phenylcyclohexane-1-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)(C2=CC=CC=C2)C(=O)OCCN3CCOCC3
4635;100497233;0.0535;203984;103434410;10250792;10280;76997100;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;1-[4-[4-(2-Methoxyphenyl)piperazino]butyl]-7-methoxy-3,4-dihydronaphthalene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(CCC=C2CCCCN3CCN(CC3)C4=CC=CC=C4OC)C=C1
4636;100444169;0.054;204470;103215594;14982965;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-Phenyl-6-(6-piperidin-1-yl-hexyloxy)-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
4637;100444345;0.054;204470;103215161;18959739;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[8-(4-Hydroxy-piperidin-1-yl)-octyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
4638;100448387;0.054;204471;103215675;18959702;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;5-[5-(4-Hydroxy-piperidin-1-yl)-pentyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCOC2=CC=CC3=C2C(=O)C=C(O3)C4=CC=CC=C4
4639;100458513;0.054;204438;103344976;15149418;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;15-[3-(1,3-Dihydroisoindol-2-yl)propyl]-5-fluoro-9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3(8),4,6-tetraene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCN4CC5=CC=CC=C5C4)NC6=C3C=C(C=C6)F
4640;100459024;0.054;204438;103211675;15646180;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;8-[4-(9,15-Diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3,5,7-tetraen-15-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3C4CCC3C5=C(C4)NC6=CC=CC=C65
4641;100468421;0.054;203697;103330080;10087999;10280;82952200;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma 1 receptor was determined in guinea pig brain membrane using [3H](+)-pentazocine as radioligand;N-[2-(3,4-Dichlorophenyl)ethyl]-N'-[2-[(tetrahydro-1H-pyrrol)-1-yl]ethyl]ethylenediamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCN(C1)CCNCCNCCC2=CC(=C(C=C2)Cl)Cl
4642;100471363;0.054;204459;103298670;9817442;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N-(1-naphthyl)-N'-(m-ethylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)NC(=NC2=CC=CC3=CC=CC=C32)N
4643;100565306;0.054;203703;103177932;11792320;10280;95442130;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;The compound was tested for the affinity on sigma 1 receptor using [3H]- pentazocine as radioligand;6-Benzoyl-3-(2-pyrrolidin-1-yl-ethyl)-3H-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(C1)CCN2C3=C(C=C(C=C3)C(=O)C4=CC=CC=C4)SC2=O
4644;101829998;0.054;255057;103468575;44403246;10280;161400110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory concentration against opioid receptor sigma 1 of guinea pig cerebral cortex using [3H](+)-pentazocine upon incubation for 150 minutes at 22 degree C;(S)-2-(2-Piperidin-1-yl-ethyl)-1,5,10,10a-tetrahydro-2H-imidazo[1,5-b]isoquinolin-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CCN(CC1)CCN2C[C@@H]3CC4=CC=CC=C4CN3C2=O
4645;255011005;0.054;625223;103198031;4917;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Prochlorperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl
4646;366366195;0.054;1558961;440124648;118562402;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;CID 118562402;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=C(C=CC=N4)C(F)(F)F
4647;366366667;0.054;1558961;440121209;118562469;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;Methyl 2-[3-oxo-4-phenyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-2-yl]acetate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;COC(=O)CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=CC=CC=C4
4648;367478259;0.054;1655949;442053121;156014333;10280;324354210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human Sigma 1 receptor by radioligand displacement assay;"4-Benzyl-1-(spiro[1,3-dithiolane-2,9'-fluorene]-4-ylmethyl)piperidine;oxalic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3CSC4(S3)C5=CC=CC=C5C6=CC=CC=C46.C(=O)(C(=O)O)O
4649;380264143;0.054;1811100;475990268;126539778;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[4-[4-(2-propan-2-yloxyethyl)piperazin-1-yl]oxan-4-yl]methyl]-N-[6-(trifluoromethyl)pyridin-2-yl]propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CCOCC1)N2CCN(CC2)CCOC(C)C)C3=CC=CC(=N3)C(F)(F)F
4650;380264306;0.054;1811100;475978055;126539219;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[1-(4-benzylpiperazin-1-yl)cyclopropyl]methyl]-2-methoxy-N-phenylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COCC(=O)N(CC1(CC1)N2CCN(CC2)CC3=CC=CC=C3)C4=CC=CC=C4
4651;380823625;0.054;1915323;374350157;53868701;10280;;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000103c SIGMAR1;N-methyl-2-(4-phenylmethoxypiperidin-1-yl)ethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CNCCN1CCC(CC1)OCC2=CC=CC=C2
4652;389483898;0.054;1805386;444858096;132060780;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example KTL-01-264;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C=CCN1CCN(CC1)C2=CC3=C(CCN(C3)S(=O)(=O)C4=CC(=CC(=C4)Cl)Cl)C=C2
4653;100497231;0.0544;203984;103389454;10021562;10280;76997100;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;1-[3-(5-Methoxy-3,4-dihydro-naphthalen-1-yl)-propyl]-4-phenyl-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCC=C2CCCN3CCN(CC3)C4=CC=CC=C4
4654;407996422;0.05495;1946583;482083809;168295364;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;3-[[(3S)-3-[[3-(trifluoromethoxy)phenyl]methoxy]piperidin-1-yl]methyl]imidazo[1,5-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C[C@@H](CN(C1)CC2=NC=C3N2C=CC=C3)OCC4=CC(=CC=C4)OC(F)(F)F
4655;100444347;0.055;204470;103215847;14983040;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-Cyclopentyl-6-[6-(4-hydroxy-piperidin-1-yl)-hexyloxy]-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)C2=CC(=O)C3=C(O2)C=CC(=C3)OCCCCCCN4CCC(CC4)O
4656;100448321;0.055;204471;103215292;14982993;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;7-[5-(4-Hydroxy-piperidin-1-yl)-pentyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCOC2=CC3=C(C=C2)C(=O)C=C(O3)C4=CC=CC=C4
4657;100448382;0.055;204471;103215528;14983046;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-Cyclohexyl-6-{[6-(piperidin-1-yl)hexyl]oxy}-4H-1-benzopyran-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)C2=CC(=O)C3=C(O2)C=CC(=C3)OCCCCCCN4CCCCC4
4658;100458395;0.055;204438;103343818;15149401;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;11-[3-(4-Fluorophenoxy)propyl]-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCOC4=CC=C(C=C4)F)NC5=CC=CC=C53
4659;100497406;0.055;203984;103431928;10384067;10280;76997100;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;1-[(E)-3-[4-(2-Methoxyphenyl)piperazino]propylidene]-1,2,3,4-tetrahydronaphthalene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1N2CCN(CC2)CC/C=C/3\CCCC4=CC=CC=C43
4660;100736352;0.055;203993;103189253;54477;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor from guinea pig brain using the radioligand [3H]SKF-10047;Remoxipride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CCC[C@H]1CNC(=O)C2=C(C=CC(=C2OC)Br)OC
4661;363665755;0.055;1415921;404706400;71223100;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;N-(1-(2-(azepan-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-4,4-difluorocyclohexanecarbox-amide maleate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCCN(CC1)CCN2C3=NC=NC(=C3C=N2)NC(=O)C4CCC(CC4)(F)F
4662;363665995;0.055;1415921;404710625;71231455;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;N-(1-(2-(piperidin-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)(1-noradamantylcarboxamide) maleate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=NC=NC(=C3C=N2)NC(=O)C45CC6CC(C4)CC5C6
4663;366366191;0.055;1558961;440137799;155528829;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;3-Phenyl-8-(2-phenylethyl)-1-oxa-3,8-diazaspiro[4.5]decan-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CN(CCC12CN(C(=O)O2)C3=CC=CC=C3)CCC4=CC=CC=C4
4664;366366660;0.055;1558961;440147454;118567552;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;4-(3-Hydroxyphenyl)-2-methyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=CC(=CC=C4)O
4665;388740423;0.055;1797293;386051312;118282942;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 67;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)S(=O)(=O)C
4666;388879264;0.055;1797475;386051312;118282942;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 67;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)S(=O)(=O)C
4667;389383760;0.055;1804286;386051312;118282942;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 67;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)S(=O)(=O)C
4668;407996421;0.055;1946583;482083809;168295364;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;3-[[(3S)-3-[[3-(trifluoromethoxy)phenyl]methoxy]piperidin-1-yl]methyl]imidazo[1,5-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C[C@@H](CN(C1)CC2=NC=C3N2C=CC=C3)OCC4=CC(=CC=C4)OC(F)(F)F
4669;100387747;0.0551;204145;103389421;10936584;10280;123830180;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine from Sigma opioid receptor type 1 of guinea pig brain;2-(1'-Benzylspiro[3,4-dihydroisochromene-1,4'-piperidine]-3-yl)acetaldehyde;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3CC(O2)CC=O)CC4=CC=CC=C4
4670;389712928;0.0556;1919146;476002749;166637130;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assay from US Patent US11535596: 'Analogs of dextromethorphan with balanced receptor activities';2-(6,10a-dimethyl-1,2,3,4-tetrahydrophenanthren-4a-yl)-N-(2-methoxyethyl)ethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC2=C(C=C1)C=CC3(C2(CCCC3)CCNCCOC)C
4671;100615710;0.0557;204447;103321225;15701660;10280;16560440;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]-(+)-3-PPP binding to sigma of guinea pig brain;[2-(3,4-Dichloro-phenyl)-ethyl]-propyl-(2-pyrrolidin-1-yl-cyclohexyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN(CCC1=CC(=C(C=C1)Cl)Cl)[C@@H]2CCCC[C@@H]2N3CCCC3
4672;388996788;0.0559;1798943;405263584;86581845;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';(S)-1-(3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)-2-(4-methyl-piperazin-1-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](C(=O)N1CCN2C(=CC3=CC=CC=C32)C1)N4CCN(CC4)C
4673;100317023;0.056;204286;103354058;119010;10280;105084250;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory activity towards Sigma opioid receptor type 1;5,6,7,8-Tetrahydroisoquinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC2=C(C1)C=CN=C2
4674;100356314;0.056;204790;103237706;10789833;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-[[(2S)-1-Benzyl-2-pyrrolidinyl]methyl]-1-methoxy-4-bromo-2-naphthalenecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)NC[C@@H]3CCCN3CC4=CC=CC=C4
4675;100476454;0.056;204462;103673095;45261755;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;"1'-(2-Phenylethyl)spiro[3,4-dihydronaphthalene-2,4'-piperidine]-1-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2(CCN(CC2)CCC3=CC=CC=C3)C(=O)C4=CC=CC=C41.Cl
4676;100558844;0.056;203684;103389255;401818;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;1-[4-(3-Phenylpropyl)piperazine-1-yl]-2-(2-methoxyphenyl)ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1CC(=O)N2CCN(CC2)CCCC3=CC=CC=C3
4677;100619164;0.056;203990;136920474;14831249;10280;18482950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma opioid receptor in guinea pig cerebral homogenate using [3H]DTG as radioligand;beta-[(R)-1-Methyl-2-phenylethylamino]propiophenone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CC1=CC=CC=C1)NCCC(=O)C2=CC=CC=C2
4678;345602968;0.056;1200082;312389816;76683988;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;N-[2-(4-cyclohexylpiperazin-1-yl)ethyl]-1-(3-fluorophenyl)triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCC(CC1)N2CCN(CC2)CCNC3=CN(N=N3)C4=CC(=CC=C4)F
4679;388740212;0.056;1797293;386051076;71276955;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 5;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC(=C(C=C3C2)Cl)Cl
4680;388878839;0.056;1797475;386051076;71276955;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 5;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC(=C(C=C3C2)Cl)Cl
4681;389383435;0.056;1804286;386051076;71276955;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 5;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=CC(=C(C=C3C2)Cl)Cl
4682;389483958;0.056;1805386;444858114;132075286;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A42;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C=CCN1CCN(CC1)C2=CC3=C(CCCN(C3)S(=O)(=O)C4=CC(=CC(=C4)Cl)Cl)C=C2
4683;407996166;0.05623;1946583;482087760;168297637;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;3-[[4-[(4-Chloro-3-fluorophenyl)methoxy]piperidin-1-yl]methyl]imidazo[1,5-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=C(C=C2)Cl)F)CC3=NC=C4N3C=CC=C4
4684;388996988;0.0565;1798943;405263595;86582150;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';(S)-2-(4-methyl-piperazin-1-yl)-1-3,4,10,10a-tetrahydro-pyrazino[1,2-a]indol-2(1H)-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](C(=O)N1CCN2[C@H](C1)CC3=CC=CC=C32)N4CCN(CC4)C
4685;100354357;0.057;204790;103237775;10551313;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-[[(2S)-1-Cyclohexyl-2-pyrrolidinyl]methyl]-1-methoxy-4-bromo-2-naphthalenecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)NC[C@@H]3CCCN3C4CCCCC4
4686;326059156;0.057;712773;103213015;68617;10280;236413110;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor;Sertraline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
4687;354664020;0.057;1288457;336874708;127031423;10280;270328900;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma1 receptor by PDSP assay;3,9-dimethoxy-10-propoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-2-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCOC1=C(C2=C(CC3C4=CC(=C(C=C4CCN3C2)OC)O)C=C1)OC
4688;363666002;0.057;1415967;404698072;145980698;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-[4-Fluoro-3-(trifluoromethyl)phenyl]-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=NC=NC(=C3C=N2)C4=CC(=C(C=C4)F)C(F)(F)F
4689;366366988;0.057;1558961;440115278;118567670;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;4-Phenyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CN(CCC12CN(C(=O)CO2)C3=CC=CC=C3)CCC4=CC=CC=C4
4690;366431542;0.057;1592018;312351721;118709751;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;3-(4-Chlorophenyl)-8-[3-(2-fluorophenyl)sulfanylpropyl]-8-azabicyclo[3.2.1]octan-3-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2CC(CC1N2CCCSC3=CC=CC=C3F)(C4=CC=C(C=C4)Cl)O
4691;403018494;0.057;1920070;104162389;9795739;10280;;Confirmatory;20240403;0;0;Active;Q99720;Ki;;BindingDB;In-Vitro Binding Assay from US Patent US20230390272: 'USE OF PRIDOPIDINE AND ANALOGS FOR THE TREATMENT OF ANXIETY AND DEPRESSION';Pridopidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCC(CC1)C2=CC(=CC=C2)S(=O)(=O)C
4692;403024130;0.057;1920119;104162389;9795739;10280;;Confirmatory;20240403;0;0;Active;Q99720;Ki;;BindingDB;In-Vitro Binding Assay from US Patent US20230414596: 'USE OF PRIDOPIDINE AND ANALOGS FOR TREATING RETT SYNDROME';Pridopidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCC(CC1)C2=CC(=CC=C2)S(=O)(=O)C
4693;366431543;0.05754;1592018;312351721;118709751;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;3-(4-Chlorophenyl)-8-[3-(2-fluorophenyl)sulfanylpropyl]-8-azabicyclo[3.2.1]octan-3-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2CC(CC1N2CCCSC3=CC=CC=C3F)(C4=CC=C(C=C4)Cl)O
4694;389712933;0.0578;1919146;476002751;166637131;10280;;Confirmatory;20231017;0;0;Active;Q99720;IC50;;BindingDB;Receptor Binding Assay from US Patent US11535596: 'Analogs of dextromethorphan with balanced receptor activities';4-(2,2-Difluoroethoxy)-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OCC(F)F
4695;100448360;0.058;204471;103215620;18959714;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;5-[4-(4-Hydroxy-piperidin-1-yl)-butoxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCOC2=CC=CC3=C2C(=O)C=C(O3)C4=CC=CC=C4
4696;100746552;0.058;204019;103336551;44341172;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-SKF-10047 binding to sigma receptor;"(E)-N-(1-benzylpiperidin-4-yl)-N,3-diphenylprop-2-enamide;(E)-but-2-enedioic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1N(C2=CC=CC=C2)C(=O)/C=C/C3=CC=CC=C3)CC4=CC=CC=C4.C(=C/C(=O)O)\C(=O)O
4697;345603243;0.058;1200082;312389808;76684214;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-(3-fluorophenyl)-N-(2-piperidin-1-ylethyl)triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)CCNC2=CN(N=N2)C3=CC(=CC=C3)F
4698;363665437;0.058;1415921;404717903;71222908;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;N-(1-(2-(Azepan-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-2,4-dichlorobenzamide hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCCN(CC1)CCN2C3=NC=NC(=C3C=N2)NC(=O)C4=C(C=C(C=C4)Cl)Cl
4699;366366390;0.058;1558961;440137689;118567543;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;CID 118567543;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CC12C(=O)N(CC3(O2)CCN(CC3)CCC4=CC=CC=C4F)C5=C(N=CC=C5)C(F)(F)F
4700;372120971;0.058;1681775;461552167;118560973;10280;330649470;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;(2R)-4-cyclopropyl-2-methyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4CC4
4701;372120978;0.058;1681775;440137689;118567543;10280;330649470;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;CID 118567543;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC12C(=O)N(CC3(O2)CCN(CC3)CCC4=CC=CC=C4F)C5=C(N=CC=C5)C(F)(F)F
4702;372306740;0.058;1701184;461533334;54673647;10280;332377850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;1-[4-[2-[[1-(3,4-Difluorophenyl)-5-methylpyrazol-3-yl]methoxy]ethyl]piperazin-1-yl]ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=NN1C2=CC(=C(C=C2)F)F)COCCN3CCN(CC3)C(=O)C
4703;100765459;0.0582;204446;103678569;45265365;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membrane was determined by using [3H]DTG as the radioligand;"N-[(3-iodophenyl)methyl]spiro[1,3-dioxolane-2,11'-pentacyclo[5.4.0.02,6.03,10.05,9]undecane]-8'-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1COC2(O1)C3C4CC5C3C(C6C5C4C26)NCC7=CC(=CC=C7)I.Cl
4704;100485149;0.0586;204636;103317801;15767676;10280;76368600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured on Sigma receptor type 1 from guinea pig brain membranes using [3H]pentazocine as radioligand.;10-Benzyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1C2CC3=CC=CC=C3C1(CCN2CC4=CC=CC=C4)C
4705;100614624;0.0588;203986;103282328;14771667;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N,N''-Bis-(5,6,7,8-tetrahydro-naphthalen-1-yl)-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC2=C(C1)C=CC=C2NC(=NC3=CC=CC4=C3CCCC4)N
4706;100471785;0.05888;203852;103367622;42601652;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;4-phenyl-N-propyl-1,2,3,4-tetrahydronaphthalen-2-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCNC1CC(C2=CC=CC=C2C1)C3=CC=CC=C3
4707;100354295;0.059;204790;103238192;10766338;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-[[(2R)-1-Cycloheptyl-2-pyrrolidinyl]methyl]-1-methoxy-4-bromo-2-naphthalenecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)NC[C@H]3CCCN3C4CCCCCC4
4708;100471332;0.059;204459;103282328;14771667;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N,N''-Bis-(5,6,7,8-tetrahydro-naphthalen-1-yl)-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC2=C(C1)C=CC=C2NC(=NC3=CC=CC4=C3CCCC4)N
4709;100539428;0.059;204458;103414721;10789674;10280;90578570;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Sigma receptor binding was determined by labeling with radioligand [3H](+)-pentazocine on frozen membranes obtained from frozen guinea pig brain;1-{2-[Bis-(4-fluoro-phenyl)-methoxy]-ethyl}-4-((E)-3-pyridin-3-yl-allyl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCOC(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)C/C=C/C4=CN=CC=C4
4710;100614383;0.059;203986;103282513;10243335;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N,N''-Di-m-tolyl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC(=CC=C1)NC(=NC2=CC=CC(=C2)C)N
4711;255027930;0.059;625223;123083191;1201549;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Benztropine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1[C@@H]2CC[C@H]1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4
4712;340051003;0.059;764175;174487459;21830793;10280;238160460;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);Cumi-101;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C(=O)C=NN(C1=O)CCCCN2CCN(CC2)C3=CC=CC=C3OC
4713;372306729;0.059;1701184;103186197;7333;10280;332377850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
4714;100485969;0.0597;204636;103173563;1235;10280;76368600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured on Sigma receptor type 1 from guinea pig brain membranes using [3H]pentazocine as radioligand.;2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-3-allyl-6,11-dimethyl-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1C2CC3=C(C1(CCN2CC=C)C)C=C(C=C3)O
4715;100497228;0.0599;203984;103196326;10385977;10280;76997100;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;1-[3-(5-Methoxytetralin-1-yl)propyl]-4-(2-methoxyphenyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1N2CCN(CC2)CCCC3CCCC4=C3C=CC=C4OC
4716;388996822;0.0599;1798943;405263607;86582463;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';(R)-2-(4-cyclohexyl-piperazin-1-yl)-1-((S)-3,4,10,10a-tetrahydro-pyrazino[1,2-a]indol-2(1H)-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](C(=O)N1CCN2[C@H](C1)CC3=CC=CC=C32)N4CCN(CC4)C5CCCCC5
4717;100448454;0.06;204471;103215048;14983047;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-(2-Chloro-phenyl)-6-(6-piperidin-1-yl-hexyloxy)-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4Cl
4718;100464201;0.06;204596;103186197;7333;10280;80219130;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor of MCF cells;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
4719;100471676;0.06;204459;103298144;10447949;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N-(3-Ethylphenyl)-4-phenylpiperidine-1-carboxamidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N=C(N)N2CCC(CC2)C3=CC=CC=C3
4720;100619161;0.06;203990;103186163;12874567;10280;18482950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma opioid receptor in guinea pig cerebral homogenate using [3H]DTG as radioligand;((R)-1-Methyl-2-phenyl-ethyl)-phenethyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CC1=CC=CC=C1)NCCC2=CC=CC=C2
4721;380264153;0.06;1811100;475996009;126509702;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[4-[4-[2-(2-methylpropoxy)ethyl]piperazin-1-yl]oxan-4-yl]methyl]-N-[6-(trifluoromethyl)pyridin-2-yl]propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CCOCC1)N2CCN(CC2)CCOCC(C)C)C3=CC=CC(=N3)C(F)(F)F
4722;380264648;0.06;1811100;475991518;126539478;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[4-(1-benzylpiperidin-4-yl)oxan-4-yl]methyl]-N-[6-(trifluoromethyl)pyridin-2-yl]propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CCOCC1)C2CCN(CC2)CC3=CC=CC=C3)C4=CC=CC(=N4)C(F)(F)F
4723;388996817;0.0608;1798943;405263577;86581844;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';1-(3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)-4-(dimethyl-amino)butan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCCC(=O)N1CCN2C(=CC3=CC=CC=C32)C1
4724;100417473;0.061;204631;103408355;10430685;10280;125703870;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity of compound was tested for Sigma receptor type 1;6-(4-Benzo[d]isoxazol-3-yl-piperazin-1-yl)-1-(2-hydroxy-phenyl)-hexan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCCCC(=O)C2=CC=CC=C2O)C3=NOC4=CC=CC=C43
4725;100448353;0.061;204471;103215849;14983039;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-Cyclobutyl-6-[6-(4-hydroxy-piperidin-1-yl)-hexyloxy]-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC(C1)C2=CC(=O)C3=C(O2)C=CC(=C3)OCCCCCCN4CCC(CC4)O
4726;100619857;0.061;203991;103186163;12874567;10280;18482950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma opioid receptor was determined in guinea pig cerebral homogenate using [3H]haloperidol as radioligand;((R)-1-Methyl-2-phenyl-ethyl)-phenethyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CC1=CC=CC=C1)NCCC2=CC=CC=C2
4727;255016780;0.061;625223;103555936;2442;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Bromhexine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CC1=C(C(=CC(=C1)Br)Br)N)C2CCCCC2
4728;345602805;0.061;1200082;312389826;76683777;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;N-(2-Morpholinoethyl)-1-(3,4-dichlorobenzyl)-1H-1,2,3-triazole-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1COCCN1CCNC2=CN(N=N2)CC3=CC(=C(C=C3)Cl)Cl
4729;366366387;0.061;1558961;440216500;126744972;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;CID 126744972;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C[C@@H]1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3F)C4=C(C=CN=C4)C(F)(F)F
4730;366437017;0.061;1594271;312389826;76683777;10280;309043830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;N-(2-Morpholinoethyl)-1-(3,4-dichlorobenzyl)-1H-1,2,3-triazole-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1COCCN1CCNC2=CN(N=N2)CC3=CC(=C(C=C3)Cl)Cl
4731;100333032;0.06166;204944;103277962;10568910;10280;108823620;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was performed using [3H](+)-pentazocine to label sigma-1 binding sites, in guinea pig cerebral cortex;1-[2-(4-Chlorophenyl)ethyl]-2-(5-pyrrolidin-1-ylpentyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CCN(C1)CCCCCN=C(N)NCCC2=CC=C(C=C2)Cl
4732;100367075;0.06177;226337;103376003;10926436;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-(1-benzylpiperidin-4-yl)-2-(naphthalen-2-yl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC3=CC=CC=C3C=C2)CC4=CC=CC=C4
4733;100317024;0.062;204286;103354056;10006;10280;105084250;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory activity towards Sigma opioid receptor type 1;Hydantoin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C(=O)NC(=O)N1
4734;100539431;0.062;204458;103414802;10094793;10280;90578570;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Sigma receptor binding was determined by labeling with radioligand [3H](+)-pentazocine on frozen membranes obtained from frozen guinea pig brain;1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-[3-(2-furyl)propyl]piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CO2)CCOC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F
4735;100737370;0.062;203993;103228269;15034728;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor from guinea pig brain using the radioligand [3H]SKF-10047;(5S)-5-[(4-hydroxy-4-spiro[1,3-benzodioxole-2,1'-cyclopentane]-5-ylpiperidin-1-yl)methyl]-3-(4-methoxyphenyl)-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)N2C[C@@H](OC2=O)CN3CCC(CC3)(C4=CC5=C(C=C4)OC6(O5)CCCC6)O
4736;100778225;0.062;204017;103272834;44313190;10280;98735270;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for [3H]- pentazocine at sigma opioid receptor;(2S,3S)-2-[(4R)-4-(4-aminobutyl)-3-benzyl-2,5-dioxoimidazolidin-1-yl]-N-benzyl-3-methylpentanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC[C@H](C)[C@@H](C(=O)NCC1=CC=CC=C1)N2C(=O)[C@H](N(C2=O)CC3=CC=CC=C3)CCCCN
4737;345602796;0.062;1200082;312389807;76684104;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-(4-chlorophenyl)-N-(2-piperidin-1-ylethyl)triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)CCNC2=CN(N=N2)C3=CC=C(C=C3)Cl
4738;363665989;0.062;1415921;404704980;71223161;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;N-(1-(4-(azepan-1-yl)butyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)pivalamide maleate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)C(=O)NC1=C2C=NN(C2=NC=N1)CCCCN3CCCCCC3
4739;388740371;0.062;1797293;386051283;118282961;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 39;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(C)C)OC(C)C)N2CC3=C(C2)C(=CC=C3)F
4740;388879204;0.062;1797475;386051283;118282961;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 39;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(C)C)OC(C)C)N2CC3=C(C2)C(=CC=C3)F
4741;389383661;0.062;1804286;386051283;118282961;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 39;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(C)C)OC(C)C)N2CC3=C(C2)C(=CC=C3)F
4742;389536468;0.062;1805702;459092177;162370617;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';benzyl (1R,8R)-5-[4-(3-methylbut-2-enyl)piperazin-1-yl]-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene-9-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=CCN1CCN(CC1)C2=CC3=C(C=C2)[C@@H]4CCN([C@@H]3C4)C(=O)OCC5=CC=CC=C5)C
4743;100481151;0.06206;204639;163322907;10107360;10280;78372400;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity towards Sigma receptor type 1 was determined by measuring its ability to displace [3H](+)-pentazocine from guinea pig brain membrane;FP-Tztp;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN1CCC=C(C1)C2=NSN=C2SCCCF
4744;112788090;0.0623;204633;103385206;10542038;10280;74907270;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to inhibit [3H](+)-pentazocine binding to guinea pig brain Sigma receptor type 1;(8E)-8-(cyclopropylmethylidene)-5-(3-hydroxyphenyl)-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1/C(=C\C3CC3)/C(=O)C2)C4=CC(=CC=C4)O
4745;100464785;0.0628;203701;103677090;45264309;10280;80279780;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity at sigma-1 site by inhibition of [3H](+)-pentazocine (PENT) binding in guinea pig brain;"2-(4-Phenylpiperazin-1-yl)ethyl 1-phenylcyclopentane-1-carboxylate;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)(C2=CC=CC=C2)C(=O)OCCN3CCN(CC3)C4=CC=CC=C4.Cl
4746;100444338;0.063;204470;103215048;14983047;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-(2-Chloro-phenyl)-6-(6-piperidin-1-yl-hexyloxy)-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4Cl
4747;100448377;0.063;204471;103214753;44285320;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-{6-[3-(2-Hydroxy-ethyl)-piperazin-1-yl]-hexyloxy}-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CC(N1)CCO)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
4748;100567421;0.063;203692;103177882;10635279;10280;95442130;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;The compound was tested for the affinity on sigma 1 receptor using [3H]- pentazocine as radioligand;3,6-Dipropanoylbenzothiazol-2(3H)-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)C1=CC2=C(C=C1)N(C(=O)S2)C(=O)CC
4749;363665668;0.063;1415967;404698478;74767213;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(2,5-Dimethylphenyl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=C(C=C1)C)C2=C3C=NN(C3=NC=N2)CCN4CCCCC4
4750;366366396;0.063;1558961;440136116;118567538;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;CID 118567538;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=C(C=CN=C4)C(F)(F)F
4751;366431536;0.063;1592018;440157814;155540848;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;1-(4-Fluorophenyl)-4-(4-pyrimidin-2-yl-1,4-diazepan-1-yl)butan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=NC=CC=N2)CCCC(=O)C3=CC=C(C=C3)F
4752;366431549;0.063;1592018;440173663;155547197;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;1-(4-Fluorophenyl)-4-(4-pyridin-2-yl-1,4-diazepan-1-yl)butan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=CC=CC=N2)CCCC(=O)C3=CC=C(C=C3)F
4753;366435756;0.063;1593893;136938128;57399494;10280;309877800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK293T cell membranes;2-[2-[4-(4-Chlorophenyl)-1,4-diazepan-1-yl]ethyl]-5-fluoro-2,3-dihydroinden-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=CC=C(C=C2)Cl)CCC3CC4=C(C3=O)C=CC(=C4)F
4754;380512534;0.063;1846430;482065033;86296794;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2S,6S)-10-(5-fluoropyridin-2-yl)-4-(oxan-4-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCC1N2C[C@H]3[C@H](C2)OCC4=C(N=NN34)C5=NC=C(C=C5)F
4755;388740374;0.063;1797293;386051307;118278088;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';Sigma-2 receptor antagonist 1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C)O
4756;388879045;0.063;1797475;386051307;118278088;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';Sigma-2 receptor antagonist 1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C)O
4757;389383650;0.063;1804286;386051307;118278088;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';Sigma-2 receptor antagonist 1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C)O
4758;342816993;0.0631;1118248;242613622;90666083;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human recombinant sigma-1 receptor expressed in CHO cells after 180 mins by beta counting analysis;(1S,2S)-2-phenyl-N-(2-pyrrolidin-1-ylethyl)cyclopropane-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;197.0;;;;C1CCN(C1)CCNC(=O)[C@H]2C[C@@H]2C3=CC=CC=C3
4759;342817234;0.0631;1118248;242613621;90666082;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human recombinant sigma-1 receptor expressed in CHO cells after 180 mins by beta counting analysis;(1S,2S)-N-[2-[di(propan-2-yl)amino]ethyl]-2-phenylcyclopropane-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;197.0;;;;CC(C)N(CCNC(=O)[C@H]1C[C@@H]1C2=CC=CC=C2)C(C)C
4760;365267547;0.0631;1512456;440131968;153287568;10280;316202300;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-3a,7,9-trimethyl-2,3,4,9b-tetrahydro-1H-chromeno[3,4-b]pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=C2[C@@H]3CCN[C@@]3(COC2=C1)C)C
4761;366431537;0.0631;1592018;440157814;155540848;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;1-(4-Fluorophenyl)-4-(4-pyrimidin-2-yl-1,4-diazepan-1-yl)butan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=NC=CC=N2)CCCC(=O)C3=CC=C(C=C3)F
4762;366435755;0.0631;1593893;136938128;57399494;10280;309877800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK293T cell membranes;2-[2-[4-(4-Chlorophenyl)-1,4-diazepan-1-yl]ethyl]-5-fluoro-2,3-dihydroinden-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=CC=C(C=C2)Cl)CCC3CC4=C(C3=O)C=CC(=C4)F
4763;366437245;0.0631;1594273;440209565;155561471;10280;309043830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;[5-[2-(1,3-Benzodioxol-5-yl)ethylamino]-2-phenyl-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)C(=O)C2=C3CC(CCC3=NN2C4=CC=CC=C4)NCCC5=CC6=C(C=C5)OCO6
4764;409047918;0.0631;1794447;461563591;162677479;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;1-(4-((3-((2,6-Dimethyl-pyridin-4-yl)-methyl)-piperidin-1-yl)-methyl)-thiazol-2-ylamino)-ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=CC(=N1)C)C[C@H]2CCCN(C2)CC3=CSC(=N3)NC(=O)C
4765;321525564;0.0633;658997;160667554;70681422;10280;225129080;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H](+)pentazocine from sigma-1 receptor expressed in human Jurkat cell membranes after 2 hrs by liquid scintillation spectroscopy;1-[4-[1-Adamantyl(phenyl)methyl]phenyl]-4-benzylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCN1CC2=CC=CC=C2)C3=CC=C(C=C3)C(C4=CC=CC=C4)C56CC7CC(C5)CC(C7)C6
4766;409047917;0.06333;1794447;461563591;162677479;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;1-(4-((3-((2,6-Dimethyl-pyridin-4-yl)-methyl)-piperidin-1-yl)-methyl)-thiazol-2-ylamino)-ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=CC(=N1)C)C[C@H]2CCCN(C2)CC3=CSC(=N3)NC(=O)C
4767;100546621;0.0639;203685;103278821;10594382;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;1-(1-Benzylpiperidine-4-yl)-3-[4-(methylthio)phenyl]urea;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CSC1=CC=C(C=C1)NC(=O)NC2CCN(CC2)CC3=CC=CC=C3
4768;100458857;0.064;229213;103359799;6604868;10280;79028700;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Tested for [3H](+)-pentazocine binding to sigma-1 receptor in guinea pig brain membrane;(R)-1-(4-Fluoro-phenyl)-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butan-1-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCC[C@H](C2=CC=C(C=C2)F)O)C3=NC=C(C=N3)F
4769;100497741;0.064;204621;103176655;71360;10280;77073150;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor using [3H]-( +)-SKF10,047 radioligand;Iloperidone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC
4770;100536689;0.064;204457;103678204;22120072;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"1-(2,5-Dichlorophenyl)-2-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N=C(N)N(C)C2=C(C=CC(=C2)Cl)Cl.Cl
4771;100778228;0.064;204017;103272267;44312948;10280;98735270;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for [3H]- pentazocine at sigma opioid receptor;(2R)-2-[(4S)-4-(4-aminobutyl)-3-benzyl-2,5-dioxoimidazolidin-1-yl]-N-benzylpentanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC[C@H](C(=O)NCC1=CC=CC=C1)N2C(=O)[C@@H](N(C2=O)CC3=CC=CC=C3)CCCCN
4772;372121205;0.064;1681775;461531691;118560969;10280;330649470;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;(2R)-4-ethyl-9-[2-(3-fluorophenyl)ethyl]-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CCC3=CC(=CC=C3)F)O[C@@H](C1=O)C
4773;372400424;0.064;1744234;461553307;162670209;10280;333727820;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane incubated for 2 hr by liquid scintillation counting method;5-(1-Benzothiophen-6-yl)-1-methyl-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;CN1C(=NC(=N1)CN2CCCC2)C3=CC4=C(C=C3)C=CS4
4774;380264646;0.064;1811100;475980641;137371332;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;CID 137371332;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CCOCC1)N2CC3CN(CC3C2)CC4=CC=CC=C4)C5=CC=CC(=N5)C(F)(F)F
4775;100497232;0.0641;203984;103389050;10092041;10280;76997100;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;1-[3-(7-Methoxytetralin-1-yl)propyl]-4-(2-methoxyphenyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(CCCC2CCCN3CCN(CC3)C4=CC=CC=C4OC)C=C1
4776;100615709;0.0649;204447;103321360;44334079;10280;16560440;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]-(+)-3-PPP binding to sigma of guinea pig brain;(2S)-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(pyrrolidin-1-yl)cyclohexan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=C(C=C1)Cl)Cl)[C@H]2CCCC[C@@H]2N3CCCC3
4777;100444481;0.065;204470;103214780;44285332;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;5-[7-(4-Hydroxy-piperidin-1-yl)-heptyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCCOC2=CC=CC3=C2C(=O)C=C(O3)C4=CC=CC=C4
4778;100513220;0.065;229197;103384519;10498740;10280;89413830;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor using radioligand ([3H](+)-pentazocine) binding assay;(2S,5R)-1-{2-[Bis-(4-fluoro-phenyl)-methoxy]-ethyl}-2,5-dimethyl-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1CN[C@@H](CN1CCOC(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)C
4779;100614618;0.065;203986;103282475;13781936;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N,N''-Bis[2-(propan-2-yl)phenyl]guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC(C)C1=CC=CC=C1NC(=NC2=CC=CC=C2C(C)C)N
4780;326034945;0.065;701162;163324285;71455165;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;(2R,6S)-2,6-dimethyl-4-[4-(5-methyl-1-naphthalen-2-ylpyrazol-3-yl)oxybutyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C[C@@H]1CN(C[C@@H](O1)C)CCCCOC2=NN(C(=C2)C)C3=CC4=CC=CC=C4C=C3
4781;363970594;0.0652;1506085;404652913;134817200;10280;299690300;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of (+)-[3H]pentazocine from human sigma1 receptor expressed in HEK293 cell membranes after 60 mins by liquid scintillation counting method;Contilisant;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C=C(C=C2)OCCCN3CCCCC3)C=C1CN(C)CC#C
4782;112788426;0.0653;204633;103328102;6273133;10280;74907270;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to inhibit [3H](+)-pentazocine binding to guinea pig brain Sigma receptor type 1;(8E)-8-[(3,4-dichlorophenyl)methylidene]-5-(3-hydroxyphenyl)-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1/C(=C\C3=CC(=C(C=C3)Cl)Cl)/C(=O)C2)C4=CC(=CC=C4)O
4783;112851460;0.0653;204465;103328102;6273133;10280;79325400;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma receptor of guinea pig brain;(8E)-8-[(3,4-dichlorophenyl)methylidene]-5-(3-hydroxyphenyl)-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1/C(=C\C3=CC(=C(C=C3)Cl)Cl)/C(=O)C2)C4=CC(=CC=C4)O
4784;372355922;0.0655;1726849;461540599;141195316;10280;342231650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]pentazocine from human sigma 1 receptor expressed in HEK293 cell membrane incubated for 2 hrs by liquid scintillation counting method;6-(3-Piperidin-1-ylpropoxy)chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCCOC2=CC3=C(C=C2)OC=CC3=O
4785;100456545;0.066;229183;103360283;14970537;10280;79028690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor in bovine cerebellum using 2.0 nM [3H]haloperidol in the presence of 25 nM unlabeled spiperone;1-(4-Bromo-phenyl)-3-[4-(4-fluoro-phenyl)-3,6-dihydro-2H-pyridin-1-yl]-propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CN(CC=C1C2=CC=C(C=C2)F)CCC(=O)C3=CC=C(C=C3)Br
4786;100458517;0.066;204438;103344467;15149405;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;2-[4-(9,15-Diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3,5,7-tetraen-15-yl)butyl]-1,3-thiazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCCC4=NC=CS4)NC5=CC=CC=C53
4787;100500317;0.066;204466;103237255;11791902;10280;85688040;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]DTG binding to sigma receptor from guinea pig brain cortex membrane;1-Benzyl-4-[3-(3,4-dihydro-naphthalen-1-yl)-propyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2=CC=CC=C2C(=C1)CCCN3CCN(CC3)CC4=CC=CC=C4
4788;100612548;0.066;204439;103283176;13781932;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to sigma receptor in guinea pig brain membrane homogenates;1,3-Bis(2,6-dimethylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=C(C(=CC=C1)C)NC(=NC2=C(C=CC=C2C)C)N
4789;101830500;0.066;255057;103468463;44403181;10280;161400110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory concentration against opioid receptor sigma 1 of guinea pig cerebral cortex using [3H](+)-pentazocine upon incubation for 150 minutes at 22 degree C;(3aS)-2-(3-piperidin-1-ylpropyl)-3a,4-dihydroimidazo[1,5-a]indole-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CCN(CC1)CCCN2C(=O)[C@@H]3CC4=CC=CC=C4N3C2=O
4790;372121195;0.066;1681775;461520157;118561095;10280;330649470;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;(2R)-4-ethyl-2-methyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CCC3=CC=CC=C3)O[C@@H](C1=O)C
4791;100403989;0.0662;204630;103295340;9981159;10280;128012230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma receptor type 1 was determined by the displacement of [3H]pentazocine radioligand;4-fluoro-N-(4-fluorophenyl)-N-(3-(4-(3-phenylpropyl)piperazin-1-yl)propyl)benzenamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)CCCN(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F
4792;100546841;0.0664;203685;103277874;3296345;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-Benzyl-4-piperidinyl)-2-(4-methoxyphenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC=C(C=C1)CC(=O)NC2CCN(CC2)CC3=CC=CC=C3
4793;408049237;0.0667;1959985;494419715;171357069;10280;299084420;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) assessed as inhibition constant;methyl (1R,2S)-2-[[(1R,9S,13S)-4-hydroxy-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methyl]-1-phenylcyclopropane-1-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2C[C@H]4C[C@@]4(C5=CC=CC=C5)C(=O)OC)C)C=C(C=C3)O
4794;100448367;0.067;204471;103215295;14983050;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(6-Piperidin-1-yl-hexyloxy)-2-pyridin-4-yl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=NC=C4
4795;100513223;0.067;229197;103384615;10687454;10280;89413830;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor using radioligand ([3H](+)-pentazocine) binding assay;(2S,5R)-1-(2-Benzhydryloxy-ethyl)-2,5-dimethyl-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1CN[C@@H](CN1CCOC(C2=CC=CC=C2)C3=CC=CC=C3)C
4796;334065181;0.067;735278;164129909;71655683;10280;235606500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aS,5R,10bS)-5-(oxan-4-yl)-9-pentyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCCCCC1=CC2=C(C=C1)N[C@@H]([C@H]3[C@@H]2OCCC3)C4CCOCC4
4797;100497403;0.0675;203984;103330835;10474042;10280;76997100;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;1-[3-[4-(2-Pyridyl)piperazino]propyl]-5-methoxy-1,2,3,4-tetrahydronaphthalene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCCC2CCCN3CCN(CC3)C4=CC=CC=N4
4798;100444480;0.068;204470;103215079;44285462;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-{6-[2-(2-Hydroxy-ethyl)-piperidin-4-yl]-hexyloxy}-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CNC(CC1CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4)CCO
4799;366366199;0.068;1558961;440115597;118562502;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;2-Methyl-9-(2-phenylethyl)-4-pyridin-3-yl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=CN=CC=C4
4800;367478796;0.068;1655949;442055165;156015695;10280;324354210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human Sigma 1 receptor by radioligand displacement assay;"4-benzyl-1-[[(2S,4R)-spiro[1,3-dithiolane-2,5'-6,7,8,9-tetrahydrobenzo[7]annulene]-4-yl]methyl]piperidine;oxalic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC[C@]2(C3=CC=CC=C3C1)SC[C@H](S2)CN4CCC(CC4)CC5=CC=CC=C5.C(=O)(C(=O)O)O
4801;367478799;0.068;1655949;442058955;156018373;10280;324354210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human Sigma 1 receptor by radioligand displacement assay;"4-benzyl-1-[[(2S,4R)-2-methyl-2-phenyl-1,3-dithiolan-4-yl]methyl]piperidine;oxalic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@]1(SC[C@H](S1)CN2CCC(CC2)CC3=CC=CC=C3)C4=CC=CC=C4.C(=O)(C(=O)O)O
4802;372120966;0.068;1681775;461515287;118560963;10280;330649470;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;(2R)-4-ethyl-9-[2-(2-fluorophenyl)ethyl]-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CCC3=CC=CC=C3F)O[C@@H](C1=O)C
4803;388996808;0.0682;1798943;405263570;86581410;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';1-(3,4-dihydropyrazino[1,2-a]indol-2(1H)-yl)-3-(4-methylpiperazin-1-yl)butan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(CC(=O)N1CCN2C(=CC3=CC=CC=C32)C1)N4CCN(CC4)C
4804;100487677;0.0686;204638;103318484;44332512;10280;76368610;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was measured on Sigma receptor type 1 using [3H]- pentazocine as radioligand;10-Benzyl-5-bromo-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=CC(=C(C=C3C1(CCN2CC4=CC=CC=C4)C)O)Br
4805;100292958;0.069;239105;103186197;7333;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
4806;100354371;0.069;204790;103237951;12084050;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;4-bromo-N-(9-cyclohexyl-9-azabicyclo[3.3.1]nonan-3-yl)-1-methoxynaphthalene-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)NC3CC4CCCC(C3)N4C5CCCCC5
4807;100470623;0.069;204469;103340352;44342843;10280;79325690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition against sigma receptor using displacement of 3 nM [3H]pentazocine in homogenate of guinea pig brain cerebellum;(1S,13S)-10-decyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCCCCCCCCN1CC[C@]2([C@@H](C1CC3=C2C=C(C=C3)O)C)C
4808;388740029;0.069;1797293;386051238;118282967;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';Isoindoline derivative 3;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C4=CC=CC=C4C=C3
4809;388740574;0.069;1797293;386051329;118282867;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 87;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)COC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C)O
4810;388879411;0.069;1797475;386052629;129155673;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';2-[(2R)-4-(3,4-dichlorophenyl)butan-2-yl]-1,3-dihydrobenzo[e]isoindole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C4=CC=CC=C4C=C3
4811;388879448;0.069;1797475;386051329;118282867;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 87;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)COC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C)O
4812;389383280;0.069;1804286;386051238;118282967;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';Isoindoline derivative 3;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C4=CC=CC=C4C=C3
4813;389383812;0.069;1804286;386051329;118282867;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 87;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)COC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C)O
4814;100627349;0.06918;204452;131279689;54583824;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-benzylspiro[6,7-dihydro-5H-naphthalene-8,4'-piperidine]-2-ol;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC2=C(C=C(C=C2)O)C3(C1)CCN(CC3)CC4=CC=CC=C4.Cl
4815;255030892;0.0697;625223;103213015;68617;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Sertraline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
4816;388996791;0.0697;1798943;405263579;86581698;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';2-(azepan-1-yl)-1-(8-methyl-3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC2=C(C=C1)N3CCN(CC3=C2)C(=O)C(C)N4CCCCCC4
4817;100536378;0.0699;204457;103673505;45262058;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"1-(3,5-Dichlorophenyl)-2-(3-ethylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N=C(N)NC2=CC(=CC(=C2)Cl)Cl.Cl
4818;100444352;0.07;204470;103215261;14982994;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;7-[6-(4-Hydroxy-piperidin-1-yl)-hexyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCOC2=CC3=C(C=C2)C(=O)C=C(O3)C4=CC=CC=C4
4819;100613258;0.07;204440;103283175;14771686;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]-DTG in guinea pig brain membrane homogenates;N-(2,6-Dimethyl-phenyl)-N''-o-tolyl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=C(C(=CC=C1)C)N=C(N)NC2=CC=CC=C2C
4820;100742338;0.07;204020;103671696;45260706;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor using [3H]-(+)-SKF- 10,047;"2-(Furan-2-yl)-9-(2-phenylethyl)-1-oxa-9-azaspiro[5.5]undec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12CC(=O)C=C(O2)C3=CC=CO3)CCC4=CC=CC=C4.Cl
4821;100746102;0.07;204298;103186197;7333;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma opioid receptor type 2 in guinea pig brain homogenate with 4 nM [3H]-(+)-DTG;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
4822;345602969;0.07;1200082;312389818;76684206;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-(3,4-difluorophenyl)-N-[2-(4,4-difluoropiperidin-1-yl)ethyl]triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CN(CCC1(F)F)CCNC2=CN(N=N2)C3=CC(=C(C=C3)F)F
4823;366431552;0.07;1592018;440209083;155561279;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;(NZ)-N-[1-(4-fluorophenyl)-4-(4-pyridin-2-yl-1,4-diazepan-1-yl)butylidene]hydroxylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=CC=CC=N2)CCC/C(=N/O)/C3=CC=C(C=C3)F
4824;380264300;0.07;1811100;475993504;126509231;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[4-(4-benzylpiperazin-1-yl)-2,2-dimethyloxan-4-yl]methyl]-N-[6-(trifluoromethyl)pyridin-2-yl]propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CCOC(C1)(C)C)N2CCN(CC2)CC3=CC=CC=C3)C4=CC=CC(=N4)C(F)(F)F
4825;389511207;0.07;1805565;459070370;118250102;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Pharmacological Activity Assay from US Patent US11007200: 'Cycloalkyl-diamines for the treatment of pain';US11007200, Example 13a;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN[C@@]1(CCCC[C@@H]1NCCCN2CCN(CC2)C)C3=CC=CC=C3Cl
4826;389686572;0.07;1806763;459070370;118250102;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Pharmacological Activity from US Patent US11426411: 'Cycloalkyl-diamines for the treatment of inflammation';US11007200, Example 13a;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN[C@@]1(CCCC[C@@H]1NCCCN2CCN(CC2)C)C3=CC=CC=C3Cl
4827;389712922;0.07;1919146;476002757;166637133;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assay from US Patent US11535596: 'Analogs of dextromethorphan with balanced receptor activities';4-(2,2-Difluoroethoxy)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC23CCNC(C2C1)CC4=C3C=C(C=C4)OCC(F)F
4828;100486011;0.0706;204637;103318396;44332475;10280;76368610;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was measured on Sigma receptor type 1 using [3H]- pentazocine as radioligand;10-Benzyl-3,5-dibromo-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=CC(=C(C(=C3C1(CCN2CC4=CC=CC=C4)C)Br)O)Br
4829;100333039;0.07079;204944;103278748;10733647;10280;108823620;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was performed using [3H](+)-pentazocine to label sigma-1 binding sites, in guinea pig cerebral cortex;1-[2-(4-Chlorophenyl)ethyl]-2-(3-pyrrolidin-1-ylpropyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CCN(C1)CCCN=C(N)NCCC2=CC=C(C=C2)Cl
4830;366431540;0.07079;1592018;312351720;118709750;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;3-(4-Chlorophenyl)-8-[3-(3-fluorophenyl)sulfanylpropyl]-8-azabicyclo[3.2.1]octan-3-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2CC(CC1N2CCCSC3=CC=CC(=C3)F)(C4=CC=C(C=C4)Cl)O
4831;100440513;0.071;229187;103248082;108046;10280;14696970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of specific binding of [125I]PIPAG to sigma receptor in Guinea pig brain membranes;alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCCC(C2=CC=C(C=C2)F)O)C3=NC=C(C=N3)F
4832;100614742;0.071;203986;103282940;407725;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;1,2-Dicyclohexylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)NC(=NC2CCCCC2)N
4833;100736351;0.071;203993;103248082;108046;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor from guinea pig brain using the radioligand [3H]SKF-10047;alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC(C2=CC=C(C=C2)F)O)C3=NC=C(C=N3)F
4834;366431539;0.071;1592018;312351720;118709750;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;3-(4-Chlorophenyl)-8-[3-(3-fluorophenyl)sulfanylpropyl]-8-azabicyclo[3.2.1]octan-3-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2CC(CC1N2CCCSC3=CC=CC(=C3)F)(C4=CC=C(C=C4)Cl)O
4835;367478253;0.071;1655949;442048237;156010809;10280;324354210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human Sigma 1 receptor by radioligand displacement assay;"4-benzyl-1-[[(3R,4'R)-spiro[1,2-dihydroindene-3,2'-1,3-dithiolane]-4'-yl]methyl]piperidine;oxalic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)C[C@@H]3CS[C@@]4(S3)CCC5=CC=CC=C45.C(=O)(C(=O)O)O
4836;100487679;0.0715;204638;103318483;44332511;10280;76368610;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was measured on Sigma receptor type 1 using [3H]- pentazocine as radioligand;10-Benzyl-3,5-dichloro-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=CC(=C(C(=C3C1(CCN2CC4=CC=CC=C4)C)Cl)O)Cl
4837;388996783;0.0716;1798943;405263610;86582616;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';(R)-2-(4-cyclohexyl-piperazin-1-yl)-1-((R)-3,4,10,10a-tetrahydro-pyrazino[1,2-a]indol-2(1H)-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](C(=O)N1CCN2[C@@H](C1)CC3=CC=CC=C32)N4CCN(CC4)C5CCCCC5
4838;100536695;0.0718;204457;103678182;45265104;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(2-Chlorophenyl)-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=CC=CC=C2Cl)N.Cl
4839;100448393;0.072;204471;103215047;14983048;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(6-Piperidin-1-yl-hexyloxy)-2-thiophen-2-yl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CS4
4840;100565307;0.072;203703;103177730;10733148;10280;95442130;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;The compound was tested for the affinity on sigma 1 receptor using [3H]- pentazocine as radioligand;3-(2-Piperidin-1-yl-ethyl)-6-propionyl-3H-benzooxazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)C1=CC2=C(C=C1)N(C(=O)O2)CCN3CCCCC3
4841;100565312;0.072;203703;103177933;473059;10280;95442130;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;The compound was tested for the affinity on sigma 1 receptor using [3H]- pentazocine as radioligand;6-Benzyl-3-(2-morpholinoethyl)-1,3-benzoxazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCN1CCN2C3=C(C=C(C=C3)CC4=CC=CC=C4)OC2=O
4842;100742379;0.072;203987;103259649;19427051;10280;;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was evaluated for binding affinity against sigma opioid receptor using [3H]DTG radioligand in guinea pig membranes;N-(Adamantan-1-yl)-N'-(cyclohexyl)acetamidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=NC1CCCCC1)NC23CC4CC(C2)CC(C4)C3
4843;345680789;0.072;1174258;312374345;118724301;10280;254622400;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor in human Jurkat cell membranes incubated for 2 hrs by liquid scintillation counting;3-[3-[Benzyl(methyl)amino]propyl]-5-phenyl-5,6-dihydrocyclopenta[f][1,3]benzoxazole-2,7-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1C2=C(C=C3C(=O)CC(C3=C2)C4=CC=CC=C4)OC1=O)CC5=CC=CC=C5
4844;345681155;0.072;1174258;312374357;118724313;10280;254622400;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor in human Jurkat cell membranes incubated for 2 hrs by liquid scintillation counting;2-[3-(1,3-Dihydroisoindol-2-yl)propyl]-1,3,4,5-tetrahydropyrido[4,3-b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CC2=C1NC3=CC=CC=C23)CCCN4CC5=CC=CC=C5C4
4845;363665657;0.072;1415967;404711885;74767042;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;3,5-Dimethyl-4-[1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidin-4-yl]-1,2-oxazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C(=NO1)C)C2=C3C=NN(C3=NC=N2)CCN4CCCCC4
4846;380512727;0.072;1846430;482065133;86297983;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-4-[(4-fluorophenyl)methyl]-10-(oxan-4-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCC1C2=C3CO[C@@H]4CN(C[C@H]4N3N=N2)CC5=CC=C(C=C5)F
4847;100444176;0.073;204470;103215293;14982992;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;7-[4-(4-Hydroxy-piperidin-1-yl)-butoxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCOC2=CC3=C(C=C2)C(=O)C=C(O3)C4=CC=CC=C4
4848;100444337;0.073;204470;103215047;14983048;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(6-Piperidin-1-yl-hexyloxy)-2-thiophen-2-yl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CS4
4849;355638081;0.073;1308619;336901329;127048369;10280;271565650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-Pentazocine from sigma 1 receptor in human RPMI8226 cell membranes;(1R,4S,7R)-2-(cyclohexylmethyl)-5-[(4-phenylphenyl)methyl]-2,5-diazabicyclo[2.2.2]octan-7-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;C1CCC(CC1)CN2C[C@@H]3C[C@H]([C@H]2CN3CC4=CC=C(C=C4)C5=CC=CC=C5)O
4850;380299660;0.073;1819827;475977722;6916184;10280;354503790;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Citalopram from sigma-1 receptor (unknown origin) expressed in HEK cell membrane incubated for 2 hrs by liquid scintillation counter analysis;(1R,9R,10S)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@]23CCCC[C@@H]2[C@H]1CC4=C3C=C(C=C4)OC
4851;388996995;0.073;1798943;405263599;86582307;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';1-(3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)-2-methyl-3-(4-methyl-piperazin-1-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(CN1CCN(CC1)C)C(=O)N2CCN3C(=CC4=CC=CC=C43)C2
4852;100630339;0.0736;229195;174515595;73354414;10280;13194930;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain, using [3H](+)-3-PPP as radioligand.;(1S,9R,13R)-10-(5-fluoropentyl)-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1[C@H]2CC3=C([C@]1(CCN2CCCCCF)C)C=C(C=C3)O
4853;100298506;0.074;239347;103458070;44398003;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;(1S,2S,7S,10R,11S,14S,15R,16S,20S,23S)-10,14,16,20-tetramethyl-22-azahexacyclo[12.10.0.02,11.05,10.015,23.017,22]tetracos-4-en-7-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1CCC2[C@H]([C@H]3[C@@H](N2C1)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)O)C)C)C
4854;100354361;0.074;204790;103238139;21846520;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-(9-benzyl-9-azabicyclo[3.3.1]nonan-3-yl)-4-bromo-1-methoxynaphthalene-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)NC3CC4CCCC(C3)N4CC5=CC=CC=C5
4855;100617249;0.074;204444;103336948;422923;10280;16627250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membranes using [3H]DTG as radioligand;1-Phenyl-4-propylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCN1CCN(CC1)C2=CC=CC=C2
4856;363665999;0.074;1415967;404715215;74766964;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(2-Methylphenyl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1C2=C3C=NN(C3=NC=N2)CCN4CCCCC4
4857;380512733;0.074;1846430;482055825;86297183;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-4-[(4-fluorophenyl)methyl]-10-(3-fluoropyridin-4-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CC=C(C=C3)F)OCC4=C(N=NN24)C5=C(C=NC=C5)F
4858;388740575;0.074;1797293;386051298;118282883;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 54;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)F
4859;388879457;0.074;1797475;386051298;118282883;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 54;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)F
4860;389383813;0.074;1804286;386051298;118282883;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 54;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)F
4861;100627651;0.07413;204452;131281713;54584791;10280;13179230;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity against sigma receptor by using [3H]-DTG ([3H]-6) as radioligand in guinea pig cerebellum.;"1'-benzyl-6-methoxyspiro[2,3-dihydro-1H-naphthalene-4,4'-piperidine];hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;COC1=CC2=C(CCCC23CCN(CC3)CC4=CC=CC=C4)C=C1.Cl
4862;354626880;0.07413;1272388;336883200;127036186;10280;267397810;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) by competition binding assay;5-methyl-N,N-diallyltryptamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC2=C(C=C1)NC=C2CCN(CC=C)CC=C
4863;100292617;0.075;239200;103442166;11440556;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;4-Benzyl-1-(8-methoxy-1,2,3,4-tetrahydro-naphthalen-2-ylmethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CC(CC2)CN3CCC(CC3)CC4=CC=CC=C4
4864;100444183;0.075;204470;103215704;14982969;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-(Benzyl-methyl-amino)-hexyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCCCCOC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3)CC4=CC=CC=C4
4865;100471374;0.075;204459;103298991;10446096;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N-Naphthalen-1-yl-N''-m-tolyl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC(=CC=C1)NC(=NC2=CC=CC3=CC=CC=C32)N
4866;380264154;0.075;1811100;475988057;126509280;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[1-(4-benzylpiperazin-1-yl)cyclopropyl]methyl]-N-(3-fluoropyridin-2-yl)propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CC1)N2CCN(CC2)CC3=CC=CC=C3)C4=C(C=CC=N4)F
4867;408049236;0.075;1959985;494417540;171355874;10280;299084420;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) assessed as inhibition constant;methyl (1S,2R)-2-[[(1R,9S,13S)-4-hydroxy-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methyl]-1-phenylcyclopropane-1-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2C[C@@H]4C[C@]4(C5=CC=CC=C5)C(=O)OC)C)C=C(C=C3)O
4868;388996999;0.0755;1798943;405263602;86582312;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';(S)-1-(3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)-2-(4-methyl-piperazin-1-yl)butan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC[C@@H](C(=O)N1CCN2C(=CC3=CC=CC=C32)C1)N4CCN(CC4)C
4869;100448337;0.076;204471;103215145;14983032;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-(4-Hydroxy-piperidin-1-yl)-hexyloxy]-2-(3-methoxy-phenyl)-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC(=C1)C2=CC(=O)C3=C(O2)C=CC(=C3)OCCCCCCN4CCC(CC4)O
4870;100458319;0.076;204437;103344976;15149418;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;15-[3-(1,3-Dihydroisoindol-2-yl)propyl]-5-fluoro-9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3(8),4,6-tetraene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCN4CC5=CC=CC=C5C4)NC6=C3C=C(C=C6)F
4871;100604300;0.076;203857;103735215;46878001;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;N-Methyl-N-[(1R)-2beta-(1-pyrrolidinyl)cyclohexan-1beta-yl]-2,4-dichlorophenoxyacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)COC3=C(C=C(C=C3)Cl)Cl
4872;100622181;0.076;203982;103166997;55445;10280;16481400;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H]DTG from sigma opioid receptor of homogenized guinea pig whole brain;3-(1-Propyl-3-piperidinyl)phenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCN1CCCC(C1)C2=CC(=CC=C2)O
4873;255012610;0.076;625223;103534218;6075;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pecazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCCC(C1)CN2C3=CC=CC=C3SC4=CC=CC=C42
4874;363665660;0.076;1415967;404715703;74767363;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(2-Chlorophenyl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=NC=NC(=C3C=N2)C4=CC=CC=C4Cl
4875;367478251;0.076;1655949;442052131;156013628;10280;324354210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human Sigma 1 receptor by radioligand displacement assay;"4-benzyl-1-[[(2S,4S)-2-methyl-2-phenyl-1,3-dithiolan-4-yl]methyl]piperidine;oxalic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@]1(SC[C@@H](S1)CN2CCC(CC2)CC3=CC=CC=C3)C4=CC=CC=C4.C(=O)(C(=O)O)O
4876;372121199;0.076;1681775;461552149;162669410;10280;330649470;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;(2R)-4-ethyl-9-[2-(4-fluorophenyl)ethyl]-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CCC3=CC=C(C=C3)F)O[C@@H](C1=O)C
4877;100464788;0.0769;203701;103677037;45264271;10280;80279780;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity at sigma-1 site by inhibition of [3H](+)-pentazocine (PENT) binding in guinea pig brain;"2-(4-Phenylpiperazin-1-yl)ethyl 1-(4-chlorophenyl)cyclopentane-1-carboxylate;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)(C2=CC=C(C=C2)Cl)C(=O)OCCN3CCN(CC3)C4=CC=CC=C4.Cl
4878;100444461;0.077;204470;103215041;14982961;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-(3-Hydroxy-piperidin-1-yl)-hexyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC(CN(C1)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4)O
4879;100604688;0.077;203857;103735214;14771443;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;N-Methyl-N-[(1S)-2alpha-(1-pyrrolidinyl)cyclohexan-1alpha-yl]naphthalene-1-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@H]1CCCC[C@H]1N2CCCC2)C(=O)CC3=CC=CC4=CC=CC=C43
4880;100614617;0.077;203986;103282474;14771666;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;1,3-Bis(3-isopropylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC(C)C1=CC(=CC=C1)NC(=NC2=CC=CC(=C2)C(C)C)N
4881;101829999;0.077;255057;103468576;44403247;10280;161400110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory concentration against opioid receptor sigma 1 of guinea pig cerebral cortex using [3H](+)-pentazocine upon incubation for 150 minutes at 22 degree C;(S)-2-(2-Piperidin-1-yl-ethyl)-1,2,3,5,10,10a-hexahydro-imidazo[1,5-b]isoquinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CCN(CC1)CCN2C[C@@H]3CC4=CC=CC=C4CN3C2
4882;388740382;0.077;1797293;386051295;118282906;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 51;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=C(C2)C(=CC=C3)F
4883;388879197;0.077;1797475;386051295;118282906;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 51;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=C(C2)C(=CC=C3)F
4884;389383658;0.077;1804286;386051295;118282906;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 51;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=C(C2)C(=CC=C3)F
4885;366431541;0.0771;1592018;136926064;3050372;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;1-(3-Phenoxypropyl)-4-phenylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCOC2=CC=CC=C2)C3=CC=CC=C3
4886;100468432;0.0775;203697;103330179;398582;10280;82952200;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma 1 receptor was determined in guinea pig brain membrane using [3H](+)-pentazocine as radioligand;Tetrahydro-1-[3-[methyl[3-[methyl[2-(3,4-dichlorophenyl)ethyl]amino]propyl]amino]propyl]-1H-pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCCN1CCCC1)CCCN(C)CCC2=CC(=C(C=C2)Cl)Cl
4887;366435747;0.07762;1593893;440135862;155527577;10280;309877800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK293T cell membranes;2-[2-[4-(4-Chlorophenyl)-1,4-diazepan-1-yl]ethyl]-5-fluoroinden-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=CC=C(C=C2)Cl)CCC3=CC4=C(C3=O)C=CC(=C4)F
4888;100449432;0.078;204443;103274770;44314137;10280;83608750;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine at sigma receptor in guinea pig brain membrane was determined;[2-(3,4-Dichloro-phenyl)-ethyl]-methyl-(1-piperidin-1-yl-cyclohexylmethyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCC1=CC(=C(C=C1)Cl)Cl)CC2(CCCCC2)N3CCCCC3
4889;100513226;0.078;229197;103384145;10575209;10280;89413830;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor using radioligand ([3H](+)-pentazocine) binding assay;(2-Benzhydryloxy-ethyl)-[1-(3-phenyl-propyl)-azepan-3-yl]-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC(C1)NCCOC(C2=CC=CC=C2)C3=CC=CC=C3)CCCC4=CC=CC=C4
4890;366435748;0.078;1593893;440135862;155527577;10280;309877800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK293T cell membranes;2-[2-[4-(4-Chlorophenyl)-1,4-diazepan-1-yl]ethyl]-5-fluoroinden-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=CC=C(C=C2)Cl)CCC3=CC4=C(C3=O)C=CC(=C4)F
4891;100622166;0.0785;204000;103166997;55445;10280;16481390;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Opioid activity in terms of inhibition of [3H]dihydromorphine binding to opioid receptor mu in rat brain membrane.;3-(1-Propyl-3-piperidinyl)phenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCN1CCCC(C1)C2=CC(=CC=C2)O
4892;100765462;0.0787;204446;103678541;45265348;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membrane was determined by using [3H]DTG as the radioligand;"N-benzylspiro[1,3-dioxolane-2,11'-pentacyclo[5.4.0.02,6.03,10.05,9]undecane]-8'-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1COC2(O1)C3C4CC5C3C(C6C5C4C26)NCC7=CC=CC=C7.Cl
4893;100448338;0.079;204471;103215161;18959739;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[8-(4-Hydroxy-piperidin-1-yl)-octyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
4894;100536382;0.079;204457;103678170;45265093;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-[3-Ethyl-2-fluoro-5-(trifluoromethyl)phenyl]-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=CC(=CC(=C2F)CC)C(F)(F)F)N.Cl
4895;100539435;0.079;204458;103414749;10599695;10280;90578570;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Sigma receptor binding was determined by labeling with radioligand [3H](+)-pentazocine on frozen membranes obtained from frozen guinea pig brain;1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-[3-(3-pyridyl)propyl]piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CN=CC=C2)CCOC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F
4896;334065183;0.079;735278;164149700;71655347;10280;235606500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aS,5R,10bS)-5-cyclohexyl-9-(3,4-dichlorophenoxy)-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCC(CC1)[C@@H]2[C@@H]3CCCO[C@@H]3C4=C(N2)C=CC(=C4)OC5=CC(=C(C=C5)Cl)Cl
4897;363665757;0.079;1415921;404698419;71223262;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;1-(1-(2-(Azepan-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-3-ethylurea hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCNC(=O)NC1=C2C=NN(C2=NC=N1)CCN3CCCCCC3
4898;389712850;0.0791;1919146;476002749;166637130;10280;;Confirmatory;20231017;0;0;Active;Q99720;IC50;;BindingDB;Receptor Binding Assay from US Patent US11535596: 'Analogs of dextromethorphan with balanced receptor activities';2-(6,10a-dimethyl-1,2,3,4-tetrahydrophenanthren-4a-yl)-N-(2-methoxyethyl)ethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC2=C(C=C1)C=CC3(C2(CCCC3)CCNCCOC)C
4899;100473772;0.07943;203852;103321699;15657209;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;N-Methyl-4-phenyl-1,2,3,4-tetrahydronaphthalen-2-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CNC1CC(C2=CC=CC=C2C1)C3=CC=CC=C3
4900;342816991;0.07943;1118248;242613632;46911069;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human recombinant sigma-1 receptor expressed in CHO cells after 180 mins by beta counting analysis;[(1S,2S)-2-phenylcyclopropyl]-(4-piperidin-1-ylpiperidin-1-yl)methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;197.0;;;;C1CCN(CC1)C2CCN(CC2)C(=O)[C@H]3C[C@@H]3C4=CC=CC=C4
4901;342816992;0.07943;1118248;242613634;90666093;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human recombinant sigma-1 receptor expressed in CHO cells after 180 mins by beta counting analysis;[4-[(cyclohexylmethylamino)methyl]piperidin-1-yl]-[(1S,2S)-2-(4-fluorophenyl)cyclopropyl]methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;197.0;;;;C1CCC(CC1)CNCC2CCN(CC2)C(=O)[C@H]3C[C@@H]3C4=CC=C(C=C4)F
4902;363701193;0.07943;1409616;103169732;2719;10280;323538590;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocin from the Sigma1 receptor;Chloroquine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl
4903;100448380;0.08;204471;103215430;14982976;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-{6-[4-(4-Chloro-phenyl)-piperazin-1-yl]-hexyloxy}-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4)C5=CC=C(C=C5)Cl
4904;100449428;0.08;204443;103274922;44314217;10280;83608750;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine at sigma receptor in guinea pig brain membrane was determined;(1-Aza-bicyclo[2.2.2]oct-3-yl)-[2-(3,4-dichloro-phenyl)-ethyl]-methyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCC1=CC(=C(C=C1)Cl)Cl)C2CN3CCC2CC3
4905;100546609;0.08;203685;103278635;10739649;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-Benzylpiperidine-4-yl)-2-(3,4,5-trimethoxyphenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC(=CC(=C1OC)OC)CC(=O)NC2CCN(CC2)CC3=CC=CC=C3
4906;100778219;0.08;204017;103272237;44312944;10280;98735270;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for [3H]- pentazocine at sigma opioid receptor;(2R)-2-[(4R)-4-(4-aminobutyl)-3-benzyl-2,5-dioxoimidazolidin-1-yl]-N-benzylpentanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC[C@H](C(=O)NCC1=CC=CC=C1)N2C(=O)[C@H](N(C2=O)CC3=CC=CC=C3)CCCCN
4907;408049185;0.08;1960000;494410585;171352065;10280;299084420;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma 1 receptor (unknown origin);(1S,9R,13R)-10-hex-5-enyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1[C@H]2CC3=C([C@]1(CCN2CCCCC=C)C)C=C(C=C3)O
4908;326034765;0.0808;701162;163320916;24743571;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;N-[1-(3,4-dichlorophenyl)pyrazol-3-yl]-2-piperidin-1-ylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)CC(=O)NC2=NN(C=C2)C3=CC(=C(C=C3)Cl)Cl
4909;100297857;0.081;239347;103458374;6713949;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;(22S,25S)-spirosolan-3beta-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1[C@H]2[C@H](C[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC[C@@H]5[C@@]4(CC[C@@H](C5)O)C)C)O[C@@]16CCC(CN6)C
4910;100458526;0.081;204438;103344852;15149395;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;11-(3-Phenylpropyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCC4=CC=CC=C4)NC5=CC=CC=C53
4911;100600968;0.081;203996;103251950;9847317;10280;25470740;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was evaluated for binding affinity towards sigma opioid receptor using [3H](+)-3-PPP in guinea pig ileum;(-)2-(3,4-Dichloro-phenyl)-N-methyl-N-(2-pyrrolidin-1-yl-cyclohexyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;21160;Ileum;CN([C@H]1CCCC[C@H]1N2CCCC2)C(=O)CC3=CC(=C(C=C3)Cl)Cl
4912;366431694;0.081;1592018;312351719;13091359;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;3-(4-Chlorophenyl)-8-[3-(4-fluorophenyl)sulfanylpropyl]-8-azabicyclo[3.2.1]octan-3-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2CC(CC1N2CCCSC3=CC=C(C=C3)F)(C4=CC=C(C=C4)Cl)O
4913;407996461;0.081;1946583;482049371;168270809;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[4-[(3,4-difluorophenyl)methoxy]piperidin-1-yl]-N-(4-fluoro-3-methylphenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC(=C1)NC(=O)CN2CCC(CC2)OCC3=CC(=C(C=C3)F)F)F
4914;100628011;0.08128;204453;103671433;45260528;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"(4aR,10bR)-3-(naphthalen-2-ylmethyl)-2,4,4a,5,6,10b-hexahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CC2=CC=CC=C2[C@H]3[C@@H]1CN(CC3)CC4=CC5=CC=CC=C5C=C4.Cl
4915;366431695;0.08128;1592018;312351719;13091359;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;3-(4-Chlorophenyl)-8-[3-(4-fluorophenyl)sulfanylpropyl]-8-azabicyclo[3.2.1]octan-3-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2CC(CC1N2CCCSC3=CC=C(C=C3)F)(C4=CC=C(C=C4)Cl)O
4916;407996462;0.08128;1946583;482049371;168270809;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[4-[(3,4-difluorophenyl)methoxy]piperidin-1-yl]-N-(4-fluoro-3-methylphenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC(=C1)NC(=O)CN2CCC(CC2)OCC3=CC(=C(C=C3)F)F)F
4917;372337845;0.0817;1718135;103722307;9795739;10280;331115250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to human sigma1 receptor expressed in HEK293 cells by liquid scintillation spectrometry;Pridopidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCC(CC1)C2=CC(=CC=C2)S(=O)(=O)C
4918;100471323;0.082;204459;103299479;9921810;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N,N'-di-(m-ethylphenyl)-N-methylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N=C(N)N(C)C2=CC=CC(=C2)CC
4919;100536371;0.082;204457;103673592;45262124;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"1,2-Bis(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N=C(N)N(C)C2=CC=CC(=C2)CC.Cl
4920;363665335;0.082;1415967;404714221;74766966;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(3-Methylphenyl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=CC=C1)C2=C3C=NN(C3=NC=N2)CCN4CCCCC4
4921;372400432;0.082;1744234;461562474;154929638;10280;333727820;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane incubated for 2 hr by liquid scintillation counting method;1-Methyl-3-(pyrrolidin-1-ylmethyl)-5-[4-(trifluoromethyl)phenyl]-1,2,4-triazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;CN1C(=NC(=N1)CN2CCCC2)C3=CC=C(C=C3)C(F)(F)F
4922;363896557;0.0821;1456743;381870275;5041;10280;284899500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma1 receptor (unknown origin);N-[1-[(4-iodophenyl)methyl]piperidin-4-yl]-N-methyl-3-propan-2-yloxypyridin-2-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)OC1=C(N=CC=C1)N(C)C2CCN(CC2)CC3=CC=C(C=C3)I
4923;101829957;0.0823;255065;103468494;44403197;10280;161400090;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory activity against opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 degree C ;(10aS)-2-[3-[(1-benzylpiperidin-4-yl)amino]propyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CN(CCC1NCCCN2C(=O)[C@@H]3CC4=CC=CC=C4CN3C2=O)CC5=CC=CC=C5
4924;100485155;0.0825;204636;103317771;15767675;10280;76368600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured on Sigma receptor type 1 from guinea pig brain membranes using [3H]pentazocine as radioligand.;3-Allyl-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1C2CC3=CC=CC=C3C1(CCN2CC=C)C
4925;372355920;0.0825;1726849;461526135;162651151;10280;342231650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]pentazocine from human sigma 1 receptor expressed in HEK293 cell membrane incubated for 2 hrs by liquid scintillation counting method;6-[5-(4-Methylpiperazin-1-yl)pentoxy]chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)CCCCCOC2=CC3=C(C=C2)OC=CC3=O
4926;100323564;0.0829;204151;103382896;3037711;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 1 using [3H](+)-pentazocine in guinea pig brain membranes;Deoxy-N-benzylnormetazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@H]1[C@H]2CC3=CC=CC=C3[C@@]1(CCN2CC4=CC=CC=C4)C
4927;100439264;0.083;203853;103248082;108046;10280;13615780;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory concentration against radioligand [3H](+)-NAN binding to haloperidol-sensitive sigma binding site in whole guinea pig brain;alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCCC(C2=CC=C(C=C2)F)O)C3=NC=C(C=N3)F
4928;100478415;0.083;203696;103185345;10331008;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;N-Phenethyl-1-pyrrolidineethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(C1)CCNCCC2=CC=CC=C2
4929;100513224;0.083;229197;103384117;620985;10280;89413830;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor using radioligand ([3H](+)-pentazocine) binding assay;[1-(2-Benzhydryloxy-ethyl)-azepan-3-yl]-(3-phenyl-propyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC(C1)NCCCC2=CC=CC=C2)CCOC(C3=CC=CC=C3)C4=CC=CC=C4
4930;407996459;0.083;1946583;494424520;171358804;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;N-(3-chloro-2-methylphenyl)-2-[1-[(3,4-difluorophenyl)methyl]-1,8-diazaspiro[4.5]decan-8-yl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC=C1Cl)NC(=O)CN2CCC3(CCCN3CC4=CC(=C(C=C4)F)F)CC2
4931;100322586;0.0831;204151;163336456;9669;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 1 using [3H](+)-pentazocine in guinea pig brain membranes;Fortral;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1[C@H]2CC3=C([C@@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
4932;100484998;0.0831;204637;163336456;9669;10280;76368610;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was measured on Sigma receptor type 1 using [3H]- pentazocine as radioligand;Fortral;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@H]2CC3=C([C@@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
4933;100485154;0.0831;204636;163336456;9669;10280;76368600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured on Sigma receptor type 1 from guinea pig brain membranes using [3H]pentazocine as radioligand.;Fortral;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1[C@H]2CC3=C([C@@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
4934;407996460;0.08318;1946583;494424520;171358804;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;N-(3-chloro-2-methylphenyl)-2-[1-[(3,4-difluorophenyl)methyl]-1,8-diazaspiro[4.5]decan-8-yl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC=C1Cl)NC(=O)CN2CCC3(CCCN3CC4=CC(=C(C=C4)F)F)CC2
4935;100622094;0.0832;203998;103240536;15061903;10280;16481390;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]DTG binding to Sigma opioid receptor;(3-Phenyl-propyl)-(6,7,8,9-tetrahydro-5H-benzocyclohepten-6-yl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC(CC2=CC=CC=C2C1)NCCCC3=CC=CC=C3
4936;100292950;0.0834;239105;103442123;11372576;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;4-Benzyl-1-(5-methoxy-1,2,3,4-tetrahydro-naphthalen-2-ylmethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCC(C2)CN3CCC(CC3)CC4=CC=CC=C4
4937;326034618;0.0834;701162;163320914;54591111;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-[4-[2-(5-Methyl-1-naphthalen-2-ylpyrazol-3-yl)oxyethyl]piperazin-1-yl]ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)OCCN4CCN(CC4)C(=O)C
4938;100448347;0.084;204471;103214919;14983043;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-Cyclohexyl-6-[6-(4-hydroxy-piperidin-1-yl)-hexyloxy]-3-methyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(OC2=C(C1=O)C=C(C=C2)OCCCCCCN3CCC(CC3)O)C4CCCCC4
4939;100448378;0.084;204471;103215126;14982964;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-Phenyl-6-(6-pyrrolidin-1-yl-hexyloxy)-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(C1)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
4940;100617133;0.084;203985;103282513;10243335;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N,N''-Di-m-tolyl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC(=CC=C1)NC(=NC2=CC=CC(=C2)C)N
4941;334065472;0.084;735278;164135552;71655748;10280;235606500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aS,5R,10bS)-9-(3-methylbutoxy)-5-(oxan-4-yl)-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC(C)CCOC1=CC2=C(C=C1)N[C@@H]([C@H]3[C@@H]2OCCC3)C4CCOCC4
4942;388996812;0.0843;1798943;405263594;86582149;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';(S)-2-(4-methyl-piperazin-1-yl)-1-((R)-3,4,10,10a-tetrahydro-pyrazino[1,2-a]indol-2(1H)-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](C(=O)N1CCN2[C@@H](C1)CC3=CC=CC=C32)N4CCN(CC4)C
4943;100317822;0.085;204295;103626805;9952420;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine.;N,N-Dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCN(CCC)CCC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2.Cl
4944;100458417;0.085;204437;103344492;15149417;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;11-[2-(Isoindolin-2-yl)ethyl]-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCN4CC5=CC=CC=C5C4)NC6=CC=CC=C63
4945;363666200;0.085;1415921;404715184;71225882;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;1-(1-(2-(piperidin-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-3-propylurea;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCNC(=O)NC1=C2C=NN(C2=NC=N1)CCN3CCCCC3
4946;389483950;0.085;1805386;444858097;132060813;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A25;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCN(CC1)C2=CC3=C(CCN(C3)C(=O)OCC4=CC=CC=C4)C=C2
4947;100473779;0.08511;203852;103321590;42601815;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;7-dimethylamino-5-phenyl-6,7,8,9-tetrahydro [5H] benzocycloheptene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)C1CCC2=CC=CC=C2C(C1)C3=CC=CC=C3
4948;354626872;0.08511;1272388;336866908;127026052;10280;267397810;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) by competition binding assay;N,N-Diallyl-5-fluoro-1H-indole-3-ethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C=CCN(CCC1=CNC2=C1C=C(C=C2)F)CC=C
4949;100448328;0.086;204471;103215041;14982961;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-(3-Hydroxy-piperidin-1-yl)-hexyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC(CN(C1)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4)O
4950;100458394;0.086;204438;103344200;15149412;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;2-Fluoro-11-benzyl-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CC4=CC=CC=C4)NC5=C3C=C(C=C5)F
4951;100559071;0.086;203684;103389969;10571528;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;[3-[4-(3-Phenylpropyl)piperazine-1-yl]-3-oxopropyl]carbamic acid tert-butyl ester;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC(=O)NCCC(=O)N1CCN(CC1)CCCC2=CC=CC=C2
4952;380512645;0.086;1846430;482064230;86297181;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-4-[(4-fluorophenyl)methyl]-10-pyridin-3-yl-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CC=C(C=C3)F)OCC4=C(N=NN24)C5=CN=CC=C5
4953;372355816;0.087;1726849;461539885;162660865;10280;342231650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]pentazocine from human sigma 1 receptor expressed in HEK293 cell membrane incubated for 2 hrs by liquid scintillation counting method;6-(5-Pyrrolidin-1-ylpentoxy)chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(C1)CCCCCOC2=CC3=C(C=C2)OC=CC3=O
4954;380512644;0.087;1846430;482052615;86295352;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;Qormyylygyptto-nvxwuhklsa-N;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CN=C(C=C3)C(F)(F)F)OCC4=C(N=NN24)C5=CC=CC=C5F
4955;100367086;0.08705;226337;103375963;10883323;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;2-Phenyl-N-[1-(4-trifluoromethyl-benzyl)-piperidin-4-yl]-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC=C(C=C3)C(F)(F)F
4956;100497407;0.0875;203984;103434448;10342773;10280;76997100;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;1-[3-[4-[3-(Trifluoromethyl)phenyl]piperazino]propyl]-7-methoxy-1,2,3,4-tetrahydronaphthalene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(CCCC2CCCN3CCN(CC3)C4=CC=CC(=C4)C(F)(F)F)C=C1
4957;100444331;0.088;204470;103215126;14982964;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-Phenyl-6-(6-pyrrolidin-1-yl-hexyloxy)-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(C1)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
4958;100448369;0.088;204471;103215586;14983042;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-Cyclohexyl-6-[6-(4-hydroxy-piperidin-1-yl)-hexyloxy]-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)C2=CC(=O)C3=C(O2)C=CC(=C3)OCCCCCCN4CCC(CC4)O
4959;100458510;0.088;204438;103343850;15149402;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;11-(4-Phenoxybutyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCCOC4=CC=CC=C4)NC5=CC=CC=C53
4960;100471349;0.088;204459;103282475;13781936;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N,N''-Bis[2-(propan-2-yl)phenyl]guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC(C)C1=CC=CC=C1NC(=NC2=CC=CC=C2C(C)C)N
4961;100745740;0.088;204454;103247718;15729901;10280;;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity towards sigma receptor by the displacement of [3H]PPP from guinea pig brain;1-(4-Fluoro-naphthalen-1-yl)-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butan-1-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC(C2=CC=C(C3=CC=CC=C32)F)O)C4=NC=C(C=N4)F
4962;366366394;0.088;1558961;440124837;118562573;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;2-Methyl-9-(2-phenylethyl)-4-pyridin-4-yl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=CC=NC=C4
4963;100745606;0.089;204454;103247663;20068655;10280;;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity towards sigma receptor by the displacement of [3H]PPP from guinea pig brain;5-Fluoro-2-{4-[3-(4-fluoro-phenoxy)-propyl]-piperazin-1-yl}-pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCOC2=CC=C(C=C2)F)C3=NC=C(C=N3)F
4964;354626042;0.089;1272497;103186197;7333;10280;267502540;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin) by radioligand displacement assay;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
4965;367490646;0.089;1661755;442062794;1178663;10280;328320230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from recombinant sigma 1 receptor (unknown origin) expressed in baculovirus infected Sf9 cell membranes after 1.5 hrs by scintillation counting analysis;3-[[benzyl(methyl)amino]methyl]-2-methyl-7-(trifluoromethyl)-1H-quinolin-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;521.0;;;;CC1=C(C(=O)C2=C(N1)C=C(C=C2)C(F)(F)F)CN(C)CC3=CC=CC=C3
4966;380264151;0.089;1811100;475981723;126539469;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[1-(4-benzylpiperazin-1-yl)cyclopropyl]methyl]-N-pyridin-2-ylpropanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CC1)N2CCN(CC2)CC3=CC=CC=C3)C4=CC=CC=N4
4967;100333031;0.08913;204944;103278749;10782132;10280;108823620;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was performed using [3H](+)-pentazocine to label sigma-1 binding sites, in guinea pig cerebral cortex;2-[(4-Chlorophenyl)methyl]-1-(5-pyrrolidin-1-ylpentyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CCN(C1)CCCCCNC(=NCC2=CC=C(C=C2)Cl)N
4968;100292611;0.0893;239200;103442109;11234470;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;6-(4-Benzyl-piperidin-1-ylmethyl)-6,7,8,9-tetrahydro-benzocyclohepten-5-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC(C(=O)C2=CC=CC=C2C1)CN3CCC(CC3)CC4=CC=CC=C4
4969;388996991;0.0893;1798943;405263597;86582154;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';1-(3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)-2-(4-methyl-piperazin-1-yl)butan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(C(=O)N1CCN2C(=CC3=CC=CC=C32)C1)N4CCN(CC4)C
4970;100605297;0.0895;203995;103735196;14771480;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity of compound to Sigma opioid receptor labelled with [3H](+)-3-PPP;(1S,2R)-N-[2-(1,3-benzodioxol-5-yl)ethyl]-N-methyl-2-pyrrolidin-1-ylcyclohexan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC2=C(C=C1)OCO2)[C@H]3CCCC[C@H]3N4CCCC4
4971;100613259;0.09;204440;103283176;13781932;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]-DTG in guinea pig brain membrane homogenates;1,3-Bis(2,6-dimethylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=C(C(=CC=C1)C)NC(=NC2=C(C=CC=C2C)C)N
4972;100613860;0.09;203986;103677548;12549981;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N,N'-Dibenzyl-Guanidine Hydrobromide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC=C(C=C1)CNC(=NCC2=CC=CC=C2)N.Br
4973;100741800;0.09;203992;103677397;45264526;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"8-(Furan-2-ylmethyl)-3-phenyl-1-oxa-8-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC12C(=O)C(=CO2)C3=CC=CC=C3)CC4=CC=CO4.Cl
4974;100746454;0.09;204018;103276794;44315181;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor using [3H](+)-SKF-10047 as radioligand;1-Benzyl-4-((Z)-3-phenyl-allyloxymethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1COC/C=C\C2=CC=CC=C2)CC3=CC=CC=C3
4975;372400430;0.09;1744234;461516368;162644304;10280;333727820;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane incubated for 2 hr by liquid scintillation counting method;1-Methyl-5-(4-phenylphenyl)-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;CN1C(=NC(=N1)CN2CCCC2)C3=CC=C(C=C3)C4=CC=CC=C4
4976;100444175;0.091;204470;103215619;18959727;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;5-[3-(4-Hydroxy-piperidin-1-yl)-propoxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCOC2=CC=CC3=C2C(=O)C=C(O3)C4=CC=CC=C4
4977;100448371;0.091;204471;103214779;14982970;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(6-Diethylamino-hexyloxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CC)CCCCCCOC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3
4978;100471351;0.091;204459;103298493;10447715;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N-(1-naphthyl)-N'-(o-isopropylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC(C)C1=CC=CC=C1N=C(N)NC2=CC=CC3=CC=CC=C32
4979;366366655;0.091;1558961;440212955;118562372;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;2-Methyl-4-phenyl-9-(2-pyridin-3-ylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CN=CC=C3)C4=CC=CC=C4
4980;408048980;0.091;1959985;494406990;171349916;10280;299084420;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) assessed as inhibition constant;N-[2-[(1R,9S,13S)-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-10-yl]ethyl]-N-methylaniline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=CC=CC=C3[C@@]1(CCN2CCN(C)C4=CC=CC=C4)C
4981;409047180;0.0912;1794447;440165585;10278851;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;4-[(2R)-2-(4-cyanophenyl)-2-hydroxy-2-(3-methylimidazol-4-yl)ethoxy]-3-[4-(trifluoromethoxy)phenyl]benzonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C=NC=C1[C@@](COC2=C(C=C(C=C2)C#N)C3=CC=C(C=C3)OC(F)(F)F)(C4=CC=C(C=C4)C#N)O
4982;380833925;0.09164;1914524;440165585;10278851;10280;;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000736a SIGMAR1;4-[(2R)-2-(4-cyanophenyl)-2-hydroxy-2-(3-methylimidazol-4-yl)ethoxy]-3-[4-(trifluoromethoxy)phenyl]benzonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C=NC=C1[C@@](COC2=C(C=C(C=C2)C#N)C3=CC=C(C=C3)OC(F)(F)F)(C4=CC=C(C=C4)C#N)O
4983;409047179;0.09164;1794447;440165585;10278851;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;4-[(2R)-2-(4-cyanophenyl)-2-hydroxy-2-(3-methylimidazol-4-yl)ethoxy]-3-[4-(trifluoromethoxy)phenyl]benzonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C=NC=C1[C@@](COC2=C(C=C(C=C2)C#N)C3=CC=C(C=C3)OC(F)(F)F)(C4=CC=C(C=C4)C#N)O
4984;388996819;0.0917;1798943;405263605;86582461;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';(S)-1-(3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)-3-(4-methyl-piperazin-1-yl)butan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](CC(=O)N1CCN2C(=CC3=CC=CC=C32)C1)N4CCN(CC4)C
4985;100314842;0.092;204161;103233517;10390222;10280;104250950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma opioid receptor type 1 in guinea pig brain membranes using [3H](+)-pentazocine as radioligand;M-Iodobenzyltrozamicol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(C[C@H]([C@@H]1O)N2CCC(CC2)C3=CC=CC=C3)CC4=CC(=CC=C4)I
4986;100444353;0.092;204470;103215295;14983050;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(6-Piperidin-1-yl-hexyloxy)-2-pyridin-4-yl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=NC=C4
4987;100444468;0.092;204470;103215292;14982993;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;7-[5-(4-Hydroxy-piperidin-1-yl)-pentyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCOC2=CC3=C(C=C2)C(=O)C=C(O3)C4=CC=CC=C4
4988;100471341;0.092;204459;103298458;10041139;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N,N''-Di-naphthalen-2-yl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC=C2C=C(C=CC2=C1)NC(=NC3=CC4=CC=CC=C4C=C3)N
4989;380264312;0.092;1811100;475981517;12471154;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[2-(4-benzylpiperazin-1-yl)ethyl]-N-phenylpropanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CCN1CCN(CC1)CC2=CC=CC=C2)C3=CC=CC=C3
4990;389483964;0.092;1805386;160849711;132060734;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';Benzyl 5-[4-(2-methylprop-2-enyl)piperazin-1-yl]-1,3-dihydroisoindole-2-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=C)CN1CCN(CC1)C2=CC3=C(CN(C3)C(=O)OCC4=CC=CC=C4)C=C2
4991;100497237;0.0928;203984;103432745;10070045;10280;76997100;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;1-[4-[4-(2-Methoxyphenyl)piperazino]butyl]-7-methoxy-1,2,3,4-tetrahydronaphthalene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(CCCC2CCCCN3CCN(CC3)C4=CC=CC=C4OC)C=C1
4992;100440516;0.093;229189;103575820;5284595;10280;14696970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of specific binding of [3H]3-PPP to sigma receptor in Guinea pig brain membranes;Nalorphine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C=CCN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O
4993;100444333;0.093;204470;103215430;14982976;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-{6-[4-(4-Chloro-phenyl)-piperazin-1-yl]-hexyloxy}-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4)C5=CC=C(C=C5)Cl
4994;100448349;0.093;204471;103214565;14983055;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-(4-Hydroxy-piperidin-1-yl)-hexyloxy]-3-methoxy-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(OC2=C(C1=O)C=C(C=C2)OCCCCCCN3CCC(CC3)O)C4=CC=CC=C4
4995;363665120;0.093;1415967;404708094;74767367;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(2,4-Difluorophenyl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=NC=NC(=C3C=N2)C4=C(C=C(C=C4)F)F
4996;100444330;0.094;204470;103214753;44285320;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-{6-[3-(2-Hydroxy-ethyl)-piperazin-1-yl]-hexyloxy}-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CC(N1)CCO)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
4997;100617141;0.094;203985;103283115;14771728;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N-(3-Hydroxy-phenyl)-N''-(2-methyl-4-nitro-phenyl)-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=C(C=CC(=C1)[N+](=O)[O-])N=C(N)NC2=CC(=CC=C2)O
4998;372120967;0.094;1681775;461516155;162644152;10280;330649470;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;(2R)-9-[2-(2,4-difluorophenyl)ethyl]-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CCC3=C(C=C(C=C3)F)F)O[C@@H](C1=O)C
4999;388740418;0.094;1797293;386051290;118282904;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 46;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C=C(C=C3)F
5000;388879208;0.094;1797475;386051290;118282904;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 46;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C=C(C=C3)F
5001;389383749;0.094;1804286;386051290;118282904;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 46;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC[C@H](CCC1=CC(=C(C=C1)Cl)Cl)N2CC3=C(C2)C=C(C=C3)F
5002;388996824;0.0947;1798943;405263609;86582768;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';(S)-2-(4-cyclohexyl-piperazin-1-yl)-1-((S)-3,4,10,10a-tetrahydro-pyrazino[1,2-a]indol-2(1H)-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](C(=O)N1CCN2[C@H](C1)CC3=CC=CC=C32)N4CCN(CC4)C5CCCCC5
5003;100444467;0.095;204470;103214875;14983045;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-Cyclohexyl-6-(6-morpholin-4-yl-hexyloxy)-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)C2=CC(=O)C3=C(O2)C=CC(=C3)OCCCCCCN4CCOCC4
5004;100448342;0.095;204471;103215142;14983035;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-(4-Fluoro-phenyl)-6-[6-(4-hydroxy-piperidin-1-yl)-hexyloxy]-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=C(C=C4)F
5005;363665326;0.095;1415967;404718097;74767126;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(4-Fluorophenyl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=NC=NC(=C3C=N2)C4=CC=C(C=C4)F
5006;366431685;0.095;1592018;440137851;155528865;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;1-(5-Chloropyridin-2-yl)-4-[4-(4-fluorophenyl)butyl]piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCCC2=CC=C(C=C2)F)C3=NC=C(C=C3)Cl
5007;100386142;0.0953;204153;103377942;11784333;10280;117841480;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma opioid receptor type 1 affinity in guinea pig brain by employing [3H](+)-pentazocine as radioligand.;1''-benzyl-3-benzyloxyspiro[3,4-dihydro-1H-isochromene-1,4''-(hexahydropyridine)];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C3=CC=CC=C3CC(O2)OCC4=CC=CC=C4)CC5=CC=CC=C5
5008;366431686;0.0955;1592018;440137851;155528865;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;1-(5-Chloropyridin-2-yl)-4-[4-(4-fluorophenyl)butyl]piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCCC2=CC=C(C=C2)F)C3=NC=C(C=C3)Cl
5009;100534481;0.09569;204795;103358861;44350649;10280;93971710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was done in guinea pig membranes by labeling the binding site with [3H](+)-pentazocine.;1-(2-Bromo-phenyl)-2-(3-phenyl-8-aza-bicyclo[3.2.1]oct-8-yl)-ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2CC(CC1N2CC(C3=CC=CC=C3Br)O)C4=CC=CC=C4
5010;100354365;0.096;204790;103238398;12084052;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;4-bromo-N-(9-cycloheptyl-9-azabicyclo[3.3.1]nonan-3-yl)-1-methoxynaphthalene-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)NC3CC4CCCC(C3)N4C5CCCCCC5
5011;100471348;0.096;204459;103282474;14771666;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;1,3-Bis(3-isopropylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC(C)C1=CC(=CC=C1)NC(=NC2=CC=CC(=C2)C(C)C)N
5012;372400669;0.096;1744234;461562330;154929730;10280;333727820;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from sigma-1 receptor in human Jurkat cell membrane incubated for 2 hr by liquid scintillation counting method;1-Methyl-5-(4-propan-2-ylphenyl)-3-(pyrrolidin-1-ylmethyl)-1,2,4-triazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;Blood;CC(C)C1=CC=C(C=C1)C2=NC(=NN2C)CN3CCCC3
5013;388740421;0.096;1797293;386051330;118282855;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 88;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)COC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)F)O
5014;388879262;0.096;1797475;386051330;118282855;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 88;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)COC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)F)O
5015;389383762;0.096;1804286;386051330;118282855;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 88;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)COC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)F)O
5016;388996809;0.0961;1798943;405263569;86581409;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';1-(3,4-dihydropyrazino[1,2-a]indol-2(1H)-yl)-2-methyl-2-(4-methylpiperazin-1-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C(=O)N1CCN2C(=CC3=CC=CC=C32)C1)N4CCN(CC4)C
5017;389712855;0.0963;1919146;329964770;6916184;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assay from US Patent US11535596: 'Analogs of dextromethorphan with balanced receptor activities';Morfinan, 3-metoxi-17-metil-, (9alfa, 13alfa, 14alfa)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@]23CCCC[C@@H]2[C@H]1CC4=C3C=C(C=C4)OC
5018;100536696;0.097;204457;103678230;45265132;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(2,3-Dichlorophenyl)-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=C(C(=CC=C2)Cl)Cl)N.Cl
5019;100619103;0.097;203990;136923775;14831246;10280;18482950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma opioid receptor in guinea pig cerebral homogenate using [3H]DTG as radioligand;N-[(R)-1-Methyl-2-phenylethyl]-3-phenyl-2-propyn-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CC1=CC=CC=C1)NCC#CC2=CC=CC=C2
5020;255028307;0.097;625223;103188875;2157;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amiodarone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I
5021;345602971;0.097;1200082;312389841;76683775;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-(1-adamantyl)-N-(2-morpholinoethyl)-1H-1,2,3-triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1COCCN1CCNC2=CN(N=N2)C34CC5CC(C3)CC(C5)C4
5022;389489781;0.097;1805386;444858100;132060792;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A28;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)N2CCN(CC2)C3=CC=CC4=C3CN(CC4)C(=O)OCC5=CC=CC=C5
5023;407996466;0.097;1946583;482078992;168292271;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[4-[(4-chloro-3-fluorophenyl)methoxy]piperidin-1-yl]-N-(3-chloro-2-methylphenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC=C1Cl)NC(=O)CN2CCC(CC2)OCC3=CC(=C(C=C3)Cl)F
5024;100403482;0.0972;204630;103294367;44321166;10280;128012230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma receptor type 1 was determined by the displacement of [3H]pentazocine radioligand;{3-[(3R,5R)-3,5-Dimethyl-4-(3-phenyl-propyl)-piperazin-1-yl]-propyl}-diphenyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(C[C@H](N1CCCC2=CC=CC=C2)C)CCCN(C3=CC=CC=C3)C4=CC=CC=C4
5025;389510952;0.0972;1805565;459070368;118250091;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Pharmacological Activity Assay from US Patent US11007200: 'Cycloalkyl-diamines for the treatment of pain';US11007200, Example 4a;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN[C@@]1(CCCC[C@@H]1NCCCC2=CC=CC=C2)C3=CC=CC=C3Cl
5026;389686471;0.0972;1806763;459070368;118250091;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Pharmacological Activity from US Patent US11426411: 'Cycloalkyl-diamines for the treatment of inflammation';US11007200, Example 4a;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN[C@@]1(CCCC[C@@H]1NCCCC2=CC=CC=C2)C3=CC=CC=C3Cl
5027;100627926;0.09772;204453;103671396;45260506;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"(4aR,10bR)-3-[(4-tert-butylphenyl)methyl]-2,4,4a,5,6,10b-hexahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CC(C)(C)C1=CC=C(C=C1)CN2CC[C@@H]3[C@H](C2)CCC4=CC=CC=C34.Cl
5028;354626876;0.09772;1272388;336884944;127036932;10280;267397810;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) by competition binding assay;N-[2-(5-chloro-1H-indol-3-yl)ethyl]-N-prop-2-enylprop-2-en-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C=CCN(CCC1=CNC2=C1C=C(C=C2)Cl)CC=C
5029;407996467;0.09772;1946583;482078992;168292271;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[4-[(4-chloro-3-fluorophenyl)methoxy]piperidin-1-yl]-N-(3-chloro-2-methylphenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC=C1Cl)NC(=O)CN2CCC(CC2)OCC3=CC(=C(C=C3)Cl)F
5030;100458431;0.098;204437;103344468;15149403;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;15-(4-Thiophen-2-ylbutyl)-9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3,5,7-tetraene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCCC4=CC=CS4)NC5=CC=CC=C53
5031;363665997;0.098;1415921;404714922;71222995;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;N-(1-(2-(pyrrolidin-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)cyclohexanecarboxamide maleate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)C(=O)NC2=C3C=NN(C3=NC=N2)CCN4CCCC4
5032;100448376;0.099;204471;103215695;44285740;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-(4-Hydroxy-piperidin-1-yl)-hex-4-enyloxy]-3-methyl-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(OC2=C(C1=O)C=C(C=C2)OCCC/C=C/CN3CCC(CC3)O)C4=CC=CC=C4
5033;345602970;0.099;1200082;312389834;118565438;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;N-[2-[(2S,6R)-2,6-dimethylpiperidin-1-yl]ethyl]-1-[(4-fluorophenyl)methyl]triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C[C@@H]1CCC[C@@H](N1CCNC2=CN(N=N2)CC3=CC=C(C=C3)F)C
5034;363665765;0.099;1415921;404696172;145979453;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;N-[1-[4-[di(propan-2-yl)amino]butyl]pyrazolo[3,4-d]pyrimidin-4-yl]adamantane-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)N(CCCCN1C2=NC=NC(=C2C=N1)NC(=O)C34CC5CC(C3)CC(C5)C4)C(C)C
5035;100497229;0.0991;203984;103376908;10248163;10280;76997100;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;1-[(E)-3-[4-(2-Pyridyl)piperazino]propylidene]-5-methoxy-1,2,3,4-tetrahydronaphthalene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC\2=C1CCC/C2=C\CCN3CCN(CC3)C4=CC=CC=N4
5036;326035326;0.0991;701162;163314015;71449812;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;4-[4-(5-Methyl-1-naphthalen-2-ylpyrazol-3-yl)oxybutyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)OCCCCN4CCOCC4
5037;100444479;0.1;204470;103214779;14982970;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(6-Diethylamino-hexyloxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CC)CCCCCCOC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3
5038;100448379;0.1;204471;103215128;15230909;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-(4-Hydroxy-piperidin-1-yl)-hexyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
5039;100456549;0.1;229183;103360155;14970528;10280;79028690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor in bovine cerebellum using 2.0 nM [3H]haloperidol in the presence of 25 nM unlabeled spiperone;1-(4-Bromo-phenyl)-3-[4-(4-chloro-phenyl)-3,6-dihydro-2H-pyridin-1-yl]-propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CN(CC=C1C2=CC=C(C=C2)Cl)CCC(=O)C3=CC=C(C=C3)Br
5040;100680631;0.1;204130;103178619;44270247;10280;119345760;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity for Sigma opioid receptor by displacement of [3H]DTG;6-[4-((3R,5S)-3,5-Dimethyl-piperazin-1-yl)-butyl]-3-methyl-3H-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(C[C@@H](N1)C)CCCCC2=CC3=C(C=C2)N(C(=O)S3)C
5041;100745603;0.1;204454;103247306;9956313;10280;;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;In vitro binding affinity towards sigma receptor by the displacement of [3H]PPP from guinea pig brain;4-Fluoro-N-{1-(4-fluoro-phenyl)-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butyl}-benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC(C2=CC=C(C=C2)F)NC(=O)C3=CC=C(C=C3)F)C4=NC=C(C=N4)F
5042;101829942;0.1;255065;103468461;44403179;10280;161400090;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Inhibitory activity against opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 degree C ;(10aS)-2-[2-[4-(2-hydroxyethyl)piperazin-1-yl]ethyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CN(CCN1CCN2C(=O)[C@@H]3CC4=CC=CC=C4CN3C2=O)CCO
5043;101829945;0.1;255065;103468462;44403180;10280;161400090;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Inhibitory activity against opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 degree C ;2-[4-[2-[(10aS)-1,3-dioxo-10,10a-dihydro-5H-imidazo[1,5-b]isoquinolin-2-yl]ethyl]piperazin-1-yl]-N-propan-2-ylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;CC(C)NC(=O)CN1CCN(CC1)CCN2C(=O)[C@@H]3CC4=CC=CC=C4CN3C2=O
5044;101829948;0.1;255065;103468472;44403187;10280;161400090;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Inhibitory activity against opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 degree C ;(10aS)-2-[3-(4-methylpiperazin-1-yl)propyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;CN1CCN(CC1)CCCN2C(=O)[C@@H]3CC4=CC=CC=C4CN3C2=O
5045;101829955;0.1;255065;103468573;44403244;10280;161400090;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Inhibitory activity against opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 degree C ;(10aS)-2-[2-(4-methylpiperazin-1-yl)ethyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;CN1CCN(CC1)CCN2C(=O)[C@@H]3CC4=CC=CC=C4CN3C2=O
5046;101829956;0.1;255065;103468477;44403189;10280;161400090;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Inhibitory activity against opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 degree C ;(10aS)-2-[3-[4-[3-(dimethylamino)propyl]piperazin-1-yl]propyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;CN(C)CCCN1CCN(CC1)CCCN2C(=O)[C@@H]3CC4=CC=CC=C4CN3C2=O
5047;101829960;0.1;255065;103468478;44403190;10280;161400090;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Inhibitory activity against opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 degree C ;(10aS)-2-[3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CN(CCN1CCCN2C(=O)[C@@H]3CC4=CC=CC=C4CN3C2=O)CCO
5048;101829965;0.1;255065;103468564;44403237;10280;161400090;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Inhibitory activity against opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 degree C ;(10aS)-2-[3-(N-methylanilino)propyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;CN(CCCN1C(=O)[C@@H]2CC3=CC=CC=C3CN2C1=O)C4=CC=CC=C4
5049;101831626;0.1;255051;103468558;44403233;10280;161400090;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Inhibitory activity against Opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 C ;2-[3-[(10aS)-1,3-dioxo-10,10a-dihydro-5H-imidazo[1,5-b]isoquinolin-2-yl]propyl-benzylamino]imidazole-1-carbaldehyde;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1[C@H]2C(=O)N(C(=O)N2CC3=CC=CC=C31)CCCN(CC4=CC=CC=C4)C5=NC=CN5C=O
5050;101886020;0.1;265284;103488450;11430856;10280;167226310;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to guinea pig sigma receptor by radioligand binding assay;Naluzotan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)NC1=CC(=CC=C1)N2CCN(CC2)CCCCNS(=O)(=O)CC3CCCCC3
5051;255026810;0.1;625223;103358193;4935;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Proparacaine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCOC1=C(C=C(C=C1)C(=O)OCCN(CC)CC)N
5052;321525567;0.1;658997;160694398;70691984;10280;225129080;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Displacement of [3H](+)pentazocine from sigma-1 receptor expressed in human Jurkat cell membranes after 2 hrs by liquid scintillation spectroscopy;4-[4-[1-Adamantyl(phenyl)methyl]phenyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1COCCN1C2=CC=C(C=C2)C(C3=CC=CC=C3)C45CC6CC(C4)CC(C6)C5
5053;342816989;0.1;1118248;242613633;90666092;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human recombinant sigma-1 receptor expressed in CHO cells after 180 mins by beta counting analysis;[(1S,2S)-2-(4-fluorophenyl)cyclopropyl]-(4-piperidin-1-ylpiperidin-1-yl)methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;197.0;;;;C1CCN(CC1)C2CCN(CC2)C(=O)[C@H]3C[C@@H]3C4=CC=C(C=C4)F
5054;345593884;0.1;1197502;312385713;118731577;10280;256029320;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor in human Jurkat cells after 120 mins by liquid scintillation counting analysis;N-benzyl-N-methyl-3-(2-methylbenzimidazol-1-yl)propan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC1=NC2=CC=CC=C2N1CCCN(C)CC3=CC=CC=C3
5055;345593885;0.1;1197502;312385719;118731583;10280;256029320;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor in human Jurkat cells after 120 mins by liquid scintillation counting analysis;1-[3-(1,3-Dihydroisoindol-2-yl)propyl]-3-methylbenzimidazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C2=CC=CC=C2N(C1=O)CCCN3CC4=CC=CC=C4C3
5056;345594059;0.1;1197502;312385714;118731578;10280;256029320;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor in human Jurkat cells after 120 mins by liquid scintillation counting analysis;3-[3-(1,3-Dihydroisoindol-2-yl)propyl]-1,3-benzoxazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1C2=CC=CC=C2CN1CCCN3C4=CC=CC=C4OC3=O
5057;345594060;0.1;1197502;312385718;118731582;10280;256029320;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor in human Jurkat cells after 120 mins by liquid scintillation counting analysis;6-Bromo-4-[3-(1,3-dihydroisoindol-2-yl)propyl]-1,4-benzoxazin-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1C2=CC=CC=C2CN1CCCN3C(=O)COC4=C3C=C(C=C4)Br
5058;345594065;0.1;1197502;103681123;44248689;10280;256029320;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor in human Jurkat cells after 120 mins by liquid scintillation counting analysis;3-[3-(N-Benzyl-N-methylamino)propyl]benzo[d]oxazol-2(3H)-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1C2=CC=CC=C2OC1=O)CC3=CC=CC=C3
5059;345594069;0.1;1197502;312385715;118731579;10280;256029320;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor in human Jurkat cells after 120 mins by liquid scintillation counting analysis;6-Bromo-3-[3-(1,3-dihydroisoindol-2-yl)propyl]-1,3-benzoxazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1C2=CC=CC=C2CN1CCCN3C4=C(C=C(C=C4)Br)OC3=O
5060;345594070;0.1;1197502;312385710;118731574;10280;256029320;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor in human Jurkat cells after 120 mins by liquid scintillation counting analysis;4-[3-[Benzyl(methyl)amino]propyl]-6-bromo-1,4-benzoxazin-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1C(=O)COC2=C1C=C(C=C2)Br)CC3=CC=CC=C3
5061;345594072;0.1;1197502;312385712;118731576;10280;256029320;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor in human Jurkat cells after 120 mins by liquid scintillation counting analysis;1-[3-[Benzyl(methyl)amino]propyl]-3-methylbenzimidazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C2=CC=CC=C2N(C1=O)CCCN(C)CC3=CC=CC=C3
5062;354626878;0.1;1272388;336885079;24839550;10280;267397810;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) by competition binding assay;N,N-Diallyltryptamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C=CCN(CCC1=CNC2=CC=CC=C21)CC=C
5063;363665332;0.1;1415967;404698202;74766963;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-phenyl-1-(2-(piperidin-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=NC=NC(=C3C=N2)C4=CC=CC=C4
5064;363665762;0.1;1415921;404712035;71223519;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;1-(1-(2-(azepan-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-3-cyclopropylurea hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCCN(CC1)CCN2C3=NC=NC(=C3C=N2)NC(=O)NC4CC4
5065;363958018;0.1;1500193;404663993;60701380;10280;287562630;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;N-[3-[benzyl(methyl)amino]propyl]benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC=CC=C1)CC2=CC=CC=C2
5066;363958019;0.1;1500193;160676443;65659;10280;287562630;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;Eprobemide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCN1CCCNC(=O)C2=CC=C(C=C2)Cl
5067;363958030;0.1;1500193;103292864;4235;10280;287562630;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;Moclobemide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl
5068;363958032;0.1;1500193;242416088;1081502;10280;287562630;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;4-chloro-N-(2-pyrrolidin-1-ylethyl)benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(C1)CCNC(=O)C2=CC=C(C=C2)Cl
5069;363958377;0.1;1500193;404658724;17644936;10280;287562630;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;4-chloro-N-[3-(4-methylpiperazin-1-yl)propyl]benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)CCCNC(=O)C2=CC=C(C=C2)Cl
5070;363958379;0.1;1500193;404662955;10356384;10280;287562630;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;4-chloro-N-[2-(4-methylpiperazin-1-yl)ethyl]benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)CCNC(=O)C2=CC=C(C=C2)Cl
5071;363958381;0.1;1500193;404653386;3126148;10280;287562630;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)-pentazocine from S1R in human Jurkat cell membranes after 2 hrs by liquid scintillation counting;4-chloro-N-[3-(pyrrolidin-1-yl)propyl]benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(C1)CCCNC(=O)C2=CC=C(C=C2)Cl
5072;366437108;0.1;1594273;440145184;146597630;10280;309043830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;[2-(4-Fluorophenyl)-5-(2-pyridin-4-ylethylamino)-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)C(=O)C2=C3CC(CCC3=NN2C4=CC=C(C=C4)F)NCCC5=CC=NC=C5
5073;388740032;0.1;1797293;386051286;118282881;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 42;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)OC1=C(C=C(C=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)F)OC(C)C
5074;388740625;0.1;1797293;386051313;118282843;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 68;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
5075;388806874;0.1;1795537;378158947;122657655;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Human Sigma1 Receptor Radioligand Assay from US Patent US10072008: 'Spiro-isoquinoline-3,4′-piperidine compounds having activity against pain';US10072008, Example 2;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12CC3=CC=CC=C3C(=O)N2)CC4=CC=CC=C4
5076;388806875;0.1;1795537;378158946;122657649;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Human Sigma1 Receptor Radioligand Assay from US Patent US10072008: 'Spiro-isoquinoline-3,4′-piperidine compounds having activity against pain';US10072008, Example 1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12CC3=CC=CC=C3C(=O)N2)CCC4=CC=CC=C4
5077;388806876;0.1;1795537;378158951;122667716;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Human Sigma1 Receptor Radioligand Assay from US Patent US10072008: 'Spiro-isoquinoline-3,4′-piperidine compounds having activity against pain';US10072008, Example 6;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC2=CC=CC=C2CC13CCN(CC3)CC4=CC=CC=C4
5078;388806877;0.1;1795537;378158948;122667717;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Human Sigma1 Receptor Radioligand Assay from US Patent US10072008: 'Spiro-isoquinoline-3,4′-piperidine compounds having activity against pain';US10072008, Example 3;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12CC3=CC=CC=C3CN2)CCC4=CC=CC=C4
5079;388806880;0.1;1795537;378158949;122667724;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Human Sigma1 Receptor Radioligand Assay from US Patent US10072008: 'Spiro-isoquinoline-3,4′-piperidine compounds having activity against pain';US10072008, Example 4;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12CC3=CC=CC=C3CN2)CC4=CC=CC=C4
5080;388878703;0.1;1797475;386051286;118282881;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 42;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)OC1=C(C=C(C=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)F)OC(C)C
5081;388879461;0.1;1797475;386051313;118282843;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 68;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
5082;389294744;0.1;1803838;433913979;129073948;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 12;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)CN2CC(OC3(C2)CC3)C4CCN(CC4)CC5=CC=CC=C5
5083;389294748;0.1;1803838;433913972;129053739;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 5;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC(OC2(C1=O)CC2)C3CCN(CC3)CC4=CC=CC=C4
5084;389294749;0.1;1803838;433913981;129053742;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 14;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC(OC2(C1)CC2)C3CCN(CC3)CC4=CC=CC=C4
5085;389294751;0.1;1803838;433914014;129053765;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 51;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CCN1CCC(CC1)C2CN(CC3(O2)CC3)C(=O)C4=CC=CC=C4
5086;389294755;0.1;1803838;433914013;129053792;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';2-(1-Benzylpiperidin-4-yl)-4-ethylmorpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CCOC(C1)C2CCN(CC2)CC3=CC=CC=C3
5087;389294757;0.1;1803838;433914010;129053735;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 47;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CCN1CCC(CC1)C2CN(CC3(O2)CC3)CC4=CC=C(C=C4)OC
5088;389294833;0.1;1803838;433914012;129053759;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';2-(1-Benzylpiperidin-4-yl)-4-(4-methoxybenzyl)moropholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)CN2CCOC(C2)C3CCN(CC3)CC4=CC=CC=C4
5089;389294841;0.1;1803838;433914008;129053754;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 45;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC12C(=O)N(CC(O2)C3CN(C3)CC4=CC=CC=C4)C5=CC=CC=C5
5090;389294843;0.1;1803838;433913971;129053725;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 4;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1C2CN(CC3(O2)CC3)C(=O)C4=CC=CC=C4)CC5=CC=CC=C5
5091;389294846;0.1;1803838;433914004;129073794;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';6-(1-Benzylpiperidin-4-yl)-4-ethylmorpholin-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC(OCC1=O)C2CCN(CC2)CC3=CC=CC=C3
5092;389383285;0.1;1804286;386051286;118282881;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 42;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)OC1=C(C=C(C=C1)CCC(C)(C)N2CC3=C(C2)C=C(C=C3)F)OC(C)C
5093;389383874;0.1;1804286;386051313;118282843;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 68;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C=C(C=C3)S(=O)(=O)C
5094;389385660;0.1;1804511;440710126;129053836;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 19;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CN(C1)CCC3=CC=CC=C3)CN(CC4(O2)CC4)C5=CC=CC=C5
5095;389385662;0.1;1804511;440710116;129053811;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 9;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCN(C1)CCC3=CC=CC=C3)CN(C(=O)C4(O2)CC4)C5=CC=CC=C5
5096;389385666;0.1;1804511;440710127;129053859;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 20;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CCN1CCCC2(C1)CN(CC3(O2)CC3)C4=CC=CC=C4
5097;389385776;0.1;1804511;440710117;129053834;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 10;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CCN1CCCC2(CC1)CN(C(=O)C3(O2)CC3)C4=CC=CC=C4
5098;389385777;0.1;1804511;440710123;129053823;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 16;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCCN(CC2)CCC3=CC=CC=C3)OC4(C1)CC4
5099;389385779;0.1;1804511;440710128;129053870;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 21;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCN(C1)CC3=CC=CC=C3)CN(CC4(O2)CC4)C5=CC=CC=C5
5100;389385780;0.1;1804511;440710110;129053856;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 3;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCCN(CC2)CCC3=CC=CC=C3)OC4(C1=O)CC4
5101;389385784;0.1;1804511;440710111;129053805;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 4;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCCN(CC2)CCC(C)C)OC3(C1=O)CC3
5102;389385785;0.1;1804511;440710134;129070158;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 27;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCN(C1)CCC3=CC=CC=C3)CN(CC4(O2)CC4)C(=O)C5=CC=CC=C5
5103;389385789;0.1;1804511;440710119;129053852;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 12;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCCN(CC2)CC3=CC=CC=C3)OC4(C1=O)CC4
5104;389385902;0.1;1804511;440710113;129053853;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 6;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CN(C2)CCC(C)C)OC3(C1=O)CC3
5105;389385903;0.1;1804511;440710140;129069863;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 33;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC12C(=O)N(CC3(O2)CN(C3)CCC4=CC=CC=C4)CC5=CC=CC=C5
5106;389385908;0.1;1804511;440710159;129053869;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 56;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCN(C1)CC3=CC=CC=C3)CN(CC4(O2)CC4)C(=O)C5=CC=CC=C5
5107;389385909;0.1;1804511;440710195;129053873;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 84;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CCN1CCCC2(CC1)CN(CC3(O2)CC3)CC4=CC=CC=C4
5108;389385912;0.1;1804511;440710197;129053806;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 86;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC(OC2(C1)CCCN(CC2)CC3=CC=CC=C3)(C)C
5109;389385914;0.1;1804511;440710121;129053814;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 14;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCN(C1)CC3=CC=CC=C3)CN(C(=O)C4(O2)CC4)C5=CC=CC=C5
5110;389385917;0.1;1804511;440710191;129069870;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 80;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CCN1CCCC2(C1)CN(CC3(O2)CC3)CC4=CC=CC=C4
5111;389386057;0.1;1804511;440710135;129070041;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 28;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CCN1CCCC2(CC1)CN(CC3(O2)CC3)C(=O)C4=CC=CC=C4
5112;389386059;0.1;1804511;440710189;129069868;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 78;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CN(C1)CC3=CC=CC=C3)CN(CC4(O2)CC4)CC5=CC=CC=C5
5113;389386060;0.1;1804511;440710194;129069922;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 83;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCN(C1)CCC3=CC=CC=C3)CN(CC4(O2)CC4)CC5=CC=CC=C5
5114;389386065;0.1;1804511;440710129;129053855;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 22;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCN(C1)CCC3=CC=CC=C3)CN(CC4(O2)CC4)C5=CC=CC=C5
5115;389386066;0.1;1804511;440710190;129069869;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 79;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CN(C1)CCC3=CC=CC=C3)CN(CC4(O2)CC4)CC5=CC=CC=C5
5116;389386072;0.1;1804511;440710137;129069859;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 30;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCCN(CC2)CCC3=CC=CC=C3)OC(C1=O)(C)C
5117;389386179;0.1;1804511;440710141;129053865;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 34;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1(CN(CC2(O1)CCCN(CC2)CCC3=CC=CC=C3)C(=O)C4=CC=CC=C4)C
5118;389386180;0.1;1804511;440710192;129069871;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 81;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CN1CCCC2(C1)CN(CC3(O2)CC3)CC4=CC=CC=C4
5119;389386181;0.1;1804511;440710160;129053801;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 57;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCCN(CC2)CC3=CC=CC=C3)OC(C1=O)(C)C
5120;389386184;0.1;1804511;440710198;129053830;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 87;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC(OC2(C1)CCCN(CC2)CCC3=CC=CC=C3)(C)C
5121;389386185;0.1;1804511;440710200;129070163;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 89;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC(OC2(C1)CCCN(CC2)CC(C)C)(C)C
5122;389386188;0.1;1804511;440710196;129070164;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 85;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CN1CCCC2(CC1)CN(CC3(O2)CC3)CC4=CC=CC=C4
5123;389386192;0.1;1804511;440710199;137390867;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 88;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCCN(CC2)CCC(C)C)OC3(C1)CC3
5124;389386194;0.1;1804511;440710193;129069867;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 82;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCN(C1)CC3=CC=CC=C3)CN(CC4(O2)CC4)CC5=CC=CC=C5
5125;389386196;0.1;1804511;440710203;129070082;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 92;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@]2(CCCN(CC2)CC3=CC=CC=C3)OC4(C1=O)CC4
5126;389386256;0.1;1804511;440710201;129070162;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 90;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC12CN(CC3(O2)CN(C3)CCC4=CC=CC=C4)CC5=CC=CC=C5
5127;389386257;0.1;1804511;440710203;129070082;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 92;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@]2(CCCN(CC2)CC3=CC=CC=C3)OC4(C1=O)CC4
5128;389489779;0.1;1805386;444858112;132075218;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A40;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)C2=CC3=C(CCCN(C3)S(=O)(=O)C4=CC(=CC(=C4)Cl)Cl)C=C2
5129;389769818;0.1;1919450;443553184;135332796;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 23;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC3=CC(=CC=C3)F)OC4(C1=O)CC4
5130;389769819;0.1;1919450;443553168;135332788;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 7;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CCC(C)C)O[C@H](C1=O)C
5131;389770094;0.1;1919450;443553187;135332881;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 26;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CC2(CCN(CC2)CC3=CC=CC=C3)OC4(C1=O)CC4
5132;389770096;0.1;1919450;443553170;135332872;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 9;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CC2(CCN(CC2)CCC(C)C)OC3(C1=O)CC3
5133;389770097;0.1;1919450;443553176;135332751;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 15;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CCC(C)C)OC(C1=O)(C)C
5134;389770100;0.1;1919450;443553163;135332709;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 2;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CCC(C)C)OCC1=O
5135;389770102;0.1;1919450;443553179;135332834;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 18;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC2(CCN(CC2)CC3=CC=CC=C3)OC4(C1=O)CC4
5136;389770103;0.1;1919450;443553162;135332692;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CCC(C)C)OC3(C1=O)CC3
5137;389770104;0.1;1919450;443553206;135332823;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 45;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CCN1CCC2(CC1)CN(C(=O)C(O2)(C)C)C(C)C
5138;389770107;0.1;1919450;443553193;135332705;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 32;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC3=CC=CC=C3)OC(C1=O)(C)C
5139;389770110;0.1;1919450;443553201;135374776;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 40;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CC2(CC2)OC3(C1)CCN(CC3)CCC4=C(C=CC=N4)F
5140;389770303;0.1;1919450;443553177;135332814;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 16;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC3=CC=C(C=C3)F)OC4(C1=O)CC4
5141;389770304;0.1;1919450;443553166;135332829;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 5;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CCN1CCC2(CC1)CN(C(=O)C3(O2)CC3)C(C)C
5142;389770308;0.1;1919450;443553180;135332759;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 19;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC3=CC=CC=C3)O[C@@H](C1=O)C
5143;389770309;0.1;1919450;443553181;135332805;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 20;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)N1CC2(CCN(CC2)CC3=CC=CC=C3)OC4(C1=O)CC4
5144;389770310;0.1;1919450;443553235;135374798;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 75;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC3=CC=C(C=C3)OC)O[C@@H](C1=O)C
5145;389770312;0.1;1919450;443553171;135332699;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 10;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CCN1CCC2(CC1)CN(C(=O)C3(O2)CC3)CC(C)C
5146;389770315;0.1;1919450;443553228;135374675;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 68;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC3=CC=C(C=C3)F)OC(C1=O)(C)C
5147;389770317;0.1;1919450;443553203;135374706;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 42;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CN1CC2(CC2)OC3(C1)CCN(CC3)CCC4=C(C=CC=N4)F
5148;389770319;0.1;1919450;443553245;135374927;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 85;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1C(=O)N(CC2(O1)CCN(CC2)CC3=CC=C(C=C3)F)C4CC4
5149;389770414;0.1;1919450;482595801;156290117;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US11649248, Example 24;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC3=CC(C(C=C3)F)F)OC4(C1=O)CC4
5150;389770417;0.1;1919450;443553183;135332752;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 22;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC3=CC=CC=C3)O[C@H](C1=O)C
5151;389770421;0.1;1919450;443553210;135332689;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 49;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CC2(CCN(CC2)CCC(C)C)OCC1=O
5152;389770424;0.1;1919450;443553236;135374638;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 76;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC3=CC=C(C=C3)Cl)OC(C1=O)(C)C
5153;389770425;0.1;1919450;443553233;135374757;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 73;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC3=CC=C(C=C3)Cl)O[C@@H](C1=O)C
5154;389770428;0.1;1919450;443553215;135374930;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 55;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CC2(CCN(CC2)CCC(C)C)O[C@H](C1=O)C
5155;389770431;0.1;1919450;443553214;135332835;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 54;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CC2(CCN(CC2)CCC(C)C)OC(C1=O)(C)C
5156;389770561;0.1;1919450;443553247;135374793;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 87;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1C(=O)N(CC2(O1)CCN(CC2)CC3=CC=C(C=C3)C#N)C4CC4
5157;389770564;0.1;1919450;443553188;135332820;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 27;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CN1CC2(CCN(CC2)CC3=CC=CC=C3)OC4(C1=O)CC4
5158;389770565;0.1;1919450;443553237;135374704;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 77;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC3=CC=C(C=C3)C#N)OC(C1=O)(C)C
5159;389770566;0.1;1919450;443553229;135374765;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 69;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1C(=O)N(CC2(O1)CCN(CC2)CC3=CC=C(C=C3)F)C(C)C
5160;389770567;0.1;1919450;443553269;135332747;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 109;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CN(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C(C)C
5161;389770569;0.1;1919450;443553248;135374642;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 88;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1C(=O)N(CC2(O1)CCN(CC2)CC3=CC=C(C=C3)C#N)C
5162;389770570;0.1;1919450;443553263;135374796;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 103;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CCN1CC2(CC2)OC3(C1)CCN(CC3)CCC4=C(C=CC=N4)F
5163;389770571;0.1;1919450;443553261;135374701;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 101;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CN1CC2(CC2)OC3(C1)CCN(CC3)CCC4=C(C=CC=N4)Cl
5164;389770573;0.1;1919450;443553262;135374728;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 102;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CN1CC2(CC2)OC3(C1)CCN(CC3)CCC4=C(C=CC=N4)C#N
5165;389770574;0.1;1919450;443553243;135374720;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 83;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1C(=O)N(CC2(O1)CCN(CC2)CC3=CC=C(C=C3)C#N)C(C)C
5166;389770575;0.1;1919450;443553230;135374933;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 70;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC3=CC=C(C=C3)F)O[C@@H](C1=O)C
5167;389770576;0.1;1919450;443553178;135332760;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 17;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC3=CC=CC=C3)OC4(C1=O)CC4
5168;389770577;0.1;1919450;443553265;135374777;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 105;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(C)N1CC2(CC2)OC3(C1)CCN(CC3)CCC4=C(C=CC=N4)F
5169;389770578;0.1;1919450;443553264;135374718;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 104;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)CN1CC2(CC2)OC3(C1)CCN(CC3)CCC4=C(C=CC=N4)F
5170;389770718;0.1;1919450;482595887;135374680;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US11649248, Example 110;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CN(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)CCC4CC4
5171;389770719;0.1;1919450;443553209;135332803;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 48;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CC2(CCN(CC2)CCC(C)(C)C)OCC1=O
5172;389770722;0.1;1919450;482595889;135332711;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US11649248, Example 112;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC(OC2(C1)CCN(CC2)CCC3=CC=CC=C3)C
5173;389770723;0.1;1919450;443553268;135374672;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 108;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1C[C@@H](OC2(C1)CCN(CC2)CCC3=C(C=CC=N3)F)C
5174;389770724;0.1;1919450;443553232;135374669;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 72;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC3=CC=C(C=C3)Cl)O[C@H](C1=O)C
5175;389770733;0.1;1919450;443553246;135374963;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 86;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1C(=O)N(CC2(O1)CCN(CC2)CC3=CC=CC=C3)C4CC4
5176;389770735;0.1;1919450;443553207;135332725;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 46;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CN1CC2(CC2)OC3(C1)CCN(CC3)CCC4=C(C=CC(=C4)F)F
5177;389770736;0.1;1919450;482595815;156290250;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US11649248, Example 38;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1C(=O)N(CC2(O1)CCN(CC2)CCC3=C(C=CC=N3)F)C(C)C
5178;389770902;0.1;1919450;443553244;135374773;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 84;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1C(=O)N(CC2(O1)CCN(CC2)CC3=CC=C(C=C3)F)C
5179;389770904;0.1;1919450;443553208;135332791;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 47;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CN1CC2(CC2)OC3(C1)CCN(CC3)CCC4=NC(=CC=C4)OC
5180;389770906;0.1;1919450;443553249;135374653;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 89;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1C(=O)N(CC2(O1)CCN(CC2)CC3=CC=C(C=C3)F)C
5181;389770907;0.1;1919450;443553227;135374726;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 67;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC2(CCN(CC2)CC3=CC=C(C=C3)F)OC4(C1=O)CC4
5182;389770909;0.1;1919450;443553234;135374802;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 74;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC3=CC=C(C=C3)C#N)O[C@@H](C1=O)C
5183;389770912;0.1;1919450;482595813;156290345;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US11649248, Example 36;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)N1CC2(CCN(CC2)CCC3=C(C=CC=N3)F)OC4(C1=O)CC4
5184;389770915;0.1;1919450;443553241;135374767;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 81;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC3=CC=C(C=C3)C#N)O[C@H](C1=O)C
5185;389770916;0.1;1919450;443553271;135374640;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 111;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC1CN2CCOC3(C2)CCN(CC3)CCC4=CC=CC=C4
5186;389770917;0.1;1919450;443553273;135374925;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 113;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)N1CC(OC2(C1)CCN(CC2)CCC3=CC=CC=C3)(C)C
5187;407928968;0.1;1929171;494397432;91810391;10280;341755420;Confirmatory;20240503;0;0;Active;Q99720;Ki;<;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in HEK293 cells membrane incubated for 120 mins by MicroBeta scintillation counter assay;N-[3-[1-[(1-phenyltriazol-4-yl)methyl]piperidin-4-yl]phenyl]propane-2-sulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)S(=O)(=O)NC1=CC=CC(=C1)C2CCN(CC2)CC3=CN(N=N3)C4=CC=CC=C4
5188;407928969;0.1;1929171;494399609;132010570;10280;341755420;Confirmatory;20240503;0;0;Active;Q99720;Ki;<;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in HEK293 cells membrane incubated for 120 mins by MicroBeta scintillation counter assay;N-(1-benzylpiperidin-4-yl)-N-(4-phenyl-1,3-thiazol-2-yl)propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(C1CCN(CC1)CC2=CC=CC=C2)C3=NC(=CS3)C4=CC=CC=C4
5189;407928970;0.1;1929171;494397346;118166784;10280;341755420;Confirmatory;20240503;0;0;Active;Q99720;Ki;<;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in HEK293 cells membrane incubated for 120 mins by MicroBeta scintillation counter assay;N-[3-[4-[[1-(2-fluorophenyl)triazol-4-yl]methyl]piperazin-1-yl]phenyl]propane-2-sulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)S(=O)(=O)NC1=CC(=CC=C1)N2CCN(CC2)CC3=CN(N=N3)C4=CC=CC=C4F
5190;407928988;0.1;1929171;494399956;132158394;10280;341755420;Confirmatory;20240503;0;0;Active;Q99720;Ki;<;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in HEK293 cells membrane incubated for 120 mins by MicroBeta scintillation counter assay;[9-(4-Benzylpiperazin-1-yl)-6-oxaspiro[4.5]decan-9-yl]-phenylmethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC2(C1)CC(CCO2)(C(=O)C3=CC=CC=C3)N4CCN(CC4)CC5=CC=CC=C5
5191;407928989;0.1;1929171;494403257;121350883;10280;341755420;Confirmatory;20240503;0;0;Active;Q99720;Ki;<;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in HEK293 cells membrane incubated for 120 mins by MicroBeta scintillation counter assay;6-Methoxy-2-methyl-1'-(2-phenylethyl)spiro[3,4-dihydroisoquinoline-1,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2=C(C13CCN(CC3)CCC4=CC=CC=C4)C=CC(=C2)OC
5192;407928990;0.1;1929171;475977914;126539121;10280;341755420;Confirmatory;20240503;0;0;Active;Q99720;Ki;<;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in HEK293 cells membrane incubated for 120 mins by MicroBeta scintillation counter assay;N-[[4-(4-benzylpiperazin-1-yl)oxan-4-yl]methyl]-N-phenylpropanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CCOCC1)N2CCN(CC2)CC3=CC=CC=C3)C4=CC=CC=C4
5193;407928991;0.1;1929171;494399978;132158302;10280;341755420;Confirmatory;20240503;0;0;Active;Q99720;Ki;<;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in HEK293 cells membrane incubated for 120 mins by MicroBeta scintillation counter assay;[9-(4-Benzylpiperazin-1-yl)-6-oxaspiro[4.5]decan-9-yl]-[6-(trifluoromethyl)pyridin-2-yl]methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC2(C1)CC(CCO2)(C(=O)C3=NC(=CC=C3)C(F)(F)F)N4CCN(CC4)CC5=CC=CC=C5
5194;407928992;0.1;1929171;494410092;121429654;10280;341755420;Confirmatory;20240503;0;0;Active;Q99720;Ki;<;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in HEK293 cells membrane incubated for 120 mins by MicroBeta scintillation counter assay;N-methyl-N-[2-[(2-methylpyrazol-3-yl)-thiophen-2-ylmethoxy]ethyl]-2-phenylethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C(=CC=N1)C(C2=CC=CS2)OCCN(C)CCC3=CC=CC=C3
5195;407928993;0.1;1929171;475995951;126509877;10280;341755420;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in HEK293 cells membrane incubated for 120 mins by MicroBeta scintillation counter assay;N-[[4-[4-(2-methylpropyl)piperazin-1-yl]oxan-4-yl]methyl]-N-[6-(trifluoromethyl)pyridin-2-yl]propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CCOCC1)N2CCN(CC2)CC(C)C)C3=CC=CC(=N3)C(F)(F)F
5196;407928994;0.1;1929171;494403338;122684111;10280;341755420;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in HEK293 cells membrane incubated for 120 mins by MicroBeta scintillation counter assay;2-methyl-1'-(2-phenylethyl)spiro[3H-isoquinoline-4,4'-piperidine]-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC2(CCN(CC2)CCC3=CC=CC=C3)C4=CC=CC=C4C1=O
5197;407928995;0.1;1929171;494405759;130228827;10280;341755420;Confirmatory;20240503;0;0;Active;Q99720;Ki;<;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in HEK293 cells membrane incubated for 120 mins by MicroBeta scintillation counter assay;3-[1-(2-Ethoxyethyl)-3-ethylazepan-3-yl]phenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC1(CCCCN(C1)CCOCC)C2=CC(=CC=C2)O
5198;407928996;0.1;1929171;494414098;126543691;10280;341755420;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in HEK293 cells membrane incubated for 120 mins by MicroBeta scintillation counter assay;N-[2-[3-[benzyl(methyl)amino]pyrrolidin-1-yl]ethyl]-N-phenylpropanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CCN1CCC(C1)N(C)CC2=CC=CC=C2)C3=CC=CC=C3
5199;407928997;0.1;1929171;494398321;121359879;10280;341755420;Confirmatory;20240503;0;0;Active;Q99720;Ki;<;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in HEK293 cells membrane incubated for 120 mins by MicroBeta scintillation counter assay;2-Methyl-1'-(2-phenylethyl)spiro[3,4-dihydroisoquinoline-1,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2=CC=CC=C2C13CCN(CC3)CCC4=CC=CC=C4
5200;407928998;0.1;1929171;494399712;91810400;10280;341755420;Confirmatory;20240503;0;0;Active;Q99720;Ki;<;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in HEK293 cells membrane incubated for 120 mins by MicroBeta scintillation counter assay;N-[3-[4-[(1-phenyltriazol-4-yl)methyl]piperazin-1-yl]phenyl]propane-2-sulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)S(=O)(=O)NC1=CC(=CC=C1)N2CCN(CC2)CC3=CN(N=N3)C4=CC=CC=C4
5201;407928999;0.1;1929171;494418850;139368806;10280;341755420;Confirmatory;20240503;0;0;Active;Q99720;Ki;<;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in HEK293 cells membrane incubated for 120 mins by MicroBeta scintillation counter assay;[9-(4-Benzylpiperazin-1-yl)-6-oxaspiro[4.5]decan-9-yl]-pyridin-2-ylmethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC2(C1)CC(CCO2)(C(=O)C3=CC=CC=N3)N4CCN(CC4)CC5=CC=CC=C5
5202;407929000;0.1;1929171;494399376;118173404;10280;341755420;Confirmatory;20240503;0;0;Active;Q99720;Ki;<;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in HEK293 cells membrane incubated for 120 mins by MicroBeta scintillation counter assay;3-[1-[(1-Phenyltriazol-4-yl)methyl]piperidin-4-yl]phenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1C2=CC(=CC=C2)O)CC3=CN(N=N3)C4=CC=CC=C4
5203;407929001;0.1;1929171;494394320;91810339;10280;341755420;Confirmatory;20240503;0;0;Active;Q99720;Ki;<;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in HEK293 cells membrane incubated for 120 mins by MicroBeta scintillation counter assay;[3-[1-[(1-Phenyltriazol-4-yl)methyl]piperidin-4-yl]phenyl] acetate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)OC1=CC=CC(=C1)C2CCN(CC2)CC3=CN(N=N3)C4=CC=CC=C4
5204;407929002;0.1;1929171;494411789;122684135;10280;341755420;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in HEK293 cells membrane incubated for 120 mins by MicroBeta scintillation counter assay;2-ethyl-1'-(2-phenylethyl)spiro[3H-isoquinoline-4,4'-piperidine]-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CCC3=CC=CC=C3)C4=CC=CC=C4C1=O
5205;407929003;0.1;1929171;494417195;121429757;10280;341755420;Confirmatory;20240503;0;0;Active;Q99720;Ki;<;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor expressed in HEK293 cells membrane incubated for 120 mins by MicroBeta scintillation counter assay;N-benzyl-N-methyl-2-[(2-methylpyrazol-3-yl)-thiophen-2-ylmethoxy]ethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C(=CC=N1)C(C2=CC=CS2)OCCN(C)CC3=CC=CC=C3
5206;407996420;0.1;1946583;103165750;5311200;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;3-((4-(4-Chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo[2,3-b]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2=CNC3=C2C=CC=N3)C4=CC=C(C=C4)Cl
5207;100448391;0.101;204471;103215594;14982965;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-Phenyl-6-(6-piperidin-1-yl-hexyloxy)-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
5208;407996419;0.101;1946583;103165750;5311200;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;3-((4-(4-Chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo[2,3-b]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2=CNC3=C2C=CC=N3)C4=CC=C(C=C4)Cl
5209;100496761;0.1017;204761;103401466;10405640;10280;78533490;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity at Sigma receptor type 1, displacement of [3H](+)-pentazocine from guinea pig brain membranes;(1S,9S,13S)-10-[[4-(dimethylamino)phenyl]methyl]-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC4=CC=C(C=C4)N(C)C)C)C=C(C=C3)O
5210;100444469;0.102;204470;103215426;14982979;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-[4-(Ethoxycarbonyl)-1-piperidinyl]hexyloxy]-2-phenyl-4H-1-benzopyran-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC(=O)C1CCN(CC1)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
5211;354626874;0.10233;1272388;336884983;127036953;10280;267397810;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) by competition binding assay;N-[2-(5-bromo-1H-indol-3-yl)ethyl]-N-prop-2-enylprop-2-en-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C=CCN(CCC1=CNC2=C1C=C(C=C2)Br)CC=C
5212;366366392;0.103;1558961;440162797;118567531;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;CID 118567531;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C[C@@H]1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3F)C4=C(C=CC=N4)C(F)(F)F
5213;100404000;0.104;204630;103294105;44321002;10280;128012230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma receptor type 1 was determined by the displacement of [3H]pentazocine radioligand;9-[3-[(3R,5R)-3,5-dimethyl-4-(3-phenylpropyl)piperazin-1-yl]propyl]carbazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(C[C@H](N1CCCC2=CC=CC=C2)C)CCCN3C4=CC=CC=C4C5=CC=CC=C53
5214;100468793;0.104;204469;103340562;44342933;10280;79325690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition against sigma receptor using displacement of 3 nM [3H]pentazocine in homogenate of guinea pig brain cerebellum;(1S,13R)-10-butyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCCN1CC[C@]2([C@H](C1CC3=C2C=C(C=C3)O)C)C
5215;372355916;0.104;1726849;461562344;162676618;10280;342231650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]pentazocine from human sigma 1 receptor expressed in HEK293 cell membrane incubated for 2 hrs by liquid scintillation counting method;6-[4-[(2R)-2-methylpyrrolidin-1-yl]butoxy]chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CCCN1CCCCOC2=CC3=C(C=C2)OC=CC3=O
5216;380581639;0.104;1861723;482062499;9245765;10280;357249250;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay;N-[3-[benzyl(methyl)amino]propyl]naphthalene-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC2=CC=CC=C2C=C1)CC3=CC=CC=C3
5217;380773039;0.104;1907474;482060034;168278492;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;Benzyl 2-[3-[4-(3-ethoxy-3-oxopropyl)piperazin-1-yl]phenyl]piperidine-1-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC(=O)CCN1CCN(CC1)C2=CC=CC(=C2)C3CCCCN3C(=O)OCC4=CC=CC=C4
5218;380773038;0.10471;1907474;482060034;168278492;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;Benzyl 2-[3-[4-(3-ethoxy-3-oxopropyl)piperazin-1-yl]phenyl]piperidine-1-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC(=O)CCN1CCN(CC1)C2=CC=CC(=C2)C3CCCCN3C(=O)OCC4=CC=CC=C4
5219;100456365;0.105;204434;103360325;14970534;10280;79028690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor in bovine cerebellum using 2.0 nM [3H]haloperidol in the presence of 25 nM unlabeled spiperone;1-(2-Chloro-phenyl)-3-[4-(4-chloro-phenyl)-3,6-dihydro-2H-pyridin-1-yl]-propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CN(CC=C1C2=CC=C(C=C2)Cl)CCC(=O)C3=CC=CC=C3Cl
5220;100458322;0.105;204437;103343688;15149404;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;11-[4-(2-Furanyl)butyl]-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCCC4=CC=CO4)NC5=CC=CC=C53
5221;345603246;0.105;1200082;312389833;76684208;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;N-[2-(4,4-difluoropiperidin-1-yl)ethyl]-1-[(4-fluorophenyl)methyl]triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CN(CCC1(F)F)CCNC2=CN(N=N2)CC3=CC=C(C=C3)F
5222;388996785;0.105;1798943;405263568;86581408;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';1-(3,4-dihydropyrazino[1,2-a]indol-2(1H)-yl)-2-(4-methylpiperazin-1-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C(=O)N1CCN2C(=CC3=CC=CC=C32)C1)N4CCN(CC4)C
5223;100445885;0.106;204470;103214565;14983055;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-(4-Hydroxy-piperidin-1-yl)-hexyloxy]-3-methoxy-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(OC2=C(C1=O)C=C(C=C2)OCCCCCCN3CCC(CC3)O)C4=CC=CC=C4
5224;354664018;0.106;1288457;336874706;10220;10280;270328900;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma1 receptor by PDSP assay;(+/-)-Isocorypalmine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C2=C(CC3C4=CC(=C(C=C4CCN3C2)OC)O)C=C1)OC
5225;100535593;0.1068;204794;103359564;44350885;10280;93971710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was done in guinea pig membranes by labeling the binding site with [3H](+)-pentazocine;(alphaR)-alpha-(3-Bromophenyl)spiro[indan-1,4'-piperidine]-1'-ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCN(CC2)C[C@@H](C3=CC(=CC=C3)Br)O)C4=CC=CC=C41
5226;100458404;0.107;204438;103344851;15149396;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;11-(5-Phenylpentyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCCCC4=CC=CC=C4)NC5=CC=CC=C53
5227;100458413;0.107;204437;103211710;15646139;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;11-[4-(4-Fluorophenyl)butyl]-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCCC4=CC=C(C=C4)F)NC5=CC=CC=C53
5228;100464774;0.107;203701;103186197;7333;10280;80279780;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity at sigma-1 site by inhibition of [3H](+)-pentazocine (PENT) binding in guinea pig brain;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
5229;100746119;0.107;204147;103186197;7333;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma opioid receptor type 1 in guinea pig brain homogenate with 0.5 nM [3H](+)-PENT;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
5230;342811256;0.107;1129882;242620285;90655534;10280;246178360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human RPMI8226 cell membranes after 120 mins by scintillation counting analysis;2-[(2S)-1-benzyl-4-(3-methylbutyl)piperazin-2-yl]ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;CC(C)CCN1CCN([C@H](C1)CCO)CC2=CC=CC=C2
5231;367478798;0.107;1655949;442055022;156015602;10280;324354210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human Sigma 1 receptor by radioligand displacement assay;"4-benzyl-1-[[(3R,4'S)-spiro[1,2-dihydroindene-3,2'-1,3-dithiolane]-4'-yl]methyl]piperidine;oxalic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)C[C@H]3CS[C@@]4(S3)CCC5=CC=CC=C45.C(=O)(C(=O)O)O
5232;100458324;0.108;204437;103343688;15149404;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;11-[4-(2-Furanyl)butyl]-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCCC4=CC=CO4)NC5=CC=CC=C53
5233;255009824;0.108;625223;103243329;3055;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Diphenidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCN(CC1)CCCC(C2=CC=CC=C2)(C3=CC=CC=C3)O
5234;255012603;0.108;625223;103555930;5572;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Trihexyphenidyl;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O
5235;334065185;0.108;735278;164138432;71655616;10280;235606500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(3aS,4R,9bS)-4-cyclohexyl-8-(3-methylbutoxy)-2,3,3a,4,5,9b-hexahydrofuro[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC(C)CCOC1=CC2=C(C=C1)N[C@@H]([C@H]3[C@@H]2OCC3)C4CCCCC4
5236;363665666;0.108;1415967;404712796;71226340;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(4,4-difluoropiperidin-1-yl)-1-(2-(piperidin-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=C(C=N2)C(=NC=N3)N4CCC(CC4)(F)F
5237;380264301;0.108;1811100;475995951;126509877;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[4-[4-(2-methylpropyl)piperazin-1-yl]oxan-4-yl]methyl]-N-[6-(trifluoromethyl)pyridin-2-yl]propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CCOCC1)N2CCN(CC2)CC(C)C)C3=CC=CC(=N3)C(F)(F)F
5238;100448392;0.109;204471;103215655;14982980;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]hexyloxy]-2-phenyl-4H-1-benzopyran-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCCCCOC3=CC4=C(C=C3)OC(=CC4=O)C5=CC=CC=C5
5239;100513232;0.109;229200;103383684;796534;10280;89413830;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor using radioligand ([3H](+)-pentazocine) binding assay;1-(3-Phenylpropyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1)CCCC2=CC=CC=C2
5240;100765460;0.109;204446;103404754;44370527;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membrane was determined by using [3H]DTG as the radioligand;5-[(3-Bromophenyl)methyl]-5-azahexacyclo[5.4.1.02,6.03,10.04,8.09,12]dodecan-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C2C3C4C1C5C2C6C3C4C5(N6CC7=CC(=CC=C7)Br)O
5241;100314844;0.11;204161;103311054;9957260;10280;104250950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma opioid receptor type 1 in guinea pig brain membranes using [3H](+)-pentazocine as radioligand;[(4aR,6R,7R,8aR)-6-Hydroxy-7-(4-phenyl-piperidin-1-yl)-octahydro-quinolin-1-yl]-phenyl-methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C[C@@H]2C[C@H]([C@@H](C[C@H]2N(C1)C(=O)C3=CC=CC=C3)N4CCC(CC4)C5=CC=CC=C5)O
5242;100317844;0.11;204297;103673261;45261876;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;TIn vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine.;"1-[4-methoxy-3-(2-phenylethoxy)phenyl]-N-propylheptan-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)NCCC.Cl
5243;100319790;0.11;204154;103172152;18986896;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;"1-[2-[4-Methoxy-3-(2-phenylethoxy)phenyl]ethyl]pyrrolidine;oxalic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C=C1)CCN2CCCC2)OCCC3=CC=CC=C3.C(=O)(C(=O)O)O
5244;100319796;0.11;204154;103673293;45261904;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;"1-[4-Methoxy-3-(2-phenylethoxy)phenyl]heptan-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N.Cl
5245;100458524;0.11;204438;103344235;15149397;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;11-(2-Phenoxyethyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCOC4=CC=CC=C4)NC5=CC=CC=C53
5246;100467669;0.11;203697;103330546;10001888;10280;82952200;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma 1 receptor was determined in guinea pig brain membrane using [3H](+)-pentazocine as radioligand;Tetrahydro-1-[2-[methyl[2-[methyl[2-[methyl[2-(3,4-dichlorophenyl)ethyl]amino]ethyl]amino]ethyl]amino]ethyl]-1H-pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCC1=CC(=C(C=C1)Cl)Cl)CCN(C)CCN(C)CCN2CCCC2
5247;100478672;0.11;204468;163336456;9669;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Tested for binding affinity against sigma receptors;Fortral;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@H]2CC3=C([C@@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
5248;100536810;0.11;204457;103678245;45265141;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-[2,5-Dichloro-3-(trifluoromethyl)phenyl]-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=CC(=CC(=C2Cl)C(F)(F)F)Cl)N.Cl
5249;100546614;0.11;203685;103278290;10829840;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-Benzylpiperidine-4-yl)-2-(3-hydroxyphenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC(=CC=C2)O)CC3=CC=CC=C3
5250;100604313;0.11;203857;103735209;46878000;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;N-Methyl-N-[(1R)-2beta-(1-pyrrolidinyl)cyclohexan-1beta-yl]-3,4-dichlorophenoxyacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)COC3=CC(=C(C=C3)Cl)Cl
5251;380264645;0.11;1811100;475987815;126539485;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[4-[4-(2-hydroxy-2-methylpropyl)piperazin-1-yl]oxan-4-yl]methyl]-N-[6-(trifluoromethyl)pyridin-2-yl]propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CCOCC1)N2CCN(CC2)CC(C)(C)O)C3=CC=CC(=N3)C(F)(F)F
5252;388740031;0.11;1797293;386051297;118282885;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 53;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)F
5253;388878696;0.11;1797475;386051297;118282885;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 53;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)F
5254;389383351;0.11;1804286;386051297;118282885;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 53;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)F
5255;100534038;0.1104;204794;103359295;10618918;10280;93971710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was done in guinea pig membranes by labeling the binding site with [3H](+)-pentazocine;1-(4-Fluorophenyl)-4-[1-methylspiro[indoline-3,4'-piperidin]-1'-yl]-1-butanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC2(CCN(CC2)CCCC(=O)C3=CC=C(C=C3)F)C4=CC=CC=C41
5256;100444344;0.111;204470;103215145;14983032;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-(4-Hydroxy-piperidin-1-yl)-hexyloxy]-2-(3-methoxy-phenyl)-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC(=C1)C2=CC(=O)C3=C(O2)C=CC(=C3)OCCCCCCN4CCC(CC4)O
5257;345603245;0.111;1200082;312389844;76684391;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-(1-adamantyl)-N-ethyl-N-(2-morpholin-4-ylethyl)triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCN(CCN1CCOCC1)C2=CN(N=N2)C34CC5CC(C3)CC(C5)C4
5258;100439285;0.112;203854;103248082;108046;10280;13615780;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory concentration against radioligand [3H]3-PPP binding to haloperidol-sensitive sigma binding site in whole guinea pig brain;alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCCC(C2=CC=C(C=C2)F)O)C3=NC=C(C=N3)F
5259;100536697;0.112;204457;103673440;45262007;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(2-Chloro-3,5-diethylphenyl)-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=CC(=CC(=C2Cl)CC)CC)N.Cl
5260;100614744;0.112;203986;103671879;14771716;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;"2-(1-Adamantyl)-1-[2-(2-phenylethyl)phenyl]guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C2CC3CC1CC(C2)(C3)N=C(N)NC4=CC=CC=C4CCC5=CC=CC=C5.Cl
5261;100745602;0.112;204454;103248082;108046;10280;;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity towards sigma receptor by the displacement of [3H]PPP from guinea pig brain;alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC(C2=CC=C(C=C2)F)O)C3=NC=C(C=N3)F
5262;363665121;0.112;1415967;404711835;74767048;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(2-Methoxypyridin-3-yl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=CC=N1)C2=C3C=NN(C3=NC=N2)CCN4CCCCC4
5263;363665324;0.112;1415967;404715496;71226102;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(Benzimidazol-1-yl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=C(C=N2)C(=NC=N3)N4C=NC5=CC=CC=C54
5264;363665665;0.112;1415967;404711981;90146004;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(4-Chloro-2-fluorophenyl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=NC=NC(=C3C=N2)C4=C(C=C(C=C4)Cl)F
5265;366366389;0.112;1558961;440120958;118567672;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;2-Methyl-4-phenyl-9-(2-pyridin-4-ylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=NC=C3)C4=CC=CC=C4
5266;100535937;0.113;204457;103673566;45262102;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(3,5-Diethyl-2-fluorophenyl)-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=CC(=CC(=C2F)CC)CC)N.Cl
5267;100536385;0.113;204457;103678103;45265053;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-[2,5-Dibromo-3-(trifluoromethoxy)phenyl]-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=C(C(=CC(=C2)Br)OC(F)(F)F)Br)N.Cl
5268;100536807;0.113;204457;103673512;45262064;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(2,5-Dibromo-3-methylsulfanylphenyl)-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=C(C(=CC(=C2)Br)SC)Br)N.Cl
5269;100614378;0.113;203986;103282472;136056476;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N-(2-Nitro-phenyl)-N''-o-tolyl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC2=CC=CC=C2[N+](=O)[O-])N
5270;366431544;0.113;1592018;440122051;155518665;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;(NZ)-N-[4-[4-(5-chloropyridin-2-yl)-1,4-diazepan-1-yl]-1-(4-fluorophenyl)butylidene]hydroxylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=NC=C(C=C2)Cl)CCC/C(=N/O)/C3=CC=C(C=C3)F
5271;372356140;0.113;1726849;461545884;162665047;10280;342231650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]pentazocine from human sigma 1 receptor expressed in HEK293 cell membrane incubated for 2 hrs by liquid scintillation counting method;6-[2-(Azepan-1-yl)ethoxy]chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCCN(CC1)CCOC2=CC3=C(C=C2)OC=CC3=O
5272;100459181;0.114;204437;103344314;15149414;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;5-Fluoro-15-(3-pyridin-3-ylpropyl)-9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3(8),4,6-tetraene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCC4=CN=CC=C4)NC5=C3C=C(C=C5)F
5273;100459185;0.114;204437;103211711;15646135;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;11-(4-Phenylbutyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCCC4=CC=CC=C4)NC5=CC=CC=C53
5274;255010204;0.114;625223;103178920;4926;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Promazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31
5275;255034397;0.114;625223;136928380;6761;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pipamazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCC1C(=O)N)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl
5276;389483967;0.114;1805386;444858075;132060722;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example KTL-01-121;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCN1C2=CC3=C(CN(C3)CC4=CC(=CC(=C4)Cl)Cl)C=C2
5277;100292841;0.115;239105;103441929;10616657;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;2-[(4-Benzylpiperidino)methyl]chromone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3=CC(=O)C4=CC=CC=C4O3
5278;100320354;0.115;204310;103382686;44361281;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 2 using [3H]- DTG in rat liver membranes;(1R,9R,13R)-10-benzyl-13-ethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;21070;Liver;CC[C@@H]1[C@H]2CCN([C@@H]1CC3=CC=CC=C23)CC4=CC=CC=C4
5279;100535935;0.115;204457;103673594;45262125;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-[2-Chloro-3-ethyl-5-(trifluoromethyl)phenyl]-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=CC(=CC(=C2Cl)CC)C(F)(F)F)N.Cl
5280;100721999;0.115;204634;103235980;44296111;10280;150260770;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma receptor type 1;{(4bR,8aS)-4b-[2-(tert-Butoxycarbonylmethyl-methyl-amino)-ethyl]-4b,5,6,7,8,8a-hexahydro-phenanthren-3-yloxy}-acetic acid tert-butyl ester;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC(=O)CN(C)CC[C@]12CCCC[C@H]1C=CC3=C2C=C(C=C3)OCC(=O)OC(C)(C)C
5281;100448386;0.116;204471;103215593;18959733;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;5-[6-(4-Hydroxy-piperidin-1-yl)-hexyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCOC2=CC=CC3=C2C(=O)C=C(O3)C4=CC=CC=C4
5282;100458521;0.116;204438;103344299;15149381;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;9-Methyl-15-(4-phenylbutyl)-9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3,5,7-tetraene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C3CCC(C2)N3CCCCC4=CC=CC=C4)C5=CC=CC=C51
5283;363666191;0.116;1415921;404706790;71223185;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;N-(1-(2-(pyrrolidin-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)cyclopentanecarboxamide maleate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)C(=O)NC2=C3C=NN(C3=NC=N2)CCN4CCCC4
5284;389483947;0.116;1805386;444858110;132060772;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A38;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C=CCN1CCN(CC1)C2=CC3=C(CN(CCC3)C(=O)OCC4=CC=CC=C4)C=C2
5285;100451649;0.117;204435;103672090;45260963;10280;81026510;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using the novel [3H]-(+/-)-4 as radioligand;"4-phenyl-N-prop-2-enyl-1,2,3,4-tetrahydronaphthalen-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C=CCNC1CC(C2=CC=CC=C2C1)C3=CC=CC=C3.Cl
5286;100533894;0.117;204794;103358520;44350538;10280;93971710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was done in guinea pig membranes by labeling the binding site with [3H](+)-pentazocine;1-(3-Bromo-phenyl)-2-(3-phenyl-8-aza-bicyclo[3.2.1]oct-8-yl)-ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2CC(CC1N2CC(C3=CC(=CC=C3)Br)O)C4=CC=CC=C4
5287;100619156;0.117;203990;136923778;10149140;10280;18482950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma opioid receptor in guinea pig cerebral homogenate using [3H]DTG as radioligand;N-Benzylamphetamine (bam);SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CC1=CC=CC=C1)NCC2=CC=CC=C2
5288;389483897;0.117;1805386;444858095;132060750;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A23;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CCN(CC1)C2=CC3=C(CCN(C3)C(=O)OCC4=CC=CC=C4)C=C2
5289;389483953;0.117;1805386;444858108;132060817;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A36;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=C)CN1CCN(CC1)C2=CC3=C(CN(CCC3)C(=O)OCC4=CC=CC=C4)C=C2
5290;255034751;0.1172;625223;103712397;657255;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);(1S,2R)-2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCCCCCN[C@H](C)[C@H](C1=CC=C(C=C1)SC(C)C)O
5291;100444341;0.118;204470;103215127;18959715;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[7-(4-Hydroxy-piperidin-1-yl)-heptyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
5292;100600839;0.118;203997;103251918;11957597;10280;25470740;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was evaluated for binding affinity towards sigma opioid receptor using [3H]DTG in guinea pig ileum;(-)-cis-(1S,2R)-U-50488 tartrate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;21160;Ileum;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)CC3=CC(=C(C=C3)Cl)Cl
5293;100614379;0.118;203986;103283115;14771728;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N-(3-Hydroxy-phenyl)-N''-(2-methyl-4-nitro-phenyl)-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=C(C=CC(=C1)[N+](=O)[O-])N=C(N)NC2=CC(=CC=C2)O
5294;372121203;0.118;1681775;461545419;118561036;10280;330649470;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;(2R)-9-[2-(2,5-difluorophenyl)ethyl]-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CCC3=C(C=CC(=C3)F)F)O[C@@H](C1=O)C
5295;380299663;0.118;1819827;374298394;5416975;10280;354503790;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Citalopram from sigma-1 receptor (unknown origin) expressed in HEK cell membrane incubated for 2 hrs by liquid scintillation counter analysis;(+)-cis-1,3,4,9,10,10a-Hexahydro-11-methyl-2H-10,4a-iminoethanophenanthren-6-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@]23CCCC[C@@H]2[C@H]1CC4=C3C=C(C=C4)O
5296;388996815;0.118;1798943;405263568;86581408;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';1-(3,4-dihydropyrazino[1,2-a]indol-2(1H)-yl)-2-(4-methylpiperazin-1-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C(=O)N1CCN2C(=CC3=CC=CC=C32)C1)N4CCN(CC4)C
5297;100448323;0.119;204471;103215524;14983049;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(6-Piperidin-1-yl-hexyloxy)-2-pyridin-3-yl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CN=CC=C4
5298;100448356;0.119;204471;103215467;14983028;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-(4-Hydroxy-piperidin-1-yl)-hexyloxy]-2-thiophen-2-yl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CS4
5299;100449441;0.119;204443;103275223;44314387;10280;83608750;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine at sigma receptor in guinea pig brain membrane was determined;1-[2-(3,4-Dichlorophenyl)ethyl]piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1)CCC2=CC(=C(C=C2)Cl)Cl
5300;354664015;0.119;1288457;336874670;127031397;10280;270328900;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma1 receptor by PDSP assay;3,9-dimethoxy-10-pentoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-2-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCCOC1=C(C2=C(CC3C4=CC(=C(C=C4CCN3C2)OC)O)C=C1)OC
5301;363666187;0.119;1415921;404699155;71223454;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;1-(1-(2-(Azepan-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-3-cyclohexylurea hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCCN(CC1)CCN2C3=NC=NC(=C3C=N2)NC(=O)NC4CCCCC4
5302;380512532;0.119;1846430;482048991;86296201;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-4-[(4-fluorophenyl)methyl]-10-(3-fluoropyridin-2-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CC=C(C=C3)F)OCC4=C(N=NN24)C5=C(C=CC=N5)F
5303;100439828;0.12;229191;103248082;108046;10280;14696970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of specific binding of [3H]DTG to sigma receptor in Guinea pig brain membranes;alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCCC(C2=CC=C(C=C2)F)O)C3=NC=C(C=N3)F
5304;100487680;0.12;204638;103318443;44332496;10280;76368610;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was measured on Sigma receptor type 1 using [3H]- pentazocine as radioligand;3,5-Dibromo-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=CC(=C(C(=C3C1(CCN2CC=C(C)C)C)Br)O)Br
5305;100613858;0.12;203986;103671917;45260847;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;"1-(1-adamantyl)-2-[(2S)-2-phenylcyclopropyl]guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1[C@H](C1N=C(N)NC23CC4CC(C2)CC(C4)C3)C5=CC=CC=C5.Cl
5306;100737364;0.12;203993;103228555;44292312;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor from guinea pig brain using the radioligand [3H]SKF-10047;(5R)-5-[[4-hydroxy-4-(4-methoxyphenyl)piperidin-1-yl]methyl]-3-(4-methoxyphenyl)-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)C2(CCN(CC2)C[C@@H]3CN(C(=O)O3)C4=CC=C(C=C4)OC)O
5307;255020068;0.12;625223;103189029;4927;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Promethazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
5308;388740027;0.12;1797293;386051273;91826734;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 28;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)F)O
5309;388878700;0.12;1797475;386051273;91826734;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 28;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)F)O
5310;389383278;0.12;1804286;386051273;91826734;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 28;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)F)O
5311;100354359;0.121;204790;103237112;12084044;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-[1-(2-adamantyl)piperidin-4-yl]-4-bromo-1-methoxynaphthalene-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)NC3CCN(CC3)C4C5CC6CC(C5)CC4C6
5312;100444332;0.121;204470;103215128;15230909;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-(4-Hydroxy-piperidin-1-yl)-hexyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
5313;100546181;0.121;203685;103278732;11793400;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-Benzylpiperidine-4-yl)-2-(3,5-dimethoxyphenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC(=CC(=C1)CC(=O)NC2CCN(CC2)CC3=CC=CC=C3)OC
5314;255014475;0.121;625223;103358404;4886;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pramoxine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCOC1=CC=C(C=C1)OCCCN2CCOCC2
5315;389712852;0.121;1919146;476002740;166637124;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assay from US Patent US11535596: 'Analogs of dextromethorphan with balanced receptor activities';(1S,9S)-3-bromo-16-methyl-16-azatetracyclo[7.5.2.01,10.02,7]hexadeca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C[C@@]23CCCCC2[C@@H]1CC4=C3C(=C(C=C4)O)Br
5316;100534024;0.1218;204794;103359368;11800052;10280;93971710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was done in guinea pig membranes by labeling the binding site with [3H](+)-pentazocine;(3R,4R)-1-[(3-iodophenyl)methyl]-3-(1-methylspiro[2H-indole-3,4'-piperidine]-1'-yl)piperidin-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC2(CCN(CC2)[C@@H]3CN(CC[C@H]3O)CC4=CC(=CC=C4)I)C5=CC=CC=C51
5317;354664021;0.122;1288457;336875528;127031949;10280;270328900;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma1 receptor by PDSP assay;3-[[2-(4-Hydroxy-3-methoxyphenyl)ethyl-methylamino]methyl]-2-methoxyphenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=C(C=C1)O)OC)CC2=C(C(=CC=C2)O)OC
5318;366366192;0.122;1558961;440154070;118567550;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;4-(4-Hydroxyphenyl)-2-methyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=CC=C(C=C4)O
5319;372121200;0.122;1681775;461530552;70552386;10280;330649470;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;4-Methyl-9-(2-phenylethyl)-2-propan-2-yl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)C1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C
5320;380512647;0.122;1846430;482054756;86297989;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-10-(2-fluorophenyl)-4-(pyridin-3-ylmethyl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CN=CC=C3)OCC4=C(N=NN24)C5=CC=CC=C5F
5321;100444171;0.123;204470;103214989;44285419;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[3-(4-Hydroxy-piperidin-1-yl)-propoxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
5322;388996792;0.123;1798943;405263589;86581996;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';1-(8-fluoro-3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)-2-(4-methyl-piperazin-1-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C(=O)N1CCN2C(=CC3=C2C=CC(=C3)F)C1)N4CCN(CC4)C
5323;389483948;0.123;1805386;444858094;132060799;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example KTL-01-257;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)C2=CC3=C(CCN(C3)S(=O)(=O)C4=CC(=CC(=C4)Cl)Cl)C=C2
5324;409047166;0.12303;1794447;461523307;44548528;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;4-(4-methylpiperazin-1-yl)-N-(2-phenylethyl)pyrimidin-2-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)C2=NC(=NC=C2)NCCC3=CC=CC=C3
5325;100403996;0.124;204630;103294805;44321397;10280;128012230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma receptor type 1 was determined by the displacement of [3H]pentazocine radioligand;[3-(3,5-Dimethyl-piperazin-1-yl)-propyl]-bis-(4-fluoro-phenyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(C[C@H](N1)C)CCCN(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F
5326;100468911;0.124;204625;103186327;44273461;10280;79325690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor was determined;(1S,13R)-1,13-dimethyl-10-prop-2-enyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1C2CC3=C([C@]1(CCN2CC=C)C)C=C(C=C3)O
5327;334065478;0.124;735278;164132736;71655746;10280;235606500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aS,5R,10bS)-5-cyclopentyl-9-(3-methylbutoxy)-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC(C)CCOC1=CC2=C(C=C1)N[C@@H]([C@H]3[C@@H]2OCCC3)C4CCCC4
5328;354664019;0.124;1288457;336874707;127031422;10280;270328900;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma1 receptor by PDSP assay;3,9-Dimethoxy-10-ethoxy-5,6,13,13a-tetrahydro-8H-dibenzo[a,g]quinolizine-2-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC1=C(C2=C(CC3C4=CC(=C(C=C4CCN3C2)OC)O)C=C1)OC
5329;100314848;0.1247;204161;103311040;10814571;10280;104250950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma opioid receptor type 1 in guinea pig brain membranes using [3H](+)-pentazocine as radioligand;trans-trans-1-(3-Iodoallyl)-7-(4-phenylpiperidin-1-yl)-decahydroquinolin-6-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C[C@@H]2C[C@H]([C@@H](C[C@H]2N(C1)C/C=C/I)N3CCC(CC3)C4=CC=CC=C4)O
5330;100444174;0.125;204470;103214919;14983043;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-Cyclohexyl-6-[6-(4-hydroxy-piperidin-1-yl)-hexyloxy]-3-methyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(OC2=C(C1=O)C=C(C=C2)OCCCCCCN3CCC(CC3)O)C4CCCCC4
5331;100448348;0.125;204471;103215619;18959727;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;5-[3-(4-Hydroxy-piperidin-1-yl)-propoxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCOC2=CC=CC3=C2C(=O)C=C(O3)C4=CC=CC=C4
5332;100461280;0.125;204456;103182699;14952694;10280;80980660;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma receptor of guinea pig brain homogenates;2-[1-[Pyrrolidin-1-yl]cyclopentyl]benzo[b]thiophene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(C1)(C2=CC3=CC=CC=C3S2)N4CCCC4
5333;100471362;0.125;204459;103283109;14771669;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;1,3-Bis(3-iodophenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC(=CC(=C1)I)NC(=NC2=CC(=CC=C2)I)N
5334;100497242;0.125;203984;103432089;10090269;10280;76997100;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;1-[3-[4-(2-Pyridyl)piperazino]propyl]-7-methoxy-1,2,3,4-tetrahydronaphthalene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(CCCC2CCCN3CCN(CC3)C4=CC=CC=N4)C=C1
5335;100536377;0.125;204457;103673438;45262005;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(2-Bromophenyl)-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=CC=CC=C2Br)N.Cl
5336;100604681;0.125;203857;103735212;14771473;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;N-Methyl-N-[(1S)-2alpha-(1-pyrrolidinyl)cyclohexan-1alpha-yl]2-phenylethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC=CC=C1)[C@H]2CCCC[C@H]2N3CCCC3
5337;100617260;0.125;204444;103184471;15723888;10280;16627250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membranes using [3H]DTG as radioligand;1-Benzoyl-4-(4-phenylbutyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCCCC2=CC=CC=C2)C(=O)C3=CC=CC=C3
5338;100778230;0.125;204017;103272194;44312921;10280;98735270;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for [3H]- pentazocine at sigma opioid receptor;(2R,3R)-2-[(4R)-4-(4-aminobutyl)-3-benzyl-2,5-dioxoimidazolidin-1-yl]-N-benzyl-3-methylpentanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC[C@@H](C)[C@H](C(=O)NCC1=CC=CC=C1)N2C(=O)[C@H](N(C2=O)CC3=CC=CC=C3)CCCCN
5339;354626046;0.125;1272497;103323195;11771731;10280;267502540;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin) by radioligand displacement assay;4-[(1S,2S)-2-(4-Benzyl-piperidin-1-yl)-1-hydroxy-propyl]-phenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]([C@H](C1=CC=C(C=C1)O)O)N2CCC(CC2)CC3=CC=CC=C3
5340;363665655;0.125;1415967;404709722;74767366;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;1-(2-Piperidin-1-ylethyl)-4-[2-(trifluoromethyl)phenyl]pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=NC=NC(=C3C=N2)C4=CC=CC=C4C(F)(F)F
5341;388996823;0.125;1798943;405263591;86581999;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';2-(4-ethylpiperazin-1-yl)-1-(8-fluoro-3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CCN(CC1)C(C)C(=O)N2CCN3C(=CC4=C3C=CC(=C4)F)C2
5342;409047165;0.1251;1794447;461523307;44548528;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;4-(4-methylpiperazin-1-yl)-N-(2-phenylethyl)pyrimidin-2-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)C2=NC(=NC=C2)NCCC3=CC=CC=C3
5343;100367070;0.12541;226337;103376010;11111624;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-(1-Benzyl-piperidin-4-yl)-2-(5-methoxy-1H-indol-3-yl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC2=C(C=C1)NC=C2CC(=O)NC3CCN(CC3)CC4=CC=CC=C4
5344;342817235;0.12589;1118248;242613620;90666081;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human recombinant sigma-1 receptor expressed in CHO cells after 180 mins by beta counting analysis;(1S,2S)-N-[2-(diethylamino)ethyl]-2-phenylcyclopropane-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;197.0;;;;CCN(CC)CCNC(=O)[C@H]1C[C@@H]1C2=CC=CC=C2
5345;363701195;0.12589;1409616;103566848;3652;10280;323538590;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocin from the Sigma1 receptor;Hydroxychloroquine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
5346;365267158;0.12589;1512456;440198304;155557042;10280;316202300;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-8-methoxy-3a-methyl-2,3,4,9b-tetrahydro-1H-chromeno[3,4-b]pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@]12COC3=C([C@@H]1CCN2)C=C(C=C3)OC
5347;365267163;0.12589;1512456;440148836;155536080;10280;316202300;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(1S,2R)-1-ethyl-7-methoxy-2-methyl-3,4-dihydro-1H-naphthalen-2-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC[C@H]1C2=C(CC[C@@]1(C)N)C=CC(=C2)OC
5348;366437094;0.12589;1594273;440198087;146641558;10280;309043830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;[5-[2-(4-Fluorophenyl)ethylamino]-1-phenyl-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)C(=O)C2=NN(C3=C2CC(CC3)NCCC4=CC=C(C=C4)F)C5=CC=CC=C5
5349;100314846;0.127;204161;103311028;10567286;10280;104250950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma opioid receptor type 1 in guinea pig brain membranes using [3H](+)-pentazocine as radioligand;(4aR,6R,7R,8aR)-7-(4-Phenyl-piperidin-1-yl)-decahydro-quinolin-6-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C[C@@H]2C[C@H]([C@@H](C[C@H]2NC1)N3CCC(CC3)C4=CC=CC=C4)O
5350;100444343;0.127;204470;103215695;44285740;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-(4-Hydroxy-piperidin-1-yl)-hex-4-enyloxy]-3-methyl-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(OC2=C(C1=O)C=C(C=C2)OCCC/C=C/CN3CCC(CC3)O)C4=CC=CC=C4
5351;367490643;0.127;1661755;442054780;56918678;10280;328320230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from recombinant sigma 1 receptor (unknown origin) expressed in baculovirus infected Sf9 cell membranes after 1.5 hrs by scintillation counting analysis;2-[3-Methyl-4-[[methyl-[(2-phenyl-1,3-thiazol-4-yl)methyl]amino]methyl]pyrazol-1-yl]ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;521.0;;;;CC1=NN(C=C1CN(C)CC2=CSC(=N2)C3=CC=CC=C3)CCO
5352;100468429;0.128;203697;103330609;10001045;10280;82952200;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma 1 receptor was determined in guinea pig brain membrane using [3H](+)-pentazocine as radioligand;Tetrahydro-1-[4-[methyl[3-[methyl[2-(3,4-dichlorophenyl)ethyl]amino]propyl]amino]butyl]-1H-pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCCCN1CCCC1)CCCN(C)CCC2=CC(=C(C=C2)Cl)Cl
5353;100604309;0.128;203857;103735202;6712752;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;N-methyl-N-[(1R,2S)-2-pyrrolidin-1-ylcyclohexyl]-2-(2,4,5-trichlorophenoxy)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)COC3=CC(=C(C=C3Cl)Cl)Cl
5354;326034764;0.128;701162;163317459;24739752;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-(1-(3,4-dichlorophenyl)-1H-pyrazol-3-yloxy)-3-morpholinopropan-2-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1COCCN1CC(COC2=NN(C=C2)C3=CC(=C(C=C3)Cl)Cl)O
5355;255029002;0.1284;625223;103250420;119584;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mosapride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC1=CC(=C(C=C1C(=O)NCC2CN(CCO2)CC3=CC=C(C=C3)F)Cl)N
5356;100448343;0.129;204471;103215708;14983030;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-(3-Fluorophenyl)-6-[6-(4-hydroxypiperidinyl)hexoxy]-4H-1-benzopyran-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC(=CC=C4)F
5357;100458520;0.129;204438;103212371;15149406;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;11-[4-(4-Fluorophenyl)-4-oxobutyl]-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCC(=O)C4=CC=C(C=C4)F)NC5=CC=CC=C53
5358;367478252;0.129;1655949;442062690;156020999;10280;324354210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human Sigma 1 receptor by radioligand displacement assay;"4-benzyl-1-[[(2R,4R)-spiro[1,3-dithiolane-2,4'-2,3-dihydro-1H-naphthalene]-4-yl]methyl]piperidine;oxalic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2=CC=CC=C2[C@]3(C1)SC[C@H](S3)CN4CCC(CC4)CC5=CC=CC=C5.C(=O)(C(=O)O)O
5359;372338887;0.129;1718132;103272786;2562;10280;331115250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin);Carbetapentane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CC)CCOCCOC(=O)C1(CCCC1)C2=CC=CC=C2
5360;388996786;0.129;1798943;405263575;86581559;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';1-(3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)-2-(piperidin-1-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C(=O)N1CCN2C(=CC3=CC=CC=C32)C1)N4CCCCC4
5361;100319788;0.13;204154;103679645;45266087;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;"1-[4-Methoxy-3-(2-phenylethoxy)phenyl]-5-methylhexan-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC(C)CCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N.Cl
5362;100370452;0.13;229201;103165750;5311200;10280;111706390;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor was determined;3-((4-(4-Chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo[2,3-b]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2=CNC3=C2C=CC=N3)C4=CC=C(C=C4)Cl
5363;100448344;0.13;204471;103214989;44285419;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[3-(4-Hydroxy-piperidin-1-yl)-propoxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
5364;100478471;0.13;203696;103186135;44273383;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;Benzyl-((R)-1-methyl-2-phenyl-ethyl)-(3-phenyl-propyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CC1=CC=CC=C1)N(CCCC2=CC=CC=C2)CC3=CC=CC=C3
5365;100536701;0.13;204457;103673511;45262063;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(2,5-Dichloro-3-methylsulfanylphenyl)-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=C(C(=CC(=C2)Cl)SC)Cl)N.Cl
5366;354664026;0.13;1288457;336874678;127031404;10280;270328900;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma1 receptor by PDSP assay;2-[(3-hydroxy-2-methoxyphenyl)methyl]-6-methoxy-1-methyl-3,4-dihydro-1H-isoquinolin-7-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2=CC(=C(C=C2CCN1CC3=C(C(=CC=C3)O)OC)OC)O
5367;388740387;0.13;1797293;386051296;118282902;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 52;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=CC4=C(C=C3C2)OCO4
5368;388740712;0.13;1797293;386051311;118283049;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 66;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)S(=O)(=O)C)O
5369;388879044;0.13;1797475;386051296;118282902;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 52;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=CC4=C(C=C3C2)OCO4
5370;388886600;0.13;1797475;386051311;118283049;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 66;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)S(=O)(=O)C)O
5371;389383753;0.13;1804286;386051296;118282902;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 52;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=CC4=C(C=C3C2)OCO4
5372;389383947;0.13;1804286;386051311;118283049;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 66;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)S(=O)(=O)C)O
5373;100485975;0.1306;204636;103318463;15767684;10280;76368600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured on Sigma receptor type 1 from guinea pig brain membranes using [3H]pentazocine as radioligand.;10-Benzyl-4-iodo-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1C2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)I
5374;100320361;0.131;204310;103382687;10333740;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 2 using [3H]- DTG in rat liver membranes;(1R,9R,13R)-10-benzyl-13-methyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;21070;Liver;C[C@@H]1[C@H]2CCN([C@@H]1CC3=CC=CC=C23)CC4=CC=CC=C4
5375;100742326;0.131;204129;103677438;45264551;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"8-Benzyl-3-(4-fluorophenyl)-1-oxa-8-azaspiro[5.5]undec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CC(=O)C(=CO2)C3=CC=C(C=C3)F)CN(C1)CC4=CC=CC=C4.Cl
5376;407996431;0.131;1946583;482083349;163322331;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;D4R antagonis-2;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC=C1Cl)NC(=O)CN2CCC(CC2)OCC3=CC(=C(C=C3)F)F
5377;407996432;0.13183;1946583;482083349;163322331;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;D4R antagonis-2;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC=C1Cl)NC(=O)CN2CCC(CC2)OCC3=CC(=C(C=C3)F)F
5378;100444477;0.132;204470;103215142;14983035;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-(4-Fluoro-phenyl)-6-[6-(4-hydroxy-piperidin-1-yl)-hexyloxy]-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=C(C=C4)F
5379;100458509;0.132;204438;103343851;15149400;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;11-(3-Phenoxypropyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCOC4=CC=CC=C4)NC5=CC=CC=C53
5380;380264644;0.132;1811100;475994920;126508789;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[4-[4-(2-ethoxyethyl)piperazin-1-yl]oxan-4-yl]methyl]-N-[6-(trifluoromethyl)pyridin-2-yl]propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CCOCC1)N2CCN(CC2)CCOCC)C3=CC=CC(=N3)C(F)(F)F
5381;100320346;0.133;204310;103382360;44361164;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 2 using [3H]- DTG in rat liver membranes;(1R,9R,13R)-10-benzyl-13-propan-2-yl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;21070;Liver;CC(C)[C@@H]1[C@H]2CCN([C@@H]1CC3=CC=CC=C23)CC4=CC=CC=C4
5382;100458400;0.133;204438;103344923;15149407;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;15-[(E)-3-phenylprop-2-enyl]-9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3,5,7-tetraene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2C/C=C/C4=CC=CC=C4)NC5=CC=CC=C53
5383;100614092;0.133;203986;103283114;344343;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;1,2-Dinaphthalen-1-ylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC=C2C(=C1)C=CC=C2NC(=NC3=CC=CC4=CC=CC=C43)N
5384;355704036;0.133;1337390;374357080;124197459;10280;276144110;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);[9-(10-aminodecyl)-9-azabicyclo[3.3.1]nonan-3-yl] N-(2-methoxy-5-methylphenyl)carbamate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=C(C=C1)OC)NC(=O)OC2CC3CCCC(C2)N3CCCCCCCCCCN
5385;372355923;0.134;1726849;461545564;162664824;10280;342231650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]pentazocine from human sigma 1 receptor expressed in HEK293 cell membrane incubated for 2 hrs by liquid scintillation counting method;6-[5-[(2R)-2-methylpyrrolidin-1-yl]pentoxy]chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CCCN1CCCCCOC2=CC3=C(C=C2)OC=CC3=O
5386;407906173;0.134;1922168;374357080;124197459;10280;362020630;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [H3]DTG from sigma 1 receptor (unknown origin) by competition binding assay;[9-(10-aminodecyl)-9-azabicyclo[3.3.1]nonan-3-yl] N-(2-methoxy-5-methylphenyl)carbamate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=C(C=C1)OC)NC(=O)OC2CC3CCCC(C2)N3CCCCCCCCCCN
5387;409047921;0.1349;1794447;312361687;59447577;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;2-[8-(1,3-Benzothiazol-2-Ylcarbamoyl)-3,4-Dihydroisoquinolin-2(1h)-Yl]-5-(3-{4-[3-(Dimethylamino)prop-1-Yn-1-Yl]-2-Fluorophenoxy}propyl)-1,3-Thiazole-4-Carboxylic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CC#CC1=CC(=C(C=C1)OCCCC2=C(N=C(S2)N3CCC4=C(C3)C(=CC=C4)C(=O)NC5=NC6=CC=CC=C6S5)C(=O)O)F
5388;100478310;0.135;203696;103186017;44273339;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;((S)-2-Cyclohexa-2,4-dienyl-1-methyl-ethyl)-dimethyl-(3-phenyl-propyl)-ammonium;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](CC1CC=CC=C1)[N+](C)(C)CCCC2=CC=CC=C2
5389;345604096;0.135;1200787;312387700;118732991;10280;257032960;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human Jurkat cell membrane by liquid scintillation spectrometry;1-[4-(2-Phenyl-2-adamantyl)piperazin-1-yl]-2-piperidin-1-ylethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCN(CC1)CC(=O)N2CCN(CC2)C3(C4CC5CC(C4)CC3C5)C6=CC=CC=C6
5390;372120980;0.135;1681775;461538019;162659525;10280;330649470;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;(2S)-9-[2-(2,5-difluorophenyl)ethyl]-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CCC3=C(C=CC(=C3)F)F)O[C@H](C1=O)C
5391;100458325;0.136;204437;103344467;15149405;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;2-[4-(9,15-Diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3,5,7-tetraen-15-yl)butyl]-1,3-thiazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCCC4=NC=CS4)NC5=CC=CC=C53
5392;380821084;0.1364;1914434;312361687;59447577;10280;;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000262b SIGMAR1;2-[8-(1,3-Benzothiazol-2-Ylcarbamoyl)-3,4-Dihydroisoquinolin-2(1h)-Yl]-5-(3-{4-[3-(Dimethylamino)prop-1-Yn-1-Yl]-2-Fluorophenoxy}propyl)-1,3-Thiazole-4-Carboxylic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CC#CC1=CC(=C(C=C1)OCCCC2=C(N=C(S2)N3CCC4=C(C3)C(=CC=C4)C(=O)NC5=NC6=CC=CC=C6S5)C(=O)O)F
5393;409047920;0.1364;1794447;312361687;59447577;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;2-[8-(1,3-Benzothiazol-2-Ylcarbamoyl)-3,4-Dihydroisoquinolin-2(1h)-Yl]-5-(3-{4-[3-(Dimethylamino)prop-1-Yn-1-Yl]-2-Fluorophenoxy}propyl)-1,3-Thiazole-4-Carboxylic Acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CC#CC1=CC(=C(C=C1)OCCCC2=C(N=C(S2)N3CCC4=C(C3)C(=CC=C4)C(=O)NC5=NC6=CC=CC=C6S5)C(=O)O)F
5394;363665329;0.137;1415967;404698241;74767128;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-[2-Methyl-5-(trifluoromethyl)pyrazol-3-yl]-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C(=CC(=N1)C(F)(F)F)C2=C3C=NN(C3=NC=N2)CCN4CCCCC4
5395;389712847;0.137;1919146;329964770;6916184;10280;;Confirmatory;20231017;0;0;Active;Q99720;IC50;;BindingDB;Receptor Binding Assay from US Patent US11535596: 'Analogs of dextromethorphan with balanced receptor activities';Morfinan, 3-metoxi-17-metil-, (9alfa, 13alfa, 14alfa)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@]23CCCC[C@@H]2[C@H]1CC4=C3C=C(C=C4)OC
5396;112851450;0.1377;204465;103328447;10641401;10280;79325400;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma receptor of guinea pig brain;(8E)-8-benzylidene-5-(3-methoxyphenyl)-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1/C(=C\C3=CC=CC=C3)/C(=O)C2)C4=CC(=CC=C4)OC
5397;100403992;0.138;204630;103294748;44321369;10280;128012230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma receptor type 1 was determined by the displacement of [3H]pentazocine radioligand;[3-((3R,5R)-3,5-Dimethyl-piperazin-1-yl)-propyl]-diphenyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(C[C@H](N1)C)CCCN(C2=CC=CC=C2)C3=CC=CC=C3
5398;100497240;0.138;203984;103432736;10070289;10280;76997100;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;1-[[2-[4-(2-Methoxyphenyl)piperazino]ethyl]thio]-7-methoxy-1,2,3,4-tetrahydronaphthalene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(CCCC2SCCN3CCN(CC3)C4=CC=CC=C4OC)C=C1
5399;112788424;0.138;204633;103328447;10641401;10280;74907270;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to inhibit [3H](+)-pentazocine binding to guinea pig brain Sigma receptor type 1;(8E)-8-benzylidene-5-(3-methoxyphenyl)-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1/C(=C\C3=CC=CC=C3)/C(=O)C2)C4=CC(=CC=C4)OC
5400;100448350;0.139;204471;103214917;14983044;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[5-(4-Hydroxy-piperidin-1-yl)-pentyloxy]-2-isobutyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CC1=CC(=O)C2=C(O1)C=CC(=C2)OCCCCCN3CCC(CC3)O
5401;100500349;0.139;204448;103237344;10738317;10280;85688040;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory activity against sigma receptor isolated from guinea pig brain cortex membrane using [3H]DTG as radioligand;1-Benzyl-4-[3-(5-methoxy-3,4-dihydro-naphthalen-1-yl)-propyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCC=C2CCCN3CCN(CC3)CC4=CC=CC=C4
5402;100680843;0.139;204287;103178531;10027435;10280;119345760;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity towards Sigma opioid receptor type 1 by using [3H]- (+)-pentazocine as radioligand;6-{4-[4-(3,4-Dichloro-benzyl)-piperazin-1-yl]-butyl}-3-methyl-3H-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C=C(C=C2)CCCCN3CCN(CC3)CC4=CC(=C(C=C4)Cl)Cl)SC1=O
5403;255027929;0.139;625223;123083191;1201549;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Benztropine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1[C@@H]2CC[C@H]1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4
5404;326034621;0.139;701162;163314018;71449814;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;4-[2-(4,5-Dimethyl-1-naphthalen-2-ylpyrazol-3-yl)oxyethyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=C(N(N=C1OCCN2CCOCC2)C3=CC4=CC=CC=C4C=C3)C
5405;372121206;0.139;1681775;461528414;118561057;10280;330649470;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;(2R)-2-ethyl-4-methyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC[C@@H]1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C
5406;100440760;0.14;203855;103359671;10020651;10280;13615780;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory concentration against radioligand [3H]DTG binding to haloperidol-sensitive sigma binding site in whole guinea pig brain;(S)-1-(4-Fluoro-phenyl)-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butan-1-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCC[C@@H](C2=CC=C(C=C2)F)O)C3=NC=C(C=N3)F
5407;100471336;0.14;204459;103298967;14977560;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;1-(1-Naphthyl)-3-benzylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC=C(C=C1)CN=C(N)NC2=CC=CC3=CC=CC=C32
5408;100615703;0.14;204447;103321331;15701661;10280;16560440;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]-(+)-3-PPP binding to sigma of guinea pig brain;[1S,2R,(+)]-N-[2-(3,4-Dichlorophenyl)ethyl]-N-propyl-2-(1-pyrrolidinyl)cyclohexanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN(CCC1=CC(=C(C=C1)Cl)Cl)[C@H]2CCCC[C@H]2N3CCCC3
5409;100617150;0.14;203985;103283072;3315413;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;1,3-Dicyclohexyl-2-hydroxyguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)NC(=NC2CCCCC2)NO
5410;100458402;0.141;204438;103344492;15149417;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;11-[2-(Isoindolin-2-yl)ethyl]-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCN4CC5=CC=CC=C5C4)NC6=CC=CC=C63
5411;363665990;0.141;1415921;404714079;71223037;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;1-(2,4-Dichlorophenyl)-3-(1-(2-(piperidin-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)urea hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=NC=NC(=C3C=N2)NC(=O)NC4=C(C=C(C=C4)Cl)Cl
5412;100367069;0.14136;226337;103375993;10948807;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;2-Phenyl-N-[1-(3-trifluoromethyl-benzyl)-piperidin-4-yl]-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC(=CC=C3)C(F)(F)F
5413;100448374;0.142;204471;103215127;18959715;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[7-(4-Hydroxy-piperidin-1-yl)-heptyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
5414;372121193;0.142;1681775;461549433;118560871;10280;330649470;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;2,4-Dimethyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C
5415;388996990;0.142;1798943;405263608;86582464;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';(S)-2-(4-cyclohexyl-piperazin-1-yl)-1-((R)-3,4,10,10a-tetrahydro-pyrazino[1,2-a]indol-2(1H)-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](C(=O)N1CCN2[C@@H](C1)CC3=CC=CC=C32)N4CCN(CC4)C5CCCCC5
5416;388997000;0.142;1798943;405263604;86582460;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';(S)-1-(3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)-2-methyl-3-(4-methyl-piperazin-1-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](CN1CCN(CC1)C)C(=O)N2CCN3C(=CC4=CC=CC=C43)C2
5417;100445882;0.143;204470;103215030;14982955;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(8-Dimethylamino-octyloxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCCCCCCCOC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3
5418;407996515;0.143;1946583;482056193;168275717;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;3-[[4-[(3,4-Difluorophenyl)methoxy]piperidin-1-yl]methyl]imidazo[1,5-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=C(C=C2)F)F)CC3=NC=C4N3C=CC=C4
5419;100487776;0.144;204638;103318200;44332389;10280;76368610;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was measured on Sigma receptor type 1 using [3H]- pentazocine as radioligand;5-Bromo-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=CC(=C(C=C3C1(CCN2CC=C(C)C)C)O)Br
5420;345602808;0.144;1200082;312389809;76684294;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-(4-fluorophenyl)-N-(2-piperidin-1-ylethyl)triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)CCNC2=CN(N=N2)C3=CC=C(C=C3)F
5421;407996516;0.14454;1946583;482056193;168275717;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;3-[[4-[(3,4-Difluorophenyl)methoxy]piperidin-1-yl]methyl]imidazo[1,5-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=C(C=C2)F)F)CC3=NC=C4N3C=CC=C4
5422;100559068;0.145;203684;103390029;10618129;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;1,4-Bis-[2-(2-methoxy-phenyl)-ethyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1CCN2CCN(CC2)CCC3=CC=CC=C3OC
5423;100612549;0.145;204439;103671874;14771735;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to sigma receptor in guinea pig brain membrane homogenates;"1,3-Dicyclohexyl-2-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN=C(NC1CCCCC1)NC2CCCCC2.Cl
5424;112788425;0.145;204633;103328447;10641401;10280;74907270;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to inhibit [3H](+)-pentazocine binding to guinea pig brain Sigma receptor type 1;(8E)-8-benzylidene-5-(3-methoxyphenyl)-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1/C(=C\C3=CC=CC=C3)/C(=O)C2)C4=CC(=CC=C4)OC
5425;380299326;0.145;1819827;475982920;166627732;10280;354503790;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Citalopram from sigma-1 receptor (unknown origin) expressed in HEK cell membrane incubated for 2 hrs by liquid scintillation counter analysis;(1S,9S,10S)-4-(difluoromethyl)-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)C(F)F
5426;100445890;0.146;204470;103215450;14982978;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-[3-(Ethoxycarbonyl)-1-piperidinyl]hexyloxy]-2-phenyl-4H-1-benzopyran-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC(=O)C1CCCN(C1)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
5427;100615711;0.146;204447;103321525;15701658;10280;16560440;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]-(+)-3-PPP binding to sigma of guinea pig brain;N-[(1S,2R)-2-Pyrrolizinocyclohexyl]-(3,4-dichlorophenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC[C@H]([C@H](C1)NC(=O)CC2=CC(=C(C=C2)Cl)Cl)N3CCCC3
5428;389510953;0.146;1805565;459070372;118250135;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Pharmacological Activity Assay from US Patent US11007200: 'Cycloalkyl-diamines for the treatment of pain';US11007200, Example 13b;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN[C@]1(CCCC[C@@H]1NCCCN2CCN(CC2)C)C3=CC=CC=C3Cl
5429;389686569;0.146;1806763;459070372;118250135;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Pharmacological Activity from US Patent US11426411: 'Cycloalkyl-diamines for the treatment of inflammation';US11007200, Example 13b;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN[C@]1(CCCC[C@@H]1NCCCN2CCN(CC2)C)C3=CC=CC=C3Cl
5430;100444179;0.147;204470;103215675;18959702;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;5-[5-(4-Hydroxy-piperidin-1-yl)-pentyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCOC2=CC=CC3=C2C(=O)C=C(O3)C4=CC=CC=C4
5431;366366204;0.147;1558961;440214863;126744800;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;N-[3-[2-(2-methyl-3-oxo-4-phenyl-1-oxa-4,9-diazaspiro[5.5]undecan-9-yl)ethyl]phenyl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC(=CC=C3)NC(=O)C)C4=CC=CC=C4
5432;380264156;0.147;1811100;475987981;137371371;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[4-(4-butylpiperazin-1-yl)oxan-4-yl]methyl]-N-[6-(trifluoromethyl)pyridin-2-yl]propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCN1CCN(CC1)C2(CCOCC2)CN(C3=CC=CC(=N3)C(F)(F)F)C(=O)CC
5433;100387473;0.148;204145;103389397;11824300;10280;123830180;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine from Sigma opioid receptor type 1 of guinea pig brain;2-(1'-benzylspiro[3,4-dihydroisochromene-1,4'-piperidine]-3-yl)-N-methylethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CNCCC1CC2=CC=CC=C2C3(O1)CCN(CC3)CC4=CC=CC=C4
5434;100458428;0.148;204437;103343818;15149401;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;11-[3-(4-Fluorophenoxy)propyl]-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCOC4=CC=C(C=C4)F)NC5=CC=CC=C53
5435;100559079;0.148;203684;103389472;401843;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;3-Amino-1-[4-(3-phenyl-propyl)-piperazin-1-yl]-propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)C(=O)CCN
5436;366431551;0.148;1592018;440196484;155556295;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;(NZ)-N-[1-(4-fluorophenyl)-4-(4-pyrimidin-2-yl-1,4-diazepan-1-yl)butylidene]hydroxylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=NC=CC=N2)CCC/C(=N/O)/C3=CC=C(C=C3)F
5437;100320357;0.149;204310;103382896;3037711;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 2 using [3H]- DTG in rat liver membranes;Deoxy-N-benzylnormetazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;21070;Liver;C[C@H]1[C@H]2CC3=CC=CC=C3[C@@]1(CCN2CC4=CC=CC=C4)C
5438;151267139;0.149;452467;103716616;46225029;10280;199549720;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor;N-[2-(3-fluorophenyl)ethyl]-5-oxahexacyclo[5.4.1.02,6.03,10.04,8.09,12]dodecan-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C2C3C4C1C5C2C6C3C4C5(O6)NCCC7=CC(=CC=C7)F
5439;100367038;0.14984;226337;103375951;11142430;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-(1-Benzyl-piperidin-4-yl)-2-(pyrimidin-2-ylsulfanyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CSC2=NC=CC=N2)CC3=CC=CC=C3
5440;100319794;0.15;204154;103361798;10503221;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;[1-(4-Methoxy-3-phenethyloxy-benzyl)-heptyl]-dipropyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N(CCC)CCC
5441;100478671;0.15;204468;103186327;44273461;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Tested for binding affinity against sigma receptors;(1S,13R)-1,13-dimethyl-10-prop-2-enyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1C2CC3=C([C@]1(CCN2CC=C)C)C=C(C=C3)O
5442;100497207;0.151;203984;103330869;10453320;10280;76997100;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;1-[[2-[4-(2-Methoxyphenyl)piperazino]ethyl]amino]-5-methoxy-1,2,3,4-tetrahydronaphthalene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1N2CCN(CC2)CCNC3CCCC4=C3C=CC=C4OC
5443;388996989;0.151;1798943;405263600;86582309;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';4-(dimethyl-amino)-1-(3,4,10,10a-tetrahydro-pyrazino[1,2-a]indol-2(1H)-yl)butan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCCC(=O)N1CCN2C(C1)CC3=CC=CC=C32
5444;100500102;0.152;204466;103237057;10759399;10280;85688040;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]DTG binding to sigma receptor from guinea pig brain cortex membrane;[3-(5-Methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-propyl]-(3-phenyl-propyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCCC2CCCNCCCC3=CC=CC=C3
5445;100546458;0.152;203687;103252465;12259685;10280;96511500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was evaluated for its inhibition constant from the competition binding assays for sigma-1 receptor in guinea pig membranes.;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
5446;380264155;0.152;1811100;475988364;137371217;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;Ethyl 3-[4-[4-[[propanoyl-[6-(trifluoromethyl)pyridin-2-yl]amino]methyl]oxan-4-yl]piperazin-1-yl]propanoate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CCOCC1)N2CCN(CC2)CCC(=O)OCC)C3=CC=CC(=N3)C(F)(F)F
5447;151267140;0.153;452467;103716561;10356463;10280;199549720;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor;5-[(3-Fluorophenyl)methyl]-5-azahexacyclo[5.4.1.02,6.03,10.04,8.09,12]dodecan-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C2C3C4C1C5C2C6C3C4C5(N6CC7=CC(=CC=C7)F)O
5448;255023588;0.153;625223;103169151;5452;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Thioridazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC
5449;100449439;0.154;204443;103274775;44314139;10280;83608750;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine at sigma receptor in guinea pig brain membrane was determined;1-(3,4-Dichlorophenethyl)hexahydro-1H-1,4-diazepine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CNCCN(C1)CCC2=CC(=C(C=C2)Cl)Cl
5450;100448325;0.155;204471;103215450;14982978;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-[3-(Ethoxycarbonyl)-1-piperidinyl]hexyloxy]-2-phenyl-4H-1-benzopyran-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC(=O)C1CCCN(C1)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
5451;100617144;0.155;203985;103676273;14771708;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;"1-(3-Hydroxyphenyl)-2-(2-methylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1N=C(N)NC2=CC(=CC=C2)O.Cl
5452;100448331;0.156;204471;103215741;14983029;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-(3-Chlorophenyl)-6-[6-(4-hydroxypiperidinyl)hexoxy]-4H-1-benzopyran-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC(=CC=C4)Cl
5453;100536561;0.156;204457;103673419;45261990;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"1-(2-Chloro-5-ethylphenyl)-2-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N=C(N)N(C)C2=C(C=CC(=C2)CC)Cl.Cl
5454;363666189;0.156;1415921;404712988;71223232;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;N-(1-(2-(azepan-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)-4-fluorobenzamide citrate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCCN(CC1)CCN2C3=NC=NC(=C3C=N2)NC(=O)C4=CC=C(C=C4)F
5455;389536403;0.156;1805702;459092165;162370613;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';(1R,8R)-9-methyl-5-[4-(trifluoromethyl)phenyl]-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@@H]2C[C@@H]1C3=C2C=CC(=C3)C4=CC=C(C=C4)C(F)(F)F
5456;100768704;0.157;204149;103315468;44330983;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to Sigma opioid receptor type 1;(1S,9S,13S)-10-allyl-1,13-dimethyl-10-azatricyclo[7.3.1.0~2,7~]trideca-2,4,6-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2CC=C)C)C=C(C=C3)O
5457;100456209;0.158;229183;103360265;14970533;10280;79028690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor in bovine cerebellum using 2.0 nM [3H]haloperidol in the presence of 25 nM unlabeled spiperone;3-[4-(4-Chloro-phenyl)-3,6-dihydro-2H-pyridin-1-yl]-1-(3,4-dichloro-phenyl)-propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CN(CC=C1C2=CC=C(C=C2)Cl)CCC(=O)C3=CC(=C(C=C3)Cl)Cl
5458;100456550;0.158;229183;103359681;10948383;10280;79028690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor in bovine cerebellum using 2.0 nM [3H]haloperidol in the presence of 25 nM unlabeled spiperone;1-(4-Chloro-phenyl)-3-[4-(4-chloro-phenyl)-3,6-dihydro-2H-pyridin-1-yl]-propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CN(CC=C1C2=CC=C(C=C2)Cl)CCC(=O)C3=CC=C(C=C3)Cl
5459;342816986;0.15849;1118248;103315491;44330991;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human recombinant sigma-1 receptor expressed in CHO cells after 180 mins by beta counting analysis;(1S,9R,13R)-1,13-dimethyl-10-prop-2-enyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;197.0;;;;C[C@H]1[C@H]2CC3=C([C@]1(CCN2CC=C)C)C=C(C=C3)O
5460;342816988;0.15849;1118248;242613619;90666080;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human recombinant sigma-1 receptor expressed in CHO cells after 180 mins by beta counting analysis;(1S,2S)-N-[3-(cyclohexylamino)propyl]-2-phenylcyclopropane-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;197.0;;;;C1CCC(CC1)NCCCNC(=O)[C@H]2C[C@@H]2C3=CC=CC=C3
5461;365267542;0.15849;1512456;440227019;153287557;10280;316202300;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-8-bromo-5-(4-bromophenyl)-3a-methyl-2,3,4,9b-tetrahydro-1H-pyrrolo[2,3-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@]12CN(C3=C([C@@H]1CCN2)C=C(C=C3)Br)C4=CC=C(C=C4)Br
5462;366437250;0.15849;1594273;440221974;146641564;10280;309043830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;[5-[(4-Fluorophenyl)methylamino]-1-phenyl-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)C(=O)C2=NN(C3=C2CC(CC3)NCC4=CC=C(C=C4)F)C5=CC=CC=C5
5463;380773033;0.15849;1907474;482066428;168283172;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;Benzyl 4-methyl-2-[3-(4-propylpiperazin-1-yl)phenyl]piperazine-1-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCN(CC1)C2=CC=CC(=C2)C3CN(CCN3C(=O)OCC4=CC=CC=C4)C
5464;100448383;0.159;204471;103215880;14983038;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-(4-Hydroxy-piperidin-1-yl)-hexyloxy]-2-pyridin-4-yl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=NC=C4
5465;100500318;0.159;204466;103237056;10711065;10280;85688040;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]DTG binding to sigma receptor from guinea pig brain cortex membrane;[3-(5-Methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-propyl]-phenethyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCCC2CCCNCCC3=CC=CC=C3
5466;100319805;0.16;204154;103361400;10616210;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;1-(4-Methoxy-3-phenethyloxy-benzyl)-pentylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N
5467;345680790;0.16;1174258;312374346;118724302;10280;254622400;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor in human Jurkat cell membranes incubated for 2 hrs by liquid scintillation counting;3-[3-[Benzyl(methyl)amino]propyl]-5-(4-chlorophenyl)-5,6-dihydrocyclopenta[f][1,3]benzoxazole-2,7-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1C2=C(C=C3C(=O)CC(C3=C2)C4=CC=C(C=C4)Cl)OC1=O)CC5=CC=CC=C5
5468;380773034;0.16;1907474;482066428;168283172;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;Benzyl 4-methyl-2-[3-(4-propylpiperazin-1-yl)phenyl]piperazine-1-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCN(CC1)C2=CC=CC(=C2)C3CN(CCN3C(=O)OCC4=CC=CC=C4)C
5469;100721058;0.161;204634;103236640;44296433;10280;150260770;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma receptor type 1;2-{[2-((4aS,10aR)-6-Methoxy-1,3,4,10a-tetrahydro-2H-phenanthren-4a-yl)-ethyl]-methyl-amino}-ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CC[C@@]12CCCC[C@@H]1C=CC3=C2C=C(C=C3)OC)CCO
5470;372121202;0.161;1681775;461537779;118561105;10280;330649470;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;12-Methyl-8-(2-phenylethyl)-4-oxa-8,12-diazadispiro[2.1.55.33]tridecan-13-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC2(CCN(CC2)CCC3=CC=CC=C3)OC4(C1=O)CC4
5471;389483907;0.162;1805386;444858106;132060819;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A34;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)C2=CC3=C(CN(CCC3)C(=O)OCC4=CC=CC=C4)C=C2
5472;365267538;0.16218;1512456;440134043;153287566;10280;316202300;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-3,3a-dimethyl-5-phenyl-1,2,4,9b-tetrahydropyrrolo[2,3-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@]12CN(C3=CC=CC=C3[C@@H]1CCN2C)C4=CC=CC=C4
5473;100612546;0.163;204439;103283111;44318068;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to sigma receptor in guinea pig brain membrane homogenates;N,N''-Dicyclohexyl-N''''-cyclopropyl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)NC(=NC2CC2)NC3CCCCC3
5474;100741799;0.163;203992;103671576;45260643;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"3-Phenyl-8-prop-2-enyl-1-oxa-8-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C=CCN1CCC2(CC1)C(=O)C(=CO2)C3=CC=CC=C3.Cl
5475;100386149;0.164;204153;103186197;7333;10280;117841480;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma opioid receptor type 1 affinity in guinea pig brain by employing [3H](+)-pentazocine as radioligand.;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
5476;100387737;0.164;204145;160677132;41011;10280;123830180;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine from Sigma opioid receptor type 1 of guinea pig brain;Guanidine, N,N'-bis(4-methylphenyl)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=C(C=C1)NC(=NC2=CC=C(C=C2)C)N
5477;100444351;0.164;204470;103215143;14983034;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-(4-Chlorophenyl)-6-[6-(4-hydroxypiperidinyl)hexoxy]-4H-1-benzopyran-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=C(C=C4)Cl
5478;100448322;0.164;204471;103215426;14982979;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-[4-(Ethoxycarbonyl)-1-piperidinyl]hexyloxy]-2-phenyl-4H-1-benzopyran-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC(=O)C1CCN(CC1)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
5479;100536552;0.164;204457;103673409;45261981;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"1-(3-Ethylphenyl)-1-methyl-2-(3-methylsulfanylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=CC(=CC=C2)SC)N.Cl
5480;100746100;0.164;204298;103248082;108046;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma opioid receptor type 2 in guinea pig brain homogenate with 4 nM [3H]-(+)-DTG;alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCCC(C2=CC=C(C=C2)F)O)C3=NC=C(C=N3)F
5481;367490640;0.164;1661755;442061510;45881521;10280;328320230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from recombinant sigma 1 receptor (unknown origin) expressed in baculovirus infected Sf9 cell membranes after 1.5 hrs by scintillation counting analysis;N-[[5-chloro-1-(2-chlorophenyl)-3-methylpyrazol-4-yl]methyl]-1-(3,5-difluorophenyl)methanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;521.0;;;;CC1=NN(C(=C1CNCC2=CC(=CC(=C2)F)F)Cl)C3=CC=CC=C3Cl
5482;100448373;0.165;204471;103214536;14982954;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(7-Dimethylamino-heptyloxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCCCCCCOC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3
5483;100471364;0.165;204459;103283114;344343;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;1,2-Dinaphthalen-1-ylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC=C2C(=C1)C=CC=C2NC(=NC3=CC=CC4=CC=CC=C43)N
5484;363666004;0.165;1415967;404699826;71225643;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(3,3-Dimethylpyrrolidin-1-yl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1(CCN(C1)C2=NC=NC3=C2C=NN3CCN4CCCCC4)C
5485;372120973;0.165;1681775;461539253;162660406;10280;330649470;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;(2S)-2,4-dimethyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C
5486;366431693;0.16596;1592018;312351718;13091356;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;3-(4-Chlorophenyl)-8-[3-(4-fluorophenoxy)propyl]-8-azabicyclo[3.2.1]octan-3-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2CC(CC1N2CCCOC3=CC=C(C=C3)F)(C4=CC=C(C=C4)Cl)O
5487;366431692;0.166;1592018;312351718;13091356;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;3-(4-Chlorophenyl)-8-[3-(4-fluorophenoxy)propyl]-8-azabicyclo[3.2.1]octan-3-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2CC(CC1N2CCCOC3=CC=C(C=C3)F)(C4=CC=C(C=C4)Cl)O
5488;100323561;0.167;204151;103382925;10086447;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 1 using [3H](+)-pentazocine in guinea pig brain membranes;(1S,9S,13S)-10-benzyl-13-propan-2-yl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC(C)[C@H]1[C@@H]2CCN([C@H]1CC3=CC=CC=C23)CC4=CC=CC=C4
5489;255011815;0.167;625223;103177051;2771;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Citalopram;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
5490;100461276;0.168;204456;103182698;192370;10280;80980660;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma receptor of guinea pig brain homogenates;1-[1-(1-Benzothiophen-2-yl)cyclohexyl]pyrrolidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)(C2=CC3=CC=CC=C3S2)N4CCCC4
5491;100543218;0.169;203699;103186327;44273461;10280;95728830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]pentazocine binding to sigma-1 sites in guinea pig brain membranes;(1S,13R)-1,13-dimethyl-10-prop-2-enyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@H]1C2CC3=C([C@]1(CCN2CC=C)C)C=C(C=C3)O
5492;408049239;0.169;1959985;103315468;44330983;10280;299084420;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) assessed as inhibition constant;(1S,9S,13S)-10-allyl-1,13-dimethyl-10-azatricyclo[7.3.1.0~2,7~]trideca-2,4,6-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2CC=C)C)C=C(C=C3)O
5493;407996260;0.16982;1946583;494410734;171352160;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[[4-(Pyridin-2-ylmethoxy)piperidin-1-yl]methyl]imidazo[1,2-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC=CC=N2)CC3=CN4C=CC=CC4=N3
5494;100319787;0.17;204154;103361384;10646068;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;[1-(4-Methoxy-3-phenethyloxy-benzyl)-nonyl]-propyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCCCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)NCCC
5495;100319802;0.17;204154;103361930;10618199;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;1-(4-Methoxy-3-phenethyloxy-benzyl)-heptylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N
5496;100387742;0.17;204145;103389395;10937393;10280;123830180;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine from Sigma opioid receptor type 1 of guinea pig brain;2-(1'-benzylspiro[3,4-dihydroisochromene-1,4'-piperidine]-3-yl)-N-methylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CNC(=O)CC1CC2=CC=CC=C2C3(O1)CCN(CC3)CC4=CC=CC=C4
5497;100458516;0.17;204438;103343688;15149404;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;11-[4-(2-Furanyl)butyl]-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCCC4=CC=CO4)NC5=CC=CC=C53
5498;100736355;0.17;203993;103228172;15034743;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor from guinea pig brain using the radioligand [3H]SKF-10047;(5S)-5-[[4-(1,3-benzodioxol-5-yl)-3,6-dihydro-2H-pyridin-1-yl]methyl]-3-(4-methoxyphenyl)-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)N2C[C@@H](OC2=O)CN3CCC(=CC3)C4=CC5=C(C=C4)OCO5
5499;389536400;0.17;1805702;384583191;137633290;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';benzyl (1R,8R)-5-(4-cyclopentylpiperazin-1-yl)-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene-9-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)N2CCN(CC2)C3=CC4=C(C=C3)[C@@H]5CCN([C@@H]4C5)C(=O)OCC6=CC=CC=C6
5500;389536408;0.17;1805702;384583191;137633290;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';benzyl (1R,8R)-5-(4-cyclopentylpiperazin-1-yl)-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene-9-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)N2CCN(CC2)C3=CC4=C(C=C3)[C@@H]5CCN([C@@H]4C5)C(=O)OCC6=CC=CC=C6
5501;407996259;0.17;1946583;494410734;171352160;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[[4-(Pyridin-2-ylmethoxy)piperidin-1-yl]methyl]imidazo[1,2-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC=CC=N2)CC3=CN4C=CC=CC4=N3
5502;326035327;0.172;701162;163324311;11668112;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;4-[2-[1-(3,4-Dichlorophenyl)-5-propan-2-ylpyrazol-3-yl]oxyethyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC(C)C1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)OCCN3CCOCC3
5503;389536474;0.172;1805702;459092176;162370616;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';benzyl (1R,8R)-5-(4-but-3-enylpiperazin-1-yl)-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene-9-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C=CCCN1CCN(CC1)C2=CC3=C(C=C2)[C@@H]4CCN([C@@H]3C4)C(=O)OCC5=CC=CC=C5
5504;389712848;0.172;1919146;476002740;166637124;10280;;Confirmatory;20231017;0;0;Active;Q99720;IC50;;BindingDB;Receptor Binding Assay from US Patent US11535596: 'Analogs of dextromethorphan with balanced receptor activities';(1S,9S)-3-bromo-16-methyl-16-azatetracyclo[7.5.2.01,10.02,7]hexadeca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C[C@@]23CCCCC2[C@@H]1CC4=C3C(=C(C=C4)O)Br
5505;100497405;0.173;203984;103389514;10406366;10280;76997100;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;1-[3-(7-Methoxy-3,4-dihydro-naphthalen-1-yl)-propyl]-4-phenyl-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(CCC=C2CCCN3CCN(CC3)C4=CC=CC=C4)C=C1
5506;100614100;0.173;203986;103283109;14771669;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;1,3-Bis(3-iodophenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC(=CC(=C1)I)NC(=NC2=CC(=CC=C2)I)N
5507;407996246;0.17378;1946583;482069051;168285068;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;3-[[4-[[3-(Trifluoromethyl)phenyl]methoxy]piperidin-1-yl]methyl]imidazo[1,5-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=CC=C2)C(F)(F)F)CC3=NC=C4N3C=CC=C4
5508;100449445;0.174;204443;103274747;44314127;10280;83608750;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine at sigma receptor in guinea pig brain membrane was determined;1-(3,4-Dichlorophenethyl)-4-methylhexahydro-1H-1,4-diazepine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN1CCCN(CC1)CCC2=CC(=C(C=C2)Cl)Cl
5509;100475261;0.174;204462;103351738;44347788;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;1'-Phenethyl-3,4-dihydrospiro[naphthalene-1(2H),4'-piperidin]-2-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2=CC=CC=C2C3(C1O)CCN(CC3)CCC4=CC=CC=C4
5510;100444464;0.175;204470;103215741;14983029;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-(3-Chlorophenyl)-6-[6-(4-hydroxypiperidinyl)hexoxy]-4H-1-benzopyran-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC(=CC=C4)Cl
5511;100534031;0.175;204794;103359384;44350817;10280;93971710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was done in guinea pig membranes by labeling the binding site with [3H](+)-pentazocine;(2S,3S)-3-(3-Phenyl-8-aza-bicyclo[3.2.1]oct-8-yl)-1,2,3,4-tetrahydro-naphthalen-2-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2CC(CC1N2[C@H]3CC4=CC=CC=C4C[C@@H]3O)C5=CC=CC=C5
5512;100559082;0.175;203684;103389998;10784820;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;[2-[4-(3-Phenylpropyl)piperazine-1-yl]-2-oxoethyl]carbamic acid tert-butyl ester;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC(=O)NCC(=O)N1CCN(CC1)CCCC2=CC=CC=C2
5513;380264309;0.175;1811100;475997526;126509634;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[1-(4-benzylpiperazin-1-yl)cyclopropyl]methyl]-N-(2-hydroxyphenyl)propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CC1)N2CCN(CC2)CC3=CC=CC=C3)C4=CC=CC=C4O
5514;388996811;0.175;1798943;405263601;86582310;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';2-methyl-2-(4-methyl-piperazin-1-yl)-1-(3,4,10,10a-tetrahydro-pyrazino[1,2-a]indol-2(1H)-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C(=O)N1CCN2C(C1)CC3=CC=CC=C32)N4CCN(CC4)C
5515;407996177;0.175;1946583;482069051;168285068;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;3-[[4-[[3-(Trifluoromethyl)phenyl]methoxy]piperidin-1-yl]methyl]imidazo[1,5-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1OCC2=CC(=CC=C2)C(F)(F)F)CC3=NC=C4N3C=CC=C4
5516;100444182;0.177;204470;103215620;18959714;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;5-[4-(4-Hydroxy-piperidin-1-yl)-butoxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCOC2=CC=CC3=C2C(=O)C=C(O3)C4=CC=CC=C4
5517;100559078;0.177;203684;103389852;10660038;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;4-[4-(3-Phenyl-propyl)-piperazin-1-yl]-butylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCCN)CCCC2=CC=CC=C2
5518;100458416;0.178;204437;103211676;15646141;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;2-Fluoro-11-(4-phenylbutyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCCC4=CC=CC=C4)NC5=C3C=C(C=C5)F
5519;100536559;0.178;204457;103673548;45262087;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(2-Chloro-5-ethyl-3-methylsulfanylphenyl)-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=C(C(=CC(=C2)CC)SC)Cl)N.Cl
5520;334065186;0.178;735278;164141241;71655416;10280;235606500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aS,5R,10bS)-9-butoxy-5-cyclohexyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCCCOC1=CC2=C(C=C1)N[C@@H]([C@H]3[C@@H]2OCCC3)C4CCCCC4
5521;255010992;0.179;625223;103219164;5472;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ticlopidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
5522;100513122;0.18;229197;103384789;10551210;10280;89413830;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor using radioligand ([3H](+)-pentazocine) binding assay;1-(2-Benzhydryloxy-ethyl)-4-(3-phenyl-propyl)-[1,4]diazocane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CCN(C1)CCCC2=CC=CC=C2)CCOC(C3=CC=CC=C3)C4=CC=CC=C4
5523;100536811;0.18;204457;103678342;45265207;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(2-Bromo-5-ethyl-3-methylsulfanylphenyl)-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=C(C(=CC(=C2)CC)SC)Br)N.Cl
5524;101878803;0.18;263537;103485024;11948707;10280;164585040;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma1 opioid receptor by radioligand binding assay;2-(4-(4-(3-methoxyphenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C(=O)C=NN(C1=O)CCCCN2CCN(CC2)C3=CC(=CC=C3)OC
5525;255012609;0.18;625223;103534218;6075;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pecazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCCC(C1)CN2C3=CC=CC=C3SC4=CC=CC=C42
5526;326034760;0.18;701162;163334750;71460635;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;4-[2-[1-(3-Chlorophenyl)-5-methylpyrazol-3-yl]oxyethyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC(=CC=C2)Cl)OCCN3CCOCC3
5527;340020966;0.18;752428;174506864;49853980;10280;236018160;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;2-(4-cyclohexylpiperazin-1-yl)-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1[C@@H]2C[C@@H](C2(C)C)C[C@@H]1NC(=O)CN3CCN(CC3)C4CCCCC4
5528;388740700;0.18;1797293;386051309;118278087;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 64;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)S(=O)(=O)C
5529;388879576;0.18;1797475;386051309;118278087;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 64;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)S(=O)(=O)C
5530;389383935;0.18;1804286;386051309;118278087;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 64;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)S(=O)(=O)C
5531;407996417;0.18;1946583;494410613;171352078;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[[4-[(6-Methylpyridin-2-yl)methoxy]piperidin-1-yl]methyl]imidazo[1,2-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NC(=CC=C1)COC2CCN(CC2)CC3=CN4C=CC=CC4=N3
5532;408049183;0.18;1960000;494412370;171353025;10280;299084420;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma 1 receptor (unknown origin);(1S,9R,13R)-1,13-dimethyl-10-pent-4-enyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1[C@H]2CC3=C([C@]1(CCN2CCCC=C)C)C=C(C=C3)O
5533;100559080;0.181;203684;103389853;10539358;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;3-[4-(3-Phenyl-propyl)-piperazin-1-yl]-propylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)CCCN
5534;363665754;0.181;1415921;404698548;71223298;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;1-Adamanthyl-3-(1-(2-(piperidin-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)urea hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=NC=NC(=C3C=N2)NC(=O)NC45CC6CC(C4)CC(C6)C5
5535;389483970;0.181;1805386;444858084;132060803;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A12;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC(C1)N2CCN(CC2)C3=CC4=C(CCN(C4)C(=O)OCC5=CC=CC=C5)C=C3
5536;100471777;0.18197;203852;103183976;5475158;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;Cinanserin;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCCSC1=CC=CC=C1NC(=O)/C=C/C2=CC=CC=C2
5537;407996418;0.18197;1946583;494410613;171352078;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[[4-[(6-Methylpyridin-2-yl)methoxy]piperidin-1-yl]methyl]imidazo[1,2-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NC(=CC=C1)COC2CCN(CC2)CC3=CN4C=CC=CC4=N3
5538;100458406;0.182;204438;103344425;44344745;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;8-Fluoro-2-(3-pyridin-4-yl-propyl)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CC2=C1NC3=C2C=C(C=C3)F)CCCC4=CC=NC=C4
5539;389712853;0.182;1919146;103915533;5360697;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assay from US Patent US11535596: 'Analogs of dextromethorphan with balanced receptor activities';Dextrorphan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)O
5540;100387469;0.183;204145;103388669;11003384;10280;123830180;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine from Sigma opioid receptor type 1 of guinea pig brain;Ethyl 2-(1'-benzylspiro[3,4-dihydroisochromene-1,4'-piperidine]-3-yl)acetate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC(=O)CC1CC2=CC=CC=C2C3(O1)CCN(CC3)CC4=CC=CC=C4
5541;100458858;0.183;229213;103359710;44350942;10280;79028700;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Tested for [3H](+)-pentazocine binding to sigma-1 receptor in guinea pig brain membrane;(S)-1-(4-Fluorophenyl)-4-[4-(2-pyridyl)piperazino]butan-1-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCC[C@@H](C2=CC=C(C=C2)F)O)C3=CC=CC=N3
5542;101897916;0.183;267942;103679206;9936494;10280;168217740;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity to sigma receptor;"1-Butyl-3-(cyclohexylmethyl)-9-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-1,4,9-triazaspiro[5.5]undecane-2,5-dione;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCN1C(=O)C(NC(=O)C12CCN(CC2)CC3=CC4=C(C=C3)OCCO4)CC5CCCCC5.Cl
5543;363665439;0.184;1415921;404695404;71225920;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;N-(1-(2-(1,4-oxazepan-4-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)pivalamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)C(=O)NC1=C2C=NN(C2=NC=N1)CCN3CCCOCC3
5544;389483968;0.186;1805386;444858089;132060804;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A17;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=C)CN1CCN(CC1)C2=CC3=C(CN(CC3)C(=O)OCC4=CC=CC=C4)C=C2
5545;100444340;0.188;204470;103214536;14982954;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(7-Dimethylamino-heptyloxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCCCCCCOC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3
5546;100778222;0.189;204017;103272193;44312920;10280;98735270;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for [3H]- pentazocine at sigma opioid receptor;(2R)-2-[(4R)-4-(4-aminobutyl)-3-benzyl-2,5-dioxoimidazolidin-1-yl]-3-cyclohexylpropanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)C[C@H](C(=O)N)N2C(=O)[C@H](N(C2=O)CC3=CC=CC=C3)CCCCN
5547;255015624;0.189;625223;103169389;2726;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Chlorpromazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl
5548;100708102;0.1891;204146;103252304;11317999;10280;146843270;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma opioid receptor of guiena pig brain membrane;N-[2-(6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-yl)ethyl]-1-methoxy-4-bromonaphthalene-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=C2CN(CCC2=C1)CCNC(=O)C3=C(C4=CC=CC=C4C(=C3)Br)OC)OC
5549;100317825;0.19;204295;103678333;9823428;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine.;"1-[4-methoxy-3-(2-phenylethoxy)phenyl]-5-methyl-N-propylhexan-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCNC(CCC(C)C)CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2.Cl
5550;100444475;0.19;204470;103215846;14983041;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-Cyclohexyl-6-[5-(4-hydroxypiperidinyl)pentoxy]-4H-1-benzopyran-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)C2=CC(=O)C3=C(O2)C=CC(=C3)OCCCCCN4CCC(CC4)O
5551;100478314;0.19;203696;103185344;18790215;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;5-Cyclohexyl-pentylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)CCCCCN
5552;372137914;0.19;1690206;123099027;49832807;10280;320709170;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to Sigma 1 receptor (unknown origin);(+/-)-3-(4-Phenylbutyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-1,7-diol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CC(C2=C1C=C(C=C2)O)O)CCCCC3=CC=CC=C3
5553;100534036;0.191;204794;103359367;44350812;10280;93971710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was done in guinea pig membranes by labeling the binding site with [3H](+)-pentazocine;(alphaR)-1-Methyl-alpha-(4-bromobenzyl)spiro[indoline-3,4'-piperidine]-1'-ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC2(CCN(CC2)C[C@@H](CC3=CC=C(C=C3)Br)O)C4=CC=CC=C41
5554;367490644;0.191;1661755;442053890;16044337;10280;328320230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from recombinant sigma 1 receptor (unknown origin) expressed in baculovirus infected Sf9 cell membranes after 1.5 hrs by scintillation counting analysis;N-(3-pyridylmethyl){5-[3-(trifluoromethyl)phenyl]-2-furyl}methanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;521.0;;;;C1=CC(=CC(=C1)C(F)(F)F)C2=CC=C(O2)CNCC3=CN=CC=C3
5555;100320350;0.192;204310;103382349;44327509;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 2 using [3H]- DTG in rat liver membranes;(9R,13R)-10-benzyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;21070;Liver;C[C@H]1[C@H]2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)O
5556;100444470;0.192;204470;103215524;14983049;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(6-Piperidin-1-yl-hexyloxy)-2-pyridin-3-yl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CN=CC=C4
5557;363665753;0.192;1415921;404698521;71223206;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;1-Cyclopentyl-3-(1-(2-(piperidin-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)urea hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=NC=NC(=C3C=N2)NC(=O)NC4CCCC4
5558;100448334;0.194;204471;103215144;14983033;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-(4-Hydroxy-piperidin-1-yl)-hexyloxy]-2-pyridin-3-yl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CN=CC=C4
5559;100604311;0.194;203857;103251918;11957597;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;(-)-cis-(1S,2R)-U-50488 tartrate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)CC3=CC(=C(C=C3)Cl)Cl
5560;334065470;0.194;735278;164138481;71655284;10280;235606500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aS,5R,10bS)-9-(4-chlorophenoxy)-5-cyclohexyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCC(CC1)[C@@H]2[C@@H]3CCCO[C@@H]3C4=C(N2)C=CC(=C4)OC5=CC=C(C=C5)Cl
5561;345602797;0.194;1200082;312389839;76683982;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-(3,4-dichlorophenyl)-N-(3-morpholin-4-ylpropyl)triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1COCCN1CCCNC2=CN(N=N2)C3=CC(=C(C=C3)Cl)Cl
5562;354626048;0.194;1272497;123099027;49832807;10280;267502540;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin) by radioligand displacement assay;(+/-)-3-(4-Phenylbutyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-1,7-diol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CC(C2=C1C=C(C=C2)O)O)CCCCC3=CC=CC=C3
5563;100534040;0.1945;204794;103359322;44350800;10280;93971710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was done in guinea pig membranes by labeling the binding site with [3H](+)-pentazocine;(3S,4S)-1-(3-Iodo-benzyl)-3-(3-phenyl-8-aza-bicyclo[3.2.1]oct-8-yl)-piperidin-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(C[C@@H]([C@H]1O)N2C3CCC2CC(C3)C4=CC=CC=C4)CC5=CC(=CC=C5)I
5564;100444178;0.195;204470;103215593;18959733;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;5-[6-(4-Hydroxy-piperidin-1-yl)-hexyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCOC2=CC=CC3=C2C(=O)C=C(O3)C4=CC=CC=C4
5565;100448365;0.195;204471;103215143;14983034;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-(4-Chlorophenyl)-6-[6-(4-hydroxypiperidinyl)hexoxy]-4H-1-benzopyran-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=C(C=C4)Cl
5566;367478257;0.195;1655949;442051444;156013137;10280;324354210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human Sigma 1 receptor by radioligand displacement assay;"4-benzyl-1-[[(2S,4S)-spiro[1,3-dithiolane-2,5'-6,7,8,9-tetrahydrobenzo[7]annulene]-4-yl]methyl]piperidine;oxalic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC[C@]2(C3=CC=CC=C3C1)SC[C@@H](S2)CN4CCC(CC4)CC5=CC=CC=C5.C(=O)(C(=O)O)O
5567;100604315;0.196;203857;103735226;46878010;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;4-Methoxy-N-methyl-N-[(1R)-2beta-(1-pyrrolidinyl)cyclohexan-1beta-yl]benzeneacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)CC3=CC=C(C=C3)OC
5568;100497410;0.198;203984;103330903;10361439;10280;76997100;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;1-[3-(4-Phenylpiperazino)propyl]-5-methoxy-1,2,3,4-tetrahydronaphthalene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCCC2CCCN3CCN(CC3)C4=CC=CC=C4
5569;342816987;0.19953;1118248;242613619;90666080;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human recombinant sigma-1 receptor expressed in CHO cells after 180 mins by beta counting analysis;(1S,2S)-N-[3-(cyclohexylamino)propyl]-2-phenylcyclopropane-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;197.0;;;;C1CCC(CC1)NCCCNC(=O)[C@H]2C[C@@H]2C3=CC=CC=C3
5570;342816997;0.19953;1118248;242613631;90666091;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human recombinant sigma-1 receptor expressed in CHO cells after 180 mins by beta counting analysis;[(1S,2S)-2-phenylcyclopropyl]-(4-pyrrolidin-1-ylpiperidin-1-yl)methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;197.0;;;;C1CCN(C1)C2CCN(CC2)C(=O)[C@H]3C[C@@H]3C4=CC=CC=C4
5571;366437107;0.19953;1594273;440203843;155559223;10280;309043830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;[2-Phenyl-5-[2-[4-(trifluoromethyl)phenyl]ethylamino]-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)C(=O)C2=C3CC(CCC3=NN2C4=CC=CC=C4)NCCC5=CC=C(C=C5)C(F)(F)F
5572;366437242;0.19953;1594273;440151802;146641788;10280;309043830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;[5-[2-(3-Hydroxyphenyl)ethylamino]-1-phenyl-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)C(=O)C2=NN(C3=C2CC(CC3)NCCC4=CC(=CC=C4)O)C5=CC=CC=C5
5573;100317823;0.2;204295;103678333;9823428;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine.;"1-[4-methoxy-3-(2-phenylethoxy)phenyl]-5-methyl-N-propylhexan-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCNC(CCC(C)C)CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2.Cl
5574;100536691;0.2;204457;103673550;45262089;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-[2-Chloro-5-ethyl-3-(trifluoromethyl)phenyl]-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=CC(=CC(=C2Cl)C(F)(F)F)CC)N.Cl
5575;100604305;0.2;203857;103735207;46877998;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;N-Methyl-N-[(1R)-2beta-(1-pyrrolidinyl)cyclohexan-1beta-yl](phenylthio)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)CSC3=CC=CC=C3
5576;255018612;0.2;625223;160708999;7010;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Valethamate bromide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC(C)C(C1=CC=CC=C1)C(=O)OCC[N+](C)(CC)CC.[Br-]
5577;345591248;0.2;1195885;312384124;118730369;10280;254898820;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to human sigma-1 receptor after 90 mins by radioligand displacement assay;"3-(3-fluorophenyl)-N-[2-(2-imidazol-1-ylpyrimidin-4-yl)ethyl]propan-1-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC(=CC(=C1)F)CCCNCCC2=NC(=NC=C2)N3C=CN=C3.Cl
5578;345680786;0.2;1174258;312374353;118724309;10280;254622400;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor in human Jurkat cell membranes incubated for 2 hrs by liquid scintillation counting;2-(3-Pyrrolidin-1-ylpropyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCN(C1)CCCN2CCC3=C(C2)NC4=CC=CC=C34
5579;345681154;0.2;1174258;312374359;118724315;10280;254622400;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor in human Jurkat cell membranes incubated for 2 hrs by liquid scintillation counting;10-[3-(1,3-Dihydroisoindol-2-yl)propyl]phenoxazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1C2=CC=CC=C2CN1CCCN3C4=CC=CC=C4OC5=CC=CC=C53
5580;345681163;0.2;1174258;312374343;118724299;10280;254622400;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor in human Jurkat cell membranes incubated for 2 hrs by liquid scintillation counting;N-benzyl-N-methyl-3-phenoxazin-10-ylpropan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1C2=CC=CC=C2OC3=CC=CC=C31)CC4=CC=CC=C4
5581;363665336;0.2;1415967;404698275;71225871;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-Piperidin-1-yl-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=C(C=N2)C(=NC=N3)N4CCCCC4
5582;100444181;0.202;204470;103215029;14982956;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(9-Dimethylamino-nonyloxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCCCCCCCCOC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3
5583;100559077;0.202;203684;103389471;10779812;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;1-[4-(3-Phenylpropyl)piperazine-1-yl]-4-amino-1-butanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)C(=O)CCCN
5584;100535934;0.203;204457;103673433;45262000;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(2-Bromo-3,5-diethylphenyl)-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=CC(=CC(=C2Br)CC)CC)N.Cl
5585;100614738;0.203;203986;103671973;14771676;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;"1,2-Bis(2-adamantyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C2CC3CC1CC(C2)C3NC(=NC4C5CC6CC(C5)CC4C6)N.Cl
5586;100458320;0.205;204437;103343850;15149402;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;11-(4-Phenoxybutyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCCOC4=CC=CC=C4)NC5=CC=CC=C53
5587;100536550;0.205;204457;103673531;45262079;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-[2-Bromo-3-ethyl-5-(trifluoromethyl)phenyl]-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=CC(=CC(=C2Br)CC)C(F)(F)F)N.Cl
5588;366366400;0.205;1558961;440163636;126744799;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;N-[3-[2-[(2R)-2-methyl-3-oxo-4-phenyl-1-oxa-4,9-diazaspiro[5.5]undecan-9-yl]ethyl]phenyl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C[C@@H]1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC(=CC=C3)NC(=O)C)C4=CC=CC=C4
5589;389483896;0.205;1805386;444858081;132060742;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example KTL-01-253;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)C2=CC3=C(CN(C3)S(=O)(=O)C4=CC(=CC(=C4)Cl)Cl)C=C2
5590;100297841;0.207;239347;103458250;16061352;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;(22R,25R)-spirosol-5-en-3beta-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1[C@H]2[C@H](C[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC=C5[C@@]4(CC[C@@H](C5)O)C)C)O[C@]16CCC(CN6)C
5591;100451427;0.207;204436;103672130;45260990;10280;81026510;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using [3H]ditolylguanidine (DTG) as radioligand.;"N,N-diethyl-4-phenyl-1,2,3,4-tetrahydronaphthalen-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCN(CC)C1CC(C2=CC=CC=C2C1)C3=CC=CC=C3.Cl
5592;100614371;0.207;203986;103676273;14771708;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;"1-(3-Hydroxyphenyl)-2-(2-methylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1N=C(N)NC2=CC(=CC=C2)O.Cl
5593;100604299;0.208;203857;103735230;46878014;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;2-Methoxy-N-methyl-N-[(1R)-2beta-(1-pyrrolidinyl)cyclohexan-1beta-yl]benzeneacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)CC3=CC=CC=C3OC
5594;342811254;0.208;1129882;103186197;7333;10280;246178360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human RPMI8226 cell membranes after 120 mins by scintillation counting analysis;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
5595;355637712;0.208;1308619;103186197;7333;10280;271565650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-Pentazocine from sigma 1 receptor in human RPMI8226 cell membranes;1,3-Di-o-tolylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;CC1=CC=CC=C1NC(=NC2=CC=CC=C2C)N
5596;366366203;0.209;1558961;440134707;118562362;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;2-(Hydroxymethyl)-4-phenyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CN(CCC12CN(C(=O)C(O2)CO)C3=CC=CC=C3)CCC4=CC=CC=C4
5597;372306726;0.209;1701184;461549878;54673476;10280;332377850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;4-[2-[(5-Methyl-1-naphthalen-2-ylpyrazol-3-yl)methoxy]ethyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)COCCN4CCOCC4
5598;380512650;0.209;1846430;482056431;86295563;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-10-(2-fluorophenyl)-4-(oxan-4-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCC1N2C[C@@H]3[C@@H](C2)OCC4=C(N=NN34)C5=CC=CC=C5F
5599;100317824;0.21;204295;103678347;19606389;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine.;"1-[4-methoxy-3-(2-phenylethoxy)phenyl]-N-propylhexan-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)NCCC.Cl
5600;100317841;0.21;204297;103678333;9823428;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;TIn vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine.;"1-[4-methoxy-3-(2-phenylethoxy)phenyl]-5-methyl-N-propylhexan-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCNC(CCC(C)C)CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2.Cl
5601;100444473;0.21;204470;103215144;14983033;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-(4-Hydroxy-piperidin-1-yl)-hexyloxy]-2-pyridin-3-yl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CN=CC=C4
5602;100448358;0.21;204471;103214979;18959700;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[5-(4-Hydroxy-piperidin-1-yl)-pentyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
5603;255015224;0.21;625223;103165728;3386;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fluoxetine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F
5604;340019680;0.21;752428;174486362;49853579;10280;236018160;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;2-(1,4-diazaspiro[5.5]undecan-4-yl)-N-methyl-N-pentylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCCN(C)C(=O)CN1CCNC2(C1)CCCCC2
5605;100604683;0.211;203857;103735229;46878013;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;3-Methoxy-N-methyl-N-[(1R)-2beta-(1-pyrrolidinyl)cyclohexan-1beta-yl]benzeneacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)CC3=CC(=CC=C3)OC
5606;100458409;0.212;204438;103344296;15149421;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;9-Phenyl-15-(4-phenylbutyl)-9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3,5,7-tetraene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCCC4=CC=CC=C4)N(C5=CC=CC=C53)C6=CC=CC=C6
5607;100746225;0.212;204018;103277703;44315578;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor using [3H](+)-SKF-10047 as radioligand;1-Benzyl-4-((1E,3E)-4-phenyl-buta-1,3-dienyloxymethyl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CO/C=C/C=C/C2=CC=CC=C2)CC3=CC=CC=C3
5608;255034740;0.212;625223;103166970;2477;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Buspirone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4
5609;100745596;0.213;204454;103247819;15729905;10280;;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity towards sigma receptor by the displacement of [3H]PPP from guinea pig brain;5-Fluoro-2-{4-[4-(4-fluoro-naphthalen-1-yl)-butyl]-piperazin-1-yl}-pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCCC2=CC=C(C3=CC=CC=C23)F)C4=NC=C(C=N4)F
5610;372355912;0.213;1726849;461543589;162663389;10280;342231650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]pentazocine from human sigma 1 receptor expressed in HEK293 cell membrane incubated for 2 hrs by liquid scintillation counting method;6-(5-Piperidin-1-ylpentoxy)chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCCCCOC2=CC3=C(C=C2)OC=CC3=O
5611;100471780;0.2138;203852;103167216;3559;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
5612;100473787;0.2138;203852;103359671;10020651;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;(S)-1-(4-Fluoro-phenyl)-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butan-1-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCC[C@@H](C2=CC=C(C=C2)F)O)C3=NC=C(C=N3)F
5613;100742361;0.214;203992;103266343;44310017;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"(E)-but-2-enedioic acid;2,8-dimethyl-2-phenyl-1-oxa-8-azaspiro[4.5]decan-4-one";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1(CC(=O)C2(O1)CCN(CC2)C)C3=CC=CC=C3.C(=C/C(=O)O)\C(=O)O
5614;255011806;0.214;625223;103405309;441383;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Terconazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=NC=N4)C5=C(C=C(C=C5)Cl)Cl
5615;100444348;0.215;204470;103214568;14982997;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;8-[6-(4-Hydroxy-piperidin-1-yl)-hexyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCOC2=CC=CC3=C2OC(=CC3=O)C4=CC=CC=C4
5616;100614740;0.215;203986;103283073;14771670;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;1,3-Bis(2-trifluoromethylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC=C(C(=C1)C(F)(F)F)NC(=NC2=CC=CC=C2C(F)(F)F)N
5617;100745607;0.215;204454;103247748;15729917;10280;;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity towards sigma receptor by the displacement of [3H]PPP from guinea pig brain;1-(4-Fluoro-naphthalen-1-yl)-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC(C2=CC=C(C3=CC=CC=C32)F)N)C4=NC=C(C=N4)F
5618;345603247;0.216;1200082;312389842;76684477;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-(3,4-dichlorophenyl)-N-ethyl-N-(2-morpholin-4-ylethyl)triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCN(CCN1CCOCC1)C2=CN(N=N2)C3=CC(=C(C=C3)Cl)Cl
5619;100448336;0.217;204471;103215846;14983041;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-Cyclohexyl-6-[5-(4-hydroxypiperidinyl)pentoxy]-4H-1-benzopyran-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)C2=CC(=O)C3=C(O2)C=CC(=C3)OCCCCCN4CCC(CC4)O
5620;255026445;0.217;625223;103558716;66265;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dexfenfluramine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
5621;389510951;0.217;1805565;459070367;162369105;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Pharmacological Activity Assay from US Patent US11007200: 'Cycloalkyl-diamines for the treatment of pain';US11007200, Example 3b;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN[C@]1(CCCC[C@@H]1NCCCC2=CC=C(C=C2)F)C3=CC=CC=C3Cl
5622;389686470;0.217;1806763;459070367;162369105;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Pharmacological Activity from US Patent US11426411: 'Cycloalkyl-diamines for the treatment of inflammation';US11007200, Example 3b;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN[C@]1(CCCC[C@@H]1NCCCC2=CC=C(C=C2)F)C3=CC=CC=C3Cl
5623;372355917;0.218;1726849;461541177;162661719;10280;342231650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]pentazocine from human sigma 1 receptor expressed in HEK293 cell membrane incubated for 2 hrs by liquid scintillation counting method;6-[5-(Diethylamino)pentoxy]chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CC)CCCCCOC1=CC2=C(C=C1)OC=CC2=O
5624;341107074;0.21878;1063782;194159776;73213196;10280;243651590;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor (unknown origin);5-Methyl-1,5-diazapentacyclo[10.8.1.02,7.08,21.013,18]henicosa-2(7),8(21),9,11,13,15,17-heptaene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2=C(C1)C3=C4N2CCC5=CC=CC=C5C4=CC=C3
5625;100617132;0.22;203985;103671884;14292034;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;"2-(4-Amino-2-methylphenyl)-1-(2-methylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC2=C(C=C(C=C2)N)C)N.Cl
5626;341107073;0.22;1063782;194159776;73213196;10280;243651590;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor (unknown origin);5-Methyl-1,5-diazapentacyclo[10.8.1.02,7.08,21.013,18]henicosa-2(7),8(21),9,11,13,15,17-heptaene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2=C(C1)C3=C4N2CCC5=CC=CC=C5C4=CC=C3
5627;345690974;0.22;1178569;194159776;73213196;10280;248637440;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin);5-Methyl-1,5-diazapentacyclo[10.8.1.02,7.08,21.013,18]henicosa-2(7),8(21),9,11,13,15,17-heptaene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2=C(C1)C3=C4N2CCC5=CC=CC=C5C4=CC=C3
5628;367490648;0.22;1661755;442055669;75448340;10280;328320230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from recombinant sigma 1 receptor (unknown origin) expressed in baculovirus infected Sf9 cell membranes after 1.5 hrs by scintillation counting analysis;3-[[[1-(3-Chloro-4-fluorophenyl)pyrrolidin-3-yl]amino]methyl]benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;521.0;;;;C1CN(CC1NCC2=CC(=CC=C2)C(=O)N)C3=CC(=C(C=C3)F)Cl
5629;388740579;0.22;1797293;386051275;118282966;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 30;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=C(C2)C=C(C=C3)F
5630;388879196;0.22;1797475;386051275;118282966;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 30;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=C(C2)C=C(C=C3)F
5631;389383809;0.22;1804286;386051275;118282966;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 30;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=C(C2)C=C(C=C3)F
5632;100536553;0.221;204457;103673441;45262008;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-[2-Bromo-5-ethyl-3-(trifluoromethyl)phenyl]-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=CC(=CC(=C2Br)C(F)(F)F)CC)N.Cl
5633;100600969;0.221;203996;103251918;11957597;10280;25470740;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was evaluated for binding affinity towards sigma opioid receptor using [3H](+)-3-PPP in guinea pig ileum;(-)-cis-(1S,2R)-U-50488 tartrate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;21160;Ileum;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)CC3=CC(=C(C=C3)Cl)Cl
5634;100741880;0.223;203992;103671581;45260646;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"2-[2-(Dimethylamino)ethyl]-2,4-diphenylfuran-3-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(C)CCC1(C(=O)C(=CO1)C2=CC=CC=C2)C3=CC=CC=C3.Cl
5635;380826175;0.223;1914570;461514852;155557564;10280;;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000741a SIGMAR1;Gsi-NC;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC(=O)N1CCCC1CNC2CCC(CC2)(C3=C(C=CC(=C3)F)F)S(=O)(=O)C4=CC=C(C=C4)Cl
5636;409047182;0.223;1794447;440199577;155557564;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Gsi-NC;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC(=O)N1CCCC1CNC2CCC(CC2)(C3=C(C=CC(=C3)F)F)S(=O)(=O)C4=CC=C(C=C4)Cl
5637;409047183;0.22387;1794447;440199577;155557564;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Gsi-NC;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC(=O)N1CCCC1CNC2CCC(CC2)(C3=C(C=CC(=C3)F)F)S(=O)(=O)C4=CC=C(C=C4)Cl
5638;100536688;0.224;204457;103673583;45262116;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-[2,5-Dibromo-3-(trifluoromethyl)phenyl]-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=CC(=CC(=C2Br)C(F)(F)F)Br)N.Cl
5639;100604310;0.224;203857;103735220;46878005;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;4-Chloro-N-methyl-N-[(1R)-2beta-(1-pyrrolidinyl)cyclohexan-1beta-yl]benzeneacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)CC3=CC=C(C=C3)Cl
5640;326035176;0.224;701162;163331302;11604103;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;4-[2-[1-(3,4-Dichlorophenyl)-5-phenylpyrazol-3-yl]oxyethyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1COCCN1CCOC2=NN(C(=C2)C3=CC=CC=C3)C4=CC(=C(C=C4)Cl)Cl
5641;100445891;0.226;204470;103215451;14982977;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-{6-[(2-Hydroxy-ethyl)-methyl-amino]-hexyloxy}-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCCCCOC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3)CCO
5642;100448355;0.227;204471;103215030;14982955;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(8-Dimethylamino-octyloxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCCCCCCCOC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3
5643;100467668;0.227;203697;103329969;10254219;10280;82952200;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma 1 receptor was determined in guinea pig brain membrane using [3H](+)-pentazocine as radioligand;Tetrahydro-1-[2-[methyl[2-[methyl[2-[methyl[2-[methyl[2-(3,4-dichlorophenyl)ethyl]amino]ethyl]amino]ethyl]amino]ethyl]amino]ethyl]-1H-pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCC1=CC(=C(C=C1)Cl)Cl)CCN(C)CCN(C)CCN(C)CCN2CCCC2
5644;100745595;0.227;204454;103247717;15729914;10280;;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity towards sigma receptor by the displacement of [3H]PPP from guinea pig brain;2-(4-Fluoro-phenyl)-5-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-pentanoic acid methyl ester;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)OC(CCCN1CCN(CC1)C2=NC=C(C=N2)F)C3=CC=C(C=C3)F
5645;372355913;0.227;1726849;461543320;141317016;10280;342231650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]pentazocine from human sigma 1 receptor expressed in HEK293 cell membrane incubated for 2 hrs by liquid scintillation counting method;6-(4-Pyrrolidin-1-ylbutoxy)chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(C1)CCCCOC2=CC3=C(C=C2)OC=CC3=O
5646;100497411;0.228;203984;103434527;192638;10280;76997100;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;4-(3-(1,2-Dihydro-6-methoxynaphthalen-4-yl)-n-propyl)-1-(2-methoxyphenyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(CCC=C2CCCN3CCN(CC3)C4=CC=CC=C4OC)C=C1
5647;100604312;0.228;203857;103735208;46877999;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;4-Bromo-N-methyl-N-[(1R)-2beta-(1-pyrrolidinyl)cyclohexan-1beta-yl]benzeneacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)CC3=CC=C(C=C3)Br
5648;389483954;0.228;1805386;444858107;132060798;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A35;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CCN(CC1)C2=CC3=C(CCCN(C3)C(=O)OCC4=CC=CC=C4)C=C2
5649;100298500;0.23;239347;103458478;50266;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;Carbizocaine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCCCCOC1=CC=CC=C1NC(=O)OC(C)CN(CC)CC
5650;100317840;0.23;204297;103361690;10668517;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;TIn vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine.;[1-(4-Methoxy-3-phenethyloxy-benzyl)-heptyl]-propyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)NCCC
5651;100317843;0.23;204297;103678347;19606389;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;TIn vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine.;"1-[4-methoxy-3-(2-phenylethoxy)phenyl]-N-propylhexan-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)NCCC.Cl
5652;100319810;0.23;204154;103361793;10599798;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;[1-(4-Methoxy-3-phenethyloxy-benzyl)-octyl]-dipropyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N(CCC)CCC
5653;100354291;0.23;204790;103237481;10718492;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-[[(2R)-1-Benzyl-2-pyrrolidinyl]methyl]-1-methoxy-4-bromo-2-naphthalenecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)NC[C@H]3CCCN3CC4=CC=CC=C4
5654;155735836;0.23;476062;103167216;3559;10280;198752050;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H](+)-pentazocine from sigma 1 opioid receptor in human Jurkat cells by scintillation counting;Haloperidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
5655;100458528;0.231;204438;103344298;15149419;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;15-(4-Phenylbutyl)-9-propan-2-yl-9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3,5,7-tetraene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)N1C2=C(C3CCC(C2)N3CCCCC4=CC=CC=C4)C5=CC=CC=C51
5656;100487778;0.231;204638;103318449;44332500;10280;76368610;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was measured on Sigma receptor type 1 using [3H]- pentazocine as radioligand;10-Benzyl-5-iodo-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=CC(=C(C=C3C1(CCN2CC4=CC=CC=C4)C)O)I
5657;100513222;0.231;229197;103384246;10732853;10280;89413830;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor using radioligand ([3H](+)-pentazocine) binding assay;N-(2-Benzhydryloxy-ethyl)-N,N''-dimethyl-ethane-1,2-diamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CNCCN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
5658;380264302;0.231;1811100;475995701;126509802;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[4-(4-propylpiperazin-1-yl)oxan-4-yl]methyl]-N-[6-(trifluoromethyl)pyridin-2-yl]propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCN(CC1)C2(CCOCC2)CN(C3=CC=CC(=N3)C(F)(F)F)C(=O)CC
5659;100323294;0.232;204789;103394707;9885114;10280;106027030;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]- pentazocine binding against guinea pig brain Sigma opioid receptor type 1;7-((4-(4-Chlorophenyl)piperazin-1-yl)methyl)-4H-1,4-benzoxazin-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2=CC3=C(C=C2)NC(=O)CO3)C4=CC=C(C=C4)Cl
5660;100445883;0.232;204470;103215467;14983028;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-(4-Hydroxy-piperidin-1-yl)-hexyloxy]-2-thiophen-2-yl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CS4
5661;100741868;0.232;203992;103677346;45264492;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"8-[(3-Chlorophenyl)methyl]-3-phenyl-1-oxa-8-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC12C(=O)C(=CO2)C3=CC=CC=C3)CC4=CC(=CC=C4)Cl.Cl
5662;363896556;0.232;1456743;103394707;9885114;10280;284899500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma1 receptor (unknown origin);7-((4-(4-Chlorophenyl)piperazin-1-yl)methyl)-4H-1,4-benzoxazin-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2=CC3=C(C=C2)NC(=O)CO3)C4=CC=C(C=C4)Cl
5663;326034951;0.233;701162;163331300;24739748;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-[1-(3,4-Dichlorophenyl)pyrazol-3-yl]oxy-3-(4-methylpiperazin-1-yl)propan-2-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CN1CCN(CC1)CC(COC2=NN(C=C2)C3=CC(=C(C=C3)Cl)Cl)O
5664;100403999;0.234;204630;103166191;5311189;10280;128012230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma receptor type 1 was determined by the displacement of [3H]pentazocine radioligand;Preclamol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCC[C@H](C1)C2=CC(=CC=C2)O
5665;100458527;0.234;204438;103344900;15149394;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;11-(2-Phenylethyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCC4=CC=CC=C4)NC5=CC=CC=C53
5666;100536554;0.234;204457;103673430;45261999;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"1-(3-Ethylphenyl)-2-(2-iodophenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=CC=CC=C2I)N.Cl
5667;388996820;0.234;1798943;405263593;86582002;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';(R)-2-(4-methyl-piperazin-1-yl)-1-((S)-3,4,10,10a-tetrahydro-pyrazino[1,2-a]indol-2(1H)-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](C(=O)N1CCN2[C@H](C1)CC3=CC=CC=C32)N4CCN(CC4)C
5668;100333245;0.23442;204944;103278781;10733648;10280;108823620;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was performed using [3H](+)-pentazocine to label sigma-1 binding sites, in guinea pig cerebral cortex;2-[(4-Chlorophenyl)methyl]-1-(4-pyrrolidin-1-ylbutyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CCN(C1)CCCCNC(=NCC2=CC=C(C=C2)Cl)N
5669;100473785;0.23442;203852;103206445;4020;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;Mazindol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN2C(=N1)C3=CC=CC=C3C2(C4=CC=C(C=C4)Cl)O
5670;100448318;0.235;204471;103214723;44285300;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-Phenyl-6-[6-(2-pyridin-2-yl-piperazin-1-yl)-hexyloxy]-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(C(CN1)C2=CC=CC=N2)CCCCCCOC3=CC4=C(C=C3)OC(=CC4=O)C5=CC=CC=C5
5671;100456542;0.235;229183;103360269;14970530;10280;79028690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor in bovine cerebellum using 2.0 nM [3H]haloperidol in the presence of 25 nM unlabeled spiperone;3-[4-(4-Chloro-phenyl)-3,6-dihydro-2H-pyridin-1-yl]-1-(3,4-difluoro-phenyl)-propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CN(CC=C1C2=CC=C(C=C2)Cl)CCC(=O)C3=CC(=C(C=C3)F)F
5672;255029000;0.2354;625223;103215995;1549008;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Terbinafine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)C#C/C=C/CN(C)CC1=CC=CC2=CC=CC=C21
5673;100366980;0.2355;226337;103376482;10946809;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-(1-Benzyl-piperidin-4-yl)-2-pyridin-2-yl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CC=N2)CC3=CC=CC=C3
5674;100444167;0.237;204470;103214778;14982971;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(6-Morpholin-4-yl-hexyloxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCN1CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
5675;100613260;0.237;204440;103671874;14771735;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]-DTG in guinea pig brain membrane homogenates;"1,3-Dicyclohexyl-2-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN=C(NC1CCCCC1)NC2CCCCC2.Cl
5676;100617157;0.237;203985;103671873;14771737;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;"1,3-Dicyclohexyl-2-octylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCCCCCN=C(NC1CCCCC1)NC2CCCCC2.Cl
5677;366366668;0.237;1558961;440140045;118567593;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;N-[4-[2-(2-methyl-3-oxo-4-phenyl-1-oxa-4,9-diazaspiro[5.5]undecan-9-yl)ethyl]phenyl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=C(C=C3)NC(=O)C)C4=CC=CC=C4
5678;100614622;0.238;203986;103671873;14771737;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;"1,3-Dicyclohexyl-2-octylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCCCCCN=C(NC1CCCCC1)NC2CCCCC2.Cl
5679;255026809;0.238;625223;103358193;4935;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Proparacaine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCOC1=C(C=C(C=C1)C(=O)OCCN(CC)CC)N
5680;100448320;0.239;204471;103214875;14983045;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-Cyclohexyl-6-(6-morpholin-4-yl-hexyloxy)-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)C2=CC(=O)C3=C(O2)C=CC(=C3)OCCCCCCN4CCOCC4
5681;100471338;0.24;204459;103299090;9995041;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N-Indan-2-yl-N''-naphthalen-1-yl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C(CC2=CC=CC=C21)N=C(N)NC3=CC=CC4=CC=CC=C43
5682;372306728;0.24;1701184;461559154;54673625;10280;332377850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;4-[2-[(1-Cyclopentyl-5-methylpyrazol-3-yl)methoxy]ethyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=NN1C2CCCC2)COCCN3CCOCC3
5683;388740581;0.24;1797293;386051302;118282837;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 58;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)F)O
5684;388879451;0.24;1797475;386051302;118282837;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 58;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)F)O
5685;389383811;0.24;1804286;386051302;118282837;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 58;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)F)O
5686;100534026;0.2403;204794;103359352;44350810;10280;93971710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was done in guinea pig membranes by labeling the binding site with [3H](+)-pentazocine;(3S,4S)-1-(4-Fluoro-benzyl)-3-(3-phenyl-8-aza-bicyclo[3.2.1]oct-8-yl)-piperidin-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(C[C@@H]([C@H]1O)N2C3CCC2CC(C3)C4=CC=CC=C4)CC5=CC=C(C=C5)F
5687;100536558;0.241;204457;103673546;22121769;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"1-(2-Chloro-5-ethylphenyl)-3-(3-ethylphenyl)-1,3-dimethylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=N)N(C)C2=C(C=CC(=C2)CC)Cl.Cl
5688;100721053;0.241;204634;103671016;45260240;10280;150260770;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma receptor type 1;"2-[(4aS,10aR)-6-methoxy-2,3,4,10a-tetrahydro-1H-phenanthren-4a-yl]-N-methyl-N-(2-phenylmethoxyethyl)ethanamine;hydrobromide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CC[C@@]12CCCC[C@@H]1C=CC3=C2C=C(C=C3)OC)CCOCC4=CC=CC=C4.Br
5689;345603249;0.241;1200082;312389848;76684479;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-[1-(3,4-Dichlorophenyl)triazol-4-yl]-1-(2-morpholin-4-ylethyl)-3-propylthiourea;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCCNC(=S)N(CCN1CCOCC1)C2=CN(N=N2)C3=CC(=C(C=C3)Cl)Cl
5690;388996787;0.241;1798943;405263592;86582000;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';2-(2-(diethylamino) ethylamino)-1-(3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CC)CCNC(C)C(=O)N1CCN2C(=CC3=CC=CC=C32)C1
5691;100448326;0.242;204471;103215451;14982977;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-{6-[(2-Hydroxy-ethyl)-methyl-amino]-hexyloxy}-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCCCCOC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3)CCO
5692;100471335;0.242;204459;103283132;13781937;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;1,3-Bis(4-isopropylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC(C)C1=CC=C(C=C1)NC(=NC2=CC=C(C=C2)C(C)C)N
5693;372121196;0.242;1681775;461559847;162674852;10280;330649470;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;4-Methyl-2-phenyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC2(CCN(CC2)CCC3=CC=CC=C3)OC(C1=O)C4=CC=CC=C4
5694;100468426;0.243;203697;103330150;10107472;10280;82952200;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma 1 receptor was determined in guinea pig brain membrane using [3H](+)-pentazocine as radioligand;N-[2-(3,4-Dichlorophenyl)ethyl]-N'-(2-aminoethyl)ethylenediamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC(=C(C=C1CCNCCNCCN)Cl)Cl
5695;100471370;0.245;204459;103282888;14771671;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N,N''-Bis(4-ethylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC=C(C=C1)NC(=NC2=CC=C(C=C2)CC)N
5696;100614093;0.245;203986;103677569;14771718;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;"2-(1-adamantyl)-1-[2-[(E)-2-(2,3,4,5,6-pentafluorophenyl)ethenyl]phenyl]guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C2CC3CC1CC(C2)(C3)N=C(N)NC4=CC=CC=C4/C=C/C5=C(C(=C(C(=C5F)F)F)F)F.Cl
5697;100614102;0.245;203986;103282888;14771671;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N,N''-Bis(4-ethylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC=C(C=C1)NC(=NC2=CC=C(C=C2)CC)N
5698;100721052;0.245;204634;103671014;45260238;10280;150260770;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma receptor type 1;"2-[(4aS,10aR)-6-methoxy-2,3,4,10a-tetrahydro-1H-phenanthren-4a-yl]-N,N-dimethylethanamine;hydroiodide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CC[C@@]12CCCC[C@@H]1C=CC3=C2C=C(C=C3)OC.I
5699;334065172;0.245;735278;164146761;71655612;10280;235606500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(3aS,4R,9bS)-4-cyclohexyl-8-pentyl-2,3,3a,4,5,9b-hexahydrofuro[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCCCCC1=CC2=C(C=C1)N[C@@H]([C@H]3[C@@H]2OCC3)C4CCCCC4
5700;372356135;0.245;1726849;461543530;141195411;10280;342231650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]pentazocine from human sigma 1 receptor expressed in HEK293 cell membrane incubated for 2 hrs by liquid scintillation counting method;6-(3-Morpholin-4-ylpropoxy)chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCN1CCCOC2=CC3=C(C=C2)OC=CC3=O
5701;380773273;0.245;1907474;482059330;168277973;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;Benzyl 3-[3-[4-(3-hydroxypropyl)piperazin-1-yl]phenyl]morpholine-4-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCO)C2=CC=CC(=C2)C3COCCN3C(=O)OCC4=CC=CC=C4
5702;389483901;0.245;1805386;160849727;132060763;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';benzyl 7-[4-(2-methylprop-2-enyl)piperazin-1-yl]-3,4-dihydro-1H-isoquinoline-2-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=C)CN1CCN(CC1)C2=CC3=C(CCN(C3)C(=O)OCC4=CC=CC=C4)C=C2
5703;380773262;0.24547;1907474;482059330;168277973;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;Benzyl 3-[3-[4-(3-hydroxypropyl)piperazin-1-yl]phenyl]morpholine-4-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCO)C2=CC=CC(=C2)C3COCCN3C(=O)OCC4=CC=CC=C4
5704;100497234;0.246;203984;103436146;10248164;10280;76997100;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;1-[3-(7-Methoxy-3,4-dihydro-naphthalen-1-yl)-propyl]-4-pyridin-2-yl-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(CCC=C2CCCN3CCN(CC3)C4=CC=CC=N4)C=C1
5705;100471352;0.247;204459;103299480;10037914;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N-Methyl-N,N''-di-m-tolyl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC(=CC=C1)N=C(N)N(C)C2=CC=CC(=C2)C
5706;389712981;0.247;1919146;476002742;166637125;10280;;Confirmatory;20231017;0;0;Active;Q99720;IC50;;BindingDB;Receptor Binding Assay from US Patent US11535596: 'Analogs of dextromethorphan with balanced receptor activities';(1S,9S)-3-bromo-4-methoxy-16-methyl-16-azatetracyclo[7.5.2.01,10.02,7]hexadeca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C[C@@]23CCCCC2[C@@H]1CC4=C3C(=C(C=C4)OC)Br
5707;100367080;0.24836;226337;103376452;10870255;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-(1-Benzyl-piperidin-4-yl)-2-(1H-imidazol-4-yl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CN=CN2)CC3=CC=CC=C3
5708;100534041;0.2493;204794;103359041;44350708;10280;93971710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was done in guinea pig membranes by labeling the binding site with [3H](+)-pentazocine;1-(3,4-Dichloro-phenyl)-2-(3-phenyl-8-aza-bicyclo[3.2.1]oct-8-yl)-ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2CC(CC1N2CC(C3=CC(=C(C=C3)Cl)Cl)O)C4=CC=CC=C4
5709;100317839;0.25;204297;103362048;10713214;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;TIn vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine.;[1-(4-Methoxy-3-phenethyloxy-benzyl)-butyl]-propyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)NCCC
5710;100600838;0.25;203997;103251950;9847317;10280;25470740;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was evaluated for binding affinity towards sigma opioid receptor using [3H]DTG in guinea pig ileum;(-)2-(3,4-Dichloro-phenyl)-N-methyl-N-(2-pyrrolidin-1-yl-cyclohexyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;21160;Ileum;CN([C@H]1CCCC[C@H]1N2CCCC2)C(=O)CC3=CC(=C(C=C3)Cl)Cl
5711;100614095;0.25;203986;103671960;45260873;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;"2-[(10R,13S,17S)-17-acetyl-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]-1-(2-methylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC2CC[C@@]3(C4CC[C@@]5([C@H](CCC5C4CC=C3C2)C(=O)C)C)C)N.Cl
5712;100737354;0.25;203993;103227675;15034740;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor from guinea pig brain using the radioligand [3H]SKF-10047;[4-[(5S)-5-[[4-(1,3-benzodioxol-5-yl)-4-hydroxypiperidin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]phenyl] acetate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)OC1=CC=C(C=C1)N2C[C@@H](OC2=O)CN3CCC(CC3)(C4=CC5=C(C=C4)OCO5)O
5713;389483905;0.25;1805386;160849619;132060743;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';Benzyl 5-(4-methylpiperazin-1-yl)-1,3-dihydroisoindole-2-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)C2=CC3=C(CN(C3)C(=O)OCC4=CC=CC=C4)C=C2
5714;100458511;0.251;204438;103344202;15149398;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;11-[2-(4-Chlorophenoxy)ethyl]-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCOC4=CC=C(C=C4)Cl)NC5=CC=CC=C53
5715;388996814;0.251;1798943;405263606;86582462;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';(R)-1-(3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)-3-(4-methyl-piperazin-1-yl)butan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CC(=O)N1CCN2C(=CC3=CC=CC=C32)C1)N4CCN(CC4)C
5716;365267164;0.25119;1512456;440152149;153287567;10280;316202300;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-3a,8-dimethyl-5-(4-methylphenyl)-2,3,4,9b-tetrahydro-1H-pyrrolo[2,3-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=C(C=C1)N2C[C@@]3([C@@H](CCN3)C4=C2C=CC(=C4)C)C
5717;366435741;0.25119;1593893;440143355;155532495;10280;309877800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK293T cell membranes;(NE)-N-[2-[2-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]ethyl]-5-fluoro-2,3-dihydroinden-1-ylidene]hydroxylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=CC=C(C=C2)Cl)CCC\3CC4=C(/C3=N/O)C=CC(=C4)F
5718;366437095;0.25119;1594273;440151474;146641787;10280;309043830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;[1-Benzyl-5-[(4-fluorophenyl)methylamino]-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)C(=O)C2=NN(C3=C2CC(CC3)NCC4=CC=C(C=C4)F)CC5=CC=CC=C5
5719;366437243;0.25119;1594273;440153424;146597677;10280;309043830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;[1-Benzyl-5-(2-pyridin-4-ylethylamino)-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)C(=O)C2=NN(C3=C2CC(CC3)NCCC4=CC=NC=C4)CC5=CC=CC=C5
5720;100448357;0.254;204471;103215565;14983037;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-(4-Hydroxypiperidinyl)hexoxy]-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=CC(=C3)OCCCCCCN4CCC(CC4)O
5721;100778220;0.254;204017;103272882;44313218;10280;98735270;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for [3H]- pentazocine at sigma opioid receptor;(2S)-2-[(4R)-4-(4-aminobutyl)-3-benzyl-2,5-dioxoimidazolidin-1-yl]-3-cyclohexylpropanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)C[C@@H](C(=O)N)N2C(=O)[C@H](N(C2=O)CC3=CC=CC=C3)CCCCN
5722;389536398;0.255;1805702;384583187;129067918;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';benzyl (1R,8R)-5-(4-propylpiperazin-1-yl)-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene-9-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCN(CC1)C2=CC3=C(C=C2)[C@@H]4CCN([C@@H]3C4)C(=O)OCC5=CC=CC=C5
5723;389536465;0.255;1805702;384583187;129067918;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';benzyl (1R,8R)-5-(4-propylpiperazin-1-yl)-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene-9-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCN(CC1)C2=CC3=C(C=C2)[C@@H]4CCN([C@@H]3C4)C(=O)OCC5=CC=CC=C5
5724;255009823;0.256;625223;103243329;3055;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Diphenidol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCN(CC1)CCCC(C2=CC=CC=C2)(C3=CC=CC=C3)O
5725;100444474;0.257;204470;103215737;14982950;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(3-Dimethylamino-propoxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCCOC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3
5726;100333028;0.25704;204944;103278260;10810249;10280;108823620;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was performed using [3H](+)-pentazocine to label sigma-1 binding sites, in guinea pig cerebral cortex;1-[(4-Chlorophenyl)methyl]-1-(7-pyrrolidin-1-ylheptyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CCN(C1)CCCCCCCN(CC2=CC=C(C=C2)Cl)C(=N)N
5727;380264152;0.258;1811100;475986785;137371411;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[4-[4-(2-methoxyethyl)piperazin-1-yl]oxan-4-yl]methyl]-N-[6-(trifluoromethyl)pyridin-2-yl]propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CCOCC1)N2CCN(CC2)CCOC)C3=CC=CC(=N3)C(F)(F)F
5728;100444478;0.259;204470;103215708;14983030;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-(3-Fluorophenyl)-6-[6-(4-hydroxypiperidinyl)hexoxy]-4H-1-benzopyran-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC(=CC=C4)F
5729;389712849;0.259;1919146;103915533;5360697;10280;;Confirmatory;20231017;0;0;Active;Q99720;IC50;;BindingDB;Receptor Binding Assay from US Patent US11535596: 'Analogs of dextromethorphan with balanced receptor activities';Dextrorphan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)O
5730;100297854;0.26;239347;103175608;5994;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;Progesterone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C
5731;100445886;0.261;204470;103214917;14983044;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[5-(4-Hydroxy-piperidin-1-yl)-pentyloxy]-2-isobutyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CC1=CC(=O)C2=C(O1)C=CC(=C2)OCCCCCN3CCC(CC3)O
5732;100536700;0.261;204457;103673500;45262053;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-[2-Bromo-5-ethyl-3-(trifluoromethoxy)phenyl]-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=C(C(=CC(=C2)CC)OC(F)(F)F)Br)N.Cl
5733;100459188;0.262;204437;103343851;15149400;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;11-(3-Phenoxypropyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCOC4=CC=CC=C4)NC5=CC=CC=C53
5734;100444472;0.263;204470;103214987;18959716;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[4-(4-Hydroxy-piperidin-1-yl)-butoxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
5735;100497243;0.263;203984;103166970;2477;10280;76997100;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity measured on sigma opioid receptor using [3H]DTG as radioligand;Buspirone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4
5736;380797855;0.263;1914295;312359684;59652086;10280;;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000726a SIGMAR1;5-[[benzyl(methyl)amino]methyl]-N-[(3-methoxyphenyl)methyl]-4-oxo-3H-thieno[2,3-d]pyrimidine-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CC1=CC=CC=C1)CC2=CSC3=C2C(=O)NC(=N3)C(=O)NCC4=CC(=CC=C4)OC
5737;409050112;0.263;1794447;312359684;59652086;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;5-[[benzyl(methyl)amino]methyl]-N-[(3-methoxyphenyl)methyl]-4-oxo-3H-thieno[2,3-d]pyrimidine-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CC1=CC=CC=C1)CC2=CSC3=C2C(=O)NC(=N3)C(=O)NCC4=CC(=CC=C4)OC
5738;409050113;0.26303;1794447;312359684;59652086;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;5-[[benzyl(methyl)amino]methyl]-N-[(3-methoxyphenyl)methyl]-4-oxo-3H-thieno[2,3-d]pyrimidine-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CC1=CC=CC=C1)CC2=CSC3=C2C(=O)NC(=N3)C(=O)NCC4=CC(=CC=C4)OC
5739;255036180;0.264;625223;103220983;3955;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Loperamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
5740;100386144;0.265;204153;103248082;108046;10280;117841480;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma opioid receptor type 1 affinity in guinea pig brain by employing [3H](+)-pentazocine as radioligand.;alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC(C2=CC=C(C=C2)F)O)C3=NC=C(C=N3)F
5741;100387738;0.265;204145;103248082;108046;10280;123830180;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine from Sigma opioid receptor type 1 of guinea pig brain;alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC(C2=CC=C(C=C2)F)O)C3=NC=C(C=N3)F
5742;100500107;0.265;204466;103237280;10337232;10280;85688040;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]DTG binding to sigma receptor from guinea pig brain cortex membrane;N-[3-[(5-Methoxy-1,2,3,4-tetrahydronaphthalen)-1-yl]propyl]-N'-phenyl-1,2-ethanediamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCCC2CCCNCCNC3=CC=CC=C3
5743;100745913;0.265;204147;103248082;108046;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma opioid receptor type 1 in guinea pig brain homogenate with 0.5 nM [3H](+)-PENT;alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCCC(C2=CC=C(C=C2)F)O)C3=NC=C(C=N3)F
5744;255025665;0.265;625223;124972228;3158;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Zonalon;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31
5745;100458397;0.267;204438;103344254;15149420;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;5-Benzyl-11-(4-phenylbutyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCCC4=CC=CC=C4)N(C5=CC=CC=C53)CC6=CC=CC=C6
5746;354664024;0.269;1288457;103720246;5290;10280;270328900;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma1 receptor by PDSP assay;3,9-dimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline-2,10-diol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=C2C3CC4=C(CN3CCC2=C1)C(=C(C=C4)O)OC)O
5747;100367076;0.26915;226337;103375771;11012319;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-(1-Benzyl-piperidin-4-yl)-2-pyridin-3-yl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CN=CC=C2)CC3=CC=CC=C3
5748;100444180;0.27;204470;103214979;18959700;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[5-(4-Hydroxy-piperidin-1-yl)-pentyloxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
5749;100500106;0.27;204466;103237425;10827238;10280;85688040;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]DTG binding to sigma receptor from guinea pig brain cortex membrane;1-[3-(7-Methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-propyl]-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(CCCC2CCCN3CCNCC3)C=C1
5750;100614628;0.27;203986;103283132;13781937;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;1,3-Bis(4-isopropylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC(C)C1=CC=C(C=C1)NC(=NC2=CC=C(C=C2)C(C)C)N
5751;100737362;0.27;203993;103228475;44292277;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor from guinea pig brain using the radioligand [3H]SKF-10047;(5R)-5-[[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]methyl]-3-(4-methoxyphenyl)-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)N2C[C@H](OC2=O)CN3CCC(CC3)(C4=CC=C(C=C4)Cl)O
5752;340019684;0.27;752428;174517049;49853576;10280;236018160;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;2-(1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazin-2-yl)-N-cyclohexylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)NC(=O)CN2CCN3CCCCC3C2
5753;100614105;0.271;203986;103283072;3315413;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;1,3-Dicyclohexyl-2-hydroxyguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)NC(=NC2CCCCC2)NO
5754;255010203;0.271;625223;103178920;4926;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Promazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31
5755;345602960;0.273;1200082;312389811;76684481;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-(2,4-difluorophenyl)-N-(2-piperidin-1-ylethyl)triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)CCNC2=CN(N=N2)C3=C(C=C(C=C3)F)F
5756;100619158;0.275;203990;103173474;6430604;10280;18482950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma opioid receptor in guinea pig cerebral homogenate using [3H]DTG as radioligand;alpha-methyl-N-(1-phenylethyl)-benzenethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(CC1=CC=CC=C1)NC(C)C2=CC=CC=C2
5757;345602973;0.275;1200082;312389819;76684304;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-[4-[2-[[1-(3,4-Dichlorophenyl)triazol-4-yl]amino]ethyl]piperazin-1-yl]ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC(=O)N1CCN(CC1)CCNC2=CN(N=N2)C3=CC(=C(C=C3)Cl)Cl
5758;366366659;0.275;1558961;440134801;118567549;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;N,N-dimethyl-2-[3-oxo-4-phenyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-2-yl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CN(C)C(=O)CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C4=CC=CC=C4
5759;100507182;0.276;204150;103346132;401810;10280;87844550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from Sigma opioid receptor type 1 in guinea pig brain membrane;4-{2-[Methyl-(2-pyrrolidin-1-yl-ethyl)-amino]-ethyl}-phenylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCC1=CC=C(C=C1)N)CCN2CCCC2
5760;389483963;0.276;1805386;444858087;132060756;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example KTL-01-Table 3.A15;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)C2=CC3=C(CN(CC3)C(=O)OCC4=CC=CC=C4)C=C2
5761;100708111;0.2765;204146;103252214;11304676;10280;146843270;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma opioid receptor of guiena pig brain membrane;N-[2-(1,2,3,4-Tetrahydroisoquinoline-2-yl)ethyl]-2,3-dimethoxy-5-bromobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC(=CC(=C1OC)C(=O)NCCN2CCC3=CC=CC=C3C2)Br
5762;100627300;0.277;229194;103330151;15113301;10280;13101140;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+) -3PPP from sigma receptor in guinea pig brain membranes;2-(3,4-Dichlorophenyl)-N-(2-aminoethyl)ethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC(=C(C=C1CCNCCN)Cl)Cl
5763;366435742;0.277;1593893;440143355;155532495;10280;309877800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK293T cell membranes;(NE)-N-[2-[2-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]ethyl]-5-fluoro-2,3-dihydroinden-1-ylidene]hydroxylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=CC=C(C=C2)Cl)CCC\3CC4=C(/C3=N/O)C=CC(=C4)F
5764;372120977;0.277;1681775;461528054;118560990;10280;330649470;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;(2R)-2,4-dimethyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)C
5765;100604314;0.278;203857;103735225;6712751;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;2-(2,4-dichlorophenyl)-N-methyl-N-[(1R,2S)-2-pyrrolidin-1-ylcyclohexyl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)CC3=C(C=C(C=C3)Cl)Cl
5766;372306741;0.278;1701184;461562331;152639484;10280;332377850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;1-[2-[[1-(3,4-Dichlorophenyl)-5-methylpyrazol-3-yl]methoxy]ethyl]piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)COCCN3CCNCC3
5767;342811089;0.279;1129882;242620284;90655533;10280;246178360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human RPMI8226 cell membranes after 120 mins by scintillation counting analysis;2-[(2S)-1-benzyl-4-butylpiperazin-2-yl]ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;CCCCN1CCN([C@H](C1)CCO)CC2=CC=CC=C2
5768;100614614;0.28;203986;103671884;14292034;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;"2-(4-Amino-2-methylphenyl)-1-(2-methylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC2=C(C=C(C=C2)N)C)N.Cl
5769;100534033;0.28075;204794;103359026;44350704;10280;93971710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was done in guinea pig membranes by labeling the binding site with [3H](+)-pentazocine;1-(4-Fluoro-phenyl)-2-(3-phenyl-8-aza-bicyclo[3.2.1]oct-8-yl)-ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2CC(CC1N2CC(=O)C3=CC=C(C=C3)F)C4=CC=CC=C4
5770;100456541;0.281;229183;103360267;14970532;10280;79028690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor in bovine cerebellum using 2.0 nM [3H]haloperidol in the presence of 25 nM unlabeled spiperone;1-Benzo[1,3]dioxol-5-yl-3-[4-(4-chloro-phenyl)-3,6-dihydro-2H-pyridin-1-yl]-propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CN(CC=C1C2=CC=C(C=C2)Cl)CCC(=O)C3=CC4=C(C=C3)OCO4
5771;100458426;0.281;204437;103344299;15149381;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;9-Methyl-15-(4-phenylbutyl)-9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3,5,7-tetraene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=C(C3CCC(C2)N3CCCCC4=CC=CC=C4)C5=CC=CC=C51
5772;100458423;0.282;204437;103344425;44344745;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;8-Fluoro-2-(3-pyridin-4-yl-propyl)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CC2=C1NC3=C2C=C(C=C3)F)CCCC4=CC=NC=C4
5773;372120970;0.282;1681775;461530597;20522011;10280;330649470;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;4-Methyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC2(CCN(CC2)CCC3=CC=CC=C3)OCC1=O
5774;100458425;0.283;204437;103212371;15149406;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;11-[4-(4-Fluorophenyl)-4-oxobutyl]-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCC(=O)C4=CC=C(C=C4)F)NC5=CC=CC=C53
5775;100534025;0.283;204794;103293288;10436105;10280;93971710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was done in guinea pig membranes by labeling the binding site with [3H](+)-pentazocine;(3R,4R)-1-(3-Iodobenzyl)-3-[spiro[indan-1,4'-piperidin]-1'-yl]piperidin-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(C[C@H]([C@@H]1O)N2CCC3(CCC4=CC=CC=C43)CC2)CC5=CC(=CC=C5)I
5776;100295636;0.285;239200;103441929;10616657;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;2-[(4-Benzylpiperidino)methyl]chromone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3=CC(=O)C4=CC=CC=C4O3
5777;100322117;0.285;204139;103394707;9885114;10280;106027030;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of [3H]- pentazocine binding against guinea pig brain Sigma opioid receptor type 1;7-((4-(4-Chlorophenyl)piperazin-1-yl)methyl)-4H-1,4-benzoxazin-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2=CC3=C(C=C2)NC(=O)CO3)C4=CC=C(C=C4)Cl
5778;100534039;0.286;204794;103359377;10780604;10280;93971710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was done in guinea pig membranes by labeling the binding site with [3H](+)-pentazocine;(1R,2R)-2-[1-Methylspiro[indoline-3,4'-piperidin]-1'-yl]cyclohexanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC2(CCN(CC2)[C@@H]3CCCC[C@H]3O)C4=CC=CC=C41
5779;255012207;0.286;625223;103170049;5035;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Raloxifene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O
5780;100546843;0.2865;203685;103278560;10805927;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-Benzyl-piperidin-4-yl)-2-(4-hydroxy-phenyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=C(C=C2)O)CC3=CC=CC=C3
5781;255020067;0.287;625223;103189029;4927;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Promethazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
5782;100333037;0.2884;204944;103278511;9930604;10280;108823620;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was performed using [3H](+)-pentazocine to label sigma-1 binding sites, in guinea pig cerebral cortex;1-(4-Chlorobenzyl)-1-(5-(pyrrolidin-1-yl)pentyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CCN(C1)CCCCCN(CC2=CC=C(C=C2)Cl)C(=N)N
5783;380823399;0.289;1914973;461559821;162674834;10280;;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000289bCl SIGMAR1;"(2R,3S,4R)-1-[2-(dibutylamino)-2-oxoethyl]-2-(2,2-dimethylpentyl)-4-(7-methoxy-1,3-benzodioxol-5-yl)pyrrolidine-3-carboxylic acid;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCN(CCCC)C(=O)CN1C[C@H]([C@@H]([C@H]1CC(C)(C)CCC)C(=O)O)C2=CC3=C(C(=C2)OC)OCO3.Cl
5784;100507189;0.291;204150;103345222;401812;10280;87844550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from Sigma opioid receptor type 1 in guinea pig brain membrane;2-{2-[Methyl-(2-pyrrolidin-1-yl-ethyl)-amino]-ethyl}-phenylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCC1=CC=CC=C1N)CCN2CCCC2
5785;363665760;0.292;1415921;404699624;71223427;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;2,4-Dichloro-N-(1-(2-(piperidin-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)benzamide hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=NC=NC(=C3C=N2)NC(=O)C4=C(C=C(C=C4)Cl)Cl
5786;388996789;0.292;1798943;405263587;86581848;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';1-(3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)-4-(4-methyl-piperazin-1-yl)butan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)CCCC(=O)N2CCN3C(=CC4=CC=CC=C43)C2
5787;326034950;0.294;701162;163320938;11544597;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-(3,4-Dichlorophenyl)-3-(2-imidazol-1-ylethoxy)-5-methylpyrazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)OCCN3C=CN=C3
5788;363666003;0.294;1415967;404698204;71225996;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(3-Phenylpyrrolidin-1-yl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=C(C=N2)C(=NC=N3)N4CCC(C4)C5=CC=CC=C5
5789;389536396;0.294;1805702;459092173;141643607;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';1-[(1R,8R)-5-(4-methylpiperazin-1-yl)-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-trien-9-yl]-3-phenylpropan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)C2=CC3=C(C=C2)[C@@H]4CCN([C@@H]3C4)C(=O)CCC5=CC=CC=C5
5790;409048611;0.29512;1794447;440153796;91827581;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(2R,3S,4R)-1-[2-(dibutylamino)-2-oxoethyl]-2-(2,2-dimethylpentyl)-4-(7-methoxy-1,3-benzodioxol-5-yl)pyrrolidine-3-carboxylic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCN(CCCC)C(=O)CN1C[C@H]([C@@H]([C@H]1CC(C)(C)CCC)C(=O)O)C2=CC3=C(C(=C2)OC)OCO3
5791;326035325;0.296;701162;163334749;54591112;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-[4-[4-(5-Methyl-1-naphthalen-2-ylpyrazol-3-yl)oxybutyl]piperazin-1-yl]ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)OCCCCN4CCN(CC4)C(=O)C
5792;100448363;0.297;204471;103215027;14982957;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(10-Dimethylamino-decyloxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCCCCCCCCCOC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3
5793;100741865;0.298;203992;103677367;45264507;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"8-Methyl-2-phenyl-1-oxa-8-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN1CCC2(CC1)C(=O)C=C(O2)C3=CC=CC=C3.Cl
5794;409048610;0.298;1794447;440153796;91827581;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(2R,3S,4R)-1-[2-(dibutylamino)-2-oxoethyl]-2-(2,2-dimethylpentyl)-4-(7-methoxy-1,3-benzodioxol-5-yl)pyrrolidine-3-carboxylic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCN(CCCC)C(=O)CN1C[C@H]([C@@H]([C@H]1CC(C)(C)CCC)C(=O)O)C2=CC3=C(C(=C2)OC)OCO3
5795;100367039;0.29847;226337;103375248;10902954;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-(1-Benzyl-piperidin-4-yl)-2-pyridin-4-yl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=NC=C2)CC3=CC=CC=C3
5796;100367072;0.29856;226337;103376009;10862129;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-(1-Benzyl-piperidin-4-yl)-2-(6-methoxy-3-oxo-indan-1-yl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC2=C(C=C1)C(=O)CC2CC(=O)NC3CCN(CC3)CC4=CC=CC=C4
5797;100536690;0.299;204457;160703007;70695521;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(2-Bromo-3-ethyl-5-methylsulfanylphenyl)-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=CC(=CC(=C2Br)CC)SC)N.Cl
5798;100467867;0.3;204005;103325632;44336430;10280;79325350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vivo binding affinity against sigma Opioid receptor was measured by using labeled ligand [3H]-SKF- 10,047 (1 nM);(4aS,7R,7aR,12bS)-3-Cyclopropylmethyl-2,3,4,4a,5,6,7,7a-octahydro-1H-8-oxa-3-aza-benzo[d]fluorene-7,9-diol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C[C@H]([C@H]2[C@@]3([C@H]1CN(CC3)CC4CC4)C5=C(O2)C(=CC=C5)O)O
5799;100614741;0.3;203986;103283316;14771698;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N-Adamantan-1-yl-N''-biphenyl-2-yl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C2CC3CC1CC(C2)(C3)N=C(N)NC4=CC=CC=C4C5=CC=CC=C5
5800;100737356;0.3;203993;103228476;44292278;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor from guinea pig brain using the radioligand [3H]SKF-10047;(5R)-5-[[4-(4-fluorophenyl)-4-hydroxypiperidin-1-yl]methyl]-3-(4-methoxyphenyl)-1,3-oxazolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)N2C[C@H](OC2=O)CN3CCC(CC3)(C4=CC=C(C=C4)F)O
5801;347072483;0.3;1256440;318396838;122195524;10280;264755180;Confirmatory;20220830;0;0;Active;Q99720;Ki;<;ChEMBL;Displacement of [3H]-Pentazocine from recombinant human sigma-1 receptor after 1.5 hrs by Microbeta scintillation counting analysis;19-[(4-Bromophenyl)methoxy]-18-methoxy-13-methyl-5,7-dioxa-13-azapentacyclo[10.7.1.02,10.04,8.016,20]icosa-1(20),2,4(8),9,16,18-hexaene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2=CC(=C(C3=C2C1CC4=CC5=C(C=C43)OCO5)OCC6=CC=C(C=C6)Br)OC
5802;363665118;0.3;1415967;404708229;74767125;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(2-Ethoxyphenyl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC1=CC=CC=C1C2=C3C=NN(C3=NC=N2)CCN4CCCCC4
5803;100604303;0.302;203857;103735223;46878008;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;3,4,5-Trimethoxy-N-methyl-N-[(1R)-2beta-(1-pyrrolidinyl)cyclohexan-1beta-yl]benzeneacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)CC3=CC(=C(C(=C3)OC)OC)OC
5804;334065184;0.302;735278;164149702;71655610;10280;235606500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(3aS,4R,9bS)-8-(4-chlorophenoxy)-4-cyclohexyl-2,3,3a,4,5,9b-hexahydrofuro[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCC(CC1)[C@@H]2[C@@H]3CCO[C@@H]3C4=C(N2)C=CC(=C4)OC5=CC=C(C=C5)Cl
5805;354626882;0.302;1272388;174496429;50878551;10280;267397810;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) by competition binding assay;N,N-Diallyl-5-methoxytryptamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(C=C1)NC=C2CCN(CC=C)CC=C
5806;100534029;0.3024;204794;103359044;44350710;10280;93971710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was done in guinea pig membranes by labeling the binding site with [3H](+)-pentazocine;1-(2,6-Dichloro-phenyl)-2-(3-phenyl-8-aza-bicyclo[3.2.1]oct-8-yl)-ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2CC(CC1N2CC(C3=C(C=CC=C3Cl)Cl)O)C4=CC=CC=C4
5807;255029001;0.3056;625223;103250420;119584;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mosapride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCOC1=CC(=C(C=C1C(=O)NCC2CN(CCO2)CC3=CC=C(C=C3)F)Cl)N
5808;100444336;0.308;204470;103215880;14983038;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-(4-Hydroxy-piperidin-1-yl)-hexyloxy]-2-pyridin-4-yl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=NC=C4
5809;100435059;0.309;203682;103275170;9513;10280;150841290;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity at opioid sigma-1 receptor in guinea pig brain membranes by (+)-[3H]pentazocine displacement.;1-Phenethylpiperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCN(CC1)CCC2=CC=CC=C2
5810;100536557;0.309;204457;103678459;45265290;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(2-Chloro-3-ethyl-5-methylsulfanylphenyl)-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=CC(=CC(=C2Cl)CC)SC)N.Cl
5811;372356137;0.309;1726849;461515486;141195342;10280;342231650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]pentazocine from human sigma 1 receptor expressed in HEK293 cell membrane incubated for 2 hrs by liquid scintillation counting method;Chromenone VII;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCCCOC2=CC3=C(C=C2)OC=CC3=O
5812;100440759;0.31;203854;103359671;10020651;10280;13615780;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory concentration against radioligand [3H]3-PPP binding to haloperidol-sensitive sigma binding site in whole guinea pig brain;(S)-1-(4-Fluoro-phenyl)-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butan-1-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCC[C@@H](C2=CC=C(C=C2)F)O)C3=NC=C(C=N3)F
5813;100467865;0.31;204005;103325618;10041278;10280;79325350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vivo binding affinity against sigma Opioid receptor was measured by using labeled ligand [3H]-SKF- 10,047 (1 nM);(4aS,7aR,12bS)-3-Cyclopropylmethyl-9-hydroxy-2,3,4,4a,5,6-hexahydro-1H-8-oxa-3-aza-benzo[d]fluoren-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC(=O)[C@H]2[C@@]3([C@H]1CN(CC3)CC4CC4)C5=C(O2)C(=CC=C5)O
5814;389483902;0.314;1805386;160849806;132060775;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';benzyl 7-(4-methylpiperazin-1-yl)-3,4-dihydro-1H-isoquinoline-2-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)C2=CC3=C(CCN(C3)C(=O)OCC4=CC=CC=C4)C=C2
5815;380821391;0.31463;1915143;381840647;121301422;10280;;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000544a SIGMAR1;CFTR corrector 8;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(C=C1)[C@H](C[C@H](O2)C3=CC(=C(C=C3)OC)OC)NC(=O)C4(CC4)C5=CC6=C(C=C5)OC(O6)(F)F
5816;409048988;0.31463;1794447;381872584;121301295;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;CFTR corrector 4;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(C=C1)[C@@H](C[C@@H](O2)C3=CC(=C(C=C3)OC)OC)NC(=O)C4(CC4)C5=CC6=C(C=C5)OC(O6)(F)F
5817;365267159;0.31623;1512456;440214664;153287574;10280;316202300;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3S,4S)-4-ethyl-3-methyl-1-phenyl-2,4-dihydroquinolin-3-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC[C@H]1C2=CC=CC=C2N(C[C@@]1(C)N)C3=CC=CC=C3
5818;366437097;0.31623;1594273;440192923;155554849;10280;309043830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;[2-(4-Hydroxyphenyl)-5-(2-phenylethylamino)-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)C(=O)C2=C3CC(CCC3=NN2C4=CC=C(C=C4)O)NCCC5=CC=CC=C5
5819;366437106;0.31623;1594273;440137804;146641556;10280;309043830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;[1-Phenyl-5-[2-[4-(trifluoromethyl)phenyl]ethylamino]-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)C(=O)C2=NN(C3=C2CC(CC3)NCCC4=CC=C(C=C4)C(F)(F)F)C5=CC=CC=C5
5820;409048989;0.31623;1794447;381872584;121301295;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;CFTR corrector 4;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(C=C1)[C@@H](C[C@@H](O2)C3=CC(=C(C=C3)OC)OC)NC(=O)C4(CC4)C5=CC6=C(C=C5)OC(O6)(F)F
5821;100458522;0.317;204438;103344451;15149411;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;3-(5-Fluoro-9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3(8),4,6-tetraen-15-yl)propan-1-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCO)NC4=C3C=C(C=C4)F
5822;334064875;0.317;735278;164146714;71654694;10280;235606500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aS,5R,10bS)-5-(1-ethylpiperidin-4-yl)-9-(3-methylbutoxy)-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCN1CCC(CC1)[C@@H]2[C@@H]3CCCO[C@@H]3C4=C(N2)C=CC(=C4)OCCC(C)C
5823;100404001;0.318;204630;103186824;3455;10280;128012230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma receptor type 1 was determined by the displacement of [3H]pentazocine radioligand;Vanoxerine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=CC=CC=C2)CCOC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F
5824;100317838;0.32;204297;103361875;9999184;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;TIn vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine.;[1-[3-(Phenethyloxy)-4-methoxybenzyl]pentyl]propylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)NCCC
5825;100448368;0.32;204471;103215386;14983031;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[5-(4-Hydroxy-piperidin-1-yl)-pentyloxy]-2-(3-methoxy-phenyl)-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC(=C1)C2=CC(=O)C3=C(O2)C=CC(=C3)OCCCCCN4CCC(CC4)O
5826;100741794;0.324;203992;103677489;45264588;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"8-Methyl-4'-phenylspiro[8-azabicyclo[3.2.1]octane-3,2'-furan]-3'-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN1C2CCC1CC3(C2)C(=O)C(=CO3)C4=CC=CC=C4.Cl
5827;255030233;0.325;625223;123099352;39468;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Levobunolol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)NC[C@@H](COC1=CC=CC2=C1CCCC2=O)O
5828;100444458;0.327;204470;103215386;14983031;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[5-(4-Hydroxy-piperidin-1-yl)-pentyloxy]-2-(3-methoxy-phenyl)-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC(=C1)C2=CC(=O)C3=C(O2)C=CC(=C3)OCCCCCN4CCC(CC4)O
5829;100364895;0.328;229202;103338822;11035765;10280;115854440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of sigma receptor;1-[3-(6-Chloro-1,3-benzodioxole-5-ylmethylamino)propyl]-1H-benzimidazole-2(3H)-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1OC2=C(O1)C=C(C(=C2)CNCCCN3C4=CC=CC=C4NC3=O)Cl
5830;100746120;0.328;204147;103265849;44309737;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma opioid receptor type 1 in guinea pig brain homogenate with 0.5 nM [3H](+)-PENT;5,5-Diphenyl-3-[4-(4-phenyl-piperazin-1-yl)-butyl]-imidazolidine-2,4-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCCCN2C(=O)C(NC2=O)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=CC=C5
5831;100317845;0.33;204297;103362119;10545203;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;TIn vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine.;[1-(4-Methoxy-3-phenethyloxy-benzyl)-propyl]-propyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCNC(CC)CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2
5832;100319804;0.33;204154;103673331;45261928;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;"1-[4-Methoxy-3-(2-phenylethoxy)phenyl]pentan-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N.Cl
5833;388740410;0.33;1797293;386051266;118282965;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 21;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC=C(C=C1)F)N2CC3=C(C2)C(=CC=C3)F
5834;388879261;0.33;1797475;386051266;118282965;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 21;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC=C(C=C1)F)N2CC3=C(C2)C(=CC=C3)F
5835;389383665;0.33;1804286;386051266;118282965;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 21;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC=C(C=C1)F)N2CC3=C(C2)C(=CC=C3)F
5836;100445884;0.332;204470;103215565;14983037;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-(4-Hydroxypiperidinyl)hexoxy]-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=CC(=C3)OCCCCCCN4CCC(CC4)O
5837;100778226;0.333;204017;103272881;44313217;10280;98735270;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for [3H]- pentazocine at sigma opioid receptor;(2R,3S)-2-[(4R)-4-(3-aminopropyl)-3-benzyl-2,5-dioxoimidazolidin-1-yl]-N-benzyl-3-methylpentanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC[C@H](C)[C@H](C(=O)NCC1=CC=CC=C1)N2C(=O)[C@H](N(C2=O)CC3=CC=CC=C3)CCCN
5838;100448359;0.334;204471;103215029;14982956;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(9-Dimethylamino-nonyloxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCCCCCCCCOC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3
5839;100444177;0.335;204470;103215491;14982953;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(6-Dimethylamino-hexyloxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCCCCCOC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3
5840;100478470;0.335;203696;103186101;10048702;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;(1-Benzyl-butyl)-dimethyl-(3-phenyl-propyl)-ammonium;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCC(CC1=CC=CC=C1)[N+](C)(C)CCCC2=CC=CC=C2
5841;100448333;0.337;204471;103214987;18959716;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[4-(4-Hydroxy-piperidin-1-yl)-butoxy]-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1O)CCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
5842;100333026;0.33884;204944;103277967;10639616;10280;108823620;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was performed using [3H](+)-pentazocine to label sigma-1 binding sites, in guinea pig cerebral cortex;1-[2-(4-Chlorophenyl)ethyl]-2-(4-pyrrolidin-1-ylbutyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CCN(C1)CCCCN=C(N)NCCC2=CC=C(C=C2)Cl
5843;100627935;0.33884;204453;103671420;45260521;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"(4aR,10bR)-3-methyl-2,4,4a,5,6,10b-hexahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CN1CC[C@@H]2[C@H](C1)CCC3=CC=CC=C23.Cl
5844;100628003;0.33884;204453;160681431;70687152;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"(4aR,10bS)-9-methoxy-3-methyl-2,4,4a,5,6,10b-hexahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CN1CC[C@H]2[C@H](C1)CCC3=C2C=C(C=C3)OC.Cl
5845;100614094;0.34;203986;103283311;428911;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;1,3-Diphenyl-2-iminoimidazolidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(C(=N)N1C2=CC=CC=C2)C3=CC=CC=C3
5846;100444349;0.341;204470;103215027;14982957;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(10-Dimethylamino-decyloxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCCCCCCCCCOC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3
5847;100471677;0.341;204459;103298145;11777643;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N-(3-Ethyl-phenyl)-2,3-dihydro-indole-1-carboxamidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N=C(N)N2CCC3=CC=CC=C32
5848;100458856;0.342;229213;103359590;15443;10280;79028700;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Tested for [3H](+)-pentazocine binding to sigma-1 receptor in guinea pig brain membrane;Azaperone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCCC(=O)C2=CC=C(C=C2)F)C3=CC=CC=N3
5849;100471345;0.343;204459;103299176;10426722;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N-(1-Naphthyl)-4-phenylpiperidine-1-carboxamidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1C2=CC=CC=C2)C(=NC3=CC=CC4=CC=CC=C43)N
5850;100458512;0.345;204438;103344901;15149393;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;11-Benzyl-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CC4=CC=CC=C4)NC5=CC=CC=C53
5851;100614387;0.345;203986;103679655;14771720;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;"2-(1-adamantyl)-1-[2-[(E)-2-phenylethenyl]phenyl]guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C2CC3CC1CC(C2)(C3)N=C(N)NC4=CC=CC=C4/C=C/C5=CC=CC=C5.Cl
5852;380264313;0.346;1811100;475982655;126539557;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[4-(4-benzylpiperazin-1-yl)-1-methylpiperidin-4-yl]methyl]-N-phenylpropanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CCN(CC1)C)N2CCN(CC2)CC3=CC=CC=C3)C4=CC=CC=C4
5853;342743642;0.34674;1152426;242648461;56852956;10280;248009400;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin) by PDSP assay;2-[3-[4-(2-Pyrimidinyl)piperazino]propyl]benzothiazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=NC3=CC=CC=C3S2)C4=NC=CC=N4
5854;100366978;0.3469;226337;103376064;10950137;10280;117281860;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-[1-(2-Iodo-benzyl)-piperidin-4-yl]-2-phenyl-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC=CC=C3I
5855;100444173;0.347;204470;103215543;14982983;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;1-{1-[6-(4-Oxo-2-phenyl-4H-chromen-6-yloxy)-hexyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCCCCOC4=CC5=C(C=C4)OC(=CC5=O)C6=CC=CC=C6
5856;100458419;0.348;204437;103344851;15149396;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;11-(5-Phenylpentyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCCCC4=CC=CC=C4)NC5=CC=CC=C53
5857;100721056;0.348;204634;103234890;5360696;10280;150260770;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma receptor type 1;Dextromethorphan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC
5858;100617142;0.35;203985;103283474;14771672;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;1,3-Bis(4-bromophenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC(=CC=C1NC(=NC2=CC=C(C=C2)Br)N)Br
5859;342743641;0.35;1152426;242648461;56852956;10280;248009400;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin) by PDSP assay;2-[3-[4-(2-Pyrimidinyl)piperazino]propyl]benzothiazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC2=NC3=CC=CC=C3S2)C4=NC=CC=N4
5860;354664025;0.35;1288457;336874679;127031405;10280;270328900;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma1 receptor by PDSP assay;3-[[Ethyl-[2-(4-hydroxy-3-methoxyphenyl)ethyl]amino]methyl]-2-methoxyphenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CCC1=CC(=C(C=C1)O)OC)CC2=C(C(=CC=C2)O)OC
5861;100471368;0.351;204459;103298720;10016031;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N,N''-Bis-(3-methoxy-phenyl)-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC=CC(=C1)NC(=NC2=CC(=CC=C2)OC)N
5862;100546622;0.352;203685;103277871;10666733;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;N-(1-Benzylpiperidine-4-yl)-2-(3,4-dimethoxyphenyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C=C1)CC(=O)NC2CCN(CC2)CC3=CC=CC=C3)OC
5863;100742341;0.352;204020;103671715;45260715;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor using [3H]-(+)-SKF- 10,047;"2-[(dimethylamino)methyl]-2-methyl-5-phenyl-3H-pyran-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1(CC(=O)C(=CO1)C2=CC=CC=C2)CN(C)C.Cl
5864;389483903;0.352;1805386;160849699;132060752;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';Benzyl 5-[4-(3-ethoxy-3-oxopropyl)piperazin-1-yl]-1,3-dihydroisoindole-2-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC(=O)CCN1CCN(CC1)C2=CC3=C(CN(C3)C(=O)OCC4=CC=CC=C4)C=C2
5865;366401190;0.354;1576130;103182112;3345;10280;313918930;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H]PPP from sigma1 receptor (unknown origin);Fentanyl;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
5866;407996174;0.35481;1946583;482073591;168288343;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;N-(3-chloro-2-methylphenyl)-2-[4-[[3-(trifluoromethyl)phenyl]methoxy]piperidin-1-yl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC=C1Cl)NC(=O)CN2CCC(CC2)OCC3=CC(=CC=C3)C(F)(F)F
5867;389483971;0.355;1805386;160849811;132060805;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';Benzyl 8-(4-methylpiperazin-1-yl)-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)C2=CC3=C(CCCN(C3)C(=O)OCC4=CC=CC=C4)C=C2
5868;100471350;0.356;204459;103282477;13781939;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;1,3-Bis(2-tert-butylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC(C)(C)C1=CC=CC=C1NC(=NC2=CC=CC=C2C(C)(C)C)N
5869;100614619;0.356;203986;103282477;13781939;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;1,3-Bis(2-tert-butylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC(C)(C)C1=CC=CC=C1NC(=NC2=CC=CC=C2C(C)(C)C)N
5870;407996173;0.358;1946583;482073591;168288343;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;N-(3-chloro-2-methylphenyl)-2-[4-[[3-(trifluoromethyl)phenyl]methoxy]piperidin-1-yl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC=C1Cl)NC(=O)CN2CCC(CC2)OCC3=CC(=CC=C3)C(F)(F)F
5871;388740221;0.36;1797293;386051299;118282977;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 55;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C=CC(=C3C2)F)F
5872;388878946;0.36;1797475;386051299;118282977;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 55;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C=CC(=C3C2)F)F
5873;389383446;0.36;1804286;386051299;118282977;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 55;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C=CC(=C3C2)F)F
5874;100444166;0.362;204470;103214569;121180;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;7-(2-Dimethylamino-ethoxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCOC1=CC2=C(C=C1)C(=O)C=C(O2)C3=CC=CC=C3
5875;100536699;0.362;204457;103678286;45265168;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"1-(3-Ethylphenyl)-1-methyl-2-(2-propan-2-ylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=CC=CC=C2C(C)C)N.Cl
5876;255023587;0.363;625223;103169151;5452;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Thioridazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC
5877;100565311;0.365;203703;103177817;10662728;10280;95442130;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;The compound was tested for the affinity on sigma 1 receptor using [3H]- pentazocine as radioligand;3-[2-(Dimethylamino)ethyl]-6-benzoylbenzoxazol-2(3H)-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCN1C2=C(C=C(C=C2)C(=O)C3=CC=CC=C3)OC1=O
5878;100458316;0.368;204437;103344852;15149395;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;11-(3-Phenylpropyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCC4=CC=CC=C4)NC5=CC=CC=C53
5879;389483895;0.368;1805386;160849728;132060765;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';Benzyl 8-[4-(3-ethoxy-3-oxopropyl)piperazin-1-yl]-1,3,4,5-tetrahydro-2-benzazepine-2-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC(=O)CCN1CCN(CC1)C2=CC3=C(CCCN(C3)C(=O)OCC4=CC=CC=C4)C=C2
5880;100448346;0.369;204471;103215543;14982983;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;1-{1-[6-(4-Oxo-2-phenyl-4H-chromen-6-yloxy)-hexyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCCCCOC4=CC5=C(C=C4)OC(=CC5=O)C6=CC=CC=C6
5881;100292621;0.37;239200;103442086;2838196;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;3-(4-Benzyl-piperidin-1-ylmethyl)-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3=COC4=CC=CC=C4C3=O
5882;100613859;0.37;203986;103671968;14771722;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;"2-(2-adamantyl)-1-[2-[(E)-2-phenylethenyl]phenyl]guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C2CC3CC1CC(C2)C3N=C(N)NC4=CC=CC=C4/C=C/C5=CC=CC=C5.Cl
5883;403018496;0.37;1920070;488871656;57810440;10280;;Confirmatory;20240403;0;0;Active;Q99720;Ki;;BindingDB;In-Vitro Binding Assay from US Patent US20230390272: 'USE OF PRIDOPIDINE AND ANALOGS FOR THE TREATMENT OF ANXIETY AND DEPRESSION';4-(3-Methylsulfonylphenyl)-1-propylpiperidin-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCC(CC1)(C2=CC(=CC=C2)S(=O)(=O)C)O
5884;403024131;0.37;1920119;488871656;57810440;10280;;Confirmatory;20240403;0;0;Active;Q99720;Ki;;BindingDB;In-Vitro Binding Assay from US Patent US20230414596: 'USE OF PRIDOPIDINE AND ANALOGS FOR TREATING RETT SYNDROME';4-(3-Methylsulfonylphenyl)-1-propylpiperidin-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCC(CC1)(C2=CC(=CC=C2)S(=O)(=O)C)O
5885;100320355;0.371;204310;103382359;10802506;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 2 using [3H]- DTG in rat liver membranes;Benzyl-[2-((1R,2S)-2-methyl-1,2-dihydro-naphthalen-1-yl)-ethyl]-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;21070;Liver;C[C@H]1C=CC2=CC=CC=C2[C@@H]1CCNCC3=CC=CC=C3
5886;363665994;0.371;1415921;404707218;71223168;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;1-Ethyl-3-(1-(2-(piperidin-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)urea hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCNC(=O)NC1=C2C=NN(C2=NC=N1)CCN3CCCCC3
5887;389712935;0.371;1919146;476002739;3037918;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assay from US Patent US11535596: 'Analogs of dextromethorphan with balanced receptor activities';Dimemorfan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC2=C(C[C@H]3[C@@H]4[C@]2(CCCC4)CCN3C)C=C1
5888;100403997;0.372;204630;103294982;10344430;10280;128012230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma receptor type 1 was determined by the displacement of [3H]pentazocine radioligand;3-(4-(3-(Bis(4-fluorophenyl)amino)propyl)piperazin-1-yl)-1-phenylpropan-1-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCN(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)CCC(C4=CC=CC=C4)O
5889;100721060;0.373;204634;103235981;10475196;10280;150260770;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma receptor type 1;tert-butyl 2-[2-[(4aS,10aR)-6-methoxy-2,3,4,10a-tetrahydro-1H-phenanthren-4a-yl]ethyl-methylamino]acetate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC(=O)CN(C)CC[C@@]12CCCC[C@@H]1C=CC3=C2C=C(C=C3)OC
5890;100354288;0.375;204790;103237952;12084056;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-[[(2R)-1-(2-Adamantyl)-2-pyrrolidinyl]methyl]-1-methoxy-4-bromo-2-naphthalenecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)NC[C@H]3CCCN3C4C5CC6CC(C5)CC4C6
5891;380581330;0.375;1861723;482054361;168274328;10280;357249250;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay;N-[3-[(3,4-dimethoxyphenyl)methyl-methylamino]propyl]-1-benzofuran-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC2=CC=CC=C2O1)CC3=CC(=C(C=C3)OC)OC
5892;334065469;0.377;735278;164132795;71655286;10280;235606500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aS,5R,10bS)-9-(3-chlorophenoxy)-5-cyclohexyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCC(CC1)[C@@H]2[C@@H]3CCCO[C@@H]3C4=C(N2)C=CC(=C4)OC5=CC(=CC=C5)Cl
5893;100534030;0.38;204794;103359511;44350870;10280;93971710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was done in guinea pig membranes by labeling the binding site with [3H](+)-pentazocine;(1S,2S)-2-(3-Phenyl-8-aza-bicyclo[3.2.1]oct-8-yl)-cyclohexanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC[C@@H]([C@H](C1)N2C3CCC2CC(C3)C4=CC=CC=C4)O
5894;388740637;0.38;1797293;386051287;118282968;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 43;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(=O)N(C)C)OC(F)(F)F)N2CC3=C(C2)C=C(C=C3)F
5895;388879578;0.38;1797475;386051287;118282968;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 43;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(=O)N(C)C)OC(F)(F)F)N2CC3=C(C2)C=C(C=C3)F
5896;389383937;0.38;1804286;386051287;118282968;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 43;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(=O)N(C)C)OC(F)(F)F)N2CC3=C(C2)C=C(C=C3)F
5897;100535945;0.381;204457;103673574;22120068;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"1-(2,5-Dibromophenyl)-3-(3-ethylphenyl)-1,3-dimethylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=N)N(C)C2=C(C=CC(=C2)Br)Br.Cl
5898;366463035;0.383;1607454;440152736;27842480;10280;323426850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from sigma1 receptor (unknown origin) after 90 mins by microbeta scintillation counting method;1H-indol-2-yl-[4-[2-(4-methoxyphenoxy)ethyl]piperazin-1-yl]methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)OCCN2CCN(CC2)C(=O)C3=CC4=CC=CC=C4N3
5899;100742367;0.384;203992;103677458;45264565;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"9-[4-(4-Fluorophenyl)-4-oxobutyl]-2-phenyl-1-oxa-9-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2(CN(C1)CCCC(=O)C3=CC=C(C=C3)F)C(=O)C=C(O2)C4=CC=CC=C4.Cl
5900;100496821;0.38637;204761;103401490;10367771;10280;78533490;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity at Sigma receptor type 1, displacement of [3H](+)-pentazocine from guinea pig brain membranes;(1S,9S,13S)-10-[(4-iodo-3-nitrophenyl)methyl]-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC4=CC(=C(C=C4)I)[N+](=O)[O-])C)C=C(C=C3)O
5901;100314845;0.388;204161;103311054;9957260;10280;104250950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma opioid receptor type 1 in guinea pig brain membranes using [3H](+)-pentazocine as radioligand;[(4aR,6R,7R,8aR)-6-Hydroxy-7-(4-phenyl-piperidin-1-yl)-octahydro-quinolin-1-yl]-phenyl-methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C[C@@H]2C[C@H]([C@@H](C[C@H]2N(C1)C(=O)C3=CC=CC=C3)N4CCC(CC4)C5=CC=CC=C5)O
5902;345602963;0.388;1200082;312389845;76684383;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;N-[1-(3,4-dichlorophenyl)triazol-4-yl]-N-(2-morpholin-4-ylethyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC(=O)N(CCN1CCOCC1)C2=CN(N=N2)C3=CC(=C(C=C3)Cl)Cl
5903;407996337;0.388;1946583;494397820;171344306;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(2S)-4-[(6-chloro-1H-indol-2-yl)methyl]-2-[(4-methyl-1,3-thiazol-2-yl)oxymethyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CSC(=N1)OC[C@@H]2CN(CCO2)CC3=CC4=C(N3)C=C(C=C4)Cl
5904;100473778;0.38905;203852;103168087;3036864;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;(R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2=CC(=C(C=C2[C@H](C1)C3=CC=CC=C3)O)Cl
5905;407996338;0.38905;1946583;494397820;171344306;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(2S)-4-[(6-chloro-1H-indol-2-yl)methyl]-2-[(4-methyl-1,3-thiazol-2-yl)oxymethyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CSC(=N1)OC[C@@H]2CN(CCO2)CC3=CC4=C(N3)C=C(C=C4)Cl
5906;100317837;0.39;204297;103361346;10691389;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;TIn vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine.;[1-(4-Methoxy-3-phenethyloxy-benzyl)-propyl]-dipropyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCN(CCC)C(CC)CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2
5907;100468428;0.39;203697;103330151;15113301;10280;82952200;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma 1 receptor was determined in guinea pig brain membrane using [3H](+)-pentazocine as radioligand;2-(3,4-Dichlorophenyl)-N-(2-aminoethyl)ethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC(=C(C=C1CCNCCN)Cl)Cl
5908;340020965;0.39;752428;174517048;49853883;10280;236018160;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;2-[(8aR)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]-N-cyclohexylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)NC(=O)CN2CCN3CCC[C@@H]3C2
5909;389536473;0.391;1805702;459092167;122576832;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';(1R,8R)-9-methyl-5-(3-methylphenyl)-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=CC=C1)C2=CC3=C(C=C2)[C@@H]4CCN([C@@H]3C4)C
5910;326020195;0.392;695286;163337628;25120700;10280;223862410;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to Sigma1;[(1R)-3-[4-(4-methoxyphenyl)piperazin-1-yl]-1-phenylpropyl] carbamate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)N2CCN(CC2)CC[C@H](C3=CC=CC=C3)OC(=O)N
5911;380512536;0.392;1846430;482053788;86295354;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2S,6S)-10-(2-fluorophenyl)-4-[(6-methoxypyridin-3-yl)methyl]-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=NC=C(C=C1)CN2C[C@H]3[C@H](C2)OCC4=C(N=NN34)C5=CC=CC=C5F
5912;100458430;0.396;204437;103344254;15149420;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;5-Benzyl-11-(4-phenylbutyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCCC4=CC=CC=C4)N(C5=CC=CC=C53)CC6=CC=CC=C6
5913;100471357;0.397;204459;103282519;7594;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;1,3-Diphenylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC=C(C=C1)NC(=NC2=CC=CC=C2)N
5914;100614621;0.397;203986;103282519;7594;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;1,3-Diphenylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC=C(C=C1)NC(=NC2=CC=CC=C2)N
5915;255011814;0.398;625223;103177051;2771;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Citalopram;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
5916;204355274;0.39811;548692;124961669;50898777;10280;210756380;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to opioid receptor Sigma1;methyl 6-[4-[(3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carbonylamino)methyl]piperidin-1-yl]hexanoate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC(=O)CCCCCN1CCC(CC1)CNC(=O)C2=C3N(CCCO3)C4=CC=CC=C42
5917;342817233;0.39811;1118248;242613624;90666085;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human recombinant sigma-1 receptor expressed in CHO cells after 180 mins by beta counting analysis;(1S,2S)-N-[3-(dimethylamino)-2,2-dimethylpropyl]-2-phenylcyclopropane-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;197.0;;;;CC(C)(CNC(=O)[C@H]1C[C@@H]1C2=CC=CC=C2)CN(C)C
5918;365267546;0.39811;1512456;440134957;155526977;10280;316202300;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3S,4S)-4-ethyl-6-methoxy-3-methyl-2,4-dihydrochromen-3-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC[C@H]1C2=C(C=CC(=C2)OC)OC[C@@]1(C)N
5919;363665988;0.399;1415921;404696660;71223119;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;N-(1-(2-(Diisopropylamino)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)pivalamide hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)N(CCN1C2=NC=NC(=C2C=N1)NC(=O)C(C)(C)C)C(C)C
5920;100354370;0.4;204790;103238483;10719188;10280;113561150;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-[(3S)-1-(Bicyclo[3.3.1]nonane-9-yl)-3-pyrrolidinyl]-1-methoxy-4-bromo-2-naphthalenecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)N[C@H]3CCN(C3)C4C5CCCC4CCC5
5921;100444342;0.4;204470;103215377;14982951;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(4-Dimethylamino-butoxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCCCOC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3
5922;100456536;0.4;229183;103360307;14970531;10280;79028690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor in bovine cerebellum using 2.0 nM [3H]haloperidol in the presence of 25 nM unlabeled spiperone;3-[4-(4-Chloro-phenyl)-3,6-dihydro-2H-pyridin-1-yl]-1-(2-fluoro-phenyl)-propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CN(CC=C1C2=CC=C(C=C2)Cl)CCC(=O)C3=CC=CC=C3F
5923;100458396;0.4;204438;103344201;15149399;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;11-[2-(3,4-Dichlorophenoxy)ethyl]-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCOC4=CC(=C(C=C4)Cl)Cl)NC5=CC=CC=C53
5924;100617156;0.4;203985;103282519;7594;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;1,3-Diphenylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC=C(C=C1)NC(=NC2=CC=CC=C2)N
5925;366431681;0.403;1592018;103359590;15443;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;Azaperone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC(=O)C2=CC=C(C=C2)F)C3=CC=CC=N3
5926;100778229;0.406;204017;103272921;44313234;10280;98735270;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for [3H]- pentazocine at sigma opioid receptor;(2R)-2-[(4S)-4-(3-aminopropyl)-3-benzyl-2,5-dioxoimidazolidin-1-yl]-3-cyclohexylpropanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)C[C@H](C(=O)N)N2C(=O)[C@@H](N(C2=O)CC3=CC=CC=C3)CCCN
5927;389483955;0.407;1805386;160849729;132060770;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';benzyl 7-[4-(3-ethoxy-3-oxopropyl)piperazin-1-yl]-3,4-dihydro-1H-isoquinoline-2-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC(=O)CCN1CCN(CC1)C2=CC3=C(CCN(C3)C(=O)OCC4=CC=CC=C4)C=C2
5928;366431682;0.40738;1592018;103359590;15443;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;Azaperone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC(=O)C2=CC=C(C=C2)F)C3=CC=CC=N3
5929;409048997;0.40738;1794447;494417403;171355807;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;1-(1-cyanocyclopropyl)-N-[(2S)-1-[[4-[3-(1-methylpyrazol-3-yl)phenyl]-1,3-thiazol-2-yl]amino]-1-oxopropan-2-yl]imidazole-4-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](C(=O)NC1=NC(=CS1)C2=CC=CC(=C2)C3=NN(C=C3)C)NC(=O)C4=CN(C=N4)C5(CC5)C#N
5930;100448335;0.408;204471;103215737;14982950;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(3-Dimethylamino-propoxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCCOC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3
5931;100467866;0.41;204005;103325548;10246015;10280;79325350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vivo binding affinity against sigma Opioid receptor was measured by using labeled ligand [3H]-SKF- 10,047 (1 nM);(4aR,7S,7aR,12bS)-3-Cyclopropylmethyl-9-methoxy-2,3,4,4a,5,6,7,7a-octahydro-1H-8-oxa-3-aza-benzo[d]fluoren-7-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1O[C@@H]3[C@]24CCN(C[C@@H]4CC[C@@H]3O)CC5CC5
5932;334065476;0.41;735278;164135551;71655681;10280;235606500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aS,5R,10bS)-5-pentan-3-yl-9-pentyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCCCCC1=CC2=C(C=C1)N[C@@H]([C@H]3[C@@H]2OCCC3)C(CC)CC
5933;340074671;0.41;772290;174498737;53245590;10280;246110850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin);2-Cyclopropyl-6,7-dimethoxy-4-(4-(2-methoxyphenyl)piperazin-1-yl)quinazoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1N2CCN(CC2)C3=NC(=NC4=CC(=C(C=C43)OC)OC)C5CC5
5934;388740474;0.41;1797293;386051304;118282905;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 60A;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)(C)C)N2CC3=C(C=CC(=C3C2)F)F
5935;388879395;0.41;1797475;386051304;118282905;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 60A;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)(C)C)N2CC3=C(C=CC(=C3C2)F)F
5936;389383766;0.41;1804286;386051304;118282905;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 60A;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC(C)(C)C)N2CC3=C(C=CC(=C3C2)F)F
5937;100615438;0.412;204447;103321304;15701665;10280;16560440;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]-(+)-3-PPP binding to sigma of guinea pig brain;[1S,2R,(+)]-N-[2-(3,4-Dichlorophenyl)ethyl]-N-cyclopropylmethyl-2-(1-pyrrolidinyl)cyclohexanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC[C@@H]([C@@H](C1)N2CCCC2)N(CCC3=CC(=C(C=C3)Cl)Cl)CC4CC4
5938;389536413;0.413;1805702;384583214;129067853;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';benzyl (1R,8R)-5-[4-(2-methylprop-2-enyl)piperazin-1-yl]-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene-9-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=C)CN1CCN(CC1)C2=CC3=C(C=C2)[C@@H]4CCN([C@@H]3C4)C(=O)OCC5=CC=CC=C5
5939;409048996;0.4169;1794447;494417403;171355807;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;1-(1-cyanocyclopropyl)-N-[(2S)-1-[[4-[3-(1-methylpyrazol-3-yl)phenyl]-1,3-thiazol-2-yl]amino]-1-oxopropan-2-yl]imidazole-4-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](C(=O)NC1=NC(=CS1)C2=CC=CC(=C2)C3=NN(C=C3)C)NC(=O)C4=CN(C=N4)C5(CC5)C#N
5940;100478416;0.418;203696;103186049;14291221;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand;N-methyl-5-phenylpentan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CNCCCCCC1=CC=CC=C1
5941;100604689;0.418;203857;103735237;14771402;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;N-Methyl-N-[(1S)-2alpha-(1-pyrrolidinyl)cyclohexan-1alpha-yl]-4-(2,4-dichlorophenoxy)butyramide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@H]1CCCC[C@H]1N2CCCC2)C(=O)CCCOC3=C(C=C(C=C3)Cl)Cl
5942;255019336;0.418;625223;123090165;2769;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Propulsid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F
5943;100317842;0.42;204297;103362047;10787011;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;TIn vitro binding affinity at Sigma opioid receptor type 2 on guinea pig brain membranes by [3H]DTG displacement in the presence of [3H]pentazocine.;[1-(4-Methoxy-3-phenethyloxy-benzyl)-butyl]-dipropyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N(CCC)CCC
5944;100319801;0.42;204154;103361823;10642861;10280;105084440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;1-(4-Methoxy-3-phenethyloxy-benzyl)-octylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N
5945;100439265;0.42;203853;103359671;10020651;10280;13615780;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibitory concentration against radioligand [3H](+)-NAN binding to haloperidol-sensitive sigma binding site in whole guinea pig brain;(S)-1-(4-Fluoro-phenyl)-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butan-1-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCC[C@@H](C2=CC=C(C=C2)F)O)C3=NC=C(C=N3)F
5946;100536384;0.421;204457;103673588;45262121;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-[2-Chloro-5-methylsulfanyl-3-(trifluoromethyl)phenyl]-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=CC(=CC(=C2Cl)C(F)(F)F)SC)N.Cl
5947;255010991;0.426;625223;103219164;5472;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Ticlopidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
5948;100438242;0.427;204445;103321360;44334079;10280;14477350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor using [3H](+)-pentazocine in guinea pig brain homogenates;(2S)-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(pyrrolidin-1-yl)cyclohexan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCC1=CC(=C(C=C1)Cl)Cl)[C@H]2CCCC[C@@H]2N3CCCC3
5949;388996810;0.427;1798943;405263598;86582458;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';1-(3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)-2-((2-(dimethyl-amino)ethyl)(methyl)amino)butan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(C(=O)N1CCN2C(=CC3=CC=CC=C32)C1)N(C)CCN(C)C
5950;100619159;0.429;203990;103173563;1235;10280;18482950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma opioid receptor in guinea pig cerebral homogenate using [3H]DTG as radioligand;2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-3-allyl-6,11-dimethyl-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=C(C1(CCN2CC=C)C)C=C(C=C3)O
5951;340020963;0.43;752428;174506863;49853881;10280;236018160;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;N-cyclohexyl-2-(4-cyclopentylpiperazin-1-yl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)NC(=O)CN2CCN(CC2)C3CCCC3
5952;389536411;0.43;1805702;384583214;129067853;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';benzyl (1R,8R)-5-[4-(2-methylprop-2-enyl)piperazin-1-yl]-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene-9-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=C)CN1CCN(CC1)C2=CC3=C(C=C2)[C@@H]4CCN([C@@H]3C4)C(=O)OCC5=CC=CC=C5
5953;100448385;0.432;204471;103215491;14982953;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(6-Dimethylamino-hexyloxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCCCCCOC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3
5954;255009826;0.433;625223;103188772;2160;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amitriptyline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
5955;100778224;0.435;204017;103272920;44313233;10280;98735270;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for [3H]- pentazocine at sigma opioid receptor;(2R)-2-[(4R)-4-(3-aminopropyl)-3-benzyl-2,5-dioxoimidazolidin-1-yl]-N-benzylpentanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC[C@H](C(=O)NCC1=CC=CC=C1)N2C(=O)[C@H](N(C2=O)CC3=CC=CC=C3)CCCN
5956;100473777;0.43652;203852;103359799;6604868;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;(R)-1-(4-Fluoro-phenyl)-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butan-1-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCC[C@H](C2=CC=C(C=C2)F)O)C3=NC=C(C=N3)F
5957;100467870;0.44;204005;103325580;10065022;10280;79325350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vivo binding affinity against sigma Opioid receptor was measured by using labeled ligand [3H]-SKF- 10,047 (1 nM);(4aR,7aR,12bS)-3-Cyclopropylmethyl-9-methoxy-2,3,4,4a,5,6-hexahydro-1H-8-oxa-3-aza-benzo[d]fluoren-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1O[C@@H]3[C@]24CCN(C[C@@H]4CCC3=O)CC5CC5
5958;100617135;0.44;203985;103283174;14771688;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N-(2-Amino-phenyl)-N''-o-tolyl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1N=C(N)NC2=CC=CC=C2N
5959;389536466;0.442;1805702;384583209;137632171;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';(1R,8R)-9-(3,5-dichlorophenyl)sulfonyl-5-(4-methylpiperazin-1-yl)-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)C2=CC3=C(C=C2)[C@@H]4CCN([C@@H]3C4)S(=O)(=O)C5=CC(=CC(=C5)Cl)Cl
5960;380512725;0.446;1846430;482074018;168288651;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-4-[(4-fluorophenyl)methyl]-10-(1-methylpiperidin-4-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC(CC1)C2=C3CO[C@@H]4CN(C[C@H]4N3N=N2)CC5=CC=C(C=C5)F
5961;100627997;0.44668;204453;160686740;70689224;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"(4aR,10bS)-3-methyl-2,4,4a,5,6,10b-hexahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CN1CC[C@H]2[C@H](C1)CCC3=CC=CC=C23.Cl
5962;363665116;0.447;1415967;404695307;74767130;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(5-Methylpyridin-3-yl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=CN=C1)C2=C3C=NN(C3=NC=N2)CCN4CCCCC4
5963;100440051;0.45;229193;103173857;53389;10280;14696970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of specific binding of [3H]NANM of sigma receptor in Guinea pig brain membranes;Rimcazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1CN(C[C@@H](N1)C)CCCN2C3=CC=CC=C3C4=CC=CC=C42
5964;100550368;0.451;204463;131279348;9931976;10280;97034600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound is evaluated for binding affinity towards Sigma receptor using [3H]pentazocine in guinea pig brain;3-[[4-(2-Methoxyphenyl)piperazin-1-yl]methyl]-5-methylsulfanyl-2,3-dihydroimidazo[1,2-c]quinazoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1N2CCN(CC2)CC3CN=C4N3C(=NC5=CC=CC=C54)SC
5965;255015625;0.451;625223;103169389;2726;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Chlorpromazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl
5966;345602792;0.451;1200082;312389843;76684475;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-(3,4-dichlorophenyl)-N-(2-morpholinoethyl)-N-propyl-1H-1,2,3-triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCCN(CCN1CCOCC1)C2=CN(N=N2)C3=CC(=C(C=C3)Cl)Cl
5967;100438240;0.455;204445;103321342;6331636;10280;14477350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor using [3H](+)-pentazocine in guinea pig brain homogenates;(2R)-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(pyrrolidin-1-yl)cyclohexan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCC1=CC(=C(C=C1)Cl)Cl)[C@@H]2CCCC[C@H]2N3CCCC3
5968;100605301;0.456;203995;103735195;14771457;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity of compound to Sigma opioid receptor labelled with [3H](+)-3-PPP;2-(1,3-benzodioxol-5-yl)-N-methyl-N-[(1S,2R)-2-pyrrolidin-1-ylcyclohexyl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@H]1CCCC[C@H]1N2CCCC2)C(=O)CC3=CC4=C(C=C3)OCO4
5969;100721057;0.456;204634;103236608;44296419;10280;150260770;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma receptor type 1;[2-((4aS,10aR)-6-Methoxy-1,3,4,10a-tetrahydro-2H-phenanthren-4a-yl)-ethyl]-methyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CNCC[C@@]12CCCC[C@@H]1C=CC3=C2C=C(C=C3)OC
5970;100333246;0.45709;204944;103278194;10716035;10280;108823620;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was performed using [3H](+)-pentazocine to label sigma-1 binding sites, in guinea pig cerebral cortex;1-[(4-Chlorophenyl)methyl]-1-(8-pyrrolidin-1-yloctyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CCN(C1)CCCCCCCCN(CC2=CC=C(C=C2)Cl)C(=N)N
5971;366431696;0.45709;1592018;440173663;155547197;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;1-(4-Fluorophenyl)-4-(4-pyridin-2-yl-1,4-diazepan-1-yl)butan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN(C1)C2=CC=CC=N2)CCCC(=O)C3=CC=C(C=C3)F
5972;409048280;0.45709;1794447;318456509;42641861;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;1-Penten-3-one, 1-(4-fluorophenyl)-2-methyl-, oxime, (1E,3E)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC/C(=N\O)/C(=C/C1=CC=C(C=C1)F)/C
5973;345602799;0.459;1200082;312389846;76684306;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;N-(1-(3,4-dichlorobenzyl)-1H-1,2,3-triazol-4-yl)-N-(2-morpholinoethyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC(=O)N(CCN1CCOCC1)C2=CN(N=N2)CC3=CC(=C(C=C3)Cl)Cl
5974;100741866;0.462;203992;103671614;45260667;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"2-Phenyl-1-oxa-8-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CNCCC12C(=O)C=C(O2)C3=CC=CC=C3.Cl
5975;100614385;0.463;203986;103283174;14771688;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N-(2-Amino-phenyl)-N''-o-tolyl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1N=C(N)NC2=CC=CC=C2N
5976;342811253;0.465;1129882;242620295;90655536;10280;246178360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human RPMI8226 cell membranes after 120 mins by scintillation counting analysis;2-[(2S)-4-butyl-1-[(4-phenylphenyl)methyl]piperazin-2-yl]ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;CCCCN1CCN([C@H](C1)CCO)CC2=CC=C(C=C2)C3=CC=CC=C3
5977;409048265;0.46774;1794447;124963756;24771824;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;N-pyridazin-3-yl-4-[[3-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methylidene]piperidine-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1=CC2=CC(=CC=C2)OC3=NC=C(C=C3)C(F)(F)F)C(=O)NC4=NN=CC=C4
5978;100500103;0.469;204466;103236998;10619619;10280;85688040;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]DTG binding to sigma receptor from guinea pig brain cortex membrane;[3-(5-Methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-propyl]-[2-(1,2,3,4-tetrahydro-naphthalen-1-yl)-ethyl]-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCCC2CCCNCCC3CCCC4=CC=CC=C34
5979;100546840;0.47;203685;103278820;10829775;10280;96323690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma-1 receptor in guinea pig brain membranes using [3H](+)-pentazocine as the radioligand;2-(4-Amino-phenyl)-N-(1-benzyl-piperidin-4-yl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=C(C=C2)N)CC3=CC=CC=C3
5980;388740222;0.47;1797293;386051293;118283107;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 49;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OC(=O)N(C)C)OC)N2CC3=C(C2)C(=CC=C3)F
5981;388878953;0.47;1797475;386051293;118283107;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 49;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OC(=O)N(C)C)OC)N2CC3=C(C2)C(=CC=C3)F
5982;389383441;0.47;1804286;386051293;118283107;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 49;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OC(=O)N(C)C)OC)N2CC3=C(C2)C(=CC=C3)F
5983;380827758;0.472;1915098;461542924;162662928;10280;;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000540a SIGMAR1;N-pyridazin-3-yl-3-[(E)-3-[6-[5-(trifluoromethyl)pyridin-2-yl]oxypyrazin-2-yl]prop-2-enyl]azetidine-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C(CN1C(=O)NC2=NN=CC=C2)C/C=C/C3=CN=CC(=N3)OC4=NC=C(C=C4)C(F)(F)F
5984;380823612;0.47206;1915088;124963756;24771824;10280;;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000306b SIGMAR1;N-pyridazin-3-yl-4-[[3-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methylidene]piperidine-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1=CC2=CC(=CC=C2)OC3=NC=C(C=C3)C(F)(F)F)C(=O)NC4=NN=CC=C4
5985;409048264;0.47206;1794447;124963756;24771824;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;N-pyridazin-3-yl-4-[[3-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methylidene]piperidine-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1=CC2=CC(=CC=C2)OC3=NC=C(C=C3)C(F)(F)F)C(=O)NC4=NN=CC=C4
5986;100458424;0.474;204437;103344975;15149386;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;N-[2-(9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3,5,7-tetraen-15-yl)ethyl]-2-(3,4-dichlorophenyl)-N-methylethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=C(C=C1)Cl)Cl)CCN2C3CCC2C4=C(C3)NC5=CC=CC=C54
5987;255018611;0.475;625223;160708999;7010;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Valethamate bromide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCC(C)C(C1=CC=CC=C1)C(=O)OCC[N+](C)(CC)CC.[Br-]
5988;363665663;0.475;1415967;404707957;74767364;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-[1-(2-Piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidin-4-yl]-1,2-thiazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=NC=NC(=C3C=N2)C4=CSN=C4
5989;100320360;0.478;204310;103382755;10108347;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 2 using [3H]- DTG in rat liver membranes;(1S,9S,13S)-10-benzyl-13-ethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;21070;Liver;CC[C@H]1[C@@H]2CCN([C@H]1CC3=CC=CC=C23)CC4=CC=CC=C4
5990;380263974;0.479;1811100;475982176;126539168;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[4-[4-(2-hydroxy-2-phenylethyl)piperazin-1-yl]oxan-4-yl]methyl]-N-[6-(trifluoromethyl)pyridin-2-yl]propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CCOCC1)N2CCN(CC2)CC(C3=CC=CC=C3)O)C4=CC=CC(=N4)C(F)(F)F
5991;100536383;0.48;204457;103673555;45262094;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-[2-Chloro-3,5-bis(methylsulfanyl)phenyl]-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=C(C(=CC(=C2)SC)SC)Cl)N.Cl
5992;101854800;0.48;259251;103476105;11676174;10280;163927980;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma1 receptor;[O-methyl-11C]2-{4-[4-(7-Methoxynaphthalen-1-yl)piperazin-1-yl]butyl}-4-methyl-2H-[1,2,4]triazine-3,5-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C(=O)C=NN(C1=O)CCCCN2CCN(CC2)C3=CC=CC4=C3C=C(C=C4)O[11CH3]
5993;100364894;0.482;229202;103339709;10907460;10280;115854440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of sigma receptor;4-[4,4-bis(4-fluorophenyl)butyl]-N-[2-(4-ethoxyphenyl)ethyl]piperazine-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC1=CC=C(C=C1)CCNC(=O)N2CCN(CC2)CCCC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F
5994;100458323;0.482;204437;103343688;15149404;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;11-[4-(2-Furanyl)butyl]-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCCC4=CC=CO4)NC5=CC=CC=C53
5995;100458399;0.482;204438;103344903;15149422;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;5-Benzyl-11-(2-phenylethyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCC4=CC=CC=C4)N(C5=CC=CC=C53)CC6=CC=CC=C6
5996;100485974;0.482;204636;103317805;3041078;10280;76368600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured on Sigma receptor type 1 from guinea pig brain membranes using [3H]pentazocine as radioligand.;3,6,11-Trimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1C2CC3=CC=CC=C3C1(CCN2C)C
5997;366389687;0.484;1571915;440183509;15599151;10280;306053310;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma receptor 1 (unknown origin);(2R,3R,4S,5S)-2-[6-[[(1R,2S,4S)-2-bicyclo[2.2.1]heptanyl]amino]purin-9-yl]-5-(chloromethyl)oxolane-3,4-diol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C[C@@H]2C[C@H]1C[C@@H]2NC3=C4C(=NC=N3)N(C=N4)[C@H]5[C@@H]([C@@H]([C@H](O5)CCl)O)O
5998;100320353;0.487;204310;103382754;44361297;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 2 using [3H]- DTG in rat liver membranes;(1S,9S,13S)-10-benzyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;21070;Liver;C[C@@H]1[C@@H]2CC3=CC=CC=C3[C@]1(CCN2CC4=CC=CC=C4)C
5999;100458432;0.487;204437;103344903;15149422;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;5-Benzyl-11-(2-phenylethyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCC4=CC=CC=C4)N(C5=CC=CC=C53)CC6=CC=CC=C6
6000;255034402;0.487;625223;103770389;10660;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dimenhydrinate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C2=C(C(=O)N(C1=O)C)NC(=N2)Cl.CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
6001;407996430;0.48978;1946583;482063176;168280776;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[[(3S)-3-[(3-fluorophenyl)methoxy]piperidin-1-yl]methyl]imidazo[1,2-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C[C@@H](CN(C1)CC2=CN3C=CC=CC3=N2)OCC4=CC(=CC=C4)F
6002;100458860;0.49;229213;103359671;10020651;10280;79028700;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Tested for [3H](+)-pentazocine binding to sigma-1 receptor in guinea pig brain membrane;(S)-1-(4-Fluoro-phenyl)-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butan-1-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCC[C@@H](C2=CC=C(C=C2)F)O)C3=NC=C(C=N3)F
6003;100561757;0.49;204461;103397324;3037308;10280;98761100;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured at the sigma receptor by the inhibition of [3H]-3-PPP binding to guinea pig cerebellum using unlabeled 3-PPP for nonspecific binding.;Abaperidone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CN(CCC1C2=NOC3=C2C=CC(=C3)F)CCCOC4=CC5=C(C=C4)C(=O)C(=CO5)CO
6004;407996429;0.49;1946583;482063176;168280776;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[[(3S)-3-[(3-fluorophenyl)methoxy]piperidin-1-yl]methyl]imidazo[1,2-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C[C@@H](CN(C1)CC2=CN3C=CC=CC3=N2)OCC4=CC(=CC=C4)F
6005;342811242;0.491;1129882;242620296;90655537;10280;246178360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human RPMI8226 cell membranes after 120 mins by scintillation counting analysis;2-[(2S)-4-butyl-1-[(4-methoxyphenyl)methyl]piperazin-2-yl]ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;CCCCN1CCN([C@H](C1)CCO)CC2=CC=C(C=C2)OC
6006;100448329;0.493;204471;103215140;14983036;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[5-(4-Hydroxy-piperidin-1-yl)-pentyloxy]-2-(4-methoxy-phenyl)-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=CC(=C3)OCCCCCN4CCC(CC4)O
6007;100536379;0.494;204457;103673589;45262122;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(3-Bromo-2-chloro-5-methylsulfanylphenyl)-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=C(C(=CC(=C2)SC)Br)Cl)N.Cl
6008;100456539;0.495;229183;103360100;14970529;10280;79028690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor in bovine cerebellum using 2.0 nM [3H]haloperidol in the presence of 25 nM unlabeled spiperone;3-[4-(4-Chloro-phenyl)-3,6-dihydro-2H-pyridin-1-yl]-1-(3,4-dimethoxy-phenyl)-propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;COC1=C(C=C(C=C1)C(=O)CCN2CCC(=CC2)C3=CC=C(C=C3)Cl)OC
6009;380264304;0.496;1811100;475988997;166630777;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[1-(4-methylpiperazin-1-yl)cyclohexyl]methyl]-N-phenylpropanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CCCCC1)N2CCN(CC2)C)C3=CC=CC=C3
6010;389536469;0.497;1805702;384583213;122576778;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';benzyl (1R,8R)-5-(4-methylpiperazin-1-yl)-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene-9-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)C2=CC3=C(C=C2)[C@@H]4CCN([C@@H]3C4)C(=O)OCC5=CC=CC=C5
6011;408049186;0.497;1960000;404686954;145973361;10280;299084420;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma 1 receptor (unknown origin);benzyl (1S,8R)-5-(4-methylpiperazin-1-yl)-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene-9-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)C2=CC3=C(C=C2)[C@H]4CCN([C@@H]3C4)C(=O)OCC5=CC=CC=C5
6012;255015223;0.499;625223;103165728;3386;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Fluoxetine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F
6013;372355910;0.499;1726849;461540591;141317755;10280;342231650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]pentazocine from human sigma 1 receptor expressed in HEK293 cell membrane incubated for 2 hrs by liquid scintillation counting method;6-(3-Pyrrolidin-1-ylpropoxy)chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(C1)CCCOC2=CC3=C(C=C2)OC=CC3=O
6014;100456546;0.5;229183;103359644;14970527;10280;79028690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor in bovine cerebellum using 2.0 nM [3H]haloperidol in the presence of 25 nM unlabeled spiperone;3-[4-(4-Chloro-phenyl)-3,6-dihydro-2H-pyridin-1-yl]-1-(4-fluoro-phenyl)-propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CN(CC=C1C2=CC=C(C=C2)Cl)CCC(=O)C3=CC=C(C=C3)F
6015;340019624;0.5;752428;174486364;49853987;10280;236018160;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;N-cyclohexyl-2-(4-cyclopentylpiperazin-1-yl)-2-methylpropanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C(=O)NC1CCCCC1)N2CCN(CC2)C3CCCC3
6016;367490101;0.5;1661634;442057063;139406866;10280;327871420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);3-(4-Carbamoylphenyl)-5-[1-[4-(trifluoromethyl)phenyl]triazol-4-yl]benzoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC(=CC=C1C2=CC(=CC(=C2)C(=O)O)C3=CN(N=N3)C4=CC=C(C=C4)C(F)(F)F)C(=O)N
6017;388806878;0.5;1795537;378158952;122657652;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Human Sigma1 Receptor Radioligand Assay from US Patent US10072008: 'Spiro-isoquinoline-3,4′-piperidine compounds having activity against pain';US10072008, Example 7;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC2=CC=CC=C2CC13CCN(CC3)CCN4CCOCC4
6018;388806879;0.5;1795537;378158950;122667725;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Human Sigma1 Receptor Radioligand Assay from US Patent US10072008: 'Spiro-isoquinoline-3,4′-piperidine compounds having activity against pain';US10072008, Example 5;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)N1CC2=CC=CC=C2CC13CCN(CC3)CCC4=CC=CC=C4
6019;388996780;0.5;1798943;405263596;86582153;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Radioligand Assay from US Patent US9963453: 'Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators';2-(1,4''-bipiperidin-1''-yl)-1-(3,4-dihydro-pyrazino[1,2-a]indol-2(1H)-yl)propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C(=O)N1CCN2C(=CC3=CC=CC=C32)C1)N4CCC(CC4)N5CCCCC5
6020;389294720;0.5;1803838;433913987;129053789;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 24;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@@H](O[C@H](C1=O)C)C2CCN(CC2)CC3=CC=CC=C3
6021;389294742;0.5;1803838;433913977;129053793;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 10;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1C2CN(C(=O)C3(O2)CC3)C4=CC=CC=C4)CC5=CC=CC=C5
6022;389294743;0.5;1803838;433913978;129053751;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 11;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC(OC2(C1)CC2)C3CCN(CC3)CCC4=CC=CC=C4
6023;389294745;0.5;1803838;433914005;129073795;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 42;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC(OC2(C1=O)CC2)C3CN(C3)CC4=CC=CC=C4
6024;389294746;0.5;1803838;433913969;129073785;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 2;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1C2CN(CC3(O2)CC3)C(=O)C4=CC=CC=C4)CCC5=CC=CC=C5
6025;389294747;0.5;1803838;433913988;129053788;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 25;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@H](O[C@@H](C1=O)C)C2CCN(CC2)CC3=CC=CC=C3
6026;389294750;0.5;1803838;433913973;129073965;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 6;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CCC(CC1)C2CN(C(=O)C3(O2)CC3)CC4=CC=C(C=C4)OC
6027;389294752;0.5;1803838;433913997;129073955;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 34;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@@H](O[C@@H](C1=O)C)C2CCN(CC2)CC3=CC=C(C=C3)C#N
6028;389294753;0.5;1803838;433913968;129053781;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)CN2CC(OC3(C2=O)CC3)C4CCN(CC4)CCC5=CC=CC=C5
6029;389294754;0.5;1803838;433913999;129073932;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 36;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC(OC2(C1=O)CC2)C3CCN(CC3)CC4=CC=C(C=C4)C#N
6030;389294756;0.5;1803838;433913980;129073947;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 13;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)CN2CC(OC3(C2)CC3)C4CCN(CC4)CCC5=CC=CC=C5
6031;389294758;0.5;1803838;433914011;129053748;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 48;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC(OC2(C1)CC2)C3CCN(CC3)CCC(C)C
6032;389294759;0.5;1803838;433913994;129053749;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 31;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@H](O[C@H](C1=O)C)C2CCN(CC2)CC3=CC=C(C=C3)C#N
6033;389294760;0.5;1803838;433913974;129053734;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 7;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC(OC2(C1=O)CC2)C3CCN(CC3)CCC4=CC=CC=C4
6034;389294832;0.5;1803838;433914006;129073793;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 43;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC(OC2(C1=O)CC2)C3CN(C3)CCC4=CC=CC=C4
6035;389294834;0.5;1803838;433913982;129073789;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 15;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CN1CCC(CC1)C2CN(C(=O)C3(O2)CC3)CC4=CC=C(C=C4)OC
6036;389294835;0.5;1803838;433913995;129053785;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 32;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@@H](O[C@H](C1=O)C)C2CCN(CC2)CC3=CC=C(C=C3)C#N
6037;389294836;0.5;1803838;433913970;129053750;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 3;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)CN2CC(OC3(C2=O)CC3)C4CCN(CC4)CC5=CC=CC=C5
6038;389294837;0.5;1803838;433913975;129073951;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 8;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)N1CC(OC2(C1=O)CC2)C3CCN(CC3)CCC4=CC=CC=C4
6039;389294838;0.5;1803838;433913983;129073770;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 16;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CCN1CCC(CC1)C2CN(C(=O)C3(O2)CC3)CC4=CC=C(C=C4)OC
6040;389294839;0.5;1803838;433913985;129053760;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 22;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC(OC2(C1=O)CC2)C3CN(C3)CCC(C)C
6041;389294840;0.5;1803838;433913984;129073775;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 21;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)CN2CC(OCC2=O)C3CCN(CC3)CC4=CC=CC=C4
6042;389294842;0.5;1803838;433914000;129073933;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 37;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)N1CC(OC2(C1=O)CC2)C3CCN(CC3)CC4=CC=CC=C4
6043;389294844;0.5;1803838;433913993;129053771;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 30;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@@H](O[C@@H](C1=O)C)C2CCN(CC2)CC3=CC=C(C=C3)F
6044;389294845;0.5;1803838;433913986;129053763;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 23;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@H](O[C@H](C1=O)C)C2CCN(CC2)CC3=CC=CC=C3
6045;389294847;0.5;1803838;433913989;129053761;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 26;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@@H](O[C@@H](C1=O)C)C2CCN(CC2)CC3=CC=CC=C3
6046;389294848;0.5;1803838;433913990;129053741;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 27;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@H](O[C@H](C1=O)C)C2CCN(CC2)CC3=CC=C(C=C3)F
6047;389294849;0.5;1803838;433913998;129073954;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 35;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC(OC2(C1=O)CC2)C3CCN(CC3)CC4=CC=C(C=C4)F
6048;389294850;0.5;1803838;433914002;129073935;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 39;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)N1CC(OC2(C1=O)CC2)C3CCN(CC3)CC4=CC=C(C=C4)C#N
6049;389294851;0.5;1803838;433914009;129053845;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 46;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CN1CCC(CC1)C2CN(CC3(O2)CC3)CC4=CC=C(C=C4)OC
6050;389294852;0.5;1803838;433913992;129053743;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 29;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@H](O[C@@H](C1=O)C)C2CCN(CC2)CC3=CC=C(C=C3)F
6051;389294853;0.5;1803838;433913976;129053768;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 9;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1C2CN(C(=O)C3(O2)CC3)C4=CC=CC=C4)CCC5=CC=CC=C5
6052;389294854;0.5;1803838;433914007;129073931;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 44;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CCN1CCC(CC1)C2CN(C(=O)C3(O2)CC3)C4=CC=CC=C4
6053;389294855;0.5;1803838;433913991;129053831;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 28;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@@H](O[C@H](C1=O)C)C2CCN(CC2)CC3=CC=C(C=C3)F
6054;389294856;0.5;1803838;433913996;129053758;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 33;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@H](O[C@@H](C1=O)C)C2CCN(CC2)CC3=CC=C(C=C3)C#N
6055;389294857;0.5;1803838;433914001;129073936;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 38;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)N1CC(OC2(C1=O)CC2)C3CCN(CC3)CC4=CC=C(C=C4)F
6056;389294858;0.5;1803838;433914003;129073796;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Receptor Radioligand Assay from US Patent US10421750: 'Substituted morpholine derivatives having activity against pain';US10421750, Example 40;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC(OC2(C1=O)CC2)C3CCN(CC3)CCC(C)C
6057;389385659;0.5;1804511;440710142;137370594;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 35;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CN(C2)CCOC(C)C)OC3(C1=O)CC3
6058;389385661;0.5;1804511;440710132;129070156;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 25;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CCN1CCCC2(C1)CN(CC3(O2)CC3)C(=O)C4=CC=CC=C4
6059;389385663;0.5;1804511;440710109;129053879;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 2;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCCN(C2)CCC3=CC=CC=C3)OC4(C1=O)CC4
6060;389385664;0.5;1804511;440710152;129069916;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 45;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1C(=O)N(CC2(O1)CN(C2)CCC(C)(C)C)C(C)C
6061;389385665;0.5;1804511;440710138;129069856;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 31;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCCN(CC2)CCC(C)C)OC(C1=O)(C)C
6062;389385667;0.5;1804511;440710114;129053862;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 7;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CN(C1)CCC3=CC=CC=C3)CN(C(=O)C4(O2)CC4)C5=CC=CC=C5
6063;389385771;0.5;1804511;440710131;129070154;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 24;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CN(C1)CCC3=CC=CC=C3)CN(CC4(O2)CC4)C(=O)C5=CC=CC=C5
6064;389385772;0.5;1804511;440710108;129053804;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCCN(C2)CCC(C)C)OC3(C1=O)CC3
6065;389385773;0.5;1804511;440710112;129070199;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 5;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CN(C2)CCC3=CC=CC=C3)OC4(C1=O)CC4
6066;389385774;0.5;1804511;440710124;129053835;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 17;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CC2)OC3(C1)CCCN(C3)CC4=CC=CC=C4
6067;389385775;0.5;1804511;440710125;129053844;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 18;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CC2)OC3(C1)CCCN(C3)CCC4=CC=CC=C4
6068;389385778;0.5;1804511;440710151;129069913;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 44;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1C(=O)N(CC2(O1)CN(C2)CCC(C)(C)C)C(C)C
6069;389385781;0.5;1804511;440710130;129070033;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 23;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CN(C1)CC3=CC=CC=C3)CN(CC4(O2)CC4)C5=CC=CC=C5
6070;389385782;0.5;1804511;440710118;129053826;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 11;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCCN(C2)CC3=CC=CC=C3)OC4(C1=O)CC4
6071;389385783;0.5;1804511;440710170;129053767;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 62;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@]2(CCCN(CC2)CC3=CC=CC=C3)O[C@H](C1=O)C
6072;389385786;0.5;1804511;440710115;129053799;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 8;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CCN1CCCC2(C1)CN(C(=O)C3(O2)CC3)C4=CC=CC=C4
6073;389385787;0.5;1804511;440710147;129069920;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 40;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1C(=O)N(CC2(O1)CN(C2)CCC(C)C)C(C)C
6074;389385788;0.5;1804511;440710120;129053838;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 13;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CN(C2)CC3=CC=CC=C3)OC4(C1=O)CC4
6075;389385790;0.5;1804511;440710156;129070180;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 49;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@]2(CCCN(CC2)CCC(C)C)O[C@H](C1=O)C
6076;389385901;0.5;1804511;440710172;137390823;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 64;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@]2(CCCN(CC2)CC3=CC=C(C=C3)C)O[C@@H](C1=O)C
6077;389385904;0.5;1804511;440710148;129069915;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 41;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1C(=O)N(CC2(O1)CN(C2)CCC(C)C)C(C)C
6078;389385905;0.5;1804511;440710162;129053858;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 59;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@@]2(CCCN(CC2)CC3=CC=CC=C3)O[C@@H](C1=O)C
6079;389385906;0.5;1804511;440710133;129070155;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 26;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CN1CCCC2(C1)CN(CC3(O2)CC3)C(=O)C4=CC=CC=C4
6080;389385907;0.5;1804511;440710181;129070036;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 72;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC2(CCCN(CC2)CC3=CC=C(C=C3)F)OC4(C1=O)CC4
6081;389385910;0.5;1804511;440710139;129069860;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 32;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCCN(CC2)CC(C)C)OC(C1=O)(C)C
6082;389385911;0.5;1804511;440710179;129070049;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 70;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@]2(CCCN(CC2)CC3=CC=C(C=C3)C#N)O[C@H](C1=O)C
6083;389385913;0.5;1804511;440710180;129070038;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 71;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC2(CCCN(CC2)CC3=CC=CC=C3)OC4(C1=O)CC4
6084;389385915;0.5;1804511;440710146;129053798;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 39;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CN(C2)CC(C)C)O[C@H](C1=O)C
6085;389385916;0.5;1804511;440710188;129070046;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 77;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1C(=O)N(CC2(O1)CN(C2)CC(C)(C)C)C(C)C
6086;389385918;0.5;1804511;440710144;137370663;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 37;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CN(C2)CCC(C)C)O[C@H](C1=O)C
6087;389385919;0.5;1804511;440710174;137390837;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 66;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@]2(CCCN(CC2)CC3=CC=C(C=C3)C)O[C@H](C1=O)C
6088;389385920;0.5;1804511;440710204;129070161;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 94;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1(CN(C[C@@]2(O1)CCCN(CC2)CCC3=CC=CC=C3)C(=O)C4=CC=CC=C4)C
6089;389386056;0.5;1804511;440710169;129053818;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 61;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@@]2(CCCN(CC2)CC3=CC=CC=C3)O[C@H](C1=O)C
6090;389386058;0.5;1804511;440710183;129070044;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 74;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CN(C2)CC(C)(C)C)O[C@H](C1=O)C
6091;389386061;0.5;1804511;440710136;129069858;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 29;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CN1CCCC2(CC1)CN(CC3(O2)CC3)C(=O)C4=CC=CC=C4
6092;389386062;0.5;1804511;440710202;129070165;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 91;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC12CN(CC3(O2)CN(C3)CCC4=CC=CC=C4)C(=O)C5=CC=CC=C5
6093;389386063;0.5;1804511;440710204;129070161;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 94;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1(CN(C[C@@]2(O1)CCCN(CC2)CCC3=CC=CC=C3)C(=O)C4=CC=CC=C4)C
6094;389386064;0.5;1804511;440710178;129070037;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 69;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@@]2(CCCN(CC2)CC3=CC=C(C=C3)C#N)O[C@H](C1=O)C
6095;389386067;0.5;1804511;440710149;129069912;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 42;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1C(=O)N(CC2(O1)CN(C2)CC(C)C)C(C)C
6096;389386068;0.5;1804511;440710150;129069914;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 43;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1C(=O)N(CC2(O1)CN(C2)CC(C)C)C(C)C
6097;389386069;0.5;1804511;440710155;129070178;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 48;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@@]2(CCCN(CC2)CCC(C)C)O[C@H](C1=O)C
6098;389386070;0.5;1804511;440710122;129053876;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 15;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CN(C1)CC3=CC=CC=C3)CN(C(=O)C4(O2)CC4)C5=CC=CC=C5
6099;389386071;0.5;1804511;440710153;137370776;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 46;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@@]2(CCCN(CC2)CCC(C)C)O[C@@H](C1=O)C
6100;389386073;0.5;1804511;440710143;137370738;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 36;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CN(C2)CCC(C)C)O[C@@H](C1=O)C
6101;389386074;0.5;1804511;440710145;129053841;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 38;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CN(C2)CC(C)C)O[C@@H](C1=O)C
6102;389386075;0.5;1804511;440710163;129053833;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 60;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@]2(CCCN(CC2)CC3=CC=CC=C3)O[C@@H](C1=O)C
6103;389386177;0.5;1804511;440710182;129070051;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 73;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC2(CCCN(CC2)CC3=CC=C(C=C3)C#N)OC4(C1=O)CC4
6104;389386178;0.5;1804511;440710158;129053822;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 55;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CN(C1)CC3=CC=CC=C3)CN(CC4(O2)CC4)C(=O)C5=CC=CC=C5
6105;389386182;0.5;1804511;440710154;129070181;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 47;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@]2(CCCN(CC2)CCC(C)C)O[C@@H](C1=O)C
6106;389386183;0.5;1804511;440710177;137370429;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 68;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@]2(CCCN(CC2)CC3=CC=C(C=C3)C#N)O[C@@H](C1=O)C
6107;389386186;0.5;1804511;440710161;129053849;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 58;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCCN(CC2)CC3=CC=C(C=C3)C#N)OC(C1=O)(C)C
6108;389386187;0.5;1804511;440710157;129070177;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 50;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)OCCN1CCCC2(CC1)CN(CC(O2)(C)C)C(=O)C3=CC=CC=C3
6109;389386189;0.5;1804511;440710171;129053850;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 63;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@@]2(CCCN(CC2)CC3=CC=C(C=C3)F)O[C@@H](C1=O)C
6110;389386190;0.5;1804511;440710186;129070045;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 75;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CN(C2)CC(C)(C)C)O[C@@H](C1=O)C
6111;389386191;0.5;1804511;440710173;137390850;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 65;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@@]2(CCCN(CC2)CC3=CC=C(C=C3)C)O[C@H](C1=O)C
6112;389386193;0.5;1804511;440710187;129070047;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 76;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1C(=O)N(CC2(O1)CN(C2)CC(C)(C)C)C(C)C
6113;389386195;0.5;1804511;440710175;137370790;10280;;Confirmatory;20230307;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US10689398: 'OXA-Diazaspiro compounds having activity against pain';US10689398, Example 67;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@@]2(CCCN(CC2)CC3=CC=C(C=C3)C#N)O[C@@H](C1=O)C
6114;389770092;0.5;1919450;443553194;135332735;10280;;Confirmatory;20231017;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 33;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)C3CCC3)OC4(C1=O)CC4
6115;389770093;0.5;1919450;443553173;135332867;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 12;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCN1CCC2(CC1)CN(C(=O)C3(O2)CC3)CC
6116;389770095;0.5;1919450;443553165;135332804;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 4;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CCC(C)C)O[C@@H](C1=O)C
6117;389770098;0.5;1919450;443553256;135374937;10280;;Confirmatory;20231017;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 96;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1C(=O)N(CC2(O1)CCN(CC2)CC3=CC(=CC=C3)C#N)C(C)C
6118;389770099;0.5;1919450;443553174;135332750;10280;;Confirmatory;20231017;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 13;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CCOCC)OC3(C1=O)CC3
6119;389770101;0.5;1919450;443553167;135332833;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 6;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC(C)C)OC3(C1=O)CC3
6120;389770105;0.5;1919450;443553175;135332816;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 14;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)C3CCCC3)OC4(C1=O)CC4
6121;389770106;0.5;1919450;443553195;135374645;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 34;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)C3CCCCC3)OC4(C1=O)CC4
6122;389770108;0.5;1919450;443553217;135332828;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 57;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1C(=O)N(CC2(O1)CCN(CC2)CCOC(C)C)C(C)C
6123;389770109;0.5;1919450;443553200;135374676;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 39;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(CC2(O1)CCN(CC2)CCC3=C(C=CC=N3)F)C(C)C
6124;389770302;0.5;1919450;443553182;135332749;10280;;Confirmatory;20231017;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 21;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CCC2(CC1)CN(C(=O)C3(O2)CC3)CC
6125;389770305;0.5;1919450;443553258;135374650;10280;;Confirmatory;20231017;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 98;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1C(=O)N(CC2(O1)CCN(CC2)CC3=CC=CC=C3)C(C)C
6126;389770306;0.5;1919450;443553223;135332848;10280;;Confirmatory;20231017;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 63;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CCC3CC3)O[C@H](C1=O)C
6127;389770307;0.5;1919450;443553164;135332743;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 3;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CCN1CCC2(CC1)CN(C(=O)C3(O2)CC3)C
6128;389770311;0.5;1919450;443553255;135374656;10280;;Confirmatory;20231017;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 95;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC3=C(C=C(C=C3)F)F)O[C@H](C1=O)C
6129;389770313;0.5;1919450;443553204;135374918;10280;;Confirmatory;20231017;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 43;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC2(CC2)OC3(C1)CCN(CC3)CCC4=C(C=CC=N4)F
6130;389770314;0.5;1919450;443553202;135374763;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 41;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CC2)OC3(C1)CCN(CC3)CCC4=C(C=CC=N4)F
6131;389770316;0.5;1919450;443553189;135332766;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 28;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC3=CC=NC=C3)OC4(C1=O)CC4
6132;389770318;0.5;1919450;443553198;135374711;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 37;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)N1CCOC2(C1)CCN(CC2)CCC3=C(C=CC=N3)F
6133;389770320;0.5;1919450;443553192;135332880;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 31;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC3=CC=CC=C3F)OC4(C1=O)CC4
6134;389770413;0.5;1919450;443553252;135374698;10280;;Confirmatory;20231017;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 92;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC3=CC(=CC=C3)C#N)O[C@H](C1=O)C
6135;389770415;0.5;1919450;443553196;135332713;10280;;Confirmatory;20231017;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 35;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)C3CCOCC3)OC4(C1=O)CC4
6136;389770416;0.5;1919450;443553169;135332810;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 8;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CCOC(C)C)OC3(C1=O)CC3
6137;389770418;0.5;1919450;443553260;135374760;10280;;Confirmatory;20231017;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 100;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1C(=O)N(CC2(O1)CCN(CC2)CC3=CC=C(C=C3)C#N)C(C)C
6138;389770419;0.5;1919450;443553257;135374771;10280;;Confirmatory;20231017;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 97;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1C(=O)N(CC2(O1)CCN(CC2)CC3=CC=CC=C3)C(C)C
6139;389770420;0.5;1919450;443553186;135332783;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 25;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC3=CN=CC=C3)OC4(C1=O)CC4
6140;389770422;0.5;1919450;443553211;135332806;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 50;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)N1CC2(CCN(CC2)CCC(C)(C)C)OCC1=O
6141;389770423;0.5;1919450;443553251;135374942;10280;;Confirmatory;20231017;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 91;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1C(=O)N(CC2(O1)CCN(CC2)CC3=CC=C(C=C3)OC(F)(F)F)C
6142;389770426;0.5;1919450;443553231;135374664;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 71;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC3=CC=C(C=C3)F)O[C@H](C1=O)C
6143;389770427;0.5;1919450;443553259;135374962;10280;;Confirmatory;20231017;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 99;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1C(=O)N(CC2(O1)CCN(CC2)CC3=CC=C(C=C3)F)C(C)C
6144;389770429;0.5;1919450;443553212;135332858;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 51;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CCC(C)(C)C)OCC1=O
6145;389770430;0.5;1919450;443553225;135332869;10280;;Confirmatory;20231017;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 65;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1C(=O)N(CC2(O1)CCN(CC2)CCC3CC3)C(C)C
6146;389770560;0.5;1919450;443553213;135332757;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 53;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CCN1CCC2(CC1)CN(C(=O)CO2)C(C)C
6147;389770562;0.5;1919450;443553250;135374643;10280;;Confirmatory;20231017;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 90;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1C(=O)N(CC2(O1)CCN(CC2)CC3=CC=CC=C3)C
6148;389770563;0.5;1919450;482595836;156290271;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US11649248, Example 59;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOCCN1CCC2(CC1)CN(C(=O)CO2)C3CC3
6149;389770568;0.5;1919450;443553190;135374649;10280;;Confirmatory;20231017;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 29;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC3=CC=CC=N3)OC4(C1=O)CC4
6150;389770572;0.5;1919450;443553242;135374613;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 82;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1C(=O)N(CC2(O1)CCN(CC2)CC3=CC=C(C=C3)C#N)C
6151;389770720;0.5;1919450;443553266;135374915;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 106;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC(OC2(C1)CCN(CC2)CCC3=C(C=CC=N3)F)(C)C
6152;389770721;0.5;1919450;443553254;135374611;10280;;Confirmatory;20231017;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 94;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC3=CC(=C(C=C3)F)C#N)O[C@H](C1=O)C
6153;389770725;0.5;1919450;443553216;135332756;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 56;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)CCN1CCC2(CC1)CN(C(=O)CO2)C3CC3
6154;389770726;0.5;1919450;443553222;135332831;10280;;Confirmatory;20231017;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 62;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1C(=O)N(CC2(O1)CCN(CC2)CCOC(C)C)C3CC3
6155;389770727;0.5;1919450;443553191;135332854;10280;;Confirmatory;20231017;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 30;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCC2(CC1)CN(C(=O)C3(O2)CC3)CC
6156;389770728;0.5;1919450;443553253;135374770;10280;;Confirmatory;20231017;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 93;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC3=CC(=C(C=C3)C#N)F)O[C@H](C1=O)C
6157;389770729;0.5;1919450;443553226;135332746;10280;;Confirmatory;20231017;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 66;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CC2(CCN(CC2)CCOC(C)C)O[C@H](C1=O)C
6158;389770730;0.5;1919450;443553218;135332786;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 58;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1C(=O)N(CC2(O1)CCN(CC2)CCC(C)C)C3CC3
6159;389770731;0.5;1919450;443553205;135332744;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 44;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1C(=O)N(CC2(O1)CCN(CC2)CCC(C)C)C(C)C
6160;389770732;0.5;1919450;482595788;156290071;10280;;Confirmatory;20231017;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US11649248, Example 11;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CCOC3=CCCC=C3)OC4(C1=O)CC4
6161;389770734;0.5;1919450;443553238;135374668;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 78;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC3=CC=C(C=C3)OC)OC(C1=O)(C)C
6162;389770903;0.5;1919450;443553220;135332708;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 60;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CCOC(C)C)O[C@H](C1=O)C
6163;389770905;0.5;1919450;443553239;135374785;10280;;Confirmatory;20231017;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 79;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC(C)(C)C)O[C@H](C1=O)C
6164;389770908;0.5;1919450;443553221;135332830;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 61;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCOC(C)C)C(C)C
6165;389770910;0.5;1919450;443553267;135374729;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 107;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C[C@@H](OC2(C1)CCN(CC2)CCC3=C(C=CC=N3)F)C
6166;389770911;0.5;1919450;443553224;135332718;10280;;Confirmatory;20231017;0;0;Unspecified;Q99720;Ki;>;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 64;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CCC3CC3)OCC1=O
6167;389770913;0.5;1919450;443553240;135374702;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US10927128, Example 80;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CC3=CC=C(C=C3)OC)O[C@H](C1=O)C
6168;389770914;0.5;1919450;482595829;135332875;10280;;Confirmatory;20231017;0;0;Active;Q99720;Ki;<;BindingDB;Radioligand Assay from US Patent US11649248: 'Oxadiazaspiro compounds for the treatment of drug abuse and addiction';US11649248, Example 52;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CCC(C)(C)C)O[C@H](C1=O)C
6169;365267165;0.50119;1512456;440140551;147653864;10280;316202300;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-6-bromo-3a-methyl-2,3,4,9b-tetrahydro-1H-chromeno[3,4-b]pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@]12COC3=C([C@@H]1CCN2)C=CC=C3Br
6170;365267166;0.50119;1512456;440133221;153287553;10280;316202300;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-3a-methyl-5-phenyl-2,3,4,9b-tetrahydro-1H-pyrrolo[2,3-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@]12CN(C3=CC=CC=C3[C@@H]1CCN2)C4=CC=CC=C4
6171;366437096;0.50119;1594273;440187843;155552895;10280;309043830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;[5-[2-(1,3-Benzodioxol-5-yl)ethylamino]-1-phenyl-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)C(=O)C2=NN(C3=C2CC(CC3)NCCC4=CC5=C(C=C4)OCO5)C6=CC=CC=C6
6172;366437098;0.50119;1594273;440203452;146597651;10280;309043830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;5-[2-(1,3-benzodioxol-5-yl)ethylamino]-N,N-dimethyl-1-propyl-4,5,6,7-tetrahydroindazole-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCCN1C2=C(CC(CC2)NCCC3=CC4=C(C=C3)OCO4)C(=N1)C(=O)N(C)C
6173;407996471;0.50119;1946583;482062743;168280464;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[[(3S)-3-[(2-methylphenyl)methoxy]piperidin-1-yl]methyl]imidazo[1,2-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1CO[C@H]2CCCN(C2)CC3=CN4C=CC=CC4=N3
6174;409047924;0.50119;1794447;318459881;87522699;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(NE)-N-[(E)-1-(4-fluoro-3-methylphenyl)-2-methylpent-1-en-3-ylidene]hydroxylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC/C(=N\O)/C(=C/C1=CC(=C(C=C1)F)C)/C
6175;407996470;0.503;1946583;482062743;168280464;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;2-[[(3S)-3-[(2-methylphenyl)methoxy]piperidin-1-yl]methyl]imidazo[1,2-a]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=CC=C1CO[C@H]2CCCN(C2)CC3=CN4C=CC=CC4=N3
6176;100745737;0.504;204454;103247693;15729907;10280;;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity towards sigma receptor by the displacement of [3H]PPP from guinea pig brain;N-{1-Cyclohexyl-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butyl}-4-fluoro-benzenesulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)C(CCCN2CCN(CC2)C3=NC=C(C=N3)F)NS(=O)(=O)C4=CC=C(C=C4)F
6177;255034739;0.504;625223;103166970;2477;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Buspirone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4
6178;380799763;0.50548;1915176;103489724;11673921;10280;;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000308b SIGMAR1;3-((5-(2,3-dichlorophenyl)-1H-tetrazol-1-yl)methyl)pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC(=C(C(=C1)Cl)Cl)C2=NN=NN2CC3=CN=CC=C3
6179;409048279;0.50548;1794447;318456509;42641861;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;1-Penten-3-one, 1-(4-fluorophenyl)-2-methyl-, oxime, (1E,3E)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC/C(=N\O)/C(=C/C1=CC=C(C=C1)F)/C
6180;255011807;0.508;625223;103405309;441383;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Terconazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=NC=N4)C5=C(C=C(C=C5)Cl)Cl
6181;345602967;0.508;1200082;312389838;76684564;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-[(3,4-dichlorophenyl)methyl]-N-(3-morpholin-4-ylpropyl)triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1COCCN1CCCNC2=CN(N=N2)CC3=CC(=C(C=C3)Cl)Cl
6182;100458407;0.509;204438;103344975;15149386;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;N-[2-(9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3,5,7-tetraen-15-yl)ethyl]-2-(3,4-dichlorophenyl)-N-methylethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=C(C=C1)Cl)Cl)CCN2C3CCC2C4=C(C3)NC5=CC=CC=C54
6183;100333034;0.51286;204944;103278474;10337119;10280;108823620;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was performed using [3H](+)-pentazocine to label sigma-1 binding sites, in guinea pig cerebral cortex;1-(4-Chlorobenzyl)-1-[6-(pyrrolidine-1-yl)hexyl]guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CCN(C1)CCCCCCN(CC2=CC=C(C=C2)Cl)C(=N)N
6184;100613256;0.513;204440;103283111;44318068;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]-DTG in guinea pig brain membrane homogenates;N,N''-Dicyclohexyl-N''''-cyclopropyl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)NC(=NC2CC2)NC3CCCCC3
6185;363665998;0.514;1415921;404696767;71223095;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;N-(1-(2-(Azepan-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)tetrahydro-2H-pyran-4-carboxamide hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCCN(CC1)CCN2C3=NC=NC(=C3C=N2)NC(=O)C4CCOCC4
6186;255026444;0.516;625223;103558716;66265;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dexfenfluramine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
6187;100459178;0.517;204437;103344923;15149407;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;15-[(E)-3-phenylprop-2-enyl]-9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3,5,7-tetraene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2C/C=C/C4=CC=CC=C4)NC5=CC=CC=C53
6188;100534037;0.5177;204794;103359297;44350787;10280;93971710;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was done in guinea pig membranes by labeling the binding site with [3H](+)-pentazocine;(alphaR)-1-Methyl-alpha-(3-bromophenyl)spiro[indoline-3,4'-piperidine]-1'-ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC2(CCN(CC2)C[C@@H](C3=CC(=CC=C3)Br)O)C4=CC=CC=C41
6189;388740577;0.52;1797293;386051285;118282835;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 41;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(=O)N(C)C)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)F
6190;388879455;0.52;1797475;386051285;118282835;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 41;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(=O)N(C)C)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)F
6191;389383880;0.52;1804286;386051285;118282835;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 41;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)OC(=O)N(C)C)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)F
6192;389712851;0.527;1919146;476002739;3037918;10280;;Confirmatory;20231017;0;0;Active;Q99720;IC50;;BindingDB;Receptor Binding Assay from US Patent US11535596: 'Analogs of dextromethorphan with balanced receptor activities';Dimemorfan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC2=C(C[C@H]3[C@@H]4[C@]2(CCCC4)CCN3C)C=C1
6193;380800877;0.52876;1915202;318459881;87522699;10280;;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000547a SIGMAR1;(NE)-N-[(E)-1-(4-fluoro-3-methylphenyl)-2-methylpent-1-en-3-ylidene]hydroxylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC/C(=N\O)/C(=C/C1=CC(=C(C=C1)F)C)/C
6194;409047923;0.52876;1794447;318459881;87522699;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(NE)-N-[(E)-1-(4-fluoro-3-methylphenyl)-2-methylpent-1-en-3-ylidene]hydroxylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC/C(=N\O)/C(=C/C1=CC(=C(C=C1)F)C)/C
6195;100448332;0.529;204471;103215417;14982952;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(5-Dimethylamino-pentyloxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCCCCOC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3
6196;363665661;0.531;1415967;404697938;74767127;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(4-Methoxyphenyl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)C2=C3C=NN(C3=NC=N2)CCN4CCCCC4
6197;366463034;0.531;1607454;163332281;53475319;10280;323426850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from sigma1 receptor (unknown origin) after 90 mins by microbeta scintillation counting method;N-((1R,3R)-3-(2-(((S)-2-amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)(propyl)amino)ethyl)-3-hydroxycyclobutyl)-2-naphthamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN(CCC1(CC(C1)NC(=O)C2=CC3=CC=CC=C3C=C2)O)[C@H]4CCC5=C(C4)SC(=N5)N
6198;100458315;0.534;204437;103344235;15149397;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;11-(2-Phenoxyethyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCOC4=CC=CC=C4)NC5=CC=CC=C53
6199;100471369;0.535;204459;160677132;41011;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;Guanidine, N,N'-bis(4-methylphenyl)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=C(C=C1)NC(=NC2=CC=C(C=C2)C)N
6200;100614097;0.535;203986;160677132;41011;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;Guanidine, N,N'-bis(4-methylphenyl)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=C(C=C1)NC(=NC2=CC=C(C=C2)C)N
6201;334065178;0.536;735278;164132737;71654693;10280;235606500;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aS,5R,10bS)-9-(3-methylbutoxy)-5-piperidin-4-yl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC(C)CCOC1=CC2=C(C=C1)N[C@@H]([C@H]3[C@@H]2OCCC3)C4CCNCC4
6202;100451424;0.538;204436;103677704;45264739;10280;81026510;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using [3H]ditolylguanidine (DTG) as radioligand.;"4-phenyl-N,N-bis(prop-2-enyl)-1,2,3,4-tetrahydronaphthalen-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C=CCN(CC=C)C1CC(C2=CC=CC=C2C1)C3=CC=CC=C3.Cl
6203;100615708;0.538;204447;103321342;6331636;10280;16560440;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H]-(+)-3-PPP binding to sigma of guinea pig brain;(2R)-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(pyrrolidin-1-yl)cyclohexan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCC1=CC(=C(C=C1)Cl)Cl)[C@@H]2CCCC[C@H]2N3CCCC3
6204;100614380;0.54;203986;103283474;14771672;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;1,3-Bis(4-bromophenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC(=CC=C1NC(=NC2=CC=C(C=C2)Br)N)Br
6205;255011811;0.542;625223;103172426;12456;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Berberine chloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC.[Cl-]
6206;100471772;0.54954;203852;103182298;5775;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;Phentolamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O
6207;100617223;0.55;204444;103183490;2760172;10280;16627250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membranes using [3H]DTG as radioligand;1-(Naphthalen-2-yl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1)C2=CC3=CC=CC=C3C=C2
6208;100623898;0.55;204627;103229443;3039881;10280;16745410;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;The compound was tested for binding affinity against sigma receptor using DTG as radioligand;3-Chloro-10,11-dihydro-N,N-dimethylspiro-(5H-dibenzo(a,d)cycloheptene-5,1'-cyclohex-2'-ene)4'-amine 1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)C1CCC2(C=C1)C3=CC=CC=C3CCC4=C2C=C(C=C4)Cl
6209;100403998;0.552;204630;103295037;44321533;10280;128012230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma receptor type 1 was determined by the displacement of [3H]pentazocine radioligand;9-[3-[(3R,5R)-3,4,5-trimethylpiperazin-1-yl]propyl]carbazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(C[C@H](N1C)C)CCCN2C3=CC=CC=C3C4=CC=CC=C42
6210;372120979;0.556;1681775;461515072;118561099;10280;330649470;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;(2R)-9-[2-(2,3-difluorophenyl)ethyl]-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CCC3=C(C(=CC=C3)F)F)O[C@@H](C1=O)C
6211;363665662;0.558;1415967;404704606;74767129;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-[1-(2-Piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidin-4-yl]benzonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=NC=NC(=C3C=N2)C4=CC=C(C=C4)C#N
6212;100440593;0.56;229192;103168867;6468;10280;14696970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of specific binding of [3H]NANM of sigma binding site in Guinea pig brain membranes;Phencyclidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)(C2=CC=CC=C2)N3CCCCC3
6213;367471382;0.56;1651997;442056651;25235287;10280;322278830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin);Veranamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NC=CC2=C1C(NC3=C2C=CC(=C3)Br)(C)C
6214;255028999;0.5602;625223;103215995;1549008;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Terbinafine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)C#C/C=C/CN(C)CC1=CC=CC2=CC=CC=C21
6215;100746107;0.562;204298;103252465;12259685;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma opioid receptor type 2 in guinea pig brain homogenate with 4 nM [3H]-(+)-DTG;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
6216;380299328;0.568;1819827;475995038;24997107;10280;354503790;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Citalopram from sigma-1 receptor (unknown origin) expressed in HEK cell membrane incubated for 2 hrs by liquid scintillation counter analysis;(1S,9S,10S)-4-(difluoromethoxy)-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC(F)F
6217;100565305;0.571;203703;103177773;10828366;10280;95442130;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;The compound was tested for the affinity on sigma 1 receptor using [3H]- pentazocine as radioligand;6-Propionyl-3-(2-pyrrolidin-1-yl-ethyl)-3H-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)C1=CC2=C(C=C1)N(C(=O)S2)CCN3CCCC3
6218;255018199;0.572;625223;103164619;2801;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Clomipramine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl
6219;363666196;0.573;1415921;404707150;145986903;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;N-[1-[4-(4-propan-2-ylpiperazin-1-yl)butyl]pyrazolo[3,4-d]pyrimidin-4-yl]adamantane-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)N1CCN(CC1)CCCCN2C3=NC=NC(=C3C=N2)NC(=O)C45CC6CC(C4)CC(C6)C5
6220;380581326;0.573;1861723;482064615;168281846;10280;357249250;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay;N-[3-[(3,4-dimethoxyphenyl)methyl-methylamino]propyl]quinoline-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=NC2=CC=CC=C2C=C1)CC3=CC(=C(C=C3)OC)OC
6221;100508506;0.579;204150;103346133;401816;10280;87844550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from Sigma opioid receptor type 1 in guinea pig brain membrane;3-{2-[Methyl-(2-pyrrolidin-1-yl-ethyl)-amino]-ethyl}-phenylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCC1=CC(=CC=C1)N)CCN2CCCC2
6222;100467864;0.58;204005;103325985;10448420;10280;79325350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vivo binding affinity against sigma Opioid receptor was measured by using labeled ligand [3H]-SKF- 10,047 (1 nM);(4aR,7S,7aR,12bS)-3-Cyclopropylmethyl-2,3,4,4a,5,6,7,7a-octahydro-1H-8-oxa-3-aza-benzo[d]fluorene-7,9-diol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C[C@@H]([C@H]2[C@@]3([C@@H]1CN(CC3)CC4CC4)C5=C(O2)C(=CC=C5)O)O
6223;100741870;0.58;203992;103671626;45260675;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"8-Methyl-3-phenyl-1-oxa-8-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN1CCC2(CC1)C(=O)C(=CO2)C3=CC=CC=C3.Cl
6224;100364896;0.581;229202;103339458;11143820;10280;115854440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of sigma receptor;8-(6-Chloro-1,3-benzodioxole-5-ylmethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decane-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CC4=CC5=C(C=C4Cl)OCO5
6225;100320348;0.587;204310;103383040;44361388;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 2 using [3H]- DTG in rat liver membranes;(1S,9S,13S)-10-benzyl-13-methyl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;21070;Liver;C[C@H]1[C@@H]2CCN([C@H]1CC3=CC=CC=C23)CC4=CC=CC=C4
6226;100471776;0.58884;203852;103173857;53389;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;Rimcazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(C[C@@H](N1)C)CCCN2C3=CC=CC=C3C4=CC=CC=C42
6227;389536397;0.589;1805702;384583197;137653463;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';benzyl (1R,8R)-5-(4-prop-2-enylpiperazin-1-yl)-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene-9-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C=CCN1CCN(CC1)C2=CC3=C(C=C2)[C@@H]4CCN([C@@H]3C4)C(=O)OCC5=CC=CC=C5
6228;100448352;0.59;204471;103215418;14982949;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(2-Dimethylamino-ethoxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCOC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3
6229;340019682;0.59;752428;174511988;49853575;10280;236018160;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;N-cyclohexyl-2-(4-cyclopentylpiperazin-1-yl)butanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(C(=O)NC1CCCCC1)N2CCN(CC2)C3CCCC3
6230;100600967;0.594;203996;103249351;6604724;10280;25470740;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was evaluated for binding affinity towards sigma opioid receptor using [3H](+)-3-PPP in guinea pig ileum;2-(3,4-dichlorophenyl)-N-methyl-N-[(1S,2S)-2-(1-pyrrolidinyl)cyclohexyl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;21160;Ileum;CN([C@H]1CCCC[C@@H]1N2CCCC2)C(=O)CC3=CC(=C(C=C3)Cl)Cl
6231;100403485;0.596;204630;103295229;44321648;10280;128012230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma receptor type 1 was determined by the displacement of [3H]pentazocine radioligand;9-[3-(3,5-Dimethyl-piperazin-1-yl)-propyl]-3-nitro-9H-carbazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(C[C@H](N1)C)CCCN2C3=C(C=C(C=C3)[N+](=O)[O-])C4=CC=CC=C42
6232;100444462;0.6;204470;103215140;14983036;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[5-(4-Hydroxy-piperidin-1-yl)-pentyloxy]-2-(4-methoxy-phenyl)-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=CC(=C3)OCCCCCN4CCC(CC4)O
6233;380773263;0.60256;1907474;482055487;168275182;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;Benzyl 2-[3-[4-(3-hydroxypropyl)piperazin-1-yl]phenyl]-4-methylpiperazine-1-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(C(C1)C2=CC(=CC=C2)N3CCN(CC3)CCCO)C(=O)OCC4=CC=CC=C4
6234;372355911;0.604;1726849;461539895;162660873;10280;342231650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]pentazocine from human sigma 1 receptor expressed in HEK293 cell membrane incubated for 2 hrs by liquid scintillation counting method;6-[2-(4-Methylpiperazin-1-yl)ethoxy]chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)CCOC2=CC3=C(C=C2)OC=CC3=O
6235;100448388;0.605;204471;103214569;121180;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;7-(2-Dimethylamino-ethoxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCOC1=CC2=C(C=C1)C(=O)C=C(O2)C3=CC=CC=C3
6236;100320345;0.607;204310;103382756;10850173;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 2 using [3H]- DTG in rat liver membranes;Benzyl-[2-((1S,2R)-2-methyl-1,2-dihydro-naphthalen-1-yl)-ethyl]-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;21070;Liver;C[C@@H]1C=CC2=CC=CC=C2[C@H]1CCNCC3=CC=CC=C3
6237;100449435;0.607;204443;103274923;44314218;10280;83608750;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine at sigma receptor in guinea pig brain membrane was determined;(1-Aza-bicyclo[2.2.2]oct-3-yl)-[2-(3,4-dichloro-phenyl)-ethyl]-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN2CCC1C(C2)NCCC3=CC(=C(C=C3)Cl)Cl
6238;372120974;0.609;1681775;461532278;162655458;10280;330649470;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;(2R)-9-[2-(2,6-difluorophenyl)ethyl]-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CCC3=C(C=CC=C3F)F)O[C@@H](C1=O)C
6239;380773264;0.609;1907474;482055487;168275182;10280;353955110;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in human HEK293T cells assessed as inhibition constant by radioligand competition binding assay;Benzyl 2-[3-[4-(3-hydroxypropyl)piperazin-1-yl]phenyl]-4-methylpiperazine-1-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(C(C1)C2=CC(=CC=C2)N3CCN(CC3)CCCO)C(=O)OCC4=CC=CC=C4
6240;380512531;0.611;1846430;482075793;86298405;10280;338263220;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2S,6S)-4-[(4-fluorophenyl)methyl]-10-pyridin-2-yl-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@H]2[C@H](CN1CC3=CC=C(C=C3)F)OCC4=C(N=NN24)C5=CC=CC=N5
6241;408049182;0.62;1960000;404687036;145973417;10280;299084420;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma 1 receptor (unknown origin);(1S,9R,13R)-10-but-3-enyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1[C@H]2CC3=C([C@]1(CCN2CCC=C)C)C=C(C=C3)O
6242;366366991;0.622;1558961;440181447;118567689;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;CID 118567689;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=N3)C4=C(C=CN=C4)C(F)(F)F
6243;100439827;0.625;229191;103575820;5284595;10280;14696970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of specific binding of [3H]DTG to sigma receptor in Guinea pig brain membranes;Nalorphine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C=CCN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O
6244;366389690;0.626;1571915;440112216;155512151;10280;306053310;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma receptor 1 (unknown origin);(2R,3R,4S,5S)-2-[6-[di(cyclobutyl)methylamino]purin-9-yl]-5-(ethylsulfanylmethyl)oxolane-3,4-diol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCSC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)NC(C4CCC4)C5CCC5)O)O
6245;100565310;0.628;203703;103177905;10614630;10280;95442130;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;The compound was tested for the affinity on sigma 1 receptor using [3H]- pentazocine as radioligand;3-(2-Dimethylamino-ethyl)-6-pentanoyl-3H-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCC(=O)C1=CC2=C(C=C1)N(C(=O)S2)CCN(C)C
6246;255036179;0.628;625223;103220983;3955;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Loperamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
6247;342816994;0.63096;1118248;242613628;90666089;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human recombinant sigma-1 receptor expressed in CHO cells after 180 mins by beta counting analysis;(1S,2S)-N-[2-[4-(2-chloro-6-fluorobenzoyl)piperazin-1-yl]ethyl]-2-phenylcyclopropane-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;197.0;;;;C1CN(CCN1CCNC(=O)[C@H]2C[C@@H]2C3=CC=CC=C3)C(=O)C4=C(C=CC=C4Cl)F
6248;366436876;0.63096;1594273;440180841;155550094;10280;309043830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-[5-(2-Phenylethylamino)-3-(piperidine-1-carbonyl)-4,5,6,7-tetrahydroindazol-2-yl]benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)C(=O)C2=C3CC(CCC3=NN2C4=CC=C(C=C4)C(=O)N)NCCC5=CC=CC=C5
6249;366437246;0.63096;1594273;440225425;146641568;10280;309043830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;[5-(Benzylamino)-1-phenyl-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCN(CC1)C(=O)C2=NN(C3=C2CC(CC3)NCC4=CC=CC=C4)C5=CC=CC=C5
6250;255025666;0.631;625223;124972228;3158;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Zonalon;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31
6251;363665112;0.634;1415967;404711381;90146246;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;1-(2-Piperidin-1-ylethyl)-4-pyridin-2-ylpyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=NC=NC(=C3C=N2)C4=CC=CC=N4
6252;389489782;0.648;1805386;444858099;132060821;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A27;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)C2=CC=CC3=C2CN(CC3)C(=O)OCC4=CC=CC=C4
6253;155735838;0.65;476062;103468525;44403211;10280;198752050;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H](+)-pentazocine from sigma 1 opioid receptor in human Jurkat cells by scintillation counting;(10aS)-2-[3-[benzyl(methyl)amino]propyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1C(=O)[C@@H]2CC3=CC=CC=C3CN2C1=O)CC4=CC=CC=C4
6254;100449434;0.654;204443;103274921;9882743;10280;83608750;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to displace [3H](+)-pentazocine at sigma receptor in guinea pig brain membrane was determined;4-[2-(3,4-Dichloro-phenyl)-ethyl]-1,4-diaza-bicyclo[3.2.2]nonane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN2CCC1N(CC2)CCC3=CC(=C(C=C3)Cl)Cl
6255;255014100;0.655;625223;103173542;4992;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pyrilamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)CCN(CC1=CC=C(C=C1)OC)C2=CC=CC=N2
6256;366366205;0.656;1558961;440127188;126744949;10280;317436420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;N-[2-[2-(2-methyl-3-oxo-4-phenyl-1-oxa-4,9-diazaspiro[5.5]undecan-9-yl)ethyl]phenyl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3NC(=O)C)C4=CC=CC=C4
6257;100619105;0.66;203990;136936839;53707349;10280;18482950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma opioid receptor in guinea pig cerebral homogenate using [3H]DTG as radioligand;(2R)-N-(cyclopropylmethyl)-1-phenylpropan-2-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CC1=CC=CC=C1)NCC2CC2
6258;100619166;0.66;203990;136940022;12329382;10280;18482950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma opioid receptor in guinea pig cerebral homogenate using [3H]DTG as radioligand;Etilamfetamine, (R)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN[C@H](C)CC1=CC=CC=C1
6259;345602526;0.662;1200082;312389827;90269112;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-[(4-fluorophenyl)methyl]-N-(2-morpholin-4-ylethyl)triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1COCCN1CCNC2=CN(N=N2)CC3=CC=C(C=C3)F
6260;100746117;0.664;204147;103264885;12351937;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma opioid receptor type 1 in guinea pig brain homogenate with 0.5 nM [3H](+)-PENT;5,5-Diphenyl-3-[2-(4-phenyl-piperazin-1-yl)-ethyl]-imidazolidine-2,4-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCN2C(=O)C(NC2=O)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=CC=C5
6261;363665114;0.666;1415967;404700052;74767050;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-[1-(2-Piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidin-4-yl]isoquinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=NC=NC(=C3C=N2)C4=CN=CC5=CC=CC=C54
6262;389483965;0.666;1805386;444858101;132060773;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A29;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC(=O)CCN1CCN(CC1)C2=CC=CC3=C2CN(CC3)C(=O)OCC4=CC=CC=C4
6263;380263971;0.667;1811100;475998545;126539162;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[4-[4-(2-hydroxy-1-phenylethyl)piperazin-1-yl]oxan-4-yl]methyl]-N-[6-(trifluoromethyl)pyridin-2-yl]propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CCOCC1)N2CCN(CC2)C(CO)C3=CC=CC=C3)C4=CC=CC(=N4)C(F)(F)F
6264;100461281;0.674;204456;103182740;398369;10280;80980660;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma receptor of guinea pig brain homogenates;1-(1-Benzo[b]thiophen-2-yl-cyclohexyl)-azepane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCCN(CC1)C2(CCCCC2)C3=CC4=CC=CC=C4S3
6265;380299327;0.675;1819827;475994936;166633719;10280;354503790;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Citalopram from sigma-1 receptor (unknown origin) expressed in HEK cell membrane incubated for 2 hrs by liquid scintillation counter analysis;(1S,9S,10S)-4-(1,1-difluoroethyl)-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C1=CC2=C(C[C@H]3[C@@H]4[C@]2(CCCC4)CCN3C)C=C1)(F)F
6266;354626045;0.676;1272497;336869570;127027941;10280;267502540;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin) by radioligand displacement assay;3-(4-Phenylbutyl)-1,2,4,5-tetrahydro-3-benzazepin-5-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CC(C2=CC=CC=C21)O)CCCCC3=CC=CC=C3
6267;100298508;0.68;239347;103458178;6437849;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;4-(2-(1-(4-Chlorocinnamyl)piperazin-4-yl)ethyl)benzoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCC2=CC=C(C=C2)C(=O)O)C/C=C/C3=CC=C(C=C3)Cl
6268;100737365;0.68;203993;103173857;53389;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against the sigma receptor from guinea pig brain using the radioligand [3H]SKF-10047;Rimcazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(C[C@@H](N1)C)CCCN2C3=CC=CC=C3C4=CC=CC=C42
6269;255011825;0.681;625223;103170049;5035;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Raloxifene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O
6270;100458412;0.683;204438;103344153;15149392;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;11-(1-Butenyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC/C=C/N1C2CCC1C3=C(C2)NC4=CC=CC=C43
6271;366389684;0.69;1571915;440114236;155513505;10280;306053310;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma receptor 1 (unknown origin);(2S,3S,4R,5R)-2-(chloromethyl)-5-[6-[di(cyclobutyl)methylamino]purin-9-yl]oxolane-3,4-diol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC(C1)C(C2CCC2)NC3=C4C(=NC=N3)N(C=N4)[C@H]5[C@@H]([C@@H]([C@H](O5)CCl)O)O
6272;100741796;0.695;203992;103677383;45264516;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"9-Benzyl-3-phenyl-1-oxa-9-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2(CN(C1)CC3=CC=CC=C3)C(=O)C(=CO2)C4=CC=CC=C4.Cl
6273;100738362;0.696;229182;123099351;3036289;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was evaluated for the binding affinity to sigma opioid receptor;trans-3,4-Dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzeneacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@H]1N2CCCC2)C(=O)CC3=CC(=C(C=C3)Cl)Cl
6274;255015210;0.697;625223;104234352;33036;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dexchlorpheniramine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)CC[C@@H](C1=CC=C(C=C1)Cl)C2=CC=CC=N2
6275;389511206;0.697;1805565;459070369;118250089;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Pharmacological Activity Assay from US Patent US11007200: 'Cycloalkyl-diamines for the treatment of pain';US11007200, Example 4b;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN[C@]1(CCCC[C@@H]1NCCCC2=CC=CC=C2)C3=CC=CC=C3Cl
6276;389686571;0.697;1806763;459070369;118250089;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Pharmacological Activity from US Patent US11426411: 'Cycloalkyl-diamines for the treatment of inflammation';US11007200, Example 4b;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN[C@]1(CCCC[C@@H]1NCCCC2=CC=CC=C2)C3=CC=CC=C3Cl
6277;380264305;0.699;1811100;475999306;44768982;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[1-(4-methylpiperazin-1-yl)cyclohexyl]methyl]-2-phenoxybenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)C2(CCCCC2)CNC(=O)C3=CC=CC=C3OC4=CC=CC=C4
6278;100292845;0.7;239105;103442086;2838196;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;3-(4-Benzyl-piperidin-1-ylmethyl)-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3=COC4=CC=CC=C4C3=O
6279;388740706;0.7;1797293;386051301;118282979;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 57;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)C
6280;388886599;0.7;1797475;386051301;118282979;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 57;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)C
6281;389383945;0.7;1804286;386051301;118282979;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 57;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)C
6282;345602807;0.701;1200082;312389835;76683978;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;N-(1-benzyltriazol-4-yl)-N',N'-diethylethane-1,2-diamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCN(CC)CCNC1=CN(N=N1)CC2=CC=CC=C2
6283;100364891;0.702;229202;103339313;10885636;10280;115854440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of sigma receptor;4-[4,4-Bis(4-fluorophenyl)butyl]piperazine-1-carboxylic acid 4-cyanophenethyl ester;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)C(=O)OCCC4=CC=C(C=C4)C#N
6284;100459027;0.702;204438;103344902;15149409;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;15-[2-(3,4-Dichlorophenyl)ethyl]-9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3,5,7-tetraene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCC4=CC(=C(C=C4)Cl)Cl)NC5=CC=CC=C53
6285;255023952;0.703;625223;103193303;5411;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tetracaine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C
6286;389483961;0.703;1805386;444858098;132060739;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example KTL-01-184;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CC2=C1C=CC(=C2)N3CCOCC3)CC4=CC(=CC(=C4)Cl)Cl
6287;100459180;0.705;204437;103344298;15149419;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;15-(4-Phenylbutyl)-9-propan-2-yl-9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3,5,7-tetraene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)N1C2=C(C3CCC(C2)N3CCCCC4=CC=CC=C4)C5=CC=CC=C51
6288;363860761;0.706;1467149;242358437;782728;10280;284950850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of (+)-[3H]-pentazocine from recombinant human sigma 1 receptor expressed in baculovirus infected Sf9 insect cell membranes after 90 mins by scintillation counting method;4-(3-Phenylpropyl)morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCN1CCCC2=CC=CC=C2
6289;100538557;0.707;204792;103373979;10389641;10280;94359030;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity was evaluated using [3H]pentazocine binding to sigma-1 receptor from guinea pig brain;9-{3-[4-(6-Isothiocyanato-hexyl)-3,5-dimethyl-piperazin-1-yl]-propyl}-9H-carbazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CN(CC(N1CCCCCCN=C=S)C)CCCN2C3=CC=CC=C3C4=CC=CC=C42
6290;363665111;0.707;1415967;404710354;74767046;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(4-Methylpyridin-3-yl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=NC=C1)C2=C3C=NN(C3=NC=N2)CCN4CCCCC4
6291;363665122;0.709;1415967;404714663;74767209;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(6-Methylpyridin-2-yl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NC(=CC=C1)C2=C3C=NN(C3=NC=N2)CCN4CCCCC4
6292;100467868;0.71;204005;103325581;10267592;10280;79325350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vivo binding affinity against sigma Opioid receptor was measured by using labeled ligand [3H]-SKF- 10,047 (1 nM);(4aR,7aR,12bS)-3-Cyclopropylmethyl-9-hydroxy-2,3,4,4a,5,6-hexahydro-1H-8-oxa-3-aza-benzo[d]fluoren-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC(=O)[C@H]2[C@@]3([C@@H]1CN(CC3)CC4CC4)C5=C(O2)C(=CC=C5)O
6293;342811252;0.711;1129882;242620294;90655535;10280;246178360;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in human RPMI8226 cell membranes after 120 mins by scintillation counting analysis;2-[(2S)-4-methyl-1-[(4-phenylphenyl)methyl]piperazin-2-yl]ethanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;14.0;;;;CN1CCN([C@H](C1)CCO)CC2=CC=C(C=C2)C3=CC=CC=C3
6294;100448389;0.713;204471;103214778;14982971;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(6-Morpholin-4-yl-hexyloxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCN1CCCCCCOC2=CC3=C(C=C2)OC(=CC3=O)C4=CC=CC=C4
6295;255027923;0.713;625223;103282519;7594;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);1,3-Diphenylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)NC(=NC2=CC=CC=C2)N
6296;363665110;0.715;1415967;404703511;74767448;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(3-Methylimidazol-4-yl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C=NC=C1C2=C3C=NN(C3=NC=N2)CCN4CCCCC4
6297;363666186;0.716;1415921;404696815;71223393;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;N-[1-(2-pyrrolidin-1-ylethyl)pyrazolo[3,4-d]pyrimidin-4-yl]cyclobutanecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(C1)CCN2C3=NC=NC(=C3C=N2)NC(=O)C4CCC4
6298;100448375;0.72;204471;103215377;14982951;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(4-Dimethylamino-butoxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCCCOC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3
6299;100461279;0.72;204456;103183222;398371;10280;80980660;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma receptor of guinea pig brain homogenates;2-[1-[Pyrrolidin-1-yl]cycloheptyl]benzo[b]thiophene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCCC(CC1)(C2=CC3=CC=CC=C3S2)N4CCCC4
6300;363665117;0.732;1415967;404699739;74766967;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(2-Methylpyridin-3-yl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC=N1)C2=C3C=NN(C3=NC=N2)CCN4CCCCC4
6301;100440511;0.735;229187;103575820;5284595;10280;14696970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of specific binding of [125I]PIPAG to sigma receptor in Guinea pig brain membranes;Nalorphine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C=CCN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O
6302;100507180;0.736;204150;103345303;10637326;10280;87844550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from Sigma opioid receptor type 1 in guinea pig brain membrane;N-Methyl-2-(2-nitro-phenyl)-N-(2-pyrrolidin-1-yl-ethyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCN1CCCC1)C(=O)CC2=CC=CC=C2[N+](=O)[O-]
6303;100470621;0.739;204469;103340516;44342911;10280;79325690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition against sigma receptor using displacement of 3 nM [3H]pentazocine in homogenate of guinea pig brain cerebellum;(1S,13R)-1,13-dimethyl-10-propyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCN1CC[C@]2([C@H](C1CC3=C2C=C(C=C3)O)C)C
6304;363665658;0.74;1415967;404718528;71225558;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(2,5-dimethyl-1H-pyrrol-1-yl)-1-(2-(piperidin-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=C(N1C2=NC=NC3=C2C=NN3CCN4CCCCC4)C
6305;326034771;0.741;701162;163324286;11618199;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-[1-(3,4-Dichlorophenyl)-5-methyl-3-(2-morpholin-4-ylethoxy)pyrazol-4-yl]ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=C(C(=NN1C2=CC(=C(C=C2)Cl)Cl)OCCN3CCOCC3)C(=O)C
6306;409048598;0.74131;1794447;440191048;146673143;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Clk-IN-T3N;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)C1=CC(=CC(=C1)C2=CN3C=C(N=C3C=C2)NC(=O)C4=CC=C(C=C4)C(C)(C)C(=O)N5CCN(CC5)C)C(C)(C)C
6307;100551430;0.743;204463;103325912;135423874;10280;97034600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound is evaluated for binding affinity towards Sigma receptor using [3H]pentazocine in guinea pig brain;2-[[4-(2-Methoxyphenyl)-1-piperazinyl]methyl]imidazo[1,2-c]quinazoline-5(6H)-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1N2CCN(CC2)CC3=CN4C(=N3)C5=CC=CC=C5NC4=O
6308;100613855;0.75;203986;103283270;14771682;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;Guanidine, N,N'-dibutyl-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCNC(=NCCCC)N
6309;388740213;0.75;1797293;386051294;118282887;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 50;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OC(=O)N(C)C)OC)N2CC3=C(C2)C=C(C=C3)F
6310;388878954;0.75;1797475;386051294;118282887;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 50;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OC(=O)N(C)C)OC)N2CC3=C(C2)C=C(C=C3)F
6311;389383438;0.75;1804286;386051294;118282887;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 50;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OC(=O)N(C)C)OC)N2CC3=C(C2)C=C(C=C3)F
6312;100708100;0.751;204146;103252787;11028157;10280;146843270;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma opioid receptor of guiena pig brain membrane;N-[4-[4-(2,3-Dichlorophenyl)piperazino]butyl]-1-methoxy-4-bromonaphthalene-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=C(C2=CC=CC=C21)Br)C(=O)NCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl
6313;100536376;0.755;204457;103673403;45261977;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-[2-Bromo-5-methylsulfanyl-3-(trifluoromethyl)phenyl]-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=CC(=CC(=C2Br)C(F)(F)F)SC)N.Cl
6314;380299661;0.757;1819827;475987193;24997117;10280;354503790;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Citalopram from sigma-1 receptor (unknown origin) expressed in HEK cell membrane incubated for 2 hrs by liquid scintillation counter analysis;CID 24997117;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC(F)(F)F
6315;100333038;0.75858;204944;103278548;10807460;10280;108823620;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma-1 binding assay was performed using [3H](+)-pentazocine to label sigma-1 binding sites, in guinea pig cerebral cortex;1-[(4-Chlorophenyl)methyl]-1-(4-pyrrolidin-1-ylbutyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CCN(C1)CCCCN(CC2=CC=C(C=C2)Cl)C(=N)N
6316;100320358;0.759;204310;103382921;14941803;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 2 using [3H]- DTG in rat liver membranes;N-Benzyl-2-[(1S,2R)-1,2-dihydro-2-ethylnaphthalene-1-yl]ethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;21070;Liver;CC[C@@H]1C=CC2=CC=CC=C2[C@H]1CCNCC3=CC=CC=C3
6317;373790390;0.759;1750146;469804618;164585473;10280;337872730;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);4-[4-(1-Formylpiperidin-4-yl)phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1C2=CC=C(C=C2)C3=C4C=CC(=CC4=CC(=C3)C(=O)O)C5=CC=C(C=C5)C(F)(F)F)C=O
6318;112788088;0.7593;204633;103385146;10546961;10280;74907270;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to inhibit [3H](+)-pentazocine binding to guinea pig brain Sigma receptor type 1;(8E)-8-[(4-chlorophenyl)methylidene]-5-(3-hydroxyphenyl)-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1/C(=C\C3=CC=C(C=C3)Cl)/C(=O)C2)C4=CC(=CC=C4)O
6319;100614107;0.76;203986;103677595;14771690;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;"1,2-Bis(2-methyl-4-nitrophenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=C(C=CC(=C1)[N+](=O)[O-])NC(=NC2=C(C=C(C=C2)[N+](=O)[O-])C)N.Cl
6320;380657417;0.76;1880165;482062771;168280485;10280;354503690;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) assessed as inhibition constant;"6-fluoro-1-(2,4,5-trimethoxyphenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC(=C(C=C1C2C3=C(CCN2)C4=C(N3)C=CC(=C4)F)OC)OC.Cl
6321;112788085;0.762;204633;103215106;44285482;10280;74907270;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Ability to inhibit [3H](+)-pentazocine binding to guinea pig brain Sigma receptor type 1;5-(3-Hydroxy-phenyl)-2-methyl-2-aza-bicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1CC(=O)C2)C3=CC(=CC=C3)O
6322;112851459;0.7623;204465;163326167;71456164;10280;79325400;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma receptor of guinea pig brain;(1S,5S)-5-(3-methoxyphenyl)-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@@]2(C[C@H]1CC(=O)C2)C3=CC(=CC=C3)OC
6323;255021237;0.763;625223;103165317;3869;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Labetalol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
6324;100617139;0.766;203985;103283073;14771670;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;1,3-Bis(2-trifluoromethylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC=C(C(=C1)C(F)(F)F)NC(=NC2=CC=CC=C2C(F)(F)F)N
6325;255030232;0.773;625223;123099352;39468;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Levobunolol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)NC[C@@H](COC1=CC=CC2=C1CCCC2=O)O
6326;363666199;0.774;1415921;404712224;145990153;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;N-[1-(4-morpholin-4-ylbutyl)pyrazolo[3,4-d]pyrimidin-4-yl]adamantane-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCN1CCCCN2C3=NC=NC(=C3C=N2)NC(=O)C45CC6CC(C4)CC(C6)C5
6327;100440515;0.78;229187;103173857;53389;10280;14696970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of specific binding of [125I]PIPAG to sigma receptor in Guinea pig brain membranes;Rimcazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1CN(C[C@@H](N1)C)CCCN2C3=CC=CC=C3C4=CC=CC=C42
6328;345603248;0.781;1200082;312389813;76683785;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-(3-fluorophenyl)-N-(2-morpholin-4-ylethyl)triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1COCCN1CCNC2=CN(N=N2)C3=CC(=CC=C3)F
6329;100458429;0.782;204437;103344201;15149399;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;11-[2-(3,4-Dichlorophenoxy)ethyl]-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCOC4=CC(=C(C=C4)Cl)Cl)NC5=CC=CC=C53
6330;372121198;0.783;1681775;461526782;118560889;10280;330649470;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;12-Ethyl-8-(2-pyridin-2-ylethyl)-4-oxa-8,12-diazadispiro[2.1.55.33]tridecan-13-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CC2(CCN(CC2)CCC3=CC=CC=N3)OC4(C1=O)CC4
6331;100320074;0.785;204310;103382350;44361163;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 2 using [3H]- DTG in rat liver membranes;N-Benzyl-2-[(1R,2S)-1,2-dihydro-2-isopropylnaphthalene-1-yl]ethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;21070;Liver;CC(C)[C@H]1C=CC2=CC=CC=C2[C@@H]1CCNCC3=CC=CC=C3
6332;380835681;0.798;1914025;440191048;146673143;10280;;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000705a SIGMAR1;Clk-IN-T3N;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)C1=CC(=CC(=C1)C2=CN3C=C(N=C3C=C2)NC(=O)C4=CC=C(C=C4)C(C)(C)C(=O)N5CCN(CC5)C)C(C)(C)C
6333;409048597;0.79834;1794447;440191048;146673143;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Clk-IN-T3N;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)C1=CC(=CC(=C1)C2=CN3C=C(N=C3C=C2)NC(=O)C4=CC=C(C=C4)C(C)(C)C(=O)N5CCN(CC5)C)C(C)(C)C
6334;100617159;0.8;203985;103283270;14771682;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;Guanidine, N,N'-dibutyl-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCNC(=NCCCC)N
6335;100621329;0.8;204131;103229417;3038603;10280;16745410;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;The compound was tested for binding affinity against Sigma opioid receptor using DTG as radioligand;Spiro(2-cyclohexene-1,5'-(5H)dibenzo(a,d)cyclohepten)-4-amine, 3'-chloro-N,N-dimethyl-, (1S,4R)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)C1CCC2(C=C1)C3=CC=CC=C3C=CC4=C2C=C(C=C4)Cl
6336;198329408;0.8;536043;103763798;46906593;10280;209657350;Confirmatory;20200626;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity to sigma1 receptor;Rac-4-Fluorodioxadrol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CNC(CC1F)C2COC(O2)(C3=CC=CC=C3)C4=CC=CC=C4
6337;198329409;0.8;536043;103763797;46906592;10280;209657350;Confirmatory;20200626;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity to sigma1 receptor;(+/-)-(2RS)-2-[(4RS)-2,2-Diphenyl-1,3-dioxolan-4-yl]-4,4-difluoropiperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CNC(CC1(F)F)C2COC(O2)(C3=CC=CC=C3)C4=CC=CC=C4
6338;198329410;0.8;536043;103196482;66270;10280;209657350;Confirmatory;20200626;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity to sigma1 receptor;Dioxadrol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCNC(C1)C2COC(O2)(C3=CC=CC=C3)C4=CC=CC=C4
6339;198329411;0.8;536043;103764722;46907276;10280;209657350;Confirmatory;20200626;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity to sigma1 receptor;Rac-4-Oxodioxadrol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CNC(CC1=O)C2COC(O2)(C3=CC=CC=C3)C4=CC=CC=C4
6340;198329412;0.8;536043;103764723;46907277;10280;209657350;Confirmatory;20200626;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity to sigma1 receptor;(+/-)-4-Hydroxydioxadrol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CNC(CC1O)C2COC(O2)(C3=CC=CC=C3)C4=CC=CC=C4
6341;363666006;0.802;1415967;404716667;74767211;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;1-(2-piperidin-1-ylethyl)-4-(1H-pyrazol-4-yl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=NC=NC(=C3C=N2)C4=CNN=C4
6342;100708105;0.809;204146;103252188;10392655;10280;146843270;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma opioid receptor of guiena pig brain membrane;N-[4-[4-(2,3-Dichlorophenyl)piperazino]butyl]-2,3-dimethoxy-5-bromobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC(=CC(=C1OC)C(=O)NCCCCN2CCN(CC2)C3=C(C(=CC=C3)Cl)Cl)Br
6343;342804596;0.809;1127667;103252188;10392655;10280;237346340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 opioid receptor (unknown origin);N-[4-[4-(2,3-Dichlorophenyl)piperazino]butyl]-2,3-dimethoxy-5-bromobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC(=CC(=C1OC)C(=O)NCCCCN2CCN(CC2)C3=C(C(=CC=C3)Cl)Cl)Br
6344;372355921;0.809;1726849;461538769;162660079;10280;342231650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]pentazocine from human sigma 1 receptor expressed in HEK293 cell membrane incubated for 2 hrs by liquid scintillation counting method;6-[3-(4-Methylpiperazin-1-yl)propoxy]chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)CCCOC2=CC3=C(C=C2)OC=CC3=O
6345;363666197;0.813;1415921;404711377;71225888;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;N-(1-(2-(4-methyl-1,4-diazepan-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)pivalamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)C(=O)NC1=C2C=NN(C2=NC=N1)CCN3CCCN(CC3)C
6346;380299662;0.813;1819827;475994583;166633527;10280;354503790;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Citalopram from sigma-1 receptor (unknown origin) expressed in HEK cell membrane incubated for 2 hrs by liquid scintillation counter analysis;(1S,9S,10S)-17-methyl-4-(trifluoromethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)C(F)(F)F
6347;345602525;0.818;1200082;312389837;76683576;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-[4-[2-[[1-[(3,4-Dichlorophenyl)methyl]triazol-4-yl]amino]ethyl]piperazin-1-yl]ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC(=O)N1CCN(CC1)CCNC2=CN(N=N2)CC3=CC(=C(C=C3)Cl)Cl
6348;363665763;0.818;1415921;404718185;71223407;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;1-Cyclohexyl-3-[1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidin-4-yl]urea;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)NC(=O)NC2=C3C=NN(C3=NC=N2)CCN4CCCCC4
6349;100475267;0.82;204462;103173857;53389;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;Rimcazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1CN(C[C@@H](N1)C)CCCN2C3=CC=CC=C3C4=CC=CC=C42
6350;372355915;0.825;1726849;461553233;141195299;10280;342231650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]pentazocine from human sigma 1 receptor expressed in HEK293 cell membrane incubated for 2 hrs by liquid scintillation counting method;6-(2-Piperidin-1-ylethoxy)chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCOC2=CC3=C(C=C2)OC=CC3=O
6351;100459026;0.836;204438;103344491;15149416;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;2-[3-(5-Fluoro-9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3(8),4,6-tetraen-15-yl)propyl]isoindole-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCN4C(=O)C5=CC=CC=C5C4=O)NC6=C3C=C(C=C6)F
6352;100746104;0.842;204298;103264885;12351937;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for Sigma opioid receptor type 2 in guinea pig brain homogenate with 4 nM [3H]-(+)-DTG;5,5-Diphenyl-3-[2-(4-phenyl-piperazin-1-yl)-ethyl]-imidazolidine-2,4-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1CCN2C(=O)C(NC2=O)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=CC=C5
6353;100320351;0.85;204310;103382383;44361167;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 2 using [3H]- DTG in rat liver membranes;N-Benzyl-2-[(1R,2S)-1,2-dihydro-2-ethylnaphthalene-1-yl]ethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;21070;Liver;CC[C@H]1C=CC2=CC=CC=C2[C@@H]1CCNCC3=CC=CC=C3
6354;100617151;0.85;203985;103677595;14771690;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;"1,2-Bis(2-methyl-4-nitrophenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=C(C=CC(=C1)[N+](=O)[O-])NC(=NC2=C(C=C(C=C2)[N+](=O)[O-])C)N.Cl
6355;100473773;0.85114;203852;103165728;3386;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;Fluoxetine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F
6356;100320352;0.854;204310;103382348;10924765;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 2 using [3H]- DTG in rat liver membranes;N-Benzyl-2-[(1S,2R)-1,2-dihydro-2-isopropylnaphthalene-1-yl]ethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;21070;Liver;CC(C)[C@@H]1C=CC2=CC=CC=C2[C@H]1CCNCC3=CC=CC=C3
6357;326034763;0.854;701162;163331283;11610271;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-(3,4-Dichlorophenyl)-3-(4-imidazol-1-ylbutoxy)-5-methylpyrazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)OCCCCN3C=CN=C3
6358;372338886;0.86;1718132;404717391;9882189;10280;331115250;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin);Blarcamesine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CC1CCOC1(C2=CC=CC=C2)C3=CC=CC=C3
6359;407906194;0.86;1922160;404717391;9882189;10280;362020630;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);Blarcamesine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CC1CCOC1(C2=CC=CC=C2)C3=CC=CC=C3
6360;100441638;0.868;229186;103168867;6468;10280;14696970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of specific binding of [125I]-PIPAG to sigma binding site in Guinea pig brain membranes;Phencyclidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)(C2=CC=CC=C2)N3CCCCC3
6361;100507191;0.869;204150;103345898;398839;10280;87844550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from Sigma opioid receptor type 1 in guinea pig brain membrane;N-Methyl-2-(4-nitro-phenyl)-N-(2-pyrrolidin-1-yl-ethyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCN1CCCC1)C(=O)CC2=CC=C(C=C2)[N+](=O)[O-]
6362;100604301;0.87;203857;103735217;46878002;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;2-Chloro-N-methyl-N-[(1R)-2beta-(1-pyrrolidinyl)cyclohexan-1beta-yl]benzeneacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)CC3=CC=CC=C3Cl
6363;100600970;0.874;203996;123099351;3036289;10280;25470740;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was evaluated for binding affinity towards sigma opioid receptor using [3H](+)-3-PPP in guinea pig ileum;trans-3,4-Dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzeneacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;21160;Ileum;CN([C@@H]1CCCC[C@H]1N2CCCC2)C(=O)CC3=CC(=C(C=C3)Cl)Cl
6364;100500108;0.877;204466;103237450;10684798;10280;85688040;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Inhibition of [3H]DTG binding to sigma receptor from guinea pig brain cortex membrane;1-(3-(5-Methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC2=C1CCCC2CCCN3CCNCC3
6365;345602806;0.878;1200082;312389828;76684096;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-[(3,4-difluorophenyl)methyl]-N-(2-morpholin-4-ylethyl)triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1COCCN1CCNC2=CN(N=N2)CC3=CC(=C(C=C3)F)F
6366;326035178;0.879;701162;163334765;57861965;10280;227840080;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;2-(1-(3,4-dichlorophenyl)-1H-pyrazol-3-yloxy)ethyl 2-morpholinoethanesulfonate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1COCCN1CCS(=O)(=O)OCCOC2=NN(C=C2)C3=CC(=C(C=C3)Cl)Cl
6367;100297855;0.88;239347;103188450;47641;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;Naftifine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C/C=C/C1=CC=CC=C1)CC2=CC=CC3=CC=CC=C32
6368;372121204;0.892;1681775;461548954;162667151;10280;330649470;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;4-[2-(2-Fluorophenyl)ethyl]-2-methyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C(=O)N(CC2(O1)CCN(CC2)CCC3=CC=CC=C3)CCC4=CC=CC=C4F
6369;100538555;0.897;204792;163319411;71452705;10280;94359030;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity was evaluated using [3H]pentazocine binding to sigma-1 receptor from guinea pig brain;9-[3-[(3S,5S)-3,4,5-trimethylpiperazin-1-yl]propyl]carbazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1CN(C[C@@H](N1C)C)CCCN2C3=CC=CC=C3C4=CC=CC=C42
6370;100403990;0.908;204630;103173857;53389;10280;128012230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma receptor type 1 was determined by the displacement of [3H]pentazocine radioligand;Rimcazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(C[C@@H](N1)C)CCCN2C3=CC=CC=C3C4=CC=CC=C42
6371;100459179;0.908;204437;103344200;15149412;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;2-Fluoro-11-benzyl-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CC4=CC=CC=C4)NC5=C3C=C(C=C5)F
6372;100471784;0.91201;203852;160677141;6540428;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;1-Methyllysergic acid butanolamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(CO)NC(=O)[C@H]1CN([C@@H]2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C
6373;255031352;0.9122;625223;103458417;2467;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Buflomedil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=CC(=C(C(=C1)OC)C(=O)CCCN2CCCC2)OC
6374;367490637;0.915;1661755;442059284;562719;10280;328320230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from recombinant sigma 1 receptor (unknown origin) expressed in baculovirus infected Sf9 cell membranes after 1.5 hrs by scintillation counting analysis;(4-Benzyl-piperazin-1-yl)-(4-trifluoromethyl-phenyl)-methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;521.0;;;;C1CN(CCN1CC2=CC=CC=C2)C(=O)C3=CC=C(C=C3)C(F)(F)F
6375;100614091;0.92;203986;103282920;14771691;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N-(2-Styryl-phenyl)-N''-o-tolyl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1N=C(N)NC2=CC=CC=C2/C=C/C3=CC=CC=C3
6376;255027577;0.926;625223;103188158;5533;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Trazodone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
6377;363665334;0.926;1415967;404707062;74767131;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;1-(2-Piperidin-1-ylethyl)-4-pyridin-3-ylpyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=NC=NC(=C3C=N2)C4=CN=CC=C4
6378;100444465;0.928;204470;103214723;44285300;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-Phenyl-6-[6-(2-pyridin-2-yl-piperazin-1-yl)-hexyloxy]-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(C(CN1)C2=CC=CC=N2)CCCCCCOC3=CC4=C(C=C3)OC(=CC4=O)C5=CC=CC=C5
6379;100604685;0.928;203857;103735198;46877990;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;N-Methyl-N-[(1R)-2beta-(1-pyrrolidinyl)cyclohexan-1beta-yl]carbamic acid benzyl ester;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)OCC3=CC=CC=C3
6380;100496760;0.92972;204761;103401367;10432985;10280;78533490;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity at Sigma receptor type 1, displacement of [3H](+)-pentazocine from guinea pig brain membranes;(1S,9S,13S)-10-[(2-iodophenyl)methyl]-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC4=CC=CC=C4I)C)C=C(C=C3)O
6381;340019628;0.93;752428;174496404;49853984;10280;236018160;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;N-(3-cyclopentylpropyl)-2-(4-methyl-1,4-diazepan-1-yl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCCN(CC1)CC(=O)NCCCC2CCCC2
6382;100614098;0.935;203986;103282919;14771692;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N-Biphenyl-2-yl-N''-naphthalen-1-yl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC=C(C=C1)C2=CC=CC=C2N=C(N)NC3=CC=CC4=CC=CC=C43
6383;340095008;0.94;779967;160703513;9852175;10280;240751450;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma1 receptor (unknown origin);Orvepitant;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC(=C1)F)[C@H]2C[C@H](CCN2C(=O)N(C)[C@H](C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)N4CCN5[C@H](C4)CCC5=O
6384;100320347;0.944;204310;103382925;10086447;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 2 using [3H]- DTG in rat liver membranes;(1S,9S,13S)-10-benzyl-13-propan-2-yl-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;21070;Liver;CC(C)[C@H]1[C@@H]2CCN([C@H]1CC3=CC=CC=C23)CC4=CC=CC=C4
6385;100487775;0.944;204638;103317758;44332157;10280;76368610;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was measured on Sigma receptor type 1 using [3H]- pentazocine as radioligand;5-Iodo-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CC3=CC(=C(C=C3C1(CCN2CC=C(C)C)C)O)I
6386;255026030;0.944;625223;103224052;2247;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Astemizole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=CC=C(C=C1)CCN2CCC(CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)F
6387;363665761;0.946;1415921;404711824;71225970;10280;301088340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;N-(1-(4-(4-tert-butylpiperidin-1-yl)butyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)pivalamide maleate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)C1CCN(CC1)CCCCN2C3=NC=NC(=C3C=N2)NC(=O)C(C)(C)C
6388;100538558;0.949;204792;103373990;44357414;10280;94359030;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity was evaluated using [3H]pentazocine binding to sigma-1 receptor from guinea pig brain;9-{3-[4-(2-Isothiocyanato-ethyl)-3,5-dimethyl-piperazin-1-yl]-propyl}-9H-carbazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CN(CC(N1CCN=C=S)C)CCCN2C3=CC=CC=C3C4=CC=CC=C42
6389;100473774;0.95499;203852;103167959;5265;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;Spiperone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CCCC(=O)C4=CC=C(C=C4)F
6390;100473775;0.95499;203852;103321168;42601649;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;N,N-dimethyl-1-phenyl-1,2,3,4-tetrahydronaphthalen-2-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)C1CCC2=CC=CC=C2C1C3=CC=CC=C3
6391;380264303;0.955;1811100;475985638;44768892;10280;342361900;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[[1-(4-methylpiperazin-1-yl)cyclohexyl]methyl]-2,2-diphenylpropanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)NCC3(CCCCC3)N4CCN(CC4)C
6392;100451425;0.96;204436;103672099;45260969;10280;81026510;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using [3H]ditolylguanidine (DTG) as radioligand.;"N,N-dimethyl-4-phenyl-1,2,3,4-tetrahydronaphthalen-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CN(C)C1CC(C2=CC=CC=C2C1)C3=CC=CC=C3.Cl
6393;100614613;0.962;203986;103282916;14771729;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;1-(4-Amino-2-methylphenyl)-3-[3-hydroxyphenyl]guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=C(C=CC(=C1)N)N=C(N)NC2=CC(=CC=C2)O
6394;255014095;0.9639;625223;103195252;5002;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Quetiapine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
6395;100513219;0.965;229197;103384376;9974013;10280;89413830;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor using radioligand ([3H](+)-pentazocine) binding assay;1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1)CCOC(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F
6396;100604317;0.966;203857;174516150;14771468;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;N-Methyl-N-(2-pyrrolidin-1-yl-cyclohexyl)-benzenesulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@H]1CCCC[C@H]1N2CCCC2)S(=O)(=O)C3=CC=CC=C3
6397;100613861;0.97;203986;103677612;14771724;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;"2-(3,5-dimethyl-1-adamantyl)-1-[2-[(E)-2-phenylethenyl]phenyl]guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC12CC3CC(C1)(CC(C3)(C2)N=C(N)NC4=CC=CC=C4/C=C/C5=CC=CC=C5)C.Cl
6398;100459184;0.988;204437;103211675;15646180;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;8-[4-(9,15-Diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3,5,7-tetraen-15-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3C4CCC3C5=C(C4)NC6=CC=CC=C65
6399;255019337;0.994;625223;123090165;2769;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Propulsid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F
6400;99825114;1.0;204128;103218636;14742527;10280;22138240;Confirmatory;20181012;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity for Sigma opioid receptor was determined by using [3H](+)-3-(3-hydroxyphenyl)N-1-propyl-piperdine((+)-3-PPP) as radioligand;2-(5-Methyl-1h-imidazol-4-ylmethyl)-4-phenylthiazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(N=CN1)CC2=NC(=CS2)C3=CC=CC=C3
6401;100292619;1.0;239200;103442108;11360254;10280;156340210;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Inhibitory constant against sigma receptor type 2 using 3 nM [3H]ditolylguanidine;2-(4-Benzyl-piperidin-1-ylmethyl)-indan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3CC4=CC=CC=C4C3=O
6402;100317427;1.0;204155;103361672;44351760;10280;105084440;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]-3-PPP displacement.;"(E)-but-2-enedioic acid;4-[[4-methoxy-3-(2-phenylethoxy)phenyl]methyl]heptan-4-amine";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCC(CCC)(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N.C(=C/C(=O)O)\C(=O)O
6403;100319795;1.0;204154;103678287;45265169;10280;105084440;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;"1-[4-Methoxy-3-(2-phenylethoxy)phenyl]butan-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N.Cl
6404;100319806;1.0;204154;103361767;10504449;10280;105084440;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;[1-(4-Methoxy-3-phenethyloxy-benzyl)-nonyl]-dipropyl-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCCCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N(CCC)CCC
6405;100319809;1.0;204154;103678353;45265213;10280;105084440;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;"1-[4-Methoxy-3-(2-phenylethoxy)phenyl]propan-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N.Cl
6406;100319811;1.0;204154;103669493;18986843;10280;105084440;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;"2-[4-Methoxy-3-(2-phenylethoxy)phenyl]ethanamine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=C(C=C(C=C1)CCN)OCCC2=CC=CC=C2.Cl
6407;100319814;1.0;204154;103361789;11794387;10280;105084440;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;In vitro binding affinity at Sigma opioid receptors on guinea pig brain membranes by [3H]3-PPP displacement.;1-(4-Methoxy-3-phenethyloxy-benzyl)-nonylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCCCCCCCC(CC1=CC(=C(C=C1)OC)OCCC2=CC=CC=C2)N
6408;100354367;1.0;204790;103238171;44297117;10280;113561150;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity for sigma-1 receptor measured on guinea pig brain membranes using [3H](+)-pentazocine as radioligand.;N-(9-Benzyl-9-aza-bicyclo[3.3.1]non-3-yl)-5-iodo-2,3-dimethoxy-benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC(=CC(=C1OC)C(=O)NC2CC3CCCC(C2)N3CC4=CC=CC=C4)I
6409;100367035;1.0;226337;103376026;11760579;10280;117281860;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;2-Phenyl-N-[1-(2-trifluoromethyl-benzyl)-piperidin-4-yl]-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC=CC=C2)CC3=CC=CC=C3C(F)(F)F
6410;100367068;1.0;226337;103375952;44358368;10280;117281860;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity for sigma 1 opioid receptor, measured on guinea pig brain membranes using [3H]- (+)-pentazocine as radioligand;N-(1-benzylpiperidin-4-yl)-2-(7-hydroxy-2-oxo-4a,8a-dihydrochromen-4-yl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC(=O)OC3C2C=CC(=C3)O)CC4=CC=CC=C4
6411;100439967;1.0;229188;103168867;6468;10280;14696970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of specific binding of [3H]3-PPP to sigma binding site in Guinea pig brain membranes;Phencyclidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)(C2=CC=CC=C2)N3CCCCC3
6412;100456537;1.0;229183;103163905;82553;10280;79028690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor in bovine cerebellum using 2.0 nM [3H]haloperidol in the presence of 25 nM unlabeled spiperone;4-Phenyl-1,2,3,6-tetrahydropyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1CNCC=C1C2=CC=CC=C2
6413;100471322;1.0;204459;103299130;9862757;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;1-(3-Ethylphenyl)-3-(1-naphthyl)-3-methylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N=C(N)N(C)C2=CC=CC3=CC=CC=C32
6414;100547848;1.0;203686;103278747;10735925;10280;96323690;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Compound tested for binding affinity towards sigma 1 receptor in quinea pig brain membranes using [3H](+)-pentazocine as the radioligand.;N-(1-Benzyl-piperidin-4-yl)-2-(3,4-dihydroxy-phenyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCC1NC(=O)CC2=CC(=C(C=C2)O)O)CC3=CC=CC=C3
6415;100722952;1.0;204635;103267925;9330;10280;150810120;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity for Sigma receptor type 1,using [3H](+)-pentazocine as radioligand;Benactyzine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CC)CCOC(=O)C(C1=CC=CC=C1)(C2=CC=CC=C2)O
6416;101829951;1.0;255065;103468574;44403245;10280;161400090;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Inhibitory activity against opioid receptor sigma 1 in guinea pig cerebral cortex using [3H](+)-pentazocine as radio ligand at pH 7.5 for 150 min at 22 degree C ;(10aS)-2-[2-[4-[3-(dimethylamino)propyl]piperazin-1-yl]ethyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;CN(C)CCCN1CCN(CC1)CCN2C(=O)[C@@H]3CC4=CC=CC=C4CN3C2=O
6417;101829997;1.0;255057;103468464;44403182;10280;161400110;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Inhibitory concentration against opioid receptor sigma 1 of guinea pig cerebral cortex using [3H](+)-pentazocine upon incubation for 150 minutes at 22 degree C;(8aS)-2-(2-piperidin-1-ylethyl)-6,7,8,8a-tetrahydro-5H-imidazo[1,5-a]pyridine-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CCN(CC1)CCN2C(=O)[C@@H]3CCCCN3C2=O
6418;101830000;1.0;255057;103468578;44403249;10280;161400110;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Inhibitory concentration against opioid receptor sigma 1 of guinea pig cerebral cortex using [3H](+)-pentazocine upon incubation for 150 minutes at 22 degree C;(10aS)-10,10a-Dihydro-7-hydroxy-2-[2-(1-piperidinyl)ethyl]imidazo[1,5-b]isoquinoline-1,3(2H,5H)-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9560;Cerebral cortex;C1CCN(CC1)CCN2C(=O)[C@@H]3CC4=C(CN3C2=O)C=C(C=C4)O
6419;155735837;1.0;476062;103744839;44818602;10280;198752050;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H](+)-pentazocine from sigma 1 opioid receptor in human Jurkat cells by scintillation counting;(10aR)-2-[3-[benzyl(methyl)amino]propyl]-10,10a-dihydro-5H-imidazo[1,5-b]isoquinoline-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(CCCN1C(=O)[C@H]2CC3=CC=CC=C3CN2C1=O)CC4=CC=CC=C4
6420;326034622;1.0;701162;163324291;11704696;10280;227840080;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;1-[4-[1-(3,4-dichlorophenyl)-5-methylpyrazol-3-yl]oxybutyl]-6,7-dihydro-5H-indol-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC(=C(C=C2)Cl)Cl)OCCCCN3C=CC4=C3CCCC4=O
6421;326034623;1.0;701162;163334753;24744816;10280;227840080;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;4-[2-(1-Tert-butylpyrazol-3-yl)oxyethyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC(C)(C)N1C=CC(=N1)OCCN2CCOCC2
6422;326034627;1.0;701162;163327762;71456959;10280;227840080;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;4-[2-(5-Methyl-1-phenylpyrazol-3-yl)oxyethyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC=CC=C2)OCCN3CCOCC3
6423;326034956;1.0;701162;163320915;57340967;10280;227840080;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;4-(2-(5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy)ethyl)morpholin-3-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC3=CC=CC=C3C=C2)OCCN4CCOCC4=O
6424;326035173;1.0;701162;163320913;71453455;10280;227840080;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;4-[2-(5-Methyl-2-naphthalen-2-ylpyrazol-3-yl)oxyethyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=NN(C(=C1)OCCN2CCOCC2)C3=CC4=CC=CC=C4C=C3
6425;326035174;1.0;701162;163331282;11544226;10280;227840080;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)pentazocine from human sigma 1 receptor transfected in HEK293 cell membranes after 120 mins by scintillation counter;4-[2-[1-(4-Methoxyphenyl)-5-methylpyrazol-3-yl]oxyethyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC1=CC(=NN1C2=CC=C(C=C2)OC)OCCN3CCOCC3
6426;334064872;1.0;735278;164132735;71655614;10280;235606500;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(3aS,4R,9bS)-8-butoxy-4-cyclohexyl-2,3,3a,4,5,9b-hexahydrofuro[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCCCOC1=CC2=C(C=C1)N[C@@H]([C@H]3[C@@H]2OCC3)C4CCCCC4
6427;334064873;1.0;735278;164144050;71655545;10280;235606500;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;N-[(4aS,5R,10bS)-5-cyclohexyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinolin-9-yl]benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCC(CC1)[C@@H]2[C@@H]3CCCO[C@@H]3C4=C(N2)C=CC(=C4)NC(=O)C5=CC=CC=C5
6428;334064876;1.0;735278;164144051;71655285;10280;235606500;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aS,5S,10bS)-9-(4-chlorophenoxy)-5-cyclohexyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCC(CC1)[C@H]2[C@@H]3CCCO[C@@H]3C4=C(N2)C=CC(=C4)OC5=CC=C(C=C5)Cl
6429;334065173;1.0;735278;164149701;71655349;10280;235606500;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aS,5R,10bS)-5-cyclohexyl-9-phenoxy-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCC(CC1)[C@@H]2[C@@H]3CCCO[C@@H]3C4=C(N2)C=CC(=C4)OC5=CC=CC=C5
6430;334065175;1.0;735278;164138479;71655478;10280;235606500;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aS,5R,10bS)-5-cyclohexyl-9-[(4-fluorophenyl)methoxy]-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCC(CC1)[C@@H]2[C@@H]3CCCO[C@@H]3C4=C(N2)C=CC(=C4)OCC5=CC=C(C=C5)F
6431;334065176;1.0;735278;164146760;71655543;10280;235606500;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aS,5R,10bS)-5-cyclohexyl-N-propyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline-9-sulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCCNS(=O)(=O)C1=CC2=C(C=C1)N[C@@H]([C@H]3[C@@H]2OCCC3)C4CCCCC4
6432;334065179;1.0;735278;164132796;71655480;10280;235606500;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aS,5R,10bS)-5,9-dicyclohexyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCC(CC1)[C@@H]2[C@@H]3CCCO[C@@H]3C4=C(N2)C=CC(=C4)C5CCCCC5
6433;334065182;1.0;735278;164141239;71655287;10280;235606500;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aS,5S,10bS)-9-(3-chlorophenoxy)-5-cyclohexyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCC(CC1)[C@H]2[C@@H]3CCCO[C@@H]3C4=C(N2)C=CC(=C4)OC5=CC(=CC=C5)Cl
6434;334065187;1.0;735278;164129952;71655477;10280;235606500;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aR,5S,10bR)-5-cyclohexyl-9-(3-methylbutoxy)-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC(C)CCOC1=CC2=C(C=C1)N[C@H]([C@@H]3[C@H]2OCCC3)C4CCCCC4
6435;334065464;1.0;735278;164129953;71716506;10280;235606500;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aS,5R,10bS)-5-cyclohexyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCC(CC1)[C@@H]2[C@@H]3CCCO[C@@H]3C4=CC=CC=C4N2
6436;334065465;1.0;735278;164129954;71655351;10280;235606500;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aS,5R,10bS)-9-butyl-5-cyclohexyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCCCC1=CC2=C(C=C1)N[C@@H]([C@H]3[C@@H]2OCCC3)C4CCCCC4
6437;334065466;1.0;735278;164138478;71718342;10280;235606500;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aR,5S,10bR)-9-(3-methylbutoxy)-5-(oxan-4-yl)-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CC(C)CCOC1=CC2=C(C=C1)N[C@H]([C@@H]3[C@H]2OCCC3)C4CCOCC4
6438;334065467;1.0;735278;164138480;71655541;10280;235606500;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aS,5R,10bS)-5-cyclohexyl-9-phenyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCC(CC1)[C@@H]2[C@@H]3CCCO[C@@H]3C4=C(N2)C=CC(=C4)C5=CC=CC=C5
6439;334065468;1.0;735278;164141240;71655288;10280;235606500;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aS,5R,10bS)-9-(2-chlorophenoxy)-5-cyclohexyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCC(CC1)[C@@H]2[C@@H]3CCCO[C@@H]3C4=C(N2)C=CC(=C4)OC5=CC=CC=C5Cl
6440;334065473;1.0;735278;164143992;71655744;10280;235606500;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aS,5S,10bS)-9-butoxy-5-phenyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCCCOC1=CC2=C(C=C1)N[C@@H]([C@H]3[C@@H]2OCCC3)C4=CC=CC=C4
6441;334065477;1.0;735278;164149640;71655685;10280;235606500;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aS,5R,10bS)-9-butoxy-5-cyclopropyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCCCOC1=CC2=C(C=C1)N[C@@H]([C@H]3[C@@H]2OCCC3)C4CC4
6442;334066177;1.0;735278;164138477;71655415;10280;235606500;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting analysis;(4aR,5S,10bR)-5-cyclohexyl-9-pentyl-3,4,4a,5,6,10b-hexahydro-2H-pyrano[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCCCCC1=CC2=C(C=C1)N[C@H]([C@@H]3[C@H]2OCCC3)C4CCCCC4
6443;342786911;1.0;1139358;242431917;45115589;10280;246904940;Confirmatory;20220830;0;0;Active;Q99720;Ki;<;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin);N-[2-[benzyl(tert-butyl)amino]ethyl]-4-[(tosylamino)methyl]benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=C(C=C1)S(=O)(=O)NCC2=CC=C(C=C2)C(=O)NCCN(CC3=CC=CC=C3)C(C)(C)C
6444;342786912;1.0;1139358;242259853;3342390;10280;246904940;Confirmatory;20220830;0;0;Active;Q99720;Ki;<;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin);4-[[(4-methylphenyl)sulfonylamino]methyl]-N-[2-[(phenylmethyl)-propan-2-ylamino]ethyl]benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC=C(C=C1)S(=O)(=O)NCC2=CC=C(C=C2)C(=O)NCCN(CC3=CC=CC=C3)C(C)C
6445;342804587;1.0;1127667;103229652;4679312;10280;237346340;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity to sigma-1 opioid receptor (unknown origin);(8-Methyl-8-azabicyclo[3.2.1]octan-3-yl) 2-(4-chlorophenoxy)butanoate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(C(=O)OC1CC2CCC(C1)N2C)OC3=CC=C(C=C3)Cl
6446;345602801;1.0;1200082;312389814;76684204;10280;256589640;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-(3,4-difluorophenyl)-N-(2-morpholin-4-ylethyl)triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1COCCN1CCNC2=CN(N=N2)C3=CC(=C(C=C3)F)F
6447;345602961;1.0;1200082;312389825;76683779;10280;256589640;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-benzyl-N-(2-morpholin-4-ylethyl)triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1COCCN1CCNC2=CN(N=N2)CC3=CC=CC=C3
6448;345603240;1.0;1200082;312389847;76684473;10280;256589640;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;N-(1-(3,4-dichlorophenyl)-1H-1,2,3-triazol-4-yl)-N-(2-morpholinoethyl)methanesulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CS(=O)(=O)N(CCN1CCOCC1)C2=CN(N=N2)C3=CC(=C(C=C3)Cl)Cl
6449;345603242;1.0;1200082;312389840;90269115;10280;256589640;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-cyclohexyl-N-(2-morpholin-4-ylethyl)triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CCC(CC1)N2C=C(N=N2)NCCN3CCOCC3
6450;363665991;1.0;1415921;404712414;71223493;10280;301088340;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;2,2-dimethyl-N-[1-(2-morpholin-4-ylethyl)pyrazolo[3,4-d]pyrimidin-4-yl]propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)C(=O)NC1=C2C=NN(C2=NC=N1)CCN3CCOCC3
6451;363851585;1.0;1449797;381884646;72950699;10280;283855030;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [125I]-IPAG from sigma1 in human MDA-MB-468 cell membranes;1,2-Bis[3-(4-fluorophenoxy)propyl]guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC(=CC=C1OCCCNC(=NCCCOC2=CC=C(C=C2)F)N)F
6452;365267539;1.0;1512456;440154067;153061504;10280;316202300;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(1S,2S)-1-ethyl-2-methyl-1,3-dihydrobenzo[f]chromen-2-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC[C@H]1C2=C(C=CC3=CC=CC=C32)OC[C@@]1(C)N
6453;365267544;1.0;1512456;440168398;153287572;10280;316202300;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3S,4S)-4-ethyl-3,6-dimethyl-2,4-dihydrochromen-3-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC[C@H]1C2=C(C=CC(=C2)C)OC[C@@]1(C)N
6454;366366193;1.0;1558961;440189012;118567678;10280;317436420;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;2-[3-Oxo-4-phenyl-9-(2-phenylethyl)-1-oxa-4,9-diazaspiro[5.5]undecan-2-yl]acetic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;C1CN(CCC12CN(C(=O)C(O2)CC(=O)O)C3=CC=CC=C3)CCC4=CC=CC=C4
6455;367490638;1.0;1661755;442054140;156015029;10280;328320230;Confirmatory;20220830;0;0;Unspecified;Q99720;Kd;>;ChEMBL;Displacement of [3H](+)-pentazocine from recombinant sigma 1 receptor (unknown origin) expressed in baculovirus infected Sf9 cell membranes after 1.5 hrs by scintillation counting analysis;2-Amino-1-(4-imidazo[1,2-b]pyridazin-6-ylpiperazin-1-yl)-3-phenylpropan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;521.0;;;;C1CN(CCN1C2=NN3C=CN=C3C=C2)C(=O)C(CC4=CC=CC=C4)N
6456;367490639;1.0;1661755;442057734;42953357;10280;328320230;Confirmatory;20220830;0;0;Unspecified;Q99720;Kd;>;ChEMBL;Displacement of [3H](+)-pentazocine from recombinant sigma 1 receptor (unknown origin) expressed in baculovirus infected Sf9 cell membranes after 1.5 hrs by scintillation counting analysis;N-[2-(dimethylamino)-1-phenylethyl]-1-(4-fluorophenyl)-5-methylpyrazole-4-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;521.0;;;;CC1=C(C=NN1C2=CC=C(C=C2)F)C(=O)NC(CN(C)C)C3=CC=CC=C3
6457;367490642;1.0;1661755;442050343;156012377;10280;328320230;Confirmatory;20220830;0;0;Unspecified;Q99720;Kd;>;ChEMBL;Displacement of [3H](+)-pentazocine from recombinant sigma 1 receptor (unknown origin) expressed in baculovirus infected Sf9 cell membranes after 1.5 hrs by scintillation counting analysis;(E)-1-(4-bromophenyl)-N-[1-[3-(trifluoromethyl)phenyl]pyrazolidin-3-yl]methanimine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;521.0;;;;C1CN(NC1/N=C/C2=CC=C(C=C2)Br)C3=CC=CC(=C3)C(F)(F)F
6458;367490645;1.0;1661755;442055929;56705499;10280;328320230;Confirmatory;20220830;0;0;Unspecified;Q99720;Kd;>;ChEMBL;Displacement of [3H](+)-pentazocine from recombinant sigma 1 receptor (unknown origin) expressed in baculovirus infected Sf9 cell membranes after 1.5 hrs by scintillation counting analysis;N-[3-(1H-indol-3-yl)-1-methylpropyl]-1-isobutyrylpiperidin-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;521.0;;;;CC(C)C(=O)N1CCC(CC1)NC(C)CCC2=CNC3=CC=CC=C32
6459;367490647;1.0;1661755;442051758;91814689;10280;328320230;Confirmatory;20220830;0;0;Unspecified;Q99720;Kd;>;ChEMBL;Displacement of [3H](+)-pentazocine from recombinant sigma 1 receptor (unknown origin) expressed in baculovirus infected Sf9 cell membranes after 1.5 hrs by scintillation counting analysis;(3-(3,4-dihydroisoquinolin-2(1H)-yl)pyrrolidin-1-yl)(1H-indol-3-yl)methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;521.0;;;;C1CN(CC1N2CCC3=CC=CC=C3C2)C(=O)C4=CNC5=CC=CC=C54
6460;371962272;1.0;1704794;461540998;135339817;10280;328778050;Confirmatory;20220318;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);7-[3-[4-(6-Fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]propoxy]-2-methyl-3,4-dihydroisoquinolin-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2=C(C1=O)C=C(C=C2)OCCCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
6461;372129073;1.0;1685177;461522750;153601027;10280;336039610;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);9-[(4-Fluorophenyl)methylamino]-2-methyl-3,4,7,8,9,10-hexahydropyrazino[1,2-b]indazol-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN2C(=C3CC(CCC3=N2)NCC4=CC=C(C=C4)F)C1=O
6462;372129074;1.0;1685177;461531598;146641800;10280;336039610;Confirmatory;20220830;0;0;Active;Q99720;Ki;<;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);4-[2-[[1-Phenyl-3-(piperidine-1-carbonyl)-4,5,6,7-tetrahydroindazol-5-yl]amino]ethyl]benzonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)C(=O)C2=NN(C3=C2CC(CC3)NCCC4=CC=C(C=C4)C#N)C5=CC=CC=C5
6463;372129075;1.0;1685177;461540828;146641802;10280;336039610;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);[5-(3,4-dihydro-1H-isoquinolin-2-yl)-1-phenyl-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)C(=O)C2=NN(C3=C2CC(CC3)N4CCC5=CC=CC=C5C4)C6=CC=CC=C6
6464;372129076;1.0;1685177;461553932;146641807;10280;336039610;Confirmatory;20220830;0;0;Active;Q99720;Ki;<;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);[5-(Oxan-4-ylmethylamino)-1-phenyl-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)C(=O)C2=NN(C3=C2CC(CC3)NCC4CCOCC4)C5=CC=CC=C5
6465;372129077;1.0;1685177;461557110;146641758;10280;336039610;Confirmatory;20220830;0;0;Active;Q99720;Ki;<;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);[5-[2-(4-fluorophenyl)ethyl]-1-propyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-3-yl]-piperidin-1-ylmethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1C2=C(CN(CC2)CCC3=CC=C(C=C3)F)C(=N1)C(=O)N4CCCCC4
6466;372129078;1.0;1685177;461519667;146641305;10280;336039610;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);4-[2-[(1-Oxo-2,3,4,5,8,9,10,11-octahydro-[1,4]diazepino[1,2-b]indazol-10-yl)amino]ethyl]benzonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CNC(=O)C2=C3CC(CCC3=NN2C1)NCCC4=CC=C(C=C4)C#N
6467;372129079;1.0;1685177;461545142;146641256;10280;336039610;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);piperidin-1-yl-[1-propyl-5-[2-[3-(trifluoromethyl)phenyl]ethyl]-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-3-yl]methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1C2=C(CN(CC2)CCC3=CC(=CC=C3)C(F)(F)F)C(=N1)C(=O)N4CCCCC4
6468;372129080;1.0;1685177;461525069;146641812;10280;336039610;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);[5-[2-(1H-imidazol-2-yl)ethylamino]-1-phenyl-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)C(=O)C2=NN(C3=C2CC(CC3)NCCC4=NC=CN4)C5=CC=CC=C5
6469;372129081;1.0;1685177;461528964;146641578;10280;336039610;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);N-(3-methoxyphenyl)-1-propyl-5-(2-pyridin-4-ylethylamino)-4,5,6,7-tetrahydroindazole-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1C2=C(CC(CC2)NCCC3=CC=NC=C3)C(=N1)C(=O)NC4=CC(=CC=C4)OC
6470;372129082;1.0;1685177;461562241;146641781;10280;336039610;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);9-[2-(1,3-benzodioxol-5-yl)ethylamino]-3,4,7,8,9,10-hexahydro-2H-pyrazino[1,2-b]indazol-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2=NN3CCNC(=O)C3=C2CC1NCCC4=CC5=C(C=C4)OCO5
6471;380264307;1.0;1811100;475984637;126539128;10280;342361900;Confirmatory;20230314;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;N-[(4-piperazin-1-yloxan-4-yl)methyl]-N-[6-(trifluoromethyl)pyridin-2-yl]propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N(CC1(CCOCC1)N2CCNCC2)C3=CC=CC(=N3)C(F)(F)F
6472;380512639;1.0;1846430;482057955;168276975;10280;338263220;Confirmatory;20230629;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-10-(5-fluoropyridin-2-yl)-4-(oxan-4-yl)-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCC1N2C[C@@H]3[C@@H](C2)OCC4=C(N=NN34)C5=NC=C(C=C5)F
6473;380512640;1.0;1846430;482070107;67404093;10280;338263220;Confirmatory;20230629;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;3,7-Diphenyl-5abeta,6,7,8-tetrahydro-4H,8aalphaH-1,2,7,8b-tetraaza-5-oxa-as-indacene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@@H]2[C@@H](CN1C3=CC=CC=C3)OCC4=C(N=NN24)C5=CC=CC=C5
6474;380512731;1.0;1846430;482072612;168287632;10280;338263220;Confirmatory;20230629;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-10-(2-fluorophenyl)-4-[(1-methylimidazol-2-yl)methyl]-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C=CN=C1CN2C[C@@H]3[C@@H](C2)OCC4=C(N=NN34)C5=CC=CC=C5F
6475;388740627;1.0;1797293;386051291;118283044;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 47;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=CC4=C(C=C3C2)OCO4
6476;388879459;1.0;1797475;386051291;118283044;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 47;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=CC4=C(C=C3C2)OCO4
6477;389383878;1.0;1804286;386051291;118283044;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 47;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=CC4=C(C=C3C2)OCO4
6478;407906175;1.0;1922168;494405242;162368342;10280;362020630;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [H3]DTG from sigma 1 receptor (unknown origin) by competition binding assay;6-({[(1S)-1-hydroxy-2-methyl-1-phenylpropan-2-yl]amino}methyl)-1-methyl-3,4-dihydroquinolin-2(1H)-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)([C@H](C1=CC=CC=C1)O)NCC2=CC3=C(C=C2)N(C(=O)CC3)C
6479;255009825;1.031;625223;103188772;2160;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Amitriptyline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
6480;380657419;1.032;1880165;482046560;168268877;10280;354503690;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) assessed as inhibition constant;2-(6-chloro-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)-5-methoxyphenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC(=C(C=C1)C2C3=C(CCN2)C4=C(N3)C=CC(=C4)Cl)O
6481;100536373;1.034;204457;103673554;45262093;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-[2-Bromo-3,5-bis(methylsulfanyl)phenyl]-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=C(C(=CC(=C2)SC)SC)Br)N.Cl
6482;100475169;1.042;204462;103673182;45261817;10280;79059260;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor of guinea pig whole brain using [3H]-SKF- 100047 radioligand;"1'-Methylspiro[3,4-dihydronaphthalene-2,4'-piperidine]-1-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN1CCC2(CCC3=CC=CC=C3C2=O)CC1.Cl
6483;100439805;1.05;229190;103168867;6468;10280;14696970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of specific binding of [3H]DTG to sigma binding site in Guinea pig brain membranes;Phencyclidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)(C2=CC=CC=C2)N3CCCCC3
6484;100513119;1.05;229197;103383611;10502049;10280;89413830;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor using radioligand ([3H](+)-pentazocine) binding assay;N-(2-Benzhydryloxy-ethyl)-N''-(3-phenyl-propyl)-butane-1,4-diamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)CCCNCCCCNCCOC(C2=CC=CC=C2)C3=CC=CC=C3
6485;408049235;1.05;1959985;494416764;171355422;10280;299084420;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) assessed as inhibition constant;methyl (1R,2S)-1-(4-chlorophenyl)-2-[[(1S,9R,13R)-4-hydroxy-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methyl]cyclopropane-1-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1[C@H]2CC3=C([C@]1(CCN2C[C@H]4C[C@@]4(C5=CC=C(C=C5)Cl)C(=O)OC)C)C=C(C=C3)O
6486;255013728;1.058;625223;103241510;36811;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dobutamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
6487;389536467;1.058;1805702;459092166;162370614;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';(1R,8R)-9-(2-phenylethyl)-5-[4-(trifluoromethyl)phenyl]-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN([C@@H]2C[C@@H]1C3=C2C=C(C=C3)C4=CC=C(C=C4)C(F)(F)F)CCC5=CC=CC=C5
6488;100496820;1.066;204761;103401126;10451373;10280;78533490;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity at Sigma receptor type 1, displacement of [3H](+)-pentazocine from guinea pig brain membranes;(1S,9S,13S)-10-[(4-tert-butylphenyl)methyl]-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC4=CC=C(C=C4)C(C)(C)C)C)C=C(C=C3)O
6489;100471354;1.07;204459;103298994;10243991;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N-(1-Naphthyl)piperidine-1-carboxamidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCN(CC1)C(=NC2=CC=CC3=CC=CC=C32)N
6490;100458411;1.084;204438;103344430;15149391;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;11-Propyl-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1C2CCC1C3=C(C2)NC4=CC=CC=C43
6491;100440014;1.09;204464;103168867;6468;10280;14696990;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was evaluated for its ability to displace [3H](+)-pentazocine from sigma receptor in Guinea pig brain;Phencyclidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)(C2=CC=CC=C2)N3CCCCC3
6492;100470629;1.09;204469;103340160;44342753;10280;79325690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition against sigma receptor using displacement of 3 nM [3H]pentazocine in homogenate of guinea pig brain cerebellum;(1R,13S)-10-ethyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCN1CC[C@@]2([C@@H](C1CC3=C2C=C(C=C3)O)C)C
6493;255014874;1.0924;625223;103274161;4746;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Perhexiline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3
6494;407996519;1.093;1946583;494396220;171343257;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(2S)-2-[(3,4-difluorophenoxy)methyl]-4-(imidazo[1,2-a]pyridin-2-ylmethyl)morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CO[C@@H](CN1CC2=CN3C=CC=CC3=N2)COC4=CC(=C(C=C4)F)F
6495;407996520;1.09648;1946583;494396220;171343257;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(2S)-2-[(3,4-difluorophenoxy)methyl]-4-(imidazo[1,2-a]pyridin-2-ylmethyl)morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CO[C@@H](CN1CC2=CN3C=CC=CC3=N2)COC4=CC(=C(C=C4)F)F
6496;255027938;1.097;625223;103188808;4932;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Propafenone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
6497;100440052;1.1;229193;103188676;62751;10280;14696970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of specific binding of [3H]NANM of sigma receptor in Guinea pig brain membranes;Tenocyclidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)(C2=CC=CS2)N3CCCCC3
6498;100461066;1.1;204456;103183155;398418;10280;80980660;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma receptor of guinea pig brain homogenates;2-(1-Piperidinocyclopentyl)benzo[b]thiophene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCN(CC1)C2(CCCC2)C3=CC4=CC=CC=C4S3
6499;367490102;1.11;1661634;442062697;156021006;10280;327871420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);3-[4-(3-Aminopropylcarbamoyl)phenyl]-5-[1-[4-(trifluoromethyl)phenyl]triazol-4-yl]benzoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC(=CC=C1C2=CC(=CC(=C2)C(=O)O)C3=CN(N=N3)C4=CC=C(C=C4)C(F)(F)F)C(=O)NCCCN
6500;100467666;1.122;203697;103330115;398580;10280;82952200;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma 1 receptor was determined in guinea pig brain membrane using [3H](+)-pentazocine as radioligand;Tetrahydro-1-[4-[methyl[4-[methyl[2-(3,4-dichlorophenyl)ethyl]amino]butyl]amino]butyl]-1H-pyrrole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCCCN1CCCC1)CCCCN(C)CCC2=CC(=C(C=C2)Cl)Cl
6501;100440016;1.13;204464;103384206;10263742;10280;14696990;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was evaluated for its ability to displace [3H](+)-pentazocine from sigma receptor in Guinea pig brain;(1alpha,5alpha)-2beta-Phenyl-2-piperidinobicyclo[3.1.0]hexane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)[C@@]2(CC[C@@H]3[C@H]2C3)C4=CC=CC=C4
6502;100741795;1.14;203992;103671608;45260664;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"3-Phenyl-1-oxa-9-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2(CNC1)C(=O)C(=CO2)C3=CC=CC=C3.Cl
6503;366431683;1.148;1592018;242648185;90644067;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;1-(4-Chlorophenyl)-4-[3-(4-fluorophenyl)sulfinylpropyl]piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCS(=O)C2=CC=C(C=C2)F)C3=CC=C(C=C3)Cl
6504;366431684;1.14815;1592018;242648185;90644067;10280;307371350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement [3H]-Pentazocine from sigma 1 receptor (unknown origin) expressed in HEK cell membranes;1-(4-Chlorophenyl)-4-[3-(4-fluorophenyl)sulfinylpropyl]piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCS(=O)C2=CC=C(C=C2)F)C3=CC=C(C=C3)Cl
6505;100617221;1.15;204444;103337425;97478;10280;16627250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membranes using [3H]DTG as radioligand;1-(4-Chlorophenyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1)C2=CC=C(C=C2)Cl
6506;100604188;1.155;203857;103735221;46878006;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;N-Methyl-N-[(1R)-2beta-(1-pyrrolidinyl)cyclohexan-1beta-yl]benzeneacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)CC3=CC=CC=C3
6507;255034401;1.158;625223;103770389;10660;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dimenhydrinate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN1C2=C(C(=O)N(C1=O)C)NC(=N2)Cl.CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
6508;380827067;1.158;1914915;103478702;11386747;10280;;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000296b SIGMAR1;Naphthyridinone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)C1=C(C2=CC(=C(N=C2N(C1=O)C)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl)NC(=O)C
6509;409047506;1.158;1794447;103478702;11386747;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;CB1 inverse agonist 1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)C1=C(C2=CC(=C(N=C2N(C1=O)C)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl)NC(=O)C
6510;100708107;1.159;204146;103252303;11191741;10280;146843270;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma opioid receptor of guiena pig brain membrane;N-[4-(6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-yl)butyl]-1-methoxy-4-bromonaphthalene-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=C2CN(CCC2=C1)CCCCNC(=O)C3=C(C4=CC=CC=C4C(=C3)Br)OC)OC
6511;409047912;1.16869;1794447;440208510;155561056;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Pptn-NC;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=C(C2=C1C=C(C=C2)C3=CC=C(C=C3)C(F)(F)F)C4=CC=C(C=C4)C5CCNCC5)C(=O)O
6512;380820395;1.169;1914986;461521123;162647678;10280;;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000337aCl SIGMAR1;"1-Methyl-4-(4-piperidin-4-ylphenyl)-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylic acid;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=C(C2=C1C=C(C=C2)C3=CC=C(C=C3)C(F)(F)F)C4=CC=C(C=C4)C5CCNCC5)C(=O)O.Cl
6513;100627999;1.1749;204453;103671419;45260520;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"(4aR,10bR)-9-methoxy-3-methyl-2,4,4a,5,6,10b-hexahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CN1CC[C@@H]2[C@H](C1)CCC3=C2C=C(C=C3)OC.Cl
6514;409047188;1.1749;1794447;134451810;42611190;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;4-((Piperindin-4-yl)-phenyl)-(7-(4-(trifluoromethyl)-phenyl)-2-naphthoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CNCCC1C2=CC=C(C=C2)C3=C4C=CC(=CC4=CC(=C3)C(=O)O)C5=CC=C(C=C5)C(F)(F)F
6515;409047513;1.1749;1794447;440177709;155548816;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;2-[1-(3a,7a-dihydro-1H-imidazo[4,5-b]pyridin-2-ylmethyl)piperidin-4-yl]-4-(1-benzofuran-2-yl)-1,3-thiazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1C2=NC(=CS2)C3=CC4=CC=CC=C4O3)CC5=NC6C(N5)C=CC=N6
6516;409047913;1.1749;1794447;440208510;155561056;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Pptn-NC;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=C(C2=C1C=C(C=C2)C3=CC=C(C=C3)C(F)(F)F)C4=CC=C(C=C4)C5CCNCC5)C(=O)O
6517;380820046;1.17984;1914675;461560318;162675169;10280;;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000752a SIGMAR1;4-(1-benzofuran-2-yl)-2-[1-(1H-imidazo[4,5-b]pyridin-2-ylmethyl)piperidin-4-yl]-1,3-thiazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1C2=NC(=CS2)C3=CC4=CC=CC=C4O3)CC5=NC6=C(N5)C=CC=N6
6518;409047512;1.17984;1794447;440177709;155548816;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;2-[1-(3a,7a-dihydro-1H-imidazo[4,5-b]pyridin-2-ylmethyl)piperidin-4-yl]-4-(1-benzofuran-2-yl)-1,3-thiazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1C2=NC(=CS2)C3=CC4=CC=CC=C4O3)CC5=NC6C(N5)C=CC=N6
6519;409047187;1.18059;1794447;134451810;42611190;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;4-((Piperindin-4-yl)-phenyl)-(7-(4-(trifluoromethyl)-phenyl)-2-naphthoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CNCCC1C2=CC=C(C=C2)C3=C4C=CC(=CC4=CC(=C3)C(=O)O)C5=CC=C(C=C5)C(F)(F)F
6520;100298510;1.2;239347;104234228;6013;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;Testosterone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C
6521;100448381;1.2;204471;103215480;14982981;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-(4-Oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)hexyloxy]-2-phenyl-4H-1-benzopyran-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CCCCCCOC4=CC5=C(C=C4)OC(=CC5=O)C6=CC=CC=C6
6522;100613863;1.2;203986;103282885;14771693;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N-(2-Iodo-phenyl)-N''-(2-styryl-phenyl)-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC=C(C=C1)/C=C/C2=CC=CC=C2NC(=NC3=CC=CC=C3I)N
6523;340019627;1.2;752428;174496403;49853577;10280;236018160;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;N-cyclopentyl-2-(4-ethyl-3-methylpiperazin-1-yl)-N-methylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1CCN(CC1C)CC(=O)N(C)C2CCCC2
6524;342804588;1.2;1127667;103252114;15205887;10280;237346340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 opioid receptor (unknown origin);1-(4-Fluoro-phenyl)-3-{4-[3-(4-fluoro-phenyl)-8-aza-bicyclo[3.2.1]oct-2-en-8-yl]-butyl}-1H-indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C=C(CC1N2CCCCC3=CN(C4=CC=CC=C43)C5=CC=C(C=C5)F)C6=CC=C(C=C6)F
6525;255028642;1.206;625223;103164951;4946;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Propranolol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O
6526;100458421;1.21;204437;103344296;15149421;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;9-Phenyl-15-(4-phenylbutyl)-9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3,5,7-tetraene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCCC4=CC=CC=C4)N(C5=CC=CC=C53)C6=CC=CC=C6
6527;100471372;1.21;204459;103298039;9858146;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N-(3-Ethylphenyl)-N,N'-dimethyl-N'-(1-naphthyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=N)N(C)C2=CC=CC3=CC=CC=C32
6528;100458418;1.212;204437;103344690;15646123;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;2-Fluoro-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2)NC4=C3C=C(C=C4)F
6529;372355918;1.22;1726849;461558930;141195324;10280;342231650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]pentazocine from human sigma 1 receptor expressed in HEK293 cell membrane incubated for 2 hrs by liquid scintillation counting method;6-[3-(Diethylamino)propoxy]chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CC)CCCOC1=CC2=C(C=C1)OC=CC2=O
6530;100604318;1.247;203857;103735199;46877991;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;N-Methyl-N-[(1R)-2beta-(1-pyrrolidinyl)cyclohexan-1beta-yl]phenoxyacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)COC3=CC=CC=C3
6531;100364892;1.25;229202;103338362;11811722;10280;115854440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of sigma receptor;8-(3-Phenoxybenzyl)-1-phenyl-1,3,8-triazaspiro[4.5]decane-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CC4=CC(=CC=C4)OC5=CC=CC=C5
6532;100456208;1.25;229183;103359996;44351070;10280;79028690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor in bovine cerebellum using 2.0 nM [3H]haloperidol in the presence of 25 nM unlabeled spiperone;3-Dipropylamino-1-phenyl-propan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCCN(CCC)CCC(=O)C1=CC=CC=C1
6533;100456548;1.25;229183;103360165;66749;10280;79028690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor in bovine cerebellum using 2.0 nM [3H]haloperidol in the presence of 25 nM unlabeled spiperone;3-(Diethylamino)propiophenone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCN(CC)CCC(=O)C1=CC=CC=C1
6534;334041130;1.25;728301;164142838;71601215;10280;234702450;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor in human jurkat cell membrane after 2 hrs by liquid scintillation counting analysis in presence of haloperidol;1-[4-(Cyclohexylmethyl)piperazin-1-yl]-5-(dithiolan-3-yl)pentan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCC(CC1)CN2CCN(CC2)C(=O)CCCCC3CCSS3
6535;342816990;1.25893;1118248;242613630;6995232;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human recombinant sigma-1 receptor expressed in CHO cells after 180 mins by beta counting analysis;[(1S,2S)-2-phenylcyclopropyl]-(4-phenylpiperazin-1-yl)methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;197.0;;;;C1CN(CCN1C2=CC=CC=C2)C(=O)[C@H]3C[C@@H]3C4=CC=CC=C4
6536;342816995;1.25893;1118248;242613623;90666084;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from human recombinant sigma-1 receptor expressed in CHO cells after 180 mins by beta counting analysis;(1S,2S)-2-phenyl-N-(4-piperidin-1-ylcyclohexyl)cyclopropane-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;197.0;;;;C1CCN(CC1)C2CCC(CC2)NC(=O)[C@H]3C[C@@H]3C4=CC=CC=C4
6537;363701198;1.25893;1409616;103224052;2247;10280;323538590;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocin from the Sigma1 receptor;Astemizole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)CCN2CCC(CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)F
6538;409047507;1.25893;1794447;103478702;11386747;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;CB1 inverse agonist 1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)C1=C(C2=CC(=C(N=C2N(C1=O)C)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl)NC(=O)C
6539;363701197;1.266;1409616;103224052;2247;10280;323538590;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocin from the Sigma1 receptor;Astemizole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)CCN2CCC(CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)F
6540;380826504;1.26844;1914637;440189837;155553652;10280;;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000748a SIGMAR1;2-[1-(3a,7a-dihydro-1H-imidazo[4,5-b]pyridin-2-ylmethyl)piperidin-4-yl]-4-(1-methylbenzimidazol-2-yl)-1,3-thiazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=CC=CC=C2N=C1C3=CSC(=N3)C4CCN(CC4)CC5=NC6C(N5)C=CC=N6
6541;100600971;1.27;203996;123099351;3036289;10280;25470740;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was evaluated for binding affinity towards sigma opioid receptor using [3H](+)-3-PPP in guinea pig ileum;trans-3,4-Dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzeneacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;21160;Ileum;CN([C@@H]1CCCC[C@H]1N2CCCC2)C(=O)CC3=CC(=C(C=C3)Cl)Cl
6542;100458415;1.276;204437;103344430;15149391;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;11-Propyl-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1C2CCC1C3=C(C2)NC4=CC=CC=C43
6543;100458317;1.28;204437;103344900;15149394;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;11-(2-Phenylethyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCC4=CC=CC=C4)NC5=CC=CC=C53
6544;407996425;1.283;1946583;494402521;171347243;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;1-methyl-5-[[(3S)-3-[(6-methylpyridin-2-yl)methoxy]piperidin-1-yl]methyl]indazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NC(=CC=C1)CO[C@H]2CCCN(C2)CC3=CC4=C(C=C3)N(N=C4)C
6545;255027939;1.284;625223;103175608;5994;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Progesterone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C
6546;409049354;1.28644;1794447;440189837;155553652;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;2-[1-(3a,7a-dihydro-1H-imidazo[4,5-b]pyridin-2-ylmethyl)piperidin-4-yl]-4-(1-methylbenzimidazol-2-yl)-1,3-thiazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=CC=CC=C2N=C1C3=CSC(=N3)C4CCN(CC4)CC5=NC6C(N5)C=CC=N6
6547;407996426;1.28825;1946583;494402521;171347243;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;1-methyl-5-[[(3S)-3-[(6-methylpyridin-2-yl)methoxy]piperidin-1-yl]methyl]indazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NC(=CC=C1)CO[C@H]2CCCN(C2)CC3=CC4=C(C=C3)N(N=C4)C
6548;409049355;1.28825;1794447;440189837;155553652;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;2-[1-(3a,7a-dihydro-1H-imidazo[4,5-b]pyridin-2-ylmethyl)piperidin-4-yl]-4-(1-methylbenzimidazol-2-yl)-1,3-thiazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2=CC=CC=C2N=C1C3=CSC(=N3)C4CCN(CC4)CC5=NC6C(N5)C=CC=N6
6549;255011810;1.289;625223;103172426;12456;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Berberine chloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC.[Cl-]
6550;100297850;1.29;239347;103458417;2467;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;Buflomedil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC(=C(C(=C1)OC)C(=O)CCCN2CCCC2)OC
6551;112851461;1.3;204465;312365756;9927617;10280;79325400;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma receptor of guinea pig brain;2-Azabicyclo[3.3.1]nonan-7-one, 5-(3-hydroxyphenyl)-2-methyl-8-(phenylmethylene)-, (1R,5R,8E)-, hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@]2(C[C@@H]1/C(=C\C3=CC=CC=C3)/C(=O)C2)C4=CC(=CC=C4)O
6552;380313615;1.3;1822903;475995234;164585354;10280;351135560;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma 1 receptor (unknown origin) assessed as binding constant;4-[4-[(1R,2R,4R)-4-amino-2-(hydroxymethyl)cyclopentyl]phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@@H](C[C@H]([C@@H]1CO)C2=CC=C(C=C2)C3=C4C=CC(=CC4=CC(=C3)C(=O)O)C5=CC=C(C=C5)C(F)(F)F)N
6553;388740373;1.3;1797293;386051310;118282842;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 65;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)S(=O)(=O)C
6554;388740377;1.3;1797293;386051288;118282886;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 44;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=C(C2)C(=CC=C3)F
6555;388879194;1.3;1797475;386051288;118282886;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 44;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=C(C2)C(=CC=C3)F
6556;388879198;1.3;1797475;386051310;118282842;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 65;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)S(=O)(=O)C
6557;389383651;1.3;1804286;386051288;118282886;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 44;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=C(C2)C(=CC=C3)F
6558;389383655;1.3;1804286;386051310;118282842;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 65;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)S(=O)(=O)C
6559;407996258;1.31826;1946583;494423810;171358397;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(2S)-4-[(1-methylindazol-5-yl)methyl]-2-[(4-methyl-1,3-thiazol-2-yl)oxymethyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CSC(=N1)OC[C@@H]2CN(CCO2)CC3=CC4=C(C=C3)N(N=C4)C
6560;407996257;1.326;1946583;494423810;171358397;10280;362831800;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H] Pentazocine from sigma 1 receptor in HEK293 cell membrane;(2S)-4-[(1-methylindazol-5-yl)methyl]-2-[(4-methyl-1,3-thiazol-2-yl)oxymethyl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CSC(=N1)OC[C@@H]2CN(CCO2)CC3=CC4=C(C=C3)N(N=C4)C
6561;100470627;1.33;204469;103340161;44342754;10280;79325690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition against sigma receptor using displacement of 3 nM [3H]pentazocine in homogenate of guinea pig brain cerebellum;(1R,13S)-1,10,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C[C@@H]1C2CC3=C([C@@]1(CCN2C)C)C=C(C=C3)O
6562;100604304;1.335;203857;103735206;46877997;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;N-Methyl-N-[(1R)-2beta-(1-pyrrolidinyl)cyclohexan-1beta-yl]benzenepropanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)CCC3=CC=CC=C3
6563;100617251;1.34;204444;103169357;4296;10280;16627250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membranes using [3H]DTG as radioligand;1-[3-(Trifluoromethyl)phenyl]piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1)C2=CC=CC(=C2)C(F)(F)F
6564;409047167;1.34029;1794447;475988474;166630510;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;3-[3,5-Difluoro-4-[[3-[5-methoxy-4-(2-methoxyanilino)pyrimidin-2-yl]indazol-1-yl]methyl]phenoxy]propan-1-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1NC2=NC(=NC=C2OC)C3=NN(C4=CC=CC=C43)CC5=C(C=C(C=C5F)OCCCO)F
6565;409047168;1.34896;1794447;475988474;166630510;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;3-[3,5-Difluoro-4-[[3-[5-methoxy-4-(2-methoxyanilino)pyrimidin-2-yl]indazol-1-yl]methyl]phenoxy]propan-1-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1NC2=NC(=NC=C2OC)C3=NN(C4=CC=CC=C43)CC5=C(C=C(C=C5F)OCCCO)F
6566;255018200;1.362;625223;103164619;2801;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Clomipramine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl
6567;100471340;1.37;204459;103298074;242976;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;C-[Bis-(3,4-dihydro-2H-quinolin-1-yl)]-methyleneamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2=CC=CC=C2N(C1)C(=N)N3CCCC4=CC=CC=C43
6568;100605295;1.372;203995;103735213;14771454;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity of compound to Sigma opioid receptor labelled with [3H](+)-3-PPP;N-methyl-2-naphthalen-2-yl-N-[(1R,2S)-2-pyrrolidin-1-ylcyclohexyl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)CC3=CC4=CC=CC=C4C=C3
6569;100473776;1.38038;203852;103321168;42601649;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;N,N-dimethyl-1-phenyl-1,2,3,4-tetrahydronaphthalen-2-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)C1CCC2=CC=CC=C2C1C3=CC=CC=C3
6570;408049238;1.381;1959985;494407429;171350171;10280;299084420;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) assessed as inhibition constant;methyl 2-[[(1R,9S,13S)-4-hydroxy-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-10-yl]methyl]-1-phenylcyclopropane-1-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1[C@@H]2CC3=C([C@@]1(CCN2CC4CC4(C5=CC=CC=C5)C(=O)OC)C)C=C(C=C3)O
6571;100458427;1.382;204437;103344451;15149411;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;3-(5-Fluoro-9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3(8),4,6-tetraen-15-yl)propan-1-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCO)NC4=C3C=C(C=C4)F
6572;100604298;1.385;203857;103735228;46878012;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;2,6-Dichloro-N-methyl-N-[(1R)-2beta-(1-pyrrolidinyl)cyclohexan-1beta-yl]benzeneacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)CC3=C(C=CC=C3Cl)Cl
6573;100404002;1.39;204630;103294804;11034920;10280;128012230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma receptor type 1 was determined by the displacement of [3H]pentazocine radioligand;Bis-(4-fluoro-phenyl)-(3-piperazin-1-yl-propyl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1)CCCN(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F
6574;100440021;1.4;229191;103173857;53389;10280;14696970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of specific binding of [3H]DTG to sigma receptor in Guinea pig brain membranes;Rimcazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@H]1CN(C[C@@H](N1)C)CCCN2C3=CC=CC=C3C4=CC=CC=C42
6575;100623899;1.4;204627;103229443;3039881;10280;16745410;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;The compound was tested for binding affinity against sigma receptor using DTG as radioligand;3-Chloro-10,11-dihydro-N,N-dimethylspiro-(5H-dibenzo(a,d)cycloheptene-5,1'-cyclohex-2'-ene)4'-amine 1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)C1CCC2(C=C1)C3=CC=CC=C3CCC4=C2C=C(C=C4)Cl
6576;112851456;1.4;204465;103215106;44285482;10280;79325400;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma receptor of guinea pig brain;5-(3-Hydroxy-phenyl)-2-methyl-2-aza-bicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1CC(=O)C2)C3=CC(=CC=C3)O
6577;373839305;1.4;1759512;469806349;164614469;10280;338315600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma 1 receptor (unknown origin);trimethyl-[2-[3-nitro-2-(trifluoromethyl)-2H-chromen-6-yl]ethynyl]silane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[Si](C)(C)C#CC1=CC2=C(C=C1)OC(C(=C2)[N+](=O)[O-])C(F)(F)F
6578;100471328;1.41;204459;103299177;10378306;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N-Naphthalen-1-yl-azepane-1-carboxamidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCCN(CC1)C(=NC2=CC=CC3=CC=CC=C32)N
6579;363476489;1.418;1353758;404659709;145954849;10280;294388910;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin);[(1R,5R)-9-(6-aminohexyl)-9-azabicyclo[3.3.1]nonan-3-yl] N-(2-methoxy-5-methylphenyl)carbamate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=C(C=C1)OC)NC(=O)OC2C[C@H]3CCC[C@H](C2)N3CCCCCCN
6580;380816674;1.43153;1914883;440134679;139600336;10280;;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (Eurofins, Bayer)) EUB0000240b SIGMAR1;CID 139600336;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN([C@H](C2=C1N=CC=C2)C3=CC=C(C=C3)F)C(=O)NC4=CN=C(N=C4)OC5=CC=C(C=C5)F
6581;409049000;1.43153;1794447;440134679;139600336;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;CID 139600336;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN([C@H](C2=C1N=CC=C2)C3=CC=C(C=C3)F)C(=O)NC4=CN=C(N=C4)OC5=CC=C(C=C5)F
6582;342804592;1.437;1127667;103609690;24968535;10280;237346340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 opioid receptor (unknown origin);[9-[[4-(dimethylamino)phenyl]methyl]-9-azabicyclo[3.3.1]nonan-3-yl] N-(2-methoxy-5-methylphenyl)carbamate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=C(C=C1)OC)NC(=O)OC2CC3CCCC(C2)N3CC4=CC=C(C=C4)N(C)C
6583;380581325;1.445;1861723;482085369;168296268;10280;357249250;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay;N-[3-[(3,4-dimethoxyphenyl)methyl-methylamino]propyl]naphthalene-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC2=CC=CC=C2C=C1)CC3=CC(=C(C=C3)OC)OC
6584;409049001;1.44544;1794447;440134679;139600336;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;CID 139600336;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN([C@H](C2=C1N=CC=C2)C3=CC=C(C=C3)F)C(=O)NC4=CN=C(N=C4)OC5=CC=C(C=C5)F
6585;100558846;1.465;203684;103390159;44364189;10280;98366120;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;1-[4-(2-Methoxyphenethyl)piperazine-1-yl]-2-(2-methoxyphenyl)ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1CCN2CCN(CC2)C(=O)CC3=CC=CC=C3OC
6586;100458403;1.473;204438;103344690;15646123;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;2-Fluoro-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2)NC4=C3C=C(C=C4)F
6587;100513225;1.48;229197;103384288;648525;10280;89413830;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor using radioligand ([3H](+)-pentazocine) binding assay;1-[2-(Diphenylmethoxy)ethyl]piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1)CCOC(C2=CC=CC=C2)C3=CC=CC=C3
6588;100538556;1.48;204792;103173857;53389;10280;94359030;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity was evaluated using [3H]pentazocine binding to sigma-1 receptor from guinea pig brain;Rimcazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(C[C@@H](N1)C)CCCN2C3=CC=CC=C3C4=CC=CC=C42
6589;366389689;1.48;1571915;103720039;97627;10280;306053310;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma receptor 1 (unknown origin);9-Riburonosyladenine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)C(=O)O)O)O)N
6590;367490100;1.48;1661634;442048338;139406787;10280;327871420;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);3-(4-Piperidin-4-ylphenyl)-5-[1-[4-(trifluoromethyl)phenyl]triazol-4-yl]benzoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CNCCC1C2=CC=C(C=C2)C3=CC(=CC(=C3)C(=O)O)C4=CN(N=N4)C5=CC=C(C=C5)C(F)(F)F
6591;380523511;1.48;1849426;482058377;168277287;10280;363677490;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-LSD from human sigma1 receptor expressed in human HEK293T cell membrane incubated for 90 mins by radioligand binding assay;N-(3,4-dichlorophenyl)-2-heptan-4-yl-3H-imidazo[4,5-c]quinolin-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCC(CCC)C1=NC2=C(N1)C(=NC3=CC=CC=C32)NC4=CC(=C(C=C4)Cl)Cl
6592;100451176;1.483;204436;103672152;45261008;10280;81026510;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using [3H]ditolylguanidine (DTG) as radioligand.;"3-Chloro-6-(dimethylamino)-8-phenyl-5,6,7,8-tetrahydronaphthalen-2-ol;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CN(C)C1CC(C2=CC(=C(C=C2C1)Cl)O)C3=CC=CC=C3.Cl
6593;100458405;1.483;204438;103344241;15149408;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;11-(3,3-Diphenylpropyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCC(C4=CC=CC=C4)C5=CC=CC=C5)NC6=CC=CC=C63
6594;342804586;1.492;1127667;242621882;56652775;10280;237346340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 opioid receptor (unknown origin);1-{3-[4-(substitutedphenyl)piperazin1-yl]propyl}-1 H-indole, 4b;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCN2C=CC3=CC=CC=C32)C4=CC=CC=C4F
6595;380657418;1.493;1880165;482082442;168294634;10280;354503690;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) assessed as inhibition constant;"6-chloro-1-(2,4,5-trimethoxyphenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC(=C(C=C1C2C3=C(CCN2)C4=C(N3)C=CC(=C4)Cl)OC)OC.Cl
6596;100550369;1.5;204463;103326343;10524644;10280;97034600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound is evaluated for binding affinity towards Sigma receptor using [3H]pentazocine in guinea pig brain;3-[[4-(2-Chlorophenyl)-1-piperazinyl]methyl]imidazo[1,2-c]quinazoline-5(6H)-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CC2=CN=C3N2C(=O)NC4=CC=CC=C43)C5=CC=CC=C5Cl
6597;100746555;1.5;204019;103336202;44341033;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-SKF-10047 binding to sigma receptor;"1-benzyl-N-phenyl-N-[(E)-3-phenylprop-2-enyl]piperidin-4-amine;(E)-but-2-enedioic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1N(C/C=C/C2=CC=CC=C2)C3=CC=CC=C3)CC4=CC=CC=C4.C(=C/C(=O)O)\C(=O)O
6598;366389685;1.5;1571915;440197289;155556618;10280;306053310;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma receptor 1 (unknown origin);(1S,2R,3S,4R,5S)-1-(chloromethyl)-4-[6-[di(cyclobutyl)methylamino]purin-9-yl]bicyclo[3.1.0]hexane-2,3-diol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC(C1)C(C2CCC2)NC3=C4C(=NC=N3)N(C=N4)[C@@H]5[C@H]6C[C@]6([C@H]([C@H]5O)O)CCl
6599;100604682;1.516;203857;103735235;14040442;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;N-Methyl-N-[(1S)-2alpha-(1-pyrrolidinyl)cyclohexan-1alpha-yl]thiophene-2-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@H]1CCCC[C@H]1N2CCCC2)C(=O)CC3=CC=CS3
6600;100745599;1.52;204454;103247624;15729897;10280;;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity towards sigma receptor by the displacement of [3H]PPP from guinea pig brain;4-Fluoro-N-{1-(4-fluoro-phenyl)-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butyl}-benzenesulfonamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC(C2=CC=C(C=C2)F)NS(=O)(=O)C3=CC=C(C=C3)F)C4=NC=C(C=N4)F
6601;100320359;1.54;204310;103252465;12259685;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 2 using [3H]- DTG in rat liver membranes;(+)-Pentazocine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;21070;Liver;C[C@@H]1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
6602;100451423;1.549;204436;103677634;45264688;10280;81026510;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using [3H]ditolylguanidine (DTG) as radioligand.;"N-methyl-4-phenyl-N-prop-2-enyl-1,2,3,4-tetrahydronaphthalen-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CN(CC=C)C1CC(C2=CC=CC=C2C1)C3=CC=CC=C3.Cl
6603;255014099;1.558;625223;103173542;4992;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pyrilamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)CCN(CC1=CC=C(C=C1)OC)C2=CC=CC=N2
6604;100471779;1.58489;203852;103196273;4910;10280;79901110;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;The compound was tested for affinity towards sigma-3 receptor;Proadifen;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)OCCN(CC)CC
6605;366437248;1.58489;1594273;440134995;45160790;10280;309043830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;5-((4-Fluorobenzyl)amino)-N,N-dimethyl-1-propyl-4,5,6,7-tetrahydro-1H-indazole-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCCN1C2=C(CC(CC2)NCC3=CC=C(C=C3)F)C(=N1)C(=O)N(C)C
6606;409049720;1.58489;1794447;440210612;155561913;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Nvs-malt1-C;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](C1=C(C=NC2=CC(=NN21)Cl)NC3=CC=C(C=C3)[C@H](C(F)(F)F)N(C)C(=O)C4CCS(=O)(=O)CC4)OC
6607;409049734;1.58489;1794447;440201576;155558331;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;MLi-2-NC;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(C[C@@H](O1)C)C2=NC=NC(=C2)C3=NN(C4=C3C=C(C=C4)OC5(CC5)C)C
6608;100742336;1.59;204020;103671739;45260725;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor using [3H]-(+)-SKF- 10,047;"5'-phenylspiro[1-azabicyclo[2.2.2]octane-3,2'-3H-pyran]-4'-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN2CCC1C3(C2)CC(=O)C(=CO3)C4=CC=CC=C4.Cl
6609;380796282;1.59368;1914028;440201576;155558331;10280;;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000706a SIGMAR1;MLi-2-NC;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(C[C@@H](O1)C)C2=NC=NC(=C2)C3=NN(C4=C3C=C(C=C4)OC5(CC5)C)C
6610;380821094;1.59368;1914632;440210612;155561913;10280;;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000747a SIGMAR1;Nvs-malt1-C;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](C1=C(C=NC2=CC(=NN21)Cl)NC3=CC=C(C=C3)[C@H](C(F)(F)F)N(C)C(=O)C4CCS(=O)(=O)CC4)OC
6611;409048617;1.59368;1794447;440201576;155558331;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;MLi-2-NC;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(C[C@@H](O1)C)C2=NC=NC(=C2)C3=NN(C4=C3C=C(C=C4)OC5(CC5)C)C
6612;409049719;1.59368;1794447;440210612;155561913;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;Nvs-malt1-C;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](C1=C(C=NC2=CC(=NN21)Cl)NC3=CC=C(C=C3)[C@H](C(F)(F)F)N(C)C(=O)C4CCS(=O)(=O)CC4)OC
6613;100623897;1.6;204627;103229417;3038603;10280;16745410;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;The compound was tested for binding affinity against sigma receptor using DTG as radioligand;Spiro(2-cyclohexene-1,5'-(5H)dibenzo(a,d)cyclohepten)-4-amine, 3'-chloro-N,N-dimethyl-, (1S,4R)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)C1CCC2(C=C1)C3=CC=CC=C3C=CC4=C2C=C(C=C4)Cl
6614;103125586;1.6;418680;103612796;44573261;10280;192431730;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor;6-Allyl-8-(4-methoxybenzyl)-6,8-diazabicyclo[3.2.2]nonan-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)CN2CC3CCC(=O)C2CN3CC=C
6615;100292961;1.606;239105;103442108;11360254;10280;156340210;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibitory constant against sigma receptor type 1 using 3 nM [3H]pentazocine;2-(4-Benzyl-piperidin-1-ylmethyl)-indan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC1CC2=CC=CC=C2)CC3CC4=CC=CC=C4C3=O
6616;100604307;1.609;203857;103735222;46878007;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;3-Nitro-N-methyl-N-[(1R)-2beta-(1-pyrrolidinyl)cyclohexan-1beta-yl]benzeneacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)CC3=CC(=CC=C3)[N+](=O)[O-]
6617;100458518;1.612;204438;103345010;15149384;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;N-[2-(9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3,5,7-tetraen-15-yl)ethyl]-2-(3,4-dichlorophenyl)-N-methylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCN1C2CCC1C3=C(C2)NC4=CC=CC=C43)C(=O)CC5=CC(=C(C=C5)Cl)Cl
6618;100448390;1.63;204471;103215587;44285702;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-Phenyl-6-[6-(2-pyrimidin-2-yl-piperazin-1-yl)-hexyloxy]-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(C(CN1)C2=NC=CC=N2)CCCCCCOC3=CC4=C(C=C3)OC(=CC4=O)C5=CC=CC=C5
6619;100619167;1.64;203990;136943212;54315083;10280;18482950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma opioid receptor in guinea pig cerebral homogenate using [3H]DTG as radioligand;Benzeneethanamine, alpha-methyl-N-propyl-, (alphaR)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN[C@H](C)CC1=CC=CC=C1
6620;255015209;1.658;625223;104234352;33036;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dexchlorpheniramine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CN(C)CC[C@@H](C1=CC=C(C=C1)Cl)C2=CC=CC=N2
6621;255016003;1.6615;625223;103261258;2484;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Butenafine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)C1=CC=C(C=C1)CN(C)CC2=CC=CC3=CC=CC=C32
6622;255012615;1.67;625223;103173037;21138;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dexpropranolol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)NC[C@H](COC1=CC=CC2=CC=CC=C21)O
6623;255023951;1.673;625223;103193303;5411;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Tetracaine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C
6624;255027922;1.696;625223;103282519;7594;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);1,3-Diphenylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC=C(C=C1)NC(=NC2=CC=CC=C2)N
6625;380313611;1.7;1822903;475982511;166627539;10280;351135560;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma 1 receptor (unknown origin) assessed as binding constant;4-[4-[(1S,5S)-8-hydroxy-3-azabicyclo[3.2.1]octan-8-yl]phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C[C@H]2CNC[C@H]1C2(C3=CC=C(C=C3)C4=C5C=CC(=CC5=CC(=C4)C(=O)O)C6=CC=C(C=C6)C(F)(F)F)O
6626;100320356;1.71;204310;103383077;44328085;10280;105798240;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity against Sigma opioid receptor type 2 using [3H]- DTG in rat liver membranes;(9S,13S)-10-benzyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;21070;Liver;C[C@@H]1[C@@H]2CC3=C(C1(CCN2CC4=CC=CC=C4)C)C=C(C=C3)O
6627;363665330;1.717;1415967;404703573;74767368;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;1-(2-Piperidin-1-ylethyl)-4-pyridin-4-ylpyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=NC=NC(=C3C=N2)C4=CC=NC=C4
6628;100461068;1.73;204456;103183412;398376;10280;80980660;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma receptor of guinea pig brain homogenates;1-Benzo[b]thiophen-2-yl-cyclopentylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(C1)(C2=CC3=CC=CC=C3S2)N
6629;100451418;1.733;204436;103672090;45260963;10280;81026510;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using [3H]ditolylguanidine (DTG) as radioligand.;"4-phenyl-N-prop-2-enyl-1,2,3,4-tetrahydronaphthalen-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C=CCNC1CC(C2=CC=CC=C2C1)C3=CC=CC=C3.Cl
6630;100459183;1.763;204437;103344153;15149392;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;11-(1-Butenyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC/C=C/N1C2CCC1C3=C(C2)NC4=CC=CC=C43
6631;100461065;1.767;204456;103168867;6468;10280;80980660;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma receptor of guinea pig brain homogenates;Phencyclidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)(C2=CC=CC=C2)N3CCCCC3
6632;100451177;1.788;204436;160708254;70697540;10280;81026510;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using [3H]ditolylguanidine (DTG) as radioligand.;"(2S,4R)-N,N,2-trimethyl-4-phenyl-3,4-dihydro-1H-naphthalen-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C[C@@]1(C[C@@H](C2=CC=CC=C2C1)C3=CC=CC=C3)N(C)C.Cl
6633;366389683;1.79;1571915;440112114;155512086;10280;306053310;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma receptor 1 (unknown origin);(1R,2R,3S,4R,5S)-4-[6-[di(cyclobutyl)methylamino]purin-9-yl]-1-(hydroxymethyl)bicyclo[3.1.0]hexane-2,3-diol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC(C1)C(C2CCC2)NC3=C4C(=NC=N3)N(C=N4)[C@@H]5[C@H]6C[C@]6([C@H]([C@H]5O)O)CO
6634;100440595;1.8;229192;103575820;5284595;10280;14696970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of specific binding of [3H]NANM of sigma binding site in Guinea pig brain membranes;Nalorphine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C=CCN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O
6635;100444339;1.8;204470;103215417;14982952;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(5-Dimethylamino-pentyloxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)CCCCCOC1=CC2=C(C=C1)OC(=CC2=O)C3=CC=CC=C3
6636;255021236;1.815;625223;103165317;3869;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Labetalol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
6637;409049738;1.8197;1794447;442048931;156011311;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;[9-(4-chloro-3-ethoxyphenyl)-3-oxa-7,9-diazabicyclo[3.3.1]nonan-7-yl]-[(2R,4S)-1-(4-chlorophenyl)-4-hydroxypyrrolidin-2-yl]methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC1=C(C=CC(=C1)N2C3CN(CC2COC3)C(=O)[C@H]4C[C@@H](CN4C5=CC=C(C=C5)Cl)O)Cl
6638;409049737;1.82852;1794447;442048931;156011311;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;[9-(4-chloro-3-ethoxyphenyl)-3-oxa-7,9-diazabicyclo[3.3.1]nonan-7-yl]-[(2R,4S)-1-(4-chlorophenyl)-4-hydroxypyrrolidin-2-yl]methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC1=C(C=CC(=C1)N2C3CN(CC2COC3)C(=O)[C@H]4C[C@@H](CN4C5=CC=C(C=C5)Cl)O)Cl
6639;100536580;1.83;204792;103373991;44357415;10280;94359030;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity was evaluated using [3H]pentazocine binding to sigma-1 receptor from guinea pig brain;9-{3-[4-(3-Isothiocyanato-propyl)-3,5-dimethyl-piperazin-1-yl]-propyl}-9H-carbazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1CN(CC(N1CCCN=C=S)C)CCCN2C3=CC=CC=C3C4=CC=CC=C42
6640;100741784;1.83;204020;103671695;45260705;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor using [3H]-(+)-SKF- 10,047;"8'-methyl-5-phenylspiro[3H-pyran-2,3'-8-azabicyclo[3.2.1]octane]-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2CCC1CC3(C2)CC(=O)C(=CO3)C4=CC=CC=C4.Cl
6641;363665327;1.834;1415967;404695734;74767291;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;2-[1-(2-Piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidin-4-yl]-1,3-thiazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=NC=NC(=C3C=N2)C4=NC=CS4
6642;100507181;1.85;204150;103345897;10851124;10280;87844550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from Sigma opioid receptor type 1 in guinea pig brain membrane;N-Methyl-2-(3-nitro-phenyl)-N-(2-pyrrolidin-1-yl-ethyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCN1CCCC1)C(=O)CC2=CC(=CC=C2)[N+](=O)[O-]
6643;100471355;1.86;204459;103299178;9835629;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N-(1-naphthyl)-N'-(m-tolyl)-N'-methylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC(=CC=C1)N(C)C(=NC2=CC=CC3=CC=CC=C32)N
6644;100451175;1.883;204436;103672017;45260913;10280;81026510;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using [3H]ditolylguanidine (DTG) as radioligand.;"(2R,4S)-N,N,2-trimethyl-4-phenyl-3,4-dihydro-1H-naphthalen-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C[C@]1(C[C@H](C2=CC=CC=C2C1)C3=CC=CC=C3)N(C)C.Cl
6645;389483966;1.892;1805386;444858103;132075285;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;TBD from US Patent US10954217: 'Sigma receptor binders';US10954217, Example Table 3.A31;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2=C(CN(C1)CC3=CC(=CC(=C3)Cl)Cl)C=C(C=C2)N4CCOCC4
6646;100458408;1.895;204438;103344228;13078350;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;5-Phenyl-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2)N(C4=CC=CC=C43)C5=CC=CC=C5
6647;100444334;1.9;204470;103215480;14982981;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-[6-(4-Oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)hexyloxy]-2-phenyl-4H-1-benzopyran-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CCCCCCOC4=CC5=C(C=C4)OC(=CC5=O)C6=CC=CC=C6
6648;100536560;1.947;204457;103673564;45262101;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(2,5-Dibromo-3-methylsulfinylphenyl)-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=C(C(=CC(=C2)Br)S(=O)C)Br)N.Cl
6649;366389688;1.97;1571915;440185901;155552117;10280;306053310;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma receptor 1 (unknown origin);(1S,2R,3S,4R,5S)-4-(6-amino-2-chloropurin-9-yl)-1-(chloromethyl)bicyclo[3.1.0]hexane-2,3-diol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@H]2[C@@]1([C@H]([C@H]([C@@H]2N3C=NC4=C(N=C(N=C43)Cl)N)O)O)CCl
6650;100617498;1.98;204450;103186537;69873;10280;16627250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;The compound was tested for its binding affinity towards sigma receptor in guinea pig brain membranes;4-Phenylpiperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CNCCC1C2=CC=CC=C2
6651;100471371;1.99;204459;103282947;22648;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N,N'-Bis(2-methoxyphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC=CC=C1NC(=NC2=CC=CC=C2OC)N
6652;100314847;2.0;204161;103311028;10567286;10280;104250950;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity against Sigma opioid receptor type 1 in guinea pig brain membranes using [3H](+)-pentazocine as radioligand;(4aR,6R,7R,8aR)-7-(4-Phenyl-piperidin-1-yl)-decahydro-quinolin-6-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C[C@@H]2C[C@H]([C@@H](C[C@H]2NC1)N3CCC(CC3)C4=CC=CC=C4)O
6653;100680633;2.0;204130;103178620;44270248;10280;119345760;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vitro binding affinity for Sigma opioid receptor by displacement of [3H]DTG;6-[2-((3R,5S)-3,5-Dimethyl-piperazin-1-yl)-ethyl]-3-methyl-3H-benzothiazol-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(C[C@@H](N1)C)CCC2=CC3=C(C=C2)N(C(=O)S3)C
6654;100963745;2.0;265275;103488450;11430856;10280;167226310;Confirmatory;20181020;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity to sigma receptor by radioligand binding assay;Naluzotan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)NC1=CC(=CC=C1)N2CCN(CC2)CCCCNS(=O)(=O)CC3CCCCC3
6655;100458327;2.005;204437;103344229;356862;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;11-Methyl-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohepta[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2CCC1C3=C(C2)NC4=CC=CC=C43
6656;100440514;2.06;229187;103188676;62751;10280;14696970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of specific binding of [125I]PIPAG to sigma receptor in Guinea pig brain membranes;Tenocyclidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)(C2=CC=CS2)N3CCCCC3
6657;100467871;2.09;204005;103325668;44336449;10280;79325350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;In vivo binding affinity against sigma Opioid receptor was measured by using labeled ligand [3H]-SKF- 10,047 (1 nM);(4aR,7aR,12bS)-9-Hydroxy-3-methyl-2,3,4,4a,5,6-hexahydro-1H-8-oxa-3-aza-benzo[d]fluoren-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@@]23[C@H](C1)CCC(=O)[C@@H]2OC4=C3C=CC=C4O
6658;100448339;2.1;204471;103215656;14982984;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(6-Amino-hexyloxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=CC(=C3)OCCCCCCN
6659;100471359;2.1;204459;103298968;10090882;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N''-Anthracen-1-yl-N-methyl-N-naphthalen-1-yl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(C1=CC=CC2=CC=CC=C21)C(=NC3=CC=CC4=CC5=CC=CC=C5C=C43)N
6660;100485163;2.1;204636;103575821;3037886;10280;76368600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured on Sigma receptor type 1 from guinea pig brain membranes using [3H]pentazocine as radioligand.;Methobenzmorphan;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@H]1[C@@H]2CC3=C([C@@]1(CCN2C)C)C=C(C=C3)O
6661;100604687;2.1;203857;103735234;14771405;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;N-methyl-N-[(1S,2R)-2-pyrrolidin-1-ylcyclohexyl]-2-thiophen-3-ylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@H]1CCCC[C@H]1N2CCCC2)C(=O)CC3=CSC=C3
6662;373839306;2.1;1759512;469825992;163198500;10280;338315600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma 1 receptor (unknown origin);6-Iodo-3-nitro-2-(trifluoromethyl)-2H-chromene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC2=C(C=C1I)C=C(C(O2)C(F)(F)F)[N+](=O)[O-]
6663;380313618;2.1;1822903;476000732;164585447;10280;351135560;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma 1 receptor (unknown origin) assessed as binding constant;4-[4-[(1R,4R,5R)-2-azabicyclo[2.2.1]heptan-5-yl]phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@H]2C[C@H]([C@@H]1CN2)C3=CC=C(C=C3)C4=C5C=CC(=CC5=CC(=C4)C(=O)O)C6=CC=C(C=C6)C(F)(F)F
6664;389536471;2.105;1805702;459092174;141643600;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';prop-2-enyl (1R,8R)-5-(4-methylpiperazin-1-yl)-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene-9-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)C2=CC3=C(C=C2)[C@@H]4CCN([C@@H]3C4)C(=O)OCC=C
6665;363476490;2.15;1353758;103520867;16202156;10280;294388910;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin);N-[4-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)butyl]-2-(2-(18F)fluoranylethoxy)-5-iodo-3-methoxybenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC(=CC(=C1OCC[18F])C(=O)NCCCCN2CCC3=CC(=C(C=C3C2)OC)OC)I
6666;100364893;2.17;229202;103339749;11047568;10280;115854440;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of sigma receptor;4-(3-Phenylpropyl)piperazine-1-carboxylic acid 4-ethoxyphenethyl ester;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC1=CC=C(C=C1)CCOC(=O)N2CCN(CC2)CCCC3=CC=CC=C3
6667;255031351;2.1705;625223;103458417;2467;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Buflomedil;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=CC(=C(C(=C1)OC)C(=O)CCCN2CCCC2)OC
6668;100471373;2.19;204459;103298966;9839973;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N-(1-naphthyl)-N'-(m-ethylphenyl)-N'-ethylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(CC)C(=NC2=CC=CC3=CC=CC=C32)N
6669;100614103;2.2;203986;103282947;22648;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N,N'-Bis(2-methoxyphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC=CC=C1NC(=NC2=CC=CC=C2OC)N
6670;354626047;2.2;1272497;336866867;127026014;10280;267502540;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin) by radioligand displacement assay;3-(3-Phenylpropyl)-1,2,4,5-tetrahydro-3-benzazepin-5-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CC(C2=CC=CC=C21)O)CCCC3=CC=CC=C3
6671;255027576;2.203;625223;103188158;5533;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Trazodone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
6672;100508508;2.22;204150;103345961;401804;10280;87844550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from Sigma opioid receptor type 1 in guinea pig brain membrane;2-(4-Methoxy-phenyl)-N-methyl-N-(2-pyrrolidin-1-yl-ethyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCN1CCCC1)C(=O)CC2=CC=C(C=C2)OC
6673;100461274;2.23;204456;103183221;398373;10280;80980660;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma receptor of guinea pig brain homogenates;2-(1-Piperidinocycloheptyl)benzo[b]thiophene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCCC(CC1)(C2=CC3=CC=CC=C3S2)N4CCCCC4
6674;103125583;2.24;418680;103612641;44573133;10280;192431730;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor;(2S)-6-allyl-8-(4-methoxybenzyl)-6,8-diazabicyclo[3.2.2]nonan-2-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)CN2CC3CC[C@@H](C2CN3CC=C)O
6675;255026029;2.246;625223;103224052;2247;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Astemizole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;COC1=CC=C(C=C1)CCN2CCC(CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)F
6676;340019678;2.25;752428;174491357;49853884;10280;236018160;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;2-[(8aS)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazin-2-yl]-N-cyclohexylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)NC(=O)CN2CCN3CCC[C@H]3C2
6677;255010649;2.255;625223;104234151;43815;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Paroxetine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
6678;151267137;2.28;452467;103716615;46225028;10280;199549720;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor;N-[(3-fluorophenyl)methyl]-5-oxahexacyclo[5.4.1.02,6.03,10.04,8.09,12]dodecan-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C2C3C4C1C5C2C6C3C4C5(O6)NCC7=CC(=CC=C7)F
6679;100471375;2.29;204459;103298114;9996818;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N-(3-Ethylphenyl)-N-methyl-N'-ethyl-N'-(1-naphthyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=N)N(CC)C2=CC=CC3=CC=CC=C32
6680;255014094;2.2935;625223;103195252;5002;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Quetiapine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
6681;388740713;2.3;1797293;386051317;118282884;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 74;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C=CC(=C3C2)F)F)O
6682;388886603;2.3;1797475;386051317;118282884;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 74;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C=CC(=C3C2)F)F)O
6683;389383951;2.3;1804286;386051317;118282884;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 74;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C=CC(=C3C2)F)F)O
6684;373790391;2.33;1750146;469812691;164585437;10280;337872730;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);3-[4-(Piperidine-4-carbonylamino)phenyl]-5-[4-[4-(trifluoromethyl)phenyl]triazol-1-yl]benzoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CNCCC1C(=O)NC2=CC=C(C=C2)C3=CC(=CC(=C3)N4C=C(N=N4)C5=CC=C(C=C5)C(F)(F)F)C(=O)O
6685;380523513;2.34;1849426;482059142;168277830;10280;363677490;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-LSD from human sigma1 receptor expressed in human HEK293T cell membrane incubated for 90 mins by radioligand binding assay;2-(1-bicyclo[3.3.1]nonanyl)-N-(3,4-dichlorophenyl)-3H-imidazo[4,5-c]quinolin-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2CCCC(C1)(C2)C3=NC4=C(N3)C(=NC5=CC=CC=C54)NC6=CC(=C(C=C6)Cl)Cl
6686;409047928;2.34423;1794447;440132040;154701643;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;[2-Amino-4-(trifluoromethoxy)phenyl]-[4-[2-methyl-7-(4-methylpiperazin-1-yl)pyrido[3,2-d]pyrimidin-4-yl]piperidin-1-yl]methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NC2=C(C(=N1)C3CCN(CC3)C(=O)C4=C(C=C(C=C4)OC(F)(F)F)N)N=CC(=C2)N5CCN(CC5)C
6687;380819157;2.36865;1914041;440132040;154701643;10280;;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000708a SIGMAR1;[2-Amino-4-(trifluoromethoxy)phenyl]-[4-[2-methyl-7-(4-methylpiperazin-1-yl)pyrido[3,2-d]pyrimidin-4-yl]piperidin-1-yl]methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NC2=C(C(=N1)C3CCN(CC3)C(=O)C4=C(C=C(C=C4)OC(F)(F)F)N)N=CC(=C2)N5CCN(CC5)C
6688;409047927;2.36865;1794447;440132040;154701643;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;[2-Amino-4-(trifluoromethoxy)phenyl]-[4-[2-methyl-7-(4-methylpiperazin-1-yl)pyrido[3,2-d]pyrimidin-4-yl]piperidin-1-yl]methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=NC2=C(C(=N1)C3CCN(CC3)C(=O)C4=C(C=C(C=C4)OC(F)(F)F)N)N=CC(=C2)N5CCN(CC5)C
6689;100604320;2.374;203857;103735231;46878015;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;4-Nitro-N-methyl-N-[(1R)-2beta-(1-pyrrolidinyl)cyclohexan-1beta-yl]benzeneacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)CC3=CC=C(C=C3)[N+](=O)[O-]
6690;380808676;2.398;1914999;440228548;155568985;10280;;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000340a SIGMAR1;(5R)-N-[4-(4-fluorophenoxy)phenyl]-5-(4-fluorophenyl)-7,8-dihydro-5H-1,6-naphthyridine-6-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN([C@@H](C2=C1N=CC=C2)C3=CC=C(C=C3)F)C(=O)NC4=CC=C(C=C4)OC5=CC=C(C=C5)F
6691;409048272;2.39828;1794447;440228548;155568985;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(5R)-N-[4-(4-fluorophenoxy)phenyl]-5-(4-fluorophenyl)-7,8-dihydro-5H-1,6-naphthyridine-6-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN([C@@H](C2=C1N=CC=C2)C3=CC=C(C=C3)F)C(=O)NC4=CC=C(C=C4)OC5=CC=C(C=C5)F
6692;409048273;2.39883;1794447;440228548;155568985;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(5R)-N-[4-(4-fluorophenoxy)phenyl]-5-(4-fluorophenyl)-7,8-dihydro-5H-1,6-naphthyridine-6-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN([C@@H](C2=C1N=CC=C2)C3=CC=C(C=C3)F)C(=O)NC4=CC=C(C=C4)OC5=CC=C(C=C5)F
6693;100778223;2.417;204017;103272869;44313208;10280;98735270;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for [3H]- pentazocine at sigma opioid receptor;(2R)-2-[(4R)-4-(5-aminopentyl)-3-benzyl-2,5-dioxoimidazolidin-1-yl]-N-benzylpentanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC[C@H](C(=O)NCC1=CC=CC=C1)N2C(=O)[C@H](N(C2=O)CC3=CC=CC=C3)CCCCCN
6694;380523510;2.42;1849426;482053284;168273532;10280;363677490;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-LSD from human sigma1 receptor expressed in human HEK293T cell membrane incubated for 90 mins by radioligand binding assay;2-[(1R,5S)-3-bicyclo[3.3.1]nonanyl]-N-(3,4-dichlorophenyl)-3H-imidazo[4,5-c]quinolin-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C[C@@H]2C[C@H](C1)CC(C2)C3=NC4=C(N3)C(=NC5=CC=CC=C54)NC6=CC(=C(C=C6)Cl)Cl
6695;99958794;2.427;204623;103167491;1220;10280;90834840;Confirmatory;20181015;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity against sigma receptor;8-OH-Dpat;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN(CCC)C1CCC2=C(C1)C(=CC=C2)O
6696;99958983;2.427;204624;103166970;2477;10280;90834840;Confirmatory;20181015;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity against sigma receptor.;Buspirone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4
6697;389536402;2.429;1805702;459092162;122576810;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';(1R,8R)-9-benzyl-5-piperidin-1-yl-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)C2=CC3=C(C=C2)[C@@H]4CCN([C@@H]3C4)CC5=CC=CC=C5
6698;408152965;2.5;1913869;440120698;134128280;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000250b SIGMAR1;(2-Amino-4-(trifluoromethoxy)phenyl)(4-(7-(4-methylpiperazin-1-yl)pyrido[3,2-d]pyrimidin-4-yl)piperidin-1-yl)methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)C2=CC3=C(C(=NC=N3)C4CCN(CC4)C(=O)C5=C(C=C(C=C5)OC(F)(F)F)N)N=C2
6699;409049349;2.50207;1794447;440120698;134128280;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(2-Amino-4-(trifluoromethoxy)phenyl)(4-(7-(4-methylpiperazin-1-yl)pyrido[3,2-d]pyrimidin-4-yl)piperidin-1-yl)methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)C2=CC3=C(C(=NC=N3)C4CCN(CC4)C(=O)C5=C(C=C(C=C5)OC(F)(F)F)N)N=C2
6700;366437101;2.51189;1594273;440181218;146597639;10280;309043830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;N,N-dimethyl-1-propyl-5-[2-[4-(trifluoromethyl)phenyl]ethylamino]-4,5,6,7-tetrahydroindazole-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCCN1C2=C(CC(CC2)NCCC3=CC=C(C=C3)C(F)(F)F)C(=N1)C(=O)N(C)C
6701;409049350;2.51189;1794447;440120698;134128280;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(2-Amino-4-(trifluoromethoxy)phenyl)(4-(7-(4-methylpiperazin-1-yl)pyrido[3,2-d]pyrimidin-4-yl)piperidin-1-yl)methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)C2=CC3=C(C(=NC=N3)C4CCN(CC4)C(=O)C5=C(C=C(C=C5)OC(F)(F)F)N)N=C2
6702;255013729;2.518;625223;103241510;36811;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dobutamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
6703;100536808;2.535;204457;103673565;60839;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;Aptiganel hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=CC=CC3=CC=CC=C32)N.Cl
6704;100471342;2.54;204459;103298772;60840;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;Aptiganel;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=CC=CC3=CC=CC=C32)N
6705;100604186;2.593;203857;103735239;14771399;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;N-Methyl-N-[(1S)-2alpha-(1-pyrrolidinyl)cyclohexan-1alpha-yl]naphthalene-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@H]1CCCC[C@H]1N2CCCC2)C(=O)C3=CC=CC4=CC=CC=C43
6706;255014873;2.5992;625223;103274161;4746;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Perhexiline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3
6707;380313612;2.6;1822903;475982545;164585550;10280;351135560;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma 1 receptor (unknown origin) assessed as binding constant;4-[4-[(1S,4S,6R)-3-oxo-2-azabicyclo[2.2.1]heptan-6-yl]phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@H]2C[C@@H]([C@H]1C3=CC=C(C=C3)C4=C5C=CC(=CC5=CC(=C4)C(=O)O)C6=CC=C(C=C6)C(F)(F)F)NC2=O
6708;255027937;2.61;625223;103188808;4932;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Propafenone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
6709;100471326;2.64;204459;103298714;10358634;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;1-(3-Nitrophenyl)-3-(1-naphthyl)-3-methylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(C1=CC=CC2=CC=CC=C21)C(=NC3=CC(=CC=C3)[N+](=O)[O-])N
6710;100458519;2.65;204438;103344229;356862;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;11-Methyl-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohepta[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C2CCC1C3=C(C2)NC4=CC=CC=C43
6711;100604684;2.67;203857;103735205;46877996;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;N-Methyl-N-[(1R)-2beta-(1-pyrrolidinyl)cyclohexan-1beta-yl]-3,4,5-trimethoxybenzenepropanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)CCC3=CC(=C(C(=C3)OC)OC)OC
6712;373790389;2.68;1750146;469812867;164585602;10280;337872730;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);4-[4-[5-(Hydroxymethyl)-1,2-oxazol-3-yl]phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC(=CC=C1C2=C3C=CC(=CC3=CC(=C2)C(=O)O)C4=CC=C(C=C4)C(F)(F)F)C5=NOC(=C5)CO
6713;100471365;2.7;204459;103298992;9994390;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;1-(3-Aminophenyl)-3-(1-naphthyl)-1-methylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(C1=CC=CC(=C1)N)C(=NC2=CC=CC3=CC=CC=C32)N
6714;100461069;2.71;204456;103183252;14952700;10280;80980660;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma receptor of guinea pig brain homogenates;1-(1-Benzo[b]thiophen-2-yl-cycloheptyl)-azepane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCCC(CC1)(C2=CC3=CC=CC=C3S2)N4CCCCCC4
6715;100617218;2.72;204444;103183489;1342;10280;16627250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membranes using [3H]DTG as radioligand;1-Naphthylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1)C2=CC=CC3=CC=CC=C32
6716;100470626;2.733;204469;103340185;12371111;10280;79325690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition against sigma receptor using displacement of 3 nM [3H]pentazocine in homogenate of guinea pig brain cerebellum;(1R,13S)-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C[C@@H]1C2CC3=C([C@@]1(CCN2)C)C=C(C=C3)O
6717;100471339;2.74;204459;103299108;10064346;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;1-(3-Azidophenyl)-3-(1-naphthyl)-3-methylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(C1=CC=CC2=CC=CC=C21)C(=NC3=CC(=CC=C3)N=[N+]=[N-])N
6718;380834115;2.74031;1915217;381872584;121301295;10280;;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000264b SIGMAR1;CFTR corrector 4;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(C=C1)[C@@H](C[C@@H](O2)C3=CC(=C(C=C3)OC)OC)NC(=O)C4(CC4)C5=CC6=C(C=C5)OC(O6)(F)F
6719;409047172;2.74031;1794447;381840647;121301422;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;CFTR corrector 8;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(C=C1)[C@H](C[C@H](O2)C3=CC(=C(C=C3)OC)OC)NC(=O)C4(CC4)C5=CC6=C(C=C5)OC(O6)(F)F
6720;100458318;2.75;204437;103344901;15149393;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;11-Benzyl-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CC4=CC=CC=C4)NC5=CC=CC=C53
6721;409047173;2.75423;1794447;381840647;121301422;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;CFTR corrector 8;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(C=C1)[C@H](C[C@H](O2)C3=CC(=C(C=C3)OC)OC)NC(=O)C4(CC4)C5=CC6=C(C=C5)OC(O6)(F)F
6722;100451371;2.755;204435;103290531;15657219;10280;81026510;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using the novel [3H]-(+/-)-4 as radioligand;Dimethyl-(1-phenyl-1,2,3,4-tetrahydro-naphthalen-2-yl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CN(C)[C@H]1CCC2=CC=CC=C2[C@H]1C3=CC=CC=C3
6723;388740024;2.8;1797293;386051289;118282889;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 45;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=C(C2)C=C(C=C3)F
6724;388878695;2.8;1797475;386051289;118282889;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 45;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=C(C2)C=C(C=C3)F
6725;389383277;2.8;1804286;386051289;118282889;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 45;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=C(C2)C=C(C=C3)F
6726;255018206;2.801;625223;103590321;91536;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)NC[C@@H](COC1=CC=CC2=CC=CC=C21)O
6727;100439966;2.85;229188;103575820;5284595;10280;14696970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of specific binding of [3H]3-PPP to sigma binding site in Guinea pig brain membranes;Nalorphine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C=CCN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O
6728;409049360;2.85233;1794447;475994610;166633549;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;[(1R)-3-(3,4-dimethoxyphenyl)-1-[3-(2-morpholin-4-ylethoxy)phenyl]propyl] (2R)-1-[(2R)-2-cyclohexyl-2-(3,4,5-trimethoxyphenyl)acetyl]piperidine-2-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=C(C=C1)CC[C@H](C2=CC(=CC=C2)OCCN3CCOCC3)OC(=O)[C@H]4CCCCN4C(=O)[C@H](C5CCCCC5)C6=CC(=C(C(=C6)OC)OC)OC)OC
6729;255028641;2.87;625223;103164951;4946;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Propranolol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O
6730;372355914;2.87;1726849;461543042;141317764;10280;342231650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]pentazocine from human sigma 1 receptor expressed in HEK293 cell membrane incubated for 2 hrs by liquid scintillation counting method;6-(2-Pyrrolidin-1-ylethoxy)chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(C1)CCOC2=CC3=C(C=C2)OC=CC3=O
6731;409049361;2.88403;1794447;475994610;166633549;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;[(1R)-3-(3,4-dimethoxyphenyl)-1-[3-(2-morpholin-4-ylethoxy)phenyl]propyl] (2R)-1-[(2R)-2-cyclohexyl-2-(3,4,5-trimethoxyphenyl)acetyl]piperidine-2-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=C(C=C1)CC[C@H](C2=CC(=CC=C2)OCCN3CCOCC3)OC(=O)[C@H]4CCCCN4C(=O)[C@H](C5CCCCC5)C6=CC(=C(C(=C6)OC)OC)OC)OC
6732;100461278;2.89;204456;103183223;608630;10280;80980660;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma receptor of guinea pig brain homogenates;1-(1-Benzo[b]thiophen-2-yl-cyclopentyl)-azepane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCCN(CC1)C2(CCCC2)C3=CC4=CC=CC=C4S3
6733;100471331;2.9;204459;103299107;9970628;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;1-(1-Naphthyl)-3-methyl-3-phenylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(C1=CC=CC=C1)C(=NC2=CC=CC3=CC=CC=C32)N
6734;403018498;2.9;1920070;488871657;118600037;10280;;Confirmatory;20240403;0;0;Active;Q99720;Ki;;BindingDB;In-Vitro Binding Assay from US Patent US20230390272: 'USE OF PRIDOPIDINE AND ANALOGS FOR THE TREATMENT OF ANXIETY AND DEPRESSION';(3R,4S)-4-(3-methylsulfonylphenyl)-1-propylpiperidin-3-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CC[C@H]([C@H](C1)O)C2=CC(=CC=C2)S(=O)(=O)C
6735;403024132;2.9;1920119;488875379;170795471;10280;;Confirmatory;20240403;0;0;Active;Q99720;Ki;;BindingDB;In-Vitro Binding Assay from US Patent US20230414596: 'USE OF PRIDOPIDINE AND ANALOGS FOR TREATING RETT SYNDROME';(3S)-4-(3-methylsulfonylphenyl)-1-propylpiperidin-3-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN1CCC([C@@H](C1)O)C2=CC(=CC=C2)S(=O)(=O)C
6736;363665325;2.915;1415967;404718821;74767365;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;1-(2-Piperidin-1-ylethyl)-4-(1-propan-2-ylpyrazol-4-yl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)N1C=C(C=N1)C2=C3C=NN(C3=NC=N2)CCN4CCCCC4
6737;100708101;2.932;204146;103252213;11488451;10280;146843270;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma opioid receptor of guiena pig brain membrane;N-[2-(6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-yl)ethyl]-2,3-dimethoxy-5-bromobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC(=CC(=C1OC)C(=O)NCCN2CCC3=CC(=C(C=C3C2)OC)OC)Br
6738;342804582;2.932;1127667;103252213;11488451;10280;237346340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 opioid receptor (unknown origin);N-[2-(6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-yl)ethyl]-2,3-dimethoxy-5-bromobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC(=CC(=C1OC)C(=O)NCCN2CCC3=CC(=C(C=C3C2)OC)OC)Br
6739;389536381;2.975;1805702;459092160;122576836;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';4-[(1R,8R)-9-[(3,5-dichlorophenyl)methyl]-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-trien-5-yl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN([C@@H]2C[C@@H]1C3=C2C=C(C=C3)N4CCOCC4)CC5=CC(=CC(=C5)Cl)Cl
6740;204392935;2.98;577016;124965644;9917021;10280;212299830;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor;Casopitant;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC(=C1)F)[C@H]2C[C@H](CCN2C(=O)N(C)[C@H](C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)N4CCN(CC4)C(=O)C
6741;409047504;3.01995;1794447;461563589;162677478;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;1-[4-[(S)-[4-chloro-2-methoxy-3-[(4-pyrazol-1-ylphenyl)methyl]quinolin-6-yl]-hydroxy-phenylmethyl]piperidin-1-yl]ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)N1CCC(CC1)[C@](C2=CC=CC=C2)(C3=CC4=C(C=C3)N=C(C(=C4Cl)CC5=CC=C(C=C5)N6C=CC=N6)OC)O
6742;100471321;3.02;204459;103299078;192277;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N-(3-Azidophenyl)-N-methyl-N'-1-naphthylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(C1=CC=CC(=C1)N=[N+]=[N-])C(=NC2=CC=CC3=CC=CC=C32)N
6743;380523515;3.02;1849426;482048801;168270412;10280;363677490;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-LSD from human sigma1 receptor expressed in human HEK293T cell membrane incubated for 90 mins by radioligand binding assay;2-cyclododecyl-N-(3,4-dichlorophenyl)-3H-imidazo[4,5-c]quinolin-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCCCCC(CCCCC1)C2=NC3=C(N2)C(=NC4=CC=CC=C43)NC5=CC(=C(C=C5)Cl)Cl
6744;389536470;3.039;1805702;459092164;122576802;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';(1R,8R)-5-(1,3-benzodioxol-5-yl)-9-benzyl-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN([C@@H]2C[C@@H]1C3=C2C=C(C=C3)C4=CC5=C(C=C4)OCO5)CC6=CC=CC=C6
6745;100458410;3.044;204438;103344213;15149413;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;5-Fluoro-15-[(2-iodophenyl)methyl]-9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3(8),4,6-tetraene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CC4=CC=CC=C4I)NC5=C3C=C(C=C5)F
6746;255027573;3.055;625223;103175608;5994;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Progesterone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C
6747;342797731;3.063;1143314;242636022;90643604;10280;248213980;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin);3-[(1S,5R,8Z)-8-benzylidene-2-methyl-2-azabicyclo[3.3.1]nonan-5-yl]phenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@@]2(CC/C(=C/C3=CC=CC=C3)/[C@@H]1C2)C4=CC(=CC=C4)O
6748;342804598;3.063;1127667;242622244;90654977;10280;237346340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 opioid receptor (unknown origin);(1R,5R,8E)-5-(3-hydroxyphenyl)-8-[(3-hydroxyphenyl)methylidene]-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@]2(C[C@@H]1/C(=C\C3=CC(=CC=C3)O)/C(=O)C2)C4=CC(=CC=C4)O
6749;100708103;3.078;204146;103252283;11165837;10280;146843270;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma opioid receptor of guiena pig brain membrane;N-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-2-methoxy-5-methylbenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=C(C=C1)OC)C(=O)NCCCCN2CCC3=CC(=C(C=C3C2)OC)OC
6750;342804589;3.078;1127667;103252283;11165837;10280;237346340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 opioid receptor (unknown origin);N-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-2-methoxy-5-methylbenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=C(C=C1)OC)C(=O)NCCCCN2CCC3=CC(=C(C=C3C2)OC)OC
6751;363476484;3.078;1353758;103252283;11165837;10280;294388910;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin);N-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-2-methoxy-5-methylbenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=C(C=C1)OC)C(=O)NCCCCN2CCC3=CC(=C(C=C3C2)OC)OC
6752;100507187;3.1;204150;103346094;401808;10280;87844550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from Sigma opioid receptor type 1 in guinea pig brain membrane;2-(3-Methoxy-phenyl)-N-methyl-N-(2-pyrrolidin-1-yl-ethyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCN1CCCC1)C(=O)CC2=CC(=CC=C2)OC
6753;409047503;3.12558;1794447;461563589;162677478;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;1-[4-[(S)-[4-chloro-2-methoxy-3-[(4-pyrazol-1-ylphenyl)methyl]quinolin-6-yl]-hydroxy-phenylmethyl]piperidin-1-yl]ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)N1CCC(CC1)[C@](C2=CC=CC=C2)(C3=CC4=C(C=C3)N=C(C(=C4Cl)CC5=CC=C(C=C5)N6C=CC=N6)OC)O
6754;365267540;3.16228;1512456;440221484;146709966;10280;316202300;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3S,4S)-4-ethyl-3-methyl-2,4-dihydrobenzo[h]chromen-3-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC[C@H]1C2=C(C3=CC=CC=C3C=C2)OC[C@@]1(C)N
6755;100461067;3.17;204456;103183157;398415;10280;80980660;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma receptor of guinea pig brain homogenates;1-(1-Benzothiophen-2-yl)cyclohexan-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCC(CC1)(C2=CC3=CC=CC=C3S2)N
6756;112851453;3.2;204465;163315788;45489962;10280;79325400;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma receptor of guinea pig brain;(1R,5S,8E)-8-[(3,4-dichlorophenyl)methylidene]-5-(3-hydroxyphenyl)-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@@]2(C[C@@H]1/C(=C\C3=CC(=C(C=C3)Cl)Cl)/C(=O)C2)C4=CC(=CC=C4)O
6757;380313617;3.2;1822903;475981459;164585387;10280;351135560;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma 1 receptor (unknown origin) assessed as binding constant;4-[4-[(1R,4R,5R)-3-oxo-2-azabicyclo[2.2.1]heptan-5-yl]phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@@H]2C[C@H]([C@@H]1C3=CC=C(C=C3)C4=C5C=CC(=CC5=CC(=C4)C(=O)O)C6=CC=C(C=C6)C(F)(F)F)C(=O)N2
6758;408049184;3.2;1960000;103315491;44330991;10280;299084420;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma 1 receptor (unknown origin);(1S,9R,13R)-1,13-dimethyl-10-prop-2-enyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1[C@H]2CC3=C([C@]1(CCN2CC=C)C)C=C(C=C3)O
6759;340019675;3.25;752428;174496402;49855131;10280;236018160;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;N-cyclohexyl-2-(4-methyl-1,4-diazepan-1-yl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCCN(CC1)CC(=O)NC2CCCCC2
6760;100604680;3.267;203857;103735203;46877994;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;1-(3,4-Dichlorophenyl)-3-methyl-3-[(1R)-2beta-(1-pyrrolidinyl)cyclohexan-1beta-yl]thiourea;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=S)NC3=CC(=C(C=C3)Cl)Cl
6761;100721054;3.3;204634;103237093;44296665;10280;150260770;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma receptor type 1;2-[(4aS,10aR)-6-methoxy-2,3,4,10a-tetrahydro-1H-phenanthren-4a-yl]ethyl-dimethyl-[(2-methylpropan-2-yl)oxycarbonyl]azanium;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC(=O)[N+](C)(C)CC[C@@]12CCCC[C@@H]1C=CC3=C2C=C(C=C3)OC
6762;100721059;3.3;204634;103237061;44296645;10280;150260770;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma receptor type 1;[2-((4aS,10aR)-6-Methoxy-1,3,4,10a-tetrahydro-2H-phenanthren-4a-yl)-ethyl]-methyl-carbamic acid ethyl ester;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC(=O)N(C)CC[C@@]12CCCC[C@@H]1C=CC3=C2C=C(C=C3)OC
6763;100451372;3.305;204435;103672125;45260987;10280;81026510;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using the novel [3H]-(+/-)-4 as radioligand;4-phenyl-2-aminotetraline HCl;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1C(CC2=CC=CC=C2C1C3=CC=CC=C3)N.Cl
6764;100459186;3.332;204437;103344491;15149416;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;2-[3-(5-Fluoro-9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3(8),4,6-tetraen-15-yl)propyl]isoindole-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCCN4C(=O)C5=CC=CC=C5C4=O)NC6=C3C=C(C=C6)F
6765;100451419;3.342;204436;103290531;15657219;10280;81026510;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using [3H]ditolylguanidine (DTG) as radioligand.;Dimethyl-(1-phenyl-1,2,3,4-tetrahydro-naphthalen-2-yl)-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CN(C)[C@H]1CCC2=CC=CC=C2[C@H]1C3=CC=CC=C3
6766;100536563;3.378;204457;103673528;45262076;10280;94358970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding assay for the sigma receptor sites is performed by utilizing [3H]N,N-di-o-tolylguanidine ([3H]DTG) and guinea pig brain membrane suspensions;"2-(2,5-Dibromo-3-methylsulfonylphenyl)-1-(3-ethylphenyl)-1-methylguanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCC1=CC(=CC=C1)N(C)C(=NC2=C(C(=CC(=C2)Br)S(=O)(=O)C)Br)N.Cl
6767;409049723;3.38844;1794447;461563597;162677482;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(3S)-N-[5-(2-azidoacetyl)-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl]-1-cyanopyrrolidine-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(C[C@H]1C(=O)NC2=NC3=C(S2)CN(CC3)C(=O)CN=[N+]=[N-])C#N
6768;100451422;3.4;204436;103672153;45261009;10280;81026510;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using [3H]ditolylguanidine (DTG) as radioligand.;"(6R,8S)-3-chloro-6-(dimethylamino)-8-phenyl-5,6,7,8-tetrahydronaphthalen-2-ol;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CN(C)[C@@H]1C[C@H](C2=CC(=C(C=C2C1)Cl)O)C3=CC=CC=C3.Cl
6769;409049722;3.42951;1794447;461563597;162677482;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;GPCRScan assay: inhibition of Sigma 1;(3S)-N-[5-(2-azidoacetyl)-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridin-2-yl]-1-cyanopyrrolidine-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(C[C@H]1C(=O)NC2=NC3=C(S2)CN(CC3)C(=O)CN=[N+]=[N-])C#N
6770;363476486;3.45;1353758;242100117;17758676;10280;294388910;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin);1-cyclohexyl-4-[3-(9H-carbazol-9-yl)propyl]piperazine hydrochloride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)N2CCN(CC2)CCCN3C4=CC=CC=C4C5=CC=CC=C53
6771;100627928;3.46737;204453;103677042;45264274;10280;13179220;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro for the binding affinity against sigma receptor by using [3H]DTG as radioligand in guinea pig cerebellum;"9-methoxy-3-methyl-2,4,5,6-tetrahydro-1H-benzo[f]isoquinoline;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CN1CCC2=C(C1)CCC3=C2C=C(C=C3)OC.Cl
6772;100614108;3.5;203986;103671877;2817952;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;1-Phenyl-4,5-dihydro-1h-imidazol-2-amine hydrobromide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(C(=N1)N)C2=CC=CC=C2.Br
6773;100742364;3.5;203992;103671673;45260696;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"2-Phenyl-1-oxa-9-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2(CNC1)C(=O)C=C(O2)C3=CC=CC=C3.Cl
6774;100745608;3.5;204454;103247662;15729922;10280;;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro binding affinity towards sigma receptor by the displacement of [3H]PPP from guinea pig brain;Benzoic acid 1-(4-fluoro-phenyl)-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butyl ester;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCC(C2=CC=C(C=C2)F)OC(=O)C3=CC=CC=C3)C4=NC=C(C=N4)F
6775;372112206;3.5;1676737;461539738;162660757;10280;329441460;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma 1 receptor incubated for 120 mins by scintillation counting analysis relative to control;6-Fluoro-4-[4-(2-fluorophenyl)piperazin-1-yl]-8-(trideuteriomethoxy)quinoline-3-carbonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;[2H]C([2H])([2H])OC1=CC(=CC2=C(C(=CN=C12)C#N)N3CCN(CC3)C4=CC=CC=C4F)F
6776;373973732;3.5;1784789;469818524;90469115;10280;344677650;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to human sigma 1 receptor;1-(3-Fluorophenyl)sulfonyl-4-piperazin-1-ylpyrrolo[3,2-c]quinoline;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1)C2=NC3=CC=CC=C3C4=C2C=CN4S(=O)(=O)C5=CC=CC(=C5)F
6777;389536410;3.519;1805702;459092163;122576835;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';(1R,8R)-9-[(3-chlorophenyl)methyl]-5-piperidin-1-yl-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)C2=CC3=C(C=C2)[C@@H]4CCN([C@@H]3C4)CC5=CC(=CC=C5)Cl
6778;409047176;3.54813;1794447;404661187;131953432;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;[3,5-bis(trifluoromethyl)phenyl]methyl (1~{S},5~{R})-6-[(1~{H}-benzotriazol-5-ylcarbonylamino)methyl]-3-azabicyclo[3.1.0]hexane-3-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@@H]2[C@@H](C2CNC(=O)C3=CC4=NNN=C4C=C3)CN1C(=O)OCC5=CC(=CC(=C5)C(F)(F)F)C(F)(F)F
6779;409047175;3.55158;1794447;404661187;131953432;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;[3,5-bis(trifluoromethyl)phenyl]methyl (1~{S},5~{R})-6-[(1~{H}-benzotriazol-5-ylcarbonylamino)methyl]-3-azabicyclo[3.1.0]hexane-3-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@@H]2[C@@H](C2CNC(=O)C3=CC4=NNN=C4C=C3)CN1C(=O)OCC5=CC(=CC(=C5)C(F)(F)F)C(F)(F)F
6780;100458523;3.56;204438;103344152;15149390;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;11-Ethyl-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C2CCC1C3=C(C2)NC4=CC=CC=C43
6781;366461878;3.57;1606849;440212108;155562467;10280;322715690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-Pentazocine from sigma 1 receptor (unknown origin) measured after 90 mins by microbeta counting analysis;(1R,2R,3S,4R,5S)-4-[6-[2-(4-hydroxy-3-methoxyphenyl)ethylamino]-2-(2-phenylethynyl)purin-9-yl]bicyclo[3.1.0]hexane-2,3-diol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=CC(=C1)CCNC2=C3C(=NC(=N2)C#CC4=CC=CC=C4)N(C=N3)[C@@H]5[C@H]6C[C@H]6[C@H]([C@H]5O)O)O
6782;100478673;3.6;204468;103389930;44364124;10280;81642640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Tested for binding affinity against sigma receptors;13-Methyl-10-prop-2-enyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CCN(C1CC3=C2C=C(C=C3)O)CC=C
6783;388740264;3.6;1797293;386051292;118282882;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 48;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=CC(=C(C=C3C2)OC)OC
6784;388879041;3.6;1797475;386051292;118282882;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 48;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=CC(=C(C=C3C2)OC)OC
6785;389383662;3.6;1804286;386051292;118282882;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 48;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)OCCO)OC)N2CC3=CC(=C(C=C3C2)OC)OC
6786;100778227;3.63;204017;103272949;44313246;10280;98735270;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for [3H]- pentazocine at sigma opioid receptor;(2R)-2-[(4R)-4-(5-aminopentyl)-3-benzyl-2,5-dioxoimidazolidin-1-yl]-3-cyclohexylpropanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)C[C@H](C(=O)N)N2C(=O)[C@H](N(C2=O)CC3=CC=CC=C3)CCCCCN
6787;100513221;3.64;229197;103384823;10841374;10280;89413830;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor using radioligand ([3H](+)-pentazocine) binding assay;(2S,5R)-1,4-Bis-{2-[bis-(4-fluoro-phenyl)-methoxy]-ethyl}-2,5-dimethyl-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN([C@H](CN1CCOC(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)C)CCOC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F
6788;100604319;3.65;203857;103735200;46877992;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;3,4-Dichloro-N-methyl-N-[(1R)-2beta-(1-pyrrolidinyl)cyclohexan-1beta-yl]cinnamamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)/C=C/C3=CC(=C(C=C3)Cl)Cl
6789;100444346;3.7;204470;103215656;14982984;10280;13158690;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;6-(6-Amino-hexyloxy)-2-phenyl-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=CC(=C3)OCCCCCCN
6790;100440013;3.72;204464;103383777;3081049;10280;14696990;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was evaluated for its ability to displace [3H](+)-pentazocine from sigma receptor in Guinea pig brain;3-Phenyl-3-(N-piperidinyl)bicyclo(3.1.0)hexane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)C2(C[C@H]3C[C@H]3C2)C4=CC=CC=C4
6791;389536406;3.777;1805702;384583211;137646151;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';4-[(1R,8R)-9-benzyl-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-trien-5-yl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN([C@@H]2C[C@@H]1C3=C2C=C(C=C3)N4CCOCC4)CC5=CC=CC=C5
6792;100617148;3.8;203985;103282947;22648;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N,N'-Bis(2-methoxyphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC=CC=C1NC(=NC2=CC=CC=C2OC)N
6793;100458314;3.84;204437;103344152;15149390;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;11-Ethyl-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C2CCC1C3=C(C2)NC4=CC=CC=C43
6794;100458566;3.95;204441;103211569;15149426;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;compound was tested for binding affinity against sigma sites in guinea pig membrane using [3H]- -(+) -3-PPP as the radioligand;5,6,7,8,9,10-Hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2)NC4=CC=CC=C43
6795;255016002;3.9533;625223;103261258;2484;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Butenafine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)(C)C1=CC=C(C=C1)CN(C)CC2=CC=CC3=CC=CC=C32
6796;255012614;3.974;625223;103173037;21138;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Dexpropranolol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)NC[C@H](COC1=CC=CC2=CC=CC=C21)O
6797;100439807;4.0;229190;103575820;5284595;10280;14696970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of specific binding of [3H]DTG to sigma binding site in Guinea pig brain membranes;Nalorphine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C=CCN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O
6798;100550370;4.0;204463;103266881;135559170;10280;97034600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound is evaluated for binding affinity towards Sigma receptor using [3H]pentazocine in guinea pig brain;2-[[4-(2-Methoxyphenyl)piperazin-1-yl]methyl]-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1N2CCN(CC2)CC3CN4C(=C5C=CC=CC5=NC4=O)N3
6799;100741872;4.0;203992;103679650;45266092;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"3-(4-Fluorophenyl)-8-methyl-1-oxa-8-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN1CCC2(CC1)C(=O)C(=CO2)C3=CC=C(C=C3)F.Cl
6800;380313614;4.0;1822903;475994825;166633661;10280;351135560;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma 1 receptor (unknown origin) assessed as binding constant;4-[4-[(1R,2S,4R)-5-methylsulfonyl-2-bicyclo[2.2.1]heptanyl]phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CS(=O)(=O)C1C[C@H]2C[C@@H]1C[C@@H]2C3=CC=C(C=C3)C4=C5C=CC(=CC5=CC(=C4)C(=O)O)C6=CC=C(C=C6)C(F)(F)F
6801;100513120;4.001;229197;103384361;10650002;10280;89413830;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor using radioligand ([3H](+)-pentazocine) binding assay;(2S,5R)-1,4-Bis-(2-benzhydryloxy-ethyl)-2,5-dimethyl-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN([C@H](CN1CCOC(C2=CC=CC=C2)C3=CC=CC=C3)C)CCOC(C4=CC=CC=C4)C5=CC=CC=C5
6802;100458422;4.007;204437;103344241;15149408;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;11-(3,3-Diphenylpropyl)-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCC(C4=CC=CC=C4)C5=CC=CC=C5)NC6=CC=CC=C63
6803;100614382;4.1;203986;103283926;12628908;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;3-Phenyl-3,4-dihydro-quinazolin-2-ylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1C2=CC=CC=C2N=C(N1C3=CC=CC=C3)N
6804;100741879;4.15;203992;103671611;45260666;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"5'-Phenylspiro[1-azabicyclo[2.2.2]octane-3,2'-furan]-3'-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN2CCC1C3(C2)C(=O)C=C(O3)C4=CC=CC=C4.Cl
6805;363912523;4.2;1464173;381840698;137634153;10280;288708020;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]prazosin from human sigma1 receptor;8-Piperazin-1-yl-2,3-dihydro-1,4-benzodioxin-5-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1)C2=C3C(=C(C=C2)O)OCCO3
6806;380313616;4.2;1822903;475980514;166626545;10280;351135560;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma 1 receptor (unknown origin) assessed as binding constant;4-[4-[(1R,4R,5R)-2-acetyl-2-azabicyclo[2.2.1]heptan-5-yl]phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)N1C[C@@H]2C[C@H]1C[C@H]2C3=CC=C(C=C3)C4=C5C=CC(=CC5=CC(=C4)C(=O)O)C6=CC=C(C=C6)C(F)(F)F
6807;100417472;4.295;204631;103408788;10069973;10280;125703870;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity of compound was tested for Sigma receptor type 1;6-(4-Benzo[d]isoxazol-3-yl-piperazin-1-yl)-1-(2-methoxy-phenyl)-hexan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1C(=O)CCCCCN2CCN(CC2)C3=NOC4=CC=CC=C43
6808;100468912;4.3;204625;103389930;44364124;10280;79325690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against sigma receptor was determined;13-Methyl-10-prop-2-enyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1C2CCN(C1CC3=C2C=C(C=C3)O)CC=C
6809;100561756;4.3;204461;103170825;5073;10280;98761100;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured at the sigma receptor by the inhibition of [3H]-3-PPP binding to guinea pig cerebellum using unlabeled 3-PPP for nonspecific binding.;Risperidone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
6810;100386150;4.4;204153;103378194;14976641;10280;117841480;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Sigma opioid receptor type 1 affinity in guinea pig brain by employing [3H](+)-pentazocine as radioligand.;3-Methoxy-1'-methylspiro[isochroman-1,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1)C3=CC=CC=C3CC(O2)OC
6811;373839307;4.4;1759512;469811652;164618319;10280;338315600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma 1 receptor (unknown origin);N-[3-[3-nitro-2-(trifluoromethyl)-2H-chromen-6-yl]prop-2-ynyl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)NCC#CC1=CC2=C(C=C1)OC(C(=C2)[N+](=O)[O-])C(F)(F)F
6812;100403486;4.42;204630;103294972;44321499;10280;128012230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma receptor type 1 was determined by the displacement of [3H]pentazocine radioligand;3,6-Dibromo-9-[3-(3,5-dimethyl-piperazin-1-yl)-propyl]-9H-carbazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(C[C@H](N1)C)CCCN2C3=C(C=C(C=C3)Br)C4=C2C=CC(=C4)Br
6813;366463033;4.446;1607454;103245538;119570;10280;323426850;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from sigma1 receptor (unknown origin) after 90 mins by microbeta scintillation counting method;Pramipexole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCN[C@H]1CCC2=C(C1)SC(=N2)N
6814;100440012;4.45;204464;103384241;10466885;10280;14696990;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was evaluated for its ability to displace [3H](+)-pentazocine from sigma receptor in Guinea pig brain;(1alpha,5alpha)-2alpha-Phenyl-2-piperidinobicyclo[3.1.0]hexane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)[C@]2(CC[C@@H]3[C@H]2C3)C4=CC=CC=C4
6815;100741871;4.52;203992;103671655;45260688;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"9-Benzyl-2-phenyl-1-oxa-9-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CC2(CN(C1)CC3=CC=CC=C3)C(=O)C=C(O2)C4=CC=CC=C4.Cl
6816;389536472;4.544;1805702;459092161;122576838;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';4-[(1R,8R)-9-[(2-fluorophenyl)methyl]-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-trien-5-yl]morpholine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN([C@@H]2C[C@@H]1C3=C2C=C(C=C3)N4CCOCC4)CC5=CC=CC=C5F
6817;100778221;4.615;204017;103272907;44313231;10280;98735270;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for [3H]- pentazocine at sigma opioid receptor;(2R,3S)-2-[(4R)-4-(5-aminopentyl)-3-benzyl-2,5-dioxoimidazolidin-1-yl]-N-benzyl-3-methylpentanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC[C@H](C)[C@H](C(=O)NCC1=CC=CC=C1)N2C(=O)[C@H](N(C2=O)CC3=CC=CC=C3)CCCCCN
6818;380523512;4.64;1849426;482066038;167312259;10280;363677490;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-LSD from human sigma1 receptor expressed in human HEK293T cell membrane incubated for 90 mins by radioligand binding assay;2-(Cyclohept-4-en-1-yl)-N-(3,4-dichlorophenyl)-1H-imidazo[4,5-c]quinolin-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC(CCC=C1)C2=NC3=C(N2)C(=NC4=CC=CC=C43)NC5=CC(=C(C=C5)Cl)Cl
6819;380800774;4.7;1915268;312387359;72551585;10280;;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000209b SIGMAR1;N-[(6-methyl-2-oxo-4-propyl-1H-pyridin-3-yl)methyl]-1-propan-2-yl-6-[6-(4-propan-2-ylpiperazin-1-yl)pyridin-3-yl]indazole-4-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCC1=C(C(=O)NC(=C1)C)CNC(=O)C2=C3C=NN(C3=CC(=C2)C4=CN=C(C=C4)N5CCN(CC5)C(C)C)C(C)C
6820;100471678;4.8;204459;103298897;9923341;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N-Methyl-N,N''-di-naphthalen-1-yl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(C1=CC=CC2=CC=CC=C21)C(=NC3=CC=CC4=CC=CC=C43)N
6821;100458321;4.876;204437;103344202;15149398;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;11-[2-(4-Chlorophenoxy)ethyl]-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCOC4=CC=C(C=C4)Cl)NC5=CC=CC=C53
6822;100441640;5.0;229186;103575820;5284595;10280;14696970;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Inhibition of specific binding of [125I]-PIPAG to sigma binding site in Guinea pig brain membranes;Nalorphine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C=CCN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O
6823;100456547;5.0;229183;103229055;77042;10280;79028690;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Binding affinity against sigma receptor in bovine cerebellum using 2.0 nM [3H]haloperidol in the presence of 25 nM unlabeled spiperone;3-(Dimethylamino)propiophenone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CN(C)CCC(=O)C1=CC=CC=C1
6824;100459600;5.0;204442;103211569;15149426;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;compound was tested for binding affinity against sigma sites in guinea pig membrane using [3H]- DTG as the radioligand;5,6,7,8,9,10-Hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2)NC4=CC=CC=C43
6825;339910673;5.0;780758;174489341;71061756;10280;241000770;Confirmatory;20180928;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) by radioligand binding assay;3-[2-[4-[2-(4-methoxyphenyl)phenyl]piperazin-1-yl]ethoxy]-N-(pyridin-2-ylmethyl)propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)C2=CC=CC=C2N3CCN(CC3)CCOCCC(=O)NCC4=CC=CC=N4
6826;339910676;5.0;780758;174489340;71061887;10280;241000770;Confirmatory;20180928;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) by radioligand binding assay;4-[2-(4-Methoxyphenyl)phenyl]-N-(4-pyridinylmethyl)-1-piperazinehexanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)C2=CC=CC=C2N3CCN(CC3)CCCCCC(=O)NCC4=CC=NC=C4
6827;339910995;5.0;780758;103605292;25107716;10280;241000770;Confirmatory;20180928;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) by radioligand binding assay;N-[(4-cyanophenyl)methyl]-6-[4-(2-phenylphenyl)piperazin-1-yl]hexanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCCCCC(=O)NCC2=CC=C(C=C2)C#N)C3=CC=CC=C3C4=CC=CC=C4
6828;339910997;5.0;780758;174489342;71061659;10280;241000770;Confirmatory;20180928;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) by radioligand binding assay;3-[2-[4-[2-(4-methoxyphenyl)phenyl]piperazin-1-yl]ethoxy]-N-(pyridin-3-ylmethyl)propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)C2=CC=CC=C2N3CCN(CC3)CCOCCC(=O)NCC4=CN=CC=C4
6829;339910999;5.0;780758;174504766;71061607;10280;241000770;Confirmatory;20180928;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) by radioligand binding assay;3-[2-[4-[2-(4-methoxyphenyl)phenyl]piperazin-1-yl]ethoxy]-N-(pyridin-4-ylmethyl)propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)C2=CC=CC=C2N3CCN(CC3)CCOCCC(=O)NCC4=CC=NC=C4
6830;366389686;5.09;1571915;163338250;70676458;10280;306053310;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma receptor 1 (unknown origin);(1R,2R,3S,4R,5S)-4-[2-chloro-6-(dicyclopentylmethylamino)purin-9-yl]bicyclo[3.1.0]hexane-2,3-diol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(C1)C(C2CCCC2)NC3=C4C(=NC(=N3)Cl)N(C=N4)[C@@H]5[C@H]6C[C@H]6[C@H]([C@H]5O)O
6831;100617134;5.1;203985;103282915;14771731;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;1,3-Bis(4-amino-2-methylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=C(C=CC(=C1)N)NC(=NC2=C(C=C(C=C2)N)C)N
6832;100741878;5.13;203992;103677470;45264574;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"2-[2-(Dimethylamino)ethyl]-2-phenylfuran-3-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(C)CCC1(C(=O)C=CO1)C2=CC=CC=C2.Cl
6833;380523514;5.15;1849426;482067213;168283716;10280;363677490;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-LSD from human sigma1 receptor expressed in human HEK293T cell membrane incubated for 90 mins by radioligand binding assay;2-cyclononyl-N-(3,4-dichlorophenyl)-3H-imidazo[4,5-c]quinolin-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCCCC(CCC1)C2=NC3=C(N2)C(=NC4=CC=CC=C43)NC5=CC(=C(C=C5)Cl)Cl
6834;100738363;5.16;229182;103414799;44375872;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was evaluated for the binding affinity to sigma opioid receptor;"2-(3,4-dichlorophenyl)-N-[(1S,2S)-5-methoxy-2-pyrrolidin-1-yl-1,2,3,4-tetrahydronaphthalen-1-yl]-N-methylacetamide;methanesulfonic acid";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1[C@H](CCC2=C1C=CC=C2OC)N3CCCC3)C(=O)CC4=CC(=C(C=C4)Cl)Cl.CS(=O)(=O)O
6835;112851455;5.2;204465;103328054;15601069;10280;79325400;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma receptor of guinea pig brain;5-(3-Methoxy-phenyl)-2-methyl-2-aza-bicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1CC(=O)C2)C3=CC(=CC=C3)OC
6836;100604686;5.303;203857;103735201;46877993;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;1-(3,4-Dichlorophenyl)-3-methyl-3-[(1R)-2beta-(1-pyrrolidinyl)cyclohexan-1beta-yl]urea;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)NC3=CC(=C(C=C3)Cl)Cl
6837;100451174;5.312;204436;103672017;45260913;10280;81026510;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using [3H]ditolylguanidine (DTG) as radioligand.;"(2R,4S)-N,N,2-trimethyl-4-phenyl-3,4-dihydro-1H-naphthalen-2-amine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C[C@]1(C[C@H](C2=CC=CC=C2C1)C3=CC=CC=C3)N(C)C.Cl
6838;255010648;5.366;625223;104234151;43815;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Paroxetine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
6839;112851451;5.4;204465;103328362;44337609;10280;79325400;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma receptor of guinea pig brain;"(8E)-8-benzylidene-5-(3-hydroxyphenyl)-2,2-dimethyl-2-azoniabicyclo[3.3.1]nonan-7-one;iodide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[N+]1(CCC2(CC1/C(=C\C3=CC=CC=C3)/C(=O)C2)C4=CC(=CC=C4)O)C.[I-]
6840;100508507;5.46;204150;103346095;401806;10280;87844550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from Sigma opioid receptor type 1 in guinea pig brain membrane;2-(2-Methoxy-phenyl)-N-methyl-N-(2-pyrrolidin-1-yl-ethyl)-acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(CCN1CCCC1)C(=O)CC2=CC=CC=C2OC
6841;100708104;5.484;204146;103252319;25184808;10280;146843270;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma opioid receptor of guiena pig brain membrane;5-Bromo-N-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-2-methoxy-benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=C(C=C1)Br)C(=O)NCCN2CCC3=CC(=C(C=C3C2)OC)OC
6842;342804590;5.484;1127667;103252319;25184808;10280;237346340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 opioid receptor (unknown origin);5-Bromo-N-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-2-methoxy-benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=C(C=C1)Br)C(=O)NCCN2CCC3=CC(=C(C=C3C2)OC)OC
6843;100403995;5.72;204630;103295105;44321569;10280;128012230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma receptor type 1 was determined by the displacement of [3H]pentazocine radioligand;9-[3-[(3R,5R)-3,5-dimethylpiperazin-1-yl]propyl]carbazol-3-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CN(C[C@H](N1)C)CCCN2C3=C(C=C(C=C3)N)C4=CC=CC=C42
6844;100617253;5.85;204444;103248645;269722;10280;16627250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membranes using [3H]DTG as radioligand;1-(4-Methoxyphenyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC=C(C=C1)N2CCNCC2
6845;100604185;5.952;203857;103735227;46878011;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;4,5-Dichloro-2-nitro-N-methyl-N-[(1R)-2beta-(1-pyrrolidinyl)cyclohexan-1beta-yl]benzeneacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)CC3=CC(=C(C=C3[N+](=O)[O-])Cl)Cl
6846;100604308;6.058;203857;103735238;14771416;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;N-Methyl-N-[(1S)-2alpha-(1-pyrrolidinyl)cyclohexan-1alpha-yl]-1-phenylcyclopropanecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@H]1CCCC[C@H]1N2CCCC2)C(=O)C3(CC3)C4=CC=CC=C4
6847;100471327;6.13;204459;103298941;9902485;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;1,3-Bis(1-naphthyl)-1-ethylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCN(C1=CC=CC2=CC=CC=C21)C(=NC3=CC=CC4=CC=CC=C43)N
6848;341107076;6.143;1063782;194152819;21509921;10280;243651590;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor (unknown origin);5-Methyl-1,5-diazapentacyclo[10.8.1.02,7.08,21.015,20]henicosa-2(7),8,10,12(21),15,17,19-heptaene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2=C(C1)C3=CC=CC4=C3N2C5=CC=CC=C5CC4
6849;100617259;6.15;204444;103169070;1355;10280;16627250;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membranes using [3H]DTG as radioligand;1-(3-Chlorophenyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1)C2=CC(=CC=C2)Cl
6850;363665337;6.194;1415967;404704943;71225858;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;1-(1-(2-(piperidin-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)pyrrolidin-2-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=C(C=N2)C(=NC=N3)N4CCCC4=O
6851;100741801;6.22;203992;103677417;45264539;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"3-Phenyl-1-oxa-8-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CNCCC12C(=O)C(=CO2)C3=CC=CC=C3.Cl
6852;100471361;6.26;204459;103298906;9966844;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;1-(3-Nitrophenyl)-3-(1-naphthyl)-1-methylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(C1=CC(=CC=C1)[N+](=O)[O-])C(=NC2=CC=CC3=CC=CC=C32)N
6853;100550367;6.27;204463;103325937;132891;10280;97034600;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Compound is evaluated for binding affinity towards Sigma receptor using [3H]pentazocine in guinea pig brain;3-((4-(2-Methoxyphenyl)piperazin-1-yl)methyl)-2,3-dihydroimidazo(1,2-c)quinazolin-5(6H)-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1N2CCN(CC2)CC3CNC4=C5C=CC=CC5=NC(=O)N34
6854;409049729;6.279;1794447;440157493;57861407;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;1-(2-ethoxyethyl)-6-oxo-N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridin-2-yl]pyridine-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOCCN1C=C(C=CC1=O)C(=O)NC2=NC=C(C=C2)N3C(=CC(=N3)C4=CN=CC=C4)C(F)(F)F
6855;100471356;6.28;204459;103299481;10037913;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N-Methyl-N,N''-di-o-tolyl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1N=C(N)N(C)C2=CC=CC=C2C
6856;408152863;6.28;1915110;440157493;57861407;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000542a SIGMAR1;1-(2-ethoxyethyl)-6-oxo-N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridin-2-yl]pyridine-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOCCN1C=C(C=CC1=O)C(=O)NC2=NC=C(C=C2)N3C(=CC(=N3)C4=CN=CC=C4)C(F)(F)F
6857;363476485;6.3;1353758;404657930;98049507;10280;294388910;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin);3-ethyl-N-[(1S,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]-2-oxobenzimidazole-1-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN1C2=CC=CC=C2N(C1=O)C(=O)NC3C[C@@H]4CC[C@@H](C3)N4C
6858;341107077;6.30957;1063782;194152819;21509921;10280;243651590;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor (unknown origin);5-Methyl-1,5-diazapentacyclo[10.8.1.02,7.08,21.015,20]henicosa-2(7),8,10,12(21),15,17,19-heptaene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2=C(C1)C3=CC=CC4=C3N2C5=CC=CC=C5CC4
6859;409049730;6.30957;1794447;440157493;57861407;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;1-(2-ethoxyethyl)-6-oxo-N-[5-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]pyridin-2-yl]pyridine-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOCCN1C=C(C=CC1=O)C(=O)NC2=NC=C(C=C2)N3C(=CC(=N3)C4=CN=CC=C4)C(F)(F)F
6860;407905612;6.4;1922011;494419994;171357206;10280;360891130;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);triethyl-[2-[3-nitro-2-(trifluoromethyl)-2H-chromen-8-yl]ethynyl]silane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC[Si](CC)(CC)C#CC1=CC=CC2=C1OC(C(=C2)[N+](=O)[O-])C(F)(F)F
6861;100551432;6.52;204463;103326124;10715370;10280;97034600;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound is evaluated for binding affinity towards Sigma receptor using [3H]pentazocine in guinea pig brain;3-[[4-(2-Methoxyphenyl)-1-piperazinyl]methyl]imidazo[1,2-c]quinazoline-5(6H)-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=CC=C1N2CCN(CC2)CC3=CN=C4N3C(=O)NC5=CC=CC=C54
6862;100458420;6.605;204437;103344228;13078350;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;5-Phenyl-5,6,7,8,9,10-hexahydro-7,10-epiminocyclohept[b]indole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2)N(C4=CC=CC=C43)C5=CC=CC=C5
6863;255018205;6.665;625223;103590321;91536;10280;;Confirmatory;20240503;0;0;Active;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(C)NC[C@@H](COC1=CC=CC2=CC=CC=C21)O
6864;100470625;6.75;204469;103339981;12371110;10280;79325690;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition against sigma receptor using displacement of 3 nM [3H]pentazocine in homogenate of guinea pig brain cerebellum;(6S)-6alpha,11alpha-Dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C[C@H]1C2CC3=C([C@]1(CCN2)C)C=C(C=C3)O
6865;409047498;6.76083;1794447;242510763;11524200;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;6-Chloro-N4-[3,5-difluoro-4-[(3-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy]phenyl]-2,4-pyrimidinediamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CNC2=NC=CC(=C12)OC3=C(C=C(C=C3F)NC4=CC(=NC(=N4)N)Cl)F
6866;380800036;6.7655;1914132;242510763;11524200;10280;;Confirmatory;20230629;0;0;Active;Q99720;Ki;=;ChEMBL;Selectivity interaction (GPCR panel (PDSP screen)) EUB0000716a SIGMAR1;ROCK Inhibitor;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CNC2=NC=CC(=C12)OC3=C(C=C(C=C3F)NC4=CC(=NC(=N4)N)Cl)F
6867;409047497;6.7655;1794447;242510763;11524200;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;6-Chloro-N4-[3,5-difluoro-4-[(3-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy]phenyl]-2,4-pyrimidinediamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CNC2=NC=CC(=C12)OC3=C(C=C(C=C3F)NC4=CC(=NC(=N4)N)Cl)F
6868;100742337;6.88;204020;103677372;45264511;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor using [3H]-(+)-SKF- 10,047;"9-Methyl-3-phenyl-1-oxa-9-azaspiro[5.5]undec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1)CC(=O)C(=CO2)C3=CC=CC=C3.Cl
6869;366434673;6.9;1593437;440146135;130442572;10280;308752190;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from sigma1 receptor (unknown origin) after 90 mins by microbeta scintillation counting method;4-[4-Imidazo[1,2-a]pyridin-5-yl-3-(trifluoromethyl)phenoxy]furo[3,2-c]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC2=NC=CN2C(=C1)C3=C(C=C(C=C3)OC4=NC=CC5=C4C=CO5)C(F)(F)F
6870;380313613;6.9;1822903;475995949;166634238;10280;351135560;Confirmatory;20230314;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of sigma 1 receptor (unknown origin) assessed as binding constant;[2-(dimethylamino)-2-oxoethyl] 4-[4-[(1R,4R,6S)-3-oxo-2-azabicyclo[2.2.1]heptan-6-yl]phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C)C(=O)COC(=O)C1=CC(=C2C=CC(=CC2=C1)C3=CC=C(C=C3)C(F)(F)F)C4=CC=C(C=C4)[C@@H]5C[C@@H]6C[C@H]5NC6=O
6871;100614384;7.15;203986;103282915;14771731;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;1,3-Bis(4-amino-2-methylphenyl)guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=C(C=CC(=C1)N)NC(=NC2=C(C=C(C=C2)N)C)N
6872;100471325;7.18;204459;103298146;10038412;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;C-[Bis-(2,3-dihydro-indol-1-yl)]-methyleneamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(C2=CC=CC=C21)C(=N)N3CCC4=CC=CC=C43
6873;100605294;7.212;203995;103735216;14771459;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity of compound to Sigma opioid receptor labelled with [3H](+)-3-PPP;2-(1,3-benzodioxol-5-yl)-N-methyl-N-[(1R,2S)-2-pyrrolidin-1-ylcyclohexyl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)CC3=CC4=C(C=C3)OCO4
6874;340020964;7.24;752428;174501672;49853882;10280;236018160;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;N-(2-cyclooctylethyl)-2-piperazin-1-ylpropanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C(=O)NCCC1CCCCCCC1)N2CCNCC2
6875;100471358;7.25;204459;103298715;10267880;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N''-(2-Isopropyl-phenyl)-N-methyl-N-naphthalen-1-yl-guanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC(C)C1=CC=CC=C1N=C(N)N(C)C2=CC=CC3=CC=CC=C32
6876;100440015;7.28;204464;103384240;10243428;10280;14696990;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was evaluated for its ability to displace [3H](+)-pentazocine from sigma receptor in Guinea pig brain;1-(2-Phenyl-bicyclo[3.1.0]hex-2-yl)-piperidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)[C@]2(CC[C@H]3[C@@H]2C3)C4=CC=CC=C4
6877;100742342;7.3;204020;103671633;45260679;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor using [3H]-(+)-SKF- 10,047;"3-(4-Fluorophenyl)-9-methyl-1-oxa-9-azaspiro[5.5]undec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1)CC(=O)C(=CO2)C3=CC=C(C=C3)F.Cl
6878;342804599;7.436;1127667;242622246;5468874;10280;237346340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 opioid receptor (unknown origin);(1R,5R,8E)-8-[(3,4-dichlorophenyl)methylidene]-5-(3-hydroxyphenyl)-2-methyl-2-azabicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@]2(C[C@@H]1/C(=C\C3=CC(=C(C=C3)Cl)Cl)/C(=O)C2)C4=CC(=CC=C4)O
6879;342797730;7.463;1143314;242636021;90643603;10280;248213980;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin);3-[(1S,5R,8Z)-8-[(3,4-dichlorophenyl)methylidene]-2-methyl-2-azabicyclo[3.3.1]nonan-5-yl]phenol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@@]2(CC/C(=C/C3=CC(=C(C=C3)Cl)Cl)/[C@@H]1C2)C4=CC(=CC=C4)O
6880;100741798;7.5;203992;103671616;45260669;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"8-[(3-Methyl-1,2-oxazol-5-yl)methyl]-3-phenyl-1-oxa-8-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=NOC(=C1)CN2CCC3(CC2)C(=O)C(=CO3)C4=CC=CC=C4.Cl
6881;100742320;7.5;204129;163316226;44311180;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;9-Benzyloxy-3-phenyl-1-oxa-spiro[5.5]undec-2-en-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCC1OCC3=CC=CC=C3)CC(=O)C(=CO2)C4=CC=CC=C4
6882;100604187;7.551;203857;103735210;9800653;10280;21725380;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity for sigma opioid receptor using [3H](+)-3-PPP as radioligand;N-Methyl-N-[(1S)-2alpha-(1-pyrrolidinyl)cyclohexan-1alpha-yl]-3,4-dichlorobenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@H]1CCCC[C@H]1N2CCCC2)C(=O)C3=CC(=C(C=C3)Cl)Cl
6883;340019679;7.6;752428;174486363;49853581;10280;236018160;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;N-butyl-2-[(2R,5S)-2,5-dimethylpiperazin-1-yl]-N-propylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCN(CCC)C(=O)CN1C[C@@H](NC[C@H]1C)C
6884;100471344;7.93;204459;103298908;10340180;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;1,3-Bis(1-naphthyl)-1-phenylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC=C(C=C1)N(C2=CC=CC3=CC=CC=C32)C(=NC4=CC=CC5=CC=CC=C54)N
6885;366434672;8.0;1593437;440215258;130442480;10280;308752190;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from sigma1 receptor (unknown origin) after 90 mins by microbeta scintillation counting method;4-[4-(6-Methylimidazo[1,2-a]pyrazin-5-yl)-3-(trifluoromethyl)phenoxy]furo[3,2-c]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(N2C=CN=C2C=N1)C3=C(C=C(C=C3)OC4=NC=CC5=C4C=CO5)C(F)(F)F
6886;100459023;8.085;204438;103344464;15149415;10280;84263630;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H]DTG as the radioligand;2-[2-(9,15-Diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3,5,7-tetraen-15-yl)ethyl]isoindole-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCN4C(=O)C5=CC=CC=C5C4=O)NC6=CC=CC=C63
6887;100471367;8.11;204459;103282943;14771673;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;N,N''-Di[1,1'-biphenyl]-2-ylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC=C(C=C1)C2=CC=CC=C2NC(=NC3=CC=CC=C3C4=CC=CC=C4)N
6888;100741793;8.11;203992;103671591;45260652;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"2-[(Dimethylamino)methyl]-2-methyl-4-phenylfuran-3-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1(C(=O)C(=CO1)C2=CC=CC=C2)CN(C)C.Cl
6889;100614623;8.113;203986;103282943;14771673;10280;19752750;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N,N''-Di[1,1'-biphenyl]-2-ylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC=C(C=C1)C2=CC=CC=C2NC(=NC3=CC=CC=C3C4=CC=CC=C4)N
6890;366434675;8.2;1593437;404702213;75201901;10280;308752190;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from sigma1 receptor (unknown origin) after 90 mins by microbeta scintillation counting method;(Rac)-PF-06256142;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=C(C=CC(=C1)OC2=NC=CC3=C2C=CO3)C4=C(N=CC5=NC=CN54)C
6891;409050119;8.24518;1794447;442063095;156021282;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;[(2R,4S)-1-(4-chlorophenyl)-4-hydroxypyrrolidin-2-yl]-[9-[(4-chlorophenyl)methyl]-3-oxa-7,9-diazabicyclo[3.3.1]nonan-7-yl]methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@@H](CN([C@H]1C(=O)N2CC3COCC(C2)N3CC4=CC=C(C=C4)Cl)C5=CC=C(C=C5)Cl)O
6892;409050120;8.31764;1794447;442063095;156021282;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;[(2R,4S)-1-(4-chlorophenyl)-4-hydroxypyrrolidin-2-yl]-[9-[(4-chlorophenyl)methyl]-3-oxa-7,9-diazabicyclo[3.3.1]nonan-7-yl]methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@@H](CN([C@H]1C(=O)N2CC3COCC(C2)N3CC4=CC=C(C=C4)Cl)C5=CC=C(C=C5)Cl)O
6893;100619101;8.32;203990;104234344;10836;10280;18482950;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma opioid receptor in guinea pig cerebral homogenate using [3H]DTG as radioligand;Methamphetamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H](CC1=CC=CC=C1)NC
6894;340019626;8.41;752428;174511992;49853885;10280;236018160;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;2-(4-cyclohexylpiperazin-1-yl)-2-methyl-N-propan-2-ylpropanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)NC(=O)C(C)(C)N1CCN(CC1)C2CCCCC2
6895;100471353;8.48;204459;103298962;10405821;10280;82952130;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;1,3-Bis(1-naphthyl)-1-ethyl-3-methylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCN(C1=CC=CC2=CC=CC=C21)C(=N)N(C)C3=CC=CC4=CC=CC=C43
6896;100543133;8.5;203698;103165765;135398737;10280;95728800;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was tested for its binding affinity towards sigma 1 receptor using [3H](+)-pentazocine from guinea pig brain;Clozapine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)C2=NC3=C(C=CC(=C3)Cl)NC4=CC=CC=C42
6897;100561758;8.5;204461;103165765;135398737;10280;98761100;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity measured at the sigma receptor by the inhibition of [3H]-3-PPP binding to guinea pig cerebellum using unlabeled 3-PPP for nonspecific binding.;Clozapine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CN1CCN(CC1)C2=NC3=C(C=CC(=C3)Cl)NC4=CC=CC=C42
6898;100297842;8.554;239347;103735490;46878220;10280;160332550;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;(1S,15S,17S)-17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-4(9),5,7-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC[C@H]1C[C@H]2C[C@@H]3C1N(C2)CCC4C3NC5=C4C=C(C=C5)OC
6899;342804591;8.554;1127667;103511008;442108;10280;237346340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 opioid receptor (unknown origin);10-Methoxyibogamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC[C@H]1C[C@H]2C[C@@H]3[C@H]1N(C2)CCC4=C3NC5=C4C=C(C=C5)OC
6900;366434674;8.8;1593437;440142105;146025727;10280;308752190;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-pentazocine from sigma1 receptor (unknown origin) after 90 mins by microbeta scintillation counting method;7-[4-Imidazo[1,2-a]pyridin-5-yl-3-(trifluoromethyl)phenoxy]thieno[2,3-c]pyridine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC2=NC=CN2C(=C1)C3=C(C=C(C=C3)OC4=NC=CC5=C4SC=C5)C(F)(F)F
6901;100403480;8.83;204630;123092435;446220;10280;128012230;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity against Sigma receptor type 1 was determined by the displacement of [3H]pentazocine radioligand;Cocaine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1[C@H]2CC[C@@H]1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC
6902;340019672;8.83;752428;174501671;49855133;10280;236018160;Confirmatory;20220830;0;0;Active;Q99720;IC50;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;N-cyclohexyl-3-[4-(cyclopropanecarbonyl)piperazin-1-yl]propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)NC(=O)CCN2CCN(CC2)C(=O)C3CC3
6903;255026031;8.872;625223;103212333;3198;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Econazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl
6904;255011007;8.953;625223;124966219;15032;10280;;Confirmatory;20240503;0;0;Active;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pregnenolone carbonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)[C@H]1[C@@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)C#N
6905;100461275;9.17;204456;103183411;398365;10280;80980660;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma receptor of guinea pig brain homogenates;1-Benzo[b]thiophen-2-yl-cycloheptylamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CCCC(CC1)(C2=CC3=CC=CC=C3S2)N
6906;389536404;9.294;1805702;384583212;137632411;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';benzyl (1R,8R)-5-[4-(3-ethoxy-3-oxopropyl)piperazin-1-yl]-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene-9-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC(=O)CCN1CCN(CC1)C2=CC3=C(C=C2)[C@@H]4CCN([C@@H]3C4)C(=O)OCC5=CC=CC=C5
6907;389536412;9.294;1805702;384583212;137632411;10280;;Confirmatory;20230307;0;0;Active;Q99720;Ki;;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';benzyl (1R,8R)-5-[4-(3-ethoxy-3-oxopropyl)piperazin-1-yl]-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene-9-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCOC(=O)CCN1CCN(CC1)C2=CC3=C(C=C2)[C@@H]4CCN([C@@H]3C4)C(=O)OCC5=CC=CC=C5
6908;363476488;9.31;1353758;104242051;197060;10280;294388910;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 receptor (unknown origin);Ibogaine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC[C@H]1C[C@@H]2C[C@@H]3[C@H]1N(C2)CCC4=C3NC5=C4C=C(C=C5)OC
6909;363666005;9.46;1415967;404718017;74767289;10280;301088350;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(1-Methylpyrazol-4-yl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C=C(C=N1)C2=C3C=NN(C3=NC=N2)CCN4CCCCC4
6910;345602974;9.616;1200082;312389836;76683881;10280;256589640;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Displacement of [3H](+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting;1-benzyl-N-[2-(4-methylpiperazin-1-yl)ethyl]triazol-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CN1CCN(CC1)CCNC2=CN(N=N2)CC3=CC=CC=C3
6911;100439808;10.0;229190;103167211;6005;10280;14696970;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Inhibition of specific binding of [3H]DTG to sigma binding site in Guinea pig brain membranes;Apomorphine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN1CCC2=C3[C@H]1CC4=C(C3=CC=C2)C(=C(C=C4)O)O
6912;100440054;10.0;229193;103164922;5355;10280;14696970;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Inhibition of specific binding of [3H]NANM of sigma receptor in Guinea pig brain membranes;Sulpiride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC
6913;100440055;10.0;229193;103193630;180081;10280;14696970;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Inhibition of specific binding of [3H]NANM of sigma receptor in Guinea pig brain membranes;Dizocilpine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@]12C3=CC=CC=C3C[C@@H](N1)C4=CC=CC=C24
6914;100440509;10.0;229187;103164922;5355;10280;14696970;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Inhibition of specific binding of [125I]PIPAG to sigma receptor in Guinea pig brain membranes;Sulpiride;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC
6915;100440510;10.0;229187;103163782;89594;10280;14696970;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Inhibition of specific binding of [125I]PIPAG to sigma receptor in Guinea pig brain membranes;Nicotine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN1CCC[C@H]1C2=CN=CC=C2
6916;100440512;10.0;229187;103193630;180081;10280;14696970;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Inhibition of specific binding of [125I]PIPAG to sigma receptor in Guinea pig brain membranes;Dizocilpine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C[C@@]12C3=CC=CC=C3C[C@@H](N1)C4=CC=CC=C24
6917;100441642;10.0;229186;103167211;6005;10280;14696970;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Inhibition of specific binding of [125I]-PIPAG to sigma binding site in Guinea pig brain membranes;Apomorphine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN1CCC2=C3[C@H]1CC4=C(C3=CC=C2)C(=C(C=C4)O)O
6918;100451173;10.0;204436;103677683;45264723;10280;81026510;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using [3H]ditolylguanidine (DTG) as radioligand.;"7-Amino-5-phenyl-5,6,7,8-tetrahydronaphthalene-2,3-diol;hydrobromide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1C(CC2=CC(=C(C=C2C1C3=CC=CC=C3)O)O)N.Br
6919;100451370;10.0;204435;103677683;45264723;10280;81026510;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using the novel [3H]-(+/-)-4 as radioligand;"7-Amino-5-phenyl-5,6,7,8-tetrahydronaphthalene-2,3-diol;hydrobromide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1C(CC2=CC(=C(C=C2C1C3=CC=CC=C3)O)O)N.Br
6920;100451420;10.0;204436;103672125;45260987;10280;81026510;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using [3H]ditolylguanidine (DTG) as radioligand.;4-phenyl-2-aminotetraline HCl;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C1C(CC2=CC=CC=C2C1C3=CC=CC=C3)N.Cl
6921;100451421;10.0;204436;103290992;15657207;10280;81026510;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using [3H]ditolylguanidine (DTG) as radioligand.;3-Chloro-6-methylamino-8-phenyl-5,6,7,8-tetrahydro-naphthalen-2-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CNC1CC(C2=CC(=C(C=C2C1)Cl)O)C3=CC=CC=C3
6922;100451426;10.0;204436;103672107;45260974;10280;81026510;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Binding affinity against sigma receptor from guinea pig brain (minus cerebellum) homogenates, using [3H]ditolylguanidine (DTG) as radioligand.;"7-(Dimethylamino)-5-phenyl-5,6,7,8-tetrahydronaphthalene-2,3-diol;hydrobromide";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CN(C)C1CC(C2=CC(=C(C=C2C1)O)O)C3=CC=CC=C3.Br
6923;100458326;10.0;204437;103345010;15149384;10280;84263630;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;N-[2-(9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3,5,7-tetraen-15-yl)ethyl]-2-(3,4-dichlorophenyl)-N-methylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCN1C2CCC1C3=C(C2)NC4=CC=CC=C43)C(=O)CC5=CC(=C(C=C5)Cl)Cl
6924;100458414;10.0;204437;103344213;15149413;10280;84263630;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;5-Fluoro-15-[(2-iodophenyl)methyl]-9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3(8),4,6-tetraene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CC4=CC=CC=C4I)NC5=C3C=C(C=C5)F
6925;100459182;10.0;204437;103344464;15149415;10280;84263630;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;2-[2-(9,15-Diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3,5,7-tetraen-15-yl)ethyl]isoindole-1,3-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCN4C(=O)C5=CC=CC=C5C4=O)NC6=CC=CC=C63
6926;100459187;10.0;204437;103344902;15149409;10280;84263630;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Binding affinity against sigma sites in guinea pig membrane using [3H](+)-3-PPP as the radioligand;15-[2-(3,4-Dichlorophenyl)ethyl]-9,15-diazatetracyclo[10.2.1.02,10.03,8]pentadeca-2(10),3,5,7-tetraene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2C3=C(CC1N2CCC4=CC(=C(C=C4)Cl)Cl)NC5=CC=CC=C53
6927;100513121;10.0;229197;103384790;10780443;10280;89413830;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Binding affinity against sigma receptor using radioligand ([3H](+)-pentazocine) binding assay;N*1*-(2-Benzhydryloxy-ethyl)-butane-1,4-diamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)C(C2=CC=CC=C2)OCCNCCCCN
6928;100513123;10.0;229197;103384375;3064081;10280;89413830;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Binding affinity against sigma receptor using radioligand ([3H](+)-pentazocine) binding assay;1,4-Bis-(2-benzhydryloxy-ethyl)-piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCOC(C2=CC=CC=C2)C3=CC=CC=C3)CCOC(C4=CC=CC=C4)C5=CC=CC=C5
6929;100513229;10.0;229200;103383765;4058484;10280;89413830;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Binding affinity against sigma receptor using radioligand ([3H](+)-pentazocine) binding assay;1,4-Bis[2-[bis(4-fluorophenyl)methoxy]ethyl]piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(CCN1CCOC(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)CCOC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F
6930;100559065;10.0;203684;103390030;44364145;10280;98366120;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity was tested against sigma-1 receptor in guinea brain membranes.;1-[4-(4-Methoxyphenethyl)piperazine-1-yl]-2-(4-methoxyphenyl)ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC=C(C=C1)CCN2CCN(CC2)C(=O)CC3=CC=C(C=C3)OC
6931;100613262;10.0;204440;103283026;112416;10280;19752750;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;In vitro inhibitory activity against [3H]-DTG in guinea pig brain membrane homogenates;1H-Perimidin-2-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC2=C3C(=C1)NC(=NC3=CC=C2)N
6932;100614381;10.0;203986;103283876;14771744;10280;19752750;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;5,7-Dihydro-dibenzo[d,f][1,3]diazepin-6-ylideneamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC=C2C(=C1)C3=CC=CC=C3N=C(N2)N
6933;100614386;10.0;203986;103671905;45260838;10280;19752750;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;"2-[(10R,13R,17R)-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]-1-(2-methylphenyl)guanidine;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CC1=CC=CC=C1NC(=NC2CC[C@@]3(C4CC[C@@]5([C@H](CCC5C4CC=C3C2)C(C)CCCC(C)C)C)C)N.Cl
6934;100617146;10.0;203985;103672004;14122788;10280;19752750;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;In vitro inhibitory activity against [3H]- (+)-3-PPP binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N,N'-dimethyl guanidine hydrogen bromide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CNC(=NC)N.Br
6935;100617258;10.0;204444;103197579;88747;10280;16627250;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membranes using [3H]DTG as radioligand;2-(1-Piperazinyl)pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1)C2=NC=CC=N2
6936;100738361;10.0;229182;103169185;5288826;10280;;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Compound was evaluated for the binding affinity to sigma opioid receptor;Morphine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O
6937;100738364;10.0;229182;103678714;45265468;10280;;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Compound was evaluated for the binding affinity to sigma opioid receptor;"2-(3,4-dichlorophenyl)-N-methyl-N-[(1S,2S)-2-pyrrolidin-1-yl-1,2,3,4-tetrahydronaphthalen-1-yl]acetamide;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN([C@@H]1[C@H](CCC2=CC=CC=C12)N3CCCC3)C(=O)CC4=CC(=C(C=C4)Cl)Cl.Cl
6938;100742323;10.0;204129;163336953;44311180;10280;;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity towards sigma receptor using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;9-Benzyloxy-3-phenyl-1-oxa-spiro[5.5]undec-2-en-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CC2(CCC1OCC3=CC=CC=C3)CC(=O)C(=CO2)C4=CC=CC=C4
6939;101037145;10.0;291662;103520919;16737207;10280;175718660;Confirmatory;20181021;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity to sigma1 receptor;Benzonitrile, 3-fluoro-5-(2-(2-(fluoromethyl)-4-thiazolyl)ethynyl)-;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=C(C=C(C=C1C#N)F)C#CC2=CSC(=N2)CF
6940;101113463;10.0;318547;103558202;16038374;10280;174834570;Confirmatory;20181023;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Displacement of [3H]pentazocine from sigma1 receptor;5-(4-chlorophenyl)-N-(3,5-dimethoxyphenyl)furan-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC(=CC(=C1)NC(=O)C2=CC=C(O2)C3=CC=C(C=C3)Cl)OC
6941;204276974;10.0;569639;124968324;51050257;10280;212079590;Confirmatory;20180917;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity to sigma 1 receptor;3-((2-Fluorothiazol-4-yl)ethynyl)-5-fluorobenzonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=C(C=C(C=C1C#N)F)C#CC2=CSC(=N2)F
6942;204355275;10.0;548692;124966791;50898778;10280;210756380;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity to opioid receptor Sigma1;6-[4-[(3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carbonylamino)methyl]piperidin-1-yl]hexanoic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN2C3=CC=CC=C3C(=C2OC1)C(=O)NCC4CCN(CC4)CCCCCC(=O)O
6943;321408284;10.0;661739;103442131;9906447;10280;223132270;Confirmatory;20180921;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity to human recombinant sigma1 receptor;(4-Fluorophenyl)(2-(2-((2R)-2-methyl-1-pyrrolidinyl)ethyl)-1-benzofuran-5-yl)methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CCCN1CCC2=CC3=C(O2)C=CC(=C3)C(=O)C4=CC=C(C=C4)F
6944;321408285;10.0;661739;160667989;56963799;10280;223132270;Confirmatory;20180921;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity to human recombinant sigma1 receptor;[2-[2-[(2R)-2-methylpyrrolidin-1-yl]ethyl]-1-benzofuran-5-yl]-(4-nitrophenyl)methanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@H]1CCCN1CCC2=CC3=C(O2)C=CC(=C3)C(=O)C4=CC=C(C=C4)[N+](=O)[O-]
6945;340051004;10.0;764175;174487458;73346042;10280;238160460;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin);2-(4-(4-(2-(2-fluoroethoxy)phenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)-dione;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C(=O)C=NN(C1=O)CCCCN2CCN(CC2)C3=CC=CC=C3OCCF
6946;340958967;10.0;1054800;103706501;16660294;10280;241478640;Confirmatory;20180928;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity to human sigma-1 receptor by PDSP assay;4-Fluoro-N-methyl-N-(4-(6-(methylamino)pyrimidin-4-yl)-1,3-thiazol-2-yl)benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CNC1=NC=NC(=C1)C2=CSC(=N2)N(C)C(=O)C3=CC=C(C=C3)F
6947;341107075;10.0;1063782;194173569;73213195;10280;243651590;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H](+)Pentazocine from sigma 1 receptor (unknown origin);5-Methyl-1,5-diazapentacyclo[10.8.1.02,7.08,21.014,19]henicosa-2(7),8,10,12(21),14,16,18-heptaene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2=C(C1)C3=CC=CC4=C3N2CC5=CC=CC=C5C4
6948;342804595;10.0;1127667;160705400;66561968;10280;237346340;Confirmatory;20220830;0;0;Active;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 opioid receptor (unknown origin);7-[(3,4-Dimethoxyphenyl)methyl]-7-azabicyclo[2.2.1]heptane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C=C(C=C1)CN2C3CCC2CC3)OC
6949;354626871;10.0;1272388;336866908;127026052;10280;267397810;Confirmatory;20220830;0;0;Active;Q99720;Ki;<;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) by competition binding assay;N,N-Diallyl-5-fluoro-1H-indole-3-ethanamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C=CCN(CCC1=CNC2=C1C=C(C=C2)F)CC=C
6950;354626873;10.0;1272388;336884983;127036953;10280;267397810;Confirmatory;20220830;0;0;Active;Q99720;Ki;<;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) by competition binding assay;N-[2-(5-bromo-1H-indol-3-yl)ethyl]-N-prop-2-enylprop-2-en-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C=CCN(CCC1=CNC2=C1C=C(C=C2)Br)CC=C
6951;354626875;10.0;1272388;336884944;127036932;10280;267397810;Confirmatory;20220830;0;0;Active;Q99720;Ki;<;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) by competition binding assay;N-[2-(5-chloro-1H-indol-3-yl)ethyl]-N-prop-2-enylprop-2-en-1-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C=CCN(CCC1=CNC2=C1C=C(C=C2)Cl)CC=C
6952;354626877;10.0;1272388;336885079;24839550;10280;267397810;Confirmatory;20220830;0;0;Active;Q99720;Ki;<;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) by competition binding assay;N,N-Diallyltryptamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C=CCN(CCC1=CNC2=CC=CC=C21)CC=C
6953;354626879;10.0;1272388;336883200;127036186;10280;267397810;Confirmatory;20220830;0;0;Active;Q99720;Ki;<;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) by competition binding assay;5-methyl-N,N-diallyltryptamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC2=C(C=C1)NC=C2CCN(CC=C)CC=C
6954;354626881;10.0;1272388;174496429;50878551;10280;267397810;Confirmatory;20220830;0;0;Active;Q99720;Ki;<;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) by competition binding assay;N,N-Diallyl-5-methoxytryptamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC2=C(C=C1)NC=C2CCN(CC=C)CC=C
6955;365267157;10.0;1512456;440132439;153287537;10280;316202300;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;1-[(3aS,9bS)-3a-methyl-5-phenyl-1,2,4,9b-tetrahydropyrrolo[2,3-c]quinolin-3-yl]ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)N1CC[C@@H]2[C@]1(CN(C3=CC=CC=C23)C4=CC=CC=C4)C
6956;365267160;10.0;1512456;440215686;147652368;10280;316202300;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3S,4S)-3-amino-4-ethyl-3-methyl-2,4-dihydrochromen-7-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC[C@H]1C2=C(C=C(C=C2)O)OC[C@@]1(C)N
6957;365267162;10.0;1512456;440146114;153287550;10280;316202300;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;1-[(3aS,9bS)-7-hydroxy-3a-methyl-1,2,4,9b-tetrahydrochromeno[3,4-b]pyrrol-3-yl]ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)N1CC[C@@H]2[C@]1(COC3=C2C=CC(=C3)O)C
6958;365267541;10.0;1512456;440117345;153287551;10280;316202300;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;1-[(3aS,9bS)-3a-methyl-6-phenyl-1,2,4,9b-tetrahydrochromeno[3,4-b]pyrrol-3-yl]ethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)N1CC[C@@H]2[C@]1(COC3=C(C=CC=C23)C4=CC=CC=C4)C
6959;365267549;10.0;1512456;440171121;147636204;10280;316202300;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-Pentazocine from human recombinant sigma1 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method;(3aS,9bS)-3a-methyl-2,3,4,9b-tetrahydro-1H-chromeno[3,4-b]pyrrol-7-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@@]12COC3=C([C@@H]1CCN2)C=CC(=C3)O
6960;366366657;10.0;1558961;103189261;5284603;10280;317436420;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor expressed in HEK293 membranes incubated for 120 mins by liquid scintillation counting method;Oxycodone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O
6961;366437099;10.0;1594273;440112262;146597678;10280;309043830;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;5-[(4-fluorophenyl)methoxy]-N,N-dimethyl-1-propyl-4,5,6,7-tetrahydroindazole-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCCN1C2=C(CC(CC2)OCC3=CC=C(C=C3)F)C(=N1)C(=O)N(C)C
6962;366437100;10.0;1594273;440129673;146597628;10280;309043830;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;5-[(4-fluorophenyl)methylsulfanyl]-N,N-dimethyl-1-propyl-4,5,6,7-tetrahydroindazole-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCCN1C2=C(CC(CC2)SCC3=CC=C(C=C3)F)C(=N1)C(=O)N(C)C
6963;366437104;10.0;1594273;440188048;146641795;10280;309043830;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;[5-[2-(4-Hydroxyphenyl)ethylamino]-1-propyl-4,5,6,7-tetrahydroindazol-3-yl]-piperidin-1-ylmethanone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCCN1C2=C(CC(CC2)NCCC3=CC=C(C=C3)O)C(=N1)C(=O)N4CCCCC4
6964;366437105;10.0;1594273;440147746;146597638;10280;309043830;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;5-[(4-fluorophenyl)sulfonylamino]-N,N-dimethyl-1-propyl-4,5,6,7-tetrahydroindazole-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCCN1C2=C(CC(CC2)NS(=O)(=O)C3=CC=C(C=C3)F)C(=N1)C(=O)N(C)C
6965;366437249;10.0;1594273;440169877;146597666;10280;309043830;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor (unknown origin) expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;5-[(4-fluorobenzoyl)amino]-N,N-dimethyl-1-propyl-4,5,6,7-tetrahydroindazole-3-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;45.0;;;;CCCN1C2=C(CC(CC2)NC(=O)C3=CC=C(C=C3)F)C(=N1)C(=O)N(C)C
6966;372120968;10.0;1681775;103189261;5284603;10280;330649470;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of 3H](+)-pentazocine from human sigma1 receptor expressed in HEK293 cell membranes incubated for 120 mins by liquid scintillation counting method;Oxycodone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O
6967;372356138;10.0;1726849;461526073;141195383;10280;342231650;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]pentazocine from human sigma 1 receptor expressed in HEK293 cell membrane incubated for 2 hrs by liquid scintillation counting method;6-(2-Morpholin-4-ylethoxy)chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1COCCN1CCOC2=CC3=C(C=C2)OC=CC3=O
6968;380264145;10.0;1811100;103189261;5284603;10280;342361900;Confirmatory;20230314;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma-1 receptor transfected in HEK293 membranes incubated for 120 mins measured by microBeta scintillation counter method;Oxycodone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O
6969;380299325;10.0;1819827;475983604;166628082;10280;354503790;Confirmatory;20230314;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-Citalopram from sigma-1 receptor (unknown origin) expressed in HEK cell membrane incubated for 2 hrs by liquid scintillation counter analysis;(1S,9S,10S)-17-methyl-4-(1,1,2,2,2-pentafluoroethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)C(C(F)(F)F)(F)F
6970;380512642;10.0;1846430;482083813;117651348;10280;338263220;Confirmatory;20230629;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(5AR,8aR)-tert-butyl 3-(2-fluorophenyl)-5a,6,8,8a-tetrahydropyrrolo[3,4-b][1,2,3]triazolo[1,5-d][1,4]oxazine-7(4H)-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC(=O)N1C[C@@H]2[C@@H](C1)OCC3=C(N=NN23)C4=CC=CC=C4F
6971;380512646;10.0;1846430;482079438;168292590;10280;338263220;Confirmatory;20230629;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma1 receptor transfected in HEK293 cell membranes assessed as inhibition constant measured after 120 mins by liquid scintillation counting analysis;(2R,6R)-4-[(4-fluorophenyl)methyl]-10-pyrimidin-2-yl-7-oxa-1,4,11,12-tetrazatricyclo[7.3.0.02,6]dodeca-9,11-diene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1[C@@H]2[C@@H](CN1CC3=CC=C(C=C3)F)OCC4=C(N=NN24)C5=NC=CC=N5
6972;380581323;10.0;1861723;482086594;43043710;10280;357249250;Confirmatory;20230629;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay;N-[3-[benzyl(methyl)amino]propyl]furan-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC=CO1)CC2=CC=CC=C2
6973;380581640;10.0;1861723;482076266;168290278;10280;357249250;Confirmatory;20230629;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay;N-[3-[(3,4-dimethoxyphenyl)methyl-methylamino]propyl]furan-2-carboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(CCCNC(=O)C1=CC=CO1)CC2=CC(=C(C=C2)OC)OC
6974;388740216;10.0;1797293;386051322;118283022;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 80;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCOCC4
6975;388740224;10.0;1797293;386051320;118283021;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 78;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)NCCN(C)C
6976;388740263;10.0;1797293;386051318;118282845;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 75;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)C(=O)O)O
6977;388740376;10.0;1797293;386051323;118283077;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 81;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)CCN(C)C
6978;388740378;10.0;1797293;386051300;118278067;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 56;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)C(=O)O
6979;388740420;10.0;1797293;386051327;118283004;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 85;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)CCO
6980;388740465;10.0;1797293;386051319;118278079;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';Isoindoline derivative 1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCNCC4
6981;388740466;10.0;1797293;386051324;118283000;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 82;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCN(CC4)C
6982;388740472;10.0;1797293;386051326;118283024;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 84;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)NCCOC
6983;388740578;10.0;1797293;386051325;123982988;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 83;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)N1CCN(CC1)C(=O)C2=CC=CC3=C2CN(C3)C(C)(C)CCC4=CC(=C(C=C4)O)OC
6984;388740623;10.0;1797293;386051303;118282980;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 59;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)C)O
6985;388740638;10.0;1797293;386051321;118283019;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 79;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)NCCO
6986;388740707;10.0;1797293;386051328;118282913;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay 2 from US Patent US10207991: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 86;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)CCOC
6987;388878947;10.0;1797475;386051320;118283021;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 78;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)NCCN(C)C
6988;388878955;10.0;1797475;386051322;118283022;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 80;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCOCC4
6989;388879042;10.0;1797475;386051318;118282845;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 75;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)C(=O)O)O
6990;388879047;10.0;1797475;386051323;118283077;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 81;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)CCN(C)C
6991;388879193;10.0;1797475;386051300;118278067;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 56;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)C(=O)O
6992;388879263;10.0;1797475;386051327;118283004;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 85;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)CCO
6993;388879266;10.0;1797475;386051324;118283000;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 82;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCN(CC4)C
6994;388879272;10.0;1797475;386051326;118283024;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 84;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)NCCOC
6995;388879396;10.0;1797475;386051319;118278079;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';Isoindoline derivative 1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCNCC4
6996;388879449;10.0;1797475;386051303;118282980;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 59;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)C)O
6997;388879452;10.0;1797475;386051325;123982988;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 83;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)N1CCN(CC1)C(=O)C2=CC=CC3=C2CN(C3)C(C)(C)CCC4=CC(=C(C=C4)O)OC
6998;388879571;10.0;1797475;386051321;118283019;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 79;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)NCCO
6999;388879579;10.0;1797475;386051328;118282913;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Radioligand Binding Assay from US Patent US9796672: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 86;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)CCOC
7000;389383439;10.0;1804286;386051320;118283021;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 78;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)NCCN(C)C
7001;389383447;10.0;1804286;386051322;118283022;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 80;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCOCC4
7002;389383654;10.0;1804286;386051300;118278067;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 56;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC(F)(F)F)N2CC3=C(C2)C(=CC=C3)C(=O)O
7003;389383656;10.0;1804286;386051323;118283077;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 81;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)CCN(C)C
7004;389383659;10.0;1804286;386051318;118282845;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 75;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)C(=O)O)O
7005;389383758;10.0;1804286;386051324;118283000;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 82;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCN(CC4)C
7006;389383763;10.0;1804286;386051319;118278079;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';Isoindoline derivative 1;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N4CCNCC4
7007;389383767;10.0;1804286;386051327;118283004;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 85;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)CCO
7008;389383768;10.0;1804286;386051326;118283024;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 84;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)NCCOC
7009;389383808;10.0;1804286;386051325;123982988;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 83;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)N1CCN(CC1)C(=O)C2=CC=CC3=C2CN(C3)C(C)(C)CCC4=CC(=C(C=C4)O)OC
7010;389383879;10.0;1804286;386051303;118282980;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 59;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)OC1=C(C=CC(=C1)CCC(C)(C)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)C)O
7011;389383936;10.0;1804286;386051321;118283019;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 79;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)NCCO
7012;389383944;10.0;1804286;386051328;118282913;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;;BindingDB;Competitive Radioligand Binding Assay from US Patent US10611728: 'Isoindoline compositions and methods for treating neurodegenerative disease';US10207991, Ex. Cpd. No. 86;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(CCC1=CC(=C(C=C1)O)OC)N2CC3=C(C2)C(=CC=C3)C(=O)N(C)CCOC
7013;389536399;10.0;1805702;459092157;122576801;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;>;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';benzyl (1R,8R)-5-chloro-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene-9-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN([C@@H]2C[C@@H]1C3=C2C=C(C=C3)Cl)C(=O)OCC4=CC=CC=C4
7014;389536401;10.0;1805702;459092172;141643613;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;>;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';(1R,8R)-9-(benzenesulfonyl)-5-(4-methylpiperazin-1-yl)-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)C2=CC3=C(C=C2)[C@@H]4CCN([C@@H]3C4)S(=O)(=O)C5=CC=CC=C5
7015;389536407;10.0;1805702;459092158;122576796;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;>;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';benzyl (1R,8R)-5-morpholin-4-yl-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene-9-carboxylate;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN([C@@H]2C[C@@H]1C3=C2C=C(C=C3)N4CCOCC4)C(=O)OCC5=CC=CC=C5
7016;389536476;10.0;1805702;459092170;162370615;10280;;Confirmatory;20230307;0;0;Inactive;Q99720;Ki;>;BindingDB;Receptor Binding Assays from US Patent US11046670: 'Piperazinyl norbenzomorphan compounds and methods for using the same';(1R,8R)-5-(4-methylpiperazin-1-yl)-9-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCN(CC1)C2=CC3=C(C=C2)[C@@H]4CCN[C@@H]3C4
7017;389712989;10.0;1919146;476002743;166637126;10280;;Confirmatory;20231017;0;0;Inactive;Q99720;IC50;>;BindingDB;Receptor Binding Assay from US Patent US11535596: 'Analogs of dextromethorphan with balanced receptor activities';(1S,9S)-5-bromo-4-methoxy-16-methyl-16-azatetracyclo[7.5.2.01,10.02,7]hexadeca-2,4,6-triene;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C[C@@]23CCCCC2[C@@H]1CC4=CC(=C(C=C34)OC)Br
7018;409047909;10.0;1794447;440204884;145925651;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;2-[1-[2-(5-Chloro-2-fluorophenyl)-5-methylpyridin-4-yl]-2-oxoimidazo[4,5-c]pyridin-3-yl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CN=C(C=C1N2C3=C(C=NC=C3)N(C2=O)CC(=O)N)C4=C(C=CC(=C4)Cl)F
7019;409047910;10.0;1794447;440204884;145925651;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;;ChEMBL;GPCRScan assay: inhibition of Sigma 1;2-[1-[2-(5-Chloro-2-fluorophenyl)-5-methylpyridin-4-yl]-2-oxoimidazo[4,5-c]pyridin-3-yl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CN=C(C=C1N2C3=C(C=NC=C3)N(C2=O)CC(=O)N)C4=C(C=CC(=C4)Cl)F
7020;100385642;10.1;204153;103378195;11758674;10280;117841480;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Sigma opioid receptor type 1 affinity in guinea pig brain by employing [3H](+)-pentazocine as radioligand.;1'-Phenyl-3-methoxy-3,4-dihydrospiro[1H-2-benzopyran-1,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1CC2=CC=CC=C2C3(O1)CCN(CC3)C4=CC=CC=C4
7021;342804597;10.32;1127667;136931086;56656039;10280;237346340;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 opioid receptor (unknown origin);2,3,4-trimethoxy-N-[4-(7-nitro-3,4-dihydro-1H-isoquinolin-2-yl)butyl]benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=C(C(=C(C=C1)C(=O)NCCCCN2CCC3=C(C2)C=C(C=C3)[N+](=O)[O-])OC)OC
7022;342804584;10.4;1127667;103252318;11338096;10280;237346340;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 opioid receptor (unknown origin);N-[2-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-2-methoxy-5-methyl-benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=C(C=C1)OC)C(=O)NCCN2CCC3=CC(=C(C=C3C2)OC)OC
7023;100708112;10.412;204146;103252318;11338096;10280;146843270;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma opioid receptor of guiena pig brain membrane;N-[2-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-2-methoxy-5-methyl-benzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC1=CC(=C(C=C1)OC)C(=O)NCCN2CCC3=CC(=C(C=C3C2)OC)OC
7024;100617219;10.48;204444;103336926;75994;10280;16627250;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membranes using [3H]DTG as radioligand;1-Benzylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1)CC2=CC=CC=C2
7025;100471337;10.7;204459;103298990;9797984;10280;82952130;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;1,3-Bis(1-naphthyl)-1,3-dimethylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(C1=CC=CC2=CC=CC=C21)C(=N)N(C)C3=CC=CC4=CC=CC=C43
7026;100471330;11.0;204459;103298525;10453690;10280;82952130;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;1,3-Bis(1-naphthyl)-1-phenyl-3-methylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(C1=CC=CC2=CC=CC=C21)C(=N)N(C3=CC=CC=C3)C4=CC=CC5=CC=CC=C54
7027;255027928;11.047;625223;123086577;55245;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mifepristone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O
7028;100617248;11.2;204444;103169108;1346;10280;16627250;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membranes using [3H]DTG as radioligand;1-(2-Methoxyphenyl)piperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC=CC=C1N2CCNCC2
7029;100617247;11.36;204444;103336754;762654;10280;16627250;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membranes using [3H]DTG as radioligand;1-Benzoylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1)C(=O)C2=CC=CC=C2
7030;100617261;11.44;204444;103169114;7096;10280;16627250;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membranes using [3H]DTG as radioligand;1-Phenylpiperazine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1CN(CCN1)C2=CC=CC=C2
7031;340019687;11.5;752428;174511989;49853672;10280;236018160;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;N-cyclohexyl-2-piperazin-1-ylhexanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCC(C(=O)NC1CCCCC1)N2CCNCC2
7032;340019674;11.6;752428;174517070;49854189;10280;236018160;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;2-[4-(cyclohexanecarbonyl)piperazin-1-yl]-N-(2-cyclooctylethyl)propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C(=O)NCCC1CCCCCCC1)N2CCN(CC2)C(=O)C3CCCCC3
7033;340019667;11.8;752428;174511993;49853983;10280;236018160;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;N-[(2R)-3,3-dimethylbutan-2-yl]-2-(4-propan-2-yl-1,4-diazepan-1-yl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](C(C)(C)C)NC(=O)CN1CCCN(CC1)C(C)C
7034;363665328;11.843;1415967;404711911;74767288;10280;301088350;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(1-Methylimidazol-4-yl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1C=C(N=C1)C2=C3C=NN(C3=NC=N2)CCN4CCCCC4
7035;372355909;12.1;1726849;461558338;141195326;10280;342231650;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Displacement of [3H]pentazocine from human sigma 1 receptor expressed in HEK293 cell membrane incubated for 2 hrs by liquid scintillation counting method;6-[2-(Diethylamino)ethoxy]chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCN(CC)CCOC1=CC2=C(C=C1)OC=CC2=O
7036;380724090;12.4;1895500;482047729;9727;10280;342640890;Confirmatory;20230629;0;0;Unspecified;Q99720;Kd;=;ChEMBL;Binding affinity to sigma 1 receptor (unknown origin) assessed as dissociation constant by competitive binding assay;N-Methyltyramine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CNCCC1=CC=C(C=C1)O
7037;100708110;12.9;204146;103252210;10458892;10280;146843270;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to Sigma opioid receptor of guiena pig brain membrane;5-bromo-N-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-2,3-dimethoxybenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC(=CC(=C1OC)C(=O)NCCCCN2CCC3=CC(=C(C=C3C2)OC)OC)Br
7038;237864819;12.9;619421;103252210;10458892;10280;218999310;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Binding affinity to sigma 1 receptor;5-bromo-N-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-2,3-dimethoxybenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC(=CC(=C1OC)C(=O)NCCCCN2CCC3=CC(=C(C=C3C2)OC)OC)Br
7039;342804593;12.9;1127667;103252210;10458892;10280;237346340;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Binding affinity to sigma-1 opioid receptor (unknown origin);5-bromo-N-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-2,3-dimethoxybenzamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=CC(=CC(=C1OC)C(=O)NCCCCN2CCC3=CC(=C(C=C3C2)OC)OC)Br
7040;100471679;13.0;204459;103299047;10446949;10280;82952130;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;=;ChEMBL;Tested in vitro for the concentration required to inhibit specific [3H]DTG radioligand binding to sigma receptor on guinea pig brain membrane;1-(3-Aminophenyl)-3-(1-naphthyl)-3-methylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN(C1=CC=CC2=CC=CC=C21)C(=NC3=CC=CC(=C3)N)N
7041;363666000;13.803;1415967;404716032;71226084;10280;301088350;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(1H-imidazol-1-yl)-1-(2-(piperidin-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=C(C=N2)C(=NC=N3)N4C=CN=C4
7042;100444168;14.2;204470;103215587;44285702;10280;13158690;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;=;ChEMBL;Potency at the sigma binding site was determined in radioligand;2-Phenyl-6-[6-(2-pyrimidin-2-yl-piperazin-1-yl)-hexyloxy]-chromen-4-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CN(C(CN1)C2=NC=CC=N2)CCCCCCOC3=CC4=C(C=C3)OC(=CC4=O)C5=CC=CC=C5
7043;100617222;14.28;204444;103336949;10632134;10280;16627250;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma receptor in guinea pig brain membranes using [3H]DTG as radioligand;4-(2-Methoxyphenyl)piperidin-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;COC1=CC=CC=C1C2(CCNCC2)O
7044;340019681;15.2;752428;174501675;49853583;10280;236018160;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;2-(1,4-diazepan-1-yl)-N-methyl-N-pentylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCCN(C)C(=O)CN1CCCNCC1
7045;340019686;15.2;752428;174501670;73350500;10280;236018160;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;2-(4-methyl-1,4-diazepan-1-yl)-N-pentan-3-ylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(CC)NC(=O)CN1CCCN(CC1)C
7046;340019670;15.8;752428;174522231;49853781;10280;236018160;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;2-piperazin-1-yl-N-[(1S,2S,3S,5R)-2,6,6-trimethyl-3-bicyclo[3.1.1]heptanyl]acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1[C@@H]2C[C@@H](C2(C)C)C[C@@H]1NC(=O)CN3CCNCC3
7047;100440011;16.3;204464;103384207;3081049;10280;14696990;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Compound was evaluated for its ability to displace [3H](+)-pentazocine from sigma receptor in Guinea pig brain;3-Phenyl-3-(N-piperidinyl)bicyclo(3.1.0)hexane;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)C2(C[C@H]3C[C@H]3C2)C4=CC=CC=C4
7048;340019683;16.3;752428;174517050;49853676;10280;236018160;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;N-butyl-2-piperazin-1-yl-N-propylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCCCN(CCC)C(=O)CN1CCNCC1
7049;100468791;16.6;204469;103340563;44342934;10280;79325690;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Inhibition against sigma receptor using displacement of 3 nM [3H]pentazocine in homogenate of guinea pig brain cerebellum;(1S,13R)-10-ethyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;CCN1CC[C@]2([C@H](C1CC3=C2C=C(C=C3)O)C)C
7050;340019676;18.0;752428;174506865;49853986;10280;236018160;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;3-(4-acetyl-1,4-diazepan-1-yl)-N-cycloheptylpropanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(=O)N1CCCN(CC1)CCC(=O)NC2CCCCCC2
7051;363665767;18.0;1415921;404707481;71226198;10280;301088340;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;1-(2-(piperidin-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=NC=NC(=C3C=N2)N
7052;100470634;18.1;204469;103340515;44342910;10280;79325690;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Inhibition against sigma receptor using displacement of 3 nM [3H]pentazocine in homogenate of guinea pig brain cerebellum;(6S)-3-Methyl-6alpha,11alpha-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;20370;Cerebellum;C[C@H]1C2CC3=C([C@]1(CCN2C)C)C=C(C=C3)O
7053;340019625;18.8;752428;174511990;49853674;10280;236018160;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;N-(3,3-dimethylbutyl)-2-piperazin-1-ylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)CCNC(=O)CN1CCNCC1
7054;100385649;19.8;204153;103378082;11064325;10280;117841480;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Sigma opioid receptor type 1 affinity in guinea pig brain by employing [3H](+)-pentazocine as radioligand.;3-Methoxy-3,4-dihydrospiro[1H-2-benzopyran-1,4'-piperidine];SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1CC2=CC=CC=C2C3(O1)CCNCC3
7055;100741791;20.0;203992;103677381;45264515;10280;;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Binding affinity for sigma receptor in guinea pig brain membrane using radiolabeled ligand [3H]-(+)-SKF- 10,047 was determined;"3-Phenyl-8-prop-2-ynyl-1-oxa-8-azaspiro[4.5]dec-2-en-4-one;hydrochloride";SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C#CCN1CCC2(CC1)C(=O)C(=CO2)C3=CC=CC=C3.Cl
7056;340019668;21.1;752428;174501674;49853886;10280;236018160;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;2-[4-(cyclohexanecarbonyl)piperazin-1-yl]-N-(3,3-dimethylbutyl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)CCNC(=O)CN1CCN(CC1)C(=O)C2CCCCC2
7057;255026032;21.109;625223;103212333;3198;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Econazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl
7058;255011008;21.3;625223;124966219;15032;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Pregnenolone carbonitrile;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC(=O)[C@H]1[C@@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)C#N
7059;363665659;23.832;1415967;404710562;74767290;10280;301088350;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;2-(1-(2-(piperidin-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl)oxazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(CC1)CCN2C3=NC=NC(=C3C=N2)C4=NC=CO4
7060;363665656;25.77;1415967;404715571;71226177;10280;301088350;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;N-methyl-1-[1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidin-4-yl]pyrrolidin-3-amine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CNC1CCN(C1)C2=NC=NC3=C2C=NN3CCN4CCCCC4
7061;255027927;26.28;625223;123086577;55245;10280;;Confirmatory;20240503;0;0;Unspecified;Q99720;IC50;=;ChEMBL;DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol);Mifepristone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O
7062;100298516;26.7;239347;103398821;11743300;10280;160332550;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;2-[[Amino(benzylamino)methylene]amino]-4-(1H-indol-2-yl)thiazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1=CC=C(C=C1)CN=C(N)NC2=NC(=CS2)C3=CC4=CC=CC=C4N3
7063;340019677;27.2;752428;160687994;68835;10280;236018160;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;Esaprazole;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCC(CC1)NC(=O)CN2CCNCC2
7064;342824633;30.0;1120674;242615199;90643787;10280;;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;=;ChEMBL;Inhibition of sigma-1 receptor (unknown origin);(1S,5R)-3-[5-(1-adamantylcarbamoyl)-6-methylsulfanylpyridin-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxylic acid;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CSC1=C(C=CC(=N1)N2C[C@@H]3[C@H](C2)C3C(=O)O)C(=O)NC45CC6CC(C4)CC(C6)C5
7065;100440592;31.0;229192;103167211;6005;10280;14696970;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Inhibition of specific binding of [3H]NANM of sigma binding site in Guinea pig brain membranes;Apomorphine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CN1CCC2=C3[C@H]1CC4=C(C3=CC=C2)C(=C(C=C4)O)O
7066;112851457;31.8;204465;103215106;44285482;10280;79325400;Confirmatory;20240503;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Inhibition of [3H](+)-pentazocine binding to sigma receptor of guinea pig brain;5-(3-Hydroxy-phenyl)-2-methyl-2-aza-bicyclo[3.3.1]nonan-7-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CCC2(CC1CC(=O)C2)C3=CC(=CC=C3)O
7067;363665996;32.731;1415921;404714150;71223275;10280;301088340;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;N-[1-(2-pyrrolidin-1-ylethyl)pyrazolo[3,4-d]pyrimidin-4-yl]cyclopropanecarboxamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1CCN(C1)CCN2C3=NC=NC(=C3C=N2)NC(=O)C4CC4
7068;100298511;35.6;239347;103333099;5753;10280;160332550;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;Corticosterone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@H]4C(=O)CO)C)O
7069;363665333;38.293;1415967;404706910;145986754;10280;301088350;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from recombinant human sigma1 receptor expressed in HEK293 cell membranes after 120 mins by microbeta scintillation counting method;4-(6-Methoxypyridin-3-yl)-1-(2-piperidin-1-ylethyl)pyrazolo[3,4-d]pyrimidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;COC1=NC=C(C=C1)C2=C3C=NN(C3=NC=N2)CCN4CCCCC4
7070;363665985;42.923;1415921;404714957;71225600;10280;301088340;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from human sigma 1 receptor transfected in HEK293 cells after 120 mins by liquid scintillation counting method;2,2-dimethyl-N-[1-[2-(4-methylpiperazin-1-yl)ethyl]pyrazolo[3,4-d]pyrimidin-4-yl]propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)(C)C(=O)NC1=C2C=NN(C2=NC=N1)CCN3CCN(CC3)C
7071;100619106;46.4;203990;103185156;32893;10280;18482950;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Binding affinity towards sigma opioid receptor in guinea pig cerebral homogenate using [3H]DTG as radioligand;Levamfetamine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H](CC1=CC=CC=C1)N
7072;340019671;86.8;752428;174511991;73353481;10280;236018160;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;=;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;N-[(1S,2S,4R)-2-bicyclo[2.2.1]heptanyl]-2-piperazin-1-ylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C1C[C@H]2C[C@@H]1C[C@@H]2NC(=O)CN3CCNCC3
7073;100297846;100.0;239347;103458173;10098;10280;160332550;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;Jervine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1C[C@@H]2[C@H]([C@H]([C@]3(O2)CC[C@H]4[C@@H]5CC=C6C[C@H](CC[C@@]6([C@H]5C(=O)C4=C3C)C)O)C)NC1
7074;100298499;100.0;239347;103458362;44398137;10280;160332550;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand;(3S,3'R,3'aS,6'S,6aS,6bS,7'aR,9R,11aS,11bR)-3',6',7'a,10,11b-pentamethylspiro[2,3,4,6,6a,6b,7,8,11,11a-decahydro-1H-benzo[a]fluorene-9,2'-3,3a,4,5,6,7-hexahydrofuro[3,2-b]pyridine]-3-ol;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C[C@H]1C[C@@]2([C@H]([C@H]([C@]3(O2)CC[C@H]4[C@@H]5CC=C6C[C@H](CC[C@@]6([C@H]5CC4=C3C)C)O)C)NC1)C
7075;100440591;100.0;229192;103170037;5284596;10280;14696970;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Inhibition of specific binding of [3H]NANM of sigma binding site in Guinea pig brain membranes;Naloxone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O
7076;100441641;100.0;229186;103170037;5284596;10280;14696970;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Inhibition of specific binding of [125I]-PIPAG to sigma binding site in Guinea pig brain membranes;Naloxone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O
7077;100467872;100.0;204005;103169185;5288826;10280;79325350;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;In vivo binding affinity against sigma Opioid receptor was measured by using labeled ligand [3H]-SKF- 10,047 (1 nM);Morphine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O
7078;100467873;100.0;204005;103170037;5284596;10280;79325350;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;>;ChEMBL;In vivo binding affinity against sigma Opioid receptor was measured by using labeled ligand [3H]-SKF- 10,047 (1 nM);Naloxone;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O
7079;100613257;100.0;204440;103283110;14657;10280;19752750;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;In vitro inhibitory activity against [3H]-DTG in guinea pig brain membrane homogenates;n,n-Diphenylguanidine;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;C1=CC=C(C=C1)N(C2=CC=CC=C2)C(=N)N
7080;100614374;100.0;203986;103672004;14122788;10280;19752750;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;In vitro inhibitory activity against [3H]DTG binding to Sigma opioid receptor in guinea pig brain membrane homogenates;N,N'-dimethyl guanidine hydrogen bromide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;9550;Brain;CNC(=NC)N.Br
7081;340019622;100.0;752428;174511987;100826;10280;236018160;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;N-Isopropyl-1-piperazineacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CC(C)NC(=O)CN1CCNCC1
7082;340019623;100.0;752428;174517051;49853777;10280;236018160;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;N-pentan-3-yl-2-(4-propanoylpiperazin-1-yl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(CC)NC(=O)CN1CCN(CC1)C(=O)CC
7083;340019669;100.0;752428;174522230;49853580;10280;236018160;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;N-(2-methylbutyl)-2-(4-propanoylpiperazin-1-yl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(C)CNC(=O)CN1CCN(CC1)C(=O)CC
7084;340019673;100.0;752428;174506862;49853778;10280;236018160;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;N-cyclohexyl-2-(4-propanoylpiperazin-1-yl)acetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N1CCN(CC1)CC(=O)NC2CCCCC2
7085;340019685;100.0;752428;174522232;49853981;10280;236018160;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;N-cyclopentyl-2-(4-propanoylpiperazin-1-yl)propanamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CCC(=O)N1CCN(CC1)C(C)C(=O)NC2CCCC2
7086;340020967;100.0;752428;174512010;43267406;10280;236018160;Confirmatory;20220830;0;0;Unspecified;Q99720;IC50;>;ChEMBL;Binding affinity to sigma1 receptor (unknown origin) by radioligand displacement assay;N-cyclopentyl-N-methyl-2-piperazin-1-ylacetamide;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;;;;;CN(C1CCCC1)C(=O)CN2CCNCC2
7087;334041131;1700.0;728301;164128735;71601216;10280;234702450;Confirmatory;20220830;0;0;Unspecified;Q99720;Ki;=;ChEMBL;Displacement of [3H]-(+)-pentazocine from sigma1 receptor in human jurkat cell membrane after 2 hrs by liquid scintillation counting analysis in presence of haloperidol;5-(1,2-Dithiolan-3-YL)-1-(4-phenylpiperazin-1-YL)pentan-1-one;SIGMAR1 - sigma non-opioid intracellular receptor 1 (human);/gene/10280;;Q99720;9606;56.0;;;;C1CSSC1CCCCC(=O)N2CCN(CC2)C3=CC=CC=C3
